PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Luck, AN; Yuan, XJ; Voronin, D; Slatko, BE; Hamza, I; Foster, JM				Luck, Ashley N.; Yuan, Xiaojing; Voronin, Denis; Slatko, Barton E.; Hamza, Iqbal; Foster, Jeremy M.			Heme acquisition in the parasitic filarial nematode Brugia malayi	FASEB JOURNAL			English	Article						iron metabolism; infectious disease; parasite metabolism	SACCHAROMYCES-CEREVISIAE; IRON-UPTAKE; WOLBACHIA-ENDOSYMBIONT; CAENORHABDITIS-ELEGANS; FERRIC REDUCTASE; IN-VITRO; RNA-SEQ; PROTEIN; HOMEOSTASIS; QUANTITATION	Nematodes lack a heme biosynthetic pathway and must acquire heme from exogenous sources. Given the indispensable role of heme, this auxotrophy may be exploited to develop drugs that interfere with heme uptake in parasites. Although multiple heme-responsive genes (HRGs) have been characterized within the free-living nematode Caenorhabditis elegans, we have undertaken the first study of heme transport in Brugia malayi, a causative agent of lymphatic filariasis. Through functional assays in yeast, as well as heme analog, RNAi, and transcriptomic experiments, we have shown that the heme transporter B. malayi HRG-1 (BmHRG-1) is indeed functional in B. malayi. In addition, BmHRG-1 localizes both to the endocytic compartments and cell membrane when expressed in yeast cells. Transcriptomic sequencing revealed that BmHRG-1, BmHRG-2, and BmMRP-5 (all orthologs of HRGs in C. elegans) are down-regulated in heme-treated B. malayi, as compared to non-heme-treated control worms. Likely because of short gene lengths, multiple exons, other HRGs in B. malayi (BmHRG-3-6) remain unidentified. Although the precise mechanisms of heme homeostasis in a nematode with the ability to acquire heme remains unknown, this study clearly demonstrates that the filarial nematode B. malayi is capable of transporting exogenous heme.	[Luck, Ashley N.; Slatko, Barton E.; Foster, Jeremy M.] New England Biolabs Inc, Genome Biol Div, Ipswich, MA USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Voronin, Denis] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	New England Biolabs; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; New York Blood Center	Foster, JM (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	foster@neb.com	Yuan, Xiaojing/V-6882-2019	Yuan, Xiaojing/0000-0002-0969-5748; Hamza, Iqbal/0000-0003-0045-0610	New England BioLabs, Inc.; New York Blood Center; U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK85035, R01DK074797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797, R01DK085035] Funding Source: NIH RePORTER	New England BioLabs, Inc.; New York Blood Center; U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Donald Comb, William Jack, Clotilde Carlow, and James Ellard (New England BioLabs, Inc.) for their continued scientific support. This work was supported by New England BioLabs, Inc., New York Blood Center intramural funding, and U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants R01DK85035 and R01DK074797 (to I.H.). The authors declare no conflicts of interest.	Adams A., 2000, METHODS YEAST GENETI; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews S., 2010, FASTQC QUALITY CONTR; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; CHEN SN, 1979, PARASITOLOGY, V78, P343, DOI 10.1017/S0031182000051209; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; COMLEY JCW, 1989, INT J PARASITOL, V19, P77, DOI 10.1016/0020-7519(89)90024-6; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; Flannery AR, 2013, CURR OPIN MICROBIOL, V16, P716, DOI 10.1016/j.mib.2013.07.018; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kelson AB, 2013, CURR OPIN PHARMACOL, V13, P707, DOI 10.1016/j.coph.2013.07.001; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Landmann F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-16; Luck AN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2083-2; Luck AN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1041; Munn Edward A., 2002, P211; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; RUTILI G, 1977, ACTA PHYSIOL SCAND, V99, P1, DOI 10.1111/j.1748-1716.1977.tb10345.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Scott AL, 2000, TROP MED SCI PRACT, V1, P5; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sinclair J, 2015, BIOMETALS, V28, P481, DOI 10.1007/s10534-015-9841-0; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Sun L, 2003, J IMMUNOL METHODS, V282, P45, DOI 10.1016/j.jim.2003.07.005; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Taylor MJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-7; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Townson Simon, 2006, Filaria J, V5, P4, DOI 10.1186/1475-2883-5-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WHO, 2010, PROGR REP 2000 2009; Wu B, 2013, P NATL ACAD SCI USA, V110, P7748, DOI 10.1073/pnas.1304049110; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785	58	9	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3501	3514		10.1096/fj.201600603R	http://dx.doi.org/10.1096/fj.201600603R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27363426	Green Published, hybrid			2022-12-26	WOS:000384329800020
J	Hosaka, T; Yoshizawa, S; Nakajima, Y; Ohsawa, N; Hato, M; DeLong, EF; Kogure, K; Yokoyama, S; Kimura-Someya, T; Iwasaki, W; Shirouzu, M				Hosaka, Toshiaki; Yoshizawa, Susumu; Nakajima, Yu; Ohsawa, Noboru; Hato, Masakatsu; DeLong, Edward F.; Kogure, Kazuhiro; Yokoyama, Shigeyuki; Kimura-Someya, Tomomi; Iwasaki, Wataru; Shirouzu, Mikako			Structural Mechanism for Light-driven Transport by a New Type of Chloride Ion Pump, Nonlabens marinus Rhodopsin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; membrane protein; protein crystallization; structure-function; tertiary structure; cell-free protein synthesis; chloride ion pump; chloride ion-releasing residues; microbial rhodopsin	PROTON PUMP; SCHIFF-BASE; BACTERIORHODOPSIN; HALORHODOPSIN; PROTEIN; SYSTEM; MEMBRANE	The light-driven inward chloride ion-pumping rhodopsin Nonlabens marinus rhodopsin-3 (NM-R3), from a marine flavobacterium, belongs to a phylogenetic lineage distinct from the halorhodopsins known as archaeal inward chloride ion-pumping rhodopsins. NM-R3 and halorhodopsin have distinct motif sequences that are important for chloride ion binding and transport. In this study, we present the crystal structure of a new type of light-driven chloride ion pump, NM-R3, at 1.58 resolution. The structure revealed the chloride ion translocation pathway and showed that a single chloride ion resides near the Schiff base. The overall structure, chloride ion-binding site, and translocation pathway of NM-R3 are different from those of halorhodopsin. Unexpectedly, this NM-R3 structure is similar to the crystal structure of the light-driven outward sodium ion pump, Krokinobacter eikastus rhodopsin 2. Structural and mutational analyses of NM-R3 revealed that most of the important amino acid residues for chloride ion pumping exist in the ion influx region, located on the extracellular side of NM-R3. In contrast, on the opposite side, the cytoplasmic regions of K. eikastus rhodopsin 2 were reportedly important for sodium ion pumping. These results provide new insight into ion selection mechanisms in ion pumping rhodopsins, in which the ion influx regions of both the inward and outward pumps are important for their ion selectivities.	[Hosaka, Toshiaki; Ohsawa, Noboru; Hato, Masakatsu; Kimura-Someya, Tomomi; Shirouzu, Mikako] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan; [Yoshizawa, Susumu; Nakajima, Yu; Kogure, Kazuhiro; Iwasaki, Wataru] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan; [DeLong, Edward F.] Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA; [Iwasaki, Wataru] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan	RIKEN; RIKEN; University of Tokyo; University of Hawaii System; University of Tokyo	Shirouzu, M (corresponding author), RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan.; Iwasaki, W (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan.; Iwasaki, W (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan.	iwasaki@bs.s.u-tokyo.ac.jp; mikako.shirouzu@riken.jp	Nakajima, Yu/AAY-7947-2020; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016; Iwasaki, Wataru/O-4917-2014; Kimura-Someya, Tomomi/C-4169-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Iwasaki, Wataru/0000-0002-9169-9245; Kimura-Someya, Tomomi/0000-0003-2232-1801; yoshizawa, susumu/0000-0001-9667-6010	Canon Foundation; Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development; CREST, Japan Science and Technology Agency; Japan Society for the Promotion of Science KAKENHI [15H02800, 15K14601, 221S0002, 15K18523]; Grants-in-Aid for Scientific Research [15K18523] Funding Source: KAKEN	Canon Foundation(Canon Foundation); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Canon Foundation (to W. I.), the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology and Japan Agency for Medical Research and Development (to S. Yokoyama), and CREST, Japan Science and Technology Agency (to K. K. and W. I.), and by Japan Society for the Promotion of Science KAKENHI Grants 15H02800 and 15K14601 (to S. Yoshizawa), 221S0002 (to W. I.) and 15K18523 (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Furuse M, 2015, ACTA CRYSTALLOGR D, V71, P2203, DOI 10.1107/S1399004715015722; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Hato Masakatsu, 2014, Journal of Structural and Functional Genomics, V15, P165, DOI 10.1007/s10969-014-9187-9; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kubo M, 2009, PHOTOCHEM PHOTOBIOL, V85, P547, DOI 10.1111/j.1751-1097.2009.00538.x; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Sato M, 2005, BIOCHEMISTRY-US, V44, P4775, DOI 10.1021/bi047500f; Sato M, 2003, BIOPHYS CHEM, V104, P209, DOI 10.1016/S0301-4622(02)00368-X; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Shimono K, 2009, PROTEIN SCI, V18, P2160, DOI 10.1002/pro.230; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	35	29	29	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17488	17495		10.1074/jbc.M116.728220	http://dx.doi.org/10.1074/jbc.M116.728220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365396	Green Published, hybrid			2022-12-26	WOS:000383241300001
J	Mukhopadyay, R; Sudasinghe, N; Schaub, T; Yukl, ET				Mukhopadyay, Roma; Sudasinghe, Nilusha; Schaub, Tanner; Yukl, Erik T.			Heme-independent Redox Sensing by the Heme-Nitric Oxide/Oxygen-binding Protein (H-NOX) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; heme; histidine kinase; nitric oxide; redox signaling	DISULFIDE BOND FORMATION; BIOFILM FORMATION; MOLECULAR CHAPERONE; GUANYLYL CYCLASES; OXIDE; SWITCH; GMP; SENSOR; HSP33; FARNESYLTRANSFERASE	Heme nitric oxide/oxygen (H-NOX)-binding proteins act as nitric oxide (NO) sensors among various bacterial species. In several cases, they act to mediate communal behavior such as biofilm formation, quorum sensing, and motility by influencing the activity of downstream signaling proteins such as histidine kinases (HisKa) in a NO-dependent manner. An H-NOX/HisKa regulatory circuit was recently identified in Vibrio cholerae, and the H-NOX protein has been spectroscopically characterized. However, the influence of the H-NOX protein on HisKa autophosphorylation has not been evaluated. This process may be important for persistence and pathogenicity in this organism. Here, we have expressed and purified the V. cholerae HisKa (HnoK) and H-NOX in its heme-bound (holo) and heme-free (apo) forms. Autophosphorylation assays of HnoK in the presence of H-NOX show that the holoprotein in the Fe(II)-NO and Fe(III) forms is a potent inhibitor of HnoK. Activity of the Fe(III) form and aerobic instability of the Fe(II) form suggested that Vibrio cholerae H-NOX may act as a sensor of the redox state as well as NO. Remarkably, the apoprotein also showed robust HnoK inhibition that was dependent on the oxidation of cysteine residues to form disulfide bonds at a highly conserved zinc site. The importance of cysteine in this process was confirmed by mutagenesis, which also showed that holo Fe(III), but not Fe(II)-NO, H-NOX relied heavily upon cysteine for activation. These results highlight a heme-independent mechanism for activation of V. cholerae H-NOX that implicates this protein as a dual redox/NO sensor.	[Mukhopadyay, Roma; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Sudasinghe, Nilusha; Schaub, Tanner] New Mexico State Univ, Chem Anal & Instrumentat Lab, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University	Yukl, ET (corresponding author), Dept Chem & Biochem, 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Mukhopadhyay, Roma/0000-0002-6248-4763; Schaub, Tanner/0000-0002-5747-4237	Office of the Vice President for Research; Center for Animal Health and Food Safety at New Mexico State University; National Science Foundation [IIA-1301346]	Office of the Vice President for Research; Center for Animal Health and Food Safety at New Mexico State University; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Office of the Vice President for Research and the Center for Animal Health and Food Safety at New Mexico State University and National Science Foundation Grant IIA-1301346. The authors declare that they have no conflicts of interest with the contents of this article.	Allaoui A, 2009, TRENDS MOL MED, V15, P571, DOI 10.1016/j.molmed.2009.10.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barbirz S, 2000, J BIOL CHEM, V275, P18759, DOI 10.1074/jbc.M001089200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson HK, 2010, MOL MICROBIOL, V77, P930, DOI 10.1111/j.1365-2958.2010.07259.x; Cremers CM, 2013, J BIOL CHEM, V288, P26489, DOI 10.1074/jbc.R113.462929; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; Furhrhop J. H., 1975, LAB METHODS PORPHYRI, P804; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Henares BM, 2012, ACS CHEM BIOL, V7, P1331, DOI 10.1021/cb300215t; Herzik MA, 2014, P NATL ACAD SCI USA, V111, pE4156, DOI 10.1073/pnas.1416936111; Hightower KE, 1999, CURR OPIN CHEM BIOL, V3, P176, DOI 10.1016/S1367-5931(99)80030-1; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f; Lucas KA, 2000, PHARMACOL REV, V52, P375; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Plate L, 2013, TRENDS BIOCHEM SCI, V38, P566, DOI 10.1016/j.tibs.2013.08.008; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Price MS, 2007, BIOCHEMISTRY-US, V46, P13677, DOI 10.1021/bi7019035; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rozema DB, 1999, BIOCHEMISTRY-US, V38, P13138, DOI 10.1021/bi990794y; Tennyson AG, 2011, CHEM BIOL, V18, P1211, DOI 10.1016/j.chembiol.2011.09.009; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Tsai AL, 2010, BIOCHEMISTRY-US, V49, P6587, DOI 10.1021/bi1002234; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Wu G, 2013, BIOCHEMISTRY-US, V52, P9432, DOI 10.1021/bi401408x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	39	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17547	17556		10.1074/jbc.M116.733337	http://dx.doi.org/10.1074/jbc.M116.733337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358409	Green Published, hybrid			2022-12-26	WOS:000383241300007
J	Kabil, O; Yadav, V; Banerjee, R				Kabil, Omer; Yadav, Vinita; Banerjee, Ruma			Heme-dependent Metabolite Switching Regulates H2S Synthesis in Response to Endoplasmic Reticulum (ER) Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE-BETA-SYNTHASE; HYDROGEN-SULFIDE; HOMOCYSTEINE METABOLISM; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; GENE-EXPRESSION; FOLIC-ACID; INJURY; HOMOCYSTINURIA; MORTALITY	Substrate ambiguity and relaxed reaction specificity underlie the diversity of reactions catalyzed by the transsulfuration pathway enzymes, cystathionine beta-synthase (CBS) and gamma-cystathionase (CSE). These enzymes either commit sulfur metabolism to cysteine synthesis from homocysteine or utilize cysteine and/or homocysteine for synthesis of H2S, a signaling molecule. We demonstrate that a kinetically controlled heme-dependent metabolite switch in CBS regulates these competing reactions where by cystathionine, the product of CBS, inhibits H2S synthesis by the second enzyme, CSE. Under endoplasmic reticulum stress conditions, induction of CSE and up-regulation of the CBS inhibitor, CO, a product of heme oxygenase-1, flip the operating preference of CSE from cystathionine to cysteine, transiently stimulating H2S production. In contrast, genetic deficiency of CBS leads to chronic stimulation of H2S production. This metabolite switch from cystathionine to cysteine and/or homocysteine renders H2S synthesis by CSE responsive to the known modulators of CBS: S-adenosylmethionine, NO, and CO. Used acutely, it regulates H2S synthesis; used chronically, it might contribute to disease pathology.	[Kabil, Omer; Yadav, Vinita; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kabil, O; Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	omerk@umich.edu; rbanerje@umich.edu	Yadav, Vinita/J-3605-2019; Kabil, Omer/AAJ-1435-2020	Yadav, Vinita/0000-0003-1026-5697; 	National Institutes of Health [HL58984]; American Heart Association [13SDG17070096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL58984 (to R. B.) and American Heart Association Grant 13SDG17070096 (to O. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Garg S, 2006, J BIOL CHEM, V281, P38712, DOI 10.1074/jbc.M606235200; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; LUNDQUIST P, 1980, CLIN CHEM, V26, P1178; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Niu WN, 2015, ANTIOXID REDOX SIGN, V22, P350, DOI 10.1089/ars.2014.5891; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PERRY TL, 1966, SCIENCE, V152, P776, DOI 10.1126/science.152.3723.776; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; ROBILLON JF, 1994, DIABETES METAB, V20, P494; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002	39	40	41	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16418	16423		10.1074/jbc.C116.742213	http://dx.doi.org/10.1074/jbc.C116.742213			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27365395	Green Published, hybrid			2022-12-26	WOS:000380826700001
J	Zhou, XH; DeLucia, M; Ahn, J				Zhou, Xiaohong; DeLucia, Maria; Ahn, Jinwoo			SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; human immunodeficiency virus (HIV); proteasome; protein degradation; viral protein; Western blot	CELL-CYCLE ARREST; VIRUS TYPE-1 VPR; HOLLIDAY JUNCTION RESOLUTION; CUL4-DDB1 UBIQUITIN LIGASE; PRIMATE LENTIVIRUSES; ACCESSORY PROTEINS; G(2) ARREST; PROTEASOMAL DEGRADATION; RECRUITING DCAF1/VPRBP; PREINTEGRATION COMPLEX	Evolutionarily conserved structure-selective endonuclease MUS81 forms a complex with EME1 and further associates with another endonuclease SLX4-SLX1 to form a four-subunit complex of MUS81-EME1-SLX4-SLX1, coordinating distinctive biochemical activities of both endonucleases in DNA repair. Viral protein R (Vpr), a highly conserved accessory protein in primate lentiviruses, was previously reported to bind SLX4 to mediate down-regulation of MUS81. However, the detailed mechanism underlying MUS81 down-regulation is unclear. Here, we report that HIV-1 Vpr down-regulates both MUS81 and its cofactor EME1 by hijacking the host CRL4-DCAF1 E3 ubiquitin ligase. Multiple Vpr variants, from HIV-1 and SIV, down-regulate both MUS81 and EME1. Furthermore, a C-terminally truncated Vpr mutant and point mutants R80A and Q65R, all of which lack G(2) arrest activity, are able to down-regulate MUS81-EME1, suggesting that Vpr-induced G(2) arrest is not correlated with MUS81-EME1 down-regulation. We also show that neither the interaction of MUS81-EME1 with Vpr nor their down-regulation is dependent on SLX4-SLX1. Together, these data provide new insight on a conserved function of Vpr in a host endonuclease down-regulation.	[Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jia12@pitt.edu	Zhou, Xiaohong/B-3416-2012	Zhou, Xiaohong/0000-0003-0519-2550	National Institutes of Health [P50 GM082251, R01 GM116642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251, R01GM116642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grants P50 GM082251 and R01 GM116642 (to J.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amangyeld T, 2014, NUCLEIC ACIDS RES, V42, P5846, DOI 10.1093/nar/gku237; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Berger G, 2015, J VIROL, V89, P230, DOI 10.1128/JVI.02307-14; Blondot ML, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0117-5; Bouzar AB, 2004, VIROLOGY, V326, P47, DOI 10.1016/j.virol.2004.05.016; Cassiday PA, 2015, VIROLOGY, V476, P19, DOI 10.1016/j.virol.2014.11.024; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DePaula-Silva AB, 2015, VIROLOGY, V477, P10, DOI 10.1016/j.virol.2014.12.040; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gummuluru S, 1999, J VIROL, V73, P5422, DOI 10.1128/JVI.73.7.5422-5430.1999; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacquot G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007514; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim K, 2013, MOL CELL, V52, P459, DOI 10.1016/j.molcel.2013.09.017; Kim K, 2012, MOL CELL BIOL, V32, P783, DOI 10.1128/MCB.06037-11; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Matos J, 2014, DNA REPAIR, V19, P176, DOI 10.1016/j.dnarep.2014.03.013; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Nair N, 2014, DNA REPAIR, V24, P131, DOI 10.1016/j.dnarep.2014.08.004; Nakagawa T, 2015, MOL CELL, V57, P247, DOI 10.1016/j.molcel.2014.12.002; Nakagawa T, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-22; Pepe A, 2014, CELL REP, V7, P1048, DOI 10.1016/j.celrep.2014.04.007; Pepe A, 2014, NUCLEIC ACIDS RES, V42, P3833, DOI 10.1093/nar/gkt1333; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Rueden CT, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112511; Sawaya BE, 1999, GENE THER, V6, P947, DOI 10.1038/sj.gt.3300907; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Transy C, 2009, CELL CYCLE, V8, P2489, DOI 10.4161/cc.8.16.9129; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Varin A, 2005, J BIOL CHEM, V280, P42557, DOI 10.1074/jbc.M502211200; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Zhou Y, 1998, VIROLOGY, V242, P414, DOI 10.1006/viro.1998.9028	69	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16936	16947		10.1074/jbc.M116.721183	http://dx.doi.org/10.1074/jbc.M116.721183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27354282	hybrid, Green Published			2022-12-26	WOS:000382643800002
J	Petersen, PE; Penman, DJ; Dahle, G; Patursson, O; Taggart, JB				Petersen, Petra E.; Penman, David J.; Dahle, Geir; Patursson, Oystein; Taggart, John B.			Differential Survival among Batches of Atlantic Cod (Gadus morhua L.) from Fertilisation through to Post-Metamorphosis	PLOS ONE			English	Article							EARLY EMBRYONIC CLEAVAGE; REPRODUCTIVE SUCCESS; HATCHING SUCCESS; LARVAL QUALITY; EGG SIZE; GROWTH; VIABILITY; COMPETITION; SELECTION	Aquaculture production of cod has decreased from over 20,000 tonnes in 2009 to less than 2,000 tonnes in 2014 and the industry faces many challenges, one of which is high and unpredictably variable mortality rates in the early life stages. Hence, full-cycle farming with hatchery produced juveniles is still considered unprofitable compared to fisheries and on-growing of wild cod. In the present study, potential batch differences in progeny survival of wild-caught, hatchery-spawned Faroe Bank cod (Gadus morhua L.) were investigated at two defined periods during early life history; i) the embryo stage (60 day degrees post fertilisation) and ii) the fry stage (110 days post hatch), post metamorphosis. The fry stage experiment was conducted in three replicates (N = 300 per replicate), and a panel of three polymorphic microsatellite markers was used for parental analysis. Mean survival rate at the embryo stage was 69% (+/- 20% SD). Survival was positively associated with egg diameter (P < 0.01), explaining 90% of the variation in egg survival rates. The data were too scarce to conclude either way concerning a possible correlation between survival rates between the two periods (P < 0.10). Offspring from three batches (from a total of eight) dominated in the fry stage, contributing over 90% of the progeny, and results were consistent over all three replicate tanks. The skewed batch representation observed may be of relevance to the effective management of selective breeding programmes for cod.	[Petersen, Petra E.; Patursson, Oystein] Aquaculture Res Stn Faroes, Dept Biotechnol, Hvalvik, Faroe Islands, Denmark; [Petersen, Petra E.; Penman, David J.; Taggart, John B.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling, Scotland; [Dahle, Geir] Inst Marine Res, Bergen, Norway	University of Stirling; Institute of Marine Research - Norway	Petersen, PE (corresponding author), Aquaculture Res Stn Faroes, Dept Biotechnol, Hvalvik, Faroe Islands, Denmark.; Petersen, PE (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling, Scotland.	petrapetersen79@gmail.com		Taggart, John/0000-0002-3843-9663	Faroese Research Council; Fiskaaling, the Aquaculture Research Station of the Faroes; MASTS (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council grant [HR09001]	Faroese Research Council; Fiskaaling, the Aquaculture Research Station of the Faroes; MASTS (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council grant	This work has received financial support from the Faroese Research Council (http://www.gransking.fo/) and Fiskaaling, the Aquaculture Research Station of the Faroes (http://www.fiskaaling.fo/) (GD and PEP). JBT and DJP are partly supported by the MASTS (The Marine Alliance for Science and Technology for Scotland; http://www.masts.ac.uk) pooling initiative which is funded by a Scottish Funding Council grant (HR09001) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annitage D, 2007, AQUACULTURE, V272, pS242, DOI 10.1016/j.aquaculture.2007.07.026; Avery TS, 2009, AQUACULTURE, V289, P265, DOI 10.1016/j.aquaculture.2008.12.011; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; Brander K., 2005, ICES COOP RES REP, V274, P1; Chambers RC, 1996, CAN J FISH AQUAT SCI, V53, P1896; *FAO, FISH STAT COLL; Gjerde B, 2004, AQUACULTURE, V236, P167, DOI 10.1016/j.aquaculture.2004.03.004; Gunnarsli KS, 2009, AQUACULTURE, V288, P344, DOI 10.1016/j.aquaculture.2008.11.039; Halldorsson JE, 2012, MAR POLICY, V36, P11, DOI 10.1016/j.marpol.2011.03.001; Hansen LA, 2004, GAD MAR DEV FUT CHAL; Hansen OJ, 2010, AQUAC RES, V41, P1791, DOI 10.1111/j.1365-2109.2010.02506.x; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Herlin M, 2008, AQUACULTURE, V274, P218, DOI 10.1016/j.aquaculture.2007.11.034; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V56, P97, DOI 10.1139/cjfas-56-1-97; ICES, 2014ACOM ICES CM; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Karlsen O, 2006, ICES J MAR SCI, V63, P355, DOI 10.1016/j.icesjms.2005.10.013; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; KJESBU OS, 1989, J FISH BIOL, V34, P195, DOI 10.1111/j.1095-8649.1989.tb03302.x; Kjesbu OS, 2006, ICES J MAR SCI, V63, P187, DOI 10.1016/j.icesjms.2005.12.003; Kjesbu OS, 1996, CAN J FISH AQUAT SCI, V53, P610, DOI 10.1139/cjfas-53-3-610; Kjorsvik E, 2003, AQUACULTURE, V227, P9, DOI 10.1016/S0044-8486(03)00492-7; Kristjansson T, 2016, AQUAC RES, V47, P349, DOI 10.1111/are.12496; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; Miller KM, 2000, MOL ECOL, V9, P238, DOI 10.1046/j.1365-294x.2000.00804-2.x; Nocillado JN, 2000, FISH PHYSIOL BIOCHEM, V22, P1, DOI 10.1023/A:1007881231664; Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x; O'Reilly PT, 2000, J FISH BIOL, V56, P1074, DOI 10.1111/j.1095-8649.2000.tb02124.x; Ottera H, 2006, ICES J MAR SCI, V63, P216, DOI 10.1016/j.icesjms.2005.11.004; Ottera H, 2005, OPPDRETT AV TORSK; Ouellet P, 2001, ICES J MAR SCI, V58, P672, DOI 10.1006/jmsc.2001.1065; PEDERSEN T, 1992, J FISH BIOL, V41, P449, DOI 10.1111/j.1095-8649.1992.tb02673.x; Pickova J, 1997, CAN J FISH AQUAT SCI, V54, P2410, DOI 10.1139/cjfas-54-10-2410; Planes S, 2004, MOL ECOL, V13, P2049, DOI 10.1111/j.1365-294X.2004.02202.x; Rakitin A, 2001, MAR BIOL, V138, P1077, DOI 10.1007/s002270100551; Rosendal GK, 2013, AQUACULTURE, V402, P97, DOI 10.1016/j.aquaculture.2013.03.026; Rosenlund G, 2006, ICES J MAR SCI, V63, P194, DOI 10.1016/j.icesjms.2005.11.012; Rowe S, 2007, CAN J FISH AQUAT SCI, V64, P219, DOI 10.1139/F06-182; Rudolfsen G, 2005, J EVOLUTION BIOL, V18, P172, DOI 10.1111/j.1420-9101.2004.00778.x; Salvesen I., 1995, Aquaculture International, V3, P155, DOI 10.1007/BF00118098; Steingrund P, 2005, SPAWNING LIFE HIST I, P50; Stottrup JG, 2002, 10702 DFU DAN I FISH; Taggart JB, 2007, MOL ECOL NOTES, V7, P412, DOI 10.1111/j.1471-8286.2006.01616.x; Teletchea F, 2014, FISH FISH, V15, P181, DOI 10.1111/faf.12006; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; Trippel Edward A., 2003, Journal of Northwest Atlantic Fishery Science, V33, P81, DOI 10.2960/J.v33.a6; Walpole RE., 2012, PROBABILITY STAT ENG, V9; Wesmajervi MS, 2006, AQUAC RES, V37, P1195, DOI 10.1111/j.1365-2109.2006.01549.x	49	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158091	10.1371/journal.pone.0158091	http://dx.doi.org/10.1371/journal.pone.0158091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362346	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200039
J	Vogele, AM; Zsoldos, RR; Kruger, B; Licka, T				Voegele, Anna Magdalena; Zsoldos, Rebeka R.; Krueger, Bjoern; Licka, Theresia			Novel Methods for Surface EMG Analysis and Exploration Based on Multi-Modal Gaussian Mixture Models	PLOS ONE			English	Article							LONGISSIMUS-DORSI MUSCLES; PELVIC LIMB MUSCLES; ELECTROMYOGRAPHIC ACTIVITY; WALKING; HORSES; IDENTIFICATION; GAIT; REPEATABILITY; BACK	This paper introduces a new method for data analysis of animal muscle activation during locomotion. It is based on fitting Gaussian mixture models (GMMs) to surface EMG data (sEMG). This approach enables researchers/users to isolate parts of the overall muscle activation within locomotion EMG data. Furthermore, it provides new opportunities for analysis and exploration of sEMG data by using the resulting Gaussian modes as atomic building blocks for a hierarchical clustering. In our experiments, composite peak models representing the general activation pattern per sensor location (one sensor on the long back muscle, three sensors on the gluteus muscle on each body side) were identified per individual for all 14 horses during walk and trot in the present study. Hereby we show the applicability of the method to identify composite peak models, which describe activation of different muscles throughout cycles of locomotion.	[Voegele, Anna Magdalena] Univ Bonn, Inst Comp Sci 2, Multimedia Simulat & Virtual Real Grp, Bonn, Germany; [Zsoldos, Rebeka R.] Univ Nat Resources & Life Sci Vienna, Dept Sustainable Agr Syst, Working Grp Anim Breeding, Vienna, Austria; [Krueger, Bjoern] Gokhale Method Inst, Stanford, CA USA; [Licka, Theresia] Univ Vet Med Vienna, Dept Small Anim & Horses, Movement Sci Grp, Vienna, Austria; [Licka, Theresia] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	University of Bonn; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; University of Edinburgh	Vogele, AM (corresponding author), Univ Bonn, Inst Comp Sci 2, Multimedia Simulat & Virtual Real Grp, Bonn, Germany.	voegele@cs.uni-bonn.de	Krüger, Björn/AAA-6944-2022; Zsoldos, Rebeka R./M-6376-2014	Zsoldos, Rebeka R./0000-0001-6690-1862; Licka, Theresia/0000-0001-7651-5180	Deutsche Forschungsgemeinschaft [KR 4309/2-1]; Austrian Science Fund as part of the GeMMQuad project [I1532-B23]; Austrian Science Fund (FWF) [I 1532] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund as part of the GeMMQuad project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft, Grant KR 4309/2-1 (http://www.dfg.de/), and Austrian Science Fund as part of the GeMMQuad project, Grant I1532-B23 (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard J, 2013, IEEE T VIS COMPUT GR, V19, P2257, DOI 10.1109/TVCG.2013.178; Bishop C. M, 2006, PATTERN RECOGNITION; Blomer J, 2013, CORR ABS 1312 5946; Boudaoud S, 2010, IEEE ENG MED BIO, P4703, DOI 10.1109/IEMBS.2010.5626378; BRUCE V, 1985, EQUINE VET J, V17, P317, DOI 10.1111/j.2042-3306.1985.tb02508.x; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Cottriall S, 2008, COMP EXERC PHYSIOL, V5, P111, DOI 10.1017/S1478061509342346; Crook TC, 2010, J ANAT, V217, P26, DOI 10.1111/j.1469-7580.2010.01241.x; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Ding Q, TRANSACTIONS ON INDU; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Farina D, 2013, J PHYSIOL-LONDON, V591, P2403, DOI 10.1113/jphysiol.2012.246082; FUGLEVAND AJ, 1992, BIOL CYBERN, V67, P143, DOI 10.1007/BF00201021; George LS, 2013, COMP EXERC PHYSIOL, V9, P23, DOI 10.3920/CEP12024; Gizzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137844; Granata KP, 2005, GAIT POSTURE, V22, P346, DOI 10.1016/j.gaitpost.2004.11.014; Groesel M, 2010, EQUINE VET J, V42, P401, DOI 10.1111/j.2042-3306.2010.00282.x; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Hermens H.J., 2000, EUROPEAN RECOMMENDAT; Hill C., 2010, 101 HORSEMANSHIP EQU; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Ju ZJ, 2013, IEEE SENS J, V13, P3302, DOI 10.1109/JSEN.2013.2259051; Kampa K, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P2578, DOI 10.1109/IJCNN.2011.6033555; Kwedlo W, 2013, ADV INTELL SYST, V226, P81, DOI 10.1007/978-3-319-00969-8_8; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka TF, 2004, AM J VET RES, V65, P155, DOI 10.2460/ajvr.2004.65.155; MARISCOTTI MA, 1967, NUCL INSTRUM METHODS, V50, P309, DOI 10.1016/0029-554X(67)90058-4; Martens J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144998; Mazoyer B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101165; Melnykov V, 2012, COMPUT STAT DATA AN, V56, P1381, DOI 10.1016/j.csda.2011.11.002; Merletti R, 2015, J ELECTROMYOGR, V25, pI, DOI 10.1016/S1050-6411(15)00131-5; Naim I, 2012, ICML ICML CC OMNIPRE; Negro F, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/036008; Olsen E, 2012, SENSORS-BASEL, V12, P8145, DOI 10.3390/s120608145; OLSON CF, 1995, PARALLEL COMPUT, V21, P1313, DOI 10.1016/0167-8191(95)00017-I; Peham C, 2001, AM J VET RES, V62, P1687, DOI 10.2460/ajvr.2001.62.1687; Rani S., 2012, INT J COMPUTER APPL, V52, P1, DOI DOI 10.5120/8282-1278; Rash G.S., 2003, ELECTROMYOGRAPHY FUN, V4; Robilliard JJ, 2007, J EXP BIOL, V210, P187, DOI 10.1242/jeb.02611; Rodrigues PP, 2008, IEEE T KNOWL DATA EN, V20, P615, DOI 10.1109/TKDE.2007.190727; Spainhour JCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111016; Staudenmann D, 2013, J ELECTROMYOGR KINES, V23, P892, DOI 10.1016/j.jelekin.2013.03.004; Valentin S, 2015, JOURNAL OF ELECTROMY; Vogele A, 2014, 2014 ACM SIGGRAPH EU; Wakeling J. M., 2006, Equine and Comparative Exercise Physiology, V3, P153; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; Wilhelm N, 2015, PROC SPIE, V9397, DOI 10.1117/12.2080001; Williams J., 2013, The Veterinary Nurse, V4, P566; Williams JM, 2014, COMP EXERC PHYSIOL, V10, P223, DOI 10.3920/CEP143004; WU CFJ, 1983, ANN STAT, V11, P95, DOI 10.1214/aos/1176346060; Zaneb H, 2009, AM J VET RES, V70, P1129, DOI 10.2460/ajvr.70.9.1129; Zhou F, 2013, IEEE T PATTERN ANAL, V35, P582, DOI 10.1109/TPAMI.2012.137; Zsoldos R, 2015, PROGRESS IN MOTOR CO; Zsoldos R, 2015, 25 C INT SOC BIOM IS; Zwarts MJ, 2000, J ELECTROMYOGR KINES, V10, P287, DOI 10.1016/S1050-6411(00)00020-1	57	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157239	10.1371/journal.pone.0157239	http://dx.doi.org/10.1371/journal.pone.0157239			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362752	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200011
J	Schirrmann, M; Joschko, M; Gebbers, R; Kramer, E; Zorner, M; Barkusky, D; Timmer, J				Schirrmann, Michael; Joschko, Monika; Gebbers, Robin; Kramer, Eckart; Zoerner, Mirjam; Barkusky, Dietmar; Timmer, Jens			Proximal Soil Sensing - A Contribution for Species Habitat Distribution Modelling of Earthworms in Agricultural Soils?	PLOS ONE			English	Article							ELECTRICAL-CONDUCTIVITY; REGRESSION; POPULATIONS; COMMUNITY; TILLAGE	Background Earthworms are important for maintaining soil ecosystem functioning and serve as indicators of soil fertility. However, detection of earthworms is time-consuming, which hinders the assessment of earthworm abundances with high sampling density over entire fields. Recent developments of mobile terrestrial sensor platforms for proximal soil sensing (PSS) provided new tools for collecting dense spatial information of soils using various sensing principles. Yet, the potential of PSS for assessing earthworm habitats is largely unexplored. This study investigates whether PSS data contribute to the spatial prediction of earthworm abundances in species distribution models of agricultural soils. Methodology/Principal Findings Proximal soil sensing data, e.g., soil electrical conductivity (EC), pH, and near infrared absorbance (NIR), were collected in real-time in a field with two management strategies (reduced tillage / conventional tillage) and sandy to loam soils. PSS was related to observations from a long-term (11 years) earthworm observation study conducted at 42 plots. Earthworms were sampled from 0.5 x 0.5 x 0.2 m(3) soil blocks and identified to species level. Sensor data were highly correlated with earthworm abundances observed in reduced tillage but less correlated with earthworm abundances observed in conventional tillage. This may indicate that management influences the sensor-earthworm relationship. Generalized additive models and state-space models showed that modelling based on data fusion from EC, pH, and NIR sensors produced better results than modelling without sensor data or data from just a single sensor. Regarding the individual earthworm species, particular sensor combinations were more appropriate than others due to the different habitat requirements of the earthworms. Earthworm species with soil-specific habitat preferences were spatially predicted with higher accuracy by PSS than more ubiquitous species. Conclusions/Significance Our findings suggest that PSS contributes to the spatial modelling of earthworm abundances at field scale and that it will support species distribution modelling in the attempt to understand the soil-earthworm relationships in agroecosystems.	[Schirrmann, Michael; Gebbers, Robin] Leibniz Inst Agr Engn Potsdam Bornim, Max Eyth Allee 100, D-14469 Potsdam, Germany; [Joschko, Monika] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Eberswalder Str 84, D-15374 Muncheberg, Germany; [Kramer, Eckart] Eberswalde Univ Sustainable Dev, Schicklerstr 5, D-16225 Eberswalde, Germany; [Zoerner, Mirjam] Forschungszentrum Julich, Inst Bio & Geosci, IBG-3,Wilhelm Johnen Str, D-52428 Julich, Germany; [Barkusky, Dietmar] Leibniz Ctr Agr Landscape Res ZALF, Res Stn Muencheberg, Eberswalder Str 84, D-15374 Muncheberg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany	Leibniz Institut fur Agrartechnik und Biookonomie (ATB); Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Eberswalde University for Sustainable Development; Helmholtz Association; Research Center Julich; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Schirrmann, M (corresponding author), Leibniz Inst Agr Engn Potsdam Bornim, Max Eyth Allee 100, D-14469 Potsdam, Germany.	mschirrmann@atb-potsdam.de			Rentenbank; Monsanto; Open Access Fund of the Leibniz Association	Rentenbank; Monsanto; Open Access Fund of the Leibniz Association	Financial support for this study was received from Rentenbank (https://www.rentenbank.de/) and Monsanto (http://www.monsanto.com/global/de/). Additionally, the publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchuk VI, 2010, PROGR SOIL SCI, P15, DOI 10.1007/978-90-481-8859-8_2; Bastian O., 2002, DEV PERSPECTIVES LAN; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Blouin M, 2013, EUR J SOIL SCI, V64, P161, DOI 10.1111/ejss.12025; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cannavacciuolo M, 1998, APPL SOIL ECOL, V9, P345, DOI 10.1016/S0929-1393(98)00087-0; Chen J, 2001, J CHEM INF COMP SCI, V41, P992, DOI 10.1021/ci0004053; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P11, DOI 10.1016/j.compag.2004.10.005; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Curry JP, EARTHWORM ECOLOGY, P91; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fox C, 2004, FRAMEWORK DEV INDICA; Gareth J., 2013, INTRO STAT LEARNING; Gebbers R, 2009, SENSITIVITY ANAL SOI, P513; Gebbers R, 2009, NEAR SURF GEOPHYS, V7, P179, DOI 10.3997/1873-0604.2009011; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hernandez P, 2007, PEDOBIOLOGIA, V51, P13, DOI 10.1016/j.pedobi.2006.11.002; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Joschko M, 2006, AGR ECOSYST ENVIRON, V112, P367, DOI 10.1016/j.agee.2005.08.026; Joschko M, 2012, ARCH ACKER PFLANZENB, V58, P252; Joschko M, 2010, J PLANT NUTR SOIL SC, V173, P584, DOI 10.1002/jpln.200800071; Joschko M, 2009, SOIL TILL RES, V102, P55, DOI 10.1016/j.still.2008.07.023; Jouquet P, 2006, APPL SOIL ECOL, V32, P153, DOI 10.1016/j.apsoil.2005.07.004; Kim HJ, 2009, J ENVIRON MONITOR, V11, P1810, DOI 10.1039/b906634a; Kladivko EJ, 1997, SOIL BIOL BIOCHEM, V29, P613, DOI 10.1016/S0038-0717(96)00187-3; Kruck S, 2006, J PLANT NUTR SOIL SC, V169, P651, DOI 10.1002/jpln.200521903; Lardo E, 2012, APPL SOIL ECOL, V61, P76, DOI 10.1016/j.apsoil.2012.06.003; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; Liebig J., 1863, NATURAL LAWS HUSBAND; Mouazen AM, 2005, SOIL TILL RES, V80, P171, DOI 10.1016/j.still.2004.03.022; Nielsen D. R., 2003, Spatial and temporal statistics: sampling field soils and their vegetation; NIELSEN DR, 1989, PLANT SOIL, V115, P285, DOI 10.1007/BF02202595; Nuutinen V, 1998, APPL SOIL ECOL, V8, P85, DOI 10.1016/S0929-1393(97)00063-2; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pelosi C, 2016, SOIL TILL RES, V156, P25, DOI 10.1016/j.still.2015.07.016; PIEARCE TG, 1972, J ANIM ECOL, V41, P167, DOI 10.2307/3511; Press W. H., 1992, ART SCI COMPUTING; R Core Team, 2013, R LANG ENV STAT COMP; RIPLEY BD, 1987, ANALYST, V112, P377, DOI 10.1039/an9871200377; Satchell J. E., 1955, P180; Schirrmann M, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0199; Schirrmann M, 2011, SENSORS-BASEL, V11, P573, DOI 10.3390/s110100573; Schirrmann M, 2011, J PLANT NUTR SOIL SC, V174, P333, DOI 10.1002/jpln.200900367; SCHRADER S, 1994, ZOOL ANZ, V233, P211; Schroder B, 2008, J PLANT NUTR SOIL SC, V171, P325, DOI 10.1002/jpln.200700027; SHUMWAY RH, 2000, TIME SERIES ANAL ITS; Sims RW, 1985, EARTHWORMS; Stenberg B, 2010, PROGR SOIL SCI, P29, DOI 10.1007/978-90-481-8859-8_3; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Valckx J, 2011, SOIL BIOL, V24, P19, DOI 10.1007/978-3-642-14636-7_2; Valckx J, 2009, APPL SOIL ECOL, V41, P315, DOI 10.1016/j.apsoil.2008.12.005; VDLUFA, 2004, METH; Vitharana UWA, 2006, SOIL USE MANAGE, V22, P405, DOI 10.1111/j.1475-2743.2006.00052.x; Webster R., 2007, STAT PRACTICE; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	62	4	4	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158271	10.1371/journal.pone.0158271	http://dx.doi.org/10.1371/journal.pone.0158271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355340	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400042
J	Minervini, S; Accogli, G; Pirone, A; Graic, JM; Cozzi, B; Desantis, S				Minervini, Serena; Accogli, Gianluca; Pirone, Andrea; Graic, Jean-Marie; Cozzi, Bruno; Desantis, Salvatore			Brain Mass and Encephalization Quotients in the Domestic Industrial Pig (Sus scrofa)	PLOS ONE			English	Article							ANTHROPOID PRIMATES; EVOLUTION; SIZE; MAMMALS; CEREBELLUM; ELEPHANTS; CETACEANS; SOCIALITY; COGNITION; SURVIVAL	In the present study we examined the brain of fetal, newborn, and adult pigs raised for meat production. The fresh and formalin-fixed weights of the brain have been recorded and used, together with body weight, to calculate the Encephalization Quotient (EQ). The weight of the cerebellum has been used to calculate the Cerebellar Quotient (CQ). The results have been discussed together with analogue data obtained in other terrestrial Cetartiodactyla (including the domestic bovine, sheep, goat, and camel), domesticated Carnivora, Proboscidata, and Primates. Our study, based on a relatively large experimental series, corrects former observations present in the literature based on smaller samples, and emphasizes that the domestic pig has a small brain relative to its body size (EQ = 0.38 for adults), possibly due to factors linked to the necessity of meat production and improved body weight. Comparison with other terrestrial Cetartiodactyla indicates a similar trend for all domesticated species.	[Minervini, Serena; Accogli, Gianluca; Desantis, Salvatore] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat DETO, Sect Vet Clin & Anim Prod, Valenzano, Ba, Italy; [Pirone, Andrea] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Graic, Jean-Marie; Cozzi, Bruno] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy	Universita degli Studi di Bari Aldo Moro; University of Pisa; University of Padua	Desantis, S (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat DETO, Sect Vet Clin & Anim Prod, Valenzano, Ba, Italy.	salvatore.desantis@uniba.it	Cozzi, Bruno/H-9618-2019; PIRONE, ANDREA/S-7228-2019; Graïc, Jean-Marie/I-2710-2019	Cozzi, Bruno/0000-0002-7531-7040; Graïc, Jean-Marie/0000-0002-1974-8356; PIRONE, ANDREA/0000-0001-6363-392X				AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Ariens Kappers CU, 1927, P ROYAL ACAD AMSTERD, V31, P5; Arloing S, 1879, TRAITE ANATOMIE COMP, P1; Ballarin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154580; Baron G, 1996, COMP NEUROBIOLOGY CH; Boddy AM, 2012, J EVOLUTION BIOL, V25, P981, DOI 10.1111/j.1420-9101.2012.02491.x; BOICE R, 1972, BEHAVIOUR, V43, P198; Bortolami R, 2006, EDAGRICOLE, V6, P1; Camerlink I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113502; Canario L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00410; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Cozzi B, 2009, NEUROANATOMIA UOMO, P1; Cozzi B, 2014, BRAIN BEHAV EVOLUT, V83, P9, DOI 10.1159/000356527; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Ellenberger W, 1912, HDB VERGLEICHENDEN A, P1; Finarelli JA, 2009, P NATL ACAD SCI USA, V106, P9345, DOI 10.1073/pnas.0901780106; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hartwig W, 2011, ANAT REC, V294, P2207, DOI 10.1002/ar.21515; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Jerison H J, 1977, Ann N Y Acad Sci, V299, P146, DOI 10.1111/j.1749-6632.1977.tb41903.x; JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kelava I, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00016; KRUSKA D, 1982, Z ZOOL SYST EVOL, V20, P1; KRUSKA D, 1973, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V11, P81; Kruska D.C.T., 2007, P143; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Larsen T, 2015, RES VET SCI, V98, P19, DOI 10.1016/j.rvsc.2014.11.001; Lauer EW, 1982, COMP CORRELATIVE NEU, P501; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Manger PR, 2012, J COMP NEUROL, V520, P2430, DOI 10.1002/cne.23046; Marino L, 2000, BRAIN BEHAV EVOLUT, V56, P204, DOI 10.1159/000047205; Marino L, 1998, BRAIN BEHAV EVOLUT, V51, P230, DOI 10.1159/000006540; Martin R.D., 1984, P73; Maseko BC, 2012, ANAT REC, V295, P661, DOI 10.1002/ar.22425; Maselyne J, 2015, PHYSIOL BEHAV, V138, P37, DOI 10.1016/j.physbeh.2014.09.012; McGeady T. A., 2006, VET EMBRYOLOGY, P331; MILLER AKH, 1977, ANN HUM BIOL, V4, P253, DOI 10.1080/03014467700007142; Perez-Barberia FJ, 2005, OECOLOGIA, V145, P41, DOI 10.1007/s00442-005-0067-7; Pillay P, 2007, EUR J NEUROSCI, V25, P2705, DOI 10.1111/j.1460-9568.2007.05524.x; Ratcliffe JM, 2006, BRAIN BEHAV EVOLUT, V67, P165, DOI 10.1159/000090980; Rault JL, 2014, J ANIM SCI, V92, P5683, DOI 10.2527/jas.2014-8238; Sack WO, 1982, ESSENTIALS PIG ANATO; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Schelenska G, 1969, J HIRNFROSCH, V15, P401; Seiferle E, 1988, TRATTATO ANATOMIA AN, V4, P1; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Shultz S, 2006, P ROY SOC B-BIOL SCI, V273, P207, DOI 10.1098/rspb.2005.3283; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Sisson S., 1982, ANATOMIA ANIMALI DOM, V2; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; St. Clair L. E., 1981, DIS SWINE; Taylor AB, 2007, J HUM EVOL, V52, P59, DOI 10.1016/j.jhevol.2006.07.010; Thorup F, 2009, LARGE ANIM REV, V15, P89; Weaver AH, 2005, P NATL ACAD SCI USA, V102, P3576, DOI 10.1073/pnas.0500692102; Witting A, 1913, HAMBURG VERHANDLUNGE, P200; Xie ZH, 2011, SELECTED RESEARCH ON GROSS ANATOMY AND HISTOLOGY OF CAMELS, P361; Xie ZH, 2011, SELECTED RESEARCH ON GROSS ANATOMY AND HISTOLOGY OF CAMELS, P355; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006; Zimmerl U., 1909, TRATTATO ANATOMIA VE, V3, P1	62	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157378	10.1371/journal.pone.0157378	http://dx.doi.org/10.1371/journal.pone.0157378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351807	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900009
J	Li, BT; Shi, YZ; Gong, JW; Li, JW; Liu, AY; Shang, HH; Gong, WK; Chen, TT; Ge, Q; Jia, CY; Lei, YK; Hu, YS; Yuan, YL				Li, Botao; Shi, Yuzhen; Gong, Juwu; Li, Junwen; Liu, Aiying; Shang, Haihong; Gong, Wankui; Chen, Tingting; Ge, Qun; Jia, Chaoyang; Lei, Yake; Hu, Yushu; Yuan, Youlu			Genetic Effects and Heterosis of Yield and Yield Component Traits Based on Gossypium Barbadense Chromosome Segment Substitution Lines in Two Gossypium Hirsutum Backgrounds	PLOS ONE			English	Article							AGRONOMIC TRAITS	We hybridized 10 chromosome segment substitution lines (CSSLs) each from two CSSL populations and produced 50 F-1 hybrids according to North Carolina Design II. We analyzed the genetic effects and heterosis of yield and yield components in the F-1 hybrids and parents in four environments via the additive-dominance genetic model. Yield and yield components of the CSSLs were controlled by combined additive and dominance effects, and lint percentage was mainly controlled by additive effects, but boll weight, boll number, seedcotton yield and lint yield were mainly controlled by dominance effects. We detected significant interaction effects between genetics and the environment for all yields traits. Similar interactions were detected between two CSSL populations (Pop CCRI 36 and Pop CCRI 45). Significant positive mid-parent heterosis was detected for all yield traits in both populations, and significant positive better-parent heterosis was also detected for all yield traits except lint percentage. The differences among parents were relatively small, but significant heterosis was detected for yield and yield components. Therefore, the relationship between heterosis and genetic distance for yield traits is complicated and requires further study. These CSSLs represent useful tools for improving yield and yield components in cotton.	[Li, Botao; Shi, Yuzhen; Gong, Juwu; Li, Junwen; Liu, Aiying; Shang, Haihong; Gong, Wankui; Chen, Tingting; Ge, Qun; Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton,Minist Agr, Anyang 455000, Henan, Peoples R China; [Li, Botao] Changde Agr Sci Res Inst, Changde 415000, Hunan, Peoples R China; [Jia, Chaoyang; Lei, Yake] Zhoukou Acad Agr Sci, Zhoukou 466001, Henan, Peoples R China; [Hu, Yushu] Liaoning Prov Inst Cash Crops, Liaoyang 111000, Liaoning, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, YL (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton,Minist Agr, Anyang 455000, Henan, Peoples R China.	yylcri@126.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31101188]; National High Technology Research and Development Program of China [2012AA101108]; National Agricultural Science and Technology Innovation Project for CAAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Agricultural Science and Technology Innovation Project for CAAS	This work was funded by the National Natural Science Foundation of China (31101188), the National High Technology Research and Development Program of China (2012AA101108), and the National Agricultural Science and Technology Innovation Project for CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Guo X, 2013, J INTEGR PLANT BIOL, V55, P759, DOI 10.1111/jipb.12054; Jenkins JN, 2012, EUPHYTICA, V187, P161, DOI 10.1007/s10681-011-0580-1; Li JunWen, 2010, Cotton Science, V22, P163; [刘芦苇 LIU Luwei], 2007, [棉花学报, Cotton Science], V19, P33; Liu YanGai, 2014, Cotton Science, V26, P25; Luan MingBao, 2008, Agricultural Sciences in China, V7, P1290, DOI 10.1016/S1671-2927(08)60177-7; Ma LiuJun, 2013, Cotton Science, V25, P486; Paterson AH, 2004, CROP SCI, V44, P1900, DOI 10.2135/cropsci2004.1900; Saha S, 2013, THEOR APPL GENET, V126, P109, DOI 10.1007/s00122-012-1965-9; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Shi YZ, 2008, CHINESE AGR SCI B, V24, P139; Song MZ, 2015, EUPHYTICA, V204, P135, DOI 10.1007/s10681-014-1348-1; Sun J., 1994, ACTA GOSSYPII SIN, V3, P135; Tang FY, 2013, EUPHYTICA, V194, P41, DOI 10.1007/s10681-013-0958-3; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; White TG, 1967, CROP RES, P34; Wu J, 2010, PLANT BREEDING, V129, P526, DOI 10.1111/j.1439-0523.2009.01715.x; Wu YaoTing, 2002, Agricultural Sciences in China, V1, P498; Xing ChaoZhu, 2007, Scientia Agricultura Sinica, V40, P1056; Yang DaiGang, 2012, Cotton Science, V24, P191; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322; [Yuang Youlu 袁有禄], 2002, [作物学报, Acta Agronomica Sinica], V28, P196; Zeng LH, 2012, EUPHYTICA, V187, P247, DOI 10.1007/s10681-012-0708-y; [张金凤 Zhang Jinfeng], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P773; Zhu J., 1993, J BIOMATH, V8, P32; Zhu J., 1998, ANAL METHODS GENETIC; 王鹏, 2008, [科学通报, Chinese Science Bulletin], V53, P1065	29	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157978	10.1371/journal.pone.0157978	http://dx.doi.org/10.1371/journal.pone.0157978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348815	Green Published, gold, Green Submitted			2022-12-26	WOS:000378801200027
J	Pegado, F; Vankrunkelsven, H; Steyaert, J; Boets, B; Op de Beeck, H				Pegado, Felipe; Vankrunkelsven, Hendrik; Steyaert, Jean; Boets, Bart; Op de Beeck, Hans			Exploring the Use of Sensorial LTP/LTD-Like Stimulation to Modulate Human Performance for Complex Visual Stimuli	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HUMAN MOTOR CORTEX; CONTRAST ADAPTATION; CORTICAL PLASTICITY; FACIAL IDENTITY; FACE; OBJECT; VISION; AREA; LTP	Is it possible to passively induce visual learning/unlearning in humans for complex stimuli such as faces? We addressed this question in a series of behavioral studies using passive visual stimulation (flickering of faces at specific temporal frequencies) inspired by well-known synaptic mechanisms of learning: long-term potentiation (LTP) vs long-term depression (LTD). We administered a face identity change detection task before and after a passive stimulation protocol to test for potential changes in visual performance. First, with bilateral stimulation, subjects undergoing high-frequency LTP-like stimulation outperformed those submitted to low-frequency LTD-like stimulation despite equivalent baseline performance (exp. 1). Second, unilateral stimulation replicated the differential modulation of performance, but in a hemifield-specific way (exp. 2). Third, for both stimulation groups, a sudden temporary drop in performance on the stimulated side immediately after the stimulation, followed by progressive recovering, can suggest either 'visual fatigue' or 'face adaptation' effects due to the stimulation. Fourth, we tested the life-time of these modulatory effects, revealing they vanish after one hour delay (exp. 3). Fifth, a control study (exp. 4) using low-level visual stimuli also failed to show longer-term effects of sensory stimulation, despite reports of strong effects in the literature. Future studies should determine the necessary and sufficient conditions enabling robust long- term modulation of visual performance using this technique. This step is required to consider further use in fundamental research (e.g., to study neural circuits involved in selective visual processing) and potential educational or clinical applications (e.g., inhibiting socially-irrelevant aspects of face processing in autism).	[Pegado, Felipe; Vankrunkelsven, Hendrik; Op de Beeck, Hans] Katholieke Univ Leuven, Dept Brain & Cognit, B-3000 Leuven, Belgium; [Pegado, Felipe; Steyaert, Jean; Boets, Bart] Katholieke Univ Leuven, Dept Neurosci Child & Adolescent Psychiat, B-3000 Leuven, Belgium; [Steyaert, Jean; Boets, Bart] Katholieke Univ Leuven, Res Grp Leuven Autism Res, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Pegado, F; Op de Beeck, H (corresponding author), Katholieke Univ Leuven, Dept Brain & Cognit, B-3000 Leuven, Belgium.; Pegado, F (corresponding author), Katholieke Univ Leuven, Dept Neurosci Child & Adolescent Psychiat, B-3000 Leuven, Belgium.	felipepegado@yahoo.com; hans.opdebeeck@kuleuven.be	Boets, Bart/AAB-1646-2020; Steyaert, Jean/B-5326-2015	Boets, Bart/0000-0002-4718-667X; Steyaert, Jean/0000-0003-2512-4694; Pegado, Felipe/0000-0001-9203-8687; Op de Beeck, Hans/0000-0002-2250-212X	KU Leuven University [ZKC5610, F+/12/029, 3H120620]; FWO (Fonds Wetenschappelijk Onderzoek) [12Q4615N]; Interdisciplinary Research Fund [IDO/10/003];  [ERC-2011-Stg-284101];  [IUAP P7/11]	KU Leuven University; FWO (Fonds Wetenschappelijk Onderzoek)(FWO); Interdisciplinary Research Fund; ; 	F.P. was funded by KU Leuven University (ZKC5610, F+/12/029, 3H120620) and FWO (Fonds Wetenschappelijk Onderzoek) postdoc fellowship (12Q4615N). H.O.B. was supported by ERC-2011-Stg-284101 and IUAP P7/11. B.B., J.S. and H.O.B. were supported by Interdisciplinary Research Fund (IDO/10/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2012, VISION RES, V61, P100, DOI 10.1016/j.visres.2011.12.013; Aberg KC, 2009, VISION RES, V49, P2087, DOI 10.1016/j.visres.2009.05.020; Ahmed B, 1997, CEREB CORTEX, V7, P559, DOI 10.1093/cercor/7.6.559; ANDERSON E, 1985, CORTEX, V21, P453, DOI 10.1016/S0010-9452(85)80009-5; Ashley S, 2012, P ROY SOC B-BIOL SCI, V279, P4143, DOI 10.1098/rspb.2012.1423; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Beste C, 2011, CURR BIOL; Beste C, 2012, CURR BIOL, V22, P1914, DOI 10.1016/j.cub.2012.08.012; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cantarero G, 2013, J NEUROSCI, V33, P4634, DOI 10.1523/JNEUROSCI.4706-12.2013; Carandini M, 2002, J NEUROSCI, V22, P10053; CARBON CC, 2005, ADV EXPT PSYCHOL, V1, P1, DOI DOI 10.2478/V10053-008-0038-8; Carbon CC, 2011, J EXP PSYCHOL HUMAN, V37, P615, DOI 10.1037/a0019949; Chance FS, 1998, J NEUROSCI, V18, P4785; Chen WR, 1996, P NATL ACAD SCI USA, V93, P8011, DOI 10.1073/pnas.93.15.8011; Clapp WC, 2006, NEUROREPORT, V17, P511, DOI 10.1097/01.wnr.0000209004.63352.10; Clapp WC, 2012, BIOL PSYCHIAT, V71, P496, DOI 10.1016/j.biopsych.2011.08.021; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Dilks DD, 2011, J NEUROSCI, V31, P11305, DOI 10.1523/JNEUROSCI.1935-11.2011; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Forsyth JK, 2015, P NATL ACAD SCI USA, V112, P15331, DOI 10.1073/pnas.1509262112; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Goesaert E, 2013, J NEUROSCI, V33, P8549, DOI 10.1523/JNEUROSCI.1829-12.2013; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kattenstroth JC, 2013, J REHABIL MED, V45, P1004, DOI 10.2340/16501977-1225; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Liu JJ, 2005, J NEUROSCI, V25, P3459, DOI 10.1523/JNEUROSCI.4206-04.2005; McMahon DBT, 2012, CURR BIOL, V22, P332, DOI 10.1016/j.cub.2012.01.003; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Oberman L, 2012, EUR J NEUROSCI, V36, P2782, DOI 10.1111/j.1460-9568.2012.08172.x; Op de Beeck HP, 2010, TRENDS COGN SCI, V14, P22, DOI 10.1016/j.tics.2009.11.002; Op de Beeck HP, 2008, J NEUROSCI, V28, P11796, DOI 10.1523/JNEUROSCI.3799-08.2008; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Oruc I, 2011, P ROY SOC B-BIOL SCI, V278, P2591, DOI 10.1098/rspb.2010.2480; Pegado F, 2014, P NATL ACAD SCI USA, V111, pE5233, DOI 10.1073/pnas.1417347111; Pegado F, 2011, NEUROIMAGE, V55, P742, DOI 10.1016/j.neuroimage.2010.11.043; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RECANZONE GH, 1990, J NEUROPHYSIOL, V63, P1213, DOI 10.1152/jn.1990.63.5.1213; Rhodes G, 2007, VISION RES, V47, P2291, DOI 10.1016/j.visres.2007.05.012; Romanska A, 2015, CEREB CORTEX, V25, P4334, DOI 10.1093/cercor/bhv016; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Smith PS, 2009, ARCH PHYS MED REHAB, V90, P2108, DOI 10.1016/j.apmr.2009.07.017; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Stigliani A, 2015, J NEUROSCI, V35, P12412, DOI 10.1523/JNEUROSCI.4822-14.2015; Teyler TJ, 2005, EUR J NEUROSCI, V21, P2045, DOI 10.1111/j.1460-9568.2005.04007.x; Vul E, 2008, J VISION, V8, DOI 10.1167/8.12.4; Wright BA, 2007, EXP BRAIN RES, V180, P727, DOI 10.1007/s00221-007-0898-z; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	54	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158312	10.1371/journal.pone.0158312	http://dx.doi.org/10.1371/journal.pone.0158312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3KZ	27341210	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600048
J	Sung, S; Jeon, TY; Yoo, SY; Hwang, SM; Choi, YH; Kim, WS; Choe, YH; Kim, JH				Sung, Siyoun; Jeon, Tae Yeon; Yoo, So-Young; Hwang, Sook Min; Choi, Young Hun; Kim, Woo Sun; Choe, Yon Ho; Kim, Ji Hye			Incremental Value of MR Cholangiopancreatography in Diagnosis of Biliary Atresia	PLOS ONE			English	Article							TRIANGULAR CORD SIGN; US DIAGNOSIS; NEONATAL CHOLESTASIS; CHOLANGIOGRAPHY; INFANTS; YOUNGER	Purpose To evaluate the incremental value of a combination of magnetic resonance cholangiopan-creatography (MRCP) and ultrasonography (US), compared to US alone, for diagnosing biliary atresia (BA) in neonates and young infants with cholestasis. Materials and Methods The institutional review board approved this retrospective study. The US and MRCP studies were both performed on 64 neonates and young infants with BA (n = 41) or without BA (non-BA) (n = 23). Two observers reviewed independently the US alone set and the combined US and MRCP set, and graded them using a five-point scale. Diagnostic performance was compared using pairwise comparison of the receiver operating characteristics (ROC) curve. The sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value were assessed. Results The diagnostic performance (the area under the ROC curve [A(z)]) for diagnosing BA improved significantly after additional review of MRCP images; A(z) improved from 0.688 to 0.901 (P = .015) for observer 1 and from 0.676 to 0.901 (P = .011) for observer 2. The accuracy of MRCP combined with US (observer 1, 95% [61/64]; observer 2 92% [59/64]) and PPV (observer 1, 95% [40/42]; observer 2 91% [40/44]) were significantly higher than those of US alone for both observers (accuracy: observer 1, 73% [47/64], P = 0.003; observer 2, 72% [46/64], P = 0.004; PPV: observer 1, 76% [35/46], P = 0.016; observer 2, 76% [34/45], P = 0.013). Interobserver agreement of confidence levels was good for US alone (kappa = 0.658, P < .001) and was excellent for the combined set of US and MRCP (kappa = 0.929, P < .001). Conclusion Better diagnostic performance was achieved with the combination of US and MRCP than with US alone for the evaluation of BA in neonates and young infants with cholestasis.	[Sung, Siyoun; Jeon, Tae Yeon; Yoo, So-Young; Hwang, Sook Min; Kim, Ji Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 06351, South Korea; [Sung, Siyoun; Jeon, Tae Yeon; Yoo, So-Young; Hwang, Sook Min; Kim, Ji Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 06351, South Korea; [Choi, Young Hun; Kim, Woo Sun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Radiol, Seoul 03080, South Korea; [Choe, Yon Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 06531, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, TY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 06351, South Korea.; Jeon, TY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 06351, South Korea.	hathor97.jeon@samsung.com		Hwang, Sook Min/0000-0003-1755-4846				Azuma T, 2003, PEDIATR SURG INT, V19, P475, DOI 10.1007/s00383-003-0962-0; BENNETT BM, 1972, BIOMETRICS, V28, P793, DOI 10.2307/2528763; El-Guindi MAS, 2014, J HEPATOL, V61, P116, DOI 10.1016/j.jhep.2014.03.016; Giannattasio A, 2008, RADIOLOGY, V247, P912, DOI 10.1148/radiol.2473071715; Han SJ, 2002, J PEDIATR SURG, V37, P599, DOI 10.1053/jpsu.2002.31617; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Humphrey TM, 2007, RADIOLOGY, V244, P845, DOI 10.1148/radiol.2443061051; Jaw TS, 1999, RADIOLOGY, V212, P249, DOI 10.1148/radiology.212.1.r99jl13249; Kanegawa K, 2003, AM J ROENTGENOL, V181, P1387, DOI 10.2214/ajr.181.5.1811387; Kendrick APAT, 2003, PEDIATR RADIOL, V33, P311, DOI 10.1007/s00247-003-0867-z; Kim WS, 2007, RADIOLOGY, V245, P549, DOI 10.1148/radiol.2452061093; Kotb MA, 2001, PEDIATRICS, V108, P416, DOI 10.1542/peds.108.2.416; Lee HJ, 2003, RADIOLOGY, V229, P395, DOI 10.1148/radiol.292020472; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088268; Mittal V, 2011, AM J ROENTGENOL, V196, pW438, DOI 10.2214/AJR.10.5180; Moyer V, 2004, J PEDIATR GASTR NUTR, V39, P115, DOI 10.1097/00005176-200408000-00001; Norton KI, 2002, RADIOLOGY, V222, P687, DOI 10.1148/radiol.2223010969; Rastogi A, 2009, J GASTROEN HEPATOL, V24, P97, DOI 10.1111/j.1440-1746.2008.05737.x; Sciveres M, 2015, J HEPATOL, V62, P985, DOI 10.1016/j.jhep.2014.11.042; Siles P, 2014, PEDIATR RADIOL, V44, P1077, DOI 10.1007/s00247-014-2953-9; Zhou LY, 2015, RADIOLOGY, V277, P181, DOI 10.1148/radiol.2015142309	21	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158132	10.1371/journal.pone.0158132	http://dx.doi.org/10.1371/journal.pone.0158132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341698	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600034
J	Coupland, KG; Kim, WS; Halliday, GM; Hallupp, M; Dobson-Stone, C; Kwok, JBJ				Coupland, Kirsten G.; Kim, Woojin S.; Halliday, Glenda M.; Hallupp, Marianne; Dobson-Stone, Carol; Kwok, John B. J.			Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; GENE; BRAIN; IDENTIFICATION; TRANSCRIPTION; RISK; METAANALYSIS; EPIGENETICS; MUTATIONS	Studies investigating the pathogenic role of the microtubule associated protein tau (MAPT) gene in Parkinson's disease (PD) have indicated that DNA methylation of the promoter region is aberrant in disease, leading to dysregulated MAPT expression. We examined two potential regulators of MAPT gene expression in respect to PD, a promoter-associated long non-coding RNA MAPT-AS1, and DNA methyltransferases (DNMTs), enzymes responsible for new and maintenance of DNA methylation. We assessed the relationship between expression levels of MAPT and the candidate MAPT-AS1, DNMT1, DNMT3A and DNMT3B transcripts in four brain regions with varying degrees of cell loss and pathology (putamen, anterior cingulate cortex, visual cortex and cerebellum) in N = 10 PD and N = 10 controls. We found a significant decrease in MAPT-AS1 expression in PD (p = 7.154 x 10(-6)). The transcript levels of both MAPT-AS1 (p = 2.569 x 10(-4)) and DNMT1 (p = 0.001) correlated with those of MAPT across the four brain regions, but not with each other. Overexpression of MAPT-AS1 decreased MAPT promoter activity by similar to 2.2 to 4.3 fold in an in vitro luciferase assay performed in two cell lines (p <= 2.678 x 10(-4)). Knock-down expression of MAPT-AS1 led to a 1.3 to 6.3 fold increase in methylation of the endogenous MAPT promoter (p <= 0.011) and a 1.2 to 1.5 fold increased expression of the 4-repeat MAPT isoform transcript (p <= 0.013). In conclusion, MAPT-AS1 and DNMT1 have been identified as potential epigenetic regulators of MAPT expression in PD across four different brain regions. Our data also suggest that increased MAPT expression could be associated with disease state, but not with PD neuropathology severity.	[Coupland, Kirsten G.; Kim, Woojin S.; Halliday, Glenda M.; Hallupp, Marianne; Dobson-Stone, Carol; Kwok, John B. J.] Neurosci Res Australia, Randwick, NSW, Australia; [Coupland, Kirsten G.; Kim, Woojin S.; Halliday, Glenda M.; Dobson-Stone, Carol; Kwok, John B. J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Kwok, JBJ (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.; Kwok, JBJ (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	j.kwok@neura.edu.au	Coupland, Kirsten/D-1944-2011; Coupland, Kirsten/ABC-2856-2021; Halliday, Glenda M/E-8555-2011	Coupland, Kirsten/0000-0002-4320-1043; Coupland, Kirsten/0000-0002-4320-1043; Halliday, Glenda M/0000-0003-0422-8398; Dobson-Stone, Carol/0000-0002-2211-0257; Kwok, John/0000-0001-9574-6195	National Health and Medical Research Council of Australia (NHMRC) [APP1021269, APP1062539, 350833, 568940]; NHMRC [1079679]; University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism [NIH (NIAAA) R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the National Health and Medical Research Council of Australia (NHMRC) seeding fund APP1021269, Project Grant APP1062539 Program Grant 350833 and Capacity Building Grant 568940. GH is a NHMRC senior principal research fellow (grant #1079679). Human brain tissue samples were received from the Sydney Brain Bank at Neuroscience Research Australia and the New South Wales Tissue Resource Centre at the University of Sydney which are supported by the University of New South Wales, Neuroscience Research Australia, Schizophrenia Research Institute and National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Human brain tissue samples were received from the Sydney Brain Bank at Neuroscience Research Australia and the New South Wales Tissue Resource Centre at the University of Sydney which are supported by the University of New South Wales, Neuroscience Research Australia, Schizophrenia Research Institute and National Institute of Alcohol Abuse and Alcoholism.	Adams SJ, 2009, AM J PATHOL, V175, P1598, DOI 10.2353/ajpath.2009.090462; Banzhaf-Strathmann J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-16; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; Caillet-Boudin ML, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0025-8; Chalei V, 2014, ELIFE, V3, DOI 10.7554/eLife.04530; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Coupland KG, 2014, MOVEMENT DISORD, V29, P1606, DOI 10.1002/mds.25784; de Souza N, 2012, NAT METHODS, V9, P1046, DOI 10.1038/nmeth.2238; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Iwata A, 2014, HUM MOL GENET, V23, P648, DOI 10.1093/hmg/ddt451; Jordan Elizabeth T, 2008, J Biomol Tech, V19, P328; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein CJ, 2013, NEUROLOGY, V80, P824, DOI 10.1212/WNL.0b013e318284076d; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Mather KA, 2014, INT J GERIATR PSYCH, V29, P1162, DOI 10.1002/gps.4183; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Penna I, 2011, INT J MOL SCI, V12, P5461, DOI 10.3390/ijms12095461; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weng YL, 2013, NEUROTHERAPEUTICS, V10, P556, DOI 10.1007/s13311-013-0223-4; Zhu L, 2014, HUM MOL GENET, V23, P1563, DOI 10.1093/hmg/ddt547; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	44	48	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157924	10.1371/journal.pone.0157924	http://dx.doi.org/10.1371/journal.pone.0157924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336847	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200065
J	Curzi, D; Sartini, S; Guescini, M; Lattanzi, D; Di Palma, M; Ambrogini, P; Savelli, D; Stocchi, V; Cuppini, R; Falcieri, E				Curzi, Davide; Sartini, Stefano; Guescini, Michele; lattanzi, DaviDe; Di Palma, Michael; Ambrogini, Patrizia; Savelli, David; Stocchi, Vilberto; Cuppini, Riccardo; Falcieri, Elisabetta			Effect of Different Exercise Intensities on the Myotendinous Junction Plasticity	PLOS ONE			English	Article							COLLAGEN-SYNTHESIS; STRUCTURAL-CHANGES; IN-VITRO; TENDON; EXPRESSION; IMMOBILIZATION; MODULATION; SURFACE; IL-6	Myotendinous junctions (MTJs) are anatomical regions specialized in transmission of contractile strength from muscle to tendon and, for this reason, a common site where acute injuries occur during sport activities. In this work we investigated the influence of exercise intensity on MTJ plasticity, as well as on the expression of insulin-like growth factor 1 (IGF-1) and transforming growth factor beta (TGF-beta) and their receptors in muscle and tendon. Three groups of rats were analyzed: control (CTRL), slow-runner (RUN-S) and fast-runner (RUN-F) trained using a treadmill. Ultrastructural and morphometric analyses of distal MTJs from extensor digitorum longus muscles have been performed. Contractile strength and hypertrophy were investigated by using in vivo tension recordings and muscle cross-sectional area (CSA) analysis, respectively. mRNA levels of PGC-1 alpha, vinculin, IGF-1Ea and TGF-beta have been quantified in muscle belly, while IGF-1Ea, TGF-beta and their receptors in tendon. Morphometry revealed an increased MTJ complexity and interaction surface between tissues in trained rats according to training intensity. CSA analysis excluded hypertrophy among groups, while muscle strength was found significantly enhanced in exercised rats in comparison to controls. In muscle tissue, we highlighted an increased mRNA expression of PGC-1a and vinculin in both trained conditions and of TGF-beta in RUN-F. In tendon, we mainly noted an enhancement of TGF-beta mRNA expression only in RUN-F group and a raise of Betaglycan tendon receptor mRNA levels proportional to exercise intensity. In conclusion, MTJ plasticity appears to be related to exercise intensity and molecular analysis suggests a major role played by TGF-beta.	[Curzi, Davide; Sartini, Stefano; Guescini, Michele; lattanzi, DaviDe; Di Palma, Michael; Ambrogini, Patrizia; Savelli, David; Stocchi, Vilberto; Cuppini, Riccardo; Falcieri, Elisabetta] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy	University of Urbino	Curzi, D (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	davide.curzi@uniurb.it	Di Palma, Michael/AAL-2413-2020; Guescini, Michele/L-1297-2019	Di Palma, Michael/0000-0002-9190-6128; Guescini, Michele/0000-0001-9372-7038; Lattanzi, Davide/0000-0002-1621-2900; Savelli, David/0000-0003-4686-5758				ABRAHAMSSON SO, 1991, J ORTHOPAED RES, V9, P495, DOI 10.1002/jor.1100090405; Askling CM, 2007, AM J SPORT MED, V35, P197, DOI 10.1177/0363546506294679; Boesen AP, 2013, J PHYSIOL-LONDON, V591, P6039, DOI 10.1113/jphysiol.2013.261263; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Curzi D, 2013, EUR J HISTOCHEM, V57, P247, DOI 10.4081/ejh.2013.e37; Curzi D, 2012, EUR J HISTOCHEM, V56, P117, DOI [10.4081/ejh.2012.e19, 10.4081/ejh.2012.19]; Curzi D, 2015, HISTOL HISTOPATHOL, V30, P465, DOI 10.14670/HH-30.465; de Palma L, 2011, ROM J MORPHOL EMBRYO, V52, P105; Doessing S, 2010, EUR J ENDOCRINOL, V163, P853, DOI 10.1530/EJE-10-0818; Frenette J, 2000, INT J SPORTS MED, V21, P313, DOI 10.1055/s-2000-3774; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Isanejad A, 2015, CYTOKINE, V73, P302, DOI 10.1016/j.cyto.2015.03.013; Jiang CY, 2012, BIOCHEM CELL BIOL, V90, P667, DOI [10.1139/O2012-024, 10.1139/o2012-024]; Kim JW, 2007, DIFFERENTIATION, V75, P147, DOI 10.1111/j.1432-0436.2006.00118.x; Knudsen AB, 2015, SCAND J MED SCI SPOR, V25, pE116, DOI 10.1111/sms.12221; Olesen JL, 2007, J APPL PHYSIOL, V102, P214, DOI 10.1152/japplphysiol.01205.2005; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PILIS W, 1993, COMP BIOCHEM PHYS A, V106, P285, DOI 10.1016/0300-9629(93)90513-4; Roffino S, 2006, CR BIOL, V329, P172, DOI 10.1016/j.crvi.2006.01.008; Sartini S, 2013, EUR J NEUROSCI, V37, P1394, DOI 10.1111/ejn.12130; Silder A, 2008, SKELETAL RADIOL, V37, P1101, DOI 10.1007/s00256-008-0546-0; Sisti D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-186; Szczodry M, 2009, J ORTHOP RES, V27, P1373, DOI 10.1002/jor.20878; Tang Y, 2015, GENE THER, V22, P610, DOI 10.1038/gt.2015.32; TIDBALL JG, 1989, CELL TISSUE RES, V257, P77; TIDBALL JG, 1992, J APPL PHYSIOL, V73, P59, DOI 10.1152/jappl.1992.73.1.59; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571; Wen XY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/402175; Yalamanchi N, 2004, PLAST RECONSTR SURG, V113, P625, DOI 10.1097/01.PRS.0000101529.47062.34	32	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158059	10.1371/journal.pone.0158059	http://dx.doi.org/10.1371/journal.pone.0158059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337061	gold, Green Submitted, Green Published			2022-12-26	WOS:000378389200100
J	Di Domenicantonio, R; Cappai, G; Sciattella, P; Belleudi, V; Di Martino, M; Agabiti, N; Mataloni, F; Ricci, R; Perucci, CA; Davoli, M; Fusco, D				Di Domenicantonio, Riccardo; Cappai, Giovanna; Sciattella, Paolo; Belleudi, Valeria; Di Martino, Mirko; Agabiti, Nera; Mataloni, Francesca; Ricci, Roberto; Perucci, Carlo Alberto; Davoli, Marina; Fusco, Danilo			The Tradeoff between Travel Time from Home to Hospital and Door to Balloon Time in Determining Mortality among STEMI Patients Undergoing PCI	PLOS ONE			English	Article							ACUTE-MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; ASSOCIATION TASK-FORCE; ST-ELEVATION; PRIMARY ANGIOPLASTY; AMERICAN-COLLEGE; SYSTEM DELAY; ONSET; CARE; PERFORMANCE	Background In ST-segment elevation myocardial infarction (STEMI), even in presence of short door to balloon time (DTBT), timely reperfusion with percutaneous coronary intervention (PCI) is hampered by pre-hospital delays. Travel time (TT) constitutes a relevant part of these delays and may contribute to worse outcomes. Objective To evaluate the relationship between TT from home to hospital and DTBT on 30-day mortality after PCI among patients with STEMI. Methods We enrolled a cohort of 3,608 STEMI patients with a DTBT within 120 minutes who underwent PCI between years 2009 and 2013 in Lazio Region (Italy). We calculated the minimum travel time from residential address to emergency department where the first medical contact occurred. We defined system delay as the sum of travel time and DTBT time. Logistic regression models, including clinical and demographic characteristics were used to estimate the effect of TT and DTBT on mortality. Results Among patients with 0-90 minutes of system delay, TT above the median value is positively associated with mortality (OR = 2.46; P = 0.009). Survival benefit associated with DTBT below the median results only among patients with TT below the median (OR for DTBT below the median = 0.39; P = 0.013), (OR for interaction between TT and DTBT = 2.36; p = 0.076). Conclusion TT affects survival after PCI for STEMI, even in the presence of health care systems compliant with current guidelines. Results emphasize the importance of health system initiatives to reduce pre-hospital delay. Utilization of TT can contribute to a better estimate of patient mortality risk in the evaluation of quality of care.	[Di Domenicantonio, Riccardo; Cappai, Giovanna; Sciattella, Paolo; Belleudi, Valeria; Di Martino, Mirko; Agabiti, Nera; Mataloni, Francesca; Perucci, Carlo Alberto; Davoli, Marina; Fusco, Danilo] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Ricci, Roberto] Local Hlth Author Roma E, Cardiol Unit, Rome, Italy		Agabiti, N (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	n.agabiti@deplazio.it	Fusco, Danilo/K-1383-2016; Fusco, Danilo/AAB-8646-2019; Mataloni, Francesca/AAC-5013-2022; Di Martino, Mirko/K-6543-2018; Agabiti, Nera/K-1053-2016; Belleudi, Valeria/J-9070-2016; belleudi, valeria/AAR-4553-2021; Di Domenicantonio, Riccardo/HII-5605-2022; Di Domenicantonio, Riccardo/H-7867-2018; Davoli, Marina/K-1975-2016	Fusco, Danilo/0000-0003-1759-5621; Fusco, Danilo/0000-0003-1759-5621; Mataloni, Francesca/0000-0003-4273-2384; Di Martino, Mirko/0000-0002-6033-7591; Agabiti, Nera/0000-0003-3385-1197; Belleudi, Valeria/0000-0002-8286-443X; belleudi, valeria/0000-0002-8286-443X; Di Domenicantonio, Riccardo/0000-0002-9726-0786; Davoli, Marina/0000-0003-4521-032X; Cappai, Giovanna/0000-0002-9692-6179; SCIATTELLA, PAOLO/0000-0002-8364-1895				Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Busingye D, 2011, SPAT SPATIO-TEMPORAL, V2, P247, DOI 10.1016/j.sste.2011.07.010; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Fusco D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-25; Graves BA, 2011, J CARDIOVASC NURS, V26, pE1, DOI 10.1097/JCN.0b013e3181ecaacb; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nallamothu BK, 2006, CIRCULATION, V113, P1189, DOI 10.1161/CIRCULATIONAHA.105.596346; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Patel Alka B, 2010, Open Med, V4, pe13; Pedigo AS, 2010, ANN EPIDEMIOL, V20, P924, DOI 10.1016/j.annepidem.2010.06.013; Renzi C, 2012, HEALTH SERV RES, V47, P1880, DOI 10.1111/j.1475-6773.2012.01401.x; Shiomi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3257; SMITH PG, 1984, INT J EPIDEMIOL, V13, P356, DOI 10.1093/ije/13.3.356; Terkelsen CJ, 2011, ANN INTERN MED, V155, P361, DOI 10.7326/0003-4819-155-6-201109200-00004; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Wei L, 2008, HEART, V94, P1141, DOI 10.1136/hrt.2007.123612	24	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158336	10.1371/journal.pone.0158336	http://dx.doi.org/10.1371/journal.pone.0158336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336859	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200131
J	Qiu, HY; Cassan, R; Johnstone, D; Han, XB; Joyee, AG; McQuoid, M; Masi, A; Merluza, J; Hrehorak, B; Reid, R; Kennedy, K; Tighe, B; Rak, C; Leonhardt, M; Dupas, B; Saward, L; Berry, JD; Nykiforuk, CL				Qiu, Hongyu; Cassan, Robyn; Johnstone, Darrell; Han, Xiaobing; Joyee, Antony George; McQuoid, Monica; Masi, Andrea; Merluza, John; Hrehorak, Bryce; Reid, Ross; Kennedy, Kieron; Tighe, Bonnie; Rak, Carla; Leonhardt, Melanie; Dupas, Brian; Saward, Laura; Berry, Jody D.; Nykiforuk, Cory L.			Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model	PLOS ONE			English	Article							TOXIN-B; INFECTION; PROTECTION; DISEASE; UPDATE; ADULTS; TRANSPLANTATION; EPIDEMIOLOGY; EXPRESSION; GUIDELINES	Clostridium difficile (C. difficile) infection (CDI) is the main cause of nosocomial antibiotic-associated colitis and increased incidence of community-associated diarrhea in industrialized countries. At present, the primary treatment of CDI is antibiotic administration, which is effective but often associated with recurrence, especially in the elderly. Pathogenic strains produce enterotoxin, toxin A (TcdA), and cytotoxin, toxin B (TcdB), which are necessary for C. difficile induced diarrhea and gut pathological changes. Administration of anti-toxin antibodies provides an alternative approach to treat CDI, and has shown promising results in preclinical and clinical studies. In the current study, several humanized anti-TcdA and anti-TcdB monoclonal antibodies were generated and their protective potency was characterized in a hamster infection model. The humanized anti-TcdA (CANmAbA4) and anti-TcdB (CANmAbB4 and CANmAbB1) antibodies showed broad spectrum in vitro neutralization of toxins from clinical strains and neutralization in a mouse toxin challenge model. Moreover, co-administration of humanized antibodies (CANmAbA4 and CANmAbB4 cocktail) provided a high level of protection in a dose dependent manner (85% versus 57% survival at day 22 for 50 mg/kg and 20 mg/kg doses, respectively) in a hamster gastrointestinal infection (GI) model. This study describes the protective effects conferred by novel neutralizing anti-toxin monoclonal antibodies against C. difficile toxins and their potential as therapeutic agents in treating CDI.	[Qiu, Hongyu; Cassan, Robyn; Johnstone, Darrell; Han, Xiaobing; Joyee, Antony George; McQuoid, Monica; Masi, Andrea; Merluza, John; Hrehorak, Bryce; Reid, Ross; Kennedy, Kieron; Tighe, Bonnie; Rak, Carla; Leonhardt, Melanie; Dupas, Brian; Saward, Laura; Berry, Jody D.; Nykiforuk, Cory L.] Cangene Corp, 155 Innovat Dr, Winnipeg, MB R3T 5Y3, Canada; [Berry, Jody D.] Grifols, Emeryville, CA 94608 USA	Grifols	Nykiforuk, CL (corresponding author), Cangene Corp, 155 Innovat Dr, Winnipeg, MB R3T 5Y3, Canada.	cnykiforuk@ebsi.com			Cangene Corporation	Cangene Corporation	The authors have no support or funding to report. All authors were employees of Cangene Corporation during the execution of these experiments and are now current employees of Emergent BioSolutions dba (doing business as) Cangene Corporation. Cangene Corporation provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14; Aslam S, 2005, LANCET INFECT DIS, V5, P549, DOI 10.1016/S1473-3099(05)70215-2; Babcock GJ, 2005, 43 ANN M INF DIS SOC; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Blondeau JM, 2009, J ANTIMICROB CHEMOTH, V63, P238, DOI 10.1093/jac/dkn477; Brandt LJ, 2013, GASTROINTEST ENDOSC, V78, P240, DOI 10.1016/j.gie.2013.03.1329; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Cassan R, 2013, Patent No. [WO2013028810A1, 2013028810]; Cassan R, 2015, Patent No. [WO2014085749A3, 2014085749]; Chaves-Olarte E, 1999, J BIOL CHEM, V274, P11046, DOI 10.1074/jbc.274.16.11046; Chow SK, 2012, TOXINS, V4, P430, DOI 10.3390/toxins4060430; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gerding DN, 2010, CLIN INFECT DIS, V51, P1306, DOI 10.1086/657116; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Gerding DN, 2015, PHASE 3 DOUBLE BLIND; Giannasca PJ, 1999, INFECT IMMUN, V67, P527, DOI 10.1128/IAI.67.2.527-538.1999; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Kaslow DC, 2011, ANNU REV MED, V62, P201, DOI 10.1146/annurev-med-051109-101544; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kee VR, 2012, AM J GERIATR PHARMAC, V10, P14, DOI 10.1016/j.amjopharm.2011.12.004; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12; LIBBY JM, 1982, INFECT IMMUN, V35, P374, DOI 10.1128/IAI.35.1.374-376.1982; LIMA AAM, 1988, INFECT IMMUN, V56, P582, DOI 10.1128/IAI.56.3.582-588.1988; Loisel S, 2007, CRIT REV ONCOL HEMAT, V62, P34, DOI 10.1016/j.critrevonc.2006.11.010; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; Mathieu R, 2003, J BIOMOL NMR, V25, P83, DOI 10.1023/A:1021990314599; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rupnik M, 2009, CLOSTRIDIUM DIFFICIL, P67; Salkind AR, 2010, SOUTH MED J, V103, P896, DOI 10.1097/SMJ.0b013e3181eab419; Sambol SP, 2000, INFECT IMMUN, V68, P5480, DOI 10.1128/IAI.68.10.5480-5487.2000; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Sorg JA, 2005, CURRENT PROTOCOLS MI; Sougioultzis S, 2005, GASTROENTEROLOGY, V128, P764, DOI 10.1053/j.gastro.2004.11.004; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Viswanathan VK, 2010, GUT MICROBES, V1, P234, DOI 10.4161/gmic.1.4.12706; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wilcox M, 2015, PHASE 3 DOUBLE BLIND; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196	69	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157970	10.1371/journal.pone.0157970	http://dx.doi.org/10.1371/journal.pone.0157970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336843	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200076
J	Eguchi, R; Nakano, T; Wakabayashi, I				Eguchi, R.; Nakano, T.; Wakabayashi, I.			Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells	ONCOGENE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; GROWTH-FACTOR; EPITHELIN PRECURSOR; TUMOR ANGIOGENESIS; PROGNOSTIC MARKER; CANCER; CISPLATIN; THERAPY; TUMORIGENESIS; EXPRESSION	Malignant mesothelioma is an aggressive tumor arising from the mesothelial cells of serous membranes and is associated with tumor angiogenesis, which is a prerequisite for tumor progression. Vascular endothelial growth factors (VEGFs) including VEGF-A have a crucial role in tumor angiogenesis. However, bevacizumab, a monoclonal antibody to VEGF-A, has recently been reported not to improve the progression-free survival of patients with malignant mesothelioma. Cell culture supernatant contains extracellular components such as serum, which can mask the existence of unknown cell-derived factors in the supernatant and make it difficult to detect the factors by subsequent protein analysis. We tried using serum-free culture for human mesothelioma cell lines, NCI-H28, NCI-H2452 and NCI-H2052, and only NCI-H2052 cells adapted to serum-free culture. We found that serum-free culture supernatant derived from NCI-H2052 cells induces the formation of capillary-like tube structures (tube formation) in three-dimensional culture, in which endothelial cells sandwiched between two layers of collagen or embedded in collagen are incubated with various angiogenic inducers. However, neither neutralization of VEGF-A nor RNA interference of VEGF receptor 2 (VEGFR2) suppressed the supernatant-induced tube formation. Using mass spectrometry, we identified a total of 399 proteins in the supernatant, among which interleukin-8 (IL-8), growth-regulated a-protein, midkine, IL-18, IL-6, hepatoma-derived growth factor, clusterin and granulin (GRN), also known as progranulin (PGRN), were included as a candidate protein inducing angiogenesis. Neutralizing assays and RNA interference showed that PGRN, but not the above seven candidate proteins, caused the supernatant-induced tube formation. We also found that NCI-H28 and NCI-H2452 cells express PGRN. Furthermore, we demonstrate that not only PGRN but also GRN-like protein have an important role in the supernatant-induced tube formation. Thus, mesothelioma-derived GRNs induce VEGF-independent angiogenesis.	[Eguchi, R.; Wakabayashi, I.] Hyogo Coll Med, Dept Environm & Prevent Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan; [Nakano, T.] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Eguchi, R (corresponding author), Hyogo Coll Med, Dept Environm & Prevent Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	r-eguchi@hyo-med.ac.jp		Eguchi, Ryoji/0000-0002-2417-7578	Hyogo College of Medicine; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; JSPS KAKENHI [16K14626]	Hyogo College of Medicine; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Ms Naoko Hamaue and Mr Daiki Haruguchi for their excellent technical assistance. This work was supported by a Grant-in-Aid for Researchers, Hyogo College of Medicine, 2013, the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2015 and JSPS KAKENHI Grant Number 16K14626.	Bao CH, 2014, FUTURE ONCOL, V10, P2675, DOI 10.2217/fon.14.194; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Davidson B, 2004, CANCER-AM CANCER SOC, V100, P2139, DOI 10.1002/cncr.20219; Dowell JE, 2012, LUNG CANCER, V77, P567, DOI 10.1016/j.lungcan.2012.05.111; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Edwards JG, 2001, BRIT J CANCER, V85, P863, DOI 10.1054/bjoc.2001.1997; Eguchi R, 2008, PROTEOMICS, V8, P2897, DOI 10.1002/pmic.200800055; Eguchi R, 2013, CELL SIGNAL, V25, P1731, DOI 10.1016/j.cellsig.2013.05.008; Eguchi R, 2012, CARCINOGENESIS, V33, P969, DOI 10.1093/carcin/bgs109; Eguchi R, 2010, INT J ONCOL, V37, P1289, DOI 10.3892/ijo_00000780; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Goudar Ranjit Kumar, 2005, Curr Oncol Rep, V7, P260, DOI 10.1007/s11912-005-0048-3; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Kadomatsu K, 2014, BRIT J PHARMACOL, V171, P936, DOI 10.1111/bph.12537; Karch CM, 2013, NEUROBIOL AGING, V34, P2538, DOI 10.1016/j.neurobiolaging.2013.05.004; Keeley EC, 2010, ADV CANCER RES, V106, P91, DOI 10.1016/S0065-230X(10)06003-3; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Kumar-Singh S, 1997, J PATHOL, V182, P211, DOI 10.1002/(SICI)1096-9896(199706)182:2<211::AID-PATH834>3.0.CO;2-D; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Palma G, 2013, BBA-REV CANCER, V1836, P296, DOI 10.1016/j.bbcan.2013.09.001; Pan CX, 2004, CLIN CANCER RES, V10, P1333, DOI 10.1158/1078-0432.CCR-1123-03; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Sun XJ, 2004, AM J RESP CELL MOL, V30, P510, DOI 10.1165/rcmb.2003-0266OC; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Vogelzang NJ, 2008, LANCET, V371, P1640, DOI 10.1016/S0140-6736(08)60703-5; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Yang D, 2015, AM J CANCER RES, V5, P3085; ZHOU J, 1993, J BIOL CHEM, V268, P10863	38	23	25	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					714	722		10.1038/onc.2016.226	http://dx.doi.org/10.1038/onc.2016.226			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27345409				2022-12-26	WOS:000394167700012
J	Li, DJ; Wang, CJ; Yao, Y; Chen, L; Liu, GY; Zhang, RX; Liu, Q; Shi, FD; Hao, JW				Li, Daojing; Wang, Chunjiong; Yao, Yang; Chen, Li; Liu, Guiyou; Zhang, Rongxin; Liu, Qiang; Shi, Fu-Dong; Hao, Junwei			mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type	FASEB JOURNAL			English	Article						ischemia; glia cells; polarization	FOCAL CEREBRAL-ISCHEMIA; MICROGLIA/MACROPHAGE POLARIZATION; MACROPHAGE POLARIZATION; OXIDATIVE STRESS; ARTERY OCCLUSION; INJURY; RAPAMYCIN; CELLS; ACTIVATION; EVEROLIMUS	Inflammatory factors secreted by microglia play an important role in focal ischemic stroke. The mammalian target of rapamycin (mTOR) pathway is a known regulator of immune responses, but the role that mTORC1 signaling plays in poststroke neuroinflammation is not clear. To explore the relationship between microglial action in the mTORC1 pathway and the impact on stroke, we administered the mTORC1 inhibitors sirolimus and everolimus to mice. Presumably, disrupting the mTORC1 pathway after focal ischemic stroke should clarify the subsequent activity of microglia. For that purpose, we generated mice deficient in the regulatory associated protein of mTOR (Raptor) in microglia, whose mTORC1 signaling was blocked, by crossing Raptor loxed (Raptor(flox/flox)) mice with CX3CR1(CreER) mice, which express Cre recombinase under the control of the CX3C chemokine receptor 1 promoter. mTORC1 blockade reduced lesion size, improved motor function, dramatically decreased production of proinflammatory cytokines and chemokines, and reduced the number of M1 type microglia. Thus, mTORC1 blockade apparently attenuated behavioral deficits and poststroke inflammation after middle cerebral artery occlusion by preventing microglia polarization toward the M1 type.	[Li, Daojing; Yao, Yang; Chen, Li; Liu, Qiang; Shi, Fu-Dong; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China; [Li, Daojing; Yao, Yang; Chen, Li; Liu, Qiang; Shi, Fu-Dong; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Wang, Chunjiong] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin, Peoples R China; [Zhang, Rongxin] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China; [Liu, Guiyou] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Liu, Qiang; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China.; Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn	Zhang, Rongxin/ABG-3679-2021; Liu, Qiang/HHZ-3181-2022	Liu, Guiyou/0000-0002-1126-2888; Zhang, Rongxin/0000-0002-4083-374X; Hao, Junwei/0000-0002-3075-5434	National Basic Research Program of China [2013CB966900]; National Natural Science Foundation of China [81571600, 81322018, 81273287, 81100887]; Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	The authors thank Professor Ding Ai (Tianjin Medical University) for kindly providing us with the transgenic mice. This work was supported by National Basic Research Program of China Grant 2013CB966900 (to F.D.S); National Natural Science Foundation of China Grants 81571600, 81322018, 81273287, and 81100887 (to J.W.H.); the Youth Top-notch Talent Support Program; and the National Key Clinical Specialty Construction Project of China. The authors declare no conflicts of interest.	Ahmad A, 2011, NEUROCHEM RES, V36, P1360, DOI 10.1007/s11064-011-0458-6; Amantea D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00147; Banerjee S, 2011, MOL CANCER THER, V10, P279, DOI 10.1158/1535-7163.MCT-10-0654; Chauhan A, 2015, EUR J PHARMACOL, V757, P28, DOI 10.1016/j.ejphar.2015.03.006; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14308; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00338; Fletcher L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068281; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gelosa P, 2014, J CEREBR BLOOD F MET, V34, P979, DOI 10.1038/jcbfm.2014.45; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kumar A., 2015, J NEUROTRAUMA; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacKeigan JP, 2015, NEURO-ONCOLOGY, V17, P1550, DOI 10.1093/neuonc/nov152; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Meng LH, 2015, ACTA PHARMACOL SIN, V36, P1163, DOI 10.1038/aps.2015.68; Moes DJAR, 2015, DRUG DISCOV TODAY, V20, P1243, DOI 10.1016/j.drudis.2015.05.006; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Saran U, 2015, CLIN SCI, V129, P895, DOI 10.1042/CS20150149; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Sosunov AA, 2012, EPILEPSIA, V53, P78, DOI 10.1111/j.1528-1167.2012.03478.x; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wolf Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00026; Xia CY, 2015, INT IMMUNOPHARMACOL, V25, P377, DOI 10.1016/j.intimp.2015.02.019; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492; Yao Y, 2014, INT J MOL SCI, V15, P20913, DOI 10.3390/ijms151120913; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	41	94	96	1	46	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3388	3399		10.1096/fj.201600495R	http://dx.doi.org/10.1096/fj.201600495R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27342766				2022-12-26	WOS:000384329800011
J	Williams, ST; Ito, S; Wakamatsu, K; Goral, T; Edwards, NP; Wogelius, RA; Henkel, T; de Oliveira, LFC; Maia, LF; Strekopytov, S; Jeffries, T; Speiser, DI; Marsden, JT				Williams, S. T.; Ito, S.; Wakamatsu, K.; Goral, T.; Edwards, N. P.; Wogelius, R. A.; Henkel, T.; de Oliveira, L. F. C.; Maia, L. F.; Strekopytov, S.; Jeffries, T.; Speiser, D. I.; Marsden, J. T.			Identification of Shell Colour Pigments in Marine Snails Clanculus pharaonius and C-margaritarius (Trochoidea; Gastropoda)	PLOS ONE			English	Article							ACID-SOLUBLE PIGMENTS; RAMAN-SPECTROSCOPY; CONJUGATED POLYENES; MOLLUSCAN SHELLS; CAROTENOIDS; PORPHYRINS; PHEOMELANIN; EUMELANIN; SPECTRA; TOOL	Colour and pattern are key traits with important roles in camouflage, warning and attraction. Ideally, in order to begin to understand the evolution and ecology of colour in nature, it is important to identify and, where possible, fully characterise pigments using biochemical methods. The phylum Mollusca includes some of the most beautiful exemplars of biological pigmentation, with the vivid colours of sea shells particularly prized by collectors and scientists alike. Biochemical studies of molluscan shell colour were fairly common in the last century, but few of these studies have been confirmed using modern methods and very few shell pigments have been fully characterised. Here, we use modern chemical and multimodal spectroscopic techniques to identify two porphyrin pigments and eumelanin in the shell of marine snails Clanculus pharaonius and C margaritarius. The same porphyrins were also identified in coloured foot tissue of both species. We use high performance liquid chromatography (HPLC) to show definitively that these porphyrins are uroporphyrin I and uroporphyrin III. Evidence from confocal microscopy analyses shows that the distribution of porphyrin pigments corresponds to the striking pink-red of C. pharaonius shells, as well as pink-red dots and lines on the early whorls of C. margaritarius and yellow-brown colour of later whorls. Additional HPLC results suggest that eumelanin is likely responsible for black spots. We refer to the two differently coloured porphyrin pigments as trochopuniceus (pinkred) and trochoxouthos (yellow-brown) in order to distinguish between them. Trochopuniceus and trochoxouthos were not found in the shell of a third species of the same superfamily, Calliostoma zizyphinum, despite its superficially similar colouration, suggesting that this species has different shell pigments. These findings have important implications for the study of colour and pattern in molluscs specifically, but in other taxa more generally, since this study shows that homology of visible colour cannot be assumed without identification of pigments.	[Williams, S. T.] Nat Hist Museum, Dept Life Sci, London, England; [Ito, S.; Wakamatsu, K.] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan; [Goral, T.; Strekopytov, S.; Jeffries, T.] Nat Hist Museum, Imaging & Anal Ctr, London, England; [Edwards, N. P.; Wogelius, R. A.; Henkel, T.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [de Oliveira, L. F. C.; Maia, L. F.] Univ Fed Juiz de Fora, NEEM, Dept Quim, Inst Ciencias Exatas, Juiz De Fora, MG, Brazil; [Speiser, D. I.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Marsden, J. T.] Kings Coll Hosp London, Reference Biochem Labs, Viapath, London, England	Natural History Museum London; Fujita Health University; Natural History Museum London; University of Manchester; Universidade Federal de Juiz de Fora; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; King's College Hospital NHS Foundation Trust; King's College Hospital	Williams, ST (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.	s.williams@nhm.ac.uk	Maia, Lenize F./N-9420-2013; Williams, Suzanne T/A-9604-2008; Wakamatsu, Kazumasa/AAZ-5877-2020; Strekopytov, Stanislav/A-8863-2011; Speiser, Daniel Isaac/AGL-4870-2022; Strekopytov, Stanislav/ABI-2251-2020	Maia, Lenize F./0000-0002-7433-4156; Williams, Suzanne T/0000-0003-2995-5823; Wakamatsu, Kazumasa/0000-0003-1748-9001; Strekopytov, Stanislav/0000-0001-5129-9880; Speiser, Daniel Isaac/0000-0001-6662-3583; Ito, Shosuke/0000-0001-9182-5144; Edwards, Nicholas/0000-0002-3760-4225	Department of Life Sciences, Natural History Museum; Brazilian agency CNPq; Brazilian agency CAPES; Brazilian agency FAPEMIG; KAUST [CRG-1-2012-BER-002, 59130357]; National Science Foundation [IOS-1457148]; NERC [NE/J023426/1]; Natural Environment Research Council [NE/J023426/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/M001253/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K09794] Funding Source: KAKEN; STFC [ST/M001253/1] Funding Source: UKRI	Department of Life Sciences, Natural History Museum; Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); KAUST(King Abdullah University of Science & Technology); National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	STW gratefully acknowledges financial support from the Department of Life Sciences, Natural History Museum. LFCO and LFM thank the Brazilian agencies CNPq, CAPES and FAPEMIG for financial support. STW's visit to the King Abdullah University of Science and Technology was funded by KAUST awards CRG-1-2012-BER-002 and 59130357 (to M.L. Berumen). DIS acknowledges funding from the National Science Foundation (IOS-1457148). We acknowledge the Diamond Light Source for synchrotron access granted under proposal SP9488 and NPE is funded by NERC grant NE/J023426/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors received no specific funding for this work.	[Anonymous], 1997, COLOURLIFE INTRO C; Aydin M, 2013, VIB SPECTROSC, V68, P141, DOI 10.1016/j.vibspec.2013.06.005; Barnard W, 2006, J RAMAN SPECTROSC, V37, P342, DOI 10.1002/jrs.1461; Bergamonti L, 2013, EUR J MINERAL, V25, P845, DOI 10.1127/0935-1221/2013/0025-2318; Bertsch PM, 2001, CHEM REV, V101, P1809, DOI 10.1021/cr990070s; Britton George, 2008, V4, P99, DOI 10.1007/978-3-7643-7499-0_6; Cai ZX, 2011, FOOD CHEM, V128, P129, DOI 10.1016/j.foodchem.2011.03.006; Caze B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126745; Church A. H., 1892, Philosophical Transactions, Vclxxxviii, P511; Church AH., 1869, PHILOS T ROYAL SOC L, V159, P627, DOI DOI 10.1098/RSTL.1869.0024; COMFORT A, 1949, BIOCHEM J, V45, P199, DOI 10.1042/bj0450199; COMFORT A, 1950, BIOCHEM J, V47, P254, DOI 10.1042/bj0470254; COMFORT A., 1950, PROC MALACOL SOC LONDON, V28, P79; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; COMFORT A., 1951, PROC MALACOL SOC LONDON, V29, P35; COMFORT A, 1949, BIOCHEM J, V45, P204, DOI 10.1042/bj0450204; COMFORT A, 1950, SCIENCE, V112, P279, DOI 10.1126/science.112.2906.279; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; de Oliveira LN, 2013, SPECTROCHIM ACTA A, V114, P541, DOI 10.1016/j.saa.2013.05.095; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; DYCK J, 1992, AUK, V109, P293, DOI 10.2307/4088197; Fernandes RF, 2015, SPECTROCHIM ACTA A, V134, P434, DOI 10.1016/j.saa.2014.06.022; Ferrer P, 2013, MARTECH 2013 5TH INT; Fischer H, 1932, H-S Z PHYSIOL CHEM, V204, P101, DOI 10.1515/bchm2.1932.204.1-2.101; Fischer H, 1930, H-S Z PHYSIOL CHEM, V190, P75, DOI 10.1515/bchm2.1930.190.1-2.75; Fletcher JS, 2006, APPL SURF SCI, V252, P6513, DOI 10.1016/j.apsusc.2006.02.213; Fox DL, 1976, ANIMAL BIOCHROMES ST, V2d; Goodwin T.W., 1972, P187; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; HENDRY GAF, 1980, J MED GENET, V17, P1, DOI 10.1136/jmg.17.1.1; Henkel T, 2014, TREATISE GEOCHEMISTR, P411, DOI DOI 10.1016/B978-0-08-095975-7.01431-5; Henkel T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2735565; Henkel T, 2009, RAPID COMMUN MASS SP, V23, P3355, DOI 10.1002/rcm.4257; Hessels J, 2004, J INHERIT METAB DIS, V27, P19, DOI 10.1023/B:BOLI.0000016613.75677.05; Ito S, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P167; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; JONES P, 1979, COMP BIOCHEM PHYS B, V63, P185, DOI 10.1016/0305-0491(79)90027-0; JORDAN PM, 1987, FEBS LETT, V225, P87, DOI 10.1016/0014-5793(87)81136-5; Karampelas S, 2007, J RAMAN SPECTROSC, V38, P217, DOI 10.1002/jrs.1626; Karampelas S, 2009, EUR J MINERAL, V21, P85, DOI 10.1127/0935-1221/2009/0021-1897; Kennedy G.Y., 1979, Advances in Marine Biology, V16, P309, DOI 10.1016/S0065-2881(08)60295-3; KENNEDY GY, 1975, ANN NY ACAD SCI, V244, P662, DOI 10.1111/j.1749-6632.1975.tb41560.x; KENNEDY GY, 1954, J MAR BIOL ASSOC UK, V33, P663, DOI 10.1017/S002531540002693X; KENNEDY GY, 1959, J MAR BIOL ASSOC UK, V38, P27, DOI 10.1017/S0025315400015551; KOBLUK D R, 1989, Palaios, V4, P63, DOI 10.2307/3514734; Konstantinidou K, 2017, STUD CONSERV, V62, P24, DOI 10.1080/00393630.2016.1150411; Kosaki T., 1947, SEIRI SEITAI, V1, P247; Lemer S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1776-x; Lindstedt C, 2010, FUNCT ECOL, V24, P759, DOI 10.1111/j.1365-2435.2010.01686.x; Macmunn C. A., 1886, Journal Physiol, Vvii, P240; Maia LF, 2013, J RAMAN SPECTROSC, V44, P560, DOI 10.1002/jrs.4226; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Maoka T, 2012, J OLEO SCI, V61, P69, DOI 10.5650/jos.61.69; McGraw K.J., 2006, BIRD COLORATION, P354; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Nakayama S, 2013, FEBS OPEN BIO, V3, P421, DOI 10.1016/j.fob.2013.10.001; NICHOLAS REH, 1949, BIOCHEM J, V45, P208, DOI 10.1042/bj0450208; NICHOLAS REH, 1951, BIOCHEM J, V50, P194, DOI 10.1042/bj0500194; Niecke M, 1999, J ORNITHOL, V140, P355, DOI 10.1007/BF01651032; OGATA T, 1979, COMP BIOCHEM PHYS B, V63, P239, DOI 10.1016/0305-0491(79)90035-X; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Ozgo M, 2012, GLOBAL CHANGE BIOL, V18, P74, DOI 10.1111/j.1365-2486.2011.02514.x; PAUL KG, 1953, J CLIN PATHOL, V6, P135, DOI 10.1136/jcp.6.2.135; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Speiser DI, 2014, J NAT HIST, V48, P2899, DOI 10.1080/00222933.2014.959572; SPIRO TG, 1990, COORDIN CHEM REV, V100, P541, DOI 10.1016/0010-8545(90)85019-O; Stemmer K, 2014, J MOLLUS STUD, V80, P365, DOI 10.1093/mollus/eyu033; Thomas DB, 2015, J EXP BIOL, V218, P2670, DOI 10.1242/jeb.124917; Thompson CM, 2014, J RAMAN SPECTROSC, V45, P349, DOI 10.1002/jrs.4470; Tixier R., 1952, Memoires Museum Histoire Nat Paris NS, V5A, P41; Tixier R., 1945, ANN I OCEANOGRAPHIQU, V22, P243; TOWNSLEY PM, 1965, CAN J ZOOLOG, V43, P167, DOI 10.1139/z65-015; UNDERWOOD AJ, 1976, J EXP MAR BIOL ECOL, V23, P229, DOI 10.1016/0022-0981(76)90022-8; URMOS J, 1991, AM MINERAL, V76, P641; Verdes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143545; VERONELLI M, 1995, J RAMAN SPECTROSC, V26, P683, DOI 10.1002/jrs.1250260815; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; WALDENSTROM J, 1937, ACTA MED SCAND     S, V82, P1; WIJESEKERA TP, 1985, ADV EXP MED BIOL, V193, P229; Williams ST, 2017, BIOL REV, V92, P1039, DOI 10.1111/brv.12268; Williams ST, 2012, ZOOL SCR, V41, P571, DOI 10.1111/j.1463-6409.2012.00552.x; WITH TK, 1955, BIOCHEM J, V60, P703, DOI 10.1042/bj0600703; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748; Zheng HP, 2010, FOOD CHEM, V122, P1164, DOI 10.1016/j.foodchem.2010.03.109	88	43	45	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156664	10.1371/journal.pone.0156664	http://dx.doi.org/10.1371/journal.pone.0156664			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367426	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900006
J	Ansari, S; Fatma, T				Ansari, Sabbir; Fatma, Tasneem			Cyanobacterial Polyhydroxybutyrate (PHB): Screening, Optimization and Characterization	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; BLUE-GREEN-ALGA; BACTERIAL POLYHYDROXYALKANOATES; BLEND FILMS; ACCUMULATION; METABOLISM; POLY(3-HYDROXYBUTYRATE); BIODEGRADATION; POLY(3-HYDROXYALKANOATES); POLY-3-HYDROXYBUTYRATE	In modern life petroleum-based plastic has become indispensable due to its frequent use as an easily available and a low cost packaging and moulding material. However, its rapidly growing use is causing aquatic and terrestrial pollution. Under these circumstances, research and development for biodegradable plastic (bioplastics) is inevitable. Polyhydroxybutyrate (PHB), a type of microbial polyester that accumulates as a carbon/energy storage material in various microorganisms can be a good alternative. In this study, 23 cyanobacterial strains (15 heterocystous and 8 non-heterocystous) were screened for PHB production. The highest PHB (6.44% w/w of dry cells) was detected in Nostoc muscorum NCCU-442 and the lowest in Spirulina platensis NCCU-S5 (0.51% w/w of dry cells), whereas no PHB was found in Cylindrospermum sp., Oscillatoria sp. and Plectonema sp. Presence of PHB granules in Nostoc muscorum NCCU-442 was confirmed microscopically with Sudan black B and Nile red A staining. Pretreatment of biomass with methanol: acetone: water: dimethylformamide [40: 40: 18: 2 (MAD-I)] with 2 h magnetic bar stirring followed by 30 h continuous chloroform soxhlet extraction acted as optimal extraction conditions. Optimized physicochemical conditions viz. 7.5 pH, 30 degrees C temperature, 10: 14 h light: dark periods with 0.4% glucose (as additional carbon source), 1.0 gl(-1) sodium chloride and phosphorus deficiency yielded 26.37% PHB on 7(th) day instead of 21(st) day. Using FTIR, H-1 NMR and GC-MS, extracted polymer was identified as PHB. Thermal properties (melting temperature, decomposition temperatures etc.) of the extracted polymer were determined by TGA and DSC. Further, the polymer showed good tensile strength and young's modulus with a low extension to break ratio comparable to petrochemical plastic. Biodegradability potential tested as weight loss percentage showed efficient degradation (24.58%) of PHB within 60 days by mixed microbial culture in comparison to petrochemical plastic.	[Ansari, Sabbir; Fatma, Tasneem] Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India	Jamia Millia Islamia	Fatma, T (corresponding author), Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India.	fatma_cbl@yahoo.com						Alves VD, 2011, CARBOHYD POLYM, V83, P1582, DOI 10.1016/j.carbpol.2010.10.010; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Arora NK, 2006, WORLD J MICROB BIOT, V22, P603, DOI 10.1007/s11274-005-9077-1; Asada Y, 1999, INT J BIOL MACROMOL, V25, P37, DOI 10.1016/S0141-8130(99)00013-6; BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954; Bhati R, 2010, BIOTECHNOL J, V5, P1181, DOI 10.1002/biot.201000252; BOTTOMLEY PJ, 1976, ARCH MICROBIOL, V108, P249, DOI 10.1007/BF00454849; Bucci DZ, 2007, POLYM TEST, V26, P908, DOI 10.1016/j.polymertesting.2007.06.013; CARR NG, 1966, BIOCHIM BIOPHYS ACTA, V120, P308, DOI 10.1016/0926-6585(66)90353-0; Carraher Jr C.E, 1996, POLYM CHEM INTRO; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Cheng GX, 2003, J MATER SCI-MATER M, V14, P1073, DOI 10.1023/B:JMSM.0000004004.37103.f4; Doi Y., 1990, MICROBIAL POLYESTERS; Furuya Ken, 1998, Journal of Oceanography, V54, P199, DOI 10.1007/BF02751695; Godbole S, 2003, BIORESOURCE TECHNOL, V86, P33, DOI 10.1016/S0960-8524(02)00110-4; GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P127, DOI 10.1016/0141-3910(84)90032-6; Gumel AM, 2014, BRAZ J MICROBIOL, V45, P427, DOI 10.1590/S1517-83822014000200009; HOARE DS, 1971, ARCH MIKROBIOL, V78, P310, DOI 10.1007/BF00412271; Jau MH, 2005, INT J BIOL MACROMOL, V36, P144, DOI 10.1016/j.ijbiomac.2005.05.002; Karbasi F., 2011, World Applied Sciences Journal, V14, P36; Kessler B, 2001, J BIOTECHNOL, V86, P97, DOI 10.1016/S0168-1656(00)00404-1; Khoja TM, 1975, EUR J PHYCOL, P139; LAW JH, 1961, J BACTERIOL, V82, P33, DOI 10.1128/JB.82.1.33-36.1961; Lee SN, 2002, J APPL POLYM SCI, V83, P2945, DOI 10.1002/app.10318; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Mallick N., 2011, NEW FRONTIERS ENV BI, P56; Nishioka M, 2001, BIOTECHNOL LETT, V23, P1095, DOI 10.1023/A:1010551614648; Oliveira FC, 2007, BIORESOURCE TECHNOL, V98, P633, DOI 10.1016/j.biortech.2006.02.022; Panda B, 2006, BIORESOURCE TECHNOL, V97, P1296, DOI 10.1016/j.biortech.2005.05.013; Parra DF, 2006, POLYM DEGRAD STABIL, V91, P1954, DOI 10.1016/j.polymdegradstab.2006.02.008; PELROY RA, 1972, ARCH MIKROBIOL, V86, P25, DOI 10.1007/BF00412397; Queiroz MI, 2011, APPL ENERG, V88, P3438, DOI 10.1016/j.apenergy.2010.12.047; RIIS V, 1988, J CHROMATOGR, V445, P285, DOI 10.1016/S0021-9673(01)84535-0; Samantaray S, 2011, APPL ENVIRON MICROB, V77, P8735, DOI 10.1128/AEM.05275-11; Sharma L, 2005, BIOTECHNOL LETT, V27, P59, DOI 10.1007/s10529-004-6586-1; Shrivastav A, 2010, INT J BIOL MACROMOL, V46, P255, DOI 10.1016/j.ijbiomac.2010.01.001; STAL LJ, 1992, FEMS MICROBIOL LETT, V103, P169, DOI 10.1111/j.1574-6968.1992.tb05835.x; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Terada M, 1999, INT J BIOL MACROMOL, V25, P207, DOI 10.1016/S0141-8130(99)00036-7; Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P1181, DOI 10.1023/B:BILE.0000036599.15302.e5; VINCENZINI M, 1990, J BACTERIOL, V172, P2791, DOI 10.1128/jb.172.5.2791-2792.1990; VINCENZINI M, 1999, CHEM MICROALGAE, P292; Wei YH, 2011, INT J MOL SCI, V12, P252, DOI 10.3390/ijms12010252; Yellore V, 1998, LETT APPL MICROBIOL, V26, P391, DOI 10.1046/j.1472-765X.1998.00362.x; Zarrouk C., 1966, THESIS; Zhang S, 1997, POLYMER, V38, P5379; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6; [No title captured]	50	60	65	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158168	10.1371/journal.pone.0158168	http://dx.doi.org/10.1371/journal.pone.0158168			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359097	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200047
J	Hassold, S; Lowry, PP; Bauert, MR; Razafintsalama, A; Ramamonjisoa, L; Widmer, A				Hassold, Sonja; Lowry, Porter P., II; Bauert, Martin R.; Razafintsalama, Annick; Ramamonjisoa, Lolona; Widmer, Alex			DNA Barcoding of Malagasy Rosewoods: Towards a Molecular Identification of CITES-Listed Dalbergia Species	PLOS ONE			English	Article							ENDANGERED ROSEWOOD; GEOGRAPHIC ORIGIN; CAOS SOFTWARE; FOREST; IVORY; INSIGHTS; TRADE; TOOL; CONSERVATION; BIODIVERSITY	Illegal selective logging of tropical timber is of increasing concern worldwide. Madagascar is a biodiversity hotspot and home to some of the world's most sought after tropical timber species. Malagasy rosewoods belong to the genus Dalbergia (Fabaceae), which is highly diverse and has a pantropical distribution, but these timber species are among the most threatened as a consequence of intensive illegal selective logging and deforestation. Reliable identification of Dalbergia species from Madagascar is important for law enforcement but is almost impossible without fertile plant material, which is often unavailable during forest inventories or when attempting to identify logged trees of cut wood. DNA barcoding has been promoted as a promising tool for species identification in such cases. In this study we tested whether DNA barcoding with partial sequences of three plastid markers (matK, rbcL and trnL (UAA)) can distinguish between Dalbergia from Madagascar and from other areas of its distributional range, and whether Malagasy species can be distinguished from one another. Phylogenetic analyses revealed that the Malagasy Dalbergia species studied form two monophyletic groups, each containing two subgroups, only one of which corresponds to a single species. We characterized diagnostic polymorphisms in the three DNA barcoding markers that allow rapid discrimination between Dalbergia from Madagascar and from other areas of its distribution range. Species identification success based on individual barcoding markers or combinations was poor, whereas subgroup identification success was much higher (up to 98%), revealing both the value and limitations of a DNA barcoding approach for the identification of closely related Malagasy rosewoods.	[Hassold, Sonja; Widmer, Alex] ETH, Inst Integrat Biol, Zurich, Switzerland; [Lowry, Porter P., II] Missouri Bot Garden, St Louis, MO USA; [Lowry, Porter P., II] Museum Natl Hist Nat, Dept Syst & Evolut, ISYEB, UMR 7205, Paris, France; [Bauert, Martin R.] Zoo Zurich AG, Zurich, Switzerland; [Razafintsalama, Annick; Ramamonjisoa, Lolona] Silo Natl Graines Forestiers, Antananarivo, Madagascar	Swiss Federal Institutes of Technology Domain; ETH Zurich; Missouri Botanical Gardens; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Widmer, A (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	alex.widmer@env.ethz.ch	Widmer, Alex/B-6841-2009	Widmer, Alex/0000-0001-8253-5137	Mercator Foundation Switzerland through the Zuerich-Basel Plant Science Center [2009-0549]; Ruebel Foundation Switzerland	Mercator Foundation Switzerland through the Zuerich-Basel Plant Science Center; Ruebel Foundation Switzerland	This work was performed as part of the PSC-Mercator PhD Fellowship: Bridging Plant Sciences and Policy supported by the Mercator Foundation Switzerland (project code 2009-0549; http://www.stiftungmercator.ch/stiftung/projektformate/wissenschaft.html) through the Zuerich-Basel Plant Science Center (http://www.plantsciences.uzh.ch/en/research/fellowships/mercator.html) and the Ruebel Foundation Switzerland. AW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babineau M, 2013, S AFR J BOT, V89, P94, DOI 10.1016/j.sajb.2013.06.018; Barrett MA, 2013, NATURE, V499, P29, DOI 10.1038/499029c; Barrett MA, 2010, SCIENCE, V328, P1109, DOI 10.1126/science.1187740; Leite FAB, 2014, TREE GENET GENOMES, V10, P307, DOI 10.1007/s11295-013-0685-x; Bennett EL, 2015, CONSERV BIOL, V29, P54, DOI 10.1111/cobi.12377; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bhagwat RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142965; Biggs D, 2013, SCIENCE, V339, P1038, DOI 10.1126/science.1229998; Bosser J, 2002, LEGUMINOSAE MADAGASC, P321; Bosser Jean, 2005, Adansonia (Paris), V27, P209; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Cardoso D, 2013, S AFR J BOT, V89, P58, DOI 10.1016/j.sajb.2013.05.001; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Degen B, 2013, FORENSIC SCI INT-GEN, V7, P55, DOI 10.1016/j.fsigen.2012.06.003; Degen B., 2007, P INT WORKSH FING ME, P6; Deguilloux MF, 2004, ANN FOREST SCI, V61, P97, DOI 10.1051/forest:2003089; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2012, MOL PHYLOGENET EVOL, V62, P275, DOI 10.1016/j.ympev.2011.09.020; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkeldey R, 2010, APPL MICROBIOL BIOT, V85, P1251, DOI 10.1007/s00253-009-2328-6; Gagnon E, 2013, S AFR J BOT, V89, P111, DOI 10.1016/j.sajb.2013.07.027; Galal-Khallaf A, 2014, FOOD CONTROL, V46, P441, DOI 10.1016/j.foodcont.2014.06.016; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; Hartvig I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138231; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holtken AM, 2012, HOLZFORSCHUNG, V66, P97, DOI 10.1515/HF.2011.142; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Innes J. L., 2010, Madagascar Conservation and Development, V5, P6; Jiao LC, 2014, HOLZFORSCHUNG, V68, P487, DOI 10.1515/hf-2013-0129; Jorger KM, 2014, SPIXIANA, V37, P21; Jolivet C, 2012, FORENSIC SCI INT-GEN, V6, P487, DOI 10.1016/j.fsigen.2011.11.002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keong CH, 2007, INT FOREST REV, V9, P805, DOI 10.1505/ifor.9.3.805; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lamendin R, 2015, FOOD CONTROL, V47, P436, DOI 10.1016/j.foodcont.2014.07.039; Lopez P., 2009, MADAGASCAR CONSERVAT, V5, P110, DOI DOI 10.4314/MCD.V5I2.63141; Lowe A., 2007, P INT WORKSH FING ME; Lowe AJ, 2011, IAWA J, V32, P251, DOI 10.1163/22941932-90000055; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Patel E. R., 2007, MADAG CONSERV DEV, V2, P11, DOI DOI 10.4314/MCD.V2I1.44124; Phong DT, 2014, ASIAN J APPL SCI, V02, P116; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Randriamalala H., 2010, Madagascar Conservation and Development, V5, P11; Ribeiro RA, 2011, HEREDITY, V106, P46, DOI 10.1038/hdy.2010.64; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Saslis-Lagoudakis CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022275; Schuurman D., 2009, Madagascar Conservation and Development, V4, P98; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Styger E, 2007, AGR ECOSYST ENVIRON, V119, P257, DOI 10.1016/j.agee.2006.07.012; Subedi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-64; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Turner B, 2013, MOL PHYLOGENET EVOL, V69, P740, DOI 10.1016/j.ympev.2013.07.002; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vatanparast M, 2013, S AFR J BOT, V89, P143, DOI 10.1016/j.sajb.2013.07.001; WAEBER PO, 2013, MADAG CONSERV DEV, V8, P52, DOI DOI 10.4314/mcd.v8i2.1; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Wilme L, 2009, PRECIOUS TREES PAY O; Wozney KM, 2012, FORENSIC SCI INT, V219, P106, DOI 10.1016/j.forsciint.2011.12.006; Zinner D, 2014, REG ENVIRON CHANGE, V14, P157, DOI 10.1007/s10113-013-0475-x	77	34	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157881	10.1371/journal.pone.0157881	http://dx.doi.org/10.1371/journal.pone.0157881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362258	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200027
J	Pignat, JM; Mauron, E; Johr, J; de Keranflec'h, CG; Van De Ville, D; Preti, MG; Meskaldji, DE; Homberg, V; Laureys, S; Draganski, B; Frackowiak, R; Diserens, K				Pignat, Jean-Michel; Mauron, Etienne; Johr, Jane; de Keranflec'h, Charlotte Gilart; Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.; Hoemberg, Volker; Laureys, Steven; Draganski, Bogdan; Frackowiak, Richard; Diserens, Karin			Outcome Prediction of Consciousness Disorders in the Acute Stage Based on a Complementary Motor Behavioural Tool	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; VEGETATIVE STATE; UNRESPONSIVE WAKEFULNESS; DIAGNOSTIC-ACCURACY; FOLLOW-UP; RECOVERY; REHABILITATION; PROGNOSIS; COMA	Introduction Attaining an accurate diagnosis in the acute phase for severely brain-damaged patients presenting Disorders of Consciousness (DOC) is crucial for prognostic validity; such a diagnosis determines further medical management, in terms of therapeutic choices and end-of-life decisions. However, DOC evaluation based on validated scales, such as the Revised Coma Recovery Scale (CRS-R), can lead to an underestimation of consciousness and to frequent misdiagnoses particularly in cases of cognitive motor dissociation due to other aetiologies. The purpose of this study is to determine the clinical signs that lead to a more accurate consciousness assessment allowing more reliable outcome prediction. Methods From the Unit of Acute Neurorehabilitation (University Hospital, Lausanne, Switzerland) between 2011 and 2014, we enrolled 33 DOC patients with a DOC diagnosis according to the CRS-R that had been established within 28 days of brain damage. The first CRS-R assessment established the initial diagnosis of Unresponsive Wakefulness Syndrome (UWS) in 20 patients and a Minimally Consciousness State (MCS) in the remaining13 patients. We clinically evaluated the patients over time using the CRS-R scale and concurrently from the beginning with complementary clinical items of a new observational Motor Behaviour Tool (MBT). Primary endpoint was outcome at unit discharge distinguishing two main classes of patients (DOC patients having emerged from DOC and those remaining in DOC) and 6 subclasses detailing the outcome of UWS and MCS patients, respectively. Based on CRS-R and MBT scores assessed separately and jointly, statistical testing was performed in the acute phase using a non-parametric Mann-Whitney U test; longitudinal CRS-R data were modelled with a Generalized Linear Model. Results Fifty-five per cent of the UWS patients and 77% of the MCS patients had emerged from DOC. First, statistical prediction of the first CRS-R scores did not permit outcome differentiation between classes; longitudinal regression modelling of the CRS-R data identified distinct outcome evolution, but not earlier than 19 days. Second, the MBT yielded a significant outcome predictability in the acute phase (p<0.02, sensitivity>0.81). Third, a statistical comparison of the CRS-R subscales weighted by MBT became significantly predictive for DOC outcome (p<0.02). Discussion The association of MBT and CRS-R scoring improves significantly the evaluation of consciousness and the predictability of outcome in the acute phase. Subtle motor behaviour assessment provides accurate insight into the amount and the content of consciousness even in the case of cognitive motor dissociation.	[Pignat, Jean-Michel; Johr, Jane; de Keranflec'h, Charlotte Gilart; Diserens, Karin] Univ Lausanne Hosp, Dept Clin Neurosci, Acute Neurorehabil Unit, Lausanne, Switzerland; [Pignat, Jean-Michel; Draganski, Bogdan; Frackowiak, Richard; Diserens, Karin] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland; [Mauron, Etienne] Univ Lausanne, Fac Med, Lausanne, Switzerland; [Laureys, Steven] Univ Liege, Coma Sci Grp, Liege, Belgium; [Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.] Univ Geneva, Fac Med, Geneva, Switzerland; [Hoemberg, Volker] SRH Gesundheitszentrum, Dept Neurol, Bad Wimpfen, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; University of Liege; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Pignat, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Acute Neurorehabil Unit, Lausanne, Switzerland.; Pignat, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland.	jean-michel.pignat@chuv.ch	Preti, Maria Giulia/X-9430-2019; Frackowiak, Richard/H-4383-2011; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Draganski, Bogdan/C-3096-2016; Jöhr, Jane/AAL-3611-2021; Van De Ville, Dimitri/A-5364-2008	Preti, Maria Giulia/0000-0002-5323-5327; Frackowiak, Richard/0000-0002-3151-822X; Laureys, Steven/0000-0002-3096-3807; Draganski, Bogdan/0000-0002-5159-5919; Van De Ville, Dimitri/0000-0002-2879-3861; Johr, Jane/0000-0003-4280-9310	German Research Foundation; National Fund for Scientific Research (NFSR); Foundation Parkinson Switzerland; Foundation Synapsis; Swiss National Science Foundation; Fondation Roger de Spoelberch; Partridge Foundation; Gianni Biaggi de Blasys Foundation; Schumacher Foundation; company Merz; company Allergan	German Research Foundation(German Research Foundation (DFG)); National Fund for Scientific Research (NFSR); Foundation Parkinson Switzerland; Foundation Synapsis; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Roger de Spoelberch; Partridge Foundation(General Electric); Gianni Biaggi de Blasys Foundation; Schumacher Foundation; company Merz; company Allergan(AbbVieAllergan)	V. Homberg received funding from the German Research Foundation. S. Laureys received funding from National Fund for Scientific Research (NFSR). B. Draganski received funding from the Foundation Parkinson Switzerland, the Foundation Synapsis, the German Research Foundation and the Swiss National Science Foundation. R. Frackowiak received funding from the Fondation Roger de Spoelberch, the Partridge Foundation and for the LREN research neuroimaging platform. K. Diserens received funding from the Gianni Biaggi de Blasys Foundation and the Schumacher Foundation. K. Diserens received also funding from the companies Merz and Allergan for research on botulinum toxin treatment. This study was financially supported by the peer reviewed Gianni Biaggi de Blasys Foundation, which had no role in study design, in data collection, analysis and interpretation, nor in writing the final report. All the aforementioned institutions and companies had no role in study design, in data collection, analysis and interpretation, nor in writing the final report.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2015, CLIN NEUROPHYSIOL, V126, P959, DOI 10.1016/j.clinph.2014.08.005; Bodart O, 2013, SEMIN NEUROL, V33, P83, DOI 10.1055/s-0033-1348965; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavanna AE, 2011, BEHAV NEUROL, V24, P107, DOI [10.1155/2011/645159, 10.3233/BEN-2011-0322]; Chatelle C, 2012, BRAIN INJURY, V26, P1510, DOI 10.3109/02699052.2012.698362; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Di Perri C, 2014, WORLD J RADIOL, V6, P589, DOI 10.4329/wjr.v6.i8.589; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Fernandez-Espejo D, 2015, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2015.2614, DOI 10.1001/JAMANEUROL.2015.2614]; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Formisano R, 2011, FUNCT NEUROL, V26, P15; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lupi A, 2014, CURR RADIOPHARM, V7, P57, DOI 10.2174/1874471007666140411103819; Owen AM, 2014, NAT REV NEUROL, V10, P370, DOI 10.1038/nrneurol.2014.102; Posner JB, 2007, PLUM POSNERS DIAGNOS; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P41, DOI 10.1177/1545968314528067; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Serrao M, 2006, J NEUROSCI, V26, P3505, DOI 10.1523/JNEUROSCI.5160-05.2006; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; 1994, NEW ENGL J MED, V330, P1572, DOI DOI 10.1056/NEJM199406023302206	45	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156882	10.1371/journal.pone.0156882	http://dx.doi.org/10.1371/journal.pone.0156882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359335	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200004
J	Baumann, M; Tchicaya, A; Lorentz, N; Le Bihan, E				Baumann, Michele; Tchicaya, Anastase; Lorentz, Nathalie; Le Bihan, Etienne			Impact of Patients' Communication with the Medical Practitioners, on Their Adherence Declared to Preventive Behaviours, Five Years after a Coronary Angiography, in Luxembourg	PLOS ONE			English	Article							LIFE SATISFACTION; DISEASE; CARE	Background Patients of the National Institute of Cardiac Surgery and Interventional Cardiology in Luxembourg who underwent coronary angiography were surveyed for hypertension, hypercholesterolemia, diabetes and overweight/obesity between 2008/9 and 2013/4. For each cardiovascular risk factor (CVRFs), we analysed the associations between the quality of the patients' communication with the medical practitioner and their adherence declared to preventive behaviours. Methods 1,289 completed a self-administered questionnaire on communication with the medical practitioner (P'Com-5 items scale; Cronbach 0.87). 61.8% stopped smoking, 57.9% reduced or stopped their consumption of salt, 71.9% of fat, and 62.8% of sugar, and whereas 65% increased their consumption of fruit and vegetables and 19.8% increased their physical activity. Around 37% reported having made changes following their doctor's advice. 90% were followed by a cardiologist and 95.9% by an attending physician. Results No link was observed between declaration of physical activity, smoking, fats, and quality of communication. Significant associations: for increased consumption of fruit and vegetables was linked with the quality of doctor-patient communication when patients were overweight (OR = 1.081), obese (OR = 1.130), hypercholesterolemic (OR = 1.102), hypertensive (OR = 1.084) or diabetic (OR = 1.103). Reduction in salt intake was linked only to patients with hypertension (OR = 1.102), whereas reduction or cessation of sugar consumption was linked to overweight (OR = 1.093), and more so obese, (OR = 1.106), hypercholesterolemics (OR = 1.103) and diabetics (OR = 1.173). Conclusions Good doctor-patient communication was related to nutrition, particularly increased consumption of fresh fruits and vegetables. Accurate perception of CVRFs by both patients and medical practitioners is essential for CV protection. The aim of instructing patients is to encourage them to make informed decisions about how to change their lifestyle. In routinely, P'Com-5 scale can collect data to assess the improvement of the professional skills. It can be used in medical training to enhance the quality of the therapeutic communication, especially for nutritional coaching, and to evaluate its efficacy in reducing CVRFs.	[Baumann, Michele; Le Bihan, Etienne] Univ Luxembourg, Inst Hlth & Behav, Res Unit INSIDE, Esch Sur Alzette, Luxembourg; [Tchicaya, Anastase; Lorentz, Nathalie] LISER, Esch Sur Alzette, Luxembourg	University of Luxembourg	Baumann, M (corresponding author), Univ Luxembourg, Inst Hlth & Behav, Res Unit INSIDE, Esch Sur Alzette, Luxembourg.	michele.baumann@uni.lu	TCHICAYA, Anastase/AAI-4994-2020		Luxembourg National Research Fund [FNR/C12/BM/3978355]	Luxembourg National Research Fund(Luxembourg National Research Fund)	The authors thank the Institut National de Chirurgie Cardiaque et de Cardiologie Interventionnelle (INCCI) in Luxembourg, and are grateful for the financial support received from the Luxembourg National Research Fund FNR/C12/BM/3978355. The project is titled 'Monitoring and DYNamics of health status through the Risk Factors for Cardiovascular disease' (MDYNRFC).; The authors thank the Institut National de Chirurgie Cardiaque et de Cardiologie Interventionnelle (INCCI) in Luxembourg, and are grateful for the financial support received from the Luxembourg National Research Fund FNR/C12/BM/3978355. The project is titled 'Monitoring and DYNamics of health status through the Risk Factors for Cardiovascular disease' (MDYNRFC).	Alaszewski A, 2005, PLOS MED, V2, P93, DOI 10.1371/journal.pmed.0020041; Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-468; Baumann M, 2007, CLIN EXP RHEUMATOL, V25, P404; Baumann M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2047-0; Baumann M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-244; Dalen JE, 2014, AM J MED, V127, P364, DOI 10.1016/j.amjmed.2013.12.014; Godin G, 2005, BRIT J SOC PSYCHOL, V44, P497, DOI 10.1348/014466604X17452; Godin G, 2008, AM J HEALTH PROMOT, V22, P180, DOI 10.4278/ajhp.22.3.180; Kolandaivelu K, 2014, EUR HEART J, V35, P3267, DOI 10.1093/eurheartj/ehu364; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; O'Neil A, 2014, EUR J PREV CARDIOL, V21, P30, DOI 10.1177/2047487312460515; OECD, 2013, HLTH GLANC 2013 OECD; Orbell S, 1998, BRIT J SOC PSYCHOL, V37, P151, DOI 10.1111/j.2044-8309.1998.tb01162.x; Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605; Ruilope LM, 2013, EUR HEART J, V34, P2931, DOI 10.1093/eurheartj/eht299; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; Wang Y, 2014, SOC INDIC RES, V116, P843, DOI 10.1007/s11205-013-0327-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, WHO GLOB BRIEF HYP	21	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157321	10.1371/journal.pone.0157321	http://dx.doi.org/10.1371/journal.pone.0157321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355320	Green Published, gold			2022-12-26	WOS:000378859400011
J	Caceres, A; Esko, T; Pappa, I; Gutierrez, A; Lopez-Espinosa, MJ; Llop, S; Bustamante, M; Tiemeier, H; Metspalu, A; Joshi, PK; Wilsonx, JF; Reina-Castillon, J; Shin, J; Pausova, Z; Paus, T; Sunyer, J; Perez-Jurado, LA; Gonzalez, JR				Caceres, Alejandro; Esko, Tonu; Pappa, Irene; Gutierrez, Armand; Lopez-Espinosa, Maria-Jose; Llop, Sabrina; Bustamante, Mariona; Tiemeier, Henning; Metspalu, Andres; Joshi, Peter K.; Wilsonx, James F.; Reina-Castillon, Judith; Shin, Jean; Pausova, Zdenka; Paus, Tomas; Sunyer, Jordi; Perez-Jurado, Luis A.; Gonzalez, Juan R.			Ancient Haplotypes at the 15q24.2 Microdeletion Region Are Linked to Brain Expression of MAN2C1 and Children's Intelligence	PLOS ONE			English	Article							PROTEIN; SUSCEPTIBILITY; GLYCOSYLATION; ORIGIN	The chromosome bands 15q24.1-15q24.3 contain a complex region with numerous segmental duplications that predispose to regional microduplications and microdeletions, both of which have been linked to intellectual disability, speech delay and autistic features. The region may also harbour common inversion polymorphisms whose functional and phenotypic manifestations are unknown. Using single nucleotide polymorphism (SNP) data, we detected four large contiguous haplotype-genotypes at 15q24 with Mendelian inheritance in 2,562 trios, African origin, high population stratification and reduced recombination rates. Although the haplotype-genotypes have been most likely generated by decreased or absent recombination among them, we could not confirm that they were the product of inversion polymorphisms in the region. One of the blocks was composed of three haplotype-genotypes (N1a, N1b and N2), which significantly correlated with intelligence quotient (IQ) in 2,735 children of European ancestry from three independent population cohorts. Homozygosity for N2 was associated with lower verbal IQ (2.4-point loss, p-value = 0.01), while homozygosity for N1b was associated with 3.2-point loss in non-verbal IQ ( p-value = 0.0006). The three alleles strongly correlated with expression levels of MAN2C1 and SNUPN in blood and brain. Homozygosity for N2 correlated with over-expression of MAN2C1 over many brain areas but the occipital cortex where N1b homozygous highly under-expressed. Our population-based analyses suggest that MAN2C1 may contribute to the verbal difficulties observed in microduplications and to the intellectual disability of microdeletion syndromes, whose characteristic dosage increment and removal may affect different brain areas.	[Caceres, Alejandro; Bustamante, Mariona; Sunyer, Jordi; Gonzalez, Juan R.] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Caceres, Alejandro; Bustamante, Mariona; Sunyer, Jordi; Gonzalez, Juan R.] Univ Pompeu Fabra, Barcelona, Spain; [Caceres, Alejandro; Lopez-Espinosa, Maria-Jose; Llop, Sabrina; Bustamante, Mariona; Sunyer, Jordi; Gonzalez, Juan R.] CIBERESP, Madrid, Spain; [Esko, Tonu] Harvard Med Sch, Dept Genet, Boston, MA USA; [Esko, Tonu] Broad Inst, Cambridge, MA USA; [Esko, Tonu] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Pappa, Irene] Erasmus Univ, Sch Pedag & Educ Sci, Rotterdam, Netherlands; [Pappa, Irene] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Gutierrez, Armand; Reina-Castillon, Judith; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Gutierrez, Armand; Reina-Castillon, Judith; Perez-Jurado, Luis A.] CIBERER, Madrid, Spain; [Gutierrez, Armand; Reina-Castillon, Judith; Sunyer, Jordi; Perez-Jurado, Luis A.] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Lopez-Espinosa, Maria-Jose; Llop, Sabrina] Univ Valencia, FISABIO, Epidemiol & Environm Hlth Joint Res Unit, Univ Jaume 1, Valencia, Spain; [Bustamante, Mariona] CRG, Genom & Dis Grp, Barcelona, Spain; [Tiemeier, Henning] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Joshi, Peter K.; Wilsonx, James F.] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Wilsonx, James F.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Shin, Jean; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Gonzalez, Juan R.] Univ Autonoma Barcelona, Dept Math, Bellaterra, Barcelona, Spain	ISGlobal; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Tartu; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat Jaume I; University of Valencia; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; University of Tartu; University of Edinburgh; University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Baycrest; Autonomous University of Barcelona	Caceres, A; Gonzalez, JR (corresponding author), ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.; Caceres, A; Gonzalez, JR (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Caceres, A; Gonzalez, JR (corresponding author), CIBERESP, Madrid, Spain.; Gonzalez, JR (corresponding author), Univ Autonoma Barcelona, Dept Math, Bellaterra, Barcelona, Spain.	acaceres@creal.cat; jrgonzalez@creal.cat	Tiemeier, Henning/H-6534-2019; Gonzalez, Juan R/B-7860-2018; lopez, maria jose/ABH-7031-2020; Pappa, Irene/AAD-2738-2019; Llop, Sabrina/L-2122-2015; Bustamante, Mariona/ABB-9142-2021; Caceres, Alejandro/ABF-4180-2021; Lopez, Maria/HHC-3659-2022; Sunyer, Jordi/G-6909-2014	Tiemeier, Henning/0000-0002-4395-1397; Gonzalez, Juan R/0000-0003-3267-2146; lopez, maria jose/0000-0003-1202-8740; Llop, Sabrina/0000-0002-6784-4211; Bustamante, Mariona/0000-0003-0127-2860; Sunyer, Jordi/0000-0002-2602-4110; Pappa, Irene/0000-0003-4936-5791; Caceres, Alejandro/0000-0001-8551-6695; Joshi, Peter/0000-0002-6361-5059	Spanish Ministry of Science and Innovation [MTM2011-26515, SAF2008-00357]; Statistical Genetics Network-GENOMET [MTM2010-09526-E]; Instituto de Salud Carlos III [FIS PI1002512, PI1302481CB06/02/0041, Red INMA G03/176, FIS PI041436, PI081151, PI041705, PS09/00432, FIS-FEDER PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI13/1944, PI14/0891]; Instituto de Salud Carlos III [Miguel Servet-FEDER] [CP11/0178, CP15/0025]; Generalitat de Catalunya [2014SGR1468, SRG1468-2014]; European Commission [HEALTH-F4-2007-201413, FP7-ENV-2011 cod 282957, HEALTH. 2010.2.4.5-1]; Fundacio La Marato de TV3, Generalitat de Catalunya [CIRIT 1999SGR00241]; Conselleria de Sanitat, Generalitat Valenciana; Fundacion Roger Torne; Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw]; Netherlands Organization for Health Research and Development [2100.0074]; Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics [EXCEGEN]; University of Tartu [SP1GVARENG], Estonian Research Council [IUT2-2]; European Regional Development Fund; Chief Scientist Office of the Scottish Government; Royal Society; MRC Human Genetics Unit; Arthritis Research UK; European Union framework program [LSHG-CT-2006-018947]; Spanish Ministry of Health (FEDER) [FIS-PI1302481]; ICREA-Academia program; Spanish Ministry of Economy and Competiveness "Programa de Excelencia Maria de Maeztu" [MDM-2014-0370]; Medical Research Council [1201677] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Statistical Genetics Network-GENOMET; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III [Miguel Servet-FEDER]; Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacio La Marato de TV3, Generalitat de Catalunya(Generalitat de Catalunya); Conselleria de Sanitat, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Fundacion Roger Torne; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw](Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Estonian Government; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics [EXCEGEN]; University of Tartu [SP1GVARENG], Estonian Research Council(Estonian Research Council); European Regional Development Fund(European Commission); Chief Scientist Office of the Scottish Government; Royal Society(Royal Society of London); MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); European Union framework program(European Commission); Spanish Ministry of Health (FEDER); ICREA-Academia program(ICREA); Spanish Ministry of Economy and Competiveness "Programa de Excelencia Maria de Maeztu"; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Spanish Ministry of Science and Innovation [MTM2011-26515]; Statistical Genetics Network-GENOMET [MTM2010-09526-E]; Instituto de Salud Carlos III [FIS PI1002512, PI1302481CB06/02/0041, Red INMA G03/176, FIS PI041436, PI081151, PI041705, PS09/00432, FIS-FEDER PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI13/1944, PI14/0891, and Miguel Servet-FEDER CP11/0178 and CP15/0025]; Generalitat de Catalunya [2014SGR1468]; Spanish Ministry of Science and Innovation [SAF2008-00357]; the European Commission [HEALTH-F4-2007-201413, FP7-ENV-2011 cod 282957, HEALTH. 2010.2.4.5-1]; Fundacio La Marato de TV3, Generalitat de Catalunya [CIRIT 1999SGR00241]; Conselleria de Sanitat, Generalitat Valenciana to MJLE; Fundacion Roger Torne to MJLE; Canadian Institutes of Health Research to TP and ZP; Heart and Stroke Foundation of Quebec to ZP; The Canadian Foundation for Innovation to ZP; Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw]; Netherlands Organization for Health Research and Development [2100.0074]; Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics [EXCEGEN]; University of Tartu [SP1GVARENG], Estonian Research Council [IUT2-2]; European Regional Development Fund; The Chief Scientist Office of the Scottish Government; The Royal Society; The MRC Human Genetics Unit; Arthritis Research UK and The European Union framework program [LSHG-CT-2006-018947]. LAPJ is funded by the Spanish Ministry of Health (FIS-PI1302481 co-funded by FEDER), the Generalitat de Catalunya (SRG1468-2014), the ICREA-Academia program, and also acknowledges support from the Spanish Ministry of Economy and Competiveness "Programa de Excelencia Maria de Maeztu" (MDM-2014-0370).	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bernon C, 2011, GLYCOBIOLOGY, V21, P363, DOI 10.1093/glycob/cwq169; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Caceres A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv073; Caceres A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-28; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Magoulas PL, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-2; McInnes LA, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-5; Mefford HC, 2012, J MED GENET, V49, P110, DOI 10.1136/jmedgenet-2011-100499; Mkrtchyan G, 2014, NEUROSCI BEHAV PHYSL, V44, P442; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; NAGLIERI JA, 1980, PSYCHOL REP, V47, P591, DOI 10.2466/pr0.1980.47.2.591; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Paterson T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-246; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Roetzer KM, 2010, AM J MED GENET A, V152A, P3173, DOI 10.1002/ajmg.a.33750; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Tellegen P, 1993, LEARNING POTENTIAL A, P267; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang L, 2013, J BIOL CHEM, V288, P11887, DOI 10.1074/jbc.M112.425702; Xiang ZG, 2010, TRANSGENIC RES, V19, P67, DOI 10.1007/s11248-009-9299-3; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157739	10.1371/journal.pone.0157739	http://dx.doi.org/10.1371/journal.pone.0157739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355585	Green Published, gold			2022-12-26	WOS:000378859400017
J	Talar, B; Gajos-Michniewicz, A; Talar, M; Chouaib, S; Czyz, M				Talar, Beata; Gajos-Michniewicz, Anna; Talar, Marcin; Chouaib, Salem; Czyz, Malgorzata			Pentoxifylline Inhibits WNT Signalling in beta-Catenin(high) Patient-Derived Melanoma Cell Populations	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; NF-KAPPA-B; BETA-CATENIN; MALIGNANT-MELANOMA; TARGETED THERAPIES; EXPRESSION; MITF; IMMUNOTHERAPY; PARTHENOLIDE; APOPTOSIS	Background The heterogeneity of melanoma needs to be addressed and combination therapies seem to be necessary to overcome intrinsic and acquired resistance to newly developed immunotherapies and targeted therapies. Although the role of WNT/beta-catenin pathway in melanoma was early demonstrated, its contribution to the lack of the melanoma patient response to treatment was only recently recognized. Using patient-derived melanoma cell populations, we investigated the influence of pentoxifylline on melanoma cells with either high or low expression of beta-catenin. Findings Our results indicate that pentoxifylline inhibits the activity of the canonical WNT pathway in melanoma cell populations with high basal activity of this signalling. This is supported by lowered overall activity of transcription factors TCF/LEF and reduced nuclear localisation of active beta-catenin. Moreover, treatment of beta-catenin(high) melanoma cell populations with pentoxifylline induces downregulation of genes that are targets of the WNT/beta-catenin pathway including connective tissue growth factor (CTGF) and microphthalmia-associated transcription factor (MITF-M), a melanocyte-and melanoma cell-specific regulator. Conclusions These results suggest that pentoxifylline, a drug approved by the FDA in the treatment of peripheral arterial disease, might be tested in a subset of melanoma patients with elevated activity of beta-catenin. This pharmaceutical might be tested as an adjuvant drug in combination therapies when the response to immunotherapy is prevented by high activity of the WNT/beta-catenin pathway.	[Talar, Beata; Gajos-Michniewicz, Anna; Czyz, Malgorzata] Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland; [Talar, Marcin] Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland; [Chouaib, Salem] Unite INSERM U1186, Inst Cancerol Gustave Roussy, Villejuif, France	Medical University Lodz; Medical University Lodz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Czyz, M (corresponding author), Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland.	malgorzata.czyz@umed.lodz.pl	Chouaib, Salem/F-7939-2016; Czyz, Malgorzata/AAD-1869-2020	Czyz, Malgorzata/0000-0002-8279-4742	National Science Centre (Poland) [2012/06/M/NZ2/00109]; Equipe labellisee par la Ligue Contre le Cancer [EL2015.LNCC/SaC]	National Science Centre (Poland); Equipe labellisee par la Ligue Contre le Cancer	This work was financially supported by 2012/06/M/NZ2/00109 from National Science Centre (Poland). SC was supported by a grant "Equipe labellisee par la Ligue Contre le Cancer" (EL2015.LNCC/SaC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. M. Sztiller-Sikorska for melanoma cell isolation and their propagation and E. Lewandowska for her excellent administrative and technical support. This work was financially supported by 2012/06/M/NZ2/00109 from National Science Centre (Poland). SC was supported by a grant "Equipe labellisee par la Ligue Contre le Cancer" (EL2015.LNCC/SaC).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anastas JN, 2014, WNT SIGNALING DEV DI; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Atkinson JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125028; Atlasi Y, 2014, CURR TOP DEV BIOL, V107, P373, DOI 10.1016/B978-0-12-416022-4.00013-5; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Chen YM, 2003, BRIT J PHARMACOL, V138, P950, DOI 10.1038/sj.bjp.0705088; Chien AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094748; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Czyz M, 2010, BRIT J PHARMACOL, V160, P1144, DOI 10.1111/j.1476-5381.2010.00749.x; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Drake CG, 2014, NAT REV CLIN ONCOL, V11, DOI 10.1038/nrclinonc.2013.208-c2; Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208; Dua P, 2006, CANCER CHEMOTH PHARM, V58, P195, DOI 10.1007/s00280-005-0155-8; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Flaherty KT, 2015, CANCER BIOL THER, V16, P645, DOI 10.1080/15384047.2015.1030553; Gahlot S, 2010, BIOCHEM PHARMACOL, V80, P1650, DOI 10.1016/j.bcp.2010.08.018; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hartman ML, 2015, J INVEST DERMATOL, V135, P352, DOI 10.1038/jid.2014.319; Hartman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095157; Hartman ML, 2016, ONCOTARGET, V10; Ho AW, 2015, J INVEST DERMATOL, V135, P1929, DOI 10.1038/jid.2015.14; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kamran MZ, 2012, BIOMED PHARMACOTHER, V66, P617, DOI 10.1016/j.biopha.2012.03.006; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Koprowska K, 2013, ANTI-CANCER DRUG, V24, P835, DOI 10.1097/CAD.0b013e3283635a04; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Marques LJ, 1999, AM J RESP CRIT CARE, V159, P508, DOI 10.1164/ajrccm.159.2.9804085; Massey PR, 2015, CANCER BIOL THER, V16, P1014, DOI 10.1080/15384047.2015.1046650; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Roesch A, 2015, ONCOGENE, V34, P2951, DOI 10.1038/onc.2014.249; Sanlorenzo M, 2014, CANCER BIOL THER, V15, P665, DOI 10.4161/cbt.28555; Seidensticker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112731; Sharma K, 2016, BIOCHEM PHARMACOL, V103, P17, DOI 10.1016/j.bcp.2015.12.018; Shukla V, 2003, CANCER BIOTHER RADIO, V18, P559, DOI 10.1089/108497803322287637; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Sztiller-Sikorska M, 2015, LAB INVEST, V95, P672, DOI 10.1038/labinvest.2015.48; Sztiller-Sikorska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090783; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; Theron T, 2000, INT J RADIAT BIOL, V76, P1197, DOI 10.1080/09553000050134438; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wyluda EJ, 2015, CANCER BIOL THER, V16, P662, DOI 10.1080/15384047.2015.1026507; Zhen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064976; Zimmerman ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069593	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158275	10.1371/journal.pone.0158275	http://dx.doi.org/10.1371/journal.pone.0158275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351373	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900049
J	Biering-Sorensen, T; Jensen, JS; Pedersen, SH; Galatius, S; Fritz-Hansen, T; Bech, J; Olsen, FJ; Mogelvang, R				Biering-Sorensen, Tor; Jensen, Jan Skov; Pedersen, Sune H.; Galatius, Soren; Fritz-Hansen, Thomas; Bech, Jan; Olsen, Flemming Javier; Mogelvang, Rasmus			Regional Longitudinal Myocardial Deformation Provides Incremental Prognostic Information in Patients with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							CORONARY-ARTERY STENOSIS; IMAGING M-MODE; TISSUE DOPPLER; STRAIN-RATE; ECHOCARDIOGRAPHY IMPROVES; DIASTOLIC FUNCTION; HEART-FAILURE; MORTALITY; MOTION; REPRODUCIBILITY	Background Global longitudinal systolic strain (GLS) has recently been demonstrated to be a superior prognosticator to conventional echocardiographic measures in patients after myocardial infarction (MI). The aim of this study was to evaluate the prognostic value of regional longitudinal myocardial deformation in comparison to GLS, conventional echocardiography and clinical information. Method In total 391 patients were admitted with ST-Segment elevation myocardial infarction (STEMI), treated with primary percutaneous coronary intervention and subsequently examined by echocardiography. All patients were examined by tissue Doppler imaging (TDI) and two-dimensional strain echocardiography (2DSE). Results During a median-follow-up of 5.3 (IQR 2.5-6.1) years the primary endpoint (death, heart failure or a new MI) was reached by 145 (38.9%) patients. After adjustment for significant confounders (including conventional echocardiographic parameters) and culprit lesion, reduced longitudinal performance in the anterior septal and inferior myocardial regions (but not GLS) remained independent predictors of the combined outcome. Furthermore, inferior myocardial longitudinal deformation provided incremental prognostic information to clinical and conventional echocardiographic information (Harrell's c-statistics: 0.63 vs. 0.67, p = 0.032). In addition, impaired longitudinal deformation outside the culprit lesion perfusion region was significantly associated with an adverse outcome (p<0.05 for all deformation parameters). Conclusion Regional longitudinal myocardial deformation measures, regardless if determined by TDI or 2DSE, are superior prognosticators to GLS. In addition, impaired longitudinal deformation in the inferior myocardial segment provides prognostic information over and above clinical and conventional echocardiographic risk factors. Furthermore, impaired longitudinal deformation outside the culprit lesion perfusion region seems to be a paramount marker of adverse outcome.	[Biering-Sorensen, Tor; Jensen, Jan Skov; Pedersen, Sune H.; Galatius, Soren; Fritz-Hansen, Thomas; Bech, Jan; Olsen, Flemming Javier; Mogelvang, Rasmus] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Biering-Sorensen, Tor; Jensen, Jan Skov] Univ Copenhagen, Fac Hlth Sci, Inst Clin Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Biering-Sorensen, T (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark.; Biering-Sorensen, T (corresponding author), Univ Copenhagen, Fac Hlth Sci, Inst Clin Med, Copenhagen, Denmark.	tor.biering@gmail.com	Olsen, Flemming/AAS-8127-2021	Olsen, Flemming Javier/0000-0001-9511-8375; Biering-Sorensen, Tor/0000-0003-4209-2778	Faculty of Health Sciences, University of Copenhagen, Denmark	Faculty of Health Sciences, University of Copenhagen, Denmark	This study was financially supported by the Faculty of Health Sciences, University of Copenhagen, Denmark. The sponsor had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Amundsen BH, 2009, EUR J ECHOCARDIOGR, V10, P229, DOI 10.1093/ejechocard/jen201; Antoni ML, 2010, EUR HEART J, V31, P1640, DOI 10.1093/eurheartj/ehq105; Anwar AM, 2012, WORLD J CARDIOL, V4, P341, DOI 10.4330/wjc.v4.i12.341; Baltabaeva A, 2008, EUR J ECHOCARDIOGR, V9, P501, DOI 10.1016/j.euje.2007.08.004; Biering-Sorensen T, 2016, EUR HEART J-CARD IMG, V17, P722, DOI 10.1093/ehjci/jew066; Biering-Sorensen T, 2014, J AM SOC ECHOCARDIOG, V27, P258, DOI 10.1016/j.echo.2013.11.005; Biering-Sorensen T, 2014, CIRC-CARDIOVASC IMAG, V7, P58, DOI 10.1161/CIRCIMAGING.113.000989; Biering-Sorensen T, 2013, CIRC-CARDIOVASC IMAG, V6, P457, DOI 10.1161/CIRCIMAGING.112.000230; Biering-Sorensen T, 2011, AM J CARDIOL, V107, P478, DOI 10.1016/j.amjcard.2010.09.044; Bijnens B, 2007, CIRCULATION, V116, P2453, DOI 10.1161/CIRCULATIONAHA.106.684357; de Knegt MC, 2014, EUR HEART J-CARD IMG, V15, P62, DOI 10.1093/ehjci/jet119; Ersboll M, 2014, EUR HEART J, V35, P648, DOI 10.1093/eurheartj/eht179; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; HACHINSKI VC, 1986, STROKE, V17, P387, DOI 10.1161/01.STR.17.3.387; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoffmann S, 2012, EUR HEART J-CARD IMG, V13, P724, DOI 10.1093/ehjci/jes001; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Huttin O, 2015, INT J CARDIOVAS IMAG, V31, P1337, DOI 10.1007/s10554-015-0690-2; KORPELAINEN JT, 1994, STROKE, V25, P787, DOI 10.1161/01.STR.25.4.787; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Mahenthiran J, 2006, AM J CARDIOL, V98, P1301, DOI 10.1016/j.amjcard.2006.06.020; Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042; Munk K, 2012, J AM SOC ECHOCARDIOG, V25, P644, DOI 10.1016/j.echo.2012.02.003; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Olsen FJ, 2015, INT J CARDIOVAS IMAG, V31, P1413, DOI 10.1007/s10554-015-0712-0; Olsen NT, 2009, ECHOCARDIOGR-J CARD, V26, P638, DOI 10.1111/j.1540-8175.2008.00872.x; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Samuels Martin A, 2007, Cleve Clin J Med, V74 Suppl 1, pS8; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; Thune JJ, 2006, J AM SOC ECHOCARDIOG, V19, P1462, DOI 10.1016/j.echo.2006.05.028; Urheim S, 2000, CIRCULATION, V102, P1158, DOI 10.1161/01.CIR.102.10.1158; VOLPI A, 1993, CIRCULATION, V88, P416, DOI 10.1161/01.CIR.88.2.416; Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44	35	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158280	10.1371/journal.pone.0158280	http://dx.doi.org/10.1371/journal.pone.0158280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348525	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200057
J	Song, GY; Hou, JH; Li, Y; Zhang, JH; He, NP				Song, Guangyan; Hou, Jihua; Li, Ying; Zhang, Jiahui; He, Nianpeng			Leaf Caloric Value from Tropical to Cold-Temperate Forests: Latitudinal Patterns and Linkage to Productivity	PLOS ONE			English	Article							PLANT TRAITS; ORGANIC-MATTER; ENERGY; ECOSYSTEMS; CHINA; SUCCESSION; TREES	Leaf caloric value (LCV) reflects the capacity of a leaf to fix and accumulate solar energy through photosynthesis. We systematically investigated the LCV of 745 plant species in 9 forests, representing a range of tropical to cold-temperate forests along the 4700-km North-South Transect of Eastern China. The goals were to explore the latitudinal patterns of LCV at the levels of species, plant functional group, and community and to establish the relationship between LCV and gross primary productivity (GPP). Our results showed that LCV for all species ranged from 12.85 to 22.15 KJ g(-1) with an average of 18.46 KJ g(-1). Plant functional groups had a significant influence on LCV, with trees > shrubs > herbs, conifers > broad-leaved trees, and evergreens > deciduous trees. The different values of LCV represented the long-termevolution and adaptation of plant species to different environments. Unexpectedly, no apparent latitudinal trends of LCV at community level were observed, although LCV at the species level clearly decreased with increasing latitude. Use efficiency of LCV (CUE, gC KJ(-1)), defined as the ratio of GPP to total LCV at the community level, varied quadratic with latitude and was lower in the middle latitudes. Climate (temperature and precipitation) may explain 52.9% of the variation in spatial patterns of CUE, which was positively correlated with aridity. Our findings are the first large-scale report of the latitudinal patterns of LCV in forests at the species, plant functional group, and community levels and provide new insights into the relationship between LCV and ecosystem functions in forest communities.	[Song, Guangyan; Hou, Jihua; Li, Ying] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing 100083, Peoples R China; [Zhang, Jiahui; He, Nianpeng] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Hou, JH (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing 100083, Peoples R China.; He, NP (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.	houjihua@bjfu.edu.cn; henp@igsnrr.ac.cn		he, nianpeng/0000-0002-0458-5953	Natural Science Foundation of China [31290221, 31570471]; Program for Kezhen Distinguished Talents in Institute of Geographic Sciences; Natural Resources Research, CAS [2013RC102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Kezhen Distinguished Talents in Institute of Geographic Sciences; Natural Resources Research, CAS	Funding for this work was applied by Dr. N.H. from the Natural Science Foundation of China (31290221, 31570471; http://www.nsfc.gov.cn/), and the Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS (2013RC102; http://www.igsnrr.ac.cn/). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2012, OECOLOGIA, V168, P519, DOI 10.1007/s00442-011-2112-z; Bobkova KS, 2001, RUSS J ECOL+, V32, P63, DOI 10.1023/A:1009582318434; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; De Martonne E., 1926, METEOROLOGIE, P449; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; GOLLEY FB, 1969, ECOLOGY, V50, P517, DOI 10.2307/1933913; GOLLEY FB, 1961, ECOLOGY, V42, P581, DOI 10.2307/1932247; GORHAM E, 1967, ECOLOGY, V48, P492, DOI 10.2307/1932684; Grigulis K, 2013, J ECOL, V101, P47, DOI 10.1111/1365-2745.12014; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Gritti ES, 2004, GLOBAL ECOL BIOGEOGR, V13, P519, DOI 10.1111/j.1466-822X.2004.00120.x; Horowitz ME, 2009, CAN J FOREST RES, V39, P2294, DOI 10.1139/X09-144; JAMES TDW, 1978, CAN J BOT, V56, P1804, DOI 10.1139/b78-216; Kumar R, 2011, BIOMASS BIOENERG, V35, P1339, DOI 10.1016/j.biombioe.2010.12.031; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lieth H, 1975, PRIMARY PRODUCTIVITY; Lin Hua, 2007, Zhiwu Shengtai Xuebao, V31, P1103; Lin H, 2008, ECOL MODEL, V217, P132, DOI 10.1016/j.ecolmodel.2008.06.012; Lin P, 1991, ACTA PHYTOECOLOGICA, V15, P114; Lin Yiming, 2000, Yingyong Shengtai Xuebao, V11, P181; Long FL, 1934, PLANT PHYSIOL, V9, P323, DOI 10.1104/pp.9.2.323; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; OVINGTON JD, 1960, J ECOL, V48, P639, DOI 10.2307/2257339; Reichstein M, 2014, P NATL ACAD SCI USA, V111, P13697, DOI 10.1073/pnas.1216065111; SINGH T, 1986, CAN J FOREST RES, V16, P1378, DOI 10.1139/x86-245; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tang ZQ, 2004, CHINESE J APPL ECOLO, V15, P1135; Vile D, 2006, ECOLOGY, V87, P504, DOI 10.1890/05-0822; [王立海 WANG Li-Hai], 2009, [生态学报, Acta Ecologica Sinica], V29, P953; Wang RL, 2016, J GEOGR SCI, V26, P15, DOI 10.1007/s11442-016-1251-x; Wang RL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14454; Wielgolaski F. E., 1975, Fennoscandian tundra ecosystems. Part 1. Plants and microorganisms., P201; Zeng WS, 2014, J FORESTRY RES, V25, P779, DOI 10.1007/s11676-014-0525-3	38	7	10	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157935	10.1371/journal.pone.0157935	http://dx.doi.org/10.1371/journal.pone.0157935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341474	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600021
J	Cui, Y; Sun, Y; Hu, S; Luo, J; Li, L; Li, X; Yeh, S; Jin, J; Chang, C				Cui, Y.; Sun, Y.; Hu, S.; Luo, J.; Li, L.; Li, X.; Yeh, S.; Jin, J.; Chang, C.			Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals	ONCOGENE			English	Article							SHOCK-PROTEIN 27; ACQUIRED DOCETAXEL RESISTANCE; MITOXANTRONE PLUS PREDNISONE; ANDROGEN RECEPTOR; P38 MAPK; CELL-SURVIVAL; GROWTH; EXPRESSION; ACTIVATION; KINASE	Prostatic neuroendocrine cells (NE) are an integral part of prostate cancer (PCa) and are associated with PCa progression. As the current androgen deprivation therapy with anti-androgens may promote the neuroendocrine PCa (NEPCa) development, and few therapies can effectively suppress NEPCa, understanding the impact of NEPCa on PCa progression may help us to develop better therapies to battle PCa. Here, we found NEPCa cells could increase the docetaxel resistance of their neighboring PCa cells. Mechanism dissection revealed that through secretion of PTHrP, NEPCa cells could alter the p38/MAPK/Hsp27 signals in their neighboring PCa cells that resulted in increased androgen receptor (AR) activity via promoting AR nuclear translocation. The consequences of increased AR function might then increase docetaxel resistance via increasing p21 expression. In vivo xenograft mice experiments also confirmed that NEPCa could increase the docetaxel resistance of neighboring PCa, and targeting this newly identified PTHrP/p38/Hsp27/AR/p21 signaling pathway with either p38 inhibitor (SB203580) or shPTHrP may result in improving/restoring the docetaxel sensitivity to better suppress PCa.	[Cui, Y.; Hu, S.; Li, X.; Jin, J.] Peking Univ, Dept Urol, Hosp 1, Beijing, Peoples R China; [Cui, Y.; Sun, Y.; Hu, S.; Luo, J.; Li, L.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Cui, Y.; Sun, Y.; Hu, S.; Luo, J.; Li, L.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Cui, Y.; Sun, Y.; Hu, S.; Luo, J.; Li, L.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA; [Cui, Y.; Sun, Y.; Hu, S.; Luo, J.; Li, L.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY USA; [Chang, C.] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Peking University; University of Rochester; University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, C (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY USA.; Jin, J (corresponding author), Peking Univ, Hosp 1, Dept Urol, Natl Urol Canc Ctr, Xishiku St 8, Beijing 100034, Peoples R China.	jinjie@vip.163.com; chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Chang, Chawnshang/0000-0001-8510-3516	NIH [CA155477, CA156700]; Taiwan Department of Health Clinical Trial, Research Center of Excellence [DOH99-TD-B-111-004]; China 973 Program [2012CB518305]; George Whipple Professorship Endowment; NATIONAL CANCER INSTITUTE [R01CA156700, R01CA155477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan Department of Health Clinical Trial, Research Center of Excellence; China 973 Program(National Basic Research Program of China); George Whipple Professorship Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants (CA155477 and CA156700), George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial, Research Center of Excellence (DOH99-TD-B-111-004 to China Medical University, Taichung, Taiwan) and China 973 Program (2012CB518305). We thank Karen Wolf for help in preparing the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; BERCHEM GJ, 1995, CANCER RES, V55, P735; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Bhardwaj A, 2014, ONCOTARGET, V5, P11490, DOI 10.18632/oncotarget.2571; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cerasuolo M, 2015, CANCER RES, V75, P2975, DOI 10.1158/0008-5472.CAN-14-3830; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; Conn EM, 2009, AM J PATHOL, V175, P1638, DOI 10.2353/ajpath.2009.090384; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Dang Q, 2015, MOL ONCOL, V9, P1241, DOI 10.1016/j.molonc.2015.02.010; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; DaSilva JO, 2013, PROSTATE, V73, P801, DOI 10.1002/pros.22624; Dizeyi N, 2004, PROSTATE, V59, P328, DOI 10.1002/pros.10374; Dizeyi N, 2011, UROL ONCOL-SEMIN ORI, V29, P436, DOI 10.1016/j.urolonc.2009.09.013; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Fizazi K, 2015, LANCET ONCOL, V16, P787, DOI 10.1016/S1470-2045(15)00011-X; Geng H, 2010, CANCER RES, V70, P3239, DOI 10.1158/0008-5472.CAN-09-3186; Guo YS, 2001, J BIOL CHEM, V276, P22941, DOI 10.1074/jbc.M101801200; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Harper ME, 1996, BRIT J CANCER, V74, P910, DOI 10.1038/bjc.1996.456; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Hobisch A, 1998, CANCER RES, V58, P4640; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Hu S, 2015, MOL ONCOL, V9, P44, DOI 10.1016/j.molonc.2014.07.013; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jia YF, 2001, J BIOL CHEM, V276, P39911, DOI 10.1074/jbc.M103510200; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Jin RJ, 2004, CANCER RES, V64, P5489, DOI 10.1158/0008-5472.CAN-03-3117; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kim JY, 2008, ENDOCRINOLOGY, V149, P3085, DOI 10.1210/en.2007-1367; Lamoureux F, 2014, EUR UROL, V66, P145, DOI 10.1016/j.eururo.2013.12.019; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Levine L, 2003, CANCER RES, V63, P3495; Liao JH, 2008, INT J CANCER, V123, P2267, DOI 10.1002/ijc.23602; Lin JQ, 1999, CANCER RES, V59, P2891; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Marengo B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.118; Marin-Aguilera M, 2014, MOL CANCER THER, V13, P1270, DOI 10.1158/1535-7163.MCT-13-0775; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Ongkeko WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085803; Park SI, 2013, CANCER RES, V73, P6574, DOI 10.1158/0008-5472.CAN-12-4692; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Razandi M, 2010, MOL CELL BIOL, V30, P3249, DOI 10.1128/MCB.01354-09; Salido M, 2004, CELL BIOL INT, V28, P397, DOI 10.1016/j.cellbi.2004.03.008; Shah GV, 2008, ENDOCR-RELAT CANCER, V15, P953, DOI 10.1677/ERC-08-0136; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Terry S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00060; Thadani-Mulero M, 2014, CANCER RES, V74, P2270, DOI 10.1158/0008-5472.CAN-13-2876; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vilches J, 2004, HISTOL HISTOPATHOL, V19, P951, DOI 10.14670/HH-19.951; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiao DM, 2002, REGUL PEPTIDES, V109, P141, DOI 10.1016/S0167-0115(02)00197-0; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zelivianski S, 2003, INT J CANCER, V107, P478, DOI 10.1002/ijc.11413; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; Zhao YP, 2006, J SURG RES, V136, P325, DOI 10.1016/j.jss.2006.06.031; Zhu YZ, 2013, MOL CANCER THER, V12, P1829, DOI 10.1158/1535-7163.MCT-13-0208; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	69	15	16	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 24	2016	35	47					6065	6076		10.1038/onc.2016.135	http://dx.doi.org/10.1038/onc.2016.135			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CE	27375022	Green Accepted			2022-12-26	WOS:000388509800003
J	Plaza, K; Kalinska, M; Bochenska, O; Meyer-Hoffert, U; Wu, ZH; Fischer, J; Falkowski, K; Sasiadek, L; Bielecka, E; Potempa, B; Kozik, A; Potempa, J; Kantyka, T				Plaza, Karolina; Kalinska, Magdalena; Bochenska, Oliwia; Meyer-Hoffert, Ulf; Wu, Zhihong; Fischer, Jan; Falkowski, Katherine; Sasiadek, Laura; Bielecka, Ewa; Potempa, Barbara; Kozik, Andrzej; Potempa, Jan; Kantyka, Tomasz			Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-PERMEABILITY ENHANCEMENT; CYSTEINE PROTEINASES; CHRONIC-PANCREATITIS; CANCER BIOMARKERS; VIRULENCE FACTORS; PEPTIDASES; PERIODONTITIS; ACTIVATION; SKIN; PATHOGENESIS	Periodontitis, a chronic inflammation driven by dysbiotic subgingival bacterial flora, is linked on clinical levels to the development of a number of systemic diseases and to the development of oral and gastric tract tumors. A key pathogen, Porphyromonas gingivalis, secretes gingipains, cysteine proteases implicated as the main factors in the development of periodontitis. Here we hypothesize that gingipains may be linked to systemic pathologies through the deregulation of kallikrein-like proteinase (KLK) family members, KLKs are implicated in cancer development and are clinically utilized as tumor progression markers. In tissues, KLK activity is strictly controlled by a limited number of tissue-specific inhibitors, including SPINK6, an inhibitor of these proteases in skin and oral epithelium. Here we identify gingipains as the only P. gingivalis proteases responsible for SPINK6 degradation. We further show that gingipains, even at low nanomolar concentrations, cleaved SPINK6 in concentration- and time-dependent manner. The proteolysis was accompanied by loss of inhibition against KLK13. We also mapped the cleavage by Arg-specific gingipains to the reactive site loop of the SPINK6 inhibitor. Moreover, we identified a significant fraction of SPINK6-sensitive proteases in healthy saliva and confirmed the ability of gingipains to inactivate SPINK6 under ex vivo conditions. Finally, we demonstrate the double-edge action of gingipains, which, in addition, can activate K1,Ks because of gingipain K-mediated proteolytic processing of the zymogenic proform of KLK13. Altogether, the results indicate the potential of P. gingivalis to disrupt the control system of KLKs, providing a possible mechanistic link between periodontal disease and tumor development.	[Plaza, Karolina; Kalinska, Magdalena; Falkowski, Katherine; Sasiadek, Laura; Bielecka, Ewa; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Bochenska, Oliwia; Kozik, Andrzej] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Analyt Biochem, PL-30387 Krakow, Poland; [Kantyka, Tomasz] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Meyer-Hoffert, Ulf; Wu, Zhihong; Fischer, Jan] Univ Clin Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Potempa, Barbara; Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Kiel; Schleswig Holstein University Hospital; University of Louisville	Potempa, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland.; Potempa, J (corresponding author), Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA.	jan.potempa@uj.edu.pl	Wu, Zhihong/AAK-3433-2020; Bielecka, Ewa/Q-4850-2018; Meyer-Hoffert, Ulf/F-4623-2012; Potempa, Jan/AAA-6850-2021	Bielecka, Ewa/0000-0002-2631-6711; Meyer-Hoffert, Ulf/0000-0003-2305-1428; Potempa, Jan/0000-0002-3600-7461; Falkowski, Katherine/0000-0002-1470-256X; Kantyka, Tomasz/0000-0003-3023-2382	Polish National Centre of Science Research [OPUS 2012/05/B/NZ6/00581, Preludium UMO-2012/07/N/ NZ1/00006, SYMFONIA UMO-2013/08/W/NZ1/00696]; Polish Ministry of Science and Higher Education luventus+ [IP2011 022171, 2975/7.PR/13/2014/2]; German Research Foundation [ME2037/3-3]; Young Scientist Grant for Faculty of Biochemistry, Biophysics, and Biotechnology [K/DSC/003271]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education, Poland; National Institutes of Health [DE 09761, DE 022597]; European Commission [FP7-HEALTH-F3-2012-306029]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	Polish National Centre of Science Research; Polish Ministry of Science and Higher Education luventus+; German Research Foundation(German Research Foundation (DFG)); Young Scientist Grant for Faculty of Biochemistry, Biophysics, and Biotechnology; European Union(European Commission); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by Polish National Centre of Science Research Grants OPUS 2012/05/B/NZ6/00581 (to T. K.), Preludium UMO-2012/07/N/ NZ1/00006 (to K. P.), and SYMFONIA UMO-2013/08/W/NZ1/00696 (to J. P.); Polish Ministry of Science and Higher Education luventus+ IP2011 022171 (to T. K.) and 2975/7.PR/13/2014/2 (to J. P.); German Research Foundation Grant ME2037/3-3 (to U. M. H.); and Young Scientist Grant for Faculty of Biochemistry, Biophysics, and Biotechnology K/DSC/003271 (to M. K.). The Faculty of Biochemistry, Biophysics, and Biotechnology of the Jagiellonian University in Krakow is a beneficiary of structural funds from the European Union (Grant POIG.02.01.00-12-064/08, "Molecular Biotechnology for Health") and a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education, Poland. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants DE 09761 and DE 022597 and European Commission Grant FP7-HEALTH-F3-2012-306029 "TRIGGER"). To whom correspondence should be addressed: Tel.: 48-12-6646343; Fax: 48-12-6646902; E-mail: jan.potempa@uj.edu.pl.	Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Fischer J, 2014, J INVEST DERMATOL, V134, P1305, DOI 10.1038/jid.2013.502; Fischer J, 2013, J INVEST DERMATOL, V133, P1170, DOI 10.1038/jid.2012.482; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Gao SG, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0049-x; Gasiorowska A, 2011, DIGEST DIS SCI, V56, P894, DOI 10.1007/s10620-010-1349-4; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Ha NH, 2015, TUMOR BIOL, V36, P9947, DOI 10.1007/s13277-015-3764-9; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; IMAMURA T, 1995, INFECT IMMUN, V63, P4877, DOI 10.1128/IAI.63.12.4877-4882.1995; IMAMURA T, 1994, J CLIN INVEST, V94, P361, DOI 10.1172/JCI117330; IMAMURA T, 1995, INFECT IMMUN, V63, P1999, DOI 10.1128/IAI.63.5.1999-2003.1995; Imamura T, 2003, CURR PROTEIN PEPT SC, V4, P443, DOI 10.2174/1389203033487027; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Into T, 2006, CLIN EXP IMMUNOL, V145, P545, DOI 10.1111/j.1365-2249.2006.03156.x; Kadowaki T, 2004, MOL PHARMACOL, V66, P1599, DOI 10.1124/mol.104.004366; Kalinska M, 2016, BIOCHIMIE, V122, P270, DOI 10.1016/j.biochi.2015.09.023; Kantyka T, 2011, PEPTIDES, V32, P1187, DOI 10.1016/j.peptides.2011.03.009; Kantyka T, 2009, BIOL CHEM, V390, P1313, DOI 10.1515/BC.2009.136; Kapadia C, 2004, BIOCHEM BIOPH RES CO, V323, P1084, DOI 10.1016/j.bbrc.2004.08.206; Kapadia C, 2003, CLIN CHEM, V49, P77, DOI 10.1373/49.1.77; Kontos CK, 2012, CLIN CHEM LAB MED, V50, P1877, DOI 10.1515/cclm-2012-0247; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Meyer J, 1997, J PERIODONTOL, V68, P256, DOI 10.1902/jop.1997.68.3.256; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Olsen I, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.24800; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Potempa Jan, 2007, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2120s49; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rockett JC, 2004, MUTAT RES-FUND MOL M, V549, P225, DOI 10.1016/j.mrfmmm.2003.11.017; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Stenman UH, 2011, ASIAN J ANDROL, V13, P628, DOI 10.1038/aja.2011.45; Tezal M, 2005, J PERIODONTOL, V76, P406, DOI 10.1902/jop.2005.76.3.406; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; Tuysuz B, 2010, ACTA DERM-VENEREOL, V90, P95, DOI 10.2340/00015555-0769; Uehara A, 2008, J MED MICROBIOL, V57, P500, DOI 10.1099/jmm.0.47679-0; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yousef GM, 2002, TUMOR BIOL, V23, P185, DOI 10.1159/000064027	47	7	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18753	18764		10.1074/jbc.M116.722942	http://dx.doi.org/10.1074/jbc.M116.722942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27354280	hybrid, Green Published			2022-12-26	WOS:000383242300013
J	Misawa, A; Takayama, K; Urano, T; Inoue, S				Misawa, Aya; Takayama, Ken-ichi; Urano, Tomohiko; Inoue, Satoshi			Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen; androgen receptor; apoptosis; long noncoding RNA (lncRNA); prostate cancer	INCREASED SURVIVAL; GENE-EXPRESSION; HUMAN GENOME; RECEPTOR; TRANSCRIPTION; REVEALS; ANTIANDROGEN; SUPPRESSOR; PROGRAM; SOCS-2	Long noncoding RNAs (lncRNA) have been associated with the development of cancer. However, the interplay between lncRNAs and androgen receptor (AR) signaling in prostate cancer is still unclear. Here, we identified lncRNAs induced by androgen in AR-positive prostate cancer cells, where induction was abolished by AR knockdown as well as an anti-androgen, bicalutamide. By combining these data, we identified an androgen-regulated lncRNA, suppressor of cytokine signaling 2-antisense transcript 1 (SOCS2-AS1), the expression of which was higher in castration-resistant prostate cancer model cells, i.e. long-term androgen-deprived (LTAD) cells, than in parental androgen-dependent LNCaP cells. SOCS2-AS1 promoted castration-resistant and androgen-dependent cell growth. We found that SOCS2-AS1 knockdown up-regulated genes related to the apoptosis pathway, including tumor necrosis factor superfamily 10 (TNFSF10), and sensitized prostate cancer cells to docetaxel treatment. Moreover, we also demonstrated that SOCS2-AS1 promotes androgen signaling by modulating the epigenetic control for AR target genes including TNFSF10. These findings suggest that SOCS2-AS1 plays an important role in the development of castration-resistant prostate cancer by repressing apoptosis.	[Misawa, Aya; Takayama, Ken-ichi; Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Tokyo Metropolitan Inst Gerontol, Dept Funct Biogerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan; [Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan	University of Tokyo; Tokyo Metropolitan Institute of Gerontology; Saitama Medical University	Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan.	sinoue@tmig.or.jp	Urano, Tomohiko/AFS-9574-2022; Takayama, Kenichi/AAK-9238-2020	Urano, Tomohiko/0000-0002-1771-024X	Cell innovation Program; P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science, Japan [15K15581, 15K15353]; Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Information (NIBIO), Japan; Ministry of Health, Labor, and Welfare (MHLW), Japan; Takeda Science Foundation; Mochida Memorial Research Foundation Japan; Yasuda Memorial Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research [16K09796] Funding Source: KAKEN	Cell innovation Program; P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Information (NIBIO), Japan; Ministry of Health, Labor, and Welfare (MHLW), Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Research Foundation Japan; Yasuda Memorial Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Cell innovation Program and the P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to S. I.); Grants 15K15581 (to K. T.) and 15K15353 (to S. I.) from the Japan Society for the Promotion of Science, Japan; a grant from the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Information (NIBIO), Japan (to S. I.); grants-in-aid from the Ministry of Health, Labor, and Welfare (MHLW), Japan (to S. I.); grants from the Takeda Science Foundation (to S. I. and K. T.); and grants from the Mochida Memorial Research Foundation Japan, the Yasuda Memorial Foundation, and the Princess Takamatsu Cancer Research Fund (all to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Arany I, 2001, ANTICANCER RES, V21, P425; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2012, J BIOL CHEM, V287, P8571, DOI 10.1074/jbc.M111.325290; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Kok JB, 2002, CANCER RES, V62, P2695; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Farooqi AA, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-22; Farooqi AA, 2012, MOL BIOL REP, V39, P4909, DOI 10.1007/s11033-011-1286-0; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoefer J, 2014, ENDOCR-RELAT CANCER, V21, P175, DOI 10.1530/ERC-13-0446; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung CL, 2014, P NATL ACAD SCI USA, V111, P18697, DOI 10.1073/pnas.1415669112; Iglesias-Gato D, 2014, CARCINOGENESIS, V35, P24, DOI 10.1093/carcin/bgt304; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Lee RS, 2013, NAT GENET, V45, P1268, DOI 10.1038/ng.2805; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Marquardt S, 2014, CELL, V157, P1712, DOI 10.1016/j.cell.2014.04.036; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Smith MR, 2011, CANCER-AM CANCER SOC, V117, P2077, DOI 10.1002/cncr.25762; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Takayama K, 2014, CANCER RES, V74, P6542, DOI 10.1158/0008-5472.CAN-14-1030; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Takayama KI, 2012, MOL ENDOCRINOL, V26, P748, DOI 10.1210/me.2011-1242; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wikman A, 2001, SCAND J CLIN LAB INV, V61, P307; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	59	106	112	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17861	17880		10.1074/jbc.M116.718536	http://dx.doi.org/10.1074/jbc.M116.718536			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27342777	Green Published, hybrid			2022-12-26	WOS:000383241300031
J	Yang, CL; Mi, L; Hu, XL; Liu, JX; Wang, JK				Yang, Chunlei; Mi, Lan; Hu, Xialu; Liu, Jianxin; Wang, Jiakun			Investigation into Host Selection of the Cecal Acetogen Population in Rabbits after Weaning	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-VITRO; FERMENTATION PATTERN; ORYCTOLAGUS-CUNICULUS; BOVINE RUMEN; AGE; EVOLUTION; COMMUNITY; HYDROGEN; CARBON	Homoacetogenic bacteria have received attention as a hydrogenotrophic population that offers a significant energetic advantage to the host animal. Reductive acetogenesis is likely an important hydrogen disposal mechanism in the cecum of rabbits. However, molecular ecology information about cecal acetogen candidates has rarely been reported. To better understand the effect of host selection in the rabbit cecal acetogen community with respect to growth, rabbits at four different age stages (30, 60, 120 and 180 days) with the same diet were studied. Although the abundance of potential acetogens and methanogens was high in the cecum of rabbits undergoing growth, many novel potential acetogen populations were observed in the cecum of rabbits across all age groups. Young and adult rabbits had their own distinct acetogen community although they received the same diet, which suggests that as the rabbit ages, acetogens in the cecum undergo developmental changes because of host selection that are independent of diet, and perhaps the different acetogen communities result in different hydrogenotrophic characteristics. The within-group similarity increased with age, indicating that the acetogen community converges to a more homogeneous and stable arrangement with aging.	[Yang, Chunlei; Mi, Lan; Hu, Xialu; Liu, Jianxin; Wang, Jiakun] Zhejiang Univ, Inst Dairy Sci, MoE Key Lab Mol Anim Nutr, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Wang, JK (corresponding author), Zhejiang Univ, Inst Dairy Sci, MoE Key Lab Mol Anim Nutr, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	jiakunwang@zju.edu.cn		Wang, Jiakun/0000-0002-7213-3721	National Natural Science Foundation of China [31372337]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Natural Science Foundation of China (31372337) for JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Stuart Denman at CSIRO, Australia, for his assistance in the data analysis of this manuscript. The authors acknowledge the financial support from Natural Science Foundation of China (31372337).	Abecia L, 2005, FEMS MICROBIOL LETT, V244, P111, DOI 10.1016/j.femsle.2005.01.028; Abecia L, 2013, J ANIM PHYSIOL AN N, V97, P80, DOI 10.1111/jpn.12049; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Belenguer A, 2011, WORLD RABBIT SCI, V19, P75, DOI 10.4995/wrs.2011.826; Bengelsdorf FR, 2013, ENVIRON TECHNOL, V34, P1639, DOI 10.1080/09593330.2013.827747; Bernalier A, 1996, ARCH MICROBIOL, V166, P176, DOI 10.1007/s002030050373; Blackmore TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075079; Bovera F, 2008, J ANIM PHYSIOL AN N, V92, P260, DOI 10.1111/j.1439-0396.2007.00748.x; BREZNAK JA, 1991, ARCH MICROBIOL, V156, P105, DOI 10.1007/BF00290981; BREZNAK JA, 1990, FEMS MICROBIOL LETT, V87, P309, DOI 10.1016/0378-1097(90)90471-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Combes S, 2011, FEMS MICROBIOL ECOL, V77, P680, DOI 10.1111/j.1574-6941.2011.01148.x; CORDRUWISCH R, 1988, ARCH MICROBIOL, V149, P350, DOI 10.1007/BF00411655; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Dong H, 2006, CLIMATE CHANGE 2006; Drake H.L., 1994, ACETOGENESIS, P3; ERNSTER L, 1957, PEDIATRICS, V20, P647; Eshar D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-62; FORSYTHE SJ, 1985, J APPL BACTERIOL, V58, P363, DOI 10.1111/j.1365-2672.1985.tb01475.x; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Gallois M, 2008, ANIMAL, V2, P525, DOI 10.1017/S1751731108001729; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GEERLIGS G, 1987, ARCH MICROBIOL, V148, P305, DOI 10.1007/BF00456709; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Godwin S, 2014, ISME J, V8, P1855, DOI 10.1038/ismej.2014.25; GOUET P, 1973, ANN BIOL ANIM BIOCH, V13, P733, DOI 10.1051/rnd:19730423; Hu WL, 2005, ANIM FEED SCI TECH, V120, P333, DOI 10.1016/j.anifeedsci.2005.02.029; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Joblin KN, 1999, AUST J AGR RES, V50, P1307, DOI 10.1071/AR99004; Kita A, 2013, J BIOSCI BIOENG, V115, P347, DOI 10.1016/j.jbiosc.2012.10.013; Kopke M, 2011, APPL ENVIRON MICROB, V77, P5467, DOI 10.1128/AEM.00355-11; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kundiyana DK, 2011, BIORESOURCE TECHNOL, V102, P6058, DOI 10.1016/j.biortech.2011.03.020; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Leaphart AB, 2001, APPL ENVIRON MICROB, V67, P1392, DOI 10.1128/AEM.67.3.1392-1395.2001; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LOROWITZ WH, 1984, APPL ENVIRON MICROB, V47, P961, DOI 10.1128/AEM.47.5.961-964.1984; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marounek M, 1999, ARCH ANIM NUTR, V52, P195, DOI 10.1080/17450399909386162; Martinez G, 2011, ADV ANIMAL BIOSCIENC, V2, P488; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Piattoni F, 1996, REPROD NUTR DEV, V36, P253, DOI 10.1051/rnd:19960303; RieuLesme F, 1996, FEMS MICROBIOL LETT, V140, P281; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Sakai S, 2005, J BIOSCI BIOENG, V99, P252, DOI 10.1263/jbb.99.252; Schink B, 1994, ACETOGENESIS, P197, DOI DOI 10.1007/978-1-4615-1777-1_7; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Warnes G.R., 2009, GPLOTS VARIOUS R PRO; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOOD HG, 1991, FASEB J, V5, P156, DOI 10.1096/fasebj.5.2.1900793; Xu KW, 2009, ANAEROBE, V15, P204, DOI 10.1016/j.anaerobe.2009.03.005; Yang B, 2015, J ANIM SCI, V93, P4984, DOI 10.2527/jas.2015-9266; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	66	7	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158768	10.1371/journal.pone.0158768	http://dx.doi.org/10.1371/journal.pone.0158768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379387	Green Submitted, Green Published, gold			2022-12-26	WOS:000379798700045
J	Aghajafari, F; Field, CJ; Kaplan, BJ; Rabi, DM; Maggiore, JA; O'Beirne, M; Hanley, DA; Eliasziw, M; Dewey, D; Weinberg, A; Ross, SJ				Aghajafari, Fariba; Field, Catherine J.; Kaplan, Bonnie J.; Rabi, Doreen M.; Maggiore, Jack A.; O'Beirne, Maeve; Hanley, David A.; Eliasziw, Misha; Dewey, Deborah; Weinberg, Amy; Ross, Sue J.		APrON Study Team	The Current Recommended Vitamin D Intake Guideline for Diet and Supplements During Pregnancy Is Not Adequate to Achieve Vitamin D Sufficiency for Most Pregnant Women	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; D DEFICIENCY; ADULTS; INSUFFICIENCY; HEALTH; RISK	Background The aims of this study were to determine if pregnant women consumed the recommended vitamin D through diet alone or through diet and supplements, and if they achieved the current reference range vitamin D status when their reported dietary intake met the current recommendations. Methods Data and banked blood samples collected in second trimester from a subset of 537 women in the APrON (Alberta Pregnant Outcomes and Nutrition) study cohort were examined. Frozen collected plasma were assayed using LC-MS/MS (liquid chromatography-tandem mass spectrometry) to determine 25(OH)D-2, 25(OH)D-3, 3-epi-25(OH)D-3 concentrations. Dietary data were obtained from questionnaires including a Supplement Intake Questionnaire and a 24-hour recall of the previous day's diet. Results Participants were 87% Caucasian; mean (SD) age of 31.3 (4.3); BMI 25.8 (4.7); 58% were primiparous; 90% had education beyond high school; 80% had a family income higher than CAN $ 70,000/year. 25(OH)D-2, 25(OH)D-3, and 3-epi-25(OH)D-3) were identified in all of the 537 plasma samples; 3-epi-25(OH)D-3 contributed 5% of the total vitamin D. The median (IQR) total 25(OH)D (D-2+D-3) was 92.7 (30.4) nmol/L and 20% of women had 25(OH)D concentration < 75 nmol/L. The median (IQR) reported vitamin D intake from diet and supplements was 600 (472) IU/day. There was a significant relationship between maternal reported dietary vitamin D intake (diet and supplement) and 25(OH)D and 3-epi-25(OH)D-3 concentrations in an adjusted linear regression model. Conclusions We demonstrated the current RDA (600 IU/day) may not be adequate to achieve vitamin D status > 75 nmol/L in some pregnant women who are residing in higher latitudes (Calgary, 51 degrees N) in Alberta, Canada and the current vitamin D recommendations for Canadian pregnant women need to be re-evaluated.	[Aghajafari, Fariba; Kaplan, Bonnie J.; Rabi, Doreen M.; O'Beirne, Maeve; Hanley, David A.; Dewey, Deborah] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Field, Catherine J.; Weinberg, Amy] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Maggiore, Jack A.] Doctors Data Inc, Res & Dev, St Charles, IL USA; [Eliasziw, Misha] Tufts Univ, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Ross, Sue J.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	University of Calgary; University of Alberta; Massachusetts Department of Public Health; Tufts University; University of Alberta	Aghajafari, F (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.	fariba.aghajafari@ucalgary.ca	Dewey, Deborah/AGK-7348-2022	Aghajafari, Fariba/0000-0002-2229-2054; Dewey, Deborah/0000-0002-1323-5832; Field, Catherine/0000-0001-7285-4767	Cumming School of Medicine, University of Calgary; Janus Research Award from College of Family Physicians of Canada	Cumming School of Medicine, University of Calgary; Janus Research Award from College of Family Physicians of Canada	This work was funded by Bridge funding from the Cumming School of Medicine, University of Calgary, and Janus Research Award from College of Family Physicians of Canada. The funder provided support in the form of research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F., 2015, J NUTR; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Bailey D, 2014, CLIN BIOCHEM, V47, P816, DOI 10.1016/j.clinbiochem.2014.01.015; Bailey D, 2013, CLIN BIOCHEM, V46, P190, DOI 10.1016/j.clinbiochem.2012.10.037; Canada Health, VIT D CALC UPD DIET; Canada Health [CD], 2004, NUTRIENT INTAKES FRO, V1; Canadian Cancer Society, 2016, BEING SAF SUN; Cashman KD, 2014, J NUTR, V144, P1050, DOI 10.3945/jn.114.192419; Food and Drug Administration, 2009, FED REGISTER, V74, P53743; Gomez MF, 2015, MATERN CHILD NUTR, V11, P497, DOI 10.1111/mcn.12038; Gozdzik A, 2010, J NUTR, V140, P2213, DOI 10.3945/jn.110.126284; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Harville EW, 2004, J AM COLL NUTR, V23, P43, DOI 10.1080/07315724.2004.10719341; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Institute of Medicine, 2012, DIET REF INT CALC VI; Kaplan BJ, 2014, MATERN CHILD NUTR, V10, P44, DOI 10.1111/j.1740-8709.2012.00433.x; Kramer CK, 2016, CLIN ENDOCRINOL, V84, P680, DOI 10.1111/cen.12989; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lucas RM, 2013, J STEROID BIOCHEM, V136, P300, DOI 10.1016/j.jsbmb.2013.01.011; Mannion CA, 2007, J AM COLL NUTR, V26, P149, DOI 10.1080/07315724.2007.10719596; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Ozias MK, 2014, J AM COLL NUTR, V33, P394, DOI 10.1080/07315724.2013.879843; Rifas-Shiman SL, 2006, PAEDIATR PERINAT EP, V20, P35, DOI 10.1111/j.1365-3016.2006.00691.x; Rucker D, 2002, CAN MED ASSOC J, V166, P1517; Sarafin K, 2015, AM J CLIN NUTR, V102, P1044, DOI 10.3945/ajcn.114.103689; Sham L, 2015, J PHOTOCH PHOTOBIO B, V145, P25, DOI 10.1016/j.jphotobiol.2015.02.007; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; van den Ouweland JMW, 2010, J CHROMATOGR B, V878, P1163, DOI 10.1016/j.jchromb.2010.03.035; Veugelers PJ, 2015, NUTRIENTS, V7, P10189, DOI 10.3390/nu7125527; Wagner CL, 2012, WOMENS HEALTH, V8, P323, DOI [10.2217/WHE.12.17, 10.2217/whe.12.17]; Wangyang L., 2011, CAN J PUBLIC HLTH, V102, P308; Whiting SJ, 2011, AM J CLIN NUTR, V94, P128, DOI 10.3945/ajcn.111.013268; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S	38	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157262	10.1371/journal.pone.0157262	http://dx.doi.org/10.1371/journal.pone.0157262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367800	gold, Green Published, Green Submitted			2022-12-26	WOS:000378914900009
J	Balestrieri, A; Bogliani, G; Boano, G; Ruiz-Gonzalez, A; Saino, N; Costa, S; Milanesi, P				Balestrieri, Alessandro; Bogliani, Giuseppe; Boano, Giovanni; Ruiz-Gonzalez, Aritz; Saino, Nicola; Costa, Stefano; Milanesi, Pietro			Modelling the Distribution of Forest-Dependent Species in Human-Dominated Landscapes: Patterns for the Pine Marten in Intensively Cultivated Lowlands	PLOS ONE			English	Article							HABITAT SELECTION; RANGE-EXPANSION; RIPARIAN; CARNIVORES; EVOLUTION; INVASIONS; PREDICT; SHIFTS	In recent years, the "forest-specialist" pine marten Martes martes has been reported to also occur also in largely fragmented, lowland landscapes of north-western Italy. The colonization of such an apparently unsuitable area provided the opportunity for investigating pine marten ecological requirements and predicting its potential south-and eastwards expansion. We collected available pine marten occurrence data in the flood plain of the River Po (N Italy) and relate them to 11 environmental variables by developing nine Species Distribution Models. To account for inter-model variability we used average ensemble predictions (EP). EP predicted a total of 482 suitable patches (8.31% of the total study area) for the pine marten. The main factors driving pine marten occurrence in the western River Po plain were the distance from watercourses and the distance from woods. EP suggested that the pine marten may further expand in the western lowland, whilst the negligible residual wood cover of large areas in the central and eastern plain makes the habitat unsuitable for the pine marten, except for some riparian corridors and the pine wood patches bordering the Adriatic coast. Based on our results, conservation strategies should seek to preserve remnant forest patches and enhance the functional connectivity provided by riparian corridors.	[Balestrieri, Alessandro; Saino, Nicola] Univ Milan, Dept Biosci, Milan, Italy; [Bogliani, Giuseppe; Milanesi, Pietro] Univ Pavia, Dept Earth & Environm Sci, Pavia, Italy; [Boano, Giovanni] Nat Hist Museum Carmagnola, Carmagnola, TO, Italy; [Ruiz-Gonzalez, Aritz] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Vitoria, Spain; [Ruiz-Gonzalez, Aritz] Univ Basque Country, UPV EHU, Lascaray Res Ctr, Systemat Biogeog & Populat Dynam Res Grp, Vitoria, Spain; [Costa, Stefano] Via Quintino Sella 16, Cossato, BI, Italy	University of Milan; University of Pavia; University of Basque Country; University of Basque Country	Balestrieri, A (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	alebls@libero.it	GONZALEZ, ARITZ RUIZ/P-3384-2019; Milanesi, Pietro/AAW-4309-2021; Ruiz-Gonzalez, Aritz/A-1613-2013	GONZALEZ, ARITZ RUIZ/0000-0001-7409-4634; Milanesi, Pietro/0000-0002-1878-9762; Boano, Giovanni/0000-0002-2670-4351	Dept. of Biosciences of the University of Milan; Dept. of Earth and Environmental Sciences, University of Pavia; Basque Government through the Research group on 'Systematics, Biogeography and Population Dynamics' [IT317-10, GIC10/76, IT575/13]; SAIOTEK research programme [S-PE11UN028]; Dept. of Education, Universities and Research of the Basque Government [DKR-2012-64]	Dept. of Biosciences of the University of Milan; Dept. of Earth and Environmental Sciences, University of Pavia; Basque Government through the Research group on 'Systematics, Biogeography and Population Dynamics'; SAIOTEK research programme; Dept. of Education, Universities and Research of the Basque Government	A. Balestrieri was supported by a Ph.D. fellowship awarded by the Dept. of Biosciences of the University of Milan. P. Milanesi was supported by the Dept. of Earth and Environmental Sciences, University of Pavia. This study has been partially funded by the Basque Government through the Research group on 'Systematics, Biogeography and Population Dynamics' (Ref. IT317-10; GIC10/76; IT575/13), the SAIOTEK research programme (Ref: S-PE11UN028). A. Ruiz-Gonzalez (Ref. DKR-2012-64) was supported by a Ph.D. and Post-doctoral fellowships awarded by the Dept. of Education, Universities and Research of the Basque Government.	Aertsen W, 2011, ENVIRON MODELL SOFTW, V221, P1119; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Althoff DP, 1997, J WILDLIFE MANAGE, V61, P450, DOI 10.2307/3802603; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Ascensao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103544; Baldwin RA, 2008, J MAMMAL, V89, P419, DOI 10.1644/07-MAMM-A-053R1.1; Balestrieri A, 2015, ETHOL ECOL EVOL; Balestrieri A, MAMMAL RES UNPUB; Balestrieri A, 2016, MAMM BIOL, V81, P439, DOI 10.1016/j.mambio.2016.05.005; Balestrieri A, 2015, ECOL RES, V30, P153, DOI 10.1007/s11284-014-1220-8; Balestrieri A, 2011, ACTA THERIOL, V56, P199, DOI 10.1007/s13364-010-0015-8; Balestrieri A, 2010, MAMM BIOL, V75, P412, DOI 10.1016/j.mambio.2009.05.003; Barrull J, 2014, MAMM BIOL, V79, P123, DOI 10.1016/j.mambio.2013.11.004; Bon M, 1995, LAV SOC VEN SCI NA S, V21; Bon M, 2012, 8 C ASS TER IT PIAC; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Broenniman O, 2014, ECOSPAT SPATIAL ECOL; BUSKIRK SW, 1992, CONSERV BIOL, V6, P318, DOI 10.1046/j.1523-1739.1992.06030318.x; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Camerano P, 2010, BOSCHI PLANIZIALI CO, DOI Torino; Carone TM, 2014, ECOL MODEL, V274, P21, DOI 10.1016/j.ecolmodel.2013.11.027; Caryl FM, 2012, J MAMMAL, V93, P464, DOI 10.1644/11-MAMM-A-149.1; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; COLES T F, 1989, Regulated Rivers Research and Management, V4, P179, DOI 10.1002/rrr.3450040210; Crickenberger S, 2016, HYDROBIOLOGIA, V763, P193, DOI 10.1007/s10750-015-2376-0; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Darimont CT, 2005, DIVERS DISTRIB, V11, P235, DOI 10.1111/j.1366-9516.2005.00135.x; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; de Rivera CE, 2011, DIVERS DISTRIB, V17, P1198, DOI 10.1111/j.1472-4642.2011.00790.x; Di Febbraro M, 2015, DIVERS DISTRIB, P1; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; DOYLE AT, 1990, J MAMMAL, V71, P14, DOI 10.2307/1381312; Ducci L, 2015, LANDSCAPE ECOL, V30, P2147, DOI 10.1007/s10980-015-0237-x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Falcucci A, 2013, BIOL CONSERV, V158, P63, DOI 10.1016/j.biocon.2012.08.029; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gherardi M, 2009, EQA-INT J ENVIRON QU, V2, P29, DOI 10.6092/issn.2281-4485/3817; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hastie T., 1986, STAT SCI, V1, P297; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Holt RD, 1996, OIKOS, V75, P182, DOI 10.2307/3546242; Kampichler C, 2010, ECOL INFORM, V254, P390; Kinlan BP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P381; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Ko CY, 2011, ECOL MODEL, V222, P947, DOI 10.1016/j.ecolmodel.2010.12.001; La Morgia V, 2011, LANDSCAPE ECOL, V26, P969, DOI 10.1007/s10980-011-9621-3; Lapini Luca, 2009, Bollettino del Museo Civico di Storia Naturale di Venezia, V60, P169; Larroque J, 2016, LANDSCAPE ECOL, V31, P517, DOI 10.1007/s10980-015-0281-6; Larroque J, 2015, ECOGRAPHY, V38, P1129, DOI 10.1111/ecog.01133; Lassini P., 2007, EUROPES LIVING LANDS, P83; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; MacArthur R.H., 1972, pvii; Mantovani Sergio, 2010, Pianura, V25, P95; Marmion M, 2009, ECOL MODEL, V6; McCullagh P, 1989, GEN LINEAR MODELS; Milanesi P, 2015, BASIC APPL ECOL; Moyle PB, 1996, ECOLOGY, V77, P1666, DOI 10.2307/2265770; Olaya-Marin EJ, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013052; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Pereboom V, 2008, CAN J ZOOL, V86, P983, DOI 10.1139/Z08-076; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prigioni C., 2001, ATLANTE MAMMIFERI LO; Remonti L, 2011, ECOL RES, V26, P487, DOI 10.1007/s11284-011-0804-9; Ripley B. D., 1996, PATTERN RECOGNITION; Salek M, 2014, EUR J WILDLIFE RES, V60, P99, DOI 10.1007/s10344-013-0755-2; Santos MJ, 2016, EUR J WILDLIFE RES, V62, P251, DOI 10.1007/s10344-016-0984-2; Savoldelli P, 2008, GRANDI PICCOLI PREDA; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Sidorovich VE, 2005, FOLIA ZOOL, V54, P39; Sindaco R, 2010, RIV PIEMONTESE STORI, V31, P397; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Stolar J, 2015, DIVERS DISTRIB, V21, P595, DOI 10.1111/ddi.12279; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tattersall FH, 2002, J APPL ECOL, V39, P643, DOI 10.1046/j.1365-2664.2002.00741.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thuiller W., 2013, R PACKAGE VERSION, V2, P560; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Uboni A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00419.1; Veech JA, 2011, J BIOGEOGR, V38, P69, DOI 10.1111/j.1365-2699.2010.02397.x; Verdade L.M., 2011, MIDDLE SIZED CARNIVO, P1; Vergara M, 2016, LANDSCAPE ECOL, V31, P1241, DOI 10.1007/s10980-015-0307-0; Virgos E, 2012, BIOL CONSERVATION MA, P255; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wereszczuk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139852; White TA, 2012, BIOL INVASIONS, V14, P2203, DOI 10.1007/s10530-012-0225-x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Zalewski A, 2006, ECOGRAPHY, V29, P31, DOI 10.1111/j.2005.0906-7590.04313.x; Zuur Alain F., 2009, P1	101	19	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158203	10.1371/journal.pone.0158203	http://dx.doi.org/10.1371/journal.pone.0158203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368056	Green Published, gold			2022-12-26	WOS:000378914900022
J	Muga, MA; Owili, PO; Hsu, CY; Rau, HH; Chao, JCJ				Muga, Miriam Adoyo; Owili, Patrick Opiyo; Hsu, Chien-Yeh; Rau, Hsiao-Hsien; Chao, Jane C-J			Association between Dietary Patterns and Cardiovascular Risk Factors among Middle-Aged and Elderly Adults in Taiwan: A Population-Based Study from 2003 to 2012	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; INSULIN-RESISTANCE; ENDOTHELIAL ACTIVATION; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; WHOLE-GRAIN; INFLAMMATION; MARKERS	Background Cardiovascular disease (CVD) is one of the leading causes of mortality and loss of disability-adjusted life years in developed countries. This study derived a dietary pattern using an a priori method and additionally derived dietary patterns using a posteriori methods, and assessed the relationship with CVD risk factors in Taiwanese middle-aged and elderly adults. Methods Cross-sectional analyses of 62,965 subjects aged 40 years and above from the Mei Jau (MJ) database collected between 2003 and 2012 in Taiwan. Diet was assessed using a 22 item semi-quantitative food frequency questionnaire. Using this information, three dietary patterns were generated. The a priori diet was labeled the Taiwanese dietary pattern and was derived using hypothesized effect of 22 food groups, while two a posteriori dietary patterns, "vegi-fruits" and "meat-processed", were derived using principal component analysis. The association between dietary patterns and a range of CVD risk factors (i.e. blood lipids, blood glucose and C-reactive protein) was evaluated using linear regression. Results The results showed that high intake (Q5, quintile 5) of Taiwanese diet was negatively associated with CVD risk factors at (p < 0.001, model 3), but not with triacylglycerol. In addition, high intake of vegi-fruit dietary pattern (Q5) was negatively associated with CVD risk factors (p < 0.001), but not with high-density lipoprotein, while high consumption of meat-processed dietary pattern (Q5) was positively associated with CVD risk factors (p < 0.001), but negatively related with triacylglycerol in Q3 level and no association with C-reactive protein. Conclusion A negative association was observed between Taiwanese or vegi-fruit dietary patterns and CVD risk factors, while a positive association was found between meat-processed dietary pattern and CVD risk factors. The findings suggested that a diet rich in vegetables and fruits has a beneficial effect in the management of CVD risk factors.	[Muga, Miriam Adoyo; Chao, Jane C-J] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Owili, Patrick Opiyo] Natl Yang Ming Univ, Inst Publ Hlth, Int Hlth Program, Taipei, Taiwan; [Hsu, Chien-Yeh] Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan; [Hsu, Chien-Yeh; Chao, Jane C-J] Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan; [Rau, Hsiao-Hsien] Taipei Med Univ, Coll Med Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Chao, Jane C-J] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan	Taipei Medical University; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chao, JCJ (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, Taipei, Taiwan.; Hsu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan.; Hsu, CY; Chao, JCJ (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan.; Chao, JCJ (corresponding author), Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan.	cyhsu@ntunhs.edu.tw; chenjui@tmu.edu.tw	Owili, Patrick Opiyo/J-8948-2019	Owili, Patrick Opiyo/0000-0002-9417-8947; Muga, Miriam/0000-0002-9180-5394				Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Akter S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-30; Arisawa K, 2014, J MED INVESTIG, V61, P333, DOI 10.2152/jmi.61.333; Bailey RL, 2007, J NUTR, V137, P421, DOI 10.1093/jn/137.2.421; Baxter AJ, 2006, ASIA PAC J CLIN NUTR, V15, P134; Brown J., 2009, SHIKEN JALT TESTING, V13, P19; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Calton EK, 2014, NUTR RES, V34, P559, DOI 10.1016/j.nutres.2014.06.012; Centritto F, 2009, NUTR METAB CARDIOVAS, V19, P697, DOI 10.1016/j.numecd.2008.11.009; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; De Biase SG, 2007, ARQ BRAS CARDIOL, V88, P35, DOI 10.1590/S0066-782X2007000100006; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Eilat-Adar S, 2013, NUTR METAB CARDIOVAS, V23, P528, DOI 10.1016/j.numecd.2011.12.005; Field A., 2012, DISCOVERING STAT USI; Fonseca MJ, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-64; Fredrikson GN, 2004, METABOLISM, V53, P1436, DOI 10.1016/j.metabol.2004.06.010; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Ganguli D, 2011, BRIT J NUTR, V105, P1520, DOI 10.1017/S0007114510005131; Garduno-Diaz SD, 2013, J HUM NUTR DIET, V26, P145, DOI 10.1111/j.1365-277X.2012.01284.x; Gorsuch R. L., 2014, FACTOR ANAL CLASSIC; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; He Y, 2013, NUTR METAB CARDIOVAS, V23, P920, DOI 10.1016/j.numecd.2012.09.001; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; HUIJBREGTS PPCW, 1995, INT J EPIDEMIOL, V24, P313, DOI 10.1093/ije/24.2.313; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Jolliffe IT., 2013, PRINCIPAL COMPONENT; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; King DE, 2007, ARCH INTERN MED, V167, P502, DOI 10.1001/archinte.167.5.502; Lin PH, 2013, ASIA PAC J CLIN NUTR, V22, P482, DOI 10.6133/apjcn.2013.22.3.05; Lockheart MSK, 2007, BRIT J NUTR, V98, P380, DOI 10.1017/S0007114507701654; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Lovegrove JA., 2015, NUTR RES METHODOLOGI; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Lutsey PL, 2007, BRIT J NUTR, V98, P397, DOI 10.1017/S0007114507700715; Lyu LC, 2007, ASIA PAC J CLIN NUTR, V16, P766; McPherson RA, 2011, HENRYS CLIN DIAGNOSI; Meyer KA, 2013, FREE RADICAL BIO MED, V57, P201, DOI 10.1016/j.freeradbiomed.2012.08.574; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Mizoue T, 2006, J NUTR, V136, P1352, DOI 10.1093/jn/136.5.1352; MJ Group, MJ HLTH SCREEN CTR Q; Teixeira RDMD, 2007, ARQ BRAS CARDIOL, V89, P237, DOI 10.1590/S0066-782X2007001600005; Naja F, 2013, EUR J NUTR, V52, P97, DOI 10.1007/s00394-011-0291-3; Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488; Nettleton JA, 2008, AM J CLIN NUTR, V88, P185, DOI 10.1093/ajcn/88.1.185; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Newby PK, 2004, AM J CLIN NUTR, V80, P759; Oliveira A, 2011, J AM DIET ASSOC, V111, P241, DOI 10.1016/j.jada.2010.10.042; ORourke Norm, 2013, STEP BY STEP APPROAC; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Rizzo NS, 2011, DIABETES CARE, V34, P1225, DOI 10.2337/dc10-1221; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Rowley K, 2003, MED J AUSTRALIA, V178, P495, DOI 10.5694/j.1326-5377.2003.tb05324.x; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Song SuJin, 2012, Korean Journal of Nutrition, V45, P80, DOI 10.4163/kjn.2012.45.1.80; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Sun Jing, 2013, Front Public Health, V1, P48, DOI 10.3389/fpubh.2013.00048; Tortosa A, 2007, DIABETES CARE, V30, P2957, DOI 10.2337/dc07-1231; Tourlouki E, 2009, CLIN INTERV AGING, V4, P319, DOI 10.2147/CIA.S5697; Walker J, 2010, INTERPRETING STAT FI; Weickert MO, 2008, J NUTR, V138, P439, DOI 10.1093/jn/138.3.439; WHO, 2003, DIET NUTR PREVENTION, V916; Willett WC, 2012, J INTERN MED, V272, P13, DOI 10.1111/j.1365-2796.2012.02553.x; Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75	72	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157745	10.1371/journal.pone.0157745	http://dx.doi.org/10.1371/journal.pone.0157745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366909	Green Submitted, gold, Green Published			2022-12-26	WOS:000378914900013
J	Saleem, A; Masood, I				Saleem, Ahsan; Masood, Imran			Pattern and Predictors of Medication Dosing Errors in Chronic Kidney Disease Patients in Pakistan: A Single Center Retrospective Analysis	PLOS ONE			English	Article							DRUG-DOSAGE ADJUSTMENTS; RENAL IMPAIRMENT; HOSPITALIZED-PATIENTS; CREATININE CLEARANCE; SERUM CREATININE; ELDERLY-PATIENTS; EPIDEMIOLOGY; PREVALENCE; GUIDELINES; COMMUNITY	Background Chronic kidney disease (CKD) alters the pharmacokinetic and pharmacodynamic response of various drugs and increases the risk of toxicity. The data regarding the pattern and predictors of medication dosing errors is scare from the developing countries. Therefore, the present study was conducted to assess the pattern and predictors of medication dosing errors in CKD patients in a tertiary care setting in Pakistan. Methods A retrospective study design was employed and medical charts of all those CKD patients who had an eGFR <= 60ml/min/1.73m(2), hospitalization >= 24 hours, and admitted in the nephrology unit during January 2013 to December 2014 were assessed. Descriptive statistics and the logistic regression analysis were done using IBM SPSS version 20. Results In total, 205 medical charts were assessed. The mean age of patients was 38.64 (+/- 16.82) years. Overall, 1534 drugs were prescribed to CKD patients, of which, nearly 34.0% drugs required dose adjustment. Among those drugs, only 41.8% were properly adjusted, and the remaining 58.2% were unadjusted. The logistic regression analysis revealed that the medication dosing errors were significantly associated with the CKD stages, i.e. stage 4 (OR 0.054; 95% CI [0.017-0.177]; p < 0.001) and stage 5 (OR 0.098; 95% CI [0.040-0.241]; p < 0.001), the number of prescribed medicines >= 5 (OR 0.306; 95% CI [0.133-0.704]; p 0.005), and the presence of a comorbidity (OR 0.455; 95% CI [0.226-0.916]; p 0.027) such as the hypertension (OR 0.453; 95% CI [0.231-0.887]; p 0.021). Conclusions It is concluded that more than half drugs prescribed to CKD patients requiring dose adjustment were unadjusted. The predictors of medication dosing errors were the severe-to-end stages of chronic kidney disease, the presence of a comorbidity such as hypertension, and a higher number of prescribed medicines. Therefore, attention should be paid to these risk factors.	[Saleem, Ahsan; Masood, Imran] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan	Islamia University of Bahawalpur	Saleem, A; Masood, I (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.	saleemahsan77@gmail.com; drimranmasoodppiub@gmail.com	Saleem, Ahsan/P-4760-2014	Saleem, Ahsan/0000-0003-1710-3578				Alahdal AM, 2012, SAUDI PHARM J, V20, P217, DOI 10.1016/j.jsps.2011.12.005; Alam Ashar, 2014, BMC Res Notes, V7, P179, DOI 10.1186/1756-0500-7-179; Bassetti M, 2016, EXPERT OPIN DRUG SAF, V15, P467, DOI 10.1517/14740338.2016.1142528; BENNETT WM, 1983, AM J KIDNEY DIS, V3, P155, DOI 10.1016/S0272-6386(83)80060-2; British Medical Association Royal Pharmaceutical Society of Great Britain, 2009, BRIT NATL FORMULARY; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Decloedt E, 2010, SAMJ S AFR MED J, V100, P304, DOI 10.7196/SAMJ.3955; Drenth-van Maanen AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128237; Erler A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-91; Getachew H, 2015, BMC NEPHROL, V15, P1; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Haider SI, 2014, VALUE HEALTH, V17, pA129, DOI 10.1016/j.jval.2014.03.747; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hanlon JT, 2011, J AM MED DIR ASSOC, V12, P377, DOI 10.1016/j.jamda.2010.04.008; Hartmann B, 2010, DTSCH ARZTEBL INT, V107, P647, DOI 10.3238/arztebl.2010.0647; Hu KT, 2001, AM J MED SCI, V322, P133, DOI 10.1097/00000441-200109000-00004; Hug BL, 2009, KIDNEY INT, V76, P1192, DOI 10.1038/ki.2009.353; Khanal A, 2015, DRUG AGING, V32, P391, DOI 10.1007/s40266-015-0261-1; Lassiter J, 2013, CLIN GERIATR MED, V29, P657, DOI 10.1016/j.cger.2013.05.008; Leendertse AJ, 2012, ANN PHARMACOTHER, V46, P625, DOI 10.1345/aph.1Q633; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marasinghe KM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006539; Markota NP, 2009, J NEPHROL, V22, P497; Munar MY, 2007, AM FAM PHYSICIAN, V75, P1487; Papaioannou A, 2000, J AM GERIATR SOC, V48, P1470, DOI 10.1111/j.1532-5415.2000.tb02639.x; Pillans PI, 2003, INTERN MED J, V33, P10, DOI 10.1046/j.1445-5994.2003.00330.x; Prajapati Arpit, 2013, J Pharm Bioallied Sci, V5, P136, DOI 10.4103/0975-7406.111829; Sah S K, 2014, J Nepal Health Res Counc, V12, P54; Salomon L, 2003, INT J QUAL HEALTH C, V15, P331, DOI 10.1093/intqhc/mzg046; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Soetikno V, 2009, MED J INDONES, V18, P108; Stevens LA, 2009, CLIN PHARMACOL THER, V86, P465, DOI 10.1038/clpt.2009.124; Sweileh WM, 2007, PHARMACOEPIDEM DR S, V16, P908, DOI 10.1002/pds.1412; Tamizuddin S, 2010, J PAK MED ASSOC, V60, P342; Ullah K, 2015, SAUDI J KIDNEY DIS T, V26, P1307, DOI 10.4103/1319-2442.168694; van Dijk EA, 2006, ANN PHARMACOTHER, V40, P1254, DOI 10.1345/aph.1G742; Verbeeck RK, 2009, EUR J CLIN PHARMACOL, V65, P757, DOI 10.1007/s00228-009-0678-8; WHO, PAK STAT 2013	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158677	10.1371/journal.pone.0158677	http://dx.doi.org/10.1371/journal.pone.0158677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367594	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900048
J	Atwell, J; Savit, R				Atwell, Jon; Savit, Robert			The Emergence of Groups and Inequality through Co-Adaptation	PLOS ONE			English	Article							SELF-ORGANIZATION; STIGMERGY; EVOLUTION; DYNAMICS; MARKETS	The emergence of groups and of inequality is often traced to pre-existing differences, exclusionary practices, or resource accumulation processes, but can the emergence of groups and their differential success simply be a feature of the behaviors of a priori equally-capable actors who have mutually adapted? Using a simple model of behavioral co-adaptation among agents whose individual actions construct a common environment, we present evidence that the formation of unequal groups is endemic to co-adaptive processes that endogenously alter the environment; agents tend to separate into two groups, one whose members stop adapting earliest (the in-group), and another comprising agents who continue to adapt (the out-group). Over a wide range of model parameters, members of the in-group are rewarded more on average than members of the out-group. The primary reason is that the in-group is able to have a more profound influence on the environment and mold it to the benefit of its members. This molding capacity proves more beneficial than the persistence of adaptivity, yet, crucially, which agents are able to form a coalition to successfully exert this control is strongly contingent on random aspects of the set of agent behaviors. In this paper, we present the model, relevant definitions, and results. We then discuss its implications for the study of complex adaptive systems generally.	[Atwell, Jon] Univ Michigan, Dept Sociol, Ann Arbor, MI 48109 USA; [Atwell, Jon; Savit, Robert] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [Savit, Robert] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Atwell, J (corresponding author), Univ Michigan, Dept Sociol, Ann Arbor, MI 48109 USA.; Atwell, J (corresponding author), Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA.	atwell@umich.edu		Atwell, Jon/0000-0002-9706-2640				Akcay E, 2011, P ROY SOC B-BIOL SCI, V278, P2198, DOI 10.1098/rspb.2010.2105; Altman E, 2007, GLOB TELECOMM CONF, P315; ANDERSON JM, 1995, LINKING SPECIES & ECOSYSTEMS, P94; Barthes Roland., 1977, ELEMENTS SEMIOLOGY; Blumer H, 1968, ANN M SOC ED SCHOL L; CARROLL GR, 1985, AM J SOCIOL, V90, P1262, DOI 10.1086/228210; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; Cisco Systems, 2012, INT TECHN HDB; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Durkheim E., 2001, ELEMENTARY FORMS REL; Goldman M, 2000, ANNU REV SOCIOL, V26, P563, DOI 10.1146/annurev.soc.26.1.563; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; HENSCHEL JR, 1995, ETHOLOGY, V101, P187; Herrnstein R J, 1994, BELL CURVE; Holland O, 1999, ARTIF LIFE, V5, P173, DOI 10.1162/106454699568737; Katznelson Ira, 2005, AFFIRMATIVE ACTION W; Keane W, 2003, LANG COMMUN, V23, P409, DOI 10.1016/S0271-5309(03)00010-7; Keister LA, 2000, ANNU REV SOCIOL, V26, P63, DOI 10.1146/annurev.soc.26.1.63; Laland K, 2014, NATURE, V514, P161, DOI 10.1038/514161a; Marx K, 1978, CAPITAL, V1; Odling-Smee J., 2003, MONOGRAPHS POPULATIO, V37; Padgett JF, 2012, EMERGENCE OF ORGANIZATIONS AND MARKETS, P1; Pager D, 2008, ANNU REV SOCIOL, V34, P181, DOI 10.1146/annurev.soc.33.040406.131740; Parziale L, 2006, TCP IP TUTORIAL TECH; Peirce Charles Sanders, 1991, PEIRCE SIGNS WRITING; Pigliucci Massimo, 2010, EVOLUTION EXTENDED S, DOI DOI 10.1016/j.tree.2008.04.005; Piketty T., 2000, HDB INCOME DISTRIBUT, V1, P430; PODOLNY JM, 1993, AM J SOCIOL, V98, P829, DOI 10.1086/230091; Roughgarden J, 2009, GENIAL GENE DECONSTR; Savit R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071828; Smith RD, 2011, ADV COMPLEX SYST, V14, P905, DOI 10.1142/S0219525911003451; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; WHITE HC, 1981, AM J SOCIOL, V87, P517, DOI 10.1086/227495; Worden L, 2007, J THEOR BIOL, V245, P411, DOI 10.1016/j.jtbi.2006.10.011	35	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158144	10.1371/journal.pone.0158144	http://dx.doi.org/10.1371/journal.pone.0158144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362837	gold, Green Published			2022-12-26	WOS:000378865200045
J	Kerepesi, C; Szalkai, B; Varga, B; Grolmusz, V				Kerepesi, Csaba; Szalkai, Balazs; Varga, Balint; Grolmusz, Vince			How to Direct the Edges of the Connectomes: Dynamics of the Consensus Connectomes and the Development of the Connections in the Human Brain	PLOS ONE			English	Article							APOPTOSIS; ELIMINATION	The human braingraph or the connectome is the object of an intensive research today. The advantage of the graph-approach to brain science is that the rich structures, algorithms and definitions of graph theory can be applied to the anatomical networks of the connections of the human brain. In these graphs, the vertices correspond to the small (1-1.5 cm(2)) areas of the gray matter, and two vertices are connected by an edge, if a diffusion-MRI based workflow finds fibers of axons, running between those small gray matter areas in the white matter of the brain. One main question of the field today is discovering the directions of the connections between the small gray matter areas. In a previous work we have reported the construction of the Budapest Reference Connectome Server http://connectome.pitgroup.org from the data recorded in the Human Connectome Project of the NIH. The server generates the consensus braingraph of 96 subjects in Version 2, and of 418 subjects in Version 3, according to selectable parameters. After the Budapest Reference Connectome Server had been published, we recognized a surprising and unforeseen property of the server. The server can generate the braingraph of connections that are present in at least k graphs out of the 418, for any value of k = 1, 2, ..., 418. When the value of k is changed from k = 418 through 1 by moving a slider at the webserver from right to left, certainly more and more edges appear in the consensus graph. The astonishing observation is that the appearance of the new edges is not random: it is similar to a growing shrub. We refer to this phenomenon as the Consensus Connectome Dynamics. We hypothesize that this movement of the slider in the webserver may copy the development of the connections in the human brain in the following sense: the connections that are present in all subjects are the oldest ones, and those that are present only in a decreasing fraction of the subjects are gradually the newer connections in the individual brain development. An animation on the phenomenon is available at https://youtu.be/yxlyudPaVUE. Based on this observation and the related hypothesis, we can assign directions to some of the edges of the connectome as follows: Let Gk+ 1 denote the consensus connectome where each edge is present in at least k + 1 graphs, and let G(k) denote the consensus connectome where each edge is present in at least k graphs. Suppose that vertex v is not connected to any other vertices in G(k+1), and becomes connected to a vertex u in G(k), where u was connected to other vertices already in G(k+1). Then we direct this (v, u) edge from v to u.	[Kerepesi, Csaba; Szalkai, Balazs; Varga, Balint; Grolmusz, Vince] Eotvos Lorand Univ, PIT Bioinformat Grp, H-1117 Budapest, Hungary; [Grolmusz, Vince] Uratim Ltd, H-1118 Budapest, Hungary; [Kerepesi, Csaba] Inst Comp Sci & Control, H-1111 Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Computer Science & Control	Grolmusz, V (corresponding author), Eotvos Lorand Univ, PIT Bioinformat Grp, H-1117 Budapest, Hungary.	grolmusz@pitgroup.org	Kerepesi, Csaba/R-1787-2017; Szalkai, Balázs/I-4315-2017; Varga, Bálint/AAC-4316-2021	Kerepesi, Csaba/0000-0001-9541-246X; Szalkai, Balázs/0000-0002-0920-5083; Varga, Bálint/0000-0001-8827-6754; Grolmusz, Vince/0000-0001-9456-8876	NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data were provided in part by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Craddock RC, 2013, NEUROIMAGE, V82, P127, DOI 10.1016/j.neuroimage.2013.05.072; GORDON N, 1995, BRAIN DEV-JPN, V17, P73, DOI 10.1016/0387-7604(94)00109-B; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Kerepesi C., 2015, ARXIV150700327; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Szalkai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130045; Szalkai B, 2015, NEUROSCI LETT, V595, P60, DOI 10.1016/j.neulet.2015.03.071	11	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158680	10.1371/journal.pone.0158680	http://dx.doi.org/10.1371/journal.pone.0158680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362431	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000378865200106
J	Nikezic, D; Beni, MS; Krstic, D; Yu, KN				Nikezic, D.; Beni, Mehrdad Shahmohammadi; Krstic, D.; Yu, K. N.			Characteristics of Protons Exiting from a Polyethylene Converter Irradiated by Neutrons with Energies between 1 keV and 10 MeV	PLOS ONE			English	Article							DOSIMETER	Monte Carlo method has been used to determine the efficiency for proton production and to study the energy and angular distributions of the generated protons. The ENDF library of cross sections is used to simulate the interactions between the neutrons and the atoms in a polyethylene (PE) layer, while the ranges of protons with different energies in PE are determined using the Stopping and Range of Ions in Matter (SRIM) computer code. The efficiency of proton production increases with the PE layer thickness. However the proton escaping from a certain polyethylene volume is highly dependent on the neutron energy and target thickness, except for a very thin PE layer. The energy and angular distributions of protons are also estimated in the present paper, showing that, for the range of energy and thickness considered, the proton flux escaping is dependent on the PE layer thickness, with the presence of an optimal thickness for a fixed primary neutron energy.	[Nikezic, D.; Beni, Mehrdad Shahmohammadi; Yu, K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China; [Nikezic, D.; Krstic, D.] Univ Kragujevac, Fac Sci, Kragujevac, Serbia	City University of Hong Kong; University of Kragujevac	Yu, KN (corresponding author), City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.	peter.yu@cityu.edu.hk	Beni, Mehrdad Shahmohammadi/ABA-8764-2020; Nikezic, Dragoslav R/B-9343-2009	Nikezic, Dragoslav/0000-0002-3236-4912; Krstic, Dragana/0000-0002-3517-9210; YU, Kwan Ngok Peter/0000-0003-1669-5348	City University of Hong Kong [7004194]	City University of Hong Kong(City University of Hong Kong)	This research was supported by a Strategic Research Grant 7004194 from the City University of Hong Kong. http://www.cityu.edu.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlen TT, 2014, NUCL DATA SHEETS, V120, P211, DOI 10.1016/j.nds.2014.07.049; Castillo F, 2013, RADIAT MEAS, V50, P71, DOI 10.1016/j.radmeas.2012.09.007; ElKhatib A, 1996, MATER LETT, V26, P59, DOI 10.1016/0167-577X(95)00205-7; Ferrari A, 2005, CERN200510; Love J., 2012, PASSIVE SHIELDING NE; MAKOVICKA L, 1986, RADIAT PROT DOSIM, V16, P273, DOI 10.1093/oxfordjournals.rpd.a079757; Nikezic D, 2004, MAT SCI ENG R, V46, P51, DOI 10.1016/j.mser.2004.07.003; Pszona S, 2014, RADIAT PROT DOSIM, V161, P237, DOI 10.1093/rpd/nct274; SADAKA S, 1986, RADIAT PROT DOSIM, V16, P281, DOI 10.1093/oxfordjournals.rpd.a079758; Tanimura Y, 2014, RADIAT PROT DOSIM, V161, P144, DOI 10.1093/rpd/nct345; Trompier F, 2014, RADIAT PROT DOSIM, V161, P78, DOI 10.1093/rpd/nct275; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091	12	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157627	10.1371/journal.pone.0157627	http://dx.doi.org/10.1371/journal.pone.0157627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362656	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200021
J	Sawano, M; Kohsaka, S; Okamura, T; Inohara, T; Sugiyama, D; Shiraishi, Y; Watanabe, M; Nakamura, Y; Higashiyama, A; Kadota, A; Okuda, N; Murakami, Y; Ohkubo, T; Fujiyoshi, A; Miura, K; Okayama, A; Ueshima, H				Sawano, Mitsuaki; Kohsaka, Shun; Okamura, Tomonori; Inohara, Taku; Sugiyama, Daisuke; Shiraishi, Yasuyuki; Watanabe, Makoto; Nakamura, Yasuyuki; Higashiyama, Aya; Kadota, Aya; Okuda, Nagako; Murakami, Yoshitaka; Ohkubo, Takayoshi; Fujiyoshi, Akira; Miura, Katsuyuki; Okayama, Akira; Ueshima, Hirotsugu		Nippon Data 80 90 Res Grp	Independent Prognostic Value of Single and Multiple Non-Specific 12-Lead Electrocardiographic Findings for Long-Term Cardiovascular Outcomes: A Prospective Cohort Study	PLOS ONE			English	Article							ST-T ABNORMALITIES; CORONARY-HEART-DISEASE; 24-YEAR FOLLOW-UP; RISK PROFILE; MORTALITY; STROKE; ASSOCIATION; TRENDS; JAPAN; ECG	Aims The long-term prognostic effect of non-specific 12-lead electrocardiogram findings is unknown. We aimed to evaluate the cumulative prognostic impact of axial, structural, and repolarization categorical abnormalities on cardiovascular death, independent from traditional risk scoring systems such as the Framingham risk score and the NIPPON DATA80 risk chart. Methods and Results A total of 16,816 healthy men and women from two prospective, longitudinal cohort studies were evaluated. 3,794 (22.6%) individuals died during a median follow-up of 15 years (range, 2.0-24 years). Hazard ratios for cardiovascular death, all-cause death, coronary death and stroke death were calculated for the cumulative and independent axial, structural, and repolarization categorical abnormalities adjusted for the Framingham risk score and the NIPPON DATA80 risk chart. Individuals with two or more abnormal categories had a higher risk of cardiovascular death after adjustment for Framingham risk score (men: HR 4.27, 95% CI 3.35-5.45; women: HR 4.83, 95% CI 3.76-6.22) and NIPPON DATA80 risk chart (men: HR 2.39, 95% CI 1.87-3.07; women: HR 2.04, 95% CI 1.58-2.64). Conclusion Cumulative findings of axial, structural, and repolarization abnormalities are significant predictors of long-term cardiovascular death in asymptomatic, healthy individuals independent of traditional risk stratification systems.	[Sawano, Mitsuaki; Kohsaka, Shun; Inohara, Taku; Shiraishi, Yasuyuki] Keio Univ Hosp, Dept Cardiol, Tokyo, Japan; [Okamura, Tomonori; Sugiyama, Daisuke] Keio Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Watanabe, Makoto] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Shiraishi, Yasuyuki] Kyoto Womens Univ, Dept Cardiovasc Epidemiol, Kyoto, Japan; [Higashiyama, Aya] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Osaka, Japan; [Kadota, Aya; Fujiyoshi, Akira; Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Shiga, Japan; [Okuda, Nagako] Univ Human Arts & Sci, Dept Hlth & Nutr, Saitama, Japan; [Murakami, Yoshitaka] Toho Univ, Sch Med, Dept Med Stat, Tokyo, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo, Japan; [Fujiyoshi, Akira; Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga, Japan; [Okayama, Akira] Res Inst Lifestyle Related Dis Prevent, Tokyo, Japan	Keio University; Keio University; National Cerebral & Cardiovascular Center - Japan; Kyoto Womens University; National Cerebral & Cardiovascular Center - Japan; Shiga University of Medical Science; Toho University; Teikyo University; Shiga University of Medical Science	Kohsaka, S (corresponding author), Keio Univ Hosp, Dept Cardiol, Tokyo, Japan.	kohsaka@cpnet.med.keio.jp	Sugiyama, Daisuke/L-4347-2013; Okamura, Tomonori/L-1693-2013	Sugiyama, Daisuke/0000-0002-6487-8934; Okamura, Tomonori/0000-0003-0488-0351; Okuda, Nagako/0000-0002-6893-0509; Ohkubo, Takayoshi/0000-0002-3283-8196; Fujiyoshi, Akira/0000-0002-5790-7119; Kohsaka, Shun/0000-0003-3779-2972	Ministry of Health, Labor, and Welfare; Health and Labor Sciences (Comprehensive Research on Aging and Health) [H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014]; Health and Labor Sciences (Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus) [H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022]; Japanese Association for Cerebro-Cardiovascular Disease Control	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences (Comprehensive Research on Aging and Health); Health and Labor Sciences (Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus); Japanese Association for Cerebro-Cardiovascular Disease Control	This study was supported by a grant-in-aid from the Ministry of Health, Labor, and Welfare under the auspices of the Japanese Association for Cerebro-Cardiovascular Disease Control, a research grant for cardiovascular diseases (7A-2) from the Ministry of Health, Labor, and Welfare, and research grants from Health and Labor Sciences (Comprehensive Research on Aging and Health H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014; Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus H22-Jyunkankitou-Seisyu-Sitei-017 and H25-Jyunkankitou-Seisyu-Sitei-022).	Al-Zaiti SS, 2014, HEART LUNG, V43, P516, DOI 10.1016/j.hrtlng.2014.05.004; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; [Anonymous], 1978, J Chronic Dis, V31, P201; Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; DAVIS TP, 1993, PROG CARDIOVASC DIS, V36, P245, DOI 10.1016/0033-0620(93)90017-8; De Leo V, 2000, MATURITAS, V36, P43, DOI 10.1016/S0378-5122(00)00123-7; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; Horibe H, 2005, J EPIDEMIOL, V15, P125, DOI 10.2188/jea.15.125; Inohara T, 2014, EUR J PREV CARDIOL, V21, P1501, DOI 10.1177/2047487313500568; Inohara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080853; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; Kita Y, 1999, INT J EPIDEMIOL, V28, P1059, DOI 10.1093/ije/28.6.1059; Kohsaka S, 2005, STROKE, V36, P2481, DOI 10.1161/01.STR.0000185682.09981.26; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; Menotti A, 1997, G Ital Cardiol, V27, P40; Nakamura Y, 2013, J ELECTROCARDIOL, V46, P360, DOI 10.1016/j.jelectrocard.2013.03.009; Nakamura Y, 2012, CIRCULATION, V125, P1226, DOI 10.1161/CIRCULATIONAHA.111.070045; Ohira T, 2003, STROKE, V34, pE250, DOI 10.1161/01.STR.0000103742.83117.FB; Okamura T, 2003, J INTERN MED, V253, P169, DOI 10.1046/j.1365-2796.2003.01080.x; Okamura T, 2004, AM HEART J, V147, P1024, DOI 10.1016/j.ahj.2003.12.020; Prineas RI, 2010, MINNESOTA CODE MANUA, pxiii; Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population, 2006, CIRCULATION J OFFICI, V70, P1249; Rumana N, 2011, AM J CARDIOL, V107, P1718, DOI 10.1016/j.amjcard.2011.02.335; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Yamamoto T, 2008, CIRC J, V72, P545	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157563	10.1371/journal.pone.0157563	http://dx.doi.org/10.1371/journal.pone.0157563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362562	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200020
J	Wang, YQ; Zhang, YH; Ji, W; Yu, P; Wang, B; Li, JP; Han, MK; Xu, XX; Wang, ZM				Wang, Yunqi; Zhang, Yinghua; Ji, Wei; Yu, Peng; Wang, Bin; Li, Jinpeng; Han, Meikun; Xu, Xuexin; Wang, Zhimin			Cultivar Mixture Cropping Increased Water Use Efficiency in Winter Wheat under Limited Irrigation Conditions	PLOS ONE			English	Article							NORTH CHINA PLAIN; BARLEY VARIETY MIXTURES; GRAIN-YIELD; PHYSIOLOGICAL TRAITS; GENETIC-IMPROVEMENT; PLANT-COMMUNITIES; HENAN PROVINCE; PERFORMANCE; BIODIVERSITY; GROUNDWATER	The effects of cultivar mixture cropping on yield, biomass, and water use efficiency (WUE) in winter wheat (Triticum aestivum L.) were investigated under non-irrigation (W0, no irrigation during growth stage), one time irrigation (W1, irrigation applied at stem elongation) and two times irrigation (W2, irrigation applied at stem elongation and anthesis) conditions. Nearly 90% of cultivar mixture cropping treatments experienced an increase in grain yield as compared with the mean of the pure stands under W0, those for W1 and W2 were 80% and 85%, respectively. Over 75% of cultivar mixture cropping treatments got greater biomass than the mean of the pure stands under the three irrigation conditions. Cultivar mixture cropping cost more water than pure stands under W0 and W1, whereas the water consumption under W2 decreased by 5.9%-6.8% as compared with pure stands. Approximately 90% of cultivar mixtures showed an increase of 5.4%-34.5% in WUE as compared with the mean of the pure stands, and about 75% of cultivar mixtures had 0.8%-28.5% higher WUE than the better pure stands under W0. Similarly, there were a majority of mixture cropping treatments with higher WUE than the mean and the better one of the pure stands under W1 and W2. On the whole, proper cultivar mixture cropping could increase yield and WUE, and a higher increase in WUE occurred under limited irrigation condition.	[Wang, Yunqi; Zhang, Yinghua; Ji, Wei; Yu, Peng; Wang, Bin; Li, Jinpeng; Han, Meikun; Xu, Xuexin; Wang, Zhimin] China Agr Univ, Coll Agron, Beijing 100193, Peoples R China	China Agricultural University	Zhang, YH; Wang, ZM (corresponding author), China Agr Univ, Coll Agron, Beijing 100193, Peoples R China.	zhangyh1216@126.com; zhimin206@263.net	Zhang, Yinghua/HGE-7633-2022	Zhang, Yinghua/0000-0002-1356-6084; Wang, Zhimin/0000-0003-1325-2015; Wang, Yunqi/0000-0002-3377-9466	Special Fund for Agro-scientific Research in the Public Interest in China [201303133]; Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop; National Natural Science Foundation of China [31401297]; Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3)	Special Fund for Agro-scientific Research in the Public Interest in China; Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3)	This study was supported by the Special Fund for Agro-scientific Research in the Public Interest in China (201303133), the Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop, the National Natural Science Foundation of China (No. 31401297), and the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Special Fund for Agro-scientific Research in the Public Interest in China (201303133), the Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop, the National Natural Science Foundation of China (No. 31401297), and the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3).	[Anonymous], 2002, SAS STAT VERS 9 0 US; Baker EFI, 1979, EXP AGR, V5, P41; BAKER RJ, 1984, CROP SCI, V24, P85, DOI 10.2135/cropsci1984.0011183X002400010019x; Biabani A, 2008, INT J PLANT PROD, V2, P215; Brooker RW, 2016, FUNCT ECOL, V30, P98, DOI 10.1111/1365-2435.12496; Brooker RW, 2015, NEW PHYTOL, V206, P107, DOI 10.1111/nph.13132; Doring TF, 2015, FIELD CROP RES, V183, P235, DOI 10.1016/j.fcr.2015.08.009; Ebeling A, 2014, BASIC APPL ECOL, V15, P229, DOI 10.1016/j.baae.2014.02.003; Fang Y, 2014, FIELD CROP RES, V156, P12, DOI 10.1016/j.fcr.2013.10.013; FREY KJ, 1967, CROP SCI, V7, P532, DOI 10.2135/cropsci1967.0011183X000700050037x; Ghosh PK, 2009, EUR J AGRON, V31, P43, DOI 10.1016/j.eja.2009.03.002; Gigot C, 2013, PLANT PATHOL, V62, P1011, DOI 10.1111/ppa.12012; HOEKSTRA GJ, 1985, CAN J PLANT SCI, V65, P481, DOI 10.4141/cjps85-069; Iqbal MA, 2014, AGR WATER MANAGE, V135, P61, DOI 10.1016/j.agwat.2013.12.012; JOKINEN K, 1991, J AGR SCI FINLAND, V63, P307; Kabululu MS, 2014, INT J VEG SCI, V20, P1; Kendy E, 2004, HYDROL PROCESS, V18, P2289, DOI 10.1002/hyp.5529; Kiaer LP, 2012, EUPHYTICA, V185, P123, DOI 10.1007/s10681-012-0640-1; Kiaer LP, 2009, FIELD CROP RES, V114, P361, DOI 10.1016/j.fcr.2009.09.006; Liu CM, 2001, WATER INT, V26, P265, DOI 10.1080/02508060108686913; MANTHEY R, 1993, CROP PROT, V12, P63, DOI 10.1016/0261-2194(93)90022-B; Marquard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075599; MARSHALL DR, 1973, EUPHYTICA, V22, P405, DOI 10.1007/BF00022654; Milbau A, 2005, FUNCT ECOL, V19, P27, DOI 10.1111/j.0269-8463.2005.00939.x; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Newton AC, 2002, EUPHYTICA, V125, P325, DOI 10.1023/A:1016052121581; PATTERSON FRED L., 1963, CROP SCI, V3, P558, DOI 10.2135/cropsci1963.0011183X000300060032x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Qin XL, 2015, FIELD CROP RES, V177, P117, DOI 10.1016/j.fcr.2015.03.013; Sharma RC, 1996, FIELD CROP RES, V48, P95, DOI 10.1016/S0378-4290(96)01031-3; SHIPLEY B, 1994, OIKOS, V69, P340, DOI 10.2307/3546158; Smith RG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102920, 10.1371/journal.pone.0097351]; Sun YY, 2014, FIELD CROP RES, V167, P1, DOI 10.1016/j.fcr.2014.07.002; Tian ZW, 2011, FIELD CROP RES, V124, P417, DOI 10.1016/j.fcr.2011.07.012; WALL GW, 1990, AGR FOREST METEOROL, V49, P81, DOI 10.1016/0168-1923(90)90044-7; Wilcox JR, 1998, PLANT DIS, V82, P303, DOI 10.1094/PDIS.1998.82.3.303; Wu HY, 2005, PROG NAT SCI-MATER, V15, P477; Wu W, 2014, EUPHYTICA, V196, P155, DOI 10.1007/s10681-013-1033-9; Xiao YG, 2012, CROP SCI, V52, P44, DOI 10.2135/cropsci2011.05.0246; Zhang XY, 2006, AGRON J, V98, P1620, DOI 10.2134/agronj2005.0358; Zhang XY, 2003, IRRIGATION SCI, V21, P159, DOI 10.1007/s00271-002-0059-x; Zhang YP, 2011, FIELD CROP RES, V123, P187, DOI 10.1016/j.fcr.2011.04.014; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015; Zhou BW, 2014, J INTEGR PLANT BIOL, V56, P492, DOI 10.1111/jipb.12148; Zhou Y, 2007, EUPHYTICA, V157, P465, DOI 10.1007/s10681-007-9376-8; Zhou Y, 2007, CROP SCI, V47, P245, DOI 10.2135/cropsci2006.03.0175; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	50	10	10	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158439	10.1371/journal.pone.0158439	http://dx.doi.org/10.1371/journal.pone.0158439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362563	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200075
J	Alami, S; Hervouet, L; Poiraudeau, S; Briot, K; Roux, C				Alami, Sophie; Hervouet, Lucile; Poiraudeau, Serge; Briot, Karine; Roux, Christian			Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views	PLOS ONE			English	Article							HIP FRACTURE; OLDER WOMEN; RISK; MORTALITY; DENSITY; PRESCRIPTIONS; IMPACT; CARE	Background Only a minority of patients at high risk for osteoporotic fracture receive treatment. Objective Study patients' and physicians' views regarding postmenopausal osteoporosis (PMO) to identify impediments to good care. Methods A qualitative study involving 18 physicians and 37 women (age 57-87) with PMO. Results All women interviewed considered PMO to be somewhat normal wear-and-tear associated with old age. The women identified a large number of "causes" for osteoporosis but finally viewed it as chance. They all described its progression as slow. Three representations of PMO severity were identified: some women tended to interpreted it as benign (21), others tended to dramatize it (11), and the rest were uncertain (5). These representations did not appear linked to age or fracture. Even the women who associated fracture and PMO were uncertain of the link between them. Fractures were considered to be random events, independent of osteoporosis. Women received general life-style recommendations from their physicians positively, but did not connect them specifically to osteoporosis. Indeed, these recommendations, along with the fear of side effects, the absence of tangible results of treatments, the view of PMO as a natural process, and the representations of PMO severity are factors that may deter treatments and impact compliance. As for the physicians, they identified eight risk factors, recognizing menopause as central to PMO and recognized the link between risk of fracture and PMO. However, some considered the impact of fractures to be limited in time, and viewed PMO as a "benign" disease. Seeing the progression of PMO as slow and inevitable reduced their urgency to diagnose and treat it as compared to other diseases. Some physicians acknowledged limited mastery of the existing therapeutic arsenal and unsuccessful handling of patient compliance. Conclusion Women's and physicians' perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease. A better understanding of women's and physicians' views, practices, and concerns related to PMO can improve osteoporosis management.	[Alami, Sophie] Interlis, Paris, France; [Hervouet, Lucile] CNRS, Inst Sci Polit, Ctr Sociol Org, UMR 7116, Paris, France; [Poiraudeau, Serge; Briot, Karine; Roux, Christian] INSERM, U1153, Paris, France; [Poiraudeau, Serge; Briot, Karine; Roux, Christian] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Poiraudeau, Serge] Hop Cochin, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, Paris, France; [Briot, Karine; Roux, Christian] Hop Cochin, AP HP, Serv Rhumatol B, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Alami, S (corresponding author), Interlis, Paris, France.	alami.sophie@noos.fr; christian.roux@aphp.fr	POIRAUDEAU, SERGE/P-5301-2016; Briot, Karine/P-2116-2016	Briot, Karine/0000-0002-6238-2601; Poiraudeau, Serge/0000-0002-1988-9124; , ALAMI/0000-0002-2999-8551	Association de Recherche Clinique en Rhumatologie, (ARCR), Paris, France; Merck Sharp and Dohme Laboratory	Association de Recherche Clinique en Rhumatologie, (ARCR), Paris, France; Merck Sharp and Dohme Laboratory	The study was funded by the Association de Recherche Clinique en Rhumatologie, (ARCR), 75006 Paris, France. The Association received a grant from Merck Sharp and Dohme Laboratory. ARCR hired Interlis (SA) to provide sociological expertise and conduct the qualitative survey. The funder (ARCR) provided support in the form of honoraries for authors (SA, LH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck Sharp and Dohme Laboratory had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Interlis has no financial conflict with the materials discussed in the manuscript.	Balasubramanian Akhila, 2014, J Bone Joint Surg Am, V96, pe52, DOI 10.2106/JBJS.L.01781; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bliuc D, 2013, J BONE MINER RES, V28, P2317, DOI 10.1002/jbmr.1968; Brody J. E., 2011, NY TIMES; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Fraser LA, 2011, OSTEOPOROSIS INT, V22, P789, DOI 10.1007/s00198-010-1359-2; Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001; Giangregorio L, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-38; Glaser B.G., 1968, DISCOV GROUNDED THEO; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Haynes RB, 1996, LANCET, V348, P383; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoang-Kim A, 2014, ARCH ORTHOP TRAUM SU, V134, P207, DOI 10.1007/s00402-013-1799-1; Jennings LA, 2010, J AM GERIATR SOC, V58, P650, DOI 10.1111/j.1532-5415.2010.02769.x; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Lyles KW, 2007, N ENGL J MED, V357; Majumdar SR, 2014, OSTEOPOROSIS INT, V25, P2173, DOI 10.1007/s00198-014-2728-z; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Meadows LM, 2007, OSTEOPOROSIS INT, V18, P159, DOI 10.1007/s00198-006-0213-z; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Peeters G, 2010, PHARMACOEPIDEMIOL AN, V23, P1303; Rimes KA, 2002, BEHAV RES THER, V40, P359, DOI 10.1016/S0005-7967(01)00015-8; Roux C., 2009, INT J CLIN RHEUMATOL, V4, P651; Sale JEM, 2014, OSTEOPOROSIS INT, V25, P2581, DOI 10.1007/s00198-014-2804-4; Sale JEM, 2014, OSTEOPOROSIS INT, V25, P281, DOI 10.1007/s00198-013-2405-7; Sale JEM, 2012, OSTEOPOROSIS INT, V23, P2829, DOI 10.1007/s00198-012-1914-0; Sambrook PN, 2010, MED J AUSTRALIA, V193, P154, DOI 10.5694/j.1326-5377.2010.tb03835.x; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Siris ES, 2011, OSTEOPOROSIS INT, V22, P27, DOI 10.1007/s00198-010-1211-8; Solomon DH, 2014, J BONE MINER RES, V29, P1929, DOI 10.1002/jbmr.2202; tain RPS of G, 1997, COMPLIANCE CONCORDAN; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; van Geel TACM, 2009, ANN RHEUM DIS, V68, P99, DOI 10.1136/ard.2008.092775; Wysowski DK, 2013, BONE, V57, P423, DOI 10.1016/j.bone.2013.09.008	44	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158365	10.1371/journal.pone.0158365	http://dx.doi.org/10.1371/journal.pone.0158365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355576	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400055
J	Le, DJ; Chung, DWD; Frausto, RF; Kim, MJ; Aldave, AJ				Le, Derek J.; Chung, Duk-Won D.; Frausto, Ricardo F.; Kim, Michelle J.; Aldave, Anthony J.			Identification of Potentially Pathogenic Variants in the Posterior Polymorphous Corneal Dystrophy 1 Locus	PLOS ONE			English	Article							GENE; MUTATIONS; CLASSIFICATION; EXCLUSION; FRAMEWORK; LINKAGE; VSX1; RNA	Posterior polymorphous corneal dystrophy 1 (PPCD1) is a genetic disorder that affects corneal endothelial cell function and leads to loss of visual acuity. PPCD1 has been linked to a locus on chromosome 20 in multiple families; however, Sanger sequencing of protein-coding genes in the consensus region failed to identify any causative missense mutations. In this study, custom capture probes were utilized for targeted next-generation sequencing of the linked region in a previously reported family with PPCD1. Variants were detected through two bioinformatics pipelines and filtered according to multiple criteria. Additionally, a high-resolution microarray was used to detect copy number variations. No non-synonymous variants in the protein-coding region of annotated genes were identified. However, 12 single nucleotide variants in 10 genes, and 9 indels in 7 genes met the filtering criteria and were considered candidate variants for PPCD1. Eleven single nucleotide variants were confirmed by Sanger sequencing, including 2 synonymous variants and 9 non-coding variants, in 9 genes. One microdeletion was detected in an intron of OVOL2 by microarray but was subsequently not identified by PCR. Using a comprehensive next-generation sequencing approach, a total of 16 genes containing single nucleotide variants or indels that segregated with the affected phenotype in an affected family previously mapped to the PPCD1 locus were identified. Screening of these candidate genes in other families previously mapped to the PPCD1 locus will likely result in the identification of the genetic basis of PPCD1.	[Le, Derek J.; Chung, Duk-Won D.; Frausto, Ricardo F.; Kim, Michelle J.; Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Aldave, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.	aldave@jsei.ucla.edu	Frausto, Ricardo/AAE-3146-2021	Frausto, Ricardo/0000-0003-3064-6745	National Eye Institute [R01EY022082, P30EY000331]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022082, P30EY000331] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The following are the sources of funding for this work: National Eye Institute (https://nei.nih.gov/), R01EY022082 (AJA), core grant P30EY000331; Research to Prevent Blindness (https://www.rpbusa.org/rpb/), unrestricted grant (AJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2005, CORNEA, V24, P151, DOI 10.1097/01.ico.0000141235.26096.1d; Aldave AJ, 2013, JAMA OPHTHALMOL, V131, P1583, DOI 10.1001/jamaophthalmol.2013.5036; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frausto RF, 2016, CELL TRANSPLANT, V25, P1159, DOI 10.3727/096368915X688948; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hosseini SM, 2008, MOL VIS, V14, P71; Jia DY, 2015, ONCOTARGET, V6, P15436, DOI 10.18632/oncotarget.3623; Jonsson F, 2015, HUM MUTAT, V36, P463, DOI 10.1002/humu.22764; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; LAGANOWSKI HC, 1991, CORNEA, V10, P224, DOI 10.1097/00003226-199105000-00008; Lai IN, 2010, MOL VIS, V16, P2829; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Oliver VF, 2016, OPHTHALMOLOGY, V123, P709, DOI 10.1016/j.ophtha.2015.12.008; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158467	10.1371/journal.pone.0158467	http://dx.doi.org/10.1371/journal.pone.0158467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355326	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400071
J	Rahman, MS; Howlader, T; Masud, MS; Rahman, ML				Rahman, M. Shafiqur; Howlader, Tamanna; Masud, Mohammad Shahed; Rahman, Mohammad Lutfor			Association of Low-Birth Weight with Malnutrition in Children under Five Years in Bangladesh: Do Mother's Education, Socio-Economic Status, and Birth Interval Matter?	PLOS ONE			English	Article							RISK-FACTORS; PRESCHOOL-CHILDREN; NUTRITIONAL-STATUS; DETERMINANTS; DHAKA; PREVALENCE; INFANTS; SLUMS; CITY; AGE	Background Malnutrition in children under five years remains a significant problem in Bangladesh, despite substantial socio-economic progress and a decade of interventions aimed at improving it. Although several studies have been conducted to identify the important risk factors of malnutrition, none of them assess the role of low birth weight (LBW) despite its high prevalence (36%). This study examines the association between LBW and malnutrition using data from the Bangladesh Demographic and Health Survey (BDHS) 2011 and provides practical guidelines for improving nutritional status of children. Methods Malnutrition in children is measured in terms of their height-for-age, weight-for-height, and weight-for-age. Children whose Z-scores for either of these indices are below two standard deviations (-2SD) from median of WHO's reference population are considered as stunted, wasted or underweight, respectively. The association between malnutrition and LBW was investigated by calculating adjusted risk-ratio (RR), which controls for potential confounders such as child's age and sex, mother's education and height, length of preceding-birth-interval, access to food, area of residence, household socio-economic status. Adjusted RR was calculated using both Cochran-Mantel-Haenszel approach and multivariable logistic regression models controlling for confounder. Results The prevalence of malnutrition was markedly higher in children with LBW than those with normal birth-weights (stunting: 51% vs 39%; wasting: 25% vs 14% and underweight: 52% vs 33%). While controlling for the known risk factors, children with LBW had significantly increased risk of becoming malnourished compared to their counter part with RR 1.23 (95% CI: 1.16-1.30), 1.71 (95% CI: 1.53-1.92) and 1.47 (95% CI: 1.38-1.56) for stunting, wasting and underweight, respectively. The observed associations were not modified by factors known to reduce the prevalence of malnutrition, such as higher education of mother, better household socio-economic conditions and longer birth-interval. Conclusions Higher education of mother, better household socio-economic conditions and prolonged birth intervals alone are not sufficient in bringing about substantial reductions in prevalence of child malnutrition in Bangladesh. Targeted interventions should be designed to reduce prevalence of LBW in addition to improving mother's education and other socio-demographic conditions.	[Rahman, M. Shafiqur; Howlader, Tamanna; Masud, Mohammad Shahed; Rahman, Mohammad Lutfor] Univ Dhaka, Inst Stat Res & Training, Dhaka 1000, Bangladesh	University of Dhaka	Rahman, MS (corresponding author), Univ Dhaka, Inst Stat Res & Training, Dhaka 1000, Bangladesh.	shafiq@isrt.ac.bd		Masud, Mohammad/0000-0003-3939-1021				Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Ahmed T, 2009, BMJ-BRIT MED J, V339, P1060; ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Anand D, 2003, ARCH DIS CHILD, V88, P135, DOI 10.1136/adc.88.2.135; Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; Balci MM, 2010, INT J CARDIOL, V144, P110, DOI 10.1016/j.ijcard.2008.12.111; Bangladesh Bureau of Statistics, 2004, NAT LOW BIRTH WEIGHT; Beiersmann C, 2013, J TROP PEDIAT, V59; Correia LL, 2014, REV SAUDE PUBL, V48, P19, DOI 10.1590/S0034-8910.2014048004828; Das S, 2008, P PAK ACAD SCI, V62, P137; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; Directorate General of Health Services, 2014, HLTH B; Ergin F, 2007, TURKISH J PEDIATR, V49, P283; GRANTHAMMCGREGOR S, 1995, J NUTR, V125, pS2233; Gulati JK, 2010, ANTHROPOLOGIST, V12, P131, DOI 10.1080/09720073.2010.11891143; Haque SMR, 2015, PUBLIC HLTH RES, V5, P184; Hossain M, 2015, FINANCIAL EXPRESS; Islam MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-11; Jesmin A, 2011, J HEALTH POPUL NUTR, P29; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Kabubo-Mariara J, 2009, J AFR EC, V18; Khanal V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-32; Khanam R, 2011, J BIOSOC SCI, V43, P437, DOI 10.1017/S0021932011000149; Khattak M, 2010, J MED SCI, V10; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Masiye F, 2010, ZAMBIA SOC SCI J, V1; Mishra K, 2014, INDIAN J PEDIATR, V81, P762, DOI 10.1007/s12098-013-1127-3; Motta Maria Eugênia Farias Almeida, 2005, J. Pediatr. (Rio J.), V81, P377, DOI 10.1590/S0021-75572005000600007; Mozumder ABMKA, 2000, J BIOSOC SCI, V32, P289, DOI 10.1017/S0021932000002893; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2011, BANGL DEM HLTH SURV; Nations United, 2015, MILL DEV GOALS REP 2; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Rahman A, 2009, ASIA-PAC J PUBLIC HE, V21, P294, DOI 10.1177/1010539509335399; Rahman M. S., 2007, Pakistan Journal of Nutrition, V6, P286; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Rasmussen K, 2001, J NUTR, V131, P601; Rattan V, 1997, WOMEN CHILD DEV SUST; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Romero CX, 2012, J HEALTH CARE POOR U, V23, P604, DOI 10.1353/hpu.2012.0065; Smith LC, 1999, EXPLAINING CHILD MAL; Sreeramareddy CT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-403; Tin TT, 1994, J REPROD HLTH, V12, P32; UNICEF East Asia & Pacific Regional Office, 2003, STRAT RED MAT CHILD; W.H. Organization, 2009, WORLD HLTH STAT 2009; WHO, 2006, WHO CHILD GROWTH STA; Wong HJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-785	49	100	102	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157814	10.1371/journal.pone.0157814	http://dx.doi.org/10.1371/journal.pone.0157814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355682	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400019
J	Brandt, C; Thronicke, A; Roehmel, JF; Krannich, A; Staab, D; Schwarz, C				Brandt, Claudia; Thronicke, Anja; Roehmel, Jobst F.; Krannich, Alexander; Staab, Doris; Schwarz, Carsten			Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FEV1 DECLINE; INFLAMMATION; ASTHMA; COPD; BRONCHODILATORS; STRATEGIES; EFFICACY; OUTCOMES; ALPHA	Background Chronic lung disease is the leading cause of death in patients with Cystic Fibrosis (CF) and is often treated with bronchodilators. It is not known whether long-term tiotropium bromide treatment may have a positive impact on lung function. Methods This retrospective cohort study estimated annual lung function decline utilizing longitudinal data for forced expiratory volume in 1 s (FEV1). Results A total of 160 adult patients with CF were analyzed. The subjects treated for 24 months with tiotropium bromide had a significantly slower decline of mean annual change of FEV1 (treated: -0.3 +/- 4.0%; control: -2.3 +/- 5.0%; p = 0.0130). In patients with FEV1 >= 70% predicted, long-term tiotropium bromide treatment was associated with greater improvements in annual lung function decline (FEV1 >= 70% predicted: treated: +0.5 +/- 4.7%; control: -4.0 +/- 6.3%; p = 0.0132; FEV1 50-69% predicted: treated: -0.5 +/- 4.4%; control: -0.8 +/- 3.8%; p = 0.7142; FEV1 <= 49% predicted: treated: -0.6 +/- 3.4%; control: -2.4 +/- 4.8%; p = 0.0898). Conclusion This study suggests that long-term tiotropium bromide treatment may be associated with reduced annual decline of FEV1 in patients with CF, particularly in adults with a mild degree of severity.	[Brandt, Claudia; Thronicke, Anja; Roehmel, Jobst F.; Staab, Doris; Schwarz, Carsten] Charite, Dept Pediat Pneumol & Immunol, Cyst Fibrosis Ctr, Augustenburger Pl 1, D-13353 Berlin, Germany; [Krannich, Alexander] Charite, Biostat Unit, Berlin Inst Hlth, Augustenburger Pl 1, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schwarz, C (corresponding author), Charite, Dept Pediat Pneumol & Immunol, Cyst Fibrosis Ctr, Augustenburger Pl 1, D-13353 Berlin, Germany.	carsten.schwarz@charite.de	Schwarz, Carsten/AAE-9576-2022; Thronicke, Anja/AAR-2482-2021; Thronicke, Anja/AAZ-3508-2020; Krannich, Alexander/AAR-1285-2021; Krannich, Alexander/N-9221-2015; Schwarz, Carsten/AFE-4586-2022	Krannich, Alexander/0000-0002-4025-6495; Krannich, Alexander/0000-0002-4025-6495; Roehmel, Jobst/0000-0002-1535-8852				Adam D, 2015, J PATHOL, V235, P408, DOI 10.1002/path.4471; Bateman Eric, 2010, Int J Chron Obstruct Pulmon Dis, V5, P197; Bhatt JM, 2013, EUR RESPIR REV, V22, P205, DOI 10.1183/09059180.00006512; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; Bradley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106195; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Chopra R, 2015, EXPERT OPIN DRUG SAF, V14, P401, DOI 10.1517/14740338.2015.994503; Colombo JL, 2003, CURR OPIN PULM MED, V9, P504, DOI 10.1097/00063198-200311000-00010; Cropp GJ, 1996, AM J MED, V100, pS19, DOI 10.1016/S0002-9343(96)80049-0; Cui Y, 2010, EUR RESPIR J, V35, P1370, DOI 10.1183/09031936.00139909; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Ferguson GT, 2015, ADV THER, V32, P523, DOI 10.1007/s12325-015-0218-0; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Halfhide C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003428.pub2; Johnson C, 2003, CHEST, V123, P20, DOI 10.1378/chest.123.1.20; Kallet RH, 2013, RESP CARE, V58, P702, DOI 10.4187/respcare.02412; Kang JY, 2012, ANN ALLERG ASTHMA IM, V109, P29, DOI 10.1016/j.anai.2012.05.005; Keam Susan J, 2004, Treat Respir Med, V3, P247, DOI 10.2165/00151829-200403040-00005; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; King SJ, 2014, CLIN NUTR, V33, P150, DOI 10.1016/j.clnu.2013.04.012; Konstan MW, 2015, J AEROSOL MED PULM D, V28, P137, DOI 10.1089/jamp.2013.1115; Konstan MW, 2012, J CYST FIBROS, V11, P405, DOI 10.1016/j.jcf.2012.03.009; Konstan MW, 2011, PEDIATR PULM, V46, P545, DOI 10.1002/ppul.21388; Konstan MW, 1999, PEDIATR PULM, V28, P248, DOI 10.1002/(SICI)1099-0496(199910)28:4<248::AID-PPUL3>3.0.CO;2-N; Liou TG, 2010, J CYST FIBROS, V9, P250, DOI 10.1016/j.jcf.2010.04.002; McCuaig S, 2013, LANCET RESP MED, V1, P137, DOI 10.1016/S2213-2600(12)70058-9; Montuschi Paolo, 2006, Int J Chron Obstruct Pulmon Dis, V1, P409, DOI 10.2147/copd.2006.1.4.409; Moser BK, 1989, COMMUNICATIONS STA A, V18; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ratjen F, 2015, J CYSTIC FIBROSIS OF; Ratjen FA, 2009, RESP CARE, V54, P595, DOI 10.4187/aarc0427; Regamey N, 2011, THORAX, V66, P624, DOI 10.1136/thx.2009.134106; Sharma A, 2014, PULM PHARMACOL THER, V29, P217, DOI 10.1016/j.pupt.2014.08.004; Stanojevic S, 2015, EUR RESPIR J, V46, P262, DOI 10.1183/09031936.00187314; Tashkin D, 2003, CHEST, V123, P1441, DOI 10.1378/chest.123.5.1441; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158193	10.1371/journal.pone.0158193	http://dx.doi.org/10.1371/journal.pone.0158193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351829	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900042
J	Samaan, Z; Vaz, SM; Bawor, M; Potter, TH; Eskandarian, S; Loeb, M				Samaan, Zainab; Vaz, Stephanie McDermid; Bawor, Monica; Potter, Tammy Hlywka; Eskandarian, Sasha; Loeb, Mark			Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada	PLOS ONE			English	Article							VERBAL-LEARNING TEST; STRESS SCALES DASS; NORMATIVE DATA; FOLLOW-UP; NEW-YORK; MULTIPLE-SCLEROSIS; MEMORY; ENCEPHALITIS; DEPRESSION; IMPAIRMENT	Background West Nile virus emerged as an important human pathogen in North America and continues to pose a risk to public health. It can cause a highly variable range of clinical manifestations ranging from asymptomatic to severe illness. Neuroinvasive disease due to West Nile virus can lead to long-term neurological deficits and psychological impairment. However, these deficits have not been well described. The objective of this study was to characterize the neuropsychological manifestations of West Nile virus infection with a focus on neuroinvasive status and time since infection. Methods Patients from Ontario Canada with a diagnosis of neuroinvasive disease (meningitis, encephalitis, or acute flaccid paralysis) and non-neuroinvasive disease who had participated in a cohort study were enrolled. Clinical and laboratory were collected, as well as demographics and medical history. Cognitive functioning was assessed using a comprehensive battery of neuropsychological tests. Results Data from 49 individuals (32 with West Nile fever and 17 with West Nile neuroinvasive disease) were included in the present cross-sectional analysis. Patterns of neuropsychological impairment were comparable across participants with both neuroinvasive and non-neuroinvasive West Nile virus infection on all cognitive measures. Neuropsychiatric impairment was also observed more frequently at two to four years post-infection compared to earlier stages of illness. Conclusions Our data provide objective evidence for cognitive difficulties among patients who were infected with West Nile virus; these deficits appear to manifest regardless of severity of West Nile virus infection (West Nile fever vs. West Nile neuroinvasive disease), and are more prevalent with increasing illness duration (2-4 years vs. 1 month). Data from this study will help inform patients and healthcare providers about the expected course of recovery, as well as the need to implement effective treatment strategies that include neuropsychological interventions.	[Samaan, Zainab; Vaz, Stephanie McDermid] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Samaan, Zainab; Eskandarian, Sasha; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Samaan, Zainab; Bawor, Monica] McMaster Univ, Chanchlani Res Ctr, Populat Genom Program, Hamilton, ON, Canada; [Vaz, Stephanie McDermid] St Josephs Healthcare, Cleghorn Early Intervent Psychosis Program, Hamilton, ON, Canada; [Bawor, Monica] McMaster Univ, MiNDS Neurosci Grad Program, Hamilton, ON, Canada; [Potter, Tammy Hlywka; Loeb, Mark] McMaster Univ, Div Infect Dis, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Div Infect Dis, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	loebm@mcmaster.ca	samaan, z/J-4289-2012					Anastasiadou A, 2013, INT J INFECT DIS, V17, pE494, DOI 10.1016/j.ijid.2012.12.006; [Anonymous], 1989, INSTR GROOV PEGB TES; [Anonymous], 2003, MMWR MORB MORTAL WKL, DOI DOI 10.15585/MMWR.MM7121-1; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Benton AL, 1976, MULTILINGUAL APHASIA; Berg Patti J, 2010, S D Med, V63, P127; Berner YN, 2002, J AM GERIATR SOC, V50, P1844, DOI 10.1046/j.1532-5415.2002.505402.x; Brandt J., 2001, HOPKINS VERBAL LEARN; Bravo G, 2002, J AM GERIATR SOC, V50, P740, DOI 10.1046/j.1532-5415.2002.50172.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Buchanan RW, 2005, SCHIZOPHRENIA BULL, V31, P5, DOI 10.1093/schbul/sbi020; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; Couderc T, 2002, J GEN VIROL, V83, P1925, DOI 10.1099/0022-1317-83-8-1925; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; Einarsson U, 2003, CLIN REHABIL, V17, P294, DOI 10.1191/0269215503cr611oa; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Golden C. J., 2002, STROOP COLOR WORD TE; Golden CJ, 1978, STROOP COLOR WORD TE; Gottfried K, 2005, SOUTH MED J, V98, P603, DOI 10.1097/01.SMJ.0000155633.43244.AC; Grace J, 2007, PARKINSONISM RELAT D, V13, P443, DOI 10.1016/j.parkreldis.2006.09.001; Groth-Marnat G, 2000, NEUROPSYCHOLOGICAL A, P129; Haaland KY, 2006, EMERG INFECT DIS, V12, P1260, DOI 10.3201/eid1708.060097; Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248; Hayes CG, 1989, ARBOVIRUSES EPIDEMIO, VV, P59; Hughes C, 1999, J CHILD PSYCHOL PSYC, V40, P705, DOI 10.1017/S0021963099004023; IWASAKI Y, 1986, ACTA NEUROPATHOL, V70, P79, DOI 10.1007/BF00689518; Johnson Richard T, 2002, Curr Neurol Neurosci Rep, V2, P496, DOI 10.1007/s11910-002-0035-0; Kavanagh D, 1987, INT J CLIN NEUROPSYC; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; Loeb M, 2008, ANN INTERN MED, V149, P232, DOI 10.7326/0003-4819-149-4-200808190-00004; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray KO, 2007, EMERG INFECT DIS, V13, P479, DOI 10.3201/eid1303.060602; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; Nolan MS, 2012, J CLIN PSYCHOL, V68, P801, DOI 10.1002/jclp.21871; Ou Alan C, 2005, J La State Med Soc, V157, P42; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; PHAC: Public Health Agency of Canada, 2007, HUM W NIL VIR CAS AS; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ryan JJ, 2001, ARCH CLIN NEUROPSYCH, V16, P151, DOI 10.1016/S0887-6177(99)00061-X; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Sampson BA, 2001, ANN NY ACAD SCI, V951, P172; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Smith A., 1982, SYMBOL DIGIT MODALIT; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Strauss E., 2006, COMPENDIUM NEUROPSYC; SUGAMATA M, 1992, J VIROL, V66, P1252, DOI 10.1128/JVI.66.2.1252-1260.1992; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Wechsler D., 1997, WAIS 3 ADM SCORING M; West R, 1997, NEUROPSYCHOLOGY, V11, P421, DOI 10.1037/0894-4105.11.3.421; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Zilmer E, 2004, TOWER OF LONDON DX	77	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158364	10.1371/journal.pone.0158364	http://dx.doi.org/10.1371/journal.pone.0158364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352145	gold, Green Submitted, Green Published			2022-12-26	WOS:000378858900056
J	van Veen, JE; Pringle, DR; McMahon, M				van Veen, J. Edward; Pringle, Daphne R.; McMahon, Martin			P2A-Fluorophore Tagging of BRAF Tightly Links Expression to Fluorescence In Vivo	PLOS ONE			English	Article							RECEPTOR	The Braf proto-oncogene is a key component of the mitogen-activated protein kinase signaling cascade and is a critical regulator of both normal development and tumorigenesis in a variety of tissues. In order to elucidate BRAF's differing roles in varying cell types, it is important to understand both the pattern and timing of BRAF expression. Here we report the production of a mouse model that links the expression of Braf with the bright red fluorescent protein, tdTomato. We have utilized a P2A knock-in strategy, ensuring that BRAF and the fluorophore are expressed from the same endogenous promoter and from the same bicistronic mRNA transcript. This mouse model (Braf(TOM)) shows bright red fluorescence in organs and cell types known to be sensitive to BRAF perturbation. We further show that on a cell-by-cell basis, fluorescence correlates with BRAF protein levels. Finally, we extend the utility of this mouse by demonstrating that the remnant P2A fragment attached to BRAF acts as a suitable epitope for immunoprecipitation and biochemical characterization of BRAF in vivo.	[van Veen, J. Edward; Pringle, Daphne R.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc, San Francisco, CA 94143 USA; [van Veen, J. Edward; Pringle, Daphne R.; McMahon, Martin] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	McMahon, M (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc, San Francisco, CA 94143 USA.; McMahon, M (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.	martin.mcmahon@hci.utah.edu		van Veen, J. Edward/0000-0003-1798-3210	SASS Foundation for Medical Research; Resource Allocation Program at the University of California, San Francisco; National Cancer Institute [CA176839, CA131261]; NATIONAL CANCER INSTITUTE [R01CA131261, R01CA176839, F32CA196000] Funding Source: NIH RePORTER	SASS Foundation for Medical Research; Resource Allocation Program at the University of California, San Francisco; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JEV received salary support from the SASS Foundation for Medical Research (sassfoundation.org). JEV received research funding from the Resource Allocation Program at the University of California, San Francisco. MM received salary and research support from the National Cancer Institute (CA176839 and CA131261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Kaul A, 2013, GENESIS, V51, P708, DOI 10.1002/dvg.22415; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Li SQ, 2014, J NEUROSCI, V34, P2169, DOI 10.1523/JNEUROSCI.4077-13.2014; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Tidyman William E., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000902; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157661	10.1371/journal.pone.0157661	http://dx.doi.org/10.1371/journal.pone.0157661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348307	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200011
J	Baron, P; Frattaroli, S				Baron, Patrick; Frattaroli, Shannon			Awareness and Perceptions of Food Safety Risks and Risk Management in Poultry Production and Slaughter: A Qualitative Study of Direct-Market Poultry Producers in Maryland	PLOS ONE			English	Article							ENVIRONMENT; SALMONELLA	The objective of this study was to document and understand the perceptions and opinions of small-scale poultry producers who market directly to consumers about microbial food safety risks in the poultry supply chain. Between January and November 2014, we conducted semi-structured, in-depth interviews with a convenience sample of 16 owner-operators of Maryland direct-market commercial poultry farms. Three overarching thematic categories emerged from these interviews that describe: 1) characteristics of Maryland direct-market poultry production and processing; 2) microbial food safety risk awareness and risk management in small-scale poultry production, slaughter and processing; and 3) motivations for prioritizing food safety in the statewide direct-market poultry supply chain. Key informants provided valuable insights on many topics relevant to evaluating microbial food safety in the Maryland direct-market poultry supply chain, including: direct-market poultry production and processing practices and models, perspectives on issues related to food safety risk management, perspectives on direct-market agriculture economics and marketing strategies, and ideas for how to enhance food safety at the direct-market level of the Maryland poultry supply chain. The findings have policy implications and provide insights into food safety in small-scale commercial poultry production, processing, distribution and retail. In addition, the findings will inform future food safety research on the small-scale US poultry supply chain.	[Baron, Patrick] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Frattaroli, Shannon] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Baron, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	pbaron1@jhu.edu			Center for a Livable Future Lerner Doctoral Fellowship	Center for a Livable Future Lerner Doctoral Fellowship	The Center for a Livable Future Lerner Doctoral Fellowship for the 2013-2014 academic year funded this research; http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-center-for-alivable-future/education/fellowships/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I would like to acknowledge Dr. David Love and Dr. Meghan Davis for their comments, input and proofreading of this manuscript. This research was carried out with funding from the 2013-14 Center for a Livable Future Lerner Doctoral Fellowship.	Baron PA, CLEAN CLEAN OU UNPUB; Creswell J. W., 2014, RES DESIGN QUALITATI; Fein SB, 2011, J FOOD PROTECT, V74, P1513, DOI 10.4315/0362-028X.JFP-11-017; Hardy B, 2013, J FOOD SCI, V78, pM1232, DOI 10.1111/1750-3841.12212; Hilimire K, 2012, RENEW AGR FOOD SYST, V27, P173, DOI 10.1017/S1742170511000287; Low SA, 2011, ERR128 USDA; Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x; Trimble LM, 2013, POULTRY SCI, V92, P3060, DOI 10.3382/ps.2013-03114; United States Department of Agriculture Agricultural Marketing Service, 2009, FACTS DIR TO CONS FO; Volkova VV, 2010, ZOONOSES PUBLIC HLTH, V57, P463, DOI 10.1111/j.1863-2378.2009.01263.x	10	4	5	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158412	10.1371/journal.pone.0158412	http://dx.doi.org/10.1371/journal.pone.0158412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341034	Green Submitted, gold, Green Published			2022-12-26	WOS:000378393600056
J	Barriocanal-Casado, E; Cueto-Urena, C; Benabdellah, K; Gutierrez-Guerrero, A; Cobo, M; Hidalgo-Gutierrez, A; Rodriguez-Sevilla, JJ; Martin, F; Lopez, LC				Barriocanal-Casado, Eliana; Cueto-Urena, Cristina; Benabdellah, Karim; Gutierrez-Guerrero, Alejandra; Cobo, Marien; Hidalgo-Gutierrez, Agustin; Jose Rodriguez-Sevilla, Juan; Martin, Francisco; Lopez, Luis C.			Gene Therapy Corrects Mitochondrial Dysfunction in Hematopoietic Progenitor Cells and Fibroblasts from Coq9(R239X) Mice	PLOS ONE			English	Article							NEURAL STEM-CELLS; COENZYME-Q; IN-VIVO; SACCHAROMYCES-CEREVISIAE; LENTIVIRAL VECTORS; OXIDATIVE STRESS; METACHROMATIC LEUKODYSTROPHY; COQ(10) DEFICIENCY; NERVOUS-SYSTEM; DIFFERENTIATION	Recent clinical trials have shown that in vivo and ex vivo gene therapy strategies can be an option for the treatment of several neurological disorders. Both strategies require efficient and safe vectors to 1) deliver the therapeutic gene directly into the CNS or 2) to genetically modify stem cells that will be used as Trojan horses for the systemic delivery of the therapeutic protein. A group of target diseases for these therapeutic strategies are mitochondrial encephalopathies due to mutations in nuclear DNA genes. In this study, we have developed a lentiviral vector (CCoq9WP) able to overexpress Coq9 mRNA and COQ9 protein in mouse embryonic fibroblasts (MEFs) and hematopoietic progenitor cells (HPCs) from Coq9(R239X) mice, an animal model of mitochondrial encephalopathy due to primary Coenzyme Q (CoQ) deficiency. Ectopic over-expression of Coq9 in both cell types restored the CoQ biosynthetic pathway and mitochondrial function, improving the fitness of the transduced cells. These results show the potential of the CCoq9WP lentiviral vector as a tool for gene therapy to treat mitochondrial encephalopathies.	[Barriocanal-Casado, Eliana; Hidalgo-Gutierrez, Agustin; Lopez, Luis C.] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain; [Barriocanal-Casado, Eliana; Cueto-Urena, Cristina; Hidalgo-Gutierrez, Agustin; Lopez, Luis C.] Univ Granada, Ctr Invest Biomed, Inst Biotecnol, Granada, Spain; [Cueto-Urena, Cristina; Benabdellah, Karim; Gutierrez-Guerrero, Alejandra; Cobo, Marien; Jose Rodriguez-Sevilla, Juan; Martin, Francisco] Univ Granada, Andalusian Reg Govt, Pfizer, Genom Med Dept,GENYO,Ctr Genom & Oncol Res, Granada, Spain	University of Granada; University of Granada; Pfizer; University of Granada	Lopez, LC (corresponding author), Univ Granada, Fac Med, Dept Fisiol, Granada, Spain.; Lopez, LC (corresponding author), Univ Granada, Ctr Invest Biomed, Inst Biotecnol, Granada, Spain.; Martin, F (corresponding author), Univ Granada, Andalusian Reg Govt, Pfizer, Genom Med Dept,GENYO,Ctr Genom & Oncol Res, Granada, Spain.	francisco.martin@genyo.es; luisca@ugr.es	Lopez, Luis Carlos/L-5129-2014; Benabdellah, karim/L-4569-2014; Casado, Eliana Barriocanal/Y-4121-2019; Ureña, Cristina Cueto/AAA-8827-2021; Rodriguez-Sevilla, JJ/AAA-6092-2019; Gutierrez, Agustin Hidalgo/X-5891-2018; Lopez, Luis Carlos/AAP-9411-2020; Martin, Francisco/K-8763-2014	Lopez, Luis Carlos/0000-0003-3355-0298; Benabdellah, karim/0000-0003-4673-2111; Casado, Eliana Barriocanal/0000-0001-8828-1182; Ureña, Cristina Cueto/0000-0002-6149-090X; Gutierrez, Agustin Hidalgo/0000-0001-6414-6859; Lopez, Luis Carlos/0000-0003-3355-0298; Martin, Francisco/0000-0003-1961-8612; Rodriguez-Sevilla, Juanjo/0000-0002-4741-7925	Ministerio de Economia y Competitividad (Spain); European Regional Development Fund (ERDF) from the European Union [SAF2013-47761-R, SAF2015-65786-R, PI12/01097]; Fondo de Investigaciones Sanitarias ISCIII (Spain); ISCIII Red de Terapia Celular TerCel [RD12/0019/0006]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia-FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia [P10-CTS-6133, P09-CTS-04532, PI-57069, PI-0001/2009, PAIDI-Bio-326, PI-0160/2012, PI-0407/2012]; NIH [P01HD080642]; foundation "todos somos raros, todos somos unicos"; 'Ramony Cajal' National Programme, Ministerio de Economia y Competitividad, Spain [RYC-2011-07643]	Ministerio de Economia y Competitividad (Spain); European Regional Development Fund (ERDF) from the European Union; Fondo de Investigaciones Sanitarias ISCIII (Spain); ISCIII Red de Terapia Celular TerCel; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia-FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); foundation "todos somos raros, todos somos unicos"; 'Ramony Cajal' National Programme, Ministerio de Economia y Competitividad, Spain	This work was supported by grants from Ministerio de Economia y Competitividad (Spain) and the European Regional Development Fund (ERDF) from the European Union, to LCL through the research grants SAF2013-47761-R and SAF2015-65786-R; by Fondo de Investigaciones Sanitarias ISCIII (Spain) and the European Regional Development Fund (ERDF) from the European Union through the research grants PI12/01097 and ISCIII Red de Terapia Celular TerCel RD12/0019/0006 to FM; by the Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia-FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia through the research grants P10-CTS-6133 to LCL; P09-CTS-04532, PI-57069, PI-0001/2009 and PAIDI-Bio-326 to F.M.; PI-0160/2012 to KB and PI-0407/2012 to MC; by the NIH through the research P01HD080642 to LCL and by the foundation "todos somos raros, todos somos unicos" to LCL. LCL is supported by the 'Ramony Cajal' National Programme, Ministerio de Economia y Competitividad, Spain (RYC-2011-07643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Carrillo-Galvez AB, 2015, STEM CELLS, V33, P183, DOI 10.1002/stem.1821; Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Danhauser K, 2016, EUR J HUM GENET, V24, P450, DOI 10.1038/ejhg.2015.133; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1026, DOI 10.1002/art.23283; Duberley KEC, 2013, J INHERIT METAB DIS, V36, P63, DOI 10.1007/s10545-012-9511-0; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206; Garcia-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530; Geraerts M, 2006, HUM GENE THER, V17, P635, DOI 10.1089/hum.2006.17.635; Gomes F, 2013, BIOCHEM J, V449, P595, DOI 10.1042/BJ20121432; Gonzalez-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243; Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226; Hoyng SA, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00032; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Luna-Sanchez M, 2015, EMBO MOL MED, DOI 10.15252/emmm.201404632; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; O'Brien LC, 2015, STEM CELLS DEV, V24, P1984, DOI 10.1089/scd.2015.0076; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Romero-Moya D, 2013, HAEMATOLOGICA, V98, P1022, DOI 10.3324/haematol.2012.079244; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24; Toscano MG, 2004, GENE THER, V11, P956, DOI 10.1038/sj.gt.3302259; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; Wong ESY, 2014, HUM GENE THER, V25, P529, DOI 10.1089/hum.2013.111; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	43	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158344	10.1371/journal.pone.0158344	http://dx.doi.org/10.1371/journal.pone.0158344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341668	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600053
J	Lee, SM; Chung, M; Hyeon, JW; Jeong, SW; Ju, YR; Kim, H; Lee, J; Kim, S; An, SSA; Cho, SB; Lee, YS; Kim, SY				Lee, Sol Moe; Chung, Myungguen; Hyeon, Jae Wook; Jeong, Seok Won; Ju, Young Ran; Kim, Heebal; Lee, Jeongmin; Kim, SangYun; An, Seong Soo A.; Cho, Sung Beom; Lee, Yeong Seon; Kim, Su Yeon			Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders	PLOS ONE			English	Article							LRRK2 P755L VARIANT; PRION PROTEIN; PARKINSONS-DISEASE; INCUBATION PERIOD; WHOLE-GENOME; MOUSE MODEL; ALZHEIMERS; SCRAPIE; COMMON; RISK	Inherited prion diseases (IPDs), including genetic Creutzfeldt-Jakob disease (gCJD), account for 10-15% of cases of prion diseases and are associated with several pathogenic mutations, including P102L, V180I, and E200K, in the prion protein gene (PRNP). The valine to isoleucine substitution at codon 180 (V180I) of PRNP is the most common pathogenic mutation causing gCJD in East Asian patients. In this study, we conducted follow-up analyses to identify candidate factors and their associations with disease onset. Wholegenome sequencing (WGS) data of five gCJD patients with V180I mutation and 145 healthy individuals were used to identify genomic differences. A total of 18,648,850 candidate variants were observed in only the patient group, 29 of them were validated as variants. Four of these validated variants were nonsense mutations, six were observed in genes directly or indirectly related to neurodegenerative disorders (NDs), such as LPA, LRRK2, and FGF20. More than half of validated variants were categorized in Gene Ontology (GO) terms of binding and/or catalytic activity. Moreover, we found differential genome variants in gCJD patients with V180I mutation, including one uniquely surviving 10 years after diagnosis of the disease. Elucidation of the relationships between gCJD and Alzheimer's disease or Parkinson's disease at the genomic level will facilitate further advances in our understanding of the specific mechanisms mediating the pathogenesis of NDs and gold standard therapies for NDs.	[Lee, Sol Moe; Hyeon, Jae Wook; Ju, Young Ran; Lee, Jeongmin; Lee, Yeong Seon; Kim, Su Yeon] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Immunol & Pathol, Div Zoonoses, Cheongju, Chungcheongbuk, South Korea; [Lee, Sol Moe; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul, South Korea; [Chung, Myungguen; Jeong, Seok Won; Cho, Sung Beom] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Biomed Informat, Ctr Genome Sci, Cheongju, Chungcheongbuk, South Korea; [Chung, Myungguen] Hanyang Univ, Div Mol & Life Sci, Seoul 133791, South Korea; [Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi Do, South Korea; [Kim, SangYun] Seoul Natl Univ, Coll Med, Gyeonggi Do, South Korea; [An, Seong Soo A.] Gachon Univ, Gachon BioNano Res Inst, Gyeonggi Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Hanyang University; Seoul National University (SNU); Seoul National University (SNU); Gachon University	Kim, SY (corresponding author), Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Immunol & Pathol, Div Zoonoses, Cheongju, Chungcheongbuk, South Korea.	tenksy@korea.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Lee, Sol Moe/0000-0002-6935-462X	Ministry of Health & Welfare (Republic of Korea) [2014-NG52003-00]; Korea Center for Disease Control and Prevention, Republic of Korea [4845-301, 4845-302, 4845-307, KBP-2015-027]	Ministry of Health & Welfare (Republic of Korea)(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Center for Disease Control and Prevention, Republic of Korea	This work was supported by Ministry of Health & Welfare (Republic of Korea, 2014-NG52003-00, http://english.mohw.go.kr/front_eng/index.jsp).; We would like to thank Young Chul Youn (Department of Neurology, Chung-Ang University College of Medicine, Seoul, South Korea) for interpretation of clinical data. The genome data of healthy Koreans was provided from the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4845-302), and Korea Biobank Project (4845-307, KBP-2015-027) that were supported by the Korea Center for Disease Control and Prevention, Republic of Korea.	Adjou KT, 2007, J COMP PATHOL, V137, P78, DOI 10.1016/j.jcpa.2007.03.007; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Bradley-Whitman MA, 2013, MECH AGEING DEV, V134, P486, DOI 10.1016/j.mad.2013.08.005; Cahill CM, 2009, BBA-GEN SUBJECTS, V1790, P615, DOI 10.1016/j.bbagen.2008.12.001; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; Cirillo D, 2013, RNA, V19, P129, DOI 10.1261/rna.034777.112; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; Compton D, 2002, NEUROSCI LETT, V331, P60, DOI 10.1016/S0304-3940(02)00703-6; Di Fonzo A, 2006, NEUROGENETICS, V7, P133, DOI 10.1007/s10048-006-0041-5; DICKINSON AG, 1964, HEREDITY, V19, P279, DOI 10.1038/hdy.1964.31; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; GOLDFARB LG, 1991, LANCET, V337, P425, DOI 10.1016/0140-6736(91)91198-4; GOLDFARB LG, 1992, ANN NEUROL, V31, P274, DOI 10.1002/ana.410310308; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Hyeon JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15283; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jin K, 2004, NEUROLOGY, V62, P502, DOI 10.1212/01.WNL.0000106954.54011.80; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; KITAMOTO T, 1993, ANN NEUROL, V34, P808, DOI 10.1002/ana.410340609; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Kobayashi S, 2010, CLIN NEUROL NEUROSUR, V112, P520, DOI 10.1016/j.clineuro.2010.03.015; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee SM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-52; Lee SM, 2012, PRION, V6, P375, DOI 10.4161/pri.20195; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Mastrianni JA, 2010, GENET MED, V12, P187, DOI 10.1097/GIM.0b013e3181cd7374; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morgan AR, 2008, AM J MED GENET B, V147B, P727, DOI 10.1002/ajmg.b.30670; Mutsukura K, 2009, DEMENT GERIATR COGN, V28, P550, DOI 10.1159/000254842; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Peoc'h K, 2000, HUM MUTAT, V15; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qina T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004968; Satoh K, 2006, CELL MOL NEUROBIOL, V26, P45, DOI 10.1007/s10571-006-9370-z; Solfrizzi V, 2002, J NEUROL NEUROSUR PS, V72, P732, DOI 10.1136/jnnp.72.6.732; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tan EK, 2008, MOVEMENT DISORD, V23, P734, DOI 10.1002/mds.21852; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Tomiyama H, 2008, J HUM GENET, V53, P1012, DOI 10.1007/s10038-008-0336-5; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang MM, 2011, INT J BIOCHEM CELL B, V43, P1550, DOI 10.1016/j.biocel.2011.08.005; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; Woerman AL, 2015, P NATL ACAD SCI USA, V112, pE4949, DOI 10.1073/pnas.1513426112; Wu T, 2006, NEUROREPORT, V17, P1859, DOI 10.1097/WNR.0b013e328010521c; Wu X, 2012, PARKINSONISM RELAT D, V18, P722, DOI 10.1016/j.parkreldis.2012.04.013; Yu LJ, 2015, LIFE SCI, V121, P104, DOI 10.1016/j.lfs.2014.11.021	61	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157540	10.1371/journal.pone.0157540	http://dx.doi.org/10.1371/journal.pone.0157540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341347	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600009
J	Martin, T; Moussay, S; Bulla, I; Bulla, J; Toupet, M; Etard, O; Denise, P; Davenne, D; Coquerel, A; Quarck, G				Martin, Tristan; Moussay, Sebastien; Bulla, Ingo; Bulla, Jan; Toupet, Michel; Etard, Olivier; Denise, Pierre; Davenne, Damien; Coquerel, Antoine; Quarck, Gaelle			Exploration of Circadian Rhythms in Patients with Bilateral Vestibular Loss	PLOS ONE			English	Article							BREAKFAST INTAKE PRIOR; BRIGHT LIGHT; INDIVIDUAL-DIFFERENCES; SLEEP PARAMETERS; WAKING TIME; PERFORMANCE; ACTIGRAPHY; PHASE; VALIDATION; STRATEGIES	Background New insights have expanded the influence of the vestibular system to the regulation of circadian rhythmicity. Indeed, hypergravity or bilateral vestibular loss (BVL) in rodents causes a disruption in their daily rhythmicity for several days. The vestibular system thus influences hypothalamic regulation of circadian rhythms on Earth, which raises the question of whether daily rhythms might be altered due to vestibular pathology in humans. The aim of this study was to evaluate human circadian rhythmicity in people presenting a total bilateral vestibular loss (BVL) in comparison with control participants. Methodology and Principal Findings Nine patients presenting a total idiopathic BVL and 8 healthy participants were compared. Their rest-activity cycle was recorded by actigraphy at home over 2 weeks. The daily rhythm of temperature was continuously recorded using a telemetric device and salivary cortisol was recorded every 3 hours from 6:00 AM to 9:00 PM over 24 hours. BVL patients displayed a similar rest activity cycle during the day to control participants but had higher nocturnal actigraphy, mainly during weekdays. Sleep efficiency was reduced in patients compared to control participants. Patients had a marked temperature rhythm but with a significant phase advance (73 min) and a higher variability of the acrophase (from 2:24 PM to 9:25 PM) with no correlation to rest-activity cycle, contrary to healthy participants. Salivary cortisol levels were higher in patients compared to healthy people at any time of day. Conclusion We observed a marked circadian rhythmicity of temperature in patients with BVL, probably due to the influence of the light dark cycle. However, the lack of synchronization between the temperature and rest-activity cycle supports the hypothesis that the vestibular inputs are salient input to the circadian clock that enhance the stabilization and precision of both external and internal entrainment.	[Martin, Tristan; Moussay, Sebastien; Denise, Pierre; Davenne, Damien; Coquerel, Antoine; Quarck, Gaelle] UNICAEN, COMETE, F-14032 Caen, France; [Martin, Tristan; Moussay, Sebastien; Denise, Pierre; Davenne, Damien; Coquerel, Antoine; Quarck, Gaelle] INSERM, U1075, F-14032 Caen, France; [Martin, Tristan; Moussay, Sebastien; Etard, Olivier; Denise, Pierre; Davenne, Damien; Coquerel, Antoine; Quarck, Gaelle] Normandie Univ, Caen, France; [Etard, Olivier; Denise, Pierre] CHU Caen, Serv Explorat Fonctionnelles, F-14000 Caen, France; [Toupet, Michel] Ctr Explorat Fonctionnelles Otoneurol, 10 Rue Falguiere, F-75015 Paris, France; [Coquerel, Antoine] CHU Caen, Lab Pharmacol Toxicol, F-14000 Caen, France; [Bulla, Ingo] Los Alamos Natl Lab, Theoret Biol & Biophys, Grp T6, Los Alamos, NM USA; [Bulla, Ingo] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, Walther Rathenau Str 47, D-17487 Greifswald, Germany; [Bulla, Jan] Univ Bergen, Dept Math, POB 7800, N-5020 Bergen, Norway	Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; United States Department of Energy (DOE); Los Alamos National Laboratory; Ernst Moritz Arndt Universitat Greifswald; University of Bergen	Martin, T (corresponding author), UNICAEN, COMETE, F-14032 Caen, France.; Martin, T (corresponding author), INSERM, U1075, F-14032 Caen, France.; Martin, T (corresponding author), Normandie Univ, Caen, France.	tristan.martin61@gmail.com	Denise, Pierre/E-2174-2011; Davenne, Damien/K-2959-2015; Davenne, Damien/K-2432-2019	Denise, Pierre/0000-0002-9049-7692; Davenne, Damien/0000-0002-9399-9970; Davenne, Damien/0000-0002-9399-9970; Etard, Olivier/0000-0003-3661-0233; Martin, Tristan/0000-0001-7576-883X	Basse-Normandie region-Emergence Program Grant [11P03919/11P03921]	Basse-Normandie region-Emergence Program Grant(Region Normandie)	This work was supported by Basse-Normandie region-Emergence Program Grant 11P03919/11P03921. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; ATKINSON G, 1993, ERGONOMICS, V36, P273, DOI 10.1080/00140139308967882; Backhaus J, 2004, PSYCHONEUROENDOCRINO, V29, P1184, DOI 10.1016/j.psyneuen.2004.01.010; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; BALOH RW, 1984, ANN NEUROL, V16, P222, DOI 10.1002/ana.410160209; Baxter C, 1983, Br J Sports Med, V17, P122; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Bessot N, 2012, GAIT POSTURE, V36, P319, DOI 10.1016/j.gaitpost.2012.02.021; Bijlenga D, 2013, J SLEEP RES, V22, P607, DOI 10.1111/jsr.12075; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; Bonmati-Carrion MA, 2015, CHRONOBIOL INT, V32, P701, DOI 10.3109/07420528.2015.1016613; Borel L, 2008, NEUROPHYSIOL CLIN, V38, P375, DOI 10.1016/j.neucli.2008.09.002; Bougard C, 2009, CHRONOBIOL INT, V26, P324, DOI 10.1080/07420520902774540; Bougard C, 2009, CHRONOBIOL INT, V26, P307, DOI 10.1080/07420520902774532; Bugnariu N, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-19; Carrier J, 2002, NEUROSCI LETT, V320, P1, DOI 10.1016/S0304-3940(02)00038-1; Chiarovano E, 2011, CLIN NEUROPHYSIOL, V122, P1650, DOI 10.1016/j.clinph.2011.01.006; CZEISLER CA, 1990, NEW ENGL J MED, V322, P1253, DOI 10.1056/NEJM199005033221801; Dauvilliers Y, 2004, EMC NEUROL, V1, P458, DOI DOI 10.1016/J.EMCN.2004.05.001; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Della Santina Charles C, 2010, Cochlear Implants Int, V11 Suppl 2, P2, DOI 10.1179/146701010X12726366068454; Denise P, 2007, SPACE TECHNOL LIB, V20, P233; Dijk DJ, 2001, AM J PHYSIOL-REG I, V281, pR1647, DOI 10.1152/ajpregu.2001.281.5.R1647; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Duffy JF, 1996, J PHYSIOL-LONDON, V495, P289, DOI 10.1113/jphysiol.1996.sp021593; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Fuller PM, 2006, J BIOL RHYTHM, V21, P177, DOI 10.1177/0748730406288148; Fuller PM, 2002, P NATL ACAD SCI USA, V99, P15723, DOI 10.1073/pnas.242251499; FURMAN JMR, 1989, ACTA OTO-LARYNGOL, V108, P355, DOI 10.3109/00016488909125539; Gauthier A, 1996, CHRONOBIOL INT, V13, P135, DOI 10.3109/07420529609037077; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Hakola T, 1996, SCAND J WORK ENV HEA, V22, P133, DOI 10.5271/sjweh.121; Heaney JLJ, 2012, PSYCHONEUROENDOCRINO, V37, P341, DOI 10.1016/j.psyneuen.2011.07.001; Henriksson M, 2011, GAIT POSTURE, V33, P661, DOI 10.1016/j.gaitpost.2011.02.018; Holley DC, 2003, J APPL PHYSIOL, V95, P1266, DOI 10.1152/japplphysiol.00707.2002; Horak FB, 2009, ANN NY ACAD SCI, V1164, P76, DOI 10.1111/j.1749-6632.2008.03708.x; HORAK FB, 1990, EXP BRAIN RES, V82, P167; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; HORNE JA, 1977, BIOL PSYCHOL, V5, P179, DOI 10.1016/0301-0511(77)90001-1; Horowitz SS, 2004, J COMP NEUROL, V474, P227, DOI 10.1002/cne.20125; Imai T, 2001, ANN NY ACAD SCI, V942, P470; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Ito Y, 2013, INT J TRYPTOPHAN RES, P75, DOI 10.4137/IJTR.S11760; Kantermann T, 2015, J BIOL RHYTHM, V30, P449, DOI 10.1177/0748730415597520; Kantermann T, 2013, WORK, V46, P273, DOI 10.3233/WOR-121531; Krauchi K, 1997, J APPL PHYSIOL, V83, P134, DOI 10.1152/jappl.1997.83.1.134; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lekhel H, 1998, GAIT POSTURE, V7, P228, DOI 10.1016/S0966-6362(98)00012-5; Lericollais R, 2011, SCAND J MED SCI SPOR, V21, pE106, DOI 10.1111/j.1600-0838.2010.01172.x; LIEBERMAN HR, 1989, NEUROBIOL AGING, V10, P259, DOI 10.1016/0197-4580(89)90060-2; Machado ML, 2012, NEUROSCI LETT, V522, P57, DOI 10.1016/j.neulet.2012.06.016; Madsen MT, 2013, J CLIN SLEEP MED; Martin T, 2015, J APPL PHYSIOL, V118, P310, DOI 10.1152/japplphysiol.00811.2014; McCall Andrew A, 2011, Front Neurol, V2, P88, DOI 10.3389/fneur.2011.00088; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; Monk TH, 2000, CHRONOBIOL INT, V17, P49, DOI 10.1081/CBI-100101031; Moussay S, 2002, CHRONOBIOL INT, V19, P1137, DOI 10.1081/CBI-120015966; Murakami DM, 2002, P NATL ACAD SCI USA, V99, P17078, DOI 10.1073/pnas.252652299; Natale V, 2014, SLEEP MED, V15, P111, DOI 10.1016/j.sleep.2013.08.792; Normand H, 1997, J APPL PHYSIOL, V82, P1734, DOI 10.1152/jappl.1997.82.6.1734; Osse Robert Jan, 2009, Interact Cardiovasc Thorac Surg, V8, P344, DOI 10.1510/icvts.2008.192278; Osse RJ, 2009, PSYCHIAT CLIN NEUROS, V63, P56, DOI 10.1111/j.1440-1819.2008.01888.x; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Peterson BT, 2012, SLEEP MED, V13, P419, DOI 10.1016/j.sleep.2011.12.003; Pinheiro J, 2001, MIXED EFFECTS MODELS; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; Rinne T, 1998, J NEUROL, V245, P314, DOI 10.1007/s004150050225; Romeijn N, 2012, PFLUG ARCH EUR J PHY, V463, P169, DOI 10.1007/s00424-011-1042-2; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sargent EW, 1997, OTOLARYNG HEAD NECK, V116, P157, DOI 10.1016/S0194-5998(97)70318-8; Sasaki O, 2001, AURIS NASUS LARYNX, V28, P295, DOI 10.1016/S0385-8146(01)00094-3; Shallo-Hoffmann J, 2003, VISION RES, V43, P1589, DOI 10.1016/S0042-6989(03)00218-9; Smith PF, 2013, FRONT HUM NEUROSCI, P7; Soehner AM, 2011, CHRONOBIOL INT, V28, P802, DOI 10.3109/07420528.2011.613137; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Tyagi S, 2014, BEHAV TREATMENT CHRO; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Vignaux G, 2012, TOXICOL APPL PHARM, V258, P61, DOI 10.1016/j.taap.2011.10.008; Vignaux G, 2013, J BONE MINER RES, V28, P2136, DOI 10.1002/jbmr.1940; Yates BJ, 2000, BRAIN RES BULL, V53, P3, DOI 10.1016/S0361-9230(00)00302-6; Yates BJ, 1996, ANN NY ACAD SCI, V781, P458, DOI 10.1111/j.1749-6632.1996.tb15720.x	85	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0155067	10.1371/journal.pone.0155067	http://dx.doi.org/10.1371/journal.pone.0155067			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341473	Green Submitted, Green Published, gold			2022-12-26	WOS:000378393600001
J	Saha, SK; Choi, HY; Kim, BW; Dayem, AA; Yang, GM; Kim, KS; Yin, YF; Cho, SG				Saha, S. K.; Choi, H. Y.; Kim, B. W.; Dayem, A. A.; Yang, G-M; Kim, K. S.; Yin, Y. F.; Cho, S-G			KRT19 directly interacts with beta-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties	ONCOGENE			English	Article							KERATIN 19 EXPRESSION; BETA-CATENIN; ESTROGEN-RECEPTOR; PERIPHERAL-BLOOD; GENE SIGNATURE; INTERMEDIATE-FILAMENTS; CELL-PROLIFERATION; DOWN-REGULATION; POOR-PROGNOSIS; TUMOR-CELLS	Studies have reported that interactions between keratins (KRTs) and other proteins initiate signaling cascades that regulate cell migration, invasion, and metastasis. In the current study, we found that expression of KRT19 was specifically high in breast cancers and significantly correlated with their invasiveness. Moreover, knockdown of KRT19 led to increased proliferation, migration, invasion, drug resistance, and sphere formation in breast cancer cells via an upregulated NOTCH signaling pathway. This was owing to reduced expression of NUMB, an inhibitory protein of the NOTCH signaling pathway. In addition, we found that KRT19 interacts with beta-catenin/RAC1 complex and enhances the nuclear translocation of beta-catenin. Concordantly, knockdown of KRT19 suppressed the nuclear translocation of beta-catenin as well as beta-catenin-mediated NUMB expression. Furthermore, modulation of KRT19mediated regulation of NUMB and NOTCH1 expression led to the repression of the cancer stem cell properties of breast cancer patient-derived CD133(high)/CXCR4(high)/ALDH1(high) cancer stem-like cells (CSLCs), which showed very low KRT19 and high NOTCH1 expression. Taken together, our study suggests a novel function for KRT19 in the regulation of nuclear import of the beta-catenin/RAC1 complex, thus modulating the NUMB-dependent NOTCH signaling pathway in breast cancers and CSLCs, which might bear potential clinical implications for cancer or CSLC treatment.	[Cho, S-G] Konkuk Univ, Dept Anim Biotechnol Stem Cell & Regenerat Biotec, 120 Neungdong Ro, Seoul 05029, South Korea; [Cho, S-G] Konkuk Univ, Incurable Dis Anim Model & Stem Cell Inst IDASI, 120 Neungdong Ro, Seoul, South Korea	Konkuk University; Konkuk University	Cho, SG (corresponding author), Konkuk Univ, Dept Anim Biotechnol Stem Cell & Regenerat Biotec, 120 Neungdong Ro, Seoul 05029, South Korea.; Cho, SG (corresponding author), Konkuk Univ, Incurable Dis Anim Model & Stem Cell Inst IDASI, 120 Neungdong Ro, Seoul, South Korea.	ssangoo@konkuk.ac.kr	Saha, Subbroto Kumar/L-2627-2018; CHOI, HYEYEON/O-1234-2019; Dayem, Ahmed M Abdal/D-4773-2011	Saha, Subbroto Kumar/0000-0003-1325-3499; Dayem, Ahmed M Abdal/0000-0003-3873-9903; Cho, Ssang-Goo/0000-0002-0968-7932	National Research Foundation (NRF) - Korean government [2013M3A9D3045880, 2015R1A5A1009701]	National Research Foundation (NRF) - Korean government(Korean Government)	This work was supported by grants from the National Research Foundation (NRF) funded by the Korean government (2013M3A9D3045880 and 2015R1A5A1009701).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bambang IF, 2009, EXP CELL RES, V315, P1964, DOI 10.1016/j.yexcr.2009.02.017; Bernemann C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-174; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bozionellou V, 2004, CLIN CANCER RES, V10, P8185, DOI 10.1158/1078-0432.CCR-03-0094; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Chen TF, 2007, LUNG CANCER, V56, P105, DOI 10.1016/j.lungcan.2006.11.006; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Dayem AA, 2014, BIOTECHNOL J, V9, P934, DOI 10.1002/biot.201300555; de Silanes IL, 2007, CELL ONCOL, V29, P1; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Esufali S, 2007, FEBS LETT, V581, P4850, DOI 10.1016/j.febslet.2007.09.013; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fradette J, 1998, J BIOL CHEM, V273, P35176, DOI 10.1074/jbc.273.52.35176; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hua GJ, 2014, ONCOL REP, V31, P2727, DOI 10.3892/or.2014.3156; Ignatiadis M, 2007, J CLIN ONCOL, V25, P5194, DOI 10.1200/JCO.2007.11.7762; Jamieson C, 2015, J CELL SCI, V128, P3933, DOI 10.1242/jcs.167742; Jang GB, 2015, SCI REP-UK, V5, DOI 10.1038/srep12465; Ju JH, 2015, CELL DEATH DIFFER, V22, P665, DOI 10.1038/cdd.2014.155; Ju JH, 2013, CLIN CANCER RES, V19, P4335, DOI 10.1158/1078-0432.CCR-12-3295; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; Kabir NN, 2014, MOL BIOL REP, V41, P7729, DOI 10.1007/s11033-014-3684-6; Karaczyn A, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-31; Katoh M, 2006, INT J MOL MED, V18, P517; Kawai T, 2015, CLIN CANCER RES, V21, P3081, DOI 10.1158/1078-0432.CCR-14-1936; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Leung WH, 2013, J EXP MED, V210, P2675, DOI 10.1084/jem.20122292; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu XH, 2013, J BIOL CHEM, V288, P17990, DOI 10.1074/jbc.M113.478487; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1589, DOI 10.1289/ehp.7345; Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1137, DOI 10.1289/ehp.7028; Moon SH, 2013, INT J ONCOL, V42, P921, DOI 10.3892/ijo.2013.1765; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Nishikawa S, 2015, ONCOL LETT, V9, P2361, DOI 10.3892/ol.2015.3063; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Patsialou A, 2015, ONCOGENE, V34, P2721, DOI 10.1038/onc.2014.226; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Pethe VV, 2011, INT J ONCOL, V39, P805, DOI 10.3892/ijo.2011.1066; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Pui CH, 2009, CANCER CELL, V15, P85, DOI 10.1016/j.ccr.2009.01.007; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stathopoulos EN, 2005, ANN ONCOL, V16, P240, DOI 10.1093/annonc/mdi043; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Strazzabosco M, 2013, J HEPATOL, V58, P181, DOI 10.1016/j.jhep.2012.08.006; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; WU YJ, 1981, CELL, V25, P627, DOI 10.1016/0092-8674(81)90170-7; Xiao YF, 2016, INT J ONCOL, V48, P437, DOI 10.3892/ijo.2015.3280; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zardawi SJ, 2010, HISTOPATHOLOGY, V56, P286, DOI 10.1111/j.1365-2559.2009.03475.x; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	95	62	66	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					332	349		10.1038/onc.2016.221	http://dx.doi.org/10.1038/onc.2016.221			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27345400	Green Published, hybrid			2022-12-26	WOS:000394166000004
J	Sumer-Bayraktar, Z; Grant, OC; Venkatakrishnan, V; Woods, RJ; Packer, NH; Thaysen-Andersen, M				Sumer-Bayraktar, Zeynep; Grant, Oliver C.; Venkatakrishnan, Vignesh; Woods, Robert J.; Packer, Nicolle H.; Thaysen-Andersen, Morten			Asn(347) Glycosylation of Corticosteroid-binding Globulin Fine-tunes the Host Immune Response by Modulating Proteolysis by Pseudomonas aeruginosa and Neutrophil Elastase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycosylation; molecular dynamics; proteolysis; Pseudomonas aeruginosa (P; aeruginosa); corticosteroid-binding globulin; P; aeruginosa elastase; cortisol; neutrophil elastase; reactive center loop	MOLECULAR-DYNAMICS SIMULATIONS; SERINE-PROTEASE INHIBITORS; REACTIVE CENTER LOOP; PARTICLE MESH EWALD; CYSTIC-FIBROSIS; CELL-MEMBRANES; SEPTIC SHOCK; CBG; CLEAVAGE; GLYCOPEPTIDES	Corticosteroid-binding globulin (CBG) delivers anti-inflammatory cortisol to inflamed tissues upon elastase-based proteolysis of the exposed reactive center loop (RCL). However, the molecular mechanisms that regulate the RCL proteolysis by co-existing host and bacterial elastases in inflamed/infected tissues remain unknown. We document that RCL-localized Asn(347) glycosylation fine-tunes the RCL cleavage rate by human neutrophil elastase (NE) and Pseudomonas aeruginosa elastase (PAE) by different mechanisms. NE- and PAE-generated fragments of native and exoglycosidase-treated blood-derived CBG of healthy individuals were monitored by gel electrophoresis and LC-MS/MS to determine the cleavage site(s) and Asn(347) glycosylation as a function of digestion time. The site-specific (Val(344)-Thr(345)) and rapid (seconds to minutes) NE-based RCL proteolysis was significantly antagonized by several volume-enhancing Asn(347) glycan features (i.e. occupancy, triantennary GlcNAc branching, and 1,6-fucosylation) and augmented by Asn(347) NeuAc-type sialylation (all p < 0.05). In contrast, the inefficient (minutes to hours) PAE-based RCL cleavage, which occurred equally well at Thr(345)-Leu(346) and Asn(347)-Leu(348), was abolished by the presence of Asn(347) glycosylation but was enhanced by sialoglycans on neighboring CBG N-sites. Molecular dynamics simulations of various Asn(347) glycoforms of uncleaved CBG indicated that multiple Asn(347) glycan features are modulating the RCL digestion efficiencies by NE/PAE. Finally, high concentrations of cortisol showed weak bacteriostatic effects toward virulent P. aeruginosa, which may explain the low RCL potency of the abundantly secreted PAE during host infection. In conclusion, site-specific CBG N-glycosylation regulates the bioavailability of cortisol in inflamed environments by fine-tuning the RCL proteolysis by endogenous and exogenous elastases. This study offers new molecular insight into host- and pathogen-based manipulation of the human immune system.	[Sumer-Bayraktar, Zeynep; Venkatakrishnan, Vignesh; Packer, Nicolle H.; Thaysen-Andersen, Morten] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Grant, Oliver C.; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Macquarie University; University System of Georgia; University of Georgia	Thaysen-Andersen, M (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	morten.andersen@mq.edu.au	Packer, Nicolle/Q-8929-2019	Packer, Nicolle/0000-0002-7532-4021; Grant, Oliver/0000-0003-4835-5161; Woods, Robert/0000-0002-2400-6293; Thaysen-Andersen, Morten/0000-0001-8327-6843	International Macquarie University postgraduate student research scholarship (iMQRES); National Institutes of Health [P41 GM103390]; ARC Super Science Grant [FS110200026]; ARC Centre of Excellence in Nanoscale Biophotonics Grant [CE140100003]; Early Career Fellowship from the Cancer Institute, New South Wales, Australia; Macquarie University Research Development Grant (MQRDG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	International Macquarie University postgraduate student research scholarship (iMQRES); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Super Science Grant(Australian Research Council); ARC Centre of Excellence in Nanoscale Biophotonics Grant(Australian Research Council); Early Career Fellowship from the Cancer Institute, New South Wales, Australia; Macquarie University Research Development Grant (MQRDG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Recipient of an International Macquarie University postgraduate student research scholarship (iMQRES).; Supported by National Institutes of Health Grant P41 GM103390.; Supported by ARC Super Science Grant FS110200026 and ARC Centre of Excellence in Nanoscale Biophotonics Grant CE140100003.; Supported by an Early Career Fellowship from the Cancer Institute, New South Wales, Australia and a Macquarie University Research Development Grant (MQRDG).	AVVAKUMOV GV, 1994, BIOCHEMISTRY-US, V33, P5759, DOI 10.1021/bi00185a012; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BERNARD BA, 1982, J BIOL CHEM, V257, P8549; Brantly M, 2002, AM J RESP CELL MOL, V27, P652, DOI 10.1165/rcmb.F250; Cameron A, 2010, J CLIN ENDOCR METAB, V95, P4689, DOI 10.1210/jc.2010-0942; Case D. A., 2014, AMBER 14 REFERENCE M, V14; Chan WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113402; Chan WL, 2013, J CLIN ENDOCR METAB, V98, P3315, DOI 10.1210/jc.2012-4280; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Crocetti L, 2013, J MED CHEM, V56, P6259, DOI 10.1021/jm400742j; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deshpande N, 2010, J PROTEOME RES, V9, P1063, DOI 10.1021/pr900956x; EmptozBonneton A, 1997, J CLIN ENDOCR METAB, V82, P3758, DOI 10.1210/jc.82.11.3758; Gardill BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052759; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Groutas WC, 2011, EXPERT OPIN THER PAT, V21, P339, DOI 10.1517/13543776.2011.551115; HAMMOND GL, 1990, BIOCHEM BIOPH RES CO, V172, P172, DOI 10.1016/S0006-291X(05)80189-5; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1991, J STEROID BIOCHEM, V40, P755, DOI 10.1016/0960-0760(91)90300-T; Hane M, 2015, GLYCOBIOLOGY, V25, P1112, DOI 10.1093/glycob/cwv049; Hansen G, 2011, J MOL BIOL, V409, P681, DOI 10.1016/j.jmb.2011.04.047; Henke MO, 2011, INFECT IMMUN, V79, P3438, DOI 10.1128/IAI.01252-10; HEYNS W, 1988, ANN NY ACAD SCI, V538, P122, DOI 10.1111/j.1749-6632.1988.tb48857.x; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HRYB DJ, 1986, P NATL ACAD SCI USA, V83, P3253, DOI 10.1073/pnas.83.10.3253; Jirikowski GF, 2007, J CHEM NEUROANAT, V34, P22, DOI 10.1016/j.jchemneu.2007.03.007; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; KHAN MS, 1984, J STEROID BIOCHEM, V20, P677, DOI 10.1016/0022-4731(84)90142-0; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee LY, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00404; Lewis JG, 2015, J STEROID BIOCHEM, V149, P53, DOI 10.1016/j.jsbmb.2015.01.020; Lewis JG, 2014, MOL CELL ENDOCRINOL, V384, P96, DOI 10.1016/j.mce.2014.01.005; Lewis JG, 2011, J STEROID BIOCHEM, V127, P289, DOI 10.1016/j.jsbmb.2011.08.006; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; LURIA SE, 1957, J BACTERIOL, V74, P461, DOI 10.1002/path.1700740226; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; MELBY JC, 1958, J CLIN INVEST, V37, P1791, DOI 10.1172/JCI103772; Meyer EJ, 2016, HORM METAB RES, V48, P359, DOI 10.1055/s-0042-108071; Mihrshahi R, 2006, J STEROID BIOCHEM, V101, P275, DOI 10.1016/j.jsbmb.2006.06.031; Misao R, 1999, HORM RES, V51, P162, DOI 10.1159/000023351; MISAO R, 1994, STEROIDS, V59, P603, DOI 10.1016/0039-128X(94)90055-8; Miska W, 2004, ANDROLOGIA, V36, P41, DOI 10.1046/j.1439-0272.2003.00601.x; Nenke MA, 2015, CLIN ENDOCRINOL, V82, P801, DOI 10.1111/cen.12680; Nenke M. A., 2016, CLIN ENDOCRINOL, V48, P359; Nenke MA, 2016, CLIN CHIM ACTA, V452, P27, DOI 10.1016/j.cca.2015.10.028; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Penesyan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138527; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; PERROTAPPLANAT M, 1984, ENDOCRINOLOGY, V115, P559, DOI 10.1210/endo-115-2-559; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; Rapala-Kozik M, 1999, BIOL CHEM, V380, P1211, DOI 10.1515/BC.1999.153; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Rutledge EA, 1996, J CELL PHYSIOL, V168, P284, DOI 10.1002/(SICI)1097-4652(199608)168:2<284::AID-JCP7>3.0.CO;2-L; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schafer HH, 2015, HORM METAB RES, V47, P596, DOI 10.1055/s-0034-1389957; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Simard M, 2014, ENDOCRINOLOGY, V155, P2900, DOI 10.1210/en.2014-1055; Sivukhina EV, 2006, HORM METAB RES, V38, P253, DOI 10.1055/s-2006-925346; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Stavenhagen K, 2013, J MASS SPECTROM, V48, P627, DOI [10.1002/jms.3189, 10.1002/jms.3210]; STRELCHYONOK OA, 1991, J STEROID BIOCHEM, V40, P795, DOI 10.1016/0960-0760(91)90305-O; Sumer-Bayraktar Z, 2012, PROTEOMICS, V12, P3315, DOI 10.1002/pmic.201200354; Sumer-Bayraktar Z, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009100; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Thaysen-Andersen M, 2009, ANAL CHEM, V81, P3933, DOI 10.1021/ac900231w; Tsigos C, 1998, J CLIN ENDOCR METAB, V83, P3379, DOI 10.1210/jc.83.9.3379; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vashchenko G, 2016, J BIOL CHEM, V291, P11300, DOI 10.1074/jbc.M116.714378; Verhoog N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110702; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012	79	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17727	17742		10.1074/jbc.M116.735258	http://dx.doi.org/10.1074/jbc.M116.735258			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339896	hybrid, Green Published			2022-12-26	WOS:000383241300022
J	Wadas, B; Borjigin, J; Huang, ZP; Oh, JH; Hwang, CS; Varshavsky, A				Wadas, Brandon; Borjigin, Jimo; Huang, Zheping; Oh, Jang-Hyun; Hwang, Cheol-Sang; Varshavsky, Alexander			Degradation of Serotonin N-Acetyltransferase, a Circadian Regulator, by the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyltransferase; circadian; proteolysis; serotonin; ubiquitin	TERMINAL ACETYLATION; MELATONIN SYNTHESIS; PINEAL-GLAND; CELLULAR-PROTEINS; IN-VIVO; PROTEASOMAL PROTEOLYSIS; ANGSTROM RESOLUTION; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; UBIQUITIN LIGASE	Serotonin N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin (NAS), a distinct biological regulator and the immediate precursor of melatonin, a circulating hormone that influences circadian processes, including sleep. N-terminal sequences of AANAT enzymes vary among vertebrates. Mechanisms that regulate the levels of AANAT are incompletely understood. Previous findings were consistent with the possibility that AANAT may be controlled through its degradation by the N-end rule pathway. By expressing the rat and human AANATs and their mutants not only in mammalian cells but also in the yeast Saccharomyces cerevisiae, and by taking advantage of yeast genetics, we show here that two complementary forms of rat AANAT are targeted for degradation by two complementary branches of the N-end rule pathway. Specifically, the N-terminally acetylated (Nt-acetylated) Ac-AANAT is destroyed through the recognition of its Nt-acetylated N-terminal Met residue by the Ac/N-end rule pathway, whereas the non-Nt-acetylated AANAT is targeted by the Arg/N-end rule pathway, which recognizes the unacetylated N-terminal Met-Leu sequence of rat AANAT. We also show, by constructing lysine-to-arginine mutants of rat AANAT, that its degradation is mediated by polyubiquitylation of its Lys residue(s). Human AANAT, whose N-terminal sequence differs from that of rodent AANATs, is longer-lived than its rat counterpart and appears to be refractory to degradation by the N-end rule pathway. Together, these and related results indicate both a major involvement of the N-end rule pathway in the control of rodent AANATs and substantial differences in the regulation of rodent and human AANATs that stem from differences in their N-terminal sequences.	[Wadas, Brandon; Oh, Jang-Hyun; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Borjigin, Jimo] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Huang, Zheping] Univ Connecticut, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea	California Institute of Technology; University of Michigan System; University of Michigan; University of Connecticut; Pohang University of Science & Technology (POSTECH)	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019; Borjigin, Jimo/GXA-3484-2022	Hwang, Cheol-Sang/0000-0002-0105-5957; Wadas, Brandon/0000-0003-2796-2384	National Institutes of Health [R01-DK039520, R01-GM031530, R01-NS057583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health Grants R01-DK039520 and R01-GM031530 (to A. V.) and R01-NS057583 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; Andrews B., 2016, BUDDING YEAST LAB MA; [Anonymous], 1991, Methods Enzymol, V194, P1; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Ausubel FM, 2010, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bernard M, 1997, J NEUROCHEM, V68, P213; BORJIGIN J, 1995, NATURE, V378, P783, DOI 10.1038/378783a0; Borjigin J, 1999, ANNU REV PHARMACOL, V39, P53, DOI 10.1146/annurev.pharmtox.39.1.53; Borjigin J, 2012, MOL CELL ENDOCRINOL, V349, P13, DOI 10.1016/j.mce.2011.07.009; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chattoraj A, 2009, REV ENDOCR METAB DIS, V10, P237, DOI 10.1007/s11154-009-9125-5; Choi BH, 2004, J NEUROCHEM, V90, P442, DOI 10.1111/j.1471-4159.2004.02495.x; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Falcon J, 2014, P NATL ACAD SCI USA, V111, P314, DOI 10.1073/pnas.1312634110; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gandhi AV, 2015, NEURON, V85, P1193, DOI 10.1016/j.neuron.2015.02.016; Ganguly S, 2001, J BIOL CHEM, V276, P47239, DOI 10.1074/jbc.M107222200; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gonzalez S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001347; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Hardeland R, 2010, CURR NEUROPHARMACOL, V8, P168, DOI 10.2174/157015910792246244; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Huang ZP, 2010, J PINEAL RES, V48, P290, DOI 10.1111/j.1600-079X.2010.00753.x; Huang ZP, 2005, J PINEAL RES, V39, P84, DOI 10.1111/j.1600-079X.2005.00222.x; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim JM, 2014, CELL CYCLE, V13, P1366, DOI 10.4161/cc.28751; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lee SJ, 2009, J PINEAL RES, V47, P75, DOI 10.1111/j.1600-079X.2009.00690.x; Li J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010051; Liu TC, 2005, J PINEAL RES, V39, P91, DOI 10.1111/j.1600-079X.2005.00223.x; Lynch M, 2007, ORIGINS GENOME ARCHI; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Matsuo M, 2013, FEBS LETT, V587, P1392, DOI 10.1016/j.febslet.2013.03.016; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Mukherjee S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00112; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Perrot M, 2008, YEAST, V25, P513, DOI 10.1002/yea.1602; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Rawashdeh O, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00027; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Schippers KJ, 2014, CELL, V159, P9, DOI 10.1016/j.cell.2014.09.004; Schomerus C, 2000, J NEUROCHEM, V75, P2123, DOI 10.1046/j.1471-4159.2000.0752123.x; Schomerus C, 2002, CELL TISSUE RES, V309, P417, DOI 10.1007/s00441-002-0588-x; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SIKORSKI RS, 1989, GENETICS, V122, P19; Slater M., 2008, PROMEGA NOTES, V100, P16; Sompol P, 2011, P NATL ACAD SCI USA, V108, P8844, DOI 10.1073/pnas.1105114108; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Szewczuk LM, 2008, BIOCHEMISTRY-US, V47, P10407, DOI 10.1021/bi801189d; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Tosini G, 2012, NEUROSCIENTIST, V18, P645, DOI 10.1177/1073858412446634; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Varland S, 2015, PROTEOMICS, V15, P2385, DOI 10.1002/pmic.201400619; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wu CG, 2009, METHODS MOL BIOL, V570, P197, DOI 10.1007/978-1-60327-394-7_8; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	102	10	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17178	17196		10.1074/jbc.M116.734640	http://dx.doi.org/10.1074/jbc.M116.734640			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339900	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000382643800022
J	Khan, AL; Al-Harrasi, A; Al-Rawahi, A; Al-Farsi, Z; Al-Mamari, A; Waqas, M; Asaf, S; Elyassi, A; Mabood, F; Shin, JH; Lee, IJ				Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Al-Farsi, Zainab; Al-Mamari, Aza; Waqas, Muhammad; Asaf, Sajjad; Elyassi, Ali; Mabood, Fazal; Shin, Jae-Ho; Lee, In-Jung			Endophytic Fungi from Frankincense Tree Improves Host Growth and Produces Extracellular Enzymes and Indole Acetic Acid	PLOS ONE			English	Article							STRESS TOLERANCE; PLANT-GROWTH; DIVERSITY; BIOSYNTHESIS; PHYLLOPLANE; CAPABILITY; BACTERIA; TISSUE	Boswellia sacra, an economically important frankincense-producing tree found in the desert woodlands of Oman, is least known for its endophytic fungal diversity and the potential of these fungi to produce extracellular enzymes and auxins. We isolated various fungal endophytes belonging to Eurotiales (11.8%), Chaetomiaceae (17.6%), Incertae sadis (29.5%), Aureobasidiaceae (17.6%), Nectriaceae (5.9%) and Sporomiaceae (17.6%) from the phylloplane (leaf) and caulosphere (stem) of the tree. Endophytes were identified using genomic DNA extraction, PCR amplification and sequencing the internal transcribed spacer regions, whereas a detailed phylogenetic analysis of the same gene fragment was made with homologous sequences. The endophytic colonization rate was significantly higher in the leaf (5.33%) than the stem (0.262%). The Shannon-Weiner diversity index was H' 0.8729, while Simpson index was higher in the leaf (0.583) than in the stem (0.416). Regarding the endophytic fungi's potential for extracellular enzyme production, fluorogenic 4-methylum-belliferone standards and substrates were used to determine the presence of cellulases, phosphatases and glucosidases in the pure culture. Among fungal strains, Penicillum citrinum BSL17 showed significantly higher amounts of glucosidases (62.15 +/- 1.8 mu M(-1)min(-1)mL) and cellulases (62.11 +/- 1.6 mu M(-1)min(-1)mL), whereas Preussia sp. BSL10 showed significantly higher secretion of glucosidases (69.4 +/- 0.79 mu M(-1)min(-1)mL) and phosphatases (3.46 +/- 0.31 mu M(-1)min(-1)mL) compared to other strains. Aureobasidium sp. BSS6 and Preussia sp. BSL10 showed significantly higher potential for indole acetic acid production (tryptophan-dependent and independent pathways). Preussia sp. BSL10 was applied to the host B. sacra tree saplings, which exhibited significant improvements in plant growth parameters and accumulation of photosynthetic pigments. The current study concluded that endophytic microbial resources producing extracellular enzymes and auxin could establish a unique niche for ecological adaptation during symbiosis with the host Frankincense tree.	[Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Al-Farsi, Zainab; Al-Mamari, Aza; Elyassi, Ali; Mabood, Fazal] Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman; [Waqas, Muhammad; Asaf, Sajjad; Shin, Jae-Ho; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Waqas, Muhammad] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan	University of Nizwa; Kyungpook National University	Al-Harrasi, A (corresponding author), Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman.; Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	aharrasi@unizwa.edu.om; ijlee@knu.ac.kr	Asaf, Sajjad/ABA-3647-2021; Mabood, Fazal/L-4868-2019; Lee, In-Jung/GLS-0432-2022	Lee, In-Jung/0000-0001-7154-4820; Khan, Abdul Latif/0000-0001-9700-8903	Open Research Grant Project [ORG/EBR/15/007]; National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program [2014R1A1A2A10058022]; Oman Research Council	Open Research Grant Project; National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program(National Research Foundation of Korea); Oman Research Council(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This work was financially supported by the Oman Research Council, Open Research Grant Project (ORG/EBR/15/007) and by National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program (2014R1A1A2A10058022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the Oman Research Council, Open Research Grant Project ( ORG/EBR/15/ 007) and by National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic- Science Research Program (2014R1A1A2A10058022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenal F, 2007, FUNGAL DIVERS, V25, P1; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bacon CW, 2000, MICROBIAL ENDOPHYTES, P28; Bischoff KM, 2009, CURR MICROBIOL, V58, P499, DOI 10.1007/s00284-008-9353-z; Castillo P, 2015, HANDBOOK FOR AZOSPIRILLUM: TECHNICAL ISSUES AND PROTOCOLS, P115, DOI 10.1007/978-3-319-06542-7_7; Coppi A, 2010, GENET RESOUR CROP EV, V57, P1041, DOI 10.1007/s10722-010-9546-8; Del Prada R, 2006, MYCOL RES, V110, P511, DOI 10.1016/j.mycres.2005.08.013; El-Nagerabi S. A. F., 2014, Biodiversitas: Journal of Biological Diversity, V15, P24; Esteves AC, 2014, CAN J MICROBIOL, V60, P332, DOI 10.1139/cjm-2014-0134; Farah MH, 2008, PROQUEST; Fouda AH, 2015, ANN AGR SCI; Garcia A, 2012, BIOL RES, V45, P139, DOI 10.4067/S0716-97602012000200006; Gazis R, 2015, FUNGAL ECOL, V17, P18, DOI 10.1016/j.funeco.2015.04.001; Gebrehiwot K, 2003, INT FOREST REV, V5, P348, DOI 10.1505/IFOR.5.4.348.22661; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Correa RCG, 2014, J IND MICROBIOL BIOT, V41, P1467, DOI 10.1007/s10295-014-1496-2; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Han ML, 2016, FUNGAL DIVERS, V80, P343, DOI 10.1007/s13225-016-0364-y; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hoffman MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073132; Hofstetter RW, 2005, J CHEM ECOL, V31, P539, DOI 10.1007/s10886-005-2035-4; Huang Q, 2015, RES MICROBIOL, V166, P45, DOI 10.1016/j.resmic.2014.12.004; Huang WY, 2009, FUNGAL DIVERS, V36, P69; Khan AL, 2016, ELECTRON J BIOTECHN, V21, P58, DOI 10.1016/j.ejbt.2016.02.001; Khan AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-86; Khan AL, 2015, J HAZARD MATER, V295, P70, DOI 10.1016/j.jhazmat.2015.04.008; Khan AL, 2014, SCI HORTIC-AMSTERDAM, V175, P167, DOI 10.1016/j.scienta.2014.06.008; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Khan SA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-231; Kim YB, 2009, TREE PHYSIOL, V29, P737, DOI 10.1093/treephys/tpp002; Kumar DSS, 2004, FUNGAL DIVERS, V17, P69; Kusari S, 2012, METABOLOMICS, P241; Limtong S, 2014, WORLD J MICROB BIOT, V30, P1785, DOI 10.1007/s11274-014-1602-7; Liu XL, 2007, FOOD CHEM, V105, P548, DOI 10.1016/j.foodchem.2007.04.008; Ludwig-Muller J, 2015, BIOTECHNOL LETT, V37, P1325, DOI 10.1007/s10529-015-1814-4; Lumyong S, 2002, CAN J MICROBIOL, V48, P1109, DOI 10.1139/W02-112; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Mercado-Blanco J., 2014, CURR BIOTECHNOL, V3, P60, DOI [10.2174/22115501113026660038, DOI 10.2174/22115501113026660038]; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Pandey SS, 2016, PLANTA, V243, P1097, DOI 10.1007/s00425-016-2467-9; Park YS, 2002, PLANTA MED, V68, P397, DOI 10.1055/s-2002-32090; Pedraza RO, 2009, EUR J SOIL BIOL, V45, P36, DOI 10.1016/j.ejsobi.2008.09.007; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Ritpitakphong U, 2016, NEW PHYTOL, V210, P1033, DOI 10.1111/nph.13808; Robl D, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-94; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Soussi A, 2015, PLANT SOIL, V28, P1; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Sun Y, 2011, MYCOSPHERE, V2, P239; Sunitha V. H., 2013, World Journal of Agricultural Sciences, V9, P1; Takahashi M, 2012, CARCINOGENESIS, V33, P2441, DOI 10.1093/carcin/bgs286; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THULIN M, 1987, Kew Bulletin, V42, P487, DOI 10.2307/4110063; Tolera M, 2013, FOREST ECOL MANAG, V304, P65, DOI 10.1016/j.foreco.2013.04.036; Ueda H, 2015, APPL MICROBIOL BIOT, V99, P6405, DOI 10.1007/s00253-015-6523-3; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Yan JF, 2015, FUNGAL ECOL, V13, P53, DOI 10.1016/j.funeco.2014.07.005; Zhao S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00024	68	72	77	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158207	10.1371/journal.pone.0158207	http://dx.doi.org/10.1371/journal.pone.0158207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359330	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200048
J	Carvalho, PS; Almeida, LR; Neto, JHA; Medina, ACQD; Menezes, ACS; Sousa, JF; Oliveira, SS; Camargo, AJ; Napolitano, HB				Carvalho, Paulo S., Jr.; Almeida, Leonardo R.; Araujo Neto, Joao H.; Medina, Ana Carolina Q. D.; Menezes, Antonio C. S.; Sousa, Jose. F.; Oliveira, Solemar S.; Camargo, Ademir J.; Napolitano, Hamilton B.			Structural and Theoretical Investigation of Anhydrous 3,4,5-Triacetoxybenzoic Acid	PLOS ONE			English	Article							GALLIC ACID; TRIMESIC ACID; CRYSTAL-STRUCTURES; PYROMELLITIC ACID; ORGANIC-SYNTHESIS; POLYMORPHISM; DENSITY; COMPLEX; SURFACE; ESTERS	A comprehensive investigation of anhydrous form of 3,4,5-Triacetoxybenzoic acid (TABA) is reported. Single crystal X-ray diffraction, Thermal analysis, Fourier Transform Infrared spectroscopy (FTIR) and DFT calculations were applied for TABA characterization. This anhydrous phase crystallizes in the triclinic P (1) over bar space group (Z' = 1) and its packing shows a supramolecular motif in a classical R-2(2)(4)ring formed by acid-acid groups association. The phase stability is accounted in terms of supramolecular architecture and its thermal behaviour. Conformation search at B3LYP/6-311++ G(2d,p) level of theory shows the existence of three stable conformers and the most stable conformation was found experimentally. The reactivity of TABA was investigated using the molecular orbital theory and molecular electrostatic potential. The calculation results were used to simulate the infrared spectrum. There is a good agreement between calculated and experimental IR spectrum, which allowed the assignment of the normal vibrational modes	[Carvalho, Paulo S., Jr.; Almeida, Leonardo R.; Medina, Ana Carolina Q. D.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Carvalho, Paulo S., Jr.; Almeida, Leonardo R.; Araujo Neto, Joao H.; Menezes, Antonio C. S.; Sousa, Jose. F.; Oliveira, Solemar S.; Camargo, Ademir J.; Napolitano, Hamilton B.] Univ Estadual Goias, Ciencias Exatas & Tecnol, BR-75132400 Anapolis, Go, Brazil; [Araujo Neto, Joao H.] Univ Fed Sao Carlos, Dept Quim, BR-13565905 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Goias; Universidade Federal de Sao Carlos	Napolitano, HB (corresponding author), Univ Estadual Goias, Ciencias Exatas & Tecnol, BR-75132400 Anapolis, Go, Brazil.	hamilton@ueg.br	Napolitano, Hamilton Barbosa/ABC-1986-2020; Oliveira, Solemar/AAP-8936-2021; CAMARGO, ADEMIR JOÃO/B-7001-2013; Carvalho Jr, Paulo S./G-8049-2016; Menezes, Antonio Carlos Severo/AAJ-7903-2021; Honorato, João/Q-1094-2019	Oliveira, Solemar/0000-0003-2892-3109; CAMARGO, ADEMIR JOÃO/0000-0001-9016-222X; Carvalho Jr, Paulo S./0000-0002-5551-9155; Menezes, Antonio Carlos Severo/0000-0001-8484-315X; Honorato, João/0000-0002-1127-6083; Almeida, Leonardo/0000-0002-6737-0642	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [313070/2014-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR) [12/05616-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 313070/2014-8 Dr. Hamilton Barbosa Napolitano and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR) 12/05616-7 Dr. Paulo S. Carvalho Jr.	Aakeroy CB, 2005, CRYSTENGCOMM, V7, P439, DOI 10.1039/b505883j; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 2009, GAUSSVIEW VERS; [Anonymous], HYPERCHEM PROF 7 5 1; [Anonymous], 2015, ADV MICROBIOLOGY, DOI [10.4236/aim.2015.57053, DOI 10.4236/AIM.2015.57053]; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERNSTEIN J, 1993, J PHYS D APPL PHYS, V26, pB66, DOI 10.1088/0022-3727/26/8B/010; Bernstein J., 2020, POLYMORPHISM MOL CRY, VVolume 30; Braun DE, 2013, CRYST GROWTH DES, V13, P19, DOI 10.1021/cg301506x; Cacialli F, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00186-5; Chen J, 2011, CRYST GROWTH DES, V11, P887, DOI 10.1021/cg101556s; Clarke HD, 2011, CRYST GROWTH DES, V11, P964, DOI 10.1021/cg2001865; Desiraju GR, 2010, J CHEM SCI, V122, P667, DOI 10.1007/s12039-010-0055-2; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Du M, 2005, CRYST GROWTH DES, V5, P1247, DOI 10.1021/cg0495680; Ermer O, 2012, HELV CHIM ACTA, V95, P872, DOI 10.1002/hlca.201200017; Frisch G. W., 2013, GAUSSIAN 09; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Hilfiker R., 2006, RELEVANCE SOLID STAT, P1; Hsu FL, 2007, APPL MICROBIOL BIOT, V74, P659, DOI 10.1007/s00253-006-0692-z; Kaur R., 2014, INT J PHARM SCI REV, V28, P16; Kaur R, 2014, CRYST GROWTH DES, V14, P423, DOI 10.1021/cg4018807; Kaur R, 2012, CRYST GROWTH DES, V12, P2744, DOI 10.1021/cg300536n; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li ZH, 2007, ACTA CRYSTALLOGR E, V63, po1167, DOI 10.1107/S1600536807004916; Locatelli C, 2013, EUR J MED CHEM, V60, P233, DOI 10.1016/j.ejmech.2012.10.056; Lu JJ, 2007, SEP PURIF TECHNOL, V55, P40, DOI 10.1016/j.seppur.2006.10.022; Lu LL, 2007, J CHEM ENG DATA, V52, P37, DOI 10.1021/je0601661; Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI [10.1107/S002188980600731X, 10.1107/S0021 88980600731X]; Mark A. S., 2013, PHYS SCR, V87, DOI 10.1088/0031-8949/87/04/048103; Martins ICB, 2016, CRYST GROWTH DES, V16, P154, DOI 10.1021/acs.cgd.5b01057; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; Miller SPFRAS, 2006, SCI CONSIDERATIONS P, P385; Nangia Ashwini, 2007, Journal of the Indian Institute of Science, V87, P133; NARAYSZABO G, 1995, CHEM REV, V95, P829, DOI 10.1021/cr00036a002; Rajput L, 2010, CRYST GROWTH DES, V10, P4565, DOI 10.1021/cg100862y; Reutzel-Edens SM, 2000, J CHEM SOC PERK T 2, V5, P913; Sartori G, 2004, CHEM REV, V104, P199, DOI 10.1021/cr0200769; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SJOBERG P, 1990, J PHYS CHEM-US, V94, P3959, DOI 10.1021/j100373a017; Spackman MA, 2002, CRYSTENGCOMM, V4, P378, DOI 10.1039/b203191b; Spackman MA, 2009, CRYSTENGCOMM, V11, P19, DOI 10.1039/b818330a; Vishweshwar P, 2006, CRYST GROWTH DES, V6, P2429, DOI 10.1021/cg060349j; Wolff S, 2007, CRYSTALEXPLORER 2 1	46	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158029	10.1371/journal.pone.0158029	http://dx.doi.org/10.1371/journal.pone.0158029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355378	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400024
J	Chang, HF; Lee, YS; Tang, TK; Cheng, JY				Chang, Hui-Fang; Lee, Ying-Shan; Tang, Tang K.; Cheng, Ji-Yen			Pulsed DC Electric Field-Induced Differentiation of Cortical Neural Precursor Cells	PLOS ONE			English	Article							NEURITE GROWTH; STEM-CELLS; PROGENITOR CELLS; RETINOIC ACID; CHICK-EMBRYO; SPINAL-CORD; IN-VIVO; SOX2; MIGRATION; NEURONS	We report the differentiation of neural stem and progenitor cells solely induced by direct current (DC) pulses stimulation. Neural stem and progenitor cells in the adult mammalian brain are promising candidates for the development of therapeutic neuroregeneration strategies. The differentiation of neural stem and progenitor cells depends on various in vivo environmental factors, such as nerve growth factor and endogenous EF. In this study, we demonstrated that the morphologic and phenotypic changes of mouse neural stem and progenitor cells (mNPCs) could be induced solely by exposure to square-wave DC pulses (magnitude 300 mV/mm at frequency of 100-Hz). The DC pulse stimulation was conducted for 48 h, and the morphologic changes of mNPCs were monitored continuously. The length of primary processes and the amount of branching significantly increased after stimulation by DC pulses for 48 h. After DC pulse treatment, the mNPCs differentiated into neurons, astrocytes, and oligodendrocytes simultaneously in stem cell maintenance medium. Our results suggest that simple DC pulse treatment could control the fate of NPCs. With further studies, DC pulses may be applied to manipulate NPC differentiation and may be used for the development of therapeutic strategies that employ NPCs to treat nervous system disorders.	[Chang, Hui-Fang; Cheng, Ji-Yen] Acad Sinica, Res Ctr Appl Sci, Taipei, Taiwan; [Lee, Ying-Shan; Tang, Tang K.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Cheng, Ji-Yen] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Cheng, Ji-Yen] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr BMIRC, Taipei, Taiwan; [Cheng, Ji-Yen] Natl Taiwan Ocean Univ, Dept Mech & Mechantron Engn, Keelung, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan Ocean University	Cheng, JY (corresponding author), Acad Sinica, Res Ctr Appl Sci, Taipei, Taiwan.; Cheng, JY (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan.; Cheng, JY (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr BMIRC, Taipei, Taiwan.; Cheng, JY (corresponding author), Natl Taiwan Ocean Univ, Dept Mech & Mechantron Engn, Keelung, Taiwan.	jycheng@gate.sinica.edu.tw	Tang, Tang K./S-7012-2018; Cheng, Ji-Yen/D-7272-2011	Tang, Tang K./0000-0002-3660-0695; Cheng, Ji-Yen/0000-0001-7623-7555	Ministry of Science and Technology, Taiwan [MOST 103-2113-M-001-003-MY2, MOST 104-2811-M-001-070]; Thematic Research Program of Academia Sinica, Taiwan [AS-104-TP-B09-1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Thematic Research Program of Academia Sinica, Taiwan(Academia Sinica - Taiwan)	The authors acknowledge financial support from Ministry of Science and Technology, Taiwan (MOST 103-2113-M-001-003-MY2 and MOST 104-2811-M-001-070) and the Thematic Research Program of Academia Sinica, Taiwan (AS-104-TP-B09-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge financial support from Ministry of Science and Technology, Taiwan (MOST 103-2113-M-001-003-MY2 and MOST 104-2811-M-001-070) and the Thematic Research Program of Academia Sinica, Taiwan (AS-104-TP-B09-1).	Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chang KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018738; Cheng JY, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2952290; CORK RJ, 1994, J NEUROBIOL, V25, P1509, DOI 10.1002/neu.480251204; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Feng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111809; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Hammerick KE, 2010, TISSUE ENG PT A, V16, P917, DOI [10.1089/ten.tea.2009.0267, 10.1089/ten.TEA.2009.0267]; Hilpert F, 2005, SCAND J IMMUNOL, V62, P399, DOI 10.1111/j.1365-3083.2005.01677.x; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; HOTARY KB, 1992, DEVELOPMENT, V114, P985; HOTARY KB, 1990, DEV BIOL, V140, P149, DOI 10.1016/0012-1606(90)90062-N; Hou HS, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4896296; Huang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025928; Kanakasabai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050500; Kim SY, 2010, J HISTOCHEM CYTOCHEM, V58, P567, DOI 10.1369/jhc.2010.955682; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Kimura K, 1998, MED BIOL ENG COMPUT, V36, P493, DOI 10.1007/BF02523221; Kindzelskii AL, 2000, BBA-MOL CELL RES, V1495, P90, DOI 10.1016/S0167-4889(99)00148-2; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Lee R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06319; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061195; Li SF, 2010, HEARING RES, V267, P111, DOI 10.1016/j.heares.2010.04.004; Lim JH, 2013, CELL REPROGRAM, V15, P405, DOI 10.1089/cell.2013.0001; Lu J, 2012, INTEGR BIOL-UK, V4, P1223, DOI 10.1039/c2ib20171b; Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mostafavi FS, 2014, INT J PREVENTIVE MED, V5, P584; NOLL E, 1994, DEVELOPMENT, V120, P649; PATEL N, 1982, J NEUROSCI, V2, P483; Pereira A, 2010, PROG NEUROBIOL, V92, P405, DOI 10.1016/j.pneurobio.2010.07.001; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Shapiro S, 2005, J NEUROSURG-SPINE, V2, P3, DOI 10.3171/spi.2005.2.1.0003; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Tsai CH, 2013, J ORTHOP RES, V31, P322, DOI 10.1002/jor.22215; Tsai HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073418; Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942	51	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158133	10.1371/journal.pone.0158133	http://dx.doi.org/10.1371/journal.pone.0158133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352251	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900035
J	Kansau, I; Barketi-Klai, A; Monot, M; Hoys, S; Dupuy, B; Janoir, C; Collignon, A				Kansau, Imad; Barketi-Klai, Amira; Monot, Marc; Hoys, Sandra; Dupuy, Bruno; Janoir, Claire; Collignon, Anne			Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis	PLOS ONE			English	Article							TOXIN-B; INCREASED SPORULATION; VIRULENCE; PROTEINS; COLONIZATION; GENES; PATHOGENESIS; ADHESIN; BINDING; LAYER	Clostridium difficile is responsible for a wide spectrum of infection from asymptomatic carriage to severe, relapsing colitis. Since 2003, C. difficile infections have increased with a higher morbidity and mortality due to the emergence of epidemic and hypervirulent C. difficile strains such as those of the epidemic lineage 027/BI/NAP1. To decipher the hypervirulence and epidemicity of 027 strains, we analyzed gene expression profiles of the R20291 027 strain using a monoxenic mouse model during the first 38h of infection. A total of 741 genes were differentially expressed during the course of infection. They are mainly distributed in functional categories involved in host adaptation. Several genes of PTS and ABC transporters were significantly regulated during the infection, underlying the ability of strain R20291 to adapt its metabolism according to nutrient availability in the digestive tract. In this animal model, despite the early sporulation process, sporulation efficiency seems to indicate that growth of R20291 vegetative cells versus spores were favored during infection. The bacterial mechanisms associated to adaptability and flexibility within the gut environment, in addition to the virulence factor expression and antibiotic resistance, should contribute to the epidemicity and hypervirulence of the C. difficile 027 strains.	[Kansau, Imad; Barketi-Klai, Amira; Hoys, Sandra; Janoir, Claire; Collignon, Anne] Univ Paris Saclay, Univ Paris 11, Unite Bacteries Pathogenes & Sante UBaPS, EA4043, F-92296 Chatenay Malabry, France; [Monot, Marc; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, 25-28 Rue Docteur Roux, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Collignon, A (corresponding author), Univ Paris Saclay, Univ Paris 11, Unite Bacteries Pathogenes & Sante UBaPS, EA4043, F-92296 Chatenay Malabry, France.	anne.collignon@u-psud.fr	Kansau, Imad/GRX-4789-2022; Monot, Marc/F-3058-2015	Kansau, Imad/0000-0002-1893-6822; Monot, Marc/0000-0003-0738-7335	EU [Health-F3-2008-223585]; Institut Pasteur; European Union [Health-F3-2008-223585]	EU(European Commission); Institut Pasteur(European Commission); European Union(European Commission)	This work was supported by EU Health-F3-2008-223585, Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Union (HEALTH-F3-2008-223585) and Institut Pasteur. The funders had no role in study design, data collection ans analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Awad MM, 2014, GUT MICROBES, V5, P579, DOI 10.4161/19490976.2014.969632; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Bouillaut L, 2015, RES MICROBIOL, V166, P375, DOI 10.1016/j.resmic.2014.10.002; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Chen JW, 2013, J PROTEOME RES, V12, P1151, DOI 10.1021/pr3007528; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Diaz-Gonzalez F, 2015, J PROTEOMICS, V123, P1, DOI 10.1016/j.jprot.2015.03.035; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Edwards AN, 2014, INFECT IMMUN, V82, P4276, DOI 10.1128/IAI.02323-14; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Govind R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002727; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knetsch CW, 2011, MICROBIOL-SGM, V157, P3113, DOI 10.1099/mic.0.051953-0; Kovacs-Simon A, 2014, J INFECT DIS, V210, P274, DOI 10.1093/infdis/jiu070; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper E J, 2007, Euro Surveill, V12, pE1; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Merrigan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078404; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Pereira FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003782; Robinson CD, 2014, INFECT IMMUN, V82, P2815, DOI 10.1128/IAI.01524-14; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Shakeri-Garakani A, 2004, MOL GENET GENOMICS, V271, P717, DOI 10.1007/s00438-004-1022-8; Stabler RA, 2010, GUT MICROBES, V1, P269, DOI 10.4161/gmic.1.4.11870; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tulli L, 2013, CELL MICROBIOL, V15, P1674, DOI 10.1111/cmi.12139; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158204	10.1371/journal.pone.0158204	http://dx.doi.org/10.1371/journal.pone.0158204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351947	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900043
J	Avery, CL; Holliday, KM; Chakladar, S; Engeda, JC; Hardy, ST; Reis, JP; Schreiner, PJ; Shay, CM; Daviglus, ML; Heiss, G; Lin, DY; Zeng, DL				Avery, Christy L.; Holliday, Katelyn M.; Chakladar, Sujatro; Engeda, Joseph C.; Hardy, Shakia T.; Reis, Jared P.; Schreiner, Pamela J.; Shay, Christina M.; Daviglus, Martha L.; Heiss, Gerardo; Lin, Dan Yu; Zeng, Donglin			Disparities in Early Transitions to Obesity in Contemporary Multi-Ethnic US Populations	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; CARDIOVASCULAR-DISEASE; AMERICAN-INDIANS; YOUNG ADULTHOOD; WEIGHT-GAIN; OVERWEIGHT; RISK; PREVALENCE; CHILDHOOD	Background Few studies have examined weight transitions in contemporary multi-ethnic populations spanning early childhood through adulthood despite the ability of such research to inform obesity prevention, control, and disparities reduction. Methods and Results We characterized the ages at which African American, Caucasian, and Mexican American populations transitioned to overweight and obesity using contemporary and nationally representative cross-sectional National Health and Nutrition Examination Survey data (n = 21,220; aged 2-80 years). Age-, sex-, and race/ethnic-specific one-year net transition probabilities between body mass index-classified normal weight, overweight, and obesity were estimated using calibrated and validated Markov-type models that accommodated complex sampling. At age two, the obesity prevalence ranged from 7.3% in Caucasian males to 16.1% in Mexican American males. For all populations, estimated one-year overweight to obesity net transition probabilities peaked at age two and were highest for Mexican American males and African American females, for whom a net 12.3%(95% CI: 7.6%-17.0%) and 11.9% (95% CI: 8.5%-15.3%) of the overweight populations transitioned to obesity by age three, respectively. However, extrapolation to the 2010 U.S. population demonstrated that Mexican American males were the only population for whom net increases in obesity peaked during early childhood; age-specific net increases in obesity were approximately constant through the second decade of life for African Americans and Mexican American females and peaked at age 20 for Caucasians. Conclusions African American and Mexican American populations shoulder elevated rates of many obesity-associated chronic diseases and disparities in early transitions to obesity could further increase these inequalities if left unaddressed.	[Avery, Christy L.; Holliday, Katelyn M.; Engeda, Joseph C.; Hardy, Shakia T.; Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Chakladar, Sujatro; Lin, Dan Yu; Zeng, Donglin] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Reis, Jared P.] NHLBI, Epidemiol Branch, Populat & Prevent Sci Program, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Shay, Christina M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Daviglus, Martha L.] Univ Illinois, Dept Med, Inst Minor Hlth Res, Chicago, IL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Avery, CL (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.	Christy_avery@unc.edu		Hardy, Shakia/0000-0001-9211-0474; Schreiner, Pamela/0000-0002-9920-6257; Holliday, Katelyn/0000-0002-2540-5974	National Heart, Lung, and Blood Institute (NHLBI) [AG0005]; University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007055, R21HL121580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007750] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was made possible in part by R21HL121580, R00HL098458, and T32HL007055. The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content.	[Anonymous], 2013, LANCET NEUROL, V12, P623, DOI 10.1016/S1474-4422(13)70137-6; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Cao Y, 2011, CANCER PREV RES, V4, P486, DOI 10.1158/1940-6207.CAPR-10-0229; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Community Preventive Services Task Force, 2014, OB PREV CONTR INT CO; Cooper R, 2000, CIRCULATION, V102, P3137; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fryar C.D., 2014, PREVALENCE OVERWEIGH; Gonzalez-Barrera A, 2013, DEMOGRAPHIC PORTRAIT; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McCullagh P, 1989, GEN LINEAR MODELS; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Passel JS, 2008, US POPULATION PROJEC; Rauscher GH, 2000, AM J EPIDEMIOL, V152, P506, DOI 10.1093/aje/152.6.506; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reis JP, 2013, JAMA-J AM MED ASSOC, V310, P280, DOI 10.1001/jama.2013.7833; Reis JP, 2013, DIABETES CARE, V36, P1241, DOI 10.2337/dc12-1714; Stenholm S, 2015, EPIDEMIOLOGY, V26, P165, DOI 10.1097/EDE.0000000000000228; Tran MK, 2016, AM J EPIDEMIOL, V183, P643, DOI 10.1093/aje/kwv233; van de Kassteele J, 2012, STAT MED, V31, P533, DOI 10.1002/sim.4423; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Zamosky Lisa, 2013, Med Econ, V90, P14; Zhang Y, 2008, CIRCULATION, V118, P1577, DOI 10.1161/CIRCULATIONAHA.108.772285	38	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158025	10.1371/journal.pone.0158025	http://dx.doi.org/10.1371/journal.pone.0158025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348868	gold, Green Submitted, Green Published			2022-12-26	WOS:000378801200028
J	Jordan, S; Giersch, JJ; Muhlfeld, CC; Hotaling, S; Fanning, L; Tappenbeck, TH; Luikart, G				Jordan, Steve; Giersch, J. Joseph; Muhlfeld, Clint C.; Hotaling, Scott; Fanning, Liz; Tappenbeck, Tyler H.; Luikart, Gordon			Loss of Genetic Diversity and Increased Subdivision in an Endemic Alpine Stonefly Threatened by Climate Change	PLOS ONE			English	Article							INDUCED RANGE CONTRACTION; EPHEMEROPTERA; BIODIVERSITY; PLECOPTERA; SOFTWARE	Much remains unknown about the genetic status and population connectivity of high-elevation and high-latitude freshwater invertebrates, which often persist near snow and ice masses that are disappearing due to climate change. Here we report on the conservation genetics of the meltwater stonefly Lednia tumana (Ricker) of Montana, USA, a cold-water obligate species. We sequenced 1530 bp of mtDNA from 116 L. tumana individuals representing "historic" (> 10 yr old) and 2010 populations. The dominant haplotype was common in both time periods, while the second-most-common haplotype was found only in historic samples, having been lost in the interim. The 2010 populations also showed reduced gene and nucleotide diversity and increased genetic isolation. We found lower genetic diversity in L. tumana compared to two other North American stonefly species, Amphinemura linda (Ricker) and Pteronarcys californica Newport. Our results imply small effective sizes, increased fragmentation, limited gene flow, and loss of genetic variation among contemporary L. tumana populations, which can lead to reduced adaptive capacity and increased extinction risk. This study reinforces concerns that ongoing glacier loss threatens the persistence of L. tumana, and provides baseline data and analysis of how future environmental change could impact populations of similar organisms.	[Jordan, Steve; Fanning, Liz] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Giersch, J. Joseph; Muhlfeld, Clint C.] US Geol Survey, Northern Rocky Mt Sci Ctr, Glacier Natl Pk, West Glacier, MT USA; [Muhlfeld, Clint C.; Tappenbeck, Tyler H.; Luikart, Gordon] Univ Montana, Flathead Lake Biol Stn, Montana Conservat Genom Lab, Div Biol Sci, Polson, MT 59860 USA; [Hotaling, Scott] Univ Kentucky, Dept Biol, Lexington, KY USA	Bucknell University; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana; University of Kentucky	Jordan, S (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	steve.jordan@bucknell.edu		Jordan, Steve/0000-0001-5949-0102	Great Northern Landscape Conservation Cooperative; United States National Science Foundation [NSF-1067613]; USGS National Climate Change and Wildlife Science Center; United States National Park Service; Bucknell University; University of Montana Flathead Lake Biological Station	Great Northern Landscape Conservation Cooperative; United States National Science Foundation(National Science Foundation (NSF)); USGS National Climate Change and Wildlife Science Center; United States National Park Service; Bucknell University; University of Montana Flathead Lake Biological Station	Funding was provided by the Great Northern Landscape Conservation Cooperative, the United States National Science Foundation (NSF-1067613 to GL), the USGS National Climate Change and Wildlife Science Center, the United States National Park Service, University of Montana Flathead Lake Biological Station, and Bucknell University.; Thanks to Jane Jordan for help with the analysis. Funding was provided by the Great Northern Landscape Conservation Cooperative, the United States National Science Foundation (NSF-1067613 to GL), the USGS National Climate Change and Wildlife Science Center, the United States National Park Service, University of Montana Flathead Lake Biological Station, and Bucknell University. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the United States Government.	Allendorf F., 2007, CONSERVATION GENETIC; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Baumann Richard W., 2010, Illiesia, V6, P315; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; DeSalle R, 2005, HEREDITY, V94, P386, DOI 10.1038/sj.hdy.6800641; Ersts PJ, 2012, GEOGRAPHIC DISTANCE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finn DS, 2006, FRESHWATER BIOL, V51, P2240, DOI 10.1111/j.1365-2427.2006.01647.x; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Finn DS, 2014, FRESHW SCI, V33, P207, DOI 10.1086/674361; Finn DS, 2010, GLOBAL CHANGE BIOL, V16, P3314, DOI 10.1111/j.1365-2486.2009.02160.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giersch JJ, 2015, FRESHW SCI, V34, P53, DOI 10.1086/679490; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Hall MHP, 2003, BIOSCIENCE, V53, P131, DOI 10.1641/0006-3568(2003)053[0131:MCIGCI]2.0.CO;2; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Hauer FR, 2007, J AM WATER RESOUR AS, V43, P104, DOI 10.1111/j.1752-1688.2007.00009.x; Jacobsen D, 2012, NAT CLIM CHANGE, V2, P361, DOI [10.1038/nclimate1435, 10.1038/NCLIMATE1435]; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kauwe JSK, 2004, J N AM BENTHOL SOC, V23, P824, DOI 10.1899/0887-3593(2004)023<0824:PANCAO>2.0.CO;2; Mantel N, 1967, CANC RES; Muhlfeld CC, 2011, CLIMATIC CHANGE, V106, P337, DOI 10.1007/s10584-011-0057-1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Rauscher SA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034424; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rubidge EM, 2012, NAT CLIM CHANGE, V2, P285, DOI 10.1038/NCLIMATE1415; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Slemmons KEH, 2013, ENVIRON SCI-PROC IMP, V15, P1794, DOI 10.1039/c3em00243h; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stark Bill P., 2013, Illiesia, V9, P101; [USFWS] United States Fish and Wildlife Service, 2012, FED REGISTER, V77, P69994; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	37	36	38	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157386	10.1371/journal.pone.0157386	http://dx.doi.org/10.1371/journal.pone.0157386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348125	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200009
J	Khan, NU; Liu, MJ; Yang, XF; Qiu, DW				Khan, Najeeb Ullah; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen			Fungal Elicitor MoHrip2 Induces Disease Resistance in Rice Leaves, Triggering Stress-Related Pathways	PLOS ONE			English	Article							ACID SIGNALING PATHWAY; PROGRAMMED CELL-DEATH; PROTEOMIC ANALYSIS; MAGNAPORTHE-ORYZAE; ABSCISIC-ACID; BLAST FUNGUS; RESPONSIVE PROTEINS; GENE-EXPRESSION; PLANTS; TOLERANCE	MoHrip2 Magnaporthe oryzae hypersensitive protein 2 is an elicitor protein of rice blast fungus M. oryzae. Rice seedlings treated with MoHrip2 have shown an induced resistance to rice blast. To elucidate the mechanism underlying this MoHrip2 elicitation in rice, we used differential-display 2-D gel electrophoresis and qRT-PCR to assess the differential expression among the total proteins extracted from rice leaves at 24 h after treatment with MoHrip2 and buffer as a control. Among similar to 1000 protein spots detected on each gel, 10 proteins were newly induced, 4 were up-regulated, and 3 were down-regulated in MoHrip2-treated samples compared with the buffer control. Seventeen differentially expressed proteins were detected using MS/MS analysis and categorized into six groups according to their putative function: defense-related transcriptional factors, signal transduction-related proteins, reactive oxygen species (ROS) production, programmed cell death (PCD), defense-related proteins, and photosynthesis and energy-related proteins. The qPCR results (relative expression level of genes) further supported the differential expression of proteins in MoHrip2-treated rice leaves identified with 2D-gel, suggesting that MoHrip2 triggers an early defense response in rice leaves via stress-related pathways, and the results provide evidence for elicitor-induced resistance at the protein level.	[Khan, Najeeb Ullah; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100081, Peoples R China; [Khan, Najeeb Ullah] Univ Agr Peshawar, Inst Biotechnol & Genet Engn, Peshawar, Pakistan	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Qiu, DW (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100081, Peoples R China.	qiudewen@caas.cn	Khan, Najeeb Ullah/AFW-4303-2022	Khan, Najeeb Ullah/0000-0003-2568-9484	National Natural Science Foundation of China [31371984]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 31371984).	Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Agrawal GK, 2006, MASS SPECTROM REV, V25, P1, DOI 10.1002/mas.20056; Baldrich Patricia, 2015, RNA Biol, V12, P847, DOI 10.1080/15476286.2015.1050577; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Chen MJ, 2014, PLANT CELL REP, V33, P1865, DOI 10.1007/s00299-014-1663-y; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037654; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Delaunois B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00249; Ding CQ, 2011, PLANT MOL BIOL REP, V29, P618, DOI 10.1007/s11105-010-0268-z; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Fan WH, 2011, J PLANT PHYSIOL, V168, P500, DOI 10.1016/j.jplph.2010.08.012; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gorg a, 2004, GE HEALTHCARE HDB, P27; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Grun S, 2006, J EXP BOT, V57, P507, DOI 10.1093/jxb/erj053; Hakeem KR, 2012, APPL BIOCHEM BIOTECH, V168, P834, DOI 10.1007/s12010-012-9823-4; Hou MM, 2012, PLANT CELL REP, V31, P895, DOI 10.1007/s00299-011-1210-z; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kim ST, 2014, PROTEOMICS, V14, P593, DOI 10.1002/pmic.201300388; Koga H, 2012, PHYSIOL MOL PLANT P, V77, P60, DOI 10.1016/j.pmpp.2011.12.001; Kuroda K, 2006, PHYSIOL MOL PLANT P, V69, P13, DOI 10.1016/j.pmpp.2006.12.003; Kuwagata T, 2012, PLANT CELL PHYSIOL, V53, P1418, DOI 10.1093/pcp/pcs087; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Li W, 2011, CELL RES, V21, P835, DOI 10.1038/cr.2011.4; Liao M, 2009, PROTEOMICS, V9, P2809, DOI 10.1002/pmic.200800192; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Mahmood T, 2009, BIOL PLANTARUM, V53, P285, DOI 10.1007/s10535-009-0052-9; Manavalan LP, 2012, J EXP BOT, V63, P163, DOI 10.1093/jxb/err258; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Obara N, 2002, BIOSCI BIOTECH BIOCH, V66, P2549, DOI 10.1271/bbb.66.2549; Patel Prabhudas S, 2005, Asian Pac J Cancer Prev, V6, P113; Rakwal R, 2002, BIOCHEM BIOPH RES CO, V295, P1041, DOI 10.1016/S0006-291X(02)00779-9; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Sharma N, 2007, PLANT SCI, V172, P95, DOI 10.1016/j.plantsci.2006.07.016; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Xie KB, 2014, PLANT CELL, V26, P3077, DOI 10.1105/tpc.114.126441; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zang X, 2007, PHYTOCHEMISTRY, V68, P426, DOI 10.1016/j.phytochem.2006.11.005	51	5	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158112	10.1371/journal.pone.0158112	http://dx.doi.org/10.1371/journal.pone.0158112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348754	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200037
J	Meehan, TL; Joudi, TF; Timmons, AK; Taylor, JD; Habib, CS; Peterson, JS; Emmanuel, S; Franc, NC; McCall, K				Meehan, Tracy L.; Joudi, Tony F.; Timmons, Allison K.; Taylor, Jeffrey D.; Habib, Corey S.; Peterson, Jeanne S.; Emmanuel, Shanan; Franc, Nathalie C.; McCall, Kimberly			Components of the Engulfment Machinery Have Distinct Roles in Corpse Processing	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; APOPTOTIC CELLS; DROSOPHILA; PHAGOCYTOSIS; RECEPTOR; INTEGRIN; DRAPER; DEGRADATION; RECOGNITION; PATHWAY	Billions of cells die in our bodies on a daily basis and are engulfed by phagocytes. Engulfment, or phagocytosis, can be broken down into five basic steps: attraction of the phagocyte, recognition of the dying cell, internalization, phagosome maturation, and acidification. In this study, we focus on the last two steps, which can collectively be considered corpse processing, in which the engulfed material is degraded. We use the Drosophila ovarian follicle cells as a model for engulfment of apoptotic cells by epithelial cells. We show that engulfed material is processed using the canonical corpse processing pathway involving the small GTPases Rab5 and Rab7. The phagocytic receptor Draper is present on the phagocytic cup and on nascent, phosphatidylinositol 3-phosphate (PI(3)P)- and Rab7-positive phagosomes, whereas integrins are maintained on the cell surface during engulfment. Due to the difference in subcellular localization, we investigated the role of Draper, integrins, and downstream signaling components in corpse processing. We found that some proteins were required for internalization only, while others had defects in corpse processing as well. This suggests that several of the core engulfment proteins are required for distinct steps of engulfment. We also performed double mutant analysis and found that combined loss of draper and alpha PS3 still resulted in a small number of engulfed vesicles. Therefore, we investigated another known engulfment receptor, Crq. We found that loss of all three receptors did not inhibit engulfment any further, suggesting that Crq does not play a role in engulfment by the follicle cells. A more complete understanding of how the engulfment and corpse processing machinery interact may enable better understanding and treatment of diseases associated with defects in engulfment by epithelial cells.	[Meehan, Tracy L.; Joudi, Tony F.; Timmons, Allison K.; Taylor, Jeffrey D.; Habib, Corey S.; Peterson, Jeanne S.; Emmanuel, Shanan; McCall, Kimberly] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Franc, Nathalie C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Boston University; Scripps Research Institute	Meehan, TL; McCall, K (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	tmeehan@bu.edu; kmccall@bu.edu	Lord, Allison/A-2990-2017	Lord, Allison/0000-0002-8412-315X; Emmanuel, Shanan/0000-0003-4571-005X	National Institute of Health [R01 GM094452, R01 GM060574, R01 AI093687]; Boston University Undergraduate Research Opportunities Programs; Boston University Summer Undergraduate Research Fellowship Program (National Science Foundation); Scripps Research Institute Advanced Discovery-Institute by Novartis; Div Of Biological Infrastructure [1262934] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060574, R01GM094452] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Undergraduate Research Opportunities Programs; Boston University Summer Undergraduate Research Fellowship Program (National Science Foundation); Scripps Research Institute Advanced Discovery-Institute by Novartis; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of Health R01 GM094452 and R01 GM060574 to KM, Boston University Undergraduate Research Opportunities Programs to JDT and CSH, Boston University Summer Undergraduate Research Fellowship Program (National Science Foundation) to SE, The Scripps Research Institute Advanced Discovery-Institute grant provided by Novartis, and a National Institute of Health grant R01 AI093687 to NCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Chen DD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003517; Cheng SY, 2015, J CELL BIOL, V210, P485, DOI 10.1083/jcb.201501038; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Etchegaray JI, 2012, DEVELOPMENT, V139, P4029, DOI 10.1242/dev.082776; Evans IR, 2015, CURR BIOL, V25, P1606, DOI 10.1016/j.cub.2015.04.037; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Fond AM, 2015, J CLIN INVEST, V125, P2748, DOI 10.1172/JCI80300; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; GIORGI F, 1976, J EMBRYOL EXP MORPH, V35, P521; Goentoro LA, 2006, GENESIS, V44, P66, DOI 10.1002/gene.20184; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Hsieh HH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002663; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lu N, 2011, MOL BIOL CELL, V22, P354, DOI 10.1091/mbc.E10-09-0756; Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245; Lu TY, 2014, P NATL ACAD SCI USA, V111, P12544, DOI 10.1073/pnas.1403450111; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mazzalupo S, 2006, CELL DEATH DIFFER, V13, P1950, DOI 10.1038/sj.cdd.4401892; Meehan TL, 2015, DIS MODEL MECH, V8, P1603, DOI 10.1242/dmm.021998; Meehan Tracy L, 2015, Methods Mol Biol, V1328, P191, DOI 10.1007/978-1-4939-2851-4_14; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nakae I, 2010, MOL BIOL CELL, V21, P2434, DOI 10.1091/mbc.E09-12-1010; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2008, OPHTHALMIC RES, V40, P120, DOI 10.1159/000119861; Nandrot EF, 2014, ADV EXP MED BIOL, V801, P77, DOI 10.1007/978-1-4614-3209-8_10; Neukomm L.J., 2014, CELL DEATH DIFFER; Nezis IP, 2000, EUR J CELL BIOL, V79, P610, DOI 10.1078/0171-9335-00088; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Nonaka S, 2013, J BIOL CHEM, V288, P10374, DOI 10.1074/jbc.M113.451427; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Penberthy Kristen K, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS259, DOI 10.1513/AnnalsATS.201405-200AW; Peterson JS, 2003, DEV BIOL, V260, P113, DOI 10.1016/S0012-1606(03)00240-9; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Sarkissian T, 2014, METHODS, V68, P89, DOI 10.1016/j.ymeth.2014.02.033; Sasaki A, 2013, MOL BIOL CELL, V24, P1584, DOI 10.1091/mbc.E12-08-0628; Shandala Tetyana, 2013, Cells, V2, P188, DOI 10.3390/cells2020188; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; Timmons A. K., 2015, PHAGOCYTOSIS GENES J; Van Goethem E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031488; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Xiao H, 2009, MOL BIOL CELL, V20, P21, DOI 10.1091/mbc.E08-04-0441; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901; Ziegenfuss JS, 2012, NAT NEUROSCI, V15, P979, DOI 10.1038/nn.3135	62	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158217	10.1371/journal.pone.0158217	http://dx.doi.org/10.1371/journal.pone.0158217			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347682	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200051
J	Nantongo, JS; Eilu, G; Geburek, T; Schueler, S; Konrad, H				Nantongo, Judith Ssali; Eilu, Gerald; Geburek, Thomas; Schueler, Silvio; Konrad, Heino			Detection of Self Incompatibility Genotypes in Prunus africana: Characterization, Evolution and Spatial Analysis	PLOS ONE			English	Article							S-ALLELE DIVERSITY; LANNESIANA VAR. SPECIOSA; GENETIC-STRUCTURE; SWEET CHERRY; AVIUM L.; REPRODUCTIVE SUCCESS; POPULATION-GENETICS; MATE AVAILABILITY; POLLEN LIMITATION; RNASE ALLELES	In flowering plants, self-incompatibility is an effective genetic mechanismthat prevents self-fertilization. Most Prunus tree species exhibit a homomorphic gametophytic self-incompatibility (GSI) system, in which the pollen phenotype is encoded by its own haploid genome. To date, no identification of S-alleles had been done in Prunus africana, the only member of the genus in Africa. To identify S-RNase alleles and hence determine S-genotypes in African cherry (Prunus africana) from Mabira Forest Reserve, Uganda, primers flanking the first and second intron were designed and these amplified two bands in most individuals. PCR bands on agarose indicated 26 and 8 different S-alleles for second and first intron respectively. Partial or full sequences were obtained for all these fragments. Comparison with published S-RNase data indicated that the amplified products were S-RNase alleles with very high interspecies homology despite the high intraspecific variation. Against expectations for a locus under balancing selection, frequency and spatial distribution of the alleles in a study plot was not random. Implications of the results to breeding efforts in the species are discussed, and mating experiments are strongly suggested to finally prove the functionality of SI in P. africana.	[Nantongo, Judith Ssali] Natl Forestry Resources Res Inst, Mukono, Uganda; [Eilu, Gerald] Makerere Univ, Kampala, Uganda; [Geburek, Thomas; Schueler, Silvio; Konrad, Heino] Austrian Fed Off & Res Ctr Forests BFW, Vienna, Austria	Makerere University	Nantongo, JS (corresponding author), Natl Forestry Resources Res Inst, Mukono, Uganda.	jsnantongo@yahoo.com	Schueler, Silvio/V-2612-2019; Konrad, Heino/ABH-1018-2021	Schueler, Silvio/0000-0003-0155-5692; Konrad, Heino/0000-0003-1820-9550	Austrian Development Agency	Austrian Development Agency	This research was funded by the Austrian Development Agency. It is the result of a collaboration between Bioversity International and the Federal Research and Training Centre for Forests, Natural Hazards and Landscape (BFW) in Austria, and of a partnership with the School of Forestry, Environmental and Geographical Sciences of Makerere University within the framework of the project 'Development of strategies for the conservation and sustainable use of Prunus africana to improve the livelihood of small-scale farmers.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Appreciation goes to all the reviewers, for the constructive criticisms. Thanks go to Dr. Samson Gwali of the National Forestry Resources Research Institute (NaFORRI), Caroline Kadu, Thomas Thalmayr and all the colleagues in BFW lab for their valuable contributions. This research was funded by the Austrian Development Agency. It is the result of a collaboration between Bioversity International and the Federal Research and Training Centre for Forests, Natural Hazards and Landscape (BFW) in Austria, and of a partnership with the School of Forestry, Environmental and Geographical Sciences of Makerere University within the framework of the project 'Development of strategies for the conservation and sustainable use of Prunus africana to improve the livelihood of small-scale farmers.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens DG, 2014, HEREDITY, V113, P401, DOI 10.1038/hdy.2014.40; Brooks RJ, 1996, HEREDITY, V76, P367, DOI 10.1038/hdy.1996.54; Castric V, 2004, MOL ECOL, V13, P2873, DOI 10.1111/j.1365-294X.2004.02267.x; Charlesworth D, 2005, NEW PHYTOL, V168, P61, DOI 10.1111/j.1469-8137.2005.01443.x; Cunningham M, 1997, TRADE PRUNUS AFRICAN; Doligez A, 1998, GENETICS, V148, P905; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ganopoulos I, 2012, TREE GENET GENOMES, V8, P1181, DOI 10.1007/s11295-012-0504-9; Glemin S, 2008, CONSERV BIOL, V22, P216, DOI 10.1111/j.1523-1739.2007.00864.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hoebee SE, 2012, J HERED, V103, P260, DOI 10.1093/jhered/esr126; Holderegger R, 2008, EVOLUTION, V62, P2922, DOI 10.1111/j.1558-5646.2008.00498.x; Kadu CAC, 2011, MOL ECOL, V20, P165, DOI 10.1111/j.1365-294X.2010.04931.x; Kato S, 2004, HEREDITY, V92, P249, DOI 10.1038/sj.hdy.6800403; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langdale-Brown I., 1964, VEGETATION UGANDA IT, DOI DOI 10.1017/S0376892903000341; Larsen B, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0448-0; Lawrence MJ, 2000, ANN BOT-LONDON, V85, P221, DOI 10.1006/anbo.1999.1044; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Ortega E, 2006, MOL GENET GENOMICS, V276, P413, DOI 10.1007/s00438-006-0146-4; Raspe O, 2002, HEREDITY, V88, P458, DOI 10.1038/sj.hdy.6800079; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Sanzol J, 2009, TREE GENET GENOMES, V5, P393, DOI 10.1007/s11295-008-0194-5; Schueler S, 2006, MOL ECOL, V15, P3231, DOI 10.1111/j.1365-294X.2006.03029.x; Shuri K, 2012, HEREDITY, V109, P188, DOI 10.1038/hdy.2012.29; Simons A. J., 1998, HerbalGram, P49; Sonneveld T, 2003, THEOR APPL GENET, V107, P1059, DOI 10.1007/s00122-003-1274-4; Stoeckel S, 2008, J EVOLUTION BIOL, V21, P889, DOI 10.1111/j.1420-9101.2008.01504.x; Suarez-Gonzalez A, 2014, ANN BOT-LONDON, V113, P595, DOI 10.1093/aob/mct289; Surbanovski N, 2007, PLANT J, V50, P723, DOI 10.1111/j.1365-313X.2007.03085.x; Sutherland BG, 2004, PLANT BREEDING, V123, P582, DOI 10.1111/j.1439-0523.2004.01016.x; Sutherland BG, 2008, MOL GENET GENOMICS, V279, P95, DOI 10.1007/s00438-007-0300-7; Tao R, 1999, J AM SOC HORTIC SCI, V124, P224, DOI 10.21273/JASHS.124.3.224; Thompson JD, NUCL ACIDS RES, V24, P4876; Ushijima K, 1998, GENE, V211, P159, DOI 10.1016/S0378-1119(98)00105-X; Vekemans X, 1998, EVOLUTION, V52, P19, DOI 10.2307/2410916; Vieira J, 2008, J MOL EVOL, V67, P179, DOI 10.1007/s00239-008-9137-x; Wagenius S, 2007, AM NAT, V169, P383, DOI 10.1086/511313; Wiersma PA, 2001, THEOR APPL GENET, V102, P700, DOI 10.1007/s001220051700; Wright S, 1939, GENETICS, V24, P538; Yaegaki H, 2001, SEX PLANT REPROD, V13, P251, DOI 10.1007/s004970100064; Yamane H, 2000, J HORTIC SCI BIOTECH, V75, P562, DOI 10.1080/14620316.2000.11511286; Young AG, 2012, ANN BOT-LONDON, V109, P643, DOI 10.1093/aob/mcr290	46	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0155638	10.1371/journal.pone.0155638	http://dx.doi.org/10.1371/journal.pone.0155638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348423	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200001
J	Faridi, RM; Kemp, TJ; Dharmani-Khan, P; Lewis, V; Tripathi, G; Rajalingam, R; Daly, A; Berka, N; Storek, J; Khan, FM				Faridi, Rehan Mujeeb; Kemp, Taylor J.; Dharmani-Khan, Poonam; Lewis, Victor; Tripathi, Gaurav; Rajalingam, Raja; Daly, Andrew; Berka, Noureddine; Storek, Jan; Khan, Faisal Masood			Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ACUTE MYELOGENOUS LEUKEMIA; BONE-MARROW-TRANSPLANTATION; IMMUNOGLOBULIN-LIKE RECEPTORS; NATURAL-KILLER-CELLS; ANTITHYMOCYTE GLOBULIN; ALLOGENEIC TRANSPLANTATION; UNRELATED TRANSPLANTATION; IMMUNE RECONSTITUTION; MYELOID-LEUKEMIA	Background Allogeneic hematopoietic cell transplantation (HCT) can be curative for many hematologic diseases. However, complications such as graft-versus-host disease (GVHD) and relapse of primary malignancy remain significant and are the leading causes of morbidity and mortality. Effects of killer Ig-like receptors (KIR)-influenced NK cells on HCT outcomes have been extensively pursued over the last decade. However, the relevance of the reported algorithms on HLA matched myeloablative HCT with rabbit antithymocyte globulin (ATG) is used for GVHD prophylaxis remains elusive. Here we examined the role of KIR and KIR-ligands of donor-recipient pairs in modifying the outcomes of ATG conditioned HLA matched sibling and unrelated donor HCT Methods and Findings The study cohort consisted of 281 HLA matched sibling and unrelated donor-recipient pairs of first allogeneic marrow or blood stem cell transplantation allocated into 'discovery' (135 pairs) and 'validation' (146 pairs) cohorts. High resolution HLA typing was obtained from the medical charts and KIR gene repertoires were obtained by a Luminex (R) based SSO method. All surviving patients were followed-up for a minimum of two years. KIR and HLA class I distributions of HCT pairs were stratified as per applicable definitions and were tested for their association with cause specific outcomes [ acute GVHD grade II-IV (aGVHD), chronic GVHD needing systemic therapy (cGVHD) and relapse] using a multivariate competing risks regression model as well as with survival outcomes [relapse-free survival (RFS), cGVHD & relapse free survival (cGRFS) and overall survival (OS)] by multivariate Cox proportional hazards regression model. A significant association between KIR genotype mismatching (KIR-B/x donor into KIR-AA recipient or vice versa) and cGVHD was found in both discovery (p = 0.001; SHR = 2.78; 95% CI: 1.50-5.17) and validation cohorts (p = 0.005; SHR = 2.61; 95% CI: 1.33-5.11). High incidence of cGVHD associated with KIR genotype mismatching was applicable to both sibling and unrelated donors and was specific to recipients who had one or two C1 bearing HLA-C epitopes (HLA-C1/x, p = 0.001; SHR = 2.40; 95% CI: 1.42-4.06). When compared with KIR genotype mismatched transplants, HLA-C1/x patients receiving grafts from KIR genotype matched donors had a significantly improved cGRFS (p = 0.013; HR = 1.62; 95% CI: 1.11-2.39). Although there was no effect of KIR genotype matching on survival outcomes, a significantly reduced incidence of relapse (p = 0.001; SHR = 0.22; 95% CI: 0.10-0.54) and improved relapse-free survival (p = 0.038; HR = 0.40; 95% CI: 0.17-0.95) was observed with one or more missing ligands for donor inhibitory KIR among the recipients of unrelated donor transplants. Conclusions The present study for the first time presents the beneficial effects of KIR genotype matching in reducing cGVHD in myeloablative transplant setting using HLA matched (sibling and unrelated) donors. The findings offer a clinically applicable donor selection strategy that can help control cGVHD without affecting the risk of relapse and/or identify patients at a high risk of developing cGVHD as potential candidates for preemptive therapy. The findings also affirm the beneficial effect of one or more missing inhibitory KIR ligands in the recipient in reducing relapse and improving a relapse free survival in unrelated donor transplants.	[Faridi, Rehan Mujeeb; Kemp, Taylor J.; Dharmani-Khan, Poonam; Tripathi, Gaurav; Berka, Noureddine; Storek, Jan; Khan, Faisal Masood] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Lewis, Victor] Univ Calgary, Alberta Childrens Hosp, Dept Oncol & Pediat, Sect Pediat Oncol Blood & Marrow Transplant, Calgary, AB, Canada; [Rajalingam, Raja] Univ Calif San Francisco, Dept Surg, Immunogenet & Transplantat Lab, San Francisco, CA USA; [Daly, Andrew; Storek, Jan] Foothills Prov Gen Hosp, Dept Med, Calgary, AB T2N 2T9, Canada; [Daly, Andrew; Storek, Jan] Foothills Prov Gen Hosp, Dept Oncol, Calgary, AB T2N 2T9, Canada; [Daly, Andrew; Storek, Jan] Tom Baker Canc Clin, Calgary, AB, Canada; [Berka, Noureddine; Khan, Faisal Masood] Univ Calgary, Calgary Lab Serv, Calgary, AB, Canada	University of Calgary; Alberta Childrens Hospital; University of Calgary; University of California System; University of California San Francisco; University of Calgary; University of Calgary; Tom Baker Cancer Clinic; University of Calgary; University of Calgary	Khan, FM (corresponding author), Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.; Khan, FM (corresponding author), Univ Calgary, Calgary Lab Serv, Calgary, AB, Canada.	fkhan@ucalgary.ca		Daly, Andrew/0000-0001-7513-1062; Tripathi, Gaurav/0000-0002-1820-6547	Alberta Innovates-health solution; Alberta Children's Hospital Foundation (ACHF fund) [RF-CAC002]; Calgary Laboratory Services; Barb Ibbotson ACHF Chair in Pediatric Hematology Award; Alberta Cancer Foundation; Buckley family foundation grant	Alberta Innovates-health solution; Alberta Children's Hospital Foundation (ACHF fund); Calgary Laboratory Services; Barb Ibbotson ACHF Chair in Pediatric Hematology Award; Alberta Cancer Foundation; Buckley family foundation grant	The study was funded in part by Alberta Innovates-health solution: http://www.aihealthsolutions.ca (JS), Alberta Children's Hospital Foundation: http://www.childrenshospital.ab.ca/ (FMK; ACHF fund: RF-CAC002), and Calgary Laboratory Services (FMK). FMK is a recipient of Barb Ibbotson ACHF Chair in Pediatric Hematology Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by Alberta Innovates-health solution, Alberta Children Hospital Foundation, Alberta Cancer Foundation, Calgary Laboratory Services and Buckley family foundation grant. FMK is a recipient of Barb Ibbotson ACHF Chair in Pediatric Hematology Award. Abstracts from this work (RMF) have been recognized by several conference awards including the 2013 American society of Hematology (ASH) Abstract Achievement Award, 2014 American society for Histocompatibility and Immunogenetics (ASHI) award for 'Most clinically relevant poster' and various other travel awards.	Asai O, 1998, J CLIN INVEST, V101, P1835, DOI 10.1172/JCI1268; Bosch M, 2012, CYTOTHERAPY, V14, P1258, DOI 10.3109/14653249.2012.715243; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Chang YJ, 2008, BIOL BLOOD MARROW TR, V14, P323, DOI 10.1016/j.bbmt.2007.12.497; Chen C, 2006, BONE MARROW TRANSPL, V38, P437, DOI 10.1038/sj.bmt.1705468; Clausen J, 2007, CLIN EXP IMMUNOL, V148, P520, DOI 10.1111/j.1365-2249.2007.03360.x; Clausen J, 2010, BIOL BLOOD MARROW TR, V16, P273, DOI 10.1016/j.bbmt.2009.10.021; Cook MA, 2004, BLOOD, V103, P1521, DOI 10.1182/blood-2003-02-0438; Cooley S, 2014, J IMMUNOL, V192, P4592, DOI 10.4049/jimmunol.1302517; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Dabas R, 2016, BIOL BLOOD MARROW TR, V22, P815, DOI 10.1016/j.bbmt.2016.01.002; Daly A, 2012, BIOL BLOOD MARROW TR, V18, P1921, DOI 10.1016/j.bbmt.2012.07.017; Enderlein G, 1984, BIOMETRICAL J, V29, P114; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foley B, 2011, BLOOD, V118, P2784, DOI 10.1182/blood-2011-04-347070; Giebel S, 2005, BRIT J HAEMATOL, V131, P483, DOI 10.1111/j.1365-2141.2005.05797.x; Giebel S, 2010, BONE MARROW TRANSPL, V45, P1022, DOI 10.1038/bmt.2009.384; Giebel S, 2009, EUR J HAEMATOL, V83, P343, DOI 10.1111/j.1600-0609.2009.01280.x; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Grullich C, 2009, BIOL BLOOD MARROW TR, V15, P173, DOI 10.1016/j.bbmt.2008.11.014; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Hoegh-Petersen M, 2012, CYTOTHERAPY, V14, P194, DOI 10.3109/14653249.2011.634402; Holtan SG, 2015, BLOOD; Kim DH, 2005, EUR J HAEMATOL, V75, P299, DOI 10.1111/j.1600-0609.2005.00514.x; Kim HJ, 2007, TRANSPLANTATION, V84, P1082, DOI 10.1097/01.tp.0000285918.72930.35; Kroger N, 2006, TRANSPLANTATION, V82, P1024, DOI 10.1097/01.tp.0000235859.24513.43; Kuan A., PHASE 3 STUDY US ATG; Landgren O, 2009, BLOOD, V113, P4992, DOI 10.1182/blood-2008-09-178046; Leung W, 2004, J IMMUNOL, V172, P644, DOI 10.4049/jimmunol.172.1.644; Lim ABM, 2015, BONE MARROW TRANSPL, V50, P566, DOI 10.1038/bmt.2014.313; Mancusi A, 2015, BLOOD, V125, P3173, DOI 10.1182/blood-2014-09-599993; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; McQueen KL, 2007, HUM IMMUNOL, V68, P309, DOI 10.1016/j.humimm.2007.01.019; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Olson JA, 2010, BLOOD, V115, P4293, DOI 10.1182/blood-2009-05-222190; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Podgorny PJ, 2014, BIOL BLOOD MARROW TR, V20, P450, DOI 10.1016/j.bbmt.2014.01.002; Pratt LM, 2013, BONE MARROW TRANSPL, V48, P722, DOI 10.1038/bmt.2012.210; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Rajalingam Raja, 2012, Methods Mol Biol, V882, P391, DOI 10.1007/978-1-61779-842-9_23; Roy DC, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.38.38; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Russell JA, 2007, BIOL BLOOD MARROW TR, V13, P299, DOI 10.1016/j.bbmt.2006.10.017; Schellekens J, 2008, MOL IMMUNOL, V45, P981, DOI 10.1016/j.molimm.2007.07.040; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Shah NN, 2015, BLOOD, V125, P784, DOI 10.1182/blood-2014-07-592881; Shilling HG, 2003, BLOOD, V101, P3730, DOI 10.1182/blood-2002-08-2568; Storek J, 2015, BIOL BLOOD MARROW TR, V21, P959, DOI 10.1016/j.bbmt.2014.11.676; Stringaris K, 2010, BIOL BLOOD MARROW TR, V16, P1257, DOI 10.1016/j.bbmt.2010.03.004; Thomas ED., 2009, THOMAS HEMATOPOIETIC; Ugarte-Torres A, 2011, BIOL BLOOD MARROW TR, V17, P574, DOI 10.1016/j.bbmt.2010.07.020; Vago L, 2008, BLOOD, V112, P3488, DOI 10.1182/blood-2007-07-103325; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503; WEIDEN PL, 1981, NEW ENGL J MED, V304, P1529, DOI 10.1056/NEJM198106183042507; Williamson PR, 2007, BIOSTATISTICS, V8, P689; Winter CC, 1998, J IMMUNOL, V161, P571; Witt CS, 2009, CURR OPIN IMMUNOL, V21, P531, DOI 10.1016/j.coi.2009.08.004; Wu S, 2015, TRANSPL P, V47, P558, DOI 10.1016/j.transproceed.2015.01.017; Yabe T, 2008, BIOL BLOOD MARROW TR, V14, P75, DOI 10.1016/j.bbmt.2007.09.012; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463	68	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158242	10.1371/journal.pone.0158242	http://dx.doi.org/10.1371/journal.pone.0158242			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341514	Green Published, gold			2022-12-26	WOS:000378393600042
J	Fillenberg, SB; Friess, MD; Korner, S; Bockmann, RA; Muller, YA				Fillenberg, Simon B.; Friess, Mario D.; Koerner, Samuel; Boeckmann, Rainer A.; Muller, Yves A.			Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors	PLOS ONE			English	Article							GNTR-FAMILY; TRANSCRIPTION FACTORS; BINDING; RECOGNITION; SYSTEM; GENES; MODEL; METABOLISM; INDUCTION; MECHANISM	Small molecule effectors regulate gene transcription in bacteria by altering the DNA-binding affinities of specific repressor proteins. Although the GntR proteins represent a large family of bacterial repressors, only little is known about the allosteric mechanism that enables their function. DasR from Streptomyces coelicolor belongs to the GntR/HutC subfamily and specifically recognises operators termed DasR-responsive elements (dre-sites). Its DNA-binding properties are modulated by phosphorylated sugars. Here, we present several crystal structures of DasR, namely of dimeric full-length DasR in the absence of any effector and of only the effector-binding domain (EBD) of DasR without effector or in complex with glucosamine-6-phosphate (GlcN-6-P) and N-acetylglucosamine-6-phosphate (GlcNAc-6-P). Together with molecular dynamics (MD) simulations and a comparison with other GntR/HutC family members these data allowed for a structural characterisation of the different functional states of DasR. Allostery in DasR and possibly in many other GntR/HutC family members is best described by a conformational selection model. In ligand-free DasR, an increased flexibility in the EBDs enables the attached DNA-binding domains (DBD) to sample a variety of different orientations and among these also a DNA-binding competent conformation. Effector binding to the EBDs of DasR significantly reorganises the atomic structure of the latter. However, rather than locking the orientation of the DBDs, the effector-induced formation of beta-strand beta* in the DBD-EBD-linker segment merely appears to take the DBDs 'on a shorter leash' thereby impeding the 'downwards' positioning of the DBDs that is necessary for a concerted binding of two DBDs of DasR to operator DNA.	[Fillenberg, Simon B.; Koerner, Samuel; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Div Biotechnol, Henkestr 91, D-91052 Erlangen, Germany; [Friess, Mario D.; Boeckmann, Rainer A.] Univ Erlangen Nurnberg, Dept Biol, Computat Biol Grp, Staudtstr 5, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Biotechnol, Henkestr 91, D-91052 Erlangen, Germany.	yves.muller@fau.de	Muller, Yves A/R-5397-2016; Böckmann, Rainer A/G-7863-2015	Muller, Yves A/0000-0003-0519-8928; Böckmann, Rainer A/0000-0002-9325-5162	Deutsche Forschungsgemeinschaft, DFG [Mu1477/6-3]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft, DFG (grant Mu1477/6-3, http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLISON SL, 1990, J BACTERIOL, V172, P5470, DOI 10.1128/jb.172.9.5470-5476.1990; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aravind L, 2003, FEMS MICROBIOL LETT, V222, P17, DOI 10.1016/S0378-1097(03)00242-8; Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colson S, 2007, J MOL MICROB BIOTECH, V12, P60, DOI 10.1159/000096460; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Denker K, 2005, J MOL BIOL, V352, P534, DOI 10.1016/j.jmb.2005.07.025; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fillenberg SB, 2015, NUCLEIC ACIDS RES, V43, P1283, DOI 10.1093/nar/gku1374; Gebhard S, 2014, J BACTERIOL, V196, P3472, DOI 10.1128/JB.01965-14; Gorelik M, 2006, PROTEIN SCI, V15, P1506, DOI 10.1110/ps.062146906; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; McCammon JA., 1987, DYNAMICS PROTEINS NU; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murphy FV, 2000, STRUCT FOLD DES, V8, pR83, DOI 10.1016/S0969-2126(00)00126-X; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Resch M, 2008, NUCLEIC ACIDS RES, V36, P4390, DOI 10.1093/nar/gkn400; Resch M, 2010, NUCLEIC ACIDS RES, V38, P2485, DOI 10.1093/nar/gkp1191; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sevvana M, 2012, J MOL BIOL, V416, P46, DOI 10.1016/j.jmb.2011.12.008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Swiatek MA, 2012, J BACTERIOL, V194, P1136, DOI 10.1128/JB.06370-11; Swiatek-Polatynska MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122479; Tenconi E, 2015, BIOCHEM BIOPH RES CO, V464, P324, DOI 10.1016/j.bbrc.2015.06.152; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	60	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157691	10.1371/journal.pone.0157691	http://dx.doi.org/10.1371/journal.pone.0157691			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337024	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200033
J	Pongsakul, N; Vinaiphat, A; Chanchaem, P; Fong-ngern, K; Thongboonkerd, V				Pongsakul, Nutkridta; Vinaiphat, Arada; Chanchaem, Prangwalai; Fong-ngern, Kedsarin; Thongboonkerd, Visith			Lamin A/C in renal tubular cells is important for tissue repair, cell proliferation, and calcium oxalate crystal adhesion, and is associated with potential crystal receptors	FASEB JOURNAL			English	Article						kidney stone; LMNA; nephrolithiasis; prevention; protein network	NUCLEAR; PROTEINS; SURFACE; IDENTIFICATION; NESPRIN-2; MEMBRANE; GROWTH	A previous study reported that lamin A/C (LMNA) expression was increased in renal tubular cells adhered with calcium oxalate monohydrate (COM) crystals; however, its functional significance in kidney stone disease remained unknown. In the present study, increased levels of LMNA and its partner, nesprin-1 (SYNE1), in Madin-Darby canine kidney cells upon COM crystal adhesion were confirmed by Western blotting and immunofluorescence staining. LMNA was then knocked down by small interfering RNA. Immunofluorescence staining confirmed the efficiency of small interfering RNA of LMNA (si-LMNA), which also reduced expression of its partner, SYNE1. Scratch assay and total cell count revealed defects in tissue repair and cell proliferation, respectively, whereas cell death quantitation showed no cytotoxicity in si-LMNA-transfected cells. Crystal-binding assay highlighted the role of LMNA in crystal adhesion, whereas protein network analysis revealed interactions between LMNA and potential COM crystal receptors. Their associations were confirmed by reduced levels of these proteins, including vimentin, tubulin, enolase, S100, and annexin A2, in si-LMNA-transfected cells. These data have demonstrated for the first time, to our knowledge, that LMNA in renal tubular cells is important for tissue repair, cell proliferation, and COM crystal adhesion and is associated with potential COM crystal receptors. Therefore, LMNA may serve as a potential target for prevention of kidney stone disease and its recurrence.	Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, Bangkok, Thailand; Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Thongboonkerd, V (corresponding author), Siriraj Hosp, Off Res & Dev, Med Prote Unit, SiMR Bldg 6th Floor,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009	Thongboonkerd, Visith/0000-0001-7865-0765	Mahidol University research grant; Mahidol University; Thailand Research Fund [RTA5680004]; Chalermphrakiat and Research Staff grants; Faculty of Medicine Siriraj Hospital; Office of the Higher Education Commission	Mahidol University research grant; Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF)); Chalermphrakiat and Research Staff grants; Faculty of Medicine Siriraj Hospital; Office of the Higher Education Commission	This work was supported by a Mahidol University research grant, Office of the Higher Education Commission, and Mahidol University under the National Research Universities Initiative and The Thailand Research Fund (RTA5680004). V.T. received Chalermphrakiat and Research Staff grants, and K.F. and P.C. are supported by Faculty of Medicine Siriraj Hospital. The authors declare no conflicts of interest.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Farell G, 2004, J AM SOC NEPHROL, V15, P3052, DOI 10.1097/01.ASN.0000144205.49134.64; Favale NO, 2007, BIOCHEM BIOPH RES CO, V364, P443, DOI 10.1016/j.bbrc.2007.10.054; Fong-ngern K, 2011, J PROTEOME RES, V10, P4463, DOI 10.1021/pr2006878; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Kanlaya R, 2013, J PROTEOMICS, V80, P55, DOI 10.1016/j.jprot.2013.01.001; Khatau SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00488; KOK DJ, 1994, KIDNEY INT, V46, P847, DOI 10.1038/ki.1994.341; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Lieske JC, 1996, SEMIN NEPHROL, V16, P458; Mandel N, 1996, SEMIN NEPHROL, V16, P364; Nikolova-Krstevski V, 2011, J MOL CELL CARDIOL, V50, P479, DOI 10.1016/j.yjmcc.2010.12.001; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Rodriguez Luis G., 2004, V294, P23; Semangoen T, 2008, PROTEOM CLIN APPL, V2, P1099, DOI 10.1002/prca.200780136; Skvortsov S, 2011, J PROTEOME RES, V10, P259, DOI 10.1021/pr100921j; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thongboonkerd V, 2006, CLIN CHIM ACTA, V367, P120, DOI 10.1016/j.cca.2005.11.033; Thongboonkerd V, 2008, J UROLOGY, V179, P1615, DOI 10.1016/j.juro.2007.11.041; Verkoelen CF, 1999, KIDNEY INT, V55, P1426, DOI 10.1046/j.1523-1755.1999.00383.x; Verkoelen CF, 2000, KIDNEY INT, V58, P1045, DOI 10.1046/j.1523-1755.2000.00262.x	26	23	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3368	3377		10.1096/fj.201600426R	http://dx.doi.org/10.1096/fj.201600426R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27358390				2022-12-26	WOS:000384329800009
J	Di Sebastiano, AR; Fahim, S; Dunn, HA; Walther, C; Ribeiro, FM; Cregan, SP; Angers, S; Schmid, S; Ferguson, SSG				Di Sebastiano, Andrea R.; Fahim, Sandra; Dunn, Henry A.; Walther, Cornelia; Ribeiro, Fabiola M.; Cregan, Sean P.; Angers, Stephane; Schmid, Susanne; Ferguson, Stephen S. G.			Role of Spinophilin in Group I Metabotropic Glutamate Receptor Endocytosis, Signaling, and Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; endocytosis; extracellular-signal-regulated kinase (ERK); glutamate receptor; receptor regulation	PHOSPHORYLATION-INDEPENDENT REGULATION; LONG-TERM DEPRESSION; BETA-GAMMA-SUBUNITS; PROTEIN PHOSPHATASE-1; CELL-SURFACE; DESENSITIZATION; BINDING; VITRO; INTERNALIZATION; INTERACTS	Activation of Group I metabotropic glutamate receptors (mGluRs) activates signaling cascades, resulting in calcium release from intracellular stores, ERK1/2 activation, and long term changes in synaptic activity that are implicated in learning, memory, and neurodegenerative diseases. As such, elucidating the molecular mechanisms underlying Group I mGluR signaling is important for understanding physiological responses initiated by the activation of these receptors. In the current study, we identify the multifunctional scaffolding protein spinophilin as a novel Group I mGluR-interacting protein. We demonstrate that spinophilin interacts with the C-terminal tail and second intracellular loop of Group I mGluRs. Furthermore, we show that interaction of spinophilin with Group I mGluRs attenuates receptor endocytosis and phosphorylation of ERK1/2, an effect that is dependent upon the interaction of spinophilin with the C-terminal PDZ binding motif encoded by Group I mGluRs. Spinophilin knock-out results in enhanced mGluR5 endocytosis as well as increased ERK1/2, AKT, and Ca2+ signaling in primary cortical neurons. In addition, the loss of spinophilin expression results in impaired mGluR5-stimulated LTD. Our results indicate that spinophilin plays an important role in regulating the activity of Group I mGluRs as well as their influence on synaptic activity.	[Di Sebastiano, Andrea R.; Fahim, Sandra; Walther, Cornelia; Cregan, Sean P.] Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, London, ON N6A 3K7, Canada; [Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, ICB, BR-31270901 Belo Horizonte, MG, Brazil; [Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Angers, Stephane] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 3M2, Canada; [Schmid, Susanne; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada; [Dunn, Henry A.] Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Dr, Ottawa, ON K1H 8M5, Canada; [Ferguson, Stephen S. G.] Heart & Stroke Fdn Ontario, Ottawa, ON, Canada; [Ferguson, Stephen S. G.] Tier 1 Canada Res Chair Brain & Mind, Ottawa, ON, Canada	Western University (University of Western Ontario); Universidade Federal de Minas Gerais; University of Toronto; University of Toronto; Western University (University of Western Ontario); University of Ottawa	Ferguson, SSG (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Dr, Ottawa, ON K1H 8M5, Canada.	sferguso@uottawa.ca	Schmid, Susanne/J-3201-2012; Angers, Stephane/E-1432-2014; Ribeiro, Fabiola/E-8831-2013	Schmid, Susanne/0000-0001-5366-8061; Angers, Stephane/0000-0001-7241-9044; Ribeiro, Fabiola/0000-0001-7042-9433; Dunn, Henry A./0000-0002-2543-4740	Canadian Institutes of Health Research Grant [MOP-119437]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-119437 (to S. S. G. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Bhattacharya M, 2004, J NEUROSCI, V24, P8752, DOI 10.1523/JNEUROSCI.3155-04.2004; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; Cheng S, 2010, J NEUROCHEM, V112, P588, DOI 10.1111/j.1471-4159.2009.06454.x; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; de Azua IR, 2012, FASEB J, V26, P4275, DOI 10.1096/fj.12-204644; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dingledine R, 1999, PHARMACOL REV, V51, P7; Esseltine JL, 2013, MOL PHARMACOL, V83, P770, DOI 10.1124/mol.112.081695; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferguson Stephen S. G., 2003, V237, P121; Fourla DD, 2012, CELL SIGNAL, V24, P2315, DOI 10.1016/j.cellsig.2012.08.002; Hamilton A, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0107-0; Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mao LM, 2008, NEUROPHARMACOLOGY, V55, P403, DOI 10.1016/j.neuropharm.2008.05.034; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; Pignatelli M, 2014, J NEUROSCI, V34, P4558, DOI 10.1523/JNEUROSCI.1846-13.2014; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; Raka F, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0111-4; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	46	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17602	17615		10.1074/jbc.M116.722355	http://dx.doi.org/10.1074/jbc.M116.722355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358397	Green Published, hybrid			2022-12-26	WOS:000383241300012
J	Millena, AC; Vo, BT; Khan, SA				Millena, Ana Cecilia; Vo, BaoHan T.; Khan, Shafiq A.			JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor- (TGF-)-induced Inhibition of Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 transcription factor (AP-1); cell proliferation; prostate cancer; protein degradation; transforming growth factor beta (TGF-B)	NF-KAPPA-B; BETA SIGNALING PATHWAY; TRANSCRIPTION FACTOR AP-1; RECEPTOR-TYPE-II; TGF-BETA; C-JUN; ACTIVATOR PROTEIN-1; ANDROGEN RECEPTOR; INTERLEUKIN-6 EXPRESSION; MALIGNANT PROSTATE	TGF- inhibits proliferation of prostate epithelial cells. However, prostate cancer cells in advanced stages become resistant to inhibitory effects of TGF-. The intracellular signaling mechanisms involved in differential effects of TGF- during different stages are largely unknown. Using cell line models, we have shown that TGF- inhibits proliferation in normal (RWPE-1) and prostate cancer (DU145) cells but does not have any effect on proliferation of prostate cancer (PC3) cells. We have investigated the role of Jun family proteins (c-Jun, JunB, and JunD) in TGF- effects on cell proliferation. Jun family members were expressed at different levels and responded differentially to TGF- treatment. TGF- effects on JunD protein levels, but not mRNA levels, correlated with its effects on cell proliferation. TGF- induced significant reduction in JunD protein in RWPE-1 and DU145 cells but not in PC3 cells. Selective knockdown of JunD expression using siRNA in DU145 and PC3 cells resulted in significant reduction in cell proliferation, and forced overexpression of JunD increased the proliferation rate. On the other hand, knockdown of c-Jun or JunB had little, if any, effect on cell proliferation; overexpression of c-Jun and JunB decreased the proliferation rate in DU145 cells. Further studies showed that down-regulation of JunD in response to TGF- treatment is mediated via the proteasomal degradation pathway. In conclusion, we show that specific Jun family members exert differential effects on proliferation in prostate cancer cells in response to TGF-, and inhibition of cell proliferation by TGF- requires degradation of JunD protein.	[Millena, Ana Cecilia; Vo, BaoHan T.; Khan, Shafiq A.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA; [Vo, BaoHan T.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	Clark Atlanta University; St Jude Children's Research Hospital	Khan, SA (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA.	skhan@cau.edu			NIMHD, National Institutes of Health [G12MD007590, 5P20MD002285]; National Institute on Minority Health and Health Disparities [G12MD007590, P20MD002285] Funding Source: NIH RePORTER	NIMHD, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIMHD, National Institutes of Health, Grants G12MD007590 and 5P20MD002285. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Axmann A, 1998, BIOCHEM BIOPH RES CO, V249, P456, DOI 10.1006/bbrc.1998.9188; Barrack ER, 1997, PROSTATE, V31, P61; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Chakrabarti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083521; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Church DR, 2005, PROSTATE, V63, P155, DOI 10.1002/pros.20172; De Boeck M, 2012, UPSALA J MED SCI, V117, P153, DOI 10.3109/03009734.2012.654858; Desruisseau S, 1996, INT J CANCER, V66, P796, DOI 10.1002/(SICI)1097-0215(19960611)66:6<796::AID-IJC15>3.0.CO;2-1; Deziel BA, 2010, J CELL BIOCHEM, V111, P742, DOI 10.1002/jcb.22761; Djonov V, 1997, INT J ONCOL, V11, P1185; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Feng ZW, 1998, ONCOGENE, V17, P2593, DOI 10.1038/sj.onc.1202195; Fitzgerald KA, 2014, EXPERT OPIN THER TAR, V18, P633, DOI 10.1517/14728222.2014.896904; FitzGerald UF, 2000, MOL CELL NEUROSCI, V16, P453, DOI 10.1006/mcne.2000.0886; Gohla G, 2008, J CELL BIOCHEM, V104, P850, DOI 10.1002/jcb.21669; Gunthert AR, 2002, BIOCHEM BIOPH RES CO, V294, P11, DOI 10.1016/S0006-291X(02)00427-8; Han SH, 1998, J PHARMACOL EXP THER, V287, P1105; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hirota Y, 2000, OSTEOARTHR CARTILAGE, V8, P241, DOI 10.1053/joca.1999.0297; Hogan KA, 2013, CYTOKINE, V64, P652, DOI 10.1016/j.cyto.2013.09.004; Hung SH, 2009, J AGR FOOD CHEM, V57, P1291, DOI 10.1021/jf8032683; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jacobs-Helber SM, 1998, MOL CELL BIOL, V18, P3699, DOI 10.1128/MCB.18.7.3699; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Johnson Aaron N., 2002, TheScientificWorldJOURNAL, V2, P892; Kajanne R, 2009, INT J ONCOL, V35, P1175, DOI 10.3892/ijo_00000434; Kang DC, 1998, INT J ONCOL, V13, P1117; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim IY, 1998, CLIN CANCER RES, V4, P1625; Kizu R, 2003, ARCH TOXICOL, V77, P335, DOI 10.1007/s00204-003-0454-y; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Krosl J, 2000, ONCOGENE, V19, P5134, DOI 10.1038/sj.onc.1203897; Kumano M, 2008, BRIT J CANCER, V98, P356, DOI 10.1038/sj.bjc.6604169; Kwon GT, 2009, J NUTR BIOCHEM, V20, P663, DOI 10.1016/j.jnutbio.2008.06.005; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lee C, 1999, PROSTATE, V39, P285; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; LOKESHWAR BL, 1992, CANCER RES, V52, P5821; Mashimo T, 2000, BIOCHEM BIOPH RES CO, V274, P370, DOI 10.1006/bbrc.2000.3139; McDonald CA, 2006, MOL ENDOCRINOL, V20, P608, DOI 10.1210/me.2005-0245; Meggiato T, 2003, PANCREAS, V26, P65, DOI 10.1097/00006676-200301000-00011; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Mehraein-Ghomi F, 2010, CANCER RES, V70, P4560, DOI 10.1158/0008-5472.CAN-09-3596; Moreno CS, 2010, AM J PATHOL, V176, P518, DOI 10.2353/ajpath.2010.090657; Nyhan KC, 2010, BBA-MOL CELL RES, V1803, P1386, DOI 10.1016/j.bbamcr.2010.09.001; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Parra E, 2011, INT J MOL MED, V28, P847, DOI 10.3892/ijmm.2011.745; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Qu X, 2014, J INVEST DERMATOL, V134, P159, DOI 10.1038/jid.2013.281; SEGARINI PR, 1991, CIBA F SYMP, V157, P29; Selvaraj N, 2015, MOL CELL BIOL, V35, P88, DOI 10.1128/MCB.00982-14; Seystahl K, 2015, NEURO-ONCOLOGY, V17, P254, DOI 10.1093/neuonc/nou218; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; Song K, 2006, J BIOL CHEM, V281, P7765, DOI 10.1074/jbc.M511781200; Strong N, 2013, PROSTATE, V73, P624, DOI 10.1002/pros.22603; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Vanhara P, 2007, BIOCHEM BIOPH RES CO, V353, P92, DOI 10.1016/j.bbrc.2006.11.124; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Vo BT, 2012, CARCINOGENESIS, V33, P2054, DOI 10.1093/carcin/bgs252; Vo BT, 2011, PROSTATE, V71, P1084, DOI 10.1002/pros.21326; Walker L, 2013, CLIN EXP METASTAS, V30, P13, DOI 10.1007/s10585-012-9494-0; WARE JL, 1993, CANCER METAST REV, V12, P287, DOI 10.1007/BF00665959; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wikstrom P, 1999, UROL RES, V27, P185, DOI 10.1007/s002400050108; Williams RH, 1996, CLIN CANCER RES, V2, P635; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; Yamaguchi Y, 1992, Nihon Rinsho, V50, P1932; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Zerbini LF, 2003, CANCER RES, V63, P2206; Zerbini LF, 2011, CELL CYCLE, V10, P2583, DOI 10.4161/cc.10.15.16057; Zhang F, 2003, EXP CELL RES, V291, P275, DOI 10.1016/j.yexcr.2003.07.007; Zhou W, 2003, ENDOCRINOLOGY, V144, P4280, DOI 10.1210/en.2003-0554; Zhou W, 2002, LIFE SCI, V72, P11, DOI 10.1016/S0024-3205(02)02183-5	88	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17964	17976		10.1074/jbc.M116.714899	http://dx.doi.org/10.1074/jbc.M116.714899			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358408	Green Published, hybrid			2022-12-26	WOS:000383241300039
J	Miner, GE; Starr, ML; Hurst, LR; Sparks, RP; Padolina, M; Fratti, RA				Miner, Gregory E.; Starr, Matthew L.; Hurst, Logan R.; Sparks, Robert P.; Padolina, Mark; Fratti, Rutilio A.			The Central Polybasic Region of the Soluble SNARE (Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor) Vam7 Affects Binding to Phosphatidylinositol 3-Phosphate by the PX (Phox Homology) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium transport; diacylglycerol; membrane fusion; phosphatidic acid; phosphatidylinositol; SNARE proteins; HOPS; ycf1	HOMOTYPIC VACUOLE FUSION; VERTEX RING DOMAIN; MEMBRANE-FUSION; YEAST VACUOLE; SACCHAROMYCES-CEREVISIAE; REGULATORY LIPIDS; COMPLEX; DOCKING; HOPS; HEMIFUSION	The yeast vacuole requires four SNAREs to trigger membrane fusion including the soluble Qc-SNARE Vam7. The N-terminal PX domain of Vam7 binds to the lipid phosphatidylinositol 3-phosphate (PI3P) and the tethering complex HOPS (homotypic fusion and vacuole protein sorting complex), whereas the C-terminal SNARE motif forms SNARE complexes. Vam7 also contains an uncharacterized middle domain that is predicted to be a coiled-coil domain with multiple helices. One helix contains a polybasic region (PBR) composed of Arg-164, Arg-168, Lys-172, Lys-175, Arg-179, and Lys-186. Polybasic regions are often associated with nonspecific binding to acidic phospholipids including phosphoinositides. Although the PX (phox homology) domain alone binds PI3P, we theorized that the Vam7 PBR could bind to additional acidic phospholipids enriched at fusion sites. Mutating each of the basic residues in the PBR to an alanine (Vam7-6A) led to attenuated vacuole fusion. The defective fusion of Vam7-6A was due in part to inefficient association with its cognate SNAREs and HOPS, yet the overall vacuole association of Vam7-6A was similar to wild type. Experiments testing the binding of Vam7 to specific signaling lipids showed that mutating the PBR to alanines augmented binding to PI3P. The increased binding to PI3P by Vam7-6A likely contributed to the observed wild type levels of vacuole association, whereas protein-protein interactions were diminished. PI3P binding was inhibited when the PX domain mutant Y42A was introduced into Vam7-6A to make Vam7-7A. Thus the Vam7 PBR affects PI3P binding by the PX domain and in turn affects binding to SNAREs and HOPS to support efficient fusion.	[Miner, Gregory E.; Starr, Matthew L.; Hurst, Logan R.; Sparks, Robert P.; Padolina, Mark; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, Roger Adams Lab 419, B-4,600 S Mathews Ave, Urbana, IL 61801 USA.	rfratti@illinois.edu		Sparks, Robert/0000-0002-0485-8317; Miner, Gregory/0000-0002-1124-4217	National Institutes of Health [GM101132]; NIGMS, National Institutes of Health Chemistry-Biology Interface Training Grant [5T32-GM070421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, R01GM101132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health Chemistry-Biology Interface Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101132 (to R. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, National Institutes of Health Chemistry-Biology Interface Training Grant 5T32-GM070421.	Boal F, 2015, J CELL SCI, V128, P815, DOI 10.1242/jcs.166314; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Fang J, 2007, BIOPHYS J, V93, P1809, DOI 10.1529/biophysj.106.100834; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hawkins PT, 2016, BIOCHEM SOC T, V44, P307, DOI 10.1042/BST20150248; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Karunakaran S, 2013, TRAFFIC, V14, P650, DOI 10.1111/tra.12064; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lawrence G, 2014, MOL BIOL CELL, V25, P1608, DOI 10.1091/mbc.E13-08-0460; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nigorikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111698; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Reese C, 2005, J CELL BIOL, V171, P981, DOI 10.1083/jcb.200510018; Roberts RL, 1999, J CELL SCI, V112, P3667; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sasser TL, 2013, J BIOL CHEM, V288, P18300, DOI 10.1074/jbc.M112.441089; Sasser TL, 2012, BIOCHEM J, V448, P365, DOI 10.1042/BJ20120847; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Xu H, 2012, P NATL ACAD SCI USA, V109, P17936, DOI 10.1073/pnas.1216201109	50	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17651	17663		10.1074/jbc.M116.725366	http://dx.doi.org/10.1074/jbc.M116.725366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365394	hybrid, Green Published			2022-12-26	WOS:000383241300016
J	Yu, M; Jiang, MX; Chen, YL; Zhang, S; Zhang, WW; Yang, XX; Li, XJ; Li, Y; Duan, SZ; Han, JH; Duan, YJ				Yu, Miao; Jiang, Meixiu; Chen, Yuanli; Zhang, Shuang; Zhang, Wenwen; Yang, Xiaoxiao; Li, Xiaoju; Li, Yan; Duan, Shengzhong; Han, Jihong; Duan, Yajun			Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; cholesterol; lipoprotein metabolism; lipoprotein receptor; macrophage; CD36; ERK1; 2; PPAR; tamoxifen	B SCAVENGER RECEPTOR; INTIMA-MEDIA THICKNESS; REGULATES EXPRESSION; ENDOTHELIAL FUNCTION; INSULIN-RESISTANCE; LESION DEVELOPMENT; ATHEROSCLEROSIS; GAMMA; THERAPY; LIGAND	Macrophage CD36 binds and internalizes oxidized low density lipoprotein (oxLDL) to facilitate foam cell formation. CD36 expression is activated by peroxisome proliferator-activated receptor (PPAR). Tamoxifen, an anti-breast cancer medicine, has demonstrated pleiotropic functions including cardioprotection with unfully elucidated mechanisms. In this study, we determined that treatment of ApoE-deficient mice with tamoxifen reduced atherosclerosis, which was associated with decreased CD36 and PPAR expression in lesion areas. At the cellular level, we observed that tamoxifen inhibited CD36 protein expression in human THP-1 monocytes, THP-1/PMA macrophages, and human blood monocyte-derived macrophages. Associated with decreased CD36 protein expression, tamoxifen reduced cellular oxLDL accumulation in a CD36-dependent manner. At the transcriptional level, tamoxifen decreased CD36 mRNA expression, promoter activity, and the binding of the PPAR response element in CD36 promoter to PPAR protein. Tamoxifen blocked ligand-induced PPAR nuclear translocation and CD36 expression, but it increased PPAR phosphorylation, which was due to that tamoxifen-activated ERK1/2. Furthermore, deficiency of PPAR expression in macrophages abolished the inhibitory effect of tamoxifen on CD36 expression or cellular oxLDL accumulation both in vitro and in vivo. Taken together, our study demonstrates that tamoxifen inhibits CD36 expression and cellular oxLDL accumulation by inactivating the PPAR signaling pathway, and the inhibition of macrophage CD36 expression can be attributed to the anti-atherogenic properties of tamoxifen.	[Yu, Miao; Zhang, Shuang; Zhang, Wenwen; Yang, Xiaoxiao; Li, Xiaoju; Li, Yan; Han, Jihong; Duan, Yajun] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Yuanli] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Sch Med, Tianjin 300071, Peoples R China; [Han, Jihong; Duan, Yajun] Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Jiang, Meixiu] Nanchang Univ, Inst Translat Med, Nanchang 330000, Peoples R China; [Chen, Yuanli; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Coll Biomed Engn, Hefei 230009, Peoples R China; [Duan, Shengzhong] Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	Nankai University; Nankai University; Nankai University; Nanchang University; Hefei University of Technology; Chinese Academy of Sciences	Duan, YJ (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy, Coll Life Sci, Tianjin 300071, Peoples R China.; Duan, YJ (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Duan, YJ (corresponding author), Hefei Univ Technol, Coll Biomed Engn, Hefei 230009, Peoples R China.; Han, JH (corresponding author), Hefei Univ Technol, Coll Biomed Engn, 193 Tongxi Rd, Hefei 230000, Peoples R China.	hanjihong2015@hfut.edu.cn; yduan@hfut.edu.cn			National Science Foundation of China [81473204, 81573427, 31400694]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; 111 Project [B08011]; International Science & Technology Cooperation Program of China [2015DFA30430]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); International Science & Technology Cooperation Program of China	This work was supported in part by National Science Foundation of China Grants 81473204 (to J.H.), 81573427 (to Y.D.), and 31400694 (to Y.C.), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13023) and 111 Project Grant B08011 (to J.H.), and the International Science & Technology Cooperation Program of China Grant 2015DFA30430 (to J.H., Y.D., and Y.C.). The authors declare no conflicts of interest with the contents of this article.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Clarke SC, 2001, CIRCULATION, V103, P1497; Dong PZ, 2011, ATHEROSCLEROSIS, V218, P435, DOI 10.1016/j.atherosclerosis.2011.06.048; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GRAINGER DJ, 1995, NAT MED, V1, P1067, DOI 10.1038/nm1095-1067; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han JH, 1999, J LIPID RES, V40, P830; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang MX, 2013, BIOCHEM J, V454, P467, DOI 10.1042/BJ20130580; Jordan VC, 2007, STEROIDS, V72, P7, DOI 10.1016/j.steroids.2006.10.009; Jordan VC, 2014, ENDOCR-RELAT CANCER, V21, pR235, DOI 10.1530/ERC-14-0092; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SX, 2010, NAT REV ENDOCRINOL, V6, P485, DOI 10.1038/nrendo.2010.92; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nicholson AC, 2001, ANN NY ACAD SCI, V947, P224; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Reckless J, 1997, CIRCULATION, V95, P1542; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simon T, 2002, CIRCULATION, V106, P2925, DOI 10.1161/01.CIR.0000041044.93571.CA; Stamatelopoulos KS, 2004, AM HEART J, V147, P1093, DOI 10.1016/j.ahj.2003.12.029; Suarez Y, 2004, CARDIOVASC RES, V64, P346, DOI 10.1016/j.cardiores.2004.06.024; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang C, 2014, BIOCHEM BIOPH RES CO, V447, P57, DOI 10.1016/j.bbrc.2014.03.103; Wasan KM, 1997, J PHARM SCI, V86, P876, DOI 10.1021/js970097w; Williams JK, 1997, ARTERIOSCL THROM VAS, V17, P403, DOI 10.1161/01.ATV.17.2.403; Yang XX, 2015, J BIOL CHEM, V290, P21788, DOI 10.1074/jbc.M115.654582	46	34	37	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16977	16989		10.1074/jbc.M116.740092	http://dx.doi.org/10.1074/jbc.M116.740092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358406	hybrid, Green Published			2022-12-26	WOS:000382643800005
J	Kumara, PM; Srimany, A; Arunan, S; Ravikanth, G; Shaanker, RU; Pradeep, T				Kumara, Patel Mohana; Srimany, Amitava; Arunan, Suganya; Ravikanth, Gudasalamani; Shaanker, Ramanan Uma; Pradeep, Thalappil			Desorption Electrospray Ionization (DESI) Mass Spectrometric Imaging of the Distribution of Rohitukine in the Seedling of Dysoxylum binectariferum Hook. F	PLOS ONE			English	Article							III POLYKETIDE SYNTHASE; SECONDARY METABOLITES; PENTAKETIDE CHROMONE; PLANT METABOLITES; KINASE INHIBITOR; FLAVOPIRIDOL; BIOSYNTHESIS; TRANSPORT; ALKALOIDS; LEAVES	Ambient ionization mass spectrometric imaging of all parts of the seedling of Dysoxylum binectariferum Hook. f (Meliaceae) was performed to reconstruct the molecular distribution of rohitukine (Rh) and related compounds. The species accumulates Rh, a prominent chromone alkaloid, in its seeds, fruits, and stem bark. Rh possesses anti- inflammatory, anticancer, and immuno-modulatory properties. Desorption electrospray ionization mass spectrometry imaging (DESI MSI) and electrospray ionization (ESI) tandem mass spectrometry (MS/MS) analysis detected Rh as well as its glycosylated, acetylated, oxidized, and methoxylated analogues. Rh was predominantly distributed in the main roots, collar region of the stem, and young leaves. In the stem and roots, Rh was primarily restricted to the cortex region. The identities of the metabolites were assigned based on both the fragmentation patterns and exact mass analyses. We discuss these results, with specific reference to the possible pathways of Rh biosynthesis and translocation during seedling development in D. binectariferum.	[Kumara, Patel Mohana; Srimany, Amitava; Arunan, Suganya; Pradeep, Thalappil] Indian Inst Technol Madras, DST Unit Nanosci, Dept Chem, Chennai 600036, Tamil Nadu, India; [Kumara, Patel Mohana; Srimany, Amitava; Arunan, Suganya; Pradeep, Thalappil] Indian Inst Technol Madras, Themat Unit Excellence, Dept Chem, Chennai 600036, Tamil Nadu, India; [Ravikanth, Gudasalamani; Shaanker, Ramanan Uma] Univ Agr Sci, GKVK, Sch Ecol & Conservat, Dept Crop Physiol, Bengaluru 560065, India; [Ravikanth, Gudasalamani; Shaanker, Ramanan Uma] Ashoka Trust Res Ecol & Environm, Jakkur 560064, Bengaluru, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; University of Agricultural Sciences Bangalore	Pradeep, T (corresponding author), Indian Inst Technol Madras, DST Unit Nanosci, Dept Chem, Chennai 600036, Tamil Nadu, India.; Pradeep, T (corresponding author), Indian Inst Technol Madras, Themat Unit Excellence, Dept Chem, Chennai 600036, Tamil Nadu, India.	pradeep@iitm.ac.in	G, Ravikanth/AAI-5668-2020	G, Ravikanth/0000-0002-9399-8580; Dalisay, Doralyn/0000-0003-2850-7797; Pradeep, T./0000-0003-3174-534X	Department of Science and Technology (DST); SERB-DST Fast Track grant [SB/YS/LS-361/2013]; Department of Biotechnology (DBT), Government of India	Department of Science and Technology (DST)(Department of Science & Technology (India)); SERB-DST Fast Track grant; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	Department of Science and Technology (DST), SERB-DST Fast Track grant (File No. SB/YS/LS-361/2013) and Department of Biotechnology (DBT), Government of India supported to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2005, J AM CHEM SOC, V127, P1362, DOI 10.1021/ja0431206; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bjarnholt N, 2014, NAT PROD REP, V31, P818, DOI 10.1039/c3np70100j; Cabral EC, 2013, J AM SOC MASS SPECTR, V24, P956, DOI 10.1007/s13361-013-0616-y; Dalisay DS, 2015, J NAT PROD, V78, P1231, DOI 10.1021/acs.jnatprod.5b00023; Gamble J. S, 1997, FLORA PRESIDENCY MAD, VI-III; HARMON AD, 1979, TETRAHEDRON LETT, P721, DOI 10.1016/S0040-4039(01)93556-7; Hemalatha RG, 2013, J AGR FOOD CHEM, V61, P7477, DOI 10.1021/jf4011998; HERBERT RB, 1995, NAT PROD REP, V12, P445, DOI 10.1039/np9951200445; HOUGHTON PJ, 1987, PLANTA MED, P262, DOI 10.1055/s-2006-962698; Houghton PJ., 2002, J CHROMATOGRAPHY A, V967; Ifa DR, 2011, ANAL METHODS-UK, V3, P1910, DOI 10.1039/c1ay05295k; Ismail IS, 2009, J NAT PROD, V72, P1879, DOI 10.1021/np9003849; Jain SK, 2012, MINI-REV MED CHEM, V12, P632; Jain SK, 2013, TETRAHEDRON LETT, V54, P7140, DOI 10.1016/j.tetlet.2013.10.096; Khadem S, 2012, MOLECULES, V17, P191, DOI 10.3390/molecules17010191; Korte AR, 2012, ANAL METHODS-UK, V4, P474, DOI 10.1039/c2ay05618f; Kueger S, 2012, PLANT J, V70, P39, DOI 10.1111/j.1365-313X.2012.04902.x; Kumara PM, 2015, PHYTOCHEMISTRY, V116, P104, DOI 10.1016/j.phytochem.2015.02.031; Kumara PM, 2014, PHYTOMEDICINE, V21, P541, DOI 10.1016/j.phymed.2013.09.019; Kumara PM, 2012, ANTON LEEUW INT J G, V101, P323, DOI 10.1007/s10482-011-9638-2; Lee YJ, 2012, PLANT J, V70, P81, DOI 10.1111/j.1365-313X.2012.04899.x; Li B, 2013, INT J MASS SPECTROM, V348, P15, DOI 10.1016/j.ijms.2013.04.018; Li B, 2013, PLANT J, V74, P1059, DOI 10.1111/tpj.12183; Mahajan V, 2015, PHARM BIOL, V53, P446, DOI 10.3109/13880209.2014.923006; Manske R.H., 1987, ALKALOIDS CHEM PHARM, V31, P123; Marques JV, 2014, MOL BIOSYST, V10, P2838, DOI 10.1039/c4mb00403e; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Mohana Kumara P., 2012, ASSESSING THE GENETI; Mohanakumara P, 2010, FITOTERAPIA, V81, P145, DOI 10.1016/j.fitote.2009.08.010; Morita H, 2007, ACTA CRYSTALLOGR F, V63, P947, DOI 10.1107/S1744309107047069; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; NAIK RG, 1988, TETRAHEDRON, V44, P2081, DOI 10.1016/S0040-4020(01)90352-7; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Petrussa E, 2013, INT J MOL SCI, V14, P14950, DOI 10.3390/ijms140714950; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Sethi P, 2012, J TROP ECOL, V28, P531, DOI 10.1017/S0266467412000648; Sirikantaramas S, 2007, PHYTOCHEMISTRY, V68, P2881, DOI 10.1016/j.phytochem.2007.08.028; Sirikantaramas Supaart, 2008, Phytochemistry Reviews, V7, P467, DOI 10.1007/s11101-007-9080-2; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Stadler WM, 2000, J CLIN ONCOL, V18, P371, DOI 10.1200/JCO.2000.18.2.371; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Velho N, 2009, J TROP ECOL, V25, P507, DOI 10.1017/S0266467409990083; Yang DH, 2004, J ASIAN NAT PROD RES, V6, P233, DOI 10.1080/10286020310001608930; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8	48	13	14	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158099	10.1371/journal.pone.0158099	http://dx.doi.org/10.1371/journal.pone.0158099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362422	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200040
J	Magalhaes, AFB; de Camargo, GMF; Fernandes, GA; Gordo, DGM; Tonussi, RL; Costa, RB; Espigolan, R; Silva, RMD; Bresolin, T; de Andrade, WBF; Takada, L; Feitosa, FLB; Baldi, F; Carvalheiro, R; Chardulo, LAL; de Albuquerque, LG				Magalhaes, Ana F. B.; de Camargo, Gregorio M. F.; Fernandes Junior, Gerardo A.; Gordo, Daniel G. M.; Tonussi, Rafael L.; Costa, Raphael B.; Espigolan, Rafael; Silva, Rafael M. de O.; Bresolin, Tiago; de Andrade, Willian B. F.; Takada, Luciana; Feitosa, Fabieli L. B.; Baldi, Fernando; Carvalheiro, Roberto; Chardulo, Luis A. L.; de Albuquerque, Lucia G.			Genome-Wide Association Study of Meat Quality Traits in Nellore Cattle	PLOS ONE			English	Article							INTRAMUSCULAR FAT DEPOSITION; LOCI AFFECTING GROWTH; BOS-TAURUS; CARCASS COMPOSITION; GENETIC EVALUATION; FULL PEDIGREE; BEEF; EXPRESSION; TENDERNESS; WEIGHT	The objective of this study was to identify genomic regions that are associated with meat quality traits in the Nellore breed. Nellore steers were finished in feedlots and slaughtered at a commercial slaughterhouse. This analysis included 1,822 phenotypic records of tenderness and 1,873 marbling records. After quality control, 1,630 animals genotyped for tenderness, 1,633 animals genotyped for marbling, and 369,722 SNPs remained. The results are reported as the proportion of variance explained by windows of 150 adjacent SNPs. Only windows with largest effects were considered. The genomic regions were located on chromosomes 5, 15, 16 and 25 for marbling and on chromosomes 5, 7, 10, 14 and 21 for tenderness. These windows explained 3,89% and 3,80% of the additive genetic variance for marbling and tenderness, respectively. The genes associated with the traits are related to growth, muscle development and lipid metabolism. The study of these genes in Nellore cattle is the first step in the identification of causal mutations that will contribute to the genetic evaluation of the breed.	[Magalhaes, Ana F. B.; de Camargo, Gregorio M. F.; Fernandes Junior, Gerardo A.; Gordo, Daniel G. M.; Tonussi, Rafael L.; Costa, Raphael B.; Espigolan, Rafael; Silva, Rafael M. de O.; Bresolin, Tiago; de Andrade, Willian B. F.; Takada, Luciana; Feitosa, Fabieli L. B.; Baldi, Fernando; Carvalheiro, Roberto; de Albuquerque, Lucia G.] Fac Ciencias Agr & Vet, Dept Zootecnia, Jaboticabal, SP, Brazil; [Carvalheiro, Roberto; Chardulo, Luis A. L.; de Albuquerque, Lucia G.] Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Brasilia, DF, Brazil; [Chardulo, Luis A. L.] Fac Med Vet & Zootecnia, Dept Melhoramento & Nutr Anim, Botucatu, SP, Brazil; [de Camargo, Gregorio M. F.] Univ Tecnol Parana, Dois Vizinhos, Parana, Brazil; [Costa, Raphael B.] Univ Fed Bahia, Dept Med Vet Prevent & Prod Anim, Salvador, BA, Brazil	Universidade Estadual Paulista; Universidade Federal da Bahia	de Albuquerque, LG (corresponding author), Fac Ciencias Agr & Vet, Dept Zootecnia, Jaboticabal, SP, Brazil.; de Albuquerque, LG (corresponding author), Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Brasilia, DF, Brazil.	lgalb@fcav.unesp.br	Carvalheiro, Roberto/AAG-2222-2020; Carvalheiro, Roberto/I-2239-2013; Albuquerque, Lucia/A-7402-2013; Camargo, Gregorio M. F./J-9511-2016; Baldi, Fernando/E-5492-2012; Espigolan, Rafael/E-6255-2017; Chardulo, Luis Artur/ABF-3928-2020; Feitosa, Fabieli L. B./D-4996-2014; Magalhães, Ana Fabrícia Braga/GLQ-5906-2022; Costa, Raphael Bermal/AAK-3528-2021	Carvalheiro, Roberto/0000-0002-4506-0555; Carvalheiro, Roberto/0000-0002-4506-0555; Albuquerque, Lucia/0000-0002-2030-7590; Baldi, Fernando/0000-0003-4094-2011; Espigolan, Rafael/0000-0003-2586-1643; Chardulo, Luis Artur/0000-0003-2656-1562; Feitosa, Fabieli L. B./0000-0003-4218-0348; de Camargo, Gregorio Miguel Ferreira/0000-0002-8736-5576	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/21969-7, 2009/16118-5]	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo < http://www.fapesp.br/>) for the first author's scholarship (No 2012/21969-7) and for funding this study (No 2009/16118-5).	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Barendse W, 2001, PLOSONE, V6; Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bressan MC, 2011, REV BRAS ZOOTECN, V40, P1250, DOI 10.1590/S1516-35982011000600013; Casas E, 2000, J ANIM SCI, V78, P560; Casas E, 1998, J ANIM SCI, V76, P468; Casas E, 2001, J ANIM SCI, V79, P854; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Cheng KKY, 2014, DIABETES, V63, P3748, DOI 10.2337/db14-0337; Cheong HS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-33; Davis GP, 2008, ANIM GENET, V39, P40, DOI 10.1111/j.1365-2052.2007.01677.x; de Castro LM, 2014, REV CIENC AGRON, V45, P393, DOI 10.1590/S1806-66902014000200022; De Lemos MVA, 2015, P 24 C AS LAT AM PRO; Eom GH, 2011, J BIOL CHEM, V286, P34733, DOI 10.1074/jbc.M110.203307; Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4; Fernandes Junior GA., 2015, THESIS; de Camargo GMF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1595-0; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Godoy TF, 2015, ANIM GENET, V46, P158, DOI 10.1111/age.12271; Hirschhorn JN., 2005, NATURE, V6; Hoshiba H, 2013, ANIM SCI J, V84, P529, DOI 10.1111/asj.12033; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Koohmaraie M, 1996, MEAT SCI, V43, pS193, DOI 10.1016/0309-1740(96)00065-4; Lee SH, 2013, PLOS ONE, V8, P10, DOI DOI 10.1371/J0URNAL.P0NE.0074677; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Loch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075716; Luo QB, 2014, GENE, V546, P200, DOI 10.1016/j.gene.2014.06.017; Maltin C, 2003, P NUTR SOC, V62, P337, DOI 10.1079/PNS2003248; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Misztal I, 2012, BLUPF90 A FLEXIBLE M; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; OConnor SF, 1997, J ANIM SCI, V75, P1822; Pinto LFB, 2010, GENET MOL RES, V9, P1431, DOI 10.4238/vol9-3gmr881; Primeaux SD, 2013, DIGEST DIS SCI, V58, P72, DOI 10.1007/s10620-012-2421-z; Ramayo-Caldas Y, 2014, J ANIM SCI, V92, P2832, DOI 10.2527/jas.2013-7484; Riley DG, 2013, LIVEST SCI, V155, P186, DOI 10.1016/j.livsci.2013.05.022; Russell PJ, 2007, BIOLOGY THE DYNAMIC, P400; Ryan MJ, 2008, HEPATOLOGY; SAATCHI M, 2014, BMC GENOMICS, V0015; Sharma A, 2014, ANIM GENET, V45, P863, DOI 10.1111/age.12204; Smith TPL, 2000, J ANIM SCI, V78, P2589; Terakado APN, 2015, THESIS; Thu NT D, 2006, SCIENCE TECHNOLOGY D, V9; Tizioto PC, 2013, PHYSIOL GENOMICS, V45, P1012, DOI 10.1152/physiolgenomics.00066.2013; Tonussi RL, 2015, GENET MOL RES, V14, P18713, DOI 10.4238/2015.December.28.20; United States Departament of Agriculture, 2000, U S STANDARDS FOR GR; USDA, 2014, LIV POULTR WORLD MAR; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; von der Heyde S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-381; Voz ML, 2004, ONCOGENE, V23, P179, DOI 10.1038/sj.onc.1207013; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Wheeler T.L., 1995, STANDARDIZED WARNER; WHEELER TL, 1994, J ANIM SCI, V72, P3145, DOI 10.2527/1994.72123145x; Williams J.L., 2008, MEAT BIOTECHNOLOGY, P21, DOI DOI 10.1007/978-0-387-79382-52.CJAS2012-100; Yoshizumi S, 2007, METABOLISM, V56, P420, DOI 10.1016/j.metabol.2006.10.027; Zhang LF, 2012, INT J BIOL SCI, V8, P838, DOI 10.7150/ijbs.4403	65	52	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157845	10.1371/journal.pone.0157845	http://dx.doi.org/10.1371/journal.pone.0157845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359122	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200025
J	Shah, KH; Varia, SN; Cook, LA; Herman, PK				Shah, Khyati H.; Varia, Sapna N.; Cook, Laura A.; Herman, Paul K.			A Hybrid-Body Containing Constituents of Both P-Bodies and Stress Granules Forms in Response to Hypoosmotic Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; CELL-FREE FORMATION; CYTOPLASMIC GRANULES; SIGNALING PATHWAY; PROCESSING BODIES; STATIONARY-PHASE; PROTEIN; YEAST; DECAY; SITES	The cytoplasm of the eukaryotic cell is a highly compartmentalized space that contains a variety of ribonucleoprotein (RNP) granules in addition to its complement of membrane-bound organelles. These RNP granules contain specific sets of proteins and mRNAs and form in response to particular environmental and developmental stimuli. Two of the better-characterized of these RNP structures are the stress granule and Processing-body (P-body) that have been conserved from yeast to humans. In this report, we examined the cues regulating stress granule assembly and the relationship between stress granule and P-body foci. These two RNP structures are generally thought to be independent entities in eukaryotic cells. However, we found here that stress granule and P-body proteins were localized to a common or merged granule specifically in response to a hypoosmotic stress. Interestingly, these hybrid-bodies were found to be transient structures that were resolved with time into separate P-body and stress granule foci. In all, these data suggest that the identity of an RNP granule is not absolute and that it can vary depending upon the nature of the induction conditions. Since the activities of a granule are likely influenced by its protein constituency, these observations are consistent with the possibility of RNP granules having distinct functions in different cellular contexts.	[Shah, Khyati H.; Varia, Sapna N.; Cook, Laura A.; Herman, Paul K.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Shah, Khyati H.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University System of Ohio; Ohio State University; Stanford University	Herman, PK (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	heman.81@osu.edu			National Institutes of Health [GM065227, GM101191]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by R01 grants from the National Institutes of Health to PKH (GM065227 and GM101191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brewster JL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005458; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dechant R, 2008, CURR OPIN CELL BIOL, V20, P678, DOI 10.1016/j.ceb.2008.09.009; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Herman PK, 1997, EMBO J, V16, P6171, DOI 10.1093/emboj/16.20.6171; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Izawa S, 2007, BIOSCI BIOTECH BIOCH, V71, P2800, DOI 10.1271/bbb.70417; Jonas S, 2013, GENE DEV, V27, P2628, DOI 10.1101/gad.227843.113; Kaiser C., 1994, METHODS YEAST GENETI; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KUO SC, 1971, J BACTERIOL, V106, P183, DOI 10.1128/JB.106.1.183-191.1971; Liu IC, 2012, MOL BIOL CELL, V23, P1231, DOI 10.1091/mbc.E11-09-0752; Lloyd RE, 2013, WIRES RNA, V4, P317, DOI 10.1002/wrna.1162; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Nostramo R, 2016, CURR GENET, V62, P503, DOI 10.1007/s00294-016-0571-9; Nostramo R, 2016, MOL CELL BIOL, V36, P173, DOI 10.1128/MCB.00609-15; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Shah KH, 2014, GENETICS, V198, P1495, DOI 10.1534/genetics.114.172031; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wen WL, 2010, NUCLEIC ACIDS RES, V38, P6555, DOI 10.1093/nar/gkq555; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019	66	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158776	10.1371/journal.pone.0158776	http://dx.doi.org/10.1371/journal.pone.0158776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359124	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200113
J	Stanish, LF; Hull, NM; Robertson, CE; Harris, JK; Stevens, MJ; Spear, JR; Pace, NR				Stanish, Lee F.; Hull, Natalie M.; Robertson, Charles E.; Harris, J. Kirk; Stevens, Mark J.; Spear, John R.; Pace, Norman R.			Factors Influencing Bacterial Diversity and Community Composition in Municipal Drinking Waters in the Ohio River Basin, USA	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; DISTRIBUTION-SYSTEM; NONTUBERCULOUS MYCOBACTERIA; LEGIONELLA-PNEUMOPHILA; FRANCISELLA-TULARENSIS; MOLECULAR ANALYSIS; MICROBIAL ECOLOGY; BIOFILM FORMATION; GEN. NOV.; PATTERNS	The composition and metabolic activities of microbes in drinking water distribution systems can affect water quality and distribution system integrity. In order to understand regional variations in drinking water microbiology in the upper Ohio River watershed, the chemical and microbiological constituents of 17 municipal distribution systems were assessed. While sporadic variations were observed, the microbial diversity was generally dominated by fewer than 10 taxa, and was driven by the amount of disinfectant residual in the water. Overall, Mycobacterium spp. (Actinobacteria), MLE1-12 (phylum Cyanobacteria), Methylobacterium spp., and sphingomonads were the dominant taxa. Shifts in community composition from Alphaproteobacteria and Betaproteobacteria to Firmicutes and Gammaproteobacteria were associated with higher residual chlorine. Alpha-and beta-diversity were higher in systems with higher chlorine loads, which may reflect changes in the ecological processes structuring the communities under different levels of oxidative stress. These results expand the assessment of microbial diversity in municipal distribution systems and demonstrate the value of considering ecological theory to understand the processes controlling microbial makeup. Such understanding may inform the management of municipal drinking water resources.	[Stanish, Lee F.; Hull, Natalie M.; Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Harris, J. Kirk; Stevens, Mark J.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Spear, John R.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO USA; [Hull, Natalie M.] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Mines; University of Colorado System; University of Colorado Boulder	Stanish, LF (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	lee.stanish@colorado.edu	Spear, John R./ABI-5873-2020; HULL, NATALIE/L-1166-2019	HULL, NATALIE/0000-0003-2876-6721; Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121; Spear, John/0000-0002-4664-7438	Alfred P. Sloan Foundation "Microbiology of the Built Environment" Program	Alfred P. Sloan Foundation "Microbiology of the Built Environment" Program	Alfred P. Sloan Foundation "Microbiology of the Built Environment" Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by generous funding from the Alfred P. Sloan Foundation's "Microbiology of the Built Environment" program. We are grateful to Jingrang Liu and Nick Ashbolt (US Environmental Protection Agency, Cincinnati OH) for their support of the field campaign. Dorothy Vesper (West Virginia University) and Gail Brion (University of Kentucky) provided vital logistical and analytical support during the sampling campaign. Thanks to Tricia Coakley and John May (University of Kentucky) for assistance with laboratory analyses. Finally, many thanks to Mark Hernandez for insights into pipe corrosion, and Kim Ross, Eric Holinger, and Mark Norman for guidance and support throughout the project.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; American Water Works Association, 2012, BUR NO LONG CONFR AM, P37; Armitage DW, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00293; Beier CL, 2002, APPL ENVIRON MICROB, V68, P6043, DOI 10.1128/AEM.68.12.6043-6050.2002; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Block J.C., 1997, P63; Buse HY, 2011, LETT APPL MICROBIOL, V53, P217, DOI 10.1111/j.1472-765X.2011.03094.x; Carrico BA, 2008, J AWWA, V157; Chandy JP, 2001, WATER RES, V35, P2677, DOI 10.1016/S0043-1354(00)00572-8; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chowdhury S, 2012, ENVIRON MONIT ASSESS, V184, P6087, DOI 10.1007/s10661-011-2407-x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Douterelo I, 2014, J APPL MICROBIOL; Dubrou S, 2013, APPL ENVIRON MICROB, V79, P5498, DOI 10.1128/AEM.00900-13; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; HENKE M, 1986, ISRAEL J MED SCI, V22, P690; Hoefel D, 2005, APPL ENVIRON MICROB, V71, P6479, DOI 10.1128/AEM.71.11.6479-6488.2005; Holinger EP, 2014, WATER RES, V49, P225, DOI 10.1016/j.watres.2013.11.027; Hull NM, 2015, WATER RES, V69, P318, DOI 10.1016/j.watres.2014.11.024; Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12; JENSEN AB, 1995, PROCESS BIOCHEM, V30, P225, DOI 10.1016/0032-9592(95)95721-T; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kapoor A, 1997, J ENVIRON ENG-ASCE, V123, P371, DOI 10.1061/(ASCE)0733-9372(1997)123:4(371); Kelly DP, 2000, INT J SYST EVOL MICR, V50, P511, DOI 10.1099/00207713-50-2-511; Kelly JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098542; Kormas KA, 2010, ENVIRON MONIT ASSESS, V165, P27, DOI 10.1007/s10661-009-0924-7; Krishna KCB, 2013, WATER RES, V47, P4666, DOI 10.1016/j.watres.2013.04.035; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lau KWK, 2007, INT J SYST EVOL MICR, V57, P2665, DOI 10.1099/ijs.0.65156-0; Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; Lee HK, 2010, APPL ENVIRON MICROB, V76, P6547, DOI 10.1128/AEM.00422-10; Li D, 2010, APPL ENVIRON MICROB, V76, P7171, DOI 10.1128/AEM.00832-10; Ling AL, 2014, ENVIRON SCI TECHNOL, V48, P7357, DOI 10.1021/es500763e; Liu G, 2013, WATER RES, V47, P3523, DOI 10.1016/j.watres.2013.03.058; Lu W, 1999, WATER RES, V33, P827, DOI 10.1016/S0043-1354(98)00229-2; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; Mathieu L, 2009, WATER RES, V43, P3375, DOI 10.1016/j.watres.2009.05.005; McColloch JS, 2012, REPORT NO 36, P172; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Nicorarat D, 2008, SOIL BIOL BIOCHEM, V40, P312, DOI 10.1016/j.soilbio.2007.08.009; Oksanen J, 2005, VEGAN R FUNCTIONS FO; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; Pillar VD, 2013, COMMUNITY ECOL, V14, P153, DOI 10.1556/ComEc.14.2013.2.5; Pinto AJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00054-15; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2011, R A LANGUAGE AND ENV; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; RIDGWAY HF, 1982, APPL ENVIRON MICROB, V44, P972, DOI 10.1128/AEM.44.4.972-987.1982; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Roeselers G, 2015, ENVIRON MICROBIOL, V17, P2505, DOI 10.1111/1462-2920.12739; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1585, DOI 10.1128/AEM.60.5.1585-1592.1994; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Smith RA, 2003, ENVIRON SCI TECHNOL, V37, P3039, DOI 10.1021/es020663b; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Srinivasan S, 2008, WATER RES, V42, P3393, DOI 10.1016/j.watres.2008.04.025; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TEMPLE KL, 1953, APPL MICROBIOL, V1, P255, DOI 10.1128/AEM.1.5.255-258.1953; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; US EPA O, 2009, REPORT NO EPA 816 R, P80; VANDERWENDE E, 1989, WATER RES, V23, P1313, DOI 10.1016/0043-1354(89)90193-0; VONREYN CF, 1994, LANCET, V343, P1137, DOI 10.1016/S0140-6736(94)90239-9; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Warton DI, 2004, ECOLOGY, V85, P858, DOI 10.1890/02-0419; Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x; Woolschlagar J, 2001, WATER SCIENCE & TECHNOLOGY: WATER SUPPLY, VOL 1, NO 4, P103, DOI 10.2166/ws.2001.0073; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zhang P, 2009, ENVIRON SCI TECHNOL, V43, P3169, DOI 10.1021/es802990e; Zhang Y, 2009, CRIT REV ENV SCI TEC, V39, P153, DOI 10.1080/10643380701631739; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	84	46	47	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157966	10.1371/journal.pone.0157966	http://dx.doi.org/10.1371/journal.pone.0157966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362708	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200033
J	Kudova, J; Prochazkova, J; Vasicek, O; Perecko, T; Sedlackova, M; Pesl, M; Pachernik, J; Kubala, L				Kudova, Jana; Prochazkova, Jirina; Vasicek, Ondrej; Perecko, Tomas; Sedlackova, Miroslava; Pesl, Martin; Pachernik, Jiri; Kubala, Lukas			HIF-1alpha Deficiency Attenuates the Cardiomyogenesis of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							CARDIAC DIFFERENTIATION; HIF-1-ALPHA; EXPRESSION; HEART; CARDIOMYOCYTES; MORPHOGENESIS; ENDODERM; HOMEOSTASIS; APOPTOSIS; DELETION	Cardiac cell formation, cardiomyogenesis, is critically dependent on oxygen availability. It is known that hypoxia, a reduced oxygen level, modulates the in vitro differentiation of pluripotent cells into cardiomyocytes via hypoxia inducible factor-1alpha (HIF-1 alpha)-dependent mechanisms. However, the direct impact of HIF-1 alpha deficiency on the formation and maturation of cardiac-like cells derived from mouse embryonic stem cells (mESC) in vitro remains to be elucidated. In the present study, we demonstrated that HIF-1 alpha deficiency significantly altered the quality and quantity of mESC-derived cardiomyocytes. It was accompanied with lower mRNA and protein levels of cardiac cell specific markers (myosin heavy chains 6 and 7) and with a decreasing percentage of myosin heavy chain alpha and beta, and cardiac troponin T-positive cells. As to structural aspects of the differentiated cardiomyocytes, the localization of contractile proteins (cardiac troponin T, myosin heavy chain alpha and beta) and the organization of myofibrils were also different. Simultaneously, HIF-1 alpha deficiency was associated with a lower percentage of beating embryoid bodies. Interestingly, an observed alteration in the in vitro differentiation scheme of HIF-1 alpha deficient cells was accompanied with significantly lower expression of the endodermal marker (hepatic nuclear factor 4 alpha). These findings thus suggest that HIF-1 alpha deficiency attenuates spontaneous cardiomyogenesis through the negative regulation of endoderm development in mESC differentiating in vitro.	[Kudova, Jana; Vasicek, Ondrej; Perecko, Tomas; Kubala, Lukas] Acad Sci Czech Republ, Inst Biophys, Brno, Czech Republic; [Kudova, Jana; Pachernik, Jiri] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic; [Kudova, Jana; Vasicek, Ondrej; Perecko, Tomas; Pachernik, Jiri; Kubala, Lukas] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic; [Prochazkova, Jirina; Sedlackova, Miroslava] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic; [Pesl, Martin] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Pesl, Martin] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Kubala, L (corresponding author), Acad Sci Czech Republ, Inst Biophys, Brno, Czech Republic.; Kubala, L (corresponding author), St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic.	kubalal@ibp.cz	Perecko, Tomas/H-1901-2014; Vasicek, Ondrej/C-4395-2015; Prochazkova, Jirina/D-4403-2015; Pesl, Martin/D-5952-2013; Kubala, Lukas/H-6329-2014	Perecko, Tomas/0000-0003-4278-4088; Vasicek, Ondrej/0000-0001-5892-0457; Prochazkova, Jirina/0000-0003-2738-8546; Pesl, Martin/0000-0001-8704-1005; Kubala, Lukas/0000-0002-7729-7338; Pesl, Martin/0000-0002-9234-2432; Pereckova, Jana/0000-0002-7565-993X	Czech Science Foundation [GJ15-13443Y, GA13-29358S]; Ministry of Education, Youth and Sports, Czech Republic project of the European Regional Development Fund FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Ministry of Education, Youth and Sports, Czech Republic project of the HistoPARK [CZ.1.07/2.3.00/20.0185]; NICHD	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports, Czech Republic project of the European Regional Development Fund FNUSA-ICRC; Ministry of Education, Youth and Sports, Czech Republic project of the HistoPARK; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Czech Science Foundation No. GJ15-13443Y and GA13-29358S (https://gacr.cz/), and Ministry of Education, Youth and Sports, Czech Republic projects of the European Regional Development Fund FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and HistoPARK CZ.1.07/2.3.00/20.0185) (www.msmt.cz/).; We wish to thank Dr. Petra Ovesna for her assistance with the statistical evaluation of data, and Lenka Vystrcilova for her expert technical assistance. We would like to thank prof. Peter F. Carmeliet from the Vesalius Research Center, VIB, University of Leuven, Belgium for providing us with the HIF-1 alpha<SUP>-/</SUP>-mESC line. Further, we would like to thank Donald A. Fishman for the development of the MF20 cell line and Paul H. Patterson for the development of the FORSE-1 cell line which was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Ateghang B, 2006, J CELL SCI, V119, P1043, DOI 10.1242/jcs.02798; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Braunwald E, 2000, CIRCULATION, V102, P14; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen K, 2010, J CELL BIOCHEM, V111, P29, DOI 10.1002/jcb.22680; Choi WY, 2012, CURR TOP DEV BIOL, V100, P319, DOI 10.1016/B978-0-12-387786-4.00010-5; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fukushima A, 2015, CURR PHARM DESIGN, V21, P3654, DOI 10.2174/1381612821666150710150445; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Liang S, 2014, DEV GROWTH DIFFER, V56, P276, DOI 10.1111/dgd.12129; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Madabhushi M, 2011, DEV CELL, V21, P907, DOI 10.1016/j.devcel.2011.08.027; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Medley TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080280; Ng KM, 2010, J MOL CELL CARDIOL, V48, P1129, DOI 10.1016/j.yjmcc.2010.01.015; Pesl M, 2014, HEART VESSELS, V29, P834, DOI 10.1007/s00380-013-0436-9; Qi YM, 2012, J CELL BIOL, V198, P103, DOI 10.1083/jcb.201111063; Radaszkiewicz KA, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941776; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Gonzalez IR, 2011, VITAM HORM, V87, P367, DOI 10.1016/B978-0-12-386015-6.00036-6; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sun XT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0447-7; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Youngblood BA, 2014, STEM CELL RES, V13, P413, DOI 10.1016/j.scr.2014.09.005	40	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158358	10.1371/journal.pone.0158358	http://dx.doi.org/10.1371/journal.pone.0158358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355368	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400053
J	Li, LL; Han, Y; Chen, WY; Lv, CM; Sun, DW				Li, Lingling; Han, Ye; Chen, Wenyuan; Lv, Congmin; Sun, Dongwang			An Improved Wavelet Packet-Chaos Model for Life Prediction of Space Relays Based on Volterra Series	PLOS ONE			English	Article							TRANSFORM	In this paper, an improved algorithm of wavelet packet-chaos model for life prediction of space relays based on volterra series is proposed. In the proposed method, the high and low frequency time sequence components of performance parameters are obtained by employing the improved wavelet packet transform to decompose the performance parameters of the relay into multiple scales. Then the optimization algorithm of parameters in volterra series is improved, and is used to construct a chaotic forecasting model for the high and low frequency time sequence components gained by the wavelet packet transform. At last, the chaotic forecasting results of the high and low frequency components are combined by taking the wavelet packet reconstruction approach, so as to predict the lifetime of the studied space relay. The algorithm can predict the life curve of the relay accurately and reflect the characteristics of the relay performance with sufficient accuracy. The proposed method is validated via a case study of a space relay.	[Li, Lingling; Han, Ye; Lv, Congmin; Sun, Dongwang] Hebei Univ Technol, Dept Elect Engn, Tianjin, Peoples R China; [Li, Lingling; Chen, Wenyuan] Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung, Taiwan; [Sun, Dongwang] Jiangxi Elect Power Design Inst, Pingxiang, Jiangxi, Peoples R China	Hebei University of Technology; National Chin-Yi University of Technology	Li, LL (corresponding author), Hebei Univ Technol, Dept Elect Engn, Tianjin, Peoples R China.; Li, LL; Chen, WY (corresponding author), Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung, Taiwan.	lilingling@hebut.edu.cn; cwy@ncut.edu.tw			National Natural Science Foundation of China [51475136]; Natural Science Foundation of Tianjin [12JCYBJC12400]; Natural Science Foundation of Hebei Province of China [E2014202230]; University Innovation Team Leader Program of Hebei Province [LJRC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); University Innovation Team Leader Program of Hebei Province	This work was supported by the National Natural Science Foundation of China, Program No. 51475136 (http://www.nsfc.gov.cn/), Natural Science Foundation of Tianjin, Program No. 12JCYBJC12400 (http://www.tstc.gov.cn/), Natural Science Foundation of Hebei Province of China, Program No. E2014202230 and University Innovation Team Leader Program of Hebei Province (Program No. LJRC003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baragona R, 2004, COMPUT STAT DATA AN, V47, P277, DOI 10.1016/j.csda.2003.11.003; BARAKA A, 2014, GRANULAR COMPUTING, P13; Bianco A, 2010, J NONPARAMETR STAT, V22, P797, DOI 10.1080/10485250903469744; Chen DY, 2010, ACTA PHYS SINICA, V61, P7623; Cherif LH, 2010, EXPERT SYST APPL, V37, P913, DOI 10.1016/j.eswa.2009.09.036; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; Evagorou D, 2010, IET SCI MEAS TECHNOL, V4, P177, DOI 10.1049/iet-smt.2009.0023; Fehri B, 2014, IEEE T MICROW THEORY, V62, P2594, DOI 10.1109/TMTT.2014.2360387; Gruber JK, 2015, INT J ROBUST NONLIN, V25, P3546, DOI 10.1002/rnc.3279; Hamidia M, 2016, DIGIT SIGNAL PROCESS, V49, P44, DOI 10.1016/j.dsp.2015.10.015; Hemmati F, 2016, APPL ACOUST, V104, P101, DOI 10.1016/j.apacoust.2015.11.003; Hu HC, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/956907; Jouini T, 2015, J STAT COMPUT SIM, V85, P2214, DOI 10.1080/00949655.2014.925898; Kaur L, 2007, DIGIT SIGNAL PROCESS, V17, P189, DOI 10.1016/j.dsp.2006.05.008; Li Jiao-jun, 2011, 2011 Proceedings of IEEE International Conference on Computer Science and Automation Engineering (CSAE), P666, DOI 10.1109/CSAE.2011.5953306; Li LL, 2015, IEEE T COMP PACK MAN, V5, P1582, DOI 10.1109/TCPMT.2015.2480229; [李玲玲 Li Lingling], 2014, [电工技术学报, Transactions of China Electrotechnical Society], V29, P187; [李志刚 Li Zhigang], 2015, [电工技术学报, Transactions of China Electrotechnical Society], V30, P233; Liu Y, 2015, IEEE T RELIAB, V64, P1287, DOI 10.1109/TR.2015.2418294; [陆俭国 Lu Jianguo], 2009, [电工技术学报, Transactions of China Electrotechnical Society], V24, P54; Lu Zhen-bo, 2007, Journal of System Simulation, V19, P2527; Ma CY, 2012, J VIB CONTROL, V18, P2176, DOI 10.1177/1077546311429587; Mohammad D, 1999, MAXIMUM ENTROPY BAYE, P71; Pence BL, 2014, IEEE T CONTR SYST T, V22, P224, DOI 10.1109/TCST.2013.2252349; Przystalka P, 2015, ENG APPL ARTIF INTEL, V41, P25, DOI 10.1016/j.engappai.2015.01.016; Shi L, 2016, ELECTRON LETT, V52, P519, DOI 10.1049/el.2015.3882; Wang ZB, 2014, ELECTR CONTACT, P43; Ye XR, 2010, 2010 11TH INTERNATIONAL CONFERENCE ON ELECTRONIC PACKAGING TECHNOLOGY & HIGH DENSITY PACKAGING (ICEPT-HDP), P1269, DOI 10.1109/ICEPT.2010.5582785; Zhang WL, 2009, SOLID STATE SCI, V11, P2008, DOI 10.1016/j.solidstatesciences.2009.06.034; Zhang YM, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P609, DOI 10.1109/ISKE.2008.4731003; Zhou R, 2010, DIGIT SIGNAL PROCESS, V20, P276, DOI 10.1016/j.dsp.2009.04.005	31	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158435	10.1371/journal.pone.0158435	http://dx.doi.org/10.1371/journal.pone.0158435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355578	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400066
J	Zhang, ZT; Telesford, QK; Giusti, C; Lim, KO; Bassett, DS				Zhang, Zitong; Telesford, Qawi K.; Giusti, Chad; Lim, Kelvin O.; Bassett, Danielle S.			Choosing Wavelet Methods, Filters, and Lengths for Functional Brain Network Construction	PLOS ONE			English	Article							RESTING-STATE; SMALL-WORLD; LOW-FREQUENCY; MOTOR CORTEX; CONNECTIVITY; CLASSIFICATION; SIGNAL; SCHIZOPHRENIA; ORGANIZATION; FLUCTUATIONS	Wavelet methods are widely used to decompose fMRI, EEG, or MEG signals into time series representing neurophysiological activity in fixed frequency bands. Using these time series, one can estimate frequency-band specific functional connectivity between sensors or regions of interest, and thereby construct functional brain networks that can be examined from a graph theoretic perspective. Despite their common use, however, practical guidelines for the choice of wavelet method, filter, and length have remained largely undelineated. Here, we explicitly explore the effects of wavelet method (MODWT vs. DWT), wavelet filter (Daubechies Extremal Phase, Daubechies Least Asymmetric, and Coiflet families), and wavelet length (2 to 24)-each essential parameters in wavelet-based methods-on the estimated values of graph metrics and in their sensitivity to alterations in psychiatric disease. We observe that the MODWT method produces less variable estimates than the DWT method. We also observe that the length of the wavelet filter chosen has a greater impact on the estimated values of graph metrics than the type of wavelet chosen. Furthermore, wavelet length impacts the sensitivity of the method to detect differences between health and disease and tunes classification accuracy. Collectively, our results suggest that the choice of wavelet method and length significantly alters the reliability and sensitivity of these methods in estimating values of metrics drawn from graph theory. They furthermore demonstrate the importance of reporting the choices utilized in neuroimaging studies and support the utility of exploring wavelet parameters to maximize classification accuracy in the development of biomarkers of psychiatric disease and neurological disorders.	[Zhang, Zitong] Tsinghua Univ, Dept Biomed Engn, Beijing 100084, Peoples R China; [Zhang, Zitong; Telesford, Qawi K.; Giusti, Chad; Bassett, Danielle S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Giusti, Chad] Univ Penn, Warren Ctr Network & Data Sci, Philadelphia, PA 19104 USA; [Lim, Kelvin O.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	Tsinghua University; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Bassett, DS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	dsb@seas.upenn.edu	Lim, Kelvin/AAF-6833-2020	Giusti, Chad/0000-0003-2412-3622; Lim, Kelvin/0000-0002-2390-7268	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; Army Research Laboratory; Army Research Office [W911NF-10-2-0022, W911NF-14-1-0679]; National Institute of Mental Health [2-R01-DC-009209-11]; National Institute of Child Health and Human Development [1R01HD086888-01]; Office of Naval Research; National Science Foundation [BCS-1441502, BCS-1430087, PHY-1554488]; US-China Summer Research Program of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009209] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); US-China Summer Research Program of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Mental Health (2-R01-DC-009209-11), the National Institute of Child Health and Human Development (1R01HD086888-01), the Office of Naval Research, and the National Science Foundation (BCS-1441502 and BCS-1430087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ZZ acknowledges support from the US-China Summer Research Program of the University of Pennsylvania. This work was supported by the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Mental Health (2-R01-DC-009209-11), the National Institute of Child Health and Human Development (1R01HD086888-01), the Office of Naval Research, and the National Science Foundation (BCS-1441502, BCS-1430087, and PHY-1554488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Sarah Feldt Muldoon for helpful comments on an early version of the manuscript.	Abu-Rezq AN, 1999, COMPUT BIOMED RES, V32, P449, DOI 10.1006/cbmr.1999.1523; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Addison P. S., 2002, ILLUSTRATED WAVELET; Akansu AN, 1992, MULTIRESOLUTION SIGN; Azpiroz-Leehan J, 2000, MED ENG PHYS, V22, P335, DOI 10.1016/S1350-4533(00)00042-4; Bassett DS, 2014, CHAOS, V24, DOI 10.1063/1.4858457; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2015, 14036034 ARXIV; Beran J., 1994, STAT LONG MEMORY PRO; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Breakspear M, 2004, HUM BRAIN MAPP, V23, P1, DOI 10.1002/hbm.20045; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Calderbank AR, 1997, P IEEE C IM PROC; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fadili MJ, 2004, NEUROIMAGE, V23, P1112, DOI 10.1016/j.neuroimage.2004.07.034; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Gencay R., 2001, INTRO WAVELETS OTHER; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hermundstad AM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003591; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Khullar S, 2011, NEUROIMAGE, V54, P2867, DOI 10.1016/j.neuroimage.2010.10.063; Laine AF, 2000, ANNU REV BIOMED ENG, V2, P511, DOI 10.1146/annurev.bioeng.2.1.511; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liang XY, 2015, BRAIN CONNECT, V5, P543, DOI 10.1089/brain.2014.0290; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lohse C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003712; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mallat S. G., 1999, WAVELET TOUR SIGNAL; Mantzaris AV, 2013, J COMPLEX NETW, V1, P83, DOI 10.1093/comnet/cnt001; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ortiz-Rosario A, 2015, J NEUROSCI METH, V246, P106, DOI 10.1016/j.jneumeth.2015.03.014; Palit M, 2010, IEEE T INSTRUM MEAS, V59, P2230, DOI 10.1109/TIM.2009.2032883; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Pritchard WS, 2014, BRAIN CONNECT, V4, P454, DOI 10.1089/brain.2013.0217; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan JR, 1993, MORGAN KAUFMANN SERI, DOI 10.1016/C2009-0-27846-9; Sarty GE, 2004, COMPUTING BRAIN ACTI; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Semler L, 2005, COMP MED SY, P265, DOI 10.1109/CBMS.2005.105; Siebenhuhner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072351; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sporns O, 2002, BEHAV BRAIN RES, V135, P69, DOI 10.1016/S0166-4328(02)00157-2; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Srikanth R, 2006, INT J NEURAL SYST, V16, P125, DOI 10.1142/S012906570600055X; Stausberg S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041914; Strela V, 1999, IEEE T IMAGE PROCESS, V8, P548, DOI 10.1109/83.753742; Subasi A, 2007, EXPERT SYST APPL, V32, P1084, DOI 10.1016/j.eswa.2006.02.005; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Turkheimer FE, 2008, J NUCL MED, V49, P657, DOI 10.2967/jnumed.107.041871; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitcher B, 2000, J GEOPHYS RES-ATMOS, V105, P14941, DOI 10.1029/2000JD900110; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001	95	79	82	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157243	10.1371/journal.pone.0157243	http://dx.doi.org/10.1371/journal.pone.0157243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355202	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400010
J	Grasman, J; Grasman, RPPP; van der Maas, HLJ				Grasman, Johan; Grasman, Raoul P. P. P.; van der Maas, Han L. J.			The Dynamics of Addiction: Craving versus Self-Control	PLOS ONE			English	Article							EGO DEPLETION; ALCOHOL-USE; SENSITIVITY; PSYCHOLOGY; MECHANISMS; RELAPSE; COCAINE; SYSTEM; MODEL; CUES	This study deals with addictive acts that exhibit a stable pattern not intervening with the normal routine of daily life. Nevertheless, in the long term such behaviour may result in health damage. Alcohol consumption is an example of such addictive habit. The aim is to describe the process of addiction as a dynamical system in the way this is done in the natural and technological sciences. The dynamics of the addictive behaviour is described by a mathematical model consisting of two coupled difference equations. They determine the change in time of two state variables, craving and self-control. The model equations contain terms that represent external forces such as societal rules, peer influences and cues. The latter are formulated as events that are Poisson distributed in time. With the model it is shown how a person can get addicted when changing lifestyle. Although craving is the dominant variable in the process of addiction, the moment of getting dependent is clearly marked by a switch in a variable that fits the definition of addiction vulnerability in the literature. Furthermore, the way chance affects a therapeutic addiction intervention is analysed by carrying out a Monte Carlo simulation. Essential in the dynamical model is a nonlinear component which determines the configuration of the two stable states of the system: being dependent or not dependent. Under identical external conditions both may be stable (hysteresis). With the dynamical systems approach possible switches between the two states are explored (repeated relapses).	[Grasman, Johan] Wageningen Univ & Res Ctr, Biometris, Wageningen, Netherlands; [Grasman, Raoul P. P. P.; van der Maas, Han L. J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	Wageningen University & Research; University of Amsterdam	Grasman, J (corresponding author), Wageningen Univ & Res Ctr, Biometris, Wageningen, Netherlands.	johan.grasman@wur.nl		van der Maas, Han L. J./0000-0001-8278-319X				Baschnagel JS, 2013, ADDICT BEHAV, V38, P2837, DOI 10.1016/j.addbeh.2013.08.005; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Caselles A, 2010, BRIT J MATH STAT PSY, V63, P449, DOI 10.1348/000711009X470768; Caselli G, 2015, ADDICT BEHAV, V44, P71, DOI 10.1016/j.addbeh.2014.07.021; Cooney NL, 1997, J ABNORM PSYCHOL, V106, P243, DOI 10.1037/0021-843X.106.2.243; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Franken IHA, 2002, PERS INDIV DIFFER, V32, P349, DOI 10.1016/S0191-8869(01)00030-7; Gelfand LA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00382; Grasman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047139; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hill AJ, 2007, P NUTR SOC, V66, P277, DOI 10.1017/S0029665107005502; Hufford MR, 2003, J ABNORM PSYCHOL, V112, P219, DOI 10.1037/0021-843X.112.2.219; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Johan G., 1999, ASYMPTOTIC METHODS F; Jones A, 2013, FRONT PSYCHIATRY, V4; Moeller FG, 2012, AM J PSYCHIAT, V169, P351, DOI 10.1176/appi.ajp.2012.12010041; Muraven M, 2002, PSYCHOL ADDICT BEHAV, V16, P113, DOI 10.1037//0893-164X.16.2.113; NICOLAYSEN LC, 1988, PHARMACOL BIOCHEM BE, V31, P327, DOI 10.1016/0091-3057(88)90354-1; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ramirez J, 2014, PSYCHOPHARMACOLOGY, V231, P1841, DOI 10.1007/s00213-013-3372-6; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Snelleman M, 2014, ADDICT BEHAV, V39, P1884, DOI 10.1016/j.addbeh.2014.07.024; Stewart MJ, 2014, J GAMBL STUD, V30, P653, DOI 10.1007/s10899-013-9383-8; Warren K, 2003, ADDICT BEHAV, V28, P369, DOI 10.1016/S0306-4603(01)00234-9; Witkiewitz K, 2007, J ABNORM PSYCHOL, V116, P378, DOI 10.1037/0021-843X.116.2.378	27	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158323	10.1371/journal.pone.0158323	http://dx.doi.org/10.1371/journal.pone.0158323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352037	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900055
J	Park, SM; Jeong, IS; Jun, SS				Park, Soon Mi; Jeong, Ihn Sook; Jun, Seong Sook			Identification of Risk Factors for Intravenous Infiltration among Hospitalized Children: A Retrospective Study	PLOS ONE			English	Article							EXTRAVASATION	This retrospective study was aimed to identify risk factors of intravenous (IV) infiltration for hospitalized children. The participants were 1,174 children admitted to a general hospital, who received peripheral intravenous injection therapy at least once, and had complete records. Data were analyzed with frequency and percentage or mean and standard deviation were calculated, and odds ratio (OR) from univariate and multiple logistic regressions. The number and % of infiltrations were 92 and 7.8%, respectively. IV infiltration risk factors were lower limb (OR = 1.72), phenytoin (OR = 11.03), 10% dextrose (OR = 6.55), steroids (OR = 6.21), vancomycin (OR = 4.10), high-concentration electrolytes (OR = 3.49), and ampicillin/sulbactam combination (OR = 3.37). Nurses working at children's hospitals should consider the risk of IV infiltration for children receiving IV infusion therapy and make a preventive effort to identify IV infiltration in high-risk children at an early stage.	[Park, Soon Mi] Pusan Natl Univ, Yangsan Hosp, Dept Nursing, Yangsan, South Korea; [Jeong, Ihn Sook; Jun, Seong Sook] Pusan Natl Univ, Coll Nursing, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University	Jeong, IS; Jun, SS (corresponding author), Pusan Natl Univ, Coll Nursing, Yangsan, South Korea.	jeongis@pusan.ac.kr; jss@pusan.ac.kr						Ahn H. S., 2012, PEDIATRICS; Amjad I, 2011, J INFUS MURS, V34, P242, DOI 10.1097/NAN.0b013e31821da1b3; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Clark E, 2013, J INFUS MURS, V36, P37, DOI 10.1097/NAN.0b013e3182798844; Clifton-Koeppel R, 2006, NEWBORN INFANT NURS, V6, P202, DOI 10.1053/j.nainr.2006.10.001; Jacinto AKD, 2011, J INFUS MURS, V34, P391, DOI 10.1097/NAN.0b013e3182306491; Doellman D, 2009, J INFUS MURS, V32, P203, DOI 10.1097/NAN.0b013e3181aac042; Dougherty Lisa, 2008, Br J Nurs, V17, pS3; Earhart A, 2011, J INFUS MURS, V34, P97, DOI 10.1097/NAN.0b013e31820b4a11; Fang L, 2011, J INFUS MURS, V34, P366, DOI 10.1097/NAN.0b013e31823061c1; Flemmer L, 1993, Pediatr Nurs, V19, P355; Glueck CJ, 2014, CLIN APPL THROMB-HEM, V20, P244, DOI 10.1177/1076029613499819; Goolsby TV, 2006, SEMIN ONCOL, V33, P139, DOI 10.1053/j.seminoncol.2005.11.007; Hadaway L, 2007, AM J NURS, V107, P64, DOI 10.1097/01.NAJ.0000282299.03441.c7; Hetzler R, 2011, J PEDIATR NURS, V26, P143, DOI 10.1016/j.pedn.2010.12.008; Infusion Nurses Society, 2006, J Infus Nurs, V29, pS1; Ji-Soo Kim，, 2012, Child Health Nursing Research, V18, P135, DOI 10.4094/jkachn.2012.18.3.135; 성세희, 2007, [Journal of Korean Clinical Nursing Research, 임상간호연구], V13, P61; Kumar RJ, 2001, ANZ J SURG, V71, P285, DOI 10.1046/j.1440-1622.2001.02104.x; Le A, 2014, ANN PHARMACOTHER, V48, P870, DOI 10.1177/1060028014527820; McCullen KL, 2006, J WOUND OSTOMY CONT, V33, P133, DOI 10.1097/00152192-200603000-00006; McDonnell PJ, 2004, PENNSYLVANIA PATIENT, V3, P1; Montgomery L A, 1999, Pediatr Nurs, V25, P167; Patient Safety Advisory, 2004, PENNSYLVANIA PATIENT, V1, P1; Payne AS, 2013, EXTRAVASATION INJURY; Sarovath A., 2006, THAI J SURG, V27, P19; Sauerland C, 2006, ONCOL NURS FORUM, V33, P1134, DOI 10.1188/06.ONF.1134-1141; Talbot SG, 2011, ANN PLAS SURG, V67, P531, DOI 10.1097/SAP.0b013e3182085915; Wilson J., 2006, INFECT CONTROL CLIN; Woody G, 2013, J INFUS MURS, V36, P413, DOI 10.1097/NAN.0000000000000013; YOSOWITZ P, 1975, ANN SURG, V182, P553, DOI 10.1097/00000658-197511000-00003	31	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158045	10.1371/journal.pone.0158045	http://dx.doi.org/10.1371/journal.pone.0158045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351488	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900028
J	Xu, SH; Soroka, CJ; Sun, AQ; Backos, DS; Mennone, A; Suchy, FJ; Boyer, JL				Xu, Shuhua; Soroka, Carol J.; Sun, An-Qiang; Backos, Donald S.; Mennone, Albert; Suchy, Frederick J.; Boyer, James L.			A Novel Di-Leucine Motif at the N-Terminus of Human Organic Solute Transporter Beta Is Essential for Protein Association and Membrane Localization	PLOS ONE			English	Article							ALPHA-OST-BETA; STEROID TRANSPORTER; CRYSTAL-STRUCTURE; TRAFFICKING; HETERODIMERIZATION; SYNTHETASE	The heteromeric membrane protein Organic Solute Transporter alpha/beta is the major bile acid efflux transporter in the intestine. Physical association of its alpha and beta subunits is essential for their polarized basolateral membrane localization and function in the transport of bile acids and other organic solutes. We identified a highly conserved acidic dileucine motif (-EL20L21EE) at the extracellular amino-tail of organic solute transporter beta from multiple species. To characterize the role of this protein interacting domain in the association of the human beta and alpha subunits and in membrane localization of the transporter, Leu20 and Leu21 on the amino-tail of human organic solute transporter beta were replaced with alanines by site-directed mutagenesis. Co-immunoprecipitation study in HEK293 cells demonstrated that substitution of the leucine residues with alanines prevented the interaction of the human beta mutant with the alpha subunit. Membrane biotinylation demonstrated that the LL/AA mutant eliminated membrane expression of both subunits. Computational-based modelling of human organic solute transporter beta suggested that the LL/AA mutation substantially alters both the structure and lipophilicity of the surface, thereby not only affecting the interaction with the alpha subunit but also possibly impacting the capacity of the beta subunit to traffick through the cell and interact with the membrane. In summary, our findings indicate that the dileucine motif in the extracellular N-terminal region of human organic solute transporter beta subunit plays a critical role in the association with the alpha subunit and in its polarized plasma membrane localization.	[Xu, Shuhua; Soroka, Carol J.; Mennone, Albert; Boyer, James L.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Xu, Shuhua; Soroka, Carol J.; Mennone, Albert; Boyer, James L.] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06510 USA; [Sun, An-Qiang; Suchy, Frederick J.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Backos, Donald S.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA	Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Boyer, JL (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Boyer, JL (corresponding author), Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06510 USA.	james.boyer@yale.edu	Backos, Donald/Q-4791-2018; Backos, Donald/N-5265-2019	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210	National Institute of Diabetes and Digestive and Kidney Diseases [DK 02563, DK P30-343989, DK84434]; NIH/NCATS [UL1 TR001082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025636, P30DK034989] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020142] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases grants DK 02563 (JLB), DK P30-343989 (JLB), and DK84434 (FS). Molecular modeling studies were conducted at the University of Colorado Computational Chemistry and Biology Core Facility, which is funded in part by NIH/NCATS UL1 TR001082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2005, EXP BIOL MED, V230, P689, DOI 10.1177/153537020523001001; Ballatori N, 2013, MOL ASPECTS MED, V34, P683, DOI 10.1016/j.mam.2012.11.005; Ballatori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2829, DOI 10.2741/3416; Christian WV, 2012, J BIOL CHEM, V287, P21233, DOI 10.1074/jbc.M112.352245; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2010, BBA-MOL CELL BIOL L, V1801, P994, DOI 10.1016/j.bbalip.2010.06.002; Diao FQ, 2010, MOL CELL NEUROSCI, V45, P75, DOI 10.1016/j.mcn.2010.06.001; Diaz-Bello B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064096; Doly S, 2015, TRENDS PHARMACOL SCI, V36, P636, DOI 10.1016/j.tips.2015.06.007; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Kasai K, 2008, CELL MOL BIOL LETT, V13, P144, DOI 10.2478/s11658-007-0043-9; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lam P, 2012, HEPATOLOGY, V55, P1901, DOI 10.1002/hep.25523; Li N, 2007, BIOCHEM J, V407, P363, DOI 10.1042/BJ20070716; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Poirier S, 2013, TRAFFIC, V14, P458, DOI 10.1111/tra.12046; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Soroka CJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-57; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Spassov VZ, 2002, J PHYS CHEM B, V106, P8726, DOI 10.1021/jp020674r; Sun AQ, 2007, AM J PHYSIOL-GASTR L, V292, pG1586, DOI 10.1152/ajpgi.00457.2006; Sun An-Qiang, 2012, Int J Biochem Mol Biol, V3, P290; Takei T, 2006, J BIOCHEM, V139, P271, DOI 10.1093/jb/mvj031; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Yi L, 2015, HUM MOL GENET, V24, P2411, DOI 10.1093/hmg/ddv002	30	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158269	10.1371/journal.pone.0158269	http://dx.doi.org/10.1371/journal.pone.0158269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351185	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900048
J	Feng, H; Su, RN; Song, YL; Wang, C; Lin, L; Ma, JM; Yang, HX				Feng, Hui; Su, Rina; Song, Yilin; Wang, Chen; Lin, Li; Ma, Jingmei; Yang, Huixia			Positive Correlation between Enhanced Expression of TLR4/MyD88/NF-kappa B with Insulin Resistance in Placentae of Gestational Diabetes Mellitus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; SERINE/THREONINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE-TISSUE; OBESE WOMEN; TOLL-LIKE-RECEPTOR-4; INFLAMMATION; PREGNANCY; TERM	Insulin resistance (IR) is a critical factor of the pathophysiology of Gestational diabetes mellitus (GDM). Studies on key organs involved in IR, such as livers and adipose tissues, showed that Toll-like receptor 4 (TLR4) can regulate insulin sensitivity. As a maternal-fetal interface with multi-functions, placentae could contribute to the development of IR for GDM. Thus, we investigated the expressions of TLR4/Myeloid Differentiation factor 88 (MyD88)/Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) in term placentae from 33 GDM women and 36 healthy pregnant women with normal glucose tolerance, evaluated local and systemic IR and furthermore identified the association between placental TLR4 and IR. TLR4 protein was expressed in various cells of term placenta, particularly in syncytiotrophoblast of villi. Compared with normal pregnancy, the expression of TLR4/MyD88/NF-kappa B pathway increased in the placenta of GDM (p < 0.05), and these differences were more pronounced in the maternal section of the placenta and the syncytiotrophoblast of villi. In addition, more severe IR was observed in the placenta of GDM patients than the control group, evidenced with higher pIRS-1(ser312) (p < 0.001) and lower IRS-1 (p < 0.05) as well as pAkt proteins (p < 0.01). The expression of TLR4 in placentae is positively correlated with local IR (pIRS-1: r = 0.76, p < 0.001 and pAkt: r = -0.47, p < 0.001) and maternal fasting (r = 0.42, p < 0.01), one-hour (r = 0.52, p < 0.01) and two-hour glucose (r = 0.54, p < 0.01) at OGTT. We found an that enhanced expression of the TLR4-MyD88-NF-kappa B pathway occurs in GDM placentae, which positively correlates with heightened local IR in placentae and higher maternal hyperglycemia. The TLR4/MyD88/NF-kappa B pathway may play a potential role in the development of IR in placentae of GDM.	[Feng, Hui; Su, Rina; Song, Yilin; Wang, Chen; Lin, Li; Ma, Jingmei; Yang, Huixia] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	Peking University	Ma, JM; Yang, HX (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	majingmeidohad@126.com; yanghuixia@bjmu.edu.cn	Ma, Jingmei/GLS-7998-2022	YANG, HUIXIA/0000-0001-9913-2721; Yang, Huixia/0000-0001-8954-2102	National Natural Science Foundation of China [81300498]; National Major Scientific Research Projects [2015CB943304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific Research Projects	Funding for this study was provided by National Natural Science Foundation of China (No. 81300498) and National Major Scientific Research Projects (No. 2015CB943304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asemi Z, 2013, AM J CLIN NUTR, V98, P1425, DOI 10.3945/ajcn.113.072785; Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Aye ILMH, 2013, MOL CELL ENDOCRINOL, V381, P46, DOI 10.1016/j.mce.2013.07.013; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; Barbour LA, 2002, AM J OBSTET GYNECOL, V186, P512, DOI 10.1067/mob.2002.121256; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Barbour LA, 2011, J CLIN ENDOCR METAB, V96, P1431, DOI 10.1210/jc.2010-2116; BECK P, 1967, J CLIN INVEST, V46, P103, DOI 10.1172/JCI105503; Beijar ECE, 2006, PLACENTA, V27, P322, DOI 10.1016/j.placenta.2004.12.012; Bo S, 2005, J ENDOCRINOL INVEST, V28, P779, DOI 10.1007/BF03347566; Boyle KE, 2013, J CLIN ENDOCR METAB, V98, pE1601, DOI 10.1210/jc.2013-1943; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; DESOYE G, 1992, DIABETOLOGIA, V35, P45, DOI 10.1007/BF00400851; Ebert T, 2015, EUR J ENDOCRINOL, V173, P1, DOI 10.1530/EJE-14-0815; Eleftheriades M, 2014, METABOLISM, V63, P1419, DOI 10.1016/j.metabol.2014.07.016; Friedman JE, 2008, DIABETES, V57, P606, DOI 10.2337/db07-1356; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kinalski M, 2005, HORM METAB RES, V37, P450, DOI 10.1055/s-2005-870238; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kumazaki K, 2004, HUM PATHOL, V35, P47, DOI 10.1016/j.humpath.2003.08.027; Kuzmicki M, 2008, HORM METAB RES, V40, P556, DOI 10.1055/s-2008-1073166; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2007, PLACENTA, V28, P1024, DOI 10.1016/j.placenta.2007.05.003; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; Sivan Eyal, 2003, Curr Diab Rep, V3, P319, DOI 10.1007/s11892-003-0024-y; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wolf M, 2003, DIABETES CARE, V26, P819, DOI 10.2337/diacare.26.3.819; Yang HX, 2012, CHINESE MED J-PEKING, V125, P1212, DOI 10.3760/cma.j.issn.0366-6999.2012.07.004; Zhang L, 2012, HYPERTENS PREGNANCY, V31, P218, DOI 10.3109/10641955.2011.642434; Zhu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126490; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	45	45	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157185	10.1371/journal.pone.0157185	http://dx.doi.org/10.1371/journal.pone.0157185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27340831	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600005
J	Latham, ADM; Latham, MC; Nugent, G; Smith, J; Warburton, B				Latham, A. David M.; Latham, M. Cecilia; Nugent, Graham; Smith, James; Warburton, Bruce			Refining Operational Practice for Controlling Introduced European Rabbits on Agricultural Lands in New Zealand	PLOS ONE			English	Article							SMALL-MAMMAL PESTS; ORYCTOLAGUS-CUNICULUS; HEMORRHAGIC-DISEASE; BIOLOGICAL-CONTROL; WILD RABBITS; IMPACT; BAIT; ERADICATION; VEGETATION; AUSTRALIA	European rabbits (Oryctolagus cuniculus) pose a major threat to agricultural production and conservation values in several countries. In New Zealand, population control via poisoning is a frontline method for limiting rabbit damage, with large areas commonly treated using the metabolic toxin sodium fluoroacetate ('1080') delivered in bait via aerial dispersal. However, this method is expensive and the high application rates of the active ingredient cause public antipathy towards it. To guide reductions in cost and toxin usage, we evaluated the economics and efficacy of rabbit control using an experimental approach of sowing 1080-bait in strips instead of the commonly-used broadcast sowing method (i.e. complete coverage). Over a 4-year period we studied aerial delivery of 0.02% 1080 on diced carrot bait over similar to 3500 ha of rabbit-prone land in the North and South islands. In each case, experimental sowing via strip patterns using 10-15 kg of bait per hectare was compared with the current best practice of aerial broadcast sowing at 30-35 kg/ha. Operational kill rates exceeded 87% in all but one case and averaged 93-94% across a total of 19 treatment replicates under comparable conditions; there was no statistical difference in overall efficacy observed between the two sowing methods. We project that strip-sowing could reduce by two thirds the amount of active 1080 applied per hectare in aerial control operations against rabbits, both reducing the non-target poisoning risk and promoting cost savings to farming operations. These results indicate that, similarly to the recently-highlighted benefits of adopting strip-sowing for poison control of introduced brushtail possums (Trichosurus vulpecula) in New Zealand, aerial strip-sowing of toxic bait could also be considered a best practice method for rabbit control in pest control policy.	[Latham, A. David M.; Latham, M. Cecilia; Nugent, Graham; Smith, James; Warburton, Bruce] Landcare Res, Wildlife Ecol & Management, POB 69040, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Latham, ADM (corresponding author), Landcare Res, Wildlife Ecol & Management, POB 69040, Lincoln 7640, New Zealand.	lathamd@landcareresearch.co.nz		Nugent, Graham/0000-0001-6223-8450	New Zealand Government - Ministry for Primary Industries Sustainable Farming Fund [12-058]; New Zealand Government - Ministry of Science and Innovation [C09X0910, C09X0507]; Federated Farmers High Country Group; Otago Regional Council	New Zealand Government - Ministry for Primary Industries Sustainable Farming Fund; New Zealand Government - Ministry of Science and Innovation; Federated Farmers High Country Group; Otago Regional Council	This work was funded by the New Zealand Government - Ministry for Primary Industries Sustainable Farming Fund (12-058); New Zealand Government - Ministry of Science and Innovation (projects C09X0910 and C09X0507 'Increasing conservation achievement through more effective and cost-efficient large-scale management of multiple mammalian pests'); Federated Farmers High Country Group; Otago Regional Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACVM, 2002, 959ACVM0702 NZ FOOD; Allen J, 1995, LC9495075; Barlow ND, 1998, ECOL MODEL, V109, P225, DOI 10.1016/S0304-3800(98)00009-X; BATCHELER CL, 1982, NEW ZEAL J ECOL, V5, P129; Bonino N, 2009, MAMMAL REV, V39, P159, DOI 10.1111/j.1365-2907.2009.00146.x; Cooke BD, 2002, WILDLIFE RES, V29, P689, DOI 10.1071/WR02010; Cooke B, 2013, AUST ECON HIST REV, V53, P91, DOI 10.1111/aehr.12000; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Eason C, 2011, NEW ZEAL J ECOL, V35, P1; Eason Charles T., 1997, Australasian Journal of Ecotoxicology, V3, P57; Evans B, 1993, UNPUB; Fisher P, 2013, LC1272; FLUX JEC, 1992, MAMMAL REV, V22, P151, DOI 10.1111/j.1365-2907.1992.tb00129.x; Fraser KW, 1985, THESIS; FUENTES ER, 1983, OECOLOGIA, V58, P411, DOI 10.1007/BF00385244; GILLHAM ME, 1963, J ECOL, V51, P275, DOI 10.2307/2257684; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Kerr IGC, 1990, RABBIT MANAGEM UNPUB; Latham ADM, 2015, BIOL INVASIONS, V17, P2821, DOI 10.1007/s10530-015-0931-2; Latham ADM, 2012, WILDLIFE RES, V39, P621, DOI 10.1071/WR12050; Lough R. S., 2009, CURRENT STATE UNPUB; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MCILROY JC, 1986, AUST WILDLIFE RES, V13, P39; McLean WH, 1966, RABBITS GALORE OTHER; Norbury G, 2001, J APPL ECOL, V38, P1350, DOI 10.1046/j.0021-8901.2001.00685.x; Norbury G, 2001, J ROY SOC NEW ZEAL, V31, P83, DOI 10.1080/03014223.2001.9517640; Norbury G, 1996, WILDLIFE RES, V23, P93, DOI 10.1071/WR9960093; NORTH SG, 1994, BIOL CONSERV, V67, P21, DOI 10.1016/0006-3207(94)90004-3; NPCA, 2012, PEST RABB MON CONTR; Nugent G, 2011, INT J PEST MANAGE, V57, P51, DOI 10.1080/09670874.2010.522265; Nugent G, 2013, NEW ZEAL J ECOL, V37, P246; Nugent G, 2012, PEST MANAG SCI, V68, P1374, DOI 10.1002/ps.3315; Nugent G, 2012, WILDLIFE RES, V39, P89, DOI 10.1071/WR11121; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; Parkes JP, 2008, WILDLIFE RES, V35, P775, DOI 10.1071/WR08008; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; R Core Team, 2013, R LANG ENV STAT COMP; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scofield RP, 2011, NEW ZEAL J ECOL, V35, P312; Scroggie MP, 2012, WILDLIFE RES, V39, P721, DOI 10.1071/WR11209; Spurr EB, 1997, SCI CONSERVATION, V62, P1; Warburton B, 2009, WILDLIFE RES, V36, P659, DOI 10.1071/WR09047; Warburton B, 1994, LC9495049; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WATSON J. S., 1961, PACIFIC SCI, V15, P591; Williams K, 1995, MANAGING VERTEBRATE; Witmer G., 2007, P 12 WILDL DAM MAN C, P160; Wright J. C., 2011, EVALUATING USE 1080	49	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158078	10.1371/journal.pone.0158078	http://dx.doi.org/10.1371/journal.pone.0158078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341209	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600028
J	Surya, W; Chooduang, S; Choong, YK; Torres, J; Boonserm, P				Surya, Wahyu; Chooduang, Sivadatch; Choong, Yeu Khai; Torres, Jaume; Boonserm, Panadda			Binary Toxin Subunits of Lysinibacillus sphaericus Are Monomeric and Form Heterodimers after In Vitro Activation	PLOS ONE			English	Article							BACILLUS-SPHAERICUS; MOSQUITO LARVAE; MOLECULAR-WEIGHT; INSECTICIDE RESISTANCE; INDIVIDUAL COMPONENTS; AEROLYSIN; BINDING; CULEX; ANOPHELES; MEMBRANES	The binary toxin from Lysinibacillus sphaericus has been successfully used for controlling mosquito-transmitted diseases. An activation step shortens both subunits BinA and BinB before their interaction with membranes and internalization in midgut cells, but the precise role of this activation step is unknown. Herein, we show conclusively using three orthogonal biophysical techniques that protoxin subunits form only monomers in aqueous solution. However, in vitro activated toxins readily form heterodimers. This oligomeric state did not change after incubation of these heterodimers with detergent. These results are consistent with the evidence that maximal toxicity in mosquito larvae is achieved when the two subunits, BinA and BinB, are in a 1: 1 molar ratio, and directly link proteolytic activation to heterodimerization. Formation of a heterodimer must thus be necessary for subsequent steps, e.g., interaction with membranes, or with a suitable receptor in susceptible mosquito species. Lastly, despite existing similarities between BinB C-terminal domain with domains 3 and 4 of pore-forming aerolysin, no aerolysin-like SDS-resistant heptameric oligomers were observed when the activated Bin subunits were incubated in the presence of detergents or lipidic membranes.	[Surya, Wahyu; Choong, Yeu Khai; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Chooduang, Sivadatch; Boonserm, Panadda] Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand; [Choong, Yeu Khai] Persiaran Univ, Nilai, Negeri Sembilan, Malaysia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mahidol University	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.; Boonserm, P (corresponding author), Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand.	jtorres@ntu.edu.sg; panadda.boo@mahidol.ac.th	Torres, Jaume/AAJ-4510-2020; Torres, Jaume/A-2179-2011	Torres, Jaume/0000-0002-1282-9727; Surya, Wahyu/0000-0001-9240-371X; Choong, Yeu Khai/0000-0002-2868-3929	Postgraduate Student Exchange Program, Mahidol University, Thailand; Thailand Research Fund; Mahidol University [RSA5680035, IRG5780009]; Singapore Ministry of Education grant Tier 1 grant [RG 51/13]	Postgraduate Student Exchange Program, Mahidol University, Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Singapore Ministry of Education grant Tier 1 grant(Ministry of Education, Singapore)	This work was supported by the 60th Year Supreme Reign of His Majesty King Bhumibol Adulyadej and Postgraduate Student Exchange Program, Mahidol University, Thailand (to SC), Thailand Research Fund and Mahidol University (RSA5680035 and IRG5780009) (to PB). W.S. is supported by Singapore Ministry of Education grant Tier 1 grant RG 51/13 (to J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; BAUMANN L, 1991, CURR MICROBIOL, V23, P51, DOI 10.1007/BF02092309; BAUMANN P, 1985, J BACTERIOL, V163, P738, DOI 10.1128/JB.163.2.738-747.1985; BERRY C, 1993, J BACTERIOL, V175, P510, DOI 10.1128/JB.175.2.510-518.1993; Boonserm P, 2006, BIOCHEM BIOPH RES CO, V342, P1273, DOI 10.1016/j.bbrc.2006.02.086; BROADWELL AH, 1990, J BACTERIOL, V172, P4032, DOI 10.1128/jb.172.7.4032-4036.1990; BROADWELL AH, 1987, APPL ENVIRON MICROB, V53, P1333, DOI 10.1128/AEM.53.6.1333-1337.1987; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; CHAPMAN HC, 1974, ANNU REV ENTOMOL, V19, P33, DOI 10.1146/annurev.en.19.010174.000341; Charles JF, 1996, ANNU REV ENTOMOL, V41, P451, DOI 10.1146/annurev.en.41.010196.002315; Charles JF, 1997, FEMS MICROBIOL LETT, V156, P153, DOI 10.1016/S0378-1097(97)00419-9; Darboux I, 2001, INSECT BIOCHEM MOLEC, V31, P981, DOI 10.1016/S0965-1748(01)00046-7; Chalegre KDD, 2012, APPL ENVIRON MICROB, V78, P6321, DOI 10.1128/AEM.01199-12; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; GARLAND WJ, 1988, INFECT IMMUN, V56, P1249, DOI 10.1128/IAI.56.5.1249-1253.1988; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Kale A, 2013, INSECT BIOCHEM MOLEC, V43, P1045, DOI 10.1016/j.ibmb.2013.07.011; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Ferreira LM, 2010, INSECT BIOCHEM MOLEC, V40, P604, DOI 10.1016/j.ibmb.2010.05.007; Mittal P. K., 2003, Journal of Vector Borne Diseases, V40, P20; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; OEI C, 1992, J GEN MICROBIOL, V138, P1515, DOI 10.1099/00221287-138-7-1515; Opota O, 2008, COMP BIOCHEM PHYS B, V149, P419, DOI 10.1016/j.cbpb.2007.11.002; Opota O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014682; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Parker MW, BACTERIAL PROTEIN TO, V24, P302; Rattanarithikul Rampa, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P1; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Schwartz JL, 2001, J MEMBRANE BIOL, V184, P171, DOI 10.1007/s00232-001-0086-1; SilvaFilha MH, 1997, EUR J BIOCHEM, V247, P754, DOI 10.1111/j.1432-1033.1997.00754.x; Smith AW, 2005, J INVERTEBR PATHOL, V88, P27, DOI 10.1016/j.jip.2004.10.005; Srisucharitpanit K, 2014, PROTEINS, V82, P2703, DOI 10.1002/prot.24636; Srisucharitpanit K, 2012, PROTEIN EXPRES PURIF, V82, P368, DOI 10.1016/j.pep.2012.02.009; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; TUCKER AD, 1990, J MOL BIOL, V212, P561, DOI 10.1016/0022-2836(90)90222-8; VANDERGOOT FG, 1993, J BIOL CHEM, V268, P18272; VANDERGOOT FG, 1994, ZBL BAKT S, V24, P349; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x	42	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158356	10.1371/journal.pone.0158356	http://dx.doi.org/10.1371/journal.pone.0158356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341696	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600054
J	Hu, RF; Ren, GM; Sun, GB; Sun, XB				Hu, Ruifeng; Ren, Guomin; Sun, Guibo; Sun, Xiaobo			TarNet: An Evidence-Based Database for Natural Medicine Research	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORKS; INSULIN-RESISTANCE; DRUG DISCOVERY; ADIPOSE-TISSUE; PHARMACOLOGY; DISEASE; SUPPRESSOR; OBESITY; POLYMORPHISMS; ASSOCIATION	Background Complex diseases seriously threaten human health. Drug discovery approaches based on "single genes, single drugs, and single targets" are limited in targeting complex diseases. The development of new multicomponent drugs for complex diseases is imperative, and the establishment of a suitable solution for drug group-target protein network analysis is a key scientific problem that must be addressed. Herbal medicines have formed the basis of sophisticated systems of traditional medicine and have given rise to some key drugs that remain in use today. The search for new molecules is currently taking a different route, whereby scientific principles of ethnobotany and ethnopharmacognosy are being used by chemists in the discovery of different sources and classes of compounds. Results In this study, we developed TarNet, a manually curated database and platform of traditional medicinal plants with natural compounds that includes potential bio-target information. We gathered information on proteins that are related to or affected by medicinal plant ingredients and data on protein-protein interactions (PPIs). TarNet includes in-depth information on both plant-compound-protein relationships and PPIs. Additionally, TarNet can provide researchers with network construction analyses of biological pathways and protein-protein interactions (PPIs) associated with specific diseases. Researchers can upload a gene or protein list mapped to our PPI database that has been manually curated to generate relevant networks. Multiple functions are accessible for network topological calculations, sub-network analyses, pathway analyses, and compound-protein relationships. Conclusions TarNet will serve as a useful analytical tool that will provide information on medicinal plant compound-affected proteins (potential targets) and system-level analyses for systems biology and network pharmacology researchers. TarNet is freely available at http://www.herbbol.org:8001/tarnet, and detailed tutorials on the program are also available.	[Hu, Ruifeng; Ren, Guomin; Sun, Guibo; Sun, Xiaobo] Peking Union Med Coll, Beijing Key Lab Innovat Drug Discovery Tradit Chi, Inst Med Plant Dev, Beijing 100021, Peoples R China; [Hu, Ruifeng; Ren, Guomin; Sun, Guibo; Sun, Xiaobo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Hu, Ruifeng; Ren, Guomin; Sun, Guibo; Sun, Xiaobo] Minist Educ, Key Lab Bioact Subst & Resource Utilizat Chinese, Beijing, Peoples R China; [Hu, Ruifeng; Ren, Guomin; Sun, Guibo; Sun, Xiaobo] Zhongguancun Open Lab Res & Dev Nat Med & Hlth Pr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Sun, XB (corresponding author), Peking Union Med Coll, Beijing Key Lab Innovat Drug Discovery Tradit Chi, Inst Med Plant Dev, Beijing 100021, Peoples R China.; Sun, XB (corresponding author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.; Sun, XB (corresponding author), Minist Educ, Key Lab Bioact Subst & Resource Utilizat Chinese, Beijing, Peoples R China.; Sun, XB (corresponding author), Zhongguancun Open Lab Res & Dev Nat Med & Hlth Pr, Beijing, Peoples R China.	xbsun@implad.ac.cn	Hu, Ruifeng/AAF-8619-2019	Hu, Ruifeng/0000-0001-5549-3082	Major Scientific and Technological Special Project [2015ZX09501001-001-003, 2012ZX09501001]; National Natural Science Foundation of China [81374011]; Special Project for National traditional Chinese medicine industry of China [201507004]	Major Scientific and Technological Special Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Project for National traditional Chinese medicine industry of China	This work was supported by the Major Scientific and Technological Special Project for 'Significant New Drugs Formulation' (Grant Numbers: 2015ZX09501001-001-003, 2012ZX09501001), the National Natural Science Foundation of China (Grant Numbers: 81374011), and the Special Project for National traditional Chinese medicine industry of China (Grant Numbers: 201507004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-320; Arikoglu H, 2014, META GENE, V2, P579, DOI 10.1016/j.mgene.2014.07.008; Arrell DK, 2010, CLIN PHARMACOL THER, V88, P120, DOI 10.1038/clpt.2010.91; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Davis D, 2015, BIOINFORMATICS, V31, P1632, DOI 10.1093/bioinformatics/btv026; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Gu HL, 2009, ENDOCRINE, V36, P546, DOI 10.1007/s12020-009-9253-4; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jiang XY, 2011, BIOMETRICS, V67, P958, DOI 10.1111/j.1541-0420.2010.01519.x; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Liberman M, 2008, PENNBIOLE ONCOLOGY 1; Liu H, 2011, NUCLEIC ACIDS RES, V39, pD991, DOI 10.1093/nar/gkq1106; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lopez-Alarcon M, 2012, GENE, V511, P404, DOI 10.1016/j.gene.2012.09.057; Narayana Y, 2009, MOL IMMUNOL, V46, P2947, DOI 10.1016/j.molimm.2009.06.019; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Pyysalo S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-50; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Ren GM, 2013, BIOINFORMATICS, V29, P279, DOI 10.1093/bioinformatics/bts666; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Wang Z, 2013, DRUG DISCOV TODAY, V18, P560, DOI 10.1016/j.drudis.2013.01.009; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Xiong JH, 2010, CANCER INFORM, V9, P61; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yamanishi Y, 2014, NUCLEIC ACIDS RES, V42, pW39, DOI 10.1093/nar/gku337; Yang DC, 2012, IEEE PES TRANSM DIST, V2012, P7, DOI [DOI 10.1371/J0URNAL.P0NE.0042076, DOI 10.1371/J0URNAL.P0NE.0033596]; Yang ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047493; Yang ZZ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat052; Yaspelkis BB, 2009, AM J PHYSIOL-REG I, V296, pR1709, DOI 10.1152/ajpregu.00117.2009; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang LF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S18; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zheng MY, 2013, TRENDS PHARMACOL SCI, V34, P549, DOI 10.1016/j.tips.2013.08.004	55	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157222	10.1371/journal.pone.0157222	http://dx.doi.org/10.1371/journal.pone.0157222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337171	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200012
J	Olenick, MA; Tokito, M; Boczkowska, M; Dominguez, R; Holzbaur, ELF				Olenick, Mara A.; Tokito, Mariko; Boczkowska, Malgorzata; Dominguez, Roberto; Holzbaur, Erika L. F.			Hook Adaptors Induce Unidirectional Processive Motility by Enhancing the Dynein-Dynactin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; dynein; intracellular trafficking; kinesin; microtubule	CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; STRUCTURAL BASIS; EARLY ENDOSOMES; PROTEIN; CARGO; COMPLEX; BINDING; MICROTUBULES; AUTOINHIBITION	Cytoplasmic dynein drives the majority of minus end-directed vesicular and organelle motility in the cell. However, it remains unclear how dynein is spatially and temporally regulated given the variety of cargo that must be properly localized to maintain cellular function. Recent work has suggested that adaptor proteins provide a mechanism for cargo-specific regulation of motors. Of particular interest, studies in fungal systems have implicated Hook proteins in the regulation of microtubule motors. Here we investigate the role of mammalian Hook proteins, Hook1 and Hook3, as potential motor adaptors. We used optogenetic approaches to specifically recruit Hook proteins to organelles and observed rapid transport of peroxisomes to the perinuclear region of the cell. This rapid and efficient translocation of peroxisomes to microtubule minus ends indicates that mammalian Hook proteins activate dynein rather than kinesin motors. Biochemical studies indicate that Hook proteins interact with both dynein and dynactin, stabilizing the formation of a supramolecular complex. Complex formation requires the N-terminal domain of Hook proteins, which resembles the calponin-homology domain of end-binding (EB) proteins but cannot bind directly to microtubules. Single-molecule motility assays using total internal reflection fluorescence microscopy indicate that both Hook1 and Hook3 effectively activate cytoplasmic dynein, inducing longer run lengths and higher velocities than the previously characterized dynein activator bicaudal D2 (BICD2). Together, these results suggest that dynein adaptors can differentially regulate dynein to allow for organelle-specific tuning of the motor for precise intracellular trafficking.	[Olenick, Mara A.; Tokito, Mariko; Boczkowska, Malgorzata; Dominguez, Roberto; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Dept Physiol, 630 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA; [Olenick, Mara A.; Tokito, Mariko; Boczkowska, Malgorzata; Dominguez, Roberto; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Olenick, Mara A.; Dominguez, Roberto; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzbaur, ELF (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, 630 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu			National Institutes of Health [GM087253, T32 GM07229]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, P01GM087253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01 domain, and a variable and predicted unstructured C-terminal GM087253 (to E. L. F. H. and R. D.) and T32 GM07229 (to M. A. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Ayloo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5807; Ballister ER, 2015, CURR BIOL, V25, pR407, DOI 10.1016/j.cub.2015.03.056; Ballister ER, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6475; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Herrmann L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119423; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nicholas MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7206; Sano H, 2007, J BIOL CHEM, V282, P7973, DOI 10.1074/jbc.M611537200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlager MA, 2014, CELL REP, V8, P1248, DOI 10.1016/j.celrep.2014.07.052; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; Terawaki S, 2015, BIOCHEM BIOPH RES CO, V460, P451, DOI 10.1016/j.bbrc.2015.03.054; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Woody M. S., 2016, BIOPHYS J IN PRESS; Xiang X, 2015, CELL MOL LIFE SCI, V72, P3267, DOI 10.1007/s00018-015-1926-y; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; Yao XL, 2014, MOL BIOL CELL, V25, P2181, DOI 10.1091/mbc.E14-04-0873; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	48	62	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18239	18251		10.1074/jbc.M116.738211	http://dx.doi.org/10.1074/jbc.M116.738211			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365401	Green Published, hybrid			2022-12-26	WOS:000383241800017
J	Hunsperger, HM; Ford, CJ; Miller, JS; Cattolico, RA				Hunsperger, Heather M.; Ford, Christopher J.; Miller, James S.; Cattolico, Rose Ann			Differential Regulation of Duplicate Light-Dependent Protochlorophyllide Oxidoreductases in the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; NADPH; IDENTIFICATION; PHOTOSYNTHESIS; MUTAGENESIS; EXPRESSION; PROTEINS; GENES; SITE; PHOTOACCLIMATION	Background Diatoms (Bacilliariophyceae) encode two light-dependent protochlorophyllide oxidoreductases (POR1 and POR2) that catalyze the penultimate step of chlorophyll biosynthesis in the light. Algae live in dynamic environments whose changing light levels induce photoacclimative metabolic shifts, including altered cellular chlorophyll levels. We hypothesized that the two POR proteins may be differentially adaptive under varying light conditions. Using the diatom Phaeodactylum tricornutum as a test system, differences in POR protein abundance and por gene expression were examined when this organism was grown on an alternating light: dark cycles at different irradiances; exposed to continuous light; and challenged by a significant decrease in light availability. Results For cultures maintained on a 12h light: 12h dark photoperiod at 200 mu Em(-2) s(-1) (200L/D), both por genes were up-regulated during the light and down-regulated in the dark, though por1 transcript abundance rose and fell earlier than that of por2. Little concordance occurred between por1 mRNA and POR1 protein abundance. In contrast, por2 mRNA and POR2 protein abundances followed similar diurnal patterns. When 200L/D P. tricornutum cultures were transferred to continuous light (200L/L), the diurnal regulatory pattern of por1 mRNA abundance but not of por2 was disrupted, and POR1 but not POR2 protein abundance dropped steeply. Under 1200 mu Em(-2) s(-1) (1200L/D), both por1 mRNA and POR1 protein abundance displayed diurnal oscillations. A compromised diel por2 mRNA response under 1200L/D did not impact the oscillation in POR2 abundance. When cells grown at 1200L/D were then shifted to 50 mu Em(-2) s(-1) (50L/D), por1 and por2 mRNA levels decreased swiftly but briefly upon light reduction. Thereafter, POR1 but not POR2 protein levels rose significantly in response to this light stepdown. Conclusion Given the sensitivity of diatom por1/POR1 to real-time light cues and adherence of por2/POR2 regulation to the diurnal cycle, we suggest that POR1 supports photoacclimation, whereas POR2 is the workhorse for daily chlorophyll synthesis.	[Hunsperger, Heather M.; Ford, Christopher J.; Miller, James S.; Cattolico, Rose Ann] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hunsperger, HM; Cattolico, RA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	hheather@uw.edu; racat@uw.edu			National Science Foundation Graduate Research Fellowship Program [DGE-0718124, DGE-1256082]; University of Washington Department of Biology Plant Biology Fellowship; Melinda Denton Writing Fellowship; US Department of Energy as part of the National Alliance for Advanced Biofuels and Bioproducts [DE-EE0003046]; NOAA Sea Grant [NA070AR4170007]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); University of Washington Department of Biology Plant Biology Fellowship; Melinda Denton Writing Fellowship; US Department of Energy as part of the National Alliance for Advanced Biofuels and Bioproducts; NOAA Sea Grant(National Oceanic Atmospheric Admin (NOAA) - USA)	HMH was supported by the National Science Foundation Graduate Research Fellowship Program (DGE-0718124; DGE-1256082; http://www.nsfgrfp.org) as well as a University of Washington Department of Biology Plant Biology Fellowship and a Melinda Denton Writing Fellowship (http://www.biology.washington.edu). This research was funded by the US Department of Energy under a contract awarded to RAC as part of the National Alliance for Advanced Biofuels and Bioproducts (DE-EE0003046; http://www.energy.gov), and by a NOAA Sea Grant to RAC (NA070AR4170007; http://seagrant.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Birve SJ, 1996, BIOCHEM J, V317, P549, DOI 10.1042/bj3170549; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Deblois CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057139; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fujita Y., 2003, PORPHYRIN HDB CHLORO, P109, DOI DOI 10.1016/B978-0-08-092387-1.50010-2; GIBBS SP, 1979, J CELL SCI, V35, P253; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Heyes DJ, 2002, BIOCHEM SOC T, V30, P601, DOI 10.1042/bst0300601; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; Hovde BT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005469; Hunsperger HM, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0286-4; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Liu H, 2010, MOL BIOL EVOL, V27, P161, DOI 10.1093/molbev/msp222; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; Maheswari U, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r85; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin GEM, 1997, BIOCHEM J, V325, P139, DOI 10.1042/bj3250139; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Masuda T, 2002, PHOTOSYNTH RES, V74, P165, DOI 10.1023/A:1020951409135; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Murchie EH, 1997, PLANT CELL ENVIRON, V20, P438, DOI 10.1046/j.1365-3040.1997.d01-95.x; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliveri P, 2014, MAR GENOM, V14, P23, DOI 10.1016/j.margen.2014.02.001; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PUTT M, 1988, J PHYCOL, V24, P315, DOI 10.1111/j.1529-8817.1988.tb04472.x; Ragni M, 2007, J PLANKTON RES, V29, P141, DOI 10.1093/plankt/fbm002; REINBOTHE C, 1995, MOL CELL BIOL, V15, P6206; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Skinner JS, 1999, PLANT MOL BIOL, V39, P577, DOI 10.1023/A:1006144630071; SPANO AJ, 1992, PLANT MOL BIOL, V18, P967, DOI 10.1007/BF00019210; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valle KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang P, 2015, PHOTOSYNTH RES, V126, P189, DOI 10.1007/s11120-015-0154-5; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Yuan M, 2012, J PLANT PHYSIOL, V169, P1311, DOI 10.1016/j.jplph.2012.05.010; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	68	3	3	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158614	10.1371/journal.pone.0158614	http://dx.doi.org/10.1371/journal.pone.0158614			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367227	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900045
J	Nilsson, AR; Soneji, S; Adolfsson, S; Bryder, D; Pronk, CJ				Nilsson, Alexandra Rundberg; Soneji, Shamit; Adolfsson, Sofia; Bryder, David; Pronk, Cornelis Jan			Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BONE-MARROW; STEM/PROGENITOR CELLS; UNRELATED DONORS; PROGENITOR CELLS; SELF-RENEWAL; TRANSPLANTATION; HIERARCHY; EXPANSION; DECLINE	Aging within the human hematopoietic system associates with various deficiencies and disease states, including anemia, myeloid neoplasms and reduced adaptive immune responses. Similar phenotypes are observed in mice and have been linked to alterations arising at the hematopoietic stem cell (HSC) level. Such an association is, however, less established in human hematopoiesis and prompted us here to detail characteristics of the most primitive human hematopoietic compartments throughout ontogeny. In addition, we also attempted to interrogate similarities between aging human and murine hematopoiesis. Coupled to the transition from human cord blood (CB) to young and aged bone marrow (BM), we observed a gradual increase in frequency of candidate HSCs. This was accompanied by functional impairments, including decreased lymphoid output and reduced proliferative potential. Downstream of human HSCs, we observed decreasing levels of common lymphoid progenitors (CLPs), and increasing frequencies of megakaryocyte/erythrocyte progenitors (MEPs) with age, which could be linked to changes in lineage-affiliated gene expression patterns in aged human HSCs. These findings were paralleled in mice. Therefore, our data support the notion that age-related changes also in human hematopoiesis involve the HSC pool, with a prominent skewing towards the megakaryocytic/erythroid lineages, and suggests conserved mechanisms underlying aging of the blood cell system.	[Nilsson, Alexandra Rundberg; Soneji, Shamit; Adolfsson, Sofia; Bryder, David; Pronk, Cornelis Jan] Lund Univ, Inst Lab Med, Fac Med, Div Mol Hematol, Lund, Sweden; [Nilsson, Alexandra Rundberg; Soneji, Shamit; Adolfsson, Sofia; Bryder, David; Pronk, Cornelis Jan] Lund Univ, Fac Med, Lund Stem Cell Ctr, Lund, Sweden; [Pronk, Cornelis Jan] Skane Univ Hosp, Dept Pediat Oncol Hematol, Lund, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Pronk, CJ (corresponding author), Lund Univ, Inst Lab Med, Fac Med, Div Mol Hematol, Lund, Sweden.; Pronk, CJ (corresponding author), Lund Univ, Fac Med, Lund Stem Cell Ctr, Lund, Sweden.; Pronk, CJ (corresponding author), Skane Univ Hosp, Dept Pediat Oncol Hematol, Lund, Sweden.	kees-jan.pronk@med.lu.se	Bryder, David/Q-6292-2019	Bryder, David/0000-0002-8761-4237	Swedish Research Council; Swedish Cancer Society; Swedish Children Cancer Foundation; StemTherapy (Lund); ALF (Avtal om Lakarutbildning och Forskning)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; StemTherapy (Lund); ALF (Avtal om Lakarutbildning och Forskning)	This work was supported by grants to D.B. from the Swedish Research Council and Swedish Cancer Society, and to C.J.P. by grants from the Swedish Research Council, Swedish Children Cancer Foundation, StemTherapy (Lund), and ALF (Avtal om Lakarutbildning och Forskning).	Balduini CL, 2014, HAEMATOLOGICA, V99, P953, DOI 10.3324/haematol.2014.106260; Banerjee ER, 2008, EXP HEMATOL, V36, P1004, DOI 10.1016/j.exphem.2008.03.008; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Berliner Nancy, 2013, Trans Am Clin Climatol Assoc, V124, P230; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Boraschi D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005624; Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Edvardsson L, 2006, EXP HEMATOL, V34, P599, DOI 10.1016/j.exphem.2006.01.017; Ferrucci L, 2008, SEMIN HEMATOL, V45, P242, DOI 10.1053/j.seminhematol.2008.06.001; Finke J, 2012, BIOL BLOOD MARROW TR, V18, P1716, DOI 10.1016/j.bbmt.2012.06.001; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; Grover A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11075; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Heining C, 2007, BONE MARROW TRANSPL, V39, P613, DOI 10.1038/sj.bmt.1705648; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Lichtman MA, 2004, SEMIN ONCOL, V31, P185, DOI 10.1053/j.seminoncol.2003.12.029; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Marley SB, 1999, BRIT J HAEMATOL, V106, P162; Mori Y, 2015, P NATL ACAD SCI USA, V112, P9638, DOI 10.1073/pnas.1512076112; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller-Sieburg C, 2008, CELL CYCLE, V7, P3798, DOI 10.4161/cc.7.24.7214; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Norddahl GL, 2012, AGING CELL, V11, P1128, DOI 10.1111/j.1474-9726.2012.00863.x; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Price EA, 2008, BLOOD CELL MOL DIS, V41, P158, DOI 10.1016/j.bcmd.2008.04.005; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Pronk CJH, 2011, METHODS MOL BIOL, V699, P275, DOI 10.1007/978-1-61737-950-5_13; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Taraldsrud E, 2009, SCAND J CLIN LAB INV, V69, P79, DOI 10.1080/00365510802419447; Umemoto T, 2008, BIOCHEM BIOPH RES CO, V365, P176, DOI 10.1016/j.bbrc.2007.10.168; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042080; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Wahlestedt M, 2015, STEM CELL TRANSL MED, V4, P186, DOI 10.5966/sctm.2014-0132; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Woolthuis CM, 2014, BIOL BLOOD MARROW TR, V20, P865, DOI 10.1016/j.bbmt.2014.03.001; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	63	57	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158369	10.1371/journal.pone.0158369	http://dx.doi.org/10.1371/journal.pone.0158369			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368054	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900032
J	Vegvari, C; Hadjichrysanthou, C; Cauet, E; Lawrence, E; Cori, A; de Wolf, F; Anderson, RM				Vegvari, Carolin; Hadjichrysanthou, Christoforos; Cauet, Emilie; Lawrence, Emma; Cori, Anne; de Wolf, Frank; Anderson, Roy M.			How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?	PLOS ONE			English	Article							INFLUENZA-VIRUS; TISSUE-CULTURE; OSELTAMIVIR; INHIBITION	Acute viral infections pose many practical challenges for the accurate assessment of the impact of novel therapies on viral growth and decay. Using the example of influenza A, we illustrate how the measurement of infection-related quantities that determine the dynamics of viral load within the human host, can inform investigators on the course and severity of infection and the efficacy of a novel treatment. We estimated the values of key infection-related quantities that determine the course of natural infection from viral load data, using Markov Chain Monte Carlo methods. The data were placebo group viral load measurements collected during volunteer challenge studies, conducted by Roche, as part of the oseltamivir trials. We calculated the values of the quantities for each patient and the correlations between the quantities, symptom severity and body temperature. The greatest variation among individuals occurred in the viral load peak and area under the viral load curve. Total symptom severity correlated positively with the basic reproductive number. The most sensitive endpoint for therapeutic trials with the goal to cure patients is the duration of infection. We suggest laboratory experiments to obtain more precise estimates of virological quantities that can supplement clinical endpoint measurements.	[Vegvari, Carolin; Hadjichrysanthou, Christoforos; Cauet, Emilie; Lawrence, Emma; Cori, Anne; Anderson, Roy M.] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [de Wolf, Frank] Janssen Prevent Ctr, Leiden, Netherlands	Imperial College London	Vegvari, C (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.	c.vegvari@imperial.ac.uk	Cori, Anne/AFL-1641-2022; Cauët, Emilie L. M./H-5849-2012	Cori, Anne/0000-0002-8443-9162; Cauët, Emilie L. M./0000-0002-2923-245X; Anderson, Roy/0000-0002-9528-3175	Janssen Prevention Center; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Janssen Prevention Center; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Janssen Prevention Center. The funder provided support in the form of salaries for authors CV, EC, CH, EL, FdW, RA, but did not have any additional role in the study design, data collection and analysis. FdW approved the final manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.; We would like to thank Hoffman La Roche for providing access to their data for this analysis and the Janssen Prevention Center for funding this research.	Atmar RL, 1996, J CLIN MICROBIOL, V34, P2604, DOI 10.1128/JCM.34.10.2604-2606.1996; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P411, DOI 10.1002/cncr.27744; Clinch B, 2015, CLIN MICROBIOL INFEC, V21, P226, DOI 10.1016/j.cmi.2015.01.014; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; FRANK AL, 1979, J CLIN MICROBIOL, V10, P32, DOI 10.1128/JCM.10.1.32-36.1979; Hadjichrysanthou C, J R SOC INT IN PRESS; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Kamal MA, 2015, ANTIMICROB AGENTS CH, V59, P5388, DOI 10.1128/AAC.00069-15; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Price GE, 1997, J GEN VIROL, V78, P2821, DOI 10.1099/0022-1317-78-11-2821; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; TCSDD TCftSoDD, 2014, COST DEV WIN MARK AP; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; Virlogeux V, 2015, EPIDEMIOLOGY; Wathen MW, 2013, INFLUENZA OTHER RESP, V7, P76, DOI 10.1111/irv.12049	27	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158237	10.1371/journal.pone.0158237	http://dx.doi.org/10.1371/journal.pone.0158237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367230	gold, Green Published, Green Submitted			2022-12-26	WOS:000378914900025
J	Bailleul, D; Ollier, S; Lecomte, J				Bailleul, Diane; Ollier, Sebastien; Lecomte, Jane			Genetic Diversity of Oilseed Rape Fields and Feral Populations in the Context of Coexistence with GM Crops	PLOS ONE			English	Article							CANOLA BRASSICA-NAPUS; HERBICIDE RESISTANCE; VOLUNTEER CANOLA; POLLEN-DISPERSAL; SEED; PERSISTENCE; PLANT; FLOW; DORMANCY; HARVEST	Despite growing concern about transgenes escaping from fields, few studies have analysed the genetic diversity of crops in an agroecosystem over several years. Accurate information about the dynamics and relationship of the genetic diversity of crops in an agroecosystem is essential for risk assessment and policies concerning the containment of genetically modified crops and their coexistence with crops grown by conventional practices. Here, we analysed the genetic diversity of oilseed rape plants from fields and feral populations over 4 years in an agricultural landscape of 41 km(2). We used exact compatibility and maximum likelihood assignment methods to assign these plants to cultivars. Even pure lines and hybrid cultivar seed lots contained several genotypes. The cultivar diversity in fields reflected the conventional view of agroecosystems quite well: that is, there was a succession of cultivars, some grown for longer than others because of their good performance, some used for one year and then abandoned, and others gradually adopted. Three types of field emerged: fields sown with a single cultivar, fields sown with two cultivars, and unassigned fields (too many cultivars or unassigned plants to reliably assign the field). Field plant diversity was higher than expected, indicating the persistence of cultivars that were grown for only one year. The cultivar composition of feral populations was similar to that of field plants, with an increasing number of cultivars each year. By using genetic tools, we found a link between the cultivars of field plants in a particular year and the cultivars of feral population plants in the following year. Feral populations on road verges were more diverse than those on path verges. All of these findings are discussed in terms of their consequences in the context of coexistence with genetically modified crops.	[Bailleul, Diane] IFREMER, UMR MARBEC, Stn Sete, Ave Jean Monnet,CS 30171, F-34203 Sete, Sete, France; [Bailleul, Diane; Ollier, Sebastien; Lecomte, Jane] Univ Paris 11, CNRS, AgroParisTech, Univ Paris Saclay,Ecol Systemat Evolut, F-91406 Orsay, France	Ifremer; Universite de Montpellier; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bailleul, D (corresponding author), IFREMER, UMR MARBEC, Stn Sete, Ave Jean Monnet,CS 30171, F-34203 Sete, Sete, France.; Bailleul, D; Lecomte, J (corresponding author), Univ Paris 11, CNRS, AgroParisTech, Univ Paris Saclay,Ecol Systemat Evolut, F-91406 Orsay, France.	diane.bailleul@gmail.com; jane.lecomte@u-psud.fr			Programme National de Recherche sur les OGM; GMBIOIMPACT project [ANR-06-POGM-0004]	Programme National de Recherche sur les OGM; GMBIOIMPACT project	This study was supported by the Programme National de Recherche sur les OGM (2006), GMBIOIMPACT project, ANR-06-POGM-0004, http://www.agence-nationale-recherche.fr/?Projet=ANR-06-POGM-0004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NS, 2010, EUR J AGRON, V32, P121, DOI 10.1016/j.eja.2009.09.001; Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Bailleul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032752; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; Bond JM, 2004, EUPHYTICA, V139, P173, DOI 10.1007/s10681-004-2781-3; Ceddia MG, 2008, DESCRIPTIVE ANAL CON, P1; Chifflet R, 2011, J APPL ECOL, V48, P689, DOI 10.1111/j.1365-2664.2010.01904.x; CHUNG MG, 1994, J PLANT RES, V107, P377, DOI 10.1007/BF02344060; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Cuthbert JL, 2001, CAN J PLANT SCI, V81, P657, DOI 10.4141/P01-070; D'Hertefeldt T, 2008, BIOL LETTERS, V4, P314, DOI 10.1098/rsbl.2008.0123; Devaux C, 2005, MOL ECOL, V14, P2269, DOI 10.1111/j.1365-294X.2005.02554.x; Devaux C, 2006, THESIS; Downey R, 2002, ISOLATION EFFECTIVEN, P1; Elling B, 2009, BASIC APPL ECOL, V10, P544, DOI 10.1016/j.baae.2009.01.005; Friesen LF, 2003, AGRON J, V95, P1342, DOI 10.2134/agronj2003.1342; Garnier A, 2008, BASIC APPL ECOL, V9, P533, DOI 10.1016/j.baae.2007.08.014; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Gruber S, 2004, J AGR SCI-CAMBRIDGE, V142, P29, DOI 10.1017/S0021859604003892; Gulden RH, 2003, WEED SCI, V51, P904, DOI 10.1614/P2002-170; Gulden RH, 2003, WEED SCI, V51, P83, DOI 10.1614/0043-1745(2003)051[0083:HLOCBN]2.0.CO;2; Hall L, 2000, WEED SCI, V48, P688, DOI 10.1614/0043-1745(2000)048[0688:PFBHRB]2.0.CO;2; Hecht M, 2014, ENVIRON SCI POLLUT R, V21, P1455, DOI 10.1007/s11356-013-1881-9; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Jorgensen RB, 2007, ADV BOT RES, V45, P451, DOI 10.1016/S0065-2296(07)45016-9; Jorgensen T, 2007, SEED SCI RES, V17, P115, DOI 10.1017/S0960258507708103; Knispel AL, 2008, WEED SCI, V56, P72, DOI 10.1614/WS-07-097.1; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Lavigne C, 1998, THEOR APPL GENET, V96, P886, DOI 10.1007/s001220050816; Mallory-Smith CA, 2011, J AGR FOOD CHEM, V59, P5813, DOI 10.1021/jf103389v; Meffin R, 2015, AGR ECOSYST ENVIRON, V203, P119, DOI 10.1016/j.agee.2015.01.024; Messean A, 2007, EUR J AGRON, V27, P115, DOI 10.1016/j.eja.2007.02.009; MIDDENDORF LR, 1992, ELECTROPHORESIS, V13, P487, DOI 10.1002/elps.11501301103; Munier DJ, 2012, ENVIRON SCI POLLUT R, V19, P2281, DOI 10.1007/s11356-011-0733-8; Ostrowski MF, 2010, HEREDITY, V105, P358, DOI 10.1038/hdy.2009.156; Pascher K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-63; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pekrun C, 1997, EUR J AGRON, V6, P245, DOI 10.1016/S1161-0301(96)02051-5; Pessel FD, 2001, THEOR APPL GENET, V102, P841, DOI 10.1007/s001220100583; Pivard S, 2008, J APPL ECOL, V45, P476, DOI 10.1111/j.1365-2664.2007.01358.x; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; Saji Hikaru, 2005, Environmental Biosafety Research, V4, P217, DOI 10.1051/ebr:2006003; Saseendran SA, 2010, AGRON J, V102, P1606, DOI 10.2134/agronj2010.0277; Sausse C, 2013, LAND USE POLICY, V30, P719, DOI 10.1016/j.landusepol.2012.05.018; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; Schoenenberger Nicola, 2012, Environmental Sciences Europe, V24, P23, DOI 10.1186/2190-4715-24-23; Schulze H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087159; Simard MJ, 2002, WEED TECHNOL, V16, P433, DOI 10.1614/0890-037X(2002)016[0433:TFAPOV]2.0.CO;2; Squire GR, 2011, ENVIRON SCI POLLUT R, V18, P111, DOI 10.1007/s11356-010-0376-1; Terres Inovia, I TECHN PROC OL PROT; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P67, DOI 10.1051/ebr:2006019	53	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158403	10.1371/journal.pone.0158403	http://dx.doi.org/10.1371/journal.pone.0158403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359342	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200070
J	Graupera, I; Sola, E; Fabrellas, N; Moreira, R; Sole, C; Huelin, P; de la Prada, G; Pose, E; Ariza, X; Risso, A; Albertos, S; Morales-Ruiz, M; Jimenez, W; Gines, P				Graupera, Isabel; Sola, Elsa; Fabrellas, Nuria; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; de la Prada, Gloria; Pose, Elisa; Ariza, Xavier; Risso, Alessandro; Albertos, Sonia; Morales-Ruiz, Manuel; Jimenez, Wladimiro; Gines, Pere			Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; SYSTEMIC INFLAMMATORY RESPONSE; ACUTE KIDNEY INJURY; CHRONIC LIVER-FAILURE; PHARMACOLOGICAL INHIBITION; MACROPHAGE INFILTRATION; CHEMOTACTIC PROTEIN-1; HEPATORENAL-SYNDROME; IMMUNE DYSFUNCTION; RENAL-FAILURE	MCP-1 (monocyte chemoattractant protein-1) is a proinflammatory cytokine involved in chemotaxis of monocytes. In several diseases, such as acute coronary syndromes and heart failure, elevated MCP-1 levels have been associated with poor outcomes. Little is known about MCP-1 in cirrhosis. AIM: To investigate the relationship between MCP-1 and outcome in decompensated cirrhosis. METHODS: Prospective study of 218 patients discharged from hospital after an admission for complications of cirrhosis. Urine and plasma levels of MCP-1 and other urine proinflammatroy biomarkers: osteopontin(OPN), trefoil-factor3 and liver-fatty-acid-binding protein were measured at admission. Urine non-inflammatory mediators cystatin-C, beta 2microglobulin and albumin were measured as control biomarkers. The relationship between these biomarkers and the 3-month hospital readmission, complications of cirrhosis, and mortality were assessed. RESULTS: 69 patients(32%) had at least one readmission during the 3-month period of follow-up and 30 patients died(14%). Urine MCP-1 and OPN levels, were associated with 3-month probability of readmission (0.85 (0.27-2.1) and 2003 (705-4586) ug/g creat vs 0.47 (0.2-1.1) and 1188 (512-2958) ug/g creat, in patients with and without readmission, respectively; p<0.05; median (IQR)). Furthermore, urine levels of MCP-1 were significantly associated with mortality (1.01 (1-3.6) vs 0.5 (0.2-1.1) mu g/g creat, in dead and alive patients at 3 months; p<0.05). Patients with higher levels of urine MCP-1 (above percentile 75th) had higher probability of development of hepatic encephalopathy, bacterial infections or AKI. Urine MCP-1 was an independent predictive factor of hospital readmission and combined end-point of readmission or dead at 3 months. Plasma levels of MCP-1 did not correlated with outcomes. CONCLUSION: Urine, but not plasma, MCP-1 levels are associated with hospital readmission, development of complications of cirrhosis, and mortality. These results suggest that in cirrhosis there is an inflammatory response that is associated with poor outcomes.	[Graupera, Isabel; Sola, Elsa; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; de la Prada, Gloria; Pose, Elisa; Ariza, Xavier; Gines, Pere] Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Spain; [Graupera, Isabel; Sola, Elsa; Fabrellas, Nuria; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; Pose, Elisa; Ariza, Xavier; Risso, Alessandro; Albertos, Sonia; Morales-Ruiz, Manuel; Jimenez, Wladimiro; Gines, Pere] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Graupera, Isabel; Sola, Elsa; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; Pose, Elisa; Ariza, Xavier; Morales-Ruiz, Manuel; Jimenez, Wladimiro; Gines, Pere] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Fabrellas, Nuria] Univ Barcelona, Sch Nursing, Barcelona, Spain; [Morales-Ruiz, Manuel; Jimenez, Wladimiro] Univ Barcelona, Hosp Clin, Biochem & Mol Genet Dept, Barcelona, Spain; [Morales-Ruiz, Manuel; Jimenez, Wladimiro] Univ Barcelona, Dept Physiol Sci, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Gines, P (corresponding author), Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Spain.; Gines, P (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.; Gines, P (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	pgines@clinic.cat	Morales-Ruiz, Manuel/L-1031-2014; Pose, Elisa/AAE-1743-2022; Morales-Ruiz, Manuel/Z-2332-2019; Morales-Ruiz, Manuel/AAM-1487-2020; Gines, Pere/B-6646-2009	Morales-Ruiz, Manuel/0000-0002-9074-2272; Morales-Ruiz, Manuel/0000-0002-9074-2272; Gines, Pere/0000-0003-4657-4504; POSE MENDEZ, ELISA/0000-0002-0224-7686; huelin alvarez, patricia/0000-0003-2340-4772; Sole, Cristina/0000-0002-6104-8345; Jimenez, Wladimiro/0000-0002-9376-0214; Graupera, Isabel/0000-0001-9170-9784; Fabrellas, Nuria/0000-0001-6720-0291; SOLA, ELSA/0000-0001-6897-2760	Fondos de Investigacion de Salud Carlos III integrated in the Plan Nacional I+D+I [FIS PI12/00330]; ICREA Academia Award; Plan Estatal I+D+I and Instituto Carlos III (Rio-Hortega fellowship) [CM14/00122]; Instituto de Salud Carlos III [FI14/00227]; University of Barcelona [APIF2015]; Instituto de Salud Carlos III; Ferring Pharmaceuticals; Sequana Medical; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund FEDER; Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) [2014/SGR 708]; Grifols S.A	Fondos de Investigacion de Salud Carlos III integrated in the Plan Nacional I+D+I; ICREA Academia Award(ICREA); Plan Estatal I+D+I and Instituto Carlos III (Rio-Hortega fellowship); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); University of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Sequana Medical; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund FEDER(European Commission); Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Grifols S.A	Some of the work mentioned has been supported by a grant awarded to Pere Gines (PG) (FIS PI12/00330), from Fondos de Investigacion de Salud Carlos III integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund FEDER and from Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) 2014/SGR 708. PG is a recipient of an ICREA Academia Award. Isabel Graupera was supported by a grant from the Plan Estatal I+D+I and Instituto Carlos III (Rio-Hortega fellowship: CM14/00122). Cristina Sole was supported by a grant from the Instituto de Salud Carlos III (FI14/00227). Patricia Huelin was supported by a grant from the University of Barcelona (APIF2015). PG is recipient of an ICREA Academia Award. CIBEREHD is funded by the Instituto de Salud Carlos III. PG has previously received funding from Ferring Pharmaceuticals, Grifols S.A, and Sequana Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Ariza X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128145; Arroyo V, 2015, J HEPATOL, V62, pS131, DOI 10.1016/j.jhep.2014.11.045; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Barreto R, 2014, J HEPATOL, V61, P35, DOI 10.1016/j.jhep.2014.02.023; Barreto R, 2014, HEPATOLOGY, V59, P1505, DOI 10.1002/hep.26687; Bernardi M, 2015, J HEPATOL, V63, P1272, DOI 10.1016/j.jhep.2015.07.004; Carl DE, 2014, LIVER INT, V34, P1001, DOI 10.1111/liv.12450; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Degre D, 2012, CLIN EXP IMMUNOL, V169, P302, DOI 10.1111/j.1365-2249.2012.04609.x; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dirchwolf M, 2016, CYTOKINE, V77, P14, DOI 10.1016/j.cyto.2015.10.006; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Giunti S, 2006, KIDNEY INT, V69, P856, DOI 10.1038/sj.ki.5000197; Haller H, 2016, CURR OPIN NEPHROL HY, V25, P42, DOI 10.1097/MNH.0000000000000186; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Kim JK, 2007, J INTERF CYTOK RES, V27, P227, DOI 10.1089/jir.2006.0055; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maiwall R, 2016, DIGEST DIS SCI, V61, P920, DOI 10.1007/s10620-015-3921-4; Marra F, 1998, AM J PATHOL, V152, P423; Michelena J, 2015, HEPATOLOGY, V62, P762, DOI 10.1002/hep.27779; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Mortensen C, 2012, EUR J GASTROEN HEPAT, V24, P619, DOI 10.1097/MEG.0b013e328351db6e; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shah N, 2013, LIVER INT, V33, P398, DOI 10.1111/liv.12047; Shah N, 2012, J HEPATOL, V56, P1047, DOI 10.1016/j.jhep.2011.11.024; Terra C, 2005, GASTROENTEROLOGY, V129, P1944, DOI 10.1053/j.gastro.2005.09.024; Thabut D, 2007, HEPATOLOGY, V46, P1872, DOI 10.1002/hep.21920; Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1	38	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157371	10.1371/journal.pone.0157371	http://dx.doi.org/10.1371/journal.pone.0157371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359339	Green Published, gold			2022-12-26	WOS:000378865200015
J	Hartmann, SB; Mohanty, S; Skovgaard, K; Brogaard, L; Flagstad, FB; Emneus, J; Wolff, A; Summerfield, A; Jungersen, G				Hartmann, Sofie Bruun; Mohanty, Soumyaranjan; Skovgaard, Kerstin; Brogaard, Louise; Flagstad, Frederikke Bjergvang; Emneus, Jenny; Wolff, Anders; Summerfield, Artur; Jungersen, Gregers			Investigating the Role of Surface Materials and Three Dimensional Architecture on In Vitro Differentiation of Porcine Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							BLOOD; CULTURE; CANCER; SYSTEMS; TISSUE; IDENTIFICATION; FABRICATION; TECHNOLOGY; SCAFFOLDS; MODEL	In vitro generation of dendritic-like cells through differentiation of peripheral blood monocytes is typically done using two-dimensional polystyrene culture plates. In the process of optimising cell culture techniques, engineers have developed fluidic micro-devises usually manufactured in materials other than polystyrene and applying three-dimensional structures more similar to the in vivo environment. Polydimethylsiloxane (PDMS) is an often used polymer for lab-on-a-chip devices but not much is known about the effect of changing the culture surface material from polystyrene to PDMS. In the present study the differentiation of porcine monocytes to monocyte-derived dendritic cells (moDCs) was investigated using CD172apos pig blood monocytes stimulated with GM-CSF and IL-4. Monocytes were cultured on surfaces made of two-and three-dimensional polystyrene as well as two-and three-dimensional PDMS and carbonised three-dimensional PDMS. Cells cultured conventionally (on two-dimensional polystyrene) differentiated into moDCs as expected. Interestingly, gene expression of a wide range of cytokines, chemokines, and pattern recognition receptors was influenced by culture surface material and architecture. Distinct clustering of cells, based on similar expression patterns of 46 genes of interest, was seen for cells isolated from two-and three-dimensional polystyrene as well as two-and three-dimensional PDMS. Changing the material from polystyrene to PDMS resulted in cells with expression patterns usually associated with macrophage expression (upregulation of CD163 and downregulation of CD1a, FLT3, LAMP3 and BATF3). However, this was purely based on gene expression level, and no functional assays were included in this study which would be necessary in order to classify the cells as being macrophages. When changing to three-dimensional culture the cells became increasingly activated in terms of IL6, IL8, IL10 and CCR5 gene expression. Further stimulation with LPS resulted in a slight increase in the expression of maturation markers (SLA-DRB1, CD86 and CD40) as well as cytokines (IL6, IL8, IL10 and IL23A) but the influence of the surfaces was unchanged. These findings highlights future challenges of combining and comparing data generated from microfluidic cell culture-devices made using alternative materials to data generated using conventional polystyrene plates used by most laboratories today.	[Hartmann, Sofie Bruun; Skovgaard, Kerstin; Brogaard, Louise; Flagstad, Frederikke Bjergvang; Jungersen, Gregers] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Mohanty, Soumyaranjan; Emneus, Jenny; Wolff, Anders] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark; [Summerfield, Artur] IVI, Mittelhausern, Switzerland; [Mohanty, Soumyaranjan] Thermo Fisher Sci, Roskilde, Denmark	Technical University of Denmark; Technical University of Denmark; Thermo Fisher Scientific	Jungersen, G (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	grju@vet.dtu.dk	Summerfield, Artur/H-6025-2019; Jungersen, Gregers/P-9767-2019; Wolff, Anders/B-7601-2011; Jungersen, Gregers/C-3940-2011; Summerfield, Artur/K-2105-2016; Emneus, Jenny/A-5763-2012	Summerfield, Artur/0000-0001-8292-4634; Jungersen, Gregers/0000-0003-3147-6960; Wolff, Anders/0000-0001-9596-1215; Jungersen, Gregers/0000-0003-3147-6960; Summerfield, Artur/0000-0001-8292-4634; Brogaard, Louise/0000-0003-4571-6822; skovgaard, kerstin/0000-0001-5663-4879; Emneus, Jenny/0000-0002-8061-201X				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barbetta A, 2005, LANGMUIR, V21, P12333, DOI 10.1021/la0520233; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Buonerba C, 2011, EXPERT REV ANTICANC, V11, P25, DOI [10.1586/era.10.180, 10.1586/ERA.10.180]; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Castiello L, 2011, CANCER IMMUNOL IMMUN, V60, P457, DOI 10.1007/s00262-010-0954-6; Cha KJ, 2011, BIOMED MICRODEVICES, V13, P877, DOI 10.1007/s10544-011-9557-z; Chamorro S, 2004, IMMUNOBIOLOGY, V209, P57, DOI 10.1016/j.imbio.2004.02.002; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; Guzylack-Piriou L, 2010, DEV COMP IMMUNOL, V34, P455, DOI 10.1016/j.dci.2009.12.006; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; Jamin A, 2006, VET IMMUNOL IMMUNOP, V114, P224, DOI 10.1016/j.vetimm.2006.08.009; Johansson E, 2003, VET IMMUNOL IMMUNOP, V91, P183, DOI 10.1016/S0165-2427(02)00310-0; Kartalov EP, 2006, J NANOSCI NANOTECHNO, V6, P2265, DOI 10.1166/jnn.2006.504; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kyrova K, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0244-1; Lopacinska JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053107; Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mohanty S, 2012, P 39 INT C MICR; Mohanty S, 2016, MAT SCI ENG C-MATER, V61, P180, DOI 10.1016/j.msec.2015.12.032; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Sanchez C, 1999, J IMMUNOL, V162, P5230; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Summerfield A, 2015, ANNU REV ANIM BIOSCI, V3, P533, DOI 10.1146/annurev-animal-022114-111009; Tehranirokh M, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4826935; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang L, 2004, ADV CANCER RES, V92, P13, DOI 10.1016/S0065-230X(04)92002-7; Zhang WJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02332	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158503	10.1371/journal.pone.0158503	http://dx.doi.org/10.1371/journal.pone.0158503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362493	Green Published, gold			2022-12-26	WOS:000378865200085
J	Ikeda, MLR; Barcellos, NT; Alencastro, PR; Wolff, FH; Moreira, LB; Gus, M; Brandao, ABM; Fuchs, FD; Fuchs, SC				Ikeda, Maria Leticia R.; Barcellos, Nemora T.; Alencastro, Paulo R.; Wolff, Fernando H.; Moreira, Leila B.; Gus, Miguel; Brandao, Ajacio B. M.; Fuchs, Flavio D.; Fuchs, Sandra C.			Alcohol Drinking Pattern: A Comparison between HIV-Infected Patients and Individuals from the General Population	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEAVY DRINKING; UNITED-STATES; USE DISORDERS; SUBSTANCE USE; CONSUMPTION; RISK; PREVALENCE; ABUSE	Background Alcohol consumption is highly prevalent in the general population and among HIV-infected population. This study aimed to compare the pattern of alcohol consumption and to describe characteristics associated with heavy alcohol consumption in individuals from the general population with patients infected with HIV. Methods Participants for this analysis came from a population-based cross-sectional study and from a consecutive sampling of patients infected with HIV. Participants aged 18 years or older were interviewed using similar questionnaires with questions pertaining to socio-demographic characteristics, alcohol consumption, smoking, physical activity, and HIV-related characteristics, among others. Blood pressure and anthropometric measures were measured using standardized procedures. Results Weekly alcohol consumption was more prevalent among individuals from the general population than HIV-infected patients: 57.0 vs. 31.1%, P<0.001. The prevalence of heavy episodic drinking was higher in the population sample as well: 46.1 vs. 17.0%, P<0.001. In the general population, heavy alcohol consumption was more prevalent in men. Cigarette smoking was independently associated with heavy alcohol consumption among HIV infected (Prevalence Ratio; PR = 5.9; 95% CI 2.6-13.9; P<0,001) and general population (PR = 2.6; 95% CI 1.9-3.0; P<0.001). Years at school were inversely associated with heavy alcohol consumption among HIV-infected patients and directly associated among participants from the general population, even after controlling for sex, age, skin color, and smoking. Conclusions Heavy alcohol consumption is more prevalent in the general population than among HIV-infected patients. Individuals aware about their disease may reduce the amount of alcoholic beverages consumption comparatively to healthy individuals from the general population.	[Ikeda, Maria Leticia R.; Moreira, Leila B.; Gus, Miguel; Fuchs, Flavio D.; Fuchs, Sandra C.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Cardiol, R Ramiro Barcelos 2600,2 Andar, Porto Alegre, RS, Brazil; [Ikeda, Maria Leticia R.; Barcellos, Nemora T.; Alencastro, Paulo R.] Hosp Sanat Partenon, State Dept Hlth, Rio Grande Sul Av Bento Goncalves 3722, BR-90650001 Porto Alegre, RS, Brazil; [Wolff, Fernando H.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Sci Gastroenterol & Hepatol, R Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil; [Brandao, Ajacio B. M.] Univ Fed Ciencias Saude Porto Alegre, Postgrad Program Med Hepatol, Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Hosp Clin Porto Alegre, Div Cardiol, Ctr Pesquisa Clin, R Ramiro Barcelos 2350, BR-90035003 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Fuchs, SC (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Cardiol, R Ramiro Barcelos 2600,2 Andar, Porto Alegre, RS, Brazil.	scfuchs@terra.com.br	Fuchs, Sandra C/T-2670-2019; Fuchs, Flávio D/L-5078-2016; MOREIRA, LEILA LEILA B/AAC-2240-2019	MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Brandao, Ajacio/0000-0001-8411-5654; fuchs, flavio/0000-0002-1191-0523	CNPq (National Council for Scientific and Technological Development); Ministry of Health/Secretariat of Health Surveillance/National STD and AIDS Programme (MOH/SHS/NAP); FIPE-HCPA (Fundo de Apoio a Pesquisa, Hospital de Clinicas de Porto Alegre) [GPPG: 06-243]	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health/Secretariat of Health Surveillance/National STD and AIDS Programme (MOH/SHS/NAP); FIPE-HCPA (Fundo de Apoio a Pesquisa, Hospital de Clinicas de Porto Alegre)	This work was partially supported by the CNPq (National Council for Scientific and Technological Development), Ministry of Health/Secretariat of Health Surveillance/National STD and AIDS Programme (MOH/SHS/NAP), and FIPE-HCPA (GPPG: 06-243; Fundo de Apoio a Pesquisa, Hospital de Clinicas de Porto Alegre). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencastro PR, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-29; Alencastro PR, 2011, AIDS PATIENT CARE ST, V25, P627, DOI 10.1089/apc.2010.0360; Almeida-Filho N, 2004, REV SAUDE PUBL, V38, P45, DOI 10.1590/S0034-89102004000100007; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Assanangkornchai S, 2010, ALCOHOL ALCOHOLISM, V45, P278, DOI 10.1093/alcalc/agq018; Atwoli L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-34; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Bonacini M, 2011, ANN HEPATOL, V10, P502, DOI 10.1016/S1665-2681(19)31519-4; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; De Boni RB, 2016, DRUG ALCOHOL DEPEN, V159, P174, DOI 10.1016/j.drugalcdep.2015.12.013; De Leon J, 2007, ALCOHOL ALCOHOLISM, V42, P252, DOI 10.1093/alcalc/agm029; Deiss RG, 2016, ALCOHOL CLIN EXP RES, V40, P529, DOI 10.1111/acer.12975; Di Castelnuovo A, 2010, INTERN EMERG MED, V5, P291, DOI 10.1007/s11739-010-0346-0; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Eigenbrodt ML, 2006, J EPIDEMIOL COMMUN H, V60, P345, DOI 10.1136/jech.2005.039735; Foulds J, 2012, ACTA PSYCHIAT SCAND, V126, P434, DOI 10.1111/j.1600-0447.2012.01871.x; Freiberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P247, DOI 10.1097/QAI.0b013e3181c6c4b7; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Fuchs SC, 2008, CAD SAUDE PUBLICA, V24, pS285, DOI 10.1590/S0102-311X2008001400013; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Ghosh S, 2012, J HEALTH POPUL NUTR, V30, P73; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grittner U, 2012, ALCOHOL ALCOHOLISM, V47, P597, DOI 10.1093/alcalc/ags040; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Helakorpi S, 2010, ALCOHOL ALCOHOLISM, V45, P286, DOI 10.1093/alcalc/agq007; Huerta MC, 2010, SOC SCI MED, V71, P143, DOI 10.1016/j.socscimed.2010.03.022; Ikeda Maria Leticia R, 2013, ScientificWorldJournal, V2013, P169825, DOI 10.1155/2013/169825; Kahler CW, 2015, AIDS BEHAV, V19, P422, DOI 10.1007/s10461-014-0896-7; Keyes KM, 2008, ADDICTION, V103, P1120, DOI 10.1111/j.1360-0443.2008.02218.x; Kloner RA, 2007, CIRCULATION, V116, P1306, DOI 10.1161/CIRCULATIONAHA.106.678375; Laranjeira R, 2010, REV BRAS PSIQUIATR, V32, P231, DOI 10.1590/S1516-44462009005000012; Latvala A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-73; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Moreira LB, 1996, J STUD ALCOHOL, V57, P253, DOI 10.15288/jsa.1996.57.253; Nguyen NPT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118185; O'Connor PG, 2001, J GEN INTERN MED, V16, P70; Pandrea I, 2010, ALCOHOL RES HEALTH, V33, P16; Peregoy J.A., 2012, SUMMARY HLTH STAT US; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f; Subramaniam M, 2012, ADDICTION, V107, P1443, DOI 10.1111/j.1360-0443.2012.03830.x; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Trevisol DJ, 2012, J HUM HYPERTENS, V26, P374, DOI 10.1038/jhh.2011.48; Vagenas P, 2015, CURR HIV-AIDS REP, V12, P421, DOI 10.1007/s11904-015-0285-5; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392	52	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158535	10.1371/journal.pone.0158535	http://dx.doi.org/10.1371/journal.pone.0158535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362541	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200086
J	Lundgren, GP; Wickstrom, A; Hasselblad, T; Dahllof, G				Lundgren, Gunilla Pousette; Wickstrom, Anette; Hasselblad, Tove; Dahllof, Goran			Amelogenesis Imperfecta and Early Restorative Crown Therapy: An Interview Study with Adolescents and Young Adults on Their Experiences	PLOS ONE			English	Article							QUALITY-OF-LIFE; ORAL-HEALTH; APPEARANCE; IMPACT; CHILD; DISABILITIES; PEOPLE	Patients with Amelogenesis imperfecta (AI) can present with rapid tooth loss or fractures of enamel as well as alterations in enamel thickness, color, and shape; factors that may compromise aesthetic appearance and masticatory function. The aim was to explore the experiences and perceptions of adolescents and young adults living with AI and receiving early prosthetic therapy. Seven patients with severe AI aged 16 to 23 years who underwent porcelain crown therapy participated in one-to-one individual interviews. The interviews followed a topic guide consisting of open-ended questions related to experiences of having AI. Transcripts from the interviews were analyzed using thematic analysis. The analysis process identified three main themes: Disturbances in daily life, Managing disturbances, and Normalization of daily life. These themes explain the experiences of patients living with enamel disturbances caused by AI and receiving early crown therapy. Experiences include severe pain and sensitivity problems, feelings of embarrassment, and dealing with dental staff that lack knowledge and understanding of their condition. The patients described ways to manage their disturbances and to reduce pain when eating or drinking, and strategies for meeting other people. After definitive treatment with porcelain crown therapy, they described feeling like a normal patient. In conclusion the results showed that adolescents and young adults describe a profound effect of AI on several aspects of their daily life.	[Lundgren, Gunilla Pousette; Hasselblad, Tove; Dahllof, Goran] Karolinska Inst, Dept Dent Med, Div Pediat Dent, Stockholm, Sweden; [Lundgren, Gunilla Pousette; Hasselblad, Tove; Dahllof, Goran] Ctr Pediat Oral Hlth Res, Stockholm, Sweden; [Lundgren, Gunilla Pousette] Publ Dent Hlth Serv, Dept Pediat Dent, Falun, Dalarna County, Sweden; [Wickstrom, Anette] Linkoping Univ, Dept Themat Studies, Child Studies, Linkoping, Sweden; [Lundgren, Gunilla Pousette] Karolinska Inst, Dept Dent Med, Div Pediat Dent, POB 4064, SE-14104 Huddinge, Sweden	Karolinska Institutet; Linkoping University; Karolinska Institutet	Lundgren, GP (corresponding author), Karolinska Inst, Dept Dent Med, Div Pediat Dent, Stockholm, Sweden.; Lundgren, GP (corresponding author), Ctr Pediat Oral Hlth Res, Stockholm, Sweden.; Lundgren, GP (corresponding author), Publ Dent Hlth Serv, Dept Pediat Dent, Falun, Dalarna County, Sweden.; Lundgren, GP (corresponding author), Karolinska Inst, Dept Dent Med, Div Pediat Dent, POB 4064, SE-14104 Huddinge, Sweden.	gunilla.pousette-lundgren@ki.se		Dahllof, Goran/0000-0001-8536-5292				Aldred M J, 1995, Oral Dis, V1, P2; BACKMAN B, 1986, COMMUNITY DENT ORAL, V14, P43, DOI 10.1111/j.1600-0528.1986.tb01493.x; Boyce C., 2006, MONITORING EVALUATIO; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Broder HL, 2014, AM J PUBLIC HEALTH, V104, P865, DOI 10.2105/AJPH.2013.301686; Brown JD, 2002, J ADOLESCENT HEALTH, V31, P153, DOI 10.1016/S1054-139X(02)00507-4; Chamlin SL, 2006, DERMATOL THER, V19, P104, DOI 10.1111/j.1529-8019.2006.00060.x; Chen CF, 2013, PEDIATR DENT, V35, P337; Coffield KD, 2005, J AM DENT ASSOC, V136, P620, DOI 10.14219/jada.archive.2005.0233; Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; Griffiths C, 2012, J HEALTH PSYCHOL, V17, P1053, DOI 10.1177/1359105311433909; Hallberg U, 2004, ACTA ODONTOL SCAND, V62, P319, DOI 10.1080/00016350410001810; Hashem A, 2013, J DENT, V41, P689, DOI 10.1016/j.jdent.2013.06.004; Jasim H, 2014, J ORAL REHABIL, V41, P122, DOI 10.1111/joor.12118; Klingberg G, 2012, EUR J ORAL SCI, V120, P232, DOI 10.1111/j.1600-0722.2012.00961.x; Kvist T, 2014, EUR J ORAL SCI, V122, P332, DOI 10.1111/eos.12143; Lovegrove E, 2005, CLEFT PALATE-CRAN J, V42, P33, DOI 10.1597/03-097.5.1; Lundgren GP, 2015, J DENT RES, V94, P1041, DOI 10.1177/0022034515584385; Lundgren GP, 2014, J DENT, V42, P1382, DOI 10.1016/j.jdent.2014.07.017; Lundgren GP, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0393-3; Malik K, 2012, BRIT DENT J, V212, P537, DOI 10.1038/sj.bdj.2012.469; Marshman Z, 2007, INT J PAEDIATR DENT, V17, P320, DOI 10.1111/j.1365-263X.2007.00845.x; McDonald S, 2012, BRIT DENT J, V212, P425, DOI 10.1038/sj.bdj.2012.366; Parekh S, 2014, INT J PAEDIATR DENT, V24, P326, DOI 10.1111/ipd.12080; Rumsey N, 2004, J ADV NURS, V48, P443, DOI 10.1111/j.1365-2648.2004.03227.x; Seehra J, 2011, BRIT DENT J, V210, P411, DOI 10.1038/sj.bdj.2011.339; Sneller J, 2014, INT J PAEDIATR DENT, V24, P409, DOI 10.1111/ipd.12086; Trulsson U, 2003, EUR J ORAL SCI, V111, P19, DOI 10.1034/j.1600-0722.2003.00001.x; Wickstrom A., 2015, MED ANTHR Q; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Yang SE, 2015, J ORAL REHABIL	31	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156879	10.1371/journal.pone.0156879	http://dx.doi.org/10.1371/journal.pone.0156879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27359125	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200003
J	de Jong, M; Ouyang, JQ; van Grunsven, RHA; Visser, ME; Spoelstra, K				de Jong, Maaike; Ouyang, Jenny Q.; van Grunsven, Roy H. A.; Visser, Marcel E.; Spoelstra, Kamiel			Do Wild Great Tits Avoid Exposure to Light at Night?	PLOS ONE			English	Article								Studies of wild populations have provided important insights into the effects of artificial light at night on organisms, populations and ecosystems. However, in most studies the exact amount of light at night individuals are exposed to remains unknown. Individuals can potentially control their nighttime light exposure by seeking dark spots within illuminated areas. This uncertainty makes it difficult to attribute effects to a direct effect of light at night, or to indirect effects, e.g., via an effect of light at night on food availability. In this study, we aim to quantify the nocturnal light exposure of wild birds in a previously dark forest-edge habitat, experimentally illuminated with three different colors of street lighting, in comparison to a dark control. During two consecutive breeding seasons, we deployed male great tits (Parus major) with a light logger measuring light intensity every five minutes over a 24h period. We found that three males from pairs breeding in brightly illuminated nest boxes close to green and red lamp posts, were not exposed to more artificial light at night than males from pairs breeding further away. This suggests, based on our limited sample size, that these males could have been avoiding light at night by choosing a roosting place with a reduced light intensity. Therefore, effects of light at night previously reported for this species in our experimental set-up might be indirect. In contrast to urban areas where light is omnipresent, bird species in non-urban areas may evade exposure to nocturnal artificial light, thereby avoiding direct consequences of light at night.	[de Jong, Maaike; Ouyang, Jenny Q.; Visser, Marcel E.; Spoelstra, Kamiel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Ouyang, Jenny Q.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [van Grunsven, Roy H. A.] Wageningen Univ, Plant Ecol & Nat Conservat Grp, Wageningen, Netherlands; [van Grunsven, Roy H. A.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Nevada System of Higher Education (NSHE); University of Nevada Reno; Wageningen University & Research; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	de Jong, M (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	m.dejong@nioo.knaw.nl	Visser, Marcel E/A-9151-2009; Spoelstra, Kamiel/B-4222-2015; KNAW, NIOO-KNAW/A-4320-2012; van Grunsven, Roy/G-7029-2011	Visser, Marcel E/0000-0002-1456-1939; Spoelstra, Kamiel/0000-0001-8614-4387; KNAW, NIOO-KNAW/0000-0002-3835-159X; van Grunsven, Roy/0000-0001-8873-1024	Dutch Technology Foundation STW; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs; Philips; Nederlandse Aardolie Maatschappij (NAM); NSF postdoctoral research fellowship in biology [DBI-1306025]	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; Philips; Nederlandse Aardolie Maatschappij (NAM); NSF postdoctoral research fellowship in biology(National Science Foundation (NSF))	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs. The project is supported by Philips and the Nederlandse Aardolie Maatschappij (NAM). JQO was supported by an NSF postdoctoral research fellowship in biology (DBI-1306025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Natuurmonumenten for allowing us to perform our experiment on effects of artificial lighting on their terrain. We thank Raymond Klaassen for instructions on deployment of loggers, Koosje Lamers, Helen Schepp, Sofia Scheltinga, Annemieke Kolvoort and Ilse Scholten for participating in the fieldwork and Peter Grey (Sigma Delta Technologies) for technological assistance. This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The project is supported by Philips and the Nederlandse Aardolie Maatschappij (NAM). J.Q.O. was supported by an NSF postdoctoral research fellowship in biology (DBI-1306025).	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Bennie J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0131; Calvo B., 1992, Ringing and Migration, V13, P129; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; de Jong M, 2016, PHYSIOL BEHAV, V155, P172, DOI 10.1016/j.physbeh.2015.12.012; de Jong M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0128; Dominoni D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3017; Dominoni DM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0118; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Dominoni DM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-60; Holker F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0130; Murray DL, 2000, METH C CONS, P15; Ouyang JQ, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0517; Raap T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13557; Rich C., 2006, ECOLOGICAL CONSEQUEN; Robert KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1745; Spoelstra K, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0129; Wakefield A, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150291	19	21	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157357	10.1371/journal.pone.0157357	http://dx.doi.org/10.1371/journal.pone.0157357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355354	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400013
J	Tokutake, T; Baba, H; Shimada, Y; Takeda, W; Sato, K; Hiroshima, Y; Kirihara, T; Shimizu, I; Nakazawa, H; Kobayashi, H; Ishida, F				Tokutake, Takayoshi; Baba, Hisami; Shimada, Yuji; Takeda, Wataru; Sato, Keijiro; Hiroshima, Yuki; Kirihara, Takehiko; Shimizu, Ikuo; Nakazawa, Hideyuki; Kobayashi, Hikaru; Ishida, Fumihiro			Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients	PLOS ONE			English	Article							FACTOR-IX; REAGENTS; BINDING; PROTEIN; CALCIUM; IONS	The activated partial thromboplastin time (APTT) assay is a basic hemostatic assay based on the time it takes for clots to form in plasma samples after the addition of calcium chloride. It is used to screen for various coagulation disorders. Several previous reports have suggested that magnesium (Mg) might contribute to coagulation reactions by binding to specific coagulation proteins. We investigated the effects of Mg on the APTT. In healthy controls, the APTT was significantly prolonged in proportion to the increase in the concentration of magnesium chloride in the range from 2.1 to 16.7 mmol/L. Among eight samples from patients with various disorders that exhibited prolonged APTT, two samples demonstrated shorter APTT when Mg was added, both of which were from patients that were positive for lupus anticoagulant. When we examined 206 clinical APTT samples, we found that Mg shortened the APTT of two samples. These two samples were also from lupus anticoagulant-positive patients (p-value: < 0.003). Our findings regarding the unique effects of exogenous Mg on the APTT of lupus anticoagulant-positive patients might shed light on the role of Mg in APTT assays and lead to the development of a novel screening method for lupus anticoagulant.	[Tokutake, Takayoshi; Baba, Hisami; Shimada, Yuji; Kobayashi, Hikaru] Nagano Red Cross Hosp, Dept Clin Lab, Nagano, Japan; [Takeda, Wataru; Sato, Keijiro; Hiroshima, Yuki; Kirihara, Takehiko; Shimizu, Ikuo; Kobayashi, Hikaru] Nagano Red Cross Hosp, Dept Hematol, Nagano, Japan; [Shimizu, Ikuo] Shinshu Univ, Sch Med, Ctr Med Educ, Matsumoto, Nagano, Japan; [Nakazawa, Hideyuki; Ishida, Fumihiro] Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano, Japan; [Ishida, Fumihiro] Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci, Matsumoto, Nagano, Japan	Nagano Red Cross Hospital; Nagano Red Cross Hospital; Shinshu University; Shinshu University; Shinshu University	Ishida, F (corresponding author), Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano, Japan.; Ishida, F (corresponding author), Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci, Matsumoto, Nagano, Japan.	fumishi@shinshu-u.ac.jp	Nakazawa, Hideyuki/Z-1259-2019	Nakazawa, Hideyuki/0000-0002-6457-5052; Shimizu, Ikuo/0000-0002-6731-7104				Agah S, 2009, J THROMB HAEMOST, V7, P1426, DOI 10.1111/j.1538-7836.2009.03506.x; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; DENISMAGDELAINE A, 1995, HAEMOSTASIS, V25, P98; Kottke-Marchant K, 2012, LAB HEMATOLOGY PRACT, P420; Krilis SA, 2014, HEMATOL-AM SOC HEMAT, P321, DOI 10.1182/asheducation-2014.1.321; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; Shikamoto Y, 2003, J BIOL CHEM, V278, P24090, DOI 10.1074/jbc.M300650200; Vadivel K, 2013, J MOL BIOL, V425, P1961, DOI 10.1016/j.jmb.2013.02.017; van den Besselaar AMHP, 2002, BLOOD COAGUL FIBRIN, V13, P19, DOI 10.1097/00001721-200201000-00003; van den Besselaar AMHP, 2003, THROMB HAEMOSTASIS, V89, P43	11	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157835	10.1371/journal.pone.0157835	http://dx.doi.org/10.1371/journal.pone.0157835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355205	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400020
J	Costa, JB; Dufeu-Duchesne, T; Leroy, V; Bertucci, I; Bouvier-Alias, M; Pouget, N; Brevot-Lutton, O; Bourliere, M; Zoulim, F; Plumas, J; Aspord, C				Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent; Bertucci, Inga; Bouvier-Alias, Magali; Pouget, Noelle; Brevot-Lutton, Ophelie; Bourliere, Marc; Zoulim, Fabien; Plumas, Joel; Aspord, Caroline		ANRS HB06 PEGAN Study Grp	Pegylated Interferon alpha-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATITIS-B-VIRUS; PLASMACYTOID DENDRITIC CELLS; PEGINTERFERON ALPHA-2A; PERIPHERAL-BLOOD; I INTERFERONS; COMBINATION; THERAPY; LAMIVUDINE; RIBAVIRIN	Pegylated interferon alpha-2a (Peg-IFN-alpha) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune responses are critical for virus control, we investigated the effects of Peg-IFN-alpha on both innate and adaptive immunity, and related it to the clinical evolution. The phenotypic and functional features of the dendritic cells (DCs), natural killer (NK) cells and HBV-specific CD4/CD8 T cells were analyzed in HBeAg-negative CHB patients treated for 48-weeks with NA alone or together with Peg-IFN-alpha, before, during and up to 2-years after therapy. Peg-IFN-alpha induced an early activation of DCs, a potent expansion of the CD56(bright) NK subset, and enhanced the activation and functionality of the CD56(dim) NK subset. Peg-IFN-alpha triggered an increase in the frequencies of Th1- and Th17-oriented HBV-specific CD4/CD8 T cells. Peg-IFN-alpha reversed the unresponsiveness of patients to a specific stimulation. Most of the parameters returned to baseline after the stop of Peg-IFN-alpha therapy. Peg-IFN-alpha impacts both innate and adaptive immunity, overcoming dysfunctional immune responses in CHB patients. These modulations were not associated with seroconversion, which questioned the benefit of the add-on Peg-IFN-alpha treatment.	[Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent; Plumas, Joel; Aspord, Caroline] Univ Grenoble Alpes, F-38041 Grenoble, France; [Costa, Juliana Bruder; Plumas, Joel; Aspord, Caroline] INSERM, U1209, Immunobiol & Immunotherapy Chron Deseases, F-38706 La Tronche, France; [Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent] CHU Grenoble, Michallon Hosp, Hepatogastroenterol Unit, F-38043 Grenoble, France; [Dufeu-Duchesne, Tania; Leroy, Vincent] INSERM, U1209, Analyt Immunol Chron Pathol, F-38706 La Tronche, France; [Bertucci, Inga] ANRS France REch Nord & Sud Sida Hiv Hepatites FR, Paris, France; [Bouvier-Alias, Magali] Univ Paris Est, Henri Mondor Hosp, Dept Virol, Creteil, France; [Bouvier-Alias, Magali] INSERM, U955, Creteil, France; [Pouget, Noelle; Brevot-Lutton, Ophelie] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMRS 113, F-75012 Paris, France; [Bourliere, Marc] St Joseph Hosp, Hepatogastroenterol Dept, F-13008 Marseille, France; [Zoulim, Fabien] Canc Res Ctr Lyon, INSERM U1052, CNRS 5286, Lyon, France; [Zoulim, Fabien] Hosp Civils Lyon, Hepatol Dept, Lyon, France; [Zoulim, Fabien] Univ Lyon, Lyon, France; [Plumas, Joel; Aspord, Caroline] EFS Rhone Alpes, R&D Lab, F-38701 La Tronche, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon	Plumas, J; Aspord, C (corresponding author), Univ Grenoble Alpes, F-38041 Grenoble, France.; Plumas, J; Aspord, C (corresponding author), INSERM, U1209, Immunobiol & Immunotherapy Chron Deseases, F-38706 La Tronche, France.; Plumas, J; Aspord, C (corresponding author), EFS Rhone Alpes, R&D Lab, F-38701 La Tronche, France.	joel.plumas@efs.sante.fr; carolineaspord@yahoo.com	Bouvier-Alias, Magali/S-5631-2018; Zoulim, Fabien/ABD-5594-2021; ASPORD, Caroline/AAU-1805-2020; ASPORD, CAROLINE/N-3179-2013	Bouvier-Alias, Magali/0000-0003-1590-5980; Zoulim, Fabien/0000-0002-2245-0083; Ganne-Carrie, Nathalie/0000-0002-7351-5027; rosa, isabelle/0000-0001-6879-3148; Cales, Paul/0000-0003-4866-5274; ASPORD, CAROLINE/0000-0002-4979-7044; Ratziu, Vlad/0000-0002-6865-3791	French Blood Service (EFS); ANRS (France REcherche Nord AMP; sud Sida-hiv Hepatites)	French Blood Service (EFS); ANRS (France REcherche Nord AMP; sud Sida-hiv Hepatites)	This work was supported by the French Blood Service (EFS) and the study was sponsored and funded by ANRS (France REcherche Nord & sud Sida-hiv Hepatites).	Boltjes A, 2013, MOL IMMUNOL, V53, P72, DOI 10.1016/j.molimm.2012.06.016; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Lampertico P, 2013, GUT, V62, P290, DOI 10.1136/gutjnl-2011-301430; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liang XS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-43; Liu YZ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-274; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Martinet J, 2012, GASTROENTEROLOGY, V143, P1586, DOI 10.1053/j.gastro.2012.08.046; Martinet J, 2012, HEPATOLOGY, V56, P1706, DOI 10.1002/hep.25879; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Penna A, 2012, J HEPATOL, V56, P1239, DOI 10.1016/j.jhep.2011.12.032; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rijckborst V, 2010, AM J GASTROENTEROL, V105, P1762, DOI 10.1038/ajg.2010.186; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Schiavoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00483; Sprinzl MF, 2014, J VIRAL HEPATITIS, V21, P633, DOI 10.1111/jvh.12189; Stelma F, 2015, J INFECT DIS, V212, P1042, DOI 10.1093/infdis/jiv180; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tan AT, 2014, J HEPATOL, V60, P54, DOI 10.1016/j.jhep.2013.08.020; Thimme R, 2013, J HEPATOL, V58, P205, DOI 10.1016/j.jhep.2012.11.007; Tujios SR, 2013, CURR OPIN GASTROEN, V29, P250, DOI 10.1097/MOG.0b013e32835ff1e9; Woltman AM, 2010, GUT, V59, P115, DOI 10.1136/gut.2009.181040; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273	38	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158297	10.1371/journal.pone.0158297	http://dx.doi.org/10.1371/journal.pone.0158297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348813	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200060
J	Kolo, MT; Khandaker, MU; Amin, YM; Abdullah, WHB				Kolo, Matthew Tikpangi; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd; Abdullah, Wan Hasiah Binti			Quantification and Radiological Risk Estimation Due to the Presence of Natural Radionuclides in Maiganga Coal, Nigeria	PLOS ONE			English	Article							FIRED POWER-PLANT; OCCURRING RADIOACTIVE MATERIALS; ENVIRONMENTAL-IMPACT; SOIL SAMPLES; WEST-BENGAL; LIGNITE; ASH; HAZARDS; MINES; RIVER	Following the increasing demand of coal for power generation, activity concentrations of primordial radionuclides were determined in Nigerian coal using the gamma spectrometric technique with the aim of evaluating the radiological implications of coal utilization and exploitation in the country. Mean activity concentrations of Ra-226, Th-232, and K-40 were 8.18 +/- 0.3, 6.97 +/- 0.3, and 27.38 +/- 0.8 Bq kg(-1), respectively. These values were compared with those of similar studies reported in literature. The mean estimated radium equivalent activity was 20.26 Bq kg(-1) with corresponding average external hazard index of 0.05. Internal hazard index and representative gamma index recorded mean values of 0.08 and 0.14, respectively. These values were lower than their respective precautionary limits set by UNSCEAR. Average excess lifetime cancer risk was calculated to be 0.04x10(-3), which was insignificant compared with 0.05 prescribed by ICRP for low level radiation. Pearson correlation matrix showed significant positive relationship between Ra-226 and Th-232, and with other estimated hazard parameters. Cumulative mean occupational dose received by coal workers via the three exposure routes was 7.69 x 10(-3) mSv y(-1), with inhalation pathway accounting for about 98%. All radiological hazard indices evaluated showed values within limits of safety. There is, therefore, no likelihood of any immediate radiological health hazards to coal workers, final users, and the environment from the exploitation and utilization of Maiganga coal.	[Kolo, Matthew Tikpangi; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd] Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia; [Abdullah, Wan Hasiah Binti] Univ Malaya, Dept Geol, Kuala Lumpur 50603, Malaysia; [Kolo, Matthew Tikpangi] Fed Univ Technol, Dept Phys, Minna, Niger State, Nigeria	Universiti Malaya; Universiti Malaya	Khandaker, MU (corresponding author), Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia.	mu_khandaker@um.edu.my	ABDULLAH, W. HASIAH/C-1007-2010; Khandaker, Mayeen Uddin/F-5376-2011	ABDULLAH, W. HASIAH/0000-0002-6748-1019; Khandaker, Mayeen Uddin/0000-0003-3772-294X	Federal Government of Nigeria through the Tertiary Education Trust Fund (TetFund); University of Malaya Research [FP042-2013A, RP006D-13AFR]	Federal Government of Nigeria through the Tertiary Education Trust Fund (TetFund); University of Malaya Research(Universiti Malaya)	This study was fully funded by the Federal Government of Nigeria through the Tertiary Education Trust Fund (TetFund). Financial support from University of Malaya Research Grants: FP042-2013A, and RP006D-13AFR, are highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademola JA., 2014, NATURAL SCI, V6, P752, DOI DOI 10.4236/NS.2014.610075; Akkurt I, 2009, INT J PHYS SCI, V4, P403; Ali M, 2013, RADIAT PROT DOSIM; Alvarez MCA, 1998, FUEL, V77, P1427, DOI 10.1016/S0016-2361(98)00044-1; Amekudzie A., 2011, World Applied Sciences Journal, V13, P2338; [Anonymous], 2013, J NUCL PART PHYS, DOI DOI 10.5923/J.JNPP.20130304.03; [Anonymous], 1996, IAEA SAF SER; Asaduzzaman K, 2014, J ENVIRON RADIOACTIV, V135, P120, DOI 10.1016/j.jenvrad.2014.04.009; Asgharizadeh F, 2013, RADIAT PROT DOSIM, V156, P376, DOI 10.1093/rpd/nct067; Bhangare RC, 2014, J RADIOANAL NUCL CH, V300, P17, DOI 10.1007/s10967-014-2942-3; Bian Z, 2010, MIN SCI TECHNOL, V20, P215, DOI DOI 10.1016/S1674-5264(09)60187-3; Burt Erica, 2013, SCI EVIDENCE HLTH EF; Cam NF, 2010, RADIAT PROT DOSIM, V142, P300, DOI 10.1093/rpd/ncq210; Cevik U, 2007, FUEL, V86, P2509, DOI 10.1016/j.fuel.2007.02.013; Charro E, 2013, RADIAT PROT DOSIM, V153, P485, DOI 10.1093/rpd/ncs126; Dabayneh KM, 2008, RADIAT PROT DOSIM, V131, P265, DOI 10.1093/rpd/ncn161; Degrange J, 2005, P INT COMF SZCZYRK 1, P230; Demir I, 2012, PHYSICOCHEM PROBL MI, V48, P341, DOI 10.5277/ppmp120202; Dowdall M, 2004, J ENVIRON RADIOACTIV, V71, P101, DOI 10.1016/S0265-931X(03)00144-9; Durasevic M, 2014, APPL RADIAT ISOTOPES, V87, P73, DOI 10.1016/j.apradiso.2013.11.096; El-Gamal A, 2007, RADIAT MEAS, V42, P457, DOI 10.1016/j.radmeas.2007.02.054; Emirhan ME, 2009, J RADIOL PROT, V29, P527, DOI 10.1088/0952-4746/29/4/007; Finkelman RB, 2002, INT J COAL GEOL, V50, P425, DOI 10.1016/S0166-5162(02)00125-8; Hasan M., 2014, IOSR J APPL PHYS, V5, P32; Hasani F, 2014, J ENVIRON RADIOACTIV, V138, P156, DOI 10.1016/j.jenvrad.2014.08.015; Huang YJ, 2015, RADIAT PHYS CHEM, V107, P82, DOI 10.1016/j.radphyschem.2014.10.001; ICRP (International Commission on Radiological Protection), 2012, ANN ICRP S, V41, pe1; Jamil K, 1998, J ENVIRON RADIOACTIV, V41, P207, DOI 10.1016/S0265-931X(97)00094-5; Jibiri NN, 2012, RADIAT PHYS CHEM, V81, P103, DOI 10.1016/j.radphyschem.2011.10.002; Khandaker MU, 2012, RADIAT PROT DOSIM, V152, P33, DOI 10.1093/rpd/ncs145; Kisic DM, 2013, HEM IND, V67, P729, DOI 10.2298/HEMIND121016120K; Kolo MT, 2015, ENVIRON SCI POLLUT R, V22, P13127, DOI 10.1007/s11356-015-4577-5; Lauer NE, 2015, ENVIRON SCI TECHNOL, V49, P11227, DOI 10.1021/acs.est.5b01978; Lu XW, 2006, CURR SCI INDIA, V91, P1508; Lu XW, 2012, ENVIRON EARTH SCI, V66, P1925, DOI 10.1007/s12665-011-1417-x; Mandal A, 2003, ENVIRON GEOL, V44, P180, DOI 10.1007/s00254-002-0744-3; Manigandan PK, 2014, J RADIAT RES APPL SI, V7, P310, DOI 10.1016/j.jrras.2014.04.001; MANOLOPOULOU M, 1992, J ENVIRON RADIOACTIV, V16, P261, DOI 10.1016/0265-931X(92)90005-E; Mishra UC, 2004, J ENVIRON RADIOACTIV, V72, P35, DOI 10.1016/S0265-931X(03)00183-8; Mondal T, 2006, CURR SCI INDIA, V91, P1387; Mora J.C., 2009, RADIOPROTECTION, V44, P577, DOI DOI 10.1051/radiopro/20095106; Mustapha AO, 2007, J RADIOL PROT, V27, P187, DOI 10.1088/0952-4746/27/2/005; NEA-OECD, 1979, REP NEA GROUP EXP NU; Papaefthymiou H, 2007, J RADIOANAL NUCL CH, V274, P123, DOI 10.1007/s10967-006-6880-6; Parmaksiz A, 2011, RADIAT PROT DOSIM; Ravisankar R, 2014, APPL RADIAT ISOTOPES, V85, P114, DOI 10.1016/j.apradiso.2013.12.005; Taskin H, 2009, J ENVIRON RADIOACTIV, V100, P49, DOI 10.1016/j.jenvrad.2008.10.012; Tsikritzis LI, 2008, J ENVIRON RADIOACTIV, V99, P230, DOI 10.1016/j.jenvrad.2007.07.014; Tso MW, 1996, J ENVIRON RADIOACTIV, V30, P1, DOI 10.1016/0265-931X(95)00042-9; Tufail M, 2012, ENVIRON MONIT ASSESS, V184, P5663, DOI 10.1007/s10661-011-2370-6; Turhan S, 2010, FUEL, V89, P3892, DOI 10.1016/j.fuel.2010.06.045; UNSCEAR, 2000, SOURC EFF ION RAD, P18; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 1982, ION RAD SOURC BIOL E	53	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158100	10.1371/journal.pone.0158100	http://dx.doi.org/10.1371/journal.pone.0158100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348624	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200036
J	Lefebvre, E; Moyle, G; Reshef, R; Richman, LP; Thompson, M; Hong, F; Chou, HI; Hashiguchi, T; Plato, C; Poulin, D; Richards, T; Yoneyama, H; Jenkins, H; Wolfgang, G; Friedman, SL				Lefebvre, Eric; Moyle, Graeme; Reshef, Ran; Richman, Lee P.; Thompson, Melanie; Hong, Feng; Chou, Hsin-I; Hashiguchi, Taishi; Plato, Craig; Poulin, Dominic; Richards, Toni; Yoneyama, Hiroyuki; Jenkins, Helen; Wolfgang, Grushenka; Friedman, Scott L.			Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; HEPATIC-FIBROSIS; PHASE 2B; IN-VITRO; DISEASE; MICE; CCR2; INJURY; PHARMACOKINETICS	Background & Aims Interactions between C-C chemokine receptor types 2 (CCR2) and 5 (CCR5) and their ligands, including CCL2 and CCL5, mediate fibrogenesis by promoting monocyte/macrophage recruitment and tissue infiltration, as well as hepatic stellate cell activation. Cenicriviroc (CVC) is an oral, dual CCR2/CCR5 antagonist with nanomolar potency against both receptors. CVC's anti-inflammatory and antifibrotic effects were evaluated in a range of preclinical models of inflammation and fibrosis. Methods Monocyte/macrophage recruitment was assessed in vivo in a mouse model of thioglycollate- induced peritonitis. CCL2-induced chemotaxis was evaluated ex vivo on mouse monocytes. CVC's antifibrotic effects were evaluated in a thioacetamide-induced rat model of liver fibrosis and mouse models of diet-induced non-alcoholic steatohepatitis (NASH) and renal fibrosis. Study assessments included body and liver/kidney weight, liver function test, liver/kidney morphology and collagen deposition, fibrogenic gene and protein expression, and pharmacokinetic analyses. Results CVC significantly reduced monocyte/macrophage recruitment in vivo at doses >= 20 mg/kg/ day (p < 0.05). At these doses, CVC showed antifibrotic effects, with significant reductions in collagen deposition (p < 0.05), and collagen type 1 protein and mRNA expression across the three animal models of fibrosis. In the NASH model, CVC significantly reduced the nonalcoholic fatty liver disease activity score (p < 0.05 vs. controls). CVC treatment had no notable effect on body or liver/kidney weight. Conclusions CVC displayed potent anti-inflammatory and antifibrotic activity in a range of animal fibrosis models, supporting human testing for fibrotic diseases. Further experimental studies are needed to clarify the underlying mechanisms of CVC's antifibrotic effects. A Phase 2b study in adults with NASH and liver fibrosis is fully enrolled (CENTAUR Study 652-2-203; NCT02217475).	[Lefebvre, Eric; Jenkins, Helen] Tobira Therapeut Inc, San Francisco, CA USA; [Moyle, Graeme] Chelsea & Westminster Hosp, London, England; [Reshef, Ran] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA; [Richman, Lee P.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Thompson, Melanie] AIDS Res Consortium Atlanta, Atlanta, GA USA; [Hong, Feng; Chou, Hsin-I; Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA; [Hashiguchi, Taishi; Yoneyama, Hiroyuki] Stelic Inst & Co Inc, Tokyo, Japan; [Plato, Craig; Richards, Toni] Plato BioPharma Inc, Westminster, CO USA; [Poulin, Dominic] Charles River Labs Montreal ULC, Montreal, PQ, Canada	Imperial College London; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai	Friedman, SL (corresponding author), Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA.	scott.friedman@mssm.edu		Reshef, Ran/0000-0003-2185-9546; Richman, Lee/0000-0002-4601-5190	Tobira Therapeutics, Inc.(South San Francisco, CA, USA) [1 (650) 741-6625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER	Tobira Therapeutics, Inc.(South San Francisco, CA, USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Tobira Therapeutics, Inc. (701 Gateway Blvd, Suite 300, South San Francisco, CA 94080, USA; 1 (650) 741-6625; www.tobiratherapeutics.com). The sponsor has been involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baba M, 2005, ANTIMICROB AGENTS CH, V49, P4584, DOI 10.1128/AAC.49.11.4584-4591.2005; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Byron MM, 2015, J IMMUNOL, V194; Byron MM, 2015, IMM 2015 AM ASS IMM; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Ding SY, 2005, ACTA PHARMACOL SIN, V26, P575, DOI 10.1111/j.1745-7254.2005.00090.x; Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2; Friedman S, 2016, CONTEMP CLIN TRIALS, V47, P356, DOI 10.1016/j.cct.2016.02.012; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Han JY, 2010, J KOREAN MED SCI, V25, P35, DOI 10.3346/jkms.2010.25.1.35; Hashimoto E, 2013, J GASTROEN HEPATOL, V28, P64, DOI 10.1111/jgh.12271; Hayashi H, 2011, AM J PHYSIOL-GASTR L, V300, pG729, DOI 10.1152/ajpgi.00013.2011; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Higashi K, 2010, NEPHROLOGY, V15, P327, DOI 10.1111/j.1440-1797.2009.01253.x; Jalbert E, 2014, 21 C RETR OPP INF CR, P530; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kang YS, 2010, KIDNEY INT, V78, P883, DOI 10.1038/ki.2010.263; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Krenkel O, 2015, J HEPATOL, V62, pS206, DOI 10.1016/S0168-8278(15)30041-6; Krenkel O, 2015, 66 ANN M AM ASS STUD, P1756; Kuroshima K, 2003, TAK65200045 TAK CHEM; Lalezari J, 2011, JAIDS-J ACQ IMM DEF, V57, P118, DOI 10.1097/QAI.0b013e318213c2c0; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lefebvre E, 2016, CTS-CLIN TRANSL SCI, V9, P139, DOI 10.1111/cts.12397; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Marier JF, 2011, ANTIMICROB AGENTS CH, V55, P2768, DOI 10.1128/AAC.00713-10; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Panzer U, 2006, CURR DRUG TARGETS, V7, P65, DOI 10.2174/138945006775270213; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Puengel T, J HEPATOL, V64, ps159; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Reshef R, 2012, NEW ENGL J MED, V367, P135, DOI 10.1056/NEJMoa1201248; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Segerer S, 1999, KIDNEY INT, V56, P52, DOI 10.1046/j.1523-1755.1999.00544.x; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Sherman K. E., 2015, HEP DART 2015 FRONT; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Thompson M, 2016, AIDS, V30, P869, DOI 10.1097/QAD.0000000000000988; Thompson M, 2014, HEPATOLOGY, V60, p424A; Tobira Therapeutics Inc. Ndhlovu Laboratory, 2015, IN VITR CCR2 CCR5 RE; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075361; Ucero AC, 2014, INT UROL NEPHROL, V46, P765, DOI 10.1007/s11255-013-0520-1; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Xia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077493; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509	56	189	198	10	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158156	10.1371/journal.pone.0158156	http://dx.doi.org/10.1371/journal.pone.0158156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347680	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200040
J	Morse, D; Webster, W; Kalanon, M; Langsley, G; McFadden, GI				Morse, David; Webster, Wesley; Kalanon, Ming; Langsley, Gordon; McFadden, Geoffrey I.			Plasmodium falciparum Rab1A Localizes to Rhoptries in Schizonts	PLOS ONE			English	Article							EARLY ENDOCYTIC PATHWAY; TOXOPLASMA-GONDII; ENDOPLASMIC-RETICULUM; SECRETORY ORGANELLE; PROTEIN; TRANSPORT; BIOGENESIS; GTPASE; FUSION; FAMILY	Over-expression of a GFP-PfRab1A fusion protein in Plasmodium falciparum schizonts produces a punctate pattern of fluorescence typical of rhoptries, secretory organelles involved in host cell invasion. The GFP-positive bodies were purified by a combination of differential and density gradient centrifugation and their protein content determined by MS/MS sequencing. Consistent with the GFP rhoptry-like pattern of transgenic parasites, four of the 19 proteins identified have been previously described to be rhoptry-associated and another four are ER or ER-associated proteins. Confirmation that GFP-PfRab1A decorates rhoptries was obtained by its co-localization with Rap1 and Ron4 in late phase schizonts. We conclude that PfRab1A potentially regulates vesicular traffic from the endoplasmic reticulum to the rhoptries in Apicomplexa parasites.	[Morse, David; Webster, Wesley; Kalanon, Ming; McFadden, Geoffrey I.] Univ Melbourne, Sch Biosci, Melbourne, Vic 3010, Australia; [Langsley, Gordon] Univ Paris 05, Lab Biol Cellulaire Comparat Apicomplexes, Inst Cochin, INSERM,U1016,CNRS,UMR 8104, F-75014 Paris, France; [Webster, Wesley] Deakin Univ, Ctr Reg & Rural Futures, Burwood, Australia; [Kalanon, Ming] Deakin Univ, Fac Law, Burwood, Australia	University of Melbourne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Deakin University; Deakin University	Morse, D (corresponding author), Univ Melbourne, Sch Biosci, Melbourne, Vic 3010, Australia.	david.morse@umontreal.ca	McFadden, Geoffrey McFadden I/F-7667-2014	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Morse, David/0000-0003-4131-4367	National Health and Medical Research Council (Australia); Australian Research Council; Labex ParaFrap [ANR-11-LABX-0024]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Labex ParaFrap	Funded by National Health and Medical Research Council (Australia); Australian Research Council; Labex ParaFrap - ANR-11-LABX-0024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Dean Goodman and other members of the McFadden laboratory for helpful advice and suggestions, to Tim Spurck for assistance with the confocal microscope, and to Kris Ford for proteomic analysis. GIM gratefully acknowledges a Program Grant from the National Health and Medical Research Council (Australia) and a Discovery Grant from Australian Research Council, and GL acknowledges support from the Labex ParaFrap (ANR-11-LABX-0024). We also thank the Australian Red Cross for blood.	Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Breinich MS, 2009, CURR BIOL, V19, P277, DOI 10.1016/j.cub.2009.01.039; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Buvelot Frei Stephanie, 2006, Mol Cell Biol, V26, P7299, DOI 10.1128/MCB.02405-05; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Collins RN, 2005, METHOD ENZYMOL, V403, P19, DOI 10.1016/S0076-6879(05)03003-X; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Elias M, 2009, J EUKARYOT MICROBIOL, V56, P348, DOI 10.1111/j.1550-7408.2009.00408.x; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; JAIKARIA NS, 1993, MOL BIOCHEM PARASIT, V57, P269, DOI 10.1016/0166-6851(93)90203-A; Jin MJ, 1996, J BIOL CHEM, V271, P30105, DOI 10.1074/jbc.271.47.30105; Kats LM, 2006, TRENDS PARASITOL, V22, P269, DOI 10.1016/j.pt.2006.04.001; Kibria KMK, 2015, BBA-MOL CELL RES, V1853, P699, DOI 10.1016/j.bbamcr.2014.12.030; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Mesa R, 2001, J CELL SCI, V114, P4041; Ngo HM, 2003, J BIOL CHEM, V278, P5343, DOI 10.1074/jbc.M208291200; PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393; Quevillon E, 2003, GENE, V306, P13, DOI 10.1016/S0378-1119(03)00381-0; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Roberts RL, 1999, J CELL SCI, V112, P3667; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792; SARASTE J, 1995, J CELL SCI, V108, P1541; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SINGERKRUGER B, 1995, J CELL SCI, V108, P3509; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; Stenmark H, 2001, GENOME BIOL, V2; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57, DOI 10.21775/cimb.007.057; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158174	10.1371/journal.pone.0158174	http://dx.doi.org/10.1371/journal.pone.0158174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348424	gold, Green Submitted, Green Published			2022-12-26	WOS:000378801200045
J	Zhang, L; Nan, ZT; Xu, Y; Li, S				Zhang, Ling; Nan, Zhuotong; Xu, Yi; Li, Shuo			Hydrological Impacts of Land Use Change and Climate Variability in the Headwater Region of the Heihe River Basin, Northwest China	PLOS ONE			English	Article							USE CHANGE SCENARIOS; WATER-RESOURCES; CLUE-S; BLUE WATER; SWAT MODEL; QUANTITATIVE ASSESSMENT; RUNOFF GENERATION; MIDDLE REACHES; USE/LAND COVER; LOESS PLATEAU	Land use change and climate variability are two key factors impacting watershed hydrology, which is strongly related to the availability of water resources and the sustainability of local ecosystems. This study assessed separate and combined hydrological impacts of land use change and climate variability in the headwater region of a typical arid inland river basin, known as the Heihe River Basin, northwest China, in the recent past (1995-2014) and near future (2015-2024), by combining two land use models (i.e., Markov chain model and Dyna-CLUE) with a hydrological model (i.e., SWAT). The potential impacts in the near future were explored using projected land use patterns and hypothetical climate scenarios established on the basis of analyzing long-term climatic observations. Land use changes in the recent past are dominated by the expansion of grassland and a decrease in farmland; meanwhile the climate develops with a wetting and warming trend. Land use changes in this period induce slight reductions in surface runoff, groundwater discharge and streamflow whereas climate changes produce pronounced increases in them. The joint hydrological impacts are similar to those solely induced by climate changes. Spatially, both the effects of land use change and climate variability vary with the sub-basin. The influences of land use changes are more identifiable in some sub-basins, compared with the basin-wide impacts. In the near future, climate changes tend to affect the hydrological regimes much more prominently than land use changes, leading to significant increases in all hydrological components. Nevertheless, the role of land use change should not be overlooked, especially if the climate becomes drier in the future, as in this case it may magnify the hydrological responses.	[Zhang, Ling] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China; [Zhang, Ling] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Nan, Zhuotong; Xu, Yi; Li, Shuo] Nanjing Normal Univ, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China; [Nan, Zhuotong] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Li, Shuo] State Key Lab Cultivat Base Geog Environm Evolut, Nanjing 210023, Jiangsu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Normal University	Nan, ZT (corresponding author), Nanjing Normal Univ, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China.; Nan, ZT (corresponding author), Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China.	nanzt@njnu.edu.cn	NAN, ZHUOTONG/D-7518-2018	NAN, ZHUOTONG/0000-0002-7930-3850	National Natural Science Foundation of China [41471059]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions [164320H116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was financially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/; No. 41471059, recipient: ZN) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (http://www.ec.js.edu.cn/; No. 164320H116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai Y, 2014, J COASTAL RES, P121, DOI 10.2112/SI68-016.1; Chen H, 2012, J HYDROL, V434, P36, DOI 10.1016/j.jhydrol.2012.02.040; Chen L, 2014, J GEOPHYS RES-ATMOS, V119, P5767, DOI 10.1002/2013JD021190; Chen YN, 2015, ENVIRON RES, V139, P11, DOI 10.1016/j.envres.2014.12.029; Cheng Chunxiao, 2014, Journal of Beijing Normal University (Natural Science), V50, P535; Cheng GD, 2014, NATL SCI REV, V1, P413, DOI 10.1093/nsr/nwu017; Chu HJ, 2010, HYDROL PROCESS, V24, P2538, DOI 10.1002/hyp.7667; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Khoi DN, 2014, HYDROL PROCESS, V28, P640, DOI 10.1002/hyp.9620; Ding Y.H., 2006, ADV CLIM CHANG RES, V2, DOI [DOI 10.3969/J.ISSN.1673-1719.2006.01.001, 10.3969/j.issn.1673-1719.2007.z1.001]; Du Y, 2006, EEARTH SCI J CHINA U, V31; Gan R, 2015, J MT SCI-ENGL, V12, P614, DOI 10.1007/s11629-013-2959-z; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Guan DJ, 2011, ECOL MODEL, V222, P3761, DOI 10.1016/j.ecolmodel.2011.09.009; He ZL, 2013, HYDROL RES, V44, P723, DOI 10.2166/nh.2012.441; Hu XL, 2015, ENERGIES, V8, P7040, DOI 10.3390/en8077040; Hu XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128960; Hu YC, 2013, CHINESE GEOGR SCI, V23, P92, DOI 10.1007/s11769-013-0594-9; Hu ZD, 2015, INT J CLIMATOL, V35, P97, DOI 10.1002/joc.3965; Huang QingHua, 2004, Journal of Nanjing Forestry University (Natural Sciences Edition), V28, P22; Hurkmans RTWL, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007574; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Islam A, 2012, WATER RESOUR MANAG, V26, P1409, DOI 10.1007/s11269-011-9965-0; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Jiang T, 2007, J HYDROL, V336, P316, DOI 10.1016/j.jhydrol.2007.01.010; Jiao WX, 2013, ENVIRON EARTH SCI, V68, P881, DOI 10.1007/s12665-012-1793-x; Kang E, 2007, J ENVIRON MANAGE, V85, P702, DOI 10.1016/j.jenvman.2006.09.007; Karlsson IB, 2016, J HYDROL, V535, P301, DOI 10.1016/j.jhydrol.2016.01.069; Kim J, 2013, SCI TOTAL ENVIRON, V452, P181, DOI 10.1016/j.scitotenv.2013.02.005; [赖正清 Lai Zhengqing], 2013, [自然资源学报, Journal of Natural Resources], V28, P1404; [蓝永超 Lan Yongchao], 2004, [高原气象, Plateau Meteorology], V23, P723; Li C., 2012, STUDY IMPROVEMENT SW; Li ZL, 2010, J HYDROL, V385, P76, DOI 10.1016/j.jhydrol.2010.01.025; Li ZL, 2009, HYDROL PROCESS, V23, P2744, DOI 10.1002/hyp.7371; Li Z, 2009, J HYDROL, V377, P35, DOI 10.1016/j.jhydrol.2009.08.007; [林炳青 Lin Bingqing], 2013, [自然资源学报, Journal of Natural Resources], V28, P1988; Liston GE, 2006, J HYDROMETEOROL, V7, P217, DOI 10.1175/JHM486.1; Mengistu DT, 2012, HYDROL EARTH SYST SC, V16, P391, DOI 10.5194/hess-16-391-2012; Mishra V, 2010, INT J CLIMATOL, V30, P2025, DOI 10.1002/joc.2095; Molina-Navarro E, 2014, J HYDROL, V509, P354, DOI 10.1016/j.jhydrol.2013.11.053; Moran-Tejeda E, 2012, REG ENVIRON CHANGE, V12, P17, DOI 10.1007/s10113-011-0236-7; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; MULLER MR, 1994, LANDSCAPE ECOL, V9, P151; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Neitsch S.L., 2011, SOIL WATER ASSESSMEN, P1, DOI [DOI 10.1016/J.SCITOTENV.2015.11.063, 10.1016/j.scitotenv.2015.11.063]; Nejadhashemi A.P., 2011, HYDROL EARTH SYST SC, V8, P3421, DOI [https://doi.org/10.5194/hessd-8-3421-2011, DOI 10.5194/HESSD-8-3421-2011, 10.5194/hessd-8-3421-2011]; Nian YY, 2014, J ARID LAND, V6, P273, DOI 10.1007/s40333-013-0209-4; Nie WM, 2011, J HYDROL, V407, P105, DOI 10.1016/j.jhydrol.2011.07.012; Niraula R, 2015, J HYDROL, V522, P439, DOI 10.1016/j.jhydrol.2015.01.007; Park JY, 2011, T ASABE, V54, P1713, DOI 10.13031/2013.39842; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Province DoSIoG, 1993, SOIL GANS PROV; Qin J, 2013, J ARID LAND, V5, P366, DOI 10.1007/s40333-013-0162-2; Rehana S, 2011, HYDROL PROCESS, V25, P3373, DOI 10.1002/hyp.8057; Sang YF, 2014, THEOR APPL CLIMATOL, V115, P187, DOI 10.1007/s00704-013-0888-y; Shi P, 2013, WATER RESOUR MANAG, V27, P1263, DOI 10.1007/s11269-012-0237-4; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Sriwongsitanon N, 2011, J HYDROL, V410, P226, DOI 10.1016/j.jhydrol.2011.09.021; Tanzeeba S, 2012, CLIMATIC CHANGE, V112, P355, DOI 10.1007/s10584-011-0221-7; The Ministry of Water Resources of the People's Republic of China, 2000, REC MAN PLANN HEIH R; Tong STY, 2012, APPL GEOGR, V32, P477, DOI 10.1016/j.apgeog.2011.06.014; Tu J, 2009, J HYDROL, V379, P268, DOI 10.1016/j.jhydrol.2009.10.009; Verburg P.H., 2004, COMPUTERS ENV URBAN, V28, P667, DOI [10.1016/j.compenvurbsys.2003.07.001, DOI 10.1016/J.COMPENVURBSYS.2003.07.001]; Verburg PH, 2009, LANDSCAPE ECOL, V24, P1167, DOI 10.1007/s10980-009-9355-7; Verburg PH, 2002, ENVIRON MANAGE, V30, P391, DOI 10.1007/s00267-002-2630-x; Wang GQ, 2014, HYDROL PROCESS, V28, P1032, DOI 10.1002/hyp.9645; Wang J, 2014, LANDUSE LANDCOVER DA, DOI [10.3972/heihe.093.2014.db, DOI 10.3972/HEIHE.093.2014.DB]; Wang J. H., 2014, LANDUSE LANDCOVER DA, DOI [10.3972/heihe.039.2014.db, DOI 10.3972/HEIHE.039.2014.DB]; [王录仓 Wang Lucang], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P60; Wang NL, 2009, CHINESE SCI BULL, V54, P2751, DOI 10.1007/s11434-009-0505-8; Wang RY, 2014, HYDROL PROCESS, V28, P5530, DOI 10.1002/hyp.10057; Wang WG, 2013, HYDROL PROCESS, V27, P1158, DOI 10.1002/hyp.9299; Wang Y, 2011, LANDUSE LANDCOVER DA, DOI [10.3972/heihe.021.2013.db, DOI 10.3972/HEIHE.021.2013.DB]; Wang Y, 2013, ENVIRON MANAGE, V52, P209, DOI 10.1007/s00267-013-0077-x; Wu F, 2014, ECOL MODELL; Wu F., 2015, ADV METEOROL; Wu F, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/410198; Wu F, 2015, PHYS CHEM EARTH, V79-82, P11, DOI 10.1016/j.pce.2014.08.002; [吴维臻 Wu Weizhen], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P143; Xu CY, 1999, PROG PHYS GEOG, V23, P229, DOI 10.1177/030913339902300204; Xu CY, 2000, WATER RESOUR MANAG, V14, P177, DOI 10.1023/A:1026502114663; Xu CY, 1999, WATER RESOUR MANAG, V13, P369, DOI 10.1023/A:1008190900459; Yang Q, 2011, HYDROL PROCESS, V25, P1271, DOI 10.1002/hyp.7896; Yang X, 2012, ECOL MODEL, V233, P11, DOI 10.1016/j.ecolmodel.2012.03.011; Ye S., 2005, STUDY 3D VISUALIZATI; [余文君 Yu Wenjun], 2013, [生态学报, Acta Ecologica Sinica], V33, P6992; Zang CF, 2012, HYDROL EARTH SYST SC, V16, P2859, DOI 10.5194/hess-16-2859-2012; Zang CF, 2013, J HYDROL, V502, P27, DOI 10.1016/j.jhydrol.2013.08.022; Zhang AJ, 2015, J HYDROL-REG STUD, V3, P106, DOI 10.1016/j.ejrh.2014.10.005; [Zhang Jishi 张济世], 2003, Journal of Geographical Sciences, V13, P286; Zhang L, 2016, ENVIRON MANAGE, V57, P412, DOI 10.1007/s00267-015-0620-z; Zhang L, 2015, WATER RESOUR MANAG, V29, P4701, DOI 10.1007/s11269-015-1085-9; Zhang P, 2013, MATH COMPUT MODEL, V58, P588, DOI 10.1016/j.mcm.2011.10.061; Zhang WB, 2014, WATER RESOUR MANAG, V28, P4715, DOI 10.1007/s11269-014-0769-x; Zhang YF, 2014, HYDROL PROCESS, V28, P186, DOI 10.1002/hyp.9564; Zhou DC, 2012, ECOL INDIC, V23, P88, DOI 10.1016/j.ecolind.2012.03.021; Zhou F, 2013, J HYDROL, V485, P113, DOI 10.1016/j.jhydrol.2012.12.040; Zhou J, 2011, HYDROL PROCESS, V25, P1964, DOI 10.1002/hyp.7952	98	77	84	7	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158394	10.1371/journal.pone.0158394	http://dx.doi.org/10.1371/journal.pone.0158394			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348224	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200065
J	Bialek, JK; Dunay, GA; Voges, M; Schafer, C; Spohn, M; Stucka, R; Hauber, J; Lange, UC				Bialek, Julia K.; Dunay, Gabor A.; Voges, Maike; Schaefer, Carola; Spohn, Michael; Stucka, Rolf; Hauber, Joachim; Lange, Ulrike C.			Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REACTIVATION; CELLS; GENERATION; THERAPY; GENES; CURE; PCR	CRISPR/Cas9 technology is currently considered the most advanced tool for targeted genome engineering. Its sequence-dependent specificity has been explored for locus-directed transcriptional modulation. Such modulation, in particular transcriptional activation, has been proposed as key approach to overcome silencing of dormant HIV provirus in latently infected cellular reservoirs. Currently available agents for provirus activation, so-called latency reversing agents (LRAs), act indirectly through cellular pathways to induce viral transcription. However, their clinical performance remains suboptimal, possibly because reservoirs have diverse cellular identities and/or proviral DNA is intractable to the induced pathways. We have explored two CRISPR/Cas9-derived activator systems as targeted approaches to induce dormant HIV-1 proviral DNA. These systems recruit multiple transcriptional activation domains to the HIV 5'long terminal repeat (LTR), for which we have identified an optimal target region within the LTR U3 sequence. Using this target region, we demonstrate transcriptional activation of proviral genomes via the synergistic activation mediator complex in various in culture model systems for HIV latency. Observed levels of induction are comparable or indeed higher than treatment with established LRAs. Importantly, activation is complete, leading to production of infective viral particles. Our data demonstrate that CRISPR/Cas9-derived technologies can be applied to counteract HIV latency and may therefore represent promising novel approaches in the quest for HIV elimination.	[Bialek, Julia K.; Dunay, Gabor A.; Voges, Maike; Schaefer, Carola; Spohn, Michael; Hauber, Joachim; Lange, Ulrike C.] Heinrich Pette Inst, Leibniz Inst Expt Virol, Hamburg, Germany; [Lange, Ulrike C.] Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany; [Stucka, Rolf] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Dunay, Gabor A.; Schaefer, Carola; Hauber, Joachim; Lange, Ulrike C.] German Ctr Infect Res DZIF, Partner Site, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; German Center for Infection Research	Lange, UC (corresponding author), Heinrich Pette Inst, Leibniz Inst Expt Virol, Hamburg, Germany.; Lange, UC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany.; Lange, UC (corresponding author), German Ctr Infect Res DZIF, Partner Site, Hamburg, Germany.	ulrike.lange@hpi.uni-hamburg.de			German Center of Infection Research [TI07.001, TI07.002]; "Viral Latency" program at the Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; Open Access Fund of the Leibniz Association	German Center of Infection Research; "Viral Latency" program at the Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; Open Access Fund of the Leibniz Association	UCL was supported by a Clinical Leave Stipend from the German Center of Infection Research (grant TI07.001; http://www.dzif.de). GAD was supported by a MD/PhD stipend from the German Center of Infection Research (grant TI07.002; http://www.dzif.de). This work received support from the "Viral Latency" program at the Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany (http://www.hpi-hamburg.de). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Calvanese V, 2013, VIROLOGY, V446, P283, DOI 10.1016/j.virol.2013.07.037; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Donahue DA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-11; Geissler R, 2015, VIROLOGY, V486, P248, DOI 10.1016/j.virol.2015.09.018; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Ji HYY, 2016, MOL THER, V24, P508, DOI 10.1038/mt.2016.7; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kulpa DA, 2015, J VIRUS ERAD, V1, P59; Kumar A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0137-6; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Martin AR, 2016, ANNU REV MED, V67, P215, DOI 10.1146/annurev-med-011514-023043; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Perdigao P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150037; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Rasmussen TA, 2016, CURR OPIN HIV AIDS, V11, P394, DOI 10.1097/COH.0000000000000279; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Sgarbanti M, 2013, CURR OPIN VIROL, V3, P394, DOI 10.1016/j.coviro.2013.06.001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Trypsteen W, 2015, ANAL BIOANAL CHEM, V407, P5827, DOI 10.1007/s00216-015-8773-4; Wang P, 2014, GENE THER, V21, P490, DOI 10.1038/gt.2014.21; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Xing SF, 2013, DRUG DISCOV TODAY, V18, P541, DOI 10.1016/j.drudis.2012.12.008; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277	48	57	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158294	10.1371/journal.pone.0158294	http://dx.doi.org/10.1371/journal.pone.0158294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341108	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600047
J	Zhang, X; Kang, ZH; Mao, M; Li, XK; Cameron, SL; de Jong, H; Wang, MQ; Yang, D				Zhang, Xiao; Kang, Zehui; Mao, Meng; Li, Xuankun; Cameron, Stephen L.; de Jong, Herman; Wang, Mengqing; Yang, Ding			Comparative Mt Genomics of the Tipuloidea (Diptera: Nematocera: Tipulomorpha) and Its Implications for the Phylogeny of the Tipulomorpha	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; EVOLUTION; SEQUENCES; INSECTA; DIVERSIFICATION; REARRANGEMENTS; DUPLICATION; FAMILIES; INSIGHTS; MIDGES	A traditionally controversial taxon, the Tipulomorpha has been frequently discussed with respect to both its familial composition and relationships with other Nematocera. The interpretation of internal relationships within the Tipuloidea, which include the Tipulidae sensu stricto, Cylindrotomidae, Pediciidae and Limoniidae, is also problematic. We sequenced the first complete mitochondrial (mt) genome of Symplecta hybrida (Meigen, 1804), which belongs to the subfamily Chioneinae of family Limoniidae, and another five nearly complete mt genomes from the Tipuloidea. We did a comparative analysis of these mt genomics and used them, along with some other representatives of the Nematocera to construct phylogenetic trees. Trees inferred by Bayesian methods strongly support a sister-group relationship between Trichoceridae and Tipuloidea. Tipulomorpha are not supported as the earliest branch of the Diptera. Furthermore, phylogenetic trees indicate that the family Limoniidae is a paraphyletic group.	[Zhang, Xiao; Kang, Zehui; Li, Xuankun; Wang, Mengqing; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Mao, Meng] Univ Wollongong, Sch Biol Sci, Ctr Med Biosci, Wollongong, NSW 2522, Australia; [Cameron, Stephen L.] Queensland Univ Technol, Earth Environm & Biol Sci Sch, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [de Jong, Herman] Nat Biodivers Ctr, Darwinweg 2, NL-2333 CR Leiden, Netherlands; [Wang, Mengqing] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	China Agricultural University; University of Wollongong; Queensland University of Technology (QUT); Naturalis Biodiversity Center; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, MQ; Yang, D (corresponding author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.; Wang, MQ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	mengqingsw@163.com; dyangcau@126.com	Cameron, Stephen L/A-3742-2008; Mao, Meng/AAP-9930-2021; Zhang, Xiao/AAD-7627-2020	Cameron, Stephen L/0000-0002-6694-4130; Zhang, Xiao/0000-0002-8054-0968; Kang, Zehui/0000-0003-1961-9578	National Natural Science Foundation of China [31272354, 3141101151, 4151101023]; Chinese Universities Scientific Fund [2015NX001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (31272354, 3141101151, 4151101023) and the Chinese Universities Scientific Fund (2015NX001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C.P., 1981, Canada Department of Agriculture Research Branch Monograph, P153; Alexander C.P., 1981, Canada Department of Agriculture Research Branch Monograph, P301; Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2011, GENOME, V54, P368, DOI [10.1139/G11-006, 10.1139/g11-006]; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Bertone MA, 2008, SYST ENTOMOL, V33, P668, DOI 10.1111/j.1365-3113.2008.00437.x; Blagoderov V, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)509[1:HTFFFD]2.0.CO;2; Boore JL, 2006, OMICS, V10, P119, DOI 10.1089/omi.2006.10.119; Boore JL, 2001, MOL BIOL EVOL, V18, P1413, DOI 10.1093/oxfordjournals.molbev.a003925; BORKENT A, 2012, ZOOTAXA 0723, P1; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2015, MITOCHONDR DNA, V26, P289, DOI 10.3109/19401736.2013.825779; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Ribeiro GC, 2008, INVERTEBR SYST, V22, P627, DOI 10.1071/IS08017; DAHL C, 1980, ZOOL SCR, V9, P165, DOI 10.1111/j.1463-6409.1980.tb00662.x; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Griffiths GCD, 1990, QUAEST ENTOMOL, V26, P117; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy CM, 2015, MITOCHONDR DNA, P1; Hardy CM, 2014, MITOCHONDR DNA, P1; Hennig W., 1954, Beitraege zur Entomologie Berlin, V4, P245; Hennig W., 1973, Handbuch der Zoologie, V4(2), P1; Hennig W., 1981, INSECT PHYLOGENY; Hua YQ, 2015, MITOCHONDR DNA, P1; Kang Z, 2014, MITOCHONDR DNA, P1; Kocher A., 2015, MITOCHONDR DNA, P1, DOI DOI 10.3109/19401736.2015.1022748.; KRZEMINSKI W, 1992, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V65, P39; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Lambkin CL, 2013, SYST ENTOMOL, V38, P164, DOI 10.1111/j.1365-3113.2012.00652.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061685; Li XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123594; Logue K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-64; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mao M, 2014, MOL BIOL EVOL, V31, P636, DOI 10.1093/molbev/mst255; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Michelsen V, 1996, ZOOL J LINN SOC-LOND, V117, P71; Miller BR, 1997, INSECT MOL BIOL, V6, P105, DOI 10.1111/j.1365-2583.1997.tb00078.x; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; OOSTERBROEK P, 1995, ZOOL J LINN SOC-LOND, V115, P267, DOI 10.1111/j.1096-3642.1995.tb02462.x; Oosterbroek P., CATALOGUE CRANEFLIES; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Petersen MJ, 2010, SYST ENTOMOL, V35, P526, DOI 10.1111/j.1365-3113.2010.00524.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; STARY J, 1992, Acta Zoologica Cracoviensia, V35, P11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timmermans MJTN, 2012, MOL PHYLOGENET EVOL, V63, P299, DOI 10.1016/j.ympev.2011.12.021; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wood D.M., 1989, Agriculture Canada Monograph, P1333; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27	67	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158167	10.1371/journal.pone.0158167	http://dx.doi.org/10.1371/journal.pone.0158167			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341029	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600036
J	Grumet, L; Eichmann, TO; Taschler, U; Zierler, KA; Leopold, C; Moustafa, T; Radovic, B; Romauch, M; Yan, C; Du, H; Haemmerle, G; Zechner, R; Fickert, P; Kratky, D; Zimmermann, R; Lass, A				Grumet, Lukas; Eichmann, Thomas O.; Taschler, Ulrike; Zierler, Kathrin A.; Leopold, Christina; Moustafa, Tarek; Radovic, Branislav; Romauch, Matthias; Yan, Cong; Du, Hong; Haemmerle, Guenter; Zechner, Rudolf; Fickert, Peter; Kratky, Dagmar; Zimmermann, Robert; Lass, Achim			Lysosomal Acid Lipase Hydrolyzes Retinyl Ester and Affects Retinoid Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrolase; lipase; retinoid; retinol; vitamin A; knockout mouse; lysosomal acid lipase; retinyl ester	CHOLESTERYL ESTER; RAT-LIVER; DEFICIENT; MICE; ABSORPTION; ENDOSOMES; TRANSPORT; CELLS; SITE	Lysosomal acid lipase (LAL) is essential for the clearance of endocytosed cholesteryl ester and triglyceride-rich chylomicron remnants. Humans and mice with defective or absent LAL activity accumulate large amounts of cholesteryl esters and triglycerides in multiple tissues. Although chylomicrons also contain retinyl esters (REs), a role of LAL in the clearance of endocytosed REs has not been reported. In this study, we found that murine LAL exhibits RE hydrolase activity. Pharmacological inhibition of LAL in the human hepatocyte cell line HepG2, incubated with chylomicrons, led to increased accumulation of REs in endosomal/lysosomal fractions. Furthermore, pharmacological inhibition or genetic ablation of LAL in murine liver largely reduced in vitro acid RE hydrolase activity. Interestingly, LAL-deficient mice exhibited increased RE content in the duodenum and jejunum but decreased RE content in the liver. Furthermore, LAL-deficient mice challenged with RE gavage exhibited largely reduced post-prandial circulating RE content, indicating that LAL is required for efficient nutritional vitamin A availability. In summary, our results indicate that LAL is the major acid RE hydrolase and required for functional retinoid homeostasis.	[Grumet, Lukas; Eichmann, Thomas O.; Taschler, Ulrike; Zierler, Kathrin A.; Romauch, Matthias; Haemmerle, Guenter; Zechner, Rudolf; Zimmermann, Robert; Lass, Achim] Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria; [Leopold, Christina; Radovic, Branislav; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Moustafa, Tarek; Fickert, Peter] Med Univ Graz, Lab Expt & Mol Hepatol, Div Gastroenterol & Hepatol, Dept Internal Med, A-8010 Graz, Austria; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA; [Lass, Achim] BioTechMed, A-8010 Graz, Austria	University of Graz; Medical University of Graz; Medical University of Graz; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lass, A (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	achim.lass@uni-graz.at	Moustafa, Tarek/P-9509-2016; Kratky, Dagmar/ABF-5699-2021; Lass, Achim/C-3332-2008	Moustafa, Tarek/0000-0002-6755-4687; Lass, Achim/0000-0002-8190-7151; Kratky, Dagmar/0000-0003-1357-7573; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Zimmermann, Robert/0000-0002-7354-870X; Du, Hong/0000-0001-6652-4702; Taschler, Ulrike/0000-0001-9000-1602; Eichmann, Thomas O./0000-0002-8521-2795	DK Molecular Enzymology [W901]; DK Metabolic and Cardiovascular Disease [W1226]; F30 SFB Lipotox; Austrian Science Fund (FWF);  [P25193];  [P21296];  [P27070]; Austrian Science Fund (FWF) [P 27070, P 25193, F 3004, F 3002, P 24944, W 901] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA152099] Funding Source: NIH RePORTER	DK Molecular Enzymology(Austrian Science Fund (FWF)); DK Metabolic and Cardiovascular Disease; F30 SFB Lipotox; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ; ; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants P25193 (to A. L.), P21296 (to R. Zimmermann), P27070 (to D. K.), DK Molecular Enzymology W901 (to R. Zimmermann and R. Zechner), DK Metabolic and Cardiovascular Disease W1226 (to D. K.), and F30 SFB Lipotox (to R. Zechner), funded by the Austrian Science Fund (FWF). The authors declare that they have no conflicts of interest with the contents of this article.	Aqul A, 2014, AM J PHYSIOL-GASTR L, V307, pG836, DOI 10.1152/ajpgi.00243.2014; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3566; Burton BK, 2015, J PEDIATR GASTR NUTR, V61, P619, DOI 10.1097/MPG.0000000000000935; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; Eichmann TO, 2015, J LIPID RES, V56, P1972, DOI 10.1194/jlr.M062372; Fouchier SW, 2013, CURR OPIN LIPIDOL, V24, P332, DOI 10.1097/MOL.0b013e328361f6c6; Hagen E, 1999, J LIPID RES, V40, P309; Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019; HARRISON EH, 1993, BIOCHIM BIOPHYS ACTA, V1170, P99, DOI 10.1016/0005-2760(93)90058-H; HARRISON EH, 1995, J LIPID RES, V36, P1498; HOEG JM, 1984, AM J HUM GENET, V36, P1190; IMANAKA T, 1984, J BIOCHEM, V96, P1089, DOI 10.1093/oxfordjournals.jbchem.a134926; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; JOUTTI A, 1981, CHEM PHYS LIPIDS, V29, P235, DOI 10.1016/0009-3084(81)90054-2; Lopez AM, 2014, BIOCHEM BIOPH RES CO, V454, P162, DOI 10.1016/j.bbrc.2014.10.063; MERCIER M, 1994, BBA-LIPID LIPID MET, V1212, P176, DOI 10.1016/0005-2760(94)90251-8; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Porto AF, 2014, PEDIATR ENDOCR REV P, V12, P125; Reboul E, 2013, NUTRIENTS, V5, P3563, DOI 10.3390/nu5093563; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a	24	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17977	17987		10.1074/jbc.M116.724054	http://dx.doi.org/10.1074/jbc.M116.724054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27354281	Green Published, hybrid			2022-12-26	WOS:000383241300040
J	Grinstead, KM; Rowe, L; Ensor, CM; Joel, S; Daftarian, P; Dikici, E; Zingg, JM; Daunert, S				Grinstead, Kristen M.; Rowe, Laura; Ensor, Charles M.; Joel, Smita; Daftarian, Pirouz; Dikici, Emre; Zingg, Jean-Marc; Daunert, Sylvia			Red-Shifted Aequorin Variants Incorporating Non-Canonical Amino Acids: Applications in In Vivo Imaging	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; REPORTER GENE-EXPRESSION; BIOLUMINESCENCE IMMUNOASSAY; PHOTOPROTEIN AEQUORIN; RENILLA LUCIFERASE; LIVING SUBJECTS; MUTANTS; MUTAGENESIS; SWITCH; CELLS	The increased importance of in vivo diagnostics has posed new demands for imaging technologies. In that regard, there is a need for imaging molecules capable of expanding the applications of current state-of-the-art imaging in vivo diagnostics. To that end, there is a desire for new reporter molecules capable of providing strong signals, are non-toxic, and can be tailored to diagnose or monitor the progression of a number of diseases. Aequorin is a non-toxic photoprotein that can be used as a sensitive marker for bioluminescence in vivo imaging. The sensitivity of aequorin is due to the fact that bioluminescence is a rare phenomenon in nature and, therefore, it does not suffer from autofluorescence, which contributes to background emission. Emission of bioluminescence in the blue-region of the spectrum by aequorin only occurs when calcium, and its luciferin coelenterazine, are bound to the protein and trigger a biochemical reaction that results in light generation. It is this reaction that endows aequorin with unique characteristics, making it ideally suited for a number of applications in bioanalysis and imaging. Herein we report the site-specific incorporation of non-canonical or non-natural amino acids and several coelenterazine analogues, resulting in a catalog of 72 cysteine-free, aequorin variants which expand the potential applications of these photoproteins by providing several red-shifted mutants better suited to use in vivo. In vivo studies in mouse models using the transparent tissue of the eye confirmed the activity of the aequorin variants incorporating L-4-iodophehylalanine and L-4-methoxyphenylalanine after injection into the eye and topical addition of coelenterazine. The signal also remained localized within the eye. This is the first time that aequorin variants incorporating non-canonical amino acids have shown to be active in vivo and useful as reporters in bioluminescence imaging.	[Grinstead, Kristen M.; Joel, Smita; Daftarian, Pirouz; Dikici, Emre; Zingg, Jean-Marc; Daunert, Sylvia] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, R Bunn Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA; [Rowe, Laura] Valparaiso Univ, Dept Chem, 1610 Campus Dr East, Valparaiso, IN 46385 USA; [Ensor, Charles M.] Univ Kentucky, Dept Pharmaceut Sci, Coll Pharm, Lexington, KY 40536 USA	University of Miami; Valparaiso University; University of Kentucky	Daunert, S (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, R Bunn Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA.	SDaunert@med.miami.edu	Zingg, Jean-Marc/H-6960-2019	Ensor, Mark/0000-0003-3065-688X; Rowe, Laura/0000-0003-4657-1194	National Institutes of Health [7R01GM047915]; Lucille P. Markey Chair; Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille P. Markey Chair; Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami	This study was funded by the National Institutes of Health, grant number 7R01GM047915, and by the Lucille P. Markey Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.D. is grateful for the financial support by the Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami. The authors are grateful to Dr. Peter Schultz of the Scripps Research Institute, La Jolla, CA for generously donating the pDULE plasmid.	Bakayan A, 2015, PFLUG ARCH EUR J PHY, V467, P2031, DOI 10.1007/s00424-014-1639-3; Bakayan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019520; Bhaumik S, 2004, J BIOMED OPT, V9, P578, DOI 10.1117/1.1647546; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351; Chatterjee A, 2012, P NATL ACAD SCI USA, V109, P14841, DOI 10.1073/pnas.1212454109; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; Daunert S, 2006, PHOTOPROTEINS BIOANA; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; Deo SK, 2001, ANAL CHEM, V73, P1903, DOI 10.1021/ac001100q; Deo SK, 2001, BIOCONJUGATE CHEM, V12, P378, DOI 10.1021/bc0001140; Desai UA, 2001, ANAL BIOCHEM, V294, P132, DOI 10.1006/abio.2001.5145; Dikici E, 2009, PROTEIN ENG DES SEL, V22, P243, DOI 10.1093/protein/gzn083; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Eremeeva EV, 2009, FEBS LETT, V583, P1939, DOI 10.1016/j.febslet.2009.04.043; Grinstead KM, 2015, AEQUORIN MUTANTS WIT; Hamorsky KT, 2008, ANGEW CHEM INT EDIT, V47, P3718, DOI 10.1002/anie.200704440; Hamorsky KT, 2012, ANAL CHEM, V84, P7648, DOI 10.1021/ac301872u; Hamorsky KT, 2012, ANAL BIOCHEM, V421, P172, DOI 10.1016/j.ab.2011.10.023; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; JOHNSON FH, 1972, NATURE-NEW BIOL, V237, P287, DOI 10.1038/newbio237287a0; Lark AR, 2016, JOVE-J VIS EXP, DOI 10.3791/53705; Leppanen O, 2006, ATHEROSCLEROSIS, V188, P323, DOI 10.1016/j.atherosclerosis.2005.11.017; Lewis JC, 2001, ANAL CHEM, V73, P3227, DOI 10.1021/ac0101914; Lewis JC, 2000, BIOCONJUGATE CHEM, V11, P65, DOI 10.1021/bc9900800; Lewis JC, 2000, FRESEN J ANAL CHEM, V366, P760, DOI 10.1007/s002160051570; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Maniatis T., 1982, MOL CLONING; Markova O, 2012, SEMIN CELL DEV BIOL, V23, P298, DOI 10.1016/j.semcdb.2012.03.006; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; Mirasoli M, 2002, ANAL BIOCHEM, V306, P204, DOI 10.1006/abio.2002.5695; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Nijegorodov N, 2001, SPECTROCHIM ACTA A, V57, P1449, DOI 10.1016/S1386-1425(00)00488-1; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Ordenes VR, 2012, CELL CALCIUM, V52, P397, DOI 10.1016/j.ceca.2012.06.008; Pantaleo MA, 2008, CANCER TREAT REV, V34, P103, DOI 10.1016/j.ctrv.2007.10.001; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Qu XG, 2007, ANAL BIOCHEM, V371, P154, DOI 10.1016/j.ab.2007.08.038; Qu XG, 2014, ANAL BIOANAL CHEM, V406, P5639, DOI 10.1007/s00216-014-8039-6; Razgulin A, 2011, CHEM SOC REV, V40, P4186, DOI 10.1039/c1cs15035a; Rowe L, 2008, PROTEIN ENG DES SEL, V21, P73, DOI 10.1093/protein/gzm073; Rowe L, 2008, ANAL CHEM, V80, P8470, DOI 10.1021/ac801209x; Rowe L, 2007, BIOCONJUGATE CHEM, V18, P1772, DOI 10.1021/bc070039u; Rowe L, 2010, ACS CHEM BIOL, V5, P455, DOI 10.1021/cb9002909; Rowe L, 2009, ANAL CHEM, V81, P8662, DOI 10.1021/ac9007286; Scott D, 2011, ANNU REV ANAL CHEM, V4, P297, DOI 10.1146/annurev-anchem-061010-113855; Scott D, 2011, BIOCONJUGATE CHEM, V22, P475, DOI 10.1021/bc100486b; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHIMOMURA O, 1988, BIOCHEM J, V251, P405, DOI 10.1042/bj2510405; Shinde R, 2006, BIOCHEMISTRY-US, V45, P11103, DOI 10.1021/bi060475o; Shrestha S, 2002, BIOCONJUGATE CHEM, V13, P269, DOI 10.1021/bc010044c; Tricoire L, 2006, CPNAS, V103, P5; Tsuzuki K, 2005, J BIOL CHEM, V280, P34324, DOI 10.1074/jbc.M505303200; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; ZENNO SH, 1990, BIOCHEM BIOPH RES CO, V171, P169, DOI 10.1016/0006-291X(90)91372-Y; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	63	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158579	10.1371/journal.pone.0158579	http://dx.doi.org/10.1371/journal.pone.0158579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367859	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900040
J	Shi, HB; Zhang, GD; Wang, J; Wang, ZZ; Liu, XX; Cheng, L; Li, WM				Shi, Hongbo; Zhang, Guangde; Wang, Jing; Wang, Zhenzhen; Liu, Xiaoxia; Cheng, Liang; Li, Weimin			Studying Dynamic Features in Myocardial Infarction Progression by Integrating miRNA-Transcription Factor Co-Regulatory Networks and Time-Series RNA Expression Data from Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MICRORNA EXPRESSION; FEEDFORWARD LOOPS; GENE-EXPRESSION; RESOURCE; MODEL	Myocardial infarction (MI) is a serious heart disease and a leading cause of mortality and morbidity worldwide. Although somemolecules (genes, miRNAs and transcription factors (TFs)) associated with MI have been studied in a specific pathological context, their dynamic characteristics in gene expressions, biological functions and regulatory interactions in MI progression have not been fully elucidated to date. In the current study, we analyzed time-series RNA expression data from peripheral blood mononuclear cells. We observed that significantly differentially expressed genes were sharply up- or down-regulated in the acute phase of MI, and then changed slowly until the chronic phase. Biological functions involved at each stage of MI were identified. Additionally, dynamic miRNA-TF co-regulatory networks were constructed based on the significantly differentially expressed genes and miRNA-TF co-regulatory motifs, and the dynamic interplay of miRNAs, TFs and target genes were investigated. Finally, a new panel of candidate diagnostic biomarkers (STAT3 and ICAM1) was identified to have discriminatory capability for patients with or without MI, especially the patients with or without recurrent events. The results of the present study not only shed new light on the understanding underlying regulatory mechanisms involved in MI progression, but also contribute to the discovery of true diagnostic biomarkers for MI.	[Shi, Hongbo; Wang, Jing; Wang, Zhenzhen; Cheng, Liang] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, Guangde; Liu, Xiaoxia] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 4, Harbin 150001, Heilongjiang, Peoples R China; [Li, Weimin] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, WM (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China.	liweimin_2009@163.com	Cheng, Liang/ABY-7421-2022	Cheng, Liang/0000-0002-6665-6710	National Natural Science Foundation of China [31500675, 81270252]; Natural Science Foundation of Heilongjiang Province, China [QC2013C019]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z15162]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); Postdoctoral Foundation of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31500675,81270252), the Natural Science Foundation of Heilongjiang Province, China (Grant No. QC2013C019) and the Postdoctoral Foundation of Heilongjiang Province (Grant No. LBH-Z15162).	Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Azuaje FJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-59; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dymacek J, 2015, TOXICOL SCI, V144, P51, DOI 10.1093/toxsci/kfu262; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallogly MM, 2010, ANTIOXID REDOX SIGN, V12, P1339, DOI 10.1089/ars.2009.2791; Hsu PC, 2011, KAOHSIUNG J MED SCI, V27, P195, DOI 10.1016/j.kjms.2010.08.003; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu JF, 2010, BIOINFORMATICS, V26, P2289, DOI 10.1093/bioinformatics/btq408; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Karangelis DE, 2010, CURR MED CHEM, V17, P4018; Kiliszek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050054; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li X, 2012, BRIEF BIOINFORM, V13, P175, DOI 10.1093/bib/bbr043; Li YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09283; Li YX, 2010, TRENDS CARDIOVAS MED, V20, P228, DOI 10.1016/j.tcm.2011.11.006; Lin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09653; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Lu Y, 2014, J CARDIOVASC PHARM, V63, P412, DOI 10.1097/FJC.0000000000000062; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mozaffarian D., 2014, CIRCULATION; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Peng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078197; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Qin S, 2015, BIOINFORMATICS, V31, P76, DOI 10.1093/bioinformatics/btu597; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Soong TT, 2008, BIOINFORMATICS, V24, P2608, DOI 10.1093/bioinformatics/btn498; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Tian W, 2016, ONCOL REP, V35, P2171, DOI 10.3892/or.2016.4561; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Turner M, 2011, ADV EXP MED BIOL, V780, P1, DOI 10.1007/978-1-4419-5632-3_1; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Lueder TG, 2011, CLIN LAB, V57, P615; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang ZF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0318-9; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamauchi T, 1998, Kansenshogaku Zasshi, V72, P286; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339; Zhang HM, 2015, BRIEF BIOINFORM, V16, P45, DOI 10.1093/bib/bbt085; Zhang T, 2014, GENE, V543, P259, DOI 10.1016/j.gene.2014.04.002	53	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158638	10.1371/journal.pone.0158638	http://dx.doi.org/10.1371/journal.pone.0158638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367417	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900046
J	Civade, R; Dejean, T; Valentini, A; Roset, N; Raymond, JC; Bonin, A; Taberlet, P; Pont, D				Civade, Raphael; Dejean, Tony; Valentini, Alice; Roset, Nicolas; Raymond, Jean-Claude; Bonin, Aurelie; Taberlet, Pierre; Pont, Didier			Spatial Representativeness of Environmental DNA Metabarcoding Signal for Fish Biodiversity Assessment in a Natural Freshwater System	PLOS ONE			English	Article							SURVEY TOOL; EDNA; CONSERVATION; PERSISTENCE; ECOLOGY; PCR	In the last few years, the study of environmental DNA (eDNA) has drawn attention for many reasons, including its advantages for monitoring and conservation purposes. So far, in aquatic environments, most of eDNA research has focused on the detection of single species using species-specific markers. Recently, species inventories based on the analysis of a single generalist marker targeting a larger taxonomic group (eDNA metabarcoding) have proven useful for bony fish and amphibian biodiversity surveys. This approach involves in situ filtering of large volumes of water followed by amplification and sequencing of a short discriminative fragment from the 12S rDNA mitochondrial gene. In this study, we went one step further by investigating the spatial representativeness (i.e. ecological reliability and signal variability in space) of eDNA metabarcoding for large-scale fish biodiversity assessment in a freshwater system including lentic and lotic environments. We tested the ability of this approach to characterize large-scale organization of fish communities along a longitudinal gradient, from a lake to the outflowing river. First, our results confirm that eDNA metabarcoding is more efficient than a single traditional sampling campaign to detect species presence, especially in rivers. Second, the species list obtained using this approach is comparable to the one obtained when cumulating all traditional sampling sessions since 1995 and 1988 for the lake and the river, respectively. In conclusion, eDNA metabarcoding gives a faithful description of local fish biodiversity in the study system, more specifically within a range of a few kilometers along the river in our study conditions, i.e. longer than a traditional fish sampling site.	[Civade, Raphael; Pont, Didier] IRSTEA, Hydrosyst & Bioproc Res Unit, Antony, France; [Dejean, Tony; Valentini, Alice] SPYGEN, Le Bourget Du Lac, France; [Roset, Nicolas; Raymond, Jean-Claude] ONEMA, Rhone Alpes Reg Direct, Bron, France; [Bonin, Aurelie; Taberlet, Pierre] CNRS, Lab Ecol Alpine LECA, Grenoble, France; [Bonin, Aurelie; Taberlet, Pierre] Univ Grenoble Alpes, Lab Ecol Alpine LECA, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Civade, R (corresponding author), IRSTEA, Hydrosyst & Bioproc Res Unit, Antony, France.	civade_raphael@hotmail.fr	valentini, alice/S-2040-2019; Valentini, Alice/AFS-1389-2022	Valentini, Alice/0000-0001-5829-5479; Bonin, Aurelie/0000-0001-7800-8609; pont, Didier/0000-0001-5187-0135	EDF (Electricity of France); ONEMA (French National Agency for Water and Aquatic Environments); SPYGEN	EDF (Electricity of France); ONEMA (French National Agency for Water and Aquatic Environments); SPYGEN	In addition to their participation to field work, data collection and preparation of the manuscript, ONEMA (French National Agency for Water and Aquatic Environments) and SPYGEN financially supported this work (Contract IRSTEA-SPYGENONEMA, 2012-2015). EDF (Electricity of France) also supported financially this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Boyer F., 2015, MOL ECOLOGY RESOURCE; COWX IG, 1983, FISH MANAGE, V14, P67; CSP-DR-Lyon, 1996, ET ICHT AIG; CSP-DR-Lyon, 2007, LAC AIG EV PEUPL PIS; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K., 2015, BIORXIV; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; European Committee for Standardization, 2005, 14757 EUR COMM STAND; European Committee for Standardization, 2003, 14011 EUR COMM STAND; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola G. F., 2010, BMC GENOMICS, V11; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Irz P, 2006, AQUAT SCI, V68, P109, DOI 10.1007/s00027-005-0812-3; Keith P., 2001, ATLAS POISSONS EAU D; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Merkes CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113346; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Raymond J-C, 2009, COMPOSITION ABONDANC; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; Schnell IB, 2015, MOL ECOL RESOUR, V15, P1289, DOI 10.1111/1755-0998.12402; Sutherland WJ, 2013, TRENDS ECOL EVOL, V28, P16, DOI 10.1016/j.tree.2012.10.022; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A., 2014, J APPL ECOLOGY; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wanzenbock J, 2000, J FISH BIOL, V56, P1553, DOI 10.1111/j.1095-8649.2000.tb02165.x; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	44	78	91	6	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157366	10.1371/journal.pone.0157366	http://dx.doi.org/10.1371/journal.pone.0157366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359116	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200014
J	Grandl, S; Sztrokay-Gaul, A; Mittone, A; Gasilov, S; Brun, E; Bravin, A; Mayr, D; Auweter, SD; Hellerhoff, K; Reiser, M; Coan, P				Grandl, Susanne; Sztrokay-Gaul, Aniko; Mittone, Alberto; Gasilov, Sergey; Brun, Emmanuel; Bravin, Alberto; Mayr, Doris; Auweter, Sigrid D.; Hellerhoff, Karin; Reiser, Maximilian; Coan, Paola			Detection of Post-Therapeutic Effects in Breast Carcinoma Using Hard X-Ray Index of Refraction Computed Tomography - A Feasibility Study	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; SPECIMEN SHRINKAGE; HIGH-RESOLUTION; CANCER; CT; MAMMOGRAPHY; THERAPY	Objectives Neoadjuvant chemotherapy is the state-of-the-art treatment in advanced breast cancer. A correct visualization of the post-therapeutic tumor size is of high prognostic relevance. Xray phase-contrast computed tomography (PC-CT) has been shown to provide improved soft-tissue contrast at a resolution formerly restricted to histopathology, at low doses. This study aimed at assessing ex-vivo the potential use of PC-CT for visualizing the effects of neoadjuvant chemotherapy on breast carcinoma. Materials and Methods The analysis was performed on two ex-vivo formalin-fixed mastectomy samples containing an invasive carcinoma removed from two patients treated with neoadjuvant chemotherapy. Images were matched with corresponding histological slices. The visibility of typical post-therapeutic tissue changes was assessed and compared to results obtained with conventional clinical imaging modalities. Results PC-CT depicted the different tissue types with an excellent correlation to histopathology. Post-therapeutic tissue changes were correctly visualized and the residual tumor mass could be detected. PC-CT outperformed clinical imaging modalities in the detection of chemotherapy-induced tissue alterations including post-therapeutic tumor size. Conclusions PC-CT might become a unique diagnostic tool in the prediction of tumor response to neoadjuvant chemotherapy. PC-CT might be used to assist during histopathological diagnosis, offering a high-resolution and high-contrast virtual histological tool for the accurate delineation of tumor boundaries.	[Grandl, Susanne; Sztrokay-Gaul, Aniko; Mittone, Alberto; Auweter, Sigrid D.; Hellerhoff, Karin; Reiser, Maximilian; Coan, Paola] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany; [Mittone, Alberto; Gasilov, Sergey; Brun, Emmanuel; Coan, Paola] Univ Munich, Dept Phys, Garching, Germany; [Gasilov, Sergey] Karlsruhe Inst Technol, ANKA Synchrotron Radiat Facil, Eggenstein, Germany; [Brun, Emmanuel; Bravin, Alberto] European Synchrotron Radiat Facil, Grenoble, France; [Mayr, Doris] Ludwig Maximilians Univ Hosp Munich, Inst Pathol, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); University of Munich	Sztrokay-Gaul, A (corresponding author), Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany.	aniko.sztrokay@med.uni-muenchen.de	brun, emmanuel/U-8780-2019; Bravin, Alberto/AAN-6114-2020; Coan, Paola/GPC-5718-2022; Mittone, Alberto/C-8653-2018; Bravin, Alberto/R-8633-2016; Brun, emmanuel/J-7942-2018; Coan, Paola/L-8804-2013	brun, emmanuel/0000-0002-0332-4903; Bravin, Alberto/0000-0001-6868-2755; Coan, Paola/0000-0003-1399-2398; Mittone, Alberto/0000-0002-2018-5714; Bravin, Alberto/0000-0001-6868-2755; Brun, emmanuel/0000-0002-0332-4903; Coan, Paola/0000-0003-1399-2398	Deutsche Forschungsgemeinschaft-Cluster of Excellence Munich-Centre for Advanced Photonics EXC158	Deutsche Forschungsgemeinschaft-Cluster of Excellence Munich-Centre for Advanced Photonics EXC158	The authors acknowledge the European Synchrotron Radiation Facility (ESRF) for provision of beamtime and laboratory facilities. The authors would like to acknowledge, T. Brochard, Dr. C. Nemoz and Dr. H. Requardt for the technical support and electronic, computing and software assistance. The study was supported by the Deutsche Forschungsgemeinschaft-Cluster of Excellence Munich-Centre for Advanced Photonics EXC158.	Akazawa K, 2006, BREAST J, V12, P130, DOI 10.1111/j.1075-122X.2006.00220.x; Arlinghaus LR, 2010, J ONCOL, V2010, DOI 10.1155/2010/919620; Balu-Maestro C, 2002, BREAST CANCER RES TR, V72, P145, DOI 10.1023/A:1014856713942; Bhattacharyya M, 2008, BRIT J CANCER, V98, P289, DOI 10.1038/sj.bjc.6604171; Brain E, 1997, BRIT J CANCER, V75, P1360, DOI 10.1038/bjc.1997.230; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; CHEVALLIER B, 1993, AM J CLIN ONCOL-CANC, V16, P223, DOI 10.1097/00000421-199306000-00006; Chollet P, 2002, BRIT J CANCER, V86, P1041, DOI 10.1038/sj/bjc/6600210; Coan P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494007; Dialani V, 2015, ANN SURG ONCOL, V22, P1416, DOI 10.1245/s10434-015-4403-9; El-Didi MH, 2000, SURG TODAY, V30, P249, DOI 10.1007/s005950050054; FARIS GW, 1988, APPL OPTICS, V27, P5202, DOI 10.1364/AO.27.005202; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher ER, 2002, CANCER-AM CANCER SOC, V95, P681, DOI 10.1002/cncr.10741; Gasilov S, 2014, OPT EXPRESS, V22, P5216, DOI 10.1364/OE.22.005216; Gunderman RB, 2006, ESSENTIAL RADIOLOGY, P10; Krekel NMA, 2012, J CLIN PATHOL, V65, P224, DOI 10.1136/jclinpath-2011-200392; Langer F, 2004, PATHOLOGE, V25, P455, DOI 10.1007/s00292-004-0713-6; Londero V, 2004, EUR RADIOL, V14, P1371, DOI 10.1007/s00330-004-2246-z; Maksimenko A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721378; Mittone A, 2015, PHYS MED BIOL, V60, P3433, DOI 10.1088/0031-9155/60/9/3433; Mittone A, 2014, PHYS MED BIOL, V59, P2199, DOI 10.1088/0031-9155/59/9/2199; Moreno A, 2002, BREAST CANCER RES TR, V75, P119, DOI 10.1023/A:1019607924403; O'Flynn EAM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2815; SINN HP, 1994, GEBURTSH FRAUENHEILK, V54, P552, DOI 10.1055/s-2007-1022338; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Wasser K, 2007, RADIOLOGE, V47, P421, DOI 10.1007/s00117-005-1303-1; Yeap BH, 2007, ASIAN J SURG, V30, P183, DOI 10.1016/S1015-9584(08)60020-2; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	32	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158306	10.1371/journal.pone.0158306	http://dx.doi.org/10.1371/journal.pone.0158306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362638	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200054
J	Homs, M; Rodriguez-Frias, F; Gregori, J; Ruiz, A; Reimundo, P; Casillas, R; Tabernero, D; Godoy, C; Barakat, S; Quer, J; Riveiro-Barciela, M; Roggendorf, M; Esteban, R; Buti, M				Homs, Maria; Rodriguez-Frias, Francisco; Gregori, Josep; Ruiz, Alicia; Reimundo, Pilar; Casillas, Rosario; Tabernero, David; Godoy, Cristina; Barakat, Salma; Quer, Josep; Riveiro-Barciela, Mar; Roggendorf, Michael; Esteban, Rafael; Buti, Maria			Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection	PLOS ONE			English	Article							RNA; REPLICATION; MUTATIONS; SEQUENCE; ANTIGEN; HETEROGENEITY; DIVERSITY; GENOME	Chronic HDV infection can cause a severe form of viral hepatitis for which there is no specific treatment. Characterization of the hepatitis B or C viral quasispecies has provided insight into treatment failure and disease recurrence following liver transplantation, has proven useful to understand hepatitis B e antigen seroconversion, and has helped to predict whether hepatitis C infection will resolve or become chronic. It is likely that characterization of the hepatitis delta virus (HDV) quasispecies will ultimately have similar value for the management of this infection. This study sought to determine the RNA evolution rates in serum of chronic hepatitis delta (CHD) treatment-naive patients, using next-generation sequencing methods. The region selected for study encompassed nucleotide positions 910 to 1270 of the genome and included the amber/W codon. Amber/W is a substrate of the editing process by the ADAR1 host enzyme and is essential for encoding the 2 delta antigens (HDAg). The amber codon encodes the small (unedited) HDAg form and theWcodon the large (edited) HDAg form. The evolution rate was analyzed taking into account the time elapsed between samples, the percentage of unedited and edited genomes, and the complexity of the viral population. The longitudinal studies included 29 sequential samples from CHD patients followed up for a mean of 11.5 years. In total, 121,116 sequences were analyzed. The HDV evolution rate ranged from 9.5x10(-3) to 1.2x10(-3) substitutions/site/year and showed a negative correlation with the time elapsed between samples (p<0.05). An accumulation of transition-type changes was found to be responsible for higher evolution rates. The percentages of unedited and edited genomes and the quasispecies complexity showed no relationships with the evolution rate, but the fluctuations in the percentages of genomes and in complexity suggest continuous adaptation of HDV to the host conditions.	[Homs, Maria; Rodriguez-Frias, Francisco; Gregori, Josep; Tabernero, David; Godoy, Cristina; Quer, Josep; Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Homs, Maria; Rodriguez-Frias, Francisco; Ruiz, Alicia; Reimundo, Pilar; Casillas, Rosario; Tabernero, David; Godoy, Cristina] Univ Autonoma Barcelona, Dept Biochem, Liver Pathol Unit, Barcelona, Spain; [Homs, Maria; Rodriguez-Frias, Francisco; Ruiz, Alicia; Reimundo, Pilar; Casillas, Rosario; Tabernero, David; Godoy, Cristina] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Microbiol, Barcelona, Spain; [Gregori, Josep; Casillas, Rosario; Quer, Josep] Vall dHebron Res Inst, Liver Dis Unit, Barcelona, Spain; [Gregori, Josep] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Barakat, Salma] Natl Ctr Gastrointestinal & Liver Dis, Dept Gastroenterol, Khartoum, Sudan; [Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Liver Unit, Barcelona, Spain; [Roggendorf, Michael] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Roche Holding; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Rodriguez-Frias, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	frarodri@vhebron.net	Gregori, Josep/J-2586-2015; Quer, Josep/A-6741-2012; Tabernero, David/AAB-3848-2019; Rodriguez-Frias, Francisco/AAC-3507-2020	Gregori, Josep/0000-0002-4253-8015; Quer, Josep/0000-0003-0014-084X; Tabernero, David/0000-0002-1146-4084; Homs, Maria/0000-0002-8370-8375; esteban, rafael/0000-0001-5280-392X; Godoy, Cristina/0000-0001-5037-1916; Buti Ferret, Maria/0000-0002-0732-3078; rodriguez-frias, francisco/0000-0002-9128-7013; Casillas, Rosario/0000-0002-6758-6734	Instituto de Salud Carlos III [PI14/01416]; European Regional Development Fund (ERDF); Roche Diagnostics	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); Roche Diagnostics	This study was funded by Instituto de Salud Carlos III (grant PI14/01416), cofinanced by the European Regional Development Fund (ERDF). Roche Diagnostics provided support in the form of a salary for JG, but did not have any role in the study design or execution, data collection or analysis, decision to publish, or preparation of the manuscript.	Beeharry Y, 2014, VIROLOGY, V450, P165, DOI 10.1016/j.virol.2013.12.017; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; CHEN PJ, 1986, P NATL ACAD SCI USA, V83, P8774, DOI 10.1073/pnas.83.22.8774; Cheng Y, 2013, GUT, V62, P1347, DOI 10.1136/gutjnl-2012-302408; Cheng Y, 2013, J HEPATOL, V58, P217, DOI 10.1016/j.jhep.2012.09.017; Cramer P, 2004, ADV PROTEIN CHEM, V67, P1; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Flores R, 2012, SEMIN LIVER DIS, V32, P201, DOI 10.1055/s-0032-1323624; Giersch K, 2015, J HEPATOL, V63, P346, DOI 10.1016/j.jhep.2015.03.011; Gregori J, 2016, VIROLOGY, V493, P227, DOI 10.1016/j.virol.2016.03.017; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Homs M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112306; Homs M, 2014, J CLIN MICROBIOL, V52, P3334, DOI 10.1128/JCM.00940-14; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Koh C, 2015, LANCET INFECT DIS, V15, P1167, DOI 10.1016/S1473-3099(15)00074-2; LEE CM, 1992, VIROLOGY, V188, P265, DOI 10.1016/0042-6822(92)90756-F; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liu F, 2011, GUT, V60, P1269, DOI 10.1136/gut.2010.226225; Lyra AC, 2002, GASTROENTEROLOGY, V123, P1485, DOI 10.1053/gast.2002.36546; Macnaughton TB, 2003, J VIROL, V77, P12048, DOI 10.1128/JVI.77.22.12048-12056.2003; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Perez-del-Pulgar S, 2015, J GEN VIROL, V96, P3493, DOI 10.1099/jgv.0.000289; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Sherman KE, 2010, J INFECT DIS, V201, P712, DOI 10.1086/650490; SOBRINO F, 1986, GENE, V50, P149, DOI 10.1016/0378-1119(86)90320-3; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; Team RC, 2016, R LANG ENV STAT COMP, V3.3.2; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158557	10.1371/journal.pone.0158557	http://dx.doi.org/10.1371/journal.pone.0158557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362848	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200090
J	Santibanez, M; Garrastazu, R; Ruiz-Nunez, M; Helguera, JM; Arenal, S; Bonnardeux, C; Leon, C; Garcia-Rivero, JL				Santibanez, Miguel; Garrastazu, Roberto; Ruiz-Nunez, Mario; Manuel Helguera, Jose; Arenal, Sandra; Bonnardeux, Cristina; Leon, Carlos; Luis Garcia-Rivero, Juan			Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							RISK-FACTORS; COPD EXACERBATIONS; ADMISSION; DEATH	Background and Aim Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients. Methods This was a retrospective population-based cohort study. We selected 900 patients with confirmed COPD aged >= 35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission. We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1-4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year. Results Of the patients, 16.4% had >= 1 severe exacerbations, varying from 9.3% in mild GOLD grade 1 to 44% in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95% confidence interval [CI], 3.53-12.83) and mortality (adjusted OR, 7.63; 95% CI, 3.41-17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated. Conclusions Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.	[Santibanez, Miguel] Univ Cantabria, IDIVAL, Prevent Med & Publ Hlth Area, Santander, Cantabria, Spain; [Garrastazu, Roberto] Ctr Salud Gama, Serv Cantabro Salud, Barcena De Cicero, Cantabria, Spain; [Ruiz-Nunez, Mario] Ctr Salud Lierganes, Serv Cantabro Salud, Miera, Cantabria, Spain; [Manuel Helguera, Jose] Ctr Salud Bajo Ason, Serv Cantabro Salud, Cantabria, Ampuero, Spain; [Arenal, Sandra] Ctr Salud Suances, Serv Cantabro Salud, Suances, Cantabria, Spain; [Bonnardeux, Cristina] Ctr Salud Campoo Los Valles, Serv Cantabro Salud, Mataporquera, Cantabria, Spain; [Leon, Carlos] Ctr Salud Suances, Serv Cantabro Salud, Suances, Cantabria, Spain; [Luis Garcia-Rivero, Juan] Hosp Laredo, Serv Cantabro Salud, Dept Pneumol, Laredo, Cantabria, Spain	Universidad de Cantabria	Santibanez, M (corresponding author), Univ Cantabria, IDIVAL, Prevent Med & Publ Hlth Area, Santander, Cantabria, Spain.	santibanezm@unican.es	Santibanez, Miguel/L-3323-2017	Santibanez, Miguel/0000-0003-2634-615X; GARCIA RIVERO, JUAN LUIS/0000-0002-6407-5832	Almirall; Boehringer-Ingelheim; Pfizer; Astra Zeneca; Chiesi; GlaxoSmithKline; Menarini; Takeda; Teva; Ferrer; Novartis; Mundipharma; AstraZeneca	Almirall(Almirall); Boehringer-Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Astra Zeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Menarini(Menarini Group); Takeda(Takeda Pharmaceutical Company Ltd); Teva(Teva Pharmaceutical Industries); Ferrer; Novartis(Novartis); Mundipharma; AstraZeneca(AstraZeneca)	Dr. Garcia Rivero reports receiving consulting and/or speaking fees from Almirall, Boehringer-Ingelheim, Pfizer, Astra Zeneca, Chiesi, GlaxoSmithKline, Menarini, Takeda, Teva, Ferrer and Novartis; Dr. Helguera, receives speaking fees from GlaxoSmithKline, Boehringer-Ingelheim, Novartis, Mundipharma, and AstraZeneca; Dr. Bonnardeaux, receives speaking fees from GlaxoSmithKline, Boehringer-Ingelheim, Ferrer, AstraZeneca, Teva, and Chiesi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P14, DOI 10.1164/arrd.1986.133.1.14; Bahadori Katayoon, 2007, Int J Chron Obstruct Pulmon Dis, V2, P241; Blasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101228; Burge S, 2003, EUR RESPIR J, V41, p46s, DOI DOI 10.1183/09031936.03.00078002; Celli BR, 2015, EUR RESPIR REV, V24, P159, DOI 10.1183/16000617.00000315; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Garcia-Aymerich J, 2011, THORAX, V66, P585, DOI 10.1136/thx.2010.152876; Glasgow RE, 2005, MED CARE, V43, P551, DOI 10.1097/01.mlr.0000163645.41407.09; Gudmundsson G, 2005, EUR RESPIR J, V26, P414, DOI 10.1183/09031936.05.00078504; HofmansOkkes IM, 1996, FAM PRACT, V13, P294, DOI 10.1093/fampra/13.3.294; Holcomb WL, 2001, OBSTET GYNECOL, V98, P685, DOI 10.1016/S0029-7844(01)01488-0; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Julian DG, 1997, INTERPRETING TRIAL R; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lusuardi M, 2008, Monaldi Arch Chest Dis, V69, P164; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; Miravitlles M, 2004, THORAX, V59, P387, DOI 10.1136/thx.2003.008730; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P155, DOI 10.1016/j.arbres.2013.09.001; Moreno A, 2009, ARCH BRONCONEUMOL, V45, P181, DOI 10.1016/j.arbres.2008.09.004; Muellerova H, 2015, CHEST, V147, P999, DOI 10.1378/chest.14-0655; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Pandya Dhruti, 2014, Open Respir Med J, V8, P59, DOI 10.2174/1874306401408010059; Persaud N, 2006, J EVAL CLIN PRACT, V12, P450, DOI 10.1111/j.1365-2753.2006.00730.x; Quintana JM, 2014, RESPIRATION, V88, P298, DOI 10.1159/000365996; Rowe BH, 2009, ACAD EMERG MED, V16, P316, DOI 10.1111/j.1553-2712.2009.00366.x; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Solanes I, 2007, ARCH BRONCONEUMOL, V43, P445, DOI 10.1016/S1579-2129(07)60101-3; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Steer J, 2010, QJM-INT J MED, V103, P817, DOI 10.1093/qjmed/hcq126; Sullivan SD, 2000, CHEST, V117, P5; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tsoumakidou M, 2004, RESP MED, V98, P178, DOI 10.1016/j.rmed.2003.09.011; Vestbo J, 2015, GLOBAL STRATEGY DIAG; Vestbo J, 2014, AM J RESP CRIT CARE, V189, P1022, DOI 10.1164/rccm.201311-2006PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; Yang H, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-18; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	47	41	43	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158727	10.1371/journal.pone.0158727	http://dx.doi.org/10.1371/journal.pone.0158727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362765	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200110
J	Wang, YY; Schroeder, HA; Nunn, KL; Woods, K; Anderson, DJ; Lai, SK; Cone, RA				Wang, Ying-Ying; Schroeder, Holly A.; Nunn, Kenetta L.; Woods, Karen; Anderson, Deborah J.; Lai, Samuel K.; Cone, Richard A.			Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; MENSTRUAL-CYCLE; FLUID; MUCINS	Human cervicovaginal mucus (CVM) is a viscoelastic gel containing a complex mixture of mucins, shed epithelial cells, microbes and macromolecules, such as antibodies, that together serve as the first line of defense against invading pathogens. Here, to investigate the affinity between IgG and different mucus constituents, we used Fluorescence Recovery After Photobleaching (FRAP) to measure the diffusion of IgG in fresh, minimally modified CVM. We found that CVM exhibits substantial spatial variations that necessitate careful selection of the regions in which to perform FRAP. In portions of CVM devoid of cells, FRAP measurements using different IgG antibodies and labeling methods consistently demonstrate that both exogenous and endogenous IgG undergo rapid diffusion, almost as fast as in saline, in good agreement with the rapid diffusion of IgG in mid-cycle endocervical mucus that is largely devoid of cells. This rapid diffusion indicates the interactions between secreted mucins and IgG must be very weak and transient. IgG also accumulated in cellular debris and shed epithelial cells that had become permeable to IgG, which may allow shed epithelial cells to serve as reservoirs of secreted IgG. Interestingly, in contrast to cell-free regions of CVM, the diffusion of cell-associated IgG was markedly slowed, suggesting greater affinity between IgG and cellular constituents. Our findings contribute to an improved understanding of the role of IgG in mucosal protection against infectious diseases, and may also provide a framework for using FRAP to study molecular interactions in mucus and other complex biological environments.	[Wang, Ying-Ying; Woods, Karen; Cone, Richard A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Schroeder, Holly A.; Lai, Samuel K.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Nunn, Kenetta L.; Lai, Samuel K.] Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Chapel Hill, NC USA; [Lai, Samuel K.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Anderson, Deborah J.] Boston Univ, Sch Med, Dept Obstet Gynecol, Boston, MA 02118 USA; [Anderson, Deborah J.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Anderson, Deborah J.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Boston University; Boston University	Cone, RA (corresponding author), Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA.; Lai, SK (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA.; Lai, SK (corresponding author), Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Chapel Hill, NC USA.; Lai, SK (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.	lai@unc.edu; cone@jhu.edu	wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022	Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [R21AI093242, U19AI096398, 1F32AI102535]; National Science Foundation CAREER Award [DMR-1151477]; Packard Foundation; Eshelman Institute of Innovation; startup funds from Eshelman School of Pharmacy at University of North Carolina-Chapel Hill;  [AI096398 S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM089569] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1151477] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Eshelman Institute of Innovation; startup funds from Eshelman School of Pharmacy at University of North Carolina-Chapel Hill; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health (http://www.nih.gov/) grants R21AI093242 (SKL), U19AI096398 (SKL, DJA and RAC), 1F32AI102535 (YYW), and Diversity Supplement AI096398 S1 (KLN); National Science Foundation (http://www.nsf.gov/) CAREER Award DMR-1151477 (SKL); Packard Foundation (https://www.packard.org/; SKL); Eshelman Institute of Innovation (http://unceii.org/; SKL), and startup funds from the Eshelman School of Pharmacy at the University of North Carolina-Chapel Hill (https://pharmacy.unc.edu/; SKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Chen A, 2014, BIOPHYS J, V106, P2028, DOI 10.1016/j.bpj.2014.02.038; CHIPPERFIELD EJ, 1975, INFECT IMMUN, V11, P215, DOI 10.1128/IAI.11.2.215-221.1975; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Fahrbach KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076176; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; Gipson IK, 1997, BIOL REPROD, V56, P999, DOI 10.1095/biolreprod56.4.999; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Gunn B. M., 2016, MUCOSAL IMMUNOL; HILL JA, 1992, AM J OBSTET GYNECOL, V166, P720, DOI 10.1016/0002-9378(92)91703-D; KREMER J, 1992, HUM REPROD, V7, P781, DOI 10.1093/oxfordjournals.humrep.a137737; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; ODEBLAD E, 1965, ACTA OBSTET GYN SCAN, V43, P360, DOI 10.3109/00016346409162686; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Rehan N, 1975, Fertil Steril, V26, P492; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Santos RS, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.46; SCHUMACHER GFB, 1988, HUM REPROD, V3, P289, DOI 10.1093/oxfordjournals.humrep.a136698; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; STONE A, 1959, AM J OBSTET GYNECOL, V78, P279, DOI 10.1016/0002-9378(59)90173-5; USALA SJ, 1989, J REPROD MED, V34, P292; WAGNER G, 1980, J REPROD FERTIL, V60, P17; Wang YY, 2014, MUCOSAL IMMUNOL, V7, P1036, DOI 10.1038/mi.2013.120; Wessler T, 2015, ACS INFECT IN PRESS	33	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158338	10.1371/journal.pone.0158338	http://dx.doi.org/10.1371/journal.pone.0158338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362256	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200060
J	Bloch, A; Tamir, D; Vakil, E; Zeilig, G				Bloch, Ayala; Tamir, Dror; Vakil, Eli; Zeilig, Gabi			Specific Deficit in Implicit Motor Sequence Learning following Spinal Cord Injury	PLOS ONE			English	Article							CLOSED HEAD-INJURY; REACTION-TIME-TASK; BASAL GANGLIA; SUPPORTED EMPLOYMENT; DEPRESSION; BRAIN; ANXIETY; MULTISITE; VETERANS; AMNESIA	Background Physical and psychosocial rehabilitation following spinal cord injury (SCI) leans heavily on learning and practicing new skills. However, despite research relating motor sequence learning to spinal cord activity and clinical observations of impeded skill-learning after SCI, implicit procedural learning following spinal cord damage has not been examined. Objective To test the hypothesis that spinal cord injury (SCI) in the absence of concomitant brain injury is associated with a specific implicit motor sequence learning deficit that cannot be explained by depression or impairments in other cognitive measures. Methods Ten participants with SCI in T1-T11, unharmed upper limb motor and sensory functioning, and no concomitant brain injury were compared to ten matched control participants on measures derived from the serial reaction time (SRT) task, which was used to assess implicit motor sequence learning. Explicit generation of the SRT sequence, depression, and additional measures of learning, memory, and intelligence were included to explore the source and specificity of potential learning deficits. Results There was no between-group difference in baseline reaction time, indicating that potential differences between the learning curves of the two groups could not be attributed to an overall reduction in response speed in the SCI group. Unlike controls, the SCI group showed no decline in reaction time over the first six blocks of the SRT task and no advantage for the initially presented sequence over the novel interference sequence. Meanwhile, no group differences were found in explicit learning, depression, or any additional cognitive measures. Conclusions The dissociation between impaired implicit learning and intact declarative memory represents novel empirical evidence of a specific implicit procedural learning deficit following SCI, with broad implications for rehabilitation and adjustment.	[Bloch, Ayala] Natl Inst Rehabil Brain Injured, Tel Aviv, Israel; [Tamir, Dror] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Vakil, Eli] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Zeilig, Gabi] Chaim Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Hebrew University of Jerusalem; Bar Ilan University; Bar Ilan University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Bloch, A (corresponding author), Natl Inst Rehabil Brain Injured, Tel Aviv, Israel.	ayalabl@shikumil.org.il		Bloch, Ayala/0000-0002-1964-7053				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baddeley A. D., 1992, NEUROPSYCHOLOGY MEMO, P309; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CRAIG AR, 1994, BRIT J CLIN PSYCHOL, V33, P221, DOI 10.1111/j.2044-8260.1994.tb01116.x; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Golden CJ, 2008, NEUROPSYCHOLOGY INPA, P79; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Lum JAG, 2014, CORTEX, V51, P1, DOI 10.1016/j.cortex.2013.10.011; Lungu O, 2010, J NEUROPHYSIOL, V103, P2675, DOI 10.1152/jn.00006.2010; Macartney-Filgate M S, 1988, Arch Clin Neuropsychol, V3, P121, DOI 10.1016/0887-6177(88)90057-1; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Osterrieth PA., 1944, ARCH PSYCHOL-GENEVE, V30, P286; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rush AJ, 2005, NEUROPSYCHOPHARMACOL, V30, P405, DOI 10.1038/sj.npp.1300614; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Schueneman AL, 1982, SCI DIG, V4, P64; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Taylor L, 1991, COMPENDIUM NEUROPSYC; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Trieschmann RB, 1988, SPINAL CORD INJURIES; Vahdat S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002186; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993	51	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158396	10.1371/journal.pone.0158396	http://dx.doi.org/10.1371/journal.pone.0158396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355834	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400058
J	Chen, C; Wang, JH; Cai, RP; Yuan, YM; Guo, ZY; Grewer, C; Zhang, Z				Chen, Chen; Wang, Jiahong; Cai, Ruiping; Yuan, Yanmeng; Guo, Zhanyun; Grewer, Christof; Zhang, Zhou			Identification of a Disulfide Bridge in Sodium-Coupled Neutral Amino Acid Transporter 2(SNAT2) by Chemical Modification	PLOS ONE			English	Article							TISSUE EXPRESSION PATTERN; SYSTEM-A; GLUTAMINE TRANSPORTER; FUNCTIONAL-CHARACTERISTICS; CYSTEINE RESIDUES; SKELETAL-MUSCLE; FAMILIES SLC32; SNAT2; CELL; SUBTYPE	Sodium-coupled neutral amino acid transporter 2 (SNAT2) belongs to solute carrier 38 (SLC38) family of transporters, which is ubiquitously expressed in mammalian tissues and mediates transport of small, neutral amino acids, exemplified by alanine(Ala, A). Yet structural data on SNAT2, including the relevance of intrinsic cysteine residues on structure and function, is scarce, in spite of its essential roles in many tissues. To better define the potential of intrinsic cysteines to form disulfide bonds in SNAT2, mutagenesis experiments and thiol-specific chemical modifications by N-ethylmaleimide (NEM) and methoxy-polyethylene glycol maleimide (mPEG-Mal, MW 5000) were performed, with or without the reducing regent dithiothreitol (DTT) treatment. Seven single mutant transporters with various cysteine (Cys, C) to alanine (Ala, A) substitutions, and a C245,279A double mutant were introduced to SNAT2 with a hemagglutinin (HA) tag at the C-terminus. The results showed that the cells expressing C245A or C279A were labeled by one equivalent of mPEG-Mal in the presence of DTT, while wild-type or all the other single Cys to Ala mutants were modified by two equivalents of mPEG-Mal. Furthermore, the molecular weight of C245,279A was not changed in the presence or absence of DTT treatment. The results suggest a disulfide bond between Cys245 and Cys279 in SNAT2 which has no effect on cell surface trafficking, as well as transporter function. The proposed disulfide bond may be important to delineate proximity in the extracellular domain of SNAT2 and related proteins.	[Chen, Chen; Wang, Jiahong; Cai, Ruiping; Yuan, Yanmeng; Zhang, Zhou] Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang 110015, Peoples R China; [Guo, Zhanyun] Tongji Univ, Inst Prot Res, Coll Life Sci & Technol, Shanghai 200092, Peoples R China; [Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Grewer, Christof] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA	Shenyang Pharmaceutical University; Tongji University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Zhang, Z (corresponding author), Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang 110015, Peoples R China.	zzhouzhang@163.com			Innovation Program of Shanghai Municipal Education Commission [13ZZ103]; National Natural Science Foundation of China [31270883]; National Science Foundation [1515028]	Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	This research was funded by the Innovation Program of Shanghai Municipal Education Commission (Grant No. 13ZZ103) and the National Natural Science Foundation of China (Grant No. 31270883) to Zhou Zhang and National Science Foundation award #1515028 to Christof Grewer.	Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; BARKER GA, 1990, EXP PHYSIOL, V75, P3, DOI 10.1113/expphysiol.1990.sp003382; Bevilacqua E, 2005, FEBS LETT, V579, P3376, DOI 10.1016/j.febslet.2005.05.002; Blot A, 2009, NEUROSCIENCE, V164, P998, DOI 10.1016/j.neuroscience.2009.09.015; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Calderon-Rivera A, 2012, CELL CALCIUM, V51, P22, DOI 10.1016/j.ceca.2011.10.002; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Cook JV, ENDOCRINOLOGY, V138, P2800; Dorn M, 2009, J BIOL CHEM, V284, P22123, DOI 10.1074/jbc.M109.023713; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Evans K, 2008, J AM SOC NEPHROL, V19, P2119, DOI 10.1681/ASN.2007101108; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Frandberg PA, 2001, BIOCHEM BIOPH RES CO, V281, P851, DOI 10.1006/bbrc.2001.4429; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Guo ZY, 2005, BIOCHEMISTRY-US, V44, P6537, DOI 10.1021/bi047409b; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Jenstad M, 2009, CEREB CORTEX, V19, P1092, DOI 10.1093/cercor/bhn151; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; KILBERG MS, 1980, J BIOL CHEM, V255, P4011; Lambert G, 2000, J MEMBRANE BIOL, V176, P143, DOI 10.1007/s002320001083; Lee IP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109803; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Messens J, 2013, ANTIOXID REDOX SIGN, V18, P1594, DOI 10.1089/ars.2012.5156; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Okudaira H, 2011, J NUCL MED, V52, P822, DOI 10.2967/jnumed.110.086074; Ortiz V, 2011, AM J PHYSIOL-ENDOC M, V300, pE1092, DOI 10.1152/ajpendo.00459.2010; OXENDER DL, 1963, J BIOL CHEM, V238, P3686; PADMANABHAN R, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0056792; Padmanabhan Rugmani, 2012, Int J Biochem Mol Biol, V3, P374; Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Varoqui H, 2002, BIOCHEM BIOPH RES CO, V290, P903, DOI 10.1006/bbrc.2001.6281; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776; Zhang Z, 2011, BIOCHEM J, V434, P287, DOI 10.1042/BJ20100507; Zhang Z, 2009, J BIOL CHEM, V284, P25314, DOI 10.1074/jbc.M109.038422	65	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158319	10.1371/journal.pone.0158319	http://dx.doi.org/10.1371/journal.pone.0158319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355203	gold, Green Submitted, Green Published			2022-12-26	WOS:000378859400050
J	Lee, JY; Linge, HM; Ochani, K; Lin, K; Miller, EJ				Lee, Ji Young; Linge, Helena M.; Ochani, Kanta; Lin, Ke; Miller, Edmund J.			N-Ethylmaleimide Sensitive Factor (NSF) Inhibition Prevents Vascular Instability following Gram-Positive Pulmonary Challenge	PLOS ONE			English	Article							WEIBEL-PALADE BODIES; ENDOTHELIAL-CELLS; SEPTIC SHOCK; EXOCYTOSIS; SEPSIS; ANGIOPOIETIN-2; MORTALITY; INJURY; CARE	Background The Acute Respiratory Distress Syndrome (ARDS), remains a significant source of morbidity and mortality in critically ill patients. Pneumonia and sepsis are leading causes of ARDS, the pathophysiology of which includes increased pulmonary microvascular permeability and hemodynamic instability resulting in organ dysfunction. We hypothesized that N-ethylmaleimide sensitive factor (NSF) regulates exocytosis of inflammatory mediators, such as Angiopoietin-2 (Ang-2), and cytoskeletal stability by modulating myosin light chain (MLC) phosphorylation. Therefore, we challenged pulmonary cells, in vivo and in vitro, with Gram Positive bacterial cell wall components, lipoteichoic acid (LTA), and peptidoglycan (PGN) and examined the effects of NSF inhibition. Methods Mice were pre-treated with an inhibitor of NSF, TAT-NSF700 (to prevent Ang-2 release). After 30min, LTA and PGN (or saline alone) were instilled intratracheally. Pulse oximetry was assessed in awake mice prior to, and 6 hour post instillation. Post mortem, tissues were collected for studies of inflammation and Ang-2. In vitro, pulmonary endothelial cells were assessed for their responses to LTA and PGN. Results Pulmonary challenge induced signs of airspace and systemic inflammation such as changes in neutrophil counts and protein concentration in bronchoalveolar lavage fluid and tissue Ang-2 concentration, and decreased physiological parameters including oxygen saturation and pulse distention. TAT-NSF700 pre-treatment reduced LTA-PGN induced changes in lung tissue Ang-2, oxygen saturation and pulse distention. In vitro, LTA-PGN induced a rapid (<2 min) release of Ang-2, which was significantly attenuated by TAT-NSF700 or anti TLR2 antibody. Furthermore, TAT-NSF700 reduced LTA-PGN-induced MLC phosphorylation at low concentrations of 1-10 nM. Conclusions TAT-NSF700 decreased Ang-2 release, improved oxygen saturation and pulse distention following pulmonary challenge by inhibiting MLC phosphorylation, an important component of endothelial cell retraction. The data suggest that inhibition of NSF in pneumonia and sepsis may be beneficial to prevent the pulmonary microvascular and hemodynamic instability associated with ARDS.	[Lee, Ji Young; Miller, Edmund J.] Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Linge, Helena M.; Ochani, Kanta; Lin, Ke; Miller, Edmund J.] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY USA; [Miller, Edmund J.] Hofstra North Shore LIJ Med Sch, Hempstead, NY USA; [Lee, Ji Young] Univ S Alabama, Dept Pulm & Crit Care Med, Mobile, AL 36688 USA	Northwell Health; Northwell Health; Hofstra University; University of South Alabama	Lee, JY (corresponding author), Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA.; Lee, JY (corresponding author), Univ S Alabama, Dept Pulm & Crit Care Med, Mobile, AL 36688 USA.	jiyounglee98@gmail.com		Linge, Helena/0000-0002-8919-0300; Lee, Ji Young/0000-0002-8005-2446	Elmezzi Graduate School of Molecular Medicine; Feinstein Institute for Medical Research	Elmezzi Graduate School of Molecular Medicine; Feinstein Institute for Medical Research	This study was supported by funds from The Elmezzi Graduate School of Molecular Medicine and The Feinstein Institute for Medical Research.	Aikawa N, 1996, Nihon Geka Gakkai Zasshi, V97, P771; Aird WC, ROLE ENDOTHELIUM SEV, P3765; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Calvert JW, 2007, CIRC RES, V101, P1247, DOI 10.1161/CIRCRESAHA.107.162610; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Friedman G, 1998, INTENS CARE MED, V24, P118, DOI 10.1007/s001340050531; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Goel A, 2010, CIRC RES, V107, P242, DOI 10.1161/CIRCRESAHA.109.210229; Linge HM, 2015, EXP LUNG RES, V41, P216, DOI 10.3109/01902148.2014.999174; Linge HM, 2010, CRITICAL CARE S2, V14, pP8; Matsushita K, 2005, MOL PHARMACOL, V67, P1137, DOI 10.1124/mol.104.004275; Morrell CN, 2005, J PHARMACOL EXP THER, V314, P155, DOI 10.1124/jpet.104.082529; National Institutes of Health. National Heart LaBI, 2007, NAT HEART LABI AC RE; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pittoni GM, 2009, CURR OPIN ANESTHESIO, V22, P232, DOI 10.1097/ACO.0b013e328323f9a8; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Sheldon R, 1993, ROLE MYOSIN LIGHT CH, pL606; Shen Q, 2010, MYOSIN LIGHT CHAIN K, P272; Siner JM, 2009, SHOCK, V31, P348, DOI 10.1097/SHK.0b013e318188bd06; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tran Q. -K., 2006, V176, P145; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; Valentijn KM, 2010, MULTIGRANULAR EXOCYT; Vincent JL, 1998, J ANTIMICROB CHEMOTH, V41, P9, DOI 10.1093/jac/41.suppl_1.9; Wu SW, 2014, PULM CIRC, V4, P110, DOI 10.1086/674879; Yamakuchi Munekazu, 2008, V440, P203, DOI 10.1007/978-1-59745-178-9_15; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549; Zupancic G, 2002, J PHYSIOL-LONDON, V544, P741, DOI 10.1113/jphysiol.2002.027490	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157837	10.1371/journal.pone.0157837	http://dx.doi.org/10.1371/journal.pone.0157837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355324	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400021
J	Dumonteil, E; Herrera, C; Martini, L; Grijalva, MJ; Guevara, AG; Costales, JA; Aguilar, HM; Breniere, SF; Waleckx, E				Dumonteil, Eric; Herrera, Claudia; Martini, Luiggi; Grijalva, Mario J.; Guevara, Angel G.; Costales, Jaime A.; Marcelo Aguilar, H.; Frederique Breniere, S.; Waleckx, Etienne			Chagas Disease Has Not Been Controlled in Ecuador	PLOS ONE			English	Editorial Material							TRYPANOSOMA-CRUZI INFECTION; VECTOR CONTROL; AMAZON REGION; RISK-FACTORS; SEROPREVALENCE; SEROPOSITIVITY; TRIATOMINE; ACCESS		[Dumonteil, Eric; Waleckx, Etienne] Univ Autonoma Yucatan, Ctr Invest Reg Hideyo Noguchi, Lab Parasitol, Merida, Yucatan, Mexico; [Dumonteil, Eric; Herrera, Claudia] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, Vector Borne Infect Dis Res Ctr, New Orleans, LA USA; [Martini, Luiggi] Lab Parasitol L Martini & Colaboradores, Guayaquil, Ecuador; [Grijalva, Mario J.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Trop Dis Inst, Athens, OH 45701 USA; [Grijalva, Mario J.; Costales, Jaime A.; Frederique Breniere, S.] Pontifical Catholic Univ Ecuador, Sch Biol Sci, Ctr Infect & Chron Dis Res, Quito, Ecuador; [Guevara, Angel G.] Univ Cent Ecuador, Ctr Biomed, Carrera Med, Quito, Ecuador; [Marcelo Aguilar, H.] Univ Cent Ecuador, Fac Ciencias Med, Inst Super Invest & Posgrad, Unidad Salud Publ, Quito, Ecuador; [Frederique Breniere, S.] IRD, UMR INTERTRYP, IRD CIRAD, Interact Hosts Vectors Parasites Environm Trop Ne, TA A-17-G,Campus Int Baillarguet, Montpellier, France	Universidad Autonoma de Yucatan; Tulane University; Ohio University; Pontificia Universidad Catolica del Ecuador; Universidad Central del Ecuador; Universidad Central del Ecuador; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Dumonteil, E (corresponding author), Univ Autonoma Yucatan, Ctr Invest Reg Hideyo Noguchi, Lab Parasitol, Merida, Yucatan, Mexico.; Dumonteil, E (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, Vector Borne Infect Dis Res Ctr, New Orleans, LA USA.	oliver@correo.uady.mx	Grijalva, Mario J/U-8356-2018; Waleckx, Etienne/GOG-9370-2022; Waleckx, Etienne/G-2439-2017; Breniere, Simone Frederique/J-9214-2016	Grijalva, Mario J/0000-0003-1964-1425; Waleckx, Etienne/0000-0002-3270-6476; Costales, Jaime/0000-0001-9418-6640; Breniere, Simone Frederique/0000-0003-4385-3989; Dumonteil, Eric/0000-0001-9376-0209				Abad-Franch F, 2003, CONTROL ENFERMEDAD C; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Amunarriz M, 2010, REV PANAM SALUD PUBL, V28, P25, DOI 10.1590/S1020-49892010000700004; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Black CL, 2007, J PARASITOL, V93, P12, DOI 10.1645/GE-899R.1; Black CL, 2009, AM J TROP MED HYG, V81, P1035, DOI 10.4269/ajtmh.2009.08-0594; Gestal MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138311; Costales JA, 2015, AM J TROP MED HYG, V92, P807, DOI 10.4269/ajtmh.14-0562; Forsyth C, 2015, SOC SCI MED, V145, P7, DOI 10.1016/j.socscimed.2015.09.022; Grijalva MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004142; Grijalva MJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-20; Grijalva MJ, 2003, AM J TROP MED HYG, V69, P380, DOI 10.4269/ajtmh.2003.69.380; Grijalva MJ, 1997, AM J TROP MED HYG, V57, P740, DOI 10.4269/ajtmh.1997.57.740; Guevara A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-358; Guevara Angel G, 2013, Trop Med Health, V41, P21, DOI 10.2149/tmh.2012-31; Manne JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002488; Ministerio de Salud Publica, 2013, MAN PROC SUBS AL ACC, P220; Nieto-Sanchez C, 2015, MEM I O CRUZ, V0; Quinde-Calderon L, 2016, TROP MED INT HEALTH, V21, P84, DOI 10.1111/tmi.12620; Buitrago NLR, 2013, INFECT GENET EVOL, V19, P141, DOI 10.1016/j.meegid.2013.07.002; Tarleton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003219; Vargas CC, 2015, AM J TROP MED HYG, V93, P774, DOI 10.4269/ajtmh.14-0807; Villa L, 2007, MEM I OSWALDO CRUZ, V102, P87, DOI 10.1590/S0074-02762007005000081; Villacis AG, 2015, AM J TROP MED HYG, V92, P187, DOI 10.4269/ajtmh.14-0250; Waleckx E, 2015, MEM I OSWALDO CRUZ, V110, P324, DOI 10.1590/0074-02760140409	25	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158145	10.1371/journal.pone.0158145	http://dx.doi.org/10.1371/journal.pone.0158145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351178	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900037
J	Johnson, GJ; Slater, BCS; Leis, LA; Rector, TS; Bach, RR				Johnson, Gerhard J.; Slater, Billie C. S.; Leis, Linda A.; Rector, Thomas S.; Bach, Ronald R.			Blood Biomarkers of Chronic Inflammation in Gulf War Illness	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHRONIC MULTISYMPTOM ILLNESS; CORONARY-HEART-DISEASE; ACID-BINDING PROTEIN; NEUROTROPHIC FACTOR; DIFFERENTIAL EXPRESSION; MYOCARDIAL-INFARCTION; CYTOKINE EXPRESSION; LYMPHOCYTE RATIO; SERUM-LEVELS	Background More than twenty years following the end of the 1990-1991 Gulf War it is estimated that approximately 300,000 veterans of this conflict suffer from an unexplained chronic, multi system disorder known as Gulf War Illness (GWI). The etiology of GWI may be exposure to chemical toxins, but it remains only partially defined, and its case definition is based only on symptoms. Objective criteria for the diagnosis of GWI are urgently needed for diagnosis and therapeutic research. Objective This study was designed to determine if blood biomarkers could provide objective criteria to assist diagnosis of GWI. Design A surveillance study of 85 Gulf War Veteran volunteers identified from the Department of Veterans Affairs Minnesota Gulf War registry was performed. All subjects were deployed to the Gulf War. Fifty seven subjects had GWI defined by CDC criteria, and 28 did not have symptomatic criteria for a diagnosis of GWI. Statistical analyses were performed on peripheral blood counts and assays of 61 plasma proteins using the Mann-Whitney rank sum test to compare biomarker distributions and stepwise logistic regression to formulate a diagnostic model. Results Lymphocyte, monocyte, neutrophil, and platelet counts were higher in GWI subjects. Six serum proteins associated with inflammation were significantly different in GWI subjects. A diagnostic model of three biomarkers lymphocytes, monocytes, and C reactive protein had a predicted probability of 90% (CI 76-90%) for diagnosing GWI when the probability of having GWI was above 70%. Significance The results of the current study indicate that inflammation is a component of the pathobiology of GWI. Analysis of the data resulted in a model utilizing three readily measurable biomarkers that appears to significantly augment the symptom-based case definition of GWI. These new observations are highly relevant to the diagnosis of GWI, and to therapeutic trials.	[Johnson, Gerhard J.; Slater, Billie C. S.; Leis, Linda A.; Rector, Thomas S.; Bach, Ronald R.] Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Johnson, Gerhard J.; Rector, Thomas S.; Bach, Ronald R.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Johnson, GJ (corresponding author), Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.; Johnson, GJ (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	gerhard.johnson@va.gov		Slater, Billie C.S./0000-0003-0738-5639	Department of Defense Congressionally Directed Medical Research Programs/Gulf War Illness Research Program [W81XWH-09-2-0047]	Department of Defense Congressionally Directed Medical Research Programs/Gulf War Illness Research Program	This work was supported by Department of Defense Congressionally Directed Medical Research Programs/Gulf War Illness Research Program Grant Number W81XWH-09-2-0047.	Aguilar-Valles A, 2015, NEUROPHARMACOLOGY, V96, P124, DOI 10.1016/j.neuropharm.2014.12.023; Akpek M, 2012, AM J CARDIOL, V110, P621, DOI 10.1016/j.amjcard.2012.04.041; Balta S, 2015, CLIN APPL THROMBOSIS; Benites-Zapata VA, 2015, AM J CARDIOL, V115, P57, DOI 10.1016/j.amjcard.2014.10.008; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Broderick Gordon, 2012, Methods Mol Biol, V934, P145, DOI 10.1007/978-1-62703-071-7_8; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Chen ZY, 2015, BRIT J CANCER, V112, P1088, DOI 10.1038/bjc.2015.61; Claycombe K, 2008, P NATL ACAD SCI USA, V105, P2017, DOI 10.1073/pnas.0712053105; Coughlin Steven S, 2011, Open Epidemiol J, V4, P140; Craddock TJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132774; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Dias CC, 2013, PEPTIDES, V50, P24, DOI 10.1016/j.peptides.2013.09.012; Dias CC, 2015, J CELLULAR BIOCH; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Faria MC, 2014, J PSYCHIATR RES, V53, P166, DOI 10.1016/j.jpsychires.2014.01.019; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gajewska E, 2014, EUR REV MED PHARMACO, V18, P3246; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; Haas L, 2010, NEUROCHEM RES, V35, P830, DOI 10.1007/s11064-010-0129-z; Hirose H, 1998, CLIN SCI, V94, P633, DOI 10.1042/cs0940633; Hopps E, 2015, EUR REV MED PHARMACO, V19, P2583; Huang CJ, 2014, PHYSIOL BEHAV, V123, P76, DOI 10.1016/j.physbeh.2013.10.004; Institute of Medicine, 2014, CHRON MULT ILLN GULF; Institute of Medicine of the National academies Committee on Gulf War and Health, 2013, GULF WAR HLTH TREATM; Johnson GJ, 2013, BLOOD COAGUL FIBRIN, V24, P736, DOI 10.1097/MBC.0b013e328362627f; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Khaiboullina SF, 2015, CYTOKINE, V72, P1, DOI 10.1016/j.cyto.2014.11.019; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Leal G., 2014, BRAIN RES; Luchting B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104883; Maloney CDRSR, 2013, MED HYPOTHESES, V80, P220, DOI 10.1016/j.mehy.2012.11.024; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V274, pE210, DOI 10.1152/ajpendo.1998.274.2.E210; Munkholm K, 2014, PSYCHONEUROENDOCRINO, V47, P199, DOI 10.1016/j.psyneuen.2014.05.011; National Resource Council, 2010, GULF WAR AND HLTH, V8; Nilsson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108183; Parkitny L, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0122-z; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Procaccini C, 2015, METABOLISM, V64, P92, DOI 10.1016/j.metabol.2014.10.014; R.A.C. on Gulf War Veterans' Illnesses, 2014, GULF WAR ILLNESS HLT; Rabkin SW, 2014, VASA, V43, P433, DOI 10.1024/0301-1526/a000390; *RES ADV COMM GULF, 2008, GULF WAR ILLN HLTH G; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Shukla V, 2013, ARCH VIROL, V158, P2561, DOI 10.1007/s00705-013-1783-7; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; Singh UP, 2014, INT REV IMMUNOL, V33, P23, DOI 10.3109/08830185.2013.809071; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Smylie AL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-29; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Thibault K, 2014, J NEUROSCI, V34, P14739, DOI 10.1523/JNEUROSCI.0860-14.2014; Thiele JR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/372432; Thrailkill KM, 2005, CLIN CHEM LAB MED, V43, P1392, DOI 10.1515/CCLM.2005.238; Trottier MD, 2012, P NATL ACAD SCI USA, V109, P7622, DOI 10.1073/pnas.1205129109; Vianello E, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-2; Vojdani A, 2004, ENVIRON HEALTH PERSP, V112, P840, DOI 10.1289/ehp.6881; Wang KF, 2013, CORONARY ARTERY DIS, V24, P23, DOI 10.1097/MCA.0b013e32835aab4a; Wedge R, 2016, GULF WAR AND HLTH, V10; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Yan GT, 2009, EUR J PHARMACOL, V616, P244, DOI 10.1016/j.ejphar.2009.06.039; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zeng RP, 2013, MOL VIS, V19, P729; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999	68	56	57	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157855	10.1371/journal.pone.0157855	http://dx.doi.org/10.1371/journal.pone.0157855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352030	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900022
J	Stepanov, VG; Tirumalai, MR; Montazari, S; Checinska, A; Venkateswaran, K; Fox, GE				Stepanov, Victor G.; Tirumalai, Madhan R.; Montazari, Saied; Checinska, Aleksandra; Venkateswaran, Kasthuri; Fox, George E.			Bacillus pumilus SAFR-032 Genome Revisited: Sequence Update and Re-Annotation	PLOS ONE			English	Article							SPACECRAFT ASSEMBLY FACILITY; HYDROGEN-PEROXIDE; BACTERIAL-SPORES; RESISTANCE; STERILIZATION; ALIGNMENT; SURVIVAL; DIOXIDE; WATER	Bacillus pumilus strain SAFR-032 is a non-pathogenic spore-forming bacterium exhibiting an anomalously high persistence in bactericidal environments. In its dormant state, it is capable of withstanding doses of ultraviolet (UV) radiation or hydrogen peroxide, which are lethal for the vast majority of microorganisms. This unusual resistance profile has made SAFR-032 a reference strain for studies of bacterial spore resistance. The complete genome sequence of B. pumilus SAFR-032 was published in 2007 early in the genomics era. Since then, the SAFR-032 strain has frequently been used as a source of genetic/genomic information that was regarded as representative of the entire B. pumilus species group. Recently, our ongoing studies of conservation of gene distribution patterns in the complete genomes of various B. pumilus strains revealed indications of misassembly in the B. pumilus SAFR-032 genome. Synteny-driven local genome resequencing confirmed that the original SAFR-032 sequence contained assembly errors associated with long sequence repeats. The genome sequence was corrected according to the new findings. In addition, a significantly improved annotation is now available. Gene orders were compared and portions of the genome arrangement were found to be similar in a wide spectrum of Bacillus strains.	[Stepanov, Victor G.; Tirumalai, Madhan R.; Montazari, Saied; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Checinska, Aleksandra; Venkateswaran, Kasthuri] CALTECH, Biotechnol & Planetary Protect Grp, Jet Prop Lab, Pasadena, CA 91125 USA	University of Houston System; University of Houston; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Fox, GE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	fox@uh.edu	Tirumalai, Madhan R/J-4988-2017; Willson, richard/AAD-4832-2019	Tirumalai, Madhan R/0000-0002-5999-333X; Stepanov, Victor/0000-0001-5540-7914; Fox, George/0000-0001-7767-8387				Alcaraz LD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-332; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Arias RS, 1999, J BASIC MICROB, V39, P283, DOI 10.1002/(SICI)1521-4028(199912)39:5/6<283::AID-JOBM283>3.0.CO;2-G; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Borodina TA, 2003, ANAL BIOCHEM, V321, P135, DOI 10.1016/S0003-2697(03)00403-2; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Checinska A, 2015, ANNU REV FOOD SCI T, V6, P351, DOI 10.1146/annurev-food-030713-092332; Checinska A, 2011, J MICROBIOL METH, V87, P70, DOI 10.1016/j.mimet.2011.07.008; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Friedline A, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0109-4; Friedline AW, 2015, J PHYS CHEM B, V119, P14033, DOI 10.1021/acs.jpcb.5b07437; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guan ZB, 2015, J BIOTECHNOL, V207, P8, DOI 10.1016/j.jbiotec.2015.04.019; Hall T., 2011, GERF B BIOSCI, V2, P60; Handtke S, 2014, J BIOTECHNOL, V192, P204, DOI 10.1016/j.jbiotec.2014.08.028; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; Kang Y, 2015, GENOME ANNOUNC, V3; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; Link L, 2004, MICROB ECOL, V47, P159, DOI 10.1007/s00248-003-1029-4; MIRONOV VN, 1994, MOL GEN GENET, V242, P201, DOI 10.1007/BF00391014; Misirli G, 2014, J INTEGR BIOINFORMAT, V11, DOI 10.2390/biecoll-jib-2014-244; Niazi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104651; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Ruckert C, 2011, J BIOTECHNOL, V155, P78, DOI 10.1016/j.jbiotec.2011.01.006; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt TR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-430; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tirumalai MR, 2013, EXTREMOPHILES, V17, P767, DOI 10.1007/s00792-013-0559-z; Tirumalai MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066012; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; Villanueva J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00327-14; Wu XH, 2014, J PROTEOME RES, V13, P2724, DOI 10.1021/pr500369b; Yuan YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10259; Zeigler DR, 2011, MICROBIOL-SGM, V157, P2033, DOI 10.1099/mic.0.048520-0	39	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157331	10.1371/journal.pone.0157331	http://dx.doi.org/10.1371/journal.pone.0157331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351589	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900007
J	Li, YH; Zhang, JG; Xu, YF; Han, YL; Jiang, BB; Huang, L; Zhu, H; Xu, YH; Yang, WL; Qin, C				Li, Yanhong; Zhang, Jigang; Xu, Yanfeng; Han, Yunlin; Jiang, Binbin; Huang, Lan; Zhu, Hua; Xu, Yuhuan; Yang, Weiling; Qin, Chuan			The Histopathological Investigation of Red and Blue Light Emitting Diode on Treating Skin Wounds in Japanese Big-Ear White Rabbit	PLOS ONE			English	Article							THERAPY; MODEL	The biological effects of different wavelengths of light emitting diode (LED) light tend to vary from each other. Research into use of photobiomodulation for treatment of skin wounds and the underlying mechanisms has been largely lacking. We explored the histopathological basis of the therapeutic effect of photobiomodulation and the relation between duration of exposure and photobiomodulation effect of different wavelengths of LED in a Japanese big-ear white rabbit skin- wound model. Skin wound model was established in 16 rabbits (three wounds per rabbit: one served as control, the other two wounds were irradiated by red and blue LED lights, respectively). Rabbits were then divided into 2 equal groups based on the duration of exposure to LED lights (15 and 30 min/exposure). The number of wounds that showed healing and the percentage of healed wound area were recorded. Histopathological examination and skin expression levels of fibroblast growth factor (FGF), epidermal growth factor (EGF), endothelial marker (CD31), proliferating cell nuclear antigen (Ki67) and macrophagocyte (CD68) infiltration, and the proliferation of skin collagen fibers was assessed. On days 16 and 17 of irradiation, the healing rates in red (15 min and 30 min) and blue (15 min and 30 min) groups were 50%, 37.5%, 25% and 37.5%, respectively, while the healing rate in the control group was 12.5%. The percentage healed area in the red light groups was significantly higher than those in other groups. Collagen fiber and skin thickness were significantly increased in both red light groups; expression of EGF, FGF, CD31 and Ki67 in the red light groups was significantly higher than those in other groups; the expression of FGF in red (30 min) group was not significantly different from that in the blue light and control groups. The effect of blue light on wound healing was poorer than that of red light. Red light appeared to hasten wound healing by promoting fibrous tissue, epidermal and endothelial cell proliferation. An increase in the exposure time to 30 min did not confer any additional benefit in both red and blue light groups. This study provides a theoretical basis for the potential therapeutic application of LED light in clinical settings.	[Li, Yanhong; Xu, Yanfeng; Han, Yunlin; Huang, Lan; Zhu, Hua; Xu, Yuhuan; Qin, Chuan] Chinese Acad Med Sci, Inst Med Lab Anim Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Beijing 100730, Peoples R China; [Li, Yanhong; Xu, Yanfeng; Han, Yunlin; Zhu, Hua; Xu, Yuhuan; Qin, Chuan] Peking Union Med Coll, State Adm Tradit Chinese Med, Key Lab Human Dis Anim Models, Beijing 100021, Peoples R China; [Zhang, Jigang; Yang, Weiling] Gen Hosp PLA Rocket Force, Dept Dermatol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qin, C (corresponding author), Chinese Acad Med Sci, Inst Med Lab Anim Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Beijing 100730, Peoples R China.; Qin, C (corresponding author), Peking Union Med Coll, State Adm Tradit Chinese Med, Key Lab Human Dis Anim Models, Beijing 100021, Peoples R China.; Yang, WL (corresponding author), Gen Hosp PLA Rocket Force, Dept Dermatol, Beijing, Peoples R China.	ywlderma@sina.com; qinchuan@pumc.edu.cn			National Major Scientific and Technological Special Project [2012ZX10004-501]; National High Technology Research and Development Program of China (853 Plan) [2003AA123310]	National Major Scientific and Technological Special Project; National High Technology Research and Development Program of China (853 Plan)	Support was provided by National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period (2012ZX10004-501) and National High Technology Research and Development Program of China (853 Plan) (2003AA123310).; This study was supported by National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period (2012ZX10004-501); National High Technology Research and Development Program of China (853 Plan) (2003AA123310). This manuscript has been edited and proofread by Medjaden Bioscience Limited.	Adamskaya N, 2011, INJURY, V42, P917, DOI 10.1016/j.injury.2010.03.023; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Becker D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020566; de Sousa APC, 2013, LASER MED SCI, V28, P981, DOI 10.1007/s10103-012-1187-z; Chen J, 2006, PATHOLOGY, P57; Cicchi R, 2016, J BIOPHOTONICS, V9, P645, DOI 10.1002/jbio.201500191; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; Fang ZL, 2003, PHYS HIGH TECHNOLOGY, V23, P295; Figurova M, 2016, PHOTOMED LASER SURG, V34, P53, DOI 10.1089/pho.2015.4013; Kleinpenning MM, 2010, PHOTODERMATOL PHOTO, V26, P16, DOI 10.1111/j.1600-0781.2009.00474.x; Lau P, 2015, J PHOTOCH PHOTOBIO B, V151, P201, DOI 10.1016/j.jphotobiol.2015.08.009; Li Q, 2011, PLAST RECONSTR SURG, V127, P2255, DOI 10.1097/PRS.0b013e3182131bb5; [李勤 LI Qin], 2008, [光学技术, Optical Technology], V34, P265; Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7; Morton CA, 2005, J DERMATOL TREAT, V16, P219, DOI 10.1080/09546630500283664; Niemz M.H., 2019, LASER TISSUE INTERAC, V4th ed.; Opel Daniel R, 2015, J Clin Aesthet Dermatol, V8, P36; Park KY, 2013, ANN DERMATOL, V25, P400, DOI 10.5021/ad.2013.25.3.400; Qin QH, 2000, FASCICULE BASIC PROB, V21, P33; [任为 Ren Wei], 2013, [第三军医大学学报, Journal of Third Military Medical University], V35, P981; Shi PN, 2014, ZHEJIANG MED, V36, P1349; Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003; Wang BY, 2000, PATHOLOGICAL TECHNIQ, P131; Weiss RA, 2005, DERMATOL SURG, V31, P1199; Whelan HT, 2001, AIP CONF PROC, V552, P35, DOI 10.1063/1.1357902; Zhao F., 2008, STUDY WOUND HEALING; [赵飞 ZHAO Fei], 2007, [第四军医大学学报, Journal of the Fourth Military Medical University], V28, P1976	27	17	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157898	10.1371/journal.pone.0157898	http://dx.doi.org/10.1371/journal.pone.0157898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347879	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200019
J	Lohmann, G; Stelzer, J; Zuber, V; Buschmann, T; Margulies, D; Bartels, A; Scheffler, K				Lohmann, Gabriele; Stelzer, Johannes; Zuber, Verena; Buschmann, Tilo; Margulies, Daniel; Bartels, Andreas; Scheffler, Klaus			Task-Related Edge Density (TED)-A New Method for Revealing Dynamic Network Formation in fMRI Data of the Human Brain	PLOS ONE			English	Article							HUMAN CONNECTOME PROJECT; FALSE DISCOVERY RATE; FUNCTIONAL CONNECTIVITY; PSYCHOPHYSIOLOGICAL INTERACTIONS; WHOLE-BRAIN; SMALL-WORLD; ACTIVATION; CORTEX; PARCELLATION; ORGANIZATION	The formation of transient networks in response to external stimuli or as a reflection of internal cognitive processes is a hallmark of human brain function. However, its identification in fMRI data of the human brain is notoriously difficult. Here we propose a new method of fMRI data analysis that tackles this problem by considering large-scale, task-related synchronisation networks. Networks consist of nodes and edges connecting them, where nodes correspond to voxels in fMRI data, and the weight of an edge is determined via task-related changes in dynamic synchronisation between their respective times series. Based on these definitions, we developed a new data analysis algorithm that identifies edges that show differing levels of synchrony between two distinct task conditions and that occur in dense packs with similar characteristics. Hence, we call this approach "Task-related Edge Density" (TED). TED proved to be a very strong marker for dynamic network formation that easily lends itself to statistical analysis using large scale statistical inference. A major advantage of TED compared to other methods is that it does not depend on any specific hemodynamic response model, and it also does not require a presegmentation of the data for dimensionality reduction as it can handle large networks consisting of tens of thousands of voxels. We applied TED to fMRI data of a fingertapping and an emotion processing task provided by the Human Connectome Project. TED revealed network-based involvement of a large number of brain areas that evaded detection using traditional GLM-based analysis. We show that our proposed method provides an entirely new window into the immense complexity of human brain function.	[Lohmann, Gabriele; Stelzer, Johannes; Scheffler, Klaus] Univ Tubingen, Univ Hosp, Dept Biomed Magnet Resonance Imaging, Tubingen, Germany; [Lohmann, Gabriele; Stelzer, Johannes; Scheffler, Klaus] Max Planck Inst Biol Cybernet, Magnet Resonance Ctr, Spemannstr 38, D-72076 Tubingen, Germany; [Buschmann, Tilo] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Zuber, Verena] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England; [Margulies, Daniel] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Bartels, Andreas] Ctr Integrat Neurosci, CIN Vis & Cognit Grp, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Fraunhofer Gesellschaft; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Max Planck Society; Eberhard Karls University of Tubingen	Lohmann, G (corresponding author), Univ Tubingen, Univ Hosp, Dept Biomed Magnet Resonance Imaging, Tubingen, Germany.; Lohmann, G (corresponding author), Max Planck Inst Biol Cybernet, Magnet Resonance Ctr, Spemannstr 38, D-72076 Tubingen, Germany.	lohmann@tuebingen.mpg.de	Bartels, Andreas/A-9446-2014; Lohmann, Gabriele/C-3590-2008; Lohmann, Gabriele/AGE-9413-2022; Margulies, Daniel/L-4719-2016	Bartels, Andreas/0000-0002-4939-7817; Lohmann, Gabriele/0000-0002-5922-9016; Margulies, Daniel/0000-0002-8880-9204; Scheffler, Klaus/0000-0001-6316-8773; Zuber, Verena/0000-0001-9827-1877	European Commission [H2020-PHC-2014 634541 CDS-QUAMRI]; 16 NIH Institutes and Centers; McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); 16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	One of the authors, Johannes Stelzer, received funding from the European Commission H2020-PHC-2014 634541 CDS-QUAMRI.; Data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boettger J, 2014, T VISUALIZATION COMP, V20, P471; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carbonell F, 2009, STAT PROBABIL LETT, V79, P780, DOI 10.1016/j.spl.2008.11.007; Cardoso PL, 2016, MAGMA; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Deco G, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00068; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Dodel S, 2005, PHILOS T R SOC B, V360, P921, DOI 10.1098/rstb.2005.1653; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gerchen MF, 2014, HUM BRAIN MAPP, V35, P5071, DOI 10.1002/hbm.22532; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gonzalez R. C., 2006, PEARSON ED, V3rd, P8; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horwitz B, 2014, PHYS LIFE REV, V11, P448, DOI 10.1016/j.plrev.2014.06.019; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Khalili-Mahani N, 2013, NEUROIMAGE, V65, P499, DOI 10.1016/j.neuroimage.2012.09.044; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Kloppel S, 2007, NEUROIMAGE, V34, P274, DOI 10.1016/j.neuroimage.2006.08.038; Liu TM, 2011, BRAIN IMAGING BEHAV, V5, P189, DOI 10.1007/s11682-011-9123-6; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2013, BRAIN CONNECT, V3, P223, DOI 10.1089/brain.2012.0133; Lohmann G, 2012, NEUROIMAGE, V59, P2322, DOI 10.1016/j.neuroimage.2011.09.025; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norman K. A, 2006, TRENDS COGNITIVE SCI, V10; Pessoa L, 2014, PHYS LIFE REV, V11, P400, DOI 10.1016/j.plrev.2014.03.005; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rosenberg MD, 2015, NEUROIMAGE, V114, P249, DOI 10.1016/j.neuroimage.2015.03.032; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Silverman BW, 1998, DENSITY ESTIMATION S; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Solano-Castiella E, 2011, NEUROIMAGE, V58, P741, DOI 10.1016/j.neuroimage.2011.06.047; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Stelzer J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00462; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Thuret S, 2014, FRONTIERS CELLULAR N, V8, DOI [10.3389/fncel.2014.00095, DOI 10.3389/FNCEL.2014.00095]; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Turner R, 2014, BRAIN CONNECT, V4, P547, DOI 10.1089/brain.2014.0261; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Worsley KJ, 1998, HUM BRAIN MAPP, V6, P364, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<364::AID-HBM6>3.3.CO;2-K; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang YQ, 2014, CEREB CORTEX, V24, P719, DOI 10.1093/cercor/bhs353	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158185	10.1371/journal.pone.0158185	http://dx.doi.org/10.1371/journal.pone.0158185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341204	gold, Green Submitted, Green Published			2022-12-26	WOS:000378393600038
J	Trudeau, MP; Verma, H; Sampedro, F; Urriola, PE; Shurson, GC; McKelvey, J; Pillai, SD; Goyal, SM				Trudeau, Michaela P.; Verma, Harsha; Sampedro, Fernando; Urriola, Pedro E.; Shurson, Gerald C.; McKelvey, Jessica; Pillai, Suresh D.; Goyal, Sagar M.			Comparison of Thermal and Non-Thermal Processing of Swine Feed and the Use of Selected Feed Additives on Inactivation of Porcine Epidemic Diarrhea Virus (PEDV)	PLOS ONE			English	Article							ACID	Infection with porcine epidemic diarrhea virus (PEDV) causes diarrhea, vomiting, and high mortality in suckling pigs. Contaminated feed has been suggested as a vehicle of transmission for PEDV. The objective of this study was to compare thermal and electron beam processing, and the inclusion of feed additives on the inactivation of PEDV in feed. Feed samples were spiked with PEDV and then heated to 120-145 degrees C for up to 30 min or irradiated at 0-50 kGy. Another set of feed samples spiked with PEDV and mixed with Ultracid P (Nutriad), Activate DA (Novus International), KEM-GEST (Kemin Agrifood), Acid Booster (Agri-Nutrition), sugar or salt was incubated at room temperature (similar to 25 degrees C) for up to 21 days. At the end of incubation, the virus titers were determined by inoculation of Vero-81 cells and the virus inactivation kinetics were modeled using the Weibull distribution model. The Weibull kinetic parameter delta represented the time or eBeam dose required to reduce virus concentration by 1 log. For thermal processing, delta values ranged from 16.52 min at 120 degrees C to 1.30 min at 145 degrees C. For eBeam processing, a target dose of 50 kGy reduced PEDV concentration by 3 log. All additives tested were effective in reducing the survival of PEDV when compared with the control sample (delta = 17.23 days). Activate DA (0.81) and KEMGEST (3.28) produced the fastest inactivation. In conclusion, heating swine feed at temperatures over 130 degrees C or eBeam processing of feed with a dose over 50 kGy are effective processing steps to reduce PEDV survival. Additionally, the inclusion of selected additives can decrease PEDV survivability.	[Trudeau, Michaela P.; Urriola, Pedro E.; Shurson, Gerald C.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55018 USA; [Verma, Harsha; Goyal, Sagar M.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55018 USA; [Sampedro, Fernando] Univ Minnesota, Ctr Anim Hlth & Food Safety, St Paul, MN 55018 USA; [McKelvey, Jessica; Pillai, Suresh D.] Texas A&M Univ, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA; [McKelvey, Jessica; Pillai, Suresh D.] Texas A&M Univ, IAEA Collaborating Ctr Electron Beam Technol, College Stn, TX 77843 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Goyal, SM (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55018 USA.	goyal001@umn.edu	Sampedro, Fernando/AAH-8332-2020	Sampedro, Fernando/0000-0003-1155-2751; Urriola, Pedro E/0000-0003-4090-6627; Shurson, Gerald/0000-0001-7095-4799	National Pork Board [14-157]; United States Department of Agriculture-National Institute of Food and Agriculture Hatch grant [H-8708]; International Atomic Energy Agency Collaborating Centre activities	National Pork Board; United States Department of Agriculture-National Institute of Food and Agriculture Hatch grant; International Atomic Energy Agency Collaborating Centre activities	This work was funded by the National Pork Board (project ID: 14-157 to SMG, GCS, PEU). The website outlining the project can be seen at http://www.pork.org/pedv-2014-research/pedv-feed/. This work was also supported in part by United States Department of Agriculture-National Institute of Food and Agriculture Hatch grant H-8708 awarded to Texas A&M AgriLife Research and as part of the International Atomic Energy Agency Collaborating Centre activities, to SDP, JM. More information on the grants can be seen at http://nifa.usda.gov/grants.	Almeida FN, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-44; Bigelow WD, 1920, J INFECT DIS, V27, P602, DOI 10.1093/infdis/27.6.602; Bowman AS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0348-2; Brauniger S, 2000, INT J HYG ENVIR HEAL, V203, P71, DOI 10.1078/S1438-4639(04)70010-3; Comes JE, 2002, J FOOD PROTECT, V65, P476, DOI 10.4315/0362-028X-65.3.476; Dee S, 2015, AN EVALUATION OF POR, P1; Dee S, 2014, AN EVALUATION OF A L, V10, P1; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; Edwards S, 2000, VET MICROBIOL, V73, P175, DOI 10.1016/S0378-1135(00)00143-7; FARAG MDEH, 1990, J FOOD PROTECT, V53, P648, DOI 10.4315/0362-028X-53.8.648; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Hamilton CR, 2002, PROTEIN SOURCES ANIM, P255; HOFMANN M, 1989, VET MICROBIOL, V20, P131, DOI 10.1016/0378-1135(89)90036-9; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kim YY, 2005, ASIAN AUSTRAL J ANIM, V18, P1048, DOI 10.5713/ajas.2005.1048; Knight CD, 1998, J ANIM SCI, V76, P781; LAWRENCE TLJ, 1978, ANIM FEED SCI TECH, V3, P179, DOI 10.1016/0377-8401(78)90045-7; Leman AD, 1986, DIS SWINE, V6th; Mafart P, 2001, ACTA HORTIC, P107, DOI 10.17660/ActaHortic.2001.566.11; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Pillai SD, 2013, GLOBAL SAFETY OF FRE; Pillai SD, 2014, ELECTRON BEAM PASTEU; Quist-Rybachuk GV, 2015, VET MICROBIOL, V181, P283, DOI 10.1016/j.vetmic.2015.10.010; Sampedro F, 2014, RISK ASSESSMENT OF F; Silindir M., 2009, FABAD J PHARM SCI, V34, P43, DOI DOI 10.1002/MAME.201600133; Silliker JH, 1980, MICROBIAL ECOLOGY OF, P215; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Thomas P, 2014, TWENTY SECOND ANNUAL, P43; Tung CM, 2006, ANIM SCI, P5; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; Van Immerseel F, 2002, WORLD POULTRY SCI J, V58, P501, DOI 10.1079/WPS20020036; Yin YL, 2001, J SCI FOOD AGR; Zhang Y, 2012, PIG PRODUCTION IN SU, V9, P1016	36	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158128	10.1371/journal.pone.0158128	http://dx.doi.org/10.1371/journal.pone.0158128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341670	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600033
J	Chang, I; Wang, CY				Chang, Insoon; Wang, Cun-Yu			Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; head and neck squamous cell carcinoma (HNSCC); proteasome; protein aggregation; signal transduction; signaling	ENDOPLASMIC-RETICULUM STRESS; BREAST-CANCER CELLS; PROTEASOME INHIBITOR; HISTONE DEACETYLASES; AGGRESOME FORMATION; PS-341; RESISTANCE; ULK1; PHOSPHORYLATION; MECHANISMS	Chemoresistance is a major barrier to effective chemotherapy of solid tumors, including head and neck squamous cell carcinoma (HNSCC). Recently, autophagy, a highly conservative intracellular recycling system, has shown to be associated with chemoresistance in cancer cells. However, little is known about how autophagy plays a role in the development of chemoresistance in HNSCC and how autophagy is initiated when HNSCC cells undergo cytotoxic stress. Here, we report that autophagy was activated when HNSCC cells are treated with the proteasome inhibitor bortezomib, proposed as an alternative chemotherapeutic agent for both primary and cisplatin-resistant HNSCC cells. Ablation of histone deacetylase 6 (HDAC6) expression and its activity in HNSCC cells significantly inhibited autophagy induction by altering the phosphorylation status of mammalian target of rapamycin and enhanced the bortezomib cytotoxicity. Similarly, a combination regimen of bortezomib and the histone deacetylase inhibitor trichostatin A abolished HDAC6 activity and decreased autophagy induction while significantly enhancing bortezomib-induced apoptosis in HNSCC cells. These data uncover a novel molecular mechanism indicating that HDAC6 may serve as a critical causal link between autophagy, apoptosis, and the cell survival response in HNSCC. A combination regimen resulting in regression of autophagy improves chemotherapeutic efficacy, thereby providing a new strategy to overcome chemoresistance and to improve the treatment and survival of HNSCC patients.	[Chang, Insoon; Wang, Cun-Yu] Univ Calif Los Angeles, Div Oral Biol & Med, Sch Dent, CHS 33-030,10833 Le Conte Ave, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Div Oral Biol & Med, Sch Dent, CHS 33-030,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu			National Institutes of Health Shared Resources from NCRR [CJX1-443835-WS-29646]; National Science Foundation Major Research Instrumentation Grant [CHE-0722519]; National Institutes of Health [P30 CA016042, 5P30AI028697]; Jonsson Comprehensive Cancer Center; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; UCLA Chancellor's Office; UCLA Vice Chancellor's Office of Research; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE023874, F30DE025159, R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health Shared Resources from NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); UCLA Chancellor's Office; UCLA Vice Chancellor's Office of Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Confocal laser scanning microscopy was performed at the California NanoSystems Institute's Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding by National Institutes of Health Shared Resources Grant CJX1-443835-WS-29646 from NCRR and National Science Foundation Major Research Instrumentation Grant CHE-0722519. Flow cytometry was performed at UCLA and Center for AIDS Research Flow Cytometry Core Facility, supported by National Institutes of Health Awards P30 CA016042 and 5P30AI028697, and by the Jonsson Comprehensive Cancer Center, the UCLA AIDS Institute, the David Geffen School of Medicine at UCLA, the UCLA Chancellor's Office, and the UCLA Vice Chancellor's Office of Research.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Caravita T, 2006, NAT CLIN PRACT ONCOL, V3, P374, DOI 10.1038/ncponc0555; Chung CH, 2010, ANN ONCOL, V21, P864, DOI 10.1093/annonc/mdp390; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Gilbert J, 2013, HEAD NECK-J SCI SPEC, V35, P942, DOI 10.1002/hed.23046; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim J, 2010, MOL CANCER THER, V9, P1977, DOI 10.1158/1535-7163.MCT-10-0141; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moriya S, 2015, INT J ONCOL, V46, P474, DOI 10.3892/ijo.2014.2773; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Rikiishi Hidemi, 2010, Cancers (Basel), V2, P2026, DOI 10.3390/cancers2042026; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sakuma T, 2006, INT J ONCOL, V29, P117; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verfaillie Tom, 2010, Int J Cell Biol, V2010, P930509, DOI 10.1155/2010/930509; Vincenz L, 2013, MOL CANCER THER, V12, P831, DOI 10.1158/1535-7163.MCT-12-0782; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yan MM, 2015, ONCOL LETT, V10, P1959, DOI 10.3892/ol.2015.3508; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031601; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343; Zhu T, 2016, NEUROBIOL AGING, V37, P91, DOI 10.1016/j.neurobiolaging.2015.09.021	53	24	25	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18199	18209		10.1074/jbc.M116.717793	http://dx.doi.org/10.1074/jbc.M116.717793			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27369083	Green Published, hybrid			2022-12-26	WOS:000383241800013
J	Sun, T; Yi, HQ; Yang, CY; Kishnani, PS; Sun, BD				Sun, Tao; Yi, Haiqing; Yang, Chunyu; Kishnani, Priya S.; Sun, Baodong			Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TYPE-II; POMPE-DISEASE; ADENOASSOCIATED VIRUS; SKELETAL-MUSCLE; NERVOUS-SYSTEM; GENE-THERAPY; METABOLISM; EXPRESSION; GABARAPL1; MODEL	A small portion of cellular glycogen is transported to and degraded in lysosomes by acid alpha-glucosidase (GAA) in mammals, but it is unclear why and how glycogen is transported to the lysosomes. Stbd1 has recently been proposed to participate in glycogen trafficking to lysosomes. However, our previous study demonstrated that knockdown of Stbd1 in GAA knockout mice did not alter lysosomal glycogen storage in skeletal muscles. To further determine whether Stbd1 participates in glycogen transport to lysosomes, we generated GAA/Stbd1 double knock-out mice. In fasted double knock-out mice, glycogen accumulation in skeletal and cardiac muscles was not affected, but glycogen content in liver was reduced by nearly 73% at 3 months of age and by 60% at 13 months as compared with GAA knock-out mice, indicating that the transport of glycogen to lysosomes was suppressed in liver by the loss of Stbd1. Exogenous expression of human Stbd1 in double knock-out mice restored the liver lysosomal glycogen content to the level of GAA knock-out mice, as did a mutant lacking the Atg8 family interacting motif (AIM) and another mutant that contains only the N-terminal 24 hydrophobic segment and the C-terminal starch binding domain (CBM20) interlinked by an HA tag. Our results demonstrate that Stbd1 plays a dominant role in glycogen transport to lysosomes in liver and that the N-terminal transmembrane region and the C-terminal CBM20 domain are critical for this function.	[Sun, Tao; Yi, Haiqing; Yang, Chunyu; Kishnani, Priya S.; Sun, Baodong] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, 905 LaSalle St,GSRB1 Bldg,Rm 4044,DUMC Box 103856, Durham, NC 27710 USA	Duke University	Sun, BD (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, 905 LaSalle St,GSRB1 Bldg,Rm 4044,DUMC Box 103856, Durham, NC 27710 USA.	baodong.sun@duke.edu	Liu, Wenjun/L-5256-2016	Liu, Wenjun/0000-0001-9380-2990; Yi, Haiqing/0000-0003-2254-6226	Alice and YT Chen Pediatrics Genetics; Genomics Research Center	Alice and YT Chen Pediatrics Genetics; Genomics Research Center	This work was supported by the Alice and YT Chen Pediatrics Genetics and Genomics Research Center. The authors declare that they have no conflicts of interest with the contents of this article.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Bouju S, 1998, BIOCHEM J, V335, P549, DOI 10.1042/bj3350549; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chakrapani A, 2010, J INHERIT METAB DIS, V33, P747, DOI 10.1007/s10545-010-9206-3; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; GEDDES R, 1977, BIOCHEM J, V163, P193, DOI 10.1042/bj1630193; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kishnani P. S., 2009, ONLINE METABOLIC MOL; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2004, J PEDIATR-US, V144, pS35, DOI 10.1016/j.jpeds.2004.01.053; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Le Grand JN, 2011, AUTOPHAGY, V7, P1098, DOI 10.4161/auto.7.10.15904; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Melvin JJ, 2000, ARCH NEUROL-CHICAGO, V57, P134, DOI 10.1001/archneur.57.1.134; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; Patel TT, 2012, MOL GENET METAB, V106, P301, DOI 10.1016/j.ymgme.2012.04.027; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2010, AUTOPHAGY, V6, P1078, DOI 10.4161/auto.6.8.13378; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Sun BD, 2008, MOL THER, V16, P1366, DOI 10.1038/mt.2008.133; Xu F, 2004, GENE THER, V11, P1590, DOI 10.1038/sj.gt.3302314; Yi HQ, 2013, MOL GENET METAB, V109, P312, DOI 10.1016/j.ymgme.2013.05.004; Yi HQ, 2012, DIS MODEL MECH, V5, P804, DOI 10.1242/dmm.009712; Zhu YQ, 2014, BIOSCIENCE REP, V34, P311, DOI 10.1042/BSR20140053	27	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16479	16484		10.1074/jbc.C116.741397	http://dx.doi.org/10.1074/jbc.C116.741397			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27358407	Green Published, hybrid			2022-12-26	WOS:000380826700008
J	Huang, SS; Su, WP; Lin, HP; Kuo, HL; Wei, HL; Chang, NS				Huang, Shenq-Shyang; Su, Wan-Pei; Lin, Hsin-Pin; Kuo, Hsiang-Ling; Wei, Hsiao-Ling; Chang, Nan-Shan			Role of WW Domain-containing Oxidoreductase WWOX in Driving T Cell Acute Lymphoblastic Leukemia Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; extracellular-signal-regulated kinase (ERK); lymphocyte; phorbol ester; phosphorylation; tumor suppressor gene	NF-KAPPA-B; TUMOR-SUPPRESSOR WWOX; TIAF1 SELF-AGGREGATION; POTENTIAL ROLE; PHORBOL ESTER; IN-VITRO; THYMOCYTE DEVELOPMENT; PHYSICALLY INTERACTS; POSITIVE SELECTION; ALZHEIMERS-DISEASE	Whether tumor suppressor WWOX (WW domain-containing oxidoreductase) stimulates immune cell maturation is largely unknown. Here, we determined that Tyr-33-phosphorylated WWOX physically binds non-phosphorylated ERK and I kappa B alpha in immature acute lymphoblastic leukemia MOLT-4 T cells and in the naive mouse spleen. The I kappa B alpha center dot ERK center dot WWOX complex was shown to localize, in part, in the mitochondria. WWOX prevents I kappa B alpha from proteasomal degradation. Upon stimulating MOLT-4 with ionophore A23187/phorbol myristate acetate, endogenous I kappa B alpha and ERK undergo rapid phosphorylation in < 5 min, and subsequently WWOX is Tyr-33 and Tyr-287 de-phosphorylated and Ser-14 phosphorylated. Three hours later, I kappa B alpha starts to degrade, and ERK returns to basal or non-phosphorylation, and this lasts for the next 12 h. Finally, expression of CD3 and CD8 occurs in MOLT-4 along with reappearance of the I kappa B alpha center dot ERK center dot WWOX complex near 24 h. Inhibition of ERK phosphorylation by U0126 or I kappa B alpha degradation by MG132 prevents MOLT-4 maturation. By time-lapse FRET microscopy, I kappa B alpha center dot ERK center dot WWOX complex exhibits an increased binding strength by 1-2-fold after exposure to ionophore A23187/phorbol myristate acetate for 15-24 h. Meanwhile, a portion of ERK and WWOX relocates to the nucleus, suggesting their role in the induction of CD3 and CD8 expression in MOLT-4.	[Huang, Shenq-Shyang; Su, Wan-Pei; Lin, Hsin-Pin; Kuo, Hsiang-Ling; Wei, Hsiao-Ling; Chang, Nan-Shan] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan; [Chang, Nan-Shan] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Nan-Shan] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan 70101, Taiwan; [Chang, Nan-Shan] New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; [Chang, Nan-Shan] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Chang, Nan-Shan] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung 40402, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; China Medical University Taiwan	Chang, NS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Lab Mol Immunol, Tainan, Taiwan.	nschang13827@gmail.com		Huang, Shenq-Shyang/0000-0001-8476-3141	United States Department of Defense [W81XWH-08-1-0682]; Ministry of Science and Education, Taiwan, ROC [NSC99-2320-B-006-012-MY3, 102-2320-B-006-018-, 102-2320-B-006-030-, 102-3011-P-006-005-]; National Health Research Institute, Taiwan, ROC [NHRI-EX99-9704BI]	United States Department of Defense(United States Department of Defense); Ministry of Science and Education, Taiwan, ROC; National Health Research Institute, Taiwan, ROC(National Health Research Institutes - Taiwan)	This work was supported by the United States Department of Defense (W81XWH-08-1-0682), the Ministry of Science and Education, Taiwan, ROC (NSC99-2320-B-006-012-MY3, 102-2320-B-006-018-, 102-2320-B-006-030-, and 102-3011-P-006-005-), and the National Health Research Institute, Taiwan, ROC (NHRI-EX99-9704BI) (to N.-S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Abu-Remaileh M, 2015, EXP BIOL MED, V240, P345, DOI 10.1177/1535370214561956; Anderson G, 2014, CURR TOP MICROBIOL, V373, P19, DOI 10.1007/82_2013_320; Bakker TR, 1999, J IMMUNOL, V162, P3456; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chang JY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.3; Chang JY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.36; Chang JY, 2010, EXP BIOL MED, V235, P796, DOI 10.1258/ebm.2010.009351; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2015, EXP BIOL MED, V240, P281, DOI 10.1177/1535370215574226; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2002, J BIOL CHEM, V277, P10323, DOI 10.1074/jbc.M106607200; Chang NS, 2002, INT J MOL MED, V9, P19; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chang Y, 2015, EXP BIOL MED, V240, P329, DOI 10.1177/1535370214561957; Chen SJ, 2015, ONCOTARGET, V6, P8007, DOI 10.18632/oncotarget.3153; Chen Szu-Jung, 2013, Transl Respir Med, V1, P15, DOI 10.1186/2213-0802-1-15; Choo A, 2015, GENE CHROMOSOME CANC, V54, P745, DOI 10.1002/gcc.22286; Dodson EJ, 2015, EXP BIOL MED, V240, P351, DOI 10.1177/1535370214566558; Ferguson BW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-593; Gibbings DJ, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-12; He HC, 1999, CELL GROWTH DIFFER, V10, P307; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Hong QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005755; Hsu LJ, 2008, CELL SIGNAL, V20, P1303, DOI 10.1016/j.cellsig.2008.02.018; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Iessi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126526; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lee MH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.83; Li MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007820; Lin Hsin-Ping, 2011, Genes Cancer, V2, P550, DOI 10.1177/1947601911418498; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Martin-Blanco NM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.438; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Reuven N, 2015, EXP BIOL MED, V240, P375, DOI 10.1177/1535370214565991; Schrock MS, 2015, EXP BIOL MED, V240, P296, DOI 10.1177/1535370214561590; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sze CI, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.251; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Takahama Y, 1996, J IMMUNOL, V157, P1508; Tanahashi M, 2001, HUM IMMUNOL, V62, P771, DOI 10.1016/S0198-8859(01)00276-2; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; VANDONGEN JJM, 1988, BLOOD, V71, P603; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Zhu MX, 2015, EXP CELL RES, V331, P387, DOI 10.1016/j.yexcr.2014.12.012; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	54	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17319	17331		10.1074/jbc.M116.716167	http://dx.doi.org/10.1074/jbc.M116.716167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339895	Green Published, hybrid			2022-12-26	WOS:000382643800032
J	Salinero-Fort, MA; Burgos-Lunar, C; Lahoz, C; Mostaza, JM; Abanades-Herranz, JC; Laguna-Cuesta, F; Estirado-de Cabo, E; Garcia-Iglesias, F; Gonzalez-Alegre, T; Fernandez-Puntero, B; Montesano-Sanchez, L; Vicent-Lopez, D; Cornejo-del Rio, V; Fernandez-Garcia, PJ; Sanchez-Arroyo, V; Sabin-Rodriguez, C; Lopez-Lopez, S; Patron-Barandio, P; Gomez-Campelo, P				Salinero-Fort, M. A.; Burgos-Lunar, C.; Lahoz, C.; Mostaza, J. M.; Abanades-Herranz, J. C.; Laguna-Cuesta, F.; Estirado-de Cabo, E.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.; Fernandez-Puntero, B.; Montesano-Sanchez, L.; Vicent-Lopez, D.; Cornejo-del Rio, V.; Fernandez-Garcia, P. J.; Sanchez-Arroyo, V.; Sabin-Rodriguez, C.; Lopez-Lopez, S.; Patron-Barandio, P.; Gomez-Campelo, P.		SPREDIA-2 Grp	Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; GLYCATED HEMOGLOBIN; POPULATION; FINDRISC; PREVALENCE; VALIDATION; PREVENTION; PREDICTION; DIAGNOSIS	Aim To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia. Methods A population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45-74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Association criteria. Results The study population comprised 1,426 participants (832 females and 594 males) with a mean age of 62 years (SD = 6.1). When HbA1c or OGTT criteria were used, the prevalence of UT2DM was 7.4% (10.4% in men and 5.2% in women; p<0.01) and the FINDRISC ROC-AUC for UT2DM was 0.72 (95% CI, 0.69-0.74). The optimal cut-off point was >= 13 (sensitivity = 63.8%, specificity = 65.1%). The ROC-AUC of MADRISC was 0.76 (95% CI, 0.72-0.81) with >= 13 as the optimal cut-off point (sensitivity = 84.8%, specificity = 54.6%). FINDRISC score >= 12 for detecting any dysglycaemia offered the best cut-off point when HbA1c alone or OGTT and HbA1c were the criteria used. Conclusions FINDRISC proved to be a useful instrument in screening for dysglycaemia and UT2DM. In the screening of UT2DM, the simplified MADRISC performed as well as FINDRISC.	[Salinero-Fort, M. A.] Consejeria Sanidad Madrid, Subdirecc Gen Invest Sanitaria, Madrid, Spain; [Salinero-Fort, M. A.; Burgos-Lunar, C.; Abanades-Herranz, J. C.; Gomez-Campelo, P.] MADIABET Res Grp, Madrid, Spain; [Salinero-Fort, M. A.; Burgos-Lunar, C.; Abanades-Herranz, J. C.; Gomez-Campelo, P.] IdiPAZ, Aging & Fragil Elderly Grp, Madrid, Spain; [Salinero-Fort, M. A.; Burgos-Lunar, C.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Burgos-Lunar, C.] Consejeria Sanidad, Direcc Gen Salud Publ, Subdirecc Promoc Prevenc & Educ Salud, Madrid, Spain; [Lahoz, C.; Mostaza, J. M.; Laguna-Cuesta, F.; Estirado-de Cabo, E.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.] Hosp Carlos III, Med Interna Serv, Madrid, Spain; [Abanades-Herranz, J. C.] Ctr Salud Monovar, Serv Madrileno Salud, Madrid, Spain; [Fernandez-Puntero, B.; Vicent-Lopez, D.; Cornejo-del Rio, V.; Fernandez-Garcia, P. J.; Sanchez-Arroyo, V.; Sabin-Rodriguez, C.; Lopez-Lopez, S.; Patron-Barandio, P.] Hosp Carlos III, Madrid, Spain; [Montesano-Sanchez, L.] Hosp Fuenlabrada, Madrid, Spain; [Gomez-Campelo, P.] Hosp La Paz, Inst Hlth Res IdiPAZ, Plataforma Apoyo Investigador Novel PAIN Platform, Madrid, Spain	Hospital Carlos III; Hospital Carlos III; Hospital Universitario Fuenlabrada; Hospital Universitario La Paz	Salinero-Fort, MA (corresponding author), Consejeria Sanidad Madrid, Subdirecc Gen Invest Sanitaria, Madrid, Spain.; Salinero-Fort, MA (corresponding author), MADIABET Res Grp, Madrid, Spain.; Salinero-Fort, MA (corresponding author), IdiPAZ, Aging & Fragil Elderly Grp, Madrid, Spain.; Salinero-Fort, MA (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain.	miguel.salinero@salud.madrid.org	Vicent, David/O-2255-2014; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Michalski, Fernanda/J-4691-2012	Vicent, David/0000-0002-6663-0350; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Michalski, Fernanda/0000-0002-8074-9964; Lahoz, Carlos/0000-0001-5690-7558; Gomez Campelo, Paloma/0000-0003-2299-1741	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant [RS_AP10/6]; FIS (Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE [12/01806, 15/00259]	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant; FIS (Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE	This work was funded by the Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant 'RS_AP10/6' and by FIS grants 12/01806 and 15/00259 (Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE. The funders had no role in the study design, data	Salinero-Fort MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007195; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Boronat M, 2010, DIABETES CARE, V33, P2671, DOI 10.2337/dc10-0529; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Costa B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-45; Eborall H, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630106; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gong W, 2009, DIABETES METAB, V35, P458, DOI 10.1016/j.diabet.2009.05.005; Gyberg V, 2012, PRIM CARE DIABETES, V6, P103, DOI 10.1016/j.pcd.2011.12.003; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ku GMV, 2013, PRIM CARE DIABETES, V7, P249, DOI 10.1016/j.pcd.2013.07.004; Lee CMY, 2013, DIABETES RES CLIN PR, V100, P285, DOI 10.1016/j.diabres.2013.01.024; Li J, 2009, HORM METAB RES, V41, P98, DOI 10.1055/s-0028-1087191; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Lopez JBC, 1997, REV ESP CARDIOL, V50, P507; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Ros JM, 2011, ATEN PRIM, V43, P516, DOI 10.1016/j.aprim.2010.09.021; Mosca A, 2007, CLIN CHEM LAB MED, V45, P1077, DOI 10.1515/CCLM.2007.246; Mostaza JM, 2015, ATHEROSCLEROSIS, V242, P377, DOI 10.1016/j.atherosclerosis.2015.07.028; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Ruiz-Ramos Miguel, 2006, Gac Sanit, V20 Suppl 1, P15, DOI 10.1157/13086022; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Waugh NR, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17350; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Witte DR, 2010, DIABETIC MED, V27, P46, DOI 10.1111/j.1464-5491.2009.02891.x; World Health Organization Consultation, 1999, 992 WHO; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	38	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158489	10.1371/journal.pone.0158489	http://dx.doi.org/10.1371/journal.pone.0158489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27352247	Green Submitted, Green Published, gold			2022-12-26	WOS:000380797500014
J	Chang, JH; Luo, Y; Wang, YY; Pathak, R; Sridharan, V; Jones, T; Mao, XW; Nelson, G; Boerma, M; Hauer-Jensen, M; Zhou, DH; Shao, LJ				Chang, Jianhui; Luo, Yi; Wang, Yingying; Pathak, Rupak; Sridharan, Vijayalakshmi; Jones, Tamako; Mao, Xiao Wen; Nelson, Gregory; Boerma, Marjan; Hauer-Jensen, Martin; Zhou, Daohong; Shao, Lijian			Low Doses of Oxygen Ion Irradiation Cause Acute Damage to Hematopoietic Cells in Mice	PLOS ONE			English	Article							BODY PROTON IRRADIATION; STEM-CELLS; RADIATION-SYNDROME; GAMMA-IRRADIATION; PROGENITOR CELLS; MOUSE; SENESCENCE; INDUCTION; DELETION; INJURY	One of the major health risks to astronauts is radiation on long-duration space missions. Space radiation from sun and galactic cosmic rays consists primarily of 85% protons, 14% helium nuclei and 1% high-energy high-charge (HZE) particles, such as oxygen (O-16), carbon, silicon, and iron ions. HZE particles exhibit dense linear tracks of ionization associated with clustered DNA damage and often high relative biological effectiveness (RBE). Therefore, new knowledge of risks from HZE particle exposures must be obtained. In the present study, we investigated the acute effects of low doses of O-16 irradiation on the hematopoietic system. Specifically, we exposed C57BL/6J mice to 0.1, 0.25 and 1.0 Gy whole body O-16 (600 MeV/n) irradiation and examined the effects on peripheral blood (PB) cells, and bone marrow (BM) hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) at two weeks after the exposure. The results showed that the numbers of white blood cells, lymphocytes, monocytes, neutrophils and platelets were significantly decreased in PB after exposure to 1.0 Gy, but not to 0.1 or 0.25 Gy. However, both the frequency and number of HPCs and HSCs were reduced in a radiation dose-dependent manner in comparison to unirradiated controls. Furthermore, HPCs and HSCs from irradiated mice exhibited a significant reduction in clonogenic function determined by the colony-forming and cobblestone area-forming cell assays. These acute adverse effects of O-16 irradiation on HSCs coincided with an increased production of reactive oxygen species (ROS), enhanced cell cycle entry of quiescent HSCs, and increased DNA damage. However, none of the O-16 exposures induced apoptosis in HSCs. These data suggest that exposure to low doses of O-16 irradiation induces acute BM injury in a dose-dependent manner primarily via increasing ROS production, cell cycling, and DNA damage in HSCs. This finding may aid in developing novel strategies in the protection of the hematopoietic system from space radiation.	[Chang, Jianhui; Luo, Yi; Wang, Yingying; Pathak, Rupak; Sridharan, Vijayalakshmi; Boerma, Marjan; Hauer-Jensen, Martin; Zhou, Daohong; Shao, Lijian] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Jones, Tamako; Mao, Xiao Wen; Nelson, Gregory] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA USA	University of Arkansas System; University of Arkansas Medical Sciences; Loma Linda University	Shao, LJ (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	lshao@uams.edu	Shao, Lijian/AAA-1074-2020; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022	mao, xiao/0000-0002-4508-8689	National Space Biomedical Research Institute [NCC 9-58]; Centers of Biomedical Research Excellence [P20, GM109005]; Arkansas Research Alliance Scholarship; Rockefeller Leukemia and Lymphoma Research Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Arkansas Research Alliance Scholarship; Rockefeller Leukemia and Lymphoma Research Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the National Space Biomedical Research Institute through NCC 9-58, Centers of Biomedical Research Excellence (P20, GM109005), Arkansas Research Alliance Scholarship, and Rockefeller Leukemia and Lymphoma Research Endowment.	Becker D, 2009, INT J RADIAT BIOL, V85, P1051, DOI 10.3109/09553000903232850; Chang JH, 2015, RADIAT RES, V183, P240, DOI 10.1667/RR13887.1; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cucinotta Francis A, 2003, Gravit Space Biol Bull, V16, P11; Gridley DS, 2008, IN VIVO, V22, P159; Habermehl D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113591; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hei TK, 2016, HEALTH PHYS, V110, P281, DOI 10.1097/HP.0000000000000452; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; Li HL, 2011, FREE RADICAL BIO MED, V51, P30, DOI 10.1016/j.freeradbiomed.2011.04.016; Miousse IR, 2014, RADIAT RES, V182, P92, DOI 10.1667/RR13580.1; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036209; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Otsuka K, 2006, RADIAT RES, V166, P474, DOI 10.1667/RR0561.1; Pathak R, 2007, MUTAT RES-GEN TOX EN, V632, P58, DOI 10.1016/j.mrgentox.2007.04.007; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Sanzari JK, 2013, RADIAT RES, V180, P7, DOI 10.1667/RR3027.1; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Stewart FM, 1998, BLOOD, V91, P3681; Stewart FM, 2001, BLOOD, V98, P1246, DOI 10.1182/blood.V98.4.1246; Tamme J, 2013, RADIAT RES, V179, P422, DOI [10.1667/RR3161.2, DOI 10.1667/RR3161.2]; Walker SA, 2013, ADV SPACE RES, V51, P1792, DOI 10.1016/j.asr.2012.12.011; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278	31	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158097	10.1371/journal.pone.0158097	http://dx.doi.org/10.1371/journal.pone.0158097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367604	Green Submitted, Green Published, gold			2022-12-26	WOS:000378914900018
J	Mujtaba, G; Khurshid, A; Sharif, S; Alam, MM; Aamir, UB; Shaukat, S; Angez, M; Rana, MS; Umair, M; Shah, AA; Zaidi, SSZ				Mujtaba, Ghulam; Khurshid, Adnan; Sharif, Salmaan; Alam, Muhammad Masroor; Aamir, Uzma Bashir; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Umair, Massab; Shah, Aamer Ali; Zaidi, Syed Sohail Zahoor			Distribution of Cytomegalovirus Genotypes among Neonates Born to Infected Mothers in Islamabad, Pakistan	PLOS ONE			English	Article							PREGNANT-WOMEN; HEARING-LOSS; VERTICAL TRANSMISSION; TOXOPLASMA-GONDII; GENOMIC VARIANTS; MIXED INFECTION; GLYCOPROTEIN-H; DISEASE; RUBELLA; SEROPREVALENCE	Background Congenital cytomegalovirus (cCMV) infection contributes to considerable long-term sequelae in neonates and children all over the world. The association between viral genotypes and severity of clinical cytomegalovirus (CMV) infection is yet to be defined. The objective of this study was to find the impact of active CMV infection during pregnancy and the clinical significance of genotypes in neonates with congenital cytomegalovirus infections in Pakistan. Methods A total of 409 blood samples from pregnant women seeking health care services at the two antenatal hospitals of Islamabad during January to December 2012 were tested by ELISA and nested-PCR. Pregnant women with active infection (detected as IgM positive, PCR positive or positive on both assays) were followed until delivery, to detect the outcome of overt cCMV infection in neonates. Genetic characterization of CMV strains was performed by sequence analysis of envelope glycoproteins: gB, gN and gH to detect the contributing CMV genotypes. Results The seroprevalence of anti-CMV IgG and IgM was 97.5% (399 out of 409) and 12.7%(52 out of 409), respectively, while 20% (82/409) pregnant women were found positive for CMV DNA by PCR. Logistic regression analysis showed a significant association of active infection with parity [OR = 2.56, 95% CI = 1.82-2.62, p = 0.04], febrile illness [OR = 1.84, 95% CI = 1.76-3.65, p = 0.01] and jaundice [OR = 22.5, 95% CI = 4.53-85.02, p = 0.002]. We were able to isolate virus in 41 out of 70 neonates; 36.6% (15 out of 41) of them were symptomatic at birth while 63.4%(26 out of 41) were asymptomatic. The most prominent clinical feature observed in symptomatic neonates was hepatosplenomegaly (26.6%; 4 out of 15). All three genotypes gB, gN and gH were found with the highest frequency of gB1 genotype, found in 75% infants with hepatic damage. Phylogenetic analysis of Pakistani strains showed 96%-100% homology to their prototype strains. Conclusions Active CMV infection during pregnancy is a major cause of congenital CMV infection with comparable distribution of all three genotypes: gB, gN and gH in symptomatic and asymptomatic neonates. Our findings emphasize to conduct a comprehensive large scale survey and introduction of country wide routine screening at maternity clinics for early diagnosis of CMV to reduce its associated devastating outcomes.	[Mujtaba, Ghulam; Shah, Aamer Ali] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan; [Khurshid, Adnan; Sharif, Salmaan; Alam, Muhammad Masroor; Aamir, Uzma Bashir; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Umair, Massab; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan	Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	sohailz@live.com	Shaukat, Shahzad/HHZ-1088-2022; Rana, Dr. Muhammad Suleman/HCH-1540-2022	Shah, Aamer/0000-0001-7454-4105	indigenous scholarship	indigenous scholarship	The study was supported by the indigenous scholarship award to Ghulam Mujtaba for his Ph. D research work.	Abu-Madi MA, 2010, AM J TROP MED HYG, V82, P626, DOI 10.4269/ajtmh.2010.09-0530; Adler SP, 2007, SEMIN PERINATOL, V31, P10, DOI 10.1053/j.semperi.2007.01.002; Ali S, 2014, J INFECT DEV COUNTR, V8, P389, DOI 10.3855/jidc.3854; Almeida LNB, 2001, REV SAUDE PUBL, V35, P124, DOI 10.1590/S0034-89102001000200004; Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Barbi M, 2001, J CLIN VIROL, V21, P75, DOI 10.1016/S1386-6532(00)00188-8; BERENBERG W, 1970, PEDIATRICS, V46, P403; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; CHOU SW, 1992, J INFECT DIS, V166, P604, DOI 10.1093/infdis/166.3.604; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Dowd JB, 2008, AM J EPIDEMIOL, V167, P112, DOI 10.1093/aje/kwm247; ElNawawy A, 1996, J TROP PEDIATRICS, V42, P154, DOI 10.1093/tropej/42.3.154; Enan KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-222; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; FRIES BC, 1994, J INFECT DIS, V169, P769, DOI 10.1093/infdis/169.4.769; Halwachs-Baumann G, 2001, J CLIN VIROL, V20, P49, DOI 10.1016/S1386-6532(00)00155-4; Hannachi N, 2011, Bull Soc Pathol Exot, V104, P62, DOI 10.1007/s13149-010-0119-z; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kusne S, 1999, Transpl Infect Dis, V1, P187, DOI 10.1034/j.1399-3062.1999.010307.x; Lisboa LF, 2012, TRANSPL INFECT DIS, V14, P132, DOI 10.1111/j.1399-3062.2011.00685.x; Ludwig A, 2009, EUROSURVEILLANCE, V14, P26; Lukacsi A, 2001, J MED VIROL, V65, P537, DOI 10.1002/jmv.2070; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Ocak S, 2007, SCAND J INFECT DIS, V39, P231, DOI 10.1080/00365540600978880; Omer AR, 2011, SAUDI MED J, V32, P55; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Paradowska E, 2014, J MED VIROL, V86, P1421, DOI 10.1002/jmv.23906; Paradowska E, 2013, J CLIN VIROL, V58, P271, DOI 10.1016/j.jcv.2013.05.024; Pati SK, 2013, PEDIATR INFECT DIS J, V32, P1050, DOI 10.1097/INF.0b013e31829bb0b9; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Pignatelli S, 2001, J GEN VIROL, V82, P2777, DOI 10.1099/0022-1317-82-11-2777; Pignatelli S, 2010, CLIN INFECT DIS, V51, P33, DOI 10.1086/653423; Rasmussen L, 1997, J INFECT DIS, V175, P179, DOI 10.1093/infdis/175.1.179; Ross SA, 2014, J INFECT DIS, V210, P1415, DOI 10.1093/infdis/jiu263; Ross SA, 2011, J INFECT DIS, V204, P1003, DOI 10.1093/infdis/jir457; Tabatabaee M, 2009, J MATERN-FETAL NEO M, V22, P517, DOI 10.1080/14767050902801678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarrago D, 2003, J CLIN MICROBIOL, V41, P2872, DOI 10.1128/JCM.41.7.2872-2877.2003; Uyar Y, 2008, NEW MICROBIOL, V31, P451; Yu ZS, 2006, INTERVIROLOGY, V49, P281, DOI 10.1159/000093458; Zhang XW, 2007, J CLIN VIROL, V40, P180, DOI 10.1016/j.jcv.2007.08.018	47	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156049	10.1371/journal.pone.0156049	http://dx.doi.org/10.1371/journal.pone.0156049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367049	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900004
J	Noutsi, P; Gratton, E; Chaieb, S				Noutsi, Pakiza; Gratton, Enrico; Chaieb, Sahraoui			Assessment of Membrane Fluidity Fluctuations during Cellular Development Reveals Time and Cell Type Specificity	PLOS ONE			English	Article							GENERALIZED POLARIZATION; LIPID-COMPOSITION; PHOSPHOLIPID-VESICLES; MYOBLAST FUSION; MESSENGER-RNA; LAURDAN; FLUORESCENCE; DEFORMABILITY; BILAYERS; PHASES	Cell membrane is made up of a complex structure of lipids and proteins that diffuse laterally giving rise to what we call membrane fluidity. During cellular development, such as differentiation cell membranes undergo dramatic fluidity changes induced by proteins such as ARC and Cofilin among others. In this study we used the generalized polarization (GP) property of fluorescent probe Laurdan using two-photon microscopy to determine membrane fluidity as a function of time and for various cell lines. A low GP value corresponds to a higher fluidity and a higher GP value is associated with a more rigid membrane. Four different cell lines were monitored such as hN2, NIH3T3, HEK293 and L6 cells. Membrane fluidity was measured at 12h, 72h and 92 h. Our results show significant changes in membrane fluidity among all cell types at different time points. GP values tend to increase significantly within 92 h in hN2 cells and 72 h in NIH3T3 cells and only at 92 h in HEK293 cells. L6 showed a marked decrease in membrane fluidity at 72 h and starts to increase at 92 h. As expected, NIH3T3 cells have more rigid membrane at earlier time points. On the other hand, neurons tend to have the highest membrane fluidity at early time points emphasizing its correlation with plasticity and the need for this malleability during differentiation. This study sheds light on the involvement of membrane fluidity during neuronal differentiation and development of other cell lines.	[Noutsi, Pakiza; Chaieb, Sahraoui] King Abdullah Univ Sci & Engn, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA USA; [Chaieb, Sahraoui] Lawrence Berkeley Natl Lab, 1 Cyclotron Rd,Mailstop 6R-2100, Berkeley, CA 94720 USA	King Abdullah University of Science & Technology; University of California System; University of California Irvine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Chaieb, S (corresponding author), King Abdullah Univ Sci & Engn, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia.; Chaieb, S (corresponding author), Lawrence Berkeley Natl Lab, 1 Cyclotron Rd,Mailstop 6R-2100, Berkeley, CA 94720 USA.	sahraoui.chaieb@kaust.edu.sa		Noutsi, Bakiza/0000-0001-5692-303X; Gratton, Enrico/0000-0002-6450-7391	National Institutes of Health [P41-GM103540, P50-GM076516]; King Abdullah University for Science and Technology (KAUST)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Abdullah University for Science and Technology (KAUST)(King Abdullah University of Science & Technology)	EG is supported by the National Institutes of Health grant P41-GM103540 and P50-GM076516. SC and PN were funded by KAUST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank King Abdullah University for Science and Technology (KAUST) for financial support. We also thank Hongtao Chen for the training on Olympus FV1000 inverted microscope, Per Niklas Hedde for helpful discussions and Milka Stakic for providing HEK293, NIH3T3 and L6 cells.	Andrisani OM, 1999, CRIT REV EUKAR GENE, V9, P19, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.20; Bieberich E, 2011, J LIPIDS, V2011, DOI 10.1155/2011/610306; Bonaventura G, 2014, CELL BIOCHEM BIOPHYS, V70, P785, DOI 10.1007/s12013-014-9982-8; Chaieb S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.078101; Cooper GM, 2009, CELL MOL APPROACH, P529; Traian MMD, 2012, J LIPID RES, V53, P609, DOI 10.1194/jlr.D021311; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; GHOSH C, 1993, NEUROCHEM INT, V23, P479, DOI 10.1016/0197-0186(93)90133-P; Golfetto O, 2013, BIOPHYS J, V104, P1238, DOI 10.1016/j.bpj.2012.12.057; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Higuchi Y, 2005, FEBS LETT, V579, P3009, DOI 10.1016/j.febslet.2005.04.054; HITZEMANN RJ, 1983, NEUROCHEM RES, V8, P121, DOI 10.1007/BF00963913; Hofstetter S, 2012, J MICROBIOL METH, V91, P93, DOI 10.1016/j.mimet.2012.07.023; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Labeed FH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025458; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LEVI M, 1993, PHOTOCHEM PHOTOBIOL, V57, P420, DOI 10.1111/j.1751-1097.1993.tb02312.x; Lin C.-B., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/967182; LIU Y, 1994, APPL PHYS LETT, V65, P919, DOI 10.1063/1.112981; Los DA, 2013, PHOTOSYNTH RES, V116, P489, DOI 10.1007/s11120-013-9823-4; M'Baye G, 2008, BIOPHYS J, V95, P1217, DOI 10.1529/biophysj.107.127480; Maloney JM, 2013, BIOPHYS J, V105, P1767, DOI 10.1016/j.bpj.2013.08.040; METSIKKO K, 1993, INT J DEV BIOL, V37, P305; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; NOZAWA Y, 1980, BIOCHIM BIOPHYS ACTA, V599, P232, DOI 10.1016/0005-2736(80)90070-X; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Paoletti R, 2012, P ADV STUDY I, P319; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1986, CELL MOL BIOL, V32, P103; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1995, BIOPHYS J, V68, P1895, DOI 10.1016/S0006-3495(95)80367-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Petrache HI, 2000, J MOL BIOL, V302, P727, DOI 10.1006/jmbi.2000.4072; Preira P, 2013, LAB CHIP, V13, P161, DOI [10.1039/c2lc40847c, 10.1039/c2lc40847]; QUINN PJ, 1989, PROG BIOPHYS MOL BIO, V53, P71, DOI 10.1016/0079-6107(89)90015-1; Sajbidor J, 1997, CRIT REV BIOTECHNOL, V17, P87, DOI 10.3109/07388559709146608; Sanchez SA, 2012, P NATL ACAD SCI USA, V109, P7314, DOI 10.1073/pnas.1118288109; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; SHERBET GV, 1989, EXP CELL BIOL, V57, P198; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; TARABOLETTI G, 1989, INT J CANCER, V44, P707, DOI 10.1002/ijc.2910440426; WAKELAM MJO, 1984, CIBA F SYMP, V103, P100; WAKELAM MJO, 1985, BIOCHEM J, V228, P1; WAKELAM MJO, 1983, BIOCHEM J, V214, P77, DOI 10.1042/bj2140077; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109	61	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158313	10.1371/journal.pone.0158313	http://dx.doi.org/10.1371/journal.pone.0158313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362860	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200057
J	Reich, M; Dacheva, I; Nobl, M; Siwy, J; Schanstra, JP; Mullen, W; Koch, FHJ; Kopitz, J; Kretz, FTA; Auffarth, GU; Koss, MJ				Reich, Michael; Dacheva, Ivanka; Nobl, Matthias; Siwy, Justyna; Schanstra, Joost P.; Mullen, William; Koch, Frank H. J.; Kopitz, Juergen; Kretz, Florian T. A.; Auffarth, Gerd U.; Koss, Michael J.			Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; MACULAR EDEMA; PROTEINS; DISEASE; EYE; IDENTIFICATION; PATHOGENESIS; CLUSTERIN	Purpose To analyze the protein profile of human vitreous of untreated patients with retinal vein occlusion (RVO). Methods Sixty-eight vitreous humor (VH) samples (44 from patients with treatment naive RVO, 24 controls with idiopathic floaters) were analyzed in this clinical-experimental study using capillary electrophoresis coupled to mass spectrometer and tandem mass spectrometry. To define potential candidate protein markers of RVO, proteomic analysis was performed on RVO patients (n = 30) and compared with controls (n = 16). To determine validity of potential biomarker candidates in RVO, receiver operating characteristic (ROC) was performed by using proteome data of independent RVO (n = 14) and control samples (n = 8). Results Ninety-four different proteins (736 tryptic peptides) could be identified. Sixteen proteins were found to be significant when comparing RVO and control samples (P = 1.43E-05 to 4.48E-02). Five proteins (Clusterin, Complement C3, Ig lambda-like polypeptide 5 (IGLL5), Opticin and Vitronectin), remained significant after using correction for multiple testing. These five proteins were also detected significant when comparing subgroups of RVO (central RVO, hemi-central RVO, branch RVO) to controls. Using independent samples ROC-Area under the curve was determined proving the validity of the results: Clusterin 0.884, Complement C3 0.955, IGLL5 1.000, Opticin 0.741, Vitronectin 0.786. In addition, validation through ELISA measurements was performed. Conclusion The results of the study reveal that the proteomic composition of VH differed significantly between the patients with RVO and the controls. The proteins identified may serve as potential biomarkers for pathogenesis induced by RVO.	[Reich, Michael] Univ Freiburg, Eye Ctr, Freiburg, Germany; [Dacheva, Ivanka; Nobl, Matthias; Kretz, Florian T. A.; Auffarth, Gerd U.; Koss, Michael J.] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Siwy, Justyna] Mosa Diagnost GmbH, Hannover, Germany; [Schanstra, Joost P.] INSERM, U1048, Inst Cardiovasc & Metab Dis, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, Toulouse, France; [Mullen, William] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Koch, Frank H. J.] Goethe Univ Frankfurt, Dept Ophthalmol, Frankfurt, Germany; [Kopitz, Juergen] Heidelberg Univ, Dept Pathol, Heidelberg, Germany; [Koss, Michael J.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA USA	University of Freiburg; Ruprecht Karls University Heidelberg; Modular Open Systems Approach (MOSA) Solutions; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Glasgow; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; University of Southern California	Koss, MJ (corresponding author), Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany.; Koss, MJ (corresponding author), Univ So Calif, Dept Ophthalmol, Los Angeles, CA USA.	Michael.koss@med.uni-heidelberg.de	Mullen, William/GWC-8078-2022; Schanstra, Joost P/X-7724-2018; Auffarth, Gerd/AAE-6805-2021	Schanstra, Joost P/0000-0002-7471-372X; Mullen, William/0000-0002-5685-1563; Auffarth, Gerd/0000-0002-6927-5251; Siwy, Justyna/0000-0003-1407-2534; Reich, Michael/0000-0002-9813-8483; Nobl, Matthias/0000-0001-8772-3583	Adolf Messer Stiftung, Konigstein, Hessen, Germany; Bayer Vital GmbH, Leverkusen, Germany; Studienstiftung des deutschen Volkes; Dr. Gabriele Lederle-Stiftung; PRO RETINAStiftung zur Verhutung von Blindheit; Mosaiques diagnostics GmbH	Adolf Messer Stiftung, Konigstein, Hessen, Germany; Bayer Vital GmbH, Leverkusen, Germany(Bayer AG); Studienstiftung des deutschen Volkes; Dr. Gabriele Lederle-Stiftung; PRO RETINAStiftung zur Verhutung von Blindheit; Mosaiques diagnostics GmbH	The research group was supported by the Adolf Messer Stiftung, Konigstein, Hessen, Germany. Parts of this research were supported by a research grant from Bayer Vital GmbH, Leverkusen, Germany. Michael Reich is a recipient of scholarships from the Studienstiftung des deutschen Volkes and the Dr. Gabriele Lederle-Stiftung. He wants to thank these organizations for their support. Matthias Nobl is a recipient of scholarships from the PRO RETINAStiftung zur Verhutung von Blindheit and the Dr. Gabriele Lederle-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mosaiques diagnostics GmbH provided support in the form of salaries for authors [JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The research group was supported by the Adolf Messer Stiftung, Konigstein, Hessen, Germany. A research grant from Bayer Vital GmbH, Leverkusen, Germany, was obtained to cover parts of the experimental costs which did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michael Reich is a recipient of scholarships from the Studienstiftung des deutschen Volkes and the Dr. Gabriele Lederle-Stiftung. He wants to thank these organizations for their support. Matthias Nobl is a recipient of scholarships from the PRO RETINA-Stiftung zur Verhutung von Blindheit and the Dr. Gabriele Lederle-Stiftung. The funding organizations had no role in the design or conduct of the research.	ANGI M, 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/148039; Aretz S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-22; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning DJ., 2012, RETINAL VEIN OCCLUSI; Cryan LM, 2008, PROTEOM CLIN APPL, V2, P762, DOI 10.1002/prca.200780094; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Koss MJ, 2012, ACTA OPHTHALMOL, V90, pe98, DOI 10.1111/j.1755-3768.2011.02292.x; Koss MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096895; Latosinska A., 2013, PROTEOMICS CLIN APPL; Mansor R, 2013, J PROTEOMICS, V85, P89, DOI 10.1016/j.jprot.2013.04.027; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Margolis Ron, 2006, Compr Ophthalmol Update, V7, P265; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Neuhaus J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067514; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Pfister M, 2013, CLIN OPHTHALMOL, V7, P1061, DOI 10.2147/OPTH.S42786; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Stalmach A, 2015, METHODS MOL BIOL, V1243, P187, DOI 10.1007/978-1-4939-1872-0_11; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Tsujikawa A, 2010, AM J OPHTHALMOL, V149, P291, DOI 10.1016/j.ajo.2009.09.007; Weissinger EM, 2014, LEUKEMIA, V28, P842, DOI 10.1038/leu.2013.210; Yamaike N, 2008, OPHTHALMOLOGY, V115, P355, DOI 10.1016/j.ophtha.2007.04.052; Yao JQ, 2013, INT J MOL MED, V32, P1421, DOI 10.3892/ijmm.2013.1509; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	42	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158001	10.1371/journal.pone.0158001	http://dx.doi.org/10.1371/journal.pone.0158001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362861	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200035
J	Hihara, K; Iyoda, M; Tachibana, S; Iseri, K; Saito, T; Yamamoto, Y; Suzuki, T; Wada, Y; Matsumoto, K; Shibata, T				Hihara, Kei; Iyoda, Masayuki; Tachibana, Shohei; Iseri, Ken; Saito, Tomohiro; Yamamoto, Yasutaka; Suzuki, Taihei; Wada, Yukihiro; Matsumoto, Kei; Shibata, Takanori			Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy	PLOS ONE			English	Article							ANTI-PLA2R ANTIBODIES; RENAL BIOPSIES; AUTOANTIBODIES; GLOMERULONEPHRITIS; DIAGNOSIS; SUBCLASS; TITER	The phospholipase A2 receptor (PLA2R) is the major target antigen (Ag) in idiopathic membranous nephropathy (IMN). Recently, several types of immunoassay systems for anti-PLA2R antibody (Ab) have been developed. However, the correlation of serum anti-PLA2R Abs and glomerular expression of PLA2R Ag, and their association with clinicopathological characteristics have yet to be proven in Japanese patients. We examined serum anti-PLA2R Abs by both ELISA and cell-based indirect immunofluorescence assay (CIIFA), and glomerular PLA2R expression by immunofluorescence (IF) in 59 biopsy-proven MN patients including IMN (n = 38) and secondary MN (SMN) (n = 21). In this study, anti-PLA2R Abs were present in 50% of IMN patients, but was absent in SMN patients. The concordance rate between ELISA and CIIFA was 100%. Serum IgG levels were significantly lower in anti-PLA2R Ab-positive patients. Serum albumin levels correlated inversely with serum anti-PLA2R Ab titers. The prevalence and intensity of glomerular staining for IgG4 by IF were significantly higher in anti-PLA2R Ab-positive patients than in-negative patients. Glomerular PLA2 Ag expression evaluated by IF was positive in 52.6% of IMN patients, but was absent in SMN patients. The concordance rate between the prevalence of glomerular PLA2R Ag expression and anti-PLA2R Ab was 84.2%. The prevalence of anti-PLA2R Abs measured by ELISA/CIIFA was equivalent to previous Japanese studies evaluated using Western blotting. These analyses showed an excellent specificity for the diagnosis of IMN, and anti-PLA2R positivity was associated with some clinicopathological features, especially glomerular IgG4-dominant deposition.	[Hihara, Kei; Iyoda, Masayuki; Tachibana, Shohei; Iseri, Ken; Saito, Tomohiro; Yamamoto, Yasutaka; Suzuki, Taihei; Wada, Yukihiro; Matsumoto, Kei; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan	Showa University	Iyoda, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan.	iyoda@med.showa-u.ac.jp	Iseri, Ken/K-6376-2019; Saito, Tomohiro/AAD-6724-2021	Iseri, Ken/0000-0002-6610-2451; 				Akiyama S, 2015, CLIN EXP NEPHROL, V19, P653, DOI 10.1007/s10157-014-1054-2; Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Behnert A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/143274; Bruschi M, 2011, J PROTEOMICS, V74, P2008, DOI 10.1016/j.jprot.2011.05.021; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Hayashi N, 2015, CLIN EXP NEPHROL, V19, P797, DOI 10.1007/s10157-014-1064-0; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2015, NEPHROL DIAL TRANSPL, V30, P1862, DOI 10.1093/ndt/gfv228; Hoxha E, 2014, CLIN J AM SOC NEPHRO, V9, P1883, DOI 10.2215/CJN.03850414; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Iwakura T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138841; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Kattah A, 2015, AM J TRANSPLANT, V15, P1349, DOI 10.1111/ajt.13133; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Larsen CP, 2013, MODERN PATHOL, V26, P709, DOI 10.1038/modpathol.2012.207; Lv JC, 2013, J AM SOC NEPHROL, V24, P1323, DOI 10.1681/ASN.2012080771; Murtas C, 2012, CLIN J AM SOC NEPHRO, V7, P1394, DOI 10.2215/CJN.02170312; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Ruggenenti P, 2015, J AM SOC NEPHROL, V26, P2545, DOI 10.1681/ASN.2014070640; Schlumberger W, 2014, AUTOIMMUN REV, V13, P108, DOI 10.1016/j.autrev.2013.09.005; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Wakui H, 1999, CLIN EXP IMMUNOL, V118, P445	33	41	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158154	10.1371/journal.pone.0158154	http://dx.doi.org/10.1371/journal.pone.0158154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355365	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400033
J	Hiraoka, K; Sumiyoshi, A; Nonaka, H; Kikkawa, T; Kawashima, R; Osumi, N				Hiraoka, Kotaro; Sumiyoshi, Akira; Nonaka, Hiroi; Kikkawa, Takako; Kawashima, Ryuta; Osumi, Noriko			Regional Volume Decreases in the Brain of Pax6 Heterozygous Mutant Rats: MRI Deformation-Based Morphometry	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; AUDITORY INTERHEMISPHERIC-TRANSFER; TRANSCRIPTION FACTOR PAX6; CONGENITAL ANIRIDIA; MENTAL-RETARDATION; CORTICAL VOLUME; OLFACTORY-BULB; VISUAL-CORTEX; ADULT BRAIN; MUTATION	Pax6 is a transcription factor that pleiotropically regulates various developmental processes in the central nervous system. In a previous study, we revealed that Pax6 heterozygous mutant (rSey(2)/+) adult rats exhibit abnormalities in social interaction. However, the brain malformations underlying the behavioral abnormality are unknown. To elucidate the brain malformations in rSey(2)/+ rats, we morphometrically analyzed brains of rSey(2)/+ and wild type rats using small-animal magnetic resonance imaging (MRI). Sixty 10-week-old rats underwent brain MRI (29 rSey(2)/+ rats and 31 wild type rats). SPM8 software was used for image preprocessing and statistical image analysis. Normalized maps of the Jacobian determinant, a parameter for the expansion and/or contraction of brain regions, were obtained for each rat. rSey(2)/+ rats showed significant volume decreases in various brain regions including the neocortex, corpus callosum, olfactory structures, hippocampal formation, diencephalon, and midbrain compared to wild type rats. Among brain regions, the anterior commissure showed significant interaction between genotype and sex, indicating the effect of genotype difference on the anterior commissure volume was more robust in females than in males. The rSey(2)/+ rats exhibited decreased volume in various gray and white matter regions of the brain, which may contribute to manifestation of abnormal social behaviors.	[Hiraoka, Kotaro] Tohoku Univ, Div Cyclotron Nucl Med, Ctr Cyclotron & Radioisotope, Sendai, Miyagi, Japan; [Sumiyoshi, Akira; Nonaka, Hiroi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi, Japan; [Kikkawa, Takako; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Neurosci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Hiraoka, K (corresponding author), Tohoku Univ, Div Cyclotron Nucl Med, Ctr Cyclotron & Radioisotope, Sendai, Miyagi, Japan.	khiraoka@cyric.tohoku.ac.jp	Osumi, Noriko/T-2823-2019; Sumiyoshi, Akira/AGR-1704-2022	Osumi, Noriko/0000-0003-0548-6452; Kikkawa, Takako/0000-0002-6643-8289; Sumiyoshi, Akira/0000-0001-9522-8064	Japan Society for the Promotion of Science (KAKENHI) [25861059, 26291046]; Grants-in-Aid for Scientific Research [16K20902, 15K08127] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by grants from Japan Society for the Promotion of Science (KAKENHI, 25861059 to Kotaro Hiraoka and 26291046 to Noriko Osumi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid H, 2009, MOL VIS, V15, P2074; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bamiou DE, 2004, ANN NEUROL, V56, P503, DOI 10.1002/ana.20227; Bamiou DE, 2007, ARCH PEDIAT ADOL MED, V161, P463, DOI 10.1001/archpedi.161.5.463; Bamiou DE, 2007, INT J AUDIOL, V46, P196, DOI 10.1080/14992020601175952; Biedermann S, 2012, NEUROIMAGE, V61, P1206, DOI 10.1016/j.neuroimage.2012.04.010; Bishop KM, 2002, J NEUROSCI, V22, P7627; Boretius S, 2009, CEREB CORTEX, V19, P2838, DOI 10.1093/cercor/bhp057; Calabrese E, 2013, NEUROIMAGE, V67, P375, DOI 10.1016/j.neuroimage.2012.11.037; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Duan DY, 2013, BRAIN STRUCT FUNCT, V218, P353, DOI 10.1007/s00429-012-0397-2; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Ellison-Wright Z, 2004, EUR J NEUROSCI, V19, P1505, DOI 10.1111/j.1460-9568.2004.03236.x; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Free SL, 2003, NEUROIMAGE, V20, P2281, DOI 10.1016/j.neuroimage.2003.07.001; FUJIWARA M, 1994, DIFFERENTIATION, V57, P31, DOI 10.1046/j.1432-0436.1994.5710031.x; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Haba H, 2009, NEUROSCI RES, V65, P116, DOI 10.1016/j.neures.2009.05.011; Hanson IM, 2003, PEDIATR RES, V54, P791, DOI 10.1203/01.PDR.0000096455.00657.98; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Heyman I, 1999, PSYCHIATR GENET, V9, P85, DOI 10.1097/00041444-199906000-00006; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Kageyama R, 2013, CORTICAL DEV NEURAL, P43, DOI DOI 10.1007/978-4-431-54496-8_3; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; Kielar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032636; Kikkawa T, 2013, GENES CELLS, V18, P636, DOI 10.1111/gtc.12061; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lauritsen MB, 2013, EUR CHILD ADOLES PSY, V22, pS37, DOI 10.1007/s00787-012-0359-5; Lentz MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105752; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Malandrini A, 2001, CLIN GENET, V60, P151, DOI 10.1034/j.1399-0004.2001.600210.x; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Moldrich RX, 2010, NEUROIMAGE, V51, P1027, DOI 10.1016/j.neuroimage.2010.03.035; Numayama-Tsuruta K A Y, 2007, RAT SMALL EYE HOMOZY, P151; Osumi N, 2001, TOHOKU J EXP MED, V193, P163, DOI 10.1620/tjem.193.163; Osumi N, 1997, DEVELOPMENT, V124, P2961; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petiet A, 2012, NEUROBIOL AGING, V33, P1533, DOI 10.1016/j.neurobiolaging.2011.03.009; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Scholz J, 2015, NEUROIMAGE, V107, P182, DOI 10.1016/j.neuroimage.2014.12.003; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Stanco A, 2014, NEURON, V84, P940, DOI 10.1016/j.neuron.2014.10.040; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sumiyoshi A, 2012, NEUROIMAGE, V60, P738, DOI 10.1016/j.neuroimage.2011.12.082; Swanson DJ, 2011, DEV BIOL, V351, P1, DOI 10.1016/j.ydbio.2010.11.018; Takahashi M, 2011, MECH DEVELOP, V128, P289, DOI 10.1016/j.mod.2011.04.001; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; van de Ven RCG, 2007, MAGN RESON MED, V58, P390, DOI 10.1002/mrm.21313; Vernon AC, 2014, BIOL PSYCHIAT, V75, P982, DOI 10.1016/j.biopsych.2013.09.012; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; Wu H, 2016, NEUROSCIENCE, V322, P221, DOI 10.1016/j.neuroscience.2016.02.043; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Yizhar O, 2012, BIOL PSYCHIAT, V71, P1075, DOI 10.1016/j.biopsych.2011.12.029	68	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158153	10.1371/journal.pone.0158153	http://dx.doi.org/10.1371/journal.pone.0158153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355350	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400032
J	Lockhart, SN; Baker, SL; Okamura, N; Furukawa, K; Ishiki, A; Furumoto, S; Tashiro, M; Yanai, K; Arai, H; Kudo, Y; Harada, R; Tomita, N; Hiraoka, K; Watanuki, S; Jagust, WJ				Lockhart, Samuel N.; Baker, Suzanne L.; Okamura, Nobuyuki; Furukawa, Katsutoshi; Ishiki, Aiko; Furumoto, Shozo; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka; Harada, Ryuichi; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Jagust, William J.			Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351	PLOS ONE			English	Article							PITTSBURGH COMPOUND-B; NEUROFIBRILLARY PATHOLOGY; MODEL; BIOMARKERS; RECEPTOR; BRAIN	Background [F-18]THK5351, a recently-developed positron emission tomography (PET) tracer for measuring tau neurofibrillary tangle accumulation, may help researchers examine aging, disease, and tau pathology in living human brains. We examined THK5351 tracer pharmacokinetics to define an optimal acquisition time for static late images. Methods Primary measurements were calculation of regional values of distribution volume ratios (DVR) and standardized uptake value ratios (SUVR) in 6 healthy older control and 10 Alzheimer's disease (AD) participants. We examined associations between DVR and SUVR, searching for a 20 min SUVR time window that was stable and comparable to DVR. We additionally examined diagnostic group differences in this 20 min SUVR. Results In healthy controls, [F-18]THK5351 uptake was low, with increased temporal relative to frontal binding. In AD, regional uptake was substantially higher than in healthy controls, with temporal exceeding frontal binding. Retention in cerebellar gray matter, which was used as the reference region, was low compared to other regions. Both DVR and SUVR values showed minimal change over time after 40 min. SUVR 20-40, 30-50, and 40-60 min were most consistently correlated with DVR; SUVR 40-60 min, the most stable time window, was used in further analyses. Significant (AD > healthy control) group differences existed in temporoparietal regions, with marginal medial temporal differences. We found high basal ganglia SUVR 40-60 min signal, with no group differences. Conclusions We examined THK5351, a new PET tracer for measuring tau accumulation, and compared multiple analysis methods for quantifying regional tracer uptake. SUVR 40-60 min performed optimally when examining 20 min SUVR windows, and appears to be a practical method for quantifying relative regional tracer retention. The results of this study offer clinical potential, given the usefulness of THK5351-PET as a biomarker of tau pathology in aging and disease.	[Lockhart, Samuel N.; Baker, Suzanne L.; Jagust, William J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Baker, Suzanne L.; Jagust, William J.] Lawrence Berkeley Natl Lab, Ctr Funct Imaging, Berkeley, CA USA; [Okamura, Nobuyuki; Yanai, Kazuhiko] Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan; [Furukawa, Katsutoshi; Ishiki, Aiko; Arai, Hiroyuki; Kudo, Yukitsuka; Harada, Ryuichi; Tomita, Naoki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Furumoto, Shozo; Tashiro, Manabu; Yanai, Kazuhiko; Hiraoka, Kotaro; Watanuki, Shoichi] Tohoku Univ, Ctr Cyclotron & Radioisotope, Sendai, Miyagi, Japan	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Tohoku University; Tohoku University; Tohoku University	Lockhart, SN (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	snl@berkeley.edu	Tashiro, Manabu/T-2859-2019; Jagust, William/ABE-6426-2020; Yanai, Kazuhiko/X-3911-2019; Okamura, Nobuyuki/C-3541-2017; Lockhart, Samuel Neal/AET-0265-2022	Yanai, Kazuhiko/0000-0001-9068-7907; Okamura, Nobuyuki/0000-0002-5991-7812; Lockhart, Samuel Neal/0000-0002-0893-5420; Furumoto, Shozo/0000-0002-9296-3079	GE Healthcare; SEI (Sumitomo Electric Industries,Ltd.) Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan [09E51025a]; Ministry of Health, Labor, and Welfare of Japan; National Institute on Aging training fellowship [F32AG050389]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15H04900, 26117003, 15K19767]; NATIONAL INSTITUTE ON AGING [F32AG050389] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K08127] Funding Source: KAKEN	GE Healthcare(General ElectricGE Healthcare); SEI (Sumitomo Electric Industries,Ltd.) Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute on Aging training fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from GE Healthcare (www.gehealthcare.com), the SEI (Sumitomo Electric Industries,Ltd.) Group CSR Foundation (http://global-sei.com/csr/), the Industrial Technology Research Grant Program of the NEDO in Japan (http://www.nedo.go.jp/english/index.html, 09E51025a), Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare (http://www.mhlw.go.jp/english/) of Japan, Grant-in-Aid for Scientific Research (B) (15H04900), Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (26117003), Grant-in-Aid for Young Scientists (B) (15K19767), and Grant-in-Aid for JSPS Fellows and "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http://www.mext.go.jp/english/), Japan. Drs. Okamura and Kudo own stock in Clino Ltd. Dr. Jagust has served as a consultant to BioClinica, Banner Alzheimer Institute, Genentech, and Novartis. Dr. Lockhart is supported by a National Institute on Aging training fellowship (https://www.nia.nih.gov/, F32AG050389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CARSON RE, 1993, J CEREBR BLOOD F MET, V13, P24, DOI 10.1038/jcbfm.1993.6; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; McNamee RL, 2009, J NUCL MED, V50, P348, DOI 10.2967/jnumed.108.057612; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Okamura N, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0500-6; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Stankoff B, 2011, ANN NEUROL, V69, P673, DOI 10.1002/ana.22320; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2	23	62	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158460	10.1371/journal.pone.0158460	http://dx.doi.org/10.1371/journal.pone.0158460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355840	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400069
J	Peng, DL; Wu, CY; Zhang, B; Huete, A; Zhang, XY; Sun, R; Lei, LP; Huang, WJ; Liu, LY; Liu, XJ; Li, J; Luo, SZ; Fang, B				Peng, Dailiang; Wu, Chaoyang; Zhang, Bing; Huete, Alfredo; Zhang, Xiaoyang; Sun, Rui; Lei, Liping; Huang, Wenjing; Liu, Liangyun; Liu, Xinjie; Li, Jun; Luo, Shezhou; Fang, Bin			The Influences of Drought and Land-Cover Conversion on Inter-Annual Variation of NPP in the Three-North Shelterbelt Program Zone of China Based on MODIS Data	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; PRIMARY PRODUCTIVITY; CLIMATE-CHANGE; CO2 EMISSIONS; TERRESTRIAL ECOSYSTEMS; PRECIPITATION GRADIENT; USE EFFICIENCY; RELATIVE ROLE; CARBON; VARIABILITY	Terrestrial ecosystems greatly contribute to carbon (C) emission reduction targets through photosynthetic C uptake. Net primary production (NPP) represents the amount of atmospheric C fixed by plants and accumulated as biomass. The Three-North Shelterbelt Program (TNSP) zone accounts for more than 40% of China's landmass. This zone has been the scene of several large-scale ecological restoration efforts since the late 1990s, and has witnessed significant changes in climate and human activities. Assessing the relative roles of different causal factors on NPP variability in TNSP zone is very important for establishing reasonable local policies to realize the emission reduction targets for central government. In this study, we examined the relative roles of drought and land cover conversion(LCC) on inter-annual changes of TNSP zone for 2001-2010. We applied integrated correlation and decomposition analyses to a Standardized Evapotranspiration Index (SPEI) and MODIS land cover dataset. Our results show that the 10-year average NPP within this region was about 420 Tg C. We found that about 60% of total annual NPP over the study area was significantly correlated with SPEI (p<0.05). The LCC-NPP relationship, which is especially evident for forests in the south-central area, indicates that ecological programs have a positive impact on C sequestration in the TNSP zone. Decomposition analysis generally indicated that the contributions of LCC, drought, and other Natural or Anthropogenic activities (ONA) to changes in NPP generally had a consistent distribution pattern for consecutive years. Drought and ONA contributed about 74% and 23% to the total changes in NPP, respectively, and the remaining 3% was attributed to LCC. Our results highlight the importance of rainfall supply on NPP variability in the TNSP zone.	[Peng, Dailiang; Zhang, Bing; Lei, Liping; Huang, Wenjing; Liu, Liangyun; Liu, Xinjie; Luo, Shezhou] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China; [Wu, Chaoyang] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Huete, Alfredo] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Sydney, NSW 2007, Australia; [Zhang, Xiaoyang] S Dakota State Univ, Geospatial Sci Ctr Excellence, Brookings, SD 57007 USA; [Sun, Rui] Chinese Acad Sci, Beijing Normal Univ & Inst Remote Sensing Applica, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Li, Jun] Chongqing Normal Univ, Coll Geog, Chongqing, Peoples R China; [Fang, Bin] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; University of Technology Sydney; South Dakota State University; Beijing Normal University; Chinese Academy of Sciences; Chongqing Normal University; Columbia University	Wu, CY (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	hefery@163.com	Liu, Liangyun/D-9891-2016; Huete, Alfredo R/C-1294-2008; Liu, Xinjie/AAB-3688-2020; Fang, Bin/T-3496-2019; Fang, Bin/P-1920-2018	Liu, Liangyun/0000-0002-7987-037X; Huete, Alfredo R/0000-0003-2809-2376; Liu, Xinjie/0000-0002-7689-3031; Fang, Bin/0000-0002-0448-7616; peng, dai liang/0000-0003-1159-0723	National Natural Science Foundation of China [41571423, 41325004]; Director Foundation of Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences [Y6SJ0200CX]; Youth Innovation Promotion Association, Chinese Academy of Sciences [Y4YR1300QM]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Director Foundation of Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences; Youth Innovation Promotion Association, Chinese Academy of Sciences	This study was jointly supported by National Natural Science Foundation of China (41571423 and 41325004), Director Foundation of Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences (Y6SJ0200CX), and Youth Innovation Promotion Association, Chinese Academy of Sciences (Y4YR1300QM).	Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Barua SK, 2012, ECOL ECON, V73, P211, DOI 10.1016/j.ecolecon.2011.10.029; Beedlow PA, 2004, FRONT ECOL ENVIRON, V2, P315, DOI 10.2307/3868407; Begueria S, 2010, B AM METEOROL SOC, V91, P1351, DOI 10.1175/2010BAMS2988.1; Belward AS, 1999, PHOTOGRAMM ENG REM S, V65, P1013; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Bordi I, 2001, WATER RESOUR MANAG, V15, P247, DOI 10.1023/A:1013353822381; Bortscheller Mary J., 2010, SUSTAINABLE DEV L PO, V10, P49; Cai SS, 2014, REMOTE SENS ENVIRON, V147, P243, DOI 10.1016/j.rse.2014.03.012; Caurla S, 2013, J FOREST ECON, V19, P450, DOI 10.1016/j.jfe.2013.09.002; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Fissore C, 2010, FRONT ECOL ENVIRON, V8, P409, DOI 10.1890/090059; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; Gonsamo A, 2016, GLOBAL CHANGE BIOL; Grant RF, 2010, TELLUS B, V62, P475, DOI 10.1111/j.1600-0889.2010.00500.x; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; Hasenauer H, 2012, FOREST ECOL MANAG, V276, P196, DOI 10.1016/j.foreco.2012.03.022; Heinsch FA., 2003, USERS GUIDE GPP NPP; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Hu ZM, 2007, SCI CHINA SER D, V50, P754, DOI 10.1007/s11430-007-0010-3; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE AR, 1994, IEEE T GEOSCI REMOTE, V32, P897, DOI 10.1109/36.298018; JACKSON RD, 1991, PREV VET MED, V11, P185, DOI 10.1016/S0167-5877(05)80004-2; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jiang X, 2015, GLOBAL ENVIRON CHANG, V35, P22, DOI 10.1016/j.gloenvcha.2015.07.010; Kang S, 2005, INT J REMOTE SENS, V26, P1659, DOI 10.1080/01431160512331326693; Klara SM, 2003, ENERG CONVERS MANAGE, V44, P2699, DOI 10.1016/S0196-8904(03)00042-6; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Krausmann F, 2003, LAND USE POLICY, V20, P1, DOI 10.1016/S0264-8377(02)00048-0; Lal R, 2003, LAND DEGRAD DEV, V14, P309, DOI 10.1002/ldr.562; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Leuning R, 2005, AGR FOREST METEOROL, V129, P151, DOI 10.1016/j.agrformet.2004.12.004; Liang QM, 2007, J POLICY MODEL, V29, P311, DOI 10.1016/j.jpolmod.2006.11.001; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; McKane A, 2007, LBNL63134 UN IND DEV; MCKEE TB, 1993, P 8 C APPL CLIM AN C; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mohamed MAA, 2004, SCI TOTAL ENVIRON, V332, P123, DOI 10.1016/j.scitotenv.2004.03.009; Muchoney D, 1999, PHOTOGRAMM ENG REM S, V65, P1061; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Omuto CT, 2010, J ARID ENVIRON, V74, P1552, DOI 10.1016/j.jaridenv.2010.04.001; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Peng CH, 1999, ECOL MODEL, V122, P175, DOI 10.1016/S0304-3800(99)00137-4; Peng DL, 2008, J INTEGR PLANT BIOL, V50, P1580, DOI 10.1111/j.1744-7909.2008.00696.x; Peng DL, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004060; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Running SW, MOD17A3H MODIS TERRA; Sanjoy M, 2013, INT J SUSTAINABLE DE, V2; Scepan J, 1999, PHOTOGRAMM ENG REM S, V65, P1051; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schulze ED, 2010, GLOBAL CHANGE BIOL, V16, P1451, DOI 10.1111/j.1365-2486.2010.02215.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017; Turner DP, 2005, GLOBAL CHANGE BIOL, V11, P666, DOI 10.1111/j.1365-2486.2005.00936.x; Vicente-Serrano S, 2006, WATER RESOUR MANAG, V20, P37, DOI 10.1007/s11269-006-2974-8; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang XM, 2010, J ARID ENVIRON, V74, P13, DOI 10.1016/j.jaridenv.2009.08.001; Wang XX, 2014, J ARID ENVIRON, V104, P67, DOI 10.1016/j.jaridenv.2014.02.003; Waring R.H., 2010, FOREST ECOSYSTEMS AN; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; Wu CY, 2014, INT J CLIMATOL, V34, P1715, DOI 10.1002/joc.3789; Wu CY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04461; Wu LB, 2005, ENERG POLICY, V33, P319, DOI 10.1016/j.enpol.2003.08.003; Wu SH, 2014, SCI TOTAL ENVIRON, V472, P397, DOI 10.1016/j.scitotenv.2013.10.128; Xu DY, 2011, J GEOGR SCI, V21, P926, DOI 10.1007/s11442-011-0890-1; Xu DY, 2009, SCI CHINA SER D, V52, P855, DOI 10.1007/s11430-009-0079-y; Xu JH, 2014, APPL ENERG, V130, P592, DOI 10.1016/j.apenergy.2014.03.004; Xu JT, 2006, ECOL ECON, V57, P595, DOI 10.1016/j.ecolecon.2005.05.008; Yang HF, 2014, CATENA, V115, P85, DOI 10.1016/j.catena.2013.11.020; Yin RS, 2010, ENVIRON MANAGE, V45, P429, DOI 10.1007/s00267-009-9373-x; Zhang X, 2014, REMOTE SENS ENVIRON, V150, P188, DOI 10.1016/j.rse.2014.05.003; Zhao M, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2004JG000004; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	82	28	29	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158173	10.1371/journal.pone.0158173	http://dx.doi.org/10.1371/journal.pone.0158173			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9FD	27348303	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200044
J	Leone, S; Picone, D				Leone, Serena; Picone, Delia			Molecular Dynamics Driven Design of pH-Stabilized Mutants of MNEI, a Sweet Protein	PLOS ONE			English	Article							SINGLE-CHAIN MONELLIN; REAL-VALUE PREDICTION; UNFOLDING SIMULATIONS; SOLVENT ACCESSIBILITY; TASTING PROTEIN; BRAZZEIN; RECEPTOR; INTERIOR; INSIGHT; MECHANISM	MNEI is a single chain derivative of monellin, a plant protein that can interact with the human sweet taste receptor, being therefore perceived as sweet. This unusual physiological activity makes MNEI a potential template for the design of new sugar replacers for the food and beverage industry. Unfortunately, applications of MNEI have been so far limited by its intrinsic sensitivity to some pH and temperature conditions, which could occur in industrial processes. Changes in physical parameters can, in fact, lead to irreversible protein denaturation, as well as aggregation and precipitation. It has been previously shown that the correlation between pH and stability in MNEI derives from the presence of a single glutamic residue in a hydrophobic pocket of the protein. We have used molecular dynamics to study the consequences, at the atomic level, of the protonation state of such residue and have identified the network of intramolecular interactions responsible for MNEI stability at acidic pH. Based on this information, we have designed a pH-independent, stabilized mutant of MNEI and confirmed its increased stability by both molecular modeling and experimental techniques.	[Leone, Serena; Picone, Delia] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	University of Naples Federico II	Leone, S (corresponding author), Univ Naples Federico II, Dept Chem Sci, Naples, Italy.	serena.leone@unina.it	Leone, Serena/AAG-9455-2020; Leone, Serena/M-7879-2016; Picone, Delia/L-2480-2015	Leone, Serena/0000-0003-4787-0882; Picone, Delia/0000-0002-7582-2581	Fondazione con il SUD [2011-PDR-19]	Fondazione con il SUD	This work was supported by grant 2011-PDR-19 by Fondazione con il SUD (www.fondazioneconilsud.it).	Aghera N, 2013, BIOCHEMISTRY-US, V52, P5770, DOI 10.1021/bi400688w; Aghera N, 2012, BIOCHEMISTRY-US, V51, P9058, DOI 10.1021/bi3008017; Aghera N, 2012, J MOL BIOL, V420, P235, DOI 10.1016/j.jmb.2012.04.019; Aghera N, 2011, BIOCHEMISTRY-US, V50, P2434, DOI 10.1021/bi101955f; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chng CP, 2008, BIOPHYS J, V94, P3858, DOI 10.1529/biophysj.107.123927; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Simone A, 2006, BIOPHYS J, V90, P3052, DOI 10.1529/biophysj.105.073171; Monaco R, 2014, J SENS STUD, V29, P385, DOI 10.1111/joss.12119; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Esposito L, 2005, BIOCHEMISTRY-US, V44, P3358, DOI 10.1021/bi0488350; Esposito V, 2006, J MOL BIOL, V360, P448, DOI 10.1016/j.jmb.2006.05.020; Esposito V, 2010, BIOCHEMISTRY-US, V49, P2805, DOI 10.1021/bi902039s; Ferrara P, 2000, J PHYS CHEM B, V104, P4511, DOI 10.1021/jp9943878; Garcia-Seisdedos H, 2012, PROTEINS, V80, P1, DOI 10.1002/prot.23166; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Goluguri RR, 2015, BIOCHEMISTRY-US, V54, P5356, DOI 10.1021/acs.biochem.5b00730; Gunner MR, 2011, PROTEINS, V79, P3306, DOI 10.1002/prot.23124; Harms MJ, 2009, J MOL BIOL, V389, P34, DOI 10.1016/j.jmb.2009.03.039; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hobbs JR, 2007, ACTA CRYSTALLOGR F, V63, P162, DOI 10.1107/S1744309107005271; Interlandi G, 2008, J MOL BIOL, V375, P837, DOI 10.1016/j.jmb.2007.09.042; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jha SK, 2009, P NATL ACAD SCI USA, V106, P11113, DOI 10.1073/pnas.0812564106; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kant R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-5; KIM SH, 1989, PROTEIN ENG, V2, P571, DOI 10.1093/protein/2.8.571; Kimura T, 2005, P NATL ACAD SCI USA, V102, P2748, DOI 10.1073/pnas.0407982102; Kimura T, 2008, P NATL ACAD SCI USA, V105, P13391, DOI 10.1073/pnas.0801316105; Kohmura M, 2002, PURE APPL CHEM, V74, P1235, DOI 10.1351/pac200274071235; KOHMURA M, 1992, BIOSCI BIOTECH BIOCH, V56, P472, DOI 10.1271/bbb.56.472; Konno T, 1999, FEBS LETT, V454, P122, DOI 10.1016/S0014-5793(99)00789-9; Konno T, 2001, PROTEIN SCI, V10, P2093, DOI 10.1110/ps.20201; LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032; Leone S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0299-0; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lin YM, 2007, BIOTECHNOL PROGR, V23, P577, DOI 10.1021/bp060380d; Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w; Meyers B, 2008, J FOOD SCI, V73, pR81, DOI 10.1111/j.1750-3841.2008.00832.x; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; Morini G, 2005, J MED CHEM, V48, P5520, DOI 10.1021/jm0503345; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; MURZIN AG, 1993, J MOL BIOL, V230, P689, DOI 10.1006/jmbi.1993.1186; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niccolai N, 2001, PROTEIN SCI, V10, P1498, DOI 10.1110/ps.30101; OGATA C, 1987, NATURE, V328, P739, DOI 10.1038/328739a0; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picone D, 2012, PLANT SCI, V195, P135, DOI 10.1016/j.plantsci.2012.07.001; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rega MF, 2015, FOOD CHEM, V173, P1179, DOI 10.1016/j.foodchem.2014.10.151; Sabareesan AT, 2014, BIOCHEMISTRY-US, V53, P1206, DOI 10.1021/bi401467p; Sborgi L, 2015, J AM CHEM SOC, V137, P6506, DOI 10.1021/jacs.5b02324; Settanni G, 2008, BIOPHYS J, V94, P4444, DOI 10.1529/biophysj.107.122606; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Spadaccini R, 2003, J MOL BIOL, V328, P683, DOI 10.1016/S0022-2836(03)00346-2; Spadaccini R, 2001, J MOL BIOL, V305, P505, DOI 10.1006/jmbi.2000.4304; Sung YH, 2001, J BIOL CHEM, V276, P19624, DOI 10.1074/jbc.M100930200; Sung YH, 2001, J BIOL CHEM, V276, P44229, DOI 10.1074/jbc.M104239200; Szczepankiewicz O, 2011, MOL BIOSYST, V7, P521, DOI 10.1039/c0mb00155d; Tancredi T, 2004, EUR J BIOCHEM, V271, P2231, DOI 10.1111/j.1432-1033.2004.04154.x; TANCREDI T, 1992, FEBS LETT, V310, P27, DOI 10.1016/0014-5793(92)81138-C; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Temussi PA, 2011, INT REV CEL MOL BIO, V291, P191, DOI 10.1016/B978-0-12-386035-4.00006-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; Walters DE, 2009, CHEM SENSES, V34, P679, DOI 10.1093/chemse/bjp048; Xue WF, 2009, BBA-PROTEINS PROTEOM, V1794, P410, DOI 10.1016/j.bbapap.2008.11.008	83	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158372	10.1371/journal.pone.0158372	http://dx.doi.org/10.1371/journal.pone.0158372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27340829	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600055
J	Tian, YH; Cai, LM; Tian, YM; Tu, YN; Qiu, HZ; Xie, GF; Huang, DL; Zheng, RH; Zhang, WJ				Tian, Yunhong; Cai, Longmei; Tian, Yunming; Tu, Yinuo; Qiu, Huizhi; Xie, Guofeng; Huang, Donglan; Zheng, Ronghui; Zhang, Weijun			miR156 alpha Mimic Represses the Epithelial-Mesenchymal Transition of Human Nasopharyngeal Cancer Cells by Targeting Junctional Adhesion Molecule A	PLOS ONE			English	Article							PLANT MICRORNAS; JAM-A; BIOINFORMATICS ANALYSIS; POOR-PROGNOSIS; BRASSICA-NAPUS; SALT STRESS; IDENTIFICATION; BIOGENESIS; EXPRESSION; BROCCOLI	MicroRNAs (miRNAs) have been documented as having an important role in the development of cancer. Broccoli is very popular in large groups of the population and has anticancer properties. Junctional adhesion molecule A (JAMA) is preferentially concentrated at tight junctions and influences cellmorphology and migration. Epithelial-mesenchymal transition (EMT) is a developmental program associated with cancer progression and metastasis. In this study we aimed to investigate the role of miRNAs from broccoli in human nasopharyngeal cancer (NPC). We demonstrated that a total of 84 conserved miRNAs and 184 putative novel miRNAs were found in broccoli by sequencing technology. Among these, miR156a was expressed the most. In addition, syntheticmiR156a mimic inhibited the EMT of NPC cells in vitro. Furthermore, it was confirmed that JAMA was the target of miR156a mimic as validated by 3'UTR luciferase reporter assays and western blotting. Knockdown of JAMA was consistent with the effects of miR156a mimic on the EMT of NPC, and the up-regulation of JAMA could partially restore EMT repressed by miR156a mimic. In conclusion, these results indicate that the miR156a mimic inhibits the EMT of NPC cells by targeting the 3'UTR of JAMA. These miRNA profiles of broccoli provide a fundamental basis for further research. Moreover, the discovery of miR156a may have clinical implications for the treatment of patients with NPC.	[Tian, Yunhong; Cai, Longmei; Tu, Yinuo; Qiu, Huizhi; Xie, Guofeng; Huang, Donglan; Zheng, Ronghui; Zhang, Weijun] Guangzhou Med Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Tian, Yunming] Huizhou Municipal Cent Hosp, Huizhou, Guangdong, Peoples R China	Guangzhou Medical University	Zheng, RH; Zhang, WJ (corresponding author), Guangzhou Med Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	xgxdfwz@qq.com; 591533086@qq.com			PhD Start-up Funds of Guangzhou Medical College, Guangdong Province, China [2014C45]; National Natural Science Foundation of China [81502342]; Major Project of Guangzhou Medical College, Guangdong Province, China [2015-yz-02]	PhD Start-up Funds of Guangzhou Medical College, Guangdong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Guangzhou Medical College, Guangdong Province, China	This study was supported by the PhD Start-up Funds of Guangzhou Medical College, Guangdong Province, China (2014C45); the National Natural Science Foundation of China (81502342); and the Major Project of Guangzhou Medical College, Guangdong Province, China (2015-yz-02).; This study was supported by the PhD Start-up Funds of Guangzhou Medical College, Guangdong Province, China (2014C45), the National Natural Science Foundation of China (81502342), and the Major Project of Guangzhou Medical College, Guangdong Province, China (2015-yz-02).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Latte KP, 2011, FOOD CHEM TOXICOL, V49, P3287, DOI 10.1016/j.fct.2011.08.019; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Millar Anthony A., 2005, Functional & Integrative Genomics, V5, P129, DOI 10.1007/s10142-005-0145-2; Muries B, 2013, PLANTA, V237, P1297, DOI 10.1007/s00425-013-1849-5; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Sugano Y, 2008, BLOOD, V111, P1167, DOI 10.1182/blood-2007-03-081554; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Tian YH, 2015, CARCINOGENESIS, V36, P41, DOI 10.1093/carcin/bgu230; Tian YH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0226-2; Tian YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074038; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Xu ML, 2016, PLANT CELL, V28, P28, DOI 10.1105/tpc.15.00854; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yi F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-212; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666	33	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157686	10.1371/journal.pone.0157686	http://dx.doi.org/10.1371/journal.pone.0157686			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341697	Green Submitted, gold, Green Published			2022-12-26	WOS:000378393600014
J	de Oliveira, FP; Mendes, RH; Dobbler, PT; Mai, V; Pylro, VS; Waugh, SG; Vairo, F; Refosco, LF; Roesch, LFW; Schwartz, IVD				de Oliveira, Felipe Pinheiro; Mendes, Roberta Hack; Dobbler, Priscila Thiago; Mai, Volker; Pylro, Victor Salter; Waugh, Sheldon G.; Vairo, Filippo; Refosco, Lilia Farret; Wurdig Roesch, Luiz Fernando; Doederlein Schwartz, Ida Vanessa			Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing	PLOS ONE			English	Article							OXIDATIVE STRESS; HOST METABOLISM; HUMAN HEALTH; MANAGEMENT; DIVERSITY; BACTERIA; DISEASE; PHENYLALANINE; COMMENSAL; CHILDREN	Phenylketonuria (PKU) is an inborn error of metabolism associated with high blood levels of phenylalanine (Phe). A Phe-restricted diet supplemented with L-amino acids is the main treatment strategy for this disease; if started early, most neurological abnormalities can be prevented. The healthy human gut contains trillions of commensal bacteria, often referred to as the gut microbiota. The composition of the gut microbiota is known to be modulated by environmental factors, including diet. In this study, we compared the gut microbiota of 8 PKU patients on Phe-restricted dietary treatment with that of 10 healthy individuals. The microbiota were characterized by 16S rRNA sequencing using the Ion Torrent T platform. The most dominant phyla detected in both groups were Bacteroidetes and Firmicutes. PKU patients showed reduced abundance of the Clostridiaceae, Erysipelotrichaceae, and Lachnospiraceae families, Clostridiales class, Coprococcus, Dorea, Lachnospira, Odoribacter, Ruminococcus and Veillonella genera, and enrichment of Prevotella, Akkermansia, and Peptostreptococcaceae. Microbial function prediction suggested significant differences in starch/glucose and amino acid metabolism between PKU patients and controls. Together, our results suggest the presence of distinct taxonomic groups within the gut microbiome of PKU patients, which may be modulated by their plasma Phe concentration. Whether our findings represent an effect of the disease itself, or a consequence of the modified diet is unclear.	[de Oliveira, Felipe Pinheiro; Mendes, Roberta Hack; Doederlein Schwartz, Ida Vanessa] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Vairo, Filippo; Refosco, Lilia Farret; Doederlein Schwartz, Ida Vanessa] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil; [de Oliveira, Felipe Pinheiro; Mendes, Roberta Hack; Doederlein Schwartz, Ida Vanessa] Hosp Clin Porto Alegre, Lab Basic Res & Adv Invest Neurosci BRAIN, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil; [Dobbler, Priscila Thiago; Wurdig Roesch, Luiz Fernando] Univ Fed Pampa, Ctr Interdisciplinar Pesquisas Biotecnol CIP, Biotec, Campus Sao Gabriel, Sao Gabriel, RS, Brazil; [Mai, Volker; Waugh, Sheldon G.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Mai, Volker; Waugh, Sheldon G.] Univ Florida, Coll Med, Emerging Pathogens Inst, Gainesville, FL USA; [Pylro, Victor Salter] Rene Rachou Res Ctr CPqRR, Genom & Computat Biol Grp, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Pampa; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Roesch, LFW (corresponding author), Univ Fed Pampa, Ctr Interdisciplinar Pesquisas Biotecnol CIP, Biotec, Campus Sao Gabriel, Sao Gabriel, RS, Brazil.	luizroesch@unipampa.edu.br	Roesch, Luiz F W/D-2838-2009; Vairo, Filippo/L-1256-2015; Schwartz, Ida Vanessa Doederlein/ABG-5471-2020; Pylro, Victor Satler/G-6045-2010; Roesch, Luiz/GRS-4638-2022; Schwartz, Ida/M-1422-2015; Dobbler, Priscila Caroline Thiago/E-4387-2018	Roesch, Luiz F W/0000-0003-1450-8828; Schwartz, Ida Vanessa Doederlein/0000-0002-7933-6687; Pylro, Victor Satler/0000-0003-2154-9150; Schwartz, Ida/0000-0002-7933-6687; Dobbler, Priscila Caroline Thiago/0000-0002-7681-5463; Waugh, Sheldon/0000-0003-3864-7726; Vairo, Filippo/0000-0001-6030-1903	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FIPE-HCPA	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FIPE-HCPA	The present study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and FIPE-HCPA.	Al Hafid N, 2015, TRANSL PEDIATR, V4, P304, DOI 10.3978/j.issn.2224-4336.2015.10.07; Aquilano K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00196; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; Blau N, 2014, EXPERT REV MOL DIAGN, V14, P655, DOI 10.1586/14737159.2014.923760; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Clayton TA, 2012, FEBS LETT, V586, P956, DOI 10.1016/j.febslet.2012.01.049; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Cleary M. A., 2011, PAEDIAT CHILD HLTH, V21, P61, DOI DOI 10.1016/J.PAED.2010.08.015; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deon M, 2015, INT J DEV NEUROSCI, V47, P259, DOI 10.1016/j.ijdevneu.2015.10.001; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hajela N, 2015, INDIAN J GASTROENTER, V34, P93, DOI 10.1007/s12664-015-0547-6; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Han DS, 2014, INTEST RES, V12, P178, DOI 10.5217/ir.2014.12.3.178; Hartstra AV, 2015, DIABETES CARE, V38, P159, DOI 10.2337/dc14-0769; He YZ, 2014, INT J DEV NEUROSCI, V38, P178, DOI 10.1016/j.ijdevneu.2014.09.002; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; KARVETTI RL, 1985, J AM DIET ASSOC, V85, P1437; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; MacDonald A, 2011, MOL GENET METAB, V104, pS55, DOI 10.1016/j.ymgme.2011.09.015; Malys MK, 2015, MEDICINA-LITHUANIA, V51, P69, DOI 10.1016/j.medici.2015.03.001; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Martin R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-71; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Monteiro Lenice Teresinha Bussolotto, 2006, Rev. Nutr., V19, P381, DOI 10.1590/S1415-52732006000300009; Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930; Ney DM, 2014, CURR OPIN CLIN NUTR, V17, P61, DOI 10.1097/MCO.0000000000000002; Oksanen J., 2016, R PACKAG; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; R Core Team, 2018, R LANG ENV STAT COMP; Sawin EA, 2015, AM J PHYSIOL-GASTR L, V309, pG590, DOI 10.1152/ajpgi.00211.2015; Singh RH, 2014, GENET MED, V16, P121, DOI 10.1038/gim.2013.179; Sirtori LR, 2005, BBA-MOL BASIS DIS, V1740, P68, DOI 10.1016/j.bbadis.2005.02.005; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Strisciuglio P, 2014, METABOLITES, V4, P1007, DOI 10.3390/metabo4041007; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Olden C, 2015, CLIN THER, V37, P1172, DOI 10.1016/j.clinthera.2015.03.008; Vargas CR, 2011, MOL GENET METAB, V104, pS97, DOI 10.1016/j.ymgme.2011.07.010; Vaziri Arash, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-204830; Verhoeven V, 2013, EUR J CANCER PREV, V22, P46, DOI 10.1097/CEJ.0b013e328355ed23; Walkowiak J, 2013, EUR REV MED PHARMACO, V17, P3056; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493	58	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157513	10.1371/journal.pone.0157513	http://dx.doi.org/10.1371/journal.pone.0157513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336782	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200020
J	Zhang, YJ; Skaar, I; Sulyok, M; Liu, XZ; Rao, MY; Taylor, JW				Zhang, Yongjie; Skaar, Ida; Sulyok, Michael; Liu, Xingzhong; Rao, Mingyong; Taylor, John W.			The Microbiome and Metabolites in Fermented Pu-erh Tea as Revealed by High-Throughput Sequencing and Quantitative Multiplex Metabolite Analysis	PLOS ONE			English	Article							MASS-SPECTROMETRIC METHOD; LYSOBACTER-CAPSICI AZ78; LIQUID-CHROMATOGRAPHY; FUNGAL; COMMUNITIES; BACTERIAL; MYCOTOXINS; DIVERSITY; CHEESE; CYCLO(L-PRO-L-TYR)	Pu-erh is a tea produced in Yunnan, China by microbial fermentation of fresh Camellia sinensis leaves by two processes, the traditional raw fermentation and the faster, ripened fermentation. We characterized fungal and bacterial communities in leaves and both Pu-erhs by high-throughput, rDNA-amplicon sequencing and we characterized the profile of bioactive extrolite mycotoxins in Pu-erh teas by quantitative liquid chromatography-tandem mass spectrometry. We identified 390 fungal and 629 bacterial OTUs from leaves and both Pu-erhs. Major findings are: 1) fungal diversity drops and bacterial diversity rises due to raw or ripened fermentation, 2) fungal and bacterial community composition changes significantly between fresh leaves and both raw and ripened Pu-erh, 3) aging causes significant changes in the microbial community of raw, but not ripened, Pu-erh, and, 4) ripened and well-aged raw Pu-erh have similar microbial communities that are distinct from those of young, raw Ph-erh tea. Twenty-five toxic metabolites, mainly of fungal origin, were detected, with patulin and asperglaucide dominating and at levels supporting the Chinese custom of discarding the first preparation of Pu-erh and using the wet tea to then brew a pot for consumption.	[Zhang, Yongjie] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Zhang, Yongjie; Taylor, John W.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Skaar, Ida] Norwegian Vet Inst, Sect Mycol, Oslo, Norway; [Sulyok, Michael] Univ Nat Resources & Life Sci, Dept Agrobiotechnol, Ctr Analyt Chem, Tulln, Austria; [Liu, Xingzhong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Rao, Mingyong] Bur Culture & Sports, Puer, Yunnan, Peoples R China	Shanxi University; University of California System; University of California Berkeley; Norwegian Veterinary Institute; University of Natural Resources & Life Sciences, Vienna; Chinese Academy of Sciences; Institute of Microbiology, CAS	Taylor, JW (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	jtaylor@berkeley.edu	Zhang, Yong-Jie/B-9054-2009; Sulyok, Michael/H-7591-2019	Zhang, Yong-Jie/0000-0002-6331-2189; Sulyok, Michael/0000-0002-3302-0732; Taylor, John/0000-0002-5794-7700	China Scholarship Council [201208140025]	China Scholarship Council(China Scholarship Council)	The support provided by China Scholarship Council during a visit of Yongjie Zhang to Berkeley (201208140025) is acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Kabir Peay, Sara Branco, Sydney Glass, and Rachel Adams for their suggestions/help during experimental implementation and/or data analyses. The support provided by China Scholarship Council during a visit of Yongjie Zhang to Berkeley (201208140025) is acknowledged.	Abe M, 2008, INT J FOOD MICROBIOL, V124, P199, DOI 10.1016/j.ijfoodmicro.2008.03.008; Adjovi YCS, 2014, FOOD MICROBIOL, V38, P151, DOI 10.1016/j.fm.2013.08.005; Alegria A, 2012, APPL ENVIRON MICROB, V78, P1890, DOI 10.1128/AEM.06081-11; [Anonymous], 2014, R LANG ENV STAT COMP; ARAI K, 1989, CHEM PHARM BULL, V37, P2937; Bansal S, 2013, FOOD RES INT, V53, P568, DOI 10.1016/j.foodres.2013.01.032; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Boer E, 2009, YEAST BIOTECHNOLOGY, P615; Bokulich NA, 2014, APPL ENVIRON MICROB, V80, P5522, DOI 10.1128/AEM.00663-14; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRANDSHORST TT, 1992, J GEN MICROBIOL, V138, P1429, DOI 10.1099/00221287-138-7-1429; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chai YJ, 2012, MAR DRUGS, V10, P559, DOI 10.3390/md10030559; Cimmino A, 2014, CHEM HETEROCYCL COM+, V50, P290, DOI 10.1007/s10593-014-1475-6; De Caceres M., 2014, INDICSPECIES RELATIO; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duan HongXing, 2012, Southwest China Journal of Agricultural Sciences, V25, P111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; FREHNER M, 1990, PLANT PHYSIOL, V94, P28, DOI 10.1104/pp.94.1.28; Frisvad J. C., 2004, Introduction to food- and airborne fungi, P321; Glaser N, 2012, FOOD CHEM TOXICOL, V50, P1796, DOI 10.1016/j.fct.2012.02.096; Haas D, 2013, INT J FOOD MICROBIOL, V166, P316, DOI 10.1016/j.ijfoodmicro.2013.07.024; Hetherington AC, 1931, PHILOS T R SOC LON B, V220, P269, DOI 10.1098/rstb.1931.0025; Ho C.T., 2008, TEA TEA PRODUCTS CHE, DOI [10.1201/9781420008036.ch4, DOI 10.1201/9781420008036.CH4]; Horie H, 2000, J CHROMATOGR A, V881, P425, DOI 10.1016/S0021-9673(99)01345-X; Hou CW, 2010, J FOOD SCI, V75, pH44, DOI 10.1111/j.1750-3841.2009.01441.x; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Isshiki K, 2001, BIOSCI BIOTECH BIOCH, V65, P1195, DOI 10.1271/bbb.65.1195; Kim KS, 2013, MOLECULES, V18, P13245, DOI 10.3390/molecules181113245; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kozlovskii AG, 2002, MICROBIOLOGY+, V71, P666, DOI 10.1023/A:1021475722091; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Liu QiFang, 2011, China Tropical Medicine, V11, P1381; Liu T, 2005, CHINESE TEA; Luo XD, 2006, CHEM BIODIVERS, V3, P224, DOI 10.1002/cbdv.200690026; Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043; Lyu CY, 2013, J SCI FOOD AGR, V93, P3165, DOI 10.1002/jsfa.6149; Malachova A, 2014, J CHROMATOGR A, V1362, P145, DOI 10.1016/j.chroma.2014.08.037; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mo HZ, 2013, LETT APPL MICROBIOL, V56, P462, DOI 10.1111/lam.12073; Mo HZ, 2005, AGRO FOOD IND HI TEC, V16, P16; Mogensen JM, 2009, INT J FOOD MICROBIOL, V132, P141, DOI 10.1016/j.ijfoodmicro.2009.04.011; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Park D.L., 2000, FOOD TOXICOLOGY, V5, P93, DOI [10.1201/9781420038316-9, DOI 10.1201/9781420038316-9]; [彭喜春 PENG Xichun], 2011, [食品科学, Food Science], V32, P196; Pinheiro EAA, 2013, NAT PROD RES, V27, P1633, DOI 10.1080/14786419.2012.750316; Pinto MD, 2013, FOOD RES INT, V53, P558, DOI 10.1016/j.foodres.2013.01.038; Preedy VR, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P1; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Puopolo G, 2014, J APPL MICROBIOL, V117, P1168, DOI 10.1111/jam.12611; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Ropars J, 2012, INT J FOOD MICROBIOL, V155, P199, DOI 10.1016/j.ijfoodmicro.2012.02.005; Saberi Helen, 2010, TEA A GLOBAL HIST; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Song EQ, 2014, FOOD CHEM TOXICOL, V71, P122, DOI [10.1016/j.fct.2014.06.009, 10.1016/j.fct.2014.06.00]; Sulyok M, 2006, RAPID COMMUN MASS SP, V20, P2649, DOI 10.1002/rcm.2640; Sun ZH, 2014, J DAIRY SCI, V97, P6085, DOI 10.3168/jds.2014-8360; Tian JQ, 2013, J FOOD SCI, V78, pM1249, DOI 10.1111/1750-3841.12218; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041; Wu JinYin, 2014, Journal of Basic & Applied Sciences, V10, P349; Xin ZH, 2005, CHINESE CHEM LETT, V16, P1227; Xu X, 2005, ENG LIFE SCI, V5, P382, DOI 10.1002/elsc.200520083; [杨晓苹 Yang Xiaoping], 2013, [食品科学, Food Science], V34, P142; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang DH, 2011, TALANTA, V85, P736, DOI 10.1016/j.talanta.2011.04.061; Zhang JH, 2014, CULT PLACE NAT, P5; Zhang L, 2013, FOOD RES INT, V53, P600, DOI 10.1016/j.foodres.2013.01.016; Zhang Y, 2012, CHINA BREWING, V31, P122; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10117; Zhao M, 2013, WORLD J MICROB BIOT, V29, P1877, DOI 10.1007/s11274-013-1351-z; Zhao ZJ, 2010, J FOOD SAFETY, V30, P769, DOI 10.1111/j.1745-4565.2010.00240.x; Zhou HongJie, 2004, Journal of Tea Science, V24, P212	80	42	55	6	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157847	10.1371/journal.pone.0157847	http://dx.doi.org/10.1371/journal.pone.0157847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337135	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200056
J	Gugnoni, M; Sancisi, V; Gandolfi, G; Manzotti, G; Ragazzi, M; Giordano, D; Tamagnini, I; Tigano, M; Frasoldati, A; Piana, S; Ciarrocchi, A				Gugnoni, M.; Sancisi, V.; Gandolfi, G.; Manzotti, G.; Ragazzi, M.; Giordano, D.; Tamagnini, I.; Tigano, M.; Frasoldati, A.; Piana, S.; Ciarrocchi, A.			Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy	ONCOGENE			English	Article							MITOCHONDRIAL FISSION; PROTEIN GABARAP; CELL-MIGRATION; EXPRESSION; TRANSFORMATION; TRANSITIONS; INHIBITION; INDUCTION; MARKER; BNIP3	The transdifferentiation of epithelial cells toward a mesenchymal condition (EMT) is a complex process that allows tumor cells to migrate to ectopic sites. Cadherins are not just structural proteins, but they act as sensors of the surrounding microenvironment and as signaling centers for cellular pathways. However, the molecular mechanisms underlying these signaling functions remain poorly characterized. Cadherin-6 (CDH6) is a type 2 cadherin, which drives EMT during embryonic development and it is aberrantly re-activated in cancer. We recently showed that CDH6 is a TGF beta target and an EMT marker in thyroid cancer, suggesting a role for this protein in the progression of this type of tumor. Papillary thyroid carcinomas (PTCs) are usually indolent lesions. However, metastatic spreading occurs in about 5% of the cases. The identification of molecular markers that could early predict the metastatic potential of these lesions would be strategic to design more tailored approaches and reduce patients overtreatment. In this work, we assessed the role of CDH6 in the metastatic progression of thyroid cancer. We showed that loss of CDH6 expression profoundly changes cellular architecture, alters the inter-cellular interaction modalities and attenuates EMT features in thyroid cancer cells. Using a yeast two-hybrid screening approach, based on a thyroid cancer patients library, we showed that CDH6 directly interacts with GABARAP, BNIP3 and BNIP3L, and that through these interactions CDH6 restrains autophagy and promotes re-organization of mitochondrial network through a DRP1-mediated mechanism. Analysis of the LIR domains suggests that the interaction with the autophagic machinery may be a common feature of many cadherin family members. Finally, the analysis of CDH6 expression in a unique cohort of human PTCs showed that CDH6 expression marks specifically EMT cells. and it is strongly associated with metastatic behavior and worse outcome of PTCs.	[Gugnoni, M.; Sancisi, V.; Gandolfi, G.; Manzotti, G.; Tigano, M.; Ciarrocchi, A.] Arcispedale S Maria Nuova IRCCS, Dept Sci Direct, Lab Translat Res, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy; [Ragazzi, M.; Tamagnini, I.; Piana, S.] Arcispedale S Maria Nuova IRCCS, Deptartment Oncol & Adv Technol, Pathol Unit, Reggio Emilia, Italy; [Giordano, D.] Arcispedale S Maria Nuova IRCCS, Otolaryngol Unit, Dept Gen Surg, Reggio Emilia, Italy; [Giordano, D.; Frasoldati, A.] Arcispedale S Maria Nuova IRCCS, Specialist Unit, Reggio Emilia, Italy; [Frasoldati, A.] Arcispedale S Maria Nuova IRCCS, Dept Gen Surg, Endocrinol Unit, Reggio Emilia, Italy	IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova	Ciarrocchi, A (corresponding author), Arcispedale S Maria Nuova IRCCS, Dept Sci Direct, Lab Translat Res, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy.	Alessia.Ciarrocchi@asmn.re.it	Sancisi, Valentina/H-6701-2018; PIANA, SIMONETTA/AAC-9158-2019; Giordano, Davide/AAC-3553-2020; Manzotti, Gloria/J-7235-2016; Ciarrocchi, Alessia/AAA-1130-2019; Ragazzi, Moira/J-5737-2018; Frasoldati, Andrea/AAB-3338-2021; Gugnoni, Mila/H-6952-2018	Sancisi, Valentina/0000-0003-4357-1228; PIANA, SIMONETTA/0000-0003-4875-6977; Manzotti, Gloria/0000-0002-0639-3605; Ciarrocchi, Alessia/0000-0002-5541-2075; Ragazzi, Moira/0000-0002-8761-9265; Frasoldati, Andrea/0000-0001-9002-9293; Gugnoni, Mila/0000-0003-4630-3958; Gandolfi, Greta/0000-0001-7498-424X; Tigano, Marco/0000-0002-4353-9220	Italian Association for Cancer Research (AIRC) [MFAG10745]; Italian Ministry of Health [GR-2011-02350937]; fellowship of the Umberto Veronesi Foundation	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); fellowship of the Umberto Veronesi Foundation(Fondazione Umberto Veronesi)	Additional Materials and Methods are supplied in the Supplementary Information. This work was supported by the Italian Association for Cancer Research (AIRC, MFAG10745) and by the Italian Ministry of Health (GR-2011-02350937). GG is supported by a fellowship of the Umberto Veronesi Foundation.	Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; BRABANT G, 1993, CANCER RES, V53, P4987; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Call G, 2012, ENDOCRINOLOGY, V153, P522, DOI 10.1210/en.2011-1572; Catalano M, 2015, MOL ONCOL, V9, P1612, DOI 10.1016/j.molonc.2015.04.016; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Cho EA, 1998, DEVELOPMENT, V125, P803; Choi PW, 2016, ONCOTARGET, V7, P4110, DOI 10.18632/oncotarget.6588; Ciarrocchi A, 2011, EUR J CANCER, V47, P934, DOI 10.1016/j.ejca.2010.11.009; Clay MR, 2014, DEVELOPMENT, V141, P2506, DOI 10.1242/dev.105551; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Davies L, 2010, ARCH OTOLARYNGOL, V136, P440, DOI 10.1001/archoto.2010.55; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gandolfi G, 2015, INT J CANCER, V137, P1001, DOI 10.1002/ijc.28976; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Gray RS, 2010, CURR OPIN CELL BIOL, V22, P640, DOI 10.1016/j.ceb.2010.08.019; Inoue T, 1997, DEV BIOL, V183, P183, DOI 10.1006/dbio.1996.8501; Inoue YU, 2008, MOL CELL NEUROSCI, V39, P95, DOI 10.1016/j.mcn.2008.05.020; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Maes H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.94; Ney PA, 2015, BBA-MOL CELL RES, V1853, P2775, DOI 10.1016/j.bbamcr.2015.02.022; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Peng YF, 2013, AUTOPHAGY, V9, P2056, DOI 10.4161/auto.26398; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Sancisi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075489; Sancisi V, 2012, J CLIN ENDOCR METAB, V97, pE2006, DOI 10.1210/jc.2012-1903; SCHEUMMAN GFW, 1995, J CLIN ENDOCR METAB, V80, P2168, DOI 10.1210/jc.80.7.2168; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shimazui T, 1998, CLIN CANCER RES, V4, P2419; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wild P, 2014, J CELL SCI, V127, P3, DOI 10.1242/jcs.140426; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Zaidel-Bar R, 2013, J CELL SCI, V126, P373, DOI 10.1242/jcs.111559; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	54	127	133	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					667	677		10.1038/onc.2016.237	http://dx.doi.org/10.1038/onc.2016.237			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27375021				2022-12-26	WOS:000394167700008
J	Zhang, Q; Liu, S; Parajuli, KR; Zhang, W; Zhang, K; Mo, Z; Liu, J; Chen, Z; Yang, S; Wang, A; Myers, L; You, Z				Zhang, Q.; Liu, S.; Parajuli, K. R.; Zhang, W.; Zhang, K.; Mo, Z.; Liu, J.; Chen, Z.; Yang, S.; Wang, A. R.; Myers, L.; You, Z.			Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition	ONCOGENE			English	Article							VASCULAR ENDOTHELIAL-CELLS; TUMOR-GROWTH; INTESTINAL TUMORIGENESIS; MATRIX-METALLOPROTEINASE; E-CADHERIN; IL-17; INFLAMMATION; MATRILYSIN; EXPRESSION; MICE	Chronic inflammation has been associated with a variety of human cancers including prostate cancer. Interleukin-17 (IL-17) is a critical pro-inflammatory cytokine, which has been demonstrated to promote development of prostate cancer, colon cancer, skin cancer, breast cancer, lung cancer and pancreas cancer. IL-17 promotes prostate adenocarcinoma with a concurrent increase of matrix metalloproteinase 7 (MMP7) expression in mouse prostate. Whether MMP7 mediates IL-17's action and the underlying mechanisms remain unknown. We generated Mmp7 and Pten double knockout (KO) (Mmp7 (-/-)) mouse model and demonstrated that MMP7 promotes prostate adenocarcinoma through induction of epithelial-to-mesenchymal transition (EMT) in Pten-null mice. MMP7 disrupted E-cadherin/beta-catenin complex to upregulate EMT transcription factors in mouse prostate tumors. IL-17 receptor C and Pten double KO mice rcapitulated the weak EMT characteristics observed in Mmp7 (-/-) mice. IL-17 induced MMP7 and EMT in human prostate cancer LNCaP, C4-2B and PC-3 cell lines, while small interfering RNA knockdown of MMP7 inhibited IL-17-induced EMT. Compound III, a selective MMP7 inhibitor, decreased development of invasive prostate cancer in Pten single KO mice. In human normal prostates and prostate tumors, IL-17 mRNA levels were positively correlated with MMP7 mRNA levels. These findings demonstrate that MMP7 mediates IL-17's function in promoting prostate carcinogenesis through induction of EMT, indicating IL-17-MMP7-EMT axis as a potential target for developing new strategies in the prevention and treatment of prostate cancer.	[Zhang, Q.; Liu, S.; Parajuli, K. R.; Mo, Z.; Liu, J.; Chen, Z.; Yang, S.; You, Z.] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave Mailbox 8649, New Orleans, LA 70112 USA; [Zhang, W.; Zhang, K.] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Zhang, W.; Zhang, K.] Xavier Univ Louisiana, Biostat Facil, RCMI Canc Res Ctr, New Orleans, LA USA; [Mo, Z.; Liu, J.] Shijiazhuang Maternal & Child Hlth Care Hosp, Dept Obstet & Gynecol, Shijiazhuang, Peoples R China; [Chen, Z.] North China Univ Sci & Technol, Dept Thorac Surg, Affiliated Hosp, Tangshan, Peoples R China; [Yang, S.] Hebei Med Univ, Dept Urol, Hosp 3, Shijiazhuang, Peoples R China; [Wang, A. R.] Tulane Univ, Dept Pathol & Lab Med, New Orleans, LA 70118 USA; [Myers, L.] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [You, Z.] Tulane Univ, Dept Orthopaed Surg, New Orleans, LA USA; [You, Z.] Tulane Univ, Tulane Canc Ctr, New Orleans, LA 70118 USA; [You, Z.] Tulane Univ, Louisiana Canc Res Consortium, New Orleans, LA 70118 USA; [You, Z.] Tulane Univ, Tulane Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70118 USA; [You, Z.] Tulane Univ, Tulane Ctr Aging, New Orleans, LA 70118 USA	Tulane University; Xavier University of Louisiana; Xavier University of Louisiana; North China University of Science & Technology; Hebei Medical University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University	You, Z (corresponding author), Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave Mailbox 8649, New Orleans, LA 70112 USA.	zyou@tulane.edu			National Institutes of Health [R01CA174714, P20GM103518]; Department of Defense [W81XWH-14-1-0050, W81XWH-14-1-0149, W81XWH-14-1-0458, W81XWH-15-1-0444]; Developmental Fund of Tulane Cancer Center (TCC); Louisiana Cancer Research Consortium (LCRC) Fund; Tulane's Institute of Integrated Engineering for Health and Medicine (TI2EHM); National Institute on Minority Health and Health Disparities [5G12MD007595]; NATIONAL CANCER INSTITUTE [R01CA174714] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103518] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Developmental Fund of Tulane Cancer Center (TCC); Louisiana Cancer Research Consortium (LCRC) Fund; Tulane's Institute of Integrated Engineering for Health and Medicine (TI2EHM); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	ZY was partially supported by the National Institutes of Health (R01CA174714 and P20GM103518), Department of Defense (W81XWH-14-1-0050, W81XWH-14-1-0149, W81XWH-14-1-0458 (PI: Feng Chen; Co-I: ZY), and W81XWH-15-1-0444), the Developmental Fund of Tulane Cancer Center (TCC), Louisiana Cancer Research Consortium (LCRC) Fund and Tulane's Institute of Integrated Engineering for Health and Medicine (TI2EHM). WZ and KZ were partially supported by the National Institute on Minority Health and Health Disparities (5G12MD007595, PIs: Gene D'Amour and Guangdi Wang).	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Chae WJ, 2011, BIOCHEM BIOPH RES CO, V414, P31, DOI 10.1016/j.bbrc.2011.09.016; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chen C, 2015, PROSTATE, V75, P883, DOI 10.1002/pros.22971; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunningham David, 2015, J Biol Methods, V2; Davies G, 2001, CLIN CANCER RES, V7, P3289; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Debelec-Butuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109868; Easwaran V, 2003, CANCER RES, V63, P3145; Edman K, 2011, CHEMMEDCHEM, V6, P769, DOI 10.1002/cmdc.201000550; Gerstenbluth RE, 2002, J UROLOGY, V167, P2267, DOI 10.1016/S0022-5347(05)65140-3; GILLES C, 1994, INT J CANCER, V59, P661, DOI 10.1002/ijc.2910590514; Gu K, 2015, AM J CANCER RES, V5, P1169; Hirahara N, 2001, ONCOLOGY-BASEL, V61, P79, DOI 10.1159/000055357; Huo N, 2002, CANCER LETT, V177, P95, DOI 10.1016/S0304-3835(01)00772-8; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Knox JD, 1996, MOL CARCINOGEN, V15, P57; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li QL, 2013, DRUG DES DEV THER, V7, P635, DOI 10.2147/DDDT.S49197; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Liu S, 2016, ONCOTARGET, V7, P13651, DOI 10.18632/oncotarget.7296; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; McAleer JP, 2014, IMMUNOL REV, V260, P129, DOI 10.1111/imr.12183; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Nishizuka I, 2001, CANCER LETT, V173, P175, DOI 10.1016/S0304-3835(01)00634-6; Noe V, 2001, J CELL SCI, V114, P111; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Schatteman PHF, 2000, EUR UROL, V37, P404, DOI 10.1159/000020161; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Sutcliffe S, 2007, UROL ONCOL-SEMIN ORI, V25, P242, DOI 10.1016/j.urolonc.2006.09.014; Tartour E, 1999, CANCER RES, V59, P3698; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108060; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; Xu BB, 2014, AM J PHYSIOL-LUNG C, V307, pL497, DOI 10.1152/ajplung.00125.2014; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang QY, 2014, PROSTATE, V74, P869, DOI 10.1002/pros.22805; Zhang QY, 2012, CANCER RES, V72, P2589, DOI 10.1158/0008-5472.CAN-11-3795; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	62	96	101	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					687	699		10.1038/onc.2016.240	http://dx.doi.org/10.1038/onc.2016.240			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27375020	Green Accepted			2022-12-26	WOS:000394167700010
J	Chowdhury, AR; Long, A; Fuchs, SY; Rustgi, A; Avadhani, NG				Chowdhury, A. Roy; Long, A.; Fuchs, S. Y.; Rustgi, A.; Avadhani, N. G.			Mitochondrial stress-induced p53 attenuates HIF-1 alpha activity by physical association and enhanced ubiquitination	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTOR; COLON-CANCER CELLS; TUMOR-SUPPRESSOR P53; FACTOR 1-ALPHA; FACTOR-I; PROLYL HYDROXYLATION; GENE-TRANSCRIPTION; MESSENGER-RNA; ACTIVATION; APOPTOSIS	Retrograde signaling is a mechanism by which mitochondrial dysfunction is communicated to the nucleus for inducing a metabolic shift essential for cell survival. Previously, we showed that partial mitochondrial DNA (mtDNA) depletion in different cell types induced mitochondrial retrograde signaling pathway (MtRS) involving Ca+2-sensitive Calcineurin (Cn) activation as an immediate upstream event of stress response. In multiple cell types, this stress signaling was shown to induce tumorigenic phenotypes in immortalized cells. In this study we show that MtRS also induces p53 expression, which was abrogated by Ca2+ chelators and short hairpin RNA-mediated knockdown of CnA beta mRNA. Mitochondrial dysfunction induced by mitochondrial ionophore, carbonyl cyanide m-chlorophenyl hydrazone and other respiratory inhibitors, which perturb the transmembrane potential, were equally efficient in inducing the expression of p53 and downregulation of MDM2. Stress-induced p53 physically interacted with hypoxiainducible factor-1 alpha (HIF-1 alpha) and attenuated the latter's binding to promoter DNA motifs. In addition, p53 promoted ubiquitination and degradation of HIF-1 alpha in partial mtDNA-depleted cells. The mtDNA depleted cells, with inhibited HIF-1 alpha, showed upregulation of glycolytic pathway genes, glucose transporter 1-4 (Glut1-4), phosphoglycerate kinase 1 and Glucokinase but not of prolyl hydroxylase isoforms. For the first time we show that p53 is induced as part of MtRS and it renders HIF-1 alpha inactive by physical interaction. In this respect, our results show that MtRS induces tumor growth independent of the HIF-1 alpha pathway.	[Chowdhury, A. Roy; Fuchs, S. Y.; Avadhani, N. G.] Univ Penn, Sch Vet Med, Dept Biomed Sci, 189E Old Vet Bldg, Philadelphia, PA 19104 USA; [Chowdhury, A. Roy; Fuchs, S. Y.; Avadhani, N. G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, 189E Old Vet Bldg, Philadelphia, PA 19104 USA; [Long, A.; Rustgi, A.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Div Gastroenterol,Dept Med & Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, 189E Old Vet Bldg, Philadelphia, PA 19104 USA.; Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, 189E Old Vet Bldg, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu			NIH grant [CA-22762, AR-067066]; Harriet Ellison Woodward trust (NGA); NIH MSTP training grant AL; NATIONAL CANCER INSTITUTE [R01CA092900, R01CA022762, R37CA022762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022986] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward trust (NGA); NIH MSTP training grant AL; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Drs Craig Thompson, Gregg Semenza and Bert Vogelstein for generously providing the promoter constructs and cell lines used in this study. This work was supported by NIH grant CA-22762, AR-067066 and an endowment from the Harriet Ellison Woodward trust (NGA) and NIH MSTP training grant AL. We also acknowledge the help of the Imaging Core facility at the School of Veterinary Medicine and the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30DK050306) and its Cell collection core.	Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Barliya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022849; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Brar SS, 2012, AM J PHYSIOL-LUNG C, V303, pL413, DOI 10.1152/ajplung.00343.2011; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Camenisch Gieri, 2002, Methods Mol Biol, V196, P117; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Guha M, 2014, ONCOGENE, V33, P5238, DOI 10.1038/onc.2013.467; Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200; Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iommarini L, 2014, HUM MOL GENET, V23, P1453, DOI 10.1093/hmg/ddt533; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Kojima K, 2011, BLOOD, V118, P4431, DOI 10.1182/blood-2011-02-334136; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Obacz J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-93; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Ravi R, 2000, GENE DEV, V14, P34; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Sun Y, 1999, MOL CARCINOGEN, V24, P25, DOI 10.1002/(SICI)1098-2744(199901)24:1<25::AID-MC4>3.3.CO;2-J; Tang WG, 2012, CARCINOGENESIS, V33, P1762, DOI 10.1093/carcin/bgs190; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang G L, 1996, Curr Opin Hematol, V3, P156; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; Xu HB, 2006, BIOCHEM BIOPH RES CO, V341, P938, DOI 10.1016/j.bbrc.2005.12.227	64	17	18	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					397	409		10.1038/onc.2016.211	http://dx.doi.org/10.1038/onc.2016.211			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27345397	Green Accepted			2022-12-26	WOS:000394166000009
J	Nordvang, RT; Nyffenegger, C; Holck, J; Jers, C; Zeuner, B; Sundekilde, UK; Meyer, AS; Mikkelsen, JD				Nordvang, Rune T.; Nyffenegger, Christian; Holck, Jesper; Jers, Carsten; Zeuner, Birgitte; Sundekilde, Ulrik K.; Meyer, Anne S.; Mikkelsen, Jorn D.			It All Starts with a Sandwich: Identification of Sialidases with Trans-Glycosylation Activity	PLOS ONE			English	Article							DIRECTED EVOLUTION; SIALYLTRANSFERASE ACTIVITY; BIOCATALYTIC PRODUCTION; TRYPANOSOMA-RANGELI; 3'-SIALYLLACTOSE; ENZYME; TRANSGLYCOSYLATION; OLIGOSACCHARIDES; NEURAMINIDASE; METHODOLOGY	Sialidases (3.2.1.18) may exhibit trans-sialidase activity to catalyze sialylation of lactose if the active site topology is congruent with that of the Trypanosoma cruzi trans-sialidase (EC 2.4.1.-). The present work was undertaken to test the hypothesis that a particular aromatic sandwich structure of two amino acids proximal to the active site of the T. cruzi trans-sialidase infers trans-sialidase activity. On this basis, four enzymes with putative trans-sialidase activity were identified through an iterative alignment from 2909 native sialidases available in GenBank, which were cloned and expressed in Escherichia coli. Of these, one enzyme, SialH, derived from Haemophilus parasuis had an aromatic sandwich structure on the protein surface facing the end of the catalytic site (Phe168; Trp366), and was indeed found to exhibit trans-sialidase activity. SialH catalyzed production of the human milk oligosaccharide 3'-sialyllactose as well as the novel trans-sialylation product 3-sialyllactose using casein glycomacropeptide as sialyl donor and lactose as acceptor. The findings corroborated that Tyr119 and Trp312 in the T. cruzi trans-sialidase are part of an aromatic sandwich structure that confers trans-sialylation activity for lactose sialylation. The in silico identification of trans-glycosidase activity by rational active site topology alignment thus proved to be a quick tool for selecting putative trans-sialidases amongst a large group of glycosyl hydrolases. The approach moreover provided data that help understand structure-function relations of trans-sialidases.	[Nordvang, Rune T.; Nyffenegger, Christian; Holck, Jesper; Jers, Carsten; Zeuner, Birgitte; Meyer, Anne S.; Mikkelsen, Jorn D.] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark; [Sundekilde, Ulrik K.] Aarhus Univ, Dept Food Sci, Arslev, Denmark	Technical University of Denmark; Aarhus University	Zeuner, B (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark.	biz@kt.dtu.dk	Zeuner, Birgitte/P-9512-2016; Sundekilde, Ulrik/J-6100-2019; Holck, Jesper/Q-4399-2016; Meyer, Anne S/AAN-2157-2020	Zeuner, Birgitte/0000-0002-8593-6742; Sundekilde, Ulrik/0000-0003-4849-0996; Holck, Jesper/0000-0002-8072-1101; Meyer, Anne S/0000-0001-8910-9931	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	This work was supported by the funding from Danish Dairy Research Foundation (Mejeribrugets Forskningsfond; www.ddrf.dk) (grant to RTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Ammar Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003710; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Demir O, 2009, BIOCHEMISTRY-US, V48, P3398, DOI 10.1021/bi802230y; Desmet T, 2012, CHEM-EUR J, V18, P10786, DOI 10.1002/chem.201103069; Feng HY, 2005, J BIOL CHEM, V280, P37088, DOI 10.1074/jbc.M502873200; Holck J, 2014, NEW BIOTECHNOL, V31, P156, DOI 10.1016/j.nbt.2013.11.006; Jers C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083902; Kone FMT, 2009, PROTEIN ENG DES SEL, V22, P37, DOI 10.1093/protein/gzn065; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo JQ, 2014, BIORESOURCE TECHNOL, V166, P9, DOI 10.1016/j.biortech.2014.05.003; Michalak M, 2014, PROCESS BIOCHEM, V49, P265, DOI 10.1016/j.procbio.2013.10.023; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Nordvang RT, 2014, SEP PURIF TECHNOL, V138, P77, DOI 10.1016/j.seppur.2014.10.012; Osanjo G, 2007, BIOCHEMISTRY-US, V46, P1022, DOI 10.1021/bi061444w; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Schmidt D, 2000, J ORG CHEM, V65, P8518, DOI 10.1021/jo000871r; Smith LE, 1997, GLYCOBIOLOGY, V7, P445, DOI 10.1093/glycob/7.3.445; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiralongo E, 2003, BIOL CHEM, V384, P1203, DOI 10.1515/BC.2003.133; Villumsen NS, 2015, INT DAIRY J, V49, P8, DOI 10.1016/j.idairyj.2015.05.003; Watson JN, 2004, FEBS LETT, V577, P265, DOI 10.1016/j.febslet.2004.10.016; Zeuner B, 2014, J AGR FOOD CHEM, V62, P9615, DOI 10.1021/jf502619p; Zeuner B, 2014, ENZYME MICROB TECH, V55, P85, DOI 10.1016/j.enzmictec.2013.12.009	32	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158434	10.1371/journal.pone.0158434	http://dx.doi.org/10.1371/journal.pone.0158434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367145	gold, Green Published			2022-12-26	WOS:000378914900034
J	Dettrick, Z; Gouda, HN; Hodge, A; Jimenez-Soto, E				Dettrick, Zoe; Gouda, Hebe N.; Hodge, Andrew; Jimenez-Soto, Eliana			Measuring Quality of Maternal and Newborn Care in Developing Countries Using Demographic and Health Surveys	PLOS ONE			English	Article							DETERMINANTS; CONTINUITY; SERVICES; IMPACT	Background One of the greatest obstacles facing efforts to address quality of care in low and middle income countries is the absence of relevant and reliable data. This article proposes a methodology for creating a single "Quality Index" (QI) representing quality of maternal and neonatal health care based upon data collected as part of the Demographic and Health Survey (DHS) program. Methods Using the 2012 Indonesian Demographic and Health Survey dataset, indicators of quality of care were identified based on the recommended guidelines outlined in the WHO Integrated Management of Pregnancy and Childbirth. Two sets of indicators were created; one set only including indicators available in the standard DHS questionnaire and the other including all indicators identified in the Indonesian dataset. For each indicator set composite indices were created using Principal Components Analysis and a modified form of Equal Weighting. These indices were tested for internal coherence and robustness, as well as their comparability with each other. Finally a single QI was chosen to explore the variation in index scores across a number of known equity markers in Indonesia including wealth, urban rural status and geographical region. Results The process of creating quality indexes from standard DHS data was proven to be feasible, and initial results from Indonesia indicate particular disparities in the quality of care received by the poor as well as those living in outlying regions. Conclusions The QI represents an important step forward in efforts to understand, measure and improve quality of MNCH care in developing countries.	[Dettrick, Zoe; Gouda, Hebe N.; Hodge, Andrew; Jimenez-Soto, Eliana] Univ Queensland, Sch Publ Hlth, Public Hlth Bldg,Herston Rd, Brisbane, Qld 4006, Australia	University of Queensland	Gouda, HN (corresponding author), Univ Queensland, Sch Publ Hlth, Public Hlth Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	h.gouda@uq.edu.au	Dettrick, Zoe A/I-1479-2017; Dettrick, Zoe/AAP-2862-2021	Dettrick, Zoe A/0000-0003-1091-1820; Dettrick, Zoe/0000-0003-1091-1820; Gouda, Hebe/0000-0002-5709-4509	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	This work was funded by an Australian Postgraduate Award scholarship administered through the University of Queensland, Australia.	[Anonymous], 2013, IND DEM HLTH SURV 20; Barber SL, 2008, HEALTH POLICY, V88, P339, DOI 10.1016/j.healthpol.2008.04.003; Basu S, 2012, PLOS MED, V9, P19, DOI DOI 10.1371/J0URNAL.PMED.1001244; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Bryce J, 2013, PLOS MED, V10; Chaturvedi S, 2014, PLOS ONE, V9; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Das J, 2012, J DEV ECON, V98, P76, DOI 10.1016/j.jdeveco.2011.07.001; Dettrick Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083070; Donabedian A, 1986, QRB Qual Rev Bull, V12, P99; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Foa R, 2012, METHODOLOGY SOCIAL D; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Harimurti P., 2013, NUTS BOLTS JAMKESMAS, P8; Hodge A, 2014, PLOS ONE, V9; Hussein J, 2004, REPROD HEALTH MATTER, V12, P160, DOI 10.1016/S0968-8080(04)24136-2; ICF International, 2014, DHS PROGR QUAL INF P; James CD, 2011, INT J QUAL HEALTH C, V23, P445, DOI 10.1093/intqhc/mzr029; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kozhimannil KB, 2014, J RURAL HLTH; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Lassi ZS, 2010, COCHRANE DB SYST REV, V11, P11; Lassi ZS, 2014, REPROD HLTH, P11; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060762; Marchant T, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0112-1; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Philippine Statistics Authority (PSA) [Philippines], 2014, INT I PHIL NAT DEM H; Pileggi-Castro C, 2014, BJOG-INT J OBSTET GY, V121, P110, DOI 10.1111/1471-0528.12637; Raven JH, 2012, MIDWIFERY, V28, pE676, DOI 10.1016/j.midw.2011.09.003; Rutstein S. O., 2004, DHS WEALTH INDEX; Salam RA, 2014, REPROD HLTH, P11; Schroders J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123629; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; Steiner D, 2008, HLTH MEASUREMENT SCA; Tabachnick B. G., 2013, USING MULTIVARIATE S; Titaley CR, 2014, ASIA PAC J CLIN NUTR, V23, P91, DOI 10.6133/apjcn.2014.23.1.18; Uzochukwu B S C, 2004, East Afr Med J, V81, P293; van Duong D, 2004, INT J QUAL HEALTH C, V16, P447, DOI 10.1093/intqhc/mzh073; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2006, PREGN CHILDB POSTP N	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157110	10.1371/journal.pone.0157110	http://dx.doi.org/10.1371/journal.pone.0157110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362354	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200006
J	Khade, NV; Sugiyama, T				Khade, Nilesh V.; Sugiyama, Tomohiko			Roles of C-Terminal Region of Yeast and Human Rad52 in Rad51-Nucleoprotein Filament Formation and ssDNA Annealing	PLOS ONE			English	Article							REPLICATION PROTEIN-A; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE RAD52; RECOMBINATION MEDIATOR FUNCTION; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; RAD51-MEDIATED RECOMBINATION; CANCER SUSCEPTIBILITY; COMPLEX-FORMATION; BRC MOTIFS	Yeast Rad52 (yRad52) has two important functions at homologous DNA recombination (HR); annealing complementary single-strand DNA (ssDNA) molecules and recruiting Rad51 recombinase onto ssDNA (recombination mediator activity). Its human homolog (hRAD52) has a lesser role in HR, and apparently lacks mediator activity. Here we show that yRad52 can load human Rad51 (hRAD51) onto ssDNA complexed with yeast RPA in vitro. This is biochemically equivalent to mediator activity because it depends on the C-terminal Rad51-binding region of yRad52 and on functional Rad52-RPA interaction. It has been reported that the N-terminal two thirds of both yRad52 and hRAD52 is essential for binding to and annealing ssDNA. Although a second DNA binding region has been found in the C-terminal region of yRad52, its role in ssDNA annealing is not clear. In this paper, we also show that the C-terminal region of yRad52, but not of hRAD52, is involved in ssDNA annealing. This suggests that the second DNA binding site is required for the efficient ssDNA annealing by yRad52. We propose an updated model of Rad52-mediated ssDNA annealing.	[Khade, Nilesh V.; Sugiyama, Tomohiko] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Sugiyama, T (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	sugiyama@ohio.edu		Sugiyama, Tomohiko/0000-0003-2942-3667	Ohio University Student Enhancement Award [SEA 12-07]	Ohio University Student Enhancement Award	This work was supported by Ohio University Student Enhancement Award (SEA 12-07; https://www.ohio.edu/research/Funding.cfm) to NVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUNDYMILLS KL, 1993, GENETICS, V133, P39; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; DONOVAN JW, 1994, GENE DEV, V8, P2552, DOI 10.1101/gad.8.21.2552; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Haber JE, 2004, PHILOS T ROY SOC B, V359, P79, DOI 10.1098/rstb.2003.1367; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Ivanov EL, 1996, GENETICS, V142, P693; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Kagawa W, 2014, NUCLEIC ACIDS RES, V42, P941, DOI 10.1093/nar/gkt986; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Li J, 2006, ONCOGENE, V25, P1186, DOI 10.1038/sj.onc.1209153; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Phillips ER, 2007, ONCOGENE, V26, P7799, DOI 10.1038/sj.onc.1210877; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158436	10.1371/journal.pone.0158436	http://dx.doi.org/10.1371/journal.pone.0158436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362509	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200074
J	Osterberg, J; Wingstrand, A; Jensen, AN; Kerouanton, A; Cibin, V; Barco, L; Denis, M; Aabo, S; Bengtsson, B				Osterberg, Julia; Wingstrand, Anne; Jensen, Annette Nygaard; Kerouanton, Annaelle; Cibin, Veronica; Barco, Lisa; Denis, Martine; Aabo, Soren; Bengtsson, Bjorn			Antibiotic Resistance in Escherichia coli from Pigs in Organic and Conventional Farming in Four European Countries	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; ANTIMICROBIAL RESISTANCE; SUSCEPTIBILITY; BACTERIA; SWINE; TRANSMISSION; HERDS; BEEF	Organic pig production differs in many ways from conventional production of pigs, e.g., in antibiotic use, herd structure, feeding regimes, access to outdoor areas and space allowance per pig. This study investigated if these differences result in a lower occurrence of antibiotic resistance in organic slaughter pigs in Denmark, France, Italy and Sweden. Samples were taken from the colon content and/or faeces and minimum inhibitory concentrations (MIC) of ten antibiotics were determined in isolates of Escherichia coli. In addition, the proportion of tetracycline (TET) resistant E. coli in colon content and/or faeces from individual pigs was determined. In all four countries the percentage resistance to ampicillin, streptomycin, sulphonamides or trimethoprim was significantly lower in E. coli from organic pigs. In France and Italy, the percentage of isolates resistant to chloramphenicol, ciprofloxacin, nalidixic acid or gentamicin was also significantly lower in the E. coli from organic pigs. Resistance to cefotaxime, was not found in any country. The percentage of E. coli isolates resistant to TET as well as the proportion of TET-resistant E. coli was significantly lower in organic than in conventional pigs, except in Sweden where TET-resistance was equally low in both production types. There were also differences between countries within production type in the percentage resistance to individual antibiotics as well as the proportion of TET-resistant E. coli with lower median proportions in Sweden and Denmark compared to France and Italy. The study shows that in each of the four countries resistance in intestinal E. coli was less common in organic than in conventional pigs, but that there were also large differences in resistance between countries within each production type, indicating that both country-and production-specific factors influence the occurrence of resistance.	[Osterberg, Julia; Bengtsson, Bjorn] Natl Vet Inst SVA, Uppsala, Sweden; [Wingstrand, Anne; Jensen, Annette Nygaard; Aabo, Soren] Tech Univ Denmark DTU, Natl Food Inst, Copenhagen, Denmark; [Kerouanton, Annaelle; Denis, Martine] French Agcy Food Environm & Occupat Hlth Safety A, Ploufragan, France; [Cibin, Veronica; Barco, Lisa] Ist Zooprofilatt Sperimentale Venezie IZSVe, Legnaro, Italy	National Veterinary Institute SVA; Technical University of Denmark; IZS delle Venezie	Osterberg, J (corresponding author), Natl Vet Inst SVA, Uppsala, Sweden.	Julia.Osterberg@sva.se	; Barco, Lisa/K-2284-2016	Jensen, Annette Nygaard/0000-0001-9681-7258; Barco, Lisa/0000-0002-6247-248X; Aabo, Soren/0000-0003-1430-1480	CORE Organic II Funding Bodies; FP7 ERA-Net project; CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems) [249667]	CORE Organic II Funding Bodies; FP7 ERA-Net project; CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems)	The authors gratefully acknowledge the financial support of the CORE Organic II Funding Bodies, partners of the FP7 ERA-Net project, CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems, project no. 249667). For further information see: (www.coreorganic2.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support of the CORE Organic II Funding Bodies, partners of the FP7 ERA-Net project, CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems, project no. 249667). For further information, see: www.coreorganic2.org.	Alvarez-Ordonez A, 2013, INT J ENV RES PUB HE, V10, P1927, DOI 10.3390/ijerph10051927; Baquero F, 2011, J ANTIMICROB CHEMOTH, V66, P1659, DOI 10.1093/jac/dkr214; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Call Douglas R., 2008, Animal Health Research Reviews, V9, P159, DOI 10.1017/S1466252308001515; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; Cuny C, 2012, APPL ENVIRON MICROB, V78, P1296, DOI 10.1128/AEM.07260-11; DANMAP 2009, 2009, US ANT AG OCC ANT RE; EFSA, 2010, EFSA J, V8, P1309, DOI [10.2903/j.efsa.2010.1309, DOI 10.2903/J.EFSA.2010.1309]; European Ctr Dis Prevention Contro, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4006, 10.2903/j.efsa.20Y15.4204]; European Food Safety Author, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3196; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; European Medicines Agency (EMA), 2014, EUR SURV VET ANT CON; Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013; Gerzova L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132892; Guarddon M, 2011, INT J FOOD MICROBIOL, V146, P284, DOI 10.1016/j.ijfoodmicro.2011.02.026; Jacob ME, 2008, FOODBORNE PATHOG DIS, V5, P721, DOI 10.1089/fpd.2008.0095; Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Miranda JM, 2009, MEAT SCI, V82, P284, DOI 10.1016/j.meatsci.2009.01.020; Nulsen MF, 2008, NEW ZEAL VET J, V56, P29, DOI 10.1080/00480169.2008.36801; Rosengren LB, 2007, MICROB DRUG RESIST, V13, P261, DOI 10.1089/mdr.2007.781; Sato K, 2004, J FOOD PROTECT, V67, P1104, DOI 10.4315/0362-028X-67.6.1104; Sato K, 2005, JAVMA-J AM VET MED A, V226, P589, DOI 10.2460/javma.2005.226.589; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Tobias TJ, 2014, PREV VET MED, V117, P207, DOI 10.1016/j.prevetmed.2014.07.017; van de Vijver LPL, 2014, ZOONOSES PUBLIC HLTH, V61, P338, DOI 10.1111/zph.12076; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; World Health Organization, 2014, ANT RES GLOB REP SUR; Wu SY, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-38; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635	34	56	56	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157049	10.1371/journal.pone.0157049	http://dx.doi.org/10.1371/journal.pone.0157049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362262	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200005
J	Polosa, A; Bessaklia, H; Lachapelle, P				Polosa, Anna; Bessaklia, Hyba; Lachapelle, Pierre			Strain Differences in Light-Induced Retinopathy	PLOS ONE			English	Article							INDUCED RETINAL DEGENERATION; OXYGEN-INDUCED RETINOPATHY; ALBINO-RATS; PIGMENT EPITHELIUM; VISUAL CYCLE; DAMAGE; RPE65; SUSCEPTIBILITY; RHODOPSIN; PHOTORECEPTORS	The purpose of this study was to better understand the role of ocular pigmentation and genetics in light-induced retinal damage. Adult pigmented [Long Evans (LE) and Brown Norway (BN)] and albino [Sprague Dawley (SD) and Lewis (LW)] rats were exposed to a bright cyclic light for 6 consecutive days and where compared with juvenile animals exposed to the same bright light environment from postnatal age 14 to 28. Flash ERGs and retinal histology were performed at predetermined days (D) post-light exposure. At D1, ERGs were similar in all adult groups with no recordable a-waves and residual b-waves. A transient recovery was noticed at D30 in the LW and LE only [b-wave: 18% and 25% of their original amplitude respectively]. Histology revealed that BN retina was the most damaged, while LE retina was best preserved. SD and LW rats were almost as damaged as BN rats. In contrast, the retina of juvenile BN was almost as resistant to the bright light exposure as that of juvenile LE rats. Our results strongly suggest that, although ocular pigmentation and genetic background are important factors in regulating the severity of light-induced retinal damage, the age of the animal at the onset of light exposure appears to be the most important determining factor.	[Polosa, Anna; Lachapelle, Pierre] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Polosa, Anna; Bessaklia, Hyba; Lachapelle, Pierre] McGill Univ, Ctr Hlth, Res Inst, Dept Ophthalmol, Montreal, PQ, Canada	McGill University; McGill University	Lachapelle, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.; Lachapelle, P (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Ophthalmol, Montreal, PQ, Canada.	pierre.lachapelle@mcgill.ca		Lachapelle, Pierre/0000-0002-7792-1102	Natural Sciences and Engineering Research Council (NSERC) of Canada [Rgpin 138448-09]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Grant # Rgpin 138448-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Grant # Rgpin 138448-09).	BORGES JM, 1990, CURR EYE RES, V9, P799, DOI 10.3109/02713689008999576; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Cachafeiro M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.303; CICERONE CM, 1976, SCIENCE, V194, P1183, DOI 10.1126/science.996550; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Dembinska O, 2002, INVEST OPHTH VIS SCI, V43, P2481; Floyd BNI, 2005, MOL VIS, V11, P524; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Garcia-Ayuso D, 2011, MOL VIS, V17, P1716; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; HALL MO, 1969, J MOL BIOL, V45, P397, DOI 10.1016/0022-2836(69)90114-4; Hebert M, 1995, DOC OPHTHALMOL, V91, P333, DOI 10.1007/BF01214651; HUMPEL C, 1992, J NEUROSCI RES, V32, P605, DOI 10.1002/jnr.490320416; Iseli HP, 2002, EXP EYE RES, V75, P407, DOI 10.1006/exer.2002.2032; Ito S, 2013, PIGM CELL MELANOMA R, V26, P357, DOI 10.1111/pcmr.12078; Jamison JA, 2011, INVEST OPHTHALMOL VI, V52; Joly S, 2006, INVEST OPHTH VIS SCI, V47, P3202, DOI 10.1167/iovs.05-1515; KUWABARA T, 1976, ARCH OPHTHALMOL-CHIC, V94, P1369; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LAVAIL MM, 1980, EFFECTS CONSTANT LIG, P357; MALIK S, 1986, INVEST OPHTH VIS SCI, V27, P164; MATSUBARA T, 1968, VISION RES, V8, P1139, DOI 10.1016/0042-6989(68)90023-0; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Noell W K, 1966, Invest Ophthalmol, V5, P450; OSTEEN WK, 1974, INVEST OPHTH VISUAL, V13, P334; PENN JS, 1987, EXP EYE RES, V44, P767, DOI 10.1016/S0014-4835(87)80040-4; Polosa A, 2016, PLOS ONE, V11, P1; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Reme C, 2005, INVEST OPHTH VIS SCI, V46, P2672, DOI 10.1167/iovs.04-1095; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Tremblay F, 2013, J NUTR BIOCHEM, V24, P647, DOI 10.1016/j.jnutbio.2012.03.011; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wielgus AR, 2005, PIGM CELL RES, V18, P454, DOI 10.1111/j.1600-0749.2005.00268.x; WILLIAMS RA, 1985, CURR EYE RES, V4, P97, DOI 10.3109/02713688508999974; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	38	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158082	10.1371/journal.pone.0158082	http://dx.doi.org/10.1371/journal.pone.0158082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355622	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400027
J	Sevastou, I; Pryce, G; Baker, D; Selwood, DL				Sevastou, Ioanna; Pryce, Gareth; Baker, David; Selwood, David L.			Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; INHIBIT INFLAMMATORY RESPONSES; MULTIPLE-SCLEROSIS PATIENTS; ACTIVATED-RECEPTOR-ALPHA; REPEAT PROTEIN 1A; LIVER X RECEPTORS; LIPID-METABOLISM; MATRIX METALLOPROTEINASE-12; ALZHEIMERS-DISEASE	Multiple sclerosis (MS) is a debilitating immune-mediated neurological disorder affecting young adults. MS is primarily relapsing-remitting, but neurodegeneration and disability accumulate from disease onset. The most commonly used mouse MS models exhibit a monophasic immune response with fast accumulation of neurological damage that does not allow the study of progressive neurodegeneration. The chronic relapsing and secondary progressive EAE (pEAE) Biozzi ABH mouse model of MS exhibits a reproducible relapsing-remitting disease course that slowly accumulates permanent neurological deficit and develops a post-relapsing progressive disease that permits the study of demyelination and neurodegeneration. RNA sequencing (RNAseq) was used to explore global gene expression in the pEAE Biozzi ABH mouse. Spinal cord tissue RNA from pEAE Biozzi ABH mice and healthy age-matched controls was sequenced. 2,072 genes were differentially expressed (q<0.05) from which 1,397 were significantly upregulated and 675 were significantly down-regulated. This hypothesis-free investigation characterised the genomic changes that describe the pEAE mouse model. The differentially expressed genes revealed a persistent immunoreactant phenotype, combined with downregulation of the cholesterol biosynthesis superpathway and the LXR/RXR activation pathway. Genes differentially expressed include the myelination genes Slc17a7, Ugt8A and Opalin, the neuroprotective genes Sprr1A, Osm and Wisp2, as well as genes identified as MS risk factors, including RGs14 and Scap2. Novel genes with unestablished roles in EAE or MS were also identified. The identification of differentially expressed novel genes and genes involved in MS pathology, opens the door to their functional study in the pEAE mouse model which recapitulates some of the important clinical features of progressive MS.	[Sevastou, Ioanna; Selwood, David L.] UCL Wolfson Inst Biomed Sci, Dept Med Chem, London WC1E 6BT, England; [Pryce, Gareth; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Neuroimmmunol Unit, Blizard Inst, London E1 2AT, England; [Sevastou, Ioanna] UCL Sch Life & Med Sci, Translat Res Off, London W1T 7DN, England	University of London; University College London; University of London; Queen Mary University London; University of London; University College London	Selwood, DL (corresponding author), UCL Wolfson Inst Biomed Sci, Dept Med Chem, London WC1E 6BT, England.	d.selwood@ucl.ac.uk		Selwood, David/0000-0002-6817-5064	Canbex Therapeutics; Technology Strategy Board UK/Innovate UK [25036-166159]; MRC [MC_PC_13037] Funding Source: UKRI; Medical Research Council [MC_PC_13037] Funding Source: researchfish	Canbex Therapeutics; Technology Strategy Board UK/Innovate UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a Canbex Therapeutics grant awarded to DLS and the Technology Strategy Board UK/Innovate UK grant no. 25036-166159 awarded to DLS and DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support of Canbex Therapeutics and the Technology Strategy Board UK/Innovate UK grant no. 25036-166159.	Abel AM, 2015, MOL IMMUNOL, V65, P336, DOI 10.1016/j.molimm.2015.02.012; Al-Izki S, 2009, MULT SCLER, V15, P795, DOI 10.1177/1352458509104594; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Alatab S, 2011, MINERVA MED, V102, P461; Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Alikhani P, 2014, MULTIPLE SCLEROSIS R, V3, P747, DOI [10.1016/j.msard.2014.09.172, DOI 10.1016/J.MSARD.2014.09.172]; Amin B, 2014, CURR MED CHEM, V21, P1544, DOI 10.2174/09298673113206660311; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Baker D, 2007, ADV CLIN NEUROSCI RE, V6, P10; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; BROWN AM, 1981, LAB INVEST, V45, P278; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; Chalmin F, 2015, J AUTOIMMUN, V56, P45, DOI 10.1016/j.jaut.2014.10.001; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Chen GQ, 2015, MOL MED REP, V12, P2465, DOI 10.3892/mmr.2015.3670; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; DUHAMELCLERIN E, 1994, GLIA, V11, P35, DOI 10.1002/glia.440110106; Evans PR, 2015, PROG MOL BIOL TRANSL, V133, P169, DOI 10.1016/bs.pmbts.2015.03.006; Feng GJ, 2003, J BIOL CHEM, V278, P33400, DOI 10.1074/jbc.M305866200; Frischer JM, 2015, ANN NEUROL, V78, P710, DOI 10.1002/ana.24497; Giorelli M, 2007, EXP NEUROL, V204, P759, DOI 10.1016/j.expneurol.2007.01.013; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guerrini MM, 2015, IMMUNITY, V43, P1174, DOI 10.1016/j.immuni.2015.10.017; Hampton DW, 2008, J NEUROIMMUNOL, V201, P200, DOI 10.1016/j.jneuroim.2008.05.034; Hampton DW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-84; Hansmann F, 2012, ACTA NEUROPATHOL, V124, P127, DOI 10.1007/s00401-012-0942-3; He MA, 2011, J CLIN INVEST, V121, P976, DOI 10.1172/JCI42650; Heck MV, 2014, NEUROGENETICS, V15, P135, DOI 10.1007/s10048-014-0397-x; Heremans H, 1996, EUR J IMMUNOL, V26, P2393, DOI 10.1002/eji.1830261019; Hikiji H, 2014, FASEB J, V28, P871, DOI 10.1096/fj.13-233106; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Honorat JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071329; Hoppmann N, 2015, BRAIN, V138, P902, DOI 10.1093/brain/awu408; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Inglis HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048555; Jackson SJ, 2009, J NEUROPATH EXP NEUR, V68, P616, DOI 10.1097/NEN.0b013e3181a41d23; Janssens K, 2015, GLIA, V63, P1729, DOI 10.1002/glia.22840; Karlstetter M, 2010, J IMMUNOL, V185, P3379, DOI 10.4049/jimmunol.0903300; Kuerten S, 2011, APMIS, V119, P336, DOI 10.1111/j.1600-0463.2011.02744.x; Kurban S, 2008, MULT SCLER, V14, P431, DOI 10.1177/1352458507084028; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Malik B, 2012, NEUROCHEM INT, V61, P321, DOI 10.1016/j.neuint.2012.05.006; Marchesi S, 2014, DEV CELL, V31, P420, DOI 10.1016/j.devcel.2014.09.009; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Mathews ES, 2014, J NEUROSCI, V34, P3402, DOI 10.1523/JNEUROSCI.4587-13.2014; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelissen K, 2012, J NEUROSCI RES, V90, P60, DOI 10.1002/jnr.22743; Noben-Trauth K, 2011, ADV EXP MED BIOL, V704, P229, DOI 10.1007/978-94-007-0265-3_13; Ohkawa Y, 2011, BIOCHEM BIOPH RES CO, V411, P483, DOI 10.1016/j.bbrc.2011.06.118; Papassotiropoulos A, 2005, NEURODEGENER DIS, V2, P233, DOI 10.1159/000090362; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Raddatz BBR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086643; Sahel A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00077; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sena A, 2003, J NEUROL, V250, P754, DOI 10.1007/s00415-003-1070-8; Shen Y, 2012, J NEUROSCI RES, V90, P105, DOI 10.1002/jnr.22722; Shete S, 2011, CANCER RES, V71, P7568, DOI 10.1158/0008-5472.CAN-11-0013; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Stevenson VL, 2015, MULT SCLER J, V21, P1583, DOI 10.1177/1352458514566416; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Tanabe Y, 2014, NEUROSCI LETT, V576, P1, DOI 10.1016/j.neulet.2014.05.013; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Thompson AJ, 2008, LANCET NEUROL, V7, P1078, DOI 10.1016/S1474-4422(08)70246-1; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai LJ, 2008, TISSUE ANTIGENS, V71, P114, DOI 10.1111/j.1399-0039.2007.00975.x; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; WEINSHENKER BG, 1995, NEUROL CLIN, V13, P119, DOI 10.1016/S0733-8619(18)30064-1; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Xu JH, 2006, J NEUROIMMUNOL, V176, P95, DOI 10.1016/j.jneuroim.2006.04.019; Yoshikawa F, 2008, J BIOL CHEM, V283, P20830, DOI 10.1074/jbc.M801314200; Zhang-Gandhi CX, 2007, J NEUROIMMUNOL, V183, P50, DOI 10.1016/j.jneuroim.2006.11.007; Zhou J, 2013, J BIOL CHEM, V288, P30064, DOI 10.1074/jbc.M113.478750; Zipp F, 2007, TRENDS PHARMACOL SCI, V28, P342, DOI 10.1016/j.tips.2007.05.001	97	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157754	10.1371/journal.pone.0157754	http://dx.doi.org/10.1371/journal.pone.0157754			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355629	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400018
J	da Silva, VH; Regitano, LCD; Geistlinger, L; Pertille, F; Giachetto, PF; Brassaloti, RA; Morosini, NS; Zimmer, R; Coutinho, LL				da Silva, Vinicius Henrique; De Almeida Regitano, Luciana Correia; Geistlinger, Ludwig; Pertille, Fabio; Giachetto, Poliana Fernanda; Brassaloti, Ricardo Augusto; Morosini, Natalia Silva; Zimmer, Ralf; Coutinho, Luiz Lehmann			Genome-Wide Detection of CNVs and Their Association with Meat Tenderness in Nelore Cattle	PLOS ONE			English	Article							COPY-NUMBER VARIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; DEPENDENT PROTEIN-KINASE; SNP GENOTYPING PLATFORMS; HEMOGLOBIN-HEME UPTAKE; NELLORE BEEF-CATTLE; SKELETAL-MUSCLE; ANGUS CATTLE; HOLSTEIN CATTLE; QUALITY TRAITS	Brazil is one of the largest beef producers and exporters in the world with the Nelore breed representing the vast majority of Brazilian cattle (Bos taurus indicus). Despite the great adaptability of the Nelore breed to tropical climate, meat tenderness (MT) remains to be improved. Several factors including genetic composition can influence MT. In this article, we report a genome-wide analysis of copy number variation (CNV) inferred from Illumina (R) High Density SNP-chip data for a Nelore population of 723 males. We detected >2,600 CNV regions (CNVRs) representing approximate to 6.5% of the genome. Comparing our results with previous studies revealed an overlap in approximate to 1400 CNVRs (>50%). A total of 1,155 CNVRs (43.6%) overlapped 2,750 genes. They were enriched for processes involving guanosine triphosphate (GTP), previously reported to influence skeletal muscle physiology and morphology. Nelore CNVRs also overlapped QTLs for MT reported in other breeds (8.9%, 236 CNVRs) and from a previous study with this population (4.1%, 109 CNVRs). Two CNVRs were also proximal to glutathione metabolism genes that were previously associated with MT. Genome-wide association study of CN state with estimated breeding values derived from meat shear force identified 6 regions, including a region on BTA3 that contains genes of the cAMP and cGMP pathway. Ten CNVRs that overlapped regions associated with MT were successfully validated by qPCR. Our results represent the first comprehensive CNV study in Bos taurus indicus cattle and identify regions in which copy number changes are potentially of importance for the MT phenotype.	[da Silva, Vinicius Henrique; Pertille, Fabio; Brassaloti, Ricardo Augusto; Morosini, Natalia Silva; Coutinho, Luiz Lehmann] Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Anim Sci, Anim Biotechnol Lab, Piracicaba, SP, Brazil; [De Almeida Regitano, Luciana Correia] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [Geistlinger, Ludwig; Zimmer, Ralf] Univ Munich, Dept Informat, Inst Bioinformat, Amalienstr 17, D-80333 Munich, Germany; [Giachetto, Poliana Fernanda] Embrapa Informat Agr, Campinas, SP, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Munich; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	da Silva, VH; Coutinho, LL (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Anim Sci, Anim Biotechnol Lab, Piracicaba, SP, Brazil.	viniciushs@usp.br; llcoutinho@usp.br	de Almeida Regitano, Luciana Correia/C-7002-2012; Zimmer, Ralf/L-9295-2019; Pértille, Fábio/L-2837-2016; Coutinho, Luiz L/C-8455-2012; Morosini, Natalia Silva/V-4166-2018; Giachetto, Poliana/ABV-6736-2022; da Silva, Vinicius Henrique/I-4920-2012; Coutinho, Luiz/P-5233-2019; Brassaloti, Ricardo/O-4260-2019	de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; Pértille, Fábio/0000-0002-7214-9184; Coutinho, Luiz L/0000-0002-7266-8881; da Silva, Vinicius Henrique/0000-0002-4368-812X; Coutinho, Luiz/0000-0002-7266-8881; Brassaloti, Ricardo/0000-0002-3880-1263; Morosini, Natalia/0000-0002-9294-9461; A. Pinheiro de Carvalho, Miguel Angelo/0000-0002-5084-870X; Giachetto, Poliana/0000-0002-9991-6566	Sao Paulo Research Foundation (FAPESP) [2012/23717-5, 2014/01438-2]; National Counsel of Technological and Scientific Development (CNPq); FAPESP [2012/23638-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	VHS received a scholarship from Sao Paulo Research Foundation (FAPESP, grant numbers: 2012/23717-5 < http://www.bv.fapesp.br/en/bolsas/141514/identification-of-cnvs-in-the-neloregenome-and-its-association-with-meat-tenderness/> and 2014/01438-2 < http://www.bv.fapesp.br/en/bolsas/150170/metabolic-pathways-and-meat-tenderness -from-cnvs-to-gene-expression-in-nelorecattle-breed/>). LAR and LC were granted by National Counsel of Technological and Scientific Development (CNPq) fellowships. The thematic FAPESP grant number is 2012/23638-8.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Agam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012839; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alzhanov DT, 2010, J BIOL CHEM, V285, P38969, DOI 10.1074/jbc.M110.160986; Bachmann VA, 2013, P NATL ACAD SCI USA, V110, P8531, DOI 10.1073/pnas.1215902110; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Bannister RA, 2008, BIOPHYS J, V94, P2631, DOI 10.1529/biophysj.107.116467; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Carvalho ME, 2014, MEAT SCI, V96, P1318, DOI 10.1016/j.meatsci.2013.11.014; Casas E, 2005, J ANIM SCI, V83, P13; Cesari M, 2004, J GERONTOL A-BIOL, V59, P249; Choi JW, 2013, MAMM GENOME, V24, P151, DOI 10.1007/s00335-013-9449-z; Cicconardi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-124; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Cong M, 1998, J BIOL CHEM, V273, P660, DOI 10.1074/jbc.273.1.660; Coro FAG, 1999, REV NAC CARNE, V17, P28; Curi RA, 2009, ANIM GENET, V40, P456, DOI 10.1111/j.1365-2052.2009.01859.x; D'Alessandro A, 2012, J PROTEOMICS, V75, P4381, DOI 10.1016/j.jprot.2012.03.052; D'Alessandro A, 2012, J PROTEOMICS, V75, P4360, DOI 10.1016/j.jprot.2012.02.013; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; de Oliveira PSN, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0100-0; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Elferink MG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-391; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Felekkis K, 2011, MOL BIOL EVOL, V28, P2421, DOI 10.1093/molbev/msr078; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Gardberg M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-55; Geesink GH, 1999, J ANIM SCI, V77, P2685; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hawke TJ, 2006, AM J PHYSIOL-CELL PH, V290, pC379, DOI 10.1152/ajpcell.00270.2005; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Herath S, 2006, J REPROD IMMUNOL, V69, P13, DOI 10.1016/j.jri.2005.09.007; Hirano T, 2000, GENOME RES, V10, P659, DOI 10.1101/gr.10.5.659; Hocquette Jean-Francois, 2006, Animal Science Papers and Reports, V24, P173; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P717, DOI 10.1007/s10142-012-0295-y; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, PROD PEC MUN; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048732; Kijas JW, 2011, GENE, V482, P73, DOI 10.1016/j.gene.2011.04.011; Kim JH, 2012, BIOINFORMATICS, V28, P1790, DOI 10.1093/bioinformatics/bts239; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Koboldt DC, 2012, METHODS MOL BIOL, V838, P369, DOI 10.1007/978-1-61779-507-7_18; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kohler LH, 2012, VIRCHOWS ARCH, V461, P49, DOI 10.1007/s00428-012-1250-y; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Li S, 2012, POULTRY SCI, V91, P150, DOI 10.3382/ps.2011-01484; Liu GE, 2012, FUNCT INTEGR GENOMIC, V12, P609, DOI 10.1007/s10142-012-0289-9; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Lomiwes D, 2014, MEAT SCI, V96, P26, DOI 10.1016/j.meatsci.2013.06.008; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meyers SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-337; MICKELSON JR, 1985, ARCH BIOCHEM BIOPHYS, V242, P127, DOI 10.1016/0003-9861(85)90486-2; Monson F, 2004, MEAT SCI, V68, P595, DOI 10.1016/j.meatsci.2004.05.011; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nonneman DJ, 2013, J ANIM SCI, V91, P4043, DOI 10.2527/jas.2013-6255; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Nowak Dariusz, 2011, Polish Journal of Food and Nutrition Sciences, V61, P231, DOI 10.2478/v10222-011-0025-5; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; OConnor SF, 1997, J ANIM SCI, V75, P1822; Olson MF, 2003, CURR BIOL, V13, pR360, DOI 10.1016/S0960-9822(03)00277-X; Ouali A, 2013, MEAT SCI, V95, P854, DOI 10.1016/j.meatsci.2013.05.010; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pfundt R, 2012, METHODS MOL BIOL, V838, P77, DOI 10.1007/978-1-61779-507-7_3; Pierzchala M, 2014, J ANIM BREED GENET, V131, P258, DOI 10.1111/jbg.12081; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pinto LFB, 2010, GENET MOL RES, V9, P1431, DOI 10.4238/vol9-3gmr881; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purslow PP, 2012, J ANIM SCI, V90, P950, DOI 10.2527/jas.2011-4448; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rehfeldt C, 2012, J ANIM SCI, V90, P184, DOI 10.2527/jas.2011-4234; Romberg CF, 2014, CHANNELS, V8, DOI 10.4161/chan.27686; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Sentandreu MA, 2002, TRENDS FOOD SCI TECH, V13, P400, DOI 10.1016/S0924-2244(02)00188-7; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Su SY, 2010, BIOINFORMATICS, V26, P1437, DOI 10.1093/bioinformatics/btq157; Suzuki J, 2000, ONCOGENE, V19, P1138, DOI 10.1038/sj.onc.1203402; Tait RG, 2014, J ANIM SCI, V92, P456, DOI 10.2527/jas.2013-7075; Tizioto PC, 2013, PHYSIOL GENOMICS, V45, P1012, DOI 10.1152/physiolgenomics.00066.2013; Tizioto PC, 2014, MEAT SCI, V96, P436, DOI 10.1016/j.meatsci.2013.08.001; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Vincent AK, 2012, CLIN GENET, V82, P540, DOI 10.1111/j.1399-0004.2011.01812.x; Wang DF, 2015, ANIM SCI J, V86, P166, DOI 10.1111/asj.12251; Wang JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087571; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weston A.R., 2002, PROF ANIM SCI, V18, P107, DOI [10.15232/S1080-7446(15)31497-2, DOI 10.15232/S1080-7446(15)31497-2]; Wheeler T. L., 1995, REC MEAT C, V50, P68; WHIPPLE G, 1990, J ANIM SCI, V68, P4193; Xu Y, 2013, MAMM GENOME, V24, P508, DOI 10.1007/s00335-013-9483-x; Yau C, 2008, CYTOGENET GENOME RES, V123, P307, DOI 10.1159/000184722; Young JM, 2008, AM J HUM GENET, V83, P228, DOI 10.1016/j.ajhg.2008.07.005; Zhan BJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-557; Zhang X, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-50; Zhao CP, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-12; Zhao CP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/756284; Zhao CP, 2012, MOL BIOL REP, V39, P4185, DOI 10.1007/s11033-011-1203-6; Zheng XJ, 2012, GENET EPIDEMIOL, V36, P253, DOI 10.1002/gepi.21618; Zhou Y, 2014, FREE RADICAL BIO MED, V71, P157, DOI 10.1016/j.freeradbiomed.2014.02.027; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	124	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157711	10.1371/journal.pone.0157711	http://dx.doi.org/10.1371/journal.pone.0157711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348523	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200013
J	Lau, YL; Lee, WC; Chen, JH; Zhong, Z; Jian, JB; Amir, A; Cheong, FW; Sum, JS; Fong, MY				Lau, Yee-Ling; Lee, Wenn-Chyau; Chen, Junhui; Zhong, Zhen; Jian, Jianbo; Amir, Amirah; Cheong, Fei-Wen; Sum, Jia-Siang; Fong, Mun-Yik			Draft Genomes of Anopheles cracens and Anopheles maculatus: Comparison of Simian Malaria and Human Malaria Vectors in Peninsular Malaysia	PLOS ONE			English	Article							PLASMODIUM-KNOWLESI; PHARMACOLOGICAL CHARACTERIZATION; CULEX-QUINQUEFASCIATUS; MOSQUITO IMMUNITY; BITING ACTIVITY; AEDES-AEGYPTI; KUALA LIPIS; IDENTIFICATION; DROSOPHILA; SEQUENCE	Anopheles cracens has been incriminated as the vector of human knowlesi malaria in peninsular Malaysia. Besides, it is a good laboratory vector of Plasmodium falciparum and P. vivax. The distribution of An. cracens overlaps with that of An. maculatus, the human malaria vector in peninsular Malaysia that seems to be refractory to P. knowlesi infection in natural settings. Whole genome sequencing was performed on An. cracens and An. maculatus collected here. The draft genome of An. cracens was 395 Mb in size whereas the size of An. maculatus draft genome was 499 Mb. Comparison with the published Malaysian An. maculatus genome suggested the An. maculatus specimen used in this study as a different geographical race. Comparative analyses highlighted the similarities and differences between An. cracens and An. maculatus, providing new insights into their biological behavior and characteristics.	[Lau, Yee-Ling; Amir, Amirah; Cheong, Fei-Wen; Sum, Jia-Siang; Fong, Mun-Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Lee, Wenn-Chyau] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Chen, Junhui; Zhong, Zhen; Jian, Jianbo] BGI, Shenzhen, Peoples R China	Universiti Malaya; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Beijing Genomics Institute (BGI)	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	lauyeeling@um.edu.my	Amir, Amirah/AAB-9628-2021; Sum, Jia Siang/ABA-1036-2020; Singh, Balbir/A-3610-2009; LEE, Wenn-Chyau/AAR-4072-2020; Lau, Yee Ling/C-6996-2009; FONG, MUN YIK/B-5443-2010; CHEONG, FEI WEN/D-1983-2010; amir, amirah/D-3624-2016	Amir, Amirah/0000-0001-9189-8925; Sum, Jia Siang/0000-0003-3621-1021; LEE, Wenn-Chyau/0000-0002-7324-5792; Lau, Yee Ling/0000-0002-2037-2165; amir, amirah/0000-0001-9189-8925; junhui, chen/0000-0002-5938-0760; Cheong, Fei Wen/0000-0001-7075-5116	University of Malaya High Impact Research (HIR) Grant UM-MOHE from the Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/MED/16]	University of Malaya High Impact Research (HIR) Grant UM-MOHE from the Ministry of Higher Education, Malaysia	This research project was supported by University of Malaya High Impact Research (HIR) Grant UM-MOHE (UM.C/HIR/MOHE/MED/16) from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai MR, 2013, J NEUROSCI, V33, P10741, DOI 10.1523/JNEUROSCI.5419-12.2013; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Amir A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-81; Andolina C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0830-0; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Attwood Terri K, 2002, Brief Bioinform, V3, P252, DOI 10.1093/bib/3.3.252; ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Ayyub C, 2000, MOL GEN GENET, V263, P498, DOI 10.1007/s004380051194; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; CHARLWOOD JD, 1986, J MED ENTOMOL, V23, P132, DOI 10.1093/jmedent/23.2.132; Chen C, 2015, NATURE, V527, P516, DOI 10.1038/nature16148; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112; Cheng TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122837; CHIANG G L, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P643; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; COLLINS WE, 1967, J PARASITOL, V53, P841, DOI 10.2307/3276783; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; EYLES D. E., 1962, MED JOUR MALAYA, V17, P85; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goswami G, 2005, ACTA TROP, V95, P92, DOI 10.1016/j.actatropica.2005.04.018; Gross AD, 2015, INSECT BIOCHEM MOLEC, V63, P47, DOI 10.1016/j.ibmb.2015.04.008; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Hii JLK, 2000, B ENTOMOL RES, V90, P211, DOI 10.1017/S000748530000033X; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Jiang XF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0459-2; Jiram AI, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-213; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Junkum Anuluck, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P333, DOI 10.1590/S0036-46652005000600005; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kampango A, 2011, MED VET ENTOMOL, V25, P240, DOI 10.1111/j.1365-2915.2010.00917.x; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lord CC, 1999, MED VET ENTOMOL, V13, P225, DOI 10.1046/j.1365-2915.1999.00170.x; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Marinotti O, 2013, NUCLEIC ACIDS RES, V41, P7387, DOI 10.1093/nar/gkt484; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; MEEK SR, 1995, ANN TROP MED PARASIT, V89, P135, DOI 10.1080/00034983.1995.11812944; Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Min SH, 2013, P NATL ACAD SCI USA, V110, pE1321, DOI 10.1073/pnas.1215680110; Molina-Cruz A, 2015, P NATL ACAD SCI USA, V112, P15178, DOI 10.1073/pnas.1520426112; Muenworn V, 2009, J VECTOR ECOL, V34, P62, DOI [10.1111/j.1948-7134.2009.00008.x, 10.3376/038.034.0108]; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; NAYAR JK, 1992, J PARASITOL, V78, P876, DOI 10.2307/3283321; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nuss AB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003515; Pothikasikorn J, 2008, J VECTOR ECOL, V33, P313, DOI 10.3376/1081-1710-33.2.313; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Reid JA, 1968, ANOPHELINE MOSQUITOE; Rohani A, 2010, SE ASIAN J TROP MED, V41, P821; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sum JS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-309; Suwonkerd W, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P273, DOI 10.5772/56347; Tempel Sebastien, 2012, Methods Mol Biol, V859, P29, DOI 10.1007/978-1-61779-603-6_2; Vythilingam I., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P354; Vythilingam I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-436; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Xu WY, 2007, EXP PARASITOL, V116, P433, DOI 10.1016/j.exppara.2007.02.013; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZAHEDI M, 1994, TROP MED PARASITOL, V45, P27; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837; Zhou D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-42, 10.1186/1471-2164-15-573]; Zhu GD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-176; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	96	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157893	10.1371/journal.pone.0157893	http://dx.doi.org/10.1371/journal.pone.0157893			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347683	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200018
J	Khunamornpong, S; Settakorn, J; Sukpan, K; Suprasert, P; Srisomboon, J; Intaraphet, S; Siriaunkgul, S				Khunamornpong, Surapan; Settakorn, Jongkolnee; Sukpan, Kornkanok; Suprasert, Prapaporn; Srisomboon, Jatupol; Intaraphet, Suthida; Siriaunkgul, Sumalee			Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; LIQUID-BASED CYTOLOGY; INTRAEPITHELIAL NEOPLASIA; PREVALENCE; PREVENTION; LESIONS; SCREEN	Background Testing for high-risk human papillomavirus DNA (HPV test) has gained increasing acceptance as an alternative method to cytology in cervical cancer screening. Compared to cytology, HPV test has a higher sensitivity for the detection of histologic high-grade squamous intraepithelial lesion or worse (HSIL+), but this could lead to a large colposcopy burden. Genotyping for HPV16/18 has been recommended in triaging HPV-positive women. This study was aimed to evaluate the screening performance of HPV testing and the role of genotyping triage in Northern Thailand. Methods A population-based cervical screening program was performed in Chiang Mai (Northern Thailand) using cytology (conventional Pap test) and HPV test (Hybrid Capture 2). Women who had abnormal cytology or were HPV-positive were referred for colposcopy. Cervical samples from these women were genotyped using the Linear Array assay. Results Of 5,456 women, 2.0% had abnormal Pap test results and 6.5% tested positive with Hybrid Capture 2. Of 5,433 women eligible for analysis, 355 with any positive test had histologic confirmation and 57 of these had histologic HSIL+. The sensitivity for histologic HSIL+ detection was 64.9% for Pap test and 100% for Hybrid Capture 2, but the ratio of colposcopy per detection of each HSIL+ was more than two-fold higher with Hybrid Capture 2 than Pap test (5.9 versus 2.8). Genotyping results were available in 316 samples. HPV52, HPV16, and HPV58 were the three most common genotypes among women with histologic HSIL+. Performance of genotyping triage using HPV16/18/52/58 was superior to that of HPV16/18, with a higher sensitivity (85.7% versus 28.6%) and negative predictive value (94.2% versus 83.9%). Conclusions In Northern Thailand, HPV testing with genotyping triage shows better screening performance than cervical cytology alone. In this region, the addition of genotyping for HPV52/58 to HPV16/18 is deemed necessary in triaging women with positive HPV test.	[Khunamornpong, Surapan; Settakorn, Jongkolnee; Sukpan, Kornkanok; Siriaunkgul, Sumalee] Chiang Mai Univ, Dept Pathol, Fac Med, Chiang Mai 50000, Thailand; [Suprasert, Prapaporn; Srisomboon, Jatupol] Chiang Mai Univ, Dept Obstet & Gynecol, Fac Med, Chiang Mai 50000, Thailand; [Intaraphet, Suthida] Boromarajonani Coll Nursing, Khon Kaen, Thailand	Chiang Mai University; Chiang Mai University	Khunamornpong, S (corresponding author), Chiang Mai Univ, Dept Pathol, Fac Med, Chiang Mai 50000, Thailand.	skhunamo@yahoo.com	Intaraphet, Suthida/AAO-6524-2020	Intaraphet, Suthida/0000-0002-8739-0827	National Research University Project, under Thailand's Office of the Higher Education Commission; Faculty of Medicine, Chiang Mai University	National Research University Project, under Thailand's Office of the Higher Education Commission; Faculty of Medicine, Chiang Mai University	This study was supported by 1) the National Research University Project, under Thailand's Office of the Higher Education Commission; and 2) the Faculty of Medicine, Chiang Mai University. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorastos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119755; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Arbyn M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008054.pub2; Azuma Y, 2014, JPN J CLIN ONCOL, V44, P910, DOI 10.1093/jjco/hyu112; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chan PKS, 2011, J INFECT DIS, V203, P1565, DOI 10.1093/infdis/jir157; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chansaenroj J, 2014, J MED VIROL, V86, P601, DOI 10.1002/jmv.23769; Chinchai T, 2012, INT J GYNECOL CANCER, V22, P1063, DOI 10.1097/IGC.0b013e318259d904; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Dijkstra MG, 2014, ANN ONCOL, V25, P927, DOI 10.1093/annonc/mdt538; Dijkstra MG, 2014, CANCER EPIDEM BIOMAR, V23, P55, DOI 10.1158/1055-9965.EPI-13-0173; Domingo EJ, 2008, VACCINE, V26, pM71, DOI 10.1016/j.vaccine.2008.05.039; Eklund C, 2014, J CLIN MICROBIOL, V52, P449, DOI 10.1128/JCM.02453-13; Ferreccio C, 2013, INT J CANCER, V132, P916, DOI 10.1002/ijc.27662; Gage JC, 2012, J CLIN MICROBIOL, V50, P61, DOI 10.1128/JCM.05989-11; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Ikenberg H, 2013, JNCI-J NATL CANCER I, V105, P1550, DOI 10.1093/jnci/djt235; Kantathavorn N, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0001-5; Louvanto K, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.033; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Monsonego J, 2015, GYNECOL ONCOL, V137, P47, DOI 10.1016/j.ygyno.2015.01.551; Nakamura Y, 2015, INT J CLIN ONCOL, V20, P974, DOI 10.1007/s10147-015-0789-4; Preisler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059765; Rijkaart DC, 2012, BRIT J CANCER, V106, P975, DOI 10.1038/bjc.2011.581; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Schiffman M, 2015, J CLIN MICROBIOL, V53, P52, DOI 10.1128/JCM.02116-14; Sigurdsson K, 2013, CYTOPATHOLOGY, V24, P254, DOI 10.1111/cyt.12037; Siriaunkgul S, 2008, GYNECOL ONCOL, V108, P555, DOI 10.1016/j.ygyno.2007.11.016; Siriaunkgul S, 2014, ASIAN PAC J CANCER P, V15, P6837, DOI 10.7314/APJCP.2014.15.16.6837; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Song JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058678; Stoler M., 2014, WHO CLASSIFICATION T, V4th, P172; Zhang CQ, 2014, J INFECT DIS, V210, P1600, DOI 10.1093/infdis/jiu310; Zhao FH, 2012, INT J CANCER, V131, P2929, DOI 10.1002/ijc.27571	36	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158184	10.1371/journal.pone.0158184	http://dx.doi.org/10.1371/journal.pone.0158184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336913	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200121
J	Nygaard, E; Slinning, K; Moe, V; Walhovd, KB				Nygaard, Egil; Slinning, Kari; Moe, Vibeke; Walhovd, Kristine B.			Behavior and Attention Problems in Eight-Year-Old Children with Prenatal Opiate and Poly-Substance Exposure: A Longitudinal Study	PLOS ONE			English	Article							YOUNG FOSTER-CHILDREN; COGNITIVE-DEVELOPMENT; EXECUTIVE ATTENTION; EFFORTFUL CONTROL; PRESCHOOL-AGE; INFANTS; METHADONE; OUTCOMES; COCAINE; MOTHERS	Multiple studies have found that children born to mothers with opioid or poly-substance use during pregnancy have more behavior and attention problems and lower cognitive functioning than non-exposed children. The present study aimed to investigate whether behavior and attention problems are more prominent than general cognitive deficits in this risk group and whether the problems wane or increase over time. This prospective longitudinal cross-informant study compared 72 children who were prenatally exposed to heroin and multiple drugs with a group of 58 children without known prenatal risk factors. Group differences in caregivers' and teachers' reports of the children's behavior and attention problems based on the Child Behavior Check List and the ADHD Rating Scale were compared based on group differences in general cognitive functioning at 41/2 and 81/2 years of age. Both parent and teacher reports suggest that the exposed group has significantly more problems in several behavioral areas than the comparison group, particularly with regard to attention problems. The preschool teachers had already reported these problems when the children were 41/2 years old, whereas the caregivers reported these problems mainly when the children were 81/2 years old. The group differences in behavioral and attentional problems were not significantly greater and some were even significantly smaller than the group differences in general cognitive abilities. These findings suggest that children subject to prenatally drug exposure have increasing problems in multiple areas related to behavior from preschool age to 81/2 years but that these problems do not seem to be specific; i.e., they are not more severe than the problems with general cognitive abilities found for this group.	[Nygaard, Egil; Walhovd, Kristine B.] Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, Oslo, Norway; [Nygaard, Egil; Slinning, Kari; Moe, Vibeke] Eastern & Southern Norway RBUP, Ctr Child & Adolescent Mental Hlth, Oslo, Norway; [Slinning, Kari; Moe, Vibeke] Univ Oslo, Dept Psychol, Oslo, Norway; [Walhovd, Kristine B.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Unit Neuropsychol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Nygaard, E (corresponding author), Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, Oslo, Norway.; Nygaard, E (corresponding author), Eastern & Southern Norway RBUP, Ctr Child & Adolescent Mental Hlth, Oslo, Norway.	egilny@psykologi.uio.no		Moe, Vibeke/0000-0002-8436-8341; Nygaard, Egil/0000-0002-8865-4265	Norwegian Research Council [190411, 213762]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council, grants 190411 and 213762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 1991, MANUAL YOUTH SELF RE; Anderson V, 2013, PRINCIPLES FRONTAL L, P118; [Anonymous], 1991, MANUAL CHILD BEHAV C; Bartlett JW, 2015, STAT METHODS MED RES, V24, P462, DOI 10.1177/0962280214521348; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Burt, 1980, CHILDREN HEROIN ADDI; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crea TM, 2008, AM J ORTHOPSYCHIAT, V78, P11, DOI 10.1037/0002-9432.78.1.11; Creanga AA, 2012, OBSTET GYNECOL, V119, P924, DOI 10.1097/AOG.0b013e31824ea276; DAVIS DD, 1988, ADDICT BEHAV, V13, P275, DOI 10.1016/0306-4603(88)90054-8; DECUBAS MM, 1993, AM J ORTHOPSYCHIAT, V63, P266, DOI 10.1037/h0079429; Degerud KM, 2005, STUDIE BARN EKSPONER; Delano K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082647; Dodge KA, 2006, HDB CHILD PSYCHOL, V3; Dorrie N, 2014, EUR CHILD ADOLES PSY, V23, P863, DOI 10.1007/s00787-014-0571-6; Duhig AM, 2000, CLIN PSYCHOL-SCI PR, V7, P435, DOI 10.1093/clipsy/7.4.435; Duncombe M, 2013, EARLY EDUC DEV, V24, P599, DOI 10.1080/10409289.2012.701536; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; Eisenberg N, 2014, HDB EMOTIONAL REGULA; England LJ, 2001, AM J EPIDEMIOL, V154, P694, DOI 10.1093/aje/154.8.694; Finnegan LP, 1975, PERINATAL ADDICTION, P141; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fodor A, 2014, LIFE SCI, V104, P1, DOI 10.1016/j.lfs.2014.04.006; Francis G, 1993, CANADIAN J SCH PSYCH, V9, P16, DOI [10.1177/082957358500900103, DOI 10.1177/082957358500900103]; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gross JJ, 2014, HDB EMOTION; Hans S L, 1996, NIDA Res Monogr, V164, P261; Hans SL, 2001, INFANT MENT HEALTH J, V22, P300, DOI 10.1002/imhj.1003; HARLAN RE, 1994, REGUL PEPTIDES, V54, P117, DOI 10.1016/0167-0115(94)90417-0; HICKEY JE, 1995, ADDICT BEHAV, V20, P43, DOI 10.1016/0306-4603(94)00044-Y; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Ivanova MY, 2007, SCHOOL PSYCHOL REV, V36, P468; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Jacobsen H, 2014, ATTACH HUM DEV, V16, P42, DOI 10.1080/14616734.2013.850102; Jacobsen H, 2013, CHILD PSYCHIAT HUM D, V44, P666, DOI 10.1007/s10578-013-0360-3; Jansson LM, 2012, CURR OPIN PEDIATR, V24, P252, DOI 10.1097/MOP.0b013e32834fdc3a; Jozefiak T, 2012, NORD J PSYCHIAT, V66, P311, DOI 10.3109/08039488.2011.638934; KAUFMAN AS, 1975, J CONSULT CLIN PSYCH, V43, P135, DOI 10.1037/h0076502; Konijnenberg C, 2015, CHILD NEUROPSYCHOL, V21, P570, DOI 10.1080/09297049.2014.967201; Konijnenberg C, 2015, EUR ADDICT RES, V21, P63, DOI 10.1159/000366018; Konijnenberg C, 2013, ADDICTION, V108, P154, DOI 10.1111/j.1360-0443.2012.04006.x; Lester BM, 2010, J ADDICT DIS, V29, P259, DOI 10.1080/10550881003684921; LESTER BM, 1994, INF MENTAL HLTH J, V15, P107, DOI 10.1002/1097-0355(199422)15:2<107::AID-IMHJ2280150203>3.0.CO;2-R; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Lu RH, 2012, NEUROSCI LETT, V522, P128, DOI 10.1016/j.neulet.2012.06.023; Lynn R, 2013, INTELLIGENCE, V41, P765, DOI 10.1016/j.intell.2013.03.008; Mactier H, 2014, ADDICTION, V109, P482, DOI 10.1111/add.12400; McCarthy D., 1972, MANUAL MCCARTHY SCAL; Melinder A, 2013, ADDICTION, V108, P2175, DOI 10.1111/add.12267; Messinger DS, 2004, PEDIATRICS, V113, P1677, DOI 10.1542/peds.113.6.1677; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Moe V, 2001, INFANT MENT HEALTH J, V22, P334, DOI 10.1002/imhj.1005; Moe V, 2002, PROSPECTIVE LONGITUD; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Nygaard E, 2015, PEDIATR RES, V78, P330, DOI 10.1038/pr.2015.95; Ornoy A, 2001, DEV MED CHILD NEUROL, V43, P668, DOI 10.1017/S0012162201001219; Ornoy A, 2010, CHILD ABUSE NEGLECT, V34, P354, DOI 10.1016/j.chiabu.2009.09.012; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Posner M, 2008, INT J PSYCHOL, V43, P168; Rothbart MK, 2007, CHILD DEV PERSPECT, V1, P2, DOI 10.1111/j.1750-8606.2007.00002.x; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; Seaman SR, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-46; Slinning K, 2004, EUR CHILD ADOLES PSY, V13, P19, DOI 10.1007/s00787-004-0350-x; Slinning K, 2003, PROSPECTIVE LONGITUD; Statistics Norway, 2012, ED LEV POP; STRAUSS ME, 1976, J PEDIATR-US, V89, P842, DOI 10.1016/S0022-3476(76)80822-0; Undheim JO, 1978, HDB WISC R WECHSLER; VANBAAR A, 1994, DEV MED CHILD NEUROL, V36, P1063; Vassoler FM, 2014, NEUROPHARMACOLOGY, V76, P269, DOI 10.1016/j.neuropharm.2013.06.016; Wachman EM, 2014, J PEDIATR-US, V165, P472, DOI 10.1016/j.jpeds.2014.05.040; Wahlsten VS, 2013, ACTA PAEDIATR, V102, P544, DOI 10.1111/apa.12210; Walhovd KB, 2007, NEUROIMAGE, V36, P1331, DOI 10.1016/j.neuroimage.2007.03.070; Walhovd KB, 2014, CURR OPIN NEUROL, V27, P176, DOI 10.1097/WCO.0000000000000074; Wang Y, 2009, NEUROSCIENCE, V160, P330, DOI 10.1016/j.neuroscience.2009.02.058; Wechsler D, 1974, HDB WECHSLER INTELLI; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x; Yumoto C, 2008, CHILD DEV, V79, P1761, DOI 10.1111/j.1467-8624.2008.01224.x	82	44	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158054	10.1371/journal.pone.0158054	http://dx.doi.org/10.1371/journal.pone.0158054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336798	Green Published, gold			2022-12-26	WOS:000378389200098
J	Prysyazhna, O; Burgoyne, JR; Scotcher, J; Grover, S; Kass, D; Eaton, P				Prysyazhna, Oleksandra; Burgoyne, Joseph Robert; Scotcher, Jenna; Grover, Steven; Kass, David; Eaton, Philip			Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G I Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cardiomyopathy; heart failure; oxidative stress; phosphodiesterases; protein kinase G (PKG)	LEFT-VENTRICULAR DYSFUNCTION; OXIDANT-INDUCED ACTIVATION; NITRIC-OXIDE; CYCLIC-GMP; BLOOD-PRESSURE; INDUCED CARDIOMYOPATHY; PDE5 INHIBITION; CGMP; APOPTOSIS; ALPHA	Phosphodiesterase 5 (PDE5) inhibitors limit myocardial injury caused by stresses, including doxorubicin chemotherapy. cGMP binding to PKG I attenuates oxidant-induced disulfide formation. Because PDE5 inhibition elevates cGMP and protects from doxorubicin-induced injury, we reasoned that this may be because it limits PKG I disulfide formation. To investigate the role of PKG I disulfide dimerization in the development of apoptosis, doxorubicin-induced cardiomyopathy was compared in male wild type (WT) or disulfide-resistant C42S PKG I knock-in (KI) mice. Echocardiography showed that doxorubicin treatment caused loss of myocardial tissue and depressed left ventricular function in WT mice. Doxorubicin also reduced pro-survival signaling and increased apoptosis in WT hearts. In contrast, KI mice were markedly resistant to the dysfunction induced by doxorubicin in WTs. In follow-on experiments the influence of the PDE5 inhibitor tadalafil on the development of doxorubicin-induced cardiomyopathy in WT and KI mice was investigated. In WT mice, co-administration of tadalafil with doxorubicin reduced PKG I oxidation caused by doxorubicin and also protected against cardiac injury and loss of function. KI mice were again innately resistant to doxorubicin-induced cardiotoxicity, and therefore tadalafil afforded no additional protection. Doxorubicin decreased phosphorylation of RhoA (Ser-188), stimulating its GTPase activity to activate Rho-associated protein kinase (ROCK) in WTs. These pro-apoptotic events were absent in KI mice and were attenuated in WTs co-administered tadalafil. PKG I disulfide formation triggers cardiac injury, and this initiation of maladaptive signaling can be blocked by pharmacological therapies that elevate cGMP, which binds kinase to limit its oxidation.	[Prysyazhna, Oleksandra; Burgoyne, Joseph Robert; Scotcher, Jenna; Eaton, Philip] Kings Coll London, Rayne Inst, British Heart Fdn Ctr Excellence, St Thomas Hosp,Cardiovasc Div, London SE1 7EH, England; [Grover, Steven] Kings Coll London, Acad Dept Surg, British Heart Fdn Ctr Excellence, St Thomas Hosp,Cardiovasc Div, London SE1 7EH, England; [Kass, David] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Johns Hopkins University; Johns Hopkins Medicine	Eaton, P (corresponding author), Kings Coll London, Div Cardiovasc, Rayne Inst, St Thomas Hosp, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	; Eaton, Philip/I-5444-2015	Grover, Steven/0000-0001-8709-8394; Burgoyne, Joseph/0000-0001-7325-7382; Prysyazhna, Oleksandra/0000-0002-0394-7000; Eaton, Philip/0000-0003-0748-2367	European Research Council (Advanced Award); British Heart Foundation; Medical Research Council; Fondation Leducq; Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre; MRC [MR/L009684/1, G1000458, G0700320, G0600785, MR/K003232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [FS/14/1/30551, FS/11/45/28859, RG/12/12/29872, PG/15/26/31373, PG/13/13/30018, PG/10/98/28655] Funding Source: researchfish; Medical Research Council [G0700320, MR/K003232/1, G1000458, 998501, MR/L009684/1, G0600785] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119012] Funding Source: NIH RePORTER	European Research Council (Advanced Award)(European Research Council (ERC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Research Council (Advanced Award), the British Heart Foundation, the Medical Research Council and Fondation Leducq, and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; BAIM DS, 1983, NEW ENGL J MED, V309, P748, DOI 10.1056/NEJM198309293091302; Blanton RM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003731; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Burgoyne JR, 2012, HYPERTENSION, V60, P1301, DOI 10.1161/HYPERTENSIONAHA.112.198754; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; da Silva FH, 2013, INT J IMPOT RES, V25, P69, DOI 10.1038/ijir.2012.35; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Fiscus RR, 2002, J CARDIAC SURG, V17, P336; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jin Z, 2013, J CARDIOL, V62, P110, DOI 10.1016/j.jjcc.2013.03.018; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Lauriol J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005262; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Li F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.243; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Muller PM, 2012, FREE RADICAL BIO MED, V53, P1574, DOI 10.1016/j.freeradbiomed.2012.08.011; Nagayama T, 2009, J AM COLL CARDIOL, V53, P207, DOI 10.1016/j.jacc.2008.08.069; Nakamura T, 2015, J CLIN INVEST, V125, P2468, DOI 10.1172/JCI80275; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Rudyk O, 2013, P NATL ACAD SCI USA, V110, P9909, DOI 10.1073/pnas.1301026110; Rudyk O, 2012, CIRCULATION, V126, P287, DOI 10.1161/CIRCULATIONAHA.112.101287; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Stubbert D, 2014, HYPERTENSION, V64, P1344, DOI 10.1161/HYPERTENSIONAHA.114.04281; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005; Wunder F, 2005, MOL PHARMACOL, V68, P1775, DOI 10.1124/mol.105.017608; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7	40	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17427	17436		10.1074/jbc.M116.724070	http://dx.doi.org/10.1074/jbc.M116.724070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27342776	Green Published, hybrid			2022-12-26	WOS:000382643800041
J	Wang, ZX; Dang, TT; Liu, TT; Chen, S; Li, L; Huang, S; Fang, M				Wang, Zixi; Dang, Tingting; Liu, Tingting; Chen, She; Li, Lin; Huang, Song; Fang, Min			NEDD4L Protein Catalyzes Ubiquitination of PIK3CA Protein and Regulates PI3K-AKT Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; E3 ubiquitin ligase; phosphatidylinositide 3-kinase (PI 3-kinase); proteasome; protein degradation; ubiquitylation (ubiquitination); NEDD4L; PIK3CA	C2 DOMAIN; CBL-B; CANCER; LIGASE; EXPRESSION; DEGRADATION; PROGRESSION; MUTATIONS; PROGNOSIS; 3-KINASE	Oncogenic PIK3CA (p110), the catalytic subunit of class IA PI3K, plays a major role in PI3K-related cancer progression. The mechanisms underlying the dynamic regulation of PIK3CA protein levels remain unknown. Here we demonstrated that PIK3CA is regulated by polyubiquitination. We identified NEDD4L as the E3 ligase that catalyzes PIK3CA polyubiquitination, leading to its proteasome-dependent degradation. NEDD4L ubiquitinates both the free and regulatory subunit-bound PIK3CA but does not ubiquitinate the regulatory subunit of PI3K. Overexpression of NEDD4L accelerates the turnover rate of PIK3CA, whereas suppression of NEDD4L results in not only the accumulation of PIK3CA but also a paradoxical decrease of AKT activation. Thus, we propose that NEDD4L negatively regulates PIK3CA protein levels via ubiquitination and is required for the maintenance of PI3K-AKT signaling pathway.	[Wang, Zixi; Dang, Tingting; Liu, Tingting; Fang, Min] Peking Univ, Div Cell Biol, Coll Life Sci, Yiheyuan Rd 5, Beijing 100871, Peoples R China; [Wang, Zixi; Dang, Tingting; Liu, Tingting; Fang, Min] Peking Univ, Joint Ctr Life Sci, Yiheyuan Rd 5, Beijing 100871, Peoples R China; [Chen, She; Li, Lin; Huang, Song] Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China	Peking University; Peking University; National Institute of Biological Sciences, Beijing	Fang, M (corresponding author), Peking Univ, Div Cell Biol, Coll Life Sci, Yiheyuan Rd 5, Beijing 100871, Peoples R China.	min.fang@pku.edu.cn	liu, ting/GZM-3326-2022	Wang, Zixi/0000-0002-9354-1206	National Basic Program of China 973 Program [2013CB910104]; National Natural Science Foundation of China [31271524]; start-up foundation from the Joint Center for Life Sciences at Peking University; post-doctoral fellowship from Joint Center for Life Sciences at Peking University	National Basic Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); start-up foundation from the Joint Center for Life Sciences at Peking University; post-doctoral fellowship from Joint Center for Life Sciences at Peking University	This work was supported by the National Basic Program of China 973 Program (2013CB910104), National Natural Science Foundation of China (31271524), and the start-up foundation from the Joint Center for Life Sciences at Peking University. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the post-doctoral fellowship from Joint Center for Life Sciences at Peking University.	Brognard J, 2001, CANCER RES, V61, P3986; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Gao CC, 2012, MED ONCOL, V29, P1733, DOI 10.1007/s12032-011-0061-3; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; He SM, 2012, JPN J CLIN ONCOL, V42, P196, DOI 10.1093/jjco/hyr195; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hellwinkel OJC, 2011, PROSTATE CANCER P D, V14, P38, DOI 10.1038/pcan.2010.48; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu XY, 2009, EJSO-EUR J SURG ONC, V35, P527, DOI 10.1016/j.ejso.2008.09.015; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Kito Y, 2014, INT J EXP PATHOL, V95, P24, DOI 10.1111/iep.12051; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sakashita H, 2013, ANN SURG ONCOL, V20, pS590, DOI 10.1245/s10434-013-3059-6; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Tanksley JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081514; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Woenckhaus J, 2002, J PATHOL, V198, P335, DOI 10.1002/path.1207; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047	34	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17467	17477		10.1074/jbc.M116.726083	http://dx.doi.org/10.1074/jbc.M116.726083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339899	hybrid, Green Published			2022-12-26	WOS:000382643800044
J	Han, S; Jin, SM; Ko, JS; Kim, YR; Gwak, MS; Son, HJ; Joh, JW; Kim, GS				Han, Sangbin; Jin, Sang-Man; Ko, Justin Sangwook; Kim, Young Ri; Gwak, Mi Sook; Son, Hee Jeong; Joh, Jae-Won; Kim, Gaab Soo			Association between Serum Bilirubin and Acute Intraoperative Hyperglycemia Induced by Prolonged Intermittent Hepatic Inflow Occlusion in Living Liver Donors	PLOS ONE			English	Article							SURGICAL SITE INFECTION; HEME OXYGENASE SYSTEM; CLINICAL-IMPLICATIONS; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; TRANSPLANTATION; MICROSTEATOSIS; MACROSTEATOSIS; RESISTANCE; TOLERANCE	Background Intermittent hepatic inflow occlusion (IHIO) is associated with acute hyperglycemia during living donor hepatectomy when the ischemia is prolonged. Bilirubin is a potent antioxidant to play an important role for maintaining insulin sensitivity and preventing hyperglycemia. Thus, we aimed to test whether serum bilirubin level is associated with prolonged IHIO-induced intraoperative hyperglycemia. Methods Seventy-five living liver donors who underwent a prolonged IHIO with a > 30 minute cumulative ischemia were included. The association between preoperative serum bilirubin concentrations and the risk of intraoperative hyperglycemia (blood glucose concentration > 180 mg/dl) was analyzed using binary logistic regression with adjusting for potential confounders including age and steatosis. Results The number of donors who underwent 3, 4, 5, and 6 rounds of IHIO was 41, 22, 7, and 5, respectively. Twenty-nine (35%) donors developed intraoperative hyperglycemia. Total bilirubin concentration was inversely associated with hyperglycemia risk (odds ratio [OR] 0.033, 95% confidence interval [CI] 0.004-0.313, P = 0.003). There was an interaction between age and total bilirubin concentration: the effect of lower serum total bilirubin (<= 0.7 mg/dl) on the development of hyperglycemia was greater in older donors (>40 years) than in younger donors (P = 0.0.028 versus P = 0.212). Both conjugated bilirubin (OR 0.001 95% CI 0.001-0.684) and unconjugated bilirubin (OR 0.011 95% CI 0.001-0.246) showed an independent association with hyperglycemia risk. Conclusions Lower preoperative serum bilirubin was associated with greater risk of prolonged IHIO-induced hyperglycemia during living donor hepatectomy particularly in older donors. Thus, more meticulous glycemic management is recommended when prolonged IHIO is necessary for surgical purposes in old living donors with lower serum bilirubin levels.	[Han, Sangbin; Ko, Justin Sangwook; Kim, Young Ri; Gwak, Mi Sook; Kim, Gaab Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Han, Sangbin; Son, Hee Jeong] Kangwon Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Chunchon, South Korea; [Jin, Sang-Man] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Joh, Jae-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kangwon National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, GS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gskim@skku.edu	Jin, Sang-Man/AFO-5933-2022					Akhtar S, 2010, ANESTH ANALG, V110, P478, DOI 10.1213/ANE.0b013e3181c6be63; Ammori JB, 2007, J SURG RES, V140, P227, DOI 10.1016/j.jss.2007.02.019; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Behrends M, 2010, J GASTROINTEST SURG, V14, P528, DOI 10.1007/s11605-009-1112-3; Bell RA, 2000, DIABETES CARE, V23, P1630, DOI 10.2337/diacare.23.11.1630; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Deyi VYM, 2002, CLIN CHEM LAB MED, V40, P1052, DOI 10.1515/CCLM.2002.184; Giugliano D, 1997, CIRCULATION, V95, P1783; Greenhill Claire, 2014, Nat Rev Gastroenterol Hepatol, V11, P270, DOI 10.1038/nrgastro.2014.59; Han SB, 2013, TRANSPL INT, V26, P623, DOI 10.1111/tri.12092; Han S, 2015, LIVER TRANSPLANT, V21, P644, DOI 10.1002/lt.24097; Han S, 2015, J HEPATOL, V62, P556, DOI 10.1016/j.jhep.2014.10.027; Han SB, 2015, LIVER TRANSPLANT, V21, P180, DOI 10.1002/lt.24029; Han SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109120; Han S, 2014, LIVER TRANSPLANT, V20, P775, DOI 10.1002/lt.23878; Han SB, 2014, LIVER TRANSPLANT, V20, P473, DOI 10.1002/lt.23824; Hiraoka A, 2015, J GASTROENTEROL, V50, P1206, DOI 10.1007/s00535-015-1068-x; Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Kersten JR, 1998, AM J PHYSIOL-HEART C, V275, pH721, DOI 10.1152/ajpheart.1998.275.2.H721; Ko JS, 2009, LIVER TRANSPLANT, V15, P381, DOI 10.1002/lt.21625; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Ohnaka K, 2010, DIABETES RES CLIN PR, V88, P103, DOI 10.1016/j.diabres.2009.12.022; Okabayashi T, 2011, WORLD J SURG, V35, P2773, DOI 10.1007/s00268-011-1299-9; Paolisso G, 1996, DIABETOLOGIA, V39, P357, DOI 10.1007/BF00418354; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Shangraw R E, 1996, Liver Transpl Surg, V2, P443, DOI 10.1002/lt.500020607; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Trotter JF, 2006, LIVER TRANSPLANT, V12, P1485, DOI 10.1002/lt.20875; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; Yu K, 2011, KOREAN J FAM MED, V32, P327, DOI 10.4082/kjfm.2011.32.6.327	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156957	10.1371/journal.pone.0156957	http://dx.doi.org/10.1371/journal.pone.0156957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367602	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900008
J	Gregory, S; Fusca, M; Rees, G; Schwarzkopf, DS; Barnes, G				Gregory, Sarah; Fusca, Marco; Rees, Geraint; Schwarzkopf, D. Samuel; Barnes, Gareth			Gamma Frequency and the Spatial Tuning of Primary Visual Cortex	PLOS ONE			English	Article							CORTICAL MAGNIFICATION; GABA CONCENTRATION; RESTING GABA; OSCILLATIONS; SIZE; VARIABILITY; V1; SEGMENTATION; PERFORMANCE; RECORDINGS	Visual stimulation produces oscillatory gamma responses in human primary visual cortex (V1) that also relate to visual perception. We have shown previously that peak gamma frequency positively correlates with central V1 cortical surface area. We hypothesized that people with larger V1 would have smaller receptive fields and that receptive field size, not V1 area, might explain this relationship. Here we set out to test this hypothesis directly by investigating the relationship between fMRI estimated population receptive field (pRF) size and gamma frequency in V1. We stimulated both the near-center and periphery of the visual field using both large and small stimuli in each location and replicated our previous finding of a positive correlation between V1 surface area and peak gamma frequency. Counter to our expectation, we found that between participants V1 size (and not PRF size) accounted for most of the variability in gamma frequency. Within-participants we found that gamma frequency increased, rather than decreased, with stimulus eccentricity directly contradicting our initial hypothesis.	[Gregory, Sarah; Rees, Geraint; Barnes, Gareth] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Gregory, Sarah; Rees, Geraint; Schwarzkopf, D. Samuel] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Fusca, Marco] Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy; [Schwarzkopf, D. Samuel] UCL, Expt Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of Trento; University of London; University College London	Gregory, S (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.; Gregory, S (corresponding author), UCL, Inst Cognit Neurosci, London WC1N 3AR, England.	s.gregory@ucl.ac.uk	Barnes, Gareth/ABB-7650-2020; Rees, Geraint/C-1493-2008	Barnes, Gareth/0000-0002-5396-7712; Rees, Geraint/0000-0002-9623-7007; Gregory, Sarah/0000-0003-4620-6963; Fusca, Marco/0000-0001-5900-9913	Wellcome Trust [091593/Z/10/Z, 100227]; European Research Council Starting Grant [310829]; Medical Research Council UK MEG Partnership Grant [MR/K005464/1]; MRC [MR/K005464/1] Funding Source: UKRI; Medical Research Council [MR/K005464/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council Starting Grant(European Research Council (ERC)); Medical Research Council UK MEG Partnership Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z (SG, MF, GB). This work was also supported by European Research Council Starting Grant (310829) (DSS), the Wellcome Trust (100227) (GR), and a Medical Research Council UK MEG Partnership Grant, MR/K005464/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann J, 2016, CEREB CORTEX, V26, P3838, DOI 10.1093/cercor/bhv186; Bergmann J, 2016, NEUROIMAGE, V124, P654, DOI 10.1016/j.neuroimage.2015.09.036; Bergmann J, 2016, CEREB CORTEX, V26, P43, DOI 10.1093/cercor/bhu168; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Haas B, 2014, CURR BIOL, V24, pR66, DOI 10.1016/j.cub.2013.11.061; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; Frien A, 2000, EUR J NEUROSCI, V12, P1453, DOI 10.1046/j.1460-9568.2000.00025.x; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Herrmann K, 2010, NAT NEUROSCI, V13, P1554, DOI 10.1038/nn.2669; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hubener M, 1997, J NEUROSCI, V17, P9270; Kujala J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16347; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Perry G, 2013, NEUROIMAGE, V68, P83, DOI 10.1016/j.neuroimage.2012.11.043; Pinotsis DA, 2013, NEUROIMAGE, V66, P563, DOI 10.1016/j.neuroimage.2012.10.078; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Robson SE, 2015, J ANAT, V227, P409, DOI 10.1111/joa.12339; Schira MM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000651; Schwarzkopf DS, 2014, J NEUROSCI, V34, P2713, DOI 10.1523/JNEUROSCI.4416-13.2014; Schwarzkopf DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060550; Schwarzkopf DS, 2012, J NEUROSCI, V32, P1507, DOI 10.1523/JNEUROSCI.4771-11.2012; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Song C, 2015, NEURON, V85, P641, DOI 10.1016/j.neuron.2014.12.041; Song C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3201; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; van Pelt S, 2013, NEUROIMAGE, V78, P439, DOI 10.1016/j.neuroimage.2013.04.040; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157374	10.1371/journal.pone.0157374	http://dx.doi.org/10.1371/journal.pone.0157374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362265	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200016
J	Lin, TY; Chen, YG; Lin, CL; Kao, CH				Lin, Te-Yu; Chen, Yu-Guang; Lin, Cheng-Li; Kao, Chia-Hung			Increased Risk of Acute Kidney Injury following Pneumococcal Pneumonia: A Nationwide Cohort Study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACUTE-RENAL-FAILURE; STREPTOCOCCUS-PNEUMONIAE; SEPSIS; MORTALITY; EPIDEMIOLOGY; MULTICENTER; DYSFUNCTION; INFECTION; DISEASE	Purpose Pneumococcal disease leads to renal complications ranging from persistent proteinuria to end-stage renal disease. Studies on the association between pneumococcal pneumonia (PP) and acute kidney injury (AKI) are scant. This study assessed the relationship between PP and risk of AKI. Methods This nationwide population-based cohort study examined data from the Taiwan National Health Insurance Research Database for the period 2000-2011. We identified inpatients with newly diagnosed PP according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. In addition, we selected a comparison cohort from inpatient claims without the diagnosis of PP that was randomly frequency-matched with the PP cohort according to age, sex, index year and comorbidities. We analyzed the risks of AKI by using Cox proportional hazards regression models, adjusted for sex, age, and comorbidities. Results A total of 10,069 patients with PP and 10,069 controls were enrolled in this study. After adjustments for age, sex, and comorbidities, patients with PP had a 1.11-fold risk of developing AKI compared with the comparison cohort. Conclusion This study indicates that AKI risks are higher in patients with PP compared with the comparison cohort. Careful follow-up observation and aggressive treatment are necessary for patients with PP to reduce the risk of AKI.	[Lin, Te-Yu] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chen, Yu-Guang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Chen LF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051452, 10.1371/journal.pone.0051512]; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Constantinescu AR, 2004, AM J KIDNEY DIS, V43, P976, DOI 10.1053/j.ajkd.2004.02.010; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Emlet DR, 2015, SEMIN NEPHROL, V35, P85, DOI 10.1016/j.semnephrol.2015.01.009; Ficek R, 2006, KIDNEY BLOOD PRESS R, V29, P203, DOI 10.1159/000095734; Himmelfarb J, 2009, SEMIN NEPHROL, V29, P658, DOI 10.1016/j.semnephrol.2009.07.008; Huang ST, 2014, KIDNEY INT, V86, P1023, DOI 10.1038/ki.2014.79; Langenberg C, 2005, CRIT CARE, V9, pR363, DOI 10.1186/cc3540; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Lee CS, 2012, NEPHROLOGY, V17, P48, DOI 10.1111/j.1440-1797.2011.01500.x; Lin TY, 2014, LUNG, V192, P159, DOI 10.1007/s00408-013-9523-z; Mongardon N, 2012, CRIT CARE, V16, DOI 10.1186/cc11471; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Naucler P, 2013, THORAX, V68, P571, DOI 10.1136/thoraxjnl-2012-203106; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Panichi V, 2002, NEPHRON, V91, P594, DOI 10.1159/000065018; Prowle JR, 2015, SEMIN NEPHROL, V35, P64, DOI 10.1016/j.semnephrol.2015.01.007; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Wittenhagen P, 2004, CLIN MICROBIOL INFEC, V10, P409, DOI 10.1111/j.1469-0691.2004.00850.x	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158501	10.1371/journal.pone.0158501	http://dx.doi.org/10.1371/journal.pone.0158501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362355	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200083
J	Raj, RR; Subramani, S				Raj, Renu R.; Subramani, Sathya			Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances	PLOS ONE			English	Article							MECHANISMS	Phenylephrine (PE) causes vasoconstriction through alpha adrenergic receptors. PE-induced vasodilatation has also been reported earlier in pre-constricted vessels. Here we demonstrate in spiral strips of goat arteries that addition of PE can decrease tone even from base-line levels (i.e. not pre-constricted) and show that this process requires nitric oxide (NO) and alpha adrenergic stimulation, but is cGMP-independent. Under control conditions, PE caused vasoconstriction, but under conditions where NO levels are higher, as with L-Arginine or sodium nitroprusside, PE decreased vessel tension. L-Arginine/PE combination was not able to decrease tension when alpha adrenoceptors were blocked with Phentolamine or endothelial nitric oxide synthase (eNOS) was blocked with N omega-Nitro-L-arginine (L-NNA). Propranolol, a beta blocker, was unable to prevent the reduction in tension by the L-Arginine/PE combination. Adrenaline and noradrenaline (and not isoproterenol) also reduced vessel tension in the presence of L-Arginine. Even when NO levels were not enhanced, relieving NO from having to stimulate the enzyme soluble guanylyl cyclase (sGC) (either by using sGC blockers, namely ODQ or methylene blue, or by enhancing cGMP levels (with sildenafil) which by negative feedback probably inhibits sGC) led to PE-induced reduction of vascular tension. PMA-phorbol myristate acetate-an agonist which stimulates Protein Kinase C was able to prevent the ability of PE to reduce vascular tension in a high NO environment. Our conclusion is that PE reduces vascular tension through alpha adrenoceptors if there is excess NO availability to activate a putative pathway. Though the reduction of vessel tone by PE is dependent on NO, it is independent of cGMP. Prior treatment with PMA or PE itself can prevent further PE-induced reduction of tension in a high NO environment. The results here suggest, counter-intuitively, that alpha blockers may be of help in the treatment of septic shock where nitric oxide levels are high.	[Raj, Renu R.; Subramani, Sathya] Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Subramani, S (corresponding author), Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India.	sathya@cmcvellore.ac.in	RAJ, RENU/AAH-7456-2021	Subramani, Sathya/0000-0002-4415-6774	Department of Physiology at Christian Medical College, Vellore	Department of Physiology at Christian Medical College, Vellore	Funds were provided by the Department of Physiology at Christian Medical College, Vellore.	BENNETT MA, 1992, BRIT J PHARMACOL, V107, P616, DOI 10.1111/j.1476-5381.1992.tb12792.x; BOND RF, 1985, CIRC SHOCK, V16, P155; BOND RF, 1984, CIRC SHOCK, V12, P9; Filippi S, 2001, J PHARMACOL EXP THER, V296, P869; Goud C, 1999, GEN PHARMACOL, V32, P51, DOI 10.1016/S0306-3623(98)00059-7; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; HOLLENBERG SM, 1993, AM J PHYSIOL, V264, pH660, DOI 10.1152/ajpheart.1993.264.2.H660; Joyner MJ, 2003, ACTA PHYSIOL SCAND, V177, P329, DOI 10.1046/j.1365-201X.2003.01090.x; OLIVER LE, 1980, MED J AUSTRALIA, V2, P42, DOI 10.5694/j.1326-5377.1980.tb125819.x; Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Torp KD, 2001, J APPL PHYSIOL, V90, P1855, DOI 10.1152/jappl.2001.90.5.1855; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Zschauer AOA, 1997, J APPL PHYSIOL, V82, P1918, DOI 10.1152/jappl.1997.82.6.1918	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158551	10.1371/journal.pone.0158551	http://dx.doi.org/10.1371/journal.pone.0158551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362703	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200088
J	Yoo, SH; Kim, JG; Kim, BS; Lee, J; Pi, SH; Lim, HD; Shin, HI; Cho, ES; You, HK				Yoo, Su-Hyang; Kim, Jae Goo; Kim, Beom-Su; Lee, Jun; Pi, Sung-Hee; Lim, Hyun-Dae; Shin, Hong-In; Cho, Eui-Sic; You, Hyung-Keun			BST2 Mediates Osteoblast Differentiation via the BMP2 Signaling Pathway in Human Alveolar-Derived Bone Marrow Stromal Cells	PLOS ONE			English	Article							MOLECULAR-CLONING; ANTIGEN-2; RUNX2; GENE; PHOSPHORYLATION; TRANSCRIPTION; SMAD1	The molecular mechanisms controlling the differentiation of bone marrow stromal stem cells into osteoblasts remain largely unknown. In this study, we investigated whether bone marrow stromal antigen 2 (BST2) influences differentiation toward the osteoblasts lineage. BST2 mRNA expression in human alveolar-derived bone marrow stromal cells (hAD-BMSCs) increased during differentiation into osteoblasts. hAD-BMSCs differentiation into osteoblasts and the mRNA expression of the bone-specific markers alkaline phosphatase, collagen type a 1, bone sialoprotein, osteocalcin, and osterix were reduced by BST2 knockdown using siRNA. Furthermore, BST2 knockdown in hAD-BMSCs resulted in decreased RUNX2 mRNA and protein expression. We hypothesized that BST2 is involved in differentiation of into osteoblasts via the BMP2 signaling pathway. Accordingly, we evaluated the mRNA expression levels of BMP2, BMP receptors (BMPR1 and 2), and the downstream signaling molecules SMAD1, SMAD4, and p-SMAD1/5/8 in BST2 knockdown cells. BMP2 expression following the induction of differentiation was significantly lower in BST2 knockdown cells than in cells treated with a non-targeting control siRNA. Similar results were found for the knockdown of the BMP2 receptor-BMPR1A. We also identified significantly lower expression of SMAD1, SMAD4, and p-SMAD1/5/8 in the BST2 knockdown cells than control cells. Our data provide the first evidence that BST2 is involved in the osteogenic differentiation of bone marrow stromal cells via the regulation of the BMP2 signaling pathway.	[Yoo, Su-Hyang; Pi, Sung-Hee; You, Hyung-Keun] Wonkwang Univ, Sch Dent, Dept Periodontol, Iksan, South Korea; [Yoo, Su-Hyang; Kim, Jae Goo] Chonbuk Natl Univ, Fac Biol Sci, Coll Nat Sci, Jeonju, South Korea; [Yoo, Su-Hyang; Kim, Jae Goo] Chonbuk Natl Univ, Coll Nat Sci, Inst Biodivers Res, Jeonju, South Korea; [Kim, Beom-Su] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Daejeon, South Korea; [Kim, Beom-Su] Bone Cell Biotech Inc, Daejeon, South Korea; [Lee, Jun] Wonkwang Univ, Daejeon Dent Hosp, Dept Oral & Maxillofacial Surg, Daejeon, South Korea; [Lim, Hyun-Dae] Wonkwang Univ, Sch Dent, Dept Oral Med, Iksan, South Korea; [Shin, Hong-In] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol, IHBR, Daegu, South Korea; [Cho, Eui-Sic] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Jeonju, South Korea	Wonkwang University; Jeonbuk National University; Jeonbuk National University; Wonkwang University; Wonkwang University; Wonkwang University; Kyungpook National University; Jeonbuk National University	You, HK (corresponding author), Wonkwang Univ, Sch Dent, Dept Periodontol, Iksan, South Korea.	hkperio@wku.ac.kr		Lim, Hyun-Dae/0000-0001-9474-3267; Kim, Beom Su/0000-0001-6562-4373; You, Hyung-Keun/0000-0002-4585-0477	National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2013M3A9B2076481]; Bone Cell Biotech	National Research Foundation (NRF) of Korea - Korean Government (MSIP); Bone Cell Biotech	This work was supported by the National Research Foundation (NRF) of Korea Grant, which was funded by the Korean Government (MSIP) (NO.2013M3A9B2076481) to HKY. Bone Cell Biotech provided support in the form of salary for BSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation (NRF) of Korea Grant, which was funded by the Korean Government (MSIP) (NO.2013M3A9B2076481). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Duque G, 2009, STEM CELLS, V27, P550, DOI 10.1634/stemcells.2008-0886; Ebisawa T, 1999, J CELL SCI, V112, P3519; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; GOTO T, 1994, BLOOD, V84, P1922; Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jones PH, 2013, VIROLOGY, V444, P124, DOI 10.1016/j.virol.2013.05.042; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; Kagami H, 2014, TISSUE ENG PART B-RE, V20, P229, DOI [10.1089/ten.teb.2013.0578, 10.1089/ten.TEB.2013.0578]; Kim BS, 2012, BONE, V51, P506, DOI 10.1016/j.bone.2012.05.012; Mahauad-Fernandez WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123931; Mahauad-Fernandez WD, 2014, J GEN VIROL, V95, P2450, DOI 10.1099/vir.0.068643-0; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ren DP, 2015, J CELL PHYSIOL, V230, P2426, DOI 10.1002/jcp.24972; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Swiecki M, 2012, J IMMUNOL, V188, P2488, DOI 10.4049/jimmunol.1103145; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Wysokinski D, 2015, DNA CELL BIOL, V34, P305, DOI 10.1089/dna.2014.2688; Yamada Y, 2013, CLIN ORAL IMPLAN RES, V24, P468, DOI 10.1111/j.1600-0501.2011.02353.x	33	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158481	10.1371/journal.pone.0158481	http://dx.doi.org/10.1371/journal.pone.0158481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359105	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200080
J	Eshwar, AK; Tall, B; Gangiredla, J; Gopinath, GR; Patel, IR; Neuhauss, SCF; Stephan, R; Lehner, A				Eshwar, Athmanya K.; Tall, Ben D.; Gangiredla, Jayanthi; Gopinath, Gopal R.; Patel, Isha R.; Neuhauss, Stephan C. F.; Stephan, Roger; Lehner, Angelika			Linking Genomo- and Pathotype: Exploiting the Zebrafish Embryo Model to Investigate the Divergent Virulence Potential among Cronobacter spp.	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; CAENORHABDITIS-ELEGANS; NEONATAL MENINGITIS; HUMAN MACROPHAGES; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; COMB. NOV.; GEN. NOV; TURICENSIS; FOOD	Bacteria belonging to the genus Cronobacter have been recognized as causative agents of life-threatening systemic infections primarily in premature, low-birth weight and immune compromised neonates. Apparently not all Cronobacter species are linked to infantile infections and it has been proposed that virulence varies among strains. Whole genome comparisons and in silico analysis have proven to be powerful tools in elucidating potential virulence determinants, the presence/absence of which may explain the differential virulence behaviour of strains. However, validation of these factors has in the past been hampered by the availability of a suitable neonatal animal model. In the present study we have used zebrafish embryos to model Cronobacter infections in vivo using wild type and genetically engineered strains. Our experiments confirmed the role of the RepF1B-like plasmids as "virulence plasmids" in Cronobacter and underpinned the importantce of two putative virulence factors-cpa and zpx-in in vivo pathogenesis. We propose that by using this model in vivo infection studies are now possible on a large scale level which will boost the understanding on the virulence strategies employed by these pathogens.	[Eshwar, Athmanya K.; Stephan, Roger; Lehner, Angelika] Univ Zurich, Inst Food Safety & Hyg, Zurich, Switzerland; [Tall, Ben D.; Gangiredla, Jayanthi; Gopinath, Gopal R.; Patel, Isha R.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; US Food & Drug Administration (FDA); University of Zurich	Lehner, A (corresponding author), Univ Zurich, Inst Food Safety & Hyg, Zurich, Switzerland.	lehnera@fsafety.uzh.ch	Lehner, Angelika/B-2363-2018; Stephan, Roger/AAP-8501-2020	Lehner, Angelika/0000-0003-1863-5090; 	Swiss National Science Foundation [310030_138533/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation 310030_138533/1 to AE, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsonosi A, 2015, EUR J CLIN MICROBIOL, V34, P1979, DOI 10.1007/s10096-015-2440-8; Bowen AB, 2006, EMERG INFECT DIS, V12, P1185, DOI 10.3201/eid1708.051509; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P297; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Eshwar AK, 2015, RES MICROBIOL, V166, P186, DOI 10.1016/j.resmic.2015.02.005; Fehr A, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.29; Forsythe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1121; Franco AA, 2011, APPL ENVIRON MICROB, V77, P3255, DOI 10.1128/AEM.03023-10; Franco AA, 2011, INFECT IMMUN, V79, P1578, DOI 10.1128/IAI.01165-10; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Grim CJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-366; Hariri S, 2013, EMERG INFECT DIS, V19, P175, DOI 10.3201/eid1901.120649; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Jaradat ZW, 2012, FRONT MICROBIOL, V3, P397; Johnson JR, 2005, ANTIMICROB AGENTS CH, V49, P4739, DOI 10.1128/AAC.49.11.4739-4744.2005; Joseph S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00397; Joseph S, 2012, INT J SYST EVOL MICR, V62, P1277, DOI 10.1099/ijs.0.032292-0; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Kothary MH, 2007, APPL ENVIRON MICROB, V73, P4142, DOI 10.1128/AEM.02729-06; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; Lee Hyun-A, 2011, Lab Anim Res, V27, P59, DOI 10.5625/lar.2011.27.1.59; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164; Mullane NR, 2007, MINERVA PEDIATR, V59; Ogrodzki P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1960-z; Pagotto FJ, 2009, INT J FOOD MICROBIOL, V136, P238, DOI 10.1016/j.ijfoodmicro.2009.05.010; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Schwizer S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-38; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh N, 2015, VIRULENCE, V6, P433, DOI 10.1080/21505594.2015.1036217; Sivamaruthi BS, 2015, ARCH MICROBIOL, V197, P327, DOI 10.1007/s00203-014-1064-1; Sivamaruthi BS, 2011, J BASIC MICROB, V51, P540, DOI 10.1002/jobm.201000377; Stephan R, 2014, INT J SYST EVOL MICR, V64, P3402, DOI 10.1099/ijs.0.059832-0; Stephan R, 2011, J BACTERIOL, V193, P309, DOI 10.1128/JB.01162-10; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Yan QQ, 2012, J APPL MICROBIOL, V113, P1, DOI 10.1111/j.1365-2672.2012.05281.x	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158428	10.1371/journal.pone.0158428	http://dx.doi.org/10.1371/journal.pone.0158428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355472	Green Accepted, Green Published, gold			2022-12-26	WOS:000378859400065
J	Son, HF; Kim, KJ				Son, Hyeoncheol Francis; Kim, Kyung-Jin			Structural Insights into a Novel Class of Aspartate Aminotransferase from Corynebacterium glutamicum	PLOS ONE			English	Article							THERMUS-THERMOPHILUS HB8; AMINO-ACIDS; CRYSTAL-STRUCTURE; REFINEMENT; MECHANISM; GENOME; HOMOLOGY; COMPLEX	Aspartate aminotransferase from Corynebacterium glutamicum (CgAspAT) is a PLP-dependent enzyme that catalyzes the production of L-aspartate and alpha-ketoglutarate from L-glutamate and oxaloacetate in L-lysine biosynthesis. In order to understand the molecular mechanism of CgAspAT and compare it with those of other aspartate aminotransferases (AspATs) from the aminotransferase class I, we determined the crystal structure of CgAspAT. CgAspAT functions as a dimer, and the CgAspAT monomer consists of two domains, the core domain and the auxiliary domain. The PLP cofactor is found to be bound to CgAspAT and stabilized through unique residues. In our current structure, a citrate molecule is bound at the active site of one molecule and mimics binding of the glutamate substrate. The residues involved in binding of the PLP cofactor and the glutamate substrate were confirmed by site-directed mutagenesis. Interestingly, compared with other AspATs from aminotransferase subgroup Ia and Ib, CgAspAT exhibited unique binding sites for both cofactor and substrate; moreover, it was found to have unusual structural features in the auxiliary domain. Based on these structural differences, we propose that CgAspAT does not belong to either subgroup Ia or Ib, and can be categorized into a subgroup Ic. The phylogenetic tree and RMSD analysis also indicates that CgAspAT is located in an independent AspAT subgroup.	[Son, Hyeoncheol Francis; Kim, Kyung-Jin] Kyungpook Natl Univ, Sch Life Sci, Creat BioRes Grp, Daehak Ro 80, Daegu 702701, South Korea	Kyungpook National University	Son, HF (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Creat BioRes Grp, Daehak Ro 80, Daegu 702701, South Korea.	kkim@knu.ac.kr			National Research Foundation of Korea (NRF) grant - Korean Government (MSIP) [2014R1A2A2A01005752, 2014M1A2A2033626]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from Ministry of Trade, Industry & Energy, Republic of Korea [20153030091360]; NRF-Global PhD Fellowship Program of the Korean Government [2015H1A2A1034233]	National Research Foundation of Korea (NRF) grant - Korean Government (MSIP); New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from Ministry of Trade, Industry & Energy, Republic of Korea; NRF-Global PhD Fellowship Program of the Korean Government	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (2014R1A2A2A01005752 and 2014M1A2A2033626), and was also supported by the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (No. 20153030091360). H-F Son was supported by the NRF-2015-Global PhD Fellowship Program of the Korean Government (2015H1A2A1034233).	Abendroth J, 2015, ACTA CRYSTALLOGR F, V71, P566, DOI 10.1107/S2053230X15001831; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUBELLIS MV, 1989, EUR J BIOCHEM, V186, P375, DOI 10.1111/j.1432-1033.1989.tb15219.x; Eggeling L, 2015, APPL MICROBIOL BIOT, V99, P3387, DOI 10.1007/s00253-015-6508-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Jeffery CJ, 1998, PROTEIN SCI, V7, P1380, DOI 10.1002/pro.5560070614; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kinoshita S, 2004, J GEN APPL MICROBIOL, V50, P331; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; KOCHHAR S, 1992, EUR J BIOCHEM, V203, P563, DOI 10.1111/j.1432-1033.1992.tb16584.x; MALASHKEVICH VN, 1982, DOKL AKAD NAUK SSSR+, V267, P1257; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McHardy AC, 2003, J BIOTECHNOL, V104, P229, DOI 10.1016/S0168-1656(03)00161-5; MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Okamoto A, 1996, J BIOCHEM-TOKYO, V119, P135; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUZOUNIS C, 1993, FEBS LETT, V322, P159, DOI 10.1016/0014-5793(93)81559-I; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Schwarzenbacher R, 2004, PROTEINS, V55, P759, DOI 10.1002/prot.10646; Ura H, 2001, J BIOCHEM, V130, P89, DOI 10.1093/oxfordjournals.jbchem.a002966; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wendisch VF, 2014, CURR OPIN BIOTECH, V30, P51, DOI 10.1016/j.copbio.2014.05.004; Wrenger C, 2011, J MOL BIOL, V405, P956, DOI 10.1016/j.jmb.2010.11.018	27	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158402	10.1371/journal.pone.0158402	http://dx.doi.org/10.1371/journal.pone.0158402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355211	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400060
J	Wu, CL; Tsai, CC; Kor, CT; Tarng, DC; Lian, IB; Yang, TH; Chiu, PF; Chang, CC				Wu, Chia-Lin; Tsai, Chun-Chieh; Kor, Chew-Teng; Tarng, Der-Cherng; Lian, Ie-Bin; Yang, Tao-Hsiang; Chiu, Ping-Fang; Chang, Chia-Chu			Stroke and Risks of Development and Progression of Kidney Diseases and End-Stage Renal Disease: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							CHRONIC PHASE; EPIDEMIOLOGY; INFLAMMATION; VALIDATION; REDUCTION; HEALTH; SALT	Background There is little information about the association between stroke and kidney diseases. We aimed to investigate the impact of stroke on long-term renal outcomes. Methods In this large population-based retrospective cohort study, we identified 100,353 subjects registered in the National Health Insurance Research Database of Taiwan from January 1, 2000, through December 31, 2012, including 33,451 stroke patients and 66,902 age-, sexand Charlson's comorbidity index score-matched controls. Results The incidence rate of chronic kidney disease (CKD) was higher in the stroke than in the control cohort (17.5 vs. 9.06 per 1000 person-years). After multivariate adjustment, the risk of developing CKD was significantly higher in patients with stroke (adjusted hazard ratio [aHR] 1.43, 95% confidence interval [CI] 1.36-1.50, P<0.001). Subgroup analysis showed that stroke patients <50 years (aHR 1.61, P<0.001) and those with concomitant diabetes mellitus (aHR 2.12, P<0.001), hyperlipidemia (aHR 1.53, P<0.001) or gout (aHR 1.84, P<0.001) were at higher risk of incident CKD. Additionally, the risks of progression to advanced CKD and end-stage renal disease (ESRD) were significantly higher for stroke patients (aHRs, 1.22 and 1.30; P = 0.04 and P = 0.008, respectively), independent of age, sex, comorbidities and long-term medications. Conclusions Stroke is associated with higher risks for incident CKD, decline in renal function and ESRD. Younger stroke patients, as well as those with concomitant diabetes mellitus, hyperlipidemia or gout are at greater risk for kidney diseases.	[Wu, Chia-Lin; Tsai, Chun-Chieh; Chiu, Ping-Fang; Chang, Chia-Chu] Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan; [Wu, Chia-Lin; Tsai, Chun-Chieh; Chiu, Ping-Fang; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Lian, Ie-Bin] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Changhua University of Education; Changhua Christian Hospital	Chiu, PF (corresponding author), Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan.; Chiu, PF (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chiu, PF (corresponding author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.	27509@cch.org.tw; 68505@cch.org.tw	Wu, Chia-Lin/V-8888-2017; Lian, Ie-Bin/AAE-3368-2021	Wu, Chia-Lin/0000-0001-6045-6956; Lian, Ie-bin/0000-0003-3992-6049	Changhua Christian Hospital Research Foundation [103-CCH-IRP-10, 104-CCH-IRP-012]	Changhua Christian Hospital Research Foundation	This study was funded by grants 103-CCH-IRP-10 and 104-CCH-IRP-012 from the Changhua Christian Hospital Research Foundation. The funder had no role in study design; in data collection, analysis, and interpretation; or in preparation of the manuscript and decision to publish.; This study was funded by grants 103-CCH-IRP-10 and 104-CCH-IRP-012 from the Changhua Christian Hospital Research Foundation. The funder had no role in study design; in data collection, analysis, and interpretation; or in preparation of the manuscript and decision to publish.	Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537; Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017; Bao YS, 2013, EUR J CLIN INVEST, V43, P829, DOI 10.1111/eci.12113; Cao W, 2015, J AM SOC NEPHROL, V26, P1619, DOI 10.1681/ASN.2014050518; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe; Folino AF, 2007, PROG CARDIOVASC DIS, V50, P49, DOI 10.1016/j.pcad.2007.01.001; Grau AJ, 2001, EUR J CLIN INVEST, V31, P999, DOI 10.1046/j.1365-2362.2001.00923.x; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Haapaniemi E, 2004, ACTA NEUROL SCAND, V110, P242, DOI 10.1111/j.1600-0404.2004.00304.x; Hsieh FI, 2014, J STROKE, V16, P59, DOI 10.5853/jos.2014.16.2.59; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Hung PH, 2014, NEPHROL DIAL TRANSPL, V29, P873, DOI 10.1093/ndt/gft534; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Kobayashi M, 2010, AM J KIDNEY DIS, V56, P468, DOI 10.1053/j.ajkd.2010.03.018; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/306189; Ninomiya T, 2013, CONTRIB NEPHROL, V179, P58, DOI 10.1159/000346724; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ou SM, 2013, KIDNEY INT, V84, P198, DOI 10.1038/ki.2013.79; Ovbiagele B, 2014, J STROKE CEREBROVASC, V23, P2265, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.016; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; The department of information services Executive Yuan R.O.C. (Taiwan), 2014, THE REPUBLIC OF CHIN; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; van Exel E, 2002, STROKE, V33, P1135, DOI 10.1161/01.STR.0000014206.05597.9E; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Walberer M, 2014, BRAIN RES, V1581, P80, DOI 10.1016/j.brainres.2014.05.030; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158533	10.1371/journal.pone.0158533	http://dx.doi.org/10.1371/journal.pone.0158533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355475	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400075
J	Ziegler, YS; Moresco, JJ; Yates, JR; Nardulli, AM				Ziegler, Yvonne S.; Moresco, James J.; Yates, John R., III; Nardulli, Ann M.			Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; 3 BINDING-PROTEIN; GROWTH-FACTOR; TUMOR-SUPPRESSOR; GENE-EXPRESSION; INCIDENCE RATES; LUNG-CANCER; CATHEPSIN-D; CELL-LINES; IN-VIVO	Cancer cells secrete factors that influence adjacent cell behavior and can lead to enhanced proliferation and metastasis. To better understand the role of these factors in oncogenesis and disease progression, estrogen and progesterone receptor positive MCF-7 cells, triple negative breast cancer MDA-MB-231, DT22, and DT28 cells, and MCF-10A non-transformed mammary epithelial cells were grown in 3D cultures. A special emphasis was placed on triple negative breast cancer since these tumors are highly aggressive and no targeted treatments are currently available. The breast cancer cells secreted factors of variable potency that stimulated proliferation of the relatively quiescent MCF-10A cells. The conditioned medium from each cell line was subjected to mass spectrometry analysis and a variety of secreted proteins were identified including glycolytic enzymes, proteases, protease inhibitors, extracellular matrix proteins, and insulin-like growth factor binding proteins. An investigation of the secretome from each cell line yielded clues about strategies used for breast cancer proliferation and metastasis. Some of the proteins we identified may be useful in the development of a serum-based test for breast cancer detection, diagnosis, prognosis, and monitoring.	[Ziegler, Yvonne S.; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Nardulli, AM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	anardull@life.illinois.edu		Moresco, James/0000-0003-1178-1642	National Institutes of Health: The National Institute of Diabetes and Digestive and Kidney Diseases [NIH R01 DK053884]; National Institute of General Medical Sciences [NIH P41 GM103533]	National Institutes of Health: The National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health: The National Institute of Diabetes and Digestive and Kidney Diseases NIH R01 DK053884, www.niddk.nih.gov, to AMN, and National Institute of General Medical Sciences NIH P41 GM103533, www.nigms.nih.gov, to JRY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Amon LM, 2012, CANCER RES, V72, P1935, DOI 10.1158/0008-5472.CAN-11-3266; Arteaga C L, 1991, Cancer Treat Res, V53, P289; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chan HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030397; Chang LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099254; Chang YF, 2011, ANAL CHEM, V83, P5324, DOI 10.1021/ac200754x; Chen D, 2011, CLIN CANCER RES, V17, P6693, DOI 10.1158/1078-0432.CCR-10-2774; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Curtis CD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-9; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Dunn BK, 2010, BREAST CANCER RES TR, V121, P281, DOI 10.1007/s10549-010-0827-x; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Fleming JM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-27; Garcia M, 1996, STEM CELLS, V14, P642, DOI 10.1002/stem.140642; Gaul DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16351; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Henshall SM, 2006, J NATL CANCER I, V98, P1420, DOI 10.1093/jnci/djj378; Huang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069155; Huang SF, 2016, TUMOUR BIOL; Jin YX, 2016, BRIT J CANCER, V114, P532, DOI 10.1038/bjc.2015.348; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kim YJ, 2015, PROTEOMICS, V15, P3116, DOI 10.1002/pmic.201400382; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kraus TS, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-63; Laubli H, 2014, J BIOL CHEM, V289, P33481, DOI 10.1074/jbc.M114.593129; Lee EJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-7; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Li XQ, 2007, CANCER SCI, V98, P1592, DOI 10.1111/j.1349-7006.2007.00565.x; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mosig RA, 2012, J OVARIAN RES, V5; MURPHY LC, 1987, CANCER RES, V47, P4160; Murthy SRK, 2010, CELL MOL NEUROBIOL, V30, P1377, DOI 10.1007/s10571-010-9592-y; Naderi A, 2015, ADV EXP MED BIOL, V846, P189, DOI 10.1007/978-3-319-12114-7_8; Nie S, 2014, J PROTEOME RES, V13, P1873, DOI 10.1021/pr400967x; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Pandey V, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0429-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perez-Silva JG, 2016, NUCLEIC ACIDS RES, V44, pD351, DOI 10.1093/nar/gkv1201; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Poon RT, 2004, CLIN CANCER RES, V10, P4150, DOI 10.1158/1078-0432.CCR-03-0435; Pranjol MZI, 2015, BIOMOLECULES, V5, P3260, DOI 10.3390/biom5043260; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Rehman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030885; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Sartori DA, 2014, CURR OPIN ONCOL, V26, P259, DOI 10.1097/CCO.0000000000000065; Sato Y, 2015, J CLIN PATHOL, V68, P795, DOI 10.1136/jclinpath-2015-202987; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Shen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013133; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Stark A, 2010, CANCER-AM CANCER SOC, V116, P4926, DOI 10.1002/cncr.25276; Syed Rakashanda, 2012, Biotechnology and Molecular Biology Reviews, V7, P90; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Tastekin D, 2014, TUMOR BIOL, V35, P6619, DOI 10.1007/s13277-014-1875-3; Tickner JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00127; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Tumminello FM, 2008, BIOMED PHARMACOTHER, V62, P130, DOI 10.1016/j.biopha.2007.07.001; Ueno K, 2011, INT J CANCER, V129, P2360, DOI 10.1002/ijc.25899; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Whelan SA, 2012, J PROTEOME RES, V11, P5034, DOI 10.1021/pr300606e; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; Yip PY, 2011, PROSTATE, V71, P1638, DOI 10.1002/pros.21381; Yu H, 1998, CLIN CANCER RES, V4, P1489; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291; Zhu L, 2013, PROSTATE, V73, P219, DOI 10.1002/pros.22560; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Ziegler YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102341; Zong M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0619-0	110	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158296	10.1371/journal.pone.0158296	http://dx.doi.org/10.1371/journal.pone.0158296			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355404	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400046
J	Kritmetapak, K; Peerapornratana, S; Srisawat, N; Somlaw, N; Lakananurak, N; Dissayabutra, T; Phonork, C; Leelahavanichkul, A; Tiranathanagul, K; Susantithapong, P; Loaveeravat, P; Suwachittanont, N; Wirotwan, TO; Praditpornsilpa, K; Tungsanga, K; Eiam-Ong, S; Kittiskulnam, P				Kritmetapak, Kittrawee; Peerapornratana, Sadudee; Srisawat, Nattachai; Somlaw, Nicha; Lakananurak, Narisorn; Dissayabutra, Thasinas; Phonork, Chayanat; Leelahavanichkul, Asada; Tiranathanagul, Khajohn; Susantithapong, Paweena; Loaveeravat, Passisd; Suwachittanont, Nattachai; Wirotwan, Thaksa-on; Praditpornsilpa, Kearkiat; Tungsanga, Kriang; Eiam-Ong, Somchai; Kittiskulnam, Piyawan			The Impact of Macro-and Micronutrients on Predicting Outcomes of Critically Ill Patients Requiring Continuous Renal Replacement Therapy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; LONG-TERM OUTCOMES; PROTEIN-INTAKE; IN-VITRO; ASSOCIATION; CLEARANCE; FAILURE; SUPPORT; BALANCE	Critically ill patients with acute kidney injury (AKI) who receive renal replacement therapy (RRT) have very high mortality rate. During RRT, there are markedly loss of macro- and micronutrients which may cause malnutrition and result in impaired renal recovery and patient survival. We aimed to examine the predictive role of macro- and micronutrients on survival and renal outcomes in critically ill patients undergoing continuous RRT (CRRT). This prospective observational study enrolled critically ill patients requiring CRRT at Intensive Care Unit of King Chulalongkorn Memorial Hospital from November 2012 until November 2013. The serum, urine, and effluent fluid were serially collected on the first three days to calculate protein metabolism including dietary protein intake (DPI), nitrogen balance, and normalized protein catabolic rate (nPCR). Serum zinc, selenium, and copper were measured for micronutrients analysis on the first three days of CRRT. Survivor was defined as being alive on day 28 after initiation of CRRT. Dialysis status on day 28 was also determined. Of the 70 critically ill patients requiring CRRT, 27 patients (37.5%) survived on day 28. The DPI and serum albumin of survivors were significantly higher than non-survivors (0.8 +/- 0.2 vs 0.5 +/- 0.3g/kg/day, p = 0.001, and 3.2 +/- 0.5 vs 2.9 +/- 0.5 g/dL, p = 0.03, respectively) while other markers were comparable. The DPI alone predicted patient survival with area under the curve (AUC) of 0.69. A combined clinical model predicted survival with AUC of 0.78. When adjusted for differences in albumin level, clinical severity score (APACHEII and SOFA score), and serum creatinine at initiation of CRRT, DPI still independently predicted survival (odds ratio 4.62, p = 0.009). The serum levels of micronutrients in both groups were comparable and unaltered following CRRT. Regarding renal outcome, patients in the dialysis independent group had higher serum albumin levels than the dialysis dependent group, p = 0.01. In conclusion, in critically ill patients requiring CRRT, DPI is a good predictor of patient survival while serum albumin is a good prognosticator of renal outcome.	[Kritmetapak, Kittrawee; Phonork, Chayanat] Konkaen Univ, Dept Med, Div Nephrol, Konkaen, Thailand; [Peerapornratana, Sadudee; Srisawat, Nattachai; Tiranathanagul, Khajohn; Susantithapong, Paweena; Loaveeravat, Passisd; Suwachittanont, Nattachai; Wirotwan, Thaksa-on; Praditpornsilpa, Kearkiat; Tungsanga, Kriang; Eiam-Ong, Somchai; Kittiskulnam, Piyawan] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Div Nephrol, Bangkok, Thailand; [Somlaw, Nicha; Lakananurak, Narisorn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Div Clin Nutr, Bangkok, Thailand; [Dissayabutra, Thasinas] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Biochem, Bangkok, Thailand; [Leelahavanichkul, Asada] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Srisawat, N (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Div Nephrol, Bangkok, Thailand.	drnattachai@yahoo.com	Srisawat, Nattachai/I-3122-2019; Lakananurak, Narisorn/AAU-8566-2020; Praditpronsilpa, Kearkiat/AFT-5058-2022	Lakananurak, Narisorn/0000-0003-3166-0856; Srisawat, Nattachai/0000-0002-8544-8132	Ratchadapisek Sompoch Research Grant, Chulalongkorn University [RA57/037]; Ratchadapisek Sompoch Research Grant, Chulalongkorn University	Ratchadapisek Sompoch Research Grant, Chulalongkorn University; Ratchadapisek Sompoch Research Grant, Chulalongkorn University	This research was supported by the funding from the Ratchadapisek Sompoch Research Grant, Chulalongkorn University, grant number RA57/037.; We thank all the physicians, nurses, scientists and technicians participating in our study. This research was supported by the funding from the Ratchadapisek Sompoch Research Grant, Chulalongkorn University.	[Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Bach-Ngohou K, 2004, ANN BIOL CLIN-PARIS, V62, P395; Bellomo R, 1997, RENAL FAILURE, V19, P111, DOI 10.3109/08860229709026265; BELLOMO R, 1991, INTENS CARE MED, V17, P399, DOI 10.1007/BF01720677; Bellomo R, 2014, BLOOD PURIFICAT, V37, P325, DOI 10.1159/000363175; Berger MM, 2004, AM J CLIN NUTR, V80, P410, DOI 10.1093/ajcn/80.2.410; Biolo G, 2013, WORLD REV NUTR DIET, V105, P12, DOI 10.1159/000341545; CHIMA CS, 1993, J AM SOC NEPHROL, V3, P1516; Churchwell MD, 2007, NEPHROL DIAL TRANSPL, V22, P2970, DOI 10.1093/ndt/gfm352; DAVIES SP, 1991, CRIT CARE MED, V19, P1510, DOI 10.1097/00003246-199112000-00012; Fiaccadori E, 2008, J NEPHROL, V21, P645; FRANKENFIELD DC, 1993, JPEN-PARENTER ENTER, V17, P551, DOI 10.1177/0148607193017006551; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Leblanc M, 1998, AM J KIDNEY DIS, V32, P444, DOI 10.1053/ajkd.1998.v32.pm9740161; Li Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005426.pub2; Macias William L., 1996, Journal of Parenteral and Enteral Nutrition, V20, P56, DOI 10.1177/014860719602000156; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Mokrzycki MH, 1996, J AM SOC NEPHROL, V7, P2259; Nakamura AT, 2004, J RENAL NUTR, V14, P214, DOI 10.1053/j.jrn.2004.07.001; Negi Shigeo, 2013, Nihon Jinzo Gakkai Shi, V55, P529; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Pasko DA, 2009, PEDIATR NEPHROL, V24, P807, DOI 10.1007/s00467-008-1083-8; Plank LD, 2003, P NUTR SOC, V62, P545, DOI 10.1079/PNS2003259; Rech M, 2014, NUTR CLIN PRACT, V29, P78, DOI 10.1177/0884533613515724; Singer P, 2007, WIEN KLIN WOCHENSCHR, V119, P218, DOI 10.1007/s00508-007-0794-3; Wald R, 2014, CRIT CARE MED, V42, P868, DOI 10.1097/CCM.0000000000000042; Wooley Jennifer A, 2005, Nutr Clin Pract, V20, P176, DOI 10.1177/0115426505020002176	28	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0156634	10.1371/journal.pone.0156634	http://dx.doi.org/10.1371/journal.pone.0156634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352307	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900003
J	Lee, S; Yeo, IY; Sadeghi, AM; McCarty, GW; Hively, WD; Lang, MW				Lee, Sangchul; Yeo, In-Young; Sadeghi, Ali M.; McCarty, Gregory W.; Hively, W. Dean; Lang, Megan W.			Impacts of Watershed Characteristics and Crop Rotations on Winter Cover Crop Nitrate-Nitrogen Uptake Capacity within Agricultural Watersheds in the Chesapeake Bay Region	PLOS ONE			English	Article							NUTRIENT-UPTAKE EFFICIENCY; MODEL CALIBRATION; UNITED-STATES; SWAT MODEL; QUALITY; SIMULATION; SOIL; MINERALIZATION; RESIDUES; CORN	The adoption rate of winter cover crops (WCCs) as an effective conservation management practice to help reduce agricultural nutrient loads in the Chesapeake Bay (CB) is increasing. However, the WCC potential for water quality improvement has not been fully realized at the watershed scale. This study was conducted to evaluate the long-term impact of WCCs on hydrology and NO3-N loads in two adjacent watersheds and to identify key management factors that affect the effectiveness of WCCs using the Soil and Water Assessment Tool (SWAT) and statistical methods. Simulation results indicated that WCCs are effective for reducing NO3-N loads and their performance varied based on planting date, species, soil characteristics, and crop rotations. Early-planted WCCs outperformed late-planted WCCs on the reduction of NO3-N loads and early-planted rye (RE) reduced NO3-N loads by similar to 49.3% compared to the baseline (no WCC). The WCCs were more effective in a watershed dominated by well-drained soils with increased reductions in NO3-N fluxes of similar to 2.5 kg N.ha(-1) delivered to streams and similar to 10.1 kg N.ha(-1) leached into groundwater compared to poorly-drained soils. Well-drained agricultural lands had higher transport of NO3-N in the soil profile and groundwater due to increased N leaching. Poorly-drained agricultural lands had lower NO3-N due to extensive drainage ditches and anaerobic soil conditions promoting denitrification. The performance of WCCs varied by crop rotations (i.e., continuous corn and corn-soybean), with increased N uptake following soybean crops due to the increased soil mineral N availability by mineralization of soybean residue compared to corn residue. The WCCs can reduce N leaching where baseline NO3-N loads are high in well-drained soils and/or when residual and mineralized N availability is high due to the cropping practices. The findings suggested that WCC implementation plans should be established in watersheds according to local edaphic and agronomic characteristics for reducing N leaching.	[Lee, Sangchul; Yeo, In-Young; Lang, Megan W.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Yeo, In-Young] Univ Newcastle, Sch Engn, Callaghan, NSW, Australia; [Sadeghi, Ali M.] USDA ARS, Hydrol & Remote Sensing Lab, Beltsville, MD USA; [McCarty, Gregory W.; Hively, W. Dean] USGS, Eastern Geog Sci Ctr, Reston, VA USA	University System of Maryland; University of Maryland College Park; University of Newcastle; United States Department of Agriculture (USDA); United States Department of the Interior; United States Geological Survey	Yeo, IY (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.; Yeo, IY (corresponding author), Univ Newcastle, Sch Engn, Callaghan, NSW, Australia.	In-Young.Yeo@newcastle.edu.au	sadeghi, ali/AAV-8756-2020; Hively, Dean/AAK-3895-2020	Hively, Dean/0000-0002-5383-8064; Yeo, In-Young/0000-0001-5991-733X; Lang, Megan/0000-0002-2702-899X	National Aeronautics and Space Administration Land Cover and Land Use Change Program; United States Department of Agriculture Conservation Effects Assessment Project; U.S. Geological Survey Land Change Science Program; UMD Libraries Open Access Publishing Fund	National Aeronautics and Space Administration Land Cover and Land Use Change Program; United States Department of Agriculture Conservation Effects Assessment Project; U.S. Geological Survey Land Change Science Program; UMD Libraries Open Access Publishing Fund	This research was supported by National Aeronautics and Space Administration Land Cover and Land Use Change Program (http://lcluc.umd.edu/), United States Department of Agriculture Conservation Effects Assessment Project (http://www.nrcs.usda.gov/wps/portal/nrcs/main/national/technical/nra/ceap/), U.S. Geological Survey Land Change Science Program (http://www.usgs.gov/climate_landuse/lcs/), and the UMD Libraries Open Access Publishing Fund (http://www.lib.umd.edu/oa/openaccessfund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CYCLES SOILS CARBON; Ator S.W., 2015, 1406 US GEOL SURV; Ator SW, 2012, J AM WATER RESOUR AS, V48, P1075, DOI 10.1111/j.1752-1688.2012.00672.x; Beeson PC, 2014, J ENVIRON QUAL, V43, P26, DOI 10.2134/jeq2012.0148; Boithias L, 2014, J ENVIRON QUAL, V43, P46, DOI 10.2134/jeq2011.0367; BRINSFIELD RB, 1991, COVER CROPS FOR CLEAN WATER, P79; Chesapeake Bay Program (CBP), ADD NEW COV CROP SPE; CHIANG S. L., 1971, Journal of Hydrology, V13, P54, DOI 10.1016/0022-1694(71)90200-9; Clark A., 2007, MANAGING COVER CROPS, V3rd ed.; Cohn T.A., 2004, TECHNIQUES METHODS; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Denver J. M., 2004, WATER QUALITY DELMAR; Denver JM, 2010, J ENVIRON QUAL, V39, P154, DOI 10.2134/jeq2009.0107; Feyereisen GW, 2006, AGRON J, V98, P1416, DOI 10.2134/agronj2005.0134; Fisher T., 2010, CHOPTANK BASIN TRANS; Gentry LE, 2001, PLANT SOIL, V236, P175, DOI 10.1023/A:1012707617126; Gitau MW, 2010, WATER-SUI, V2, P849, DOI 10.3390/w2040849; Hively WD, 2009, J SOIL WATER CONSERV, V64, P303, DOI 10.2489/jswc.64.5.303; Jha MK, 2007, T ASABE, V50, P479, DOI 10.13031/2013.22660; Kaboneka S, 1997, COMMUN SOIL SCI PLAN, V28, P1359, DOI 10.1080/00103629709369880; Klocke NL, 1999, T ASAE, V42, P1621, DOI 10.13031/2013.13328; Larose M, 2007, J ENVIRON QUAL, V36, P521, DOI 10.2134/jeq2006.0154; Lee KY, 2000, BIOGEOCHEMISTRY, V49, P143, DOI 10.1023/A:1006375530844; Maryland Department of Agriculture (MDA), MAR 2014 2015 COV CR; McCarty GW, 2008, J SOIL WATER CONSERV, V63, P461, DOI 10.2489/jswc.63.6.461; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Neitsch S.L., 2011, SOIL WATER ASSESSMEN, DOI [10.1016/j.scitotenv.2015.11.063, DOI 10.1016/J.SCITOTENV.2015.11.063]; NRC, 2011, ACH NUTR SED RED GOA; Prabhakara K, 2015, INT J APPL EARTH OBS, V39, P88, DOI 10.1016/j.jag.2015.03.002; Qiu LJ, 2012, INT J SEDIMENT RES, V27, P226, DOI 10.1016/S1001-6279(12)60030-4; Sadeghi A., 2007, P 2007 ASABE ANN INT; Seo M, 2014, J ENVIRON QUAL, V43, P869, DOI 10.2134/jeq2013.11.0450; Singer J, COVER CROPS MIDWEST; Singh A, 2014, HYDROLOG SCI J, V59, P351, DOI 10.1080/02626667.2013.872787; SMITH SJ, 1990, AGRON J, V82, P112, DOI 10.2134/agronj1990.00021962008200010025x; STAVER K, 1989, 2 PAN ICID REG C DEN, P163; Ullrich A, 2010, ENVIRON MONIT ASSESS, V171, P513, DOI 10.1007/s10661-009-1296-8; Van Liew MW, 2007, J HYDROL ENG, V12, P173, DOI 10.1061/(ASCE)1084-0699(2007)12:2(173); Weed DAJ, 1996, J ENVIRON QUAL, V25, P709, DOI 10.2134/jeq1996.00472425002500040010x; Yeo IY, 2014, HYDROL EARTH SYST SC, V18, P5239, DOI 10.5194/hess-18-5239-2014	40	25	25	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157637	10.1371/journal.pone.0157637	http://dx.doi.org/10.1371/journal.pone.0157637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352119	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900012
J	Cai, JH; Okamoto, M; Atieno, J; Sutton, T; Li, YL; Miklavcic, SJ				Cai, Jinhai; Okamoto, Mamoru; Atieno, Judith; Sutton, Tim; Li, Yongle; Miklavcic, Stanley J.			Quantifying the Onset and Progression of Plant Senescence by Color Image Analysis for High Throughput Applications	PLOS ONE			English	Article							LEAF SENESCENCE; SINGLE IMAGE; LEAVES; BARLEY; ROOTS; WHEAT; YIELD; NDVI	Leaf senescence, an indicator of plant age and ill health, is an important phenotypic trait for the assessment of a plant's response to stress. Manual inspection of senescence, however, is time consuming, inaccurate and subjective. In this paper we propose an objective evaluation of plant senescence by color image analysis for use in a high throughput plant phenotyping pipeline. As high throughput phenotyping platforms are designed to capture whole-of-plant features, camera lenses and camera settings are inappropriate for the capture of fine detail. Specifically, plant colors in images may not represent true plant colors, leading to errors in senescence estimation. Our algorithm features a color distortion correction and image restoration step prior to a senescence analysis. We apply our algorithm to two time series of images of wheat and chickpea plants to quantify the onset and progression of senescence. We compare our results with senescence scores resulting from manual inspection. We demonstrate that our procedure is able to process images in an automated way for an accurate estimation of plant senescence even from color distorted and blurred images obtained under high throughput conditions.	[Cai, Jinhai; Miklavcic, Stanley J.] Univ S Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5095, Australia; [Okamoto, Mamoru; Atieno, Judith; Li, Yongle] Univ Adelaide, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia; [Sutton, Tim] South Australian Res & Dev Inst, 2b Hartley Grove, Urrbrae, SA 5064, Australia	University of South Australia; University of Adelaide; South Australian Research & Development Institute (SARDI)	Miklavcic, SJ (corresponding author), Univ S Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5095, Australia.	Stan.Miklavcic@unisa.edu.au	Sutton, Tim/ABC-8454-2020; Okamoto, Mamoru/AAF-4265-2019; Li, Yongle/G-3227-2017	Okamoto, Mamoru/0000-0002-2989-607X; Li, Yongle/0000-0003-3966-8596; Sutton, Timothy/0000-0002-9059-0774; Miklavcic, Stanley/0000-0002-2361-246X	Australian Research Council; Australian Grains Research and Development Corporation; South Australian Government; South Australian Government Department of Further Education, Employment, Science and Technology; Australia-India Strategic Research Fund; Australian Research Council Linkage Grant [LP140100347]; Department of Industry and Science, Australian Federal Government	Australian Research Council(Australian Research Council); Australian Grains Research and Development Corporation(Grains R&D Corp); South Australian Government; South Australian Government Department of Further Education, Employment, Science and Technology; Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council Linkage Grant(Australian Research Council); Department of Industry and Science, Australian Federal Government	The authors express their gratitude for partial funding provided by the Australian Research Council, the Australian Grains Research and Development Corporation, the South Australian Government, and the South Australian Government Department of Further Education, Employment, Science and Technology (http://www.sa.gov.au/) for partial support of JC, MO, YL and JA; and the Australia-India Strategic Research Fund, Department of Industry and Science, Australian Federal Government. Australian Research Council Linkage Grant # LP140100347 was received by SM and JC (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs Hamid Laga and Jason Connor from the University of South Australia, Associate Professor Qiongyan Li from Bejing Forest University and Dr. Bettina Berger from The Plant Accelerator at Adelaide University for many insightful discussions. Finally, we express our gratitude for partial funding provided by the Australian Research Council, the Australian Grains Research and Development Corporation, the South Australian Government, and the Australia-India Strategic Research Fund, Department of Industry and Science, Australian Federal Government.	Bergstrasser S, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0043-0; Cai JH, 2015, J EXP BOT, V66, P6551, DOI 10.1093/jxb/erv359; Campisi P., 2007, BLIND IMAGE DECONVOL; Can S, 1997, PLANT PHYSIOL, V113, P313; Di Bellat CM, 2004, INT J REMOTE SENS, V25, P5415, DOI 10.1080/01431160412331269724; Distelfeld A, 2014, J EXP BOT, V65, P3783, DOI 10.1093/jxb/ert477; Fergus R, 2006, ACM T GRAPHIC, V25, P787, DOI 10.1145/1141911.1141956; Furbank R. T., 2009, FUNCT PLANT BIOL, V36, P5; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gregersen PL, 2014, BIOTECH AGR FOREST, V69, P113, DOI 10.1007/978-3-662-44406-1_7; Harris BN, 2010, PLANT SOIL, V336, P377, DOI 10.1007/s11104-010-0489-9; Kant S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116349; Kumar P, 2014, PLANT SOIL, V380, P193, DOI 10.1007/s11104-014-2071-3; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Maliro MFA, 2008, GENET RESOUR CROP EV, V55, P53, DOI 10.1007/s10722-007-9214-9; NICHOLSON SE, 1994, REMOTE SENS ENVIRON, V50, P107, DOI 10.1016/0034-4257(94)90038-8; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; Nishiyama M, 2011, IEEE T PATTERN ANAL, V33, P838, DOI 10.1109/TPAMI.2010.203; Romer C, 2012, FUNCT PLANT BIOL, V39, P878, DOI 10.1071/FP12060; Shan Q, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360672; Tai YW, 2009, IEEE IMAGE PROC, P1797, DOI 10.1109/ICIP.2009.5414620; Whyte O, 2012, INT J COMPUT VISION, V98, P168, DOI 10.1007/s11263-011-0502-7; Zhang L, 2006, ACM T GRAPHIC, V25, P907, DOI 10.1145/1141911.1141974; Zhu X, 2013, IEEE T IMAGE PROCESS, V22, P4879, DOI 10.1109/TIP.2013.2279316	25	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157102	10.1371/journal.pone.0157102	http://dx.doi.org/10.1371/journal.pone.0157102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348807	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000378801200005
J	Maruta, H; Yoshimura, Y; Araki, A; Kimoto, M; Takahashi, Y; Yamashita, H				Maruta, Hitomi; Yoshimura, Yukihiro; Araki, Aya; Kimoto, Masumi; Takahashi, Yoshitaka; Yamashita, Hiromi			Activation of AMP-Activated Protein Kinase and Stimulation of Energy Metabolism by Acetic Acid in L6 Myotube Cells	PLOS ONE			English	Article							MYOCYTE ENHANCER FACTOR-2; BOX TRANSCRIPTION FACTORS; GROWTH-FACTOR-BETA; FATTY OLETF RATS; GLUCOSE-TRANSPORTER; SKELETAL-MUSCLE; GENE-EXPRESSION; TRANSGENIC MICE; GLUT4 GENE; INSULIN-RESISTANCE	Previously, we found that orally administered acetic acid decreased lipogenesis in the liver and suppressed lipid accumulation in adipose tissue of Otsuka Long-Evans Tokushima Fatty rats, which exhibit hyperglycemic obesity with hyperinsulinemia and insulin resistance. Administered acetic acid led to increased phosphorylation of AMP-activated protein kinase (AMPK) in both liver and skeletal muscle cells, and increased transcripts of myoglobin and glucose transporter 4 (GLUT4) genes in skeletal muscle of the rats. It was suggested that acetic acid improved the lipid metabolism in skeletal muscles. In this study, we examined the activation of AMPK and the stimulation of GLUT4 and myoglobin expression by acetic acid in skeletal muscle cells to clarify the physiological function of acetic acid in skeletal muscle cells. Acetic acid added to culture medium was taken up rapidly by L6 cells, and AMPK was phosphorylated upon treatment with acetic acid. We observed increased gene and protein expression of GLUT4 and myoglobin. Uptake of glucose and fatty acids by L6 cells were increased, while triglyceride accumulation was lower in treated cells compared to untreated cells. Furthermore, treated cells also showed increased gene and protein expression of myocyte enhancer factor 2A (MEF2A), which is a well-known transcription factor involved in the expression of myoglobin and GLUT4 genes. These results indicate that acetic acid enhances glucose uptake and fatty acid metabolism through the activation of AMPK, and increases expression of GLUT4 and myoglobin.	[Maruta, Hitomi; Araki, Aya] Okayama Prefectural Univ, Grad Sch Hlth & Welf Sci, Soja Shi, Okayama, Japan; [Yoshimura, Yukihiro; Kimoto, Masumi; Takahashi, Yoshitaka; Yamashita, Hiromi] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Soja Shi, Okayama, Japan	Okayama Prefectural University; Okayama Prefectural University	Yamashita, H (corresponding author), Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Soja Shi, Okayama, Japan.	yamashit@fhw.oka-pu.ac.jp	Yoshimura, Yukihiro/AAJ-5213-2020		JSPS KAKENHI [15K07437, 26850087]; Grants-in-Aid for Scientific Research [26850087, 16K08916] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following sources of funding: JSPS KAKENHI 15K07437 for Grant-in-Aid for Scientific Research (C) and JSPS KAKENHI 26850087 for Grant-in-Aid for Young Scientists (B).	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; BALLARD FJ, 1972, AM J CLIN NUTR, V25, P773; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; BREMER J, 1984, FATTY ACID METABOLIS, P113; De Angelis L, 1998, P NATL ACAD SCI USA, V95, P12358, DOI 10.1073/pnas.95.21.12358; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Guariguata L, 2014, DIABETES RES CLIN PR, P103; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Kanatous SB, 1999, J APPL PHYSIOL, V86, P1247, DOI 10.1152/jappl.1999.86.4.1247; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LIU ML, 1994, J BIOL CHEM, V269, P28514; Magnan C, 1996, LIPIDS, V31, P1141, DOI 10.1007/BF02524288; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Mittendorfer B, 1998, AM J PHYSIOL-ENDOC M, V274, pE978, DOI 10.1152/ajpendo.1998.274.6.E978; Molkentin JD, 1996, MOL CELL BIOL, V16, P3814; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Moore F, 1999, EUR J BIOCHEM, V199, P691; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Morisaki T, 1997, J BIOCHEM-TOKYO, V122, P939, DOI 10.1093/oxfordjournals.jbchem.a021855; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; Neufer PD, 1998, AM J PHYSIOL-CELL PH, V274, pC341, DOI 10.1152/ajpcell.1998.274.2.C341; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Pouteau E, 1996, AM J PHYSIOL-ENDOC M, V271, pE58, DOI 10.1152/ajpendo.1996.271.1.E58; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sharma K., 2011, KIDNEY INT S, V4, P113; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; TREADWAY JL, 1994, J BIOL CHEM, V269, P29956; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; UNDERWOOD LE, 1987, AM J PHYSIOL, V252, pC450, DOI 10.1152/ajpcell.1987.252.4.C450; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Yamashita H, 2001, BBA-MOL CELL BIOL L, V1532, P79, DOI 10.1016/S1388-1981(01)00117-2; Yamashita H, 2007, BIOSCI BIOTECH BIOCH, V71, P1236, DOI 10.1271/bbb.60668; Yamashita H, 2009, BIOSCI BIOTECH BIOCH, V73, P570, DOI 10.1271/bbb.80634; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Yu YT, 1996, J BIOL CHEM, V271, P24675; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zheng D., 1985, J APPL PHYSIOL, V91, P1073; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	63	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158055	10.1371/journal.pone.0158055	http://dx.doi.org/10.1371/journal.pone.0158055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348124	gold, Green Submitted, Green Published			2022-12-26	WOS:000378801200031
J	Ping, XJ; Jin, XM				Ping, Xingjie; Jin, Xiaoming			Chronic Posttraumatic Epilepsy following Neocortical Undercut Lesion in Mice	PLOS ONE			English	Article							V PYRAMIDAL NEURONS; CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; EPILEPTOGENESIS; SEIZURES; HYPEREXCITABILITY; PLASTICITY; MODELS; CORTEX	Posttraumatic epilepsy (PTE) usually develops in a small percentage of patients of traumatic brain injury after a varying latent period. Modeling this chronic neurological condition in rodents is time consuming and inefficient, which constitutes a significant obstacle in studying its mechanism and discovering novel therapeutics for its prevention and treatment. Partially isolated neocortex, or undercut, is known to induce cortical hyperexcitability and epileptiform activity in vitro, and has been used extensively for studying the neurophysiological mechanism of posttraumatic epileptogenesis. However, whether the undercut lesion in rodents causes chronic epileptic seizures has not been systematically characterized. Here we used a miniature telemetry system to continuously monitor electroencephalography (EEG) in adult C57BL mice for up to 3 months after undercut surgery. We found that 50% of animals developed spontaneous seizures between 16-50 days after injury. The mean seizure duration was 8.9 +/- 3.6 seconds, and the average seizure frequency was 0.17 +/- 0.17 times per day. There was no progression in seizure frequency and duration over the recording period. Video monitoring revealed behavioral arrests and clonic limb movement during seizure attacks. A pentylenetetrazol (PTZ) test further showed increased seizure susceptibility in the undercut mice. We conclude that undercut lesion in mice is a model of chronic PTE that involves spontaneous epileptic seizures.	[Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indiana Spinal Cord & Brain Injury Res Grp, 320 W 15th St, Indianapolis, IN 46202 USA	Goodman Campbell Brain & Spine; Indiana University System; Indiana University Bloomington	Jin, XM (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indiana Spinal Cord & Brain Injury Res Grp, 320 W 15th St, Indianapolis, IN 46202 USA.	xijin@iupui.edu	Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; ping, xingjie/AAW-4597-2020	Jin, Xiaoming/0000-0002-8671-8640; 	National Institute of Health/NINDS [NS057940]; Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [A70-1-079438, A70-3-079971, A70-4-079956]; CURE Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS057940, R00NS057940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039530] Funding Source: NIH RePORTER	National Institute of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health; CURE Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Health/NINDS NS057940, the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (A70-1-079438, A70-3-079971, and A70-4-079956), and CURE Epilepsy Foundation to XJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; [Anonymous], [No title captured]; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Chauvette S, 2016, J NEUROSCI METH, V260, P185, DOI 10.1016/j.jneumeth.2015.08.030; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Li HF, 2005, J NEUROPHYSIOL, V93, P146, DOI 10.1152/jn.00665.2004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SCOVILLE WB, 1960, P ROY SOC MED, V53, P721; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2014, INT REV NEUROBIOL, V114, P9, DOI 10.1016/B978-0-12-418693-4.00002-9; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Xiong WH, 2011, JOVE-J VIS EXP, DOI 10.3791/2840; Zayachkivsky A, 2013, J NEUROPHYSIOL, V109, P900, DOI 10.1152/jn.00593.2012; Zayachkivsky A, 2015, JOVE-J VIS EXP, DOI 10.3791/52554	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158231	10.1371/journal.pone.0158231	http://dx.doi.org/10.1371/journal.pone.0158231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348225	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200054
J	Rosendaal, NTA; Hendriks, ME; Verhagen, MD; Bolarinwa, OA; Sanya, EO; Kolo, PM; Adenusi, P; Agbede, K; van Eck, D; Tan, SS; Akande, TM; Redekop, W; Schultsz, C; Gomez, GB				Rosendaal, Nicole T. A.; Hendriks, Marleen E.; Verhagen, Mark D.; Bolarinwa, Oladimeji A.; Sanya, Emmanuel O.; Kolo, Philip M.; Adenusi, Peju; Agbede, Kayode; van Eck, Diederik; Tan, Siok Swan; Akande, Tanimola M.; Redekop, William; Schultsz, Constance; Gomez, Gabriela B.			Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE PREVENTION; FACILITY QUALITY IMPROVEMENT; SYSTOLIC BLOOD-PRESSURE; ACUTE HEART-FAILURE; MYOCARDIAL-INFARCTION; RACIAL-DIFFERENCES; STROKE INCIDENCE; BURDEN; INTERVENTIONS; EPIDEMIOLOGY	Background High blood pressure is a leading risk factor for death and disability in sub-Saharan Africa (SSA). We evaluated the costs and cost-effectiveness of hypertension care provided within the Kwara State Health Insurance (KSHI) program in rural Nigeria. Methods A Markov model was developed to assess the costs and cost-effectiveness of population-level hypertension screening and subsequent antihypertensive treatment for the population at-risk of cardiovascular disease (CVD) within the KSHI program. The primary outcome was the incremental cost per disability-adjusted life year (DALY) averted in the KSHI scenario compared to no access to hypertension care. We used setting-specific and empirically-collected data to inform the model. We defined two strategies to assess eligibility for antihypertensive treatment based on 1) presence of hypertension grade 1 and 10-year CVD risk of >20%, or grade 2 hypertension irrespective of 10-year CVD risk (hypertension and risk based strategy) and 2) presence of hypertension in combination with a CVD risk of >20% (risk based strategy). We generated 95% confidence intervals around the primary outcome through probabilistic sensitivity analysis. We conducted one-way sensitivity analyses across key model parameters and assessed the sensitivity of our results to the performance of the reference scenario. Results Screening and treatment for hypertension was potentially cost-effective but the results were sensitive to changes in underlying assumptions with a wide range of uncertainty. The incremental cost-effectiveness ratio for the first and second strategy respectively ranged from US$ 1,406 to US$ 7,815 and US$ 732 to US$ 2,959 per DALY averted, depending on the assumptions on risk reduction after treatment and compared to no access to antihypertensive treatment. Conclusions Hypertension care within a subsidized private health insurance program may be cost-effective in rural Nigeria and public-private partnerships such as the KSHI program may provide opportunities to finance CVD prevention care in SSA.	[Rosendaal, Nicole T. A.; Hendriks, Marleen E.; Verhagen, Mark D.; Schultsz, Constance; Gomez, Gabriela B.] Univ Amsterdam, Dept Global Hlth, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Pietersbergweg 17, NL-1105 BM Amsterdam, Netherlands; [Rosendaal, Nicole T. A.] Univ Hawaii, Off Publ Hlth Studies, John A Burns Sch Med, 1960 East West Rd, Honolulu, HI 96822 USA; [Bolarinwa, Oladimeji A.; Akande, Tanimola M.] Univ Ilorin, Teaching Hosp, Dept Epidemiol & Community Hlth, PMB 1459, Ilorin 240001, Nigeria; [Sanya, Emmanuel O.; Kolo, Philip M.] Univ Ilorin, Teaching Hosp, Dept Med, PMB 1459, Ilorin 240001, Nigeria; [Adenusi, Peju] Hygeia Nigeria Ltd, 13B Idejo St, Lagos, Nigeria; [Agbede, Kayode] Ogo Oluwa Hosp, Bacita, Kwara State, Nigeria; [van Eck, Diederik] PharmAccess Fdn, Amsterdam, Netherlands; [Tan, Siok Swan; Redekop, William] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [Gomez, Gabriela B.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Hawaii System; University of Ilorin; University of Ilorin; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine	Hendriks, ME (corresponding author), Univ Amsterdam, Dept Global Hlth, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Pietersbergweg 17, NL-1105 BM Amsterdam, Netherlands.	m.hendriks@aighd.org	Redekop, Ken/AAA-2423-2020; Kolo, Philip/AAY-7469-2021; Akande, Tanimola Makanjuola/U-1362-2019	Kolo, Philip/0000-0003-2837-2853; Verhagen, Mark/0000-0003-2746-0309; Redekop, Ken/0000-0001-9538-4083; Tan, Siok Swan/0000-0002-9522-2321	Health Insurance Fund; PharmAccess Foundation; Hygeia Nigeria limited	Health Insurance Fund; PharmAccess Foundation; Hygeia Nigeria limited	This study was funded by the Health Insurance Fund (www.hifund.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hygeia Nigeria Ltd. provided support in the form of a salary for co-author, Dr. Peju Adenusi (PA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.r We thank PharmAccess Foundation and Hygeia Nigeria limited for their support of the study.	Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Adoukonou T, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.121.2790; Alkali Nura H, 2013, Niger Med J, V54, P129, DOI 10.4103/0300-1652.110051; Amsterdam EA, 2014, CIRCULATION, V130, P2246; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Birabi Bridget N, 2012, Glob J Health Sci, V4, P17, DOI 10.5539/gjhs.v4n6p17; Callender T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001699; Chandra V., 2006, NEUROLOGICAL DISORDE, P627; Damasceno A, 2010, STROKE, V41, P2463, DOI 10.1161/STROKEAHA.110.594275; Danesi MA, 2013, J NEUROL SCI, V331, P43, DOI 10.1016/j.jns.2013.04.026; Desalu OO, 2011, ANN AFR MED, V10, P80, DOI 10.4103/1596-3519.82061; Ekwunife Obinna Ikechukwu, 2013, Cost Eff Resour Alloc, V11, P2, DOI 10.1186/1478-7547-11-2; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Gaziano, 2006, CARDIOVASCULUAR DIS, P645; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gombet T R, 2009, Med Trop (Mars), V69, P45; Guinhouya KM, 2010, SANTE, DOI [10.1684/san.2010.0192, DOI 10.1684/SAN.2010.0192]; Hannerz H, 2001, STROKE, V32, P1739, DOI 10.1161/01.STR.32.8.1739; Hendriks ME, 2016, INT J CARDIOL, V202, P477, DOI 10.1016/j.ijcard.2015.09.036; Hendriks ME, 2015, J HYPERTENS, V33, P376, DOI 10.1097/HJH.0000000000000402; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Howard G, 2013, JAMA INTERN MED, V173, P46, DOI 10.1001/2013.jamainternmed.857; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Hutchins R, 2015, CIRC-CARDIOVASC QUAL, V8, P155, DOI 10.1161/CIRCOUTCOMES.114.001240; Hygeia group, HYG COMM HLTH CAR; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Jolly S, 2010, AM J MED, V123, P811, DOI 10.1016/j.amjmed.2010.04.020; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x; Kolo P., 2010, COST MANAGING UNPUB; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lawes C, 2004, COMP QUANTIFICATION, P281; Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Makubi A, 2014, HEART, V100, P1235, DOI 10.1136/heartjnl-2014-305599; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Mendis S, 2013, PROG CARDIOVASC DIS, V56, P314, DOI 10.1016/j.pcad.2013.09.001; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National High Blood Pressure Education Program, 2004, 7 REP JOINT NAT COMM; National Institute for Health and Clinical Excellence (NICE) International, 2014, METHODS EC EVALUATIO; NHIS, 2011, NHIS HEALTHC PROV SE; Ntsekhe M, 2013, HEART, V99, P1230, DOI 10.1136/heartjnl-2012-303585; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Ogah OS, 2014, JACC-HEART FAIL, V2, P250, DOI 10.1016/j.jchf.2013.12.005; Ogun SA, 2005, STROKE, V36, P1120, DOI 10.1161/01.STR.0000166182.50840.31; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; OSUNTOKUN BO, 1979, STROKE, V10, P205, DOI 10.1161/01.STR.10.2.205; Pikija S, 2012, NEUROEPIDEMIOLOGY, V38, P164, DOI 10.1159/000336114; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Reinier K, 2015, CIRCULATION, P380; Robberstad Bjarne, 2007, Cost Eff Resour Alloc, V5, P3, DOI 10.1186/1478-7547-5-3; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Sliwa K, 2013, HEART, V99, P1317, DOI 10.1136/heartjnl-2013-303592; The World Bank, HLTH EXP PER CAP; Toure K, 2005, Med Trop (Mars), V65, P458; Wahab KW, 2008, INT J STROKE, V3, P290, DOI 10.1111/j.1747-4949.2008.00217.x; Walker RW, 2011, J NEUROL NEUROSUR PS, V82, P1001, DOI 10.1136/jnnp.2010.231944; Walker RW, 2003, STROKE, V34, P1604, DOI 10.1161/01.STR.0000077943.63718.67; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2018, GLOBAL HLTH OBSERVAT; WHO, 2007, PREV CARD DIS; WHO, 2011, GLOBAL STATUS REPORT; WHO, SCAL ACT NCDS MUCH W; WHO. WHO, 2008, WHO HLTH SERV DEL CO; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Bank, 2014, OUT OF POCK HLTH EXP; World Bank, GDP PER CAP CURR US; ZUKEL WJ, 1969, AM HEART J, V78, P159, DOI 10.1016/0002-8703(69)90004-0	77	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157925	10.1371/journal.pone.0157925	http://dx.doi.org/10.1371/journal.pone.0157925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348310	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378801200022
J	Foss, L; Reisen, WK; Fang, Y; Kramer, V; Padgett, K				Foss, Leslie; Reisen, William K.; Fang, Ying; Kramer, Vicki; Padgett, Kerry			Evaluation of Nucleic Acid Preservation Cards for West Nile Virus Testing in Dead Birds	PLOS ONE			English	Article							MOLECULAR-DETECTION; VIRAL-RNA; CALIFORNIA; INFECTION; PCR; SURVEILLANCE; STORAGE; SYSTEM; FIELD	The California West Nile virus (WNV) Dead Bird Surveillance Program (DBSP) is an important component of WNV surveillance in the state. We evaluated FTA (TM) and RNASound (TM) cards as an alternative method for sampling dead birds for WNV molecular testing as these cards allow for more cost effective, rapid, and safer diagnostic sampling than the shipment of bird carcasses. To evaluate accuracy of results among avian sampling regimes, Reverse-Transcription Polymerase Chain Reaction (RT-PCR) results from FTA (TM) and RNASound (TM) cards were compared with results from kidney tissue, brain tissue, or oral swabs in lysis buffer in 2012-2013. In addition, RT-PCR results were compared with results from oral swabs tested by rapid antigen tests (RAMP (TM) and VecTOR (TM)). While test results from the cards were not as sensitive as kidney tissue testing, they were more likely to provide accurate results than rapid antigen tests, and detected WNV in corvids as well as in other passerines, raptors, and waterfowl. Overall, WNV RT-PCR cycle threshold (Ct) scores from the cards were higher than those from tissue testing, but both card products displayed high sensitivity and specificity. American Crow samples provided the highest sensitivity. The cards also proved to be easier and more convenient vehicles for collecting and shipping samples, and in 2014 our program launched use of RNASound (TM) cards in the DBSP. Both FTA (TM) and RNASound (TM) products displayed 96% agreement with tissue results and are an adequate alternative sampling method for WNV dead bird testing.	[Foss, Leslie; Padgett, Kerry] Calif Dept Publ Hlth, Vector Borne Dis Sect, 850 Marina Bay Pkwy, Richmond, CA USA; [Reisen, William K.; Fang, Ying] Univ Calif Davis, Davis Arbovirus Res & Training Lab, Dept Pathol Microbiol & Immunol, Sch Vet Med, 3331 VetMed3A, Davis, CA 95616 USA; [Kramer, Vicki] Calif Dept Publ Hlth, Vector Borne Dis Sect, 1616 Capitol Ave,MS 7307,POB 997377, Sacramento, CA USA	California Department of Public Health; University of California System; University of California Davis; California Department of Public Health	Foss, L (corresponding author), Calif Dept Publ Hlth, Vector Borne Dis Sect, 850 Marina Bay Pkwy, Richmond, CA USA.	leslie.foss@cdph.ca.gov		Foss, Leslie/0000-0003-4269-3557; Padgett, Kerry/0000-0002-9535-3401	Epidemiology and Laboratory Capacity for Infectious Diseases from the US Centers for Disease Control and Prevention [3U50CK000410]	Epidemiology and Laboratory Capacity for Infectious Diseases from the US Centers for Disease Control and Prevention	This study was supported by the Epidemiology and Laboratory Capacity for Infectious Diseases cooperative agreement number 3U50CK000410 from the US Centers for Disease Control and Prevention.	Anderson J, 2012, P MOSQ VECTOR CONTRO, V80, P84; Brault AC, 2015, J MED ENTOMOL, V52, P491, DOI 10.1093/jme/tjv021; CARNEY R, 2005, P CALIFORNIA MOSQUIT, V73, P105; Chouicha N, 2013, P CALIF MOSQ VECTOR, V81, P28; Dauner AL, 2015, AM J TROP MED HYG, V93, P46, DOI 10.4269/ajtmh.15-0110; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Foss L, 2015, J WILDLIFE DIS, V51, P576, DOI 10.7589/2014-06-144; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Keeler SP, 2012, AVIAN DIS, V56, P200, DOI 10.1637/9862-072611-Reg.1; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kraus RHS, 2011, JOVE-J VIS EXP, DOI 10.3791/2832; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; MCCAUGHEY K, 2003, P MOSQ VECTOR CONTRO, V71, P38; Moscoso H, 2004, AVIAN DIS, V48, P841, DOI 10.1637/7215-060104; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Padgett KA, 2006, VECTOR-BORNE ZOONOT, V6, P183, DOI 10.1089/vbz.2006.6.183; Reisen WK, 2013, VECTOR-BORNE ZOONOT, V13, P401, DOI 10.1089/vbz.2012.1097; Reisen WK, 2006, P CALIF MOSQ VECTOR, V74, P33; Shi PY, 2003, EXPERT REV MOL DIAGN, V3, P357, DOI 10.1586/14737159.3.3.357; VanDalen KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068537; Weingartl HM, 2004, VET PATHOL, V41, P362, DOI 10.1354/vp.41-4-362; Wheeler SS, 2009, CONDOR, V111, P1, DOI 10.1525/cond.2009.080013	24	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157555	10.1371/journal.pone.0157555	http://dx.doi.org/10.1371/journal.pone.0157555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341492	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600011
J	Berens, EB; Sharif, GM; Schmidt, MO; Yan, G; Shuptrine, CW; Weiner, LM; Glasgow, E; Riegel, AT; Wellstein, A				Berens, E. B.; Sharif, G. M.; Schmidt, M. O.; Yan, G.; Shuptrine, C. W.; Weiner, L. M.; Glasgow, E.; Riegel, A. T.; Wellstein, A.			Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion	ONCOGENE			English	Article							INTERMEDIATE-FILAMENTS; EXPRESSION; MICROENVIRONMENT; DISSEMINATION; PROGRESSION; METASTASIS; MOTILITY; ADHESION	Cancer cell vascular invasion is a crucial step in the malignant progression toward metastasis. Here we used a genome-wide RNA interference screen with E0771 mammary cancer cells to uncover drivers of endothelial monolayer invasion. We identified keratin-associated protein 5-5 (Krtap5-5) as a candidate. Krtap5-5 belongs to a large protein family that is implicated in crosslinking keratin intermediate filaments during hair formation, yet these Krtaps have no reported role in cancer. Depletion of Krtap5-5 from cancer cells led to cell blebbing and a loss of keratins 14 and 18, in addition to the upregulation of vimentin intermediate filaments. This intermediate filament subtype switching induced dysregulation of the actin cytoskeleton and reduced the expression of hemidesmosomal a6/beta 4-integrins. We further demonstrate that knockdown of keratin 18 phenocopies the loss of Krtap5-5, suggesting that Krtap5-5 crosstalks with keratin 18 in E0771 cells. Disruption of the keratin cytoskeleton by perturbing Krtap5-5 function broadly altered the expression of cytoskeleton regulators and the localization of cell surface markers. Krtap5-5 depletion did not impact cell viability but reduced cell motility and extracellular matrix invasion, as well as extravasation of cancer cells into tissues in zebrafish and mice. We conclude that Krtap5-5 is a previously unknown regulator of cytoskeletal function in cancer cells that modulates motility and vascular invasion. Thus, in addition to its physiologic function, a Krtap can serve as a switch toward malignant progression.	[Berens, E. B.; Sharif, G. M.; Schmidt, M. O.; Yan, G.; Shuptrine, C. W.; Weiner, L. M.; Glasgow, E.; Riegel, A. T.; Wellstein, A.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University	Wellstein, A (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Canc Ctr, 3970 Reservoir Rd, Washington, DC 20007 USA.	wellstea@georgetown.edu	Schmidt, Marcel/AAV-8054-2021	Schmidt, Marcel/0000-0002-3991-2766; Sharif, Ghada/0000-0001-5344-3575; Glasgow, Eric/0000-0001-7729-3954	NIH/NCI [CA71508, CA51008, CA177466, CA113477]; NATIONAL CANCER INSTITUTE [R01CA050633, P30CA051008, R01CA071508, R01CA113477, R33CA177466, T32CA009686] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Peter Johnson of the Georgetown University Microscopy Core for assistance with immunofluorescence, Dr Karen Creswell and Alex Joseph of the Georgetown University Flow Cytometry Core for running our FACS samples, and Idalia Cruz for assistance with the tail vein injections. We extend our gratitude to Dr Rudolf Leube and Dr Nicole Schwarz for generously providing the KRT18 expression vector used in this study, as well as to Dr Anne Cress for the HYD1 hemidesmosomal integrin blocker. Finally, we thank Dr Ian Gallicano for critical evaluation of the manuscript and for providing constructive feedback. This study was supported by NIH/NCI grants CA71508, CA51008, CA177466 (AW) and CA113477 (ATR).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Berens EB, 2015, JOVE-J VIS EXP, DOI 10.3791/53409; Bornschlogl T, 2016, P NATL ACAD SCI USA, V113, P5940, DOI 10.1073/pnas.1520302113; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Cobb JP, 1996, BRIT J ANAESTH, V77, P3, DOI 10.1093/bja/77.1.3; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Cummings MC, 2014, J PATHOL, V232, P23, DOI 10.1002/path.4288; de Pereda JM, 2009, CELL ADHES MIGR, V3, P361, DOI 10.4161/cam.3.4.9525; Deb-Choudhury S, 2015, PROTEINS, V83, P224, DOI 10.1002/prot.24727; DeRoock IB, 2001, CANCER RES, V61, P3308; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Ewens A, 2005, ANTICANCER RES, V25, P3905; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fujikawa H, 2013, J INVEST DERMATOL, V133, P2780, DOI 10.1038/jid.2013.233; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Khan I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-779; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Lefkowitz GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027603; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moller B., 2016, J OPEN RES STW, V4, P6, DOI [10.5334/jors.103, DOI 10.5334/JORS.103]; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Schaller G, 1996, CLIN CANCER RES, V2, P1879; Seltmann K, 2015, J INVEST DERMATOL, V135, P1609, DOI 10.1038/jid.2015.46; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Sharif GM, 2015, ONCOGENE, V34, P5879, DOI 10.1038/onc.2015.44; Shimomura Y, 2015, J INVEST DERMATOL, V10, P230; Sroka TC, 2006, CARCINOGENESIS, V27, P1748, DOI 10.1093/carcin/bgl005; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Wu DD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-241; Yahagi S, 2004, BIOCHEM BIOPH RES CO, V318, P655, DOI 10.1016/j.bbrc.2004.04.074; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	45	17	17	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					593	605		10.1038/onc.2016.234	http://dx.doi.org/10.1038/onc.2016.234			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27375028	Green Accepted			2022-12-26	WOS:000394167700002
J	Subramaniam, S; Ozdener, MH; Abdoul-Azize, S; Saito, K; Malik, B; Maquart, G; Hashimoto, T; Marambaud, P; Aribi, M; Tordoff, MG; Besnard, P; Khan, NA				Subramaniam, Selvakumar; Ozdener, Mehmet Hakan; Abdoul-Azize, Souleymane; Saito, Katsuyoshi; Malik, Bilal; Maquart, Guillaume; Hashimoto, Toshihiro; Marambaud, Philippe; Aribi, Mourad; Tordoff, Michael G.; Besnard, Philippe; Khan, Naim Akhtar			ERK1/2 activation in human taste bud cells regulates fatty acid signaling and gustatory perception of fat in mice and humans	FASEB JOURNAL			English	Article						MAPK; CALHM1; lipids	PROTEIN-TYROSINE KINASES; ION-CHANNEL; SRC KINASE; CD36; PREFERENCE; CALHM1; OBESE; INVOLVEMENT; SENSITIVITY; HOMEOSTASIS	Obesity is a major public health problem. An in-depth knowledge of the molecular mechanisms of oro-sensory detection of dietary lipids may help fight it. Humans and rodents can detect fatty acids via lipido-receptors, such as CD36 and GPR120. We studied the implication of the MAPK pathways, in particular, ERK1/2, in the gustatory detection of fatty acids. Linoleic acid, a dietary fatty acid, induced via CD36 the phosphorylation of MEK1/2-ERK1/2-ETS-like transcription factor-1 cascade, which requires Fyn-Src kinase and lipid rafts in human taste bud cells (TBCs). ERK1/2 cascade was activated by Ca2+ signaling via opening of the calcium-homeostasis modulator-1 (CALHM1) channel. Furthermore, fatty acid-evoked Ca2+ signaling and ERK1/2 phosphorylation were decreased in both human TBCs after small interfering RNA knockdown of CALHM1 channel and in TBCs from Calhm1(-/-) mice. Targeted knockdown of ERK1/2 by small interfering RNA or PD0325901 (MEK1/2 inhibitor) in the tongue and genetic ablation of Erk1 or Calhm1 genes impaired preference for dietary fat in mice. Lingual inhibition of ERK1/2 in healthy volunteers also decreased orogustatory sensitivity for linoleic acid. Our data demonstrate that ERK1/2-MAPK cascade is regulated by the opening of CALHM1 Ca2+ channel in TBCs to modulate orogustatory detection of dietary lipids in mice and humans.	[Subramaniam, Selvakumar; Abdoul-Azize, Souleymane; Maquart, Guillaume; Besnard, Philippe; Khan, Naim Akhtar] Univ Bourgogne, AgroSup, Unite Mixte Rech INSERM U866, Dijon, France; [Ozdener, Mehmet Hakan; Malik, Bilal; Tordoff, Michael G.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Saito, Katsuyoshi] Kao Corp, Tokyo, Japan; [Hashimoto, Toshihiro] Tokushima Bunri Univ, Tokushima, Japan; [Marambaud, Philippe] Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA; [Aribi, Mourad] Abou Bekr Bel Kaid Univ, Lab Appl Mol Biol & Immunol, Tilimsen, Algeria; [Subramaniam, Selvakumar] Bharathiar Univ, Coimbatore, Tamil Nadu, India	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Monell Chemical Senses Center; KAO Corporation; Tokushima Bunri University; Northwell Health; Bharathiar University	Khan, NA (corresponding author), Univ Bourgogne, AgroSup, Physiol Nutr & Toxicol, Unite Mixte Rech INSERM U866, 6 Blvd Gabriel, F-21000 Dijon, France.	naim.khan@u-bourgogne.fr	Selvakumar, Subramaniam/AAI-2163-2020; Aribi, Mourad/M-9790-2018; Ozdener, Mehmet Hakan/I-4097-2019; Aribi, Mourad/Q-1290-2016; Abdoul-Azize, Souleymane/AAB-2181-2021	Selvakumar, Subramaniam/0000-0001-9471-7632; Aribi, Mourad/0000-0002-6522-7252; Aribi, Mourad/0000-0002-6522-7252; Khan, Naim Akhtar/0000-0002-8930-9332; Abdoul-Azize, Souleymane/0000-0003-2065-9091	French Ministry of Higher Education and Research, Region Bourgogne "Innovation PARI"; ANR SensoFat-2 [ANR-12-BSV1-0027-01]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK46791]; NIH National Institute on Aging [R01-AG042508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018125] Funding Source: NIH RePORTER	French Ministry of Higher Education and Research, Region Bourgogne "Innovation PARI"(Region Bourgogne-Franche-Comte); ANR SensoFat-2(French National Research Agency (ANR)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the French Ministry of Higher Education and Research, Region Bourgogne "Innovation PARI" (Post Doctoral; to S.S.), ANR SensoFat-2 (ANR-12-BSV1-0027-01; to P.B.), and U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK46791 (to M.G.T.) and NIH National Institute on Aging Grant R01-AG042508 (to P.M.). The authors thank Dr. Gilles Pages and Dr. Jacques Pouyssegur (Institute for Research on Cancer and Aging, Nice, France) for providing Erk<SUP>-/-</SUP> mice. The authors also sincerely thank Dr. A. Hichami (INSERM U866, Dijon, France), and N. Remla, Z. Tarhda, and Dr. Ghezzaz (Universite Aboubekr Belkaid, Tlemcen, Algeria) for helping with orosensorial detection of fatty acids in human volunteers. The authors declare no conflicts of interest.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Ayorinde FO, 2000, RAPID COMMUN MASS SP, V14, P608, DOI 10.1002/(SICI)1097-0231(20000415)14:7<608::AID-RCM918>3.0.CO;2-4; Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Besnard P, 2016, PHYSIOL REV, V96, P151, DOI 10.1152/physrev.00002.2015; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chale-Rush A, 2007, CHEM SENSES, V32, P423, DOI 10.1093/chemse/bjm007; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Chevrot M, 2013, J LIPID RES, V54, P2485, DOI 10.1194/jlr.M039446; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Dreses-Werringloer U, 2013, J CELL SCI, V126, P1199, DOI 10.1242/jcs.117135; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Gilbertson TA, 2005, PHYSIOL BEHAV, V86, P681, DOI 10.1016/j.physbeh.2005.08.057; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; Gilbertson TA, 2014, PROG LIPID RES, V53, P82, DOI 10.1016/j.plipres.2013.11.001; Goto J, 2010, CELL CALCIUM, V47, P1, DOI 10.1016/j.ceca.2009.10.004; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2008, BIOL PHARM BULL, V31, P1847, DOI 10.1248/bpb.31.1847; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Kulkarni B, 2013, CHEM SENSES, V38, P119, DOI 10.1093/chemse/bjs095; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Mattes RD, 2009, CHEM SENSES, V34, P415, DOI 10.1093/chemse/bjp015; Maulon L, 2001, ONCOGENE, V20, P1964, DOI 10.1038/sj.onc.1204266; MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908; Moyer BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007682; Ozdener MH, 2014, GASTROENTEROLOGY, V146, P995, DOI 10.1053/j.gastro.2014.01.006; Ozdener MH, 2011, CHEM SENSES, V36, P601, DOI 10.1093/chemse/bjr012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Sayed A, 2015, INT J OBESITY, V39, P920, DOI 10.1038/ijo.2015.20; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046	44	21	22	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3489	3500		10.1096/fj.201600422R	http://dx.doi.org/10.1096/fj.201600422R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27358389	Green Published			2022-12-26	WOS:000384329800019
J	Bassani, B; Bartolini, D; Pagani, A; Principi, E; Zollo, M; Noonan, DM; Albini, A; Bruno, A				Bassani, Barbara; Bartolini, Desiree; Pagani, Arianna; Principi, Elisa; Zollo, Massimo; Noonan, Douglas M.; Albini, Adriana; Bruno, Antonino			Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3 alpha/beta-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids	PLOS ONE			English	Article							CANCER STEM-CELLS; TUMOR-INITIATING CELLS; BREAST-CANCER; IN-VITRO; INDUCED APOPTOSIS; N-(4-HYDROXYPHENYL) RETINAMIDE; STEM/PROGENITOR CELLS; MOLECULAR PATHOLOGY; MALIGNANT GLIOMAS; PHASE-II	Medulloblastoma (MB), a neuroectodermal tumor arising in the cerebellum, represents the most frequent childhood brain malignancy. Current treatments for MB combine radiation and chemotherapy and are often associated with relevant side effects; novel therapeutic strategies are urgently needed. N-(4-Hydroxyphenyl) retinamide (4-HPR, fenretinide), a synthetic analogue of all-trans retinoic acid, has emerged as a promising and well-tolerated cancer chemopreventive and chemotherapeutic agent for various neoplasms, from breast cancer to neuroblastoma. Here we investigated the effects of 4-HPR on MB cell lines and identified the mechanism of action for a potential use in therapy of MB. Flow cytometry analysis was performed to evaluate 4-HPR induction of apoptosis and oxygen reactive species (ROS) production, as well as cell cycle effects. Functional analysis to determine 4-HPR ability to interfere with MB cell migration and invasion were performed. Western Blot analysis were used to investigate the crucial molecules involved in selected signaling pathways associated with apoptosis (caspase-9 and PARP-1), cell survival (ERK 1/2) and tumor progression (Wnt3a and beta-catenin). We show that 4-HPR induces caspase 9-dependent cell death in DAOY and ONS-76 cells, associated with increased ROS generation, suggesting that free radical intermediates might be directly involved. We observed 4-HPR induction of cell cycle arrest in G1/S phase, inactivated beta-catenin, and inhibition of MB cell migration and invasion. We also evaluated the ability of 4-HPR to target MB cancer-stem/cancer-initiating cells, using an MB spheroids model, followed by flow cytometry and quantitative real-time PCR. 4-HPR treatment reduced DAOY and ONS-76 spheroid formation, in term of number and size. Decreased expression of the surface markers CD133(+) and ABCG2(+) as well as Oct-4 and Sox-2 gene expression were observed on BTICs treated with 4-HPR further reducing BITIC invasive activities. Finally, we analyzed 4-HPR ability to inhibit MB tumor cell growth in vivo in nude mice. Taken together, our data suggest that 4-HPR targets both parental and MB tumor stem/initiating cell-like populations. Since 4-HPR exerts low toxicity, it could represent a valid compound in the treatment of human MB.	[Bassani, Barbara; Bartolini, Desiree; Pagani, Arianna; Principi, Elisa; Noonan, Douglas M.; Albini, Adriana; Bruno, Antonino] IRCCS MultiMed, Sci & Technol Pole, Milan, Italy; [Zollo, Massimo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Zollo, Massimo] Ceinge Biotecnol Avanzate, Naples, Italy; [Noonan, Douglas M.] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	IRCCS Multimedica; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Insubria	Albini, A (corresponding author), IRCCS MultiMed, Sci & Technol Pole, Milan, Italy.	adriana.albini@multimedica.it	bassani, barbara/AAB-5832-2019; Bartolini, Desirée/K-5319-2016; Bruno, Antonino/J-7066-2016; Principi, Elisa/O-2424-2015	Bartolini, Desirée/0000-0003-3849-757X; Bruno, Antonino/0000-0002-4790-0861; Albini, Adriana/0000-0002-9624-5103; Bassani, Barbara/0000-0002-8002-1607; Principi, Elisa/0000-0003-3747-1167	AIRC (Associazione Italaiana per la Ricerca sul Cancro); FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship; AIRC	AIRC (Associazione Italaiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	These studies were funded by AIRC (Associazione Italaiana per la Ricerca sul Cancro). AB is a FUV (Fondazione Umberto Veronesi) fellow. AB and EP were previously funded by a FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship. AP was awarded the "Caterina Forni" Fellowship from the AIRC. BB is a PhD student enrolled in the PhD program of Biotechnology, Biosciences and Surgical Technologies, at University of Insubria, Varese (Italy). Adriana Albini is the Scientific Director of Fondazione MultiMedica Onlus.	Albini A, 2011, CURR PHARM BIOTECHNO, V12, P171, DOI 10.2174/138920111794295756; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Albini A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv213; Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017; Antoniou A, 2013, CELL CYCLE, V12, P3743, DOI 10.4161/cc.27305; Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142; Bonanni B, 2007, EXPERT REV ANTICANC, V7, P423, DOI 10.1586/14737140.7.4.423; Bose D, 2011, BRIT J CANCER, V105, P1759, DOI 10.1038/bjc.2011.449; Brandes Alba A, 2014, Am Soc Clin Oncol Educ Book, pe82, DOI 10.14694/EdBook_AM.2014.34.e82; Brown CC, 2015, EUR J IMMUNOL, V45, P1287, DOI 10.1002/eji.201344398; Cazzaniga M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/172897; Cevatemre B, 2013, ANTI-CANCER DRUG, V24, P577, DOI 10.1097/CAD.0b013e328360a921; Cuperus R, 2008, INT J ONCOL, V32, P1011; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; DeSouza RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00176; Di Paolo D, 2013, J CONTROL RELEASE, V170, P445, DOI 10.1016/j.jconrel.2013.06.015; Du YZ, 2014, ANTIOXID REDOX SIGN, V20, P1866, DOI 10.1089/ars.2012.4935; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Durante S, 2014, ONCOTARGET, V5, P4811, DOI 10.18632/oncotarget.2038; Ellison D, 2002, NEUROPATH APPL NEURO, V28, P257, DOI 10.1046/j.1365-2990.2002.00419.x; Ferrari N, 2005, CLIN CANCER RES, V11, P4610, DOI 10.1158/1078-0432.CCR-04-2210; Fossati P, 2009, CANCER TREAT REV, V35, P79, DOI 10.1016/j.ctrv.2008.09.002; Gajjar A, 2004, J CLIN ONCOL, V22, P984, DOI 10.1200/JCO.2004.06.032; Gerber NU, 2014, CANCER TREAT REV, V40, P356, DOI 10.1016/j.ctrv.2013.11.010; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Gouaze-Andersson V, 2011, PROSTATE, V71, P1064, DOI 10.1002/pros.21321; Gupta T, 2015, CURR PEDIATR REV, V11, P106, DOI 10.2174/1573396311666150702104030; Hadjipanayis CG, 2009, J MOL MED, V87, P363, DOI 10.1007/s00109-009-0440-9; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hail N, 2010, FREE RADICAL BIO MED, V49, P109, DOI 10.1016/j.freeradbiomed.2010.04.006; Hail N, 2009, APOPTOSIS, V14, P849, DOI 10.1007/s10495-009-0356-4; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Irollo E, 2013, AM J TRANSL RES, V5, P563; Kalemkerian GP, 1999, CANCER CHEMOTH PHARM, V43, P145, DOI 10.1007/s002800050875; Kang H, 2012, J CELL BIOCHEM, V113, P2845, DOI 10.1002/jcb.24159; Kim HJ, 2006, ONCOGENE, V25, P2785, DOI 10.1038/sj.onc.1209303; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lovat PE, 2000, EXP CELL RES, V260, P50, DOI 10.1006/excr.2000.4988; Lovat PE, 2004, ANN NY ACAD SCI, V1028, P81, DOI 10.1196/annals.1322.009; Maenhaut C, 2010, CARCINOGENESIS, V31, P149, DOI 10.1093/carcin/bgp259; Manoranjan B, 2012, PEDIATR RES, V71, P516, DOI 10.1038/pr.2011.62; Maurer BJ, 2013, PEDIATR BLOOD CANCER, V60, P1801, DOI 10.1002/pbc.24643; Messner MC, 2011, CANCER CHEMOTH PHARM, V68, P477, DOI 10.1007/s00280-010-1504-9; Mimeault M, 2014, CANCER EPIDEM BIOMAR, V23, P234, DOI 10.1158/1055-9965.EPI-13-0785; Mittal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110410; Montaldo PG, 1999, INT J CANCER, V81, P262, DOI 10.1002/(SICI)1097-0215(19990412)81:2<262::AID-IJC16>3.3.CO;2-1; Moore MM, 2010, CANCER CHEMOTH PHARM, V66, P845, DOI 10.1007/s00280-009-1228-x; Northcott PA, 2015, LANCET ONCOL, V16, pE293, DOI 10.1016/S1470-2045(14)71206-9; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Puduvalli VK, 2004, J CLIN ONCOL, V22, P4282, DOI 10.1200/JCO.2004.09.096; Puduvalli VK, 1999, CLIN CANCER RES, V5, P2230; Read TA, 2012, CANCER CELL, V21, P1, DOI 10.1016/j.ccr.2011.12.011; Reddy CD, 2006, CANCER LETT, V231, P262, DOI 10.1016/j.canlet.2005.02.013; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Scatena R, 2011, PROTEOM CLIN APPL, V5, P590, DOI 10.1002/prca.201000142; Scatena R, 2011, EXPERT OPIN BIOL TH, V11, P875, DOI 10.1517/14712598.2011.573780; Schmidt C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv353; Schneider BJ, 2009, INVEST NEW DRUG, V27, P571, DOI 10.1007/s10637-009-9228-6; Sega-Pondel Dorota, 2007, Med Wieku Rozwoj, V11, P343; Simeone AM, 2005, CARCINOGENESIS, V26, P1000, DOI 10.1093/carcin/bgi038; Singh M, 2014, INT J MOL SCI, V15, P9117, DOI 10.3390/ijms15059117; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SMITH MA, 1992, J CLIN ONCOL, V10, P839, DOI 10.1200/JCO.1992.10.5.839; Sogna I, 2009, RECENT RESULTS CANC, V181, P71; Sogno I, 2010, CRIT REV ONCOL HEMAT, V75, P2, DOI 10.1016/j.critrevonc.2009.10.007; Stoll EA, 2013, AGING CELL, V12, P733, DOI 10.1111/acel.12104; Sun L, 2013, J RADIAT RES, V54, P61, DOI 10.1093/jrr/rrs078; Thompson EM, 2016, LANCET ONCOL, V17, P484, DOI 10.1016/S1470-2045(15)00581-1; Ulukaya E, 2014, BIOMED PHARMACOTHER, V68, P477, DOI 10.1016/j.biopha.2014.03.013; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995; WANG H, 2013, BIOMED RES INT, V2013; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Yoshida GJ, 2016, CANCER SCI, V107, P5, DOI 10.1111/cas.12817; Zanini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063748; Zhang H, 2013, P NATL ACAD SCI USA, V110, P5606, DOI 10.1073/pnas.1302352110; Zhao JH, 2016, PHARMACOL THERAPEUT, V160, P145, DOI 10.1016/j.pharmthera.2016.02.008	81	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0154111	10.1371/journal.pone.0154111	http://dx.doi.org/10.1371/journal.pone.0154111			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367907	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900001
J	Carniglia, L; Ramirez, D; Durand, D; Saba, J; Caruso, C; Lasaga, M				Carniglia, Lila; Ramirez, Delia; Durand, Daniela; Saba, Julieta; Caruso, Carla; Lasaga, Mercedes			[Nle(4), D-Phe(7)]-alpha-MSH Inhibits Toll-Like Receptor (TLR)2-and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype	PLOS ONE			English	Article							NF-KAPPA-B; MELANOCYTE-STIMULATING-HORMONE; ADAPTIVE IMMUNE-RESPONSES; MELANOCORTIN 4 RECEPTOR; CENTRAL-NERVOUS-SYSTEM; C-REL; AUTOIMMUNE INFLAMMATION; HUMAN MONOCYTES; NEURONAL DEATH; NITRIC-OXIDE	alpha-melanocyte stimulating hormone (alpha-MSH) is an anti-inflammatory peptide, proved to be beneficial in many neuroinflammatory disorders acting through melanocortin receptor 4 (MC4R). We previously determined that rat microglial cells express MC4R and that NDPMSH, an analog of alpha-MSH, induces PPAR-gamma expression and IL-10 release in these cells. Given the great importance of modulation of glial activation in neuroinflammatory disorders, we tested the ability of NDP-MSH to shape microglial phenotype and to modulate Toll-like receptor (TLR)-mediated inflammatory responses. Primary rat cultured microglia were stimulated with NDP-MSH followed by the TLR2 agonist Pam(3)CSK(4) or the TLR4 agonist LPS. NDP-MSH alone induced expression of the M2a/M2c marker Ag1 and reduced expression of the M2b marker Il-4ra and of the LPS receptor Tlr4. Nuclear translocation of NF-kappa B subunits p65 and c-Rel was induced by LPS and these effects were partially prevented by NDP-MSH. NDP-MSH reduced LPS- and Pam(3)CSK(4)-induced TNF-alpha release but did not affect TLR-induced IL-10 release. Also, NDP-MSH inhibited TLR2-induced HMGB1 translocation from nucleus to cytoplasm and TLR2-induced phagocytic activity. Our data show that NDP-MSH inhibits TLR2- and TLR4-mediated proinflammatory mechanisms and promotes microglial M2-like polarization, supporting melanocortins as useful tools for shaping microglial activation towards an alternative immunomodulatory phenotype.	[Carniglia, Lila; Ramirez, Delia; Durand, Daniela; Saba, Julieta; Caruso, Carla; Lasaga, Mercedes] Univ Buenos Aires, Sch Med, Inst Biomed Res INBIOMED UBA CONICET, RA-1121 Buenos Aires, DF, Argentina	University of Buenos Aires	Lasaga, M (corresponding author), Univ Buenos Aires, Sch Med, Inst Biomed Res INBIOMED UBA CONICET, RA-1121 Buenos Aires, DF, Argentina.	mlasaga@fmed.uba.ar	Caruso, Carla/AAR-5914-2020	Caruso, Carla/0000-0002-0889-0293; Ramirez, Delia/0000-0003-2253-1710; Carniglia, Lila/0000-0002-9354-8037; Lasaga, Mercedes/0000-0001-9916-3712	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica) [PICT 0894]; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 630]; University of Buenos Aires [20020130100120BA]	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica)(ANPCyT); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires)	This research was supported by grants from ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica) PICT 0894, CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) PIP 630 and University of Buenos Aires 20020130100120BA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carniglia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057313; Caruso C, 2004, NEUROENDOCRINOLOGY, V79, P278, DOI 10.1159/000079321; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Clarke CJP, 1998, EUR J IMMUNOL, V28, P1719, DOI 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Delgado R, 1998, J LEUKOCYTE BIOL, V63, P740, DOI 10.1002/jlb.63.6.740; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Funderburg NT, 2011, IMMUNOLOGY, V134, P151, DOI 10.1111/j.1365-2567.2011.03475.x; Giuliani D, 2007, EUR J PHARMACOL, V570, P57, DOI 10.1016/j.ejphar.2007.05.025; Giuliani D, 2006, EUR J PHARMACOL, V538, P48, DOI 10.1016/j.ejphar.2006.03.038; Giuliani D, 2014, NEUROBIOL AGING, V35, P537, DOI 10.1016/j.neurobiolaging.2013.08.030; Gonzalez P, 2013, BRAIN BEHAV IMMUN, V34, P141, DOI 10.1016/j.bbi.2013.08.007; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heyen JRR, 2000, MOL BRAIN RES, V77, P138, DOI 10.1016/S0169-328X(00)00042-5; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawanaka N, 2011, J NEUROIMMUNOL, V232, P17, DOI 10.1016/j.jneuroim.2010.09.025; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lasaga M, 2008, PEPTIDES, V29, P1825, DOI 10.1016/j.peptides.2008.06.009; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado I, 2015, BRAIN BEHAV IMMUN, V46, P137, DOI 10.1016/j.bbi.2015.01.012; MALEFYT RD, 1991, J EXP MED, V174, P1209; Manna SK, 1998, J IMMUNOL, V161, P2873; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sarkar A, 2003, FEBS LETT, V553, P286, DOI 10.1016/S0014-5793(03)01029-9; SUZUMURA A, 1994, J NEUROIMMUNOL, V53, P209, DOI 10.1016/0165-5728(94)90031-0; Taylor AW, 2008, BRAIN BEHAV IMMUN, V22, P639, DOI 10.1016/j.bbi.2007.11.001; Tian SJ, 2015, AM J PHYSIOL-RENAL, V308, pF69, DOI 10.1152/ajprenal.00484.2014; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Gonzalez PV, 2009, BRAIN BEHAV IMMUN, V23, P817, DOI 10.1016/j.bbi.2009.03.001; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	60	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158564	10.1371/journal.pone.0158564	http://dx.doi.org/10.1371/journal.pone.0158564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359332	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200092
J	Campos, PHA; Alves, TJM; Dias, MT; Assuncao, CM; Munk, M; Mattos, MS; Kraemer, LR; Almeida, BG; Russo, RC; Barcelos, L; Camargo, LSA; Viana, JHM				Henrique Almeida Campos-Junior, Paulo; Melo Alves, Thalys Jair; Dias, Marco Tulio; Assuncao, Carolina Marinho; Munk, Michele; Mattos, Matheus Silverio; Kraemer, Lucas Rocha; Almeida, Brigida Gomes; Russo, Remo Castro; Barcelos, Luciola; Almeida Camargo, Luiz Sergio; Moreira Viana, Joao Henrique			Ovarian Grafts 10 Days after Xenotransplantation: Folliculogenesis and Recovery of Viable Oocytes	PLOS ONE			English	Article							FOLLICULAR DEVELOPMENT; TISSUE; ANGIOGENESIS; EXPRESSION; FOLLICLES; GROWTH; CRYOPRESERVATION; TRANSPLANTATION; GONADOTROPINS; STIMULATION	Ovarian xenotransplantation is a promising alternative to preserve fertility of oncologic patients. However, several functional aspects of this procedure remained to be addressed. The aim of this study was evaluate the feasibility of xenotransplantation as a strategy to maintain bovine ovarian grafts and produce oocytes. Adult ovarian cortical pieces were xenotransplanted to the dorsal subcutaneous of female NOD-SCID mice (n = 62). Grafts were recovered ten days after xenotransplantation. Host and graft weights; folliculogenesis progression; blood perfusion, relative gene expression and number of macrophage and neutrophil of xenografts; in vitro developmental competence of graft-derived oocytes were evaluated. Folliculogenesis was supported in the grafts, as indicated by the presence of primordial, primary, secondary, antral, and atretic follicles. The xenografts showed a greater volumetric density of atretic follicles and higher hyperemia and number of host-derived macrophage and neutrophil (P<0.05), when compared to non-grafted fragments. There was a higher blood perfusion under the back skin in the transplantation sites of host animals than in control and non-grafted (P<0.01). BAX and PRDX1 genes were up-regulated, while BCL2, FSHR, IGF1R and IGF2R were down-regulated, when compared to the control (P<0.01). Twenty seven oocytes were successfully harvested from grafts, and some of these oocytes were able to give rise to blastocysts after in vitro fertilization. However, cleavage and blastocyst rates of xenograft derived oocytes were lower than in control (P<0.01). Despite showing some functional modifications, the ovarian xenografts were able to support folliculogenesis and produce functional oocytes.	[Henrique Almeida Campos-Junior, Paulo; Melo Alves, Thalys Jair; Dias, Marco Tulio] Univ Fed Sao Joao del Rei, Dept Nat Sci, Fertil Preservat Res Grp, BR-36301160 Sao Joao Del Rei, MG, Brazil; [Assuncao, Carolina Marinho; Munk, Michele] Univ Fed Juiz de Fora, Dept Biol, Lab Genet & Biotechnol, BR-36036900 Juiz De Fora, MG, Brazil; [Mattos, Matheus Silverio; Kraemer, Lucas Rocha; Almeida, Brigida Gomes; Russo, Remo Castro; Barcelos, Luciola] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil; [Almeida Camargo, Luiz Sergio] EMBRAPA, BR-36038330 Juiz De Fora, MG, Brazil; [Moreira Viana, Joao Henrique] EMBRAPA, BR-70770917 Brasilia, DF, Brazil	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Juiz de Fora; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Campos, PHA (corresponding author), Univ Fed Sao Joao del Rei, Dept Nat Sci, Fertil Preservat Res Grp, BR-36301160 Sao Joao Del Rei, MG, Brazil.	paulohenrique@ufsj.edu.br	Barcelos, Lucíola S/A-1109-2013; Munk, Michele/T-3422-2019; Pereira, Michele Munk/D-4068-2013; da Silva Barcelos, Lucíola/AAP-5595-2021; Russo, Remo Castro/O-8980-2019; Munk, Michele/R-5882-2019; Mattos, Matheus/AAW-6644-2020; Russo, Remo Castro/F-9048-2010; Viana, Joao Henrique Moreira/O-1635-2016; Campos-Junior, Paulo HA/H-5751-2015	Barcelos, Lucíola S/0000-0001-9133-4011; Pereira, Michele Munk/0000-0001-8927-6190; da Silva Barcelos, Lucíola/0000-0001-9133-4011; Russo, Remo Castro/0000-0002-1715-3834; Munk, Michele/0000-0001-8927-6190; Mattos, Matheus/0000-0002-9163-6279; Russo, Remo Castro/0000-0002-1715-3834; Viana, Joao Henrique Moreira/0000-0002-3742-2368; Campos-Junior, Paulo HA/0000-0003-2400-2548	National Council for Scientific and Technological Development (CNPq, Brazil); Minas Gerais State Research Foundation (FAPEMIG, Brazil); CNPq; FAPEMIG	National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Foundation (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by the National Council for Scientific and Technological Development (CNPq, Brazil) and Minas Gerais State Research Foundation (FAPEMIG, Brazil). Thalys Jair Melo Alves and Marco Tulio Dias received grants from CNPq and FAPEMIG, respectively.	Alm H, 2005, THERIOGENOLOGY, V63, P2194, DOI 10.1016/j.theriogenology.2004.09.050; Campos PHA, 2014, REPRODUCTION, V147, P291, DOI 10.1530/REP-13-0581; Campos PHA, 2012, REPROD BIOL, V12, P41, DOI 10.1016/S1642-431X(12)60076-X; Amorim CA, 2012, FERTIL STERIL, V98, P1291, DOI 10.1016/j.fertnstert.2012.07.1109; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; Barcelos LS, 2005, J LEUKOCYTE BIOL, V78, P352, DOI 10.1189/jlb.1104682; Cai CY, 2015, EJSO-EUR J SURG ONC, V41, P228, DOI 10.1016/j.ejso.2014.11.037; Campos PHA, 2011, LAB ANIM-UK, V45, P254, DOI 10.1258/la.2011.011031; Campos PHA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095430; Dittrich R, 2010, Minerva Ginecol, V62, P63; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Hernandez-Fonseca H, 2004, FERTIL STERIL, V81, P888, DOI 10.1016/j.fertnstert.2003.10.017; Hernandez-Fonseca HJ, 2005, FERTIL STERIL, V83, P1180, DOI 10.1016/j.fertnstert.2004.07.985; Kim SS, 2002, FERTIL STERIL, V78, P77, DOI 10.1016/S0015-0282(02)03144-8; Lee Yu-Il, 2011, Clin Exp Reprod Med, V38, P18, DOI 10.5653/cerm.2011.38.1.18; Lotz L, 2016, REPROD BIOMED ONLINE, V32, P394, DOI 10.1016/j.rbmo.2015.12.012; Lotz L, 2014, FERTIL STERIL, V101, P1477, DOI 10.1016/j.fertnstert.2014.01.038; Lotz L, 2011, FERTIL STERIL, V95, P2612, DOI 10.1016/j.fertnstert.2011.05.003; Maltaris T, 2007, FERTIL STERIL, V87, P195, DOI 10.1016/j.fertnstert.2006.05.058; Mazerbourg S, 2003, REPROD DOMEST ANIM, V38, P247, DOI 10.1046/j.1439-0531.2003.00440.x; Messinis IE, 2010, ANN NY ACAD SCI, V1205, P5, DOI 10.1111/j.1749-6632.2010.05660.x; Onions VJ, 2013, MOL HUM REPROD, V19, P205, DOI 10.1093/molehr/gas053; Pfaffl MW, 2012, NUCLEIC ACIDS RES, V30, pe36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Senbon S, 2005, ZYGOTE, V13, P309, DOI 10.1017/S0967199405003400; Snow M, 2002, SCIENCE, V297, P2227, DOI 10.1126/science.1073693; Batista RITP, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-33; Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048; Varricchi G, 2015, J AM ACAD DERMATOL, V73, P144, DOI 10.1016/j.jaad.2015.03.041; Viana JHM, 2004, ANIM REPROD SCI, V84, P1, DOI 10.1016/j.anireprosci.2003.12.002; von Schonfeldt V, 2011, FERTIL STERIL, V95, P1428, DOI 10.1016/j.fertnstert.2010.11.003; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158109	10.1371/journal.pone.0158109	http://dx.doi.org/10.1371/journal.pone.0158109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362486	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200041
J	Hung, MS; Chen, IC; Lung, JH; Lin, PY; Li, YC; Tsai, YH				Hung, Ming-Szu; Chen, I-Chuan; Lung, Jr-Hau; Lin, Paul-Yann; Li, Ya-Chin; Tsai, Ying-Huang			Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; METASTATIC BREAST-CANCER; EGFR KINASE DOMAIN; 1ST-LINE TREATMENT; VE-CADHERIN; VASCULOGENIC MIMICRY; OPEN-LABEL; CHEMOTHERAPY; GEFITINIB; ADENOCARCINOMA	Epidermal growth factor receptor (EGFR) activation has been shown to play a critical role in tumor angiogenesis. In this study, we investigate the correlation between EGFR mutations and cadherin-5 (CDH5), which is an angiogenic factor, in lung cancer cells. Increased expression CDH5 is observed in lung cancer cells with EGFR mutations. Stable lung cancer cell lines expressing mutant (exon 19 deletion E746-A750, and exon 21 missense mutation L858R) and wild type EGFR genes are established. A significantly higher expression of CDH5 is observed in exon 19 deletion stable lung cancer cells and mouse xenografts. Further studies show that expression of CDH5 is decreased after the inhibition of EGFR and downstream Akt pathways in lung cancer cells with EGFR mutation. In addition, mutant EGFR genes potentiates angiogenesis in lung cancer cells, which is inhibited by CDH5 siRNA, and potentiates migration and invasion in lung cancer cells. Our study shows that mutant EGFR genes are associated with overexpression of CDH5 through increased phosphorylation of EGFR and downstream Akt pathways. Our result may provide an insight into the association of mutant EGFR and CDH5 expression in lung cancer and aid further development of target therapy for NSCLC in the future.	[Hung, Ming-Szu; Li, Ya-Chin; Tsai, Ying-Huang] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Thorac Oncol, Chiayi, Taiwan; [Hung, Ming-Szu] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Hung, Ming-Szu] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi, Taiwan; [Lung, Jr-Hau] Chang Gung Mem Hosp, Dept Med Res, Chiayi, Taiwan; [Lin, Paul-Yann] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Anat Pathol, Chiayi, Taiwan; [Tsai, Ying-Huang] Chang Gung Univ, Coll Med, Dept Resp Care, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chang Gung University	Hung, MS (corresponding author), Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Thorac Oncol, Chiayi, Taiwan.; Hung, MS (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.; Hung, MS (corresponding author), Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan.	m12049@adm.cgmh.org.tw			Chang Gung Memorial Hospital, Chiayi, Taiwan (R.O.C.) [CMRPG6B0231, CMRPG6B0232, CMRPG6E0081]	Chang Gung Memorial Hospital, Chiayi, Taiwan (R.O.C.)	This study is supported by grants CMRPG6B0231, CMRPG6B0232 and CMRPG6E0081 (to MSH) in Chang Gung Memorial Hospital, Chiayi, Taiwan (R.O.C.).	Arteaga CL, 2002, ONCOLOGIST, V7, P31; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Bruns CJ, 2000, CANCER RES, V60, P2926; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Fry SA, 2016, BRIT J CANCER, V114, P1019, DOI 10.1038/bjc.2016.66; Fry SA, 2013, CANCER LETT, V328, P335, DOI 10.1016/j.canlet.2012.10.011; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hsieh RK, 2005, CHEST, V128, P317, DOI 10.1378/chest.128.1.317; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; Lagendijk AK, 2015, CURR TOP DEV BIOL, V112, P325, DOI 10.1016/bs.ctdb.2014.11.024; Li B, 2015, J NEURO-ONCOL, V124, P79, DOI 10.1007/s11060-015-1776-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mao XG, 2013, NEURO-ONCOLOGY, V15, P865, DOI 10.1093/neuonc/not029; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pomme G, 2015, VIRCHOWS ARCH, V467, P55, DOI 10.1007/s00428-015-1767-y; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Rezaei M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3367; Rosell R, 2005, LUNG CANCER-J IASLC, V50, P25, DOI 10.1016/j.lungcan.2005.05.017; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tseng JC, 2014, J CANCER RES CLIN, V140, P61, DOI 10.1007/s00432-013-1544-8; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Zhou C, 2015, ANN ONCOL, V26, P1877, DOI 10.1093/annonc/mdv276; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	36	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158395	10.1371/journal.pone.0158395	http://dx.doi.org/10.1371/journal.pone.0158395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362942	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200068
J	Kamiya, K; Narita, N; Iwaki, S				Kamiya, Kazunobu; Narita, Noriyuki; Iwaki, Sunao			Improved Prefrontal Activity and Chewing Performance as Function of Wearing Denture in Partially Edentulous Elderly Individuals: Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SPATIAL WORKING-MEMORY; CEREBRAL-BLOOD-FLOW; TOOTH LOSS; ORAL-HEALTH; COGNITIVE IMPAIRMENT; MASTICATORY PERFORMANCE; ALZHEIMERS-DISEASE; OCCLUSAL FORCE; NATURAL TEETH	The purpose of this study was to elucidate the effects of wearing a denture on prefrontal activity during chewing performance. We specifically examined that activity in 12 elderly edentulous subjects [63.1 +/- 6.1 years old (mean +/- SD)] and 12 young healthy controls (22.1 +/- 2.3 years old) using functional near-infrared spectroscopy (fNIRS) in order to evaluate the quality of prefrontal functionality during chewing performance under the conditions of wearing a denture and tooth loss, and then compared the findings with those of young healthy controls. fNIRS and electromyography were used simultaneously to detect prefrontal and masticatory muscle activities during chewing, while occlusal force and masticatory score were also examined by use of a food intake questionnaire. A significant increase in prefrontal activity was observed during chewing while wearing a denture, which was accompanied by increased masticatory muscle activity, occlusal force, and masticatory score, as compared with the tooth loss condition. Prefrontal activation during chewing while wearing a denture in the elderly subjects was not much different from that in the young controls. In contrast, tooth loss in the elderly group resulted in marked prefrontal deactivation, accompanied by decreased masticatory muscle activity, occlusal force, and masticatory score, as compared with the young controls. We concluded that intrinsic prefrontal activation during chewing with a denture may prevent prefrontal depression induced by tooth loss in elderly edentulous patients.	[Kamiya, Kazunobu; Narita, Noriyuki] Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba, Japan; [Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 6, Automot Human Factors Res Ctr, Ibaraki, Japan	Nihon University; National Institute of Advanced Industrial Science & Technology (AIST)	Narita, N (corresponding author), Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba, Japan.	narita.noriyuki@nihon-u.ac.jp	Iwaki, Sunao/B-1079-2011	Iwaki, Sunao/0000-0002-7123-7203	JSPS KAKENHI Grant [16591969]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16591969, https://kaken.nii.ac.jp/d/p/16591969.ja.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinet CT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00272; Araki T, 2014, INT J GERIATR PSYCH, V29, P881, DOI 10.1002/gps.4074; Aras K, 2009, INT J PROSTHODONT, V22, P204; Avlund Kirsten, 2004, Gerodontology, V21, P17, DOI 10.1046/j.1741-2358.2003.00003.x; Banu F, 2016, CLIN IMPLANT DENT R, V18, P580, DOI 10.1111/cid.12336; Batista MJ, 2014, BRAZ ORAL RES, V28, P260, DOI 10.1590/1807-3107BOR-2014.vol28.0040; Bortoluzzi MC, 2012, CONTEMP CLIN DENT, V3, P393, DOI 10.4103/0976-237X.107424; Brambilla M, 2015, BEHAV BRAIN RES, V293, P125, DOI 10.1016/j.bbr.2015.07.037; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Chen Yan, 2009, Zhonghua Kou Qiang Yi Xue Za Zhi, V44, P193; Chiang TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106943; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dable RA, 2013, J CLIN DIAGN RES, V7, P2063, DOI 10.7860/JCDR/2013/6377.3406; Derosiere G, 2014, NEUROIMAGE, V85, P471, DOI 10.1016/j.neuroimage.2013.02.006; Eichner K, 1955, DEUT ZAHNAERZTL Z, V10, P1831; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fried PJ, 2014, EUR J NEUROSCI, V39, P1973, DOI 10.1111/ejn.12584; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; Garrett NR, 1996, J PROSTHET DENT, V76, P403, DOI 10.1016/S0022-3913(96)90546-6; Hansson P, 2013, EUR J ORAL SCI, V121, P333, DOI 10.1111/eos.12060; Harty S, 2014, J NEUROSCI, V34, P3646, DOI 10.1523/JNEUROSCI.5308-13.2014; Hasegawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066313; Hatipoglu MG, 2011, GERODONTOLOGY, V28, P302, DOI 10.1111/j.1741-2358.2010.00401.x; Hayasaka K, 2013, J AM GERIATR SOC, V61, P815, DOI 10.1111/jgs.12225; Herrmann MJ, 2008, AM J GERIAT PSYCHIAT, V16, P125, DOI 10.1097/JGP.0b013e3180cc1fbc; Hiraba H, 2005, SOMATOSENS MOT RES, V22, P307, DOI 10.1080/08990220500420525; Hirai T, 1994, Int J Prosthodont, V7, P454; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Hirano Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/367026; Hirotomi T, 2015, COMMUNITY DENT ORAL, V43, P226, DOI 10.1111/cdoe.12146; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Ichikawa N, 2001, MEDIX, V34, P47; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Ikebe K, 2012, J DENT, V40, P71, DOI 10.1016/j.jdent.2011.10.007; Jou YT, 2012, J PROSTHO IMPLANTOL, V1, P6; Karton I, 2014, BEHAV BRAIN RES, V271, P89, DOI 10.1016/j.bbr.2014.05.059; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Kim JK, 2013, J DENT SCI, V8, P115, DOI 10.1016/j.jds.2012.12.011; Kimoto K, 2011, J PROSTHODONT RES, V55, P89, DOI 10.1016/j.jpor.2010.09.006; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lexomboon D, 2012, J AM GERIATR SOC, V60, P1951, DOI 10.1111/j.1532-5415.2012.04154.x; Li ZH, 2015, J NEUROSCI METH, V241, P101, DOI 10.1016/j.jneumeth.2014.12.020; Liao X, 2015, J ALZHEIMERS DIS, V48, P463, DOI 10.3233/JAD-150346; Lin JD, 2015, RES DEV DISABIL, V36, P532, DOI 10.1016/j.ridd.2014.10.051; Listl S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-70; Lund JP, 2006, J COMMUN DISORD, V39, P381, DOI 10.1016/j.jcomdis.2006.06.014; Luo JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120986; Marumo K, 2014, NEUROIMAGE, V85, P518, DOI 10.1016/j.neuroimage.2013.04.050; Minn YK, 2013, J KOREAN MED SCI, V28, P929, DOI 10.3346/jkms.2013.28.6.929; Miura H, 1998, J ORAL REHABIL, V25, P190; Nakajima S, 2015, SCHIZOPHR RES, V164, P164, DOI 10.1016/j.schres.2015.01.043; Narita N, 2009, J PROSTHODONT RES, V53, P126, DOI 10.1016/j.jpor.2009.02.005; Niesten D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-839; Noble JM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0384-x; Nordstrom MA, 2007, ARCH ORAL BIOL, V52, P338, DOI 10.1016/j.archoralbio.2006.09.013; Obayashi S, 2013, NEUROPSYCHOLOGIA, V51, P418, DOI 10.1016/j.neuropsychologia.2012.11.023; Ohsugi H, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-10; Ohtani T, 2015, J AFFECT DISORDERS, V176, P78, DOI 10.1016/j.jad.2015.01.042; Okada E, 2010, ADV EXP MED BIOL, V662, P231, DOI 10.1007/978-1-4419-1241-1_33; Okada N, 2016, ADDICT BIOL, V21, P489, DOI 10.1111/adb.12224; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Okamoto N, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-77; Ono Y, 2015, PSYCHIAT RES-NEUROIM, V233, P1, DOI 10.1016/j.pscychresns.2015.04.003; OSTERBERG T, 1990, COMMUNITY DENT ORAL, V18, P313, DOI 10.1111/j.1600-0528.1990.tb00087.x; Otsuka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/373769; Pu SH, 2015, J AFFECT DISORDERS, V181, P9, DOI 10.1016/j.jad.2015.04.010; Richter MM, 2007, WORLD J BIOL PSYCHIA, V8, P23, DOI 10.1080/15622970600960132; Savikko N, 2013, J AM GERIATR SOC, V61, P849, DOI 10.1111/jgs.12233; Sawa M, 2012, EUR ARCH PSY CLIN N, V262, P493, DOI 10.1007/s00406-012-0296-9; Shoi K, 2014, J ORAL REHABIL, V41, P486, DOI 10.1111/joor.12169; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Singhrao SK, 2014, J ALZHEIMERS DIS, V42, P723, DOI 10.3233/JAD-140387; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Spraker MB, 2009, CEREB CORTEX, V19, P2640, DOI 10.1093/cercor/bhp015; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Syrjala AMH, 2007, ACTA ODONTOL SCAND, V65, P103, DOI 10.1080/00016350601083521; Takeuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141737; TALLGREN A, 1991, J ORAL REHABIL, V18, P285, DOI 10.1111/j.1365-2842.1991.tb00060.x; Tamura M, 1997, PHILOS T ROY SOC B, V352, P737, DOI 10.1098/rstb.1997.0056; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Teixeira FB, 2014, INT J MED SCI, V11, P209, DOI 10.7150/ijms.6801; Tian FH, 2014, NEUROIMAGE, V85, P166, DOI 10.1016/j.neuroimage.2013.07.016; Tomiok H, 2009, NEUROSCI LETT, V451, P252, DOI 10.1016/j.neulet.2008.12.059; Tsakos G, 2015, J AM GERIATR SOC, V63, P91, DOI 10.1111/jgs.13190; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vermeij A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00303; Vermeij A, 2014, NEUROIMAGE, V85, P608, DOI 10.1016/j.neuroimage.2013.04.107; Vermeij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046210; Yan C, 2008, EUR J ORAL SCI, V116, P387, DOI 10.1111/j.1600-0722.2008.00557.x	94	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158070	10.1371/journal.pone.0158070	http://dx.doi.org/10.1371/journal.pone.0158070			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362255	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200038
J	Zou, Y; Li, QL; Jiang, LZ; Guo, CX; Li, YB; Yu, Y; Li, Y; Duan, JC; Sun, ZW				Zou, Yang; Li, Qiuling; Jiang, Lizhen; Guo, Caixia; Li, Yanbo; Yu, Yang; Li, Yang; Duan, Junchao; Sun, Zhiwei			DNA Hypermethylation of CREB3L1 and Bcl-2 Associated with the Mitochondrial-Mediated Apoptosis via PI3K/Akt Pathway in Human BEAS-2B Cells Exposure to Silica Nanoparticles	PLOS ONE			English	Article							BREAST-CANCER CELLS; CONSUMER PRODUCTS; METHYLATION; TOXICITY; NANOTECHNOLOGY; NANOMATERIALS; MECHANISMS; GENOTOXICITY	The toxic effects of silica nanoparticles (SiNPs) are raising concerns due to its widely applications in biomedicine. However, current information about the epigenetic toxicity of SiNPs is insufficient. In this study, the epigenetic regulation of low-dose exposure to SiNPs was evaluated in human bronchial epithelial BEAS-2B cells over 30 passages. Cell viability was decreased in a dose- and passage-dependent manner. The apoptotic rate, the expression of caspase-9 and caspase-3, were significantly increased induced by SiNPs. HumanMethylation450 BeadChip analysis identified that the PI3K/Akt as the primary apoptosis-related pathway among the 25 significant altered processes. The differentially methylated sites of PI3K/Akt pathway involved 32 differential genes promoters, in which the CREB3L1 and Bcl-2 were significant hypermethylated. The methyltransferase inhibitor, 5-aza, further verified that the DNA hypermethylation status of CREB3L1 and Bcl-2 were associated with downregulation of their mRNA levels. In addition, mitochondrial-mediated apoptosis was triggered by SiNPs via the downregulation of PI3K/Akt/CREB/Bcl-2 signaling pathway. Our findings suggest that long-term low-dose exposure to SiNPs could lead to epigenetic alterations.	[Zou, Yang; Li, Qiuling; Jiang, Lizhen; Guo, Caixia; Li, Yanbo; Yu, Yang; Li, Yang; Duan, Junchao; Sun, Zhiwei] Capital Med Univ, Sch Publ Hlth, Dept Toxicol & Sanit Chem, Beijing 100069, Peoples R China; [Zou, Yang; Li, Qiuling; Jiang, Lizhen; Guo, Caixia; Li, Yanbo; Yu, Yang; Li, Yang; Duan, Junchao; Sun, Zhiwei] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University	Duan, JC; Sun, ZW (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Toxicol & Sanit Chem, Beijing 100069, Peoples R China.; Duan, JC; Sun, ZW (corresponding author), Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China.	jcduan@ccmu.edu.cn; zwsun@ccmu.edu.cn			National Natural Science Foundation of China [81571130090, 81230065, 81502830]; Special Project of Beijing Municipal Science & Technology Commission [KZ201410025022]; Training Programme Foundation for the Talents by the Beijing Ministry of Education [2014000020124G152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Project of Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Training Programme Foundation for the Talents by the Beijing Ministry of Education	This work was supported by National Natural Science Foundation of China (No. 81571130090, 81230065, 81502830), Special Project of Beijing Municipal Science & Technology Commission (KZ201410025022), and Training Programme Foundation for the Talents by the Beijing Ministry of Education (2014000020124G152).	Al-Kaabi A, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/260549; Badr G, 2014, CELL PHYSIOL BIOCHEM, V34, P1640, DOI 10.1159/000366366; Bai WL, 2015, INT J NANOMED, V10, P5561, DOI 10.2147/IJN.S88059; Balansky R, 2013, MUTAT RES-FUND MOL M, V751, P42, DOI 10.1016/j.mrfmmm.2013.08.006; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen QQ, 2013, INT J NANOMED, V8, P1129, DOI 10.2147/IJN.S42242; Cho Y, 2012, EXP BIOL MED, V237, P1387, DOI 10.1258/ebm.2012.012244; Choi AO, 2008, J MOL MED-JMM, V86, P291, DOI 10.1007/s00109-007-0274-2; Coccini T, 2013, HISTOL HISTOPATHOL, V28, P195, DOI 10.14670/HH-28.195; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Duan JC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0050-8; Duan JC, 2013, BIOMATERIALS, V34, P5853, DOI 10.1016/j.biomaterials.2013.04.032; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eom HJ, 2014, TOXICOL LETT, V229, P311, DOI 10.1016/j.toxlet.2014.05.019; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fard JK, 2015, ADV PHARM BULL, V5, P447, DOI 10.15171/apb.2015.061; Geng WJ, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-015-3305-x; Golbamaki N, 2015, NANOSCALE, V7, P2154, DOI 10.1039/c4nr06670g; Gong CM, 2010, BIOCHEM BIOPH RES CO, V397, P397, DOI 10.1016/j.bbrc.2010.05.076; Guo CX, 2015, INT J NANOMED, V10, P1463, DOI 10.2147/IJN.S76114; Hansen SF, 2008, ECOTOXICOLOGY, V17, P438, DOI 10.1007/s10646-008-0210-4; Iavicoli I, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-78; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Perreault F, 2012, SCI TOTAL ENVIRON, V441, P117, DOI 10.1016/j.scitotenv.2012.09.065; Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Shridhar K, 2016, ORAL ONCOL, V53, P1, DOI 10.1016/j.oraloncology.2015.11.012; Shyamasundar S, 2015, EPIGENOMICS-UK, V7, P395, DOI 10.2217/epi.15.3; Siddiqui MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069534; Sui XB, 2015, CANCER LETT, V360, P106, DOI 10.1016/j.canlet.2015.02.009; Tucci P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.76; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Vecchio G, 2014, SMALL, V10, P2721, DOI 10.1002/smll.201303359; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101572; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061346	44	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158475	10.1371/journal.pone.0158475	http://dx.doi.org/10.1371/journal.pone.0158475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362941	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200079
J	Castley, A; Williams, L; James, I; Guelfi, G; Berry, C; Nolan, D				Castley, Alison; Williams, Leah; James, Ian; Guelfi, George; Berry, Cassandra; Nolan, David			Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNE ACTIVATION; MONOCYTE ACTIVATION; SOLUBLE CD14; T-CELL; VASCULAR INFLAMMATION; OXIDIZED LDL; THERAPY; RALTEGRAVIR; INDIVIDUALS	We investigate the associations of three established plasma biomarkers in the context of HIV and treatment-related variables including a comprehensive cardiovascular disease risk assessment, within a large ambulatory HIV cohort. Patients were recruited in 2010 to form the Royal Perth Hospital HIV/CVD risk cohort. Plasma sCD14, sCD163 and CXCL10 levels were measured in 475 consecutive patients with documented CVD risk (age, ethnicity, gender, smoking, blood pressure, BMI, fasting metabolic profile) and HIV treatment history including immunological/virological outcomes. The biomarkers assessed showed distinct associations with virological response: CXCL10 strongly correlated with HIV-1 RNA (p<0.001), sCD163 was significantly reduced among 'aviraemic' patients only (p = 0.02), while sCD14 was unaffected by virological status under 10,000 copies/mL (p>0.2). Associations between higher sCD163 and protease inhibitor therapy (p = 0.05) and lower sCD14 with integrase inhibitor therapy (p = 0.02) were observed. Levels of sCD163 were also associated with CVD risk factors (age, ethnicity, HDL, BMI), with a favourable influence of Framingham score <10% (p = 0.04). Soluble CD14 levels were higher among smokers (p = 0.002), with no effect of other CVD risk factors, except age (p = 0.045). Our findings confirm CXCL10, sCD163 and sCD14 have distinct associations with different aspects of HIV infection and treatment. Levels of CXCL10 correlated with routinely monitored variables, sCD163 levels reflect a deeper level of virological suppression and influence of CVD risk factors, while sCD14 levels were not associated with routinely monitored variables, with evidence of specific effects of smoking and integrase inhibitor therapy warranting further investigation.	[Castley, Alison; Williams, Leah; Guelfi, George; Nolan, David] Royal Perth Hosp, Dept Clin Immunol, PathWest Lab Med, Perth, WA, Australia; [Castley, Alison; Berry, Cassandra] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [James, Ian; Nolan, David] Murdoch Univ, IIID, Perth, WA, Australia	Royal Perth Hospital; Murdoch University; Murdoch University	Nolan, D (corresponding author), Royal Perth Hosp, Dept Clin Immunol, PathWest Lab Med, Perth, WA, Australia.; Nolan, D (corresponding author), Murdoch Univ, IIID, Perth, WA, Australia.	David.Nolan@health.wa.gov.au	Berry, Cassandra/AAX-7145-2020	Berry, Cassandra/0000-0003-0768-0857	Practitioner Research Fellowship by Royal Perth Hospital Medical Research Foundation	Practitioner Research Fellowship by Royal Perth Hospital Medical Research Foundation	This investigation was funded with support from a Practitioner Research Fellowship awarded to Dr. David Nolan provided by the Royal Perth Hospital Medical Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; Angelovich TA, 2015, JAIDS-J ACQ IMM DEF, V69, P11, DOI 10.1097/QAI.0000000000000559; Anzinger JJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/569819; Arenaccio C, 2014, J VIROL, V88, P11529, DOI 10.1128/JVI.01712-14; Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Buechler Christa, 2013, Inflammation & Allergy Drug Targets, V12, P391; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Byakwaga H, 2011, J INFECT DIS, V204, P1532, DOI 10.1093/infdis/jir559; Castley A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115226; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Cioe PA, 2015, JAIDS-J ACQ IMM DEF, V70, P400, DOI 10.1097/QAI.0000000000000759; Duong M, 2006, HIV CLIN TRIALS, V7, P41, DOI 10.1310/7381-M1YD-RTV5-4RYT; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; Fjeldborg K, 2014, J MOL ENDOCRINOL, V53, P227, DOI 10.1530/JME-14-0089; Fjeldborg K, 2013, OBESITY, V21, P2437, DOI 10.1002/oby.20376; Funderburg NT, 2015, JAIDS-J ACQ IMM DEF, V68, P396, DOI 10.1097/QAI.0000000000000478; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hileman CO, 2015, J INFECT DIS, V212, P345, DOI 10.1093/infdis/jiv004; Ilter A, 2015, INT J CLIN EXP MED, V8, P9394; Kahle EM, 2015, J INFECT DIS, V211, P1451, DOI 10.1093/infdis/jiu621; Kelesidis T, 2015, CLIN INFECT DIS, V61, P651, DOI 10.1093/cid/civ327; Lake JE, 2014, HIV MED, V15, P431, DOI 10.1111/hiv.12128; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; McKibben RA, 2015, J INFECT DIS, V211, P1219, DOI 10.1093/infdis/jiu594; McKinnon E, 2015, HIV ME IN PRESS 1104; Mendez-Lagares G, 2013, J INFECT DIS, V207, P1221, DOI 10.1093/infdis/jit025; Moreno JA, 2012, EUR HEART J, V33, P252, DOI 10.1093/eurheartj/ehr123; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Ostrowski SR, 2008, SCAND J IMMUNOL, V68, P652, DOI 10.1111/j.1365-3083.2008.02184.x; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Ramirez LA, 2014, J LEUKOCYTE BIOL, V96, P1055, DOI 10.1189/jlb.3A0414-232RR; Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421; Reus S, 2013, JAIDS-J ACQ IMM DEF, V62, P129, DOI 10.1097/QAI.0b013e3182745ab0; Ruggiero A, 2015, EBIOMEDICINE, V2, P1153, DOI 10.1016/j.ebiom.2015.07.025; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545; Younas M, 2015, HIV ME IN PRESS 1010; Zidar DA, 2015, JAIDS-J ACQ IMM DEF, V69, P154, DOI 10.1097/QAI.0000000000000566	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158169	10.1371/journal.pone.0158169	http://dx.doi.org/10.1371/journal.pone.0158169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355513	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400035
J	Hemminki, K; Liu, XD; Ji, JG; Forsti, A				Hemminki, Kari; Xiangdong Liu; Jianguang Ji; Foersti, Asta			Origin of B-Cell Neoplasms in Autoimmune Disease	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; METAANALYSIS; DIAGNOSIS; SUBTYPE	Autoimmune diseases (ADs) are associated with a number of B-cell neoplasms but the associations are selective in regard to the type of neoplasm and the conferred risks are variable. So far no mechanistic bases for these differential associations have been demonstrated. We speculate that developmental origin of B-cells might propose a mechanistic rationale for their carcinogenic response to autoimmune stimuli and tested the hypothesis on our previous studies on the risks of B-cell neoplasms after any of 33 ADs. We found that predominantly germinal center (GC)-derived B-cells showed multiple associations with ADs: diffuse large B cell lymphoma associated with 15 ADs, follicular lymphoma with 7 ADs and Hodgkin lymphoma with 11 ADs. Notably, these neoplasms shared significant associations with 5 ADs (immune thrombocytopenic purpura, polymyositis/dermatomyositis, rheumatoid arthritis, Sjogren syndrome and systemic lupus erythematosis). By contrast, primarily non-GC neoplasms, acute lymphocytic leukemia, chronic lymphocytic leukemia and myeloma associated with 2 ADs only and mantle cell lymphoma with 1 AD. None of the neoplasms shared associated ADs. These data may suggest that autoimmune stimulation critically interferes with the rapid cell division, somatic hypermutation, class switch recombination and immunological selection of maturing B-cell in the GC and delivers damage contributing to transformation.	[Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Neuenheimer Feld 580, D-69120 Heidelberg, Germany; [Hemminki, Kari; Xiangdong Liu; Jianguang Ji; Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden; [Xiangdong Liu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Dept Measles, Beijing, Peoples R China	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Hemminki, K (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.; Hemminki, K (corresponding author), Lund Univ, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden.	k.hemminki@dkfz.de	Ji, Jianguang/E-9579-2011	Ji, Jianguang/0000-0003-0324-9496	Multiple Myeloma Research Foundation; German Ministry of Education and Science [01ZX1309B]; Deutsche Krebshilfe	Multiple Myeloma Research Foundation; German Ministry of Education and Science; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Multiple Myeloma Research Foundation, the German Ministry of Education and Science (01ZX1309B) and Deutsche Krebshilfe.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Fallah M, 2014, ANN ONCOL, V25, P2025, DOI 10.1093/annonc/mdu365; Fallah M, 2014, ANN ONCOL, V25, P1397, DOI 10.1093/annonc/mdu144; Forabosco P, 2009, EUR J HUM GENET, V17, P236, DOI 10.1038/ejhg.2008.163; Goldin LR, 2009, INT J CANCER, V124, P1497, DOI 10.1002/ijc.24141; Hemminki K, 2013, BRIT J HAEMATOL, V161, P677, DOI 10.1111/bjh.12330; Hemminki K, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-59; Kruszka P, 2009, AM FAM PHYSICIAN, V79, P465; Li YR, 2015, NAT MED, V21, P1018, DOI 10.1038/nm.3933; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Seifert Marc, 2013, Methods Mol Biol, V971, P1, DOI 10.1007/978-1-62703-269-8_1; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	15	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158360	10.1371/journal.pone.0158360	http://dx.doi.org/10.1371/journal.pone.0158360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355450	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400054
J	Lin, HR; Shen, L; Zhang, XJ; Xie, JH; Hao, HX; Zhang, YX; Chen, ZH; Yamamoto, H; Liao, WJ; Bin, JP; Cao, SP; Huang, XB; Liao, YL				Lin, Hairuo; Shen, Liang; Zhang, Xiajun; Xie, Jiahe; Hao, Huixin; Zhang, Yingxue; Chen, Zhenhuan; Yamamoto, Hiroshi; Liao, Wangjun; Bin, Jianping; Cao, Shiping; Huang, Xiaobo; Liao, Yulin			HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload	PLOS ONE			English	Article							STIMULATES MACROPHAGES; MYOCARDIAL APOPTOSIS; HEART-FAILURE; HYPERTROPHY; RECEPTOR; EXPRESSION; RELEASE; PROTEIN; INFLAMMATION; PROMOTES	High-mobility group box1 (HMGB1) exerts effects on inflammation by binding to receptor for advanced glycation end products (RAGE) or Toll-like receptor 4. Considering that inflammation is involved in pressure overload-induced cardiac hypertrophy, we herein attempted to investigate whether HMGB1 plays a role in myocardial hypertrophy in RAGE knockout mice as well as in the growth and apoptosis of cardiomyocytes. The myocardial expression of RAGE was not significantly changed while TLR4 mRNA was upregulated in response to transverse aortic constriction (TAC) for 1 week. The myocardial expression of HMGB1 protein was markedly increased in TAC group when compared to the sham group. Heart weight to body weight ratio (HW/BW) and lung weight to body weight ratio (LW/BW) were evaluated in RAGE knockout (KO) and wild-type (WT) mice 1 week after TAC. Significant larger HW/BW and LW/BW ratios were found in TAC groups than the corresponding sham groups, but no significant difference was found between KO and WT TAC mice. Similar results were also found when TAC duration was extended to 4 weeks. Cultured neonatal rat cardiomyocytes were treated with different concentrations of recombinant HMGB1, then cell viability was determined using MTT and CCK8 assays and cell apoptosis was determined by Hoechst staining and TUNEL assay. The results came out that HMGB1 exerted no influence on viability or apoptosis of cardiomyocytes. Besides, the protein expression levels of Bax and Bcl2 in response to different concentrations of HMGB1 were similar. These findings indicate that HMGB1 neither exerts influence on cardiac remodeling by binding to RAGE nor induces apoptosis of cardiomyocytes under physiological condition.	[Lin, Hairuo; Shen, Liang; Zhang, Xiajun; Xie, Jiahe; Hao, Huixin; Zhang, Yingxue; Chen, Zhenhuan; Bin, Jianping; Cao, Shiping; Huang, Xiaobo; Liao, Yulin] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Shen, Liang] Jiaxing Univ, Affiliated Hosp 1, Dept Cardiol, Jiaxing, Zhejiang, Peoples R China; [Liao, Wangjun] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Yamamoto, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan	Southern Medical University - China; Jiaxing University; Southern Medical University - China; Kanazawa University	Liao, YL (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.	liao18@msn.com	Liao, Yulin/AAP-6315-2021					Bangert A, 2016, P NATL ACAD SCI USA, V113, pE155, DOI 10.1073/pnas.1522288113; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen HM, 2014, AM J CHINESE MED, V42, P785, DOI 10.1142/S0192415X14500505; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; Ehrentraut H, 2011, EUR J HEART FAIL, V13, P602, DOI 10.1093/eurjhf/hfr035; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Funayama A, 2013, CARDIOVASC RES, V99, P657, DOI 10.1093/cvr/cvt128; Glezeva N, 2014, HEART FAIL REV, V19, P681, DOI 10.1007/s10741-013-9405-8; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Herzog C, 2014, CARDIOVASC RES, V101, P400, DOI 10.1093/cvr/cvt275; Jhun J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0663-1; Jia Z, 2014, HMGB1 IS INVOLVED PR, V2014; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Li XX, 2015, ONCOTARGET, V6, P18829, DOI 10.18632/oncotarget.4774; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Luo T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0342-4; Melis MHM, 2013, CELL DEATH DIFFER, V20, P765, DOI 10.1038/cdd.2013.8; Meng QB, 2014, TUMOR BIOL, V35, P12265, DOI 10.1007/s13277-014-2535-3; MOSEVITSKY MI, 1989, EUR J BIOCHEM, V185, P303, DOI 10.1111/j.1432-1033.1989.tb15116.x; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Nakamura Y, 2015, J ATHEROSCLER THROMB, V22, P570, DOI 10.5551/jat.27235; Narayanan KB, 2015, APOPTOSIS, V20, P196, DOI 10.1007/s10495-014-1073-1; Narumi T, 2015, J MOL CELL CARDIOL, V82, P1, DOI 10.1016/j.yjmcc.2015.02.018; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Su FF, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/805149; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Wang WK, 2014, J CELL MOL MED, V18, P2311, DOI 10.1111/jcmm.12399; Wei X, 2015, CIRCULATION, V131, P1506, DOI 10.1161/CIRCULATIONAHA.114.013789; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Xu X, 2014, SCAND J IMMUNOL, V79, P386, DOI 10.1111/sji.12174; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Yan L, 2014, ARTERIOSCL THROM VAS, V34, P1399, DOI 10.1161/ATVBAHA.114.303508; Yoshida T, 2014, J MOL CELL CARDIOL, V75, P141, DOI 10.1016/j.yjmcc.2014.07.007; Zeng Z, 2014, CLIN SCI, V127, P435, DOI 10.1042/CS20130716; Zhang L, 2015, J CELL MOL MED; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	41	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158514	10.1371/journal.pone.0158514	http://dx.doi.org/10.1371/journal.pone.0158514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355349	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400072
J	Ranjith, AP; Quicke, DLJ; Saleem, UKA; Butcher, BA; Zaldivar-Riveron, A; Nasser, M				Ranjith, A. P.; Quicke, Donald L. J.; Saleem, U. K. A.; Butcher, Buntika A.; Zaldivar-Riveron, Alejandro; Nasser, M.			Entomophytophagy ('Sequential Predatory, then Phytophagous Behaviour') in an Indian Braconid 'Parasitoid' Wasp (Hymenoptera): Specialized Larval Morphology, Biology and Description of a New Species	PLOS ONE			English	Article							MESOSTOINAE; STRATEGIES; GENUS	The vast majority of braconid wasps are parasitoids of other insects. Although a few cases of pure phytophagy (primary gall production and seed predation) are known, no previous entomophytophagous species (i.e. ones that display entomophagy and phytophagy sequentially), has been discovered among braconids. We describe the detailed biology and specialized larval morphology for the first confirmed entomophytophagous braconid species. Leaf galls on Garuga pinnata Roxb. (Burseraceae) in India, induced by the psyllid, Phacopteron lentiginosum Buckton (Hemiptera: Psylloidea, Phacopteronidae) were sampled throughout a period of several months and found to suffer a high level of attack by a new species Bracon garugaphagae Ranjith & Quicke which is here described and illustrated. The wasps oviposit singly into the galls without paralysing the psyllids. The larvae first attack psyllid nymphs which they seek out within the gall, kill them with a single bite and consume them. Unique dorsal abdominal tubercles, with eversible tips present on the abdominal segments of the larvae that are used to help maintain larval position while feeding, are illustrated. After consuming all available prey, the larvae continue feeding on gall tissue until mature enough to spin cocoons and pupate. The new species illustrates, for the first time, a possible intermediate stage in the evolution of pure phytophagy within the Braconidae. Interestingly, the two unrelated seed predator Bracon species are also associated with Burseraceae, perhaps indicating that this plant family is particularly suited as a food for braconine wasps.	[Ranjith, A. P.; Saleem, U. K. A.; Nasser, M.] Univ Calicut, Dept Zool, Insect Ecol & Ethol Lab, Calicut 673635, Kerala, India; [Ranjith, A. P.] Malabar Christian Coll, Dept Zool, Calicut 673001, Kerala, India; [Quicke, Donald L. J.; Butcher, Buntika A.] Chulalongkorn Univ, Dept Biol, Fac Sci, Phayathai Rd, Pathumwan 10330, Bkk, Thailand; [Zaldivar-Riveron, Alejandro] Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Insectos, 3er Circuito Exterior S-N Cd Univ,AP 70-233, Coyoacan 04510, DF, Mexico; [Saleem, U. K. A.] Govt Coll Madappally, Dept Zool, Calicut 686546, Kerala, India	University of Calicut; Chulalongkorn University; Universidad Nacional Autonoma de Mexico	Nasser, M (corresponding author), Univ Calicut, Dept Zool, Insect Ecol & Ethol Lab, Calicut 673635, Kerala, India.	drnasher@gmail.com	Ranjith, Avunjikkattu Parambil/N-4483-2019		SAP and UGC	SAP and UGC	APR is grateful to Kiran Kishore and Sruthy Vasudevan for contributing much effort to the lengthy gall dissections. APR and MN are grateful to the University of Calicut for facilities provided and MN is grateful to SAP and UGC for their support. Chris Raper kindly stacked the light microscopy larval head capsule images for us.	Austin AD, 1998, AUST J BOT, V46, P559; Belshaw R, 2001, BIOL J LINN SOC, V73, P411, DOI 10.1111/j.1095-8312.2001.tb01370.x; CAPEK M, 1970, Canadian Entomologist, V102, P846; Carleton M., 1939, Journal of the Linnean Society London Zoology, V40, P575; CHADWICK C E, 1976, Journal of the Entomological Society of Australia (N. S. W.), V9, P28; DEMACEDO MV, 1989, J NEW YORK ENTOMOL S, V97, P358; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; EADY RD, 1968, PROC R ENTOMOL SOC A, V43, P66, DOI 10.1111/j.1365-3032.1968.tb01029.x; Flores S, 2005, J NAT HIST, V39, P3663, DOI 10.1080/00222930500392659; Gauld ID, 2002, ZOOL J LINN SOC-LOND, V136, P421, DOI 10.1046/j.1096-3642.2002.00031.x; GLOVER P. M., 1936, PROC INDIAN ACAD SCI SECT B, V3, P195; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goolsby J.A., 2001, Journal of Hymenoptera Research, V10, P163; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; HENNEICKE K, 1992, J NAT HIST, V26, P1047, DOI 10.1080/00222939200770621; Jervis M. A., 1996, P375; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; Li F., 2000, Zoologische Mededelingen (Leiden), V74, P359; Marsh Paul M., 2002, Memoirs of the American Entomological Institute (Gainesville), V70, P1; MARSH PM, 1991, P ENTOMOL SOC WASH, V93, P92; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Perioto Nelson Wanderley, 2011, Zootaxa, V3000, P59; QUICKE DLJ, 1987, J NAT HIST, V21, P43, DOI 10.1080/00222938700770031; QUICKE DLJ, 1989, J NAT HIST, V23, P1309, DOI 10.1080/00222938900770691; Quicke DLJ, 2015, BRACONID ICHNEUMOID; Quicke Donald L. J., 2005, Journal of Hymenoptera Research, V14, P182; R Development Core Team, R LANG ENV STAT COMP; Salt G., 1931, Bulletin of Entomological Research London, V22, P479, DOI 10.1017/S0007485300035355; Shaw M.R., 1991, Handbooks for the Identification of British Insects, V7, P1; SLOBODCHIKOFF CN, 1967, PAN-PAC ENTOMOL, V43, P161; van Achterberg C., 1979, Tijdschrift voor Entomologie, V122, P241; van Achterberg C., 2000, Zoologische Mededelingen (Leiden), V74, P51; van Achterberg C, 1988, ZOOL VERH, V249, P1; Wei P, 2013, ZOOTAXA, V3640, P465, DOI 10.11646/zootaxa.3640.3.8; WHARTON RA, 1993, ANNU REV ENTOMOL, V38, P121, DOI 10.1146/annurev.en.38.010193.001005; Wharton Robert A., 2005, P495; Yu Douglas W., 1997, Journal of Hymenoptera Research, V6, P419; Zaldivar-Riveron A, 2006, MOL PHYLOGENET EVOL, V38, P130, DOI 10.1016/j.ympev.2005.08.006; Zaldivar-Riveron A, 2013, INVERTEBR SYST, V27, P673, DOI 10.1071/IS13021; Zaldivar-Riveron A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-329	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0156997	10.1371/journal.pone.0156997	http://dx.doi.org/10.1371/journal.pone.0156997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355679	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400008
J	Kono, K; Hiruma, H; Kobayashi, S; Sato, Y; Tanaka, M; Sawada, R; Niimi, S				Kono, Ken; Hiruma, Hitomi; Kobayashi, Shingo; Sato, Yoji; Tanaka, Masaru; Sawada, Rumi; Niimi, Shingo			In Vitro Endothelialization Test of Biomaterials Using Immortalized Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN ADSORPTION; POLY(2-METHOXYETHYL ACRYLATE); BLOOD COMPATIBILITY; PLATELET-ADHESION; WATER-STRUCTURE; POLYMERS; SURFACE; PMEA; PHOSPHORYLCHOLINE	Functionalizing biomaterials with peptides or polymers that enhance recruitment of endothelial cells (ECs) can reduce blood coagulation and thrombosis. To assess endothelialization of materials in vitro, primary ECs are generally used, although the characteristics of these cells vary among the donors and change with time in culture. Recently, primary cell lines immortalized by transduction of simian vacuolating virus 40 large T antigen or human telomerase reverse transcriptase have been developed. To determine whether immortalized ECs can substitute for primary ECs in material testing, we investigated endothelialization on biocompatible polymers using three lots of primary human umbilical vein endothelial cells (HUVEC) and immortalized microvascular ECs, TIME-GFP. Attachment to and growth on polymer surfaces were comparable between cell types, but results were more consistent with TIME-GFP. Our findings indicate that TIME-GFP is more suitable for in vitro endothelialization testing of biomaterials.	[Kono, Ken; Sato, Yoji; Sawada, Rumi] Natl Inst Hlth Sci, Div Cell Based Therapeut Prod, Tokyo, Japan; [Hiruma, Hitomi; Niimi, Shingo] Natl Inst Hlth Sci, Div Med Devices, Tokyo, Japan; [Kobayashi, Shingo; Tanaka, Masaru] Kyushu Univ, Inst Mat Chem & Engn, Soft Mat Chem, Fukuoka 812, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kyushu University	Sawada, R (corresponding author), Natl Inst Hlth Sci, Div Cell Based Therapeut Prod, Tokyo, Japan.	rsawada@nihs.go.jp	Kobayashi, Shingo/ABG-6136-2020; Tanaka, Masaru/O-3388-2018	Kobayashi, Shingo/0000-0002-8357-8654; Tanaka, Masaru/0000-0002-1115-2080	Health and Labor Sciences Research Grants for Research on Regulatory Science of Pharmaceuticals and Medical Devices from the Ministry of Health, Labor and Welfare of Japan [H24-IYAKU-SHITEI-018]	Health and Labor Sciences Research Grants for Research on Regulatory Science of Pharmaceuticals and Medical Devices from the Ministry of Health, Labor and Welfare of Japan	The work was supported by the Health and Labor Sciences Research Grants for Research on Regulatory Science of Pharmaceuticals and Medical Devices (H24-IYAKU-SHITEI-018) from the Ministry of Health, Labor and Welfare of Japan, SN.	Anderson DEJ, 2014, CELLS TISSUES ORGANS, V199, P238, DOI 10.1159/000368223; Cockcroft JR, 2005, AM J HYPERTENS, V18, p177S, DOI 10.1016/j.amjhyper.2005.09.001; de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k; Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8; Glynn JJ, 2014, TISSUE ENG PART B-RE, V20, P294, DOI [10.1089/ten.teb.2013.0285, 10.1089/ten.TEB.2013.0285]; Greenfield Benjamin L, 2002, J Extra Corpor Technol, V34, P267; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hoshiba T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136066; Hoshiba T, 2014, ADV HEALTHC MATER, V3, P775, DOI 10.1002/adhm.201300309; ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809; Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7; Jaffer IH, 2015, J THROMB HAEMOST, V13, pS72, DOI 10.1111/jth.12961; Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579; Kanie K, 2012, BIOTECHNOL BIOENG, V109, P1808, DOI 10.1002/bit.24459; Kitakami E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/102648; Kruer A, 2015, CLIN HEMORHEOL MICRO, V60, P153, DOI 10.3233/CH-151943; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039; Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Mueller XM, 2002, INT J ARTIF ORGANS, V25, P223, DOI 10.1177/039139880202500309; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; Ozer HL, 1996, EXP GERONTOL, V31, P303, DOI 10.1016/0531-5565(95)00024-0; Prasad CK, 2007, J BIOMED MATER RES A, V80A, P644, DOI 10.1002/jbm.a.30968; Rubens FD, 2002, J BIOMAT SCI-POLYM E, V13, P485, DOI 10.1163/156856202320253974; Sato K, 2015, MACROMOL BIOSCI, V15, P1296, DOI 10.1002/mabi.201500078; Seguin C, 2008, ENDOTHELIUM-J ENDOTH, V15, P143, DOI 10.1080/10623320802125508; Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006; Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y; Tanaka M., JP patent, Patent No. [pending. JP2014-105221, 2014105221]; Triplett DA, 2000, CLIN CHEM, V46, P1260; Tsuruta T, 2010, J BIOMAT SCI-POLYM E, V21, P1831, DOI 10.1163/092050610X488269; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338; Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242; Zhang F, 2002, BIOMATERIALS, V23, P787, DOI 10.1016/S0142-9612(01)00184-3; Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047	41	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158289	10.1371/journal.pone.0158289	http://dx.doi.org/10.1371/journal.pone.0158289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348615	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200058
J	Choi, H; Jin, S; Kwon, JT; Kim, J; Jeong, J; Kim, J; Jeon, S; Park, ZY; Jung, KJ; Park, K; Cho, C				Choi, Heejin; Jin, Sora; Kwon, Jun Tae; Kim, Jihye; Jeong, Juri; Kim, Jaehwan; Jeon, Suyeon; Park, Zee Yong; Jung, Kang-Jin; Park, Kwangsung; Cho, Chunghee			Characterization of Mammalian ADAM2 and Its Absence from Human Sperm	PLOS ONE			English	Article							DEPTH PROTEOMIC ANALYSIS; TESTICULAR GERM-CELLS; EGG PLASMA-MEMBRANE; FERTILIN ALPHA; EXPRESSION ANALYSIS; DISINTEGRIN DOMAIN; REPRODUCTIVE ADAMS; HUMAN SPERMATOZOA; SEQUENCE-ANALYSIS; EPIDIDYMAL ADAMS	The members of the ADAM (a disintegrin and metalloprotease) family are membrane-anchored multi-domain proteins that play prominent roles in male reproduction. ADAM2, which was one of the first identified ADAMs, is the best studied ADAM in reproduction. In the male germ cells of mice, ADAM2 and other ADAMs form complexes that contribute to sperm-sperm adhesion, sperm-egg interactions, and the migration of sperm in the female reproductive tract. Here, we generated specific antibodies against mouse and human ADAM2, and investigated various features of ADAM2 in mice, monkeys and humans. We found that the cytoplasmic domain of ADAM2 might enable the differential association of this protein with other ADAMs in mice. Western blot analysis with the anti-human ADAM2 antibodies showed that ADAM2 is present in the testis and sperm of monkeys. Monkey ADAM2 was found to associate with chaperone proteins in testis. In humans, we identified ADAM2 as a 100-kDa protein in the testis, but failed to detect it in sperm. This is surprising given the results in mice and monkeys, but it is consistent with the failure of ADAM2 identification in the previous proteomic analyses of human sperm. These findings suggest that the reproductive functions of ADAM2 differ between humans and mice. Our protein analysis showed the presence of potential ADAM2 complexes involving yet-unknown proteins in human testis. Taken together, our results provide new information regarding the characteristics of ADAM2 in mammalian species, including humans.	[Choi, Heejin; Jin, Sora; Kwon, Jun Tae; Kim, Jihye; Jeong, Juri; Kim, Jaehwan; Jeon, Suyeon; Park, Zee Yong; Cho, Chunghee] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Jung, Kang-Jin] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongju, South Korea; [Park, Kwangsung] Chonnam Natl Univ, Sch Med, Dept Urol, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea.	choch@gist.ac.kr	Park, Kwangsung/AAQ-7740-2020	Park, Kwangsung/0000-0001-8827-162X	Mid-career Researcher Program through NRF grant - MEST [NRF-2015R1A2A2A01005300]; Bio & Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF 2013M3A9A7046297]; GIST Systems Biology Infrastructure Establishment grant	Mid-career Researcher Program through NRF grant - MEST; Bio & Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; GIST Systems Biology Infrastructure Establishment grant	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (NRF-2015R1A2A2A01005300), the Bio & Medical Technology Development Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF 2013M3A9A7046297) and GIST Systems Biology Infrastructure Establishment grant.	Baker MA, 2007, PROTEOM CLIN APPL, V1, P524, DOI 10.1002/prca.200601013; Baker MA, 2013, PROTEOMICS, V13, P61, DOI 10.1002/pmic.201200350; BLOBEL CP, 1990, J CELL BIOL, V111, P69, DOI 10.1083/jcb.111.1.69; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Burkin HR, 1997, GENOMICS, V40, P190, DOI 10.1006/geno.1996.4531; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Cho CH, 2000, DEV BIOL, V222, P289, DOI 10.1006/dbio.2000.9703; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Cho C, 2012, NAT REV UROL, V9, P550, DOI 10.1038/nrurol.2012.167; Choi H, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130252; Day AE, 2003, ANIM GENET, V34, P375, DOI 10.1046/j.1365-2052.2003.01029.x; de Mateo S, 2007, PROTEOMICS, V7, P4264, DOI 10.1002/pmic.200700521; Desiderio UV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013744; Dun MD, 2012, HUM REPROD UPDATE, V18, P420, DOI 10.1093/humupd/dms009; EVANS JP, 1995, J CELL SCI, V108, P3267; Finn S, 2010, J MOL EVOL, V71, P231, DOI 10.1007/s00239-010-9382-7; Frayne J, 1998, MOL HUM REPROD, V4, P429, DOI 10.1093/molehr/4.5.429; Guo XJ, 2010, J ANDROL, V31, P419, DOI 10.2164/jandrol.109.007534; Gupta SK, 1996, BIOCHEM BIOPH RES CO, V224, P318, DOI 10.1006/bbrc.1996.1027; Gyamera-Acheampong C, 2010, FERTIL STERIL, V93, P1112, DOI 10.1016/j.fertnstert.2008.12.013; Han C, 2010, FERTIL STERIL, V93, P2754, DOI 10.1016/j.fertnstert.2010.03.013; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; Hardy CM, 1996, MOL REPROD DEV, V45, P107, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;107::AID-MRD1&gt;3.0.CO;2-X; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Kim E, 2006, J BIOL CHEM, V281, P5634, DOI 10.1074/jbc.M510558200; Kim E, 2003, BIOCHEM BIOPH RES CO, V304, P313, DOI 10.1016/S0006-291X(03)00588-6; Kim E, 2010, ANIM REPROD SCI, V117, P155, DOI 10.1016/j.anireprosci.2009.04.002; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Li JY, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.004630, 10.1074/mcp.M110.006536]; Liu HW, 2000, MOL HUM REPROD, V6, P422, DOI 10.1093/molehr/6.5.422; Liu MX, 2013, PROTEOMICS, V13, P1200, DOI 10.1002/pmic.201200489; Marcello MR, 2011, J BIOL CHEM, V286, P13060, DOI 10.1074/jbc.M110.175463; Martinez-Heredia J, 2006, PROTEOMICS, V6, P4356, DOI 10.1002/pmic.200600094; McLaughlin EA, 1997, MOL HUM REPROD, V3, P801, DOI 10.1093/molehr/3.9.801; Mitchell LA, 2007, MOL HUM REPROD, V13, P605, DOI 10.1093/molehr/gam043; Mori C, 1997, DEV DYNAM, V208, P125; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nishimura H, 2007, J BIOL CHEM, V282, P17900, DOI 10.1074/jbc.M702268200; Nixon B, 2011, J CELL PHYSIOL, V226, P2651, DOI 10.1002/jcp.22615; Oh J, 2005, BIOCHEM BIOPH RES CO, V331, P1374, DOI 10.1016/j.bbrc.2005.04.067; PERRY ACF, 1995, BIOCHEM J, V307, P843, DOI 10.1042/bj3070843; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Siva AB, 2010, MOL HUM REPROD, V16, P452, DOI 10.1093/molehr/gaq009; Skerget S, 2013, MOL CELL PROTEOMICS, V12, P3052, DOI 10.1074/mcp.M112.026476; Sun GH, 2000, MOL HUM REPROD, V6, P429, DOI 10.1093/molehr/6.5.429; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Vidaeus CM, 1997, MOL REPROD DEV, V46, P363; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wang J, 2014, PROTEOMICS, V14, P1393, DOI 10.1002/pmic.201300149; Waters SI, 1997, BIOL REPROD, V56, P1245, DOI 10.1095/biolreprod56.5.1245; WOLFSBERG TG, 1993, P NATL ACAD SCI USA, V90, P10783, DOI 10.1073/pnas.90.22.10783; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Yi C, 2010, GENE EXPR PATTERNS, V10, P152, DOI 10.1016/j.gep.2010.01.003; Zhou T, 2015, PROTEOMICS, V15, P1564, DOI 10.1002/pmic.201400248; Zhu XL, 2000, J BIOL CHEM, V275, P7677, DOI 10.1074/jbc.275.11.7677; Zhu XL, 2002, BIOL REPROD, V66, P1193, DOI 10.1095/biolreprod66.4.1193	63	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158321	10.1371/journal.pone.0158321	http://dx.doi.org/10.1371/journal.pone.0158321			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341348	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600049
J	Dinger, SC; Fridjhon, P; Rubin, DM				Dinger, Steven C.; Fridjhon, Peter; Rubin, David M.			Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; RELAXATION; HYPERTHERMIA	Theoretical and experimental investigations into the thermal excitation of liquid paramagnetic contrast agents using the spin resonance relaxation mechanism are presented. The electronic spin-lattice relaxation time tau(1e) of gadolinium-based contrast agents, which is estimated at 0.1 ns, is ten orders of magnitude faster than the relaxation time of protons in water. The shorter relaxation time is found to significantly increase the rate of thermal energy deposition. To the authors' knowledge this is the first study of gadolinium based contrast agents in a liquid state used as thermal agents. Analysis shows that when t1e and other experimental parameters are optimally selected, a maximum theoretical heating rate of 29.4 degrees C.s(-1) could be achieved which would suffice for clinical thermal ablation of neoplasms. The experimental results show a statistically significant thermal response for two out of the four contrast agents tested. The results are compared to the simulated estimates via analysis of a detailed model of the system. While these experimentally determined temperature rises are small and thus of no clinical utility, their presence supports the theoretical analysis and strongly suggests that the chemical structure of the selected compounds plays an important role in this mechanism of heat deposition. There exists an opportunity for the development of alternative gadolinium-based compounds with an order of magnitude longer t1e in a diluted form to be used as an efficient hyperthermia agent for clinical use.	[Dinger, Steven C.; Rubin, David M.] Univ Witwatersrand, Sch Elect & Informat Engn, Johannesburg, Gauteng, South Africa; [Fridjhon, Peter] Univ Witwatersrand, Sch Stat & Actuarial Sci, Johannesburg, Gauteng, South Africa	University of Witwatersrand; University of Witwatersrand	Dinger, SC (corresponding author), Univ Witwatersrand, Sch Elect & Informat Engn, Johannesburg, Gauteng, South Africa.	steven.dinger@wits.ac.za		Dinger, Steven/0000-0001-7611-7211; Rubin, David/0000-0003-0316-9197	School of Electrical & Information Engineering, University of Witwatersrand	School of Electrical & Information Engineering, University of Witwatersrand	The authors received funding for this work from their home department, which is the School of Electrical & Information Engineering, University of Witwatersrand.	Abragam A, 2012, INT SERIES MONOGRAPH, P64; Aime S, 2005, ADV INORG CHEM, V57, P173, DOI 10.1016/S0898-8838(05)57004-1; Andrade JM, 2014, ANAL CHIM ACTA, V838, P1, DOI 10.1016/j.aca.2014.04.057; Atsarkin VA, 2001, J PHYS CHEM A, V105, P9323, DOI 10.1021/jp0111158; Borel A, 2008, CHEM-EUR J, V14, P2658, DOI 10.1002/chem.200701747; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Choi Y, 2011, J KOREAN CERAM SOC, V48, P577, DOI 10.4191/kcers.2011.48.6.577; David P.B., 2010, QUANTITATIVE EPR; Drake P, 2007, J MATER CHEM, V17, P4914, DOI 10.1039/b711962c; Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Lynn John G., 1942, JOUR GEN PHYSIOL, V26, P179, DOI 10.1085/jgp.26.2.179; McRobbie DW, 2003, MRI PICTURE PROTON, P156; Morrish AH., 1965, WILEY SERIES SCI TEC, P57; Neoptix, 2014, T1 FIBR OPT TEMP PRO; Ogunlade O, 2014, SPIE BIOS; PARKER DL, 1984, IEEE T BIO-MED ENG, V31, P161, DOI 10.1109/TBME.1984.325382; Pittman ME, 1964, 3 4 COIL SYSTEMS HOM; Rast S, 2001, J CHEM PHYS, V115, P7554, DOI 10.1063/1.1392364; Rinard G.A., 2005, BIO MAGN RE, P19, DOI 10.1007/0-306-48533-8_2; Rinard GA, 2002, CONCEPT MAGNETIC RES, V15, P51, DOI 10.1002/cmr.10018; Ripert T, 2010, PROSTATE CANCER P D, V13, P132, DOI 10.1038/pcan.2009.57; Slichter CP., 1990, SPRINGER SERIES SOLI, P4; Tweedle MF, 1997, EUR RADIOL, V7, pS225, DOI 10.1007/PL00006897; Usselman RJ, 2015, APPL MAGN RESON, V46, P349, DOI 10.1007/s00723-014-0639-y; Weil JA, 2007, ELECT PARAMAGNETIC R, P306	26	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158194	10.1371/journal.pone.0158194	http://dx.doi.org/10.1371/journal.pone.0158194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341338	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600039
J	Hicks, DM; Ouvrard, P; Baldock, KCR; Baude, M; Goddard, MA; Kunin, WE; Mitschunas, N; Memmott, J; Morse, H; Nikolitsi, M; Osgathorpe, LM; Potts, SG; Robertson, KM; Scott, AV; Sinclair, F; Westbury, DB; Stone, GN				Hicks, Damien M.; Ouvrard, Pierre; Baldock, Katherine C. R.; Baude, Mathilde; Goddard, Mark A.; Kunin, William E.; Mitschunas, Nadine; Memmott, Jane; Morse, Helen; Nikolitsi, Maria; Osgathorpe, Lynne M.; Potts, Simon G.; Robertson, Kirsty M.; Scott, Anna V.; Sinclair, Frazer; Westbury, Duncan B.; Stone, Graham N.			Food for Pollinators: Quantifying the Nectar and Pollen Resources of Urban Flower Meadows	PLOS ONE			English	Article							BEE ANTHOPHORA-PLUMIPES; APIS-MELLIFERA; HONEY-BEES; HERBACEOUS PERENNIALS; WILDFLOWER STRIPS; FLORAL RESOURCES; SOLITARY BEES; AMINO-ACIDS; DIVERSITY; ABUNDANCE	Planted meadows are increasingly used to improve the biodiversity and aesthetic amenity value of urban areas. Although many 'pollinator-friendly' seed mixes are available, the floral resources these provide to flower-visiting insects, and how these change through time, are largely unknown. Such data are necessary to compare the resources provided by alternative meadow seed mixes to each other and to other flowering habitats. We used quantitative surveys of over 2 million flowers to estimate the nectar and pollen resources offered by two exemplar commercial seed mixes (one annual, one perennial) and associated weeds grown as 300m(2) meadows across four UK cities, sampled at six time points between May and September 2013. Nectar sugar and pollen rewards per flower varied widely across 65 species surveyed, with native British weed species (including dandelion, Taraxacum agg.) contributing the top five nectar producers and two of the top ten pollen producers. Seed mix species yielding the highest rewards per flower included Leontodon hispidus, Centaurea cyanus and C. nigra for nectar, and Papaver rhoeas, Eschscholzia californica and Malva moschata for pollen. Perennial meadows produced up to 20x more nectar and up to 6x more pollen than annual meadows, which in turn produced far more than amenity grassland controls. Perennial meadows produced resources earlier in the year than annual meadows, but both seed mixes delivered very low resource levels early in the year and these were provided almost entirely by native weeds. Pollen volume per flower is well predicted statistically by floral morphology, and nectar sugar mass and pollen volume per unit area are correlated with flower counts, raising the possibility that resource levels can be estimated for species or habitats where they cannot be measured directly. Our approach does not incorporate resource quality information ( for example, pollen protein or essential amino acid content), but can easily do so when suitable data exist. Our approach should inform the design of new seed mixes to ensure continuity in floral resource availability throughout the year, and to identify suitable species to fill resource gaps in established mixes.	[Hicks, Damien M.; Ouvrard, Pierre; Sinclair, Frazer; Stone, Graham N.] Univ Edinburgh, Inst Evolutionary Biol, Kings Bldg,Charlotte Auerbach Rd, Edinburgh EH9 3JT, Midlothian, Scotland; [Ouvrard, Pierre] Catholic Univ Louvain, Earth & Life Inst Agron, Pl Croix Sud 2, B-1348 Louvain La Neuve, Belgium; [Baldock, Katherine C. R.; Baude, Mathilde; Mitschunas, Nadine; Memmott, Jane; Morse, Helen; Osgathorpe, Lynne M.] Univ Bristol, Sch Biol Sci, 24 Tyndall Ave, Bristol BS8 1TQUG, Avon, England; [Baldock, Katherine C. R.; Memmott, Jane] Univ Bristol, Cabot Inst, Woodland Rd, Bristol BS8 1UJ, Avon, England; [Baude, Mathilde] Univ Orleans, Coll Sci & Tech, EA 1207, LBLGC, F-45067 Orleans, France; [Goddard, Mark A.; Kunin, William E.; Nikolitsi, Maria; Robertson, Kirsty M.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Mitschunas, Nadine; Potts, Simon G.; Scott, Anna V.] Univ Reading, Ctr Agri Environm Res, Sch Agr Policy & Dev, Reading RG6 6AR, Berks, England; [Sinclair, Frazer] Royal Soc Protect Birds, Gola Rainforest Natl Pk, Kenema, Sierra Leone; [Westbury, Duncan B.] Univ Worcester, Inst Sci & Environm, Henwick Grove WR2 6AJ, Worcs, England; [Goddard, Mark A.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Edinburgh; Universite Catholique Louvain; University of Bristol; University of Bristol; Universite de Orleans; University of Leeds; University of Reading; Royal Society for Protection of Birds; University of Worcester; Newcastle University - UK	Stone, GN (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Kings Bldg,Charlotte Auerbach Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	graham.stone@ed.ac.uk	Goddard, Mark/D-1166-2010; Potts, Simon G/C-7250-2008; Westbury, Duncan/AAU-7578-2021; Potts, Simon/ABF-9221-2020; Baldock, Katherine/J-8469-2012	Goddard, Mark/0000-0002-2283-6752; Potts, Simon G/0000-0002-2045-980X; Westbury, Duncan/0000-0001-7094-0362; Potts, Simon/0000-0002-2045-980X; Baldock, Katherine/0000-0001-6849-8747; Ouvrard, Pierre/0000-0002-2805-4583; Hicks, Damien/0000-0001-7884-5239; Sinclair, Frazer/0000-0001-5017-3215; Stone, Graham/0000-0002-2737-696X	Biotechnology and Biological Sciences Research Council (BBSRC); UK Government Department for Environment, Food and Rural Affairs (Defra); Natural Environment Research Council (NERC); Wellcome Trust, under the Insect Pollinators Initiative [BB/I000305/1, BB/I00047X/1, BB/H014934/1]; Scottish Government; BBSRC [BB/I000364/1, BB/I00047X/1] Funding Source: UKRI; NERC [NE/M006956/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000364/1, BB/I00047X/1, BB/I000305/1] Funding Source: researchfish; Natural Environment Research Council [NE/M006956/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Government Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust, under the Insect Pollinators Initiative(Wellcome Trust); Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded jointly by a grant from Biotechnology and Biological Sciences Research Council (BBSRC), The UK Government Department for Environment, Food and Rural Affairs (Defra), Natural Environment Research Council (NERC), the Scottish Government and the Wellcome Trust, under the Insect Pollinators Initiative (www.bbsrc.ac.uk/funding/opportunities/2009/insectpollinators-initiative/), (grant numbers BB/I000305/1, BB/I00047X/1) to Jane Memmott, Graham N. Stone, Simon G. Potts and William E. Kunin, a second Insect Pollinators Initiative grant (grant number BB/H014934/1) to William E. Kunin, Simon G. Potts and Jane Memmott, and Impact Acceleration Account funding from the Natural Environment Research Council to Graham N. Stone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Albrecht M, 2007, J ANIM ECOL, V76, P1015, DOI 10.1111/j.1365-2656.2007.01264.x; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Balzan MV, 2016, ENTOMOL EXP APPL, V158, P304, DOI 10.1111/eea.12403; Balzan MV, 2014, J INSECT CONSERV, V18, P713, DOI 10.1007/s10841-014-9680-2; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Baude M, 2016, NATURE, V530, P85, DOI 10.1038/nature16532; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Blackmore LM, 2014, INSECT CONSERV DIVER, V7, P480, DOI 10.1111/icad.12071; BOLTEN AB, 1979, OECOLOGIA, V41, P301, DOI 10.1007/BF00377434; BOWERS MA, 1986, ENVIRON ENTOMOL, V15, P750, DOI 10.1093/ee/15.3.750; Bretagnolle V, 2015, AGRON SUSTAIN DEV, V35, P891, DOI 10.1007/s13593-015-0302-5; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; BUCHMANN SL, 1991, GRANA, V30, P591, DOI 10.1080/00173139109427817; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; CARTAR RV, 1991, CAN ENTOMOL, V123, P283, DOI 10.4039/Ent123283-2; Carvalheiro LG, 2014, ECOL LETT, V17, P1389, DOI 10.1111/ele.12342; Carvell C, 2004, BIOL CONSERV, V118, P327, DOI 10.1016/j.biocon.2003.09.012; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; CHAMBERS VH, 1946, J ANIM ECOL, V15, P9, DOI 10.2307/1621; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; COURTNEY SP, 1982, OIKOS, V38, P260, DOI 10.2307/3544030; Dafni A., 2005, PRACTICAL POLLINATIO; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Denisow B, 2014, J APIC SCI, V58, P93, DOI 10.2478/JAS-2014-0009; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dicks LV, 2015, ECOL ENTOMOL, V40, P22, DOI 10.1111/een.12226; Dover JW, 1996, J APPL ECOL, V33, P723, DOI 10.2307/2404943; Erhardt A, 1998, OECOLOGIA, V117, P536, DOI 10.1007/s004420050690; Ferrazzi P., 2000, Insect Social Life, V3, P107; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; FREE JB, 1974, J APPL ECOL, V11, P925, DOI 10.2307/2401754; FUSSELL M, 1992, J APPL ECOL, V29, P451, DOI 10.2307/2404513; Gallai N, 2008, FAOSTAT; Genissel A, 2002, ENTOMOL EXP APPL, V104, P329, DOI 10.1023/A:1021279220995; Gerard F, 2010, PROG PHYS GEOG, V34, P183, DOI 10.1177/0309133309360141; Gong YB, 2014, PLANT BIOLOGY, V16, P843, DOI 10.1111/plb.12151; Goodwin SG, 1995, J APICULT RES, V34, P79, DOI 10.1080/00218839.1995.11100891; Gunnarsson B, 2014, J INSECT CONSERV, V18, P1185, DOI 10.1007/s10841-014-9729-2; Hanley ME, 2008, FUNCT ECOL, V22, P592, DOI 10.1111/j.1365-2435.2008.01415.x; HARRINGTON JB, 1963, AM J BOT, V50, P532, DOI 10.2307/2440028; Harrison T, 2015, FUNCT ECOL, V29, P879, DOI 10.1111/1365-2435.12486; Hass A, 2012, MITT DEUT GES ALLGEM, V18, P147; Hennig EI, 2011, PERSPECT PLANT ECOL, V13, P137, DOI 10.1016/j.ppees.2011.03.003; Hitchmough J, 1999, LANDSCAPE URBAN PLAN, V45, P107, DOI 10.1016/S0169-2046(99)00031-6; Hitchmough J, 2004, THE DYNAMIC LANDSCAP; Hitchmough JD, 2000, LANDSCAPE URBAN PLAN, V51, P37, DOI 10.1016/S0169-2046(00)00092-X; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Hulsmann M, 2015, APIDOLOGIE, V46, P760, DOI 10.1007/s13592-015-0366-x; Jivan A., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P263; Jones EL, 2012, EUR J ENTOMOL, V109, P463, DOI 10.14411/eje.2012.060; Junge X, 2015, LANDSCAPE URBAN PLAN, V133, P67, DOI 10.1016/j.landurbplan.2014.09.010; Kaczorowski RL, 2008, EVOLUTION, V62, P1738, DOI 10.1111/j.1558-5646.2008.00400.x; Kaplan R, 1989, THE EXPERIENCE OF NA; Kells AR, 2001, J INSECT CONSERV, V5, P283, DOI 10.1023/A:1013307822575; Kendle AD, 2000, LANDSCAPE URBAN PLAN, V47, P19, DOI 10.1016/S0169-2046(99)00070-5; Kovacs-Hostyanszki A, 2013, ECOL APPL, V23, P1938, DOI 10.1890/12-2012.1; Larkin LL, 2008, APIDOLOGIE, V39, P133, DOI 10.1051/apido:2007064; Larson JL, 2014, J INSECT CONSERV, V18, P863, DOI 10.1007/s10841-014-9694-9; Lazaro A, 2010, AM J BOT, V97, P760, DOI 10.3732/ajb.0900263; Leiss KA, 2005, FUNCT ECOL, V19, P454, DOI 10.1111/j.1365-2435.2005.00986.x; Lindemann-Matthies P, 2010, BIOL CONSERV, V143, P195, DOI 10.1016/j.biocon.2009.10.003; LOPER GM, 1987, J ECON ENTOMOL, V80, P14, DOI 10.1093/jee/80.1.14; LOPER GM, 1980, APIDOLOGIE, V11, P181, DOI 10.1051/apido:19800208; Lowenstein DM, 2015, OECOLOGIA, V179, P811, DOI 10.1007/s00442-015-3389-0; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; MACIOR LW, 1968, ECOLOGY, V49, P20, DOI 10.2307/1933556; MacIvor JS, 2014, URBAN ECOSYST, V17, P139, DOI 10.1007/s11252-013-0321-4; Maurizio A., 1951, REPORT OF THE XIVTH, P320; Meeus S, 2013, J ECOL, V101, P1353, DOI 10.1111/1365-2745.12150; Moerman R, 2016, J ECON ENTOMOL, V109, P25, DOI 10.1093/jee/tov279; Muller A, 2008, BIOL J LINN SOC, V95, P719, DOI 10.1111/j.1095-8312.2008.01113.x; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199563562.001.0001; Nohl W, 2001, LANDSCAPE URBAN PLAN, V54, P223, DOI 10.1016/S0169-2046(01)00138-4; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olive A, 2013, APPL GEOGR, V43, P56, DOI 10.1016/j.apgeog.2013.06.004; Orford KA, J APPL ECOL IN PRESS; Pardee GL, 2014, URBAN ECOSYST, V17, P641, DOI 10.1007/s11252-014-0349-0; Parmentier L, 2014, ENVIRON MONIT ASSESS, V186, P2357, DOI 10.1007/s10661-013-3543-2; PERCIVAL M, 1947, NEW PHYTOL, V46, P142, DOI 10.1111/j.1469-8137.1947.tb05076.x; PERCIVAL M. S., 1955, NEW PHYTOL, V54, P353, DOI 10.1111/j.1469-8137.1955.tb06192.x; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; Petanidou Theodora, 1999, Systematics and Geography of Plants, V68, P233, DOI 10.2307/3668604; Pinheiro LA, 2013, BIOCONTROL, V58, P797, DOI 10.1007/s10526-013-9535-x; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Pohlert T., 2014, THE PAIRWISE MULTIPL; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Praz CJ, 2008, ECOLOGY, V89, P795, DOI 10.1890/07-0751.1; Prys-Jones OE, 1991, NATURALISTS HANDBOOK; Pywell RF, 2011, J INSECT CONSERV, V15, P853, DOI 10.1007/s10841-011-9383-x; R Core Team, 2013, R LANG ENV STAT COMP; Raine NE, 2007, ENTOMOL GEN, V30, P191; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; RAW A, 1974, OIKOS, V25, P54, DOI 10.2307/3543545; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Rusterholz HP, 2000, ECOL ENTOMOL, V25, P81, DOI 10.1046/j.1365-2311.2000.00233.x; Salisbury A, 2015, J APPL ECOL, V52, P1156, DOI 10.1111/1365-2664.12499; Schmidt K, 2015, J HORTIC SCI BIOTECH, V90, P47, DOI 10.1080/14620316.2015.11513152; Seeley T, 1995, THE WISDOM OF THE HI; Selzer AK, 2010, POLIT POWER SOC THEO, V21, P171, DOI 10.1108/S0198-8719(2010)0000021012; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Shenstone J., 1912, J BOT, V50, P117; Sirohi MH, 2015, J INSECT CONSERV, V19, P487, DOI 10.1007/s10841-015-9769-2; Sosnoskie LM, 2009, WEED SCI, V57, P404, DOI 10.1614/WS-08-157.1; Speranza A, 1997, SEX PLANT REPROD, V10, P110, DOI 10.1007/s004970050076; Stace C, 2010, NEW FLORA OF THE BRI; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Stimec J, 1997, CAN FIELD NAT, V111, P454; STONE GN, 1994, ECOL ENTOMOL, V19, P177, DOI 10.1111/j.1365-2311.1994.tb00408.x; STONE GN, 1995, ECOL ENTOMOL, V20, P169, DOI 10.1111/j.1365-2311.1995.tb00443.x; Storkey J, 2015, ECOL APPL, V25, P1034, DOI 10.1890/14-1605.1; Synge A. D., 1947, JOUR ANIMAL ECOL, V16, P122, DOI 10.2307/1492; Turrini T, 2015, GLOBAL CHANGE BIOL, V21, P1652, DOI 10.1111/gcb.12825; U.K. National Ecosystem Assessment, 2011, THE UK NATIONAL ECOS; ULRICH RS, 1986, LANDSCAPE URBAN PLAN, V13, P29, DOI 10.1016/0169-2046(86)90005-8; Vanbergen A. J., 2014, STATUS VALUE POLLINA; Vanparys V, 2011, PLANT ECOL EVOL, V144, P3, DOI 10.5091/plecevo.2011.434; Verboven HAF, 2014, LANDSCAPE URBAN PLAN, V126, P31, DOI 10.1016/j.landurbplan.2014.02.017; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083; Westbury DB, 2008, WEED RES, V48, P113, DOI 10.1111/j.1365-3180.2007.00614.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams NM, 2003, OECOLOGIA, V134, P228, DOI 10.1007/s00442-002-1104-4; Wist TJ, 2006, ANN BOT-LONDON, V97, P177, DOI 10.1093/aob/mcj027; Wuertz D., 2014, R PACKAGE VERSION; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	137	168	170	20	345	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158117	10.1371/journal.pone.0158117	http://dx.doi.org/10.1371/journal.pone.0158117			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3KZ	27341588	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378393600032
J	Khasnatinov, MA; Tuplin, A; Gritsun, DJ; Slovak, M; Kazimirova, M; Lickova, M; Havlikova, S; Klempa, B; Labuda, M; Gould, EA; Gritsun, TS				Khasnatinov, Maxim A.; Tuplin, Andrew; Gritsun, Dmitri J.; Slovak, Mirko; Kazimirova, Maria; Lickova, Martina; Havlikova, Sabina; Klempa, Boris; Labuda, Milan; Gould, Ernest A.; Gritsun, Tamara S.			Tick-Borne Encephalitis Virus Structural Proteins Are the Primary Viral Determinants of Non-Viraemic Transmission between Ticks whereas Non-Structural Proteins Affect Cytotoxicity	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; IXODES-RICINUS; FEVER VIRUS; FLAVIVIRUSES; STRAINS; ASSOCIATION; ATTENUATION; MECHANISMS; NUCLEOTIDE; EVOLUTION	Over 50 million humans live in areas of potential exposure to tick-borne encephalitis virus (TBEV). The disease exhibits an estimated 16,000 cases recorded annually over 30 European and Asian countries. Conventionally, TBEV transmission to Ixodes spp. ticks occurs whilst feeding on viraemic animals. However, an alternative mechanism of non-viraemic transmission (NVT) between infected and uninfected ticks co-feeding on the same transmission-competent host, has also been demonstrated. Here, using laboratory-bred I. ricinus ticks, we demonstrate low and high efficiency NVT for TBEV strains Vasilchenko (Vs) and Hypr, respectively. These virus strains share high sequence similarity but are classified as two TBEV subtypes. The Vs strain is a Siberian subtype, naturally associated with I. persulcatus ticks whilst the Hypr strain is a European subtype, transmitted by I. ricinus ticks. In mammalian cell culture (porcine kidney cell line PS), Vs and Hypr induce low and high cytopathic effects (cpe), respectively. Using reverse genetics, we engineered a range of viable Vs/Hypr chimaeric strains, with substituted genes. No significant differences in replication rate were detected between wild-type and chimaeric viruses in cell culture. However, the chimaeric strain Vs[Hypr str] (Hypr structural and Vs non-structural genomic regions) demonstrated high efficiency NVT in I. ricinus whereas the counterpart Hypr[Vs str] was not transmitted by NVT, indicating that the virion structural proteins largely determine TBEV NVT transmission efficiency between ticks. In contrast, in cell culture, the extent of cpe was largely determined by the non-structural region of the TBEV genome. Chimaeras with Hypr non-structural genes were more cytotoxic for PS cells when compared with Vs genomebased chimaeras.	[Khasnatinov, Maxim A.] Sci Ctr Family Hlth & Human Reprod Problems, Fed State Publ Sci Inst, Irkutsk, Russia; [Tuplin, Andrew] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Tuplin, Andrew] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct & Mol Biol, Leeds, W Yorkshire, England; [Gritsun, Dmitri J.; Gritsun, Tamara S.] Oxford Progress Ltd, Oxford, England; [Slovak, Mirko; Kazimirova, Maria; Lickova, Martina] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Havlikova, Sabina; Klempa, Boris; Labuda, Milan] Slovak Acad Sci, Inst Virol, Bratislava, Slovakia; [Klempa, Boris] Charite Sch Med, Inst Virol, Berlin, Germany; [Gould, Ernest A.] Aix Marseille Univ, Fac Med, UMR Emergence Pathol Virales 190, Marseille, France	Irkutsk Science Centre of the Russian Academy of Sciences; Scientific Centre for Family Health & Human Reproduction Problems; University of Leeds; University of Leeds; Slovak Academy of Sciences; Slovak Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD)	Khasnatinov, MA (corresponding author), Sci Ctr Family Hlth & Human Reprod Problems, Fed State Publ Sci Inst, Irkutsk, Russia.	khasnatinov@gmail.com	Khasnatinov, Maxim/F-2153-2011; Khasnatinov, Maxim/S-7266-2016; Ličková, Martina/ABC-1387-2020; Klempa, Boris/J-8876-2012; Kazimirova, Maria/U-8222-2017; Klempa, Boris/N-3096-2019	Khasnatinov, Maxim/0000-0002-8441-3640; Ličková, Martina/0000-0001-5357-6618; Klempa, Boris/0000-0002-6931-1224; Kazimirova, Maria/0000-0001-6904-8342; Klempa, Boris/0000-0002-6931-1224; Tuplin, Andrew/0000-0003-2524-707X	Biotechnology and Biological Sciences Research Council (UK) [BBS/B/00697]; European Community's Seventh Framework Programme (SILVER EU Project) [260644]; European Community's Seventh Framework Programme (PREDEMICS EU Project) [278433]; Medical Research Council (UK) [87652]; Biotechnology and Biological Sciences Research Council [BBS/B/00697] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Community's Seventh Framework Programme (SILVER EU Project); European Community's Seventh Framework Programme (PREDEMICS EU Project); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (UK) grant no. BBS/B/00697 (TSG), the European Community's Seventh Framework Programme (SILVER EU Project no. 260644 and PREDEMICS EU Project no. 278433) (EAG) and Medical Research Council (UK) grant ID 87652 (TSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEKSEEV A N, 1991, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P50; ALEKSEEV AN, 1992, PARAZITOLOGIYA+, V26, P506; Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001; CHUNIKHIN SP, 1979, ACTA VIROL, V23, P257; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; DZHIVANY.TI, 1973, VOP VIRUSOL+, P86; DZHIVANYAN TI, 1974, ARCH GES VIRUSFORSCH, V45, P209, DOI 10.1007/BF01249683; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Filippova N, 1985, TAIGA TICK IXODES PE, P211; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Golovljova I, 2008, INT J MED MICROBIOL, V298, P108, DOI 10.1016/j.ijmm.2007.12.004; GOULD EA, 1985, J GEN VIROL, V66, P1369, DOI 10.1099/0022-1317-66-7-1369; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; Gritsun TS, 1998, J VIROL METHODS, V76, P109, DOI 10.1016/S0166-0934(98)00130-X; Gritsun TS, 1995, VIROLOGY, V214, P611, DOI 10.1006/viro.1995.0072; Gritsun TS, 2001, J GEN VIROL, V82, P1667, DOI 10.1099/0022-1317-82-7-1667; Gritsun TS, 1997, VIRUS RES, V49, P27, DOI 10.1016/S0168-1702(97)01451-2; GRITSUN TS, 1993, VIRUS RES, V27, P201, DOI 10.1016/0168-1702(93)90082-X; GRITSUN TS, 1993, J GEN VIROL, V74, P287, DOI 10.1099/0022-1317-74-2-287; GRITSUN TS, 1995, VIRUS RES, V35, P307, DOI 10.1016/0168-1702(94)00090-Y; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; Hayasaka D, 1999, J GEN VIROL, V80, P3127, DOI 10.1099/0022-1317-80-12-3127; Heinz FX, 2004, ARCH VIROL, P133; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Heinze DM, 2012, J VIROL, V86, P8663, DOI 10.1128/JVI.01013-12; Jaaskelainen AE, 2006, EMERG INFECT DIS, V12, P1568, DOI 10.3201/eid1210.060320; Jones LD, 1997, MED VET ENTOMOL, V11, P172, DOI 10.1111/j.1365-2915.1997.tb00309.x; Khasnatinov MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007295; Konnai S, 2008, JPN J VET RES, V55, P85; Kovalev SY, 2010, J GEN VIROL, V91, P2941, DOI 10.1099/vir.0.023879-0; Kurz M, 2012, VIRUS RES, V168, P48, DOI 10.1016/j.virusres.2012.06.012; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lundkvist A, 2001, J MED VIROL, V65, P730, DOI 10.1002/jmv.2097; Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998; Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; POSPISIL L, 1954, Lek List, V9, P3; RADDA A, 1969, ACTA VIROL, V13, P74; RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D; Romanova LI, 2007, VIROLOGY, V362, P75, DOI 10.1016/j.virol.2006.12.013; Schrauf S, 2009, J VIROL, V83, P11201, DOI 10.1128/JVI.01025-09; Silva PAGC, 2007, J GEN VIROL, V88, P1738, DOI 10.1099/vir.0.82811-0; Slovak M, 2014, TICKS TICK-BORNE DIS, V5, P962, DOI 10.1016/j.ttbdis.2014.07.019; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Suss J, 2008, Euro Surveill, V13; Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237; Walpole R.E., 2007, PROBABILITY STAT ENG	52	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158105	10.1371/journal.pone.0158105	http://dx.doi.org/10.1371/journal.pone.0158105			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341437	Green Published, gold			2022-12-26	WOS:000378393600030
J	Cao, XC; Ma, QX; Zhong, C; Yang, X; Zhu, LF; Zhang, JH; Jin, QY; Wu, LH				Cao, Xiaochuang; Ma, Qingxu; Zhong, Chu; Yang, Xin; Zhu, Lianfeng; Zhang, Junhua; Jin, Qianyu; Wu, Lianghuan			Elevational Variation in Soil Amino Acid and Inorganic Nitrogen Concentrations in Taibai Mountain, China	PLOS ONE			English	Article							DISSOLVED ORGANIC NITROGEN; MICROBIAL-POPULATION; PLANT; FORMS; MINERALIZATION; DYNAMICS; TUNDRA; MICROORGANISMS; AVAILABILITY; ASSIMILATION	Amino acids are important sources of soil organic nitrogen (N), which is essential for plant nutrition, but detailed information about which amino acids predominant and whether amino acid composition varies with elevation is lacking. In this study, we hypothesized that the concentrations of amino acids in soil would increase and their composition would vary along the elevational gradient of Taibai Mountain, as plant-derived organic matter accumulated and N mineralization and microbial immobilization of amino acids slowed with reduced soil temperature. Results showed that the concentrations of soil extractable total N, extractable organic N and amino acids significantly increased with elevation due to the accumulation of soil organic matter and the greater N content. Soil extractable organic N concentration was significantly greater than that of the extractable inorganic N (NO3--N + NH4+-N). On average, soil adsorbed amino acid concentration was approximately 5-fold greater than that of the free amino acids, which indicates that adsorbed amino acids extracted with the strong salt solution likely represent a potential source for the replenishment of free amino acids. We found no appreciable evidence to suggest that amino acids with simple molecular structure were dominant at low elevations, whereas amino acids with high molecular weight and complex aromatic structure dominated the high elevations. Across the elevational gradient, the amino acid pool was dominated by alanine, aspartic acid, glycine, glutamic acid, histidine, serine and threonine. These seven amino acids accounted for approximately 68.9% of the total hydrolyzable amino acid pool. The proportions of isoleucine, tyrosine and methionine varied with elevation, while soil major amino acid composition (including alanine, arginine, aspartic acid, glycine, histidine, leucine, phenylalanine, serine, threonine and valine) did not vary appreciably with elevation (p>0.10). The compositional similarity of many amino acids across the elevational gradient suggests that soil amino acids likely originate from a common source or through similar biochemical processes.	[Cao, Xiaochuang; Zhong, Chu; Zhu, Lianfeng; Zhang, Junhua; Jin, Qianyu] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Ma, Qingxu; Yang, Xin; Wu, Lianghuan] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecosyst Hlth, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Jin, QY (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.; Wu, LH (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecosyst Hlth, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China.	jinqy@mail.hz.zj.cn; 11014041@zju.edu.cn		Ma, Qingxu/0000-0003-2050-7725	National Basic Research Program of China [2015CB150502]; National Natural Science Foundation of China [31270035, 31172032]; Zhejiang Provincial Natural Science Foundation of China [LQ15C130004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the National Basic Research Program of China (2015CB150502) (http://www.973.gov.cn/), the National Natural Science Foundation of China (No. 31270035, 31172032) (http://www.nsfc.gov.cn/) and Zhejiang Provincial Natural Science Foundation of China (LQ15C130004) (http://www.zjnsf.gov.cn/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUARGHUB SM, 1988, NEW PHYTOL, V108, P433, DOI 10.1111/j.1469-8137.1988.tb04184.x; BARAK P, 1990, SOIL SCI SOC AM J, V54, P769, DOI 10.2136/sssaj1990.03615995005400030024x; Bonde TA, 2001, BIOL FERT SOILS, V34, P179, DOI 10.1007/s003740100395; Cao XC, 2013, SOIL BIOL BIOCHEM, V62, P13, DOI 10.1016/j.soilbio.2013.02.018; CHAPIN FS, 1986, J ECOL, V74, P167; Chen XY, 2013, J INTEGR AGR, V12, P732, DOI 10.1016/S2095-3119(13)60291-9; Christou M, 2006, SOIL BIOL BIOCHEM, V38, P2265, DOI 10.1016/j.soilbio.2006.01.025; Friedel JK, 2002, SOIL BIOL BIOCHEM, V34, P315, DOI 10.1016/S0038-0717(01)00185-7; Gonod LV, 2006, EUR J SOIL SCI, V57, P320, DOI 10.1111/j.1365-2389.2005.00744.x; GOTOH S, 1986, SOIL SCI PLANT NUTR, V32, P535, DOI 10.1080/00380768.1986.10557536; HADAS A, 1992, SOIL BIOL BIOCHEM, V24, P137, DOI 10.1016/0038-0717(92)90269-4; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Henry HAL, 2003, J ECOL, V91, P627, DOI 10.1046/j.1365-2745.2003.00791.x; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; IVARSON KC, 1969, CAN J SOIL SCI, V49, P121, DOI 10.4141/cjss69-014; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P179, DOI 10.1016/j.soilbio.2004.07.021; Jones DL, 2002, SOIL BIOL BIOCHEM, V34, P1893, DOI 10.1016/S0038-0717(02)00203-1; Jones DL, 1999, SOIL BIOL BIOCHEM, V31, P1331, DOI 10.1016/S0038-0717(99)00056-5; Kastovska E, 2011, SOIL BIOL BIOCHEM, V43, P1285, DOI 10.1016/j.soilbio.2011.02.021; Kielland K, 2007, ECOSYSTEMS, V10, P360, DOI 10.1007/s10021-007-9037-8; Kielland K, 1995, BIOGEOCHEMISTRY, V31, P85, DOI 10.1007/BF00000940; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; KUMARI K, 1987, J LIQ CHROMATOGR, V10, P1299, DOI 10.1080/01483918708066770; Lei M., 2001, GEOGR RES-AUST, V20, P83; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Lipson DA, 1999, BIOL FERT SOILS, V29, P257, DOI 10.1007/s003740050550; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; Lipson DA, 1999, ECOLOGY, V80, P1623; Morot-Gaudry JF, 2000, NITROGEN ASSIMILATIO; Nasholm T, 2001, NEW PHYTOL, V150, P59, DOI 10.1046/j.1469-8137.2001.00072.x; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Ohlund J, 2001, TREE PHYSIOL, V21, P1319, DOI 10.1093/treephys/21.18.1319; Owen AG, 2001, SOIL BIOL BIOCHEM, V33, P651, DOI 10.1016/S0038-0717(00)00209-1; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Qualls RG, 2003, BIOGEOCHEMISTRY, V62, P197, DOI 10.1023/A:1021150503664; Raab TK, 1999, ECOLOGY, V80, P2408, DOI 10.1890/0012-9658(1999)080[2408:SAAUAS]2.0.CO;2; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; READ DJ, 1985, P ROY SOC EDINB B, V85, P317, DOI 10.1017/S0269727000004097; Rothstein DE, 2009, BIOGEOCHEMISTRY, V92, P201, DOI 10.1007/s10533-009-9284-1; Rothstein DE, 2010, SOIL BIOL BIOCHEM, V42, P1210; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schulten HR, 1997, BIOL FERT SOILS, V26, P1, DOI 10.1007/s003740050335; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Tang ZY, 2006, AGR FOREST METEOROL, V139, P200, DOI 10.1016/j.agrformet.2006.07.001; VANCLEVE K, 1993, CAN J FOREST RES, V23, P941, DOI 10.1139/x93-122; Warren CR, 2006, FUNCT PLANT BIOL, V33, P653, DOI 10.1071/FP06045; Warren CR, 2007, TREE PHYSIOL, V27, P413, DOI 10.1093/treephys/27.3.413; Warren CR, 2010, SOIL BIOL BIOCHEM, V42, P353, DOI 10.1016/j.soilbio.2009.11.017; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; Weintraub MN, 2005, BIOGEOCHEMISTRY, V73, P359, DOI 10.1007/s10533-004-0363-z; Werdin-Pfisterer NR, 2009, SOIL BIOL BIOCHEM, V41, P1210, DOI 10.1016/j.soilbio.2009.03.001; Yu Z, 2002, BIOGEOCHEMISTRY, V61, P173, DOI 10.1023/A:1020221528515	55	13	15	8	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157979	10.1371/journal.pone.0157979	http://dx.doi.org/10.1371/journal.pone.0157979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337100	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200078
J	Meng, XK; Li, CR; Xiu, CL; Zhang, JH; Li, JJ; Huang, LX; Zhang, YX; Liu, ZW				Meng, Xiangkun; Li, Chunrui; Xiu, Chunli; Zhang, Jianhua; Li, Jingjing; Huang, Lixin; Zhang, Yixi; Liu, Zewen			Identification and Biochemical Properties of Two New Acetylcholinesterases in the Pond Wolf Spider (Pardosa pseudoannulata)	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; INSECT PESTS; BUTYRYLCHOLINESTERASE; EXPRESSION; RESISTANCE; MUTATION; NEMATODE; GENES; CHOLINESTERASES; ALZHEIMERS	Acetylcholinesterase (AChE), an important neurotransmitter hydrolase in both invertebrates and vertebrates, is targeted by organophosphorus and carbamate insecticides. In this study, two new AChEs were identified in the pond wolf spider Pardosa pseudoannulata, an important predatory natural enemy of several insect pests. In total, four AChEs were found in P. pseudoannulata (including two AChEs previously identified in our laboratory). The new putative AChEs PpAChE3 and PpAChE4 contain most of the common features of the AChE family, including cysteine residues, choline binding sites, the conserved sequence 'FGESAG' and conserved aromatic residues but with a catalytic triad of 'SDH' rather than 'SEH'. Recombinant enzymes expressed in Sf9 cells showed significant differences in biochemical properties compared to other AChEs, such as the optimal pH, substrate specificity, and catalytic efficiency. Among three test substrates, PpAChE1, PpAChE3 and PpAChE4 showed the highest catalytic efficiency (V-max/K-M) for ATC (acetylthiocholine iodide), with PpAChE3 exhibiting a clear preference for ATC based on the V-max(ATC)/V-max(BTC) ratio. In addition, the four PpAChEs were more sensitive to the AChE-specific inhibitor BW284C51, which acts against ATC hydrolysis, than to the BChE-specific inhibitor ISO-OMPA, which acts against BTC hydrolysis, with at least a 8.5-fold difference in IC50 values for each PpAChE. PpAChE3, PpAChE4, and PpAChE1 were more sensitive than PpAChE2 to the tested Carb insecticides, and PpAChE3 was more sensitive than the other three AChEs to the tested OP insecticides. Based on all the results, two new functional AChEs were identified from P. pseudoannulata. The differences in AChE sequence between this spider and insects enrich our knowledge of invertebrate AChE diversity, and our findings will be helpful for understanding the selectivity of insecticides between insects and natural enemy spiders.	[Meng, Xiangkun; Li, Chunrui; Xiu, Chunli; Zhang, Jianhua; Li, Jingjing; Huang, Lixin; Zhang, Yixi; Liu, Zewen] Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, YX; Liu, ZW (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China.	liuzewen@njau.edu.cn; zhangyixi@njau.edu.cn			National Key Technology Research and Development Program [2012BAD19B01]; Jiangsu Science Program for Distinguished Young Scholars [BK20130028]; National Natural Science Foundation of China [31322045, 31130045]	National Key Technology Research and Development Program(National Key Technology R&D Program); Jiangsu Science Program for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology Research and Development Program (2012BAD19B01), Jiangsu Science Program for Distinguished Young Scholars (BK20130028) and National Natural Science Foundation of China (31322045 and 31130045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; Arpagaus M, 1998, J PHYSIOLOGY-PARIS, V92, P363, DOI 10.1016/S0928-4257(99)80006-0; Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; Bencharit S, 2002, NAT STRUCT BIOL, V9, P337, DOI 10.1038/nsb790; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; FOURNIER D, 1988, J NEUROCHEM, V50, P1158, DOI 10.1111/j.1471-4159.1988.tb10587.x; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hussein AS, 2002, MOL BIOCHEM PARASIT, V123, P125, DOI 10.1016/S0166-6851(02)00141-X; Iyo M, 1997, LANCET, V349, P1805, DOI 10.1016/S0140-6736(96)09124-6; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Kang JS, 2011, MOL BIOCHEM PARASIT, V175, P154, DOI 10.1016/j.molbiopara.2010.11.005; Kim YH, 2013, INSECT BIOCHEM MOLEC, V43, P47, DOI 10.1016/j.ibmb.2012.11.004; Lazari O, 2003, MOL BIOCHEM PARASIT, V132, P83, DOI 10.1016/j.molbiopara.2003.09.001; Li B, 2010, PESTIC BIOCHEM PHYS, V98, P19, DOI 10.1016/j.pestbp.2010.04.004; Lou YG, 2014, BIOL CONTROL, V68, P103, DOI 10.1016/j.biocontrol.2013.09.018; Masson P, 1996, EUR J BIOCHEM, V235, P36, DOI 10.1111/j.1432-1033.1996.00036.x; MASSOULIE J, 1993, PROG BRAIN RES, V98, P139; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCNAUGHTON RA, 1949, P SOC EXP BIOL MED, V70, P165; Meng XK, 2015, PESTIC BIOCHEM PHYS, V125, P26, DOI 10.1016/j.pestbp.2015.06.006; Meng XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125242; Moores GD, 1996, PESTIC BIOCHEM PHYS, V56, P102, DOI 10.1006/pest.1996.0064; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; Oh SH, 2006, PESTIC BIOCHEM PHYS, V85, P46, DOI 10.1016/j.pestbp.2005.10.003; Pezzementi L, 2003, COMP BIOCHEM PHYS B, V136, P813, DOI 10.1016/S1096-4959(03)00259-8; Pezzementi L, 2010, CHEM-BIOL INTERACT, V187, P27, DOI 10.1016/j.cbi.2010.03.043; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Rinne JO, 2003, J NEUROL NEUROSUR PS, V74, P113, DOI 10.1136/jnnp.74.1.113; Selkirk ME, 2005, CHEM-BIOL INTERACT, V157, P263, DOI 10.1016/j.cbi.2005.10.039; Shafferman A, 2005, CHEM-BIOL INTERACT, V157, P123, DOI 10.1016/j.cbi.2005.10.021; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; SUSSMAN JL, 1993, CHEM-BIOL INTERACT, V87, P187, DOI 10.1016/0009-2797(93)90042-W; Tanaka K, 2000, APPL ENTOMOL ZOOL, V35, P177, DOI 10.1303/aez.2000.177; Temeyer KB, 2004, J MED ENTOMOL, V41, P259, DOI 10.1603/0022-2585-41.3.259; Temeyer KB, 2010, VET PARASITOL, V172, P114, DOI 10.1016/j.vetpar.2010.04.016; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Wessler I, 2003, LIFE SCI, V72, P2055, DOI 10.1016/S0024-3205(03)00083-3; Williams ET, 2010, MOL PHYLOGENET EVOL, V57, P23, DOI 10.1016/j.ympev.2010.05.018; Zhang YX, 2014, INSECT BIOCHEM MOLEC, V46, P25, DOI 10.1016/j.ibmb.2014.01.004	44	12	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158011	10.1371/journal.pone.0158011	http://dx.doi.org/10.1371/journal.pone.0158011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337188	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200088
J	Deng, Z; Rong, Y; Teng, Y; Zhuang, X; Samykutty, A; Mu, J; Zhang, L; Cao, P; Yan, J; Miller, D; Zhang, HG				Deng, Z.; Rong, Y.; Teng, Y.; Zhuang, X.; Samykutty, A.; Mu, J.; Zhang, L.; Cao, P.; Yan, J.; Miller, D.; Zhang, H-G			Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis	ONCOGENE			English	Article							SUPPRESSOR-CELLS; BREAST-CANCER; THERAPEUTIC AGENTS; DRUG-RESISTANCE; CHEMOTHERAPY; EXPRESSION; MICRORNA-126-5P; INTERLEUKIN-33; BIOGENESIS; CORRELATE	Acquired resistance to chemotherapy remains a major stumbling block in cancer treatment. Chronic inflammation has a crucial role in induction of chemoresistance and results, in part, from the induction and expansion of inflammatory cells that include myeloidderived suppressor cells (MDSCs) and IL-13(+) Th2 cells. The mechanisms that lead to induction of activated MDSCs and IL-13(+) Th2 cells have not yet been identified. Here we demonstrated that doxorubicin (DOX) treatment of 4T1 breast tumor-bearing mice led to the induction of IL-13R(+) miR-126a(+) MDSCs (DOX-MDSC). DOX-MDSC promote breast tumor lung metastasis through MDSC miR-126a(+) exosomal-mediated induction of IL-13(+) Th2 cells and tumor angiogenesis. The induction of DOX-MDSC is regulated in a paracrine manner. DOX treatment not only increases interleukin (IL)-33 released from breast tumor cells, which is crucial for the induction of IL-13(+) Th2 cells, but it also participates in the induction of IL-13 receptors and miR-126a expressed on/in the MDSCs. IL-13 released from IL-13(+) Th2 cells then promotes the production of DOX-MDSC and MDSC miR-126a(+) exosomes via MDSC IL-13R. MDSC miR-126a+ exosomes further induce IL13(+) Th2 cells in a positive feed-back loop manner. We also showed that MDSC miR-126a rescues DOX-induced MDSC death in a S100A8/A9-dependent manner and promotes tumor angiogenesis. Our findings provide insight into the MDSC exosomal-mediated chemoresistance mechanism, which will be useful for the design of inhibitors targeting the blocking of induction of miR-126a(+) MDSCs.	[Deng, Z.; Rong, Y.; Teng, Y.; Zhuang, X.; Samykutty, A.; Mu, J.; Zhang, L.; Cao, P.; Yan, J.; Miller, D.; Zhang, H-G] Univ Louisville, Dept Microbiol & Immunol, James Graham Brown Canc Ctr, CTRB 309,505 Hancock St, Louisville, KY 40292 USA; [Zhang, H-G] Robley Rex VA Med Ctr, Louisville, KY USA	University of Louisville	Deng, Z; Zhang, HG (corresponding author), Univ Louisville, Dept Microbiol & Immunol, James Graham Brown Canc Ctr, CTRB 309,505 Hancock St, Louisville, KY 40292 USA.	z0deng01@louisville.edu; H0Zhan17@louisville.edu	Yan, Jun/A-8988-2008; samykutty, Abhilash/J-6575-2019	samykutty, Abhilash/0000-0003-3551-045X	National Institutes of Health (NIH) [R01AT008617, UH3TR000875]; Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants; Research Career Scientist (RCS) Award; US Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000875, UH2TR000875] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT008617] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants; Research Career Scientist (RCS) Award; US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (NIH) (R01AT008617, UH3TR000875) and the Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants (to H-G Zhang). H-G Zhang is supported by a Research Career Scientist (RCS) Award, funded by the US Department of Veterans Affairs. We thank Dr Jerald Ainsworth for editorial assistance.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Alizadeh D, 2014, CANCER RES, V74, P104, DOI 10.1158/0008-5472.CAN-13-1545; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Burke MC, 2014, J PROTEOME RES, V13, P5965, DOI 10.1021/pr500854x; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; de Leeuw DC, 2014, CANCER RES, V74, P2094, DOI 10.1158/0008-5472.CAN-13-1733; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Ebrahimi F, 2015, EXP CELL RES, V339, P333, DOI 10.1016/j.yexcr.2015.10.004; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Ghiringhelli F, 2014, EXPERT REV CLIN IMMU, V10, P19, DOI 10.1586/1744666X.2014.865520; Goerke SM, 2015, BIOL CHEM, V396, P245, DOI 10.1515/hsz-2014-0259; Guabiraba R, 2014, MUCOSAL IMMUNOL, V7, P1079, DOI 10.1038/mi.2013.124; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Joshi BH, 2009, IMMUNOTHERAPY-UK, V1, P321, DOI 10.2217/IMT.09.8; Koch R, 2016, CLIN CANCER RES, V22, P395, DOI 10.1158/1078-0432.CCR-15-0577; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lieberman J, 2013, CELL, V153, P9, DOI 10.1016/j.cell.2013.03.019; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Ohshima K, 2014, PROTEOMICS, V14, P2297, DOI 10.1002/pmic.201300477; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Payne KK, 2013, BREAST CANCER RES TR, V142, P45, DOI 10.1007/s10549-013-2733-5; Ran S, 2015, CANCER RES, V75, P2405, DOI 10.1158/0008-5472.CAN-14-3525; Reichenbach DK, 2015, BLOOD, V125, P3183, DOI 10.1182/blood-2014-10-606830; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Schmieder A, 2012, CYTOKINE, V60, P514, DOI 10.1016/j.cyto.2012.06.286; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Seidelin JB, 2011, MUCOSAL IMMUNOL, V4, P496, DOI 10.1038/mi.2011.22; Shen J, 2015, CANCER RES, V75, P783, DOI 10.1158/0008-5472.CAN-14-2568; Shibayama Y, 2015, ONCOL REP, V33, P2176, DOI 10.3892/or.2015.3839; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Umansky V, 2012, CANCER IMMUNOL IMMUN, V61, P275, DOI 10.1007/s00262-011-1164-6; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wang QL, 2015, CANCER RES, V75, P2520, DOI 10.1158/0008-5472.CAN-14-3095; Wang QL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2886; Xiang XY, 2010, AM J PATHOL, V177, P1606, DOI 10.2353/ajpath.2010.100245; Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575; Yang Z, 2015, INT J CLIN EXP PATHO, V8, P8869; Yin Y, 2013, CANCER IMMUNOL RES, V1, P256, DOI 10.1158/2326-6066.CIR-13-0073	54	122	129	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					639	651		10.1038/onc.2016.229	http://dx.doi.org/10.1038/onc.2016.229			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27345402	Green Accepted			2022-12-26	WOS:000394167700006
J	Khosravi, F; Michel, V; Galuska, CE; Bhushan, S; Christian, P; Schuppe, HC; Pilatz, A; Galuska, SP; Meinhardt, A				Khosravi, Farhad; Michel, Vera; Galuska, Christina E.; Bhushan, Sudhanshu; Christian, Philipp; Schuppe, Hans-Christian; Pilatz, Adrian; Galuska, Sebastian P.; Meinhardt, Andreas			Desialylation of Spermatozoa and Epithelial Cell Glycocalyx Is a Consequence of Bacterial Infection of the Epididymis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; glycosylation; glycosylation inhibitor; reproduction; sialic acid; sialidase; sperm; spermatozoa	PERFORMANCE LIQUID-CHROMATOGRAPHY; MAMMALIAN SPERM; SIALIC ACIDS; ACROSOME REACTION; POLYSIALIC ACIDS; NEURAMINIDASE; SIALYLATION; CAPACITATION; PERSPECTIVE; SIALIDASES	Urinary tract infections caused by uropathogenic Escherichia coli (UPEC) pathovars belong to the most frequent infections in humans. In men, pathogens can also spread to the genital tract via the continuous ductal system, eliciting bacterial prostatitis and/or epididymo-orchitis. Antibiotic treatment usually clears pathogens in acute epididymitis; however, the fertility of patients can be permanently impaired. Because a premature acrosome reaction was observed in an UPEC epididymitis mouse model, and sialidases on the sperm surface are considered to be activated via proteases of the acrosome, we aimed to investigate whether alterations of the sialome of epididymal spermatozoa and surrounding epithelial cells occur during UPEC infection. In UPEC-elicited acute epididymitis in mice, a substantial loss of N-acetylneuraminic acid residues was detected in epididymal spermatozoa and epithelial cells using combined laser microdissection/HPLC-ESI-MS analysis. In support, a substantial reduction of sialic acid residues bound to the surface of spermatozoa was documented in men with a recent history of E. coli-associated epididymitis. In vitro, such an UPEC induced N-acetylneuraminic acid release from human spermatozoa was effectively counteracted by a sialidase inhibitor. These findings strongly suggest a substantial remodeling of the glycocalyx of spermatozoa and epididymal epithelial cells by endogenous sialidases after a premature acrosome reaction during acute epididymitis.	[Khosravi, Farhad; Michel, Vera; Bhushan, Sudhanshu; Meinhardt, Andreas] Univ Giessen, Inst Anat & Cell Biol, Fac Med, D-35392 Giessen, Germany; [Khosravi, Farhad; Galuska, Christina E.; Christian, Philipp; Galuska, Sebastian P.] Univ Giessen, Inst Biochem, Fac Med, D-35392 Giessen, Germany; [Schuppe, Hans-Christian; Pilatz, Adrian] Univ Giessen, Dept Urol Pediat Urol & Androl, Fac Med, D-35392 Giessen, Germany; [Galuska, Sebastian P.] Leibniz Inst Farm Anim Biol, Dept Reprod Biol, D-18196 Dummerstorf, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Forschungsinstitut fur Nutztierbiologie (FBN)	Meinhardt, A (corresponding author), Univ Giessen, Inst Anat & Cell Biol, Fac Med, D-35392 Giessen, Germany.; Galuska, SP (corresponding author), Leibniz Inst Farm Anim Biol, Dept Reprod Biol, D-18196 Dummerstorf, Germany.	galuska.sebastian@fbn-dummerstorf.de; andreas.meinhardt@anatomie.med.uni-giessen.de	郑, 丽丽/HGE-2239-2022	Khosravi, Farhad/0000-0003-0730-2266	Deutsche Forschungsgemeinschaft [GA 1755/1-2, GRK 1871/1]; von Behring-Roentgen-Stiftung; Faculty of Medicine of the Justus Liebig University of Giessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Roentgen-Stiftung; Faculty of Medicine of the Justus Liebig University of Giessen	This work was supported by Deutsche Forschungsgemeinschaft Grants GA 1755/1-2 (to S. P. G.) GRK 1871/1 (to A. M.), the von Behring-Roentgen-Stiftung, and the Faculty of Medicine of the Justus Liebig University of Giessen. The authors declare that they have no conflicts of interest with the contents of this article.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bartel J, 2014, ANAL CHEM, V86, P2326, DOI 10.1021/ac403966h; Bayer NB, 2013, MOLECULES, V18, P2571, DOI 10.3390/molecules18032571; BERGER RE, 1987, J INFECT DIS, V155, P1341, DOI 10.1093/infdis/155.6.1341; Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Cairo CW, 2014, MEDCHEMCOMM, V5, P1067, DOI 10.1039/c4md00089g; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Galuska SP, 2013, SIALOBIOLOGY: BIOSYNTHESIS, STRUCTURE AND FUNCTION: SIALIC ACID GLYCOCONJUGATES IN HEALTH AND DISEASE, P448; Galuska SP, 2012, J PROTEOMICS, V75, P5266, DOI 10.1016/j.jprot.2012.06.011; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; JANTOS C, 1992, INFECT IMMUN, V60, P2324, DOI 10.1128/IAI.60.6.2324-2328.1992; Kang Taek Won, 2007, J Infect, V54, pe69, DOI 10.1016/j.jinf.2006.04.005; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Lang TL, 2014, INFECT IMMUN, V82, P1104, DOI 10.1128/IAI.01373-13; Lang TL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110379; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Ma F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380584; Ma X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137810; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Michel V., 2016, J PATHOL; Michel V, 2015, ASIAN J ANDROL, V17, P756, DOI 10.4103/1008-682X.155770; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Paulson JC, 2011, NAT BIOTECHNOL, V29, P406, DOI 10.1038/nbt.1859; Pilatz A, 2015, EUR UROL, V68, P428, DOI 10.1016/j.eururo.2014.12.005; Rusz A, 2012, WORLD J UROL, V30, P23, DOI 10.1007/s00345-011-0726-8; Sajo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146398; Sakarya S, 2003, FEMS IMMUNOL MED MIC, V39, P45, DOI 10.1016/S0928-8244(03)00185-8; Sakaue T, 2010, J BIOL CHEM, V285, P2184, DOI 10.1074/jbc.M109.063495; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shahraz A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16800; Simon P, 2013, J BIOL CHEM, V288, P18825, DOI 10.1074/jbc.M113.451112; SRIVASTAVA PN, 1988, J EXP ZOOL, V245, P106, DOI 10.1002/jez.1402450116; SRIVASTAVA PN, 1970, BIOCHEM BIOPH RES CO, V39, P575, DOI 10.1016/0006-291X(70)90242-1; SRIVASTAVA PN, 1977, BIOCHEM J, V161, P193, DOI 10.1042/bj1610193; Stammler A, 2015, HUM REPROD, V30, P1557, DOI 10.1093/humrep/dev112; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; TALBOT P, 1974, J REPROD FERTIL, V39, P429, DOI 10.1530/jrf.0.0390429; Tambe A S, 2001, Indian J Med Sci, V55, P125; Tecle E, 2015, MOL REPROD DEV, V82, P635, DOI 10.1002/mrd.22500; TOSHIMORI K, 1991, ARCH ANDROLOGY, V27, P79, DOI 10.3109/01485019108987656; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Younglai EV, 2001, HUM REPROD, V16, P1950, DOI 10.1093/humrep/16.9.1950	54	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17717	17726		10.1074/jbc.M116.718072	http://dx.doi.org/10.1074/jbc.M116.718072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339898	Green Published, hybrid			2022-12-26	WOS:000383241300021
J	Liu, HJ; Ooms, LM; Srijakotre, N; Man, J; Vieusseux, J; Waters, JE; Feng, Y; Bailey, CG; Rasko, JEJ; Price, JT; Mitchell, CA				Liu, Heng-Jia; Ooms, Lisa M.; Srijakotre, Nuthasuda; Man, Joey; Vieusseux, Jessica; Waters, JoAnne E.; Feng, Yue; Bailey, Charles G.; Rasko, John E. J.; Price, John T.; Mitchell, Christina A.			PtdIns(3,4,5)P-3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell migration; cell proliferation; cell signaling; ERK; guanine nucleotide exchange factor (GEF)	CYCLIN D1; FACTOR RECEPTOR; PROTEIN-KINASE; RHO GTPASES; P-REX1; PATHWAY; METASTASIS; INHIBITOR; MIGRATION; IDENTIFICATION	PtdIns(3,4,5)P-3-dependent Rac exchanger 1 (PREX1) is a Rac-guanine nucleotide exchange factor (GEF) overexpressed in a significant proportion of human breast cancers that integrates signals from upstream ErbB2/3 and CXCR4 membrane surface receptors. However, the PREX1 domains that facilitate its oncogenic activity and downstream signaling are not completely understood. We identify that ERK1/2 MAPK acts downstream of PREX1 and contributes to PREX1-mediated anchorage-independent cell growth. PREX1 overexpression increased but its shRNA knockdown decreased ERK1/2 phosphorylation in response to EGF/IGF-1 stimulation, resulting in induction of the cell cycle regulators cyclin D1 and p21(WAF1/CIP1). PREX1-mediated ERK1/2 phosphorylation, anchorage-independent cell growth, and cell migration were suppressed by inhibition of MEK1/2/ERK1/2 signaling. PREX1 overexpression reduced staurosporine-induced apoptosis whereas its shRNA knockdown promoted apoptosis in response to staurosporine or the anti-estrogen drug tamoxifen. Expression of wild-type but not GEF-inactive PREX1 increased anchorage-independent cell growth. In addition, mouse xenograft studies revealed that expression of wild-type but not GEF-dead PREX1 resulted in the formation of larger tumors that displayed increased phosphorylation of ERK1/2 but not AKT. The impaired anchorage-independent cell growth, apoptosis, and ERK1/2 signaling observed in stable PREX1 knockdown cells was restored by expression of wild-type but not GEF-dead-PREX1. Therefore, PREX1-Rac-GEF activity is critical for PREX1-dependent anchorage-independent cell growth and xenograft tumor growth and may represent a possible therapeutic target for breast cancers that exhibit PREX1 overexpression.	[Liu, Heng-Jia; Ooms, Lisa M.; Srijakotre, Nuthasuda; Man, Joey; Vieusseux, Jessica; Waters, JoAnne E.; Rasko, John E. J.; Price, John T.; Mitchell, Christina A.] Monash Univ, Canc Program, Monash Biomed Discovery Inst, 23 Innovat Walk, Clayton, Vic 3800, Australia; [Liu, Heng-Jia; Ooms, Lisa M.; Srijakotre, Nuthasuda; Man, Joey; Vieusseux, Jessica; Waters, JoAnne E.; Rasko, John E. J.; Price, John T.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, 23 Innovat Walk, Clayton, Vic 3800, Australia; [Feng, Yue; Bailey, Charles G.] Centenary Inst Canc Med & Cell Biol, Camperdown, NSW 2050, Australia; [Bailey, Charles G.; Rasko, John E. J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Cell & Mol Therapies, Camperdown, NSW 2050, Australia; [Price, John T.] Victoria Univ, Ctr Chron Dis, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia	Monash University; Monash University; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Victoria University	Mitchell, CA (corresponding author), Monash Univ, Canc Program, Monash Biomed Discovery Inst, 23 Innovat Walk, Clayton, Vic 3800, Australia.; Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, 23 Innovat Walk, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Ooms, Lisa/AGZ-7420-2022	Mitchell, Christina A/0000-0001-9372-3192; Price, John/0000-0002-8244-1023; Ooms, Lisa Michelle/0000-0002-8918-9932; rasko, John/0000-0003-2975-807X; Bailey, Charles/0000-0002-4725-7829	National Health and Medical Research Council [APP1044737]; Tour de Cure	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Tour de Cure	This work was supported by a grant from the National Health and Medical Research Council (APP1044737) and a fellowship and research grant from Tour de Cure (to C. G. B. and J. E. J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajabnoor GMA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.139; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219; Barrio-Real L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003543; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Dillon LM, 2015, ONCOGENE, V34, P3968, DOI 10.1038/onc.2014.328; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Liu Y, 1996, CANCER RES, V56, P31; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Morimura S., 2011, INT J CELL BIOL, V2011; Ooms LM, 2015, CANCER CELL, V28, P155, DOI 10.1016/j.ccell.2015.07.003; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rynkiewicz Natalie K, 2012, Adv Biol Regul, V52, P265; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stumpf E, 2000, GENE CHROMOSOME CANC, V29, P83, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1011>3.0.CO;2-Z; Thompson DS, 2009, J CLIN ONCOL, V27; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Zezula J, 1997, J BIOL CHEM, V272, P29967, DOI 10.1074/jbc.272.47.29967	51	14	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17258	17270		10.1074/jbc.M116.743401	http://dx.doi.org/10.1074/jbc.M116.743401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358402	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000382643800027
J	Medina-Aguilar, R; Perez-Plasencia, C; Marchat, LA; Gariglio, P; Mena, JG; Cuevas, SR; Ruiz-Garcia, E; Astudillo-de la Vega, H; Juarez, JH; Flores-Perez, A; Lopez-Camarillo, C				Medina-Aguilar, Rubiceli; Perez-Plasencia, Carlos; Marchat, Laurence A.; Gariglio, Patricio; Garcia Mena, Jaime; Rodriguez Cuevas, Sergio; Ruiz-Garcia, Erika; Astudillo-de la Vega, Horacio; Hernandez Juarez, Jennifer; Flores-Perez, Ali; Lopez-Camarillo, Cesar			Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol	PLOS ONE			English	Article							PTEN/AKT PATHWAY; GENE-EXPRESSION; DNA METHYLATION; TUMOR-CELLS; CYCLIN B1; PREVENTION; HEXOKINASE; CARCINOMA; APOPTOSIS	Aberrant DNA methylation is a frequent epigenetic alteration in cancer cells that has emerged as a pivotal mechanism for tumorigenesis. Accordingly, novel therapies targeting the epigenome are being explored with the aim to restore normal DNA methylation patterns on oncogenes and tumor suppressor genes. A limited number of studies indicate that dietary compound resveratrol modulates DNA methylation of several cancer-related genes; however a complete view of changes in methylome by resveratrol has not been reported yet. In this study we performed a genome-wide survey of DNA methylation signatures in triple negative breast cancer cells exposed to resveratrol. Our data showed that resveratrol treatment for 24 h and 48 h decreased gene promoter hypermethylation and increased DNA hypomethylation. Of 2476 hypermethylated genes in control cells, 1,459 and 1,547 were differentially hypomethylated after 24 h and 48 h, respectively. Remarkably, resveratrol did not induce widespread non-specific DNA hyper- or hypomethylation as changes in methylation were found in only 12.5% of 27,728 CpG loci. Moreover, resveratrol restores the hypomethylated and hypermethylated status of key tumor suppressor genes and oncogenes, respectively. Importantly, the integrative analysis of methylome and transcriptome profiles in response to resveratrol showed that methylation alterations were concordant with changes in mRNA expression. Our findings reveal for the first time the impact of resveratrol on the methylome of breast cancer cells and identify novel potential targets for epigenetic therapy. We propose that resveratrol may be considered as a dietary epidrug as it may exert its anti-tumor activities by modifying the methylation status of cancer-related genes which deserves further in vivo characterization.	[Medina-Aguilar, Rubiceli; Gariglio, Patricio; Garcia Mena, Jaime; Hernandez Juarez, Jennifer] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Perez-Plasencia, Carlos] FES Iztacala UNAM, Unidad Biomed, Lab Genom Func, Tlalnepantla, Estado De Mexic, Mexico; [Marchat, Laurence A.] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Programa Biomed Mol & Red Biotecnol, Mexico City, DF, Mexico; [Rodriguez Cuevas, Sergio] FUCAM, Inst Enfermedades Mama, Mexico City, DF, Mexico; [Ruiz-Garcia, Erika] Inst Nacl Cancerol, Lab Med Translac, Mexico City, DF, Mexico; [Astudillo-de la Vega, Horacio] Hosp Oncol, Ctr Med Siglo 21, Lab Invest Canc & Terapia Celular, Mexico City, DF, Mexico; [Flores-Perez, Ali; Lopez-Camarillo, Cesar] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Cancerologia (INCAN)	Lopez-Camarillo, C (corresponding author), Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico.	genomicas@yahoo.com.mx	Marchat, Laurence A./S-8418-2018; Lopez-Camarillo, Cesar/I-1946-2019; Perez-Plasencia, Carlos/P-2372-2019; García-Mena, Jaime/B-1625-2008	Marchat, Laurence A./0000-0003-1615-8614; Lopez-Camarillo, Cesar/0000-0002-9417-2609; Perez-Plasencia, Carlos/0000-0002-8593-8211; García-Mena, Jaime/0000-0002-0595-3711; Ali, Flores-Perez/0000-0001-9141-9234; Ruiz-Garcia, Erika/0000-0002-0446-123X	CONACYT SALUD [233370, 222335]; CONACYT fellowship; Universidad Autonoma de la Ciudad de Mexico (UACM)	CONACYT SALUD(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Autonoma de la Ciudad de Mexico (UACM)	The authors acknowledge CONACYT SALUD for support of this work (233370 and 222335 grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rubiceli Medina was supported by a CONACYT fellowship. The authors also thank Universidad Autonoma de la Ciudad de Mexico (UACM) for support.; We thanks to Universidad Autonoma de la Ciudad de Mexico (UACM) for support. Rubiceli Medina was supported by CONACYT fellowship.	Adriaens ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-42; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; Chae SW, 2011, YONSEI MED J, V52, P445, DOI 10.3349/ymj.2011.52.3.445; Chimonidou M, 2011, CLIN CHEM, V57, P1169, DOI 10.1373/clinchem.2011.165902; Colin D, 2011, CANCER PREV RES, V4, P1095, DOI 10.1158/1940-6207.CAPR-10-0274; Dai WQ, 2015, ONCOTARGET, V6, P13703, DOI 10.18632/oncotarget.3800; Dhar S, 2015, BBA-MOL CELL RES, V1853, P265, DOI 10.1016/j.bbamcr.2014.11.004; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fanale D, 2013, BREAST CANCER RES TR, V140, P505, DOI 10.1007/s10549-013-2649-0; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000637; Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Li D, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-26; Lin CY, 2013, J FUNCT FOODS, V5, P790, DOI 10.1016/j.jff.2013.01.025; Link A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057709; Medina A, 2016, ONCOLOGY REPORTS; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Ong TP, 2011, J NUTRIGENET NUTRIGE, V4, P275, DOI 10.1159/000334585; Ou YW, 2013, CANCER BIOL THER, V14, P45, DOI 10.4161/cbt.22627; Paluszczak J, 2010, TOXICOL LETT, V192, P119, DOI 10.1016/j.toxlet.2009.10.010; Papoutsis AJ, 2010, J NUTR, V140, P1607, DOI 10.3945/jn.110.123422; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Phuah NH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/804510; Ross SA, 2008, NUTR REV, V66, pS1, DOI 10.1111/j.1753-4887.2008.00055.x; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Thakur VS, 2014, AAPS J, V16, P151, DOI 10.1208/s12248-013-9548-5; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Udali S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0077-1; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xiang TX, 2013, CHIN J CANCER, V32, P12, DOI 10.5732/cjc.011.10344; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	38	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157866	10.1371/journal.pone.0157866	http://dx.doi.org/10.1371/journal.pone.0157866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355345	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400022
J	Stickland, MK; Fuhr, DP; Edgell, H; Byers, BW; Bhutani, M; Wong, EYL; Steinback, CD				Stickland, Michael K.; Fuhr, Desi P.; Edgell, Heather; Byers, Brad W.; Bhutani, Mohit; Wong, Eric Y. L.; Steinback, Craig D.			Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CAROTID CHEMORECEPTOR MODULATION; SYMPATHETIC-NERVE ACTIVITY; ARTERIAL STIFFNESS; BLOOD-FLOW; CHEMOREFLEX FUNCTION; AT(1) RECEPTOR; HEART-FAILURE; VITAMIN-C; HYPOXIA	COPD is associated with elevated cardiovascular risk and a potentiated ventilatory response to exercise. Enhanced carotid chemoreceptor (CC) activity/sensitivity is present in other clinical conditions, has been shown to contribute to sympathetic vasoconstrictor outflow, and is predictive of mortality. CC activity/sensitivity, and the resulting functional significance, has not been well examined in COPD. We hypothesized that CC activity/sensitivity would be elevated in COPD, and related to increased pulse wave velocity (a marker of CV risk) and the ventilatory response to exercise. Methods: 30 COPD patients and 10 healthy age-matched controls were examined. Participants performed baseline cardiopulmonary exercise and pulmonary function testing. CC activity was later evaluated by the drop in ventilation with breathing 100% O-2, and CC sensitivity was then assessed by the ventilatory response to hypoxia (Delta VE/Delta SpO(2)). Peripheral arterial stiffness was subsequently evaluated by measurement of pulse wave velocity (PWV) using applanation tonometry while the subjects were breathing room air, and then following chemoreceptor inhibition by breathing 100% O-2 for 2 minutes. Results: CC activity, CC sensitivity, PWV and the ventilatory response to exercise were all increased in COPD relative to controls. CC sensitivity was related to PWV; however, neither CC activity nor CC sensitivity was related to the ventilatory response to exercise in COPD. CC inhibition by breathing 100% O-2 normalized PWV in COPD, while no effect was observed in controls. Conclusion: CC activity and sensitivity are elevated in COPD, and appear related to cardiovascular risk; however, CC activity/sensitivity does not contribute to the potentiated ventilatory response to exercise.	[Stickland, Michael K.; Fuhr, Desi P.; Edgell, Heather; Byers, Brad W.; Bhutani, Mohit; Wong, Eric Y. L.] Univ Alberta, Dept Med, Div Pulm, Edmonton, AB, Canada; [Stickland, Michael K.] Covenant Hlth, GF MacDonald Ctr Lung Hlth, Edmonton, AB, Canada; [Steinback, Craig D.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	University of Alberta; University of Alberta	Stickland, MK (corresponding author), Univ Alberta, Dept Med, Div Pulm, Edmonton, AB, Canada.; Stickland, MK (corresponding author), Covenant Hlth, GF MacDonald Ctr Lung Hlth, Edmonton, AB, Canada.	michael.stickland@ualberta.ca	Edgell, Heather/ABE-3182-2020	Edgell, Heather/0000-0001-8865-1921; Byers, Bradley/0000-0003-1109-9897	Canadian Institutes of Health Research [310994]; Heart and Stroke Foundation of Canada New Investigator Salary Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada New Investigator Salary Award	This research was supported by a grant from the Canadian Institutes of Health Research (grant # 310994; http://www.cihr-irsc.gc.ca/e/193.html). MS is supported by a Heart and Stroke Foundation of Canada New Investigator Salary Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 1998, J PHYSIOL-LONDON, V510, P773, DOI 10.1111/j.1469-7793.1998.773bj.x; Andreas S, 2014, LUNG, V192, P235, DOI 10.1007/s00408-013-9544-7; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; BALKOWIEC A, 1993, RESP PHYSIOL, V92, P91; Bartels MN, 2004, RESP MED, V98, P84, DOI 10.1016/j.rmed.2002.09.001; Bartels MN, 2000, CHEST, V118, P691, DOI 10.1378/chest.118.3.691; Beloka S, 2008, MED SCI SPORT EXER, V40, P1932, DOI 10.1249/MSS.0b013e31817fbe11; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; BRADLEY CA, 1979, AM REV RESPIR DIS, V120, P21; Bratel T, 2000, RESP MED, V94, P1221, DOI 10.1053/rmed.2000.0953; Curran AK, 2000, J APPL PHYSIOL, V88, P1840, DOI 10.1152/jappl.2000.88.5.1840; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; DEJOURS P, 1962, PHYSIOL REV, V42, P335, DOI 10.1152/physrev.1962.42.3.335; DEJOURS P, 1963, ANN NY ACAD SCI, V109, P682, DOI 10.1111/j.1749-6632.1963.tb13497.x; Dinenno FA, 2000, AM J PHYSIOL-HEART C, V278, pH1205, DOI 10.1152/ajpheart.2000.278.4.H1205; Edgell H, 2015, J APPL PHYSIOL, V118, P839, DOI 10.1152/japplphysiol.00898.2014; ERBLAND ML, 1990, CHEST, V97, P1289, DOI 10.1378/chest.97.6.1289; Giannoni A, 2009, J AM COLL CARDIOL, V53, P1975, DOI 10.1016/j.jacc.2009.02.030; Guyenet PG, 2000, RESP PHYSIOL, V121, P147, DOI 10.1016/S0034-5687(00)00125-0; Heindl S, 2001, AM J RESP CRIT CARE, V164, P597, DOI 10.1164/ajrccm.164.4.2007085; Holm SM, 2014, RESP PHYSIOL NEUROBI, V192, P30, DOI 10.1016/j.resp.2013.11.009; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leung PS, 2000, J ENDOCRINOL, V167, P517, DOI 10.1677/joe.0.1670517; Mak S, 2002, AM J PHYSIOL-HEART C, V282, pH2414, DOI 10.1152/ajpheart.00947.2001; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; McKelvie RS, 2013, CAN J CARDIOL, V29, P168, DOI 10.1016/j.cjca.2012.10.007; McNulty PH, 2007, J APPL PHYSIOL, V102, P2040, DOI 10.1152/japplphysiol.00595.2006; MIYAMOTO K, 1992, AM REV RESPIR DIS, V145, P1384, DOI 10.1164/ajrccm/145.6.1384; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Donnell DE, 2007, CAN RESPIR J, V14, p5B, DOI 10.1155/2007/830570; Parati G, 2014, BLOOD PRESSURE ARTER; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; Porzionato A, 2013, RESP PHYSIOL NEUROBI, V187, P31, DOI 10.1016/j.resp.2013.02.017; Raupach T, 2008, EUR RESPIR J, V32, P387, DOI 10.1183/09031936.00109607; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Scalvini S, 1999, EUR RESPIR J, V13, P119, DOI 10.1183/09031936.99.13111999; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Solomon IC, 2000, RESP PHYSIOL, V121, P101, DOI 10.1016/S0034-5687(00)00122-5; SOMERS VK, 1988, HYPERTENSION, V11, P608, DOI 10.1161/01.HYP.11.6.608; Stickland MK, 2008, J PHYSIOL-LONDON, V586, P1743, DOI 10.1113/jphysiol.2007.147421; Stickland MK, 2007, CIRC RES, V100, P1371, DOI 10.1161/01.RES.0000266974.84590.d2; Stickland MK, 2013, RESP PHYSIOL NEUROBI, V189, P188, DOI 10.1016/j.resp.2013.08.001; Stickland MK, 2011, J PHYSIOL-LONDON, V589, P6219, DOI 10.1113/jphysiol.2011.218099; SUN MK, 1994, PROG NEUROBIOL, V44, P197, DOI 10.1016/0301-0082(94)90038-8; Sun SY, 1999, J APPL PHYSIOL, V86, P1264, DOI 10.1152/jappl.1999.86.4.1264; Swierblewska E, 2010, J HYPERTENS, V28, P979, DOI 10.1097/HJH.0b013e328336ed9a; Timmers HJLM, 2003, J HYPERTENS, V21, P591, DOI 10.1097/00004872-200303000-00026; van de Borne P, 1998, CIRCULATION, V98, P126, DOI 10.1161/01.CIR.98.2.126; van Helvoort HAC, 2005, RESP MED, V99, P1555, DOI 10.1016/j.rmed.2005.03.028; Vedam H, 2009, EUR J APPL PHYSIOL, V105, P19, DOI 10.1007/s00421-008-0868-6; WARD SA, 1989, J PHYSIOL-LONDON, V411, P27, DOI 10.1113/jphysiol.1989.sp017557; WHIPP BJ, 1980, FED PROC, V39, P2668; Wolk R, 2005, J CARD FAIL, V11, P333, DOI 10.1016/j.cardfail.2004.11.008; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067	59	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158341	10.1371/journal.pone.0158341	http://dx.doi.org/10.1371/journal.pone.0158341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355356	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400052
J	Fantoni, C; Rigutti, S; Piccoli, V; Sommacal, E; Carnaghi, A				Fantoni, Carlo; Rigutti, Sara; Piccoli, Valentina; Sommacal, Elena; Carnaghi, Andrea			Faster but Less Careful Prehension in Presence of High, Rather than Low, Social Status Attendees	PLOS ONE			English	Article							MERE PRESENCE; UNIVERSAL DIMENSIONS; BINOCULAR VISION; GENDER HIERARCHY; MIRROR NEURONS; ONLINE CONTROL; MOTOR CONTROL; FACILITATION; COORDINATION; HAND	Ample evidence attests that social intention, elicited through gestures explicitly signaling a request of communicative intention, affects the patterning of hand movement kinematics. The current study goes beyond the effect of social intention and addresses whether the same action of reaching to grasp an object for placing it in an end target position within or without a monitoring attendee's peripersonal space, can be moulded by pure social factors in general, and by social facilitation in particular. A motion tracking system (Optotrak Certus) was used to record motor acts. We carefully avoided the usage of communicative intention by keeping constant both the visual information and the positional uncertainty of the end target position, while we systematically varied the social status of the attendee (a high, or a low social status) in separated blocks. Only thirty acts performed in the presence of a different social status attendee, revealed a significant change of kinematic parameterization of hand movement, independently of the attendee's distance. The amplitude of peak velocity reached by the hand during the reach-to-grasp and the lift-to-place phase of the movement was larger in the high rather than in the low social status condition. By contrast, the deceleration time of the reach-to-grasp phase and the maximum grasp aperture was smaller in the high rather than in the low social status condition. These results indicated that the hand movement was faster but less carefully shaped in presence of a high, but not of a low social status attendee. This kinematic patterning suggests that being monitored by a high rather than a low social status attendee might lead participants to experience evaluation apprehension that informs the control of motor execution. Motor execution would rely more on feedforward motor control in the presence of a high social status human attendee, vs. feedback motor control, in the presence of a low social status attendee.	[Fantoni, Carlo; Rigutti, Sara; Piccoli, Valentina; Sommacal, Elena; Carnaghi, Andrea] Univ Trieste, Psychol Unit Gaetano Kanizsa, Dept Life Sci, Via Weiss 21, I-34128 Trieste, Italy	University of Trieste	Fantoni, C (corresponding author), Univ Trieste, Psychol Unit Gaetano Kanizsa, Dept Life Sci, Via Weiss 21, I-34128 Trieste, Italy.	cfantoni@units.it		Fantoni, Carlo/0000-0002-7749-1771	University of Trieste [FRA-2013]	University of Trieste	This work was supported by the University of Trieste with a grant to CF (FRA-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2014, FRONT PSYCHOL, V5; Arbib M. A., 2011, HDB PHYSL NERVOUS SY, P1449, DOI [DOI 10.1016/J.JPHYSPARIS.2008.03.001, 10.1002/cphy.cp010233]; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BANAJI MR, 1995, J PERS SOC PSYCHOL, V68, P181, DOI 10.1037/0022-3514.68.2.181; Banaji MR, 1996, PSYCHOL SCI, V7, P136, DOI 10.1111/j.1467-9280.1996.tb00346.x; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Bates D., 2015, LINEAR MIXED EFFECTS; Bates D.M., 2010, LME4 MIXED EFFECTS M; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Blascovich J, 1999, J PERS SOC PSYCHOL, V77, P68, DOI 10.1037/0022-3514.77.1.68; Bohns VK, 2012, J EXP SOC PSYCHOL, V48, P341, DOI 10.1016/j.jesp.2011.05.022; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; Bozzacchi C, 2014, J NEUROPHYSIOL, V112, P3189, DOI 10.1152/jn.00439.2014; Bradshaw MF, 2004, SPATIAL VISION, V17, P95, DOI 10.1163/156856804322778288; Bradshaw MF, 2003, SPATIAL VISION, V16, P295, DOI 10.1163/156856803322467545; Brambilla M, 2011, SOC PSYCHOL-GERMANY, V42, P101, DOI 10.1027/1864-9335/a000054; Braun D, 2011, EXP BRAIN RES, V211, P631, DOI 10.1007/s00221-011-2642-y; BUSS DM, 1988, J PERS SOC PSYCHOL, V54, P616, DOI 10.1037/0022-3514.54.4.616; Buunk A.P., 2009, J EVOLUTIONARY PSYCH, V7, P37, DOI [DOI 10.1556/JEP.7.2009.1.5, 10.1556/JEP.7.2009.1.5]; Candidi M, 2014, CEREB CORTEX, V24, P435, DOI 10.1093/cercor/bhs325; Carnaghi A, 2014, J SOC PSYCHOL, V154, P105, DOI 10.1080/00224545.2013.863174; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Coello Y., 2015, SOCIOAFFECTIVE NEURO, V2015, P5; Commission European, 2015, GEND EQ SPEC EUROBAR, P428; Costantini M, 2011, PLOS ONE, V6; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Cottrell N. B., 1972, EXPT SOCIAL PSYCHOL, V185, P236; COTTRELL NB, 1968, J PERS SOC PSYCHOL, V9, P245, DOI 10.1037/h0025902; Craighero L, 2011, COGNITION, V120, P26, DOI 10.1016/j.cognition.2011.02.011; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dalmaso M, 2011, BIOL LETT, P11; Dalmaso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093139; de la Rosa S, 2014, PLOS ONE, V9; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desy MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000971; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Ferri F, 2011, PLOS ONE, V6; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flatters IJ, 2012, PLOS ONE, V7; Foster R, 2011, ACTA PSYCHOL, V136, P300, DOI 10.1016/j.actpsy.2010.12.003; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gerbino W, 2014, P HUM FACT ERG SOC E, P403; Gianelli C, 2013, PSYCHOL RES-PSYCH FO, V77, P40, DOI 10.1007/s00426-011-0401-0; Gielen CCAM, 2009, CORTEX, V45, P340, DOI 10.1016/j.cortex.2008.02.009; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Glover S, 2004, BEHAV BRAIN SCI, V27, P57; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodale MA, 1996, ADV MOTOR LEARNING C, P87; Goodwin S. A, 2000, GROUP PROCESS INTERG, V3, P227, DOI [10.1177/1368430200003003001, DOI 10.1177/1368430200003003001]; GUERIN B, 1982, BRIT J SOC PSYCHOL, V21, P7, DOI 10.1111/j.2044-8309.1982.tb00506.x; Halekoh U, 2014, J STAT SOFTW, V59, P1; HENCHY T, 1968, J PERS SOC PSYCHOL, V10, P446, DOI 10.1037/h0026814; Holt RJ, 2013, PLOS ONE, P8; Iachini T, 2016, J ENVIRON PSYCHOL, V45, P154, DOI 10.1016/j.jenvp.2016.01.004; Innocenti A, 2012, PLOS ONE, P7; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Jallais C, 2010, BEHAV RES METHODS, V42, P318, DOI 10.3758/BRM.42.1.318; JEANNEROD M, 1986, BEHAV BRAIN RES, V19, P99, DOI 10.1016/0166-4328(86)90008-2; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kliegl R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00238; Kucera D, 2012, PROCD SOC BEHV, V69, P31, DOI 10.1016/j.sbspro.2012.11.380; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Loftus A, 2004, EXP BRAIN RES, V158, P317, DOI 10.1007/s00221-004-1905-2; Losin EAR, 2012, NEUROIMAGE, V59, P3594, DOI 10.1016/j.neuroimage.2011.10.074; LOVELAND K A, 1991, Ecological Psychology, V3, P99, DOI 10.1207/s15326969eco0302_3; Maner JK, 2013, EVOL HUM BEHAV, V34, P412, DOI 10.1016/j.evolhumbehav.2013.07.005; MARKUS H, 1978, J EXP SOC PSYCHOL, V14, P389, DOI 10.1016/0022-1031(78)90034-3; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; Nicolini C, 2014, PROC SPIE, V9014, DOI 10.1117/12.2045459; PAULUS PB, 1971, J EXP SOC PSYCHOL, V7, P280, DOI 10.1016/0022-1031(71)90028-X; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Pezzulo G, 2011, EXP BRAIN RES, V211, P613, DOI 10.1007/s00221-011-2712-1; PRATT J, 1994, PSYCHOL AGING, V9, P325, DOI 10.1037/0882-7974.9.2.325; PROTEAU L, 1992, Q J EXP PSYCHOL-A, V44, P557, DOI 10.1080/14640749208401298; Quesque F, 2013, FRONT NEUROROBOTICS, V7; Quesque F, 2016, Q J EXP PSYCHOL, V69, P1451, DOI 10.1080/17470218.2015.1083596; Rigutti S, 2015, WEB PARTY EFFECT COC, V3; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roney JR, 2003, PERS SOC PSYCHOL B, V29, P393, DOI 10.1177/0146167202250221; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Rosenbaum DA, 1999, EXP BRAIN RES, V128, P92, DOI 10.1007/s002210050823; Rudman LA, 1999, J PERS SOC PSYCHOL, V77, P1004, DOI 10.1037/0022-3514.77.5.1004; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Rudman LA, 2012, J EXP SOC PSYCHOL, V48, P165, DOI 10.1016/j.jesp.2011.10.008; Saad G, 2009, ORGAN BEHAV HUM DEC, V110, P80, DOI 10.1016/j.obhdp.2009.06.001; Sacheli LM, 2015, FRONT PSYCHOL, V6; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schultz W, 2013, FRONT NEUROSCI, V7; Scorolli C, 2014, NEUROPSYCHOLOGIA, V57, P196, DOI 10.1016/j.neuropsychologia.2014.03.006; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; SERVOS P, 1994, EXP BRAIN RES, V98, P119; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; Servos P, 2000, EXP BRAIN RES, V130, P35, DOI 10.1007/s002210050004; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Straulino E, 2015, CORTEX, V70, P179, DOI 10.1016/j.cortex.2015.02.012; Strauss B, 2002, PSYCHOL SPORT EXERC, V3, P237, DOI 10.1016/S1469-0292(01)00019-X; Sun G, 2010, HEREDITY, V105, P333, DOI 10.1038/hdy.2010.11; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI [10.2307/1412188, DOI 10.2307/1412188]; Turner JC, 1981, CAHIERS PSYCHOL COGN, V1, P93; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Uziel L, 2007, J RES PERS, V41, P579, DOI 10.1016/j.jrp.2006.06.008; Volcic R, 2013, J NEUROSCI, V 33, P17081, DOI 10.1523/JNEUROSCI.2936-13.2013; Watt SJ, 2000, NEUROPSYCHOLOGIA, V38, P1473, DOI 10.1016/S0028-3932(00)00065-8; Wolpert DM, 2012, CURR OPIN NEUROBIOL, V22, P996, DOI 10.1016/j.conb.2012.05.003; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Yap AJ, 2013, PSYCHOL SCI, V24, P2281, DOI 10.1177/0956797613492425; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	140	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158095	10.1371/journal.pone.0158095	http://dx.doi.org/10.1371/journal.pone.0158095			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351978	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900032
J	Lins, BR; Pushie, JM; Jones, M; Howard, DL; Howland, JG; Hackett, MJ				Lins, Brittney R.; Pushie, Jake M.; Jones, Michael; Howard, Daryl L.; Howland, John G.; Hackett, Mark J.			Mapping Alterations to the Endogenous Elemental Distribution within the Lateral Ventricles and Choroid Plexus in Brain Disorders Using X-Ray Fluorescence Imaging	PLOS ONE			English	Article							PRENATAL IMMUNE ACTIVATION; CEREBROSPINAL-FLUID SYSTEM; HIPPOCAMPAL-FORMATION; ANIMAL-MODELS; SCHIZOPHRENIA; SEROTONIN; CALCIFICATION; INFECTION; CHLORIDE; LEADS	The choroid plexus and cerebral ventricles are critical structures for the production of cerebral spinal fluid (CSF) and play an important role in regulating ion and metal transport in the brain, however many aspects of its roles in normal physiology and disease states, such as psychiatric illness, remain unknown. The choroid plexus is difficult to examine in vivo, and in situ ex vivo, and as such has typically been examined indirectly with radiolabeled tracers or ex vivo stains, making measurements of the endogenous K+, Cl-, and Ca+ distributions unreliable. In the present study, we directly examined the distribution of endogenous ions and biologically relevant transition metals in the choroid plexus and regions surrounding the ventricles (ventricle wall, cortex, corpus callosum, striatum) using X-ray fluorescence imaging (XFI). We find that the choroid plexus was rich in Cl- and Fe while K+ levels increase further from the ventricle as Cl- levels decrease, consistent with the known role of ion transporters in the choroid plexus CSF production. A polyI:C offspring displayed enlarged ventricles, elevated Cl- surrounding the ventricles, and intraventricular calcifications. These observations fit with clinical findings in patients with schizophrenia and suggest maternal treatment with polyI: C may lead to dysfunctional ion regulation in offspring. This study demonstrates the power of XFI for examining the endogenous elemental distributions of the ventricular system in healthy brain tissue as well as disease models.	[Lins, Brittney R.; Howland, John G.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK, Canada; [Pushie, Jake M.] Univ Saskatchewan, Coll Med, Saskatoon, SK S7N 0W0, Canada; [Jones, Michael; Howard, Daryl L.] Australian Synchrotron, Clayton, Vic, Australia; [Jones, Michael] La Trobe Univ, La Trobe Inst Mol Sci, ARC Ctr Excellence Adv Mol Imaging, Bundoora, Vic 3086, Australia; [Hackett, Mark J.] Curtin Univ, Dept Chem, Perth, WA 6845, Australia	University of Saskatchewan; University of Saskatchewan; La Trobe University; Curtin University	Howland, JG (corresponding author), Univ Saskatchewan, Dept Physiol, Saskatoon, SK, Canada.; Hackett, MJ (corresponding author), Curtin Univ, Dept Chem, Perth, WA 6845, Australia.	john.howland@usask.ca; mark.j.hackett@curtin.edu.au	Jones, Michael/M-6895-2013; Lins, Brittney/GWU-4974-2022; Jones, Michael/AAA-3860-2021; Howard, Daryl/E-9107-2013	Jones, Michael/0000-0002-0720-8715; Lins, Brittney/0000-0002-7960-7782; Jones, Michael/0000-0002-0720-8715; Howard, Daryl/0000-0001-6071-2382; Pushie, M. Jake/0000-0001-7494-5427; hackett, mark/0000-0002-3296-7270	Canadian Institutes for Health Research (CIHR) [125984]; CIHR; Saskatchewan Health Research Foundation Postdoctoral Fellowship; joint Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant [CIF 99472]; University of Saskatchewan; DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation Postdoctoral Fellowship; joint Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a Canadian Institutes for Health Research (CIHR) Operating Grant to JGH (#125984). JGH is a CIHR New Investigator. MJH received salary support from a CIHR Postdoctoral Fellowship and a Saskatchewan Health Research Foundation Postdoctoral Fellowship. During this research MJH was a member of the CIHR-Training grant in Health Research Using Synchrotron Techniques (CIHR-THRUST) program and a postdoctoral fellow funded by the joint Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant #CIF 99472. BRL received salary support from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Quentin Greba for his help administering maternal treatments and flash freezing brain tissue. Part of this research was undertaken on the XFM beamline of the Australian Synchrotron, Victoria, Australia. We would like to thank the members of the Australian Synchrotron XFM beamline, Martin de Jonge, David Paterson, and Simon James for their assistance in experiments performed at the Australian Synchrotron. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209). We would like to thank Sam Webb and Courtney Roach for their assistance in experiments performed at the Stanford Synchrotron Radiation Lightsource.	Abi-Dargham A, 1997, J NEUROPSYCH CLIN N, V9, P1; Bersani G, 1999, NEUROSCI LETT, V259, P169, DOI 10.1016/S0304-3940(98)00935-5; Boksa P, 2004, BRAIN RES REV, V45, P1, DOI 10.1016/j.brainresrev.2004.01.001; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Chwiej J, 2012, ANAL BIOANAL CHEM, V404, P3071, DOI 10.1007/s00216-012-6425-5; Chwiej J, 2012, J BIOL INORG CHEM, V17, P731, DOI 10.1007/s00775-012-0892-1; Chwiej J, 2011, J BIOL INORG CHEM, V16, P275, DOI 10.1007/s00775-010-0724-0; Chwiej J, 2008, J BIOL INORG CHEM, V13, P1267, DOI 10.1007/s00775-008-0411-6; COPPEN AJ, 1988, J CLIN PSYCHIAT, V49, P4; Cornford EM, 1997, EXP BRAIN RES, V116, P399, DOI 10.1007/PL00005768; Davies KM, 2013, METALLOMICS, V5, P43, DOI 10.1039/c2mt20151h; DELISI LE, 1986, ARCH GEN PSYCHIAT, V43, P148; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; FISONE G, 1995, J BIOL CHEM, V270, P2427, DOI 10.1074/jbc.270.6.2427; Grubman A, 2014, CHEM SCI, V5, P2503, DOI 10.1039/c4sc00316k; Hackett MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500911; Hackett MJ, 2015, ACS CHEM NEUROSCI, V6, P226, DOI 10.1021/cn500157j; Hackett MJ, 2012, ACS CHEM NEUROSCI, V3, P178, DOI 10.1021/cn200097s; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Hare DJ, 2016, METALLOMICS, V8, P156, DOI [10.1039/c5mt00288e, 10.1039/C5MT00288E]; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; JOHANSON CE, 1990, AM J PHYSIOL, V258, pC211, DOI 10.1152/ajpcell.1990.258.2.C211; JOHNSON DC, 1987, J APPL PHYSIOL, V63, P1591, DOI 10.1152/jappl.1987.63.4.1591; JOHNSTONE EC, 1976, LANCET, V2, P924; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Marinescu I, 2013, ROM J MORPHOL EMBRYO, V54, P365; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Piontkewitz Y, 2012, NEUROPHARMACOLOGY, V62, P1273, DOI 10.1016/j.neuropharm.2011.04.019; Piontkewitz Y, 2011, BIOL PSYCHIAT, V70, P842, DOI 10.1016/j.biopsych.2011.06.007; Pushie MJ, 2014, CHEM REV, V114, P8499, DOI 10.1021/cr4007297; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Pushkar Y, 2013, AGING CELL, V12, P823, DOI 10.1111/acel.12112; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Robison G, 2012, PLOS ONE; Ryan CG, 2014, J PHYS CONF SER, V499, DOI 10.1088/1742-6596/499/1/012002; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; SANDYK R, 1990, SCHIZOPHR RES, V3, P361, DOI 10.1016/0920-9964(90)90024-2; SANDYK R, 1993, INT J NEUROSCI, V71, P87, DOI 10.3109/00207459309000595; Skipor J, 2008, ACTA NEUROBIOL EXP, V68, P414; SMITH QR, 1981, J NEUROCHEM, V37, P107, DOI 10.1111/j.1471-4159.1981.tb05297.x; SMITH QR, 1986, J NEUROCHEM, V46, P1732; Spector R, 2015, EXP NEUROL, V267, P78, DOI 10.1016/j.expneurol.2015.02.032; Szczerbowska-Boruchowska M, 2012, X-RAY SPECTROM, V41, P328, DOI 10.1002/xrs.2407; Tauscher J, 2001, AM J PSYCHIAT, V158, P1326, DOI 10.1176/appi.ajp.158.8.1326; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wang XQ, 2008, TOXICOL APPL PHARM, V230, P167, DOI 10.1016/j.taap.2008.02.024; Wang ZY, 2004, NEUROREPORT, V15, P1801, DOI 10.1097/01.wnr.0000132918.05366.81; WEINBERGER DR, 1979, ARCH GEN PSYCHIAT, V36, P735; WEINBERGER DR, 1980, ARCH GEN PSYCHIAT, V37, P11; Winter C, 2008, EUR NEUROPSYCHOPHARM, V18, P712, DOI 10.1016/j.euroneuro.2008.06.001; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	60	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158152	10.1371/journal.pone.0158152	http://dx.doi.org/10.1371/journal.pone.0158152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351594	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900040
J	Sapcariu, SC; Kanashova, T; Dilger, M; Diabate, S; Oeder, S; Passig, J; Radischat, C; Buters, J; Sippula, O; Streibel, T; Paur, HR; Schlager, C; Mulhopt, S; Stengel, B; Rabe, R; Harndorf, H; Krebs, T; Karg, E; Groger, T; Weiss, C; Dittmar, G; Hiller, K; Zimmermann, R				Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Karg, Erwin; Groeger, Thomas; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf			Metabolic Profiling as Well as Stable Isotope Assisted Metabolic and Proteomic Analysis of RAW 264.7 Macrophages Exposed to Ship Engine Aerosol Emissions: Different Effects of Heavy Fuel Oil and Refined Diesel Fuel	PLOS ONE			English	Article							IN-VITRO; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; LUNG-CELLS; EXHAUST; RESPONSES; SPECTROMETRY; EXPRESSION; IL-1-BETA; PARTICLES	Exposure to air pollution resulting from fossil fuel combustion has been linked to multiple short-term and long term health effects. In a previous study, exposure of lung epithelial cells to engine exhaust from heavy fuel oil (HFO) and diesel fuel (DF), two of the main fuels used in marine engines, led to an increased regulation of several pathways associated with adverse cellular effects, including pro-inflammatory pathways. In addition, DF exhaust exposure was shown to have a wider response on multiple cellular regulatory levels compared to HFO emissions, suggesting a potentially higher toxicity of DF emissions over HFO. In order to further understand these effects, as well as to validate these findings in another cell line, we investigated macrophages under the same conditions as a more inflammation-relevant model. An air-liquid interface aerosol exposure system was used to provide a more biologically relevant exposure system compared to submerged experiments, with cells exposed to either the complete aerosol (particle and gas phase), or the gas phase only (with particles filtered out). Data from cytotoxicity assays were integrated with metabolomics and proteomics analyses, including stable isotope-assisted metabolomics, in order to uncover pathways affected by combustion aerosol exposure in macrophages. Through this approach, we determined differing phenotypic effects associated with the different components of aerosol. The particle phase of diluted combustion aerosols was found to induce increased cell death in macrophages, while the gas phase was found more to affect the metabolic profile. In particular, a higher cytotoxicity of DF aerosol emission was observed in relation to the HFO aerosol. Furthermore, macrophage exposure to the gas phase of HFO leads to an induction of a pro-inflammatory metabolic and proteomic phenotype. These results validate the effects found in lung epithelial cells, confirming the role of inflammation and cellular stress in the response to combustion aerosols.	[Sapcariu, Sean C.; Hiller, Karsten] Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4362 Esch Sur Alzette, Luxembourg; [Kanashova, Tamara; Dittmar, Gunnar] Max Delbruck Ctr Mol Med Berlin Buch, Mass Spectrometry Core Unit, Berlin, Germany; [Dilger, Marco; Diabate, Silvia; Weiss, Carsten] Karlsruhe Inst Technol, ITG, Campus North, D-76021 Karlsruhe, Germany; [Dilger, Marco; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja] Karlsruhe Inst Technol, ITC, Campus North, Karlsruhe, Germany; [Oeder, Sebastian; Buters, Jeroen] Helmholtz Zentrum Munchen, Ctr Allergy & Environm ZAUM, Munich, Germany; [Oeder, Sebastian; Buters, Jeroen] Tech Univ Munich, D-80290 Munich, Germany; [Oeder, Sebastian; Buters, Jeroen] CK CARE, Davos, Switzerland; [Passig, Johannes; Radischat, Christian; Streibel, Thorsten; Zimmermann, Ralf] Univ Rostock, Inst Chem, Div Analyt & Tech Chem, Joint Mass Spectrometry Ctr, D-18055 Rostock, Germany; [Sippula, Olli] Univ Eastern Finland, Dept Environm Sci, POB 1627, FI-70211 Kuopio, Finland; [Streibel, Thorsten; Karg, Erwin; Groeger, Thomas; Zimmermann, Ralf] Helmholtz Zentrum Munchen, CMA, Joint Mass Spectrometry Ctr, Neuherberg, Germany; [Stengel, Benjamin; Rabe, Rom; Harndorf, Horst] Univ Rostock, Chair Piston Machines & Internal Combust Engines, D-18055 Rostock, Germany; [Krebs, Tobias] Vitrocell GmbH, Tubingen, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Neuherberg, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Rostock, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Munich, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Karlsruhe, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Berlin, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Waldkirch, Germany; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Kuopio, Finland; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Cardiff, Wales; [Sapcariu, Sean C.; Kanashova, Tamara; Dilger, Marco; Diabate, Silvia; Oeder, Sebastian; Passig, Johannes; Radischat, Christian; Buters, Jeroen; Sippula, Olli; Streibel, Thorsten; Paur, Hanns-Rudolf; Schlager, Christoph; Muelhopt, Sonja; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Krebs, Tobias; Weiss, Carsten; Dittmar, Gunnar; Hiller, Karsten; Zimmermann, Ralf] Esch Belval, Esch Belval, Luxembourg; [Oeder, Sebastian; Buters, Jeroen] German Ctr Lung Res DZL, Munich, Germany	University of Luxembourg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Rostock; University of Eastern Finland; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Rostock	Sapcariu, SC (corresponding author), Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4362 Esch Sur Alzette, Luxembourg.; Zimmermann, R (corresponding author), Univ Rostock, Inst Chem, Div Analyt & Tech Chem, Joint Mass Spectrometry Ctr, D-18055 Rostock, Germany.; Zimmermann, R (corresponding author), Helmholtz Zentrum Munchen, CMA, Joint Mass Spectrometry Ctr, Neuherberg, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Neuherberg, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Rostock, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Munich, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Karlsruhe, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Berlin, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Waldkirch, Germany.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Kuopio, Finland.; Sapcariu, SC; Zimmermann, R (corresponding author), HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Cardiff, Wales.; Sapcariu, SC; Zimmermann, R (corresponding author), Esch Belval, Esch Belval, Luxembourg.	sean.sapcariu@uni.lu; ralf.zimmermann@helmholtz-muenchen.de	BUTERS, JEROEN/AAF-6949-2020; Dittmar, Gunnar/B-6383-2016; Paur, Hanns-Rudolf/H-1340-2013; Buters, Jeroen T/G-5070-2011; Dittmar, Gunnar/C-6333-2019; Weiss, Carsten/I-1811-2013	Dittmar, Gunnar/0000-0003-3647-8623; Paur, Hanns-Rudolf/0000-0001-5133-9459; Dittmar, Gunnar/0000-0003-3647-8623; Weiss, Carsten/0000-0002-5380-3208; Hiller, Karsten/0000-0001-9322-5820; Passig, Johannes/0000-0002-3876-1716; Mulhopt, Sonja/0000-0003-3951-0131; Sippula, Olli/0000-0002-6981-2694; Dilger, Marco/0000-0002-9038-3863; Buters, Jeroen/0000-0003-3581-5472	Impulse and Networking Funds (INF) of the Helmholtz Association (HGF), Berlin, Germany; HICE by the Helmholtz Zentrum Munchen; University of Rostock; Fonds National de la Recherche (FNR); Academy of Finland [258315, 259946]; Saastamoinen foundation; strategic funding of the University of Eastern Finland for project "sustainable bioenergy, climate change and health"; German Science Foundation [DFG ZI 764/5-1, ZI 764/3-1, INST 264/56-1, 264/77-1]; DACH project WOOSHI; Vitrocell GmbH; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health: Aerosol and Health; Fonds National de la Recherche, Luxembourg [ATTRACT A10/03]; CK-CARE Teilbereich A. Sean Sapcariu	Impulse and Networking Funds (INF) of the Helmholtz Association (HGF), Berlin, Germany; HICE by the Helmholtz Zentrum Munchen; University of Rostock; Fonds National de la Recherche (FNR)(Luxembourg National Research Fund); Academy of Finland(Academy of Finland); Saastamoinen foundation; strategic funding of the University of Eastern Finland for project "sustainable bioenergy, climate change and health"; German Science Foundation(German Research Foundation (DFG)); DACH project WOOSHI; Vitrocell GmbH; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health: Aerosol and Health; Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); CK-CARE Teilbereich A. Sean Sapcariu	HICE partners received funding from the Impulse and Networking Funds (INF) of the Helmholtz Association (HGF), Berlin, Germany. The support of HICE by the Helmholtz Zentrum Munchen and University of Rostock is gratefully acknowledged. Sebastian Oeder also received funding from CK-CARE Teilbereich A. Sean Sapcariu and Karsten Hiller acknowledge financial support from the Fonds National de la Recherche (FNR), specifically the ATTRACT program Metabolomics Junior Group. Funding from the Academy of Finland (Grant No: 258315 & 259946), Saastamoinen foundation and the strategic funding of the University of Eastern Finland for project "sustainable bioenergy, climate change and health" is acknowledged. Funding from the German Science Foundation (DFG ZI 764/5-1, ZI 764/3-1, INST 264/56-1 and 264/77-1) helped to achieve the presented results. The authors also thank SNSF and DFG for funding for the DACH project WOOSHI. Vitrocell GmbH provided support in the form of a salary for author T. Krebs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health: Aerosol and Health (www.hice-vi.eu). We would like to thank the entire HICE consortium for their aid an assistance for these experiments. SCS and KH are supported by the Fonds National de la Recherche, Luxembourg (ATTRACT A10/03).	Andersson JT, 2015, POLYCYCL AROMAT COMP, V35, P330, DOI 10.1080/10406638.2014.991042; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bhavaraju L, 2014, CHEMOSPHERE, V104, P126, DOI 10.1016/j.chemosphere.2013.10.080; BITTERMAN PB, 1984, J CLIN INVEST, V74, P460, DOI 10.1172/JCI111443; CASTRANOVA V, 1985, ENVIRON RES, V36, P405, DOI 10.1016/0013-9351(85)90034-9; Comouth A, 2013, J AEROSOL SCI, V63, P103, DOI 10.1016/j.jaerosci.2013.04.009; Corbett JJ, 2007, ENVIRON SCI TECHNOL, V41, P8512, DOI 10.1021/es071686z; Diabate S, 2008, ATLA-ALTERN LAB ANIM, V36, P285, DOI 10.1177/026119290803600306; Eschner MS, 2011, APPL SPECTROSC, V65, P806, DOI 10.1366/11-06233; Ewald JC, 2009, ANAL CHEM, V81, P3623, DOI 10.1021/ac900002u; Fritsch-Decker S, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-23; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hiller K, 2011, CURR PHARM BIOTECHNO, V12, P1075, DOI 10.2174/138920111795909096; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanashova T, 2015, ANAL BIOANAL CHEM, V407, P5965, DOI 10.1007/s00216-015-8595-4; Kang HJ, 2014, ENVIRON SCI TECHNOL, V48, P2962, DOI 10.1021/es404342k; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knebel JW, 2002, TOXICOL IN VITRO, V16, P185, DOI 10.1016/S0887-2333(01)00110-2; Li N, 2002, J IMMUNOL, V169, P4531, DOI 10.4049/jimmunol.169.8.4531; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mulhopt S, 2016, J AEROSOL SCI, V96, P38, DOI 10.1016/j.jaerosci.2016.02.005; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Oeder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126536; Olsen HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043644; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Paur HR, 2011, J AEROSOL SCI, V42, P668, DOI 10.1016/j.jaerosci.2011.06.005; Radischat C, 2015, ANAL BIOANAL CHEM, P1; Reda AA, 2014, ATMOS ENVIRON, V94, P467, DOI 10.1016/j.atmosenv.2014.05.053; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Schwarze PE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685142; Seagrave J, 2007, EXP LUNG RES, V33, P27, DOI 10.1080/01902140601113088; Shaw CA, 2011, AM J RESP CELL MOL, V44, P840, DOI 10.1165/rcmb.2010-0011OC; Sippula O, 2014, ENVIRON SCI TECHNOL, V48, P11721, DOI 10.1021/es502484z; Steiner S, 2013, ATMOS ENVIRON, V81, P117, DOI 10.1016/j.atmosenv.2013.08.029; Streibel T, 2015, P COMBUST INST, V35, P1771, DOI 10.1016/j.proci.2014.07.046; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vondracek J, 2007, ENVIRON TOXICOL CHEM, V26, P2308, DOI 10.1897/07-161R.1; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegner A, 2014, ANAL CHEM, V86, P2221, DOI 10.1021/ac403879d; Wegner A, 2013, ANAL CHEM, V85, P4030, DOI 10.1021/ac303774z; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	50	25	25	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157964	10.1371/journal.pone.0157964	http://dx.doi.org/10.1371/journal.pone.0157964			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348622	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000378801200025
J	Maksuti, E; Westerhof, N; Westerhof, BE; Broome, M; Stergiopulos, N				Maksuti, Elira; Westerhof, Nico; Westerhof, Berend E.; Broome, Michael; Stergiopulos, Nikos			Contribution of the Arterial System and the Heart to Blood Pressure during Normal Aging - A Simulation Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; LEFT-VENTRICULAR HYPERTROPHY; MIDDLE-AGED MEN; WALL STRESS; STIFFNESS; VOLUME; DETERMINANTS; IMPEDANCE; ADULTS; MODEL	During aging, systolic blood pressure continuously increases over time, whereas diastolic pressure first increases and then slightly decreases after middle age. These pressure changes are usually explained by changes of the arterial system alone (increase in arterial stiffness and vascular resistance). However, we hypothesise that the heart contributes to the age-related blood pressure progression as well. In the present study we quantified the blood pressure changes in normal aging by using a Windkessel model for the arterial system and the time-varying elastance model for the heart, and compared the simulation results with data from the Framingham Heart Study. Parameters representing arterial changes (resistance and stiffness) during aging were based on literature values, whereas parameters representing cardiac changes were computed through physiological rules (compensated hypertrophy and preservation of end-diastolic volume). When taking into account arterial changes only, the systolic and diastolic pressure did not agree well with the population data. Between 20 and 80 years, systolic pressure increased from 100 to 122 mmHg, and diastolic pressure decreased from 76 to 55 mmHg. When taking cardiac adaptations into account as well, systolic and diastolic pressure increased from 100 to 151 mmHg and decreased from 76 to 69 mmHg, respectively. Our results show that not only the arterial system, but also the heart, contributes to the changes in blood pressure during aging. The changes in arterial properties initiate a systolic pressure increase, which in turn initiates a cardiac remodelling process that further augments systolic pressure and mitigates the decrease in diastolic pressure.	[Maksuti, Elira; Broome, Michael] KTH Royal Inst Technol, Sch Technol & Hlth, Dept Med Engn, Stockholm, Sweden; [Maksuti, Elira] Karolinska Inst, Dept Clin Physiol, S-10401 Stockholm, Sweden; [Westerhof, Nico] Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Physiol, Amsterdam, Netherlands; [Westerhof, Nico] Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Pulm Dis, Amsterdam, Netherlands; [Westerhof, Berend E.] Crit Care Noninvas, Edwards Lifesci BMEYE, Amsterdam, Netherlands; [Westerhof, Berend E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Lab Clin Cardiovasc Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Broome, Michael] Karolinska Univ Hosp, ECMO Dept, Stockholm, Sweden; [Broome, Michael] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Stergiopulos, Nikos] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Lab Hemodynam & Cardiovasc Technol, Inst Bioengn, Lausanne, Switzerland	Royal Institute of Technology; Karolinska Institutet; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Edwards Lifesciences; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Maksuti, E (corresponding author), KTH Royal Inst Technol, Sch Technol & Hlth, Dept Med Engn, Stockholm, Sweden.; Maksuti, E (corresponding author), Karolinska Inst, Dept Clin Physiol, S-10401 Stockholm, Sweden.	elira.maksuti@sth.kth.se		Stergiopulos, Nikolaos/0000-0002-0519-0160; Maksuti, Elira/0000-0002-9654-447X	Swedish Research Council [2012-2800]; Hans Werthen scholarship from The Royal Swedish Academy of Engineering Sciences (IVA)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Hans Werthen scholarship from The Royal Swedish Academy of Engineering Sciences (IVA)	EM and MB were supported by Grant No 2012-2800 from the Swedish Research Council. EM was also supported by the Hans Werthen scholarship from The Royal Swedish Academy of Engineering Sciences (IVA).	Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; Berge HM, 2015, BRIT J SPORT MED, V49, P716, DOI 10.1136/bjsports-2014-093976; Biernacka A, 2011, AGING DIS, V2, P158; Borlaug BA, 2013, CIRC-HEART FAIL, V6, P944, DOI 10.1161/CIRCHEARTFAILURE.113.000383; Cain Peter A, 2009, BMC Med Imaging, V9, P2, DOI 10.1186/1471-2342-9-2; Carlsson M, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-51; Chirinos JA, 2012, HYPERTENSION, V60, P64, DOI 10.1161/HYPERTENSIONAHA.112.190710; Claessens TE, 2007, AM J PHYSIOL-HEART C, V292, pH856, DOI 10.1152/ajpheart.00759.2006; Cole RT, 2005, ANN BIOMED ENG, V33, P1555, DOI 10.1007/s10439-005-7785-1; Dhalla NS, 2012, HEART FAIL REV, V17, P671, DOI 10.1007/s10741-011-9278-7; Donker DW, 2007, AM J PHYSIOL-HEART C, V292, pH2324, DOI 10.1152/ajpheart.00392.2006; Franklin SS, 1997, CIRCULATION, V96, P308; Ganau A, 1995, J HYPERTENS, V13, P1818; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Herbert A, 2014, EUR HEART J, V35, P3122, DOI 10.1093/eurheartj/ehu293; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Ioannou CV, 2009, J VASC RES, V46, P417, DOI 10.1159/000194272; Kobayashi S, 1996, CIRCULATION, V94, P3362, DOI 10.1161/01.CIR.94.12.3362; KOSTIS JB, 1982, CIRCULATION, V65, P141, DOI 10.1161/01.CIR.65.1.141; LAKATTA EG, 1990, EUR HEART J, V11, P22, DOI 10.1093/eurheartj/11.suppl_C.22; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mitchell GF, 2008, HYPERTENSION, V51, P105, DOI 10.1161/HYPERTENSIONAHA.107.099721; Mynard JP, 2012, INT J NUMER METH BIO, V28, P626, DOI 10.1002/cnm.1466; O'Rourke MF, 2007, VASC MED, V12, P329, DOI 10.1177/1358863x07083392; Quinn U, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012024; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; SABA PS, 1995, J HYPERTENS, V13, P971, DOI 10.1097/00004872-199509000-00006; Scuteri A, 2014, HYPERTENSION, V64, P1219, DOI 10.1161/HYPERTENSIONAHA.114.04127; Segers P, 2000, AM J PHYSIOL-HEART C, V279, pH1120, DOI 10.1152/ajpheart.2000.279.3.H1120; Segers P, 2000, HYPERTENSION, V36, P760, DOI 10.1161/01.HYP.36.5.760; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Slotwiner DJ, 1998, AM J CARDIOL, V82, P621, DOI 10.1016/S0002-9149(98)00390-7; Stergiopulos N, 1996, AM J PHYSIOL-HEART C, V270, pH2050, DOI 10.1152/ajpheart.1996.270.6.H2050; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH81; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Vardoulis O, 2012, ANN BIOMED ENG, V40, P2619, DOI 10.1007/s10439-012-0600-x; Weber T, 2015, J HYPERTENS, V33, P1023, DOI 10.1097/HJH.0000000000000518; Wilkinson IB, 2001, HYPERTENSION, V38, P1461, DOI 10.1161/hy1201.097723; WILLEMS JL, 1970, CIRCULATION, V42, P37, DOI 10.1161/01.CIR.42.1.37	41	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157493	10.1371/journal.pone.0157493	http://dx.doi.org/10.1371/journal.pone.0157493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341106	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600007
J	Spensieri, F; Siena, E; Borgogni, E; Zedda, L; Cantisani, R; Chiappini, N; Schiavetti, F; Rosa, D; Castellino, F; Montomoli, E; Bodinham, CL; Lewis, DJ; Medini, D; Bertholet, S; Del Giudice, G				Spensieri, Fabiana; Siena, Emilio; Borgogni, Erica; Zedda, Luisanna; Cantisani, Rocco; Chiappini, Nico; Schiavetti, Francesca; Rosa, Domenico; Castellino, Flora; Montomoli, Emanuele; Bodinham, Caroline L.; Lewis, David J.; Medini, Duccio; Bertholet, Sylvie; Del Giudice, Giuseppe			Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; MEMORY TFH CELLS; B-CELLS; INFLUENZA; EXPRESSION; NONRESPONDERS; CORRELATE; VACCINES; TRIAL	CD4(+) T follicular helper cells (T-FH) have been identified as the T-cell subset specialized in providing help to B cells for optimal activation and production of high affinity antibody. We recently demonstrated that the expansion of peripheral blood influenza-specific CD4(+) IL-21(+) ICOS1(+) T helper (T-H) cells, three weeks after vaccination, associated with and predicted the rise of protective neutralizing antibodies to avian H5N1. In this study, healthy adults were vaccinated with plain seasonal trivalent inactivated influenza vaccine (TIIV), MF59 (R)-adjuvanted TIIV (ATIIV), or saline placebo. Frequencies of circulating CD4(+) T(FH)1 ICOS+ T-FH cells and H1N1-specific CD4(+-) IL-21(+) ICOS+ CXCR5(+) T-FH and CXCR5-T-H cell subsets were determined at various time points after vaccination and were then correlated with hemagglutination inhibition (HI) titers. All three CD4(+) T cell subsets expanded in response to TIIV and ATIIV, and peaked 7 days after vaccination. To demonstrate that these T-FH cell subsets correlated with functional antibody titers, we defined an alternative endpoint metric, decorrelated HI (DHI), which removed any correlation between day 28/day 168 and day 0 HI titers, to control for the effect of preexisting immunity to influenza vaccine strains. The numbers of total circulating CD4(+) T(FH)1 ICOS+ cells and of H1N1-specific CD4(+)IL-21(+)ICOS(+)CXCR5(+), measured at day 7, were significantly associated with day 28, and day 28 and 168 DHI titers, respectively. Altogether, our results show that CD4(+) T-FH subsets may represent valuable biomarkers of vaccine-induced long-term functional immunity.	[Spensieri, Fabiana; Siena, Emilio; Borgogni, Erica; Zedda, Luisanna; Cantisani, Rocco; Chiappini, Nico; Schiavetti, Francesca; Rosa, Domenico; Castellino, Flora; Medini, Duccio; Bertholet, Sylvie; Del Giudice, Giuseppe] Novartis Vaccines & Diagnost Srl, Siena, Italy; [Montomoli, Emanuele] Univ Siena, Dept Mol & Dev Med, Siena, Italy; [Montomoli, Emanuele] VisMederi Srl, Siena, Italy; [Bodinham, Caroline L.; Lewis, David J.] Univ Surrey, Surrey Clin Res Ctr, Guildford GU2 5XH, Surrey, England; [Spensieri, Fabiana; Siena, Emilio; Borgogni, Erica; Zedda, Luisanna; Chiappini, Nico; Schiavetti, Francesca; Rosa, Domenico; Medini, Duccio; Bertholet, Sylvie; Del Giudice, Giuseppe] GSK Vaccines Srl, Siena, Italy; [Cantisani, Rocco] Univ Hosp, Lab Immunohematol, Pisa, Italy; [Castellino, Flora] NHLBI, Ctr Human Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA	Novartis; University of Siena; University of Surrey; GlaxoSmithKline; University of Pisa; Azienda Ospedaliero Universitaria Pisana; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bertholet, S (corresponding author), Novartis Vaccines & Diagnost Srl, Siena, Italy.; Bertholet, S (corresponding author), GSK Vaccines Srl, Siena, Italy.	sylvie.c.bertholet-girardin@gsk.com	Medini, Duccio/Q-9556-2016; Cantisani, Rocco/K-2224-2018; MONTOMOLI, EMANUELE/Q-2122-2015	Medini, Duccio/0000-0001-6041-2603; Cantisani, Rocco/0000-0002-6836-3399; MONTOMOLI, EMANUELE/0000-0001-7595-4974	Innovative Medicines Initiative Joint Undertaking [115308]; European Union's Seventh Framework Programme; EFPIA companies'	Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme(European Commission); EFPIA companies'	These studies were funded by the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115308, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2010, VACCINE, V28, P4123, DOI 10.1016/j.vaccine.2010.04.030; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bentebibel SE, 2015, METHODS MOL BIOL, V1291, P187, DOI 10.1007/978-1-4939-2498-1_16; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lewis DJM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909406; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; MacLeod MKL, 2011, J IMMUNOL, V186, P2889, DOI 10.4049/jimmunol.1002955; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540	33	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157066	10.1371/journal.pone.0157066	http://dx.doi.org/10.1371/journal.pone.0157066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336786	Green Published, gold			2022-12-26	WOS:000378389200009
J	Tesarova, L; Simara, P; Stejskal, S; Koutna, I				Tesarova, Lenka; Simara, Pavel; Stejskal, Stanislav; Koutna, Irena			The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture	PLOS ONE			English	Article							EPIGENETIC MEMORY; SOMATIC-CELLS; DIFFERENTIATION; EXPRESSION	The potential clinical applications of human induced pluripotent stem cells (hiPSCs) are limited by genetic and epigenetic variations among hiPSC lines and the question of their equivalency with human embryonic stem cells (hESCs). We used MethylScreen technology to determine the DNA methylation profile of pluripotency and differentiation markers in hiPSC lines from different source cell types compared to hESCs and hiPSC source cells. After derivation, hiPSC lines compromised a heterogeneous population characterized by variable levels of aberrant DNA methylation. These aberrations were induced during somatic cell reprogramming and their levels were associated with the type of hiPSC source cells. hiPSC population heterogeneity was reduced during prolonged culture and hiPSCs acquired an hESC-like methylation profile. In contrast, the expression of differentiation marker genes in hiPSC lines remained distinguishable from that in hESCs. Taken together, in vitro culture facilitates hiPSC acquisition of hESC epigenetic characteristics. However, differences remain between both pluripotent stem cell types, which must be considered before their use in downstream applications.	[Tesarova, Lenka; Simara, Pavel; Stejskal, Stanislav; Koutna, Irena] Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic; [Tesarova, Lenka; Simara, Pavel; Koutna, Irena] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Tesarova, L (corresponding author), Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic.; Tesarova, L (corresponding author), St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic.	lenkatesarov@gmail.com	Stejskal, Stanislav/AAH-1411-2019; Koutná, Irena/H-9260-2016; Koutna, Irena/ABH-3539-2020; Simara, Pavel/K-8244-2013	Koutna, Irena/0000-0002-1680-5052; Simara, Pavel/0000-0001-7581-7048	Grant Agency of the Czech Republic [302/12/G157]; European Regional Development Fund (FNUSA-ICRC) [CZ.1.05/1.1.00/02.0123]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Regional Development Fund (FNUSA-ICRC)	This study was generously supported by Grant Agency of the Czech Republic (302/12/G157) and European Regional Development Fund (FNUSA-ICRC, No. CZ.1.05/1.1.00/02.0123).	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Garitaonandia I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118307; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Isagawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026052; Kang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131128; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Laskowski AI, 2012, CELL STEM CELL, V11, P732, DOI 10.1016/j.stem.2012.11.012; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Na J, 2014, PROTEIN CELL, V5, P569, DOI 10.1007/s13238-014-0073-9; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; SILVA AJ, 1993, DEV BIOL, V156, P391, DOI 10.1006/dbio.1993.1086; Simara P, 2014, FOLIA BIOL-PRAGUE, V60, P85; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesarova L, 2014, FOLIA BIOL-PRAGUE, V60, P90; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Yang CS, 2014, CELL REP, V8, P326, DOI 10.1016/j.celrep.2014.07.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	44	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157974	10.1371/journal.pone.0157974	http://dx.doi.org/10.1371/journal.pone.0157974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336948	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200077
J	Martin, PL; Yin, JJ; Seng, V; Casey, O; Corey, E; Morrissey, C; Simpson, RM; Kelly, K				Martin, P. L.; Yin, J-J; Seng, V.; Casey, O.; Corey, E.; Morrissey, C.; Simpson, R. M.; Kelly, K.			Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer	ONCOGENE			English	Article							MITOCHONDRIAL HEXOKINASES; MASS-SPECTROMETRY; PTEN; APOPTOSIS; GROWTH; AKT; MECHANISMS; RESISTANCE; TRANSITION; DELETION	Prostate cancer is characterized by a dependence upon androgen receptor (AR) signaling, and androgen deprivation therapy (ADT) is the accepted treatment for progressive prostate cancer. Although ADT is usually initially effective, acquired resistance termed castrate-resistant prostate cancer (CRPC) develops. PTEN and TP53 are two of the most commonly deleted or mutated genes in prostate cancer, the compound loss of which is enriched in CRPC. To interrogate the metabolic alterations associated with survival following ADT, we used an orthotopic model of Pten/Tp53 null prostate cancer. Metabolite profiles and associated regulators were compared in tumors from androgen-intact mice and in tumors surviving castration. AR inhibition led to changes in the levels of glycolysis and tricarboxylic acid (TCA) cycle pathway intermediates. As anticipated for inhibitory reciprocal feedback between AR and PI3K/AKT signaling pathways, pAKT levels were increased in androgen-deprived tumors. Elevated mitochondrial hexokinase 2 (HK2) levels and enzyme activities also were observed in androgen-deprived tumors, consistent with pAKT-dependent HK2 protein induction and mitochondrial association. Competitive inhibition of HK2-mitochondrial binding in prostate cancer cells led to decreased viability. These data argue for AKT-associated HK2-mediated metabolic reprogramming and mitochondrial association in PI3K-driven prostate cancer as one survival mechanism downstream of AR inhibition.	[Martin, P. L.; Yin, J-J; Seng, V.; Casey, O.; Kelly, K.] NCI, Lab Genitourinary Canc Pathogenesis, Ctr Canc Res, NIH, Bldg 37,Room 1068 A, Bethesda, MD 20892 USA; [Corey, E.; Morrissey, C.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Simpson, R. M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Martin, P. L.] Medimmune, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); AstraZeneca; Medimmune	Kelly, K (corresponding author), NCI, Lab Genitourinary Canc Pathogenesis, Ctr Canc Res, NIH, Bldg 37,Room 1068 A, Bethesda, MD 20892 USA.	kellyka@mail.nih.gov			Intramural Research Program; Center for Cancer Research; NCI; Pacific Northwest Prostate Cancer SPORE [P50CA97186]; PO1 NIH [PO1CA085859]; Richard M. LUCAS Foundation; NATIONAL CANCER INSTITUTE [P50CA097186, P01CA085859, ZIGBC010931] Funding Source: NIH RePORTER	Intramural Research Program; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PO1 NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. LUCAS Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciated the patients and their families who participated in the Prostate Cancer Donor Program. We thank the investigators Drs Robert Vessella, Celestia Higano, Bruce Montgomery, Evan Yu, Peter Nelson, Paul Lange, Martine Roudier and Lawrence True for their contributions to the University of Washington Medical Center Prostate Cancer Donor Rapid Autopsy Program. This research was supported by the Intramural Research Program, Center for Cancer Research, NCI and by the Pacific Northwest Prostate Cancer SPORE (P50CA97186), the PO1 NIH grant (PO1CA085859) and the Richard M. LUCAS Foundation.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Abou-Kheir W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026112; Agarwal S., 2015, CELL REP; American Cancer Society, 2015, CANC FACTS FIG 2015; ARORA KK, 1988, J BIOL CHEM, V263, P17422; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Bonizzi G, 2012, TRENDS MOL MED, V18, P6, DOI 10.1016/j.molmed.2011.08.002; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chaux A, 2012, MODERN PATHOL, V25, P1543, DOI 10.1038/modpathol.2012.104; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Craft N, 1999, CANCER RES, V59, P5030; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Gao H, 2006, CANCER RES, V66, P7929, DOI 10.1158/0008-5472.CAN-06-1637; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Jadvar H, 2013, J NUCL MED, V54, P1685, DOI 10.2967/jnumed.113.126094; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lotan TL, 2011, CLIN CANCER RES, V17, P6563, DOI 10.1158/1078-0432.CCR-11-1244; Lunardi A, 2013, NAT GENET, V45, P747, DOI 10.1038/ng.2650; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Martin P, 2011, AM J PATHOL, V179, P422, DOI 10.1016/j.ajpath.2011.03.035; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; McCall P, 2008, BRIT J CANCER, V99, P1296, DOI 10.1038/sj.bjc.6604680; McDunn JE, 2013, PROSTATE, V73, P1547, DOI 10.1002/pros.22704; Morrissey C, 2013, J BONE MINER RES, V28, P333, DOI 10.1002/jbmr.1749; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Priolo C, 2014, CANCER RES, V74, P7198, DOI 10.1158/0008-5472.CAN-14-1490; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P364, DOI 10.1038/cdd.2014.208; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Stenman K, 2011, BIOMARK INSIGHTS, V6, P39, DOI 10.4137/BMI.S6794; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Terry S, 2006, PROSTATE, V66, P1100, DOI 10.1002/pros.20446; Toivanen R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005688; Wang L, 2014, CELL REP, V8, P1461, DOI 10.1016/j.celrep.2014.07.053; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Wu RX, 2012, EMBO MOL MED, V4, P633, DOI 10.1002/emmm.201200240; Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010; Zong Y, 2013, NAT REV UROL, V10, P90, DOI [10.1038/nruro1.2012.237, 10.1038/nrurol.2012.237]	52	31	32	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					525	533		10.1038/onc.2016.223	http://dx.doi.org/10.1038/onc.2016.223			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27375016	Green Accepted			2022-12-26	WOS:000394166700009
J	Wang, J; Sinnett-Smith, J; Stevens, JV; Young, SH; Rozengurt, E				Wang, Jia; Sinnett-Smith, James; Stevens, Jan V.; Young, Steven H.; Rozengurt, Enrique			Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; G protein-coupled receptor (GPCR); protein kinase C (PKC); protein kinase D (PKD); yes-associated protein (YAP)	ACTIVATION LOOP SER(744); NUCLEAR EXPORT SIGNALS; HIPPO PATHWAY; IN-VIVO; DNA-SYNTHESIS; ANG-II; G(Q)-COUPLED RECEPTORS; LYSOPHOSPHATIDIC ACID; ANTITUMOR-ACTIVITY; PHORBOL ESTERS	We examined the regulation of Yes-associated protein (YAP) localization, phosphorylation, and transcriptional activity in intestinal epithelial cells. Our results show that stimulation of intestinal epithelial IEC-18 cells with the G protein-coupled receptor (GPCR) agonist angiotensin II, a potent mitogen for these cells, induced rapid translocation of YAP from the nucleus to the cytoplasm (within 15 min) and a concomitant increase in YAP phosphorylation at Ser(127) and Ser(397). Angiotensin II elicited YAP phosphorylation and cytoplasmic accumulation in a dose-dependent manner (ED50 = 0.3 nm). Similar YAP responses were provoked by stimulation with vasopressin or serum. Treatment of the cells with the protein kinase D (PKD) family inhibitors CRT0066101 and kb NB 142-70 prevented the increase in YAP phosphorylation on Ser(127) and Ser(397) via Lats2, YAP cytoplasmic accumulation, and increase in the mRNA levels of YAP/TEAD-regulated genes (Ctgf and Areg). Furthermore, siRNA-mediated knockdown of PKD1, PKD2, and PKD3 markedly attenuated YAP nuclear-cytoplasmic shuttling, phosphorylation at Ser(127), and induction of Ctgf and Areg expression in response to GPCR activation. These results identify a novel role for the PKD family in the control of biphasic localization, phosphorylation, and transcriptional activity of YAP in intestinal epithelial cells. In turn, YAP and TAZ are necessary for the stimulation of the proliferative response of intestinal epithelial cells to GPCR agonists that act via PKD. The discovery of interaction between YAP and PKD pathways identifies a novel cross-talk in signal transduction and demonstrates, for the first time, that the PKDs feed into the YAP pathway.	[Wang, Jia; Sinnett-Smith, James; Stevens, Jan V.; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Rozengurt, Enrique] Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Dept Med, Sch Med, 900 Vet Ave,Warren Hall Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [R01DK100405, P30DK41301, P01CA163200]; Department of Veterans Affair Grant [1I01BX001473]; Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK100405] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair Grant; Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01DK100405, P30DK41301, and P01CA163200, by Department of Veterans Affair Grant 1I01BX001473 (to E.R.), and by the Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research (to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Blake JF, 2012, J MED CHEM, V55, P8110, DOI 10.1021/jm301024w; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Collak FK, 2012, J BIOL CHEM, V287, P23698, DOI 10.1074/jbc.M112.358713; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gong R, 2015, CELL RES, V25, P985, DOI 10.1038/cr.2015.88; Guha S, 2002, CANCER RES, V62, P1632; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kim D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009616; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lee KW, 2015, CLIN CANCER RES, V21, P357, DOI 10.1158/1078-0432.CCR-14-1374; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ni Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073149; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Raufman JP, 2008, CANCER RES, V68, P3573, DOI 10.1158/0008-5472.CAN-07-6810; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rey O, 2003, J CELL PHYSIOL, V196, P483, DOI 10.1002/jcp.10323; Rey O, 2012, J BIOL CHEM, V287, P1158, DOI 10.1074/jbc.M111.274589; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Scholz RP, 2011, EXP CELL RES, V317, P496, DOI 10.1016/j.yexcr.2010.11.003; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shanzer M, 2015, ONCOGENE, V34, P4190, DOI 10.1038/onc.2014.347; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2014, AM J PHYSIOL-CELL PH, V306, pC961, DOI 10.1152/ajpcell.00048.2014; Sinnett-Smith J, 2011, J BIOL CHEM, V286, P511, DOI 10.1074/jbc.M110.167528; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Slice LW, 2005, J BIOL CHEM, V280, P1582, DOI 10.1074/jbc.M408172200; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Suh E, 1996, MOL CELL BIOL, V16, P619; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Waldron RT, 2012, CELL SIGNAL, V24, P914, DOI 10.1016/j.cellsig.2011.12.014; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Wu SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1432, DOI 10.1152/ajpcell.00323.2001; Young SH, 2006, AM J PHYSIOL-CELL PH, V290, pC728, DOI 10.1152/ajpcell.00310.2005; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Young SH, 2012, AM J PHYSIOL-GASTR L, V303, pG356, DOI 10.1152/ajpgi.00025.2012; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014	75	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17988	18005		10.1074/jbc.M115.711275	http://dx.doi.org/10.1074/jbc.M115.711275			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27369082	Green Published, hybrid			2022-12-26	WOS:000383241300041
J	Wittmann, A; Lamprinaki, D; Bowles, KM; Katzenellenbogen, E; Knirel, YA; Whitfield, C; Nishimura, T; Matsumoto, N; Yamamoto, K; Iwakura, Y; Saijo, S; Kawasaki, N				Wittmann, Alexandra; Lamprinaki, Dimitra; Bowles, Kristian M.; Katzenellenbogen, Ewa; Knirel, Yuriy A.; Whitfield, Chris; Nishimura, Takashi; Matsumoto, Naoki; Yamamoto, Kazuo; Iwakura, Yoichiro; Saijo, Shinobu; Kawasaki, Norihito			Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; lectin; lipopolysaccharide (LPS); polysaccharide; Toll-like receptor 4 (TLR4)	C-TYPE LECTIN; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; DENDRITIC CELLS; SERRATIA-MARCESCENS; STRUCTURAL-ANALYSIS; PRESENTING CELLS; RECEPTOR; POLYSACCHARIDE; IDENTIFICATION	LPS consists of a relatively conserved region of lipid A and core oligosaccharide and a highly variable region of O-antigen polysaccharide. Whereas lipid A is known to bind to the Toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD2) complex, the role of the O-antigen remains unclear. Here we report a novel molecular interaction between dendritic cell-associated C-type lectin-2 (Dectin-2) and mannosylated O-antigen found in a human opportunistic pathogen, Hafnia alvei PCM 1223, which has a repeating unit of [-Man-1,3-Man-1,2-Man-1,2-Man-1,2-Man-1,3-]. H. alvei LPS induced higher levels of TNF and IL-10 from mouse bone marrow-derived dendritic cells (BM-DCs), when compared with Salmonella enterica O66 LPS, which has a repeat of [-Gal-1,6-Gal-1,4-[Glc-1,3]GalNAc-1,3-GalNAc-1,3-]. In a cell-based reporter assay, Dectin-2 was shown to recognize H. alvei LPS. This binding was inhibited by mannosidase treatment of H. alvei LPS and by mutations in the carbohydrate-binding domain of Dectin-2, demonstrating that H. alvei LPS is a novel glycan ligand of Dectin-2. The enhanced cytokine production by H. alvei LPS was Dectin-2-dependent, because Dectin-2 knock-out BM-DCs failed to do so. This receptor cross-talk between Dectin-2 and TLR4 involved events including spleen tyrosine kinase (Syk) activation and receptor juxtaposition. Furthermore, another mannosylated LPS from Escherichia coli O9a also bound to Dectin-2 and augmented TLR4 activation of BM-DCs. Taken together, these data indicate that mannosylated O-antigens from several Gram-negative bacteria augment TLR4 responses through interaction with Dectin-2.	[Wittmann, Alexandra; Lamprinaki, Dimitra; Kawasaki, Norihito] Inst Food Res, Food & Hlth Inst Strateg Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England; [Bowles, Kristian M.] Univ East Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Katzenellenbogen, Ewa] Ludwik Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Nishimura, Takashi; Matsumoto, Naoki; Yamamoto, Kazuo; Kawasaki, Norihito] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Chiba 2780022, Japan; [Saijo, Shinobu] Chiba Univ, Dept Mol Immunol, Med Mycol Res Ctr, Chiba 2608673, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of East Anglia; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; University of Guelph; University of Tokyo; Tokyo University of Science; Chiba University	Kawasaki, N (corresponding author), Inst Food Res, Food & Hlth Inst Strateg Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	norihito.kawasaki@ifr.ac.uk	Saijo, Shinobu/I-1501-2017; Iwakura, Yoichiro/E-5457-2011; Knirel, Yuriy A/E-2058-2014	Saijo, Shinobu/0000-0002-3802-8821; Iwakura, Yoichiro/0000-0002-9934-5775; Bowles, Kristian/0000-0003-1334-4526; Lamprinaki, Dimitra/0000-0001-6959-4917	BBSRC [BBS/E/F/00044486]; Big C cancer research grant; European Union; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042723, BBS/E/F/00044486] Funding Source: researchfish; BBSRC [BBS/E/F/00042723] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Big C cancer research grant; European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC strategic core Grant BBS/E/F/00044486 (to the Institute of Food Research) and a Big C cancer research grant (to N. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Marie-Curie International Incoming Fellowship from the European Union 7th Framework Programme.	Akatsuka A, 2010, INT IMMUNOL, V22, P783, DOI 10.1093/intimm/dxq430; Aucken HM, 1996, FEMS MICROBIOL LETT, V138, P77; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Cardile AP, 2011, TRANSPL INFECT DIS, V13, P407, DOI 10.1111/j.1399-3062.2011.00600.x; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garcia-Vallejo JJ, 2014, J EXP MED, V211, P1457, DOI 10.1084/jem.20122192; Gavino ACP, 2005, EXP DERMATOL, V14, P281, DOI 10.1111/j.0906-6705.2005.00312.x; GORDEUK VR, 1992, BLOOD, V79, P1855; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Herget S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-35; Inagaki M, 2003, FEMS MICROBIOL LETT, V226, P221, DOI 10.1016/S0378-1097(03)00601-3; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Jiang LY, 2014, CARBOHYD RES, V397, P27, DOI 10.1016/j.carres.2014.07.022; Kanazawa N, 2004, J INVEST DERMATOL, V122, P1522, DOI 10.1111/j.0022-202X.2004.22602.x; Katzenellenbogen E, 2001, FEMS IMMUNOL MED MIC, V30, P223; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki N, 2014, J IMMUNOL, V193, P1560, DOI 10.4049/jimmunol.1303278; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Khanna A, 2013, J CLIN DIAGN RES, V7, P243, DOI 10.7860/JCDR/2013/5010.2737; Kocharova NA, 2001, CARBOHYD RES, V333, P335, DOI 10.1016/S0008-6215(01)00158-6; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; Lai CC, 2010, J HOSP INFECT, V76, P332, DOI 10.1016/j.jhin.2010.06.006; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Liu B, 2010, MICROBIOL-SGM, V156, P1642, DOI 10.1099/mic.0.037325-0; Lugowski Czeslaw, 1995, Acta Biochimica Polonica, V42, P51; Lukasiewicz J, 2010, J LIPID RES, V51, P564, DOI 10.1194/jlr.M001362; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Mann E, 2016, J BIOL CHEM, V291, P9748, DOI 10.1074/jbc.M116.719344; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mesci A, 2007, J IMMUNOL METHODS, V323, P78, DOI 10.1016/j.jim.2007.02.007; Michalski M, 2015, IMMUNOBIOLOGY, V220, P117, DOI 10.1016/j.imbio.2014.08.012; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Nagarjuna D., 2015, New Microbes and New Infections, V7, P57, DOI 10.1016/j.nmni.2015.05.006; Norimoto A, 2014, AM J RESP CELL MOL, V51, P201, DOI 10.1165/rcmb.2013-0522OC; Olsthoorn MMA, 1998, J BIOL CHEM, V273, P3817, DOI 10.1074/jbc.273.7.3817; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Parsons MW, 2014, J IMMUNOL, V192, P1361, DOI 10.4049/jimmunol.1301809; Pfrengle F, 2013, J IMMUNOL, V191, P1724, DOI 10.4049/jimmunol.1300921; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; PREHM P, 1976, EUR J BIOCHEM, V67, P53, DOI 10.1111/j.1432-1033.1976.tb10631.x; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rudick CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041273; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Tichaczek-Goska D, 2012, ADV CLIN EXP MED, V21, P289; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhao LJ, 2002, BLOOD, V100, P3233, DOI 10.1182/blood-2002-01-0252	71	24	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17629	17638		10.1074/jbc.M116.741256	http://dx.doi.org/10.1074/jbc.M116.741256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358401	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000383241300014
J	Amari, Y; Morimoto, S; Nakajima, F; Ando, T; Ichihara, A				Amari, Yoshifumi; Morimoto, Satoshi; Nakajima, Fumitaka; Ando, Takashi; Ichihara, Atsuhiro			Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							PRO RENIN RECEPTOR; RENIN/PRORENIN RECEPTOR; BLOOD-PRESSURE; ANGIOTENSIN; PHYSIOLOGY; EXPRESSION; CLEARANCE; PRORENIN	The (pro)renin receptor [(P)RR] is cleaved by furin to generate soluble (P)RR [s(P)RR], which reflects the status of the tissue renin-angiotensin system. Hemodialysis patients have advanced atherosclerosis. The aim of this study was to investigate the relationships between serum s(P)RR levels and background factors, including indices of atherosclerosis, in hemodialysis patients. Serum s(P)RR levels were measured in hemodialysis patients and clearance of s(P)RR through the membrane of the dialyzer was examined. Furthermore, relationships between serum s(P)RR levels and background factors were assessed. Serum s(P)RR levels were significantly higher in hemodialysis patients (30.4 +/- 6.1 ng/ml, n = 258) than those in subjects with normal renal function (21.4 +/- 6.2 ng/ml, n = 39, P < 0.0001). Clearance of s(P) RR and creatinine were 56.9 +/- 33.5 and 147.6 +/- 9.50 ml/min, respectively. Serum s(P) RR levels were significantly higher in those with ankle-brachial index (ABI) of < 0.9, an indicator of severe atherosclerosis, than those with ABI of >= 0.9 (32.2 +/- 5.9 and 30.1 +/- 6.2 ng/ml, respectively, P < 0.05). An association between low ABI and high serum s(P)RR levels was observed even after correction for age, history of smoking, HbA1c, and LDL-C. Serum s(P)RR levels were significantly higher in hemodialysis patients when compared with subjects with normal renal function, although s(P)RR is dialyzed to some extent, but to a lesser extent than creatinine. High serum s(P)RR levels may be associated with atherosclerosis independent of other risk factors, suggesting that serum s(P)RR could be used as a marker for atherosclerotic conditions in hemodialysis patients.	[Amari, Yoshifumi; Morimoto, Satoshi; Ando, Takashi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan; [Amari, Yoshifumi; Nakajima, Fumitaka] Moriguchi Keijinkai Hosp, Dept Nephrol, Osaka, Japan	Tokyo Women's Medical University	Morimoto, S (corresponding author), Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan.	smorimoto@endm.twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461258, 16K09657]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461258 and 16K09657 to S. M.)	Achard V, 2011, J ENDOCRINOL INVEST, V34, P840, DOI 10.3275/7627; Achard V, 2007, AM J PHYSIOL-REG I, V292, pR274, DOI 10.1152/ajpregu.00439.2005; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Hamada K, 2013, CLIN EXPT NEPHROLOGY; Hirose T, 2010, REGUL PEPTIDES, V159, P93, DOI 10.1016/j.regpep.2009.11.006; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2010, HYPERTENS RES, V33, P177, DOI 10.1038/hr.2009.214; Iseki K, 2011, CLIN EXP NEPHROL; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Lindsay RM, 2001, AM J KIDNEY DIS, V38, P565, DOI 10.1053/ajkd.2001.26874; Lowrie EG, 2004, KIDNEY INT, V66, P2077, DOI 10.1111/j.1523-1755.2004.00987.x; Maruyama Nobuhiro, 2013, Front Biosci (Elite Ed), V5, P583; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morimoto S, 2014, HYPERTENSION RES OFF; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2008, CURR OPIN PHARMACOL, V8, P127, DOI 10.1016/j.coph.2007.12.009; Nguyen G, 2014, HYPERTENSION, V63, P297, DOI 10.1161/HYPERTENSIONAHA.113.02217; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; Tsuchida K, 2011, CONTRIB NEPHROL, V173, P76, DOI 10.1159/000328957; van Eps CL, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-51; Watanabe N, 2013, J CLIN ENDOCR METAB, V98, P2528, DOI 10.1210/jc.2012-4139; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418; Weir MR, 1999, AM J HYPERTENS, V12, p205S; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253; Yurugi T, 2012, CLIN EXP NEPHROL, V16, P156, DOI 10.1007/s10157-011-0544-8	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158068	10.1371/journal.pone.0158068	http://dx.doi.org/10.1371/journal.pone.0158068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367528	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900017
J	Huang, M; Zhang, RC; Jiang, P; Xie, XB; Zhou, XF; Cao, FB; Zou, YB				Huang, Min; Zhang, Ruichun; Jiang, Peng; Xie, Xiaobing; Zhou, Xuefeng; Cao, Fangbo; Zou, Yingbin			Temperature-Related Yield Constraints of Early-Rice in South China: A Cross-Location Analysis	PLOS ONE			English	Article							CHLOROPHYLL METER; NIGHT TEMPERATURE; IRRIGATED RICE; USE EFFICIENCY; SUPER HYBRID; GRAIN-YIELD; DRY-MATTER; NITROGEN; MANAGEMENT; IMPACT	Warm temperature during post-heading is generally hypothesized to be the critical factor limiting grain yield of early-rice in South China. However, there is no direct evidence to confirm this hypothesis in the field. This study was conducted to determine the temperature-related yield constraints of early-rice in South China. Field experiments were carried out in Huaiji (a location in South China) and Changsha (a location in the Yangtze River basin) in 2011-2013. In each year, two rice cultivars were grown in early-rice growing season in Huaiji and in single-rice growing season in Changsha. Huaiji had higher average daily maximum temperature during post-heading than Changsha. The higher temperature during post-heading induced early plant senescence (slower crop growth rate and shorter grain filling duration), but grain weight did not reduce because it was compensated for by increased translocation of pre-heading biomass. The higher temperature during post-heading also did not cause a reduction in grain filling percentage. Huaiji had lower temperature during pre-heading than Changsha, which to some extent resulted in slower crop growth rate and consequently lower biomass production and smaller sink size in Huaiji than in Changsha. As a result, grain yield was about 30% lower in Huaiji than in Changsha. Our results indicate that grain yield of early-rice in South China is limited not by warm temperature during post-heading but partially by cool temperature during pre-heading, and suggest that enhancing sink size and meanwhile maintaining good translocation of pre-heading biomass may be an effective way to achieve high yield for early-rice in South China.	[Huang, Min; Zhang, Ruichun; Jiang, Peng; Xie, Xiaobing; Zhou, Xuefeng; Cao, Fangbo; Zou, Yingbin] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China; [Zhang, Ruichun] Hengyang Inst Agr Sci, Henyang, Peoples R China; [Jiang, Peng] Sichuan Acad Agr Sci, Rice & Sorghum Res Inst, Deyang, Peoples R China; [Jiang, Peng] Minist Agr, Key Lab Southwest Rice Biol & Genet Breeding, Deyang, Peoples R China	Hunan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS); Ministry of Agriculture & Rural Affairs	Huang, M (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China.	jxhuangmin@163.com		Huang, Min/0000-0002-6944-8538	Earmarked Fund for China Agriculture Research System [CARS-01]	Earmarked Fund for China Agriculture Research System	The work was supported by the Earmarked Fund for China Agriculture Research System (CARS-01).	[Anonymous], 1999, SOIL TAX BAS SYST SO; [Anonymous], 1994, BREAKING YIELD BARRI; Horie T, 1997, FIELD CROP RES, V52, P55, DOI 10.1016/S0378-4290(96)03458-2; Huang JL, 2008, FIELD CROP RES, V105, P70, DOI 10.1016/j.fcr.2007.07.006; Huang M, 2013, FIELD CROP RES, V146, P10, DOI 10.1016/j.fcr.2013.03.007; Huang Min, 2013, Australian Journal of Crop Science, V7, P600; Huang M, 2011, AGR SCI CHINA, V10, P1537, DOI 10.1016/S1671-2927(11)60149-1; Katsura K, 2008, FIELD CROP RES, V107, P1, DOI 10.1016/j.fcr.2007.12.007; Liu QH, 2013, CHIL J AGR RES, V73, P85, DOI 10.4067/S0718-58392013000200001; Liu ZH, 2013, J GEOGR SCI, V23, P1005, DOI 10.1007/s11442-013-1059-x; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; Mohammed AR, 2009, AGR FOREST METEOROL, V149, P999, DOI 10.1016/j.agrformet.2008.12.003; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; Peng ChangLian, 2005, Rice Science, V12, P179; Peng S, 1996, FIELD CROP RES, V47, P243, DOI 10.1016/0378-4290(96)00018-4; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Shi WJ, 2013, NEW PHYTOL, V197, P825, DOI 10.1111/nph.12088; Shimoda Seiji, 2011, Journal of Agricultural Meteorology, V67, P259, DOI 10.2480/agrmet.67.4.2; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tang L, 2009, NJAS-WAGEN J LIFE SC, V57, P83, DOI 10.1016/j.njas.2009.12.003; TASHIRO T, 1989, ANN BOT-LONDON, V64, P59, DOI 10.1093/oxfordjournals.aob.a087808; TASHIRO T, 1991, AUST J PLANT PHYSIOL, V18, P259, DOI 10.1071/PP9910259; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yin XH, 2012, RES CROP, V13, P809; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008	27	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158601	10.1371/journal.pone.0158601	http://dx.doi.org/10.1371/journal.pone.0158601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366908	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900043
J	Munhoz, AC; Riva, P; Simoes, D; Curi, R; Carpinelli, AR				Munhoz, Ana Claudia; Riva, Patricia; Simoes, Daniel; Curi, Rui; Carpinelli, Angelo Rafael			Control of Insulin Secretion by Production of Reactive Oxygen Species: Study Performed in Pancreatic Islets from Fed and 48-Hour Fasted Wistar Rats	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; NADPH OXIDASE ACTIVITY; BETA-CELL FUNCTION; SUPEROXIDE-PRODUCTION; OXIDATIVE STRESS; GLUCOSE-METABOLISM; GLUCAGON-SECRETION; MOUSE ISLETS; EXPRESSION; INHIBITION	Mitochondria and NADPH oxidase are important sources of reactive oxygen species in particular the superoxide radical (ROS) in pancreatic islets. These molecules derived from molecular oxygen are involved in pancreatic beta-cells signaling and control of insulin secretion. We examined the involvement of ROS produced through NADPH oxidase in the leucine-and/or glucose-induced insulin secretion by pancreatic islets from fed or 48-hour fasted rats. Glucose-stimulated insulin secretion (GSIS) in isolated islets was evaluated at low (2.8 mM) or high (16.7 mM) glucose concentrations in the presence or absence of leucine (20 mM) and/or NADPH oxidase inhibitors (VAS2870-20 mu M or diphenylene iodonium -DPI-5 mu M). ROS production was determined in islets treated with dihydroethidium (DHE) or MitoSOX Red reagent for 20 min and dispersed for fluorescence measurement by flow cytometry. NADPH content variation was examined in INS-1E cells (an insulin secreting cell line) after incubation in the presence of glucose (2.8 or 16.7 mM) and leucine (20 mM). At 2.8 mM glucose, VAS2870 and DPI reduced net ROS production (by 30%) and increased GSIS (by 70%) in a negative correlation manner (r = -0.93). At 16.7 mM glucose or 20 mM leucine, both NADPH oxidase inhibitors did not alter insulin secretion neither net ROS production. Pentose phosphate pathway inhibition by treatment with DHEA (75 mu M) at low glucose led to an increase in net ROS production in pancreatic islets from fed rats (by 40%) and induced a marked increase (by 144%) in islets from 48-hour fasted rats. The NADPH/NADP(+) ratio was increased when INS-1E cells were exposed to high glucose (by 4.3-fold) or leucine (by 3-fold). In conclusion, increased ROS production through NADPH oxidase prevents the occurrence of hypoglycemia in fasting conditions, however, in the presence of high glucose or high leucine levels, the increased production of NADPH and the consequent enhancement of the activity of the antioxidant defenses mitigate the excess of ROS production and allow the secretory process of insulin to take place.	[Munhoz, Ana Claudia; Riva, Patricia; Simoes, Daniel; Curi, Rui; Carpinelli, Angelo Rafael] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo	Munhoz, AC (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	anamunoz@icb.usp.br	Carpinelli, Angelo R/G-8566-2011; Curi, Rui/AAT-7970-2021	Carpinelli, Angelo R/0000-0002-0781-4934; Curi, Rui/0000-0001-5095-9154; Munhoz, Ana Claudia/0000-0002-7484-0518; de Jesus, Daniel/0000-0002-0828-0305	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (ARC, RC), http://www.capes.gov.br/; Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP) (DS), http://www.fapesp.br/; Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) (ACM, RC, ARC), http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Baillet A, 2011, FASEB J, V25, P2333, DOI 10.1096/fj.10-173807; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BOSBOOM RS, 1973, DIABETOLOGIA, V9, P243, DOI 10.1007/BF01221849; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; CARPINELLI AR, 1986, CELL BIOCHEM FUNCT, V4, P123, DOI 10.1002/cbf.290040208; CHENG HM, 1976, INVEST OPHTH VISUAL, V15, P279; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Costal F, 2013, DIABETES-METAB RES, V29, P296, DOI 10.1002/dmrr.2390; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Frederiks WM, 2007, J HISTOCHEM CYTOCHEM, V55, P975, DOI 10.1369/jhc.7A7222.2007; Fu JQ, 2013, PHARM RES-DORDR, V30, P2248, DOI 10.1007/s11095-013-1013-8; GIDDINGS SJ, 1993, AM J PHYSIOL, V265, pE259, DOI 10.1152/ajpendo.1993.265.2.E259; Graciano MF, 2013, ISLETS, V5, P139, DOI 10.4161/isl.25459; Hatanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058626; HEDESKOV CJ, 1974, BIOCHEMISTRY-US, V140, P423, DOI 10.1042/bj1400423; Hegde KR, 2010, MOL CELL BIOCHEM, V343, P101, DOI 10.1007/s11010-010-0503-9; Jin HM, 2013, ENDOCRINOLOGY, V154, P4068, DOI 10.1210/en.2013-1115; KORANYI L, 1992, DIABETOLOGIA, V35, P1125, DOI 10.1007/BF00401365; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Laurindo FRM, 2008, METHOD ENZYMOL, V441, P237, DOI 10.1016/S0076-6879(08)01213-5; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lucena CF, 2015, PANCREAS, V44, P287, DOI 10.1097/MPA.0000000000000249; MALAISSE WJ, 1967, AM J PHYSIOL, V213, P843, DOI 10.1152/ajplegacy.1967.213.4.843; Michalska M, 2010, BIOSCIENCE REP, V30, P445, DOI 10.1042/BSR20090138; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Zanquetta MM, 2006, METABOLISM, V55, P1538, DOI 10.1016/j.metabol.2006.06.026; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oliveira HR, 1999, AM J PHYSIOL-CELL PH, V276, pC507, DOI 10.1152/ajpcell.1999.276.2.C507; OLIVER JR, 1977, P SOC EXP BIOL MED, V154, P210, DOI 10.3181/00379727-154-39639; PERMUTT MA, 1975, FED PROC, V34, P1549; PINILLA M, 1981, ACTA BIOL MED GER, V40, P707; PRIETO JC, 1978, REV ESP FISIOL, V34, P291; Puleston Daniel, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot086298; RABINOVITCH A, 1976, J CLIN INVEST, V58, P1209, DOI 10.1172/JCI108574; RAPOPORT I, 1979, ACTA BIOL MED GER, V38, P901; Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010; Valle MMR, 2011, PANCREAS, V40, P390, DOI 10.1097/MPA.0b013e31820569d0; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Sarre A, 2012, FREE RADICAL BIO MED, V52, P142, DOI 10.1016/j.freeradbiomed.2011.10.437; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; SVENNINGSEN A, 1984, METABOLISM, V33, P612, DOI 10.1016/0026-0495(84)90058-1; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; TRENT DF, 1984, HORM RES, V19, P70, DOI 10.1159/000179869; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Veras K, 2014, FEBS OPEN BIO, V4, P141, DOI 10.1016/j.fob.2014.01.005; Wang LY, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/217670; Weaver JR, 2015, DIABETOLOGIA, V58, P113, DOI 10.1007/s00125-014-3398-2; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Zhang JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12846; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zraika S, 2006, DIABETOLOGIA, V49, P1254, DOI 10.1007/s00125-006-0212-9	59	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158166	10.1371/journal.pone.0158166	http://dx.doi.org/10.1371/journal.pone.0158166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362938	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200046
J	Surova, Y; Lampinen, B; Nilsson, M; Latt, J; Hall, S; Widner, H; van Westen, D; Hansson, O				Surova, Yulia; Lampinen, Bjorn; Nilsson, Markus; Latt, Jimmy; Hall, Sara; Widner, Hakan; van Westen, Danielle; Hansson, Oskar		Swedish BioFINDER Study	Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE-SYSTEM ATROPHY; IN-VIVO; MEAN DIFFUSIVITY; HUMAN BRAIN; DIAGNOSIS; MRI; VARIANT; MICROSTRUCTURE; DEGENERATION	In Parkinson's disease (PD), pathological microstructural changes occur and such changes might be detected using diffusion magnetic resonance imaging (dMRI). However, it is unclear whether dMRI improves PD diagnosis or helps differentiating between phenotypes, such as postural instability gait difficulty (PIGD) and tremor dominant (TD) PD. We included 105 patients with PD and 44 healthy controls (HC), all of whom underwent dMRI as part of the prospective Swedish BioFINDER study. Diffusion kurtosis imaging (DKI) and neurite density imaging (NDI) analyses were performed using regions of interest in the basal ganglia, the thalamus, the pons and the midbrain as well as tractography of selected white matter tracts. In the putamen, the PD group showed increased mean diffusivity (MD) (p =.003), decreased fractional anisotropy (FA) (p =.001) and decreased mean kurtosis (MK), compared to HC (p =.024). High MD and a low MK in the putamen were associated with more severe motor and cognitive symptomatology (p <.05). Also, patients with PIGD exhibited increased MD in the putamen compared to the TD patients (p =.009). In the thalamus, MD was increased (p =.001) and FA was decreased (p =.032) in PD compared to HC. Increased MD and decreased FA correlated negatively with motor speed and balance (p <.05). In the superior longitudinal fasciculus (SLF), MD (p =.019) and fiso were increased in PD compared to HC (p =.03). These changes correlated negatively with motor speed (p <.002) and balance (p <.037). However, most of the observed changes in PD were also present in cases with either multiple system atrophy (n = 11) or progressive supranuclear palsy (n = 10). In conclusion, PD patients exhibit microstructural changes in the putamen, the thalamus, and the SLF, which are associated with worse disease severity. However, the dMRI changes are not sufficiently specific to improve the diagnostic work-up of PD. Longitudinal studies should evaluate whether dMRI measures can be used to track disease progression.	[Surova, Yulia; Hall, Sara; Widner, Hakan; van Westen, Danielle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Surova, Yulia; Hall, Sara; Widner, Hakan] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Lampinen, Bjorn] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [Nilsson, Markus; van Westen, Danielle] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Latt, Jimmy] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [Hansson, Oskar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Surova, Y (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.; Surova, Y (corresponding author), Skane Univ Hosp, Dept Neurol, Lund, Sweden.	yulia.surova@med.lu.se	Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Hansson, Oskar/0000-0001-8467-7286; van Westen, Danielle/0000-0001-8649-9874; Nilsson, Markus/0000-0002-3140-8223	European Research Council; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society [CAN 2009/1076]; Swedish Foundation for Strategic Research [AM13-0090]; Swedish Federal Government under the ALF Agreement	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Federal Government under the ALF Agreement	The study was supported by the European Research Council, the Swedish Research Council, The Parkinson Foundation of Sweden, the Swedish Brain Foundation, the Swedish Cancer Society (grant no. CAN 2009/1076), the Swedish Foundation for Strategic Research (AM13-0090), and the Swedish Federal Government under the ALF Agreement. The funding sources had no role in the design and conduct of the study; in the collection, analysis, interpretation of the data; or in the preparation, review, or approval of the manuscript.	Andersson JLR, 2007, REPORT NO FMRIB TECH; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eden M, 2002, CONCEPTS MAGNETIC A, V18, P24; Erbetta A, 2009, AM J NEURORADIOL, V30, P1482, DOI 10.3174/ajnr.A1615; Eriksson S, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4913502; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Farina E, 2000, EUR J NEUROL, V7, P259, DOI 10.1046/j.1468-1331.2000.00066.x; Fregly AR., 1974, HDB SENSORY PHYSL, P321; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; Hess CP, 2014, AM J NEURORADIOL, V35, P897, DOI 10.3174/ajnr.A3832; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kamagata K, 2016, EUR RADIOL, V26, P2567, DOI 10.1007/s00330-015-4066-8; Kamagata K, 2014, NEURORADIOLOGY, V56, P251, DOI 10.1007/s00234-014-1327-1; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kim HJ, 2013, NEUROSCI LETT, V550, P64, DOI 10.1016/j.neulet.2013.06.050; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Lampinen B, 2015, P ISMRM, P2772; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; Levin J, 2014, ACTA NEUROPATHOL, V127, P779, DOI 10.1007/s00401-014-1265-3; Lim LIIK, 2005, PARKINSONISM RELAT D, V11, P19, DOI 10.1016/j.parkreldis.2004.06.003; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meijer FJA, 2015, NEURORADIOLOGY, V57, P655, DOI 10.1007/s00234-015-1515-7; Nicoletti G, 2006, BRAIN, V129, P2679, DOI 10.1093/brain/awl166; Nielsen NP, 2004, PERCEPT MOTOR SKILL, V99, P1201, DOI 10.2466/PMS.99.7.1201-1204; Nilsson M, 2014, P ISMRM, P2569; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; Paviour DC, 2007, MOVEMENT DISORD, V22, P68, DOI 10.1002/mds.21204; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Perrone D, 2015, NEUROIMAGE, V120, P441, DOI 10.1016/j.neuroimage.2015.06.068; Piattella MC, 2015, J NEUROL, V262, P1850, DOI 10.1007/s00415-015-7779-3; Planetta PJ, 2013, AM J NEURORADIOL, V34, P74, DOI 10.3174/ajnr.A3178; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Saini J, 2012, NEURORADIOLOGY, V54, P771, DOI 10.1007/s00234-011-0983-7; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Schwab R.S., 1969, 3 S PARK DIS, P152; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Stebbins GT, 2004, NEUROLOGY, V63, P1409; Surova Y, 2015, NEURORADIOLOGY, V57, P1079, DOI 10.1007/s00234-015-1563-z; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Veraart J, 2016, MAGN RESON MED, V76, P301, DOI 10.1002/mrm.25866; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Weingarten CP, 2015, NEUROSCI BIOBEHAV R, V59, P16, DOI 10.1016/j.neubiorev.2015.09.007; Youn J, 2015, PARKINSONISM RELAT D, V21, P12, DOI 10.1016/j.parkreldis.2014.10.003; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256	72	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157755	10.1371/journal.pone.0157755	http://dx.doi.org/10.1371/journal.pone.0157755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362763	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200022
J	Su, ZH; Zhang, ML				Su, Zhi-Hao; Zhang, Ming-Li			Evolutionary History of a Desert Shrub Ephedra przewalskii (Ephedraceae): Allopatric Divergence and Range Shifts in Northwestern China	PLOS ONE			English	Article							NORTH-WESTERN CHINA; GLACIAL REFUGIA; TARIM BASIN; GENETIC CONSEQUENCES; POPULATION-GROWTH; DNA POLYMORPHISM; CHLOROPLAST DNA; SEQUENCE DATA; PHYLOGEOGRAPHY; QUATERNARY	Based on two chloroplast DNA sequences, psbA-trnH and trnT-trnF, phylogeographical patterns of a desert shrub, Ephedra przewalskii, were examined across most of its geographic range in northwestern China. A total of sixteen haplotypes were detected. There was a common haplotype in each basin, that was haplotype A in Tarim Basin, haplotype G in Junggar Basin, and haplotype M in Qaidam Basin. Genetic variance mainly occurred among populations, geographic regions, and eleven geographic groups subdivided by SAMOVA analysis. E. przewalskii likely had a smaller and more fragmented geographic range during the Last Glacial Maximum, which was determined based on ecological niche modelling. Three groups of E. przewalskii populations were detected to have experience range expansion, and this was based on significant values of Fu's F-S, Tajima's D, and unimodel mismatch distributions. The cold and dry climate during the glacial period of the Quaternary is postulated to have been a driver for significant genetic isolation and divergence among populations or groups in E. przewalskii, whereas the warmer and wetter climate during the interglacial period is speculated to have provided favourable conditions for range expansion of the species.	[Su, Zhi-Hao; Zhang, Ming-Li] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.; Zhang, ML (corresponding author), Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China.	zhangml@ibcas.ac.cn			China National Key Basic Research Program [2014CB954201]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Key Basic Research Program(National Basic Research Program of China); Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by China National Key Basic Research Program (2014CB954201) to MLZ, and Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences to MLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2009, GLOBAL ECOL BIOGEOGR, V18, P223, DOI 10.1111/j.1466-8238.2008.00439.x; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; Clegg MT, 1992, MOL SYSTEMATICS PLAN, P2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; [党荣理 Dang Rongli], 2002, [广西植物, Guihaia], V22, P121; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fu LG, 1999, FLORA CHINA, V4, P98; Fu YX, 1997, GENETICS, V147, P915; Guo Z.T., 1999, QUAT SCI, V19, P556; Guu YP, 2010, J SYST EVOL, V48, P153, DOI 10.1111/j.1759-6831.2010.00073.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Li WY, 1998, CHINESE QUATERNARY V; Li ZH, 2012, J SYST EVOL, V50, P351, DOI 10.1111/j.1759-6831.2012.00201.x; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Ma SM, 2012, AUST J BOT, V60, P20, DOI 10.1071/BT11055; Marske KA, 2011, MOL PHYLOGENET EVOL, V59, P89, DOI 10.1016/j.ympev.2011.01.005; Mellick R, 2012, J BIOGEOGR, V39, P2292, DOI 10.1111/j.1365-2699.2012.02747.x; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Shi YF, 2005, QUATERNARY GLACIATIO, P99; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SLATKIN M, 1991, GENETICS, V129, P555; Smith CI, 2005, MOL ECOL, V14, P1025, DOI 10.1111/j.1365-294X.2005.02472.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Su ZH, 2016, CONSERV GENET, V17, P485, DOI 10.1007/s10592-015-0798-x; Su ZH, 2013, BIOL J LINN SOC, V109, P757, DOI 10.1111/bij.12088; Su ZH, 2012, PLANT SYST EVOL, V298, P1767, DOI 10.1007/s00606-012-0677-6; Sun JM, 2008, QUATERNARY SCI REV, V27, P1012, DOI 10.1016/j.quascirev.2008.01.011; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Williams MA, 1993, QUATERNARY ENV; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu .Z.Y., 2010, FLORISTICS SEED PLAN; Xu XK, 2010, BOREAS, V39, P215, DOI 10.1111/j.1502-3885.2009.00118.x; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zheng HB, 2003, TECTONOPHYSICS, V375, P49, DOI 10.1016/S0040-1951(03)00333-0; 方小敏, 1997, 科学通报, V42, P2521; 奚晓霞, 1998, 沉积学报, V16, P155	73	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158284	10.1371/journal.pone.0158284	http://dx.doi.org/10.1371/journal.pone.0158284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351630	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900051
J	Suenami, S; Paul, RK; Takeuchi, H; Okude, G; Fujiyuki, T; Shirai, K; Kubo, T				Suenami, Shota; Paul, Rajib Kumar; Takeuchi, Hideaki; Okude, Genta; Fujiyuki, Tomoko; Shirai, Kenichi; Kubo, Takeo			Analysis of the Differentiation of Kenyon Cell Subtypes Using Three Mushroom Body-Preferential Genes during Metamorphosis in the Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							PUTATIVE TRANSCRIPTION FACTOR; PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; OLFACTORY MEMORY; PHOSPHOLIPASE-C; MESSENGER-RNA; EXPRESSION; BRAIN; BODIES; BEE	The adult honeybee (Apis mellifera L.) mushroom bodies (MBs, a higher center in the insect brain) comprise four subtypes of intrinsic neurons: the class-I large-, middle-, and small-type Kenyon cells (lKCs, mKCs, and sKCs, respectively), and class-II KCs. Analysis of the differentiation of KC subtypes during metamorphosis is important for the better understanding of the roles of KC subtypes related to the honeybee behaviors. In the present study, aiming at identifying marker genes for KC subtypes, we used a cDNA microarray to comprehensively search for genes expressed in an MB-preferential manner in the honeybee brain. Among the 18 genes identified, we further analyzed three genes whose expression was enriched in the MBs: phospholipase C epsilon (PLCe), synaptotagmin 14 (Syt14), and discs large homolog 5 (dlg5). Quantitative reverse transcription-polymerase chain reaction analysis revealed that expression of PLCe, Syt14, and dlg5 was more enriched in the MBs than in the other brain regions by approximately 31-, 6.8-, and 5.6-fold, respectively. In situ hybridization revealed that expression of both Syt14 and dlg5 was enriched in the lKCs but not in the mKCs and sKCs, whereas expression of PLCe was similar in all KC subtypes (the entire MBs) in the honeybee brain, suggesting that Syt14 and dlg5, and PLCe are available as marker genes for the lKCs, and all KC subtypes, respectively. In situ hybridization revealed that expression of PLCe is already detectable in the class-II KCs at the larval fifth instar feeding stage, indicating that PLCe expression is a characteristic common to the larval and adult MBs. In contrast, expression of both Syt14 and dlg5 became detectable at the day three pupa, indicating that Syt14 and dlg5 expressions are characteristic to the late pupal and adult MBs and the lKC specific molecular characteristics are established during the late pupal stages.	[Suenami, Shota; Paul, Rajib Kumar; Takeuchi, Hideaki; Okude, Genta; Fujiyuki, Tomoko; Shirai, Kenichi; Kubo, Takeo] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.	stkubo@bs.s.u-tokyo.ac.jp	Fujiyuki, Tomoko Kaito/GYD-6398-2022; KUBO, TAKEO/G-4951-2014; Takeuchi, Hideaki/W-6739-2018	Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Takeuchi, Hideaki/0000-0001-6610-3895	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26291068]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for Scientific Research [(B) 26291068] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Akiko Wakamoto (DNA Chip Research Inc) for her support to prepare the cDNA microarray. We also thank Mr. Hiroki Kohno and Dr. Takayuki Ueno for their gifting us primers and standard samples in quantification of gapdh and Mblk-1, respectively. This work was supported by the Grant-in-Aid for Scientific Research [(B) 26291068] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya GH, 2015, CHEM SENSES, V40, P233, DOI 10.1093/chemse/bjv001; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Doi H, 2011, AM J HUM GENET, V89, P320, DOI 10.1016/j.ajhg.2011.07.012; Eisenhardt D, 2001, INSECT MOL BIOL, V10, P173, DOI 10.1046/j.1365-2583.2001.00252.x; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Farris SM, 2004, J COMP NEUROL, V474, P325, DOI 10.1002/cne.20146; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fukuda M, 2003, J BIOCHEM, V133, P641, DOI 10.1093/jb/mvg082; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gehring KB, 2016, J COMP NEUROL, V524, P1165, DOI 10.1002/cne.23894; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; Kaneko K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071732; Kaneko K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009213; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kobayashi M, 2006, P NATL ACAD SCI USA, V103, P14417, DOI 10.1073/pnas.0606571103; Kurshan PT, 2003, J COMP NEUROL, V466, P91, DOI 10.1002/cne.10864; Leboulle G, 2013, INSECT BIOCHEM MOLEC, V43, P959, DOI 10.1016/j.ibmb.2013.07.006; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Mobbs P.G., 1985, P299; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Moda LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064815; Mustard JA, 2005, J COMP NEUROL, V483, P66, DOI 10.1002/cne.20420; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Park JM, 2003, J BIOL CHEM, V278, P18689, DOI 10.1074/jbc.M300486200; Park JM, 2002, BIOCHEM BIOPH RES CO, V291, P23, DOI 10.1006/bbrc.2002.6397; Paul RK, 2005, INSECT MOL BIOL, V14, P9, DOI 10.1111/j.1365-2583.2004.00524.x; Quintero-Rivera F, 2007, AM J MED GENET A, V143A, P558, DOI 10.1002/ajmg.a.31618; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Roat TC, 2010, J BIOSCIENCES, V35, P415, DOI 10.1007/s12038-010-0047-x; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Rybak J, 1998, LEARN MEMORY, V5, P133; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sen Sarma M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006408; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Takeuchi H, 2004, CELL TISSUE RES, V316, P281, DOI 10.1007/s00441-004-0865-y; Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; Ugajin A, 2013, FEBS LETT, V587, P3224, DOI 10.1016/j.febslet.2013.08.014; Uno Y, 2013, INSECT MOL BIOL, V22, P52, DOI 10.1111/imb.12002; Uno Y, 2007, FEBS LETT, V581, P97, DOI 10.1016/j.febslet.2006.12.004; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; VONFRISCH K, 1967, SCIENCE, V158, P1072; Wang SHJ, 2014, J NEUROSCI, V34, P12745, DOI 10.1523/JNEUROSCI.1280-14.2014; WEIS K, 1994, J BIOL CHEM, V269, P19142; Winston M. L, 1986, BIOL HONEYBEE; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016	64	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157841	10.1371/journal.pone.0157841	http://dx.doi.org/10.1371/journal.pone.0157841			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351839	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900020
J	Woo, YJ; Wang, T; Guadalupe, T; Nebel, RA; Vino, A; Del Bene, VA; Molholm, S; Ross, LA; Zwiers, MP; Fisher, SE; Foxe, JJ; Abrahams, BS				Woo, Young Jae; Wang, Tao; Guadalupe, Tulio; Nebel, Rebecca A.; Vino, Arianna; Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Zwiers, Marcel P.; Fisher, Simon E.; Foxe, John J.; Abrahams, Brett S.			A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; COPY NUMBER VARIANTS; RECURRENT MICRODELETIONS; CEREBRAL-CORTEX; SEVERE SPEECH; SCHIZOPHRENIA; BRAIN; GENE; PROTEIN; RISK	Copy number variants (CNVs) at the Breakpoint 1 to Breakpoint 2 region at 15q11.2 (BP1-2) are associated with language-related difficulties and increased risk for developmental disorders in which language is compromised. Towards underlying mechanisms, we investigated relationships between single nucleotide polymorphisms (SNPs) across the region and quantitative measures of human brain structure obtained by magnetic resonance imaging of healthy subjects. We report an association between rs4778298, a common variant at CYFIP1, and inter-individual variation in surface area across the left supramarginal gyrus (Ih.SMG), a cortical structure implicated in speech and language in independent discovery (n = 100) and validation cohorts (n = 2621). In silico analyses determined that this same variant, and others nearby, is also associated with differences in levels of CYFIP1 mRNA in human brain. One of these nearby polymorphisms is predicted to disrupt a consensus binding site for FOXP2, a transcription factor implicated in speech and language. Consistent with a model where FOXP2 regulates CYFIP1 levels and in turn influences Ih.SMG surface area, analysis of publically available expression data identified a relationship between expression of FOXP2 and CYFIP1 mRNA in human brain. We propose that altered CYFIP1 dosage, through aberrant patterning of the Ih.SMG, may contribute to language-related difficulties associated with BP1-2 CNVs. More generally, this approach may be useful in clarifying the contribution of individual genes at CNV risk loci.	[Woo, Young Jae; Nebel, Rebecca A.; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Wang, Tao] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Guadalupe, Tulio; Vino, Arianna; Zwiers, Marcel P.; Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Foxe, John J.] Albert Einstein Coll Med, CERC, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, Bronx, NY USA; [Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Foxe, John J.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Foxe, John J.] Nathan S Kline Inst Psychiat Res, Cognit Neurophysiol Lab, Orangeburg, NY USA; [Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Foxe, John J.; Abrahams, Brett S.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Max Planck Society; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Radboud University Nijmegen; Nathan Kline Institute for Psychiatric Research; Yeshiva University; Albert Einstein College of Medicine	Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.; Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	brett.abrahams@einstein.yu.edu	Zwiers, Marcel P/D-2968-2009; Del Bene, Victor/AAD-8017-2021; Fisher, Simon E./E-9130-2012	Zwiers, Marcel P/0000-0001-5483-2935; Fisher, Simon E./0000-0002-3132-1996; Molholm, Sophie/0000-0002-0094-4015; Woo, Young/0000-0002-9233-5099	Einstein New Investigator Award; IDDRC pilot [P30HD071593]; Autism Center of Excellence [9R01 MH100027]; Training Program in Cellular and Molecular Biology and Genetics [T32GM007491]; Biobanking and Biomolecular Resources Research Infrastructure Netherlands; Hersenstichting Nederland; Netherlands Organisation for Scientific Research; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	Einstein New Investigator Award; IDDRC pilot; Autism Center of Excellence; Training Program in Cellular and Molecular Biology and Genetics; Biobanking and Biomolecular Resources Research Infrastructure Netherlands; Hersenstichting Nederland; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by an Einstein New Investigator Award (www.einstein.yu.edu), an IDDRC pilot (P30HD071593, www.nichd.nih.gov), and a subcontract from an Autism Center of Excellence (9R01 MH100027, www.nimh.nih.gov) to BSA. Support for RAN was provided through the Training Program in Cellular and Molecular Biology and Genetics (T32GM007491, www.nigms.nih.gov). The Cognomics Initiative (www.cognomics.nl/) is supported by participating groups in Nijmegen and funds from the Biobanking and Biomolecular Resources Research Infrastructure Netherlands (www.bbmri.eu), the Hersenstichting Nederland (www.hersenstichting.nl), and the Netherlands Organisation for Scientific Research (www.nwo.nl/en). TG, AV and SEF are supported by the Max Planck Society (www.mpi.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone D, 2008, SCHIZOPHR RES, V101, P124, DOI 10.1016/j.schres.2008.01.005; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bittel DC, 2006, PEDIATRICS, V118, pE1276, DOI 10.1542/peds.2006-0424; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Chaste P, 2014, AUTISM RES, V7, P355, DOI 10.1002/aur.1378; Chung L, 2015, BRAIN RES, V1629, P340, DOI 10.1016/j.brainres.2015.10.015; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dufor O, 2007, NEUROIMAGE, V34, P1692, DOI 10.1016/j.neuroimage.2006.10.034; Ecker C, 2014, NAT REV NEUROL, V10, P82, DOI 10.1038/nrneurol.2013.276; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Graham SA, 2013, CURR OPIN NEUROBIOL, V23, P43, DOI 10.1016/j.conb.2012.11.006; Guadalupe T, 2015, CORTEX, V62, P41, DOI 10.1016/j.cortex.2014.07.015; Guadalupe T, 2014, HUM BRAIN MAPP, V35, P3277, DOI 10.1002/hbm.22401; Guadalupe T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00261; Guo WB, 2015, SCHIZOPHRENIA BULL, V41, P57, DOI 10.1093/schbul/sbu126; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; Jahn JA, 2014, EPILEPSY RES, V108, P109, DOI 10.1016/j.eplepsyres.2013.10.001; Jiang YW, 2012, HUM GENET, V131, P1217, DOI 10.1007/s00439-012-1149-3; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liegeois Frederique, 2014, Curr Dev Disord Rep, V1, P215; Linkersdorfer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043122; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mullen SA, 2013, NEUROLOGY, V81, P1507, DOI 10.1212/WNL.0b013e3182a95829; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Oguro-Ando A, 2015, MOL PSYCHIATR, V20, P1069, DOI 10.1038/mp.2014.124; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, R LANG ENV STAT COMP; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Ruff S, 2002, NEUROREPORT, V13, P1285, DOI 10.1097/00001756-200207190-00014; Sandelin Albin, 2003, Functional & Integrative Genomics, V3, P125, DOI 10.1007/s10142-003-0086-6; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Sliwinska MW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00161; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Temple E, 2002, CURR OPIN NEUROBIOL, V12, P178, DOI 10.1016/S0959-4388(02)00303-3; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Waltes R, 2014, HUM GENET, V133, P781, DOI 10.1007/s00439-013-1416-y; Wang J, 2015, ANN HUM GENET, V79, P329, DOI 10.1111/ahg.12121; Xie H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109749; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197	71	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158036	10.1371/journal.pone.0158036	http://dx.doi.org/10.1371/journal.pone.0158036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351196	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900026
J	Mills, KE; Robbins, J; von Keyserlingk, MAG				Mills, Katelyn E.; Robbins, Jesse; von Keyserlingk, Marina A. G.			Tail Docking and Ear Cropping Dogs: Public Awareness and Perceptions	PLOS ONE			English	Article							WARMTH; PERSONALITY; STEREOTYPE; BEHAVIOR; PETS	Tail docking and ear cropping are two surgical procedures commonly performed on many dog breeds. These procedures are classified as medically unnecessary surgeries whose purpose is primarily cosmetic. Available attitude research surrounding these controversial practices has been limited to surveys of veterinarians and dog breeders familiar with both practices. The aim of this project was to: 1) assess public awareness of tail docking and ear cropping, 2) determine whether physical alteration of a dog affects how the dog, and 3) owner are perceived. In Experiment 1 awareness was measured using a combination of both explicit and implicit measures. We found that 42% of participants (n = 810) were unable to correctly explain the reason why tail docked and ear cropped dogs had short ears and tails. Similarly, an implicit measure of awareness ('nature vs nurture task'), found that the majority of participants believed short tails and erect ears were a consequence of genetics rather than something the owner or breeder had done. The results obtained in Experiment 2 (n = 392) provide evidence that ear cropped and tail docked dogs are perceived differently than an identical dog in its 'natural' state. Modified dogs were perceived as being more aggressive, more dominant, less playful and less attractive than natural dogs. Experiment 3 (n = 410) is the first evidence that owners of modified dogs are perceived as being more aggressive, more narcissistic, less playful, less talkative and less warm compared to owners of natural dogs. Taken together, these results suggest that although a significant proportion of subjects appear unaware of the practices of tail docking and ear cropping in dogs, these procedures have significant impacts on how modified dogs and their owners are perceived by others.	[Mills, Katelyn E.; Robbins, Jesse; von Keyserlingk, Marina A. G.] Univ British Columbia, Anim Welf Program, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	von Keyserlingk, MAG (corresponding author), Univ British Columbia, Anim Welf Program, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada.	nina@mail.ubc.ca	von Keyserlingk, Marina/AAB-6353-2019; Mills, Katelyn/AAH-3137-2019	von Keyserlingk, Marina/0000-0002-1427-3152; Mills, Katelyn/0000-0001-7296-9214	UBC Animal Welfare Program	UBC Animal Welfare Program	This work was funded through generous donations to the UBC Animal Welfare Program.	American Kennel Club, 2013, MOST POP DOG BREEDS, V1, P22; American Society of the Prevention of Cruelty to Animals, 2015, PET STAT, V8, P13; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Ashton-James CE, 2014, PAIN, V155, P2656, DOI 10.1016/j.pain.2014.09.031; Australian Veterinary Association, SURG ALT NAT STAT AN; Belk R., 1982, ADV CONSUM RES, V9, P523; Bennett PC, 2003, AUST VET J, V81, P208, DOI 10.1111/j.1751-0813.2003.tb11473.x; Bollen KS, 2008, APPL ANIM BEHAV SCI, V112, P120, DOI 10.1016/j.applanim.2007.07.007; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Council of Europe, 1987, EUR CONV PROT PET AN; Cuddy AJC, 2004, J SOC ISSUES, V60, P701, DOI 10.1111/j.0022-4537.2004.00381.x; Diesel G, 2010, VET REC, V166, P812, DOI 10.1136/vr.b4880; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fox M, 2010, LAW CULT HUMANIT, V6, P37, DOI 10.1177/1743872109348990; Fratkin JL, 2013, ANTHROZOOS, V26, P125, DOI 10.2752/175303713X13534238631632; Ghirlanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074770; Ramirez MTG, 2014, ANTHROZOOS, V27, P351, DOI 10.2752/175303714X13903827487926; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Henderson R, 2003, TXB SMALL ANIMAL SUR, V1, P1737; Herzog H., 2001, STATE ANIMALS, P55; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Hill C., 2012, FORBES MAGAZINE; Jones A. C, 2009, THESIS; Konrath S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103469; Ley J, 2008, J VET BEHAV, V3, P182, DOI DOI 10.1016/J.JVEB.2007.12.004; Mills KE, 2016, JAVMA-J AM VET MED A, V248, P162, DOI 10.2460/javma.248.2.162; Momement KM, 2010, J APPL ANIM WELF SCI, V13, P1661; Nakajima S, 2009, ANTHROZOOS, V22, P173, DOI 10.2752/175303709X434194; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; Noonan GJ, 1996, AUST VET J, V73, P86, DOI 10.1111/j.1751-0813.1996.tb09982.x; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Park S, 2014, J PERS, P279; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pedersen N, 2013, J ANIM BREED GENET, V130, P236, DOI 10.1111/jbg.12017; Roy MM, 2004, PSYCHOL SCI, V15, P361, DOI 10.1111/j.0956-7976.2004.00684.x; Stephen J, 2007, APPL ANIM BEHAV SCI, V107, P88, DOI 10.1016/j.applanim.2006.09.012; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Swabe J, 2000, COMPANION ANIMALS AND US, P292; TERWOGT MM, 1993, BRIT J PSYCHOL, V84, P499, DOI 10.1111/j.2044-8295.1993.tb02497.x; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wells M, 2001, ANTHROZOOS, V14, P161, DOI 10.2752/089279301786999472; Whiteley P, 2005, PERSPECT POLIT, P680; Wright JC, 2007, J APPL ANIM WELF SCI, V10, P255, DOI 10.1080/10888700701353956; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2	48	3	3	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158131	10.1371/journal.pone.0158131	http://dx.doi.org/10.1371/journal.pone.0158131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9FD	27348817	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200038
J	Nadeem, M; Ahmad, M; Akhtar, MS; Shaari, A; Riaz, S; Naseem, S; Masood, M; Saeed, MA				Nadeem, Muhammad; Ahmad, Munir; Akhtar, Muhammad Saeed; Shaari, Amiruddin; Riaz, Saira; Naseem, Shahzad; Masood, Misbah; Saeed, M. A.			Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications	PLOS ONE			English	Article							RELEASE; DESIGN	The current study emphasizes the synthesis of iron oxide nanoparticles (IONPs) and impact of hydrophilic polymer polyvinyl alcohol (PVA) coating concentration as well as anticancer drug doxorubicin (DOX) loading on saturation magnetization for target drug delivery applications. Iron oxide nanoparticles particles were synthesized by a reformed version of the coprecipitation method. The coating of polyvinyl alcohol along with doxorubicin loading was carried out by the physical immobilization method. X-ray diffraction confirmed the magnetite (Fe3O4) structure of particles that remained unchanged before and after polyvinyl alcohol coating and drug loading. Microstructure and morphological analysis was carried out by transmission electron microscopy revealing the formation of nanoparticles with an average size of 10 nm with slight variation after coating and drug loading. Transmission electron microscopy, energy dispersive, and Fourier transform infrared spectra further confirmed the conjugation of polymer and doxorubicin with iron oxide nanoparticles. The room temperature superparamagnetic behavior of polymer-coated and drug-loaded magnetite nanoparticles were studied by vibrating sample magnetometer. The variation in saturation magnetization after coating evaluated that a sufficient amount of polyvinyl alcohol would be 3 wt. % regarding the externally controlled movement of IONPs in blood under the influence of applied magnetic field for in-vivo target drug delivery.	[Nadeem, Muhammad; Shaari, Amiruddin; Saeed, M. A.] Univ Teknol Malaysia, Fac Sci, Dept Phys, Skudai 81310, Johor, Malaysia; [Nadeem, Muhammad; Riaz, Saira; Naseem, Shahzad] Univ Punjab, Ctr Excellence Solid State Phys, Lahore 54590, Pakistan; [Ahmad, Munir] Inst Nucl Med & Oncol INMOL, Dept Med Phys, Lahore, Pakistan; [Ahmad, Munir] Univ Lahore, Dept Phys, Lahore 54600, Pakistan; [Akhtar, Muhammad Saeed] Univ Educ, Div Sci & Technol, Township Campus, Lahore, Pakistan; [Masood, Misbah] Inst Nucl Med & Oncol INMOL, Dept Oncol, Lahore, Pakistan	Universiti Teknologi Malaysia; University of Punjab; University of Lahore	Nadeem, M; Saeed, MA (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Phys, Skudai 81310, Johor, Malaysia.; Nadeem, M (corresponding author), Univ Punjab, Ctr Excellence Solid State Phys, Lahore 54590, Pakistan.	badaninadeem@gmail.com; saeed@utm.my	Akhtar, Muhammad Saeed/K-6545-2018; Nadeem, Dr.Muhammad/P-8873-2019; Saeed, M Alam/J-7455-2012; Naseem, Shahzad/H-6024-2019	Akhtar, Muhammad Saeed/0000-0003-2431-9932; Saeed, M Alam/0000-0002-3529-9255; Naseem, Shahzad/0000-0002-7814-7577; Riaz, Saira/0000-0003-4720-1996	Ministry of Higher Education (MOHE) Malaysia; Universiti Teknologi Malaysia (UTM), Skudai, Johor, Malaysia [12H75/4F736]	Ministry of Higher Education (MOHE) Malaysia; Universiti Teknologi Malaysia (UTM), Skudai, Johor, Malaysia	This work was funded by the Ministry of Higher Education (MOHE) Malaysia and Universiti Teknologi Malaysia (UTM), Skudai, Johor, Malaysia under grant no. 12H75/4F736.	Ahmd M, 2012, J COLLOID SCI BIOTEC, V1, P201, DOI 10.1166/jcsb.2012.1021; Ahmed SR, 2002, APPL PHYS LETT, V80, P1616, DOI 10.1063/1.1456258; Alexiou C, 2000, CANCER RES, V60, P6641; Alexiou C.h., 2001, MAGNETOHYDRODYNAMICS, V37, P318, DOI [10.22364/mhd, DOI 10.22364/MHD]; Alexiou C, 2006, EUR BIOPHYS J BIOPHY, V35, P446, DOI 10.1007/s00249-006-0042-1; Batlle X, 1997, PHYS REV B, V55, P6440, DOI 10.1103/PhysRevB.55.6440; Batlle X, 2011, J APPL PHYS, V109, DOI 10.1063/1.3559504; Bedanta S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/1/013001; BERKOWIT.AE, 1968, J APPL PHYS, V39, P1261, DOI 10.1063/1.1656256; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Boyer C, 2010, NPG ASIA MATER, V2, P23, DOI 10.1038/asiamat.2010.6; Cavalieri F, 2008, BIOMACROMOLECULES, V9, P1967, DOI 10.1021/bm800225v; Chastellain A, 2004, J COLLOID INTERF SCI, V278, P353, DOI 10.1016/j.jcis.2004.06.025; Cullity B. D., 1972, INTRO MAGNETIC MAT; D'Souza AJM, 2004, J PHARM SCI-US, V93, P1962, DOI 10.1002/jps.20096; Dave SR, 2009, WIRES NANOMED NANOBI, V1, P583, DOI 10.1002/wnan.51; Deng JG, 2003, POLYM INT, V52, P1182, DOI 10.1002/pi.1237; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Douziech-Eyrolles L, 2007, INT J NANOMED, V2, P541; Ganguly A, 2008, J CHEM SCI, V120, P521, DOI 10.1007/s12039-008-0081-5; Gomez-Lopera SA, 2001, J COLLOID INTERF SCI, V240, P40, DOI 10.1006/jcis.2001.7579; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Huang ZB, 2005, J COLLOID INTERF SCI, V281, P432, DOI 10.1016/j.jcis.2004.08.121; Huong NT, 2009, J PHYS C SERIES; Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266; Issa B, 2011, J MAGN RESON IMAGING, V34, P1192, DOI 10.1002/jmri.22703; Javed KR, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000617; Jiang WQ, 2004, J MAGN MAGN MATER, V283, P210, DOI 10.1016/j.jmmm.2004.05.022; Kayal S, 2010, MAT SCI ENG C-MATER, V30, P484, DOI 10.1016/j.msec.2010.01.006; Kodama RH, 1999, J MAGN MAGN MATER, V200, P359, DOI 10.1016/S0304-8853(99)00347-9; Krimm S., 1960, INFRARED SPECTRA HIG; Kuznetsov A, 1999, J MAGN MAT, V22, P194; Li PX, 2004, J APPL POLYM SCI, V93, P894, DOI 10.1002/app.20522; Lubbe AS, 1996, CANCER RES, V56, P4686; Ma L, 2013, ACS NANO, V7, P9518, DOI 10.1021/nn405674m; Mahmoudi M, 2008, J PHYS CHEM B, V112, P14470, DOI 10.1021/jp803016n; Martinez B, 1998, PHYS REV LETT, V80, P181, DOI 10.1103/PhysRevLett.80.181; Mohapatra S, 2006, J NANOSCI NANOTECHNO, V6, P823, DOI 10.1166/jnn.2006.117; Nadeem M, 2015, IET NANOBIOTECHNOLOG; Nikiforov V.N., 2009, MAGNETIC NANOPARTICL, P393, DOI DOI 10.1002/9783527627561.CH10; Obaidat IM, 2015, NANOMATERIALS-BASEL, V5, P63, DOI 10.3390/nano5010063; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Papaefthymiou GC, 2009, NANO TODAY, V4, P438, DOI 10.1016/j.nantod.2009.08.006; Petri-Fink A, 2005, BIOMATERIALS, V26, P2685, DOI 10.1016/j.biomaterials.2004.07.023; Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006; Rudra A, 2010, INT J NANOMED, V5, P811, DOI 10.2147/IJN.S13031; Sakulkhu U, 2014, SCI REP-UK, V4, DOI 10.1038/srep05020; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang J, 2010, INT J NANOMED, V5, P861, DOI 10.2147/IJN.S13662; Yan Y, 2013, ACS NANO, V7, P9512, DOI 10.1021/nn405632s; Yu H, 2005, NANO LETT, V5, P379, DOI 10.1021/nl047955q; Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8	53	59	60	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158084	10.1371/journal.pone.0158084	http://dx.doi.org/10.1371/journal.pone.0158084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348436	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200034
J	Pierce, JV; Bernstein, HD				Pierce, Jessica V.; Bernstein, Harris D.			Genomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; PATHOGENICITY ISLAND; BACTERIAL BIOFILMS; GUT SYMBIONT; EVOLUTION; SEQUENCE; PATHWAY; PROTEIN; SHAPES; GROWTH	Enterotoxigenic (ETBF) strains of Bacteroides fragilis are the subset of strains that secrete a toxin called fragilysin (Bft). Although ETBF strains are known to cause diarrheal disease and have recently been associated with colorectal cancer, they have not been well characterized. By sequencing the complete genome of four ETBF strains, we found that these strains exhibit considerable variation at the genomic level. Only a small number of genes that are located primarily in the Bft pathogenicity island (BFT PAI) and the flanking CTn86 conjugative transposon are conserved in all four strains and a fifth strain whose genome was previously sequenced. Interestingly, phylogenetic analysis strongly suggests that the BFT PAI was acquired by non-toxigenic (NTBF) strains multiple times during the course of evolution. At the phenotypic level, we found that the ETBF strains were less fit than the NTBF strain NCTC 9343 and were susceptible to a growth-inhibitory protein that it produces. The ETBF strains also showed a greater tendency to form biofilms, which may promote tumor formation, than NTBF strains. Although the genomic diversity of ETBF strains raises the possibility that they vary in their pathogenicity, our experimental results also suggest that they share common properties that are conferred by different combinations of non-universal genetic elements.	[Pierce, Jessica V.; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075086] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Cynthia Sears and Andy Goodman for the gift of B. fragilis strains and Harold Smith (NIDDK Genomics Core) for sequencing the genome of ETBF strain 2-078382-3 and providing bioinformatics support. We would also like to thank Marlena Wilson for the anti-TssD antiserum and for helpful discussions. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Avelar KES, 1999, LETT APPL MICROBIOL, V29, P264, DOI 10.1046/j.1365-2672.1999.00603.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Castillo D, 2014, FEMS MICROBIOL LETT, V351, P51, DOI 10.1111/1574-6968.12342; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chatzidaki-Livanis M, 2016, P NATL ACAD SCI USA, V113, P3627, DOI 10.1073/pnas.1522510113; Chatzidaki-Livanis M, 2014, MOL MICROBIOL, V94, P1361, DOI 10.1111/mmi.12839; Cheng LF, 2012, AVIAN DIS, V56, P321, DOI 10.1637/9770-050411-Reg.1; Coyne MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01305-14; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Fernandez B, 2013, J APPL MICROBIOL, V114, P877, DOI 10.1111/jam.12081; Franco AA, 1999, J BACTERIOL, V181, P6623, DOI 10.1128/JB.181.21.6623-6633.1999; Franco AA, 2004, J BACTERIOL, V186, P6077, DOI 10.1128/jb.186.18.6077-6092.2004; Franco AA, 1997, INFECT IMMUN, V65, P1007, DOI 10.1128/IAI.65.3.1007-1013.1997; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011; Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Moncrief JS, 1998, INFECT IMMUN, V66, P1735, DOI 10.1128/IAI.66.4.1735-1739.1998; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; Mundy LM, 1996, CLIN INFECT DIS, V23, P269, DOI 10.1093/clinids/23.2.269; Murphy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020852; MYERS LL, 1987, J CLIN MICROBIOL, V25, P2330, DOI 10.1128/JCM.25.12.2330-2333.1987; Nikitina AS, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00450-15; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Papastathopoulou A, 1997, ANAEROBE, V3, P203, DOI 10.1006/anae.1997.0106; Pumbwe L, 2007, MICROB PATHOGENESIS, V43, P78, DOI 10.1016/j.micpath.2007.04.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Salomon D, 2014, P NATL ACAD SCI USA, V111, P9271, DOI 10.1073/pnas.1406110111; Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334; TerAvest MA, 2014, BIOTECHNOL BIOENG, V111, P165, DOI 10.1002/bit.24994; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; WEIKEL CS, 1992, INFECT IMMUN, V60, P321, DOI 10.1128/IAI.60.2.321-327.1992; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	52	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158171	10.1371/journal.pone.0158171	http://dx.doi.org/10.1371/journal.pone.0158171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348220	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200043
J	Navarrete, M; Alvarado-Rojas, C; Le Van Quyen, M; Valderrama, M				Navarrete, Miguel; Alvarado-Rojas, Catalina; Le Van Quyen, Michel; Valderrama, Mario			RIPPLELAB: A Comprehensive Application for the Detection, Analysis and Classification of High Frequency Oscillations in Electroencephalographic Signals	PLOS ONE			English	Article							OPEN SOURCE TOOLBOX; HZ; EPILEPSY; TRANSFORM; SOFTWARE; DYNAMICS	High Frequency Oscillations (HFOs) in the brain have been associated with different physiological and pathological processes. In epilepsy, HFOs might reflect a mechanism of epileptic phenomena, serving as a biomarker of epileptogenesis and epileptogenicity. Despite the valuable information provided by HFOs, their correct identification is a challenging task. A comprehensive application, RIPPLELAB, was developed to facilitate the analysis of HFOs. RIPPLELAB provides a wide range of tools for HFOs manual and automatic detection and visual validation; all of them are accessible from an intuitive graphical user interface. Four methods for automated detection-as well as several options for visualization and validation of detected events-were implemented and integrated in the application. Analysis of multiple files and channels is possible, and new options can be added by users. All features and capabilities implemented in RIPPLELAB for automatic detection were tested through the analysis of simulated signals and intracranial EEG recordings from epileptic patients (n = 16; 3,471 analyzed hours). Visual validation was also tested, and detected events were classified into different categories. Unlike other available software packages for EEG analysis, RIPPLELAB uniquely provides the appropriate graphical and algorithmic environment for HFOs detection (visual and automatic) and validation, in such a way that the power of elaborated detection methods are available to a wide range of users (experts and non-experts) through the use of this application. We believe that this open-source tool will facilitate and promote the collaboration between clinical and research centers working on the HFOs field. The tool is available under public license and is accessible through a dedicated web site.	[Navarrete, Miguel; Valderrama, Mario] Univ Los Andes, Dept Biomed Engn, Bogota, Colombia; [Alvarado-Rojas, Catalina; Le Van Quyen, Michel] Hop La Pitie Salpetriere, INSERM UMRS 975, CNRS UPR640, Ctr Rech,Inst Cerveau & Moelle Epiniere CRICM, Paris, France; [Navarrete, Miguel] Univ Los Andes, Dept Elect & Elect Engn, Bogota, Colombia; [Alvarado-Rojas, Catalina] Pontificia Univ Javeriana, Dept Elect Engn, Bogota, Colombia	Universidad de los Andes (Colombia); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universidad de los Andes (Colombia); Pontificia Universidad Javeriana	Valderrama, M (corresponding author), Univ Los Andes, Dept Biomed Engn, Bogota, Colombia.	mvalderr@uniandes.edu.co	Alvarado-Rojas, Catalina/AAR-8761-2021; Navarrete, Miguel/E-3130-2019	Navarrete, Miguel/0000-0002-4903-2156; Alvarado-Rojas, Catalina/0000-0002-2315-5692; Valderrama, Mario/0000-0001-8791-6078	COLCIENCIAS [567]; Likewise	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Likewise	This research was partially supported by COLCIENCIAS (Grant 567), http://www.colciencias.gov.co/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Likewise, there was no additional external funding received for this study.; We would like to thank Vincent Navarro (Centre de Recherche de L'Institut du Cerveau et de la Moelle Epiniere, Paris, France) for valuable suggestions on the interface design, Samuel Ahn, (Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, USA) and Gerriet Janssen for helpful comments on the manuscript. This research was partially supported by COLCIENCIAS (Grant 567).	Alvarado-Rojas C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04545; Alvarado-Rojas C, 2015, ANN NEUROL, V77, P281, DOI 10.1002/ana.24324; BARNES CW, 1985, IEEE T CIRCUITS SYST, V32, P530, DOI 10.1109/TCS.1985.1085756; Benar CG, 2010, CLIN NEUROPHYSIOL, V121, P301, DOI 10.1016/j.clinph.2009.10.019; Birot G, 2013, J NEUROSCI METH, V213, P236, DOI 10.1016/j.jneumeth.2012.12.013; Blanco JA, 2010, J NEUROPHYSIOL, V104, P2900, DOI 10.1152/jn.01082.2009; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Brazdil M, 2010, EPILEPSY RES, V90, P28, DOI 10.1016/j.eplepsyres.2010.03.003; Burnos S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094381; Chaibi S., 2012, 2012 IEEE International Conference on Emerging Signal Processing Applications, P56, DOI 10.1109/ESPA.2012.6152445; Colombet B, 2015, J NEUROSCI METH, V242, P118, DOI 10.1016/j.jneumeth.2015.01.017; Crepon B, 2010, BRAIN, V133, P33, DOI 10.1093/brain/awp277; de la Prida LM, 2015, J CLIN NEUROPHYSIOL, V32, P207, DOI 10.1097/WNP.0000000000000150; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dumpelmann M, 2015, EPILEPSIA, V56, P197, DOI 10.1111/epi.12844; Dumpelmann M, 2012, CLIN NEUROPHYSIOL, V123, P1721, DOI 10.1016/j.clinph.2012.02.072; Egert U, 2002, J NEUROSCI METH, V117, P33, DOI 10.1016/S0165-0270(02)00045-6; Esteller R, 2005, CLIN NEUROPHYSIOL, V116, P517, DOI 10.1016/j.clinph.2004.10.015; Esteller R, 2001, 2001 C P 23 ANN INT, P2; Gardner AB, 2007, CLIN NEUROPHYSIOL, V118, P1134, DOI 10.1016/j.clinph.2006.12.019; Gliske SV, 2016, CLIN NEUROPHYSIOL, V127, P1057, DOI 10.1016/j.clinph.2015.07.016; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Guerrini R, 2013, DESIRE DEV EPILEPSY; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HERRMANN O, 1970, ELECTRON LETT, V6, P329, DOI 10.1049/el:19700232; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; JACKSON LB, 1979, IEEE T CIRCUITS SYST, V26, P149, DOI 10.1109/TCS.1979.1084623; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Klatt J, 2012, EPILEPSIA, V53, P1669, DOI 10.1111/j.1528-1167.2012.03564.x; Le TP, 2004, J SOUND VIB, V277, P73, DOI 10.1016/j.jsv.2003.08.049; Le Van Quyen M, 2006, TRENDS NEUROSCI, V29, P419, DOI 10.1016/j.tins.2006.06.001; Lidierth M, 2009, J NEUROSCI METH, V178, P188, DOI 10.1016/j.jneumeth.2008.11.004; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Matsumoto A, 2013, J NEUROPHYSIOL, V110, P1958, DOI 10.1152/jn.00341.2013; MORLET J, 1982, GEOPHYSICS, V47, P222, DOI 10.1190/1.1441329; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pail M, 2013, CLIN NEUROPHYSIOL, V124, P1935, DOI 10.1016/j.clinph.2013.03.032; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Worrell GA, 2012, PROG NEUROBIOL, V98, P265, DOI 10.1016/j.pneurobio.2012.02.006; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; Xiang J, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00057; Zelmann R, 2012, CLIN NEUROPHYSIOL, V123, P106, DOI [10.1016/j.clinph.2011.06.006, 10.1016/j.clinph.2011.02.022]; Zelmann R, 2010, IEEE ENG MED BIO, P2329, DOI 10.1109/IEMBS.2010.5627464; Zelmann R, 2009, CLIN NEUROPHYSIOL, V120, P1457, DOI 10.1016/j.clinph.2009.05.029; Zijlmans M, 2011, CLIN NEUROPHYSIOL, V122, P664, DOI 10.1016/j.clinph.2010.09.021	50	55	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158276	10.1371/journal.pone.0158276	http://dx.doi.org/10.1371/journal.pone.0158276			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341033	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378393600046
J	Zhou, KL; Liang, ZW; Wang, C; Hu, FY; Ning, CY; Lan, Y; Tang, XP; Tucker, JD; Cai, WP				Zhou, Kali; Liang, Zhiwei; Wang, Charles; Hu, Fengyu; Ning, Chuanyi; Lan, Yun; Tang, Xiaoping; Tucker, Joseph D.; Cai, Weiping			Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naive HIV/HCV Co-Infected Patients in China	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; NS3 PROTEASE; DECREASED SENSITIVITY; VIROLOGICAL RESPONSE; VIRUS-RESISTANCE; PLUS RIBAVIRIN; SWISS-MODEL; DRUG-USERS; SOFOSBUVIR; MUTATIONS	Background The advent of direct-acting agents (DAAs) has improved treatment of HCV in HIV co-infection, but may be limited by primary drug resistance. This study reports the prevalence of natural polymorphisms conferring resistance to NS3/4A protease inhibitors and NS5B polymerase inhibitors in treatment-naive HIV/HCV co-infected individuals in China. Methods Population based NS3/4A sequencing was completed for 778 treatment-naive HIV/HCV co-infected patients from twelve provinces. NS3 sequences were amplified by nested PCR using in-house primers for genotypes 1-6. NS5B sequencing was completed for genotyping in 350 sequences. Resistance-associated variants (RAVs) were identified in positions associated with HCV resistance. Results Overall, 72.8%(566/778) of all HCV sequences had at least one RAV associated with HCV NS3/4A protease inhibitor resistance. Variants were found in 3.6% (7/193) of genotype 1, 100% (23/23) of genotype 2, 100% (237/237) of genotype 3 and 92% (299/325) of genotype 6 sequences. The Q80K variant was present in 98.4% of genotype 6a sequences. Highlevel RAVs were rare, occurring in only 0.8% of patients. 93% (64/69) patients with genotype 1b also carried the C316N variant associated with NS5B low-level resistance. Conclusions The low frequency of high-level RAVs associated with primary HCV DAA resistance among all genotypes in HIV/HCV co-infected patients is encouraging. Further phenotypic studies and clinical research are needed.	[Zhou, Kali; Liang, Zhiwei; Hu, Fengyu; Ning, Chuanyi; Lan, Yun; Tang, Xiaoping; Tucker, Joseph D.; Cai, Weiping] Guangzhou Eighth Peoples Hosp, 627 Dongfeng Dong Rd, Guangzhou 510060, Guangdong, Peoples R China; [Zhou, Kali] Univ Calif San Francisco, Dept Med, Div Gastroenterol, 513 Parnassus Ave,Room S-357, San Francisco, CA 94143 USA; [Wang, Charles; Ning, Chuanyi; Tucker, Joseph D.] Univ N Carolina, UNC Project China, Div Infect Dis, Dept Med,UNC Chapel Hill Sch Med, 130 Mason Farm Rd,2nd Floor, Chapel Hill, NC 27599 USA; [Wang, Charles] Brown Univ, Sch Med, Dept Med, Div Gastroenterol, 593 Eddy St,APC 406, Providence, RI 02903 USA	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Brown University	Cai, WP (corresponding author), Guangzhou Eighth Peoples Hosp, 627 Dongfeng Dong Rd, Guangzhou 510060, Guangdong, Peoples R China.	caiwp@163.net	Ning, Chuanyi/AAF-5601-2020	Ning, Chuanyi/0000-0002-8748-2780; Tucker, Joseph/0000-0003-2804-1181; Zhou, Kali/0000-0001-8554-2906	Chinese National Key Technologies Research and Development Program [2012 ZX 10001003-003]; People's Livelihood Science and Technology Program from Science and Information Technology of Guangzhou [201300000092]; National Institutes of Health [FIC R25TW0093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Chinese National Key Technologies Research and Development Program; People's Livelihood Science and Technology Program from Science and Information Technology of Guangzhou; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Chinese National Key Technologies Research and Development Program for the 12th Five-year Plan [2012 ZX 10001003-003]; the People's Livelihood Science and Technology Program from Science and Information Technology of Guangzhou [Grant No. 201300000092]; and the National Institutes of Health [FIC R25TW0093].; This work was supported by the Chinese National Key Technologies Research and Development Program for the 12th Five-year Plan [2012 ZX 10001003-003]; the People's Livelihood Science and Technology Program from Science and Information Technology of Guangzhou [Grant No. 201300000092]; and the National Institutes of Health [FIC R25TW0093]. The authors would like to acknowledge Dr. David McGivern and Dr. Stanley M. Lemon at the University of North Carolina-Chapel Hill for their contributions to editing. We would also like to thank Dr. Jun Liu at Sun-Yat Sen University for his assistance with molecular modeling.	Aloia AL, 2014, ANTIVIRAL THERAPY; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae A, 2010, ANTIMICROB AGENTS CH, V54, P5288, DOI 10.1128/AAC.00777-10; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Berger KL, 2014, ANTIMICROB AGENTS CH, V58, P698, DOI 10.1128/AAC.01976-13; Chao DT, 2011, ALIMENT PHARM THER, V34, P286, DOI 10.1111/j.1365-2036.2011.04714.x; De Meyer S, 2012, HEPATOLOGY, V56, P2106, DOI 10.1002/hep.25962; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; Duan ZP, 2014, J CLIN GASTROENTEROL, V48, P679, DOI 10.1097/MCG.0000000000000109; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Halfon P, 2008, AIDS, V22, P1694, DOI 10.1097/QAD.0b013e32830a989b; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedskog C, 2015, J VIRAL HEPATITIS, V22, P871, DOI 10.1111/jvh.12405; Jabara CB, 2014, ANTIMICROB AGENTS CH, V58, P6079, DOI 10.1128/AAC.03466-14; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14; Kim AY, 2009, J INFECT DIS, V199, P737, DOI 10.1086/596657; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwong Ann D, 2011, Gastroenterology, V140, P755, DOI 10.1053/j.gastro.2011.01.029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lisboa-Neto G, 2014, ANTIVIRAL THERAPY; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Moreno C HC, THE EUROPEAN ASSOCIA; Morsica G, 2009, JAIDS-J ACQ IMM DEF, V51, P106, DOI 10.1097/QAI.0b013e3181a02fda; Palanisamy N, 2013, ANTIVIR RES, V99, P12, DOI 10.1016/j.antiviral.2013.04.018; Paolucci S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-245; PHENOTYPE WORKING GROUP H DRUG DEVELOPMENT ADVISORY GROUP H, 2012, ANN FORUM COLLAB HIV, V14, P1; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trimoulet P, 2011, HIV MED, V12, P506, DOI 10.1111/j.1468-1293.2011.00913.x; Vallet S, 2011, ANTIVIR THER, V16, P1093, DOI 10.3851/IMP1900; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Wang Y, 2015, CHINESE MED J-PEKING, V128, P2625, DOI 10.4103/0366-6999.166038; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	52	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157438	10.1371/journal.pone.0157438	http://dx.doi.org/10.1371/journal.pone.0157438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341031	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600006
J	Glykys, J; Staley, KJ				Glykys, Joseph; Staley, Kevin J.			Developmental Decrease of Neuronal Chloride Concentration Is Independent of Trauma in Thalamocortical Brain Slices	PLOS ONE			English	Article							EXCITATORY ACTIONS; NETWORK ACTIVITY; GABA; MECHANISM; MATRIX; METALLOPROTEINASES; RECORDINGS; WATER; NKCC1	The intraneuronal chloride concentration ([Cl-](i)) is paramount for determining the polarity of signaling at GABA(A) synapses in the central nervous system. Sectioning hippocampal brain slices increases [Cl-](i) in the superficial layers. It is not known whether cutting trauma also increases [Cl-](i) in the neocortex and thalamus, and whether the effects of trauma change during development. We used Cl- imaging to study the [Cl-](i) vs. the distance from the cut surface in acute thalamocortical slices from mice at developmental ages ranging from postnatal day 5 (P5) to P20. We demonstrate: 1) [Cl-](i) is higher in the most superficial areas in both neocortical and thalamic brain slices at all ages tested and, 2) there is a developmental decrease in [Cl-](i) that is independent of acute trauma caused by brain slicing. We conclude that [Cl-](i) has a developmental progression during P5-20 in both the neocortex and thalamus. However, in both brain regions and during development the neurons closest to the slicing trauma have an elevated [Cl-](i) .	[Glykys, Joseph; Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Div Child Neurol, Boston, MA 02114 USA; [Glykys, Joseph; Staley, Kevin J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Glykys, J (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Div Child Neurol, Boston, MA 02114 USA.; Glykys, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jglykys@mgh.harvard.edu		Glykys, Joseph/0000-0002-1499-9172	National Institute of Health/National Institute of Neurological Disorders and Stroke [K08 1K08NS091248, 5R01NS40109-14]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS091248, R01NS040109] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JG was supported by the National Institute of Health/National Institute of Neurological Disorders and Stroke K08 1K08NS091248. KS was supported by the National Institute of Health/National Institute of Neurological Disorders and Stroke 5R01NS40109-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Bregestovski P, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00065; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fischer KF, 1998, J NEUROSCI, V18, P3767; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Glykys J, 2015, ANN CLIN TRANSL NEUR, V2, P1055, DOI 10.1002/acn3.259; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Gonzalez-Islas C, 2010, J NEUROSCI, V30, P13016, DOI 10.1523/JNEUROSCI.1659-10.2010; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Khazipov R, 2014, CNS NEUROSCI THER, V21, P1; Kirmse K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8750; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Moyer J. R., 2002, PATCH CLAMP ANAL ADV, P135; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Owens DF, 1996, J NEUROSCI, V16, P6414; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Reinhard SM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00280; Rheims S, 2008, J NEUROPHYSIOL, V100, P609, DOI 10.1152/jn.90402.2008; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Valeeva G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00020; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Zeuthen T, 2012, J PHYSIOL-LONDON, V590, P1139, DOI 10.1113/jphysiol.2011.226316; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158012	10.1371/journal.pone.0158012	http://dx.doi.org/10.1371/journal.pone.0158012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337272	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200089
J	Bullard, SA; Seo, S; Schilling, B; Dyle, MC; Dierdorff, JM; Ebert, SM; DeLau, AD; Gibson, BW; Adams, CM				Bullard, Steven A.; Seo, Seongjin; Schilling, Birgit; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Gibson, Bradford W.; Adams, Christopher M.			Gadd45a Protein Promotes Skeletal Muscle Atrophy by Forming a Complex with the Protein Kinase MEKK4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; mass spectrometry (MS); muscle; muscle atrophy; skeletal muscle; skeletal muscle metabolism; Gadd45a; MEKK4	GENE-EXPRESSION PROFILE; ACTIVATION; MTK1/MEKK4; MASS; PROTEOMICS; QUANTITATION; RESPONSES; NETWORK; PATHWAY; SKYLINE	Skeletal muscle atrophy is a serious and highly prevalent condition that remains poorly understood at the molecular level. Previous work found that skeletal muscle atrophy involves an increase in skeletal muscle Gadd45a expression, which is necessary and sufficient for skeletal muscle fiber atrophy. However, the direct mechanism by which Gadd45a promotes skeletal muscle atrophy was unknown. To address this question, we biochemically isolated skeletal muscle proteins that associate with Gadd45a as it induces atrophy in mouse skeletal muscle fibers in vivo. We found that Gadd45a interacts with multiple proteins in skeletal muscle fibers, including, most prominently, MEKK4, a mitogen-activated protein kinase kinase kinase that was not previously known to play a role in skeletal muscle atrophy. Furthermore, we found that, by forming a complex with MEKK4 in skeletal muscle fibers, Gadd45a increases MEKK4 protein kinase activity, which is both sufficient to induce skeletal muscle fiber atrophy and required for Gadd45a-mediated skeletal muscle fiber atrophy. Together, these results identify a direct biochemical mechanism by which Gadd45a induces skeletal muscle atrophy and provide new insight into the way that skeletal muscle atrophy occurs at the molecular level.	[Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Seo, Seongjin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Dyle, Michael C.; Ebert, Scott M.; Adams, Christopher M.] Emmyon Inc, Coralville, IA 52241 USA; [Schilling, Birgit; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Adams, CM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212; Seo, Seongjin/0000-0002-7908-3210	National Institutes of Health [R01AR059115, R01EY022616]; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [IBX000976A]; United States Department of Veterans Affairs Rehabilitation and Research Development Service Grant [1I01RX001477]; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; National Institutes of Health Shared Instrumentation Grant [1S10 OD016281]; NATIONAL EYE INSTITUTE [R01EY022616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016281] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976, I01RX001477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant; United States Department of Veterans Affairs Rehabilitation and Research Development Service Grant; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01AR059115 and R01EY022616, United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant IBX000976A, the United States Department of Veterans Affairs Rehabilitation and Research Development Service Grant 1I01RX001477, the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa, and National Institutes of Health Shared Instrumentation Grant 1S10 OD016281 for the TripleTOF mass spectrometric system at the Buck Institute (to B. W. G.). C. M. A., S. M. E., and M. C. D. hold equity in Emmyon, Inc. C. M. A. is a founder and officer of Emmyon, Inc. S. M. E. and M. C. D. are employees of Emmyon, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; Bettinger BT, 2007, J CELL BIOCHEM, V101, P34, DOI 10.1002/jcb.21289; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Mizote I, 2010, J MOL CELL CARDIOL, V48, P302, DOI 10.1016/j.yjmcc.2009.10.010; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5	40	30	31	9	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17496	17509		10.1074/jbc.M116.740308	http://dx.doi.org/10.1074/jbc.M116.740308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358404	Green Published, hybrid			2022-12-26	WOS:000383241300002
J	Niu, LY; Feng, SW; Ding, WH; Li, G				Niu, Liyuan; Feng, Suwei; Ding, Weihua; Li, Gan			Influence of Speed and Rainfall on Large-Scale Wheat Lodging from 2007 to 2014 in China	PLOS ONE			English	Article							WINTER-WHEAT; RESISTANCE; CULTIVARS; YIELD	Strong wind and heavy rain remain the two most important causes of large acreage wheat (Triticum aestivum L.) lodging in China. For research the influence of wind speed and rainfall-separately as well as together-on the extent and degree of lodging, five levels of the severity of lodging were defined based on a combination of the lodging area and the degree of tilting. Detailed meteorological information was studied on 52 instances of large-scale lodging that occurred from 2007 to 2014. The results showed that strong wind's lodging accounted for 8% of the instances studied, continuous rainfall's lodging accounted for 19% and strong winds-heavy rainfall's accounted for 73%. The minimum instantaneous wind speed that could cause large-scale lodging was closely related to rainfall. Without rainfall, the wind speed that resulted in lodging ranging in severity from slight to severe (Level 2 to Level 5) was 14.9 m/s, 19.3 m/s, 21.5 m/s, and 26.5 m/s, respectively; when accompanied by rainfall, the wind speed that resulted in lodging of the same severity decreased linearly with the increase of rainfall. These results will be particularly useful in preventing and alleviating wheat lodging as well screening wheat varieties with good lodging resistance.	[Niu, Liyuan] Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China; [Feng, Suwei; Ding, Weihua; Li, Gan] Henan Inst Sci & Technol, Wheat Breeding Inst, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology; Henan Institute of Science & Technology	Niu, LY (corresponding author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China.	nly1962@163.com			National Natural Science Foundation of China [31371525]; High-Level Personnel Research Project of Henan Institute of Science and Technology [2011002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Level Personnel Research Project of Henan Institute of Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 31371525) (http://www.nsfc.gov.cn/) and the High-Level Personnel Research Project of Henan Institute of Science and Technology (No. 2011002) (http://www.hist.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural bureau of Jingzhou district, 2012, LARG SCAL WHEAT LODG; Ai D, 2012, STRONG CONVECTIVE WE; [Anonymous], 2008, SHANDONG NEWS; Bai HB, 2011, STORM CAUSED 2 200 H; Baker CJ, 1998, J THEOR BIOL, V194, P587, DOI 10.1006/jtbi.1998.0778; Berry PM, 2003, AGR FOREST METEOROL, V119, P167, DOI 10.1016/S0168-1923(03)00139-4; Berry PM, 2003, FIELD CROP RES, V80, P111, DOI 10.1016/S0378-4290(02)00174-0; Che JJ, 2013, HEAVY RAIN LED WHEAT; Chen YD, 2009, ZHAO YAZHONG 63 REGI; China weather channel, 2013, HEAV RAIN HIT HEB LA; CROOK MJ, 1994, J AGR SCI, V123, P167, DOI 10.1017/S0021859600068428; EASSON DL, 1993, J AGR SCI, V121, P145, DOI 10.1017/S0021859600077005; Feng WY, 2013, HEAVY RAIN CAUSED 20; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Gao Z, 2013, TECHNICIANS WUQIAO C; Geng YF, 2013, STRONG WIND FROST OT; Guang JJ, 2012, HEAVY RAIN RUSHED AW; Gui SY, 2013, STORM CAUSED WHEAT L; Han JW, 2012, HEAVY RAIN 50 YEARS; Han K, 2013, HEAVY RAIN WIND ATTA; He T, 2009, TAKES MEASURES DEAL; He W, 2008, WEISHI COUNTY NEARLY; He XF, 2011, DISASTER WEATHER HIT; Hei P, 2011, DRAGON BOAT FESTIVAL; Hou YX, 2013, QUFU RAINSTORM EMERG; Hu B, 2013, WIND RAIN LED WHEAT; Hu B, 2012, HAIL CAUSE FLAKY WHE; Hua X, 2013, STORMS HIT PARTS CHI; Huang ZH, 2013, AGR EXPERTS WENT PAV; Lang Xi BBS, 2012, WHEAT RAPE LODGING S; Langya news, 2013, LANGYA NEWS; Li FM, 2013, SEVERE CONVECTIVE WE; Li HC, 2013, HEAVY RAINS CAUSED J; Liu HP, 2009, STORM HAIL HIT LUYI; LIU HP, 2012, SHANDONG AGR SCI, V44, P55; Liu W, 2012, HAIL SUCH JUJUBE CAU; Liu Y, 2010, GALE HEAVY RAIN DISA; Lu TC, 2013, STORMY RAIDED WHEAT; Mei Y, 2013, RAINSTORM WINTER WHE; Mei Y, 2013, HEAVY RAIN LED SUQIA; Meteorological bureau of Lingbi county, 2012, STRONG CONV WEATH HI; Mobile Xinxiang, 2013, HEAV RAIN WHEAT LODG; News Hebei, 2013, GAL HAIL HIT DAM COU; Niu LY, 2012, FIELD CROP RES, V139, P1, DOI 10.1016/j.fcr.2012.10.014; Pang LL, 2013, WIND RAIN HIT SHANDO; Qi K, 2013, CONTINUOUS RAINFALL; Qi S, 2010, HEAVY RAIN CAUSED WH; Qilu P, 2013, ONE 3 WHEAT LODGING; Qin QX, 2013, HEAVY RAIN CAUSED SE; Shen Y, 2013, CHINA DAILY PRECIPIT; Tao XQ, 2013, CONVECTIVE WEATHER C; Tie J, 2013, DEZHOU CITY WHEAT LO; Wang JC, 2013, DAYS RAIN BINZHOU CI; Wang Q, 2013, HEAVY RAINS LED SOME; Wang SD, 2013, RAIN STOPS TOMORROW; Wang YN, 2013, BAD WEATHER HIT LIAO; Wei Q, 2013, SHIJIAZHUANG CITY BR; Wen M, 2013, WHEAT LODGING; Wu M, 2011, AGR MACHINERY DEP AC; Wu M, 2012, SEIZE TIME REDUCE LO; Wu M, 2013, 5 FARM SUFFERED WIND; Wu W, 2013, LARGE SCALE WHEAT LO; Wu YG, 2012, STORM CAUSED JIYANG; Xinhua news agency, 2010, THUND STRONG WIND HA; Xiong JW, 2013, STORM CAUSED HEZENEA; Xuzhou bureau of meteorology, 2013, INFL HEAV RAIN MAY 2; Yang ZH, 2013, 1 SUMMER THUNDERSTOR; Yi Y, 2013, STORM RAID RESULTED; Youku video, 2012, STORM LED SOM VILL W; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhai T, 2013, EXPERTS SUGGESTED PR; Zhang HL, 2007, CONTINUOUS RAINFALL; Zhang HL, 2013, HAIL DONGE COUNTYS 6; Zhang JB, 2007, HEAVY WIND HAIL CAUS; Zhao PP, 2013, WIND RAIN LED 6600 H; Zhu XinKai, 2006, Journal of Triticeae Crops, V26, P87; Zou FL, 2013, CHINA LAND CLIMATE D	77	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157677	10.1371/journal.pone.0157677	http://dx.doi.org/10.1371/journal.pone.0157677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367926	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900011
J	Choi, SW; Kweon, SS; Lee, YH; Ryu, SY; Choi, JS; Rhee, JA; Nam, HS; Jeong, SK; Park, KS; Kim, HN; Shin, MH				Choi, Seong-Woo; Kweon, Sun-Seog; Lee, Young-Hoon; Ryu, So-Yeon; Choi, Jin-Su; Rhee, Jung-Ae; Nam, Hae-Sung; Jeong, Seul-Ki; Park, Kyeong-Soo; Kim, Hee Nam; Shin, Min-Ho			25-Hydroxyvitamin D and Parathyroid Hormone Levels Are Independently Associated with the Hemoglobin A(1c) Level of Korean Type 2 Diabetic Patients: The Dong-Gu Study	PLOS ONE			English	Article							VITAMIN-D STATUS; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR-DISEASE; CALCIUM HOMEOSTASIS; INSULIN SENSITIVITY; NATIONAL-HEALTH; SERUM-CALCIUM; GLUCOSE; PLASMA; POPULATION	In type 2 diabetic patients, the relationships between 25-hydroxyvitamin D and parathyroid hormone levels, and glycemic control, remain unclear. We evaluated associations between 25-hydroxyvitamin D, parathyroid hormone, and hemoglobin A(1c) levels after adjusting for other covariates, including log transformed 25-hydroxyvitamin D levels and log transformed parathyroid hormone levels, in Korean patients with type 2 diabetes. In total, 1,175 patients with type 2 diabetes were selected from 8,857 individuals who completed the baseline survey of the Dong-gu study, conducted in Korea from 2007 to 2010. After adjusting for other covariates, we found that the mean hemoglobin A(1c) level was inversely associated with the 25-hydroxyvitamin D level (Q1: 7.47% [7.30-7.63], Q2: 7.25% [7.09-7.40], Q3: 7.17% [7.02-7.32], Q4: 7.19% [7.02-7.35]; p for trend = 0.021, p for between groups = 0.050) and the parathyroid hormone level (Q1: 7.35%[7.19-7.51], Q2: 7.34%[7.19-7.50], Q3: 7.28% [7.13-7.43], Q4: 7.09% [6.94-7.24]; p for trend = 0.022, p for between groups = 0.048). However, the mean fasting glucose level was not associated with either the 25-hydroxyvitamin D or parathyroid hormone level. In conclusion, inverse associations were evident between hemoglobin A(1c), 25-hydroxyvitamin D and parathyroid hormone levels in Korean patients with type 2 diabetes. The associations remained significant after adjusting for other covariates, including the log transformed 25-hydroxyvitamin D levels and log transformed parathyroid hormone levels.	[Choi, Seong-Woo; Ryu, So-Yeon] Chosun Univ, Sch Med, Dept Prevent Med, 309 Pilmun Daero, Kwangju 501759, South Korea; [Kweon, Sun-Seog; Choi, Jin-Su; Rhee, Jung-Ae; Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, 160 Baekseo Ro, Kwangju 501746, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, 322 Seoyang Ro, Hwasun 519809, Jeollanamdo, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Dept Prevent Med, 344-2 Shinyong Dong, Iksan 570711, Jeollabukdo, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, 344-2 Shinyong Dong, Iksan 570711, Jeollabukdo, South Korea; [Nam, Hae-Sung] Chungnam Natl Univ, Sch Med, Dept Prevent Med, Munhwa 1 Il Dong, Daejeon 301747, South Korea; [Jeong, Seul-Ki] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Inst Biomed, Dept Neurol, San 2-20, Jeonju 561180, Jeollabukdo, South Korea; [Jeong, Seul-Ki] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Inst Biomed, Res Inst Clin Med, San 2-20, Jeonju 561180, Jeollabukdo, South Korea; [Park, Kyeong-Soo] Seonam Univ, Coll Med, Dept Prevent Med, 439 Chunhyang Ro, Namwon 590711, Jeollabukdo, South Korea; [Kim, Hee Nam; Shin, Min-Ho] Chonnam Natl Univ, Ctr Creat Biomed Scientists, 77 Yongbong Ro, Kwangju 500757, South Korea	Chosun University; Chonnam National University; Chonnam National University; Wonkwang University; Wonkwang University; Chungnam National University; Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Seonam University; Chonnam National University	Shin, MH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Prevent Med, 160 Baekseo Ro, Kwangju 501746, South Korea.; Shin, MH (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, 77 Yongbong Ro, Kwangju 500757, South Korea.	mhshinx@paran.com	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550; Lee, Young-Hoon/0000-0003-1367-025X; Choi, Seong-Woo/0000-0002-6150-3934; Nam, Hae-Sung/0000-0003-0911-4576; Jeong, Seul-Ki/0000-0002-9868-621X				Alemzadeh R, 2012, METAB SYNDR RELAT D, V10, P422, DOI 10.1089/met.2012.0056; Chagas CEA, 2012, NUTRIENTS, V4, P52, DOI 10.3390/nu4010052; Bischof MG, 2006, HORM RES, V66, P211, DOI 10.1159/000094932; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Boland ARD, 1990, ENDOCRINOLOGY, V127; Brandstedt J, 2016, CANCER CAUSE CONTROL, V27, P69, DOI 10.1007/s10552-015-0684-3; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Christodoulou S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396541; Dalgard C, 2011, DIABETES CARE, V34, P1284, DOI 10.2337/dc10-2084; DEMDEN MC, 1989, BIOCHEM BIOPH RES CO, V164, P413, DOI 10.1016/0006-291X(89)91735-X; El Lithy A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-362; Farrell CJL, 2012, CLIN CHEM, V58, P531, DOI 10.1373/clinchem.2011.172155; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hagstrom E, 2007, DIABETOLOGIA, V50, P317, DOI 10.1007/s00125-006-0532-9; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick Michael F., 1999, P1; Inouye K, 2001, Biotechnol Annu Rev, V7, P179, DOI 10.1016/S1387-2656(01)07037-5; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Kweon SS, 2014, INT J EPIDEMIOL, V43, P558, DOI 10.1093/ije/dys244; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Mezquita-Raya P, 2001, J BONE MINER RES, V16, P1408, DOI 10.1359/jbmr.2001.16.8.1408; Minambres I, 2015, ENDOCR RES, V40, P160, DOI 10.3109/07435800.2014.982326; Oh YJ, 2012, NEPHROL DIAL TRANSPL, V27, P2396, DOI 10.1093/ndt/gfr763; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sahota O, 2004, BONE, V35, P312, DOI 10.1016/j.bone.2004.02.003; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Souberbielle JC, 2001, J CLIN ENDOCR METAB, V86, P3086, DOI 10.1210/jc.86.7.3086; Sun XM, 2015, J ATHEROSCLER THROMB, V22, P355, DOI 10.5551/jat.26070; van Dam RM, 2007, AM J CLIN NUTR, V85, P755, DOI 10.1093/ajcn/85.3.755; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wareham NJ, 1997, METABOLISM, V46, P1171, DOI 10.1016/S0026-0495(97)90212-2; WHO, 2016, GLOB REP PSOR; Woerle HJ, 2004, ARCH INTERN MED, V164, P1627, DOI 10.1001/archinte.164.15.1627; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zhang MC, 2014, MED SCI MONITOR, V20, P1274, DOI 10.12659/MSM.890930	46	6	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158764	10.1371/journal.pone.0158764	http://dx.doi.org/10.1371/journal.pone.0158764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362844	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200111
J	Engelmann, R; Biemelt, A; Cordshagen, A; Johl, A; Kuthning, D; Muller-Hilke, B				Engelmann, Robby; Biemelt, Andra; Cordshagen, Antje; Johl, Anja; Kuthning, Daniela; Mueller-Hilke, Brigitte			The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse	PLOS ONE			English	Article							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; SELECTION; ANTIBODY; DISEASE; ENZYMES; MICE; SELF	Objectives To assess the prerequisites for negative selection of peptidylcitrulline-specific T cells in the thymus. In detail, we here analyzed murine medullary thymic epithelial cells for the expression of peptidylarginine deiminases (PAD) and subsequent citrullination. Methods Medullary thymic epithelial cells were sorted, their mRNA was isolated and the expression of Pad genes was analyzed by quantitative PCR. Citrullination was detected by Western Blot in lysates of sorted medullary thymic epithelial cells and histologically by immunofluorescence of thymic thin sections. Results Pad2 and Pad4 are the main Pad isoforms expressed in mature medullary thymic epithelial cells of the mouse and their levels of expression are comparable to that of insulin (Ins2), another highly and promiscuously expressed protein in the thymus. Citrullination was detected in medullary thymic epithelial cells as shown by Western Blot and immunofluorescence. Conclusions Even though we here show that the murine thymus harbors the prerequisites for central tolerance to PAD and citrullinated peptides, it remains an open question whether the emergence of peptidylcitrulline-specific T cells and of autoantibodies recognizing citrullinated epitopes is caused by a failure of central or peripheral tolerance mechanisms.	[Engelmann, Robby; Biemelt, Andra; Cordshagen, Antje; Johl, Anja; Kuthning, Daniela; Mueller-Hilke, Brigitte] Univ Rostock, Med Ctr, Inst Immunol, Schillingallee 70, D-18057 Rostock, Germany	University of Rostock	Engelmann, R (corresponding author), Univ Rostock, Med Ctr, Inst Immunol, Schillingallee 70, D-18057 Rostock, Germany.	robby.engelmann@med.uni-rostock.de		Engelmann, Robby/0000-0002-1048-3638	Fritz Thyssen foundation;  [10.12.2.146];  [FORUN 889018-2013]	Fritz Thyssen foundation; ; 	The work was supported by a grant of the Fritz Thyssen foundation (http://www.fritz-thyssen-stiftung.de/foerderung/gefoerderte-vorhaben/projekt/pl/pad-gene-und-citrullinierung/p/647/?no_cache). The grant 10.12.2.146 was passed to RE. Furthermore, the project was supported by an intramural grant (FORUN 889018-2013; https://www.med.uni-rostock.de/forschung-lehre/forschung/interne-foerderung/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Bos WH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4511; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Darrah E, 2012, ANN RHEUM DIS, V71, P92, DOI 10.1136/ard.2011.151712; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Garcia-Lozano JR, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4141; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Martinez RJ, 2012, J IMMUNOL, V188, P170, DOI 10.4049/jimmunol.1101311; Thiele GM, 2012, INT IMMUNOPHARMACOL, V13, P424, DOI 10.1016/j.intimp.2012.05.007; van Beers JJBC, 2013, BIOCHIMIE, V95, P299, DOI 10.1016/j.biochi.2012.09.029; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211	22	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158773	10.1371/journal.pone.0158773	http://dx.doi.org/10.1371/journal.pone.0158773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362943	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200112
J	Hasan, NH; Ebrahimie, E; Ignjatovic, J; Tarigan, S; Peaston, A; Hemmatzadeh, F				Hasan, Noor Haliza; Ebrahimie, Esmaeil; Ignjatovic, Jagoda; Tarigan, Simson; Peaston, Anne; Hemmatzadeh, Farhid			Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INTEGRAL MEMBRANE-PROTEIN; A-VIRUS; MATRIX PROTEIN-2; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODY; EXTRACELLULAR DOMAIN; COMPETITIVE ELISA; ECTODOMAIN; VACCINE	A common approach for developing diagnostic tests for influenza virus detection is the use of mouse or rabbit monoclonal and/or polyclonal antibodies against a target antigen of the virus. However, comparative mapping of the target antigen using antibodies from different animal sources has not been evaluated before. This is important because identification of antigenic determinants of the target antigen in different species plays a central role to ensure the efficiency of a diagnostic test, such as competitive ELISA or immunohistochemistry- based tests. Interest in the matrix 2 ectodomain (M2e) protein of avian influenza virus (AIV) as a candidate for a universal vaccine and also as a marker for detection of virus infection in vaccinated animals (DIVA) is the rationale for the selection of this protein for comparative mapping evaluation. This study aimed to map the epitopes of the M2e protein of avian influenza virus H5N1 using chicken, mouse and rabbit monoclonal or monospecific antibodies. Our findings revealed that rabbit antibodies (rAbs) recognized epitope (EVETPTRN13)-E-6 of the M2e, located at the N-terminal of the protein, while mouse (mAb) and chicken antibodies (cAbs) recognized epitope (PTRNEWECK18)-P-10, located at the centre region of the protein. The findings highlighted the difference between the M2e antigenic determinants recognized by different species that emphasized the importance of comparative mapping of antibody reactivity from different animals to the same antigen, especially in the case of multi-host infectious agents such as influenza. The findings are of importance for antigenic mapping, as well as diagnostic test and vaccine development.	[Hasan, Noor Haliza; Ebrahimie, Esmaeil; Peaston, Anne; Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia; [Hasan, Noor Haliza] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Sabah, Malaysia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Adelaide, SA 5005, Australia; [Ebrahimie, Esmaeil] Univ S Australia, Div Informat Technol Engn & Environm, Sch Informat Technol & Math Sci, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia; [Ignjatovic, Jagoda] Univ Melbourne, Sch Vet & Agr Sci, Melbourne, Vic 3010, Australia; [Tarigan, Simson] Indonesian Res Ctr Vet Sci, Bogor, Indonesia	University of Adelaide; Universiti Malaysia Sabah; University of Adelaide; University of South Australia; Flinders University South Australia; University of Melbourne	Hasan, NH; Ebrahimie, E; Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia.; Hasan, NH (corresponding author), Univ Malaysia Sabah, Inst Trop Biol & Conservat, Sabah, Malaysia.; Ebrahimie, E (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Adelaide, SA 5005, Australia.; Ebrahimie, E (corresponding author), Univ S Australia, Div Informat Technol Engn & Environm, Sch Informat Technol & Math Sci, Adelaide, SA, Australia.; Ebrahimie, E (corresponding author), Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia.	noorhaliza.hasan@adelaide.edu.au; esmaeil.ebrahimie@flinders.edu.au; farhid.hemmatzadeh@adelaide.edu.au	Peaston, Anne E/H-7158-2013; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Hemmatzadeh, Farhid/0000-0002-4572-8869; Peaston, Anne/0000-0002-7501-2415; Hasan, Noor Haliza/0000-0003-0319-9417	Australian Centre for International Agricultural Research ACIAR [AH/2006/050, AH/2010/039]; Ministry of Education Malaysia	Australian Centre for International Agricultural Research ACIAR(Australian Ctr Intl Agr Res); Ministry of Education Malaysia	This research is funded by Australian Centre for International Agricultural Research ACIAR (http://aciar.gov.au/) grant numbers AH/2006/050 and AH/2010/039. NHH was funded by the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MIN 17 STAT SOFTW; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Cho KJ, 2015, J VIROL, V89, P3700, DOI 10.1128/JVI.02576-14; DARNULE TV, 1980, EXPERIENTIA, V36, P606, DOI 10.1007/BF01965829; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2011, J GEN VIROL, V92, P301, DOI 10.1099/vir.0.027086-0; Ebrahimi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096984; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Finlay WJJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00342; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hadifar F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108420; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hemmatzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056801; Hjelm B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045817; Hjelm B, 2010, NEW BIOTECHNOL, V27, P129, DOI 10.1016/j.nbt.2009.11.001; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kim MC, 2010, CLIN VACCINE IMMUNOL, V17, P1977, DOI 10.1128/CVI.00191-10; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LAMB RA, 1981, VIROLOGY, V112, P729, DOI 10.1016/0042-6822(81)90317-2; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Lambrecht B, 2007, AVIAN DIS, V51, P221, DOI 10.1637/7589-040206R.1; Leung HC, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.22; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9; McCown MF, 2005, J VIROL, V79, P3595, DOI 10.1128/JVI.79.6.3595-3605.2005; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Park EK, 1998, J VIROL, V72, P2449, DOI 10.1128/JVI.72.3.2449-2455.1998; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; ROTTER V, 1983, J IMMUNOL, V131, P329; Shafer AL, 1998, AVIAN DIS, V42, P28, DOI 10.2307/1592573; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; SUGRUE RJ, 1990, EMBO J, V9, P3469, DOI 10.1002/j.1460-2075.1990.tb07555.x; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Sun J, 2011, IMMUNOME RES, V7, P11; Tarigan S, 2015, AVIAN PATHOL, V27, P1, DOI DOI 10.1080/03079457.2015; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang YJ, 2009, BIOCHEM BIOPH RES CO, V385, P118, DOI 10.1016/j.bbrc.2009.04.129; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; ZEBEDEE SL, 1985, J VIROL, V56, P502, DOI 10.1128/JVI.56.2.502-511.1985; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang MX, 2006, MOL IMMUNOL, V43, P2195, DOI 10.1016/j.molimm.2005.12.015; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhou C, 2012, VACCINE, V30, P3463, DOI 10.1016/j.vaccine.2012.03.021; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678; Zou P, 2005, INT IMMUNOPHARMACOL, V5, P631, DOI 10.1016/j.intimp.2004.12.005	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156418	10.1371/journal.pone.0156418	http://dx.doi.org/10.1371/journal.pone.0156418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362795	Green Published, gold, Green Accepted			2022-12-26	WOS:000378865200001
J	Petrezselyova, S; Lopez-Malo, M; Canadell, D; Roque, A; Serra-Cardona, A; Marques, MC; Vilaprinyo, E; Alves, R; Yenush, L; Arino, J				Petrezselyova, Silvia; Lopez-Malo, Maria; Canadell, David; Roque, Alicia; Serra-Cardona, Albert; Carmen Marques, M.; Vilaprinyo, Ester; Alves, Rui; Yenush, Lynne; Arino, Joaquin			Regulation of the Na+/K+-ATPase Ena1 Expression by Calcineurin/Crz1 under High pH Stress: A Quantitative Study	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; PHOSPHATE TRANSPORTER; NUCLEAR-LOCALIZATION; PROTEIN PHOSPHATASE; ALKALINE STRESS; YEAST; SODIUM; PATHWAY	Regulated expression of the Ena1 Na+-ATPase is a crucial event for adaptation to high salt and/or alkaline pH stress in the budding yeast Saccharomyces cerevisiae. ENA1 expression is under the control of diverse signaling pathways, including that mediated by the calcium-regulatable protein phosphatase calcineurin and its downstream transcription factor Crz1. We present here a quantitative study of the expression of Ena1 in response to alkalinization of the environment and we analyze the contribution of Crz1 to this response. Experimental data and mathematical models substantiate the existence of two stress-responsive Crz1-binding sites in the ENA1 promoter and estimate that the contribution of Crz1 to the early response of the ENA1 promoter is about 60%. The models suggest the existence of a second input with similar kinetics, which would be likely mediated by high pH-induced activation of the Snf1 kinase.	[Petrezselyova, Silvia; Lopez-Malo, Maria; Canadell, David; Serra-Cardona, Albert; Arino, Joaquin] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Petrezselyova, Silvia; Lopez-Malo, Maria; Canadell, David; Roque, Alicia; Serra-Cardona, Albert; Arino, Joaquin] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona 08193, Spain; [Carmen Marques, M.; Yenush, Lynne] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, E-46022 Valencia, Spain; [Vilaprinyo, Ester; Alves, Rui] Univ Lleida, IRB Lleida, Lleida 25198, Spain; [Vilaprinyo, Ester; Alves, Rui] Univ Lleida, Lleida 25198, Spain; [Petrezselyova, Silvia] ASCR, Inst Mol Genet, Vvi, Transgen Models Dis & Transgen Unit,BIOCEV, Prumyslova 595, CZ-25242 Vestec, Czech Republic; [Canadell, David] Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universitat de Lleida; Universitat de Lleida; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Pompeu Fabra University	Arino, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.; Arino, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona 08193, Spain.	Joaquin.Arino@uab.es	Petrezselyova, Silvia/AAI-4044-2020; Petrezselyova, Silvia/G-6324-2014; Vilaprinyo, Ester/A-6702-2010; Alves, Rui/C-5920-2009; Yenush, Lynne/J-8815-2014; Marqués, Maricarmen/AAC-8432-2019; Canadell, David/ABE-9698-2021; Córdova, Alicia Roque/W-5229-2019; López Malo, Maria/C-2789-2017; Arino, Joaquin/D-3756-2011	Petrezselyova, Silvia/0000-0003-3054-540X; Vilaprinyo, Ester/0000-0002-5787-5890; Alves, Rui/0000-0002-8112-5184; Yenush, Lynne/0000-0001-8589-7002; Marqués, Maricarmen/0000-0001-8392-453X; Canadell, David/0000-0003-0682-2980; Córdova, Alicia Roque/0000-0002-6206-6481; López Malo, Maria/0000-0002-8612-2118; Arino, Joaquin/0000-0002-6774-2987; Serra-Cardona, Albert/0000-0003-0282-7311; Arino Carmona, Joaquin/0000-0002-0390-4270	Fondo Europeo de Desarrollo Regional [FEDER]; Ajut SGR-4 award (Generalitat de Catalunya); Spanish Ministry of Education; SysMo2 [EUI2009-04147]; Ministry of Industry and Competitivity, Spain;  [BFU2011-30197-C3-01];  [BFU2014-54591-C2-1-P]	Fondo Europeo de Desarrollo Regional [FEDER](European Commission); Ajut SGR-4 award (Generalitat de Catalunya)(Generalitat de Catalunya); Spanish Ministry of Education(Spanish Government); SysMo2; Ministry of Industry and Competitivity, Spain; ; 	This work was supported by grants BFU2011-30197-C3-01, BFU2014-54591-C2-1-P and EUI2009-04147 (SysMo2) to JA. (Ministry of Industry and Competitivity, Spain, and Fondo Europeo de Desarrollo Regional [FEDER]). JA is the recipient of an Ajut 2014SGR-4 award (Generalitat de Catalunya). DC was recipient of a predoctoral fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Alves R, 2008, BIOTECHNOL GENET ENG, P251; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Berkey CD, 2004, EUKARYOT CELL, V3, P311, DOI 10.1128/EC.3.2.311-317.2004; Bodvard K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053404; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Brachmann CB, 1998, YEAST, V14, P115; Bush A, 2012, USING CELL ID 1 4 R; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Canadell D, 2015, BBA-GENE REGUL MECH, V1849, P653, DOI 10.1016/j.bbagrm.2015.04.001; Marques MC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov017; Comas J, 2016, PLANT J IN PRESS; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Deneke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055442; Farre G, 2013, PLANT J, V75, P441, DOI 10.1111/tpj.12214; Finn EM, 2013, BBA-MOL CELL RES, V1833, P1096, DOI 10.1016/j.bbamcr.2012.12.020; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lee Y, 2011, MATH BIOSCI, V231, P49, DOI 10.1016/j.mbs.2011.03.001; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Mendizabal I, 2001, MOL GENET GENOMICS, V265, P801, DOI 10.1007/s004380100474; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Palumbo MC, 2015, WIRES RNA, V6, P327, DOI 10.1002/wrna.1277; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Ramos J, 2011, FEMS MICROBIOL LETT, V317, P1, DOI 10.1111/j.1574-6968.2011.02214.x; Reynolds A., 1997, CURRENT PROTOCOLS MO; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; Ruiz A, 2008, J BIOL CHEM, V283, P13923, DOI 10.1074/jbc.M708683200; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Rybakova KN, 2015, NUCLEIC ACIDS RES, V43, P153, DOI 10.1093/nar/gku1272; Salvado B, 2011, MATH BIOSCI, V231, P3, DOI 10.1016/j.mbs.2011.02.005; Savageau M., 2010, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serra-Cardona A, 2015, MICROB CELL, V2, P182, DOI 10.15698/mic2015.06.205; Serra-Cardona A, 2014, MOL CELL BIOL, V34, P4420, DOI 10.1128/MCB.01089-14; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Vilaprinyo E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-184; Vilaprinyo E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000674; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2012, 1 COURSE SYSTEMS BIO, DOI DOI 10.4324/9780203702260; Vyas VK, 2005, EUKARYOT CELL, V4, P1882, DOI 10.1128/EC.4.11.1882-1891.2005; Wadskog I, 2006, MOL BIOL CELL, V17, P4988, DOI 10.1091/mbc.E05-08-0798; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zvyagilskaya RA, 2008, FEMS YEAST RES, V8, P685, DOI 10.1111/j.1567-1364.2008.00408.x	67	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158424	10.1371/journal.pone.0158424	http://dx.doi.org/10.1371/journal.pone.0158424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362362	Green Published, gold			2022-12-26	WOS:000378865200072
J	Robinson, DP; Jaidah, MY; Bach, S; Lee, K; Jabado, RW; Rohner, CA; March, A; Caprodossi, S; Henderson, AC; Mair, JM; Ormond, R; Pierce, SJ				Robinson, David P.; Jaidah, Mohammed Y.; Bach, Steffen; Lee, Katie; Jabado, Rima W.; Rohner, Christoph A.; March, Abi; Caprodossi, Simone; Henderson, Aaron C.; Mair, James M.; Ormond, Rupert; Pierce, Simon J.			Population Structure, Abundance and Movement of Whale Sharks in the Arabian Gulf and the Gulf of Oman	PLOS ONE			English	Article							RHINCODON-TYPUS; NINGALOO REEF; OF-CALIFORNIA; SIZE; IDENTIFICATION; CONSERVATION; AGGREGATIONS; RESIDENCY; FISHERIES; BIOLOGY	Data on the occurrence of whale sharks, Rhincodon typus, in the Arabian Gulf and Gulf of Oman were collected by dedicated boat surveys and via a public-sightings scheme during the period from 2011 to 2014. A total of 422 individual whale sharks were photo-identified from the Arabian Gulf and the northern Gulf of Oman during that period. The majority of sharks (81%, n = 341) were encountered at the Al Shaheen area of Qatar, 90 km off the coast, with the Musandam region of Oman a secondary area of interest. At Al Shaheen, there were significantly more male sharks (n = 171) than females (n = 78; X2 = 17.52, P < 0.05). Mean estimated total length (TL) for sharks was 6.90 m +/- 1.24 (median = 7 m; n = 296). Males (7.25 m +/- 1.34; median = 8 m, n = 171) were larger than females (6.44 m +/- 1.09; median = 7 m, n = 78; Mann-Whitney U test, p < 0.01). Of the male sharks assessed for maturity 63% were mature (n = 81), with 50% attaining maturity by 7.29 m and 100% by 9.00 m. Two female sharks of > 9 m individuals were visually assessed as pregnant. Connectivity among sharks sighted in Qatari, Omani and UAE waters was confirmed by individual spot pattern matches. A total of 13 identified sharks were re-sighted at locations other than that at which they were first sighted, including movements into and out of the Arabian Gulf through the Strait of Hormuz. Maximum likelihood techniques were used to model an estimated combined population for the Arabian Gulf and Gulf of Oman of 2837 sharks +/- 1243.91 S.E. (95% C. I. 1720-6295). The Al Shaheen aggregation is thus the first site described as being dominated by mature males while the free-swimming pregnant females are the first reported from the Indian Ocean.	[Robinson, David P.; Mair, James M.; Ormond, Rupert] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Jaidah, Mohammed Y.] Qatar Minist Environm, Doha, Qatar; [Bach, Steffen] Maersk Oil Res & Technol Ctr, Doha, Qatar; [Lee, Katie; March, Abi] Univ York, Dept Environm, York, N Yorkshire, England; [Jabado, Rima W.] Gulf Elasmo Project, Dubai, U Arab Emirates; [Rohner, Christoph A.; Pierce, Simon J.] Marine Megafauna Fdn, Truckee, CA USA; [Robinson, David P.; Caprodossi, Simone] Sharkwatch Arabia, Dubai, U Arab Emirates; [Henderson, Aaron C.] Sch Field Studies, Santiago, Chile; [Ormond, Rupert] Marine Conservat Int, Edinburgh, Midlothian, Scotland	Heriot Watt University; University of York - UK	Robinson, DP (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.; Robinson, DP (corresponding author), Sharkwatch Arabia, Dubai, U Arab Emirates.	sharkwatcharabia@gmail.com	Pierce, Simon J./A-7621-2010	Pierce, Simon J./0000-0002-9375-5175; Jabado, Rima/0000-0001-6239-6723; Rohner, Christoph/0000-0001-8760-8972; Henderson, Aaron/0000-0001-8873-0785	MORTC; Save Our Seas Foundation; Shark Foundation	MORTC; Save Our Seas Foundation; Shark Foundation	Logistics for this project were provided by the Qatar Ministry of Environment (QMOE) and Maersk Oil Research and Technology Centre (MORTC). SB acted as an independent researcher throughout this study with financial support in the form of a salary from the MORTC. The MORTC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DPR's work on this manuscript was supported by two small grants from the Save Our Seas Foundation. SJP's work on this manuscript was supported by the Shark Foundation and private donors. The journal publication fees for this manuscript were provided by the MORTC. All other funders, apart from collaborators from the QMOE, had no role in the preparation or decision to publish the manuscript.	Acuna-Marrero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115946; Afonso P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102060; Alava MN, 1997, 13 AM EL SOC AES ANN, V26; Alava MNR, 2002, ELASMOBRANCH BIODIVE, P132; Anderson R.C., 1993, SHARK FISHERIES MALD; Araujo G, 2014, PEERJ, V2, DOI 10.7717/peerj.543; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Beech MJ, 2005, EMIRATES NATURAL HIS; Berumen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103536; BISHOP JM, 1993, J FISH BIOL, V43, P939, DOI 10.1006/jfbi.1993.1197; Blegvad H, 1944, DANISH SCI INVESTI 3; Brooks Katie, 2010, Western Indian Ocean Journal of Marine Science, V9, P185; Brown B., 1992, Tribulus, V2, P22; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno V LJ, 2001, SHARKS WORLD ANNOTAT, V2, P186; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Duffy CAJ, 2002, NEW ZEAL J MAR FRESH, V36, P565, DOI 10.1080/00288330.2002.9517112; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fox S, 2013, J FISH BIOL, V83, P574, DOI 10.1111/jfb.12195; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Hanfee F, 2001, GENTLE GIANTS SEA IN; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; Hsu HH, 2012, J FISH BIOL, V80, P1595, DOI 10.1111/j.1095-8649.2012.03234.x; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Li W, 2012, J FISH BIOL, V80, P1608, DOI 10.1111/j.1095-8649.2012.03250.x; MacLeod C., 2013, INTRO USING GIS MARI; Mahdi N, 1971, ADDITIONS MARINE FIS, V28; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Norman B, 2005, IUCN 2012 IUCN RED L; Norman BM, 2004, 2127 DEP ENV HER COA; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; Pierce SJ, 2010, AQUAT CONSERV, V20, P782, DOI 10.1002/aqc.1149; RAMACHANDRAN A, 1990, Fishery Technology, V27, P138; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Reynolds RM, 1993, MARINE POLLUTION B, V27, P1; Riley MJ, 2010, AQUAT BIOL, V8, P145, DOI 10.3354/ab00215; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rohner C, 2013, MARINE ECOLOGY PROGR, V493, P1; Rohner CA, 2011, J FISH BIOL, V78, P378, DOI 10.1111/j.1095-8649.2010.02861.x; Rohner CA, 2015, PEERJ, V3, DOI 10.7717/peerj.886; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; ROWAT D, 1997, PHELSUMA NATURE PROT, V5, P77; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; TAYLOR G, 1989, Western Australian Naturalist, V18, P7; Taylor JG, 2007, FISH RES, V84, P65, DOI 10.1016/j.fishres.2006.11.014; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Trono R., 1996, IUCN NEWSLETTER SHAR, V7, P13; Tyminski JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142156; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Vignaud TM, 2014, MOL ECOL, V23, P2590, DOI 10.1111/mec.12754; White A.W., 1971, COMMON SEA FISHES AR; White AE, 1971, SURVEY TRUCIAL STATE, V1; Whitehead H, 2001, ECOLOGY, V82, P1417, DOI 10.1890/0012-9658(2001)082[1417:AOAMUO]2.0.CO;2; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wilson S., 2002, STATUS CORAL REEFS W, P53; Wimmer T, 2004, CAN J ZOOL, V82, P1782, DOI 10.1139/Z04-168	68	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158593	10.1371/journal.pone.0158593	http://dx.doi.org/10.1371/journal.pone.0158593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362839	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200100
J	Oh, BL; Lee, EJ; Kim, H; Girard, MJA; Mari, JM; Kim, TW				Oh, Baek-Lok; Lee, Eun Ji; Kim, Hyunjoong; Girard, Michael J. A.; Mari, Jean Martial; Kim, Tae-Woo			Anterior Lamina Cribrosa Surface Depth in Open-Angle Glaucoma: Relationship with the Position of the Central Retinal Vessel Trunk	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE ELEVATION; AGE-RELATED-CHANGES; NERVE HEAD; EXTRACELLULAR-MATRIX; DISPLACEMENT; DEFORMATION; ENHANCEMENT; COMPONENTS; LOCATION	Purpose To determine the factors influencing the anterior lamina cribrosa (LC) surface depth (LCD) in patients with open-angle glaucoma (OAG), focusing on the association between LCD and the position of the central retinal vessel trunk (CRVT) at the anterior LC surface. Methods Optic nerve heads of 205 OAG eyes were scanned using swept-source optical coherence tomography (SS-OCT). After processing the images using adaptive compensation, the LCD was determined from 11 horizontal B-scan images that divided the optic disc vertically into 12 equal parts. Eyes were divided into two groups (central or peripheral) according to where the CRVT exits from the anterior LC surface. The influence of CRVT position on LCD was evaluated, taking into account age, gender, untreated intraocular pressure (IOP), IOP at optic-disc scanning, retinal nerve fiber layer (RNFL) thickness, visual-field mean deviation, central corneal thickness, and axial length. Results Patients in the peripheral CRVT group were younger and more myopic, and had a larger mean LCD and thinner global RNFL than those in the central CRVT group (all P <= 0.023). On multivariate analysis, the peripheral CRVT location was significantly associated with a larger LCD (P = 0.002), together with the significant association of younger age (P < 0.001), higher untreated IOP (P = 0.010), and thinner RNFL (P = 0.003) on the larger LCD. Conclusion In OAG, CRVT location was an independent factor influencing the LCD, together with age, untreated IOP, and global RNFL thickness. The data indicate that the CRVT may contribute to the resistance of the LC against deformation. A longitudinal prospective observation is required to clarify this relationship.	[Oh, Baek-Lok; Lee, Eun Ji; Kim, Tae-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Kim, Hyunjoong] Yonsei Univ, Dept Appl Stat, Seoul, South Korea; [Girard, Michael J. A.] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Girard, Michael J. A.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ Polynesie Francaise, GePaSud, Faaa, France	Seoul National University (SNU); Yonsei University; National University of Singapore; National University of Singapore; Singapore National Eye Center	Lee, EJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	opticdisc@gmail.com	Girard, Michael/F-9323-2015	Girard, Michael/0000-0003-4408-5918; Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea Grant - Korean Government [2013R1A1A1A05004781]; Seoul National University Bundang Hospital Research Fund [02-2013-036]; Basic Science Research program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012R1A1A2042177]	National Research Foundation of Korea Grant - Korean Government; Seoul National University Bundang Hospital Research Fund; Basic Science Research program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by National Research Foundation of Korea Grant funded by Korean Government (2013R1A1A1A05004781), the Seoul National University Bundang Hospital Research Fund (02-2013-036), and by Basic Science Research program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012R1A1A2042177). The funding organizations had no role in the design or conduct of this research.	Albon J, 2000, BRIT J OPHTHALMOL, V84, P311, DOI 10.1136/bjo.84.3.311; Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; EMERY JM, 1974, T AM ACAD OPHTHALMOL, V78, pO290; GAASTERLAND D, 1978, INVEST OPHTH VIS SCI, V17, P838; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; HERNANDEZ MR, 1989, AM J OPHTHALMOL, V107, P476, DOI 10.1016/0002-9394(89)90491-1; Huang HL, 2013, BRIT J OPHTHALMOL, V97, P96, DOI 10.1136/bjophthalmol-2012-302068; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P99, DOI 10.1136/bjo.78.2.99; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; Kim TW, 2013, CURR EYE RES, V38, P903, DOI 10.3109/02713683.2013.800888; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; LEVY NS, 1984, ARCH OPHTHALMOL-CHIC, V102, P782; Loh WY, 2002, STAT SINICA, V12, P361; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; MORRISON JC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1220, DOI 10.1001/archopht.1989.01070020286040; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Rho CR, 2012, CLIN EXP OPHTHALMOL, V40, pE183, DOI 10.1111/j.1442-9071.2011.02669.x; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; YAN DB, 1994, BRIT J OPHTHALMOL, V78, P643, DOI 10.1136/bjo.78.8.643; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P477, DOI 10.1167/iovs.13-11897	37	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158443	10.1371/journal.pone.0158443	http://dx.doi.org/10.1371/journal.pone.0158443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355646	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400067
J	Renoux, C; Romana, M; Joly, P; Ferdinand, S; Faes, C; Lemonne, N; Skinner, S; Garnier, N; Etienne-Julan, M; Bertrand, Y; Petras, M; Cannas, G; Divialle-Doumdo, L; Nader, E; Cuzzubbo, D; Lamarre, Y; Gauthier, A; Waltz, X; Kebaili, K; Martin, C; Hot, A; Hardy-Dessources, MD; Pialoux, V; Connes, P				Renoux, Celine; Romana, Marc; Joly, Philippe; Ferdinand, Severine; Faes, Camille; Lemonne, Nathalie; Skinner, Sarah; Garnier, Nathalie; Etienne-Julan, Maryse; Bertrand, Yves; Petras, Marie; Cannas, Giovanna; Divialle-Doumdo, Lydia; Nader, Elie; Cuzzubbo, Daniela; Lamarre, Yann; Gauthier, Alexandra; Waltz, Xavier; Kebaili, Kamila; Martin, Cyril; Hot, Arnaud; Hardy-Dessources, Marie-Dominique; Pialoux, Vincent; Connes, Philippe			Effect of Age on Blood Rheology in Sickle Cell Anaemia and Sickle Cell Haemoglobin C Disease: A Cross-Sectional Study	PLOS ONE			English	Article							OXIDATIVE STRESS; VISCOSITY; CHILDREN; HYDROXYUREA; FREQUENCY; CRISES; AGGREGATION; THALASSEMIA; ADHESION; BALANCE	Objectives Blood rheology plays a key role in the pathophysiology of sickle cell anaemia (SS) and sickle cell haemoglobin C disease (SC), but its evolution over the lifespan is unknown. Materials and Methods Blood viscosity, red blood cell (RBC) deformability and aggregation, foetal haemoglobin (HbF) and haematocrit were measured in 114 healthy individuals (AA), 267 SS (161 children + 106 adults) and 138 SC (74 children + 64 adults) patients. Results Our results showed that 1) RBC deformability is at its maximal value during the early years of life in SS and SC populations, mainly because HbF level is also at its peak, 2) during childhood and adulthood, hydroxycarbamide treatment, HbF level and gender modulated RBC deformability in SS patients, independently of age, 3) blood viscosity is higher in older SS and SC patients compared to younger ones and 4) haematocrit decreases as SS patients age. Conclusion The hemorheological changes detected in older patients could play a role in the progressive development of several chronic disorders in sickle cell disease, whose prevalence increases with age. Retarding these age-related haemorheological impairments, by using suitable drugs, may minimize the risks of vaso-occlusive events and chronic disorders.	[Renoux, Celine; Joly, Philippe] Hosp Civils Lyon, Unite Pathol Mol Globule Rouge, Lab Biochim & Biol Mol, Hop Edouard Herriot, Lyon, France; [Renoux, Celine; Joly, Philippe; Faes, Camille; Skinner, Sarah; Nader, Elie; Martin, Cyril; Pialoux, Vincent; Connes, Philippe] Univ Lyon 1, Lab Interuniv Biol Motricite, Equipe Vasc Biol & Red Blood Cell, Lyon, France; [Romana, Marc; Ferdinand, Severine; Lamarre, Yann; Waltz, Xavier; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Univ Antilles Guyane, Hop Pointe A Pitre, UMR Inserm U1134, Hop Ricou, Pointe A Pitre 97159, Guadeloupe, France; [Lemonne, Nathalie; Etienne-Julan, Maryse; Petras, Marie; Divialle-Doumdo, Lydia] Hop Ricou, Hop Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre 97159, Guadeloupe, France; [Garnier, Nathalie; Bertrand, Yves; Cuzzubbo, Daniela; Gauthier, Alexandra; Kebaili, Kamila] Hosp Civils Lyon, Inst Hematol & Oncol Pediat, Lyon, France; [Cannas, Giovanna; Hot, Arnaud] Hosp Civils Lyon, Hop Edouard Herriot, Serv Med Interne, Lyon, France; [Renoux, Celine; Romana, Marc; Joly, Philippe; Ferdinand, Severine; Faes, Camille; Skinner, Sarah; Nader, Elie; Lamarre, Yann; Waltz, Xavier; Martin, Cyril; Hardy-Dessources, Marie-Dominique; Pialoux, Vincent; Connes, Philippe] PRES Sorbonne, Lab Excellence Globule Rouge LABEX GR Ex, Paris, France; [Connes, Philippe] Inst Univ France, Paris, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; CHU Guadeloupe; CHU Lyon; CHU Lyon; Institut Universitaire de France	Connes, P (corresponding author), Univ Lyon 1, Lab Interuniv Biol Motricite, Equipe Vasc Biol & Red Blood Cell, Lyon, France.; Connes, P (corresponding author), Univ Antilles Guyane, Hop Pointe A Pitre, UMR Inserm U1134, Hop Ricou, Pointe A Pitre 97159, Guadeloupe, France.; Connes, P (corresponding author), PRES Sorbonne, Lab Excellence Globule Rouge LABEX GR Ex, Paris, France.; Connes, P (corresponding author), Inst Univ France, Paris, France.	philippe.connes@univ-lyon1.fr	Nader, Elie/AAL-3767-2020; , Hardy-dessources/K-9189-2017; Romana, Marc/K-6442-2017; WALTZ, Xavier/M-3606-2016; MARTIN, Cyril/HGB-8079-2022; Connes, Philippe/J-7835-2019; Lamarre, Yann/ABC-2074-2020; RENOUX, Céline/AAL-3556-2020	, Hardy-dessources/0000-0003-0861-3648; Romana, Marc/0000-0002-8715-9836; WALTZ, Xavier/0000-0002-0838-290X; Connes, Philippe/0000-0002-9232-0268; Nader, Elie/0000-0002-6054-2456; ETIENNE-JULAN, Maryse/0000-0003-1339-6545; FERDINAND, Severine/0000-0001-8258-5089; RENOUX, Celine/0000-0002-7263-805X; MARTIN, Cyril/0000-0003-3378-5249				Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charlot K, 2016, BLOOD CELL MOL DIS, V56, P41, DOI 10.1016/j.bcmd.2015.10.005; Chirico EN, 2012, IUBMB LIFE, V64, P72, DOI 10.1002/iub.584; Cita KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154866; Colin Y, 2014, CURR OPIN HEMATOL, V21, P186, DOI 10.1097/MOH.0000000000000036; Connes P, 2015, BLOOD REV; Connes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079680; Ferrone FA, 2015, AM J HEMATOL, V90, P438, DOI 10.1002/ajh.23958; Gurses D, 2014, IRAN J PEDIATR, V24, P166; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Lamarre Y, 2014, CLIN HEMORHEOL MICRO, V57, P63, DOI 10.3233/CH-131772; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; Lemonne N, 2015, HAEMATOLOGICA, V100, pE383, DOI 10.3324/haematol.2015.130435; Lemonne N, 2014, HAEMATOLOGICA, V99, pE74, DOI 10.3324/haematol.2014.104745; MACKINTOSH TF, 1973, ARCH DIS CHILD, V48, P547, DOI 10.1136/adc.48.7.547; MORRIS J, 1991, BRIT J HAEMATOL, V77, P382, DOI 10.1111/j.1365-2141.1991.tb08588.x; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Noubouossie D, 2015, BLOOD REV; Renoux C, 2015, CLIN HEMORHEOL MICRO; Serjeant G R, 1995, Curr Opin Hematol, V2, P103; SERJEANT GR, 1981, BRIT J HAEMATOL, V48, P533, DOI 10.1111/j.1365-2141.1981.tb02750.x; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Simmonds MJ, 2014, BIORHEOLOGY, V51, P121, DOI 10.3233/BIR-140653; STEINBERG MH, 1995, AM J HEMATOL, V48, P175, DOI 10.1002/ajh.2830480307; STEVENS MCG, 1985, BRIT J HAEMATOL, V60, P279, DOI 10.1111/j.1365-2141.1985.tb07414.x; Tancer-Elci H, 2015, CLIN HEMORHEOL MICRO, V60, P273, DOI 10.3233/CH-131740; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852	33	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158182	10.1371/journal.pone.0158182	http://dx.doi.org/10.1371/journal.pone.0158182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355589	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400036
J	Spicer, OS; Wong, TT; Zmora, N; Zohar, Y				Spicer, Olivia Smith; Wong, Ten-Tsao; Zmora, Nilli; Zohar, Yonathan			Targeted Mutagenesis of the Hypophysiotropic Gnrh3 in Zebrafish (Danio rerio) Reveals No Effects on Reproductive Performance	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; MORONE-SAXATILIS; GENE DISRUPTION; STRIPED BASS; 3 FORMS; EXPRESSION; ONTOGENY; LH; COMPENSATION	Gnrh is the major neuropeptide regulator of vertebrate reproduction, triggering a cascade of events in the pituitary-gonadal axis that result in reproductive competence. Previous research in mice and humans has demonstrated that Gnrh/GNRH null mutations result in hypogonadotropic hypogonadism and infertility. The goal of this study was to eliminate gnrh3 (the hypophysiotropic Gnrh form) function in zebrafish (Danio rerio) to determine how ontogeny and reproductive performance are affected, as well as factors downstream of Gnrh3 along the reproductive axis. Using the TALEN technology, we developed a gnrh3(-/-) zebrafish line that harbors a 62 bp deletion in the gnrh3 gene. Our gnrh3(-/-) zebrafish line represents the first targeted and heritable mutation of a Gnrh isoform in any organism. Using immunohistochemistry, we verified that gnrh3(-/-) fish do not possess Gnrh3 peptide in any regions of the brain. However, other than changes in mRNA levels of pituitary gonadotropin genes (fshb, lhb, and cga) during early development, which are corrected by adulthood, there were no changes in ontogeny and reproduction in gnrh3(-/-) fish. The gnrh3(-/-) zebrafish are fertile, displaying normal gametogenesis and reproductive performance in males and females. Together with our previous results that Gnrh3 cell ablation causes infertility, these results indicate that a compensatory mechanism is being activated, which is probably primed early on upon Gnrh3 neuron differentiation and possibly confined to Gnrh3 neurons. Potential compensation factors and sensitive windows of time for compensation during development and puberty should be explored.	[Zohar, Yonathan] Univ Maryland Baltimore Cty, Dept Marine Biotechnol, Baltimore, MD 21228 USA; Univ Maryland Baltimore Cty, Inst Marine & Environm Technol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University of Maryland Baltimore County	Zohar, Y (corresponding author), Univ Maryland Baltimore Cty, Dept Marine Biotechnol, Baltimore, MD 21228 USA.	zohar@umbc.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	Homer and Martha Gudelsky Family Foundation, Inc.; Homer and Martha Gudelsky Family Foundation, Inc.	Homer and Martha Gudelsky Family Foundation, Inc.; Homer and Martha Gudelsky Family Foundation, Inc.	This work was supported by the Homer and Martha Gudelsky Family Foundation, Inc.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; Aizen J, 2007, GEN COMP ENDOCR, V153, P323, DOI 10.1016/j.ygcen.2007.04.004; Aizen J, 2012, GEN COMP ENDOCR, V178, P28, DOI 10.1016/j.ygcen.2012.04.002; Alok D, 2000, MOL CELL ENDOCRINOL, V168, P65, DOI 10.1016/S0303-7207(00)00317-8; AMOSS M, 1971, BIOCHEM BIOPH RES CO, V44, P205, DOI 10.1016/S0006-291X(71)80179-1; Biran J, 2012, P NATL ACAD SCI USA, V109, P10269, DOI 10.1073/pnas.1119165109; Brent R, 1997, CURRENT PROTOCOLS MO, P11; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Cheng Z, 2013, NAT BIOTECHNOL, V31, P934, DOI 10.1038/nbt.2674; Chu LH, 2014, MOL ENDOCRINOL, V28, P1785, DOI 10.1210/me.2014-1061; COE IR, 1995, MOL CELL ENDOCRINOL, V115, P113, DOI 10.1016/0303-7207(95)03675-W; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Dungan HM, 2007, J NEUROSCI, V27, P12088, DOI 10.1523/JNEUROSCI.2748-07.2007; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gehlert DR, 2008, NEUROPEPTIDES, V42, P367, DOI 10.1016/j.npep.2007.10.005; Golan M, 2015, ENDOCRINOLOGY, V156, P4163, DOI 10.1210/en.2015-1150; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Guzman JM, 2009, COMP BIOCHEM PHYS A, V154, P37, DOI 10.1016/j.cbpa.2009.04.623; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hassin S, 2000, BIOL REPROD, V63, P1691, DOI 10.1095/biolreprod63.6.1691; Hassin S, 1999, BIOL REPROD, V61, P1608, DOI 10.1095/biolreprod61.6.1608; Hoskins LJ, 2008, HORM BEHAV, V54, P379, DOI 10.1016/j.yhbeh.2008.04.011; Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Marshall JC, 1990, RECENT PROG HORM RES, V47, P155; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; Mengen E, 2016, HORM RES PAEDIAT, V85, P107, DOI 10.1159/000441977; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mylonas CC, 2001, REV FISH BIOL FISHER, V10, P463; Nishiguchi R, 2012, FRONT ENDOCRINOL, P3; NOZAKI M, 1990, GEN COMP ENDOCR, V77, P358, DOI 10.1016/0016-6480(90)90225-B; Okubo K, 2001, GEN COMP ENDOCR, V124, P125, DOI 10.1006/gcen.2001.7698; Ottinger MA, 2002, SEMIN AVIAN EXOT PET, V11, P71, DOI 10.1053/saep.2002.122896; Palevitch O, 2007, CELL TISSUE RES, V327, P313, DOI 10.1007/s00441-006-0279-0; POWELL JFF, 1994, P NATL ACAD SCI USA, V91, P12081, DOI 10.1073/pnas.91.25.12081; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; Takahashi A, 2015, ENDOCR REV, V36, pFRI; Tang HP, 2015, ENDOCRINOLOGY, V156, P589, DOI 10.1210/en.2014-1204; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; Wong TT, 2004, BIOL REPROD, V71, P1026, DOI 10.1095/biolreprod.104.028019; Xia W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03676; Yang JJ, 2012, ENDOCRINOLOGY, V153, P1498, DOI 10.1210/en.2011-1949; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Zhang ZW, 2015, ENDOCRINOLOGY, V156, P3747, DOI 10.1210/en.2015-1039; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	60	54	55	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158141	10.1371/journal.pone.0158141	http://dx.doi.org/10.1371/journal.pone.0158141			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355207	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400030
J	Hu, TY; Phiwpan, K; Guo, JT; Zhang, W; Guo, J; Zhang, ZM; Zou, MG; Zhang, XJ; Zhang, JH; Zhou, XY				Hu, Tanyu; Phiwpan, Krung; Guo, Jitao; Zhang, Wei; Guo, Jie; Zhang, Zhongmei; Zou, Mangge; Zhang, Xuejie; Zhang, Jianhua; Zhou, Xuyu			MicroRNA-142-3p Negatively Regulates Canonical Wnt Signaling Pathway	PLOS ONE			English	Article							POLYPOSIS-COLI GENE; BETA-CATENIN; ACTIVATION; CELLS; DIFFERENTIATION; BIOGENESIS; MUTATIONS; SELECTION; CANCER; LEADS	Wnt/beta-catenin signaling pathway plays essential roles in mammalian development and tissue homeostasis. MicroRNAs (miRNAs) are a class of regulators involved in modulating this pathway. In this study, we screened miRNAs regulating Wnt/beta-catenin signaling by using a TopFlash based luciferase reporter. Surprisingly, we found that miR-142 inhibited Wnt/beta-catenin signaling, which was inconsistent with a recent study showing that miR-142-3p targeted Adenomatous Polyposis Coli (APC) to upregulate Wnt/beta-catenin signaling. Due to the discordance, we elaborated experiments by using extensive mutagenesis, which demonstrated that the stem-loop structure was important for miR-142 to efficiently suppress Wnt/beta-catenin signaling. Moreover, the inhibitory effect of miR-142 relies on miR-142-3p rather than miR-142-5p. Further, we found that miR-142-3p directly modulated translation of Ctnnb1 mRNA (encoding beta-catenin) through binding to its 3' untranslated region (3' UTR). Finally, miR-142 was able to repress cell cycle progression by inhibiting active Wnt/beta-catenin signaling. Thus, our findings highlight the inhibitory role of miR-142-3p in Wnt/beta-catenin signaling, which help to understand the complex regulation of Wnt/beta-catenin signaling.	[Hu, Tanyu; Phiwpan, Krung; Guo, Jitao; Zhang, Wei; Guo, Jie; Zhang, Zhongmei; Zou, Mangge; Zhang, Xuejie; Zhang, Jianhua; Zhou, Xuyu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Hu, Tanyu; Phiwpan, Krung; Zhang, Zhongmei; Zou, Mangge; Zhang, Xuejie] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Phiwpan, Krung] Univ Phayao, Fac Allied Hlth Sci, 19 Moo 2 Tambon Maeka Amphore Muang, Phayao, Thailand	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Phayao	Zhou, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	zhouxy@im.ac.cn	Zhou, Xuyu/L-7422-2019; Guo, Jitao/AAP-4971-2020	Zhou, Xuyu/0000-0002-6626-0898; PHIWPAN, KRUNG/0000-0003-3332-5912; zhang, zhongmei/0000-0001-7450-8040; Guo, Jitao/0000-0002-0927-4249	National Natural Science Foundation of China [31070804]; National Key Basic Research and Development 973 Program of China [2012CB917102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development 973 Program of China(National Basic Research Program of China)	This work was supported by grants to XYZ from the National Natural Science Foundation of China (Grant No. 31070804), http://www.nsfc.gov.cn, and the National Key Basic Research and Development 973 Program of China under Grant No. 2012CB917102, http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dudek H, 2014, MOL THER, V22, P92, DOI 10.1038/mt.2013.233; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Huang K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-252; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Isobe T, 2014, ELIFE, V3, DOI 10.7554/eLife.01977; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lu X, 2013, NATURE CELL RES, P1; Mildner A, 2012, BLOOD; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Murai K, 1998, P NATL ACAD SCI USA, V95, P3461, DOI 10.1073/pnas.95.7.3461; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nimmo R, 2013, DEV CELL, P1; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Shrestha A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136913; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Sun YP, 2015, J CLIN INVEST, V125, P2825, DOI 10.1172/JCI78753; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; van Loosdregt J, 2013, IMMUNITY, P1; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	45	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158432	10.1371/journal.pone.0158432	http://dx.doi.org/10.1371/journal.pone.0158432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348426	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200067
J	Li, X; Wang, YK; Song, ZQ; Du, ZQ; Yang, CX				Li, Xuan; Wang, Yan-Kui; Song, Zhi-Qiang; Du, Zhi-Qiang; Yang, Cai-Xia			Dimethyl Sulfoxide Perturbs Cell Cycle Progression and Spindle Organization in Porcine Meiotic Oocytes	PLOS ONE			English	Article							IN-VITRO MATURATION; ACTIVATION; DMSO; DIMETHYLSULFOXIDE; CRYOPRESERVATION; FERTILIZATION; CYTOTOXICITY; COMPETENCE; INCREASES; EMBRYOS	Meiotic maturation of mammalian oocytes is a precisely orchestrated and complex process. Dimethyl sulfoxide (DMSO), a widely used solvent, drug, and cryoprotectant, is capable of disturbing asymmetric cytokinesis of oocyte meiosis in mice. However, in pigs, DMSO's effect on oocyte meiosis still remains unknown. We aimed to evaluate if DMSO treatment will affect porcine oocyte meiosis and the underlying molecular changes as well. Interestingly, we did not observe the formation of the large first polar body and symmetric division for porcine oocytes treated with DMSO, contrary to findings reported in mice. 3% DMSO treatment could inhibit cumulus expansion, increase nuclear abnormality, disturb spindle organization, decrease reactive oxygen species level, and elevate mitochondrial membrane potential of porcine oocytes. There was no effect on germinal vesicle breakdown rate regardless of DMSO concentration. 3% DMSO treatment did not affect expression of genes involved in spindle organization (Bub1 and Mad2) and apoptosis (NF-kappa B, Pten, Bcl2, Caspase3 and Caspase9), however, it significantly decreased expression levels of pluripotency genes (Oct4, Sox2 and Lin28) in mature oocytes. Therefore, we demonstrated that disturbed cumulus expansion, chromosome alignment, spindle organization and pluripotency gene expression could be responsible for DMSO-induced porcine oocyte meiotic arrest and the lower capacity of subsequent embryo development. Our results provide new insights on DMSO's effect on porcine oocyte meiosis and raise safety concerns over DMSO's usage on female reproduction in both farm animals and humans.	[Li, Xuan; Wang, Yan-Kui; Song, Zhi-Qiang; Du, Zhi-Qiang; Yang, Cai-Xia] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Du, ZQ; Yang, CX (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin 150030, Heilongjiang, Peoples R China.	zhqdu@neau.edu.cn; caixiayang@neau.edu.cn	Yang, Cai-Xia/HGC-2198-2022		National Natural Science Foundation of China [31472098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding support was provided by the National Natural Science Foundation of China (grant No. 31472098).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Appeltant R, 2015, THERIOGENOLOGY, V83, P567, DOI 10.1016/j.theriogenology.2014.10.026; Borges EN, 2009, CRYOBIOLOGY, V59, P195, DOI 10.1016/j.cryobiol.2009.07.003; Choi T, 2011, CYTOTECHNOLOGY, V63, P279, DOI 10.1007/s10616-011-9339-8; Czysz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117689; Da Violante G, 2002, BIOL PHARM BULL, V25, P1600, DOI 10.1248/bpb.25.1600; Doria RGS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0472-z; Fan JP, 2015, MOLECULES, V20, P11981, DOI 10.3390/molecules200711981; Gajda B, 2015, CRYOLETTERS, V36, P8; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gupta MK, 2007, THERIOGENOLOGY, V67, P238, DOI 10.1016/j.theriogenology.2006.07.015; Hebling J, 2015, DENT MATER, V31, P399, DOI 10.1016/j.dental.2015.01.007; Ju JC, 2004, MOL REPROD DEV, V68, P125, DOI 10.1002/mrd.20054; Kim E, 2015, THERIOGENOLOGY, V84, P226, DOI 10.1016/j.theriogenology.2015.03.006; Kita H, 2015, ONCOL LETT, V10, P661, DOI 10.3892/ol.2015.3306; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Lin T, 2015, ANIM REPROD SCI, V152, P65, DOI 10.1016/j.anireprosci.2014.11.009; Liu J, 2015, MUTAGENESIS, V30, P527, DOI 10.1093/mutage/gev015; Malekinejad H, 2007, BIOL REPROD, V77, P840, DOI 10.1095/biolreprod.107.062711; Martinez CA, 2015, THERIOGENOLOGY, V83, P693, DOI 10.1016/j.theriogenology.2014.11.001; Miao YL, 2012, ENVIRON MOL MUTAGEN, V53, P561, DOI 10.1002/em.21717; Miller MP, 2012, ELIFE, V1, DOI 10.7554/eLife.00117; MORLEY P, 1993, J CELL PHYSIOL, V156, P219, DOI 10.1002/jcp.1041560202; Niikura Y, 2010, AGING-US, V2, P999, DOI 10.18632/aging.100255; Osman AMM, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0258-1; Pal R, 2012, ARCH TOXICOL, V86, P651, DOI 10.1007/s00204-011-0782-2; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; Parikh FR, 2006, FERTIL STERIL, V86, P839, DOI 10.1016/j.fertnstert.2006.03.028; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Schatten H, 2011, REPRODUCTION, V142, P793, DOI 10.1530/REP-11-0261; Schatten H, 2011, MOL REPROD DEV, V78, P757, DOI 10.1002/mrd.21380; Silva JRV, 2016, DOMEST ANIM ENDOCRIN, V55, P123, DOI 10.1016/j.domaniend.2015.12.006; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Sun QY, 2003, J REPROD DEVELOP, V49, P347, DOI 10.1262/jrd.49.347; Van Blerkom J, 2003, HUM REPROD, V18, P2429, DOI 10.1093/humrep/deg466; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; WANG WH, 1994, BIOL REPROD, V50, P510, DOI 10.1095/biolreprod50.3.510; Yang CX, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096669; Yang D, 2010, J EXP CLIN ASSIST RE, V7, P4; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447; Zhang DX, 2010, MOL REPROD DEV, V77, P462, DOI 10.1002/mrd.21166; Zhang T, 2014, HISTOCHEM CELL BIOL, V142, P185, DOI 10.1007/s00418-014-1182-5; Zhou DJ, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-28	45	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158074	10.1371/journal.pone.0158074	http://dx.doi.org/10.1371/journal.pone.0158074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348312	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200033
J	Malkov, YA; Ponomarenko, A				Malkov, Yury A.; Ponomarenko, Alexander			Growing Homophilic Networks Are Natural Navigable Small Worlds	PLOS ONE			English	Article							RICH-CLUB; SIMILARITY; SEARCH; GROWTH	Navigability, an ability to find a logarithmically short path between elements using only local information, is one of the most fascinating properties of real-life networks. However, the exact mechanism responsible for the formation of navigation properties remained unknown. We show that navigability can be achieved by using only two ingredients present in the majority of networks: network growth and local homophily, giving a persuasive answer how the navigation appears in real-life networks. A very simple algorithm produces hierarchical self-similar optimally wired navigable small world networks with exponential degree distribution by using only local information. Adding preferential attachment produces a scale-free network which has shorter greedy paths, but worse (power law) scaling of the information extraction locality (algorithmic complexity of a search). Introducing saturation of the preferential attachment leads to truncated scale-free degree distribution that offers a good trade-off between these parameters and can be useful for practical applications. Several features of the model are observed in real-life networks, in particular in the brain neural networks, supporting the earlier suggestions that they are navigable.	[Malkov, Yury A.] Russian Acad Sci, Inst Appl Phys, Fed State Budgetary Inst Sci, 46 Ulyanov St, Nizhnii Novgorod 603950, Russia; [Ponomarenko, Alexander] Natl Res Univ, Higher Sch Econ, Lab Algorithms & Technol Network Anal, Nizhnii Novgorod, Russia	Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; HSE University (National Research University Higher School of Economics)	Malkov, YA (corresponding author), Russian Acad Sci, Inst Appl Phys, Fed State Budgetary Inst Sci, 46 Ulyanov St, Nizhnii Novgorod 603950, Russia.	yurymalkov@mail.ru			Russian Foundation for Basic Research [16-31-60104 mol_a_dk]; Government of Russian Federation [14. Z50.31.0033]; Institute of Applied Physics of RAS; Laboratory of Algorithms and Technologies for Network Analysis; National Research University Higher School of Economics; RFBR	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Government of Russian Federation; Institute of Applied Physics of RAS; Laboratory of Algorithms and Technologies for Network Analysis; National Research University Higher School of Economics; RFBR(Russian Foundation for Basic Research (RFBR))	The reported study was funded by Russian Foundation for Basic Research, according to research project No. 16-31-60104 mol_a_dk (http://www.rfbr.ru/rffi/eng), and supported by the Government of Russian Federation, agreement #14. Z50.31.0033, with the Institute of Applied Physics of RAS (http://M(sic)HO6pHayK(sic).p(sic)/) (receiver: YAM). AP is grateful for the support from the Laboratory of Algorithms and Technologies for Network Analysis, National Research University Higher School of Economics (https://nnov.hse.ru/en/latna/). The grants have sponsored the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The reported study was funded by RFBR, according to the research project No. 16-31-60104 mol_a_dk and supported by Government of Russian Federation (agreement #14.Z50.31.0033 with the Institute of Applied Physics of RAS). Alexander Ponomarenko is grateful for the support from the Laboratory of Algorithms and Technologies for Network Analysis, National Research University Higher School of Economics.	Arbib MA., 2003, HDB BRAIN THEORY NEU; Arya S, 1993, APPROXIMATE NEAREST; Ball G, 2014, P NATL ACAD SCI USA, V111, P7456, DOI 10.1073/pnas.1324118111; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beaumont O, 2007, PAR DISTR PROC S 200; Beaumont O, 2007, LECT NOTES COMPUT SC, V4878, P315; Betzel Richard F, 2016, Neuroimage, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Boytsov L, 2013, LECT NOTES COMPUT SC, V8199, P280, DOI 10.1007/978-3-642-41062-8_28; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chaintreau A, 2008, LECT NOTES COMPUT SC, V5125, P133, DOI 10.1007/978-3-540-70575-8_12; Chavez E, 2001, ACM COMPUT SURV, V33, P273, DOI 10.1145/502807.502808; Clarke I, 2001, DESIGNING PRIVACY EN; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Colomer-de-Simon P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02517; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Gallos LK, P NATL ACAD SCI, V2, P2825; Hajebi K., 2011, PROC INT JOINT C ART, P1312, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-222; Hu YQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.108701; Huang W, 2014, PHYSICA A, V393, P132, DOI 10.1016/j.physa.2013.09.014; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Krioukov D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036106; Li G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042810; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Lifshits Y, 2009, SOC IND APPL MATH; Lim S, 2015, BIOL CYBERN, V109, P275, DOI 10.1007/s00422-014-0641-3; Malkov Yury, 2012, Similarity Search and Applications. Proceedings of the 5th International Conference, SISAP 2012, P132, DOI 10.1007/978-3-642-32153-5_10; Malkov Y, 2014, INFORM SYST, V45, P61, DOI 10.1016/j.is.2013.10.006; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Naidan B, 2015, PROC VLDB ENDOW, V8, P1618; Navarro G, 2002, VLDB J, V11, P28, DOI 10.1007/s007780200060; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nicosia V, 2013, P NATL ACAD SCI USA, V110, P7880, DOI 10.1073/pnas.1300753110; Ozik J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026108; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Ponomarenko A., 2014, DATA ANAL; Ponomarenko A, 2011, ICT&A 2011/DEMSET 2011: INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGIES AND APPLICATIONS / INTERNATIONAL CONFERENCE ON DESIGN AND MODELING IN SCIENCE, EDUCATION, AND TECHNOLOGY, P40; Qi S, J NEUROSCIENCE METHO; Rubinov Mikail, 2013, Dialogues Clin Neurosci, V15, P339; Sandberg O., 2006, ARXIVCS0607025; Sebastian TB, 2002, PATT REC 2002 P 16 I; Serrano MA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078701; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Thadakamalla HP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/190; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Varier S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001044; Vertes PE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0531; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Wang BA, 2013, PHYSICA A, V392, P1902, DOI 10.1016/j.physa.2013.01.001; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang Z, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1329, DOI 10.1145/2736277.2741110; Zhuo Z, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053030; Zitin A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07047	62	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158162	10.1371/journal.pone.0158162	http://dx.doi.org/10.1371/journal.pone.0158162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348120	Green Published, gold, Green Submitted			2022-12-26	WOS:000378801200042
J	Wright, EA; d'Esterre, CD; Morrison, LB; Cockburn, N; Kovacs, M; Lee, TY				Wright, Eric A.; d'Esterre, Christopher D.; Morrison, Laura B.; Cockburn, Neil; Kovacs, Michael; Lee, Ting-Yim			Absolute Cerebral Blood Flow Infarction Threshold for 3-Hour Ischemia Time Determined with CT Perfusion and F-18-FFMZ-PET Imaging in a Porcine Model of Cerebral Ischemia	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BENZODIAZEPINE-RECEPTORS; COMPUTED-TOMOGRAPHY; ARTERY OCCLUSION; FOCAL ISCHEMIA; STROKE; PENUMBRA; BRAIN; CORE; REPERFUSION	CT Perfusion (CTP) derived cerebral blood flow (CBF) thresholds have been proposed as the optimal parameter for distinguishing the infarct core prior to reperfusion. Previous threshold-derivation studies have been limited by uncertainties introduced by infarct expansion between the acute phase of stroke and follow-up imaging, or DWI lesion reversibility. In this study a model is proposed for determining infarction CBF thresholds at 3hr ischemia time by comparing contemporaneously acquired CTP derived CBF maps to F-18-FFMZ-PET imaging, with the objective of deriving a CBF threshold for infarction after 3 hours of ischemia. Endothelin-1 (ET-1) was injected into the brain of Duroc-Cross pigs (n = 11) through a burr hole in the skull. CTP images were acquired 10 and 30 minutes post ET-1 injection and then every 30 minutes for 150 minutes. 370 MBq of F-18-FFMZ was injected similar to 120 minutes post ET-1 injection and PET images were acquired for 25 minutes starting similar to 155-180 minutes post ET-1 injection. CBF maps from each CTP acquisition were co-registered and converted into a median CBF map. The median CBF map was co-registered to blood volume maps for vessel exclusion, an average CT image for grey/white matter segmentation, and F-18-FFMZ-PET images for infarct delineation. Logistic regression and ROC analysis were performed on infarcted and non-infarcted pixel CBF values for each animal that developed infarct. Six of the eleven animals developed infarction. The mean CBF value corresponding to the optimal operating point of the ROC curves for the 6 animals was 12.6 +/- 2.8 mL.min(-1).100g(-1) for infarction after 3 hours of ischemia. The porcine ET-1 model of cerebral ischemia is easier to implement then other large animal models of stroke, and performs similarly as long as CBF is monitored using CTP to prevent reperfusion.	[Wright, Eric A.; Kovacs, Michael; Lee, Ting-Yim] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Wright, Eric A.; Lee, Ting-Yim] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Wright, Eric A.; Morrison, Laura B.; Cockburn, Neil; Kovacs, Michael; Lee, Ting-Yim] Lawson Hlth Res Inst, Lawson Imaging, London, ON, Canada; [d'Esterre, Christopher D.] Univ Calgary, Dept Radiol, Foothills Med Ctr, Calgary, AB, Canada; [Kovacs, Michael; Lee, Ting-Yim] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Oncol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Calgary; Western University (University of Western Ontario); Western University (University of Western Ontario)	Wright, EA (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.; Wright, EA (corresponding author), Univ Western Ontario, Robarts Res Inst, London, ON, Canada.; Wright, EA (corresponding author), Lawson Hlth Res Inst, Lawson Imaging, London, ON, Canada.	ewrigh32@uwo.ca	Lee, Ting-Yim/M-1721-2013		Canadian Institutes of Health Research [246794-MPI]; Heart and Stroke Foundation of Canada [NA6758]; Canada Foundation for Innovation [30954]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by funding from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (Grant Number: 246794-MPI, received by TL), the Heart and Stroke Foundation of Canada (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm) (Grant Number: NA6758, received by TL), and the Canada Foundation for Innovation (http://www.innovation.ca/) (Grant Number: 30954, received by TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by the Canadian Institute of Health Research and the Canadian Foundation for Innovation. The authors would like to thank Jennifer Hadway and Lise Desjardins for their assistance with handling the animals and the team working at the cyclotron at St. Joseph's Hospital for producing the <SUP>18</SUP>F-FFMZ for PET imaging.	Bao DZ, 2013, EXP THER MED, V6, P133, DOI 10.3892/etm.2013.1107; Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326; d'Esterre CD, 2015, STROKE, V46, P3390, DOI 10.1161/STROKEAHA.115.009250; d'Esterre CD, 2015, TRANSL STROKE RES, V6, P234, DOI 10.1007/s12975-015-0394-x; Eilaghi A, 2014, AM J NEURORADIOL, V35, P472, DOI 10.3174/ajnr.A3740; Freeman JW, 2013, STROKE, V44, P1629, DOI 10.1161/STROKEAHA.111.000486; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Grunder G, 2001, EUR J NUCL MED, V28, P1463, DOI 10.1007/s002590100594; Heiss WD, 2004, STROKE, V35, P1892, DOI 10.1161/01.STR.0000134746.93535.9b; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Imai H, 2006, J NEUROSURG, V104, P123, DOI 10.3171/ped.2006.104.2.123; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Konstas AA, 2009, AM J NEURORADIOL, V30, P885, DOI 10.3174/ajnr.A1492; Labeyrie MA, 2012, STROKE, V43, P2986, DOI 10.1161/STROKEAHA.112.661009; Leveque P, 2003, EUR J NUCL MED MOL I, V30, P1630, DOI 10.1007/s00259-003-1304-0; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Murphy BD, 2008, RADIOLOGY, V247, P818, DOI 10.1148/radiol.2473070551; Nikolova S, 2009, J NEUROSCI METH, V179, P22, DOI 10.1016/j.jneumeth.2009.01.009; O'Brien MD, 1973, STROKE, V4, P201, DOI 10.1161/01.STR.4.2.201; Olivot JM, 2009, STROKE, V40, P1692, DOI 10.1161/STROKEAHA.108.538082; Onetti Y, 2015, AM J PHYSIOL-HEART C, V308, pH862, DOI 10.1152/ajpheart.00001.2015; Pan JW, 2013, J COMPUT ASSIST TOMO, V37, P645, DOI 10.1097/RCT.0b013e31829866fc; Platt SR, 2014, EXP TRANSL STROKE ME, V6, P1, DOI DOI 10.1186/2040-7378-6-5; Qiao YJ, 2014, STROKE, V45, P1355, DOI 10.1161/STROKEAHA.113.003362; RICHARDS JG, 1984, J RECEPTOR RES, V4, P657, DOI 10.3109/10799898409042579; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; TRAUPE H, 1982, STROKE, V13, P615, DOI 10.1161/01.STR.13.5.615; Van Winkle JA, 2013, J NEUROSCI METH, V213, P63, DOI 10.1016/j.jneumeth.2012.12.004; Virley D, 2004, J CEREBR BLOOD F MET, V24, P24, DOI 10.1097/01.WCB.0000095801.98378.4A; Yu Y, 2016, SCI REP, V10, P1, DOI DOI 10.1007/S10535-016-598-2	31	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158157	10.1371/journal.pone.0158157	http://dx.doi.org/10.1371/journal.pone.0158157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347877	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200041
J	Theilmann, RJ; Darquenne, C; Elliott, AR; Bailey, BA; Conrad, DJ				Theilmann, Rebecca J.; Darquenne, Chantal; Elliott, Ann R.; Bailey, Barbara A.; Conrad, Douglas J.			Characterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology	PLOS ONE			English	Article							INERT-GAS WASHOUT; CLEARANCE INDEX; VENTILATION HETEROGENEITY; COMPUTED-TOMOGRAPHY; SURFACE DEHYDRATION; CHILDREN; MULTIPLE; ACINAR; CF; INFLAMMATION	Translational investigations in cystic fibrosis (CF) have a need for improved quantitative and longitudinal measures of disease status. To establish a non-invasive quantitative MRI technique to monitor lung health in patients with CF and correlate MR metrics with airway physiology as measured by multiple breath washout (MBW). Data were collected in 12 CF patients and 12 healthy controls. Regional (central and peripheral lung) measures of fractional lung water density (FLD: air to 100% fluid) were acquired both at FRC and TLC on a 1.5T MRI. The median FLD (mFLD) and the FRC-to-TLC mFLD ratio were calculated for each region at both lung volumes. Spirometry and MBW data were also acquired for each subject. Ventilation inhomogeneities were quantified by the lung clearance index (LCI) and by indices S-cond* and S-acin* that assess inhomogeneities in the conducting (central) and acinar (peripheral) lung regions, respectively. MBW indices and mFLD at TLC (both regions) were significantly elevated in CF (p<0.01) compared to controls. The mFLD at TLC (central: R=0.82) and the FRC-to-TLC mFLD ratio (peripheral: R=-0.77) were strongly correlated with S-cond* and LCI. CF patients had high lung water content at TLC when compared to controls. This is likely due to the presence of retained airway secretions and airway wall edema (more water) and to limited expansions of air trapping areas (less air) in CF subjects. FRC-to-TLC ratios of mFLD strongly correlated with central ventilation inhomogeneities. These combined measures may provide a useful marker of both retained mucus and air trapping in CF lungs.	[Theilmann, Rebecca J.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Darquenne, Chantal; Elliott, Ann R.; Conrad, Douglas J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Bailey, Barbara A.] Univ Calif San Diego, Dept Math & Stat, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Theilmann, RJ (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	rtheilmann@ucsd.edu			National Center for Research Resources [UL1 RR031980]; National Institute of Biomedical Imaging and Bioengineering [R21 EB015579]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015579] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Support was provided by: 1) (RJT) National Center for Research Resources, UL1 RR031980 (http://grantome.com/grant/NIH/UL1-RR031980-02-8741). Ctsa Infrastructure for Clinical Trials PI: Firestein, Gary Steven University of California San Diego, La Jolla, CA, United States; 2) (RJT) National Institute of Biomedical Imaging and Bioengineering, R21 EB015579. PI: Theilmann. University of California San Diego, CA, United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2011, EUR RESPIR J, V37, P806, DOI 10.1183/09031936.00072510; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; Belessis Y, 2012, AM J RESP CRIT CARE, V185, P862, DOI 10.1164/rccm.201109-1631OC; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; de Jong PA, 2006, THORAX, V61, P80, DOI 10.1136/thx.2005.045146; De Rse V, 2002, EUR RESPIR J, V19, P333, DOI 10.1183/09031936.02.00229202; Downie SR, 2007, THORAX, V62, P684, DOI 10.1136/thx.2006.069682; Eckley WT, 1902, FOUNDED ON GRAY AND, Vviii; Ellemunter H, 2010, RESP MED, V104, P1834, DOI 10.1016/j.rmed.2010.06.010; Fuchs SI, 2010, PEDIATR PULM, V45, P301, DOI 10.1002/ppul.21180; Gibson GJ, 1996, EUR RESPIR J, V9, P2640, DOI 10.1183/09031936.96.09122640; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henderson AC, 2012, RESP PHYSIOL NEUROBI, V180, P331, DOI 10.1016/j.resp.2011.12.013; Holverda S, 2011, J MAGN RESON IMAGING, V34, P220, DOI 10.1002/jmri.22600; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Horsley A, 2015, RESPIROLOGY, V20, P33, DOI 10.1111/resp.12382; Horsley A, 2009, RESP MED, V103, P793, DOI 10.1016/j.rmed.2009.01.025; Horsley AR, 2008, RESP PHYSIOL NEUROBI, V162, P197, DOI 10.1016/j.resp.2008.06.014; Jain M, 2014, AM J RESP CRIT CARE, V189, P1181, DOI 10.1164/rccm.201402-0203UP; LANDAU LI, 1973, AM REV RESPIR DIS, V108, P593; MARKS J, 1986, AM REV RESPIR DIS, V133, P414; Martinez S, 2008, RADIOGRAPHICS, V28, P1369, DOI 10.1148/rg.285075212; Munro B. H., 2005, STAT METHODS HLTH CA, DOI DOI 10.1093/annonc/mdx645; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; PHIPPS PR, 1989, AM REV RESPIR DIS, V139, P1516, DOI 10.1164/ajrccm/139.6.1516; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; Robinson PD, 2010, THORAX, V65, P659, DOI 10.1136/thx.2009.121590; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Robinson PD, 2009, PEDIATR PULM, V44, P733, DOI 10.1002/ppul.20956; Robinson PD, 2009, RESPIRATION, V78, P339, DOI 10.1159/000225373; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; Stuart-Andrews CR, 1985, J APPL PHYSIOL, V112, P1073, DOI DOI 10.1152/JAPPLPHYSI0L.00372.2011; Takeda H, 1997, PROSTAG OTH LIPID M, V54, P805, DOI 10.1016/S0090-6980(97)00158-5; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; Verbanck S, 1999, AM J RESP CRIT CARE, V159, P1545, DOI 10.1164/ajrccm.159.5.9809017; Verbanck S, 1998, AM J RESP CRIT CARE, V157, P1573, DOI 10.1164/ajrccm.157.5.9710042; Verbanck S, 1997, J APPL PHYSIOL, V83, P1907, DOI 10.1152/jappl.1997.83.6.1907; Verbanck S, 2013, EUR RESPIR J, V42, P380, DOI 10.1183/09031936.00125312; Verbanck S, 2013, RESP PHYSIOL NEUROBI, V188, P124, DOI 10.1016/j.resp.2013.05.011; Verbanck S, 2012, THORAX, V67, P789, DOI 10.1136/thoraxjnl-2011-201484; Verbanck S, 2012, J APPL PHYSIOL, V112, P782, DOI 10.1152/japplphysiol.01221.2011; Vermeulen F, 2014, THORAX, V69, P39, DOI 10.1136/thoraxjnl-2013-203807; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157177	10.1371/journal.pone.0157177	http://dx.doi.org/10.1371/journal.pone.0157177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337056	Green Submitted, gold, Green Published			2022-12-26	WOS:000378389200011
J	Daly, C; Castanaro, C; Zhang, W; Zhang, Q; Wei, Y; Ni, M; Young, TM; Zhang, L; Burova, E; Thurston, G				Daly, C.; Castanaro, C.; Zhang, W.; Zhang, Q.; Wei, Y.; Ni, M.; Young, T. M.; Zhang, L.; Burova, E.; Thurston, G.			FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling	ONCOGENE			English	Article							COMPARATIVE GENOMIC ANALYSIS; SQUAMOUS-CELL CARCINOMA; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; GENE FUSIONS; LUNG-CANCER; CETUXIMAB; GROWTH; HEAD; ANTIBODY	The epidermal growth factor receptor (EGFR) is a clinically validated target in head and neck squamous cell carcinoma (HNSCC), where EGFR-blocking antibodies are approved for first-line treatment. However, as with other targeted therapies, intrinsic/acquired resistance mechanisms limit efficacy. In the FaDu HNSCC xenograft model, we show that combined blockade of EGFR and ERBB3 promotes rapid tumor regression, followed by the eventual outgrowth of resistant cells. RNA sequencing revealed that resistant cells express FGFR3-TACC3 fusion proteins, which were validated as drivers of the resistant phenotype by several approaches, including CRISPR-mediated inactivation of FGFR3-TACC3 fusion genes. Interestingly, analysis of signaling in resistant cell lines demonstrated that FGFR3-TACC3 fusion proteins promote resistance by preferentially substituting for EGFR/RAS/ERK signaling rather than ERBB3/PI3K/AKT signaling. Furthermore, although FGFR3-TACC3 fusion proteins promote resistance of additional EGFR-dependent HNSCC and lung cancer cell lines to EGFR blockade, they are unable to compensate for inhibition of PI3K signaling in PIK3CA-mutant HNSCC cell lines. Validation of FGFR3-TACC3 fusion proteins as endogenous drivers of resistance in our screen provides strong evidence that these fusions are capable of substituting for EGFR signaling. Thus, FGFR3-TACC3 fusion proteins may represent a novel mechanism of acquired resistance in EGFR-dependent cancers of multiple cell lineages.	[Daly, C.; Castanaro, C.; Zhang, W.; Zhang, Q.; Wei, Y.; Ni, M.; Young, T. M.; Zhang, L.; Burova, E.; Thurston, G.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Zhang, Q.] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA	Regeneron; Roche Holding; Genentech	Daly, C (corresponding author), Regeneron Pharmaceut Inc, Dept Oncol, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	christopher.daly@regeneron.com		Daly, Christopher/0000-0003-3800-8174; Thurston, Gavin/0000-0002-4105-5919	Regeneron Pharmaceuticals Inc.	Regeneron Pharmaceuticals Inc.(Regeneron)	We thank Elizabeth Pasnikowski, Chandrika Taduriyasas, Jennifer Espert and David D'Ambrosio for technical assistance and Neil Stahl and George Yancopoulos for helpful comments and suggestions. All research was fully supported by Regeneron Pharmaceuticals Inc.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Capelletti M, 2014, CLIN CANCER RES, V20, P6551, DOI 10.1158/1078-0432.CCR-14-1337; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Gaykalova DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093102; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Herrera-Abreu MT, 2013, CANCER DISCOV, V3, P1058, DOI 10.1158/2159-8290.CD-12-0569; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang S, 2013, CANCER RES, V73, P824, DOI 10.1158/0008-5472.CAN-12-1611; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jiang N, 2014, MOL CANCER THER, V13, P1826, DOI 10.1158/1535-7163.MCT-13-1093; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Juanpere N, 2012, HUM PATHOL, V43, P1573, DOI 10.1016/j.humpath.2011.10.026; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Knowles MA, 2008, FUTURE ONCOL, V4, P71, DOI 10.2217/14796694.4.1.71; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Marshall ME, 2011, CLIN CANCER RES, V17, P5016, DOI 10.1158/1078-0432.CCR-11-0050; Mirschberger C, 2013, CANCER RES, V73, P5183, DOI 10.1158/0008-5472.CAN-13-0099; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Nelson KN, 2016, MOL CANCER RES, V14, P458, DOI 10.1158/1541-7786.MCR-15-0497; Oliveras-Ferraros C, 2012, BRIT J CANCER, V106, P1406, DOI 10.1038/bjc.2012.103; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; [王如松 Wang Rusong], 2014, [生态学报, Acta Ecologica Sinica], V34, P1; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yuan L, 2014, CANCER BIOL THER, V15, P1613, DOI 10.4161/15384047.2014.961874; Zhang L, 2014, MOL CANCER THER, V13, P1345, DOI 10.1158/1535-7163.MCT-13-1033	47	31	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					471	481		10.1038/onc.2016.216	http://dx.doi.org/10.1038/onc.2016.216			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27345413	Green Published, hybrid			2022-12-26	WOS:000394166700004
J	Schmidt, T; Ye, F; Situ, AJ; An, W; Ginsberg, MH; Ulmer, TS				Schmidt, Thomas; Ye, Feng; Situ, Alan J.; An, Woojin; Ginsberg, Mark H.; Ulmer, Tobias S.			A Conserved Ectodomain-Transmembrane Domain Linker Motif Tunes the Allosteric Regulation of Cell Surface Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cytokine; integrin; isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); protein dynamics; receptor signaling; transmembrane cell surface receptors	GROWTH-FACTOR RECEPTOR; INTEGRIN ACTIVATION; DIPOLAR COUPLINGS; PROTEIN STRUCTURES; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS; ALPHA-SUBUNIT; COMPLEX	In many families of cell surface receptors, a single transmembrane (TM) -helix separates ecto- and cytosolic domains. A defined coupling of ecto- and TM domains must be essential to allosteric receptor regulation but remains little understood. Here, we characterize the linker structure, dynamics, and resulting ecto-TM domain coupling of integrin IIb in model constructs and relate it to other integrin subunits by mutagenesis. Cellular integrin activation assays subsequently validate the findings in intact receptors. Our results indicate a flexible yet carefully tuned ecto-TM coupling that modulates the signaling threshold of integrin receptors. Interestingly, a proline at the N-terminal TM helix border, termed NBP, is critical to linker flexibility in integrins. NBP is further predicted in 21% of human single-pass TM proteins and validated in cytokine receptors by the TM domain structure of the cytokine receptor common subunit and its P441A-substituted variant. Thus, NBP is a conserved uncoupling motif of the ecto-TM domain transition and the degree of ecto-TM domain coupling represents an important parameter in the allosteric regulation of diverse cell surface receptors.	[Schmidt, Thomas; Situ, Alan J.; Ulmer, Tobias S.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Schmidt, Thomas; Situ, Alan J.; Ulmer, Tobias S.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [An, Woojin] Univ Southern Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [An, Woojin] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schmidt, Thomas] NIDDK, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA	University of Southern California; University of Southern California; University of California System; University of California San Diego; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ulmer, TS (corresponding author), 1501 San Pablo St,ZNI 111, Los Angeles, CA 90033 USA.	tulmer@usc.edu			American Heart Association [15GRNT23200010]; National Institutes of Health [HL31950, HL078784, HL117807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117807, P01HL031950, P01HL078784] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 15GRNT23200010 (to T. S. U.) and National Institutes of Health Grants HL31950, HL078784, and HL117807 (to M. H. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bessman NJ, 2014, CURR OPIN STRUC BIOL, V29, P95, DOI 10.1016/j.sbi.2014.10.002; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Dai A, 2015, J BIOL CHEM, V290, P27168, DOI 10.1074/jbc.M115.682377; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Grigoryan G, 2011, ANNU REV BIOCHEM, V80, P211, DOI 10.1146/annurev-biochem-091008-152423; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hercus TR, 2013, CYTOKINE GROWTH F R, V24, P189, DOI 10.1016/j.cytogfr.2013.03.002; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; KAMATH U, 1989, J BIOL CHEM, V264, P5586; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2002, BIOCHEMISTRY-US, V41, P15618, DOI 10.1021/bi026822l; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; SCHIMMEL PR, 1968, J MOL BIOL, V34, P105, DOI 10.1016/0022-2836(68)90237-4; Schlessinger J, 2014, COLD SPRING HARBOR P, V6; Schmidt T, 2015, J BIOL CHEM, V290, P8283, DOI 10.1074/jbc.M114.623504; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; Shelar A, 2014, PROTEINS, V82, P3420, DOI 10.1002/prot.24696; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Situ AJ, 2014, J MOL BIOL, V426, P3670, DOI 10.1016/j.jmb.2014.08.020; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Surya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074281; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Wang W, 2010, BIOCHEMISTRY-US, V49, P10158, DOI 10.1021/bi101462h; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	60	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17536	17546		10.1074/jbc.M116.733683	http://dx.doi.org/10.1074/jbc.M116.733683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365391	hybrid, Green Published			2022-12-26	WOS:000383241300006
J	Holter, JC; Ueland, T; Norseth, J; Brunborg, C; Froland, SS; Husebye, E; Aukrust, P; Heggelund, L				Holter, Jan C.; Ueland, Thor; Norseth, Jon; Brunborg, Cathrine; Froland, Stig S.; Husebye, Einar; Aukrust, Pal; Heggelund, Lars			Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D DEFICIENCY; D SUPPLEMENTATION; RISK; ASSOCIATION; PREVENTION; RESPONSES; INNATE; PHASE; KABUL	Background Low vitamin D status has been associated with short-term (30-day) mortality in hospitalized adults with community-acquired pneumonia (CAP). Data on its prevalence in these patients are scarce, and impact on long-term prognosis is unknown. We examined the prevalence of vitamin D deficiency and inadequacy and their effect on long-term mortality in hospitalized adults with CAP. Methods Secondary follow-up analysis of data from a prospectively recruited (January 2008-January 2011) well-defined cohort of 241 hospital survivors of CAP (Norway, latitude 60 degrees N). Serum 25-hydroxyvitamin D levels, demographic, clinical, and laboratory data were measured within 48 hours of admission. The etiology of CAP was established in 63% of patients through extensive microbiological investigations. Mortality data were obtained from the national Cause of Death Registry. Explanatory strategy and Cox regression models were used to explore the association between vitamin D status and all-cause mortality. Results Median age was 66 years. Eighty-seven (36%) patients were vitamin D deficient (<30 nmol/L), 81 (34%) were inadequate (30-49 nmol/L), and 73 (30%) were sufficient (>= 50 nmol/L). Seventy-two patients died over a median of 1839 days (range 1-2520 days), corresponding to cumulative 5-year survival rates of 66.2%(95% CI 56.2-76.2%), 77.0% (67.6-86.4%), and 77.8% (67.8-87.8%) for vitamin D deficient, inadequate, and sufficient patients, respectively. After adjusting for confounders (age, chronic obstructive pulmonary disease, immunocompromization and season), vitamin D deficiency, but not inadequacy, was significantly associated with higher mortality compared to patients with sufficiency (HR 1.91, 95% CI 1.06-3.45; P = .031). Conclusions There is a high prevalence of vitamin D deficiency and inadequacy among hospitalized adults with CAP. The results of this study also suggest that vitamin D deficiency is associated with an increased risk of mortality way beyond the short-term in these patients.	[Holter, Jan C.; Husebye, Einar; Heggelund, Lars] Vestre Viken Hosp Trust, Drammen Hosp, Dept Internal Med, Drammen, Norway; [Holter, Jan C.; Ueland, Thor; Froland, Stig S.; Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Holter, Jan C.; Ueland, Thor; Froland, Stig S.; Husebye, Einar; Aukrust, Pal; Heggelund, Lars] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Norseth, Jon] Vestre Viken Hosp Trust, Baerum Hosp, Clin Med Diagnost, Rud, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Froland, Stig S.; Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Holter, JC (corresponding author), Vestre Viken Hosp Trust, Drammen Hosp, Dept Internal Med, Drammen, Norway.; Holter, JC (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway.; Holter, JC (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	jancho@mail.uio.no	Heggelund, Lars/GSN-0026-2022		Vestre Viken Hospital Trust	Vestre Viken Hospital Trust	This study was funded by Vestre Viken Hospital Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Cangemi R, 2015, AM J CARDIOL, V116, P647, DOI 10.1016/j.amjcard.2015.05.028; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; Choudhary N, 2012, INDIAN PEDIATR, V49, P449, DOI 10.1007/s13312-012-0073-x; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2011, J INFECTION, V63, P187, DOI 10.1016/j.jinf.2011.06.009; Guertler C, 2011, EUR RESPIR J, V37, P1439, DOI 10.1183/09031936.00121510; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148741; Holter JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0803-5; Jovanovich AJ, 2014, NUTRIENTS, V6, P2196, DOI 10.3390/nu6062196; Kim HJ, 2015, INT J TUBERC LUNG D, V19, P729, DOI 10.5588/ijtld.14.0696; Lamberg-Allardt C, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22671; Larose TL, 2014, J EPIDEMIOL COMMUN H, V68, P165, DOI 10.1136/jech-2013-202587; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Martineau AR, 2015, LANCET RESP MED, V3, P120, DOI 10.1016/S2213-2600(14)70255-3; Mortensen EM, 2012, SEMIN RESP CRIT CARE, V33, P319, DOI 10.1055/s-0032-1315644; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Olliver M, 2013, J INFECT DIS, V208, P1474, DOI 10.1093/infdis/jit355; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pletz MW, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-53; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Remmelts HHF, 2012, CLIN INFECT DIS, V55, P1488, DOI 10.1093/cid/cis751; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sandvall B, 2013, CLIN INFECT DIS, V56, P1145, DOI 10.1093/cid/cis1207; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Scott MG, 2015, CLIN CHEM, V61, P462, DOI 10.1373/clinchem.2014.222521; Silva MC, 2015, NUTR RES, V35, P91, DOI 10.1016/j.nutres.2014.12.008; Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812; Watkins RR, 2015, CAN J PHYSIOL PHARM, V93, P363, DOI 10.1139/cjpp-2014-0352; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Yaktine AL., 2011, COMMITTEE REV DIETAR; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847	45	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158536	10.1371/journal.pone.0158536	http://dx.doi.org/10.1371/journal.pone.0158536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367810	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900039
J	Marconi, DG; Resende, BD; Rauber, E; Soares, PD; Fernandes, JM; Mehta, N; Carvalho, AL; Kupelian, PA; Chen, A				Marconi, Daniel Grossi; Resende, Bruno da Costa; Rauber, Erick; Soares, Paula de Cassia; Fernandes Junior, Jose Maria; Mehta, Niraj; Carvalho, Andre Lopes; Kupelian, Patrick A.; Chen, Allen			Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases	PLOS ONE			English	Article							DERMATOLOGICAL TRAINING CENTERS; MOHS MICROGRAPHIC SURGERY; SQUAMOUS-CELL CARCINOMAS; BASAL-CELL; RADIATION-THERAPY; IONIZING-RADIATION; RECURRENCE RATES; RADIOTHERAPY; EXPERIENCE; LESIONS	Introduction To report a single-institutional experience with the use of Superficial X-Ray Therapy (SXRT) for head and neck non-melanoma skin cancer (N-MSC) and to compare outcomes by prescribed fractionation schedules. Materials and Methods The medical records of 597 patients with 1021 lesions (720 BCC, 242 SCC, 59 SCC in situ) treated with kilovoltage radiation from 1979-2013 were retrospectively reviewed. The majority of patients were treated according to 1 of 3 institutional protocols based on the discretion of the radiation oncologist: 1) 22 x 2.5 Gy; 2) 20 x 2.5 Gy; 3) 30 x 2.0 Gy. "T" stage at first presentation was as follows: Tis (59); T1 (765); T2 (175); T3 (6), T4 (9); Tx, (7). All patients were clinical N0 and M0 at presentation. Chi-square test was used to evaluate any potential association between variables. The Kaplan-Meier method was used to analyze survival with the Log Rank test used for comparison. A Cox Regression analysis was performed for multivariate analysis. Results The median follow up was 44 months. No significant difference was observed among the 3 prescribed fractionation schemes (p = 0.78) in terms of RTOG toxicity. There were no failures among SCC in situ, 37 local failures (23 BCC, 14 SCC), 5 regional failures (all SCC) and 2 distant failures (both SCC). For BCC, the 5-year LC was 96% and the 10-year LC was 94%. For SCC the corresponding rates of local control were 92% and 87%, respectively (p = 0.03). The use of > 2.0 Gy daily was significantly associated with improved LC on multivariate analysis (HR: 0.17; CI 95%: 0.05-0.59). Conclusion SXRT for N-MSC of the head and neck is well tolerated, achieves excellent local control, and should continue to be recommended in the management of this disease. Fractionation schedules using > 2.0 Gy daily appear to be associated with improved LC.	[Marconi, Daniel Grossi; Resende, Bruno da Costa; Rauber, Erick; Soares, Paula de Cassia; Fernandes Junior, Jose Maria] Barretos Canc Hosp, Dept Radiat Oncol, Barretos, Brazil; [Mehta, Niraj] South Florida Radiat Oncol, Miami, FL USA; [Carvalho, Andre Lopes] Barretos Canc Hosp, Head & Neck Div, Barretos, Brazil; [Kupelian, Patrick A.; Chen, Allen] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; University of California System; University of California Los Angeles	Marconi, DG (corresponding author), Barretos Canc Hosp, Dept Radiat Oncol, Barretos, Brazil.	dgmarconi@gmail.com	Carvalho, Andre Lopes/S-7053-2016; MARCONI, DANIEL GROSSI/M-9484-2013; Kupelian, Patrick/AAU-6311-2021	Carvalho, Andre Lopes/0000-0001-7214-6402; 				ASHBY MA, 1989, CANCER, V63, P1863; Caccialanza M, 2005, INT J DERMATOL, V44, P513, DOI 10.1111/j.1365-4632.2005.02103.x; Caccialanza M, 2003, EUR J DERMATOL, V13, P462; Caccialanza M, 2009, J EUR ACAD DERMATOL, V23, P1044, DOI 10.1111/j.1468-3083.2009.03247.x; Cognetta AB, 2012, J AM ACAD DERMATOL, V67, P1235, DOI 10.1016/j.jaad.2012.06.001; de Launey JW, 1998, J DERMATOL, V37, P71; GOLDSCHMIDT H, 1986, ARCH DERMATOL, V122, P1385, DOI 10.1001/archderm.122.12.1385; GOLDSCHMIDT H, 1994, J AM ACAD DERMATOL, V30, P157, DOI 10.1016/S0190-9622(94)70014-1; Hernandez-Machin B, 2007, INT J DERMATOL, V46, P453, DOI 10.1111/j.1365-4632.2006.03108.x; Huynh NT, 2002, J DERMATOL, V43, P15; Jay L, 2001, INT J RADIAT ONCOL, V51, P748; KINGERY FAJ, 1986, J AM ACAD DERMATOL, V14, P1108, DOI 10.1016/S0190-9622(86)70134-5; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P253, DOI 10.1016/j.jaad.2005.02.059; Leibovitch I, 2005, J AM ACAD DERMATOL, V52, P997, DOI 10.1016/j.jaad.2004.12.033; Mendenhall WM, 2009, LARYNGOSCOPE, V119, P1994, DOI 10.1002/lary.20608; Panizzon R., 1991, MODERN DERMATOLOGIC; Panizzon R, 1982, P 16 INT C DERM, P482; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P315, DOI 10.1111/j.1524-4725.1989.tb03166.x; Schalock PC, 2006, J AM ACAD DERMATOL, V55, P912, DOI 10.1016/j.jaad.2005.10.044; Schulte KW, J AM ACAD DERMATOL, V53, P993; Silva JJ, 2000, INT J RADIAT ONCOL, V47, P451, DOI 10.1016/S0360-3016(00)00410-7; STOLL HL, 1964, ARCH DERMATOL, V90, P577, DOI 10.1001/archderm.1964.01600060043007; Thom GA, AUSTRALAS J DERMATOL, V44, P174; Zagrodnik B, 2003, CANCER, V98, P2708, DOI 10.1002/cncr.11798; Zagrodnik B, 2003, CANCER, V98	25	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156544	10.1371/journal.pone.0156544	http://dx.doi.org/10.1371/journal.pone.0156544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367229	gold, Green Published, Green Submitted			2022-12-26	WOS:000378914900005
J	Papworth, DJ; Marini, S; Conversi, A				Papworth, Danny J.; Marini, Simone; Conversi, Alessandra			A Novel, Unbiased Analysis Approach for Investigating Population Dynamics: A Case Study on Calanus finmarchicus and Its Decline in the North Sea	PLOS ONE			English	Article							LONG-TERM CHANGES; MARINE PLANKTON ECOSYSTEMS; REGIME SHIFTS; PHYTOPLANKTON BIOMASS; NORWEGIAN SEA; BOTTOM-UP; ENVIRONMENTAL-CONDITIONS; TROPHIC INTERACTIONS; COD RECRUITMENT; TRANS-ATLANTIC	Marine populations are controlled by a series of drivers, pertaining to both the physical environment and the biological environment (trophic predator-prey interactions). There is heated debate over drivers, especially when trying to understand the causes of major ecosystem events termed regime shifts. In this work, we have researched and developed a novel methodology based on Genetic Programming (GP) for distinguishing which drivers can influence species abundance. This methodology benefits of having no a priori assumptions either on the ecological parameters used or on the underlying mathematical relationships among them. We have validated this methodology applying it to the North Sea pelagic ecosystem. We use the target species Calanus finmarchicus, a key copepod in temperate and subarctic ecosystems, along with 86 biological, hydrographical and climatic time series, ranging from local water nutrients and fish predation, to large scale climate pressure patterns. The chosen study area is the central North Sea, from 1972 to 2011, during which period there was an ecological regime shift. The GP based analysis identified 3 likely drivers of C. finmarchicus abundance, which highlights the importance of considering both physical and trophic drivers: temperature, North Sea circulation (net flow into the North Atlantic), and predation (herring). No large scale climate patterns were selected, suggesting that when there is availability of both data types, local drivers are more important. The results produced by the GP based procedure are consistent with the literature published to date, and validate the use of GP for interpreting species dynamics. We propose that this methodology holds promises for the highly non-linear field of ecology.	[Papworth, Danny J.] Univ Plymouth, Sch Marine Sci & Engn, Fac Sci & Technol, Plymouth PL4 8AA, Devon, England; [Marini, Simone; Conversi, Alessandra] CNR Natl Res Council Italy, ISMAR Marine Sci Inst La Spezia, I-19032 Lerici, SP, Italy; [Conversi, Alessandra] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	University of Plymouth; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Plymouth	Conversi, A (corresponding author), CNR Natl Res Council Italy, ISMAR Marine Sci Inst La Spezia, I-19032 Lerici, SP, Italy.; Conversi, A (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	a.conversi@ismar.cnr.it	Marini, Simone/C-3872-2012; Marini, Simone/AAA-3513-2022; Conversi, Alessandra/G-3899-2011	Marini, Simone/0000-0003-0665-7815; Marini, Simone/0000-0003-0665-7815; Conversi, Alessandra/0000-0002-8566-8282	European Union [PIEF-GA-2010-275790]	European Union(European Commission)	AC has received partial funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no PIEF-GA-2010-275790, Marie Curie project SYNRESH.; The authors wish to especially thank David Johns and Darren Stevens for help accessing the CPR data, as well as all those at the Sir Alister Hardy Foundation for Ocean Science who support and maintain the CPR dataset. They are particularly thankful to Morten Skogen for providing the North Atlantic and English Channel flow data. They thank Beatriz Roel and Sophie Pitois from CEFAS for advice on fisheries data, and finally ICES and NOAA for supplying data on nutrients, hydrography and climate. The research leading to these results has received partial funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no PIEF-GA-2010-275790, Marie Curie project SYNRESH. The authors have no conflict of interest to declare.	Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Alheit J, 2009, INT J EARTH SCI, V98, P261, DOI 10.1007/s00531-007-0232-9; Alvarez-Fernandez S, 2012, MAR ECOL PROG SER, V462, P21, DOI 10.3354/meps09817; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Augusto DA, 2000, NEUR NETW 2000 P 6 B; Batten SD, 2003, J PLANKTON RES, V25, P697, DOI 10.1093/plankt/25.7.697; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2004, MAR ECOL PROG SER, V284, P35, DOI 10.3354/meps284035; Beaugrand G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0272; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0264; Beaugrand G, 2014, MAR ECOL PROG SER, V502, P85, DOI 10.3354/meps10693; Beaugrand G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3350; Beaugrand G, 2012, ICES J MAR SCI, V69, P1549, DOI 10.1093/icesjms/fss153; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Bergmeir C, 2012, INFORM SCIENCES, V191, P192, DOI 10.1016/j.ins.2011.12.028; Blenckner Thorsten, 2012, ENCY THEORETICAL ECO, P609; Cao HQ, 2014, IEEE T EVOLUT COMPUT, V18, P793, DOI 10.1109/TEVC.2013.2286404; Casini M, 2010, MAR ECOL PROG SER, V413, P241, DOI 10.3354/meps08592; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Castellani C, 2008, J PLANKTON RES, V30, P1095, DOI 10.1093/plankt/fbn074; Clark RA, 2001, J PLANKTON RES, V23, P27, DOI 10.1093/plankt/23.1.27; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; Conversi A, 1998, ICES J MAR SCI, V55, P739, DOI 10.1006/jmsc.1998.0394; Conversi A, 2009, JOURNAL OF GEOPHYSIC, V114; Conversi A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0279; Conversi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010633; Corgnati L, 2014, COMPUTER VISION ANAL; Corriveau G, 2013, APPL SOFT COMPUT, V13, P9, DOI 10.1016/j.asoc.2012.08.046; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dippner JW, 2013, J MARINE SYST, V111, P263, DOI 10.1016/j.jmarsys.2012.09.009; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fauchald P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022729; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Gardmark A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0262; Goberville E, 2014, J MARINE SYST, V129, P189, DOI 10.1016/j.jmarsys.2013.05.008; Greene CH, 2003, PROG OCEANOGR, V58, P301, DOI 10.1016/j.pocean.2003.08.009; Greene CH, 2013, LIMNOL OCEANOGR, V58, P803, DOI 10.4319/lo.2013.58.3.0803; Greene CH, 2012, OCEANOGRAPHY, V25, P208, DOI 10.5670/oceanog.2012.64; Guyon I., 2006, FEATURE EXTRACTION F, V207; Harms JH, 2000, ICES J MAR SCI, V57, P1694, DOI 10.1006/jmsc.2000.0981; Harris V, 2014, J MARINE SYST, V133, P55, DOI 10.1016/j.jmarsys.2013.07.001; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Head EJH, 2013, PROG OCEANOGR, V114, P46, DOI 10.1016/j.pocean.2013.05.004; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; Heath Michael R., 1999, Fisheries Oceanography, V8, P163, DOI 10.1046/j.1365-2419.1999.00008.x; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Helaouet P, 2016, J MARINE SYST, V153, P18, DOI 10.1016/j.jmarsys.2015.09.001; Helaouet P, 2011, PROG OCEANOGR, V91, P217, DOI 10.1016/j.pocean.2010.11.003; Hjermann DO, 2013, MAR ECOL PROG SER, V480, P263, DOI 10.3354/meps10315; Huang CJ, 2012, NEURAL COMPUT APPL, V21, P2057, DOI 10.1007/s00521-011-0628-0; Hunt GL, 2006, PROG OCEANOGR, V68, P115, DOI 10.1016/j.pocean.2006.02.008; HUTHNANCE J.M., 1991, OCEAN SHORELINE MANA, V16, P199, DOI DOI 10.1016/0951-8312(91)90005-M; IBANEZ F, 1993, CR ACAD SCI III-VIE, V316, P745; ICES, 2012, REP HERR ASS WORK GR; ICES, 2012, REP WORK GROUP ASS D; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Jonasdottir SH, 2011, J PLANKTON RES, V33, P85, DOI 10.1093/plankt/fbq085; Kala R, 2012, EXPERT SYST APPL, V39, P3817, DOI 10.1016/j.eswa.2011.09.090; Kehayias G, 2005, J MAR BIOL ASSOC UK, V85, P1525, DOI 10.1017/S0025315405012737; Kimmel DG, 2008, MAR ECOL PROG SER, V366, P111, DOI 10.3354/meps07523; Kirby RR, 2007, MAR ECOL PROG SER, V330, P31, DOI 10.3354/meps330031; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Knight J. R., 2006, GEOPHYS RES LETT, V33, P1, DOI DOI 10.1029/2006GL026242; Kohavi R., 2001, INT JOINT C ART INT; Koza JR, 2010, GENET PROGRAM EVOL M, V11, P251, DOI 10.1007/s10710-010-9112-3; Koza JR, 1992, GENETIC PROGRAMMING; Lassalle G, 2013, ICES J MAR SCI, V70, P135, DOI 10.1093/icesjms/fss168; Lauria V, 2013, MAR ECOL PROG SER, V488, P11, DOI 10.3354/meps10401; Lauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047408; Lefebvre M., 2007, APPL PROBABILITY STA; Link JS, 2010, ICES J MAR SCI, V67, P787, DOI 10.1093/icesjms/fsp258; Llope M, 2009, LIMNOL OCEANOGR, V54, P512, DOI 10.4319/lo.2009.54.2.0512; Lones MA, 2014, IEEE T EVOLUT COMPUT, V18, P559, DOI 10.1109/TEVC.2013.2281532; Luczak C, 2012, BIOL LETTERS, V8, P821, DOI 10.1098/rsbl.2012.0474; Maar M, 2013, PROG OCEANOGR, V111, P24, DOI 10.1016/j.pocean.2012.10.004; Mackas DL, 2012, PROG OCEANOGR, V97, P31, DOI 10.1016/j.pocean.2011.11.005; Mackinson S, 2009, ECOL MODEL, V220, P2972, DOI 10.1016/j.ecolmodel.2008.10.021; Marini Simone, 2012, Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Proceedings of the 10th European Conference, EvoBIO 2012, P50, DOI 10.1007/978-3-642-29066-4_5; McQuatters-Gollop A, 2007, LIMNOL OCEANOGR, V52, P635, DOI 10.4319/lo.2007.52.2.0635; Melle W, 2014, PROG OCEANOGR, V129, P244, DOI 10.1016/j.pocean.2014.04.026; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Moller EF, 2012, LIMNOL OCEANOGR, V57, P211, DOI 10.4319/lo.2012.57.1.0211; Moloney CL, 2011, J MARINE SYST, V84, P106, DOI 10.1016/j.jmarsys.2010.06.012; MULLIN MM, 1989, FISH B-NOAA, V87, P633; Muttil N, 2005, ECOL MODEL, V189, P363, DOI 10.1016/j.ecolmodel.2005.03.018; Nejstgaard JC, 1997, MAR ECOL PROG SER, V147, P197, DOI 10.3354/meps147197; Nelson GC, 2006, ECOL SOC, V11; O'Connor MI, 2015, GLOBAL ECOL BIOGEOGR, V24, P64, DOI 10.1111/geb.12218; Olsen EM, 2011, P ROY SOC B-BIOL SCI, V278, P504, DOI 10.1098/rspb.2010.1465; OSPAR, 2010, QUAL STAT REP 2010; OSPAR Commission, 2000, QUAL STAT REP 2000; Owens NJP, 2013, J MARINE SYST, V128, P240, DOI 10.1016/j.jmarsys.2013.05.003; Parker G, 2008, 2008 WORLD AUTOMATION CONGRESS PROCEEDINGS, VOLS 1-3, P411; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Payne MR, 2009, ICES J MAR SCI, V66, P272, DOI 10.1093/icesjms/fsn211; Pershing AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0265; Petursdottir H, 2012, ICES J MAR SCI, V69, P1277, DOI 10.1093/icesjms/fss125; Pierson JJ, 2013, J PLANKTON RES, V35, P504, DOI 10.1093/plankt/fbt022; Pitois SG, 2012, MAR ECOL PROG SER, V456, P169, DOI 10.3354/meps09710; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Planque B, 2000, ICES J MAR SCI, V57, P1528, DOI 10.1006/jmsc.2000.0970; Poli R., 2008, FIELD GUIDE GENETIC; Prokopchuk I, 2006, ICES J MAR SCI, V63, P117, DOI 10.1016/j.icesjms.2005.08.005; Raab K, 2012, MAR ECOL PROG SER, V470, P101, DOI 10.3354/meps09919; Raab K, 2011, J SEA RES, V65, P131, DOI 10.1016/j.seares.2010.09.002; Raitsos DE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022484; Record NR, 2010, J MARINE SYST, V82, P96, DOI 10.1016/j.jmarsys.2010.04.001; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Reid PC, 2012, J MAR BIOL ASSOC UK, V92, P1435, DOI 10.1017/S0025315412000549; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Reygondeau G, 2011, GLOBAL CHANGE BIOL, V17, P756, DOI 10.1111/j.1365-2486.2010.02310.x; Reygondeau G, 2011, J PLANKTON RES, V33, P119, DOI 10.1093/plankt/fbq091; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Richardson AJ, 2004, DEEP-SEA RES PT I, V51, P1283, DOI 10.1016/j.dsr.2004.04.002; Rosenblatt AE, 2013, ROLES LARGE TOP PRED; Schluter MH, 2012, J SEA RES, V67, P91, DOI 10.1016/j.seares.2011.11.001; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Simonsen CS, 2006, MAR BIOL, V149, P937, DOI 10.1007/s00227-005-0172-5; Soiland H, 2000, ICES J MAR SCI, V57, P816, DOI 10.1006/jmsc.2000.0567; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Tande KS, 2000, ICES J MAR SCI, V57, P1527, DOI 10.1006/jmsc.2000.0983; Usov N, 2013, HYDROBIOLOGIA, V706, P11, DOI 10.1007/s10750-012-1435-z; Utne KR, 2012, MAR BIOL RES, V8, P527, DOI 10.1080/17451000.2011.642804; van Deurs M, 2009, MAR ECOL PROG SER, V381, P249, DOI 10.3354/meps07960; Vladislavleva E, 2013, RENEW ENERG, V50, P236, DOI 10.1016/j.renene.2012.06.036; Vladislavleva E, 2010, IEEE T EVOLUT COMPUT, V14, P252, DOI 10.1109/TEVC.2009.2029697	141	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158230	10.1371/journal.pone.0158230	http://dx.doi.org/10.1371/journal.pone.0158230			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366910	gold, Green Submitted, Green Published			2022-12-26	WOS:000378914900023
J	Valbuena, R; Heiskanen, J; Aynekulu, E; Pitkanen, S; Packalen, P				Valbuena, Ruben; Heiskanen, Janne; Aynekulu, Ermias; Pitkanen, Sari; Packalen, Petteri			Sensitivity of Above-Ground Biomass Estimates to Height-Diameter Modelling in Mixed-Species West African Woodlands	PLOS ONE			English	Article							FOREST BIOMASS; ALLOMETRIC EQUATIONS; TREE ALLOMETRY; RANDOM-COEFFICIENTS; ERROR PROPAGATION; VOLUME EQUATIONS; SUDANIAN SAVANNA; CARBON STOCKS; PINE; PREDICTION	It has been suggested that above-ground biomass (AGB) inventories should include tree height (H), in addition to diameter (D). As H is a difficult variable to measure, H-D models are commonly used to predict H. We tested a number of approaches for H-D modelling, including additive terms which increased the complexity of the model, and observed how differences in tree-level predictions of H propagated to plot-level AGB estimations. We were especially interested in detecting whether the choice of method can lead to bias. The compared approaches listed in the order of increasing complexity were: (B0) AGB estimations from D-only; (B1) involving also H obtained from a fixed-effects H-D model; (B2) involving also species; (B3) including also between-plot variability as random effects; and (B4) involving multilevel nested random effects for grouping plots in clusters. In light of the results, the modelling approach affected the AGB estimation significantly in some cases, although differences were negligible for some of the alternatives. The most important differences were found between including H or not in the AGB estimation. We observed that AGB predictions without H information were very sensitive to the environmental stress parameter (E), which can induce a critical bias. Regarding the H-D modelling, the most relevant effect was found when species was included as an additive term. We presented a two-step methodology, which succeeded in identifying the species for which the general H-D relation was relevant to modify. Based on the results, our final choice was the single-level mixed-effects model (B3), which accounts for the species but also for the plot random effects reflecting site-specific factors such as soil properties and degree of disturbance.	[Valbuena, Ruben; Pitkanen, Sari; Packalen, Petteri] Univ Eastern Finland, Sch Forest Sci, Joensuu, Finland; [Heiskanen, Janne] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Aynekulu, Ermias] World Agroforestry Ctr ICRAF, Nairobi, Kenya	University of Eastern Finland; University of Helsinki; CGIAR; World Agroforestry (ICRAF)	Valbuena, R (corresponding author), Univ Eastern Finland, Sch Forest Sci, Joensuu, Finland.	rubenval@uef.fi	Valbuena, Ruben RV/D-8066-2017; Valbuena, Ruben/I-6127-2019; Heiskanen, Janne/K-4668-2019; Aynekulu, Ermias/M-1825-2017	Valbuena, Ruben RV/0000-0003-0493-7581; Valbuena, Ruben/0000-0003-0493-7581; Heiskanen, Janne/0000-0002-3899-8860; Aynekulu, Ermias/0000-0002-1955-6995; Packalen, Petteri/0000-0003-1804-0011	Ministry for Foreign Affairs of Finland	Ministry for Foreign Affairs of Finland	This work is part of the Building Biocarbon and Rural Development in West Africa (BIODEV) project funded by the Ministry for Foreign Affairs of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WARS FRAM REDD; Baker TR, 2009, BIOGEOSCIENCES, V6, P297, DOI 10.5194/bg-6-297-2009; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Boffa J. M., 1999, AGROFORESTRY PARKLAN; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Castedo-Dorado F, 2006, FOREST ECOL MANAG, V229, P202, DOI 10.1016/j.foreco.2006.04.028; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Ciais P, 2011, PHILOS T R SOC A, V369, P2038, DOI 10.1098/rsta.2010.0328; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Coble DW, 2011, SOUTH J APPL FOR, V35, P12, DOI 10.1093/sjaf/35.1.12; Coulibaly-Lingani P, 2011, FOREST POLICY ECON, V13, P292, DOI 10.1016/j.forpol.2011.02.005; Cuny HE, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.160, 10.1038/nplants.2015.160]; CURTIS RO, 1967, FOREST SCI, V13, P365; Eerikainen K, 2009, FOREST SCI, V55, P480; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Flores O, 2011, METHODS ECOL EVOL, V2, P214, DOI 10.1111/j.2041-210X.2010.00068.x; Greenhill AG., 1881, P CAMBRIDGE PHILOS S, V4, P65, DOI DOI 10.1051/JPHYSTAP:018820010033701; Guendehou GHS, 2012, SOUTH FORESTS, V74, P77, DOI 10.2989/20702620.2012.701432; Henry M, 2011, SILVA FENN, V45, P477, DOI 10.14214/sf.38; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; ICRAF World Agroforestry Centre-CGIAR, 2015, TREE FUNCT ATTR EC D; IPCC, 2006, IPCC GUIDELINES NATL; Jayaraman K, 2001, FOREST ECOL MANAG, V142, P155, DOI 10.1016/S0378-1127(00)00347-9; Jones A., 2013, SOIL ATLAS OF AFRICA; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; King DA, 1996, J TROP ECOL, V12, P25, DOI 10.1017/S0266467400009299; Kuyah S, 2015, AGROFOREST SYST, V89, P125, DOI 10.1007/s10457-014-9747-9; Kuyah S, 2012, AGR ECOSYST ENVIRON, V158, P216, DOI 10.1016/j.agee.2012.05.011; Lappi J, 2006, MANAG FOR ECOSYST, V10, P85; LAPPI J, 1991, FOREST SCI, V37, P781; LAPPI J, 1988, FOREST SCI, V34, P907; Larsen DR, 1987, HEIGHT DIAMETER EQUA; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mehtatalo L., 2004, PREDICTING STAND CHA; Mehtatalo L, 2012, LMFOR FUNCTIONS FORE; Mehtatalo L, 2015, CAN J FOREST RES, V45, P826, DOI 10.1139/cjfr-2015-0054; Meng SX, 2008, FOREST ECOL MANAG, V256, P570, DOI 10.1016/j.foreco.2008.05.002; MEYER HANS ARTHUR, 1940, JOUR FOREST, V38, P415; Molto Q, 2014, BIOGEOSCIENCES, V11, P3121, DOI 10.5194/bg-11-3121-2014; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; Nelson BW, 1999, FOREST ECOL MANAG, V117, P149, DOI 10.1016/S0378-1127(98)00475-7; Nygard R, 2000, ANN FOR SCI, V57, P143; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2000, MIXED EFFECTS MODELS; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro SC, 2011, FOREST ECOL MANAG, V262, P491, DOI 10.1016/j.foreco.2011.04.017; Rutishauser E, 2013, FOREST ECOL MANAG, V307, P219, DOI 10.1016/j.foreco.2013.07.013; Sampaio E, 2010, FOREST ECOL MANAG, V259, P1135, DOI 10.1016/j.foreco.2009.12.028; Sawadogo L, 2002, ANN FOREST SCI, V59, P185, DOI 10.1051/forest:2002005; Sawadogo Louis, 2010, Journal of Forestry Research (Harbin), V21, P475, DOI 10.1007/s11676-010-0101-4; Schmidt M, 2011, EUR J FOREST RES, V130, P303, DOI 10.1007/s10342-010-0434-8; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Sharma M, 2007, FOREST ECOL MANAG, V249, P187, DOI 10.1016/j.foreco.2007.05.006; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Temesgen H, 2004, EUR J FOR RES, V123, P45, DOI 10.1007/s10342-004-0020-z; Temesgen H, 2015, SCAND J FOREST RES, V30, P326, DOI 10.1080/02827581.2015.1012114; Tesfaye MA, 2016, ANN FOREST SCI, V73, P411, DOI 10.1007/s13595-015-0533-2; United Nations Development Programme, 2010, 3970 UNDP PIMS SUBPR; Vagen T.-G., 2010, LAND DEGRADATION SUR; Valentini R, 2014, BIOGEOSCIENCES, V11, P381, DOI 10.5194/bg-11-381-2014; Vargas-Larreta B, 2009, FORESTRY, V82, P445, DOI 10.1093/forestry/cpp016; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zeide B., 2002, General Technical Report - Southern Research Station, USDA Forest Service, P463; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zianis D., 2005, Silva Fennica Monographs, P1	74	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158198	10.1371/journal.pone.0158198	http://dx.doi.org/10.1371/journal.pone.0158198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367857	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900020
J	Huang, WY; Wang, B; Wright, JS; Chen, RY				Huang, Wenyu; Wang, Bin; Wright, Jonathon S.; Chen, Ruyan			On the Non-Stationary Relationship between the Siberian High and Arctic Oscillation	PLOS ONE			English	Article							ASIAN WINTER MONSOON; SEA-ICE; VARIABILITY; TEMPERATURE; PACIFIC; CLIMATE; PRECIPITATION; CIRCULATION	An area-weighted kappa-means clustering method based on pattern correlations is proposed and used to explore the relationship between the Siberian High (SH) and Arctic Oscillation (AO) during the winter months (December-January-February) of 1948-2014. Five regimes are identified. Four of these five regimes (comprising 171 of 201 months) show a negative correlation between the SH and AO indices, while the last regime (30 months) shows a positive correlation. The location of the SH shifts southward into China under two of the four negative-correlation regimes (117 months), with pressure variations over the center of activity for the SH opposite to pressure variations over the climatological center of the SH (which is used to define the SH index). Adjusting the SH index to account for these spatial shifts suggests positive rather than negative correlations between major variations in the SH and AO under these regimes. Under one of the two remaining negative-correlation regimes, pressure anomalies are weak over the Arctic Ocean. In total, only one regime comprising 21 of 201 months strictly obeys the negative correlation between the SH and AO reported by previous studies. The climate regime characterized by an intensified SH is associated with a greater frequency of cold surges over northern and southeastern China, and the weakening of the East Asian winter monsoon during the 1980s was accompanied by a sharp reduction in the occurrence of this regime.	[Huang, Wenyu; Wang, Bin; Wright, Jonathon S.; Chen, Ruyan] Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing, Peoples R China; [Wang, Bin] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Huang, WY (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing, Peoples R China.	huangwenyu@mail.tsinghua.edu.cn	Huang, Wenyu/J-4257-2019; Wang, Bin/P-9121-2014; Huang, Wenyu/M-7584-2014; Wang, Bin/D-9724-2012	Huang, Wenyu/0000-0001-9722-5502; Wang, Bin/0000-0001-7374-3786; Huang, Wenyu/0000-0001-9722-5502; Wang, Bin/0000-0002-3133-7197; Wright, Jonathon/0000-0001-6551-7017; Chen, Ruyan/0000-0001-9855-4914	National Basic Research Program of China [2015CB953703, 2014CB441302]; National Natural Science Foundation of China [41505063]; China Meteorological Welfare Research Fund [GYHY201406007]; Tsinghua University Initiative Scientific Research Program [20131089356]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Meteorological Welfare Research Fund; Tsinghua University Initiative Scientific Research Program	This work was supported by the National Basic Research Program of China (2015CB953703, 2014CB441302), the National Natural Science Foundation of China (41505063), the China Meteorological Welfare Research Fund (GYHY201406007), and the Tsinghua University Initiative Scientific Research Program (20131089356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaum MHP, 2001, J CLIMATE, V14, P3495, DOI 10.1175/1520-0442(2001)014<3495:AOONAO>2.0.CO;2; Budikova D, 2012, GEOGR COMPASS, V6, P401, DOI 10.1111/j.1749-8198.2012.00498.x; Cassou C, 2004, J CLIMATE, V17, P1055, DOI 10.1175/1520-0442(2004)017<1055:NAWCRS>2.0.CO;2; Chen W, 2000, ADV ATMOS SCI, V17, P48; Cho MH, 2014, ASIA-PAC J ATMOS SCI, V50, P15, DOI 10.1007/s13143-014-0046-1; Cohen J, 2001, GEOPHYS RES LETT, V28, P299, DOI 10.1029/2000GL011927; DING YH, 1990, METEOROL ATMOS PHYS, V44, P281; Dunn-Sigouin E, 2013, J GEOPHYS RES-ATMOS, V118, P1179, DOI 10.1002/jgrd.50143; Estivill-Castro V, 2001, ALGORITHMICA, V30, P216, DOI 10.1007/s00453-001-0010-1; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang W, 2016, J GEOPHYS RES ATMOSP; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jeong JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023024; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kirsten M., 1998, Inductive Logic Programming. 8th International Conference, ILP-98. Proceedings, P261, DOI 10.1007/BFb0027330; Overland JE, 1999, J CLIMATE, V12, P1542, DOI 10.1175/1520-0442(1999)012<1542:DVOTAL>2.0.CO;2; Pak G, 2014, J CLIMATE, V27, P8185, DOI 10.1175/JCLI-D-13-00500.1; Park TW, 2011, J CLIMATE, V24, P68, DOI 10.1175/2010JCLI3529.1; Rawat R, 2011, LECT NOTES COMPUT SC, V6612, P29, DOI 10.1007/978-3-642-20291-9_6; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riddle EE, 2013, CLIM DYNAM, V40, P1749, DOI 10.1007/s00382-012-1493-y; SAHSAMANOGLOU HS, 1991, INT J CLIMATOL, V11, P827, DOI 10.1002/joc.3370110803; Takaya K, 2005, J ATMOS SCI, V62, P4423, DOI 10.1175/JAS3629.1; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Wang L, 2010, ADV ATMOS SCI, V27, P855, DOI 10.1007/s00376-009-9094-3; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Wu BY, 2002, ADV ATMOS SCI, V19, P297; Zhang XB, 2011, WIRES CLIM CHANGE, V2, P851, DOI 10.1002/wcc.147	32	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158122	10.1371/journal.pone.0158122	http://dx.doi.org/10.1371/journal.pone.0158122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362556	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200042
J	Mariapun, J; Hairi, NN; Ng, CW				Mariapun, Jeevitha; Hairi, Noran N.; Ng, Chiu-Wan			Are the Poor Dying Younger in Malaysia? An Examination of the Socioeconomic Gradient in Mortality	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; GROWTH; INEQUALITIES; DETERMINANTS; CHILDREN; EQUITY; TRENDS	Introduction Socioeconomic inequalities in health represent unfairness in the health distribution of a population. Efforts to produce information on mortality distributions in many low and middle income countries (LMICs) are mostly hampered by lack of data disaggregated by socioeconomic groups. In this paper we describe how mortality statistics obtained from multiple data sources were combined to provide an evaluation of the socioeconomic distribution of mortality in Malaysia, a LMIC located in the Asia Pacific region. Methods This study has an ecological design. As a measure of socioeconomic status, we used principal component analysis to construct a socioeconomic index using census data. Districts were ranked according to the standardised median index of households and assigned to each individual in the 5-year mortality data. The mortality indicators of interest were potential years of life lost (PYLL), standardised mortality ratio (SMR), infant mortality rate (IMR) and under-5 mortality rate (U5MR). Both socioeconomic status and mortality outcomes were used compute the concentration index which provided the summary measure of the magnitude of inequality. Results Socially disadvantaged districts were found to have worse mortality outcomes compared to more advantaged districts. The values of the concentration index for the overall population of the Peninsula are C = -0.1334 (95% CI: -0.1605 to -0.1063) for the PYLL, C = -0.0685 (95% CI: -0.0928 to -0.0441) for the SMR, C = -0.0997 (95% CI: -0.1343 to -0.0652) for the IMR and C = -0.1207 (95% CI: -0.1523 to -0.0891) for the U5MR. Mortality outcomes within ethnic groups were also found to be less favourable among the poor. Conclusion The findings of this study suggest that socioeconomic inequalities disfavouring the poor exist in Malaysia.	[Mariapun, Jeevitha; Hairi, Noran N.; Ng, Chiu-Wan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Ng, CW (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur 50603, Malaysia.	chiuwan.ng@ummc.edu.my	NG, CHIU WAN/B-9222-2010; Mariapun, Jeevitha/AAL-1607-2020; HAIRI, NORAN/B-9339-2010; NG, CHIU WAN/B-5218-2010	Mariapun, Jeevitha/0000-0003-3421-0527; HAIRI, NORAN/0000-0002-2692-9016; NG, CHIU WAN/0000-0002-7687-2310	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]; University of Malaya Grand Challenge PEACE grant [GC001A-14HTM]; Ministry of Education High Impact Research STeMM grant [E000010-20001]	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant; University of Malaya Grand Challenge PEACE grant; Ministry of Education High Impact Research STeMM grant	This study was a part of the STeMM Programme supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant number E000010-20001). NNH's work was supported by the University of Malaya Grand Challenge PEACE grant (GC001A-14HTM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This study is supported by the Ministry of Education High Impact Research STeMM grant (E000010-20001). NNH's work is supported by the University of Malaya Grand Challenge PEACE grant (GC001A-14HTM).	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; [Anonymous], 2012, LEV TRENDS CHILD MOR; [Anonymous], 2008, ANAL HLTH EQUITY USI; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Chee HL, 2005, ACHIEVING MDGS HLTH; Chiu-Wan Ng, 2012, ASSESSING FAIR FINAN; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Department of Statistics M, 1999, IMPR DEM STAT SAB SA; Department of Statistics Malaysia, 2013, HOUS INC BAS AM SURV; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Economic Planning Unit, 2004, MAL 30 YEARS POV RED; Faaland J., 2003, GROWTH ETHNIC INEQUA; Fam S-F, 2011, INT J ARTS SCI, V4, P257; Faudzi A., 2011, MED J MALAYS, V66, P33; Griffiths C., 2006, HLTH STAT Q, V31, P34; Helgeson VS, 2009, PSYCHOL GENDER; Houweling TAJ, 2006, J EPIDEMIOL COMMUN H, V60, P62, DOI 10.1136/jech.2005.036079; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; ICSU I, 2015, REV TARG SUST DEV GO; Institute for Public health, 2012, REP GLOB AD TOB SURV; Kakwani N, 1980, ECONOMETRICA, P437; Kaplan GA, 2001, AM J PUBLIC HEALTH, V91, P351, DOI 10.2105/AJPH.91.3.351; Malaysia DoS, 2013, VIT STAT 2012; Marmot M, 2014, AM J PUBLIC HEALTH, V104, pS517, DOI 10.2105/AJPH.2014.302200; Marmot Michael, 2004, SIGNIFICANCE, V1, P150, DOI DOI 10.1111/J.1740-9713.2004.00058.X; Menon J, 2014, J ASIA PAC ECON, V19, P247, DOI 10.1080/13547860.2013.820471; Merican M I, 2004, Med J Malaysia, V59, P84; Nagaraj S, 2008, J POPUL RES, V25, P183, DOI 10.1007/BF03031948; Ng C.W., 2014, NAT POP C INT POP DY; References Blaxter M, 1981, HLTH CHILDREN REV RE; Reidpath Daniel D, 2007, Int J Equity Health, V6, P16, DOI 10.1186/1475-9276-6-16; Roslan A. H., 2001, INCOME INEQUALITY PO; Saari MY, 2015, WORLD DEV, V76, P311, DOI 10.1016/j.worlddev.2015.07.015; Sastry N, 2004, DEMOGRAPHY, V41, P443, DOI 10.1353/dem.2004.0027; Savedoff WD, 2011, ACHIEVING UNIVERSAL; United Nations Economic Planning Unit Malaysia, 2015, MAL MILL DEV GOALS 2; United Nations General Assembly, 2014, A68970 UN GEN ASS; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; World Health Organization, 2014, WORLD HLTH STAT 2014; Yu CP, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-15	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158685	10.1371/journal.pone.0158685	http://dx.doi.org/10.1371/journal.pone.0158685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362581	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200108
J	Korber, I; Katayama, S; Einarsdottir, E; Krjutskov, K; Hakala, P; Kere, J; Lehesjoki, AE; Joensuu, T				Korber, Inken; Katayama, Shintaro; Einarsdottir, Elisabet; Krjutskov, Kaarel; Hakala, Paula; Kere, Juha; Lehesjoki, Anna-Elina; Joensuu, Tarja			Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb(-/-) Microglia	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; CYSTATIN-B DEFICIENCY; I INTERFERONS; MOUSE MODEL; DISEASE; EPM1; DIFFERENTIATION; NORMALIZATION; INFLAMMATION; MACROPHAGES	Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1, OMIM254800) is an autosomal recessive neurodegenerative disorder characterized by stimulus-sensitive and action-activated myoclonus, tonic-clonic epileptic seizures, and ataxia. Loss-of-function mutations in the gene encoding the cysteine protease inhibitor cystatin B (CSTB) underlie EPM1. The deficiency of CSTB in mice (Cstb(-/-) mice) generates a phenotype resembling the symptoms of EPM1 patients and is accompanied by microglial activation at two weeks of age and an upregulation of immune system-associated genes in the cerebellum at one month of age. To shed light on molecular pathways and processes linked to CSTB deficiency in microglia we characterized the transcriptome of cultured Cstb(-/-) mouse microglia using microarray hybridization and RNA sequencing (RNA-seq). The gene expression profiles obtained with these two techniques were in good accordance and not polarized to either pro- or anti-inflammatory status. In Cstb(-/-) microglia, altogether 184 genes were differentially expressed. Of these, 33 genes were identified by both methods. Several interferon-regulated genes were weaker expressed in Cstb(-/-) microglia compared to control. This was confirmed by quantitative real-time PCR of the transcripts Irf7 and Stat1. Subsequently, we explored the biological context of CSTB deficiency in microglia more deeply by functional enrichment and canonical pathway analysis. This uncovered a potential role for CSTB in chemotaxis, antigen-presentation, and in immune-and defense response-associated processes by altering JAK-STAT pathway signaling. These data support and expand the previously suggested involvement of inflammatory processes to the disease pathogenesis of EPM1 and connect CSTB deficiency in microglia to altered expression of interferon-regulated genes.	[Korber, Inken; Einarsdottir, Elisabet; Hakala, Paula; Kere, Juha; Lehesjoki, Anna-Elina; Joensuu, Tarja] Folkhalsan Inst Genet, Helsinki, Finland; [Korber, Inken; Einarsdottir, Elisabet; Hakala, Paula; Kere, Juha; Lehesjoki, Anna-Elina; Joensuu, Tarja] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Korber, Inken; Hakala, Paula; Lehesjoki, Anna-Elina; Joensuu, Tarja] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Katayama, Shintaro; Einarsdottir, Elisabet; Krjutskov, Kaarel; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Krjutskov, Kaarel] Competence Ctr Hlth Technol, Tartu, Estonia	University of Helsinki; University of Helsinki; Karolinska Institutet	Joensuu, T (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.; Joensuu, T (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.; Joensuu, T (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	tarja.joensuu@helsinki.fi	Kere, Juha/AAX-9117-2021; Joensuu, Tarja/F-3059-2011; Kere, Juha/A-9179-2008; Katayama, Shintaro/F-2958-2010	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Katayama, Shintaro/0000-0001-7581-5157; Einarsdottir, Elisabet/0000-0003-3101-2285	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Academy of Finland [137950]; Epilepsiatutkimussaatio; Doctoral Programme in Biomedicine; Swedish Research Council; Karolinska Institutet Distinguished Professor Award; Strategic Research Program funding on Diabetes; EU FP7-PEOPLE-IAPP grant SARM [324509]; SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2014069]	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Epilepsiatutkimussaatio; Doctoral Programme in Biomedicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Distinguished Professor Award; Strategic Research Program funding on Diabetes; EU FP7-PEOPLE-IAPP grant SARM; SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)	This study was funded by the Folkhalsan Research Foundation, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), and Academy of Finland (project 137950) (http://www.aka.fi/en); and Epilepsiatutkimussaatio (www.epilepsia.fi) and the Doctoral Programme in Biomedicine (http://www.helsinki.fi/dpbm) to I.K. Work in the J.K. laboratory was supported by the Swedish Research Council (http://www.vr.se/inenglish), the Karolinska Institutet Distinguished Professor Award, Strategic Research Program funding on Diabetes to Karolinska Institutet (http://www.ki.se/en/srp-diabetes), and EU FP7-PEOPLE-2012-IAPP grant SARM (324509) (http://www.ec.europa.eu/research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The computations were performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under Project b2014069. We would like to thank Per Harald Jonson, PhD, for commenting on the manuscript.	Ahn J, 2015, BIOCHEM BIOPH RES CO, V466, P52, DOI 10.1016/j.bbrc.2015.08.104; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Franceschetti S, 2007, NEUROBIOL DIS, V25, P675, DOI 10.1016/j.nbd.2006.11.006; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hofer MJ, 2010, J NEUROSCI, V30, P1149, DOI 10.1523/JNEUROSCI.3711-09.2010; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Inacio AR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0427-0; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Joensuu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089321; Kalviainen R, 2008, EPILEPSIA, V49, P549, DOI 10.1111/j.1528-1167.2008.01546.x; Katayama S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1671-5; Katayama S, 2013, BIOINFORMATICS, V29, P2943, DOI 10.1093/bioinformatics/btt511; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koskenkorva P, 2012, AM J NEURORADIOL, V33, P878, DOI 10.3174/ajnr.A2882; Krjutskov K, 2016, HUM REPROD, V31, P844, DOI 10.1093/humrep/dew008; Kuo Ping-Chang, 2016, J Am Heart Assoc, V5, DOI 10.1161/JAHA.115.002610; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Ma CY, 2014, DEVELOPMENT, V141, P4697, DOI 10.1242/dev.117937; Maher K, 2014, J BIOL CHEM, V289, P31736, DOI 10.1074/jbc.M114.609396; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; Manninen O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090709; Manninen O, 2013, RADIOLOGY, V269, P232, DOI 10.1148/radiol.13122458; Mascalchi M, 2002, NEUROLOGY, V58, P1686, DOI 10.1212/WNL.58.11.1686; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Nallar SC, 2014, J INTERF CYTOK RES, V34, P559, DOI 10.1089/jir.2014.0021; Okuneva O, 2015, GLIA, V63, P400, DOI 10.1002/glia.22760; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Prinz M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00067; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon P, 2002, J NEUROPATH EXP NEUR, V61, P1085, DOI 10.1093/jnen/61.12.1085; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Tohonen V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9207; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Wang JP, 2002, P NATL ACAD SCI USA, V99, P16209, DOI 10.1073/pnas.252454799; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	57	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158195	10.1371/journal.pone.0158195	http://dx.doi.org/10.1371/journal.pone.0158195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355630	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400037
J	Putzhammer, R; Doppler, C; Jakschitz, T; Heinz, K; Forste, J; Danzl, K; Messner, B; Bernhard, D				Putzhammer, Raphaela; Doppler, Christian; Jakschitz, Thomas; Heinz, Katharina; Foerste, Juliane; Danzl, Katarina; Messner, Barbara; Bernhard, David			Vapours of US and EU Market Leader Electronic Cigarette Brands and Liquids Are Cytotoxic for Human Vascular Endothelial Cells	PLOS ONE			English	Article							RISK-ASSESSMENT; SMOKE; NICOTINE; SAFETY; IDENTIFICATION; PRODUCTS; EXTRACT; MASS	The present study was conducted to provide toxicological data on e-cigarette vapours of different e-cigarette brands and liquids from systems viewed as leaders in the e-cigarette market and to compare e-cigarette vapour toxicity to the toxicity of conventional strong high-nicotine cigarette smoke. Using an adapted version of a previously constructed cigarette smoke constituent sampling device, we collected the hydrophilic fraction of e-cigarette vapour and exposed human umbilical vein endothelial cells (HUVECs) to the mixture of compounds present in the vapour of 4 different single-use e-cigarettes, 6 different liquid vapours produced by the same refillable e-cigarette, and one e-cigarette with an exchangeable liquid cartridge. After incubation of cells with various concentrations and for various periods of time we analysed cell death induction, proliferation rates, the occurrence of intracellular reactive oxygen species, cell morphology, and we also measured e-cigarette heating coil temperatures. Overall, conventional cigarette smoke extract showed the most severe impact on endothelial cells. However, some e-cigarette vapour extracts showed high cytotoxicity, inhibition of cell proliferation, and alterations in cell morphology, which were comparable to conventional high-nicotine cigarettes. The vapours generated from different liquids using the same e-cigarette show substantial differences, pointing to the liquids as an important source for toxicity. E-cigarette vapour-mediated induction of oxidative stress was significant in one out of the 11 analysed vapours. There is a high variability in the acute cytotoxicity of e-cigarette vapours depending on the liquid and on the e-cigarettes used. Some products showed toxic effects close to a conventional high-nicotine cigarette. Liquid nicotine, menthol content, and the formation of acute intracellular reactive oxygen species do not seem to be the central elements in e-cigarette vapour toxicity.	[Putzhammer, Raphaela; Doppler, Christian; Heinz, Katharina; Foerste, Juliane; Danzl, Katarina; Bernhard, David] Med Univ Innsbruck, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria; [Putzhammer, Raphaela; Foerste, Juliane] MCI Management Ctr Innsbruck, Biotechnol, Innsbruck, Austria; [Jakschitz, Thomas] Austrian Drug Screening Inst GmbH, Innsbruck, Austria; [Messner, Barbara] Med Univ Vienna, Dept Cardiac Surg, Cardiac Surg Res Lab, Vienna, Austria	Medical University of Innsbruck; Medical University of Vienna	Bernhard, D (corresponding author), Med Univ Innsbruck, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria.	david.bernhard@i-med.ac.at	Messner, Barbara/GLS-8150-2022	Messner, Barbara/0000-0001-8331-6497; Bernhard, David/0000-0002-2383-6607	official funds of the laboratory (internal sources of the Medical University of Innsbruck); ADSI	official funds of the laboratory (internal sources of the Medical University of Innsbruck); ADSI	This project was financed by the official funds of the laboratory (internal sources of the Medical University of Innsbruck) and private funds of the corresponding author (DB). The authors have no other financial relationships relevant to this article to disclose. ADSI provided support in the form of salaries for one author [TJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of TJ are articulated in the 'author contributions' section.	Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Bernhard D, 2007, CURR MED CHEM, V14, P1703; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bernhard D, 2005, FASEB J, V19, P1096, DOI 10.1096/fj.04-3192com; Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje; Bernhard David, 2004, Journal of Pharmacological and Toxicological Methods, V50, P45, DOI 10.1016/j.vascn.2004.01.003; Bertholon JF, 2013, RESPIRATION, V86, P433, DOI 10.1159/000353253; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Chausse P, 2015, CHEST, V148, pE29, DOI 10.1378/chest.15-0497; Cheah NP, 2014, TOB CONTROL, V23, P119, DOI 10.1136/tobaccocontrol-2012-050483; Costigan S, 2015, REGUL TOXICOL PHARM, V72, P361, DOI 10.1016/j.yrtph.2015.05.018; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; Drummond M Bradley, 2014, Ann Am Thorac Soc, V11, P236, DOI 10.1513/AnnalsATS.201311-391FR; El Golli N, 2016, LIFE SCI, V146, P131, DOI 10.1016/j.lfs.2015.12.049; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Geiss O, 2016, INT J HYG ENVIR HEAL, V219, P268, DOI 10.1016/j.ijheh.2016.01.004; Gillman IG, 2016, REGUL TOXICOL PHARM, V75, P58, DOI 10.1016/j.yrtph.2015.12.019; Goniewicz ML, 2015, INT J DRUG POLICY, V26, P583, DOI 10.1016/j.drugpo.2015.01.020; Hadwiger ME, 2010, J CHROMATOGR A, V1217, P7547, DOI 10.1016/j.chroma.2010.10.018; Harrell PT, 2014, OTOLARYNG HEAD NECK, V151, P381, DOI 10.1177/0194599814536847; Hutzler C, 2014, ARCH TOXICOL, V88, P1295, DOI 10.1007/s00204-014-1294-7; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Lerner CA, 2015, ENVIRON POLLUT, V198, P100, DOI 10.1016/j.envpol.2014.12.033; Messner B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.162; Messner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058342; Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Shen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23984; Strasser AA, 2009, EXP CLIN PSYCHOPHARM, V17, P405, DOI 10.1037/a0017649; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987	33	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157337	10.1371/journal.pone.0157337	http://dx.doi.org/10.1371/journal.pone.0157337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351725	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900008
J	Satue, M; Rodrigo, MJ; Otin, S; Bambo, MP; Fuertes, MI; Ara, JR; Martin, J; Polo, V; Larrosa, JM; Pablo, L; Garcia-Martin, E				Satue, Maria; Jesus Rodrigo, Maria; Otin, Sofia; Pilar Bambo, Maria; Isabel Fuertes, Maria; Ramon Ara, Jose; Martin, Jesus; Polo, Vicente; Manuel Larrosa, Jose; Pablo, Luis; Garcia-Martin, Elena			Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; GRAY-MATTER ATROPHY; COLOR-VISION; NEURODEGENERATION; THICKNESS; INFLAMMATION; DISABILITY; PATHOLOGY; REPRODUCIBILITY	Aim To evaluate structural changes in the retina and their correlation with visual dysfunction in patients with multiple sclerosis. Methods Patients with multiple sclerosis (n = 84) and healthy controls (n = 84) underwent structural evaluation of the retinal nerve fiber layer, and macular and ganglion cell layer thicknesses using Spectral domain optical coherence tomography (SD-OCT). All subjects underwent high and low contrast visual acuity, color vision (using the Farnsworth and L'Anthony desaturated D15 color tests), and contrast sensitivity vision using the Pelli Robson chart and CSV 1000E test. Results Macular, retinal nerve fiber layer, and ganglion cell layer thinning was observed in multiple sclerosis patients compared to healthy controls (p<0.05). High-and low-contrast visual acuity and contrast sensitivity vision at four different spatial frequencies were significantly reduced in comparison with healthy subjects (p<0.05). Macular, retinal nerve fiber layer and ganglion cell layer measurements correlated with high and low contrast visual acuity, and contrast sensitivity vision. Contrast sensitivity vision was the functional parameter that most strongly correlated with the structural measurements in multiple sclerosis and was associated with ganglion cell layer measurements. The L'Anthony color vision score (age-corrected color confusion index) was associated with macular measurements. Conclusions Patients with multiple sclerosis had visual dysfunction that correlated with structural changes evaluated by SD-OCT. Macular and ganglion cell layer measurements may be good indicators of visual impairment in multiple sclerosis patients.	[Satue, Maria; Jesus Rodrigo, Maria; Otin, Sofia; Pilar Bambo, Maria; Isabel Fuertes, Maria; Polo, Vicente; Manuel Larrosa, Jose; Pablo, Luis; Garcia-Martin, Elena] Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Satue, Maria; Jesus Rodrigo, Maria; Otin, Sofia; Pilar Bambo, Maria; Isabel Fuertes, Maria; Ramon Ara, Jose; Martin, Jesus; Polo, Vicente; Manuel Larrosa, Jose; Pablo, Luis; Garcia-Martin, Elena] Aragon Hlth Res Inst IACS IIS Aragon, Zaragoza, Spain; [Ramon Ara, Jose; Martin, Jesus] Miguel Servet Univ Hosp, Dept Neurol, Zaragoza, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital	Satue, M (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain.; Satue, M (corresponding author), Aragon Hlth Res Inst IACS IIS Aragon, Zaragoza, Spain.	mariasatue@gmail.com	rodrigo, maria jesus/AAE-4101-2020	rodrigo, maria jesus/0000-0002-4009-3075; Larrosa, Jose Manuel/0000-0003-4403-4854; Satue, Maria/0000-0002-1609-5994; Otin Mallada, Sofia Zaira/0000-0002-6591-0801; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; Polo Llorens, Vicente/0000-0002-1402-3129; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Ara Callizo, Jose Ramon/0000-0002-9788-2083; Perez-Olivan, Susana/0000-0003-3513-4714; Pablo, Luis/0000-0003-2389-8282; Bambo, Maria Pilar/0000-0001-5320-7839				Balcer LJ, 2010, NEUROLOGY, V74, pS16, DOI 10.1212/WNL.0b013e3181dbb664; Bock M, 2012, BRIT J OPHTHALMOL, V96, P62, DOI 10.1136/bjo.2010.193581; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Fairless R, 2012, J NEUROSCI, V32, P5585, DOI 10.1523/JNEUROSCI.5705-11.2012; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Garcia-Martin E, 2013, NEUROLOGY, V81, P76, DOI 10.1212/WNL.0b013e318299ccd9; Garcia-Martin E, 2011, INVEST OPHTH VIS SCI, V52, P4124, DOI 10.1167/iovs.10-6643; Gonzalez-Lopez JJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/128517; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gundogan FC, 2013, INDIAN J OPHTHALMOL, V61, P100, DOI 10.4103/0301-4738.99842; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Leat SJ, 1999, OPTOMETRY VISION SCI, V76, P198, DOI 10.1097/00006324-199904000-00023; Martinez-Lapiscina Elena H, 2014, BMC Res Notes, V7, P910, DOI 10.1186/1756-0500-7-910; MCDONALD WI, 1992, J NEUROL NEUROSUR PS, V55, P747, DOI 10.1136/jnnp.55.9.747; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; Palace J, 2007, J NEUROL SCI, V259, P46, DOI 10.1016/j.jns.2006.05.072; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Schinzel J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-31; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Villoslada P, 2012, MULT SCLER J, V18, P991, DOI 10.1177/1352458511431972; VINGRYS AJ, 1988, INVEST OPHTH VIS SCI, V29, P50; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032	35	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157293	10.1371/journal.pone.0157293	http://dx.doi.org/10.1371/journal.pone.0157293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351450	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900006
J	Liu, LN; Duan, XG; Wu, J				Liu, Lina; Duan, Xuguo; Wu, Jing			L-Tryptophan Production in Escherichia coli Improved by Weakening the Pta-AckA Pathway	PLOS ONE			English	Article							ACETYL PHOSPHATE; AMINO-ACIDS; PHOSPHOTRANSACETYLASE; MUTANT; HYPERPRODUCTION; ACCUMULATION; EXPRESSION; STRAINS; OPERON; GROWTH	Acetate accumulation during the fermentation process of Escherichia coli FB-04, an L-tryptophan production strain, is detrimental to L-tryptophan production. In an initial attempt to reduce acetate formation, the phosphate acetyltransferase gene (pta) from E. coli FB-04 was deleted, forming strain FB-04(Delta pta). Unfortunately, FB-04(Delta pta) exhibited a growth defect. Therefore, pta was replaced with a pta variant (pta1) from E. coli CCTCC M 2016009, forming strain FB-04(pta1). Pta1 exhibits lower catalytic capacity and substrate affinity than Pta because of a single amino acid substitution (Pro69Leu). FB-04(pta1) lacked the growth defect of FB-04(Delta pta) and showed improved fermentation performance. Strain FB-04(pta1) showed a 91% increase in L-tryptophan yield in flask fermentation experiments, while acetate production decreased by 35%, compared with its parent FB-04. Throughout the fed-batch fermentation process, acetate accumulation by FB-04(pta1) was slower than that by FB-04. The final L-tryptophan titer of FB-04(pta1) reached 44.0 g/L, representing a 15% increase over that of FB-04. Metabolomics analysis showed that the pta1 genomic substitution slightly decreased carbon flux through glycolysis and significantly increased carbon fluxes through the pentose phosphate and common aromatic pathways. These results indicate that this strategy enhances L-tryptophan production and decreases acetate accumulation during the L-tryptophan fermentation process.	[Liu, Lina; Duan, Xuguo; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Liu, Lina; Duan, Xuguo; Wu, Jing] Jiangnan Univ, Sch Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Liu, Lina; Duan, Xuguo; Wu, Jing] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	jingwu@jiangnan.edu.cn	liu, li/HGC-0900-2022; Wu, Jing/GZK-5063-2022	Duan, Xuguo/0000-0002-2136-0449	National Science Fund for Distinguished Young Scholars [31425020]; National Natural Science Foundation of China [31271813, 31401636]; project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province [BK20140142]; 111 Project [111-2-06]; Research and Innovation Project for College Graduates of Jiangsu Province [KYLX15-1143]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project); Research and Innovation Project for College Graduates of Jiangsu Province	This work was supported by the National Science Fund for Distinguished Young Scholars (31425020) to JW, The National Natural Science Foundation of China (31271813 and 31401636) to JW, The project of outstanding scientific and technological innovation group of Jiangsu Province (Jing Wu) to JW, The Natural Science Foundation of Jiangsu Province (BK20140142) to JW, The 111 Project (No. 111-2-06) to JW, The Research and Innovation Project for College Graduates of Jiangsu Province (no. KYLX15-1143) to LL. The authors would also like to thank Shanghai ProfLeader Biotech Co, Ltd for assistance with the GC-MS experiments and data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31425020), the National Natural Science Foundation of China (31271813 and 31401636), the project of outstanding scientific and technological innovation group of Jiangsu Province (Jing Wu), the Natural Science Foundation of Jiangsu Province (BK20140142), the 111 Project (No. 111-2-06), and the Research and Innovation Project for College Graduates of Jiangsu Province (no. KYLX15-1143). We would also like to thank Shanghai ProfLeader Biotech Co, Ltd for assistance with the GC-MS experiments and data analysis.	AZUMA S, 1993, APPL MICROBIOL BIOT, V39, P471, DOI 10.1007/BF00205035; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAUER KA, 1990, APPL ENVIRON MICROB, V56, P1296, DOI 10.1128/AEM.56.5.1296-1302.1990; Bongaerts J, 2001, METAB ENG, V3, P289, DOI 10.1006/mben.2001.0196; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; CHAN EC, 1993, APPL MICROBIOL BIOT, V40, P301, DOI 10.1007/BF00170384; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; Gao XF, 2010, ANAL CHEM, V82, P6447, DOI 10.1021/ac1006552; Gu PF, 2013, APPL MICROBIOL BIOT, V97, P4121, DOI 10.1007/s00253-012-4665-0; Gu PF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-30; HAHM DH, 1994, APPL MICROBIOL BIOT, V42, P100, DOI 10.1007/s002530050223; HAN K, 1992, BIOTECHNOL BIOENG, V39, P663, DOI 10.1002/bit.260390611; Ikeda M, 2006, APPL MICROBIOL BIOT, V69, P615, DOI 10.1007/s00253-005-0252-y; Ikeda M, 1999, APPL ENVIRON MICROB, V65, P2497; KAKUDA H, 1994, J BIOCHEM-TOKYO, V116, P916, DOI 10.1093/oxfordjournals.jbchem.a124616; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Madyagol M, 2011, FOLIA MICROBIOL, V56, P253, DOI 10.1007/s12223-011-0035-z; MAYER MAG, 1995, MICROBIOL-UK, V141, P2891, DOI 10.1099/13500872-141-11-2891; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Phue JN, 2010, BIOTECHNOL LETT, V32, P1897, DOI 10.1007/s10529-010-0369-7; Ramalingam S, 2007, BIOCHEM ENG J, V33, P34, DOI 10.1016/j.bej.2006.09.019; Schmid JW, 2004, METAB ENG, V6, P364, DOI 10.1016/j.ymben.2004.06.003; SHIMIZU M, 1969, BIOCHIM BIOPHYS ACTA, V191, P550, DOI 10.1016/0005-2744(69)90348-9; Suarez DC, 2000, PROCESS BIOCHEM, V35, P1051, DOI 10.1016/S0032-9592(00)00140-0; TRIBE DE, 1979, APPL ENVIRON MICROB, V38, P181, DOI 10.1128/AEM.38.2.181-190.1979; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Wang J, 2013, APPL MICROBIOL BIOT, V97, P7587, DOI 10.1007/s00253-013-5026-3; Zhao ZJ, 2011, J IND MICROBIOL BIOT, V38, P1921, DOI 10.1007/s10295-011-0978-8	32	23	28	8	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158200	10.1371/journal.pone.0158200	http://dx.doi.org/10.1371/journal.pone.0158200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348810	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200049
J	Phairoh, P; Suthibatpong, T; Rattanarojpong, T; Jongruja, N; Senapin, S; Choowongkomon, K; Khunrae, P				Phairoh, Panapat; Suthibatpong, Thana; Rattanarojpong, Triwit; Jongruja, Nujarin; Senapin, Saengchan; Choowongkomon, Kiattawee; Khunrae, Pongsak			ICP35 Is a TREX-Like Protein Identified in White Spot Syndrome Virus	PLOS ONE			English	Article							AICARDI-GOUTIERES SYNDROME; EXONUCLEASE TREX1; ESCHERICHIA-COLI; PENAEUS-MONODON; GENOME SEQUENCE; DNA; SHRIMP; PURIFICATION; LUPUS; GENE	ICP35 is a non-structural protein from White spot syndrome virus believed to be important in viral replication. Since ICP35 was found to localize in the host nucleus, it has been speculated that the function of ICP35 might be involved in the interaction of DNA. In this study, we overexpressed, purified and characterized ICP35. The thioredoxin-fused ICP35 (thio-ICP35) was strongly expressed in E. coli and be able to form itself into dimers. Investigation of the interaction between ICP35 and DNA revealed that ICP35 can perform DNase activity. Structural model of ICP35 was successfully built on TREX1, suggesting that ICP35 might adopt the folding similar to that of TREX1 protein. Several residues important for dimerization in TREX1 are also conserved in ICP35. Residue Asn126 and Asp132, which are seen to be in close proximity to metal ions in the ICP35 model, were shown through site-directed mutagenesis to be critical for DNase activity.	[Phairoh, Panapat; Rattanarojpong, Triwit; Jongruja, Nujarin; Khunrae, Pongsak] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok 10140, Thailand; [Suthibatpong, Thana] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Phys, Bangkok 10140, Thailand; [Senapin, Saengchan] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand; [Senapin, Saengchan] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol, 272 Rama 6 Rd, Bangkok, Thailand; [Choowongkomon, Kiattawee] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok 10900, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Kasetsart University	Khunrae, P (corresponding author), King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok 10140, Thailand.	pongsak.khu@kmutt.ac.th	Senapin, Saengchan/F-1323-2011; choowongkomon, kiattawee/M-6528-2014	Senapin, Saengchan/0000-0002-5599-4343; choowongkomon, kiattawee/0000-0002-2421-7859	National Research Council of Thailand [55000579, 56000166]; Faculty of Science, KMUTT, Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Faculty of Science, KMUTT, Thailand	This study was financially supported by National Research Council of Thailand (Grant No. 55000579 and 56000166). PP was funded by a scholarship from the Faculty of Science, KMUTT, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyakova NV, 2010, BIOL BULL+, V37, P464, DOI 10.1134/S1062359010050043; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; CH W, 1995, DIS AQUAT ORGAN, V23, P239, DOI [10.3354/dao023239, DOI 10.3354/DAO023239]; Chen LL, 2002, VIROLOGY, V301, P136, DOI 10.1006/viro.2002.1536; Chen LL, 2002, VIROLOGY, V293, P44, DOI 10.1006/viro.2001.1273; Farshadzadeh Z, 2010, JUNDISHAPUR J MICROB, V3, P53; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Kang ST, 2013, J VIROL, V87, P13263, DOI 10.1128/JVI.01732-13; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Kong B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085890; LaVallie ER, 2000, METHOD ENZYMOL, V326, P322; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Miyazaki T, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.547331; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Wang ZZ, 2008, BIOSCI BIOTECH BIOCH, V72, P1550, DOI 10.1271/bbb.80057; WONGTEERASUPAYA C, 1995, DIS AQUAT ORGAN, V21, P69, DOI 10.3354/dao021069; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zhan WB, 1998, J AQUAT ANIM HEALTH, V10, P405, DOI 10.1577/1548-8667(1998)010&lt;0405:WSSVIO&gt;2.0.CO;2	22	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158301	10.1371/journal.pone.0158301	http://dx.doi.org/10.1371/journal.pone.0158301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348862	Green Published, gold, Green Submitted			2022-12-26	WOS:000378801200061
J	Venturelli, M; Ce, E; Limonta, E; Muti, E; Scarsini, R; Brasioli, A; Schena, F; Esposito, F				Venturelli, Massimo; Ce, Emiliano; Limonta, Eloisa; Muti, Ettore; Scarsini, Renato; Brasioli, Anna; Schena, Federico; Esposito, Fabio			Possible Predictors of Involuntary Weight Loss in Patients with Alzheimer's Disease	PLOS ONE			English	Article								Loss in body mass (Delta BM) is a common feature in patients with Alzheimer's disease (AD). However, the etiology of this phenomenon is unclear. The aim of this cohort study was to observe possible Delta BM in AD patients following a standard institutionalized diet. Secondary objective was to identify possible predictors of Delta BM. To this end, 85 AD patients (age: 76 +/- 4 yrs; stature: 165 +/- 3 cm; BM: 61.6 +/- 7.4 kg; mean +/- standard deviation) and 86 controls (CTRL; age: 78 +/- 5 yrs; stature: 166 +/- 4 cm; BM: 61.7 +/- 6.4 kg) were followed during one year of standard institutionalized diet (similar to 1800 kcal/24h). BM, daily energy expenditure, albuminemia, number of medications taken, and cortisolism, were recorded PRE and POST the observation period. Potential predictors of Delta BM in women (W) and men (M) with AD were calculated with a forward stepwise regression model. After one year of standard institutionalized diet, BM decreased significantly in AD (-2.5 kg; p < 0.01), while in CTRL remained unchanged (-0.4 kg; p = 0.8). AD patients and CTRL exhibited similar levels of daily energy expenditure (similar to 1625 kcal/24h). The combination of three factors, number of medications taken, albuminemia, and cortisolism, predicted Delta BM in W with AD. At contrary, the best predictor of Delta BM in M with AD was the cortisolism. Despite a controlled energy intake and similar energy expenditure, both W and M with AD suffered of Delta BM. Therefore, controlled diet did not prevent this phenomenon. The assessments of these variables may predict W and M with AD at risk of weight loss.	[Venturelli, Massimo; Ce, Emiliano; Limonta, Eloisa; Esposito, Fabio] Univ Milan, Dept Biomed Sci Hlth, Via Colombo 71, I-20133 Milan, Italy; [Muti, Ettore; Scarsini, Renato; Brasioli, Anna] Mons Mazzali Fdn, Via Trento 10, I-46100 Mantua, Italy; [Schena, Federico] Univ Verona, Dept Neurol & Movement Sci, Via Casorati 43, I-47131 Verona, Italy	University of Milan; University of Verona	Venturelli, M (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Via Colombo 71, I-20133 Milan, Italy.	massimo.venturelli@unimi.it	Venturelli, Massimo/AAQ-4613-2020; Venturelli, Massimo/F-3235-2014; Esposito, Fabio/E-9340-2011; Cè, Emiliano/E-9697-2011; Limonta, Eloisa/K-2304-2018	Venturelli, Massimo/0000-0002-2469-8787; Venturelli, Massimo/0000-0002-2469-8787; Esposito, Fabio/0000-0002-4420-2611; Cè, Emiliano/0000-0003-0691-3153; Limonta, Eloisa/0000-0001-7246-2819; Schena, Federico/0000-0002-2052-5117	Department of Biomedical Sciences for Health, University of Milan [15-6-3016000-115]; Italian Ministry for Research (PRIN) [KL2Y73_004]	Department of Biomedical Sciences for Health, University of Milan; Italian Ministry for Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The study was supported by grant #15-6-3016000-115 accorded to MV by the Department of Biomedical Sciences for Health, University of Milan, by the grant #KL2Y73_004 from the Italian Ministry for Research (PRIN 2010), accorded to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Donaldson KE, 1996, J AM GERIATR SOC, V44, P1232, DOI 10.1111/j.1532-5415.1996.tb01375.x; Droogsma E, 2013, NEUROLOGY, V80, P1622, DOI 10.1212/01.wnl.0000429720.59289.81; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillette-Guyonnet S, 2000, AM J CLIN NUTR, V71, p637S; Gillette-Guyonnet S, 2013, BRIT J CLIN PHARMACO, V75, P738, DOI 10.1111/bcp.12058; Han BH, 2015, P NATL ACAD SCI US; Italian Department of Health, 2015, LIN IND NAZ RIST OSP; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; MAHONEY F I, 1965, Md State Med J, V14, P61; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Olin AO, 1996, JPEN-PARENTER ENTER, V20, P93, DOI 10.1177/014860719602000293; Poehlman ET, 1997, NEUROLOGY, V48, P997, DOI 10.1212/WNL.48.4.997; Praisoody A, 2012, J AM GERIATR SOC, V60, P805, DOI 10.1111/j.1532-5415.2011.03872.x; Rembach A, 2014, J NEUROIMMUNOL, V273, P65, DOI 10.1016/j.jneuroim.2014.05.005; Secher M, 2013, INT J GERIATR PSYCH, V28, P998, DOI 10.1002/gps.3914; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; SINGH S, 1988, AGE AGEING, V17, P21, DOI 10.1093/ageing/17.1.21; Song C, 1999, PSYCHIAT RES, V85, P71, DOI 10.1016/S0165-1781(98)00130-9; Swanwick GRJ, 1998, AM J PSYCHIAT, V155, P286; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; van Kan GA, 2013, AGE AGEING, V42, P196, DOI 10.1093/ageing/afs173; Venturelli M, 2015, ACTA PHYSIOL, V215, P58, DOI 10.1111/apha.12524; VENTURELLI M, 2014, CLIN SCI, V127, P5; Venturelli M, 2016, J ALZHEIMERS DIS, V53, P1631, DOI 10.3233/JAD-160392; Venturelli M, 2013, J AM GERIATR SOC, V61, P2055, DOI 10.1111/jgs.12491; WOLFKLEIN GP, 1995, NUTRITION, V11, P264	29	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157384	10.1371/journal.pone.0157384	http://dx.doi.org/10.1371/journal.pone.0157384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9FD	27347878	Green Submitted, gold, Green Published			2022-12-26	WOS:000378801200008
J	Khunjan, U; Ekchaweng, K; Panrat, T; Tian, MY; Churngchow, N				Khunjan, Uraiwan; Ekchaweng, Kitiya; Panrat, Tanate; Tian, Miaoying; Churngchow, Nunta			Molecular Cloning of HbPR-1 Gene from Rubber Tree, Expression of HbPR-1 Gene in Nicotiana benthamiana and Its Inhibition of Phytophthora palmivora	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; TOBACCO-MOSAIC-VIRUS; DISEASE RESISTANCE; PR-1 PROTEIN; SYSTEM; PLANTS; FAMILY; MODEL; OVEREXPRESSION; SUPPRESSION	This is the first report to present a full-length cDNA (designated HbPR-1) encoding a putative basic HbPR-1 protein from rubber tree (Hevea brasiliensis) treated with salicylic acid. It was characterized and also expressed in Nicotiana benthamiana using Agrobacterium-mediated transient gene expression system in order to investigate the role of HbPR-1 gene in rubber tree against its oomycete pathogen Phytopthora palmivora and to produce recombinant HbPR-1 protein for microbial inhibition test. The HbPR-1 cDNA was 647 bp long and contained an open reading frame of 492 nucleotides encoding 163 amino acid residues with a predicted molecular mass of 17,681 Da and an isoelectric point (pI) of 8.56, demonstrating that HbPR-1 protein belongs to the basic PR-1 type. The predicted 3D structure of HbPR-1 was composed of four alpha-helices, three beta-sheets, seven strands, and one junction loop. Expression and purification of recombinant HbPR-1 protein were successful using Agrobacterium- mediated transient expression and one-step of affinity chromatography. Heterologous expression of HbPR-1 in N. benthamiana reduced necrosis areas which were inoculated with P. palmivora zoospores, indicating that the expressed HbPR-1 protein played an important role in plant resistance to pathogens. The purified recombinant HbPR-1 protein was found to inhibit 64% of P. palmivora zoospore germination on a water agar plate compared with control, suggesting that it was an antimicrobial protein against P. palmivora.	[Khunjan, Uraiwan; Ekchaweng, Kitiya; Churngchow, Nunta] Prince Songkla Univ, Fac Sci, Dept Biochem, Hat Yai, Songkhla, Thailand; [Khunjan, Uraiwan; Ekchaweng, Kitiya; Tian, Miaoying] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Manoa, HI USA; [Panrat, Tanate] Prince Songkla Univ, Digital Media Program, Int Coll, Hat Yai, Songkhla, Thailand; [Panrat, Tanate] Prince Songkla Univ, Fac Sci, Ctr Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand	Prince of Songkla University; University of Hawaii System; University of Hawaii Manoa; Prince of Songkla University; Prince of Songkla University	Churngchow, N (corresponding author), Prince Songkla Univ, Fac Sci, Dept Biochem, Hat Yai, Songkhla, Thailand.	nunta.c@psu.ac.th	Panrat, Tanate/J-8841-2013	Panrat, Tanate/0000-0002-8511-9283; Tian, Miaoying/0000-0001-8900-6414	Office of the Higher Education Commission Strategic Scholarships Fellowships Frontier Research Networks (Specific for Southern region); government budget of Prince of Songkla University; Biochemistry Excellence Strengthening Program; Graduate School, Prince of Songkla University; Faculty of Science, Prince of Songkla University 4	Office of the Higher Education Commission Strategic Scholarships Fellowships Frontier Research Networks (Specific for Southern region); government budget of Prince of Songkla University; Biochemistry Excellence Strengthening Program; Graduate School, Prince of Songkla University; Faculty of Science, Prince of Songkla University 4	This work was funded by the Office of the Higher Education Commission Strategic Scholarships Fellowships Frontier Research Networks (Specific for Southern region), the government budget of Prince of Songkla University, a grant from the Biochemistry Excellence Strengthening Program, Faculty of Science, Prince of Songkla University 4, and research funding of the Graduate School, Prince of Songkla University.	Agrawal GK, 2000, BIOCHEM BIOPH RES CO, V278, P290, DOI 10.1006/bbrc.2000.3781; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Breton F, 1997, J PLANT PHYSIOL, V151, P595, DOI 10.1016/S0176-1617(97)80236-2; Buch F, 2014, PHYTOCHEMISTRY, V100, P43, DOI 10.1016/j.phytochem.2014.01.014; CUTT JR, 1989, VIROLOGY, V173, P89, DOI 10.1016/0042-6822(89)90224-9; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; Gao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064189; Garabagi F, 2012, PLANT BIOTECHNOL J, V10, P1118, DOI 10.1111/j.1467-7652.2012.00742.x; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P576; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Kim YJ, 2000, PHYSIOL PLANTARUM, V108, P51, DOI 10.1034/j.1399-3054.2000.108001051x./; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Laitaoja M, 2013, INORG CHEM, V52, P10983, DOI 10.1021/ic401072d; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Li ZT, 2011, PLANT CELL REP, V30, P1, DOI 10.1007/s00299-010-0934-5; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu QP, 2006, J GENET, V85, P193, DOI 10.1007/BF02935330; Lu SW, 2013, J PLANT PHYSIOL, V170, P105, DOI 10.1016/j.jplph.2012.08.006; Lu SW, 2011, MOL GENET GENOMICS, V285, P485, DOI 10.1007/s00438-011-0618-z; Ma PD, 2009, APPL BIOCHEM BIOTECH, V158, P243, DOI 10.1007/s12010-008-8332-y; Maheshwari S, 2015, J MOL RECOGNIT, V28, P35, DOI 10.1002/jmr.2410; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Park SC, 2010, BIOTECHNOL LETT, V32, P125, DOI 10.1007/s10529-009-0126-y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Riviere MP, 2008, J EXP BOT, V59, P1225, DOI 10.1093/jxb/ern044; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santen K, 2005, PHYSIOL MOL PLANT P, V66, P45, DOI 10.1016/j.pmpp.2005.04.006; Sarowar S, 2005, PLANT CELL REP, V24, P216, DOI 10.1007/s00299-005-0928-x; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SHAMLOUL M, 2014, JOVE-J VIS EXP, V86, P1; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Shin SH, 2014, PLANT PATHOLOGY J, V30, P208, DOI 10.5423/PPJ.NT.11.2013.0112; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yang HR, 2011, SCI HORTIC-AMSTERDAM, V128, P166, DOI 10.1016/j.scienta.2011.01.015; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu F, 2012, BIOTECHNOL LETT, V34, P919, DOI 10.1007/s10529-012-0851-5	61	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157591	10.1371/journal.pone.0157591	http://dx.doi.org/10.1371/journal.pone.0157591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337148	Green Submitted, gold, Green Published			2022-12-26	WOS:000378389200023
J	Li, Y; Wong, YL; Ng, FM; Liu, BP; Wong, YX; Poh, ZY; Liu, S; Then, SW; Lee, MY; Ng, HQ; Huang, QW; Hung, AW; Cherian, J; Hill, J; Keller, TH; Kang, CB				Li, Yan; Wong, Ying Lei; Ng, Fui Mee; Liu, Boping; Wong, Yun Xuan; Poh, Zhi Ying; Liu, Shuang; Then, Siew Wen; Lee, Michelle Yueqi; Ng, Hui Qi; Huang, Qiwei; Hung, Alvin W.; Cherian, Joseph; Hill, Jeffrey; Keller, Thomas H.; Kang, CongBao			Escherichia coli Topoisomerase IV E Subunit and an Inhibitor Binding Mode Revealed by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; DNA gyrase; DNA topoisomerase; drug discovery; NMR	DNA GYRASE INHIBITORS; F-19 NMR; ANTIBACTERIAL AGENTS; CRYSTAL-STRUCTURE; LIGAND COMPLEXES; PARE SUBUNIT; DISCOVERY; FRAGMENT; PROTEIN; SUBSTANTIATE	Bacterial topoisomerases are attractive antibacterial drug targets because of their importance in bacterial growth and low homology with other human topoisomerases. Structure-based drug design has been a proven approach of efficiently developing new antibiotics against these targets. Past studies have focused on developing lead compounds against the ATP binding pockets of both DNA gyrase and topoisomerase IV. A detailed understanding of the interactions between ligand and target in a solution state will provide valuable information for further developing drugs against topoisomerase IV targets. Here we describe a detailed characterization of a known potent inhibitor containing a 9H-pyrimido[4,5-b]indole scaffold against the N-terminal domain of the topoisomerase IV E subunit from Escherichia coli (eParE). Using a series of biophysical and biochemical experiments, it has been demonstrated that this inhibitor forms a tight complex with eParE. NMR studies revealed the exact protein residues responsible for inhibitor binding. Through comparative studies of two inhibitors of markedly varied potencies, it is hypothesized that gaining molecular interactions with residues in the 4 and residues close to the loop of 1-2 and residues in the loop of 3-4 might improve the inhibitor potency.	[Li, Yan; Wong, Ying Lei; Ng, Fui Mee; Liu, Boping; Wong, Yun Xuan; Poh, Zhi Ying; Liu, Shuang; Then, Siew Wen; Lee, Michelle Yueqi; Ng, Hui Qi; Huang, Qiwei; Hung, Alvin W.; Cherian, Joseph; Hill, Jeffrey; Keller, Thomas H.; Kang, CongBao] ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre	Kang, CB (corresponding author), 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.	cbkang@etc.a-star.edu.sg	Liu, Bo/HCG-9782-2022; Li, Yan/G-4642-2013; LI, feng/HIR-1703-2022; Kang, Congbao/AAP-7572-2020	Liu, Bo/0000-0003-1685-7968; Li, Yan/0000-0003-1963-839X; Kang, Congbao/0000-0002-9886-9374; Liu, Shuang/0000-0003-3287-2404; Keller, Thomas/0000-0002-7553-6235	A*STAR JCO Grants [1331A028, 1231B015]	A*STAR JCO Grants	This work was supported by A*STAR JCO Grants 1331A028 and 1231B015. The authors declare that they have no conflicts of interest with the contents of this article.	Basarab GS, 2013, J MED CHEM, V56, P8712, DOI 10.1021/jm401208b; Bellon S, 2004, ANTIMICROB AGENTS CH, V48, P1856, DOI 10.1128/AAC.48.5.1856-1864.2004; Brvar M, 2012, J MED CHEM, V55, P6413, DOI 10.1021/jm300395d; Campos-Olivas R, 2011, CURR TOP MED CHEM, V11, P43, DOI 10.2174/156802611793611887; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen GY, 2015, CHEMPLUSCHEM, V80, P1250, DOI 10.1002/cplu.201500197; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dias DM, 2016, BIOCHEM J, V473, P335, DOI 10.1042/BJ20141555; Didenko T, 2013, CURR OPIN STRUC BIOL, V23, P740, DOI 10.1016/j.sbi.2013.07.011; Entress RMH, 1998, CHEM BIOL, V5, P329, DOI 10.1016/S1074-5521(98)90171-5; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089; Grossman TH, 2007, ANTIMICROB AGENTS CH, V51, P657, DOI 10.1128/AAC.00596-06; Hughes TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4571; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kang CB, 2015, BIOPHYS J, V109, P1969, DOI 10.1016/j.bpj.2015.10.001; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Li Y, 2016, BIOMOL NMR ASSIGN, V10, P135, DOI 10.1007/s12104-015-9652-9; Li Y, 2015, BIOCHEM BIOPH RES CO, V467, P961, DOI 10.1016/j.bbrc.2015.10.036; Li Y, 2015, FEBS LETT, V589, P2683, DOI 10.1016/j.febslet.2015.07.044; Lubbers T, 2000, BIOORG MED CHEM LETT, V10, P821, DOI 10.1016/S0960-894X(00)00109-8; Manchester JI, 2012, BIOORG MED CHEM LETT, V22, P5150, DOI 10.1016/j.bmcl.2012.05.128; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Miller JR, 2010, EXPERT OPIN DRUG DIS, V5, P145, DOI 10.1517/17460440903493449; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147; Saito H, 2010, PROG NUCL MAG RES SP, V57, P181, DOI 10.1016/j.pnmrs.2010.04.005; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Skedelj V, 2011, J MED CHEM, V54, P915, DOI 10.1021/jm101121s; Stanger FV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107289; Suzuki Y, 2013, BIOCHEMISTRY-US, V52, P1903, DOI 10.1021/bi400027y; Suzuki Y, 2012, BIOCHEMISTRY-US, V51, P8154, DOI 10.1021/bi3012548; Tari LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084409; Tsai FTF, 1997, PROTEINS, V28, P41; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vulpetti A, 2010, J FLUORINE CHEM, V131, P570, DOI 10.1016/j.jfluchem.2009.12.024; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001	42	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17743	17753		10.1074/jbc.M116.737429	http://dx.doi.org/10.1074/jbc.M116.737429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365392	Green Published, hybrid			2022-12-26	WOS:000383241300023
J	Shao, W; Zumer, K; Fujinaga, K; Peterlin, BM				Shao, Wei; Zumer, Kristina; Fujinaga, Koh; Peterlin, B. Matija			FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; gene regulation; protein phosphorylation; transcription factor; ubiquitylation (ubiquitination); AIRE; FBXO3; P-TEFb	THYMIC EPITHELIAL-CELLS; P-TEFB; GENE-EXPRESSION; IMMUNOLOGICAL-TOLERANCE; TARGET GENES; INTERACTING PROTEIN; UBIQUITIN LIGASE; HISTONE H3K4; PHD FINGER; ELONGATION	The autoimmune regulator (AIRE) is a transcription factor which is expressed in medullary thymic epithelial cells. It directs the expression of otherwise tissue-specific antigens, which leads to the elimination of autoreactive T cells during development. AIRE is modified post-translationally by phosphorylation and ubiquitylation. In this report we connected these modifications. AIRE, which is phosphorylated on two specific residues near its N terminus, then binds to the F-box protein 3 (FBXO3) E3 ubiquitin ligase. In turn, this SCFFBXO3 (SKP1-CUL1-F box) complex ubiquitylates AIRE, increases its binding to the positive transcription elongation factor b (P-TEFb), and potentiates its transcriptional activity. Because P-TEFb is required for the transition from initiation to elongation of transcription, this interaction ensures proper expression of AIRE-responsive tissue-specific antigens in the thymus.	[Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Zumer, Kristina] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society	Peterlin, BM (corresponding author), Rm U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu			Nora Eccles Treadwell Foundation	Nora Eccles Treadwell Foundation	This work was supported by a grant from the Nora Eccles Treadwell Foundation. The authors declare that they have no conflict of interest with the contents of this article.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen ZW, 2014, NUCLEIC ACIDS RES, V42, P11560, DOI 10.1093/nar/gku876; Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194; Eifler TT, 2015, MOL CELL BIOL, V35, P468, DOI 10.1128/MCB.01157-14; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Kainulainen M, 2014, J VIROL, V88, P3464, DOI 10.1128/JVI.02914-13; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326; Lee M, 2014, J CELL SCI, V127, P4037, DOI 10.1242/jcs.151944; Li DN, 2015, BIOCHEM BIOPH RES CO, V458, P941, DOI 10.1016/j.bbrc.2015.02.089; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meloni A, 2010, J BIOL CHEM, V285, P13012, DOI 10.1074/jbc.M109.037747; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rattay K, 2015, J IMMUNOL, V194, P921, DOI 10.4049/jimmunol.1402694; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Seiden-Long IM, 2006, ONCOGENE, V25, P91, DOI 10.1038/sj.onc.1209005; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Unanue ER, 2014, ANNU REV IMMUNOL, V32, P579, DOI 10.1146/annurev-immunol-032712-095941; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Zumer K, 2013, J IMMUNOL, V190, P2479, DOI 10.4049/jimmunol.1203210; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11; Zumer K, 2011, NUCLEIC ACIDS RES, V39, P7908, DOI 10.1093/nar/gkr527	47	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17953	17963		10.1074/jbc.M116.724401	http://dx.doi.org/10.1074/jbc.M116.724401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365398	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000383241300038
J	Thompson, M; Elliott, C; Willis, C; Ward, R; Falkmer, M; Falkmer, T; Gubbay, A; Girdler, S				Thompson, Melanie; Elliott, Catherine; Willis, Claire; Ward, Roslyn; Falkmer, Marita; Falkmer, Torbjorn; Gubbay, Anna; Girdler, Sonya			Can, Want and Try: Parents' Viewpoints Regarding the Participation of Their Child with an Acquired Brain Injury	PLOS ONE			English	Article							Q-METHODOLOGY; PHYSICAL-DISABILITIES; YOUTH; INTERVENTION; THERAPY; WORKING; LIFE	Background Acquired brain injury (ABI) is a leading cause of permanent disability, currently affecting 20,000 Australian children. Community participation is essential for childhood development and enjoyment, yet children with ABI can often experience barriers to participation. The factors which act as barriers and facilitators to community participation for children with an ABI are not well understood. Aim To identify the viewpoints of parents of children with an ABI, regarding the barriers and facilitators most pertinent to community participation for their child. Methods Using Q-method, 41 parents of children with moderate/severe ABI sorted 37 statements regarding barriers and facilitators to community participation. Factor analysis identified three viewpoints. Results This study identified three distinct viewpoints, with the perceived ability to participate decreasing with a stepwise trend from parents who felt their child and family "can" participate in viewpoint one, to "want" in viewpoint two and "try" in viewpoint three. Conclusions Findings indicated good participation outcomes for most children and families, however some families who were motivated to participate experienced significant barriers. The most significant facilitators included child motivation, supportive relationships from immediate family and friends, and supportive community attitudes. The lack of supportive relationships and attitudes was perceived as a fundamental barrier to community participation. Significance This research begins to address the paucity of information regarding those factors that impact upon the participation of children with an ABI in Australia. Findings have implications for therapists, service providers and community organisations.	[Thompson, Melanie; Elliott, Catherine; Falkmer, Marita; Falkmer, Torbjorn; Girdler, Sonya] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Willis, Claire] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA, Australia; [Ward, Roslyn; Gubbay, Anna] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia	Curtin University; University of Western Australia; University of Western Australia	Girdler, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia.	sonya.girdler@curtin.edu.au	Willis, Claire/AAM-9564-2020; Girdler, Sonya/ABC-9629-2021; Ward, Roslyn/AAE-6164-2022; Elliott, Catherine/B-6718-2014	Willis, Claire/0000-0002-3794-2902; Girdler, Sonya/0000-0001-7992-0800; Elliott, Catherine/0000-0002-5324-8216; Ward, Roslyn/0000-0003-4488-1199	Princess Margaret Hospital Foundation (PMHF) via the PMHF top-up scholarship	Princess Margaret Hospital Foundation (PMHF) via the PMHF top-up scholarship	Princess Margaret Hospital Foundation (PMHF) is acknowledged for their support via the PMHF top-up scholarship. PMHF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge all parents and families who generously contributed their time to participate in this research. Additionally, we would like to acknowledge the Participate Project Steering Group, whose expertise and contributions were invaluable. All staff in the Acquired Brain Injury team at PMH are thanked for their help in piloting and collecting and supporting this research. The Princess Margaret Hospital Foundation (PMHF) is acknowledged for their support via the PMHF top-up scholarship and the Telethon Kids Institute for additional data analysis.	Anderson V, 2006, AM J PHYS MED REHABI, V19, P191; Andrews J, 2014, DISABILITY REHABILIT, V1; [Anonymous], 1960, EDUCATIONAL AND PSYC, DOI [DOI 10.1177/001316446002000116, 10.1177/001316446002000116]; Australian Government, 2007, DIS AUSTR AQ BRAIN I; Australian Institute of Health and Welfare, 2004, CHILDR DIS AUSTR; Barbosa JC, 1998, ACAD EMERG MED, V5, P1032, DOI 10.1111/j.1553-2712.1998.tb02786.x; Barr M, 2011, J INTELL DISABIL RES, V55, P1020, DOI 10.1111/j.1365-2788.2011.01425.x; Bedell G, 2012, ARCH PHYS MED REHABI; Blosser J, 1996, PAEDIAT TAUMATIC BRI; Brown S.R., 1980, POLITICAL SUBJECTIVI; Brown SR, 1996, QUAL HEALTH RES, V6, P561, DOI 10.1177/104973239600600408; Bult MK, 2011, RES DEV DISABIL, V32, P1521, DOI 10.1016/j.ridd.2011.01.045; Buttimer J, 2005, J INTELLECT DISABILI, V9, P25, DOI 10.1177/1744629505049728; Case-Smith J, 2010, OCCUPATIONAL THERAPY, P62; Case-Smith J., 2010, OCCUPATIONAL THERAPY; Centre for Disease Control and Prevention, 2009, HLTH DAT INT NAT CTR; Combes H, 2004, J APPL RES INTELLECT, V17, P149, DOI 10.1111/j.1468-3148.2004.00191.x; Corr S., 2001, BRIT J OCCUP THER, V64, P293, DOI DOI 10.1177/030802260106400605; Corr S, 2006, RES OCCUPATIONAL THE, P389; Darrah J, 2011, DEV MED CHILD NEUROL, V53, P615, DOI 10.1111/j.1469-8749.2011.03959.x; Dempsey I, 2005, COMMUNITY DISABILITY, DOI Sydney; DENNIS KE, 1986, ADV NURS SCI, V8, P6, DOI 10.1097/00012272-198604000-00003; DIMDI, 2005, INT CLASS FUNCT DIS; Donner J. C., 2001, SOCIAL DEV PAPERS, V36, P24; Eccles J.S., 2002, REV RES ED, V26, P113, DOI [10.3102/0091732X026001113, DOI 10.3102/0091732X026001113]; Fink N, 2012, DEV NEUROREHABIL, V15, P336, DOI 10.3109/17518423.2012.655798; Finkelstein V., 1991, SOCIAL WORK DISABLED, P69; Foo WS, 2012, DEV NEUROREHABIL, V15, P1, DOI 10.3109/17518423.2011.623142; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Graham F, 2009, AUST OCCUP THER J, V56, P16, DOI 10.1111/j.1440-1630.2008.00736.x; Granlund M, 2012, AM J PHYS MED REHAB, V91, pS84, DOI 10.1097/PHM.0b013e31823d5376; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Havens CA., 2005, COMMUNICATION; Heah Tom, 2007, Can J Occup Ther, V74, P38; Hutzler Y, 2002, ADAPT PHYS ACT Q, V19, P300, DOI 10.1123/apaq.19.3.300; Imms C, 2009, DISABIL REHABIL, V31, P2204, DOI 10.3109/09638280902971406; Jobling A, 2001, Downs Syndr Res Pract, V6, P117, DOI 10.3104/perspectives.102; King G, 2003, PHYS OCCUPATIONAL TH, V23; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Law MC, 2011, DEV MED CHILD NEUROL, V53, P621, DOI 10.1111/j.1469-8749.2011.03962.x; Letts L, 2007, QUALITATIVE REV FORM, V31, P357; Maxwell G, 2012, DEV NEUROREHABIL, V15, P274, DOI 10.3109/17518423.2012.689780; Mckenzie A, 2012, CONSUMER COMMUNITY P; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Oates A, 2011, DISABIL REHABIL, V33, P1880, DOI 10.3109/09638288.2011.553701; Palisano RJ, 2012, DISABIL REHABIL, V34, P1041, DOI 10.3109/09638288.2011.628740; Patterson J, 1996, ARCH PEDIAT ADOL MED, V150, P692, DOI 10.1001/archpedi.1996.02170320038006; Rosenbaum P., 1998, FAMILY CENTRED SERVI, V18, P1, DOI [10.1080/J006v18n01, DOI 10.1080/J006V18N01, DOI 10.1080/J006v18n01_01]; Sayers Menear Kristi, 2007, Downs Syndr Res Pract, V12, P60; Schmolk P, 2013, PQ METHOD; Shinebourne P., 2009, INT J QUAL METH, V8, P93, DOI [DOI 10.1177/160940690900800109, 10.1177/160940690900800109]; Simpkins Sandra D, 2005, New Dir Youth Dev, P51, DOI 10.1002/yd.107; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Toronto Aquired Brain Injury Network, 2005, DEF ACQ BRAIN INJ TO; Viscardis L., 1998, PHYSICAL OCCUPATIONA, V18, P41, DOI [DOI 10.1080/J006V18N01_03, 10.1080/J006v18n01_03]; Wagman P, 2012, SCAND J OCCUP THER, V19, P377, DOI 10.3109/11038128.2011.645552; Watts S., 2012, DOING Q METHODOLOGIC; WHO, 2001, WHO INT CLASS FUNCT; Wilcock A. A., 2015, OCCUPATIONAL PERSPEC; Willis CE, 2014, 26 ANN EUR AC CHILDH; Yan-Ting Chee D, 2014, DEV NEUROREHABILITAT, V1	62	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157951	10.1371/journal.pone.0157951	http://dx.doi.org/10.1371/journal.pone.0157951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367231	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900015
J	Bar-Lev, Y; Moshitch-Moshkovitz, S; Tsarfaty, G; Kaufman, D; Horev, J; Resau, JH; Tsarfaty, I				Bar-Lev, Yamit; Moshitch-Moshkovitz, Sharon; Tsarfaty, Galia; Kaufman, Dafna; Horev, Judith; Resau, James H.; Tsarfaty, Ilan			Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice	PLOS ONE			English	Article							MITOCHONDRIAL CARRIER HOMOLOG; RENAL LIPID-ACCUMULATION; ELEMENT-BINDING PROTEINS; DIET-INDUCED OBESITY; SKELETAL-MUSCLE; NONALCOHOLIC STEATOHEPATITIS; DIABETES-MELLITUS; BETA-OXIDATION; ADIPOSE-TISSUE; LIVER-DISEASE	Objective Metabolic dysfunctions, such as fatty liver, obesity and insulin resistance, are among the most common contemporary diseases worldwide, and their prevalence is continuously rising. Mimp/Mtch2 is a mitochondrial carrier protein homologue, which localizes to the mitochondria and induces mitochondrial depolarization. Mimp/Mtch2 single-nucleotide polymorphism is associated with obesity in humans and its loss in mice muscle protects from obesity. Our aim was to study the effects of Mimp/Mtch2 overexpression in vivo. Methods Transgenic mice overexpressing Mimp/Mtch2-GFP were characterized and monitored for lipid accumulation, weight and blood glucose levels. Transgenic mice liver and kidneys were used for gene expression analysis. Results Mimp/Mtch2-GFP transgenic mice express high levels of fatty acid synthase and of beta-oxidation genes and develop fatty livers and kidneys. Moreover, high-fat diet-fed Mimp/Mtch2 mice exhibit high blood glucose levels. Our results also show that Mimp/Mtch2 is involved in lipid accumulation and uptake in cells and perhaps in human obesity. Conclusions Mimp/Mtch2 alters lipid metabolism and may play a role in the onset of obesity and development of insulin resistance.	[Bar-Lev, Yamit; Horev, Judith; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Moshitch-Moshkovitz, Sharon] Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Tsarfaty, Galia] Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel; [Kaufman, Dafna; Resau, James H.] Van Andel Res Inst, Grand Rapids, MI 49503 USA	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Van Andel Institute	Tsarfaty, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.	ilants@post.tau.ac.il		Tsarfaty, Ilan/0000-0002-5230-7093; Bar-Lev, Yamit/0000-0002-2850-859X	United States-Israel Binational Science Foundation (BSF) [2009293]; Breast Cancer Research Foundation (BCRF)	United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Breast Cancer Research Foundation (BCRF)	Funding provided by United States-Israel Binational Science Foundation (BSF), No. 2009293 and Breast Cancer Research Foundation (BCRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Bobulescu IA, 2008, AM J PHYSIOL-RENAL, V294, pF1315, DOI 10.1152/ajprenal.00550.2007; Bonnet F, 2000, DIABETES METAB, V26, P254; BRADY LJ, 1985, BIOCHEM J, V231, P439, DOI 10.1042/bj2310439; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Chalasani N, 2003, HEPATOLOGY, V37, P544, DOI 10.1053/jhep.2003.50095; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Edvardsson U, 2003, PROTEOMICS, V3, P468, DOI 10.1002/pmic.200390061; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fall T, 2012, DIABET MED; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Fisler JS, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-38; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; He MA, 2010, ARTERIOSCL THROM VAS, V30, P327, DOI 10.1161/ATVBAHA.109.196196; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Kulyte A, 2011, J CLIN ENDOCR METAB, V96, pE1661, DOI 10.1210/jc.2010-3050; Leibowitz-Amit R, 2006, CANCER RES, V66, P8687, DOI 10.1158/0008-5472.CAN-05-2294; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901; Moshitch-Moshkovitz S, 2006, NEOPLASIA, V8, P353, DOI 10.1593/neo.05634; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Reisin E, 2009, MED CLIN N AM, V93, P733, DOI 10.1016/j.mcna.2009.02.010; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schmid PM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-48; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; SILVERMAN JF, 1989, PATHOL ANNU, V24, P275; Spencer MW, 2004, AM J NEPHROL, V24, P20, DOI 10.1159/000075362; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yerushalmi GM, 2002, NEOPLASIA, V4, P510, DOI 10.1038/sj.neo.7900272; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157850	10.1371/journal.pone.0157850	http://dx.doi.org/10.1371/journal.pone.0157850			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359329	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200026
J	Gertz, EM; Chowdhury, SA; Lee, WJ; Wangsa, D; Heselmeyer-Haddad, K; Ried, T; Schwartz, R; Schaffer, AA				Gertz, E. Michael; Chowdhury, Salim Akhter; Lee, Woei-Jyh; Wangsa, Darawalee; Heselmeyer-Haddad, Kerstin; Ried, Thomas; Schwartz, Russell; Schaffer, Alejandro A.			FISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CELL GENETIC-ANALYSIS; COPY NUMBER CHANGES; CLONAL EVOLUTION; CANCER PROGRESSION; MAXIMUM-LIKELIHOOD; ONCOGENETIC TREE; MODELS; HETEROGENEITY; MUTATIONS	Advances in fluorescence in situ hybridization (FISH) make it feasible to detectmultiple copy-number changes in hundreds of cells of solid tumors. Studies using FISH, sequencing, and other technologies have revealed substantial intra-tumor heterogeneity. The evolution of subclones in tumors may bemodeled by phylogenies. Tumors often harbor aneuploid or polyploid cell populations. Using a FISH probe to estimate changes in ploidy can guide the creation of trees that model changes in ploidy and individual gene copy-number variations. We present FISHtrees 3.0, which implements a ploidy-based tree building method based on mixed integer linear programming (MILP). The ploidy-based modeling in FISHtrees includes a new formulation of the problem of merging trees for changes of a single gene into trees modeling changes in multiple genes and the ploidy. When multiple samples are collected from each patient, varying over time or tumor regions, it is useful to evaluate similarities in tumor progression among the samples. Therefore, we further implemented in FISHtrees 3.0 a new method to build consensus graphs for multiple samples. We validate FISHtrees 3.0 on a simulated data and on FISH data from paired cases of cervical primary and metastatic tumors and on paired breast ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). Tests on simulated data show improved accuracy of the ploidy-based approach relative to prior ploidyless methods. Tests on real data further demonstrate novel insights these methods offer into tumor progression processes. Trees for DCIS samples are significantly less complex than trees for paired IDC samples. Consensus graphs show substantial divergence among most paired samples from both sets. Low consensus between DCIS and IDC trees may help explain the difficulty in finding biomarkers that predict which DCIS cases are at most risk to progress to IDC. The FISHtrees software is available at ftp://ftp.ncbi.nih.gov/pub/FISHtrees.	[Gertz, E. Michael] US Natl Inst Hlth, Natl Ctr Biotechnol Informat, Computat Biol Branch, 31 Ctr Dr, Bethesda, MD 20892 USA; [Chowdhury, Salim Akhter; Schwartz, Russell] Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA USA; [Chowdhury, Salim Akhter] Carnegie Mellon Univ Pittsburgh, Joint PhD Program Computat Biol, Pittsburgh, PA USA; [Wangsa, Darawalee; Heselmeyer-Haddad, Kerstin; Ried, Thomas] US Natl Inst Hlth, Sect Canc Genom, Genet Branch, Ctr Canc Res,Natl Canc Inst, Bethesda, MD USA; [Schwartz, Russell] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA USA; [Chowdhury, Salim Akhter] Simons Fdn, Simons Ctr Data Anal, New York, NY USA; [Chowdhury, Salim Akhter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA; [Lee, Woei-Jyh] Univ Maryland, Robert H Smith Sch Business, Dept Decis Operat & Informat Technol, College Pk, MD USA	National Institutes of Health (NIH) - USA; Carnegie Mellon University; Carnegie Mellon University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Carnegie Mellon University; Princeton University; University System of Maryland; University of Maryland College Park	Gertz, EM (corresponding author), US Natl Inst Hlth, Natl Ctr Biotechnol Informat, Computat Biol Branch, 31 Ctr Dr, Bethesda, MD 20892 USA.	gertz@ncbi.nlm.nih.gov	Schwartz, Russell/A-1998-2016; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Schwartz, Russell/0000-0002-4970-2252; 	Intramural Research Program of the National Institutes of Health, NLM and NCI; U.S. National Institutes of Health [1R01CA140214]; NATIONAL CANCER INSTITUTE [ZIABC010834] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NLM and NCI; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NLM and NCI, and by U.S. National Institutes of Health award 1R01CA140214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg T, 2009, MATH PROGRAM COMPUT, V1, P1, DOI 10.1007/s12532-008-0001-1; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Carraro DM, 2014, BIOSCIENCE REP, V34, P18, DOI 10.1042/BSR20130077; Catanzaro D, 2016, IEEE ACM T COMPUT BI, V13, P643, DOI 10.1109/TCBB.2015.2476808; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chowdhury SA, 2013, BIOINFORMATICS, V31, pi258; Chowdhury SA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003740; Chowdhury SA, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/btt205; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Diaz-Uriarte R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0466-7; Ding L, 2013, CANCER LETT, V340, P212, DOI 10.1016/j.canlet.2012.12.028; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; El-Kebir M, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btv261; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Farahani HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065773; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Hainke K, 2012, BIOMETRICAL J, V54, P617, DOI 10.1002/bimj.201100186; Hajirasouliha I, 2014, BIOINFORMATICS, V30, P78, DOI 10.1093/bioinformatics/btu284; Heselmeyer-Haddad K, 2002, CANCER RES, V62, P2365; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Heselmeyer-Haddad KM, 2014, AM J PATHOL, V184, P2671, DOI 10.1016/j.ajpath.2014.06.030; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Janocko LE, 2001, CYTOMETRY, V46, P136, DOI 10.1002/cyto.1098; Jiao W, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-35; Karp R, 1971, NETWORKS, V1, P265, DOI DOI 10.1002/NET.3230010305; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Lecca P, 2015, FRONT GENET, V6, DOI [10.3339/fgene.2015.00309, 10.3389/fgene.2015.00309]; Lin Y, 2012, IEEE ACM T COMPUT BI, V9, P1014, DOI 10.1109/TCBB.2011.157; Malikic S, 2015, BIOINFORMATICS, V31, P1349, DOI 10.1093/bioinformatics/btv003; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Niknafs N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004416; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pennington Gregory, 2007, J Bioinform Comput Biol, V5, P407, DOI 10.1142/S021972000700259X; Polyak K, 2008, CLIN CANCER RES, V14, P339, DOI 10.1158/1078-0432.CCR-07-2188; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Ramazzotti D, 2015, BIOINFORMATICS, V31, P3016, DOI 10.1093/bioinformatics/btv296; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Strino F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt641; Szabo A, 2002, MATH BIOSCI, V176, P219, DOI 10.1016/S0025-5564(02)00086-X; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Turajlic S, 2015, BBA-REV CANCER, V1855, P264, DOI 10.1016/j.bbcan.2015.03.005; Von Heydebreck A, 2004, BIOSTATISTICS, V5, P545, DOI 10.1093/biostatistics/kxh007; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wangsa D, 2016, INT J CANCER, V138, P98, DOI 10.1002/ijc.29691; Wangsa D, 2009, AM J PATHOL, V175, P2637, DOI 10.2353/ajpath.2009.090289; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zare H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003703; Zhou J, 2015, LECT N BIOINFORMAT, V9289, P108, DOI 10.1007/978-3-662-48221-6_8	74	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158569	10.1371/journal.pone.0158569	http://dx.doi.org/10.1371/journal.pone.0158569			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362268	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200093
J	Petrova, L; Gran, C; Bjoras, M; Doetsch, PW				Petrova, Lucy; Gran, Christine; Bjoras, Magnar; Doetsch, Paul W.			Efficient and Reliable Production of Vectors for the Study of the Repair, Mutagenesis, and Phenotypic Consequences of Defined DNA Damage Lesions in Mammalian Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL MUTAGENESIS; ENDONUCLEASE-III; OXIDIZED BASES; N-GLYCOSYLASE; STRANDED-DNA; URACIL; ASSAYS; DIHYDROURACIL; SUBSTRATE; BYPASS	Mammalian cells are constantly and unavoidably exposed to DNA damage from endogenous and exogenous sources, frequently to the detriment of genomic integrity and biological function. Cells acquire a large number of chemically diverse lesions per day, and each can have a different genetic fate and biological consequences. However, our knowledge of how and when specific lesions are repaired or how they may compromise the fidelity of DNA replication or transcription and lead to deleterious biological endpoints in mammalian cells is limited. Studying individual lesions requires technically challenging approaches for the targeted introduction of defined lesions into relevant DNA sequences of interest. Here, we present a systematic analysis of factors influencing yield and an improved, efficient and reliable protocol for the production of mammalian expression phagemid vectors containing defined DNA base modifications in any sequence position of either complementary DNA strand. We applied our improved protocol to study the transcriptional mutagenesis-mediated phenotypic consequences of the common oxidative lesion 5-hydroxyuracil, placed in the G12 mutational hotspot of the KRAS oncogene. 5-OHU induced sustained oncogenic signaling in Neil1(-/-)Neil2(-/-) mouse cells. The resulting advance in technology will have broad applicability for investigation of single lesion DNA repair, mutagenesis, and DNA damage responses in mammalian cells.	[Petrova, Lucy] Emory Univ, Program Genet & Mol Biol, Atlanta, GA USA; [Petrova, Lucy; Doetsch, Paul W.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Gran, Christine; Bjoras, Magnar] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Gran, Christine; Bjoras, Magnar] Univ Oslo, Oslo, Norway; [Bjoras, Magnar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway; [Doetsch, Paul W.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Doetsch, Paul W.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Doetsch, Paul W.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Emory University; Emory University; Emory University	Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.; Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.; Doetsch, PW (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.	medpwd@emory.edu	Bjørås, Magnar/N-9286-2017		National Institutes of Health [ES011163 CA120288]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institutes of Health ES011163 CA120288.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bregeon D, 2003, MOL CELL, V12, P959, DOI 10.1016/S1097-2765(03)00360-5; Bregeon D, 2004, BIOTECHNIQUES, V37, P760, DOI 10.2144/04375ST01; Bregeon D, 2006, METHOD ENZYMOL, V409, P345, DOI 10.1016/S0076-6879(05)09020-8; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dizdaroglu M, 1996, NUCLEIC ACIDS RES, V24, P418, DOI 10.1093/nar/24.3.418; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Hegde ML, 2013, P NATL ACAD SCI USA, V110, pE3090, DOI 10.1073/pnas.1304231110; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kiss-Toth E, 2001, ANAL BIOCHEM, V288, P230, DOI 10.1006/abio.2000.4858; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Liu J, 1998, NUCLEIC ACIDS RES, V26, P1707, DOI 10.1093/nar/26.7.1707; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luhnsdorf B, 2012, ANAL BIOCHEM, V425, P47, DOI 10.1016/j.ab.2012.03.001; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shivji MKK, 1999, METH MOL B, V113, P373; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Venkhataraman R, 2001, NUCLEIC ACIDS RES, V29, P407, DOI 10.1093/nar/29.2.407; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Zhou BS, 2009, ANAL BIOCHEM, V389, P177, DOI 10.1016/j.ab.2009.03.044	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158581	10.1371/journal.pone.0158581	http://dx.doi.org/10.1371/journal.pone.0158581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362559	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200097
J	Si, WK; Chung, JW; Cho, J; Baeg, JY; Jang, ES; Yoon, H; Kim, J; Shin, CM; Park, YS; Hwang, JH; Jeong, SH; Kim, N; Lee, DH; Lim, S; Kim, JW				Si, Won Keun; Chung, Jung Wha; Cho, Junhyeon; Baeg, Joo Yeong; Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lim, Soo; Kim, Jin-Wook			Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes	PLOS ONE			English	Article							FATTY LIVER; DIAGNOSTIC-VALUE; VIRAL-HEPATITIS; CIRRHOSIS; MELLITUS; FIBROSIS; ALCOHOL; CANCER; COHORT; SYNERGISM	Epidemiological data indicate that type 2 diabetes is associated with increased risk of hepatocellular carcinoma (HCC). However, risk stratification for HCC has not been fully elucidated in diabetic population. The aim of this study was to identify potential predictors of HCC in diabetic patients without chronic viral hepatitis. A cohort of 3,544 diabetic patients without chronic viral hepatitis or alcoholic cirrhosis was established and subjects were randomly allocated into a derivation and a validation set. A scoring system was developed by using potential predictors of increased risk of HCC from the Cox proportional hazards model. The performance of the scoring system was tested for validation by using receiver operating characteristics analysis. During median follow-up of 55 months, 36 cases of HCC developed (190 per 100,000 person-years). The 5- and 10-year cumulative incidences of HCC were 1.0%, and 2.2%, respectively. Multivariate Cox regression analysis showed that age > 65 years, low triglyceride levels and high gamma-glutamyl transferase levels were independently associated with an increased risk of HCC. DM-HCC risk score, a weighted sum of scores from these 3 parameters, predicted 10-year development of HCC with area under the receiver operating characteristics curve of 0.86, and discriminated different risk categories for HCC in the derivation and validation cohort. In conclusion, old age, low triglyceride level and high gamma-glutamyl transferase level may help to identify individuals at high risk of developing HCC in diabetic patients without chronic viral hepatitis or alcoholic cirrhosis.	[Si, Won Keun; Chung, Jung Wha; Cho, Junhyeon; Baeg, Joo Yeong; Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lim, Soo; Kim, Jin-Wook] Seoul Natl Univ, Bundang Hosp, Dept Med, Seongnam, South Korea; [Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lim, Soo; Kim, Jin-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Med, Seongnam, South Korea.; Kim, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kimjw@snubh.org	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Kim, Nayoung/0000-0002-9397-0406; Kim, Jin-Wook/0000-0003-0934-3344	National Research Foundation of Korea (NRF) - Korean Government [2013R1A1A2061509]	National Research Foundation of Korea (NRF) - Korean Government(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant to J-W Kim, funded by the Korean Government (2013R1A1A2061509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Atreja A, 2008, AM J GASTROENTEROL, V103, P2171, DOI 10.1111/j.1572-0241.2008.01890.x; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen HF, 2010, HEPATOLOGY, V52, P155, DOI 10.1002/hep.23641; Cui R, 2003, BRIT J CANCER, V88, P1878, DOI 10.1038/sj.bjc.6601018; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Dixon JB, 2006, OBES SURG, V16, P1278, DOI 10.1381/096089206778663805; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghadir MR, 2010, HEPAT MON, V10, P285; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Koh WP, 2013, BRIT J CANCER, V108, P1182, DOI 10.1038/bjc.2013.25; Koruk M, 2003, J CLIN GASTROENTEROL, V37, P177, DOI 10.1097/00004836-200308000-00017; Lai MS, 2006, HEPATOLOGY, V43, P1295, DOI 10.1002/hep.21208; LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Li Q, 2012, INT J CANCER, V131, P1197, DOI 10.1002/ijc.27337; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105728; Lin CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-381; Mancebo A, 2013, CLIN GASTROENTEROL H, V11, P95, DOI 10.1016/j.cgh.2012.09.007; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; TESCHKE R, 1983, GUT, V24, P625, DOI 10.1136/gut.24.7.625; Testino G, 2014, WORLD J GASTROENTERO, V20, P15943, DOI 10.3748/wjg.v20.i43.15943; Tietge UJF, 1998, HEPATO-GASTROENTEROL, V45, P2255; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; XU KC, 1992, AM J GASTROENTEROL, V87, P991; Yang SW, 2015, J GASTROEN HEPATOL, V30, P1175, DOI 10.1111/jgh.12921; Yang WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027326; Yoo S, 2013, STUD HEALTH TECHNOL, V192, P1015, DOI 10.3233/978-1-61499-289-9-1015; Yoo S, 2012, HEALTHC INFORM RES, V18, P145, DOI 10.4258/hir.2012.18.2.145; Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427; Zhang XD, 2014, HEPATOLOGY, V60, P2008, DOI 10.1002/hep.27199; Zheng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084776	47	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158066	10.1371/journal.pone.0158066	http://dx.doi.org/10.1371/journal.pone.0158066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359325	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200037
J	Smalley, C; Bechelli, J; Rockx-Brouwer, D; Saito, T; Azar, SR; Ismail, N; Walker, DH; Fang, R				Smalley, Claire; Bechelli, Jeremy; Rockx-Brouwer, Dedeke; Saito, Tais; Azar, Sasha R.; Ismail, Nahed; Walker, David H.; Fang, Rong			Rickettsia australis Activates Inflammasome in Human and Murine Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NLRP3 INFLAMMASOME; GAMMA-INTERFERON; DENDRITIC CELLS; MELANOMA 2; EXPRESSION; MODEL; INTERLEUKIN-10; INVOLVEMENT; INFECTIONS	Rickettsiae actively escape from vacuoles and replicate free in the cytoplasm of host cells, where inflammasomes survey the invading pathogens. In the present study, we investigated the interactions of Rickettsia australis with the inflammasome in both mouse and human macrophages. R. australis induced a significant level of IL-1 beta secretion by human macrophages, which was significantly reduced upon treatment with an inhibitor of caspase-1 compared to untreated controls, suggesting caspase-1-dependent inflammasome activation. Rickettsia induced significant secretion of IL-1 beta and IL-18 in vitro by infected mouse bone marrow-derived macrophages (BMMs) as early as 8-12 h post infection (p.i.) in a dose-dependent manner. Secretion of these cytokines was accompanied by cleavage of caspase-1 and was completely abrogated in BMMs deficient in caspase-1/caspase-11 or apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), suggesting that R. australis activate the ASC-dependent inflammasome. Interestingly, in response to the same quantity of rickettsiae, NLRP3(-/-) BMMs significantly reduced the secretion level of IL-1 beta compared to wild type (WT) controls, suggesting that NLRP3 inflammasome contributes to cytosolic recognition of R. australis in vitro. Rickettsial load in spleen, but not liver and lung, of R. australis-infected NLRP3(-/-) mice was significantly greater compared to WT mice. These data suggest that NLRP3 inflammasome plays a role in host control of bacteria in vivo in a tissue-specific manner. Taken together, our data, for the first time, illustrate the activation of ASC-dependent inflammasome by R. australis in macrophages in which NLRP3 is involved.	[Smalley, Claire; Bechelli, Jeremy; Rockx-Brouwer, Dedeke; Saito, Tais; Azar, Sasha R.; Walker, David H.; Fang, Rong] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Rockx-Brouwer, Dedeke] Intravacc, Bilthoven, Netherlands	University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fang, R (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	rofang@utmb.edu	Fang, Rong/ABD-6123-2020; Bechelli, Jeremy/ABC-6193-2020	Azar, Sasha/0000-0002-9182-216X; Fang, Rong/0000-0003-0213-0960; Bechelli, Jeremy/0000-0002-8786-7795	National Institute of Allergy and Infectious Diseases [AI101413]; Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101413] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI101413 from the National Institute of Allergy and Infectious Diseases. Claire Smalley is supported by Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant AI101413 from the National Institute of Allergy and Infectious Diseases. Claire Smalley is supported by a Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston.	Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Casson CN, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00111; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Cragun WC, 2010, ARCH DERMATOL, V146, P641, DOI 10.1001/archdermatol.2010.48; de Sousa R, 2007, J INFECT DIS, V196, P770, DOI 10.1086/519739; Eremeeva ME, 1999, RICKETTSIAE RICKETTS, P128; Fang R, 2007, INFECT IMMUN, V75, P3112, DOI 10.1128/IAI.00007-07; Fang R, 2012, AM J PATHOL, V181, P185, DOI 10.1016/j.ajpath.2012.03.020; Fang R, 2009, INFECT IMMUN, V77, P3838, DOI 10.1128/IAI.00349-09; FENG HM, 1993, AM J PATHOL, V142, P1471; Feng HM, 1997, J IMMUNOL, V158, P5314; FENG HM, 1994, INFECT IMMUN, V62, P1952, DOI 10.1128/IAI.62.5.1952-1960.1994; Graves S, 2009, ANN NY ACAD SCI, V1166, P151, DOI 10.1111/j.1749-6632.2009.04530.x; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Johnston L, 2015, IMMUNOBIOLOGY, V220, P1305, DOI 10.1016/j.imbio.2015.07.014; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Jordan JM, 2007, J INFECT DIS, V196, P629, DOI 10.1086/519686; Jordan JM, 2009, J INFECT DIS, V199, P236, DOI 10.1086/595833; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuo J, 2015, INFECT IMMUN, V83, P2917, DOI 10.1128/IAI.02968-14; Melehani JH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004970; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Radulovic S, 2002, INFECT IMMUN, V70, P2576, DOI 10.1128/IAI.70.5.2576-2582.2002; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Valbuena G, 2003, AM J PATHOL, V163, P1357, DOI 10.1016/S0002-9440(10)63494-3; Walker DH, 2007, CLIN INFECT DIS, V45, pS39, DOI 10.1086/518145; WALKER DH, 1994, LAB INVEST, V70, P358; Walker DH, 2000, LAB INVEST, V80, P1361, DOI 10.1038/labinvest.3780144; Walker DH, 1999, MODERN PATHOL, V12, P529; Walker DH, 2001, INFECT IMMUN, V69, P1841, DOI 10.1128/IAI.69.3.1841-1846.2001; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Xin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034062; Yang Q, 2015, AM J PATHOL, V185, P446, DOI 10.1016/j.ajpath.2014.10.005; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	44	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157231	10.1371/journal.pone.0157231	http://dx.doi.org/10.1371/journal.pone.0157231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362650	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200010
J	Edmondson, R; Adcock, AF; Yang, LJ				Edmondson, Rasheena; Adcock, Audrey F.; Yang, Liju			Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins	PLOS ONE			English	Article							III BETA-TUBULIN; BASEMENT-MEMBRANE MATRIX; 3-DIMENSIONAL 3D CULTURE; EMBRYONIC STEM-CELLS; BREAST-CANCER; IN-VITRO; GENE-EXPRESSION; TUMOR SPHEROIDS; P53 ISOFORMS; GROWTH	This study investigated the effects of matrix on the behaviors of 3D-cultured cells of two prostate cancer cell lines, LNCaP and DU145. Two biologically-derived matrices, Matrigel and Cultrex BME, and one synthetic matrix, the Alvetex scaffold, were used to culture the cells. The cell proliferation rate, cellular response to anti-cancer drugs, and expression levels of proteins associated with drug sensitivity/ resistance were examined and compared amongst the 3D-cultured cells on the three matrices and 2D-cultured cells. The cellular responses upon treatment with two common anti-cancer drugs, Docetaxel and Rapamycin, were examined. The expressions of epidermal growth factor receptor (EGFR) and beta-III tubulin in DU145 cells and p53 in LNCaP cells were examined. The results showed that the proliferation rates of cells cultured on the three matrices varied, especially between the synthetic matrix and the biologically-derived matrices. The drug responses and the expressions of drug sensitivity-associated proteins differed between cells on various matrices as well. Among the 3D cultures on the three matrices, increased expression of beta-III tubulin in DU145 cells was correlated with increased resistance to Docetaxel, and decreased expression of EGFR in DU145 cells was correlated with increased sensitivity to Rapamycin. Increased expression of a p53 dimer in 3D-cultured LNCaP cells was correlated with increased resistance to Docetaxel. Collectively, the results showed that the matrix of 3D cell culture models strongly influences cellular behaviors, which highlights the imperative need to achieve standardization of 3D cell culture technology in order to be used in drug screening and cell biology studies.	[Edmondson, Rasheena; Adcock, Audrey F.; Yang, Liju] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise BRITE, Durham, NC 27707 USA	University of North Carolina; North Carolina Central University	Yang, LJ (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise BRITE, Durham, NC 27707 USA.	lyang@nccu.edu			NSF (CBET) [1159871]	NSF (CBET)(National Science Foundation (NSF))	NSF (CBET #1159871).; This research was supported by NSF (CBET #1159871).	Adcock A.F., 2015, J ANAL BIOANAL TECH, V6, DOI [10.4172/2155-9872.1000249, DOI 10.4172/2155-9872.1000249]; Alessandri M, 2014, MATRIX BIOL, V33, P68, DOI 10.1016/j.matbio.2013.08.001; Avery-Kiejda KA, 2014, CARCINOGENESIS, V35, P586, DOI 10.1093/carcin/bgt411; Babichenko II, 2014, INT J CLIN EXP PATHO, V7, P9090; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Bar J, 2004, ONCOGENE, V23, P2128, DOI 10.1038/sj.onc.1207325; Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0; Bialkowska A, 2015, INTESTINAL TUMORIGEN; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Chambers KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111029; Chitcholtan K, 2013, EXP CELL RES, V319, P75, DOI 10.1016/j.yexcr.2012.09.012; Chitcholtan K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-38; Corning, 2015, CORN MATR MATR 2015; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Engelman JA, 2008, CANCER CELL, V13, P375, DOI 10.1016/j.ccr.2008.04.008; Fallica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048024; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Glaysher Sharon, 2014, BMC Res Notes, V7, P397, DOI 10.1186/1756-0500-7-397; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Gurski L.A., 2010, ONCOL ISSUES, V25, P20, DOI [10.1080/10463356.2010.11883480, DOI 10.1080/10463356.2010.11883480]; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Holmes B, 2015, TISSUE ENG PT A, V21, P403, DOI [10.1089/ten.TEA.2014.0138, 10.1089/ten.tea.2014.0138]; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jaganathan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06468; Januchowski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365867; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kibbey Maura C., 1994, Journal of Tissue Culture Methods, V16, P227, DOI 10.1007/BF01540656; Kim JW, 2011, ANTICANCER RES, V31, P3237; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KWOK TT, 1985, INT J CANCER, V35, P675, DOI 10.1002/ijc.2910350517; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Lieberman MA, 2012, MARKS BASIC MED BIOC; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lipski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042615; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Liu TR, 2011, MOL CANCER THER, V10, P1460, DOI 10.1158/1535-7163.MCT-10-0925; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Magdolen V, 2012, KALLIKREIN-RELATED PEPTIDASES, VOL 2: NOVEL CANCER-RELATED BIOMARKERS, P1; Makinoshima H, 2015, J BIOL CHEM, V290, P17495, DOI 10.1074/jbc.M115.660498; Maria OM, 2011, INT J BIOCHEM CELL B, V43, P622, DOI 10.1016/j.biocel.2011.01.001; McCarroll JA, 2015, ONCOTARGET, V6, P2235, DOI 10.18632/oncotarget.2946; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Okorokov AL, 2006, EMBO J, V25, P5191, DOI 10.1038/sj.emboj.7601382; Olivier M, 2009, CANCER GENE THER, V16, P1, DOI 10.1038/cgt.2008.69; Patra B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21061; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Price KJ, 2012, BIOCHEM BIOPH RES CO, V427, P343, DOI 10.1016/j.bbrc.2012.09.059; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; REPROCELL, 2015, WHAT IS ALV; Fernandez-Fernandez MR, 2011, PROTEIN ENG DES SEL, V24, P41, DOI 10.1093/protein/gzq074; Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632; Schmid K, 2010, BRIT J CANCER, V103, P622, DOI 10.1038/sj.bjc.6605761; Seto B, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-29; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Sodunke TR, 2007, BIOMATERIALS, V28, P4006, DOI 10.1016/j.biomaterials.2007.05.021; Song SM, 2015, CLIN CANCER RES, V21, P2580, DOI 10.1158/1078-0432.CCR-14-2191; Stengel C, 2010, BRIT J CANCER, V102, P316, DOI 10.1038/sj.bjc.6605489; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tome-Garcia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099525; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-37; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wong S, 2007, MONOLITHIC 3D INTEGR	90	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158116	10.1371/journal.pone.0158116	http://dx.doi.org/10.1371/journal.pone.0158116			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352049	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900033
J	Hadjinicolaou, AE; Cloherty, SL; Hung, YS; Kameneva, T; Ibbotson, MR				Hadjinicolaou, Alex E.; Cloherty, Shaun L.; Hung, Yu-Shan; Kameneva, Tatiana; Ibbotson, Michael R.			Frequency Responses of Rat Retinal Ganglion Cells	PLOS ONE			English	Article							INTRINSIC PHYSIOLOGICAL-PROPERTIES; UNDERLYING CONTRAST ADAPTATION; RECEPTIVE-FIELD PROPERTIES; AXON INITIAL SEGMENT; CAT VISUAL-CORTEX; ELECTRICAL-STIMULATION; MAMMALIAN RETINA; OPTIC TRACT; IN-VIVO; NEURONS	There are 15-20 different types of retinal ganglion cells (RGC) in the mammalian retina, each encoding different aspects of the visual scene. The mechanism by which post-synaptic signals from the retinal network generate spikes is determined by each cell's intrinsic electrical properties. Here we investigate the frequency responses of morphologically identified rat RGCs using intracellular injection of sinusoidal current waveforms, to assess their intrinsic capabilities with minimal contributions from the retinal network. Recorded cells were classified according to their morphological characteristics (A, B, C or D-type) and their stratification (inner (i), outer (o) or bistratified) in the inner plexiform layer (IPL). Most cell types had low-or band-pass frequency responses. A2, C1 and C4o cells were band-pass with peaks of 15-30 Hz and low-pass cutoffs above 56 Hz (A2 cells) and similar to 42 Hz (C1 and C4o cells). A1 and C2i/o cells were low-pass with peaks of 10-15 Hz (cutoffs 19-25 Hz). Bistratified D1 and D2 cells were also low-pass with peaks of 5-10 Hz (cutoffs similar to 16 Hz). The least responsive cells were the B2 and C3 types (peaks: 2-5 Hz, cutoffs: 8-11 Hz). We found no difference between cells stratifying in the inner and outer IPL (i. e., ON and OFF cells) or between cells with large and small somas or dendritic fields. Intrinsic physiological properties (input resistance, spike width and sag) had little impact on frequency response at low frequencies, but account for 30-40% of response variability at frequencies >30 Hz.	[Hadjinicolaou, Alex E.; Cloherty, Shaun L.; Hung, Yu-Shan; Ibbotson, Michael R.] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia; [Hadjinicolaou, Alex E.; Cloherty, Shaun L.; Hung, Yu-Shan; Ibbotson, Michael R.] Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct, Parkville, Vic 3052, Australia; [Hadjinicolaou, Alex E.; Cloherty, Shaun L.; Hung, Yu-Shan; Ibbotson, Michael R.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Cloherty, Shaun L.; Kameneva, Tatiana] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Hadjinicolaou, AE (corresponding author), Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia.; Hadjinicolaou, AE (corresponding author), Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct, Parkville, Vic 3052, Australia.; Hadjinicolaou, AE (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	a.e.hadjinicolaou@gmail.com	Cloherty, Shaun L./AAH-5029-2019; ibbotson, michael/F-9030-2011	Cloherty, Shaun L./0000-0002-7679-1764; Hung, Yu-Shan/0000-0002-7030-9834; ibbotson, michael/0000-0002-3803-6653	National Health and Medical Research Council of Australia [585440]; Australian Research Council [DP0881247]; Australian Research Council, Special Research Initiative (SRI) in Bionic Vision Science and Technology grant [SR1000005]; ARC Centre of Excellence for Integrative Brain Function [CE140100007]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Research Council, Special Research Initiative (SRI) in Bionic Vision Science and Technology grant(Australian Research Council); ARC Centre of Excellence for Integrative Brain Function(Australian Research Council)	This work was funded by National Health and Medical Research Council of Australia, 585440; Australian Research Council, Discovery Project, DP0881247; Australian Research Council, Special Research Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic Vision Australia (BVA), SR1000005; and ARC Centre of Excellence for Integrative Brain Function, CE140100007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chader GJ, 2002, VISION RES, V42, P393, DOI 10.1016/S0042-6989(01)00212-7; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Cho AK, 2011, IEEE ENG MED BIO, P1081, DOI 10.1109/IEMBS.2011.6090252; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Freeman DK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/016008; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fried SI, INVEST OPHTHALMOL VI; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Hadjinicolaou AE, 2015, IEEE T NEUR SYS REH, V23, P169, DOI 10.1109/TNSRE.2014.2361900; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heine WF, 2011, VISUAL NEUROSCI, V28, P403, DOI 10.1017/S0952523811000307; Hietanen MA, 2007, J PHYSIOL-LONDON, V584, P451, DOI 10.1113/jphysiol.2007.131631; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huxlin KR, 1997, J COMP NEUROL, V385, P309; Ibbotson M. R., 2005, FITTING MIND WORLD A, P17; Ibbotson MR, 1998, J NEUROPHYSIOL, V79, P1481, DOI 10.1152/jn.1998.79.3.1481; Ibbotson MR, 2005, J NEUROPHYSIOL, V94, P136, DOI 10.1152/jn.00980.2004; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; NEHER E, 1992, METHOD ENZYMOL, V207, P123; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Robinson DW, 1997, CURR BIOL, V7, P366, DOI 10.1016/S0960-9822(06)00184-9; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sefton AJ, RAT NERVOUS SYSTEM, P1083; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Toib A, 1998, J NEUROSCI, V18, P1893; Tsai D, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066007; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; Wainwright MJ, 2002, NEURAL INF PROCESS S, P203; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong RCS, 2012, J NEUROPHYSIOL, V108, P2008, DOI 10.1152/jn.01091.2011; Xu Y, 2005, J NEUROPHYSIOL, V93, P2388, DOI 10.1152/jn.01088.2004; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	48	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157676	10.1371/journal.pone.0157676	http://dx.doi.org/10.1371/journal.pone.0157676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341669	gold, Green Published			2022-12-26	WOS:000378393600013
J	Huang, XQ; Das, A; Sahu, BB; Srivastava, SK; Leandro, LF; O'Donnell, K; Bhattacharyya, MK				Huang, Xiaoqiu; Das, Anindya; Sahu, Binod B.; Srivastava, Subodh K.; Leandro, Leonor F.; O'Donnell, Kerry; Bhattacharyya, Madan K.			Identification of Highly Variable Supernumerary Chromosome Segments in an Asexual Pathogen	PLOS ONE			English	Article							SUDDEN-DEATH SYNDROME; BEAN ROOT-ROT; COLLETOTRICHUM-GLOEOSPORIOIDES; FUSARIUM-VIRGULIFORME; TRANSPOSABLE ELEMENT; FILAMENTOUS FUNGI; SPECIES COMPLEX; SOUTH-AMERICA; EVOLUTION; CYTOCHROME-P450	Supernumerary chromosome segments are known to harbor different transposons from their essential counterparts. The aim of this study was to investigate the role of transposons in the origin and evolution of supernumerary segments in the asexual fungal pathogen Fusarium virguliforme. We compared the genomes of 11 isolates comprising six Fusarium species that cause soybean sudden death syndrome (SDS) or bean root rot (BRR), and identified significant levels of genetic variation in A+T-rich repeat blocks of the essential chromosomes and in A+T-neutral regions of the supernumerary segments. The A+T-rich repeat blocks in the essential chromosomes were highly variable between F. virguliforme and non-F. virguliforme isolates, but were scarcely variable between F. virguliforme isolates. The A+T-neutral regions in the supernumerary segments, however, were highly variable between F. virguliforme isolates, with a statistically significant number (21 standard deviations above the mean) of single nucleotide polymorphisms (SNPs). And supernumerary sequence types and rearrangement patterns of some F. virguliforme isolates were present in an isolate of F. cuneirostrum but not in the other F. virguliforme isolates. The most variable and highly expressed region in the supernumerary segments contained an active DNA transposon that was a most conserved match between F. virguliforme and the unrelated fungus Tolypocladiuminflatum. This transposon was absent from two of the F. virguliforme isolates. Furthermore, transposons in the supernumerary segments of some F. virguliforme isolates were present in non-F. virguliforme isolates, but were absent from the other F. virguliforme isolates. Two supernumerary P450 enzymes were 43% and 57% identical to their essential counterparts. This study has raised the possibility that transposons generate genetic variation in supernumerary chromosome segments by frequent horizontal transfer within and between closely related species.	[Huang, Xiaoqiu; Das, Anindya] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Huang, Xiaoqiu] Iowa State Univ, Inst Plant Sci, Ames, IA USA; [Sahu, Binod B.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA USA; [Srivastava, Subodh K.] Univ Arkansas, Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Leandro, Leonor F.] Iowa State Univ, Dept Plant Pathol, Ames, IA USA; [O'Donnell, Kerry] ARS, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA; [Srivastava, Subodh K.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Iowa State University; Iowa State University; Iowa State University; University of Arkansas System; University of Arkansas Fayetteville; Iowa State University; United States Department of Agriculture (USDA); Clemson University	Huang, XQ (corresponding author), Iowa State Univ, Dept Comp Sci, Ames, IA USA.; Huang, XQ (corresponding author), Iowa State Univ, Inst Plant Sci, Ames, IA USA.	xqhuang@iastate.edu	Sahu, Binod B/O-8394-2017; Sahu, Binod B./C-3369-2009; Sahu, Binod Bihari/S-4290-2019	Sahu, Binod B/0000-0002-2151-0654; Sahu, Binod Bihari/0000-0002-2151-0654	United States Department of Agriculture National Institute of Food and Agriculture; Iowa Soybean Association; Iowa State University;  [2013-68004-20374]; ARS [ARS-0424489] Funding Source: Federal RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Iowa Soybean Association; Iowa State University; ; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by the United States Department of Agriculture National Institute of Food and Agriculture to MKB, LFL and XH (http://nifa.usda.gov and Grant no. 2013-68004-20374); Iowa Soybean Association to MKB (http://www.iasoybeans.com); and Iowa State University to XH (http://www.iastate.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Aoki T, 2012, MYCOLOGIA, V104, P1068, DOI 10.3852/11-303; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; CAMBARERI EB, 1991, GENETICS, V127, P699; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Covert SF, 2007, FUNGAL GENET BIOL, V44, P799, DOI 10.1016/j.fgb.2006.12.009; Covert SF, 1998, CURR GENET, V33, P311, DOI 10.1007/s002940050342; Croll D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002608; DANIELS SB, 1990, GENETICS, V124, P339; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Doyle J. J., 1987, PHYTOCHEM B, P11; Durairaj P, 2015, ENZYME MICROB TECH, V70, P58, DOI 10.1016/j.enzmictec.2014.12.013; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grandaubert J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-891; He CZ, 1998, GENETICS, V150, P1459; HIRREL M.C, 1983, PHYTOPATHOLOGY S, V77, P1689; Huang XQ, 2014, PEERJ, V2, DOI 10.7717/peerj.650; Huang XQ, 2004, BIOINFORMATICS, V20, P2529, DOI 10.1093/bioinformatics/bth279; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Huang XQ, 2003, BIOINFORMATICS, V19, P228, DOI 10.1093/bioinformatics/19.2.228; Hughes TJ, 2014, MYCOLOGIA, V106, P686, DOI 10.3852/13-318; Jin H, 1996, PHYTOPATHOLOGY, V86, P277, DOI 10.1094/Phyto-86-277; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KISTLER HC, 1992, ANNU REV PHYTOPATHOL, V30, P131, DOI 10.1146/annurev.py.30.090192.001023; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H., 2013, ARXIV 13033997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mansouri S., 2012, THESIS; MASEL AM, 1993, MOL GEN GENET, V237, P73, DOI 10.1007/BF00282786; Masel AM, 1996, MOL PLANT MICROBE IN, V9, P339, DOI 10.1094/MPMI-9-0339; Mbofung GYC, 2012, CAN J PLANT PATHOL, V34, P83, DOI 10.1080/07060661.2012.664564; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; O'Donnell K, 2010, PHYTOPATHOLOGY, V100, P58, DOI 10.1094/PHYTO-100-1-0058; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schuler MA., 2015, CYTOCHROME P450 STRU, p450s; Seidl MF, 2014, BIOESSAYS, V36, P335, DOI 10.1002/bies.201300155; Srivastava SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081832; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stukenbrock EH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001189	50	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158183	10.1371/journal.pone.0158183	http://dx.doi.org/10.1371/journal.pone.0158183			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341103	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600037
J	Behrendt, F; de Lussanet, MHE; Zentgraf, K; Zschorlich, VR				Behrendt, Frank; de Lussanet, Marc H. E.; Zentgraf, Karen; Zschorlich, Volker R.			Motor-Evoked Potentials in the Lower Back Are Modulated by Visual Perception of Lifted Weight	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BIOLOGICAL MOTION PERCEPTION; ERECTOR SPINAE MUSCLES; CORTICOSPINAL EXCITABILITY; PREMOTOR CORTEX; BRAIN ACTIVITY; HAND; EXECUTION; FACILITATION; MOVEMENTS	Facilitation of the primary motor cortex (M1) during the mere observation of an action is highly congruent with the observed action itself. This congruency comprises several features of the executed action such as somatotopy and temporal coding. Studies using reach-grasp-lift paradigms showed that the muscle-specific facilitation of the observer's motor system reflects the degree of grip force exerted in an observed hand action. The weight judgment of a lifted object during action observation is an easy task which is the case for hand actions as well as for lifting boxes from the ground. Here we investigated whether the cortical representation in M1 for lumbar back muscles is modulated due to the observation of a whole-body lifting movement as it was shown for hand action. We used transcranial magnetic stimulation (TMS) to measure the corticospinal excitability of the m. erector spinae (ES) while subjects visually observed the recorded sequences of a person lifting boxes of different weights from the floor. Consistent with the results regarding hand action the present study reveals a differential modulation of corticospinal excitability despite the relatively small M1 representation of the back also for lifting actions that mainly involve the lower back musculature.	[Behrendt, Frank] Univ Childrens Hosp Basle, Basel, Switzerland; [Behrendt, Frank] Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland; [de Lussanet, Marc H. E.; Zentgraf, Karen] Univ Munster, Inst Sport & Exercise Sci, D-48149 Munster, Germany; [Zschorlich, Volker R.] Univ Rostock, Inst Sport Sci, Dept Kinesiol, D-18055 Rostock, Germany	University of Munster; University of Rostock	Behrendt, F (corresponding author), Univ Childrens Hosp Basle, Basel, Switzerland.; Behrendt, F (corresponding author), Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland.; Zentgraf, K (corresponding author), Univ Munster, Inst Sport & Exercise Sci, D-48149 Munster, Germany.	frank.behrendt@ukbb.ch; karen.zentgraf@uni-muenster.de	, volker.zschorlich@uni-rostock.de/ABH-8796-2020	, volker.zschorlich@uni-rostock.de/0000-0001-8158-6223; Behrendt, Frank/0000-0001-6967-0000	German Federal Ministry of Education and Research, BMBF [01EC1003A]; Open Access Publication Fund of University of Muenster	German Federal Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Open Access Publication Fund of University of Muenster	Marc H.E. de Lussanet and Frank Behrendt were supported by the German Federal Ministry of Education and Research, BMBF (grant 01EC1003A). The authors acknowledge support by Open Access Publication Fund of University of Muenster.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alaerts K, 2012, PSYCHOL RES-PSYCH FO, V76, P503, DOI 10.1007/s00426-011-0380-1; Alaerts K, 2010, NEUROPSYCHOLOGIA, V48, P2082, DOI 10.1016/j.neuropsychologia.2010.03.029; Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Behrendt F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104981; Behrendt F, 2013, ACTA PSYCHOL, V142, P343, DOI 10.1016/j.actpsy.2013.01.001; BINGHAM GP, 1987, J EXP PSYCHOL HUMAN, V13, P155, DOI 10.1037/0096-1523.13.2.155; Bischoff M, 2015, PERCEPT MOTOR SKILL, V120, P39, DOI 10.2466/22.24.PMS.120v10x7; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Borroni P, 2008, SOC NEUROSCI-UK, V3, P276, DOI 10.1080/17470910701515269; Bosbach S, 2005, NAT NEUROSCI, V8, P1295, DOI 10.1038/nn1535; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Catley MJ, 2013, RHEUMATOLOGY, V52, P1454, DOI 10.1093/rheumatology/ket140; Cheng YW, 2005, NEUROREPORT, V16, P1711, DOI 10.1097/01.wnr.0000183325.13618.5f; Chong E, 2016, P NATL ACAD SCI USA, V113, P1453, DOI 10.1073/pnas.1512144113; De Lussanet MHE, 2008, EUR J NEUROSCI, V27, P514, DOI 10.1111/j.1460-9568.2007.06009.x; de Lussanet MHE, 2013, HUM MOVEMENT SCI, V32, P938, DOI 10.1016/j.humov.2013.05.002; de Lussanet MHE, 2012, PAIN, V153, P1459, DOI 10.1016/j.pain.2012.04.002; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; DELOOZE MP, 1993, J BIOMECH, V26, P1067, DOI 10.1016/S0021-9290(05)80006-5; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dishman JD, 2008, J MANIP PHYSIOL THER, V31, P258, DOI 10.1016/j.jmpt.2008.03.002; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; FERBERT A, 1992, ELECTROEN CLIN NEURO, V85, P382, DOI 10.1016/0168-5597(92)90051-C; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Guillot A, 2007, INT J PSYCHOPHYSIOL, V66, P18, DOI 10.1016/j.ijpsycho.2007.05.009; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Helm F, 2015, NEUROSCIENCE, V290, P398, DOI 10.1016/j.neuroscience.2015.01.050; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; LEMON RN, 1995, J NEUROSCI, V15, P6145; Lorey B, 2010, NEUROIMAGE, V49, P3239, DOI 10.1016/j.neuroimage.2009.11.038; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Michels L, 2009, NEUROIMAGE, V45, P151, DOI 10.1016/j.neuroimage.2008.10.063; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Mulder T, 2005, EXP BRAIN RES, V163, P344, DOI 10.1007/s00221-004-2179-4; Penfield W, 1950, LANE MED LECT; Poliakoff E, 2010, EXP BRAIN RES, V204, P327, DOI 10.1007/s00221-009-1976-1; Rauss K, 2011, NEUROSCI BIOBEHAV R, V35, P1237, DOI 10.1016/j.neubiorev.2010.12.011; Reuter EM, 2015, EXP GERONTOL, V65, P79, DOI 10.1016/j.exger.2015.03.008; Ridderinkhof KR, 2014, NEUROSCI BIOBEHAV R, V46, P3, DOI 10.1016/j.neubiorev.2014.05.008; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Romani M, 2005, NEUROIMAGE, V26, P755, DOI 10.1016/j.neuroimage.2005.02.027; Runeson S, 1981, HUMAN PERCEPTION PER, V7, P733, DOI [DOI 10.1037/0096-1523.7.4.733), DOI 10.1037/0096-1523.7.4.733]; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Servos P, 2002, CEREB CORTEX, V12, P772, DOI 10.1093/cercor/12.7.772; Shim J, 2004, PERCEPTION, V33, P277, DOI 10.1068/p3434; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Tokay T, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/684238; Tokay T, 2009, NEUROSCI LETT, V461, P150, DOI 10.1016/j.neulet.2009.06.032; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; ZSCHORLICH V R, 1989, Electromyography and Clinical Neurophysiology, V29, P81; Zschorlich VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083845	73	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157811	10.1371/journal.pone.0157811	http://dx.doi.org/10.1371/journal.pone.0157811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336751	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200053
J	Cidre-Aranaz, F; Grunewald, TGP; Surdez, D; Garcia-Garcia, L; Lazaro, JC; Kirchner, T; Gonzalez-Gonzalez, L; Sastre, A; Garcia-Miguel, P; Lopez-Perez, SE; Monzon, S; Delattre, O; Alonso, J				Cidre-Aranaz, F.; Gruenewald, T. G. P.; Surdez, D.; Garcia-Garcia, L.; Lazaro, J. Carlos; Kirchner, T.; Gonzalez-Gonzalez, L.; Sastre, A.; Garcia-Miguel, P.; Lopez-Perez, S. E.; Monzon, S.; Delattre, O.; Alonso, J.			EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma	ONCOGENE			English	Article							FIBROBLAST-GROWTH-FACTOR; MOLECULAR PATHOGENESIS; EWS/FLI1 ONCOPROTEIN; DOWN-REGULATION; TARGET GENES; EXPRESSION; MIGRATION; INVASION; RECEPTOR; FUSION	Ewing sarcoma is characterized by chromosomal translocations fusing the EWS gene with various members of the ETS family of transcription factors, most commonly FLI1. EWS-FLI1 is an aberrant transcription factor driving Ewing sarcoma tumorigenesis by either transcriptionally inducing or repressing specific target genes. Herein, we showed that Sprouty 1 (SPRY1), which is a physiological negative feedback inhibitor downstream of fibroblast growth factor (FGF) receptors (FGFRs) and other RAS-activating receptors, is an EWS-FLI1 repressed gene. EWS-FLI1 knockdown specifically increased the expression of SPRY1, while other Sprouty family members remained unaffected. Analysis of SPRY1 expression in a panel of Ewing sarcoma cells showed that SPRY1 was not expressed in Ewing sarcoma cell lines, suggesting that it could act as a tumor suppressor gene in these cells. In agreement, induction of SPRY1 in three different Ewing sarcoma cell lines functionally impaired proliferation, clonogenic growth and migration. In addition, SPRY1 expression inhibited extracellular signal-related kinase/mitogen-activated protein kinase (MAPK) signaling induced by serum and basic FGF (bFGF). Moreover, treatment of Ewing sarcoma cells with the potent FGFR inhibitor PD-173074 reduced bFGF-induced proliferation, colony formation and in vivo tumor growth in a dose-dependent manner, thus mimicking SPRY1 activity in Ewing sarcoma cells. Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort. Taken together, our data indicate that EWS-FLI1-mediated repression of SPRY1 leads to unrestrained bFGF-induced cell proliferation, suggesting that targeting the FGFR/MAPK pathway can constitute a promising therapeutic approach for this devastating disease.	[Cidre-Aranaz, F.; Garcia-Garcia, L.; Lazaro, J. Carlos; Gonzalez-Gonzalez, L.; Lopez-Perez, S. E.; Monzon, S.; Alonso, J.] Inst Salud Carlos III, Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Ctra Majadahonda Pozuelo Km 2, Majadahonda Madrid 28220, Spain; [Gruenewald, T. G. P.; Surdez, D.; Delattre, O.] Genet & Biol Canc Inst Curie Res Ctr, INSERM U830, Paris, France; [Gruenewald, T. G. P.] Ludwig Maximilians Univ Munchen, Inst Pathol, Lab Pediat Sarcoma Biol, Munich, Germany; [Sastre, A.; Garcia-Miguel, P.] Hosp Infantil Univ La Paz, Unidad Hematooncol Pediat, Madrid, Spain; [Monzon, S.] Inst Salud Carlos III, CIBERER U758, Madrid, Spain	Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Munich; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Alonso, J (corresponding author), Inst Salud Carlos III, Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Ctra Majadahonda Pozuelo Km 2, Majadahonda Madrid 28220, Spain.	fjalonso@isciii.es	Alonso, Javier/B-6012-2013; Surdez, Didier/ABG-4565-2020; Monzon, Sara/AAG-2909-2021; Grünewald, Thomas G. P./O-2317-2013	Alonso, Javier/0000-0002-6287-8391; Monzon, Sara/0000-0002-0740-6324; Grünewald, Thomas G. P./0000-0003-0920-7377; GARCIA, LAURA/0000-0002-8585-849X; Gonzalez-Gonzalez, Laura/0000-0003-0372-2650; Cidre Aranaz, Florencia/0000-0002-0246-7179; delattre, olivier/0000-0002-8730-2276	Asociacion Pablo Ugarte and Miguelanez SA; ASION-La Hucha de Tomas; Fundacion La Sonrisa de Alex; Instituto de Salud Carlos III [PI12/00816, RTICC RD12/0036/0027]; Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LMU Munchen (WiFoMed); Daimler and Benz Foundation; LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative; Mehr LEBEN fur krebskranke Kinder-Bettina-Brau-Stiftung; Walter Schulz Foundation; German Cancer Aid [DKH-111886, DKH-70112257]; Ligue Nationale Contre Le Cancer (Equipe labellisee); European PROVABES grant; Reinhard Frank Foundation; Fritz Thyssen Foundation [FTH-40.15.0.030MN]; European ASSET grant; European EEC FP7 grant	Asociacion Pablo Ugarte and Miguelanez SA; ASION-La Hucha de Tomas; Fundacion La Sonrisa de Alex; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LMU Munchen (WiFoMed); Daimler and Benz Foundation; LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative; Mehr LEBEN fur krebskranke Kinder-Bettina-Brau-Stiftung; Walter Schulz Foundation; German Cancer Aid(Deutsche Krebshilfe); Ligue Nationale Contre Le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); European PROVABES grant; Reinhard Frank Foundation; Fritz Thyssen Foundation; European ASSET grant; European EEC FP7 grant	FC-A, LG-G, JCL, AS, PG-M, SEL-P, SM and JA are supported by Asociacion Pablo Ugarte and Miguelanez SA, ASION-La Hucha de Tomas, Fundacion La Sonrisa de Alex and Instituto de Salud Carlos III (PI12/00816 and Spanish Cancer Network RTICC RD12/0036/0027). TGPG is supported by a grant from 'Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LMU Munchen (WiFoMed)', the Daimler and Benz Foundation in cooperation with the Reinhard Frank Foundation, by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative, the 'Mehr LEBEN fur krebskranke Kinder-Bettina-Brau-Stiftung', the Walter Schulz Foundation, the Fritz Thyssen Foundation (FTH-40.15.0.030MN) and by the German Cancer Aid (DKH-111886 and DKH-70112257). The 'Genetics and Biology of Cancers' team (TGPG, DS and OD) is supported by grants from the Ligue Nationale Contre Le Cancer (Equipe labellisee). This work was also supported by the European PROVABES, ASSET and EEC FP7 grants. We also thank the following associations for their invaluable support: the Societe Francaise des Cancers de l'Enfant, Courir pour Mathieu, Dans les pas du Geant, Olivier Chape, Les Bagouzamanon, Enfants et Sante and les Amis de Claire. We thank Dr S Navarro (University of Valencia, Valencia, Spain) and Dr TJ Triche (Children's Hospital Los Angeles, Los Angeles, USA) for providing us with Ewing sarcoma cell lines A4573 and TTC-466, respectively.	Agelopoulos K, 2015, CLIN CANCER RES, V21, P4935, DOI 10.1158/1078-0432.CCR-14-2744; Agra N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066281; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bilke S, 2013, GENOME RES, V23, P1797, DOI 10.1101/gr.151340.112; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Cidre-Aranaz F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00162; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; Gaspar N, 2015, J CLIN ONCOL, V33, P3036, DOI 10.1200/JCO.2014.59.5256; Grohar PJ, 2013, PHARMACOL THERAPEUT, V137, P216, DOI 10.1016/j.pharmthera.2012.10.004; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Grunewald TGP, 2015, NAT GENET, V47, P1073, DOI 10.1038/ng.3363; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; Kovar H, 2003, ONCOGENE, V22, P3193, DOI 10.1038/sj.onc.1206391; Kovar H, 2014, EXPERT OPIN THER TAR, V18, P1315, DOI 10.1517/14728222.2014.947963; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Kwabi-Addo B, 2009, EPIGENETICS, V4, P54, DOI 10.4161/epi.4.1.7400; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511; Masoumi-Moghaddam S, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-61; Mekkawy AH, 2014, TUMOR BIOL, V35, P5037, DOI 10.1007/s13277-014-1665-y; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Minowada G, 1999, DEVELOPMENT, V126, P4465; Navarro D, 2010, CARCINOGENESIS, V31, P394, DOI 10.1093/carcin/bgp317; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Surdez D, 2012, CANCER RES, V72, P4494, DOI 10.1158/0008-5472.CAN-12-0371; Terada N, 2014, J CELL BIOCHEM, V115, P1505, DOI 10.1002/jcb.24805; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Touat M, 2015, CLIN CANCER RES, V21, P2684, DOI 10.1158/1078-0432.CCR-14-2329; Wiles ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059369; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; YAMAGUCHI F, 1994, P NATL ACAD SCI USA, V91, P484, DOI 10.1073/pnas.91.2.484; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhu LM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00230	52	21	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					766	776		10.1038/onc.2016.244	http://dx.doi.org/10.1038/onc.2016.244			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27375017	Green Accepted			2022-12-26	WOS:000394168200004
J	Tournillon, AS; Lopez, I; Malbert-Colas, L; Findakly, S; Naski, N; Olivares-Illana, V; Karakostis, K; Vojtesek, B; Nylander, K; Fahraeus, R				Tournillon, A-S; Lopez, I.; Malbert-Colas, L.; Findakly, S.; Naski, N.; Olivares-Illana, V.; Karakostis, K.; Vojtesek, B.; Nylander, K.; Fahraeus, R.			p53 binds the mdmx mRNA and controls its translation	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DNA-DAMAGE; EMBRYONIC LETHALITY; FEEDBACK LOOP; ACTIVATION; PROTEIN; GENE; DOMAIN; AMPLIFICATION; RECOGNITION	MDMX and MDM2 are two nonredundant essential regulators of p53 tumor suppressor activity. MDM2 controls p53 expression levels, whereas MDMX is predominantly a negative regulator of p53 trans-activity. The feedback loops between MDM2 and p53 are well studied and involve both negative and positive regulation on transcriptional, translational and post-translational levels but little is known on the regulatory pathways between p53 and MDMX. Here we show that overexpression of p53 suppresses mdmx mRNA translation in vitro and in cell-based assays. The core domain of p53 binds the 5' untranslated region (UTR) of the mdmx mRNA in a zinc-dependent manner that together with a trans-suppression domain located in p53 N-terminus controls MDMX synthesis. This interaction can be visualized in the nuclear and cytoplasmic compartment. Fusion of the mdmx 5' UTR to the ovalbumin open reading frame leads to suppression of ovalbumin synthesis. Interestingly, the transcription inactive p53 mutant R273H has a different RNA-binding profile compared with the wild-type p53 and differentiates the synthesis of MDMX isoforms. This study describes p53 as a trans-suppressor of the mdmx mRNA and adds a further level to the intricate feedback system that exist between p53 and its key regulatory factors and emphasizes the important role of mRNA translation control in regulating protein expression in the p53 pathway.	[Tournillon, A-S; Lopez, I.; Malbert-Colas, L.; Findakly, S.; Naski, N.; Karakostis, K.; Fahraeus, R.] Univ Paris 07, Hop St Louis, Inst Natl Sante & Rech Med, Inst Genet Mol,Equipe Labellisee Ligue Canc,UMR11, 27 Rue Juliette Dodu, F-75010 Paris, France; [Olivares-Illana, V.] Univ Auonoma San Luis Potosi, Inst Fis, San Luis Potosi, Mexico; [Vojtesek, B.; Fahraeus, R.] Masaryk Mem Canc Inst, RECAMO, Brno, Czech Republic; [Nylander, K.; Fahraeus, R.] Umea Univ, Dept Med Biosci, Umea, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Masaryk Memorial Cancer Institute; Umea University	Fahraeus, R (corresponding author), Univ Paris 07, Hop St Louis, Inst Natl Sante & Rech Med, Inst Genet Mol,Equipe Labellisee Ligue Canc,UMR11, 27 Rue Juliette Dodu, F-75010 Paris, France.	robin.fahraeus@inserm.fr	Karakostis, Konstantinos/AGJ-3251-2022; Karakostis, Konstantinos/ABC-9700-2020; Karakostis, Konstantinos/GNW-4090-2022; Olivares-Illana, Vanesa/AAF-9710-2021; fahraeus, robin/K-8726-2014	Karakostis, Konstantinos/0000-0003-1122-7860; Olivares-Illana, Vanesa/0000-0001-6949-5986; Lopez, Ignacio/0000-0001-9669-8906	la Ligue Contre le Cancer; PACRI; AXA Research Fund; Fondation pour la Recherche Medicale [FDT20150532276]; GACR [16-07321S]; MH CZ-DRO (MMCI) [00209805]; Inserm;  [MEYS-NPS I-L01413]	la Ligue Contre le Cancer(Ligue nationale contre le cancer); PACRI; AXA Research Fund(AXA Research Fund); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); GACR(Grant Agency of the Czech Republic); MH CZ-DRO (MMCI); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); 	This work was supported by la Ligue Contre le Cancer and Inserm. A-ST is supported by PACRI. IL is supported by AXA Research Fund and Fondation pour la Recherche Medicale (FDT20150532276). BV was supported by GACR 16-07321S and BV and RF were supported by MEYS-NPS I-L01413 and MH CZ-DRO (MMCI, 00209805). We thank the IUH platform for technical assistance.	Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Gajjar M, 2012, CANCER CELL, V21, P25, DOI 10.1016/j.ccr.2011.11.016; Galy B, 2001, ONCOGENE, V20, P4613, DOI 10.1038/sj.onc.1204630; Galy B, 2001, ONCOGENE, V20, P1669, DOI 10.1038/sj.onc.1204271; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hudson WH, 2014, NAT REV MOL CELL BIO, V15, P749, DOI 10.1038/nrm3884; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Lopez I, 2015, CELL CYCLE, V14, P3373, DOI 10.1080/15384101.2015.1090066; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Malbert-Colas L, 2014, MOL CELL, V54, P500, DOI 10.1016/j.molcel.2014.02.035; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Miller SJ, 2000, MOL CELL BIOL, V20, P8420, DOI 10.1128/MCB.20.22.8420-8431.2000; Mlynarczyk C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6067; Montes de Oca LR, 1995, NATURE, V378, P203; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pant V, 2013, GENE DEV, V27, P1857, DOI 10.1101/gad.227249.113; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Perry ME, 2000, J BIOL CHEM, V275, P5733, DOI 10.1074/jbc.275.8.5733; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Riley KJL, 2006, RNA, V12, P620, DOI 10.1261/rna.2286706; Saucedo LJ, 1999, J BIOL CHEM, V274, P8161, DOI 10.1074/jbc.274.12.8161; Scrable H, 2005, INT J BIOCHEM CELL B, V37, P913, DOI 10.1016/j.biocel.2004.11.014; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; Tournillon AS, 2015, CELL CYCLE, V14, P449, DOI 10.4161/15384101.2014.977081; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801	37	17	17	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					723	730		10.1038/onc.2016.236	http://dx.doi.org/10.1038/onc.2016.236			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27375027				2022-12-26	WOS:000394167700013
J	Dong, H; Ma, L; Gan, J; Lin, W; Chen, C; Yao, Z; Du, L; Zheng, L; Ke, C; Huang, X; Song, H; Kumar, R; Yeung, SC; Zhang, H				Dong, H.; Ma, L.; Gan, J.; Lin, W.; Chen, C.; Yao, Z.; Du, L.; Zheng, L.; Ke, C.; Huang, X.; Song, H.; Kumar, R.; Yeung, S. C.; Zhang, H.			PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2	ONCOGENE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; MAMMARY TUMORIGENESIS; CANCER PATIENTS; RECEPTOR; ACTIVATION; EXPRESSION; TRANSFORMATION; THERAPY	The plasma membrane-associated tyrosine phosphatase PTPRO is frequently transcriptionally repressed in cancers and signifies poor prognosis of breast cancer patients. In this study, deletion of Ptpro in MMTV-Erbb2 transgenic mice dramatically shortened the mammary tumor latency and accelerated tumor growth due to loss of Ptpro within the breast cancer cells but not in surrounding tissue as confirmed by hetero-transplantation studies. Both in vitro and in vivo data demonstrated that the phosphatase activity was required for the inactivation of ERBB2 and its downstream signaling. PTPRO regulated the phosphorylation status of ERBB2 at Y1248. Co-immunoprecipitation and proximity ligation assay (Duolink) indicated that PTPRO directly physically interacted with ERBB2. Moreover, PTPRO phosphatase activity shortened the half-life of ERBB2 by increasing endocytotic degradation. PTPRO reexpression by demethylation treatment using 5-azacytidine reduced the proliferation and colony formation potential in ERBB2positive breast cancer cells. Taken together, PTPRO inhibited ERBB2-driven breast cancer through dephosphorylation leading to dual effects of ERBB2 signaling suppression and endosomal internalization of ERBB2, Therefore, reexpression of PTPRO may be a potential therapy for ERBB2-overexpressing breast cancer.	[Dong, H.; Gan, J.; Lin, W.; Chen, C.; Yao, Z.; Du, L.; Zheng, L.; Ke, C.; Yeung, S. C.; Zhang, H.] Shantou Univ, Canc Res Ctr, Coll Med, Xinling Rd 22, Shantou 515041, Peoples R China; [Ma, L.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol, Houston, TX 77030 USA; [Huang, X.] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Song, H.] Xi An Jiao Tong Univ, Dept Cell Biol, Suzhou Acad, Suzhou, Peoples R China; [Kumar, R.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Yeung, S. C.] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Yeung, S. C.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Zhang, H.] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Biotherapy, Shantou, Peoples R China	Shantou University; University of Texas System; UTMD Anderson Cancer Center; Nanjing University; Xi'an Jiaotong University; George Washington University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Shantou University	Zhang, H (corresponding author), Shantou Univ, Canc Res Ctr, Coll Med, Xinling Rd 22, Shantou 515041, Peoples R China.; Yeung, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA.	syeung@mdanderson.org; haozhang@stu.edu.cn	Yeung, Sai-Ching/AAI-6178-2021; Kumar, Rakesh/ABD-1065-2020; Yeung, Sai-Ching/AAP-8079-2020	Yeung, Sai-Ching/0000-0001-5170-0822; Kumar, Rakesh/0000-0001-7664-0803; huang, xingxu/0000-0001-8934-1247; Du, Liang/0000-0002-1191-2465	National Natural Science Foundation of China NSFC [81071736, 30973508, 81572876, 31271495]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	This work was supported in part by National Natural Science Foundation of China NSFC (81071736, 30973508 and 81572876 to HZ and 31271495 to HS), the funding for Collaborative and Creative Center, Molecular Diagnosis and Personalized Medicine, Shantou University, Guangdong Province, and the funding from the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases. We thank Dr Stanley Lin for the careful reading the manuscript.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Asbagh LA, 2014, ONCOTARGET, V5, P10070, DOI 10.18632/oncotarget.2458; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chen B, 2005, J NEUROSCI, V25, P880, DOI 10.1523/JNEUROSCI.4365-04.2005; Cicenas J, 2006, EUR J CANCER, V42, P636, DOI 10.1016/j.ejca.2005.11.012; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gensler M, 2004, J BIOL CHEM, V279, P12110, DOI 10.1074/jbc.M309527200; Gradishar WJ, 2013, ANN ONCOL, V24, P2492, DOI 10.1093/annonc/mdt217; Hayashi N, 2011, ONCOLOGIST, V16, P956, DOI 10.1634/theoncologist.2010-0409; Hou JJ, 2013, HEPATOLOGY, V57, P678, DOI 10.1002/hep.25980; Huang YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-245; Hudelist G, 2006, INT J CANCER, V118, P1126, DOI 10.1002/ijc.21492; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lui VWY, 2014, P NATL ACAD SCI USA, V111, P1114, DOI 10.1073/pnas.1319551111; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Meyer DS, 2014, ONCOGENE, V33, P398, DOI 10.1038/onc.2012.585; Miaczynska M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009035; Monast CS, 2012, BIOPHYS J, V102, P2012, DOI 10.1016/j.bpj.2012.03.037; Mori Y, 2004, CANCER RES, V64, P2434, DOI 10.1158/0008-5472.CAN-03-3508; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Ramaswamy B, 2009, MOL ENDOCRINOL, V23, P176, DOI 10.1210/me.2008-0211; Ramsauer VP, 2006, MOL BIOL CELL, V17, P2931, DOI 10.1091/mbc.E05-09-0895; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Schneeberger VE, 2015, ONCOTARGET, V6, P6191, DOI 10.18632/oncotarget.3356; Stepanek L, 2001, J CELL BIOL, V154, P867, DOI 10.1083/jcb.200105019; Stern HM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3001539; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Taniyama K, 2008, BREAST CANCER-TOKYO, V15, P231, DOI 10.1007/s12282-007-0026-8; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wang HM, 2014, CELL RES, V24, P1067, DOI 10.1038/cr.2014.99; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; You YJ, 2012, CANCER LETT, V315, P138, DOI 10.1016/j.canlet.2011.08.032; Yu M, 2012, MOL CELL BIOL, V32, P3913, DOI 10.1128/MCB.00068-12; Yuan TC, 2010, J BIOL CHEM, V285, P14861, DOI 10.1074/jbc.M109.099879; Zhang H, 2004, CANCER RES, V64, P7169, DOI 10.1158/0008-5472.CAN-04-1176; Zhang H, 2006, GENE DEV, V20, P2943, DOI 10.1101/gad.1461706; Zhao S, 2015, ONCOGENE, V34, P3885, DOI 10.1038/onc.2014.326; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	53	23	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					410	422		10.1038/onc.2016.213	http://dx.doi.org/10.1038/onc.2016.213			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27345410	Green Published, hybrid			2022-12-26	WOS:000394166000010
J	Skalka, N; Caspi, M; Lahav-Ariel, L; Loh, YP; Hirschberg, K; Rosin-Arbesfeld, R				Skalka, N.; Caspi, M.; Lahav-Ariel, L.; Loh, Y. P.; Hirschberg, K.; Rosin-Arbesfeld, R.			Carboxypeptidase E (CPE) inhibits the secretion and activity of Wnt3a	ONCOGENE			English	Article							CELL-PROLIFERATION; ENDOCRINE; AUTOPHAGY; SURVIVAL; STRESS	The Wnt pathway has essential roles in cell proliferation, cell fate determination and tumorigenesis by regulating the expression of a wide range of target genes. As a core signaling cascade, the canonical Wnt pathway is regulated at different levels by numerous proteins. We have previously shown that carboxypeptidase E (CPE) is a novel regulator of the canonical Wnt signaling pathway. Here, we show that CPE and the Wnt3a ligand are co-secreted from cells. We show that although the C'-terminal Lys residue of Wnt3a is critical for its activity and is important for the effect of CPE on the Wnt pathway, CPE does not execute its effect by removing this Wnt3a residue. Interestingly, CPE through its N'-terminal sequence, forms aggregates with Wnt3a and possible endoplasmic reticulum (ER) stress leading to its loss of function. Together, our current results provide a mechanistic insight into the way CPE regulates the canonical Wnt signaling pathway.	[Skalka, N.; Caspi, M.; Lahav-Ariel, L.; Rosin-Arbesfeld, R.] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Loh, Y. P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Neurobiol, Program Dev Neurosci, NIH, Bethesda, MD USA; [Hirschberg, K.] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tel Aviv University; Sackler Faculty of Medicine	Rosin-Arbesfeld, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	arina@post.tau.ac.il			Rising Tide Foundation for Clinical Cancer Research; Gateway for Cancer Research Foundation; Israel Science Foundation [20120016]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Rising Tide Foundation for Clinical Cancer Research; Gateway for Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Rising Tide Foundation for Clinical Cancer Research, by the Gateway for Cancer Research Foundation and by the Israel Science Foundation (Grant no. 20120016).	Bar F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102347; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Du C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033830; FRICKER LD, 1983, J BIOL CHEM, V258, P950; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Holzer T, 2012, FEBS LETT, V586, P1638, DOI 10.1016/j.febslet.2012.04.035; Kim HJ, 2014, MOL CELLS, V37, P685, DOI 10.14348/molcells.2014.0179; Kunz M, 2004, DEV BIOL, V273, P390, DOI 10.1016/j.ydbio.2004.06.015; Li XH, 2015, INFLAMM RES, V64, P1, DOI 10.1007/s00011-014-0772-y; Liang XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-412; Liu AA, 2014, TUMOR BIOL, V35, P12459, DOI 10.1007/s13277-014-2564-y; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; Murthy SRK, 2013, ENDOCRINOLOGY, V154, P3284, DOI 10.1210/en.2013-1118; Murthy SRK, 2013, CANCER LETT, V341, P204, DOI 10.1016/j.canlet.2013.08.011; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Park JJ, 2008, MOL ENDOCRINOL, V22, P989, DOI 10.1210/me.2007-0473; Polakis P, 2000, GENE DEV, V14, P1837; Qian YM, 1999, J BIOL CHEM, V274, P11582, DOI 10.1074/jbc.274.17.11582; Qin XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112996; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Selvaraj P, 2015, MOL CELL NEUROSCI, V68, P222, DOI 10.1016/j.mcn.2015.08.005; Sharma K, 2016, BIOCHEM PHARMACOL, V103, P17, DOI 10.1016/j.bcp.2015.12.018; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Skalka N, 2013, ONCOGENE, V32, P2836, DOI 10.1038/onc.2012.308; Thouennon E, 2015, J NEUROCHEM, V134, P463, DOI 10.1111/jnc.13152; Varlamov O, 1996, J BIOL CHEM, V271, P13981, DOI 10.1074/jbc.271.24.13981; Wallkamm V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109428; Wang L, 2009, J BONE MINER RES, V24, P265, DOI [10.1359/jbmr.081014, 10.1359/JBMR.081014]; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Zhang JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147218; Zhou K, 2013, TUMOR BIOL, V34, P3691, DOI 10.1007/s13277-013-0952-3	38	7	7	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 15	2016	35	50					6416	6428		10.1038/onc.2016.173	http://dx.doi.org/10.1038/onc.2016.173			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TP	27375026	Bronze			2022-12-26	WOS:000390247600006
J	Li, XQ; Liu, P; Gan, SZ; Zhang, CM; Zheng, YL; Jiang, YQ; Yuan, Y				Li, Xueqin; Liu, Peng; Gan, Shuzhen; Zhang, Chunmao; Zheng, Yuling; Jiang, Yongqiang; Yuan, Yuan			Mechanisms of Host-Pathogen Protein Complex Formation and Bacterial Immune Evasion of Streptococcus suis Protein Fhb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement; host defense; infection; secretion; Streptococcus; Streptococcus suis; Fhb; Factor H; complement 3; immune evasion; streptococcus; streptococcus suis	H-BINDING-PROTEIN; INNATE IMMUNITY; SURFACE PROTEIN; INHIBITION; INFECTION; VIRULENCE; REGION; SERIES	Streptococcus suis serotype 2 (S. suis 2)-induced sepsis and meningitis are often accompanied by bacteremia. The evasion of polymorphonuclear leukocyte-mediated phagocytic clearance is central to the establishment of bacteremia caused by S. suis 2 and is facilitated by the ability of factor H (FH)-binding protein (Fhb) to bind FH on the bacterial surface, thereby impeding alternative pathway complement activation and phagocytic clearance. Here, C3b/C3d was found to bind to Fhb, along with FH, forming a large immune complex. The formation of this immune complex was mediated by domain II of Fhb via electrostatic and hydrophobic interactions, which, to our knowledge, is a new type of interaction. Interestingly, Fhb was found to be associated with the cell envelope and also present in the culture supernatant, where secreted Fhb inhibited complement activation via interactions with domain II, thereby enhancing antiphagocytic clearance by polymorphonuclear leukocytes. Thus, Fhb is a multifunctional bacterial protein, which binds host complement component C3 as well as FH and interferes with innate immune recognition in a secret protein manner. S. suis 2 therefore appears to have developed a new strategy to combat host innate immunity and enhance survival in host blood.	[Li, Xueqin; Liu, Peng; Gan, Shuzhen; Zhang, Chunmao; Zheng, Yuling; Jiang, Yongqiang; Yuan, Yuan] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Li, Xueqin] Wannan Med Coll, Yijishan Hosp, Cent Lab, Wuhu 241001, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Wannan Medical College	Jiang, YQ; Yuan, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	jiangyq@nic.bmi.ac.cn; miniminiyuan@163.com	Liu, Peng/V-9305-2019		National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation [81171528, 81371766]; State Key Laboratory of Pathogen and Biosecurity Foundation (Academy of Military Medical Science) [SKLPBS1414]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pathogen and Biosecurity Foundation (Academy of Military Medical Science)	This work was supported by National Basic Research Program (973) of China Grant 2012CB518804 (to Y. J.), National Natural Science Foundation Grants 81171528 and 81371766 (to Y. J.), and State Key Laboratory of Pathogen and Biosecurity Foundation (Academy of Military Medical Science) Grant SKLPBS1414 (to Y. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Areschoug T, 2002, J BACTERIOL, V184, P6376, DOI 10.1128/JB.184.22.6376-6393.2002; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Durdagi S, 2012, J MED CHEM, V55, P5529, DOI 10.1021/jm3004587; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Johnsson E, 1998, J IMMUNOL, V161, P4894; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Liu P, 2014, J INFECT DIS, V210, P35, DOI 10.1093/infdis/jiu050; Miller DP, 2012, J BIOL CHEM, V287, P12715, DOI 10.1074/jbc.M112.339721; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Sharma AK, 1997, INFECT IMMUN, V65, P484, DOI 10.1128/IAI.65.2.484-487.1997; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Huong VTL, 2014, EMERG INFECT DIS, V20, P1105, DOI 10.3201/eid2007.131594; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Yuan ZZ, 2013, J BIOL CHEM, V288, P956, DOI 10.1074/jbc.M112.388686; Zhang CM, 2015, BIOCHEM BIOPH RES CO, V466, P413, DOI 10.1016/j.bbrc.2015.09.040; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	31	12	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17122	17132		10.1074/jbc.M116.719443	http://dx.doi.org/10.1074/jbc.M116.719443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27342778	Green Published, hybrid			2022-12-26	WOS:000382643800018
J	Gharaee-Kermani, M; Moore, BB; Macoska, JA				Gharaee-Kermani, Mehrnaz; Moore, Bethany B.; Macoska, Jill A.			Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS; MOLECULAR TARGETS; OXIDATIVE STRESS; EGR-1 GENE; TGF-BETA; EXPRESSION; LIVER; FIBROBLASTS	Background Resveratrol, a phytoalexin found in berries, peanuts, grapes, and red wine, inhibits oxidation, inflammation, and cell proliferation and collagen synthesis in multiple cell types and or animal models. It represses collagen deposition in the vasculature, heart, lung, kidney, liver, and esophagus in animal models and may have some utility as an anti-fibrotic. Recent studies have shown that increased collagen deposition and tissue stiffness in the peri-urethral area of the prostate are associated with lower urinary tract dysfunction (LUTD) and urinary obstructive symptoms. The aim of this study was to determine whether Resveratrol might be useful to inhibit or revert TGF beta- and/or CXCL12-mediated myofibroblast phenoconversion of prostate fibroblasts in vitro, and therefore whether the use of anti-fibrotic therapeutics might be efficacious for the treatment of LUTD. Methods Primary prostate and lung tissues were explanted and fibroblast monolayers expanded in vitro. Primary and N1 immortalized prostate stromal fibroblasts, as well as primary fibroblasts cultured from a normal lung and one affected by idiopathic pulmonary fibrosis (IPF) for comparison, were grown in serum-free defined media supplemented with vehicle, TGF beta or CXCL12, pre- or post-treatment with Resveratrol, and were evaluated using immunofluorescence for alpha smooth muscle actin (alpha SMA) and collagen I (COL1) protein expression and assessed for cell proliferation, apoptosis, and COL1 and EGR1 transcript expression. Results This study showed that low concentrations of Resveratrol (<= 50 mu M) had no effect on N1 or primary prostate fibroblast cell proliferation, apoptosis, or COL1 or EGR1 gene transcription but repressed and reversed myofibroblast phenoconversion. As expected, these same effects were observed for IPF lung fibroblasts though higher levels of Resveratrol (>= 100uM) were required. Taken together, these data suggest that, like lung fibroblasts, prostate fibroblast to myofibroblast phenoconversion can be both repressed and reversed by Resveratrol treatment. Thus, anti-fibrotic therapeutics might be efficacious for the treatment of LUTD.	[Gharaee-Kermani, Mehrnaz; Macoska, Jill A.] Univ Massachusetts, Dept Biol, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; [Moore, Bethany B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Boston; University of Michigan System; University of Michigan	Macoska, JA (corresponding author), Univ Massachusetts, Dept Biol, Ctr Personalized Canc Therapy, Boston, MA 02125 USA.	Jill.Macoska@umb.edu		Moore, Bethany/0000-0003-3051-745X	Grant NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [DK104310]; Grant NIH/NCATS (National Center for Advancing Translational Sciences) [UL1TR000433]; National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases award [U54DK104310]; National Center for Advancing Translational Sciences of the National Institutes of Health award [UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310] Funding Source: NIH RePORTER	Grant NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); Grant NIH/NCATS (National Center for Advancing Translational Sciences); National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases award; National Center for Advancing Translational Sciences of the National Institutes of Health award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) DK104310 (JAM); and Grant NIH/NCATS (National Center for Advancing Translational Sciences) UL1TR000433 (MG-K).; This work was supported by National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases award U54DK104310 (JAM) and the National Center for Advancing Translational Sciences of the National Institutes of Health award UL1TR000433 (MG-K).	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Akgedik R, 2012, INFLAMMATION, V35, P1732, DOI 10.1007/s10753-012-9491-0; Bai YH, 2014, BIOCHEM PHARMACOL, V92, P484, DOI 10.1016/j.bcp.2014.09.002; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Begley LA, 2007, J BIOL CHEM, V282, P26767, DOI 10.1074/jbc.M700440200; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bhattacharyya S, 2011, MATRIX BIOL, V30, P235, DOI 10.1016/j.matbio.2011.03.005; Bishayee A, 2010, LIVER INT, V30, P1103, DOI 10.1111/j.1478-3231.2010.02295.x; Chen KH, 2011, CHEM-BIOL INTERACT, V190, P45, DOI 10.1016/j.cbi.2011.01.033; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chen TS, 2015, AM J PHYSIOL-HEART C, V308, pH424, DOI 10.1152/ajpheart.00454.2014; Conte E, 2015, HISTOL HISTOPATHOL, V30, P523, DOI 10.14670/HH-30.523; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Dyson OF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033364; Faghihzadeh F, 2014, NUTR RES, V34, P837, DOI 10.1016/j.nutres.2014.09.005; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Garcia P, 2012, AM J PHYSIOL-GASTR L, V302, pG326, DOI 10.1152/ajpgi.00083.2011; Gharaee-Kermani M, 2009, CURR MED CHEM, V16, P1400, DOI 10.2174/092986709787846497; Gharaee-Kermani M, 2013, PROSTATE, V73, P1123, DOI 10.1002/pros.22662; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Goldacre MJ, 2009, BEST PRACT RES CL GA, V23, P793, DOI 10.1016/j.bpg.2009.10.008; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hollingsworth JM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4474; Ji Q, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1119-y; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013; Miloso M, 1999, NEUROSCI LETT, V264, P141, DOI 10.1016/S0304-3940(99)00194-9; Novelle MG, 2015, AGEING RES REV, V21, P1, DOI 10.1016/j.arr.2015.01.002; Novo E, 2009, INT J BIOCHEM CELL B, V41, P2089, DOI 10.1016/j.biocel.2009.03.010; Park JH, 2012, MOL CELL BIOCHEM, V368, P61, DOI 10.1007/s11010-012-1342-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Quinones A, 2003, LIFE SCI, V72, P2975, DOI 10.1016/S0024-3205(03)00230-3; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rossler OG, 2015, EXP CELL RES, V332, P116, DOI 10.1016/j.yexcr.2015.01.013; Royce SG, 2011, PATHOBIOL AGING AGE, V1, DOI [10.3402/PBA.v1i0.7134, 10.3402/pba.v1i0.7134]; Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sener G, 2007, PULM PHARMACOL THER, V20, P642, DOI 10.1016/j.pupt.2006.07.003; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Tsang SW, 2015, BIOMED PHARMACOTHER, V71, P91, DOI 10.1016/j.biopha.2015.02.013; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhang YQ, 2015, CLIN NUTR, V34, P752, DOI 10.1016/j.clnu.2014.08.014	55	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158357	10.1371/journal.pone.0158357	http://dx.doi.org/10.1371/journal.pone.0158357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367854	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900030
J	Dey, J; Kerwin, WS; Grenley, MO; Casalini, JR; Tretyak, I; Ditzler, SH; Thirstrup, DJ; Frazier, JP; Pierce, DW; Carleton, M; Klinghoffer, RA				Dey, Joyoti; Kerwin, William S.; Grenley, Marc O.; Casalini, Joseph R.; Tretyak, Ilona; Ditzler, Sally H.; Thirstrup, Derek J.; Frazier, Jason P.; Pierce, Daniel W.; Carleton, Michael; Klinghoffer, Richard A.			A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; NAB-PACLITAXEL; CANCER; INHIBITION; NAVITOCLAX; MELANOMA; SURVIVAL; THERAPY; PREDICT; AGENTS	While advances in high-throughput screening have resulted in increased ability to identify synergistic anti-cancer drug combinations, validation of drug synergy in the in vivo setting and prioritization of combinations for clinical development remain low-throughput and resource intensive. Furthermore, there is currently no viable method for prospectively assessing drug synergy directly in human patients in order to potentially tailor therapies. To address these issues we have employed the previously described CIVO platform and developed a quantitative approach for investigating multiple combination hypotheses simultaneously in single living tumors. This platform provides a rapid, quantitative and cost effective approach to compare and prioritize drug combinations based on evidence of synergistic tumor cell killing in the live tumor context. Using a gemcitabine resistant model of pancreatic cancer, we efficiently investigated nine rationally selected Abraxane-based combinations employing only 19 xenografted mice. Among the drugs tested, the BCL2/BCLxL inhibitor ABT-263 was identified as the one agent that synergized with Abraxane (R) to enhance acute induction of localized apoptosis in this model of human pancreatic cancer. Importantly, results obtained with CIVO accurately predicted the outcome of systemic dosing studies in the same model where superior tumor regression induced by the Abraxane/ABT-263 combination was observed compared to that induced by either single agent. This supports expanded use of CIVO as an in vivo platform for expedited in vivo drug combination validation and sets the stage for performing toxicity-sparing drug combination studies directly in cancer patients with solid malignancies.	[Dey, Joyoti; Kerwin, William S.; Grenley, Marc O.; Casalini, Joseph R.; Tretyak, Ilona; Ditzler, Sally H.; Thirstrup, Derek J.; Frazier, Jason P.; Carleton, Michael; Klinghoffer, Richard A.] Presage Biosci Inc, Seattle, WA USA; [Pierce, Daniel W.] Celgene Corp, San Francisco, CA USA	Bristol-Myers Squibb; Celgene Corporation	Klinghoffer, RA (corresponding author), Presage Biosci Inc, Seattle, WA USA.	rich.klinghoffer@presagebio.com			Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	Funding for this study was provided in part by Celgene Corporation.	Amundson SA, 2000, CANCER RES, V60, P6101; Bhaw-Luximon A, 2015, CANCER LETT, V369, P266, DOI 10.1016/j.canlet.2015.09.007; Brower V, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju417; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chen NH, 2015, CANCER CHEMOTH PHARM, V76, P699, DOI 10.1007/s00280-015-2833-5; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cioffi M, 2015, CLIN CANCER RES, V21, P2325, DOI 10.1158/1078-0432.CCR-14-1399; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Klinghoffer RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7489; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Ocal O, 2015, DIS MODEL MECH, V8, P1201, DOI 10.1242/dmm.020933; Ocana A, 2011, JNCI-J NATL CANCER I, V103, P16, DOI 10.1093/jnci/djq463; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Tan N, 2011, CLIN CANCER RES, V17, P1394, DOI 10.1158/1078-0432.CCR-10-2353; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Villarroel MC, 2011, MOL CANCER THER, V10, P3, DOI 10.1158/1535-7163.MCT-10-0893; Volk LD, 2011, NEOPLASIA, V13, P327, DOI 10.1593/neo.101490; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120913; Wong M, 2012, MOL CANCER THER, V11, P1026, DOI 10.1158/1535-7163.MCT-11-0693	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158617	10.1371/journal.pone.0158617	http://dx.doi.org/10.1371/journal.pone.0158617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359113	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200102
J	Hu, SD; Zou, ZY; Li, H; Zou, GJ; Li, Z; Xu, J; Wang, LD; Du, XH				Hu, Shidong; Zou, Zhenyu; Li, Hao; Zou, Guijun; Li, Zhao; Xu, Jian; Wang, Lingde; Du, Xiaohui			The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients	PLOS ONE			English	Article							ABSOLUTE MONOCYTE; FOLLICULAR LYMPHOMA; CADHERIN PROMOTES; COLON-CANCER; CELLS; DISEASE; GROWTH; TRIAL	Background Colorectal cancer (CRC) is the third most common malignancy in males and the second most common in females worldwide. Distant metastases have a strong negative impact on the prognosis of CRC patients. The most common site of CRC metastases is the liver. Both disease progression and metastasis have been related to the patient's peripheral blood monocyte count. We therefore performed a case-control study to assess the relationship between the preoperative peripheral blood monocyte count and colorectal liver metastases (CRLM). Methods Clinical data from 117 patients with colon cancer and 93 with rectal cancer who were admitted to the Chinese People's Liberation Army General Hospital (Beijing, China) between December 2003 and May 2015 were analysed retrospectively, with the permission of both the patients and the hospital. Results Preoperative peripheral blood monocyte counts, the T and N classifications of the primary tumour and its primary site differed significantly between the two groups (P < 0.001, P < 0.001, P = 0.002, P < 0.001), whereas there were no differences in the sex, age, degree of tumour differentiation or largest tumour diameter. Lymph node metastasis and a high preoperative peripheral blood monocyte count were independent risk factors for liver metastasis (OR: 2.178, 95% CI: 1.148 similar to 4.134, P = 0.017; OR: 12.422, 95% CI: 5.076 similar to 30.398, P < 0.001), although the risk was lower in patients with rectal versus colon cancer (OR: 0.078, 95% CI: 0.020 similar to 0.309, P < 0.001). Primary tumour site (P<0.001), degree of tumour differentiation (P = 0.009), T, N and M classifications, TNM staging and preoperative monocyte counts (P<0.001) were associated with the 5-year overall survival (OS) of CRC patients. A preoperative peripheral blood monocyte count > 0.505 x 10(9) cells/L, high T classification and liver metastasis were independent risk factors for 5-year OS (RR: 2.737, 95% CI: 1.573 similar to 4.764, P <0.001; RR: 2.687, 95% CI: 1.498 similar to 4.820, P = 0.001; RR: 4.928, 95% CI: 2.871 similar to 8.457, P < 0.001). Conclusions The demonstrated association between preoperative peripheral blood monocyte count and liver metastasis in patients with CRC recommends the former as a useful predictor of postoperative prognosis in CRC patients.	[Hu, Shidong; Zou, Zhenyu; Zou, Guijun; Xu, Jian; Wang, Lingde; Du, Xiaohui] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Li, Hao] Chinese Peoples Liberat Army Air Force Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Li, Zhao] Chinese Peoples Liberat Army 474 Hosp, Dept Gen Surg, Urumqi, Xinjiang, Peoples R China	Chinese People's Liberation Army General Hospital; Air Force General Hospital PLA	Du, XH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China.	duxiaohui301@sina.com			Natural Science Foundation of China [61170123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China (no. 61170123) (URL: http://www.nsfc.gov.cn/).	Adam R, 2004, ANN ONCOL, V15, P103, DOI 10.1093/annonc/mdh912; Bie YC, 2015, ONCOL LETT, V10, P67, DOI 10.3892/ol.2015.3198; Chen MH, 2009, J CANCER RES CLIN, V135, P1783, DOI 10.1007/s00432-009-0625-1; Chen XB, 2012, MOL BIOL REP, V39, P6707, DOI 10.1007/s11033-012-1494-2; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Ganti SN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12255; Gustafson MP, 2015, CLIN CANCER RES, V21, P4224, DOI 10.1158/1078-0432.CCR-15-0260; Heeren AM, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1009296; Hur K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju492; Kemeny NE, 2013, J CLIN ONCOL, V31, P1913, DOI 10.1200/JCO.2013.49.4500; Marcheselli L, 2015, BRIT J HAEMATOL, V169, P544, DOI 10.1111/bjh.13332; Sasaki A, 2006, SURGERY, V139, P755, DOI 10.1016/j.surg.2005.10.009; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Sun LC, 2011, AM J PATHOL, V179, P380, DOI 10.1016/j.ajpath.2011.03.046; Tadmor T, 2015, MAYO CLIN PROC, V90, P756, DOI 10.1016/j.mayocp.2015.03.025; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Ye LC, 2013, J CLIN ONCOL, V31, P1931, DOI 10.1200/JCO.2012.44.8308; Zhao W, 2015, ONCOL LETT, V10, P233, DOI 10.3892/ol.2015.3207	23	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157486	10.1371/journal.pone.0157486	http://dx.doi.org/10.1371/journal.pone.0157486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355390	gold, Green Submitted, Green Published			2022-12-26	WOS:000378859400015
J	Li, XH; Fang, YS; Li, X; Liang, JR; Jiang, DH; Geng, Y; Ning, W				Li, Xiaohe; Fang, Yinshan; Li, Xue; Liang, Jiurong; Jiang, Dianhua; Geng, Yan; Ning, Wen			Apical Secretion of FSTL1 in the Respiratory Epithelium for Normal Lung Development	PLOS ONE			English	Article							FOLLISTATIN-LIKE 1; BONE MORPHOGENETIC PROTEIN-4; TRANSGENIC MICE; EXPRESSION; GROWTH; GENE; CLONING; ANTAGONIST; FRP	Follistatin-like 1 (FSTL1) is a secreted bone morphogenetic protein (BMP) antagonist, and it plays a crucial role in normal lung development. Deletion of Fstl1 leads to postnatal death in mice due to respiratory failure. To further explore the role of FSTL1 in mouse lung development, we created a transgene SFTPC-Fstl1 allele mouse displaying significant epithelial overexpression of Fstl1 in all stages of lung development. However, epithelial overexpression of Fstl1 did not alter lung morphogenesis, epithelial differentiation and lung function. Moreover, we found that FSTL1 function was blocked by the epithelial polarization, which was reflected by the remarkable apical secretion of FSTL1 and the basolateral BMP signaling. Taken together, this study demonstrates that tightly spatial interaction of FSTL1 and BMP signaling plays an essential role in lung development.	[Li, Xiaohe; Fang, Yinshan; Li, Xue; Geng, Yan; Ning, Wen] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Liang, Jiurong; Jiang, Dianhua; Geng, Yan] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Geng, Yan] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China	Nankai University; Cedars Sinai Medical Center; Jiangnan University	Geng, Y; Ning, W (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China.; Geng, Y (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.; Geng, Y (corresponding author), Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China.	gengyan@jiangnan.edu.cn; ningwen108@nankai.edu.cn	Geng, Yan/ABH-7789-2022; Liang, Carol Jiurong/AAI-4963-2021; Fang, Yinshan/AAU-4250-2021; Jiang, Dianhua/B-1421-2009	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016; Geng, Yan/0000-0001-8861-7686	National Natural Science Foundation of China (NSFC) [81430001, 31471373, 31271559, 31201020]; 111 project of China [B08011]; NIH [R01 HL122068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122068] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 111 project of China(Ministry of Education, China - 111 Project); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China (NSFC) grants 81430001, 31471373, 31271559, 31201020 and 111 project of China (B08011). This work was also supported in part by NIH grant R01 HL122068 (to D. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bragg AD, 2001, MECH DEVELOP, V109, P13, DOI 10.1016/S0925-4773(01)00508-1; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Chaly Y, 2014, IMMUNOL RES, V59, P266, DOI 10.1007/s12026-014-8526-z; Chinoy MR, 2003, FRONT BIOSCI-LANDMRK, V8, pD392, DOI 10.2741/974; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Dong YY, 2015, J EXP MED, V212, P235, DOI 10.1084/jem.20121878; Donovan J, 2005, CURR PROTOC NEUROSCI, V4; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Okabayashi K, 1999, BIOCHEM BIOPH RES CO, V254, P42, DOI 10.1006/bbrc.1998.9892; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Patel K, 1996, DEV BIOL, V178, P327, DOI 10.1006/dbio.1996.0222; Saitoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062659; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Sylva M, 2013, BIRTH DEFECTS RES C, V99, P61, DOI 10.1002/bdrc.21030; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Weaver M, 1999, DEVELOPMENT, V126, P4005; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Wilson DC, 2010, ARTHRITIS RHEUM-US, V62, P2510, DOI 10.1002/art.27485; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Zhou L, 1996, DEV BIOL, V175, P227, DOI 10.1006/dbio.1996.0110; ZWIJSEN A, 1994, EUR J BIOCHEM, V225, P937, DOI 10.1111/j.1432-1033.1994.0937b.x	31	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158385	10.1371/journal.pone.0158385	http://dx.doi.org/10.1371/journal.pone.0158385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355685	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400057
J	Mowlaboccus, S; Perkins, TT; Smith, H; Sloots, T; Tozer, S; Prempeh, LJ; Tay, CY; Peters, F; Speers, D; Keil, AD; Kahler, CM				Mowlaboccus, Shakeel; Perkins, Timothy T.; Smith, Helen; Sloots, Theo; Tozer, Sarah; Prempeh, Lydia-Jessica; Tay, Chin Yen; Peters, Fanny; Speers, David; Keil, Anthony D.; Kahler, Charlene M.			Temporal Changes in BEXSERO (R) Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; STRAIN COVERAGE; QUANTITATIVE ASSESSMENT; MULTICOMPONENT VACCINE; POPULATION-STRUCTURE; UNITED-STATES; DISEASE; 4CMENB; PROTEIN; SURVEILLANCE	Neisseria meningitidis is the causative agent of invasive meningococcal disease (IMD). The BEXSERO (R) vaccine which is used to prevent serogroup B disease is composed of four sub-capsular protein antigens supplemented with an outer membrane vesicle. Since the sub-capsular protein antigens are variably expressed and antigenically variable amongst meningococcal isolates, vaccine coverage can be estimated by the meningococcal antigen typing system (MATS) which measures the propensity of the strain to be killed by vaccinated sera. Whole genome sequencing (WGS) which identifies the alleles of the antigens that may be recognised by the antibody response could represent, in future, an alternative estimate of coverage. In this study, WGS of 278 meningococcal isolates responsible for 62% of IMD inWestern Australia from 2000-2014 were analysed for association of genetic lineage (sequence type [ST], clonal complex [cc]) with BEXSERO (R) antigen sequence type (BAST) and MATS to predict the annual vaccine coverage. A hyperendemic period of IMD between 2000-05 was caused by cc41/44 with the major sequence type of ST-146 which was not predicted by MATS or BAST to be covered by the vaccine. An increase in serogroup diversity was observed between 2010-14 with the emergence of cc11 serogroup W in the adolescent population and cc23 serogroup Y in the elderly. BASTs were statistically associated with clonal complex although individual antigens underwent antigenic drift from the major type. BAST and MATS predicted an annual range of 44-91% vaccine coverage. Periods of low vaccine coverage in years post-2005 were not a result of the resurgence of cc41/44: ST-146 but were characterised by increased diversity of clonal complexes expressing BASTs which were not predicted by MATS to be covered by the vaccine. The driving force behind the diversity of the clonal complex and BAST during these periods of low vaccine coverage is unknown, but could be due to immune selection and inter-strain competition with carriage of non-disease causing meningococci.	[Mowlaboccus, Shakeel; Perkins, Timothy T.; Prempeh, Lydia-Jessica; Tay, Chin Yen; Peters, Fanny; Kahler, Charlene M.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Pathol & Lab Med, Perth, WA, Australia; [Smith, Helen] Hlth Support Queensland Dept Hlth, Publ Hlth Microbiol Forens & Sci Serv, Brisbane, Qld, Australia; [Sloots, Theo; Tozer, Sarah] Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Speers, David] PathWest Lab Med WA, QEII Med Ctr, Dept Microbiol, Perth, WA, Australia; [Keil, Anthony D.] PathWest Lab Med WA, Princess Margaret Hosp Children, Dept Microbiol, Perth, WA, Australia; [Kahler, Charlene M.] Telethon Kids Inst, Perth, WA, Australia	University of Western Australia; Royal Children's Hospital Brisbane; Telethon Kids Institute	Kahler, CM (corresponding author), Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Pathol & Lab Med, Perth, WA, Australia.; Kahler, CM (corresponding author), Telethon Kids Inst, Perth, WA, Australia.	charlene.kahler@uwa.edu.au	Tay, Alfred Chin Yen/H-5938-2014; Kahler, Charlene M/H-5159-2014; Tay, Chin Yen/AAZ-8785-2021	Tay, Alfred Chin Yen/0000-0001-9705-4010; Kahler, Charlene M/0000-0003-4322-3055; Tay, Chin Yen/0000-0001-9705-4010; Tozer, Sarah/0000-0002-3001-7642; Mowlaboccus, Shakeel/0000-0001-9408-6068	Amanda Young Foundation; National Health and Medical Research Council of Australia [APP1003697]; International Postgraduate Research Student award from the University of Western Australia; Novartis; Wellcome Trust; European Union	Amanda Young Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Student award from the University of Western Australia; Novartis(Novartis); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	This work was supported by grant funding from the Amanda Young Foundation (http://www.amandayoungfoundation.org.au/), a not-for-profit, charitable organisation of Western Australia awarded to C.M.K. C.M.K. is also supported by the National Health and Medical Research Council of Australia (APP1003697). S.M. is supported by an International Postgraduate Research Student award from the University of Western Australia. H.S., T.S. and S.T. were supported by funding from Novartis. This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant funding from the Amanda Young Foundation (http://www.amandayoungfoundation.org.au/), a not-for-profit, charitable organisation of Western Australia awarded to C.M.K. C.M.K. is also supported by the National Health and Medical Research Council of Australia (APP1003697). S.M. is supported by an International Postgraduate Research Student award from the University of Western Australia. H.S., T.S. and S.T. were supported by funding from Novartis. Thanks to David Atlas, Jane Bew, and other scientific staff at the PathWest Laboratory Medicine WA microbiology laboratory at the Princess Margaret Hospital for Children, for serogrouping, storage and data collection of the meningococcal isolates. This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Welcome Trust and European Union. We would like to thank Dr Geoff Coombs for editing the manuscript.	Araya P, 2015, EMERG INFECT DIS, V21, P339, DOI 10.3201/eid2102.140746; Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Barra GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066006; Boan P, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0686-x; Corvisy R, 2015, COMMUN DIS INTELL, V39, pE46; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Fagnocchi L, 2013, INFECT IMMUN, V81, P560, DOI 10.1128/IAI.01085-12; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Harrison LH, 2001, JAMA-J AM MED ASSOC, V286, P694, DOI 10.1001/jama.286.6.694; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Levy C, 2010, PEDIATR INFECT DIS J, V29, P618, DOI 10.1097/INF.0b013e3181d3ce32; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0147; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Nissen M TS, 2012, 18 INT PATH NEISS C; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2015, J INFECT DIS, V211, P1887, DOI 10.1093/infdis/jiu842; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	34	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158315	10.1371/journal.pone.0158315	http://dx.doi.org/10.1371/journal.pone.0158315			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355628	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400049
J	Ansari, SA; Pendurthi, UR; Sen, P; Rao, LVM				Ansari, Shabbir A.; Pendurthi, Usha R.; Sen, Prosenjit; Rao, L. Vijaya Mohan			The Role of Putative Phosphatidylserine-Interactive Residues of Tissue Factor on Its Coagulant Activity at the Cell Surface	PLOS ONE			English	Article							FACTOR-FACTOR-VIIA; FACTOR DE-ENCRYPTION; DISULFIDE BOND; SUBSTRATE RECOGNITION; ENDOTHELIAL-CELLS; FACTOR EXPRESSION; THIOL PATHWAYS; FACTOR-X; COMPLEX; PROCOAGULANT	Exposure of phosphatidylserine (PS) on the outer leaflet of the cell membrane is thought to play a critical role in tissue factor (TF) decryption. Recent molecular dynamics simulation studies suggested that the TF ectodomain may directly interact with PS. To investigate the potential role of TF direct interaction with the cell surface phospholipids on basal TF activity and the enhanced TF activity following the decryption, one or all of the putative PS-interactive residues in the TF ectodomain were mutated and tested for their coagulant activity in cell systems. Out of the 9 selected TF mutants, five of them -TFS160A, TFS161A, TFS162A, TFK165A, and TFD180A-exhibited a similar TF coagulant activity to that of the wild-type TF. The specific activity of three mutants, TFK159A, TFS163A, and TFK166A, was reduced substantially. Mutation of the glycine residue at the position 164 markedly abrogated the TF coagulant activity, resulting in similar to 90% inhibition. Mutation of all nine lipid binding residues together did not further decrease the activity of TF compared to TFG164A. A similar fold increase in TF activity was observed in wild-type TF and all TF mutants following the treatment of THP-1 cells with either calcium ionomycin or HgCl2, two agents that are commonly used to decrypt TF. Overall, our data show that a few select TF residues that are implicated in interacting with PS contribute to the TF coagulant activity at the cell surface. However, our data also indicate that TF regions outside of the putative lipid binding region may also contribute to PS-dependent decryption of TF.	[Ansari, Shabbir A.; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Sen, Prosenjit] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 700032, India	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Rao, LVM (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA.	vijay.rao@uthct.edu	Ansari, Shabbir/GNW-5542-2022; ansari, shabbir/HDO-7187-2022	ansari, shabbir/0000-0002-1939-7066	American Society of Hematology Bridge Grant Award; National Heart, Lung, and Blood Institute grant [HL124055]; American Heart Association, Southwest [15GRNT22620004]	American Society of Hematology Bridge Grant Award; National Heart, Lung, and Blood Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association, Southwest	This work was supported by grant support from American Society of Hematology Bridge Grant Award and National Heart, Lung, and Blood Institute grant HL124055 (to LVMR) and American Heart Association, Southwest Affiliate Grant-In-Aid (15GRNT22620004, to UP).	Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Butenas S, 2009, ARTERIOSCL THROM VAS, V29, P1989, DOI 10.1161/ATVBAHA.108.177402; Chen VM, 2013, J THROMB HAEMOST, V11, P277, DOI 10.1111/jth.12228; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; DRAKE TA, 1989, AM J PATHOL, V134, P1087; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Gajsiewicz JM, 2015, BIOCHEMISTRY-US, V54, P4665, DOI 10.1021/acs.biochem.5b00608; Huang QL, 1996, J BIOL CHEM, V271, P21752, DOI 10.1074/jbc.271.36.21752; Ke K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088675; Kirchhofer D, 2000, BIOCHEMISTRY-US, V39, P7380, DOI 10.1021/bi000182+; Kothari H, 2013, J THROMB HAEMOST, V11, P1353, DOI 10.1111/jth.12272; Kothari H, 2010, BLOOD, V116, P502, DOI 10.1182/blood-2010-05-283150; Kothari H, 2010, BLOOD, V115, P4273, DOI 10.1182/blood-2009-09-241356; LE DT, 1992, J BIOL CHEM, V267, P15447; Le DT, 1994, THROMB HAEMOSTASIS, V72, P848; Liang HPH, 2008, BLOOD, V112, P912, DOI 10.1182/blood-2008-05-156877; Morrissey JH, 2012, THROMB RES, V129, pS8, DOI 10.1016/j.thromres.2012.02.019; Morrissey JH, 1997, THROMB HAEMOSTASIS, V78, P112; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; OSTERUD B, 1983, THROMB HAEMOSTASIS, V49, P5; Pendurthi UR, 2007, BLOOD, V110, P3900, DOI 10.1182/blood-2007-07-101469; Popescu NI, 2010, THROMB RES, V125, pS38, DOI 10.1016/j.thromres.2010.01.034; Rao LVM, 2012, J THROMB HAEMOST, V10, P2242, DOI 10.1111/jth.12003; Rao LVM, 2012, THROMB RES, V129, pS13, DOI 10.1016/j.thromres.2012.02.021; Rao L Vijaya Mohan, 2012, Front Biosci (Elite Ed), V4, P1513; RAO LVM, 1992, THROMB RES, V67, P517, DOI 10.1016/0049-3848(92)90013-Z; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; RAO LVM, 1992, CANCER METAST REV, V11, P249; RAO LVM, 1988, THROMB RES, V51, P373, DOI 10.1016/0049-3848(88)90373-8; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; ROY S, 1991, J BIOL CHEM, V266, P22063; RUF W, 1992, J BIOL CHEM, V267, P6375; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Ruf W, 2012, THROMB RES, V129, pS11, DOI 10.1016/j.thromres.2012.02.020; Ruf W, 2010, THROMB RES, V125, pS36, DOI 10.1016/S0049-3848(10)70010-4; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; Versteeg HH, 2011, CURR OPIN HEMATOL, V18, P343, DOI 10.1097/MOH.0b013e32834981de; Williams Julie C, 2012, Front Biosci (Elite Ed), V4, P358; Wolberg AS, 1999, BLOOD COAGUL FIBRIN, V10, P201, DOI 10.1097/00001721-199906000-00007	42	43	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158377	10.1371/journal.pone.0158377	http://dx.doi.org/10.1371/journal.pone.0158377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348126	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200064
J	Chaubey, PM; Hofstetter, L; Roschitzki, B; Stieger, B				Chaubey, Pururawa Mayank; Hofstetter, Lia; Roschitzki, Bernd; Stieger, Bruno			Proteomic Analysis of the Rat Canalicular Membrane Reveals Expression of a Complex System of P4-ATPases in Liver	PLOS ONE			English	Article							SALT EXPORT PUMP; FAMILIAL INTRAHEPATIC CHOLESTASIS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; PROTEIN IDENTIFICATION; ABC-TRANSPORTERS; LIPID FLIPPASES; P4 ATPASES; BILE-ACIDS; VESICLES	Transport processes in the canalicular membrane are key elements in bile formation and are the driving force of the enterohepatic circulation of bile salts. The canalicular membrane is constantly exposed to the detergent action of bile salts. One potential element protecting the canalicular membrane from the high canalicular bile salt concentrations may be bile salt resistant microdomains, however additional factors are likely to play a role. To obtain more insights into the molecular composition of the canalicular membrane, the proteome of highly purified rat canalicular membrane vesicles was determined. Isolated rat canalicular membrane vesicles were stripped from adhering proteins, deglycosylated and protease digested before subjecting the samples to shot gun proteomic analysis. The expression of individual candidates was studied by PCR, Western blotting and immunohistochemistry. A total of 2449 proteins were identified, of which 1282 were predicted to be membrane proteins. About 50% of the proteins identified here were absent from previously published liver proteomes. In addition to ATP8B1, four more P4-ATPases were identified. ATP8A1 and ATP9A showed expression specific to the canalicular membrane, ATP11C at the bLPM and ATP11A in an intracellular vesicular compartment partially colocalizing with RAB7A and EEA1 as markers of the endosomal compartment. This study helped to identify additional P4-ATPases from rat liver particularly in the canalicular membrane, previously not known to be expressed in liver. These P4-ATPases might be contributing for maintaining transmembrane lipid homeostasis in hepatocytes.	[Chaubey, Pururawa Mayank; Hofstetter, Lia; Stieger, Bruno] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Roschitzki, Bernd] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Stieger, B (corresponding author), Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland.	bruno.stieger@uzh.ch	Stieger, Bruno/U-6323-2017	Stieger, Bruno/0000-0002-7190-5785	Swiss National Science Foundation [310030_144195/1]; Center for Microscopy and Image Analysis, University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center for Microscopy and Image Analysis, University of Zurich	This work was supported by the Swiss National Science Foundation (grant #310030_144195/1, www.snf.ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Andrea Schlegel from the Department of Surgery and Transplantation for her help with liver perfusion and Dr. Thimios Mitsiadis from the Institute of Oral Biology for giving us access to immunohistochemical equipment. Imaging was performed with support of the Center for Microscopy and Image Analysis, University of Zurich.	Alissa FT, 2008, J PEDIATR GASTR NUTR, V46, P241, DOI 10.1097/MPG.0b013e3181596060; Ansari IUH, 2015, J BIOL CHEM, V290, P23110, DOI 10.1074/jbc.M115.655027; Berndt P, 1999, ELECTROPHORESIS, V20, P3521, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3521::AID-ELPS3521>3.0.CO;2-8; BERR F, 1993, J BIOL CHEM, V268, P3976; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; Clifton JG, 2007, J CHROMATOGR B, V849, P293, DOI 10.1016/j.jchromb.2006.08.047; Cutillas PR, 2005, PROTEOMICS, V5, P101, DOI 10.1002/pmic.200400886; Eloranta JJ, 2012, MOL PHARMACOL, V82, P37, DOI 10.1124/mol.112.077909; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Fountoulakis M, 2002, J CHROMATOGR B, V782, P197, DOI 10.1016/S1570-0232(02)00562-7; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Golizeh M, 2013, J PROTEOMICS, V82, P166, DOI 10.1016/j.jprot.2013.02.001; Guyot C, 2011, J HEPATOL, V55, P1368, DOI 10.1016/j.jhep.2011.04.014; Ismair MG, 2009, HEPATOLOGY, V49, P1673, DOI 10.1002/hep.22807; Jacquemin E, 2012, CLIN RES HEPATOL GAS, V36, pS26, DOI 10.1016/S2210-7401(12)70018-9; KAST C, 1994, J BIOL CHEM, V269, P5179; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Madon J, 2000, MOL PHARMACOL, V57, P634, DOI 10.1124/mol.57.3.634; Matsuzaka Y, 2015, MOL PHARMACOL, V88, P1085, DOI 10.1124/mol.115.100578; Mayank P, 2012, PLANT J, V72, P89, DOI 10.1111/j.1365-313X.2012.05061.x; MEIER PJ, 1990, METHOD ENZYMOL, V192, P534; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Miyoshi N, 2010, ONCOL REP, V23, P505, DOI 10.3892/or_00000662; MORIYAMA Y, 1991, ARCH BIOCHEM BIOPHYS, V286, P252, DOI 10.1016/0003-9861(91)90037-J; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Paulusma CC, 2010, FEBS LETT, V584, P2708, DOI 10.1016/j.febslet.2010.04.071; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; QUARONI A, 1985, DEV BIOL, V111, P267, DOI 10.1016/0012-1606(85)90482-8; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Slijepcevic D, 2015, HEPATOLOGY, V62, P207, DOI 10.1002/hep.27694; Small DM, 2003, P NATL ACAD SCI USA, V100, P4, DOI 10.1073/pnas.0237205100; Soupene E, 2008, J RECEPT LIGAND CH R, V1, P1; STIEGER B, 1994, HEPATOLOGY, V20, P201, DOI 10.1016/0270-9139(94)90154-6; Stieger B, 2011, CURR DRUG TARGETS, V12, P661, DOI 10.2174/138945011795378496; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Trauner M, 2008, WIEN MED WOCHENSCHR, V158, P542, DOI 10.1007/s10354-008-0592-1; van der Velden LM, 2010, BIOCHEM J, V431, P1, DOI 10.1042/BJ20100644; VANDE SE, 2010, J CLIN INVEST, V120, P2942, DOI DOI 10.1172/JCI42168; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wlcek K, 2014, BIOCHEM PHARMACOL, V88, P106, DOI 10.1016/j.bcp.2013.12.026; Zappacosta F, 2015, J PROTEOME RES, V14, P997, DOI 10.1021/pr501025e; Zhang B, 2005, BLOOD, V106, P1355, DOI 10.1182/blood-2004-09-3655	51	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158033	10.1371/journal.pone.0158033	http://dx.doi.org/10.1371/journal.pone.0158033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347675	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200029
J	Selt, M; Tennstaedt, A; Beyrau, A; Nelles, M; Schneider, G; Lowik, C; Hoehn, M				Selt, Marion; Tennstaedt, Annette; Beyrau, Andreas; Nelles, Melanie; Schneider, Gabriele; Lowik, Clemens; Hoehn, Mathias			In Vivo Non-Invasive Tracking of Macrophage Recruitment to Experimental Stroke	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; MAGNETIC-RESONANCE; BONE-MARROW; FUNCTIONAL RECOVERY; INFLAMMATORY CELLS; RAT-BRAIN; MICE; IMPLANTATION	Brain-infiltrating monocyte-derived macrophages are one of the key players in the local immune response after stroke. It is now widely accepted that the inflammatory response is not an exclusively destructive process. However, the underlying molecular mechanisms needed for proper regulation still remain to be elucidated. Here, we propose an in vitro labelling strategy for multimodal in vivo observation of macrophage dynamics distinguished from brain-residing microglia response. Prior to intracerebral transplantation into the striatum of recipient mice or systemic administration, monocytes and macrophages, isolated from luciferase- expressing mice, were labelled with superparamagnetic iron oxide particles. Temporo-spatial localization was monitored by magnetic resonance imaging, whereas survival of grafted cells was investigated using bioluminescence imaging. The labelling procedure of the isolated cells did not significantly influence cell characteristics and resulted in detection of as few as 500 labelled cells in vivo. Two weeks after stereotactic transplantation, the luciferase signal was sustained traceable, with approximately 18% of the original luciferase signal detectable for monocytes and about 30% for macrophages. Hypointensity in MRI of the graft appeared unaltered in spatial location. In a therapeutically relevant approach, systemic cell administration after stroke resulted in accumulation mostly in thoracic regions, as could be visualized with BLI. For detection of homing to ischemic brain tissue more cells need to be administered. Nevertheless, during parallel MRI sessions recruitment of i.v. injected cells to the lesion site could be detected by day 2 post stroke as scattered hypointense signal voids. With further increase in sensitivity, our multi-facetted labelling strategy will provide the basis for in vivo tracking and fate specification of tissue-infiltrating macrophages and their distinct role in stroke-related neuro-inflammation.	[Selt, Marion; Tennstaedt, Annette; Beyrau, Andreas; Nelles, Melanie; Schneider, Gabriele; Hoehn, Mathias] Max Planck Inst Metab Res, In Vivo NMR Lab, Cologne, Germany; [Lowik, Clemens; Hoehn, Mathias] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Hoehn, Mathias] Percuros BV, Enschede, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoehn, M (corresponding author), Max Planck Inst Metab Res, In Vivo NMR Lab, Cologne, Germany.; Hoehn, M (corresponding author), Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.; Hoehn, M (corresponding author), Percuros BV, Enschede, Netherlands.	mathias@sf.mpg.de			EU [HEALTH-F2-2012-279017, PIAPP-GA-2013-612360]; Percuros	EU(European Commission); Percuros	This work was financially supported by grants from the EU-FP7 programs TargetBraIn (HEALTH-F2-2012-279017) and BrainPath (PIAPP-GA-2013-612360). The funder (Percuros) provided support in the form of salaries for one author (MH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; Aswendt M, 2012, NEUROIMAGE, V62, P1685, DOI 10.1016/j.neuroimage.2012.05.029; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Cianciaruso C, 2014, NANOMEDICINE-UK, V9, P1457, DOI [10.2217/nnm.14.84, 10.2217/NNM.14.84]; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Vocht N, 2012, JOVE-J VIS EXP, DOI 10.3791/3906; De Vocht N, 2011, MOL IMAGING BIOL, V13, P1133, DOI 10.1007/s11307-011-0469-3; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kallur T, 2011, EUR J NEUROSCI, V34, P382, DOI 10.1111/j.1460-9568.2011.07759.x; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Stroh A, 2006, NEUROIMAGE, V33, P886, DOI 10.1016/j.neuroimage.2006.07.009; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	30	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0156626	10.1371/journal.pone.0156626	http://dx.doi.org/10.1371/journal.pone.0156626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341631	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600003
J	Kazmi, SZH; Zhang, HG; Aziz, W; Monfredi, O; Abbas, SA; Shah, SA; Kazmi, SSH; Butt, WH				Kazmi, Syed Zaki Hassan; Zhang, Henggui; Aziz, Wajid; Monfredi, Oliver; Abbas, Syed Ali; Shah, Saeed Arif; Kazmi, Syeda Sobia Hassan; Butt, Wasi Haider			Inverse Correlation between Heart Rate Variability and Heart Rate Demonstrated by Linear and Nonlinear Analysis	PLOS ONE			English	Article							MORTALITY	The dynamical fluctuations in the rhythms of biological systems provide valuable information about the underlying functioning of these systems. During the past few decades analysis of cardiac function based on the heart rate variability (HRV; variation in R wave to R wave intervals) has attracted great attention, resulting in more than 17000-publications (PubMed list). However, it is still controversial about the underling mechanisms of HRV. In this study, we performed both linear (time domain and frequency domain) and nonlinear analysis of HRV data acquired from humans and animals to identify the relationship between HRV and heart rate (HR). The HRV data consists of the following groups: (a) human normal sinus rhythm (n = 72); (b) human congestive heart failure (n = 44); (c) rabbit sinoatrial node cells (SANC; n = 67); (d) conscious rat (n = 11). In both human and animal data at variant pathological conditions, both linear and nonlinear analysis techniques showed an inverse correlation between HRV and HR, supporting the concept that HRV is dependent on HR, and therefore, HRV cannot be used in an ordinary manner to analyse autonomic nerve activity of a heart.	[Kazmi, Syed Zaki Hassan; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Kazmi, Syed Zaki Hassan; Aziz, Wajid; Abbas, Syed Ali; Shah, Saeed Arif; Kazmi, Syeda Sobia Hassan] Univ Azad Jammu & Kashmir, Dept CS&IT, Muzaffarabad, Pakistan; [Butt, Wasi Haider] Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi, Pakistan; [Aziz, Wajid] Univ Jeddah, Dept Comp Sci, Fac Comp & IT, Jeddah, Saudi Arabia; [Monfredi, Oliver] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	University of Manchester; University of Azad Jammu & Kashmir; National University of Sciences & Technology - Pakistan; University of Jeddah; University of Manchester	Kazmi, SZH (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England.; Kazmi, SZH (corresponding author), Univ Azad Jammu & Kashmir, Dept CS&IT, Muzaffarabad, Pakistan.	zaki.mzd@gmail.com	Zhang, Henggui/D-6712-2011; Zhang, Henggui/AAM-1043-2020; Monfredi, Oliver/AAH-9507-2021; Butt, Wasi Haider/AAH-8517-2019	Butt, Wasi Haider/0000-0002-1347-3662	EPSRC [EP/J00958X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J00958X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Aziz W, 2013, MEASUREMENT, V46, P2300, DOI 10.1016/j.measurement.2013.04.007; Aziz W, 2012, CLIN AUTON RES, V22, P91, DOI 10.1007/s10286-011-0149-z; Biala T, 2012, MEASUREMENT, V45, P2096, DOI 10.1016/j.measurement.2012.05.005; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Camm AJ, 1996, CIRCULATION, V93, P1043; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; COUMEL P, 1994, J CARDIOVASC ELECTR, V5, P899, DOI 10.1111/j.1540-8167.1994.tb01130.x; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Dekker JM, 1997, AM J EPIDEMIOL, V145, P899, DOI 10.1093/oxfordjournals.aje.a009049; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mangin L, 1998, J CARDIOVASC PHARM, V32, P601, DOI 10.1097/00005344-199810000-00012; Monfredi O, 2014, HYPERTENSION, V64, P1334, DOI 10.1161/HYPERTENSIONAHA.114.03782; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039	17	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157557	10.1371/journal.pone.0157557	http://dx.doi.org/10.1371/journal.pone.0157557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336907	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200021
J	Behnan, J; Stangeland, B; Hosainey, SAM; Joel, M; Olsen, TK; Micci, F; Glover, JC; Isakson, P; Brinchmann, JE				Behnan, J.; Stangeland, B.; Hosainey, S. A. M.; Joel, M.; Olsen, T. K.; Micci, F.; Glover, J. C.; Isakson, P.; Brinchmann, J. E.			Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency	ONCOGENE			English	Article							TUMOR-INITIATING CELLS; HUMAN GLIOBLASTOMA; HUMAN GLIOMAS; LINES; BONE; IDENTIFICATION; HETEROGENEITY; PROLIFERATION; ANGIOGENESIS; PROGRESSION	Glioblastoma Multiforme (GBM) is characterized by high cancer cell heterogeneity and the presence of a complex tumor microenvironment. Those factors are a key obstacle for the treatment of this tumor type. To model the disease in mice, the current strategy is to grow GBM cells in serum-free non-adherent condition, which maintains their tumor-initiating potential. However, the so-generated tumors are histologically different from the one of origin. In this work, we performed high-throughput marker expression analysis and investigated the tumorigenicity of GBM cells enriched under different culture conditions. We identified a marker panel that distinguished tumorigenic sphere cultures from non-tumorigenic serum cultures (high CD56, SOX2, SOX9, and low CD105, CD248, aSMA). Contrary to previous work, we found that 'mixed cell cultures' grown in serum conditions are tumorigenic and express cancer stem cell (CSC) markers. As well, 1% serum plus bFGF and TGF-alpha preserved the tumorigenicity of sphere cultures and induced epithelial-to-mesenchymal transition gene expression. Furthermore, we identified 12 genes that could replace the 840 genes of The Cancer Genome Atlas (TCGA) used for GBM-subtyping. Our data suggest that the tumorigenicity of GBM cultures depend on cell culture strategies that retain CSCs in culture rather than the presence of serum in the cell culture medium.	[Behnan, J.; Stangeland, B.; Glover, J. C.; Brinchmann, J. E.] Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Dept Immunol, 4950 Nydalen, N-0424 Oslo, Norway; [Behnan, J.; Stangeland, B.; Glover, J. C.; Brinchmann, J. E.] Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Stangeland, B.] Oslo Univ Hosp, Inst Surg Res, Dept Neurosurg, Oslo, Norway; [Hosainey, S. A. M.] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Hosainey, S. A. M.] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Joel, M.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Olsen, T. K.; Micci, F.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway; [Olsen, T. K.; Micci, F.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Isakson, P.] Sahlgrens Univ Hosp, Dept Clin Immunol & Transfus Med, Gothenburg, Sweden	University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Sahlgrenska University Hospital	Behnan, J (corresponding author), Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Dept Immunol, 4950 Nydalen, N-0424 Oslo, Norway.	jinan.bahnan@rr-research.no	Stangeland, Biljana/W-4912-2019; Behnan, Jinan/C-9263-2009	Stangeland, Biljana/0000-0002-1723-9742; Behnan, Jinan/0000-0001-5780-0971	Neurosurgery Department and Institute for Surgical Research; Research Council of Norway; Helse Sor-Ost; Oslo University Hospital	Neurosurgery Department and Institute for Surgical Research; Research Council of Norway(Research Council of Norway); Helse Sor-Ost; Oslo University Hospital	We thank Neurosurgery Department and Institute for Surgical Research for provision of patients' samples and financial support. Grazyna Babinska, Hong Qu, Birthe Mikkelsen, Aphirak Juthajan and Petter Brandal for technical support; Yan Zhang for flow cytometry core facility. High-resolution histological images were acquired at the Norbrain Slide Scanning Facility at the Institute of Basic Medical Sciences, the University of Oslo, funded by the Research Council of Norway. We also thank Marianne Hanna for participating in the graphic drawing; Wayne Murrell for improving the language clarity; Jan Helge Solbakk and Peter Kierulf for guidance. This work was funded by Helse Sor-Ost and Oslo University Hospital. Microarray data have been deposited in the Gene Expression Omnibus (GEO) database (accession number GSE74571).	[Anonymous], 2011, GUIDE CARE USE LAB A; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrantes-Freer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130519; Behnan J, 2014, STEM CELLS, V32, P1110, DOI 10.1002/stem.1614; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Clara CA, 2014, NEUROPATHOLOGY, V34, P343, DOI 10.1111/neup.12111; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hadjipanayis CG, 2009, J MOL MED, V87, P363, DOI 10.1007/s00109-009-0440-9; Hagerstrand D, 2011, NEURO-ONCOLOGY, V13, P1178, DOI 10.1093/neuonc/nor113; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Hong X, 2012, INT J ONCOL, V41, P1693, DOI 10.3892/ijo.2012.1592; Hossain A, 2015, STEM CELLS, V33, P2400, DOI 10.1002/stem.2053; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Murrell W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071334; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Soeda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07979; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stoczynska-Fidelus E, 2014, TUMOR BIOL, V35, P11311, DOI 10.1007/s13277-014-2444-5; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang L, 2012, MED ONCOL, V29, P3484, DOI 10.1007/s12032-012-0267-z; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042	39	38	38	3	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					570	584		10.1038/onc.2016.230	http://dx.doi.org/10.1038/onc.2016.230			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27345406	Green Published, hybrid			2022-12-26	WOS:000394166700013
J	Silversmith, RE; Wang, BY; Fulcher, NB; Wolfgang, MC; Bourret, RB				Silversmith, Ruth E.; Wang, Boya; Fulcher, Nanette B.; Wolfgang, Matthew C.; Bourret, Robert B.			Phosphoryl Group Flow within the Pseudomonas aeruginosa Pil-Chp Chemosensory System: DIFFERENTIAL FUNCTION OF THE EIGHT PHOSPHOTRANSFERASE AND THREE RECEIVER DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; chemotaxis; histidine kinase; phosphoryl transfer; Pseudomonas aeruginosa (P; aeruginosa); type IV pili	SIGNAL-TRANSDUCTION SYSTEM; TWITCHING MOTILITY; RESPONSE REGULATOR; IV PILI; CRYSTAL-STRUCTURE; HISTIDINE; CHEMOTAXIS; CHEA; PATHWAYS; CYCLASE	Bacterial chemosensory signal transduction systems that regulate motility by type IV pili (T4P) can be markedly more complex than related flagellum-based chemotaxis systems. In T4P-based systems, the CheA kinase often contains numerous potential sites of phosphorylation, but the signaling mechanisms of these systems are unknown. In Pseudomonas aeruginosa, the Pil-Chp system regulates T4P-mediated twitching motility and cAMP levels, both of which play roles in pathogenesis. The Pil-Chp histidine kinase (ChpA) has eight Xpt domains; six are canonical histidine-containing phosphotransfer (Hpt) domains and two have a threonine (Tpt) or serine (Spt) in place of the histidine. Additionally, there are two stand-alone receiver domains (PilG and PilH) and a ChpA C-terminal receiver domain (ChpArec). Here, we demonstrate that the ChpA Xpts are functionally divided into three categories as follows: (i) those phosphorylated with ATP (Hpt4-6); (ii) those reversibly phosphorylated by ChpArec (Hpt2-6), and (iii) those with no detectable phosphorylation (Hpt1, Spt, and Tpt). There was rapid phosphotransfer from Hpt2-6 to ChpArec and from Hpt3 to PilH, whereas transfer to PilG was slower. ChpArec also had a rapid rate of autodephosphorylation. The biochemical results together with in vivo cAMP and twitching phenotypes of key ChpA phosphorylation site point mutants supported a scheme whereby ChpArec functions both as a phosphate sink and a phosphotransfer element linking Hpt4-6 to Hpt2-3. Hpt2 and Hpt3 are likely the dominant sources of phosphoryl groups for PilG and PilH, respectively. The data are synthesized in a signaling circuit that contains fundamental features of two-component phosphorelays.	[Silversmith, Ruth E.; Wolfgang, Matthew C.; Bourret, Robert B.] Univ N Carolina, Dept Microbiol & Immunol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Wang, Boya; Fulcher, Nanette B.; Wolfgang, Matthew C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Silversmith, RE (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	silversr@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	National Institutes of Health [R01GM050860, AI069116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM050860 (to R. B. B.) and AI069116 (to M. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansaldi M, 2001, J BACTERIOL, V183, P2691, DOI 10.1128/JB.183.8.2691-2695.2001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000306; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Bourret RB, 2010, METHOD ENZYMOL, V471, P89, DOI 10.1016/S0076-6879(10)71006-5; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Csikasz-Nagy A, 2011, J R SOC INTERFACE, V8, P480, DOI 10.1098/rsif.2010.0336; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Fassler JS, 2013, EUKARYOT CELL, V12, P1052, DOI 10.1128/EC.00083-13; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Garzon A, 1996, J BACTERIOL, V178, P6752, DOI 10.1128/jb.178.23.6752-6758.1996; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; Hahn HP, 1997, GENE, V192, P99, DOI 10.1016/S0378-1119(97)00116-9; Inclan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015867; Janiak-Spens F, 2000, MOL MICROBIOL, V37, P136, DOI 10.1046/j.1365-2958.2000.01973.x; Jimenez-Pearson MA, 2005, MICROBIOL-SGM, V151, P3299, DOI 10.1099/mic.0.28217-0; Jin F, 2011, P NATL ACAD SCI USA, V108, P12617, DOI 10.1073/pnas.1105073108; Kim JR, 2006, COMPUT BIOL CHEM, V30, P438, DOI 10.1016/j.compbiolchem.2006.09.004; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Knudsen M, 2012, J THEOR BIOL, V300, P7, DOI 10.1016/j.jtbi.2012.01.007; Kothamachu VB, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0234; Kothamachu VB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003322; Laub MT, 2007, METHOD ENZYMOL, V423, P531, DOI 10.1016/S0076-6879(07)23026-5; Leech AJ, 2006, J BACTERIOL, V188, P8479, DOI 10.1128/JB.00157-06; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mourey L, 2001, J BIOL CHEM, V276, P31074, DOI 10.1074/jbc.M101943200; Nishiyama S, 2014, J BACTERIOL, V196, P257, DOI 10.1128/JB.01167-13; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Quezada CM, 2005, J BIOL CHEM, V280, P30581, DOI 10.1074/jbc.M505316200; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Stewart RC, 2000, BIOCHEMISTRY-US, V39, P13157, DOI 10.1021/bi001100k; Topal H, 2012, J MOL BIOL, V416, P271, DOI 10.1016/j.jmb.2011.12.045; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Whitchurch CB, 2004, MOL MICROBIOL, V52, P873, DOI 10.1111/j.1365-2958.2004.04026.x; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	54	10	10	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17677	17691		10.1074/jbc.M116.737528	http://dx.doi.org/10.1074/jbc.M116.737528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27354279	Green Published, hybrid			2022-12-26	WOS:000383241300018
J	Liu, ZX; Li, HH; Fan, XH; Huang, W; Yang, JY; Li, CD; Wen, ZX; Li, YH; Guan, RX; Guo, Y; Chang, RZ; Wang, DC; Wang, SM; Qiu, LJ				Liu, Zhangxiong; Li, Huihui; Fan, Xuhong; Huang, Wen; Yang, Jiyu; Li, Candong; Wen, Zixiang; Li, Yinghui; Guan, Rongxia; Guo, Yong; Chang, Ruzhen; Wang, Dechun; Wang, Shuming; Qiu, Li-Juan			Phenotypic Characterization and Genetic Dissection of Growth Period Traits in Soybean (Glycine max) Using Association Mapping	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECOMBINANT INBRED LINES; AGRONOMIC TRAITS; QTL ANALYSIS; PHOTOPERIOD-SENSITIVITY; YIELD COMPONENTS; SEED YIELD; MATURITY; POPULATIONS; L.	The growth period traits are important traits that affect soybean yield. The insights into the genetic basis of growth period traits can provide theoretical basis for cultivated area division, rational distribution, and molecular breeding for soybean varieties. In this study, genome-wide association analysis (GWAS) was exploited to detect the quantitative trait loci (QTL) for number of days to flowering (ETF), number of days from flowering tomaturity (FTM), and number of days to maturity (ETM) using 4032 single nucleotide polymorphism (SNP) markers with 146 cultivars mainly from Northeast China. Results showed that abundant phenotypic variation was presented in the population, and variation explained by genotype, environment, and genotype by environment interaction were all significant for each trait. The whole accessions could be clearly clustered into two subpopulations based on their genetic relatedness, and accessions in the same group were almost from the same province. GWAS based on the unified mixed model identified 19 significant SNPs distributed on 11 soybean chromosomes, 12 of which can be consistently detected in both planting densities, and 5 of which were pleotropic QTL. Of 19 SNPs, 7 SNPs located in or close to the previously reported QTL or genes controlling growth period traits. The QTL identified with high resolution in this study will enrich our genomic understanding of growth period traits and could then be explored as genetic markers to be used in genomic applications in soybean breeding.	[Liu, Zhangxiong; Li, Huihui; Li, Yinghui; Guan, Rongxia; Guo, Yong; Chang, Ruzhen; Qiu, Li-Juan] Chinese Acad Agr Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat, Minist Agr,Inst Crop Sci, Beijing, Peoples R China; [Fan, Xuhong; Wang, Shuming] Jilin Acad Agr Sci, Inst Soybean Res, Changchun, Peoples R China; [Huang, Wen] Tonghua Acad Agr Sci, Meihekou, Peoples R China; [Yang, Jiyu] Jilin City Acad Agr Sci, Jilin, Peoples R China; [Li, Candong] Jiamusi Branch Heilongjiang Agr Sci, Jiamusi, Peoples R China; [Wen, Zixiang; Wang, Dechun] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Academy of Agricultural Sciences; Michigan State University	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat, Minist Agr,Inst Crop Sci, Beijing, Peoples R China.; Wang, SM (corresponding author), Jilin Acad Agr Sci, Inst Soybean Res, Changchun, Peoples R China.	shumingw@263.net; qiulijuan@caas.cn			Crop Germplasm Resources Protection [2014NWB030, 2015NWB030-05]; Platform of National Crop Germplasm Resources of China [2014-004, 2015-004]; National Key Technology RD Program [2011BAD35B06-2-9]; Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS)	Crop Germplasm Resources Protection; Platform of National Crop Germplasm Resources of China; National Key Technology RD Program(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS)	This work was supported by the Crop Germplasm Resources Protection (2014NWB030, 2015NWB030-05), Platform of National Crop Germplasm Resources of China (2014-004, 2015-004), The National Key Technology R&D Program (2011BAD35B06-2-9), and The Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS).	Akond M., 2013, J PLANT GENOME SCI, V1, P80, DOI DOI 10.5147/JPGS.2013.0090; [Anonymous], 1977, **NON-TRADITIONAL**; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chen QS., 2007, SCI AGR SINICA, V6, P399; [陈学珍 Chen Xuezhen], 2004, [分子植物育种, Molecular Plant Breeding], V2, P247; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2010, THEOR APPL GENET, V120, P1005, DOI 10.1007/s00122-009-1228-6; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Csanadi G, 2001, THEOR APPL GENET, V103, P912, DOI 10.1007/s001220100621; Vieira Antonio José Dias, 2006, Braz. J. Plant Physiol., V18, P281, DOI 10.1590/S1677-04202006000200004; Du WJ, 2009, J GENET GENOMICS, V36, P721, DOI 10.1016/S1673-8527(08)60165-4; Eskandari M, 2013, THEOR APPL GENET, V126, P1677, DOI 10.1007/s00122-013-2083-z; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan CM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-9; Funatsuki H, 2005, THEOR APPL GENET, V111, P851, DOI 10.1007/s00122-005-0007-2; Gai Junyi, 2007, Frontiers of Agriculture in China, V1, P1, DOI 10.1007/s11703-007-0001-3; Garner WW, 1919, J AGRIC RES, V18, P0553; Githiri SM, 2007, J HERED, V98, P360, DOI 10.1093/jhered/esm042; Guzman PS, 2007, CROP SCI, V47, P111, DOI 10.2135/cropsci2006.01.0003; Han YP, 2012, THEOR APPL GENET, V125, P671, DOI 10.1007/s00122-012-1859-x; Hao DR, 2012, EUPHYTICA, V186, P919, DOI 10.1007/s10681-012-0697-x; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hartwig E. E., 1973, AGRONOMY, P187; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Hyten DL, 2004, THEOR APPL GENET, V109, P552, DOI 10.1007/s00122-004-1661-5; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kantolic AG, 2005, FIELD CROP RES, V93, P212, DOI 10.1016/j.fcr.2004.10.001; Khan NA, 2008, THEOR APPL GENET, V117, P479, DOI 10.1007/s00122-008-0792-5; Kisha TJ, 1997, CROP SCI, V37, P1317, DOI 10.2135/cropsci1997.0011183X003700040048x; Komatsu K, 2011, BREEDING SCI, V61, P646, DOI 10.1270/jsbbs.61.646; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Korir PC, 2013, THEOR APPL GENET, V126, P1659, DOI 10.1007/s00122-013-2082-0; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; MCBLAIN BA, 1987, CAN J PLANT SCI, V67, P105, DOI 10.4141/cjps87-012; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Molnar SJ, 2003, GENOME, V46, P1024, DOI [10.1139/g03-079, 10.1139/G03-079]; NEI M, 1972, THEOR POPUL BIOL, V3, P460, DOI 10.1016/0040-5809(72)90017-2; Norman A.G., 1978, SOYBEAN PHYSL AGRONO; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Palomeque L, 2009, THEOR APPL GENET, V119, P417, DOI 10.1007/s00122-009-1049-7; Panthee DR, 2007, PLANT BREEDING, V126, P51, DOI 10.1111/j.1439-0523.2006.01305.x; Pooprompan P., 2006, Kasetsart Journal, Natural Sciences, V40, P573; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2010, GENOME, V53, P957, DOI 10.1139/G10-058; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Reyna N, 2001, CROP SCI, V41, P1317, DOI 10.2135/cropsci2001.4141317x; Roberts EH, 1996, THEOR APPL GENET, V93, P519, DOI 10.1007/BF00417943; Rossi ME, 2013, THEOR APPL GENET, V126, P1809, DOI 10.1007/s00122-013-2094-9; SAINDON G, 1989, CROP SCI, V29, P1361, DOI 10.2135/cropsci1989.0011183X002900060006x; Sayama T, 2010, BREEDING SCI, V60, P380, DOI 10.1270/jsbbs.60.380; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Sun YN, 2012, MOL BIOL REP, V39, P9435, DOI 10.1007/s11033-012-1808-4; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Woodworth C. M., 1923, J AM SOC AGRON, V15, P485; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhai H, 2014, PLOS ONE, V9, P1; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao C, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0704-9; Zuo QM, 2013, PLANT BREEDING, P1	83	8	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158602	10.1371/journal.pone.0158602	http://dx.doi.org/10.1371/journal.pone.0158602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367048	Green Submitted, Green Published, gold			2022-12-26	WOS:000378914900044
J	Woo, HC; White, P; Ng, HK; Lai, CWK				Woo, Hoi-Chi; White, Peter; Ng, Ho-Kwan; Lai, Christopher W. K.			Development of Kinematic Graphs of Median Nerve during Active Finger Motion: Implications of Smartphone Use	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; ULTRASOUND ASSESSMENT; GENERAL-POPULATION; FLEXOR TENDON; RISK-FACTORS; DEFORMATION; DISPLACEMENT; PATHOPHYSIOLOGY; PREVALENCE; MOVEMENT	Background Certain hand activities cause deformation and displacement of the median nerve at the carpal tunnel due to the gliding motion of tendons surrounding it. As smartphone usage escalates, this raises the public's concern whether hand activities while using smartphones can lead to median nerve problems. Objective The aims of this study were to 1) develop kinematic graphs and 2) investigate the associated deformation and rotational information of median nerve in the carpal tunnel during hand activities. Methods Dominant wrists of 30 young adults were examined with ultrasonography by placing a transducer transversely on their wrist crease. Ultrasound video clips were recorded when the subject performing 1) thumb opposition with the wrist in neutral position, 2) thumb opposition with the wrist in ulnar deviation and 3) pinch grip with the wrist in neutral position. Six still images that were separated by 0.2-second intervals were then captured from the ultrasound video for the determination of 1) cross-sectional area (CSA), 2) flattening ratio (FR), 3) rotational displacement (RD) and 4) translational displacement (TD) of median nerve in the carpal tunnel, and these collected information of deformation, rotational and displacement of median nerve were compared between 1) two successive time points during a single hand activity and 2) different hand motions at the same time point. Finally, kinematic graphs were constructed to demonstrate the mobility of median nerve during different hand activities. Results Performing different hand activities during this study led to a gradual reduction in CSA of the median nerve, with thumb opposition together with the wrist in ulnar deviation causing the greatest extent of deformation of the median nerve. Thumb opposition with the wrist in ulnar deviation also led to the largest extent of TD when compared to the other two hand activities of this study. Kinematic graphs showed that the motion pathways of median nerve during different hand activities were complex. Conclusion We observed that the median nerve in the carpal tunnel was rotated, deformed and displaced during the hand activities that people may be performed when using a smartphone, suggesting an increased risk of carpal tunnel syndrome (CTS). In addition, the kinematic graphs of median nerve developed in the present study provide new clues for further studies on the pathophysiology of CTS, and alerting smartphone users to establish proper postural habits when using handheld electronic devices.	[Woo, Hoi-Chi; White, Peter; Ng, Ho-Kwan; Lai, Christopher W. K.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Lai, CWK (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	chris.lai@polyu.edu.hk	Lai, Christopher Wai Keung/A-3852-2014	Lai, Christopher Wai Keung/0000-0002-8010-7232; White, Peter/0000-0001-6744-6566				Aboonq MS, 2015, NEUROSCIENCES, V20, P4; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Bathala L, 2014, MUSCLE NERVE, V49, P284, DOI 10.1002/mus.23912; Cartwright MS, 2008, MUSCLE NERVE, V37, P566, DOI 10.1002/mus.21009; Chemali KR, 2005, CLEV CLIN J MED, V72, P37, DOI 10.3949/ccjm.72.1.37; Drake R. L., 2010, GRAYS ANATOMY STUDEN; Eleftheriou A, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-16; Ettema AM, 2008, J BIOMECH, V41, P292, DOI 10.1016/j.jbiomech.2007.09.017; Ettema AM, 2007, CLIN ANAT, V20, P292, DOI 10.1002/ca.20379; Fung BKK, 2007, J HAND SURG-ASIAN-PA, V12, P13, DOI 10.1142/S0218810407003341; Goetz JE, 2013, ANN BIOMED ENG, V41, P2099, DOI 10.1007/s10439-013-0809-3; Hedrick W., 2005, ULTRASOUND PHYS INST, V4th ed; HSIEH YH, 2010, FORMOS J MUSCULOSKEL, V1, P16; Ibrahim I, 2012, Open Orthop J, V6, P69, DOI 10.2174/1874325001206010069; Inal EE, 2015, MUSCLE NERVE, V52, P183, DOI 10.1002/mus.24695; Katz JN, 2002, NEW ENGL J MED, V346, P1807, DOI 10.1056/NEJMcp013018; Keir PJ, 1997, J HAND SURG-AM, V22, P628, DOI 10.1016/S0363-5023(97)80119-0; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; Ko Cheolwoong, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P343, DOI 10.1080/10255840701430480; Lai WKC, 2014, MANUAL THER, V19, P608, DOI 10.1016/j.math.2014.06.005; LeBlanc KE, 2011, AM FAM PHYSICIAN, V83, P952; Maghsoudipour M, 2008, J OCCUP REHABIL, V18, P152, DOI 10.1007/s10926-008-9125-4; Moghtaderi A, 2005, ACTA NEUROL SCAND, V112, P375, DOI 10.1111/j.1600-0404.2005.00528.x; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; Nadar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079273; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Shim JM, 2012, J PHYS THER SCI, V24, P1251, DOI 10.1589/jpts.24.1251; Toge Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083565; van Doesburg MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037081; van Doesburg MHM, 2012, J ORTHOP RES, V30, P643, DOI 10.1002/jor.21562; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Wang YX, 2014, ACAD RADIOL, V21, P472, DOI 10.1016/j.acra.2013.12.012; Wang YX, 2014, ULTRASOUND MED BIOL, V40, P53, DOI 10.1016/j.ultrasmedbio.2013.09.009; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; Wong SM, 2004, RADIOLOGY, V232, P93, DOI 10.1148/radiol.2321030071; Wong SM, 2002, ARTHRITIS RHEUM, V46, P1914, DOI 10.1002/art.10385; Yoshii Y, 2013, J ORTHOP RES, V31, P1876, DOI 10.1002/jor.22462; Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653	38	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158455	10.1371/journal.pone.0158455	http://dx.doi.org/10.1371/journal.pone.0158455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367447	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900036
J	Irz, X; Leroy, P; Requillart, V; Soler, LG				Irz, Xavier; Leroy, Pascal; Requillart, Vincent; Soler, Louis-Georges			Beyond Wishful Thinking: Integrating Consumer Preferences in the Assessment of Dietary Recommendations	PLOS ONE			English	Article							POTENTIAL CONSUMPTION IMPACTS; COST CONSTRAINT; ENERGY DENSITY; HEALTHY DIET; FOOD; NUTRITION; AMERICANS; SELECTION; OBESITY; NORMS	Convenience, taste, and prices are the main determinants of food choices. Complying with dietary recommendations therefore imposes a "taste cost" on consumers, potentially hindering adoption of those recommendations. The study presents and applies a new methodology, based on economic theory, to quantify this taste cost and assess the health and welfare effects of different dietary recommendations. Then, by comparison of those effects, we identify socially desirable recommendations that are most compatible with consumer preferences (i.e., that best balance health benefits against"taste cost") and should be prioritized for promotion. The methodology proceeds in three-steps: first, an economic-behavioral model simulates how whole diets would change if consumers complied with dietary recommendations; second, an epidemiological model estimates the number of deaths avoided (DA) due to the dietary change; third, an efficiency analysis weighs the health benefits against the taste and policy costs of each recommendation. The empirical model is calibrated using French data. We find that recommendations to reduce consumption of red meat and soft-drinks, or raise consumption of milk products and fish/seafood impose relatively moderate taste costs. By comparison, recommendations related to F&V consumption and, to a lesser extent, butter/cream/cheese, snacks, and all meats impose larger taste costs on consumers. The F&V recommendation is the costliest for consumers to comply with, but it also reduces diet-related mortality the most, so that a large budget could be allocated to promoting F&V consumption while keeping this policy cost-beneficial. We conclude that promotion of most dietary recommendations improves social welfare. Our framework complements the programming models available in nutrition and public health: those models are best used to identify dietary targets, following which our framework identifies cost-beneficial ways of moving towards those targets.	[Irz, Xavier] Nat Resources Inst Finland Luke, Econ & Soc Res Unit, Helsinki, Finland; [Leroy, Pascal; Soler, Louis-Georges] INRA, INRA ALISS, UR 1303, Ivry, France; [Requillart, Vincent] Univ Toulouse Capitole, INRA, Toulouse Sch Econ, Toulouse, France	Natural Resources Institute Finland (Luke); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics	Irz, X (corresponding author), Nat Resources Inst Finland Luke, Econ & Soc Res Unit, Helsinki, Finland.	xavier.irz@luke.fi	Irz, Xavier/ABH-7230-2020; Irz, Xavier/AAI-7950-2020	Irz, Xavier/0000-0001-5659-5291	project ANR-ALID-OCAD (Foundation Daniel and Nina Carasso) in France; project FOODPOL-DIDIT (Foundation Daniel and Nina Carasso) in France; project EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France; project Vastuufoorumi (MAKERA fund) in Finland; project EraNet SUSDIET (MAKERA fund) in Finland; EU [633692]	project ANR-ALID-OCAD (Foundation Daniel and Nina Carasso) in France(French National Research Agency (ANR)); project FOODPOL-DIDIT (Foundation Daniel and Nina Carasso) in France; project EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France; project Vastuufoorumi (MAKERA fund) in Finland; project EraNet SUSDIET (MAKERA fund) in Finland; EU(European Commission)	This research was partially funded by projects ANR-ALID-OCAD, FOODPOL-DIDIT, and EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France, projects Vastuufoorumi and EraNet SUSDIET (MAKERA fund) in Finland, as well as EU Horizon 2020 Programme under Grant Agreement no 633692 (SUSFANS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors do not have any conflict of interest to declare. They want to thank Olivier Allais for providing some of the data and parameters upon which the empirical model is based. All the authors are responsible for the design and implementation of the study, as well as the writing and final content of the article. This research was partially funded by: Projects ANR-ALID-OCAD, FOODPOL-DIDIT, and EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France; Projects Vastuufoorumi and EraNet SUSDIET (MAKERA fund) in Finland; And EU Horizon 2020 Programme under Grant Agreement no 633692 (SUSFANS).	Allais O, 2010, AM J AGR ECON, V92, P228, DOI 10.1093/ajae/aap004; Arnoult MH, 2010, LAND USE POLICY, V27, P1046, DOI 10.1016/j.landusepol.2010.02.001; Buttriss JL, 2014, NUTR BULL, V39, P115, DOI 10.1111/nbu.12076; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2003, APPETITE, V41, P315, DOI 10.1016/S0195-6663(03)00113-2; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; de Abreu D, 2013, CLIN NUTR, V32, P783, DOI 10.1016/j.clnu.2012.11.022; DGCA, 2015, SCI REP 2015 DIET GU; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; GLANZ K, 1998, J AM DIET ASSOC, V98, P1118; Guenther PM, 2009, FASEB J, V23; HENSON S, 1991, J AGR ECON, V42, P380, DOI 10.1111/j.1477-9552.1991.tb00362.x; Irz X, 2015, J HEALTH ECON, V39, P188, DOI 10.1016/j.jhealeco.2014.09.002; Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Maillot M, 2010, AM J CLIN NUTR, V91, P421, DOI 10.3945/ajcn.2009.28426; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Martin Ambroise, 2001, Sciences des Aliments, V21, P309, DOI 10.3166/sda.21.317-319; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Nesheim MC, 2014, AM J CLIN NUTR, V99, P973, DOI 10.3945/ajcn.114.086488; Popkin BM, 2015, LANCET DIABETES ENDO; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Shankar B, 2008, REV AGR ECON, V30, P151, DOI 10.1111/j.1467-9353.2007.00397.x; Srinivasan CS, 2006, FOOD POLICY, V31, P53, DOI 10.1016/j.foodpol.2005.08.002; Stigler GJ, 1945, J FARM ECON, V27, P303, DOI 10.2307/1231810; Treich N., 2015, FUTURIBLES, P61; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; Webb D, 2015, ADV NUTR, V6, P391, DOI 10.3945/an.115.008441; WHO Dietary Norms, 2006, 2006 ANN M AUG 12 18	38	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158453	10.1371/journal.pone.0158453	http://dx.doi.org/10.1371/journal.pone.0158453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362764	Green Published, gold			2022-12-26	WOS:000378865200077
J	Lange, M; Weihmann, F; Schliebner, I; Horbach, R; Deising, HB; Wirsel, SGR; Peiter, E				Lange, Mario; Weihmann, Fabian; Schliebner, Ivo; Horbach, Ralf; Deising, Holger B.; Wirsel, Stefan G. R.; Peiter, Edgar			The Transient Receptor Potential (TRP) Channel Family in Colletotrichum graminicola: A Molecular and Physiological Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CA2+ SIGNATURES; CALCIUM; YEAST; GROWTH; PROTEIN; EXPRESSION; GENE; PATHOGENICITY; GERMINATION	Calcium (Ca2+) is a universal second messenger in all higher organisms and centrally involved in the launch of responses to environmental stimuli. Ca2+ signals in the cytosol are initiated by the activation of Ca2+ channels in the plasma membrane and/or in endomembranes. Yeast (Saccharomyces cerevisiae) contains a Ca2+-permeable channel of the TRP family, TRPY1, which is localized in the vacuolar membrane and contributes to cytosolic free Ca2+ ([Ca2+](cyt)) elevations, for example in response to osmotic upshock. A TRPY1 homologue in the rice blast fungus is known to be important for growth and pathogenicity. To determine the role of the TRP channel family in the maize pathogen Colletotrichum graminicola, proteins homologous to TRPY1 were searched. This identified not one, but four genes in the C. graminicola genome, which had putative orthologs in other fungi, and which we named CgTRPF1 through 4. The topology of the CgTRPF proteins resembled that of TRPY1, albeit with a variable number of transmembrane (TM) domains additional to the six-TM-domain core and a diverse arrangement of putatively Ca2+-binding acidic motifs. All CgTRPF genes were expressed in axenic culture and throughout the infection of maize. Like TRPY1, all TRPF proteins of C. graminicola were localized intracellularly, albeit three of them were found not in large vacuoles, but co-localized in vesicular structures. Deletion strains for the CgTRPF genes were not altered in processes thought to involve Ca2+ release from internal stores, i.e. spore germination, the utilization of complex carbon sources, and the generation of tip-focussed [Ca2+](cyt) spikes. Heterologous expression of CgTRPF1 through 4 in a tryp1. yeast mutant revealed that none of the channels mediated the release of Ca2+ in response to osmotic upshock. Accordingly, aequorin-based [Ca2+](cyt) measurements of C. graminicola showed that in this fungus, osmotic upshock-triggered [Ca2+](cyt) elevations were generated entirely by influx of Ca2+ from the extracellular space. Cgtrpf mutants did not show pathogenicity defects in leaf infection assays. In summary, our study reveals major differences between different fungi in the contribution of TRP channels to Ca2+-mediated signal transduction.	[Lange, Mario; Peiter, Edgar] Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nut Sci IAEW, Plant Nutr Lab, Halle, Germany; [Weihmann, Fabian; Schliebner, Ivo; Horbach, Ralf; Deising, Holger B.; Wirsel, Stefan G. R.] Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nut Sci IAEW, Phytopathol & Plant Protect, Halle, Germany; [Lange, Mario; Schliebner, Ivo; Horbach, Ralf; Deising, Holger B.; Wirsel, Stefan G. R.; Peiter, Edgar] Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res IZN, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Peiter, E (corresponding author), Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nut Sci IAEW, Plant Nutr Lab, Halle, Germany.; Peiter, E (corresponding author), Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res IZN, Halle, Germany.	edgar.peiter@landw.uni-halle.de	Peiter, Edgar/C-2577-2013	Peiter, Edgar/0000-0002-9104-3238; Deising, Holger Bruno/0000-0001-5789-4269; Wirsel, Stefan/0000-0003-2043-9494	Deutsche Forschungsgemeinschaft (DFG) [PE1500/2-1, FOR 666]; Ministry of Agriculture and the Environment of the Federal State of Sachsen-Anhalt	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Agriculture and the Environment of the Federal State of Sachsen-Anhalt	This work was supported by a grant (PE1500/2-1 within the Research Unit FOR 666) from the Deutsche Forschungsgemeinschaft (DFG) to EP and by a grant from the Ministry of Agriculture and the Environment of the Federal State of Sachsen-Anhalt to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarouki E, 2014, MOL MICROBIOL, V92, P338, DOI 10.1111/mmi.12561; ALLEN DG, 1977, SCIENCE, V195, P996, DOI 10.1126/science.841325; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Behr M, 2010, MOL PLANT MICROBE IN, V23, P879, DOI 10.1094/MPMI-23-7-0879; Bergstrom GC, 1999, PLANT DIS, V83, P596, DOI 10.1094/PDIS.1999.83.7.596; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; Cai XJ, 2012, PURINERG SIGNAL, V8, P11, DOI 10.1007/s11302-011-9261-8; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Harren K, 2013, EUKARYOT CELL, V12, P712, DOI 10.1128/EC.00338-12; Horbach R, 2009, PLANT CELL, V21, P3379, DOI 10.1105/tpc.108.064188; Hu Y, 2014, FUNGAL GENET BIOL, V73, P12, DOI 10.1016/j.fgb.2014.09.005; Ihara M, 2013, J BIOL CHEM, V288, P15303, DOI 10.1074/jbc.M112.434795; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Jung C, 2009, PFLUG ARCH EUR J PHY, V459, P105, DOI 10.1007/s00424-009-0706-7; Kim HS, 2015, FUNGAL GENET BIOL, V82, P145, DOI 10.1016/j.fgb.2015.07.003; Kim HS, 2012, FUNGAL GENET BIOL, V49, P589, DOI 10.1016/j.fgb.2012.05.011; Krijger JJ, 2008, MOL PLANT MICROBE IN, V21, P1325, DOI 10.1094/MPMI-21-10-1325; Lange M, 2016, FUNGAL GENET BIOL, V91, P55, DOI 10.1016/j.fgb.2016.04.001; Lange M, 2014, CURR GENET, V60, P343, DOI 10.1007/s00294-014-0429-y; Lange M, 2014, ANAL BIOCHEM, V453, P58, DOI 10.1016/j.ab.2014.02.023; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Lingner U, 2011, PLANT PHYSIOL, V156, P1565, DOI 10.1104/pp.111.178624; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Ludwig N, 2014, MOL PLANT MICROBE IN, V27, P315, DOI 10.1094/MPMI-09-13-0267-R; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; MINET M, 1992, PLANT J, V2, P417; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson G, 2004, MOL MICROBIOL, V52, P1437, DOI 10.1111/j.1365-2958.2004.04066.x; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Oliveira-Garcia E, 2013, PLANT CELL, V25, P2356, DOI 10.1105/tpc.112.103499; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Peiter E, 2005, FEBS LETT, V579, P5697, DOI 10.1016/j.febslet.2005.09.058; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042404; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Schliebner I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-842; Schulz TA, 2004, BIOCHEMISTRY-US, V43, P3987, DOI 10.1021/bi036082w; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Silverman-Gavrila LB, 2002, J CELL SCI, V115, P5013, DOI 10.1242/jcs.00180; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Steinhorst L, 2013, BBA-MOL CELL RES, V1833, P1573, DOI 10.1016/j.bbamcr.2012.10.009; Su ZW, 2009, J MEMBRANE BIOL, V227, P141, DOI 10.1007/s00232-009-9153-9; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Walters JRF, 2006, J BONE MINER RES, V21, P1770, DOI 10.1359/JBMR.060721; Wang S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-219; Warwar V, 1996, APPL ENVIRON MICROB, V62, P74, DOI 10.1128/AEM.62.1.74-79.1996; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werner S, 2007, MOL PLANT MICROBE IN, V20, P1555, DOI 10.1094/MPMI-20-12-1555; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu QL, 2014, INT J MED MICROBIOL, V304, P339, DOI 10.1016/j.ijmm.2013.11.022; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001; Zhou XL, 2005, EUR BIOPHYS J BIOPHY, V34, P413, DOI 10.1007/s00249-005-0465-0; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	71	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158561	10.1371/journal.pone.0158561	http://dx.doi.org/10.1371/journal.pone.0158561			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359114	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200091
J	Li, D; Shi, JJ; Du, YH; Chen, KM; Liu, ZP; Li, B; Li, J; Tao, F; Gu, H; Jiang, CZ; Fang, JM				Li, Dong; Shi, Jiejun; Du, Yanhua; Chen, Kaiming; Liu, Zhenping; Li, Bing; Li, Jie; Tao, Fei; Gu, Hua; Jiang, Cizhong; Fang, Jianmin			Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER; ANGIOGENESIS; CHROMATIN; TUMORIGENESIS; HETEROGENEITY; ACETYLATION; METHYLATION; MUTATIONS; PROGNOSIS	Tumor cells become resistant after long-term use of anti-VEGF (vascular endothelial growth factor) agents. Our previous study shows that treatment with a VEGF inhibitor (VEGF-Trap) facilitates to develop tumor resistance through regulating angiogenesis-related genes. However, the underlying molecular mechanisms remain elusive. Histone modifications as a key epigenetic factor play a critical role in regulation of gene expression. Here, we explore the potential epigenetic gene regulatory functions of key histone modifications during tumor resistance in a mouse Lewis lung carcinoma (LLC) cell line. We generated high resolution genome-wide maps of key histone modifications in sensitive tumor sample (LLC-NR) and resistant tumor sample (LLC-R) after VEGF-Trap treatment. Profiling analysis of histone modifications shows that histone modification levels are effectively predictive for gene expression. Composition of promoters classified by histone modification state is different between LLC-NR and LLC-R cell lines regardless of CpG content. Histone modification state change between LLC-NR and LLC-R cell lines shows different patterns in CpG-rich and CpG-poor promoters. As a consequence, genes with different level of CpG content whose gene expression level are altered are enriched in distinct functions. Notably, histone modification state change in promoters of angiogenesis-related genes consists with their expression alteration. Taken together, our findings suggest that treatment with anti-VEGF therapy results in extensive histone modification state change in promoters with multiple functions, particularly, biological processes related to angiogenesis, likely contributing to tumor resistance development.	[Li, Dong; Chen, Kaiming; Li, Jie; Tao, Fei; Gu, Hua; Fang, Jianmin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Shi, Jiejun; Du, Yanhua; Liu, Zhenping; Li, Bing; Jiang, Cizhong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Fang, JM (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.; Jiang, CZ (corresponding author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn; jfang@tongji.edu.cn	Shi, Jiejun/P-3329-2019	Shi, Jiejun/0000-0001-9777-1183	National Key Basic Research Program of China (973 Program), China [2015CB553706, SQ2015CB050449]; National Natural Science Foundation of China, China [31270987, 31470896]; Shanghai Committee of Science and Technology, China [10PJ1409400, 12431901000]; Suzhou Science and Technology Project, China [ZXY2012029]	National Key Basic Research Program of China (973 Program), China; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Suzhou Science and Technology Project, China	This study was supported by grants from National Key Basic Research Program of China (973 Program), China (2015CB553706 and SQ2015CB050449), National Natural Science Foundation of China, China (31270987 and 31470896), grants from Shanghai Committee of Science and Technology, China (10PJ1409400, 12431901000) (http://www.stcsm.gov.cn), and Suzhou Science and Technology Project, China (ZXY2012029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from National Key Basic Research Program of China (973 Program), China (2015CB553706), National Natural Science Foundation of China, China (31270987 and 31470896) and Suzhou Science and Technology Project, China (ZXY2012029).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099743; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Fontanini G, 1997, CLIN CANCER RES, V3, P861; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Hong JP, 2013, INT J MOL MED, V31, P1436, DOI 10.3892/ijmm.2013.1337; Hong SD, 2015, J CANCER RES CLIN, V141, P909, DOI 10.1007/s00432-014-1862-5; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jakopovic M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00261; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Joukov V, 1996, EMBO J, V15, P290; Kanayasu-Toyoda T, 2015, J CELL PHYSIOL, V230, P2763, DOI 10.1002/jcp.25002; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Khuri FR, 2000, J CLIN ONCOL, V18, P2798, DOI 10.1200/JCO.2000.18.15.2798; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kim J, 2012, EPIGENETICS-US, V7, P191, DOI 10.4161/epi.7.2.18973; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SY, 2015, MOL CARCINOGEN, V54, P93, DOI 10.1002/mc.22077; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li D, 2014, CANCER LETT, V346, P45, DOI 10.1016/j.canlet.2013.12.004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pallis AG, 2013, CRIT REV ONCOL HEMAT, V86, P130, DOI 10.1016/j.critrevonc.2012.10.003; Qiao YB, 2015, J BIOL CHEM, V290, P2508, DOI 10.1074/jbc.M114.603761; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shin MR, 2015, INT ENDOD J, V48, P705, DOI 10.1111/iej.12396; Spaans JN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00233; Tudisco L, 2014, EPIGENETICS-US, V9, P600, DOI 10.4161/epi.27835; WILLIAMS DE, 1981, J THORAC CARDIOV SUR, V82, P70; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Yang AN, 2011, CANCER RES, V71, P3573, DOI 10.1158/0008-5472.CAN-10-4489; Zhang B, 2013, GENOME RES, V23, P917, DOI 10.1101/gr.149674.112	41	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158214	10.1371/journal.pone.0158214	http://dx.doi.org/10.1371/journal.pone.0158214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362259	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200049
J	Soumiya, H; Godai, A; Araiso, H; Mori, S; Furukawa, S; Fukumitsu, H				Soumiya, Hitomi; Godai, Ayumi; Araiso, Hiromi; Mori, Shingo; Furukawa, Shoei; Fukumitsu, Hidefumi			Neonatal Whisker Trimming Impairs Fear/Anxiety-Related Emotional Systems of the Amygdala and Social Behaviors in Adult Mice	PLOS ONE			English	Article							MOUSE CEREBRAL-CORTEX; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; MATERNAL SEPARATION; CRITICAL PERIOD; PLASTICITY; VIBRISSAE; LAYER; DEPRIVATION; EXPERIENCE	Abnormalities in tactile perception, such as sensory defensiveness, are common features in autism spectrum disorder (ASD). While not a diagnostic criterion for ASD, deficits in tactile perception contribute to the observed lack of social communication skills. However, the influence of tactile perception deficits on the development of social behaviors remains uncertain, as do the effects on neuronal circuits related to the emotional regulation of social interactions. In neonatal rodents, whiskers are the most important tactile apparatus, so bilateral whisker trimming is used as a model of early tactile deprivation. To address the influence of tactile deprivation on adult behavior, we performed bilateral whisker trimming in mice for 10 days after birth (BWT10 mice) and examined social behaviors, tactile discrimination, and c-Fos expression, a marker of neural activation, in adults after full whisker regrowth. Adult BWT10 mice exhibited significantly shorter crossable distances in the gap-crossing test than age-matched controls, indicating persistent deficits in whisker-dependent tactile perception. In contrast to controls, BWT10 mice exhibited no preference for the social compartment containing a conspecific in the three-chamber test. Furthermore, the development of amygdala circuitry was severely affected in BWT10 mice. Based on the c-Fos expression pattern, hyperactivity was found in BWT10 amygdala circuits for processing fear/anxiety-related responses to height stress but not in circuits for processing reward stimuli during whisker-dependent cued learning. These results demonstrate that neonatal whisker trimming and concomitant whisker-dependent tactile discrimination impairment severely disturbs the development of amygdala-dependent emotional regulation.	[Soumiya, Hitomi; Godai, Ayumi; Araiso, Hiromi; Mori, Shingo; Furukawa, Shoei; Fukumitsu, Hidefumi] Gifu Pharmaceut Univ, Mol Biol Lab, Dept Biofunct Anal, Gifu, Japan	Gifu Pharmaceutical University	Fukumitsu, H (corresponding author), Gifu Pharmaceut Univ, Mol Biol Lab, Dept Biofunct Anal, Gifu, Japan.	hfukumi@gifu-pu.ac.jp			JSPS KAKENHI Grant [24591519]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24591519. There was no additional external funding received for this study.	AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arnett MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109116; Baranek Grace T, 2008, Phys Occup Ther Pediatr, V28, P79; Bowlby J., 1969, ATTACHMENT AND LOSS; Carvell GE, 1996, J NEUROSCI, V16, P2750; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Foss-Feig JH, 2012, RES AUTISM SPECT DIS, V6, P337, DOI 10.1016/j.rasd.2011.06.007; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; KATZ RJ, 1976, BEHAV BIOL, V17, P399, DOI 10.1016/S0091-6773(76)90753-7; Landers MS, 2012, DEV NEUROSCI-BASEL, V34, P101, DOI 10.1159/000336732; Landers MS, 1999, J NEUROSCI, V19, P5131; Lee LJ, 2009, EXP NEUROL, V219, P524, DOI 10.1016/j.expneurol.2009.07.012; Long JM, 2004, GENES BRAIN BEHAV, V3, P51, DOI 10.1046/j.1601-183x.2003.00045.x; LONG SY, 1972, ANIM BEHAV, V20, P10, DOI 10.1016/S0003-3472(72)80167-2; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maciag CM, 2002, NEUROPSYCHOPHARMACOL, V26, P574, DOI 10.1016/S0893-133X(01)00398-0; Macri S, 2004, BEHAV BRAIN RES, V154, P231, DOI 10.1016/j.bbr.2004.02.009; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Maroun M, 2003, J NEUROSCI, V23, P4406; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Papaioannou S, 2013, BRAIN BEHAV, V3, P24, DOI 10.1002/brb3.102; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen CCH, 2014, ANNU REV NEUROSCI, V37, P183, DOI 10.1146/annurev-neuro-062012-170344; Rebsam A, 2002, J NEUROSCI, V22, P8541; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Sehara K, 2010, J NEUROSCI, V30, P3082, DOI 10.1523/JNEUROSCI.6096-09.2010; Shishelova A Yu, 2006, Neurosci Behav Physiol, V36, P883, DOI 10.1007/s11055-006-0102-0; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Soumiya H, 2011, J NEUROSCI RES, V89, P1342, DOI 10.1002/jnr.22636; STROZIK E, 1981, LAB ANIM, V15, P309, DOI 10.1258/002367781780953040; Sullivan RM, 2003, SOMATOSENS MOT RES, V20, P157, DOI 10.1080/0899022031000105190; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Venerosi A, 2003, PHARMACOL BIOCHEM BE, V74, P671, DOI 10.1016/S0091-3057(02)01068-7; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; WOLFFGRAMM J, 1991, PHARMACOL BIOCHEM BE, V38, P389, DOI 10.1016/0091-3057(91)90297-F; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	51	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158583	10.1371/journal.pone.0158583	http://dx.doi.org/10.1371/journal.pone.0158583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362655	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200098
J	Uboni, A; Horstkotte, T; Kaarlejarvi, E; Seveque, A; Stammler, F; Olofsson, J; Forbes, BC; Moen, J				Uboni, Alessia; Horstkotte, Tim; Kaarlejarvi, Elina; Seveque, Anthony; Stammler, Florian; Olofsson, Johan; Forbes, Bruce C.; Moen, Jon			Long-Term Trends and Role of Climate in the Population Dynamics of Eurasian Reindeer	PLOS ONE			English	Article							SEMI-DOMESTICATED REINDEER; RANGIFER-TARANDUS; SPATIAL SYNCHRONY; ARCTIC OSCILLATION; CARIBOU; SCALE; SNOW; RESPONSES; DECLINES; WEATHER	Temperature is increasing in Arctic and sub-Arctic regions at a higher rate than anywhere else in the world. The frequency and nature of precipitation events are also predicted to change in the future. These changes in climate are expected, together with increasing human pressures, to have significant impacts on Arctic and sub-Arctic species and ecosystems. Due to the key role that reindeer play in those ecosystems, it is essential to understand how climate will affect the region's most important species. Our study assesses the role of climate on the dynamics of fourteen Eurasian reindeer (Rangifer tarandus) populations, using for the first time data on reindeer abundance collected over a 70-year period, including both wild and semi-domesticated reindeer, and covering more than half of the species' total range. We analyzed trends in population dynamics, investigated synchrony among population growth rates, and assessed the effects of climate on population growth rates. Trends in the population dynamics were remarkably heterogeneous. Synchrony was apparent only among some populations and was not correlated with distance among population ranges. Proxies of climate variability mostly failed to explain population growth rates and synchrony. For both wild and semi-domesticated populations, local weather, biotic pressures, loss of habitat and human disturbances appear to have been more important drivers of reindeer population dynamics than climate. In semi-domesticated populations, management strategies may have masked the effects of climate. Conservation efforts should aim to mitigate human disturbances, which could exacerbate the potentially negative effects of climate change on reindeer populations in the future. Special protection and support should be granted to those semi-domesticated populations that suffered the most because of the collapse of the Soviet Union, in order to protect the livelihood of indigenous peoples that depend on the species, and the multi-faceted role that reindeer exert in Arctic ecosystems.	[Uboni, Alessia; Kaarlejarvi, Elina; Seveque, Anthony; Olofsson, Johan; Moen, Jon] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Horstkotte, Tim] Univ Turku, Dept Geog & Geol, Turku, Finland; [Kaarlejarvi, Elina] Vrije Univ Brussel, Plant Biol & Nat Management, Brussels, Belgium; [Stammler, Florian; Forbes, Bruce C.] Univ Lapland, Arctic Ctr, Rovaniemi, Finland; [Uboni, Alessia] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden	Umea University; University of Turku; Vrije Universiteit Brussel; University of Lapland; Swedish University of Agricultural Sciences	Uboni, A (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.; Uboni, A (corresponding author), Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden.	auboni@mtu.edu	Uboni, Alessia/N-3443-2019; Forbes, Bruce C./L-4431-2013; Olofsson, Johan/A-9362-2009; Stammler, Florian M/L-4454-2013; Stammler, Florian/H-8183-2016	Forbes, Bruce C./0000-0002-4593-5083; Horstkotte, Tim/0000-0003-3951-5370; Seveque, Anthony/0000-0003-4363-4137; Stammler, Florian/0000-0002-6243-773X	Swedish Research Council Formas [2012-170]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council Formas, grant number 2012-170 awarded to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 2002, ECOL LETT, V5, P445, DOI 10.1046/j.1461-0248.2002.00340.x; Alaruikka Y, 1964, SUOMEN POROTALOUS; Ambaum MHP, 2001, J CLIMATE, V14, P3495, DOI 10.1175/1520-0442(2001)014<3495:AOONAO>2.0.CO;2; [Anonymous], 2001, RESSURSREGNSKAP REIN; Bartsch A, 2010, ECOL APPL, V20, P2346, DOI 10.1890/09-1927.1; Baskin Leonid M., 2005, Rangifer, V25, P51; Bastille-Rousseau G, 2013, CAN J ZOOL, V91, P820, DOI 10.1139/cjz-2013-0154; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Berg A, 2008, FOREST ECOL MANAG, V256, P1009, DOI 10.1016/j.foreco.2008.06.003; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bragina EV, 2015, CONSERV BIOL, V29, P844, DOI 10.1111/cobi.12450; CAFF International Secretariat, 2010, ARCT BIOD TRENDS 201; Deser C, 2004, J CLIMATE, V17, P3109, DOI 10.1175/1520-0442(2004)017<3109:PICVLB>2.0.CO;2; Forbes B. C., 2006, REINDEER MANAGEMENT, P245, DOI [10.1007/3-540-31392-3, DOI 10.1007/3-540-31392-3]; Forbes BC, 1999, POLAR RES, V18, P367, DOI 10.1111/j.1751-8369.1999.tb00316.x; Forbes BC, 2013, ECOL SOC, V18, DOI 10.5751/ES-05791-180436; Forbes BC, 2009, P NATL ACAD SCI USA, V106, P22041, DOI 10.1073/pnas.0908286106; Forbes BC, 2009, GEOGR COMPASS, V3, P1356, DOI 10.1111/j.1749-8198.2009.00250.x; Fox J., 2018, R COMPANION APPL REG, VThird; Gottel H, 2008, CLIMATIC CHANGE, V87, P35, DOI 10.1007/s10584-007-9341-5; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; Hausner VH, 2011, ECOL SOC, V16, DOI 10.5751/ES-04193-160304; Heggberget Thrine Moen, 2002, Rangifer, V22, P13; HELLE T, 1993, ARCTIC, V46, P72; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Helle Timo, 2004, Suomen Riista, V50, P18; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; Hurrell JW, 1996, GEOPHYS RES LETT, V23, P665, DOI 10.1029/96GL00459; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jernsletten J.-L. L., 2002, SUSTAINABLE REINDEER; Joly K, 2011, ECOGRAPHY, V34, P345, DOI 10.1111/j.1600-0587.2010.06377.x; Kaarlejarvi E, 2013, FUNCT ECOL, V27, P1244, DOI 10.1111/1365-2435.12113; Klein DR, 2000, POLAR RES-SWEDEN, V19, P91, DOI 10.1111/j.1751-8369.2000.tb00332.x; Klokov Konstantin B., 2012, Rangifer, V32, P19; Kolpaschikov L, 2015, ECOL SOC, V20, DOI 10.5751/ES-07129-200109; Krupnik I, 2000, POLAR RES, V19, P49, DOI 10.1111/j.1751-8369.2000.tb00327.x; Kumpula J, 2003, POLAR RES, V22, P225, DOI 10.1111/j.1751-8369.2003.tb00109.x; Kumpula T, 2012, REMOTE SENS-BASEL, V4, P1046, DOI 10.3390/rs4041046; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Lillegard M, 2005, OIKOS, V109, P342, DOI 10.1111/j.0030-1299.2005.13816.x; Lundholm M, 2011, INTRO RS TIME SERIES, P1; Moen J, 2008, AMBIO, V37, P304, DOI 10.1579/0044-7447(2008)37[304:CCEOTE]2.0.CO;2; Moen Jon, 2006, Conservation Biology Series (Cambridge), V11, P50; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Post, 2013, ECOLOGY CLIMATE CHAN; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; Post E, 2006, QUATERN INT, V151, P99, DOI 10.1016/j.quaint.2006.01.016; R Core Team, 2021, R LANGUAGE ENV STAT; Ranta Esa, 2006, P1; Rees WG, 2008, CLIMATIC CHANGE, V87, P199, DOI 10.1007/s10584-007-9345-1; Safronov V, 2005, EKOLOGIYA ISPOLZOVAN; Schaefer JA, 2007, J WILDLIFE MANAGE, V71, P1753, DOI 10.2193/2005-479; Skarin A, 2014, POLAR BIOL, V37, P1041, DOI 10.1007/s00300-014-1499-5; Stammler Florian, 2005, REINDEER NOMADS MEET; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Stien A, 2012, BIOL LETT; Syroechkovskii EE, 2000, WILD DOMESTIC REINDE; Tatusko RL, 1990, COOPERATION CLIMATE; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Turi J, 2002, NO TIMBERLINE FOREST; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Tyler NJC, 2010, ECOL MONOGR, V80, P197, DOI 10.1890/09-1070.1; van de Pol M, 2013, ECOGRAPHY, V36, P249, DOI 10.1111/j.1600-0587.2012.00143.x; Vikhamar-Schuler D, 2013, ANN GLACIOL, V54, P214, DOI 10.3189/2013AoG62A306; Volodina O, 2010, STATUS GAME ANIMAL R; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weir JN, 2007, WILDLIFE BIOL, V13, P66, DOI 10.2981/0909-6396(2007)13[66:EOMDOW]2.0.CO;2; Weladji RB, 2003, OECOLOGIA, V136, P317, DOI 10.1007/s00442-003-1257-9; Wolfe SA, 2000, POLAR RES, V19, P63, DOI 10.1111/j.1751-8369.2000.tb00329.x; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yuzhakov AA, 2006, NENETS ABORIGINAL BR	76	42	43	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158359	10.1371/journal.pone.0158359	http://dx.doi.org/10.1371/journal.pone.0158359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362499	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200063
J	Zhang, YZ; Li, XH; Hao, ZK; Xi, RC; Cai, YJ; Liao, XR				Zhang, Yanzhou; Li, Xunhang; Hao, Zhikui; Xi, Ruchun; Cai, Yujie; Liao, Xiangru			Hydrogen Peroxide-Resistant CotA and YjqC of Bacillus altitudinis Spores Are a Promising Biocatalyst for Catalyzing Reduction of Sinapic Acid and Sinapine in Rapeseed Meal	PLOS ONE			English	Article							MANGANESE CATALASE; GLUCOSE-OXIDASE; LACCASE; SUBTILIS; DEGRADATION; CATHODES; ENZYME; DEHYDROGENASE; LICHENIFORMIS; TEMPERATURE	For the more efficient detoxification of phenolic compounds, a promising avenue would be to develop a multi-enzyme biocatalyst comprising peroxidase, laccase and other oxidases. However, the development of this multi-enzyme biocatalyst is limited by the vulnerability of fungal laccases and peroxidases to hydrogen peroxide (H2O2)-induced inactivation. Therefore, H2O2-resistant peroxidase and laccase should be exploited. In this study, H2O2-stable CotA and YjqC were isolated from the outer coat of Bacillus altitudinis SYBC hb4 spores. In addition to the thermal and alkali stability of catalytic activity, CotA also exhibited a much higher H2O2 tolerance than fungal laccases from Trametes versicolor and Trametes trogii. YjqC is a sporulation-related manganese (Mn) catalase with striking peroxidase activity for sinapic acid (SA) and sinapine (SNP). In contrast to the typical heme-containing peroxidases, the peroxidase activity of YjqC was also highly resistant to inhibition by H2O2 and heat. CotA could also catalyze the oxidation of SA and SNP. CotA had a much higher affinity for SA than B. subtilis CotA. CotA and YjqC rendered from B. altitudinis spores had promising laccase and peroxidase activities for SA and SNP. Specifically, the B. altitudinis spores could be regarded as a multi-enzyme biocatalyst composed of CotA and YjqC. The B. altitudinis spores were efficient for catalyzing the degradation of SA and SNP in rapeseed meal. Moreover, efficiency of the spore-catalyzed degradation of SA and SNP was greatly improved by the presence of 15 mM H2O2. This effect was largely attributed to synergistic biocatalysis of the H2O2-resistant CotA and YjqC toward SA and SNP.	[Zhang, Yanzhou; Li, Xunhang; Cai, Yujie; Liao, Xiangru] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Li, Xunhang] Jiangxi Agr Univ, Biosci & Engn Coll, Nanchang 330045, Peoples R China; [Hao, Zhikui] Taizhou Vocat & Tech Coll, Inst Appl Biotechnol, Taizhou 318000, Peoples R China; [Xi, Ruchun] South China Agr Univ, Coll Forestry, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou 510642, Guangdong, Peoples R China	Jiangnan University; Jiangxi Agricultural University; South China Agricultural University	Liao, XR (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	Microfer@126.com			Fundamental Research Funds for the Central Universities; Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province [BY2014023-28]; Agricultural Support Project, Wuxi Science & Technology Development [CLE01N1310]; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou [1302ky08]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province; Agricultural Support Project, Wuxi Science & Technology Development; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou	This work was supported by the Fundamental Research Funds for the Central Universities. The research was funded by Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province (BY2014023-28) and Agricultural Support Project, Wuxi Science & Technology Development (CLE01N1310). This work was also financially supported by the Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou (No. 1302ky08).	Abhyankar W, 2011, PROTEOMICS, V11, P4541, DOI 10.1002/pmic.201100003; Amo T, 2002, J BACTERIOL, V184, P3305, DOI 10.1128/JB.184.12.3305-3312.2002; Bao X, 2014, ENZYME MICROB TECH, V54, P51, DOI 10.1016/j.enzmictec.2013.10.003; Chagas PMB, 2015, INT J BIOL MACROMOL, V81, P568, DOI 10.1016/j.ijbiomac.2015.08.061; Brander S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099402; Checinska A, 2012, APPL ENVIRON MICROB, V78, P6413, DOI 10.1128/AEM.01211-12; Chen B, 2015, INT J BIOL MACROMOL, V76, P39, DOI 10.1016/j.ijbiomac.2015.02.019; Crestini C, 2011, BIOORGAN MED CHEM, V19, P5071, DOI 10.1016/j.bmc.2011.05.058; Fan LL, 2015, APPL MICROBIOL BIOT, V99, P9483, DOI 10.1007/s00253-015-6720-0; Gashtasbi F, 2014, ENZYME MICROB TECH, V64-65, P17, DOI 10.1016/j.enzmictec.2014.05.006; Gunne M, 2013, J BIOTECHNOL, V168, P252, DOI 10.1016/j.jbiotec.2013.06.011; Handtke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085625; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Khattab RY, 2014, J AM OIL CHEM SOC, V91, P89, DOI 10.1007/s11746-013-2345-6; Knecht LD, 2011, ANAL BIOANAL CHEM, V400, P977, DOI 10.1007/s00216-011-4835-4; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Liu Y, 2015, INT J SYST EVOL MICR, V65, P2769, DOI 10.1099/ijs.0.000336; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P3351, DOI 10.1007/s00253-015-6512-6; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P2225, DOI 10.1007/s00253-014-6060-5; Lu DB, 2012, BIODEGRADATION, V23, P209, DOI 10.1007/s10532-011-9500-2; Lu L, 2012, BIORESOURCE TECHNOL, V115, P35, DOI 10.1016/j.biortech.2011.07.111; Martins LO, 2015, CELL MOL LIFE SCI, V72, P911, DOI 10.1007/s00018-014-1822-x; Milton RD, 2014, J ELECTROCHEM SOC, V161, pH3011, DOI 10.1149/2.0031413jes; Milton RD, 2014, CHEM COMMUN, V50, P94, DOI 10.1039/c3cc47689h; Milton RD, 2013, PHYS CHEM CHEM PHYS, V15, P19371, DOI 10.1039/c3cp53351d; Minh HNT, 2011, APPL MICROBIOL BIOT, V90, P1409, DOI 10.1007/s00253-011-3183-9; Niciforovic N, 2014, REV FOOD SCI FOOD SA, V13, P1541; Niu Y, 2014, PLOS ONE, V10; Niwa T, 1999, FEBS LETT, V459, P43, DOI 10.1016/S0014-5793(99)01216-8; Prasetyo EN, 2015, INT J ENVIRON SCI TE, V12, P1343, DOI 10.1007/s13762-014-0526-y; Rao MA, 2014, CHEMOSPHERE, V107, P145, DOI 10.1016/j.chemosphere.2013.12.059; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Scodeller P, 2010, J AM CHEM SOC, V132, P11132, DOI 10.1021/ja1020487; Smyk B, 2015, J MOL LIQ, V208, P1, DOI 10.1016/j.molliq.2015.03.058; Tan IS, 2014, ENV MICROBIOL REP, V6, P212, DOI 10.1111/1758-2229.12130; Touahar IE, 2014, SCI TOTAL ENVIRON, V481, P90, DOI 10.1016/j.scitotenv.2014.01.132; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; Xie T, 2015, J STRUCT BIOL, V190, P155, DOI 10.1016/j.jsb.2015.03.005; Yadav S, 2015, J ENVIRON SCI-CHINA, V33, P229, DOI 10.1016/j.jes.2015.01.018; Zhang C, 2013, J AGR FOOD CHEM, V61, P5468, DOI 10.1021/jf4010498; Zhang C, 2012, BIORESOURCE TECHNOL, V126, P80, DOI 10.1016/j.biortech.2012.09.055; Zhang YZ, 2016, ANN MICROBIOL, V66, P559, DOI 10.1007/s13213-015-1135-9; Zhang YZ, 2016, ANN MICROBIOL, V66, P131, DOI 10.1007/s13213-015-1089-y	44	10	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158351	10.1371/journal.pone.0158351	http://dx.doi.org/10.1371/journal.pone.0158351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362423	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200062
J	Chassanidis, C; Boutou, E; Voskaridou, E; Balassopoulou, A				Chassanidis, Christos; Boutou, Effrossyni; Voskaridou, Ersi; Balassopoulou, Angeliki			Development of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean Populations	PLOS ONE			English	Article							THALASSEMIA; HEMOGLOBINOPATHIES	Beta-thalassaemia is one of the most common autosomal recessive disorders worldwide. The disease's high incidence, which is observed in the broader Mediterranean area has led to the establishment of molecular diagnostics' assays to prevent affected births. Therefore, the development of a reliable, cost-effective and rapid scanning method for beta globin gene point mutations, easily adapted to a routine laboratory, is absolutely essential. Here, we describe, for the first time, the development of a High-Resolution Melting Analysis (HRMA) approach, suitable for scanning the particularly heterogeneous beta globin gene mutations present in the Greek population, and thus adaptable to the Mediterranean and other areas where these mutations have been identified. Within this context, beta globin gene regions containing mutations frequently identified in the Greek population were divided in ten overlapping amplicons. Our reactions' setup allowed for the simultaneous amplification of multiple primer sets and partial multiplexing, thereby resulting in significant reduction of the experimental time. DNA samples from beta-thalassaemia patients/carriers with defined genotypes were tested. Distinct genotypes displayed distinguishable melting curves, enabling accurate detection of mutations. The described HRMA can be adapted to a high-throughput level. It represents a rapid, simple, cost-effective, reliable, highly feasible and sensitive method for beta-thalassaemia gene scanning.	[Chassanidis, Christos; Boutou, Effrossyni; Balassopoulou, Angeliki] Laikon Gen Hosp, Thalassaemia & Hemoglobinopathies Ctr, Mol Genet Lab, Athens, Greece; [Voskaridou, Ersi] Laikon Gen Hosp, Thalassaemia & Hemoglobinopathies Ctr, Athens, Greece	Laiko General Hospital; Laiko General Hospital	Chassanidis, C; Balassopoulou, A (corresponding author), Laikon Gen Hosp, Thalassaemia & Hemoglobinopathies Ctr, Mol Genet Lab, Athens, Greece.	xxmbgcc@gmail.com; angbalip@gmail.com		Voskaridou, Ersi/0000-0002-0979-5722; Boutou, Effrossyni/0000-0003-0343-2434	ThalaMoSS (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia) from Seventh Framework Programme (EU) [306201]	ThalaMoSS (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia) from Seventh Framework Programme (EU)	This work was supported by the ThalaMoSS (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia) 306201 grant from Seventh Framework Programme (EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouti I, 2008, EUR J HAEMATOL, V80, P346, DOI 10.1111/j.1600-0609.2007.01017.x; Boussiou M, 2008, BLOOD CELL MOL DIS, V40, P317, DOI 10.1016/j.bcmd.2007.11.003; Cao A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011775; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Er TK, 2012, CLIN CHIM ACTA, V414, P197, DOI 10.1016/j.cca.2012.09.012; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Hex X, 2010, GENET TEST MOL BIOMA, V14, P851, DOI [10.1089/gtmb.2010.0048, DOI 10.1089/GTMB.2010.0048]; Joly P, 2011, CLIN CHIM ACTA, V412, P1257, DOI 10.1016/j.cca.2011.03.025; Ladis V, 2013, EUR J HAEMATOL, V90, P313, DOI 10.1111/ejh.12076; Lin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102243; Loukopoulos Dimitris, 2011, Indian J Med Res, V134, P572; Prajantasen T, 2015, CLIN CHIM ACTA, V441, P56, DOI 10.1016/j.cca.2014.12.015; Saetung R, 2013, SE ASIAN J TROP MED, V44, P1055; Samara M, 2007, AM J HEMATOL, V82, P634, DOI 10.1002/ajh.20889; Shih HC, 2009, CLIN BIOCHEM, V42, P1667, DOI 10.1016/j.clinbiochem.2009.07.017; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P137, DOI 10.1017/CBO9780511596582.012; Thein SL, 1998, BAILLIERE CLIN HAEM, V11, P91, DOI 10.1016/S0950-3536(98)80071-1; Thein SL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011700; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Vinciguerra M, 2015, INT J LAB HEMATOL; Voskaridou E, 2012, ANN HEMATOL, V91, P1451, DOI 10.1007/s00277-012-1465-7; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019	22	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157393	10.1371/journal.pone.0157393	http://dx.doi.org/10.1371/journal.pone.0157393			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351925	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900010
J	Siemerink, MJ; Hughes, MR; Dallinga, MG; Gora, T; Cait, J; Vogels, IMC; Yetin-Arik, B; Van Noorden, CJF; Klaassen, I; McNagny, KM; Schlingemann, RO				Siemerink, Martin J.; Hughes, Michael R.; Dallinga, Marchien G.; Gora, Tomek; Cait, Jessica; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; McNagny, Kelly M.; Schlingemann, Reinier O.			CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TIP CELLS; ANGIOGENESIS; EXPRESSION; VASCULARIZATION; QUANTIFICATION; PERMEABILITY; INFLAMMATION; FILOPODIA; MICE	The sialomucins CD34 and podocalyxin (PODXL) are anti-adhesive molecules expressed at the luminal membrane of endothelial cells of small blood vessels and facilitate vascular lumen formation in the developing mouse aorta. CD34 transcript and protein levels are increased during human angiogenesis, its expression is particularly enriched on endothelial tip cell filopodia and CD34 is a marker for tip cells in vitro. Here, we investigated whether CD34 merely marks endothelial tip cells or has a functional role in tip cells and angiogenesis. We assessed that silencing CD34 in human microvascular endothelial cells has little effect on endothelial cell migration or invasion, but has a significant effect on vascular-endothelial growth factor-induced angiogenic sprouting activity in vitro. In vivo, the absence of CD34 reduced the density of filopodia on retinal endothelial tip cells in neonatal mice, but did not influence the overall architecture of the retinal vascular network. In oxygen-induced retinopathy, Cd34(-/-) mice showed normal intra-retinal regenerative angiogenesis but the number of pathological epi-retinal neovascular tufts were reduced. We conclude that CD34 is not essential for developmental vascularization in the retina, but its expression promotes the formation of pathological, invasive vessels during neovascularization.	[Siemerink, Martin J.; Dallinga, Marchien G.; Gora, Tomek; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [Siemerink, Martin J.; Dallinga, Marchien G.; Gora, Tomek; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Siemerink, Martin J.; Dallinga, Marchien G.; Gora, Tomek; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Amsterdam, Netherlands; [Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Hughes, Michael R.; Cait, Jessica; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Cait, Jessica; McNagny, Kelly M.] Univ British Columbia, Dept Expt Med, Vancouver, BC, Canada	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; University of British Columbia; University of British Columbia	Schlingemann, RO (corresponding author), Univ Amsterdam, Acad Med Ctr, Ocular Angiogenesis Grp, Amsterdam, Netherlands.; Schlingemann, RO (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.; Schlingemann, RO (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Amsterdam, Netherlands.	r.schlingemann@amc.uva.nl	Hughes, Michael/N-6039-2015; McNagny, Kelly/P-5239-2014; Klaassen, Ingeborg/F-7333-2015	Hughes, Michael/0000-0002-7925-6070; McNagny, Kelly/0000-0003-4737-3499; Klaassen, Ingeborg/0000-0003-1695-9403	Dutch Cancer Society (KWF); Centre for Blood Research at the University of British Columbia; Heart and Stroke Foundation of Canada; Edmond and Marianne Blaauw Fonds	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Centre for Blood Research at the University of British Columbia; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Edmond and Marianne Blaauw Fonds	MJS received support from the Dutch Cancer Society (KWF). MRH and JC received a PDF-summer student award (2014) from the Centre for Blood Research at the University of British Columbia (http://cbr.ubc.ca/). This study was partially supported by a Grant In-Aid to KMM from the Heart and Stroke Foundation of Canada (BC/Yukon) (www.heartandstroke.com). KMM is a Senior Scholar of the Michael Smith Foundation for Health Research (http://www.msfhr.org/). This study was supported by the Edmond and Marianne Blaauw Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; BAUMHUETER S, 1994, BLOOD, V84, P2554; Blanchet MR, 2007, BLOOD, V110, P2005, DOI 10.1182/blood-2006-12-062448; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Budd S, 2009, EXP EYE RES, V89, P718, DOI 10.1016/j.exer.2009.06.011; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; FINA L, 1990, BLOOD, V75, P2417; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hellwig SMM, 1997, CANCER LETT, V120, P203, DOI 10.1016/S0304-3835(97)00310-8; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; ITO A, 1995, LAB INVEST, V72, P532; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; KLOSOVSKII B N, 1963, Arkh Patol, V35(3), P38; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Koziol A, 2012, FASEB J, V26, P4481, DOI 10.1096/fj.12-205906; Maltby S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018160; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; MARINPADILLA M, 1985, J COMP NEUROL, V241, P237, DOI 10.1002/cne.902410210; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SCHLINGEMANN RO, 1990, LAB INVEST, V62, P690; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SCHOEFL GI, 1963, VIRCHOWS ARCH A, V337, P97, DOI 10.1007/BF00963592; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Testa JE, 2009, AM J PHYSIOL-LUNG C, V297, pL251, DOI 10.1152/ajplung.90565.2008; Wood HB, 1997, BLOOD, V90, P2300; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196	41	17	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157902	10.1371/journal.pone.0157902	http://dx.doi.org/10.1371/journal.pone.0157902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352134	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900023
J	Kant, C; Pradhan, S; Bhatia, S				Kant, Chandra; Pradhan, Seema; Bhatia, Sabhyata			Dissecting the Root Nodule Transcriptome of Chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; RECEPTOR KINASE GENE; MEDICAGO-TRUNCATULA; LOTUS-JAPONICUS; BRADYRHIZOBIUM-JAPONICUM; CALCIUM SPIKING; BETA-AMYRIN; RNA-SEQ; LEGUME; NODULATION	A hallmark trait of chickpea (Cicer arietinum L.), like other legumes, is the capability to convert atmospheric nitrogen (N-2) into ammonia (NH3) in symbiotic association with Mesorhizobium ciceri. However, the complexity of molecular networks associated with the dynamics of nodule development in chickpea need to be analyzed in depth. Hence, in order to gain insights into the chickpea nodule development, the transcriptomes of nodules at early, middle and late stages of development were sequenced using the Roche 454 platform. This generated 490.84 Mb sequence data comprising 1,360,251 reads which were assembled into 83,405 unigenes. Transcripts were annotated using Gene Ontology (GO), Cluster of Orthologous Groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways analysis. Differential expression analysis revealed that a total of 3760 transcripts were differentially expressed in at least one of three stages, whereas 935, 117 and 2707 transcripts were found to be differentially expressed in the early, middle and late stages of nodule development respectively. MapMan analysis revealed enrichment of metabolic pathways such as transport, protein synthesis, signaling and carbohydrate metabolism during root nodulation. Transcription factors were predicted and analyzed for their differential expression during nodule development. Putative nodule specific transcripts were identified and enriched for GO categories using BiNGO which revealed many categories to be enriched during nodule development, including transcription regulators and transporters. Further, the assembled transcriptome was also used to mine for genic SSR markers. In conclusion, this study will help in enriching the transcriptomic resources implicated in understanding of root nodulation events in chickpea.	[Kant, Chandra; Pradhan, Seema; Bhatia, Sabhyata] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg,Post Box 10531, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg,Post Box 10531, New Delhi 110067, India.	sabhyatabhatia@nipgr.ac.in		Bhatia, Sabhyata/0000-0003-0811-219X	Department of Biotechnology, India [BT/PR3305/AGR/2/816/2011]; Council of Scientific and Industrial Research (India); Department of Biotechnology (India)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (India)(Department of Biotechnology (DBT) India)	The study was funded by grant (BT/PR3305/AGR/2/816/2011) from Department of Biotechnology, India (http://www.dbtindia.nic.in). CK acknowledges the award of research fellowship from the Council of Scientific and Industrial Research (India). SP acknowledges the award of research fellowship from the Department of Biotechnology (India).	Afonso-Grunz F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00325; Asamizu E, 2005, MOL PLANT MICROBE IN, V18, P487, DOI 10.1094/MPMI-18-0487; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Charpentier M, 2008, PLANT CELL, V20, P3467, DOI 10.1105/tpc.108.063255; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Confalonieri M, 2009, PLANT BIOTECHNOL J, V7, P172, DOI 10.1111/j.1467-7652.2008.00385.x; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Godiard L, 2011, NEW PHYTOL, V191, P391, DOI 10.1111/j.1469-8137.2011.03718.x; Guttikonda SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-243; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jeong JY, 2004, PLANT PHYSIOL, V134, P969, DOI 10.1104/pp.103.032102; Kaiser BN, 1998, SCIENCE, V281, P1202, DOI 10.1126/science.281.5380.1202; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kanamori N, 2006, P NATL ACAD SCI USA, V103, P359, DOI 10.1073/pnas.0508883103; Kemen AC, 2014, P NATL ACAD SCI USA, V111, P8679, DOI 10.1073/pnas.1401553111; Libault M, 2010, PLANT PHYSIOL, V152, P541, DOI 10.1104/pp.109.148379; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Montiel J, 2016, MOL PLANT MICROBE IN, V29, P210, DOI 10.1094/MPMI-09-15-0213-R; Moreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016463; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nandasena K, 2014, STAND GENOMIC SCI, V9, P462, DOI 10.4056/sigs.4458283; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Penterman J, 2014, P NATL ACAD SCI USA, V111, P3561, DOI 10.1073/pnas.1400450111; Pradhan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00698; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Saito K, 2007, PLANT CELL, V19, P610, DOI 10.1105/tpc.106.046938; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Soyano T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003352; Sugiyama A, 2007, PLANT PHYSIOL, V144, P2000, DOI 10.1104/pp.107.096727; Takanashi K, 2012, MOL PLANT MICROBE IN, V25, P869, DOI 10.1094/MPMI-01-12-0011-R; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xie F, 2012, P NATL ACAD SCI USA, V109, P633, DOI 10.1073/pnas.1113992109; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	61	16	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157908	10.1371/journal.pone.0157908	http://dx.doi.org/10.1371/journal.pone.0157908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348121	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200020
J	Mehaisen, GMK; Eshak, MG; El Sabry, MI; Abass, AO				Mehaisen, Gamal M. K.; Eshak, Mariam G.; El Sabry, M. I.; Abass, Ahmed O.			Expression of Inflammatory and Cell Death Program Genes and Comet DNA Damage Assay Induced by Escherichia coli in Layer Hens	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; EIMERIA-TENELLA; PROXIMAL CHROMOSOME-7; SIGNALING PATHWAYS; INDUCED APOPTOSIS; IMMUNE-RESPONSES; BROILER-CHICKENS; IMPRINTED GENE	Modern methods of industrial poultry and egg production systems involve stressful practices that stimulate Escherichia coli (E. coli) activity causing endotoxic shock. This investigation was conducted to evaluate the expression of pro-inflammatory cytokines and cell death program genes and DNA damage induced by E. coli in the brain and liver tissues of laying hens. A total of two hundred and ten H&N brown layer hens with 20 week age, were used in this research. First, preliminary experiments were designed (60 hens in total) to establish the optimal exposure dose of E. coli and to determine the nearest time of notable response to be used in the remainder studies of this research. At 35-wk of age, 150 hens were randomly assigned into 2 groups with 3 replicates of 25 birds each; the first group was injected in the brachial wing vein with 10(7) E. coli colony/hen, while the second group was injected with saline and served as a control. The body temperature and plasma corticosterone concentration were measured 3 hr after injection. Specimens of liver and brain were obtained from each group and the gene expression of p38 mitogen-activated protein kinase, interlukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), Bax, and caspase-3 genes were measured by quantitative real-time PCR. DNA damage in the brain and liver tissues were also measured by comet assay. Hens treated with E. coli showed significant (P<0.05) increase of body temperature and plasma corticosterone (42.6 degrees C and 14.5 ng/ml, respectively) compared to the control group (41.1 degrees C and 5.5 ng/ml, respectively). Additional remarkable over-inflammation gene expression of p38, IL-1 beta and TNF-alpha.genes were also detected in the brain (2.2-fold, 2.0-fold and 3.3-fold, respectively) and the liver (2.1-fold, 1.9-fold and 3.0-fold, respectively) tissues of the infected chickens. It is also important to note that hens injected with E. coli showed an increase in DNA damage in the brain and liver cells (P<0.05). These results were synchronized with activating cell death program since our data showed significant high expression of Bax gene by 2.8- and 2.7-fold and caspase-3 gene by 2.5- and 2.7-fold in the brain and liver tissues of infected chickens, respectively (P<0.05). In conclusion, the current study indicates that E. coli injection induces inflammatory physiological response and triggers cell death program in the brain and liver. Our results provide more understanding to endotoxic shock by E. coli in chickens at cellular level. Further studies are required to confirm if such responses are destructive or protective to set the means through which a chicken mounts a successful defense against avian pathogenic E. coli.	[Mehaisen, Gamal M. K.; El Sabry, M. I.; Abass, Ahmed O.] Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt; [Eshak, Mariam G.] Natl Res Ctr, Dept Cell Biol, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Mehaisen, GMK (corresponding author), Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt.	gamoka@cu.edu.eg	Mehaisen, Gamal/I-5277-2019; El Sabry, Mohamed Ibrahem/H-8481-2019	Mehaisen, Gamal/0000-0003-2006-4290; El Sabry, Mohamed Ibrahem/0000-0001-6855-0111; Nassar, Farid/0000-0003-0786-0612	Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP); General Scientific Research Department at Cairo University (GSRD-CU)	Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP); General Scientific Research Department at Cairo University (GSRD-CU)(Cairo University)	This work was supported by Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP), funded from General Scientific Research Department at Cairo University (GSRD-CU). AOA was the principal investigator of the project and the fund was awarded to him during the management of the project. The funders have approved the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agas D, 2008, J CELL PHYSIOL, V214, P145, DOI 10.1002/jcp.21170; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; ARP LH, 1980, AVIAN DIS, V24, P153, DOI 10.2307/1589774; Ask B, 2006, POULTRY SCI, V85, P415, DOI 10.1093/ps/85.3.415; Assenmacher I., 1973, P183; Baert K, 2005, BRIT POULTRY SCI, V46, P137, DOI 10.1080/0071660500065151; Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Bolha L, 2013, POULTRY SCI, V92, P3134, DOI 10.3382/ps.2013-03332; BRAUN W, 1971, ANN NY ACAD SCI, V185, P417; BYRNES S, 1993, INT J PARASITOL, V23, P639, DOI 10.1016/0020-7519(93)90170-4; Calati R, 2013, PROG NEURO-PSYCHOPH, V44, P271, DOI 10.1016/j.pnpbp.2013.03.005; Cao SL, 2014, POULTRY SCI, V93, P2158, DOI 10.3382/ps.2013-03796; Cavero D, 2009, POULTRY SCI, V88, P2063, DOI 10.3382/ps.2009-00168; De Boever S, 2008, AVIAN PATHOL, V37, P39, DOI 10.1080/03079450701784875; Dziarski R, 1996, J INFECT DIS, V174, P777, DOI 10.1093/infdis/174.4.777; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ellestad LE, 2009, J MOL ENDOCRINOL, V42, P171, DOI 10.1677/JME-08-0066; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FRAIFELD V, 1995, LIFE SCI, V56, P1343, DOI 10.1016/0024-3205(95)00086-0; Frenzen PD, 2005, J FOOD PROTECT, V68, P2502; Gao QX, 2012, VET MICROBIOL, V160, P395, DOI 10.1016/j.vetmic.2012.06.009; Garcia-Rodriguez S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/495934; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hacker H, 2002, J IMMUNOL, V169, P3172, DOI 10.4049/jimmunol.169.6.3172; Heggen CL, 2000, AVIAN DIS, V44, P59, DOI 10.2307/1592508; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; JONES CA, 1981, POULTRY SCI, V60, P2189, DOI 10.3382/ps.0602189; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Laurent F, 2001, INFECT IMMUN, V69, P2527, DOI 10.1128/IAI.69.4.2527-2534.2001; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Li LL, 2000, GENOMICS, V63, P333, DOI 10.1006/geno.1999.6103; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Ling Y, 2009, ANTICANCER RES, V29, P411; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Munyaka PM, 2013, POULTRY SCI, V92, P105, DOI 10.3382/ps.2012-02579; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Nakamura K, 1998, POULTRY SCI, V77, P908, DOI 10.1093/ps/77.6.908; Nii T, 2011, POULTRY SCI, V90, P2332, DOI 10.3382/ps.2011-01596; Nolan LK., 2020, DIS POULTRY, P770, DOI 10.1002/9781119421481.ch18; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; O Besedovsky H, 2006, NAT IMMUNOL, V7, P537, DOI 10.1038/ni0606-537; Oliver L, 2005, APOPTOSIS, V10, P277, DOI 10.1007/s10495-005-0802-x; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Peighambari SM, 2002, AVIAN DIS, V46, P287, DOI 10.1637/0005-2086(2002)046[0287:SIAEOT]2.0.CO;2; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Russell SM, 2003, POULTRY SCI, V82, P1326, DOI 10.1093/ps/82.8.1326; Sadeyen JR, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-19; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; SCHLECH WF, 1993, INT J FOOD MICROBIOL, V18, P15, DOI 10.1016/0168-1605(93)90003-Y; Shao QL, 2015, INT J CLIN EXP PATHO, V8, P14465; Shaughnessy RG, 2009, VET IMMUNOL IMMUNOP, V132, P191, DOI 10.1016/j.vetimm.2009.06.007; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; SIEGEL HS, 1985, WORLD POULTRY SCI J, V41, P36, DOI 10.1079/WPS19850003; Star L, 2008, POULTRY SCI, V87, P1031, DOI 10.3382/ps.2007-00143; Sun HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142570; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Upadhya D, 2013, DEVELOPMENT, V140, P1573, DOI 10.1242/dev.081042; USDA-National Agricultural Statistics Service, 2015, POULTR PROD VAL 2014; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wang H., 2003, CYTOKINE HDB, V4th ed., P837; Watson RWG, 1996, J IMMUNOL, V156, P3986; Wigley P., 2003, BRAZ J POULTRY SCI, V5, P1; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Zhang SP, 1995, AVIAN DIS, V39, P859, DOI 10.2307/1592424; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	79	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158314	10.1371/journal.pone.0158314	http://dx.doi.org/10.1371/journal.pone.0158314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347679	Green Published, gold, Green Submitted			2022-12-26	WOS:000378801200062
J	Arboe, B; El-Galaly, TC; Clausen, MR; Munksgaard, PS; Stoltenberg, D; Nygaard, MK; Klausen, TW; Christensen, JH; Gorlov, JS; Brown, PD				Arboe, Bente; El-Galaly, Tarec Christoffer; Clausen, Michael Roost; Munksgaard, Peter Svenssen; Stoltenberg, Danny; Nygaard, Mette Kathrine; Klausen, Tobias Wirenfeldt; Christensen, Jacob Haaber; Gorlov, Jette Sonderskov; Brown, Peter de Nully			The Danish National Lymphoma Registry: Coverage and Data Quality	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; HODGKINS-DISEASE; POPULATION; EPIDEMIOLOGY; RITUXIMAB	Background The Danish National Lymphoma Register (LYFO) prospectively includes information on all lymphoma patients newly diagnosed at hematology departments in Denmark. The validity of the clinical information in the LYFO has never been systematically assessed. Aim To test the coverage and data quality of the LYFO. Methods The coverage was tested by merging data of the LYFO with the Danish Cancer Register and the Danish National Patient Register, respectively. The validity of the LYFO was assessed by crosschecking with information from medical records in subgroups of patients. A random sample of 3% (N = 364) was made from all patients in the LYFO. In addition, four subtypes of lymphomas were validated: CNS lymphomas, diffuse large B-cell lymphomas, peripheral T-cell lymphomas, and Hodgkin lymphomas. A total of 1,706 patients from the period 2000-2012 were included. The positive predictive values (PPVs) and completeness of selected variables were calculated for each subgroup and for the entire cohort of patients. Results The comparison of data from the LYFO with the Danish Cancer Register and the Danish National Patient Register revealed a high coverage. In addition, the data quality was good with high PPVs (87% to 100%), and high completeness (92% to 100%). Conclusion The LYFO is a unique, nationwide clinical database characterized by high validity, good coverage and prospective data entry. It represents a valuable resource for future lymphoma research.	[Arboe, Bente; Gorlov, Jette Sonderskov; Brown, Peter de Nully] Copenhagen Univ Hosp, Dept Hematol, Copenhagen, Denmark; [El-Galaly, Tarec Christoffer; Munksgaard, Peter Svenssen; Nygaard, Mette Kathrine] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark; [Clausen, Michael Roost] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark; [Stoltenberg, Danny; Klausen, Tobias Wirenfeldt] Copenhagen Univ Hosp, Dept Hematol, Herlev, Denmark; [Christensen, Jacob Haaber] Odense Univ Hosp, Dept Hematol, DK-5000 Odense, Denmark	University of Copenhagen; Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Arboe, B (corresponding author), Copenhagen Univ Hosp, Dept Hematol, Copenhagen, Denmark.	bentearboe@hotmail.com		Clausen, Michael Roost/0000-0003-3218-3633; El-Galaly, Tarec Christoffer/0000-0002-4406-380X	Danish Cancer Society [R-94-A5765-14-S21]	Danish Cancer Society(Danish Cancer Society)	PB received funding from the Danish Cancer Society (R-94-A5765-14-S21), https://www.cancer.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson A, 2014, BLOOD, V124, P1288, DOI 10.1182/blood-2014-03-559930; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; CARBONE PP, 1971, CANCER RES, V31, P1860; CROWTHER D, 1990, BRIT J CANCER, V62, P551, DOI 10.1038/bjc.1990.328; Danish Lymphoma Group [webpage on the Internet], 2013, LYFO ANN REP; El-Galaly TC, 2014, AM J HEMATOL, V89, P575, DOI 10.1002/ajh.23688; El-Galaly TC, 2015, AM J HEMATOL, V90, P975, DOI 10.1002/ajh.24128; Erichsen Rune, 2010, Clin Epidemiol, V2, P51; Erlangsen A, 2015, SCAND J PUBLIC HEALT, V43, P333, DOI 10.1177/1403494815575193; Frederiksen BL, 2012, BRIT J CANCER, V106, P988, DOI 10.1038/bjc.2012.3; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martensson Solvej, 2012, Qual Manag Health Care, V21, P278; Norgaard M, 2005, EUR J CANCER PREV, V14, P201, DOI 10.1097/00008469-200506000-00002; Ostgard Lene Sofie Granfeldt, 2013, Clin Epidemiol, V5, P335, DOI 10.2147/CLEP.S48411; Paulsen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035087; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Rosendaal FR, 2014, EUR J EPIDEMIOL, V29, P539, DOI 10.1007/s10654-014-9935-y; Schmidt M, 2015, CLIN EPIDEM IN PRESS, P449, DOI [DOI 10.2147/CLEP.S91125, 10.2147/CLEP.S91125]; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Solal-celigny P, 2011, FOLLICULAR LYMPHOMA, V104, P1258, DOI [10.1182/blood-2003-12-4434, DOI 10.1182/BLOOD-2003-12-4434]; Sorensen HT, 1996, INT J EPIDEMIOL, V25, P435, DOI 10.1093/ije/25.2.435; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; Wahi MM, 2008, J AM MED INFORM ASSN, V15, P386, DOI 10.1197/jamia.M2381; Wasterlid T, 2013, ANN ONCOL, V24, P1879, DOI 10.1093/annonc/mdt058; Zhou Z, 2014, BLOOD, V123, P837, DOI 10.1182/blood-2013-09-524108	29	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157999	10.1371/journal.pone.0157999	http://dx.doi.org/10.1371/journal.pone.0157999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336800	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200085
J	Tai, TW; Lin, TC; Ho, CJ; Yang, YHK; Yang, CY				Tai, Ta-Wei; Lin, Tzu-Chieh; Ho, Chia-Jung; Yang, Yea-Huei Kao; Yang, Chyun-Yu			Frequent Dental Scaling Is Associated with a Reduced Risk of Periprosthetic Infection following Total Knee Arthroplasty: A Nationwide Population-Based Nested Case-Control Study	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; HIP	Oral bacteremia has been presumed to be an important risk factor for total knee arthroplasty (TKA) infection. We aimed to investigate whether dental scaling could reduce the risk of TKA infection. A nested case-control study was conducted to compare 1,291 TKA patients who underwent resection arthroplasty for infected TKA and 5,004 matched controls without infection in the TKA cohort of Taiwan's National Health Insurance Research Database (NHIRD). The frequency of dental scaling was analyzed. Multiple conditional logistic regression was used to assess the frequency of dental scaling and the risk of TKA infection. The percentage of patients who received dental scaling was higher in the control group than in the TKA infection group. The risk for TKA infection was 20% lower for patients who received dental scaling at least once within a 3-year period than for patients who never received dental scaling. Moreover, the risk of TKA infection was reduced by 31% among patients who underwent more frequent dental scaling (5-6 times within 3 years). Frequent and regular dental scaling is associated with a reduced risk of TKA infection.	[Tai, Ta-Wei; Yang, Chyun-Yu] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Orthopaed, Tainan 70101, Taiwan; [Tai, Ta-Wei] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan; [Lin, Tzu-Chieh; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 701, Taiwan; [Ho, Chia-Jung] Joy Dent Clin, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Yang, CY (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Orthopaed, Tainan 70101, Taiwan.	cyyang@mail.ncku.edu.tw						American Academy of Orthopaedic Surgeons, 2012, PREVENTION OF ORTHOP; American Dental Association, 2003, J AM DENT ASSOC, V134, P895; [Anonymous], 2000, ORAL HEALTH IN AMERI; Beirne P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub3; Beltran-Aguilar ED, 2005, MMWR SURVEILL SUMM, V54, P1; Berbari EF, 2010, CLIN INFECT DIS, V50, P8, DOI 10.1086/648676; Centers for Medicare and Medicaid Services, 2012, DENTAL CARE; Centers for Medicare and Medicaid Services, 2012, DENTAL SERVICES; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Duchman KR, 2015, J BONE JOINT SURG AM, V97A, P1049, DOI 10.2106/JBJS.N.01016; Dye BA, 2007, SPEC CARE DENT, V27, P177, DOI 10.1111/j.1754-4505.2007.tb00343.x; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Lalani T, 2008, SCAND J INFECT DIS, V40, P973, DOI 10.1080/00365540802245146; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; Maharaj B, 2012, CARDIOVASC J AFR, V23, P340, DOI 10.5830/CVJA-2012-016; Murdoch DR, 2001, CLIN INFECT DIS, V32, P647, DOI 10.1086/318704; Napenas JJ, 2009, J CAN DENT ASSOC, V75, P447; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; Sendi P, 2011, J INFECTION, V63, P17, DOI 10.1016/j.jinf.2011.05.005; Suleiman LI, 2012, J SURG RES, V174, P7, DOI 10.1016/j.jss.2011.05.057; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Uckay I, 2009, J INFECTION, V59, P337, DOI 10.1016/j.jinf.2009.08.015; Waghmare Alka S, 2013, J Indian Soc Periodontol, V17, P725, DOI 10.4103/0972-124X.124480; Worthington HV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub4; Zimmerli W, 2004, NEW ENGL J MED; Zmistowski B, 2013, J BONE JOINT SURG AM, V95A, P2177, DOI 10.2106/JBJS.L.00789	29	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158096	10.1371/journal.pone.0158096	http://dx.doi.org/10.1371/journal.pone.0158096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336912	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200109
J	Pesta, DH; Tsirigotis, DN; Befroy, DE; Caballero, D; Jurczak, MJ; Rahimi, Y; Cline, GW; Dufour, S; Birkenfeld, AL; Rothman, DL; Carpenter, TO; Insogna, K; Petersen, KF; Bergwitz, C; Shulman, GI				Pesta, Dominik H.; Tsirigotis, Dimitrios N.; Befroy, Douglas E.; Caballero, Daniel; Jurczak, Michael J.; Rahimi, Yasmeen; Cline, Gary W.; Dufour, Sylvie; Birkenfeld, Andreas L.; Rothman, Douglas L.; Carpenter, Thomas O.; Insogna, Karl; Petersen, Kitt Falk; Bergwitz, Clemens; Shulman, Gerald I.			Hypophosphatemia promotes lower rates of muscle ATP synthesis	FASEB JOURNAL			English	Article						[P-31]MRS; saturation transfer; inorganic phosphate	OXIDATIVE-PHOSPHORYLATION; INORGANIC-PHOSPHATE; SKELETAL-MUSCLE; IN-VIVO; MITOCHONDRIAL; HYPERCALCIURIA; MICE; DYSFUNCTION; MUTATIONS; WEAKNESS	Hypophosphatemia can lead to muscle weakness and respiratory and heart failure, but the mechanism is unknown. To address this question, we noninvasively assessed rates of muscle ATP synthesis in hypophosphatemic mice by using in vivo saturation transfer [P-31]-magnetic resonance spectroscopy. By using this approach, we found that basal and insulin-stimulated rates of muscle ATP synthetic flux (V-ATP) and plasma inorganic phosphate (P-i) were reduced by 50% in mice with diet-induced hypophosphatemia as well as in sodium-dependent P-i transporter solute carrier family 34, member 1 (NaPi2a)-knockout (NaPi2a(-/-)) mice compared with their wild-type littermate controls. Rates of V-ATP normalized in both hypophosphatemic groups after restoring plasma P-i concentrations. Furthermore, V-ATP was directly related to cellular and mitochondrial P-i uptake in L6 and RC13 rodent myocytes and isolated muscle mitochondria. Similar findings were observed in a patient with chronic hypophosphatemia as a result of a mutation in SLC34A3 who had a 50% reduction in both serum P-i content and muscle V-ATP. After oral P-i repletion and normalization of serum P-i levels, muscle V-ATP completely normalized in the patient. Taken together, these data support the hypothesis that decreased muscle ATP synthesis, in part, may be caused by low blood P-i concentrations, which may explain some aspects of muscle weakness observed in patients with hypophosphatemia.-Pesta, D. H., Tsirigotis, D. N., Befroy, D. E., Caballero, D., Jurczak, M. J., Rahimi, Y., Cline, G. W., Dufour, S., Birkenfeld, A. L., Rothman, D. L., Carpenter, T. O., Insogna, K., Petersen, K. F., Bergwitz, C., Shulman, G. I. Hypophosphatemia promotes lower rates of muscle ATP synthesis.	[Pesta, Dominik H.; Caballero, Daniel; Jurczak, Michael J.; Rahimi, Yasmeen; Cline, Gary W.; Birkenfeld, Andreas L.; Insogna, Karl; Petersen, Kitt Falk; Bergwitz, Clemens; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Tsirigotis, Dimitrios N.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [Befroy, Douglas E.; Rothman, Douglas L.] Yale Univ, Sch Med, Dept Radiol & Biomed Engn, New Haven, CT USA; [Carpenter, Thomas O.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Dufour, Sylvie; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06510 USA; [Petersen, Kitt Falk; Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Novo Nordisk Foundation; University of Copenhagen	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Pesta, Dominik/AAV-7108-2020; Birkenfeld, Andreas L./U-3954-2019; Caballero, Daniel/GXV-3082-2022; Shulman, Gerald I./P-7176-2019	Pesta, Dominik/0000-0002-5089-3586; Birkenfeld, Andreas L./0000-0003-1407-9023; Shulman, Gerald I./0000-0003-1529-5668; Caballero, Daniel/0000-0001-9232-8991; Insogna, Karl/0000-0001-6973-5679	Austrian Science Fund (FWF) [J-3267]; German Science Association (DFG) [BI1292/ 4-2]; U.S. National Institutes of Health [DK-40936, DK-059635]; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK-45735]; U.S. National Institutes of Health (National Institute on Aging) [AG-23686]; Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023686, R01AG023686] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Science Association (DFG)(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Austrian Science Fund (FWF; J-3267); the German Science Association (DFG; BI1292/ 4-2); U.S. National Institutes of Health Grants DK-40936, DK-059635, and DK-45735 (National Institute of Diabetes and Digestive and Kidney Diseases), and AG-23686 (National Institute on Aging); and the Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen). The authors thank Mario Kahn, Blas Guigni, Tomas Jelenik, John Stack, Gina Butrico, Ali Nasiri, Bryce Perler, and Maria Batsu for technical assistance and Oroboros Instruments for the loan of an Oxygraph-2k. The authors also thank the Hospital Research Unit (Yale-New Haven Hospital, New Haven, CT, USA) for help with clinical studies. The authors declare no conflicts of interest.	Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; Andersen H, 2004, DIABETES, V53, P1543, DOI 10.2337/diabetes.53.6.1543; Andreassen CS, 2006, DIABETES, V55, P806, DOI 10.2337/diabetes.55.03.06.db05-1237; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Berndt T, 2007, ANNU REV PHYSIOL, V69, P341, DOI 10.1146/annurev.physiol.69.040705.141729; Brooks KJ, 2004, NMR BIOMED, V17, P28, DOI 10.1002/nbm.861; CAMP MA, 1990, MINER ELECTROL METAB, V16, P365; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; FULLER TJ, 1976, J CLIN INVEST, V57, P1019, DOI 10.1172/JCI108343; Gariballa S, 2008, NUTRITION, V24, P604, DOI 10.1016/j.nut.2008.01.053; Geerse DA, 2010, CRIT CARE, V14, DOI 10.1186/cc9215; GRAVELYN TR, 1988, AM J MED, V84, P870, DOI 10.1016/0002-9343(88)90065-4; Haran M, 2014, MITOCHONDRION, V19, P3, DOI 10.1016/j.mito.2014.09.007; HETTLEMAN BD, 1983, J CLIN INVEST, V72, P582, DOI 10.1172/JCI111006; Imel EA, 2012, J CLIN ENDOCR METAB, V97, P696, DOI 10.1210/jc.2011-1319; Jensen N, 2013, J MOL NEUROSCI, V51, P994, DOI 10.1007/s12031-013-0085-6; Jones AO, 2001, J AM SOC NEPHROL, V12, P507, DOI 10.1681/ASN.V123507; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; Jucker BM, 2000, J BIOL CHEM, V275, P39279, DOI 10.1074/jbc.M007760200; KHANANSHVILI D, 1985, BIOCHEMISTRY-US, V24, P2482, DOI 10.1021/bi00331a014; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; LARDY HA, 1952, J BIOL CHEM, V195, P215; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; LEMASTERS JJ, 1979, J BIOL CHEM, V254, P1248; Lemos RR, 2015, HUM MUTAT, V36, P489, DOI 10.1002/humu.22778; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Schubert L, 2010, ARCH BIOCHEM BIOPHYS, V500, P157, DOI 10.1016/j.abb.2010.05.029; Segawa H, 2009, BONE, V45, pS2, DOI 10.1016/j.bone.2009.02.003; Sinha A, 2013, J CLIN ENDOCR METAB, V98, pE509, DOI 10.1210/jc.2012-3592; SMITH R, 1984, CLIN SCI, V67, P505, DOI 10.1042/cs0670505; Soyoral Y, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.04.011; TAGER JM, 1983, FEBS LETT, V151, P1, DOI 10.1016/0014-5793(83)80330-5; TANAKA A, 1989, J BIOL CHEM, V264, P10034; Veilleux LN, 2012, J CLIN ENDOCR METAB, V97, pE1492, DOI 10.1210/jc.2012-1336; Wang Cecilia C Low, 2007, Atherosclerosis, V195, pe65, DOI 10.1016/j.atherosclerosis.2007.02.032; WILSON DF, 1974, BIOCHEM J, V140, P57, DOI 10.1042/bj1400057; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	44	48	53	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3378	3387		10.1096/fj.201600473R	http://dx.doi.org/10.1096/fj.201600473R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27338702	Green Published, hybrid			2022-12-26	WOS:000384329800010
J	Kim, D; Pauer, SH; Yong, HM; An, SS; Liggett, SB				Kim, Donghwa; Pauer, Susan H.; Yong, Hwan M.; An, Steven S.; Liggett, Stephen B.			beta(2)-Adrenergic Receptors Chaperone Trapped Bitter Taste Receptor 14 to the Cell Surface as a Heterodimer and Exert Unidirectional Desensitization of Taste Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; chronic obstructive pulmonary disease (COPD); cyclic AMP (cAMP); dimerization; G protein; receptor internalization; smooth muscle; bitter taste receptor	AIRWAY SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; BETA-2-ADRENERGIC RECEPTORS; MAMMALIAN TASTE; PHOSPHORYLATION; EXPRESSION; LACKING; GRK	Bitter taste receptors (TAS2Rs) are G-protein-coupled receptors now recognized to be expressed on extraoral cells, including airway smooth muscle (ASM) where they evoke relaxation. TAS2Rs are difficult to express in heterologous systems, with most receptors being trapped intracellularly. We find, however, that co-expression of (2)-adrenergic receptors ((2)AR) in HEK-293T routes TAS2R14 to the cell surface by forming receptor heterodimers. Cell surface TAS2R14 expression was increased by approximate to 5-fold when (2)AR was co-expressed. Heterodimer formation was shown by co-immunoprecipitation with tagged receptors, biomolecular fluorescence complementation, and merged confocal images. The dynamic nature of this interaction was shown by: a gene-dose relationship between transfected (2)AR and TAS2R14 expression, enhanced (up to 3-fold) TAS2R14 agonist stimulation of [Ca2+](i) with (2)AR co-transfection, approximate to 53% decrease in [Ca2+](i) signaling with shRNA knockdown of (2)AR in H292 cells, and approximate to 60% loss of [Ca2+](i) responsiveness in AR knock-out mouse ASM. Once expressed on the surface, we detected unidirectional, conformation-dependent, interaction within the heterodimer, with (2)AR activation rapidly uncoupling TAS2R14 function (approximate to 65% desensitization). Cross-talk was independent of (2)AR internalization and cAMP/PKA, and not accompanied by TAS2R14 internalization. With prolonged -agonist exposure, TAS2R14 internalized, consistent with slow recycling of naked TAS2R14 in the absence of the heterodimeric milieu. In studies of ASM mechanics, rapid cross-talk was confirmed at the physiologic level, where relaxation from TAS2R14 agonist was decreased by approximate to 50% with -agonist co-treatment. Thus the (2)AR acts as a double-edged sword: increasing TAS2R14 cell surface expression, but when activated by -agonist, partially offsetting the expression phenotype by direct receptor:receptor desensitization of TAS2R14 function.	[Kim, Donghwa; Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL 33612 USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Kim, Donghwa; Pauer, Susan H.; Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Ctr Personalized Med & Genom, Tampa, FL 33612 USA; [Yong, Hwan M.; An, Steven S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Liggett, SB (corresponding author), 12901 Bruce B Downs Blvd,MDC02, Tampa, FL 33612 USA.	sliggett@health.usf.edu	Kim, Donghwa/AAJ-8148-2021; An, Steven/AAM-3848-2020	Kim, Donghwa/0000-0002-8994-8513; An, Steven/0000-0003-4723-1888; Liggett, Stephen B./0000-0002-0128-3669	National Institutes of Health [HL114471, HL045967, HL107361]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045967, R01HL107361, R56HL045967, R37HL045967, P01HL114471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL114471, HL045967, and HL107361. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; An SS, 2016, J ALLERGY CLIN IMMUN, V138, P294, DOI 10.1016/j.jaci.2015.12.1315; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Billington CK, 2003, RESP RES, V4; Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Krzywinski M, 2014, NAT METHODS, V11, P977, DOI 10.1038/nmeth.3137; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; McGraw DW, 1999, J BIOL CHEM, V274, P32241, DOI 10.1074/jbc.274.45.32241; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; Swift SM, 2007, AM J RESP CELL MOL, V36, P236, DOI 10.1165/rcmb.2006-0257OC; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	27	17	17	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17616	17628		10.1074/jbc.M116.722736	http://dx.doi.org/10.1074/jbc.M116.722736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27342779	hybrid, Green Published			2022-12-26	WOS:000383241300013
J	Kempster, RM; Egeberg, CA; Hart, NS; Ryan, L; Chapuis, L; Kerr, CC; Schmidt, C; Huveneers, C; Gennari, E; Yopak, KE; Meeuwig, JJ; Collin, SP				Kempster, Ryan M.; Egeberg, Channing A.; Hart, Nathan S.; Ryan, Laura; Chapuis, Lucille; Kerr, Caroline C.; Schmidt, Carl; Huveneers, Charlie; Gennari, Enrico; Yopak, Kara E.; Meeuwig, Jessica J.; Collin, Shaun P.			How Close is too Close? The Effect of a Non-Lethal Electric Shark Deterrent on White Shark Behaviour	PLOS ONE			English	Article							PROTECTIVE GILL NETS; NEW-SOUTH-WALES; CARCHARODON-CARCHARIAS; DASYATIS-SABINA; STEREO-VIDEO; AFRICA; FISH; PATTERNS; CAUGHT; FIELDS	Sharks play a vital role in the health of marine ecosystems, but the potential threat that sharks pose to humans is a reminder of our vulnerability when entering the ocean. Personal shark deterrents are being marketed as the solution to mitigate the threat that sharks pose. However, the effectiveness claims of many personal deterrents are based on our knowledge of shark sensory biology rather than robust testing of the devices themselves, as most have not been subjected to independent scientific studies. Therefore, there is a clear need for thorough testing of commercially available shark deterrents to provide the public with recommendations of their effectiveness. Using a modified stereo-camera system, we quantified behavioural interactions between white sharks (Carcharodon carcharias) and a baited target in the presence of a commercially available, personal electric shark deterrent (Shark Shield Freedom7 (TM)). The stereo-camera system enabled an accurate assessment of the behavioural responses of C. carcharias when encountering a non-lethal electric field many times stronger than what they would naturally experience. Upon their first observed encounter, all C. carcharias were repelled at a mean (+/- std. error) proximity of 131 (+/- 10.3) cm, which corresponded to a mean voltage gradient of 9.7 (+/- 0.9) V/m. With each subsequent encounter, their proximity decreased by an average of 11.6 cm, which corresponded to an increase in tolerance to the electric field by an average of 2.6 (+/- 0.5) V/m per encounter. Despite the increase in tolerance, sharks continued to be deterred from interacting for the duration of each trial when in the presence of an active Shark Shield (TM). Furthermore, the findings provide no support to the theory that electric deterrents attract sharks. The results of this study provide quantitative evidence of the effectiveness of a non-lethal electric shark deterrent, its influence on the behaviour of C. carcharias, and an accurate method for testing other shark deterrent technologies.	[Kempster, Ryan M.; Egeberg, Channing A.; Hart, Nathan S.; Ryan, Laura; Chapuis, Lucille; Kerr, Caroline C.; Schmidt, Carl; Yopak, Kara E.; Meeuwig, Jessica J.; Collin, Shaun P.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Kempster, Ryan M.; Egeberg, Channing A.; Hart, Nathan S.; Ryan, Laura; Chapuis, Lucille; Kerr, Caroline C.; Schmidt, Carl; Yopak, Kara E.; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Hart, Nathan S.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Huveneers, Charlie] Flinders Univ S Australia, Sch Biol Sci, Bedford Pk, SA 5042, Australia; [Gennari, Enrico] Oceans Res, Mossel Bay, South Africa; [Gennari, Enrico] South African Inst Aquat Biodivers, Private Bag 1015, Grahamstown, South Africa; [Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Ctr Marine Futures, Crawley, WA, Australia	University of Western Australia; University of Western Australia; Macquarie University; Flinders University South Australia; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; University of Western Australia	Kempster, RM (corresponding author), Univ Western Australia, Oceans Inst, Crawley, WA, Australia.; Kempster, RM (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	ryankempster@supportoursharks.com	Collin, Shaun/K-8827-2012; Hart, Nathan S/B-8564-2011; Chapuis, Lucille/A-6535-2010; Yopak, Kara E/A-5549-2012	Collin, Shaun/0000-0001-6236-0771; Hart, Nathan S/0000-0002-7289-9399; Chapuis, Lucille/0000-0003-3001-983X; Yopak, Kara E/0000-0002-7870-9066; Meeuwig, Jessica/0000-0003-1169-8785; Huveneers, Charlie/0000-0001-8937-1358; Ryan, Laura/0000-0002-3436-2048; Gennari, Enrico/0000-0002-4334-727X	University of Western Australia; West Australian State Government Shark Hazard Mitigation Applied Research Program; South African Department of Environmental Affairs: Biodiversity and Coastal Research, Oceans and Coasts Branch; UWA Neuroecology Group	University of Western Australia; West Australian State Government Shark Hazard Mitigation Applied Research Program; South African Department of Environmental Affairs: Biodiversity and Coastal Research, Oceans and Coasts Branch; UWA Neuroecology Group	This study was funded by The University of Western Australia and the West Australian State Government Shark Hazard Mitigation Applied Research Program. The UWA Neuroecology Group would also like to express sincere gratitude and appreciation for the continued support and generous financial assistance provided by Craig and Katrina Burton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by The University of Western Australia and the West Australian State Government Shark Hazard Mitigation Applied Research Program. The UWA Neuroecology Group would also like to express sincere gratitude and appreciation for the continued support and generous financial assistance provided by Craig and Katrina Burton. Without which, completion of this research would not have been possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors wish to thank the South African Department of Environmental Affairs: Biodiversity and Coastal Research, Oceans and Coasts Branch for their support and help in conducting this research. The authors also wish to thank all of the interns at the Oceans Research campus in Mossel Bay for all of their help and hard work during this investigation. Finally, the authors would like to thank the anonymous reviewers for their thorough and critical feedback of this research, which ultimately resulted in a much improved final manuscript.	Atwood TB, 2015, NAT CLIM CHANGE, V5, P1038, DOI 10.1038/NCLIMATE2763; Bedore CN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P298, DOI 10.1086/669973; Bikson M., 2004, REV HAZARDS ASS EXPO; Brill R, 2009, FISH B-NOAA, V107, P298; Broad A, 2010, MAR ECOL PROG SER, V408, P295, DOI 10.3354/meps08591; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Cisneros-Montemayor A. M., 2013, ORYX, V47, P1; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Cliff G, 1996, GREAT WHITE SHARKS, P351, DOI 10.1016/B978-012415031-7/50033-1; CLIFF G, 1995, S AFR J MARINE SCI, V15, P105; CLIFF G, 1992, AUST J MAR FRESH RES, V43, P263; DUDLEY SFJ, 1993, S AFR J MARINE SCI, V13, P237, DOI 10.2989/025776193784287356; Dudley SFJ, 1997, OCEAN COAST MANAGE, V34, P1, DOI 10.1016/S0964-5691(96)00061-0; Dunbrack RL, 2006, FISH RES, V82, P327, DOI 10.1016/j.fishres.2006.08.017; Egeberg CA, 2014, MAR FRESHWATER RES, V65, P1003, DOI 10.1071/MF13213; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Hart NS, 2015, INTEGR ZOOL, V10, P38, DOI 10.1111/1749-4877.12095; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; House D., 2014, W AUSTR SHARK HAZARD; Huveneers C, 2012, EFFECTS SHARK SHIELD; Huveneers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062730; Jordan LK, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot002; Jordan LK, 2011, J EXP MAR BIOL ECOL, V409, P345, DOI 10.1016/j.jembe.2011.09.016; Kajiura SM, 2003, MAR BIOL, V143, P603, DOI 10.1007/s00227-003-1099-3; Kajiura SM, 2009, ZOOLOGY, V112, P241, DOI 10.1016/j.zool.2008.07.001; Kalmijn A.J., 1974, P147; Kalmijn A.J., 1972, BIOELECTRIC FIELDS S; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1981, ANN BIOMED ENG, V9, P363, DOI 10.1007/BF02364656; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; KALMIJN AJ, 1988, DETECT WEAK ELECTR, P151; Kalmijn AJ, 1973, ELECTROORIENTATION S; Kempster RM, 2016, MAR FRESHWATER RES, V67, P187, DOI 10.1071/MF14245; Kempster R. M., 2013, BRAIN BEHAV EVOLUT, V81, P1; Kempster RM, 2014, ROLE ELECTRORECEPTIO; Kempster RM, 2014, EARTHSCAN OCEAN, P213; Kempster RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052551; Kimber JA, 2014, ANIM COGN, V17, P55, DOI 10.1007/s10071-013-0637-8; Kock A., 2006, WWF S AFRICA REPORT, P1; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Letessier T.B., 2013, METHODS OCEANOGR, V8, P41, DOI [10.1016/j.mio.2013.11.003, DOI 10.1016/J.MIO.2013.11.003]; Letessier TB, 2015, J EXP MAR BIOL ECOL, V466, P120, DOI 10.1016/j.jembe.2015.02.013; Marcotte MM, 2008, MAR TECHNOL SOC J, V42, P53, DOI 10.4031/002533208786829133; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; McGowan DW, 2009, J EXP BIOL, V212, P1544, DOI 10.1242/jeb.025247; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; O'Connell CP, 2014, OCEAN COAST MANAGE, V97, P2, DOI 10.1016/j.ocecoaman.2012.11.005; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Ryklief R, 2014, AFR J MAR SCI, V36, P449, DOI 10.2989/1814232X.2014.967296; SeaGIS, 2016, CAL STER CAM CAL; Sisneros JA, 2002, J PHYSIOL-PARIS, V96, P379, DOI 10.1016/S0928-4257(03)00016-0; Sisneros JA, 2002, BRAIN BEHAV EVOLUT, V59, P130, DOI 10.1159/000064160; Smit CE, 2003, ESTIMATING PROBABILI, P59; Smith E., 1974, T KOREAN I ELECT ENG, V65, P1; Smith E. D., 1991, Power Engineering Journal, V5, P167, DOI 10.1049/pe:19910036; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Wetherbee Bradley M., 1994, Pacific Science, V48, P95; Zintzen V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048522	63	22	22	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157717	10.1371/journal.pone.0157717	http://dx.doi.org/10.1371/journal.pone.0157717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368059	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900012
J	Godoi, D; Barela, JA				Godoi, Daniela; Barela, Jose A.			Optical Flow Structure Effects in Children's Postural Control	PLOS ONE			English	Article							VISUAL INFORMATION; PERIPHERAL-VISION; BODY SWAY; STANCE; ADAPTATION; SENSITIVITY; INFANTS; BALANCE; INTEGRATION; PERCEPTION	The aim of this study was to investigate the effect of distance and optic flow structure on visual information and body sway coupling in children and young adults. Thirty children (from 4 to 12 years of age) and 10 young adults stood upright inside of a moving room oscillating at 0.2 Hz, at 0.25 and 1.5 m from the front wall, and under three optical flow conditions (global, central, and peripheral). Effect of distance and optic flow structure on the coupling of visual information and body sway is age-dependent, with 4-year-olds being more affected at 0.25 m distance than older children and adults are. No such difference was observed at 1.5 m from the front wall. Moreover, 4-year-olds' sway was larger and displayed higher variability. These results suggest that despite being able to accommodate change resulting from varying optic flow conditions, young children have difficulty in dodging stronger visual stimuli. Lastly, difference in sway performance may be due to immature inter-modality sensory reweighting.	[Godoi, Daniela] Fed Univ Sao Carlos UFSCar, Ctr Biol Sci & Hlth, Dept Phys Educ, Sao Carlos, SP, Brazil; [Barela, Jose A.] Cruzeiro Sul Univ UNICSUL, Inst Phys Act & Sport Sci, Sao Paulo, SP, Brazil; [Barela, Jose A.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Phys Educ, Rio Claro, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Cruzeiro do Sul; Universidade Estadual Paulista	Godoi, D (corresponding author), Fed Univ Sao Carlos UFSCar, Ctr Biol Sci & Hlth, Dept Phys Educ, Sao Carlos, SP, Brazil.	danielagodoij@gmail.com	Barela, José A/F-4284-2012; Godoi Jacomassi, Daniela/O-4220-2014	Barela, José A/0000-0003-0951-254X; Godoi Jacomassi, Daniela/0000-0002-7043-7529				Bair WN, 2011, GAIT POSTURE, V34, P183, DOI 10.1016/j.gaitpost.2011.04.007; Barela AMF, 2009, MOTOR CONTROL, V13, P119, DOI 10.1123/mcj.13.2.119; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barela JA, 2000, INFANT BEHAV DEV, V23, P285, DOI 10.1016/S0163-6383(01)00045-5; Barela JA, 2011, J VISION, V11, DOI 10.1167/11.12.10; BERTENTHAL BI, 1989, DEV PSYCHOL, V25, P936, DOI 10.1037/0012-1649.25.6.936; Ellemberg D, 2004, VISION RES, V44, P2403, DOI 10.1016/j.visres.2004.05.006; FIGURA F, 1991, J SPORT MED PHYS FIT, V31, P235; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Freitas Junior PB, 2004, NEUROSCI LETT, V369, P64, DOI 10.1016/j.neulet.2004.07.075; Godoi D, 2008, DEV PSYCHOBIOL, V50, P77, DOI 10.1002/dev.20272; Gunn A, 2002, NEUROREPORT, V13, P843, DOI 10.1097/00001756-200205070-00021; Higgins CI, 1996, DEV PSYCHOL, V32, P836, DOI 10.1037/0012-1649.32.5.836; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Jeka JJ, 2008, EXP BRAIN RES, V191, P453, DOI 10.1007/s00221-008-1539-x; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Metcalfe JS, 2005, DEV PSYCHOBIOL, V46, P19, DOI 10.1002/dev.20037; Ferronato PAM, 2011, MOTOR CONTROL, V15, P481, DOI 10.1123/mcj.15.4.481; Nougier V, 1997, GAIT POSTURE, V5, P34, DOI 10.1016/S0966-6362(96)01071-5; Nougier V, 1998, J EXP CHILD PSYCHOL, V68, P202, DOI 10.1006/jecp.1997.2427; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Polastri PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082215; Polastri PF, 2012, EXP BRAIN RES, V223, P99, DOI 10.1007/s00221-012-3244-z; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Rinaldi NM, 2009, NEUROSCI LETT, V467, P225, DOI 10.1016/j.neulet.2009.10.042; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; Schmuckler MA, 1997, J EXP PSYCHOL HUMAN, V23, P528, DOI 10.1037/0096-1523.23.2.528; Schoner G, 1998, ECOL PSYCHOL, V10, P323, DOI 10.1207/s15326969eco103&4_9; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; STOFFREGEN TA, 1985, J EXP PSYCHOL HUMAN, V11, P554, DOI 10.1037/0096-1523.11.5.554; STOFFREGEN TA, 1986, PERCEPT PSYCHOPHYS, V39, P355, DOI 10.3758/BF03203004; TAGUCHI K, 1988, INT CONGR SER, V812, P59; Usui N, 1995, DEV MED CHILD NEUROL, V37, P985; Williams AM, 1999, INDIRECT THEORIES PE, P3; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215; WOOLLACOTT M, 1987, J MOTOR BEHAV, V19, P167	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158416	10.1371/journal.pone.0158416	http://dx.doi.org/10.1371/journal.pone.0158416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352305	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900058
J	Peverill, RE; Chou, B; Donelan, L; Mottram, PM; Gelman, JS				Peverill, Roger E.; Chou, Bon; Donelan, Lesley; Mottram, Philip M.; Gelman, John S.			Possible Mechanisms Underlying Aging-Related Changes in Early Diastolic Filling and Long Axis Motion-Left Ventricular Length and Blood Pressure	PLOS ONE			English	Article							TRANSMITRAL FLOW VELOCITY; AGE-RELATED-CHANGES; DOPPLER-ECHOCARDIOGRAPHY; HEALTHY-SUBJECTS; HEART-RATE; REFERENCE VALUES; MITRAL ANNULUS; RELAXATION; DYSFUNCTION; HUMANS	Background The transmitral E wave and the peak velocity of early diastolic mitral annular motion (e') both decrease with age, but the mechanisms underlying these age-related changes are incompletely understood. This study investigated the possible contributions of blood pressure (BP) and left ventricular end-diastolic length (LVEDL) to age-related reductions in E and e'. Methods The study group were 82 healthy adult subjects <55 years of age who were not obese or hypertensive. Transmitral flow and mitral annular motion were recorded using pulsed-wave Doppler. LVEDL was measured from the mitral annular plane to the apical endocardium. Results Age was positively correlated with diastolic BP and septal wall thickness (SWT), inversely correlated with LVEDL (beta = -0.25) after adjustment for sex and body surface area, but was not related to left ventricular end-diastolic diameter (LVEDD). Age was also inversely correlated with E (r = -0.36), septal e'(r = -0.53) and lateral e'(r = -0.53). On multivariable analysis, E was inversely correlated with diastolic BP and LVEDD, septal e' was inversely correlated with diastolic BP and positively correlated with SWT and LVEDL, after adjusting for body mass index, whilst lateral e' was inversely correlated with diastolic BP and positively correlated with LVEDL. Conclusion The above findings are consistent with higher BP being a contributor to age-related reductions in both E and e' and shortening of LVEDL with age being a contributor to the age-related reduction in e'. An implication of these findings is that slowing of myocyte relaxation is unlikely to be the sole, and may not be the main, mechanism underlying age-related decreases in E and e'.	[Peverill, Roger E.] Monash Univ, Monash Cardiovasc Res Ctr, Monash Heart, Clayton, Vic, Australia; Monash Univ, Dept Med, Sch Clin Sci, Monash Med Ctr, Clayton, Vic, Australia; Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, Monash Heart, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				Alam M, 1999, J AM SOC ECHOCARDIOG, V12, P618, DOI 10.1053/je.1999.v12.a99246; Appleton C. P., 2008, KLEIN GARCIA DIASTOL, P115; Batterham A, 2008, EUR J ECHOCARDIOGR, V9, P542, DOI 10.1093/ejechocard/jen114; BENJAMIN EJ, 1992, AM J CARDIOL, V70, P508, DOI 10.1016/0002-9149(92)91199-E; Biering-Sorensen T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002687; BONOW RO, 1988, J AM COLL CARDIOL, V11, P50, DOI 10.1016/0735-1097(88)90166-0; Borlaug BA, 2007, J AM COLL CARDIOL, V50, P1570, DOI 10.1016/j.jacc.2007.07.032; CAPASSO JM, 1983, AM J PHYSIOL, V245, pH72, DOI 10.1152/ajpheart.1983.245.1.H72; Carrick-Ranson G, 2012, AM J PHYSIOL-HEART C, V303, P315, DOI 10.1152/ajpheart.00142.2012; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Chirinos JA, 2013, HYPERTENSION, V61, P296, DOI 10.1161/HYPERTENSIONAHA.111.00530; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; CHOONG CY, 1988, CIRCULATION, V78, P672, DOI 10.1161/01.CIR.78.3.672; Chung CS, 2008, AM J PHYSIOL-HEART C, V294, pH1589, DOI 10.1152/ajpheart.00990.2007; COURTOIS M, 1992, CIRCULATION, V85, P1132, DOI 10.1161/01.CIR.85.3.1132; COURTOIS M, 1988, CIRCULATION, V78, P661, DOI 10.1161/01.CIR.78.3.661; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; Davies CH, 1996, CARDIOVASC RES, V31, P152, DOI 10.1016/0008-6363(95)00187-5; De Mey S, 2001, AM J PHYSIOL-HEART C, V280, pH2936, DOI 10.1152/ajpheart.2001.280.6.H2936; de Simone G, 2005, HYPERTENSION, V45, P64, DOI 10.1161/01.HYP.0000150108.37527.57; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DOWNES TR, 1989, AM J CARDIOL, V64, P523, DOI 10.1016/0002-9149(89)90433-5; Edner M, 2000, Eur J Echocardiogr, V1, P87, DOI 10.1053/euje.2000.0013; FERRARA N, 1995, J MOL CELL CARDIOL, V27, P1141, DOI 10.1016/0022-2828(95)90050-0; Franklin SS, 1997, CIRCULATION, V96, P308; FREEMAN GL, 1987, CIRC RES, V61, P455, DOI 10.1161/01.RES.61.3.455; Gardin JM, 1998, AM J CARDIOL, V82, P345, DOI 10.1016/S0002-9149(98)00339-7; GENOVESIEBERT A, 1991, J HYPERTENS, V9, P345, DOI 10.1097/00004872-199104000-00006; Gibson DG, 2003, HEART, V89, P231, DOI 10.1136/heart.89.2.231; GILBERT JC, 1989, CIRC RES, V64, P827, DOI 10.1161/01.RES.64.5.827; GILLEBERT TC, 1991, AM J PHYSIOL, V261, pH805, DOI 10.1152/ajpheart.1991.261.3.H805; GRAETTINGER WF, 1987, J AM COLL CARDIOL, V10, P1280, DOI 10.1016/S0735-1097(87)80132-8; GROSSMAN W, 1977, CIRCULATION, V56, P845, DOI 10.1161/01.CIR.56.5.845; Hees PS, 2002, AM J CARDIOL, V90, P1231, DOI 10.1016/S0002-9149(02)02840-0; Hees PS, 2004, AM J PHYSIOL-HEART C, V286, pH782, DOI 10.1152/ajpheart.01092.2002; Henein M, 2002, EUR HEART J, V23, P162, DOI 10.1053/euhj.2001.3032; HIROTA Y, 1980, CIRCULATION, V62, P756, DOI 10.1161/01.CIR.62.4.756; Iketani T, 1998, JPN CIRC J, V62, P581, DOI 10.1253/jcj.62.581; Jasaityte R, 2014, ULTRASOUND MED BIOL, V40, P37, DOI 10.1016/j.ultrasmedbio.2013.09.005; KAPUKU GK, 1993, AM HEART J, V125, P1710, DOI 10.1016/0002-8703(93)90763-Y; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; KLEIN AL, 1994, MAYO CLIN PROC, V69, P212, DOI 10.1016/S0025-6196(12)61059-3; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; MANTERO A, 1995, EUR HEART J, V16, P94, DOI 10.1093/eurheartj/16.1.94; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; Mellor KM, 2014, AGE, V36, P1155, DOI 10.1007/s11357-014-9630-7; Mogelvang R, 2009, EUR HEART J, V30, P731, DOI 10.1093/eurheartj/ehn596; Muller-Brunotte R, 2003, J HUM HYPERTENS, V17, P841, DOI 10.1038/sj.jhh.1001622; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Mureddu GF, 1997, HYPERTENSION, V29, P544, DOI 10.1161/01.HYP.29.2.544; Mureddu GF, 1996, AM J CARDIOL, V77, P509, DOI 10.1016/S0002-9149(97)89346-0; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nikitin NP, 2005, AGE AGEING, V34, P343, DOI 10.1093/ageing/afi043; Nooyens ACJ, 2009, PUBLIC HEALTH NUTR, V12, P862, DOI 10.1017/S1368980008003091; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; Ohte N, 1998, AM J CARDIOL, V82, P1414, DOI 10.1016/S0002-9149(98)00651-1; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P476, DOI 10.1016/S0894-7317(99)70084-2; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Ommen SR, 2000, CIRCULATION, V102, P1788; Paulus WJ, 2007, EUR HEART J; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Popovic ZB, 2006, AM J PHYSIOL-HEART C, V290, pH1454, DOI 10.1152/ajpheart.00902.2005; Prasad A, 2005, CIRCULATION, V111, P1499, DOI 10.1161/01.CIR.0000159353.31271.F2; Prasad A, 2007, AM J CARDIOL, V99, P1629, DOI 10.1016/j.amjcard.2007.01.050; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Slotwiner DJ, 1998, AM J CARDIOL, V82, P621, DOI 10.1016/S0002-9149(98)00390-7; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Solomon SD, 2010, HYPERTENSION, V55, P241, DOI 10.1161/HYPERTENSIONAHA.109.138529; SPIRITO P, 1988, BRIT HEART J, V59, P672; STARLING MR, 1987, CIRCULATION, V76, P1274, DOI 10.1161/01.CIR.76.6.1274; Subherwal S, 2010, AM HEART J, V159, P1081, DOI 10.1016/j.ahj.2010.02.024; Svealv BG, 2006, EUR J ECHOCARDIOGR, V7, P298, DOI 10.1016/j.euje.2005.06.008; SWINNE CJ, 1992, AM J CARDIOL, V69, P823, DOI 10.1016/0002-9149(92)90518-4; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Yamakado T, 1997, CIRCULATION, V95, P917; Yamakado T, 1998, AM HEART J, V135, P584, DOI 10.1016/S0002-8703(98)70271-6; Yano M, 2001, AM J PHYSIOL-HEART C, V280, pH1846, DOI 10.1152/ajpheart.2001.280.4.H1846	86	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158302	10.1371/journal.pone.0158302	http://dx.doi.org/10.1371/journal.pone.0158302			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351745	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900052
J	Xue, MF; Gong, SL; Dai, JP; Chen, G; Hu, JY				Xue, MingFeng; Gong, SuiLiang; Dai, JiaPing; Chen, Gang; Hu, JunYu			The Treatment of Fibrosis of Joint Synovium and Frozen Shoulder by Smad4 Gene Silencing in Rats	PLOS ONE			English	Article							TGF-BETA; DIFFERENTIATION; CELLS	Soft tissue fibrosis at the joint induced by inflammation is the pathological basis of frozen shoulder. In the present study, we utilized a lentiviral approach to silence the Smad4 gene in an in vitro fibrosis model of fibroblasts and an in vivo frozen shoulder model. We observed the change in the fibrosis process and the biological indicators of frozen shoulder. The in vitro fibrosis models (Rat myoblasts L6, Rat synovial cell RSC-364 and Rat chondrocytes RCs) were established using TGF-beta 1 induction, and the effect of Smad4 gene silencing on fibrosis was analyzed. The method of Kanno A was employed to establish a rat model of frozen shoulder, and Smad4 in the relevant part was knocked down with the lentiviral approach. We then examined the abduction and rotation angles and the length of synovial intima and measured the inflammatory factors in effusion and the fibrotic markers of tissues. We found that Smad4 knockdown suppressed the proliferation and expression of fibrotic markers in L6, RSC-364 and RCs cells induced by TGF-beta 1. MMP activity measurements showed that Smad4 knockdown significantly reversed the decrease in MMP activity in these three cell lines that were induced by TGF-beta 1. Furthermore, using lentivirus in the rat frozen shoulder model, we found that Smad4 silencing attenuated the inflammatory response and fibrosis. It significantly inhibited the increase of the Vimentin, a-SMA, collagen I and III, Lama1 and Timp1 proteins in synovial tissue as well as the inflammatory factors of TNF-alpha, IL-1 alpha/beta, IL-6 and IL-10 in effusion. MMP acidity assays revealed that Smad4 silencing inhibited MMP activity in the synovial, cartilage and ligament tissues in the model animals. The assessment of the phosphorylated Smad2/3 in the nuclei isolated from the synovial tissues showed that Smad4 silencing significantly inhibited the phosphorylation and subsequent nuclear translocation of Smad2/3 proteins. Moreover, Smad4-shRNA lentivirus inhibited the decrease in both the abduction and rotation angles caused by immobilization as well as the decrease in the length of the synovial intima. Based on shoulder movement data, Smad4 knockdown can increase the rotation limitation caused by immobilization. In summary, Smad4 silencing can suppress chronic inflammation and fibrosis in joint tissues by inhibiting the TGF-beta/Smad pathway and can play a positive role in the prevention and treatment of joint stiffness.	[Xue, MingFeng; Gong, SuiLiang; Dai, JiaPing; Chen, Gang; Hu, JunYu] Jiaxing Second Hosp, Dept Orthopaed Surg, Jia Xing 31400, Peoples R China		Gong, SL (corresponding author), Jiaxing Second Hosp, Dept Orthopaed Surg, Jia Xing 31400, Peoples R China.	suiliangg55@163.com			Jia Xing Science & Technology Bureau [2012AY1071-7]	Jia Xing Science & Technology Bureau	This study was supported by Fund of Jia Xing Science & Technology Bureau (2012AY1071-7).	Asghari MH, 2015, RES PHARM SCI, V10, P429; [陈疾忤 Chen Jiwu], 2004, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V22, P55; Foster W, 2003, J ORTHOP RES, V21, P798, DOI 10.1016/S0736-0266(03)00059-7; Goto Y, 2004, CELL TISSUE RES, V315, P209, DOI 10.1007/s00441-003-0824-z; Hand GCR, 2007, J BONE JOINT SURG BR, V89B, P928, DOI 10.1302/0301-620X.89B7.19097; Hao JM, 1999, J MOL CELL CARDIOL, V31, P667, DOI 10.1006/jmcc.1998.0902; Kanno A, 2010, J SHOULDER ELB SURG, V19, P700, DOI 10.1016/j.jse.2010.02.004; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; [李宏云 LI Hong-yun], 2009, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V29, P1363; Li YC, 2016, AM J PHYSIOL-GASTR L, V310, pG262, DOI 10.1152/ajpgi.00257.2015; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Omari A, 2001, J SHOULDER ELB SURG, V10, P353, DOI 10.1067/mse.2001.115986; Pennison M, 2007, CURR OPIN ONCOL, V19, P579, DOI 10.1097/CCO.0b013e3282f0ad0e; Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002	15	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158093	10.1371/journal.pone.0158093	http://dx.doi.org/10.1371/journal.pone.0158093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351864	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900031
J	An, QY; Wu, J; Fan, XS; Pan, LY; Sun, W				An, Qingyu; Wu, Jun; Fan, Xuesong; Pan, Liyang; Sun, Wei			Using a Negative Binomial Regression Model for Early Warning at the Start of a Hand Foot Mouth Disease Epidemic in Dalian, Liaoning Province, China	PLOS ONE			English	Article							SURVEILLANCE	Background The hand foot and mouth disease (HFMD) is a human syndrome caused by intestinal viruses like that coxsackie A virus 16, enterovirus 71 and easily developed into outbreak in kindergarten and school. Scientifically and accurately early detection of the start time of HFMD epidemic is a key principle in planning of control measures and minimizing the impact of HFMD. The objective of this study was to establish a reliable early detection model for start timing of hand foot mouth disease epidemic in Dalian and to evaluate the performance of model by analyzing the sensitivity in detectability. Methods The negative binomial regression model was used to estimate the weekly baseline case number of HFMD and identified the optimal alerting threshold between tested difference threshold values during the epidemic and non-epidemic year. Circular distribution method was used to calculate the gold standard of start timing of HFMD epidemic. Results From 2009 to 2014, a total of 62022 HFMD cases were reported (36879 males and 25143 females) in Dalian, Liaoning Province, China, including 15 fatal cases. The median age of the patients was 3 years. The incidence rate of epidemic year ranged from 137.54 per 100,000 population to 231.44 per 100,000 population, the incidence rate of non-epidemic year was lower than 112 per 100,000 population. The negative binomial regression model with AIC value 147.28 was finally selected to construct the baseline level. The threshold value was 100 for the epidemic year and 50 for the non-epidemic year had the highest sensitivity(100%) both in retrospective and prospective early warning and the detection time-consuming was 2 weeks before the actual starting of HFMD epidemic. Conclusions The negative binomial regression model could early warning the start of a HFMD epidemic with good sensitivity and appropriate detection time in Dalian.	[An, Qingyu; Wu, Jun; Fan, Xuesong; Pan, Liyang; Sun, Wei] Dalian Ctr Dis Control & Prevent, Dalian, Liaoning Provin, Peoples R China		An, QY (corresponding author), Dalian Ctr Dis Control & Prevent, Dalian, Liaoning Provin, Peoples R China.	anqingyu@163.com	qingyu, an/AAY-2102-2020; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; qingyu, an/0000-0001-7889-6968				An QY, 2015, SE ASIAN J TROP MED, V46, P285; An QingYu, 2014, Modern Preventive Medicine, V41, P3; Chen Ling, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P126, DOI 10.3969/j.issn.1672-7347.2012.02.002; Flor de Lima Barbara, 2013, BMC Res Notes, V6, P441, DOI 10.1186/1756-0500-6-441; Khan MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/710917; Li ZJ, 2014, B WORLD HEALTH ORGAN, V92, P656, DOI 10.2471/BLT.13.130666; Lu Y, 2014, STRAIT J PREV MED, V20, P19; Ming FH, 2007, NEURAL REGEN RES, V2, P532; Ministry of Health of the People's Republic of China, 2009, GUID HAND FOOT MOUTH; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Rafei A, 2012, IRAN J PUBLIC HEALTH, V41, P87; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119923; Xie ZhongHang, 2013, Disease Surveillance, V28, P839; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu Jiang, 2011, Occupation and Health, V27, P1019; Yang Hao, 2015, China Tropical Medicine, V15, P301; Zeng M, 2012, EPIDEMIOL INFECT, V140, P1122, DOI 10.1017/S0950268811001622; [张王剑 Zhang Wangjian], 2014, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V35, P607	20	3	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157815	10.1371/journal.pone.0157815	http://dx.doi.org/10.1371/journal.pone.0157815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348747	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200015
J	Park, B; Kim, J				Park, Boyoung; Kim, Jeongseon			Oral Contraceptive Use, Micronutrient Deficiency, and Obesity among Premenopausal Females in Korea: The Necessity of Dietary Supplements and Food Intake Improvement	PLOS ONE			English	Article							RETINOIC ACID; FREQUENCY; INDUCTION	This study addressed the associations between oral contraceptive (OC) use and obesity as measured by recording the body mass index (BMI) of premenopausal females, and possible interactions with micronutrient intake were considered. A group of 39,189 premenopausal females aged 35-59 were included in the analysis; they were in the Health Examinee cohort. Participant BMIs were calculated from anthropometric measurements, and females with a BMI >= 25kg/m(2) were considered obese. Individual OC use, age at first OC use, duration of OC use, nutrient intake, and other covariates were measured with a structured questionnaire. A multivariate logistic regression with an interaction term was applied to identify the odds ratio (OR) and 95% confidence intervals (CI) between OC use and obesity along with consideration of micronutrient intake interactions. OC use is associated with an increased risk of obesity (OR = 1.12, 95% CI = 1.04-1.20), and females who used OCs for more than 6 months over their lifetimes were more likely to be obese (OR = 1.15, 95% CI = 1.01-1.32) compared with those who used OCs for <6 months. There were interaction effects between phosphorus, potassium, vitamin A, vitamin B-1, vitamin B-2, niacin, vitamin C intake and total duration of OC use on being obesity (P-value<0.05). When stratified by micronutrient intake, the associations between total OC use duration and obesity were present only among those with calcium, phosphorus, potassium, vitamin A, B-1, B-2, C, niacin, and folate intakes below the recommended levels. Efforts to estimate nutrient intake and prevent micronutrient depletion with supplements or food should be considered by clinicians for females who take OC for a long period.	[Park, Boyoung; Kim, Jeongseon] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang Si, South Korea; [Park, Boyoung] Natl Canc Ctr, Canc Early Detect Branch, Div Canc Management Policy, Natl Canc Control Inst, Goyang Si, South Korea; [Kim, Jeongseon] Natl Canc Ctr, Mol Epidemiol Branch, Div Canc Epidemiol & Prevent, Res Inst, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, J (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang Si, South Korea.; Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Div Canc Epidemiol & Prevent, Res Inst, Goyang Si, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022		National Cancer Center of Korea [1410692-3, 1510040-1]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (No. 1410692-3 and 1510040-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Berenson AB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.052; de Melo NR, 2004, CONTRACEPTION, V70, P65, DOI 10.1016/j.contraception.2003.10.016; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Gallo M, 2014, COCHRANE DB SYST REV, P78; Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x; Gordis L., 2013, EPIDEMIOLOGY; Group HES, 2014, ASIAN PAC J CANCER P, V16, P1591; Kim HS, 2000, BIOCHEM BIOPH RES CO, V270, P76, DOI 10.1006/bbrc.2000.2373; Kimmons Joel E, 2006, MedGenMed, V8, P59; Korea Institute for Health and Social Welfare, 2012, 2012 NAT SURV FERT F; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055106; Menendez C, 2001, J ENDOCRINOL, V170, P425, DOI 10.1677/joe.0.1700425; OAKLEY D, 1991, FAM PLANN PERSPECT, V23, P150, DOI 10.2307/2135737; Obeid OA, 2013, OBES REV, V14, P659, DOI 10.1111/obr.12039; 변은경, 2005, Endocrinology and Metabolism, V20, P120; Oja P, 2010, BMC PUBLIC HEALTH, V10, DOI [10.1186/1471-2458-10-10, 10.1186/1471-2458-10-463]; Palmery M, 2013, EUR REV MED PHARMACO, V17, P1804; Picardo Carla M, 2003, J Am Med Womens Assoc (1972), V58, P112; ROSENBERG MJ, 1995, CONTRACEPTION, V51, P283, DOI 10.1016/0010-7824(95)00074-K; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Sung Y-A, 2010, END ABSTR, pP486; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; Via Michael, 2012, ISRN Endocrinol, V2012, P103472, DOI 10.5402/2012/103472; Westhoff CL, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.015; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wilson SMC, 2011, NUTR REV, V69, P572, DOI 10.1111/j.1753-4887.2011.00419.x; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zemel MB, 2004, AM J CLIN NUTR, V79, P907	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158177	10.1371/journal.pone.0158177	http://dx.doi.org/10.1371/journal.pone.0158177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348598	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200047
J	Gao, T; Chen, J; Shi, ZQ				Gao, Tao; Chen, Jian; Shi, Zhiqi			Fusarium graminearum pyruvate dehydrogenase kinase 1 (FgPDK1) Is Critical for Conidiation, Mycelium Growth, and Pathogenicity	PLOS ONE			English	Article							HEAD BLIGHT; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; ARABIDOPSIS-THALIANA; FUNGAL DEVELOPMENT; SYNTHASE GENE; WINTER-WHEAT; CARBENDAZIM; METABOLISM; RESISTANCE	Pyruvate dehydrogenase kinase (PDK) is an important mitochondrial enzyme that blocks the production of acetyl-CoA by selectively inhibiting the activity of pyruvate dehydrogenase (PDH) through phosphorylation. PDK is an effectively therapeutic target in cancer cells, but the physiological roles of PDK in phytopathogens are largely unknown. To address these gaps, a PDK gene (FgPDK1) was isolated from Fusarium graminearum that is an economically important pathogen infecting cereals. The deletion of FgPDK1 in F. graminearum resulted in the increase in PDH activity, coinciding with several phenotypic defects, such as growth retardation, failure in perithecia and conidia production, and increase in pigment formation. The Delta FgPDK1 mutants showed enhanced sensitivity to osmotic stress and cell membrane-damaging agent. Physiological detection indicated that reactive oxygen species (ROS) accumulation and plasma membrane damage (indicated by PI staining, lipid peroxidation, and electrolyte leakage) occurred in Delta FgPDK1 mutants. The deletion of FgPDK1 also prohibited the production of deoxynivalenol (DON) and pathogenicity of F. graminearum, which may resulted from the decrease in the expression of Tri6. Taken together, this study firstly identified the vital roles of FgPDK1 in the development of phytopathogen F. graminearum, which may provide a potentially novel clue for target-directed development of agricultural fungicides.	[Gao, Tao; Chen, Jian; Shi, Zhiqi] Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China; [Gao, Tao; Chen, Jian; Shi, Zhiqi] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Gao, Tao; Chen, Jian; Shi, Zhiqi] Minist Agr, Key Lab Control Technol & Stand Agroprod Safety &, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Chen, J; Shi, ZQ (corresponding author), Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China.; Chen, J; Shi, ZQ (corresponding author), State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Chen, J; Shi, ZQ (corresponding author), Minist Agr, Key Lab Control Technol & Stand Agroprod Safety &, Nanjing, Jiangsu, Peoples R China.	jacksonchen206@gmail.com; shizhiqi@jaas.ac.cn			National Natural Science Foundation of China [31501692]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (no. 31501692), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas A, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fov101; Belozerskaya TA, APPL BIOCH MICROBIOL, V43, P506; Chen CJ, 2007, PEST MANAG SCI, V63, P1201, DOI 10.1002/ps.1449; Chen Y, 2008, PHYTOPARASITICA, V36, P326, DOI 10.1007/BF02980812; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Duan YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep07094; Duan YB, 2013, PESTIC BIOCHEM PHYS, V106, P61, DOI 10.1016/j.pestbp.2013.04.004; FIRSTENCEL H, 1990, J INVERTEBR PATHOL, V55, P258, DOI 10.1016/0022-2011(90)90061-A; Gao T, 2014, FEMS MICROBIOL LETT, V351, P42, DOI 10.1111/1574-6968.12350; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Gu Q, 2015, NEW PHYTOL, V206, P315, DOI 10.1111/nph.13158; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; Hu LB, 2011, WATER AIR SOIL POLL, V217, P105, DOI 10.1007/s11270-010-0571-1; Hynes MJ, 2007, GENETICS, V176, P139, DOI 10.1534/genetics.107.070904; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Jiang JH, 2012, FUNGAL GENET BIOL, V49, P653, DOI 10.1016/j.fgb.2012.06.005; Kong WW, 2012, FUNGAL GENET BIOL, V49, P15, DOI 10.1016/j.fgb.2011.12.003; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li RJ, 2011, PLANT CELL REP, V30, P1533, DOI 10.1007/s00299-011-1066-2; Litsanov B, 2012, MICROB BIOTECHNOL, V5, P116, DOI [10.1111/j.1751-7915.2011.00310.x, 10.1111/j.1751-7915.2012.00347.x]; Liu SM, 2010, PEST MANAG SCI, V66, P482, DOI 10.1002/ps.1897; Maier FJ, 2005, FEMS YEAST RES, V5, P653, DOI 10.1016/j.femsyr.2004.12.008; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marillia EF, 2003, J EXP BOT, V54, P259, DOI 10.1093/jxb/erg020; Merhej J, 2011, APPL MICROBIOL BIOT, V91, P519, DOI 10.1007/s00253-011-3397-x; Nasmith CG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002266; Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195; Pereira RR, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov003; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PROCTOR RH, 1995, APPL ENVIRON MICROB, V61, P1923, DOI 10.1128/AEM.61.5.1923-1930.1995; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Qiu JB, 2011, PEST MANAG SCI, V67, P191, DOI 10.1002/ps.2050; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Shen CM, 2012, PLANT DIS, V96, P1172, DOI 10.1094/PDIS-11-11-0974-RE; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Steensma HY, 2008, YEAST, V25, P9, DOI 10.1002/yea.1543; Sun HY, 2014, AUSTRALAS PLANT PATH, V43, P631, DOI 10.1007/s13313-014-0309-4; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Suzuki Y, 2012, MOL MICROBIOL, V84, P942, DOI 10.1111/j.1365-2958.2012.08067.x; Thelen JJ, 2000, BIOCHEM J, V349, P195, DOI 10.1042/0264-6021:3490195; Weraduwage SM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00095; Yang Y, 2012, APPL ENVIRON MICROB, V78, P5845, DOI 10.1128/AEM.00218-12; Zhang LG, 2015, PLANT PATHOL, V64, P1014, DOI 10.1111/ppa.12339; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhang W, 2015, INT J BIOL SCI, V11, P1390, DOI 10.7150/ijbs.13325; Zhang YJ, 2009, PHYTOPATHOLOGY, V99, P95, DOI 10.1094/PHYTO-99-1-0095	53	15	16	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158077	10.1371/journal.pone.0158077	http://dx.doi.org/10.1371/journal.pone.0158077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341107	Green Submitted, gold, Green Published			2022-12-26	WOS:000378393600027
J	Papaioannou, AI; Kostikas, K; Manali, ED; Papadaki, G; Roussou, A; Spathis, A; Mazioti, A; Tomos, I; Papanikolaou, I; Loukides, S; Chainis, K; Karakitsos, P; Griese, M; Papiris, S				Papaioannou, Andriana I.; Kostikas, Konstantinos; Manali, Effrosyni D.; Papadaki, Georgia; Roussou, Aneza; Spathis, Aris; Mazioti, Argyro; Tomos, Ioannis; Papanikolaou, Ilias; Loukides, Stelios; Chainis, Kyriakos; Karakitsos, Petros; Griese, Matthias; Papiris, Spyros			Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)	PLOS ONE			English	Article							AIRWAY INFLAMMATION; SMOKING-CESSATION; LUNG SURFACTANT; DISEASE; MUTATIONS; COPD; BIOMARKERS; DIAGNOSIS; SURVIVAL; KL-6	Introduction Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients and their associations to disease severity and survival. Methods 122 consecutive patients (31 emphysema, 62 IPF, and 29 CPFE) and 25 healthy controls underwent PFTs, ABG-measurements, 6MWT and chest HRCT. Serum levels of SPs were measured. Patients were followed-up for 1-year. Results SP-A and SP-D levels differed between groups (p = 0.006 and p<0.001 respectively). In post-hoc analysis, SP-A levels differed only between controls and CPFE (p<0.05) and CPFE and emphysema (p<0.05). SP-D differed between controls and IPF or CPFE (p<0.001 for both comparisons). In IPF SP-B correlated to pulmonary function while SP-A, correlated to the Composite Physiological Index (CPI). Controls current smokers had higher SP-A and SP-D levels compared to non-smokers (p = 0.026 and p = 0.023 respectively). SP-D levels were higher in CPFE patients with extended emphysema (p = 0.042). In patients with IPF, SP-B levels at the upper quartile of its range (>= 26 ng/mL) presented a weak association with reduced survival (p = 0.05). Conclusion In conclusion, serum SP-A and SP-D levels were higher where fibrosis exists or coexists and related to disease severity, suggesting that serum SPs relate to alveolar damage in fibrotic lungs and may reflect either local overproduction or overleakage. The weak association between high levels of SP-B and survival needs further validation in clinical trials.	[Papaioannou, Andriana I.; Kostikas, Konstantinos; Manali, Effrosyni D.; Papadaki, Georgia; Roussou, Aneza; Tomos, Ioannis; Loukides, Stelios; Papiris, Spyros] Natl & Kapodistrian Univ Athens, Athens Med Sch, Attikon Univ Hosp, Resp Med Dept 2, Athens 11528, Greece; [Spathis, Aris; Karakitsos, Petros] Natl & Kapodistrian Univ Athens, Athens Med Sch, Attikon Univ Hosp, Dept Cytopathol, Athens 11528, Greece; [Mazioti, Argyro] Natl & Kapodistrian Univ Athens, Athens Med Sch, Attikon Univ Hosp, Dept Radiol, Athens 11528, Greece; [Papanikolaou, Ilias; Chainis, Kyriakos] Corfu Gen Hosp, Dept Resp Med, Corfu, Greece; [Griese, Matthias] Univ Munich, Hauner Childrens Univ Hosp, German Ctr Lung Res, Lindwurmstr 4, D-80337 Munich, Germany	National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; University of Munich	Papaioannou, AI (corresponding author), Natl & Kapodistrian Univ Athens, Athens Med Sch, Attikon Univ Hosp, Resp Med Dept 2, Athens 11528, Greece.	papaioannouandriana@gmail.com	Mazioti, Argyro/ABG-7794-2020; Spathis, Aris T/A-2442-2015; Tomos, Ioannis/ABF-9379-2020; PAPIRIS, SPYROS/AAD-1825-2020	Spathis, Aris T/0000-0001-8867-3661; Kostikas, Konstantinos/0000-0003-0774-3942; Papanikolaou, Ilias/0000-0003-1391-2925; Mazioti, Argyro/0000-0003-2705-5696	Greek State Scholarship Foundation	Greek State Scholarship Foundation(Greek Ministry of Development-GSRT)	The manuscript has been supported by the Greek State Scholarship Foundation -Fellowships of Excellence- Siemens.	Akella A, 2013, INDIAN J EXP BIOL, V51, P5; Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Baekvad-Hansen M, 2011, EUR RESPIR J, V37, P791, DOI 10.1183/09031936.00026410; Baekvad-Hansen M, 2010, RESP MED, V104, P418, DOI 10.1016/j.rmed.2009.10.012; Baekvad-Hansen M, 2010, AM J RESP CRIT CARE, V181, P17, DOI 10.1164/rccm.200906-0963OC; Barlo NP, 2009, SARCOIDOSIS VASC DIF, V26, P155; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chiba S, 2012, PULM MED, V2012, DOI 10.1155/2012/492960; Christmann U, 2009, J VET INTERN MED, V23, P227, DOI 10.1111/j.1939-1676.2008.0269.x; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Cottin V, 2011, AM J RESP CRIT CARE, V183, P1113, DOI 10.1164/ajrccm.183.8.1113; Cottin V, 2011, THORAX, V66, P918, DOI 10.1136/thx.2010.151407; Cottin V, 2011, ARTHRITIS RHEUM-US, V63, P295, DOI 10.1002/art.30077; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Daniil Z, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-81; Devendra G, 2002, RESPIR RES, V3, DOI 10.1186/rr168; Devine MS, 2012, CLIN CHEST MED, V33, P95, DOI 10.1016/j.ccm.2011.11.001; Dunbar AE, 2000, PEDIATR RES, V48, P275, DOI 10.1203/00006450-200009000-00003; Foreman MG, 2008, EUR RESPIR J, V32, P938, DOI 10.1183/09031936.00040208; Froese AR, 2016, AM J RESP CRIT CARE, V194, P84, DOI 10.1164/rccm.201508-1638OC; Greene KE, 2002, EUR RESPIR J, V19, P439, DOI 10.1183/09031936.02.00081102; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Guo X, 2001, EUR RESPIR J, V18, P482, DOI 10.1183/09031936.01.00043401; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Hinz Boris, 2012, Proc Am Thorac Soc, V9, P137, DOI 10.1513/pats.201202-017AW; Hogg JC, 2006, THORAX, V61, P96, DOI 10.1136/thx.2005.049502; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Ilumets H, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-19; Jaw JE, 2012, EXPERT REV RESP MED, V6, P147, DOI [10.1586/ERS.12.5, 10.1586/ers.12.5]; Kim HJ, 2010, CLIN EXP RHEUMATOL, V28, pS26; Kinder BW, 2009, CHEST, V135, P1557, DOI 10.1378/chest.08-2209; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kobayashi H, 2008, BIOMARKERS, V13, P385, DOI [10.1080/13547500801903651, 10.1080/13547500801903651 ]; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kropski JA, 2015, EUR RESPIR J, V45, P1717, DOI 10.1183/09031936.00163814; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; Lawson WE, 2004, THORAX, V59, P977, DOI 10.1136/thx.2004.026336; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; Lutz D, 2015, AM J RESP CELL MOL, V52, P232, DOI 10.1165/rcmb.2014-0078OC; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; MASON GR, 1983, CHEST, V83, P6, DOI 10.1378/chest.83.1.6; Matsuoka S, 2015, J COMPUT ASSIST TOMO, V39, P153, DOI 10.1097/RCT.0000000000000184; Mazur W, 2011, EUR RESPIR J, V38, P277, DOI 10.1183/09031936.00110510; Miller M, 2011, CHEST, V139, P1380, DOI 10.1378/chest.10-0705; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Ozyurek BA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-36; Papaioannou AI, 2010, RESP MED, V104, P275, DOI 10.1016/j.rmed.2009.09.016; Papiris SA, 2013, EXPERT REV RESP MED, V7, P19, DOI [10.1586/ERS.12.80, 10.1586/ers.12.80]; Park KJ, 1999, RADIOLOGY, V211, P541, DOI 10.1148/radiology.211.2.r99ma52541; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Samukawa T, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-55; Schmidt SL, 2011, EUR RESPIR J, V38, P176, DOI 10.1183/09031936.00114010; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P1109, DOI 10.1164/ajrccm.162.3.9910080; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904	71	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157789	10.1371/journal.pone.0157789	http://dx.doi.org/10.1371/journal.pone.0157789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337142	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200045
J	Blanchart, A; Fernando, R; Haring, M; Assaife-Lopes, N; Romanov, RA; Andang, M; Harkany, T; Ernfors, P				Blanchart, A.; Fernando, R.; Haring, M.; Assaife-Lopes, N.; Romanov, R. A.; Andang, M.; Harkany, T.; Ernfors, P.			Endogenous GAB(AA) receptor activity suppresses glioma growth	ONCOGENE			English	Article							INTEGRATED GENOMIC ANALYSIS; STEM-CELL; TUMOR PROGRESSION; INITIATING CELLS; SELF-RENEWAL; BRAIN-TUMORS; FACTOR-B; PDGF-B; GLIOBLASTOMA; GABA	Although genome alterations driving glioma by fueling cell malignancy have largely been resolved, less is known of the impact of tumor environment on disease progression. Here, we demonstrate functional GABAA receptor-activated currents in human glioblastoma cells and show the existence of a continuous GABA signaling within the tumor cell mass that significantly affects tumor growth and survival expectancy in mouse models. Endogenous GABA released by tumor cells, attenuates proliferation of the glioma cells with enriched expression of stem/progenitor markers and with competence to seed growth of new tumors. Our results suggest that GABA levels rapidly increase in tumors impeding further growth. Thus, shunting chloride ions by a maintained local GABAA receptor activity within glioma cells has a significant impact on tumor development by attenuating proliferation, reducing tumor growth and prolonging survival, a mechanism that may have important impact on therapy resistance and recurrence following tumor resection.	[Blanchart, A.; Fernando, R.; Haring, M.; Assaife-Lopes, N.; Harkany, T.; Ernfors, P.] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Scheeles VA, S-17177 Stockholm, Sweden; [Romanov, R. A.; Harkany, T.] Med Univ Vienna, Ctr Brain Res, Dept Mol Neurosci, Vienna, Austria; [Andang, M.] Karolinska Inst, Dept Physiol & Pharmacol Biophys Stem Cell & Tiss, Stockholm, Sweden; [Fernando, R.] Hop St Eloi, Inst Neurosci Montpellier, INSERM U1051, BP 74103, Montpellier, France	Karolinska Institutet; Medical University of Vienna; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Scheeles VA, S-17177 Stockholm, Sweden.	patrik.ernfors@ki.se	Romanov, Roman/J-2349-2015; Andäng, Michael/GRE-9898-2022	Romanov, Roman/0000-0002-3937-518X; Harkany, Tibor/0000-0002-6637-5900; Andang, Michael/0000-0002-2886-7891	Wallenberg Foundation; Swedish Research Council for Medicine and Health; Swedish Cancer Society grant; SFO grant; Swedish Brain Foundation; Wallenberg Scholar and Soderberg Foundation; ERC advanced grant [232675]; European Commission FP7 (Marie Curie Actions) [GA-2012-600394]; NovoNordisk Foundation; European Commission FP7 PAINCAGE grant; Alzheimers Research UK [ART-EG2009A-1] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010695, NNF15OC0015964, NNF17OC0027294] Funding Source: researchfish	Wallenberg Foundation(European Commission); Swedish Research Council for Medicine and Health; Swedish Cancer Society grant; SFO grant; Swedish Brain Foundation; Wallenberg Scholar and Soderberg Foundation; ERC advanced grant(European Research Council (ERC)); European Commission FP7 (Marie Curie Actions); NovoNordisk Foundation(Novo Nordisk Foundation); European Commission FP7 PAINCAGE grant; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Dr Lene Uhrbom for critically reading our manuscript and for kindly providing the Gtv-a/p19ARF WT and KO mice, Dr Jonas Frisen for kindly providing the Nestin: CrexRosa26LacZ and Helena Samuelsson for technical support, the CLICK Imaging Facility supported by the Wallenberg Foundation. This work was supported by the Swedish Research Council for Medicine and Health, the Swedish Cancer Society and SFO grants, the Swedish Brain Foundation, Wallenberg Scholar and Soderberg Foundation. ERC advanced grant (232675). RAR is an EMBO long-term research fellow (ALTF 596-2014) co-funded by the European Commission FP7 (Marie Curie Actions, EMBOCOFUND2012, GA-2012-600394), NovoNordisk Foundation, Swedish Brain Foundation and European Commission FP7 PAINCAGE grant to TH.	Andang M, 2008, NAT PROTOC, V3, P1013, DOI 10.1038/nprot.2008.65; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bleau AM, 2009, CELL CYCLE, V8, P2936; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carlen M, 2006, EXP CELL RES, V312, P2851, DOI 10.1016/j.yexcr.2006.05.012; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chandra D, 2010, NEUROPSYCHOPHARMACOL, V35, P999, DOI 10.1038/npp.2009.203; CURTIS DR, 1970, NATURE, V228, P676, DOI 10.1038/228676a0; D'Urso PI, 2012, INT J ONCOL, V41, P228, DOI 10.3892/ijo.2012.1420; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; KROGSGAARDLARSEN P, 1979, J NEUROCHEM, V32, P1717, DOI 10.1111/j.1471-4159.1979.tb02284.x; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Li SC, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-41; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Mares P, 2000, EPILEPSY RES, V42, P183, DOI 10.1016/S0920-1211(00)00179-0; Noble M, 2004, TRENDS NEUROSCI, V27, P148, DOI 10.1016/j.tins.2003.12.007; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Prestegarden L, 2010, CANCER RES, V70, P4274, DOI 10.1158/0008-5472.CAN-09-3904; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smits A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037041; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Synowitz M, 2001, EUR J NEUROSCI, V14, P1294, DOI 10.1046/j.0953-816x.2001.01764.x; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Terrile M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-550; Ueno S, 1997, J NEUROSCI, V17, P625; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 1998, CANCER RES, V58, P5275; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	55	37	37	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					777	786		10.1038/onc.2016.245	http://dx.doi.org/10.1038/onc.2016.245			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27375015				2022-12-26	WOS:000394168200005
J	Nguyen, HA; Su, Y; Lavie, A				Hien Anh Nguyen; Su, Ying; Lavie, Arnon			Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; enzyme kinetics; enzyme mutation; leukemia; structural biology; structure-function; substrate specificity	VIBRIO-SUCCINOGENES; ESCHERICHIA-COLI; DEPLETION; ENZYME; MECHANISM; CHILDREN; LEUKEMIA; THERAPY; INSIGHT; ASSAY	Current FDA-approved l-asparaginases also possess significant l-glutaminase activity, which correlates with many of the toxic side effects of these drugs. Therefore, l-asparaginases with reduced l-glutaminase activity are predicted to be safer. We exploited our recently described structures of the Erwinia chrysanthemil-asparaginase (ErA) to inform the design of mutants with diminished ability to hydrolyze l-glutamine. Structural analysis of these variants provides insight into the molecular basis for the increased l-asparagine specificity. A primary role is attributed to the E63Q mutation that acts to hinder the correct positioning of l-glutamine but not l-asparagine. The substitution of Ser-254 with either an asparagine or a glutamine increases the l-asparagine specificity but only when combined with the E63Q mutation. The A31I mutation reduces the substrate K-m value; this is a key property to allow the required therapeutic l-asparagine depletion. Significantly, an ultra-low l-glutaminase ErA variant maintained its cell killing ability. By diminishing the l-glutaminase activity of these highly active l-asparaginases, our engineered ErA variants hold promise as l-asparaginases with fewer side effects.	[Hien Anh Nguyen; Su, Ying; Lavie, Arnon] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Hien Anh Nguyen; Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavie, A (corresponding author), 900 South Ashland Ave,MBRB Rm 1108, Chicago, IL 60607 USA.	Lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722	DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013685] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001919] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Veterans Affairs(US Department of Veterans Affairs)	We appreciate the technical support of the staff at LS-CAT during data collection. We also thank Dr. Schalk for review of the manuscript. This research used the resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Aldoss I, 2016, EUR J HAEMATOL, V96, P375, DOI 10.1111/ejh.12600; Alsaid Y, 2013, CASE REP HEMATOL, V2013, DOI 10.1155/2013/841057; Alvarez OA, 2000, MED PEDIATR ONCOL, V34, P200, DOI 10.1002/(SICI)1096-911X(200003)34:3<200::AID-MPO7>3.0.CO;2-T; BERENBAUM MC, 1970, NATURE, V225, P550, DOI 10.1038/225550a0; Bhojwani D, 2014, EUR J CANCER, V50, P2685, DOI 10.1016/j.ejca.2014.06.023; Bushman JE, 2000, LEUKEMIA RES, V24, P559, DOI 10.1016/S0145-2126(00)00017-5; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; DISTASIO JA, 1982, INT J CANCER, V30, P343, DOI 10.1002/ijc.2910300314; DISTASIO JA, 1977, P SOC EXP BIOL MED, V155, P528; DURDEN DL, 1981, INT J CANCER, V27, P59, DOI 10.1002/ijc.2910270110; DURDEN DL, 1983, CANCER RES, V43, P1602; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; GELLA FJ, 1982, ANAL BIOCHEM, V127, P322; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; Nguyen HA, 2016, BIOCHEMISTRY-US, V55, P1246, DOI 10.1021/acs.biochem.5b01351; HOROWITZ B, 1968, SCIENCE, V160, P533, DOI 10.1126/science.160.3827.533; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KAFKEWITZ D, 1983, AM J CLIN NUTR, V37, P1025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Parmentier JH, 2015, LEUKEMIA RES, V39, P757, DOI 10.1016/j.leukres.2015.04.008; Payne JH, 2007, BRIT J HAEMATOL, V138, P430, DOI 10.1111/j.1365-2141.2007.06677.x; Raja RA, 2014, BRIT J HAEMATOL, V165, P126, DOI 10.1111/bjh.12733; Ramya LN, 2012, APPL BIOCHEM BIOTECH, V167, P2144, DOI 10.1007/s12010-012-9755-z; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Rizzari C, 2013, CURR OPIN ONCOL, V25, pS1, DOI 10.1097/CCO.0b013e32835d7d85; Salzer WL, 2014, ANN NY ACAD SCI, V1329, P81, DOI 10.1111/nyas.12496; Schalk AM, 2016, J BIOL CHEM, V291, P5088, DOI 10.1074/jbc.M115.699884; Schalk AM, 2014, J BIOL CHEM, V289, P33175, DOI 10.1074/jbc.M114.609552; Truelove E, 2013, LEUKEMIA, V27, P553, DOI 10.1038/leu.2012.290; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	35	41	46	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17664	17676		10.1074/jbc.M116.728485	http://dx.doi.org/10.1074/jbc.M116.728485			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27354283	hybrid, Green Published			2022-12-26	WOS:000383241300017
J	Junkunlo, K; Soderhall, K; Soderhall, I; Noonin, C				Junkunlo, Kingkamon; Soderhall, Kenneth; Soderhall, Irene; Noonin, Chadanat			Reactive Oxygen Species Affect Transglutaminase Activity and Regulate Hematopoiesis in a Crustacean	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; hematopoiesis; invertebrate; reactive oxygen species (ROS); transglutaminase	STEM-CELL FUNCTION; TISSUE TRANSGLUTAMINASE; INVERTEBRATE HEMATOPOIESIS; EXTRACELLULAR-MATRIX; DROSOPHILA LARVAE; OXIDATIVE STRESS; GROWTH-FACTORS; DIFFERENTIATION; PROGENITORS; PROLIFERATION	Reactive oxygen species (ROS) serve as a prime signal in the commitment to hematopoiesis in both mammals and Drosophila. In this study, the potential function of ROS during hematopoiesis in the crayfish Pacifastacus leniusculus was examined. The antioxidant N-acetylcysteine (NAC) was used to decrease ROS in both in vivo and in vitro experiments. An increase in ROS was observed in the anterior proliferation center (APC) after LPS injection. In the absence of NAC, the LPS-induced increase in ROS levels resulted in the rapid restoration of the circulating hemocyte number. In the presence of NAC, a delay in the recovery rate of the hemocyte number was observed. NAC treatment also blocked the spread of APC and other hematopoietic tissue (HPT) cells, maintaining these cells at an undifferentiated stage. Extracellular transglutaminase (TGase) has been shown previously to play a role in maintaining HPT cells in an undifferentiated form. In this study, we show that extracellular TGase activity increased when the ROS level in HPT or APC cells was reduced after NAC treatment. In addition, collagen, a major component of the extracellular matrix and a TGase substrate were co-localized on the HPT cell surface. Taken together, the results of this study show that ROS are involved in crayfish hematopoiesis, in which a low ROS level is required to maintain hematopoietic progenitor cells in the tissue and to reduce hemocyte release. The potential roles of TGase in this process are investigated and discussed.	[Junkunlo, Kingkamon; Soderhall, Kenneth; Soderhall, Irene; Noonin, Chadanat] Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden	Uppsala University	Noonin, C (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	chadanat.noonin@ebc.uu.se	Soderhall, Irene/AAS-5433-2020; Noonin, Chadanat/AAD-6269-2022		Swedish Science Research Council [VR 20114797, VR 621-2012-2418]	Swedish Science Research Council	This work was supported by Swedish Science Research Council, VR 20114797 (to I. S.) and VR 621-2012-2418 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Chaga Oleg, 1995, Animal Biology, V4, P59; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107768; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Gold KS, 2014, EXP HEMATOL, V42, P717, DOI 10.1016/j.exphem.2014.06.002; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Grigorian M, 2013, DEV BIOL, V384, P301, DOI 10.1016/j.ydbio.2013.03.007; Grigorian M, 2013, DEV GENES EVOL, V223, P103, DOI 10.1007/s00427-012-0428-2; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lin XH, 2010, J BIOL CHEM, V285, P28577, DOI 10.1074/jbc.M110.138560; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Lindner JR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-121; Liu HP, 2007, DEV COMP IMMUNOL, V31, P340, DOI 10.1016/j.dci.2006.07.007; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Monnier J, 2010, CANCER LETT, V296, P144, DOI 10.1016/j.canlet.2010.06.011; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Negri L, 2009, INT REV NEUROBIOL, V85, P145, DOI 10.1016/S0074-7742(09)85011-3; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Noonin C, 2012, STEM CELLS DEV, V21, P3173, DOI 10.1089/scd.2012.0077; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Piercy-Kotb SA, 2012, J CELL PHYSIOL, V227, P2936, DOI 10.1002/jcp.23040; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Small C, 2014, GENETICS, V197, P471, DOI 10.1534/genetics.113.159210; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2016, DEV COMP IMMUNOL, V58, P129, DOI 10.1016/j.dci.2015.12.009; Song SW, 2009, STEM CELLS, V27, P1358, DOI 10.1002/stem.47; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Wang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.318; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5	41	26	27	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17593	17601		10.1074/jbc.M116.741348	http://dx.doi.org/10.1074/jbc.M116.741348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339892	hybrid, Green Published			2022-12-26	WOS:000383241300011
J	Parra, LA; Baust, TB; Smith, AD; Jaumotte, JD; Zigmond, MJ; Torres, S; Leak, RK; Pino, JA; Torres, GE				Parra, Leonardo A.; Baust, Tracy B.; Smith, Amanda D.; Jaumotte, Juliann D.; Zigmond, Michael J.; Torres, Soledad; Leak, Rehana K.; Pino, Jose A.; Torres, Gonzalo E.			The Molecular Chaperone Hsc70 Interacts with Tyrosine Hydroxylase to Regulate Enzyme Activity and Synaptic Vesicle Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complex; dopamine; enzyme; protein targeting; synapse; Hsc70	VESICULAR MONOAMINE TRANSPORTER-2; ALPHA-SYNUCLEIN; GTP CYCLOHYDROLASE; DOPAMINE SYNTHESIS; FUNCTIONAL INTERACTION; PARKINSONS-DISEASE; CYTOSOLIC DOPAMINE; SUBSTANTIA-NIGRA; PROTEIN; BIOSYNTHESIS	We previously reported that the vesicular monoamine transporter 2 (VMAT2) is physically and functionally coupled with Hsc70 as well as with the dopamine synthesis enzymes tyrosine hydroxylase (TH) and aromatic amino acid decarboxylase, providing a novel mechanism for dopamine homeostasis regulation. Here we expand those findings to demonstrate that Hsc70 physically and functionally interacts with TH to regulate the enzyme activity and synaptic vesicle targeting. Co-immunoprecipitation assays performed in brain tissue and heterologous cells demonstrated that Hsc70 interacts with TH and aromatic amino acid decarboxylase. Furthermore, in vitro binding assays showed that TH directly binds the substrate binding and carboxyl-terminal domains of Hsc70. Immunocytochemical studies indicated that Hsc70 and TH co-localize in midbrain dopaminergic neurons. The functional significance of the Hsc70-TH interaction was then investigated using TH activity assays. In both dopaminergic MN9D cells and mouse brain synaptic vesicles, purified Hsc70 facilitated an increase in TH activity. Neither the closely related protein Hsp70 nor the unrelated Hsp60 altered TH activity, confirming the specificity of the Hsc70 effect. Overexpression of Hsc70 in dopaminergic MN9D cells consistently resulted in increased TH activity whereas knockdown of Hsc70 by short hairpin RNA resulted in decreased TH activity and dopamine levels. Finally, in cells with reduced levels of Hsc70, the amount of TH associated with synaptic vesicles was decreased. This effect was rescued by addition of purified Hsc70. Together, these data demonstrate a novel interaction between Hsc70 and TH that regulates the activity and localization of the enzyme to synaptic vesicles, suggesting an important role for Hsc70 in dopamine homeostasis.	[Parra, Leonardo A.; Baust, Tracy B.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Smith, Amanda D.; Jaumotte, Juliann D.; Zigmond, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Torres, Soledad] Univ Valparaiso, Ctr Invest & Modelamiento Fenomenos Aleatorios Va, Fac Engn, Valparaiso 2362905, Chile; [Leak, Rehana K.] Duquesne Univ, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA; [Pino, Jose A.; Torres, Gonzalo E.] Univ Florida, Dept Pharmacol & Therapeut, Coll Med, 1200 Newell Dr,ARB R5-252,POB 100267, Gainesville, FL 32610 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad de Valparaiso; Duquesne University; State University System of Florida; University of Florida	Torres, GE (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Coll Med, 1200 Newell Dr,ARB R5-252,POB 100267, Gainesville, FL 32610 USA.	gonzalotorres@ufl.edu	Pino, José/AAF-4359-2021; Leak, Rehana K./I-2607-2019	Pino, José/0000-0002-1542-0660; Leak, Rehana K./0000-0003-2817-7417; Parra Rivas, Leonardo/0000-0002-6707-1255	National Institutes of Health [DA038598]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant DA038598 (to G. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bowling KM, 2008, J BIOL CHEM, V283, P31449, DOI 10.1074/jbc.M802552200; Carlsson A, 1987, Adv Neurol, V45, P513; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; CHRISTENSON JG, 1972, P NATL ACAD SCI USA, V69, P343, DOI 10.1073/pnas.69.2.343; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Greengard P, 2001, BIOSCIENCE REP, V21, P247, DOI 10.1023/A:1013205230142; Guo JT, 2008, CELL MOL NEUROBIOL, V28, P35, DOI 10.1007/s10571-007-9227-0; Hastings TG, 1996, ADV EXP MED BIOL, V387, P97; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; Hinzpeter A, 2006, AM J PHYSIOL-CELL PH, V290, pC45, DOI 10.1152/ajpcell.00209.2005; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Meimaridou E, 2011, MOL ENDOCRINOL, V25, P1650, DOI 10.1210/me.2011-1020; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; Requena DF, 2009, J NEUROCHEM, V110, P581, DOI 10.1111/j.1471-4159.2009.06135.x; Roth Robert H., 1995, P227; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; SKAGERBERG G, 1984, BRAIN RES, V307, P99, DOI 10.1016/0006-8993(84)90465-7; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Ungewickell E, 1997, J BIOL CHEM, V272, P19594, DOI 10.1074/jbc.272.31.19594; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang Z, 2011, J NEUROCHEM, V119, P1294, DOI 10.1111/j.1471-4159.2011.07517.x; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	50	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17510	17522		10.1074/jbc.M116.728782	http://dx.doi.org/10.1074/jbc.M116.728782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365397	Green Published, hybrid			2022-12-26	WOS:000383241300003
J	Sato, A; Kamekura, R; Kawata, K; Kawada, M; Jitsukawa, S; Yamashita, K; Sato, N; Himi, T; Ichimiya, S				Sato, Akinori; Kamekura, Ryuta; Kawata, Koji; Kawada, Masaya; Jitsukawa, Sumito; Yamashita, Keiji; Sato, Noriyuki; Himi, Tetsuo; Ichimiya, Shingo			Novel Mechanisms of Compromised Lymphatic Endothelial Cell Homeostasis in Obesity: The Role of Leptin in Lymphatic Endothelial Cell Tube Formation and Proliferation	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; HEREDITARY LYMPHEDEMA; SOLUBLE RECEPTOR; EXPRESSION; IL-6; ANGIOGENESIS; IDENTIFICATION; INFLAMMATION; DYSFUNCTION	Leptin is a hormone produced by adipose tissue that regulates various physiological processes. Recent studies have shown that the level of circulating leptin is elevated in obese patients and have suggested a relationship between obesity and postoperative lymphedema. However, the mechanisms by which postoperative lymphedema develops in obese patients and the mechanisms by which leptin regulates lymphatic endothelial cell homeostasis such as tube formation and cell proliferation remain unknown. Here we report that leptin regulates tube formation and cell proliferation in human dermal lymphatic endothelial cells (HDLECs) by activation of the signal transducer and activator of transcription 3 pathway, which is downstream signaling of the leptin receptor. Additionally, we found that upregulation of suppressor of cytokine signaling 3 underlies the mechanisms by which a high dose of leptin inhibits cell proliferation and tube formation. Leptin also enhanced expression of the proinflammatory cytokine IL-6 in HDLECs. Interestingly, IL-6 rescues the compromised cell proliferation and tube formation caused by treatment with a high dose of leptin in an autocrine or paracrine manner. Taken together, our findings reveal a novel mechanism by which compromised HDLECs maintain their homeostasis during inflammation mediated by leptin and IL-6. Thus, regulating the level of leptin or IL-6 may be a viable strategy to reduce the incidence of postoperative lymphedema.	[Sato, Akinori; Kamekura, Ryuta; Kawata, Koji; Jitsukawa, Sumito; Yamashita, Keiji; Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan; [Sato, Akinori; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido, Japan; [Sato, Akinori; Kawada, Masaya] Tonan Hosp, KKR Sapporo Med Ctr, Div Breast Surg, Sapporo, Hokkaido, Japan; [Kamekura, Ryuta; Jitsukawa, Sumito; Yamashita, Keiji; Himi, Tetsuo] Sapporo Med Univ, Dept Otolaryngol, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Ichimiya, S (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan.	ichimiya@sapmed.ac.jp			GSK Japan Research Grant; Japanese Society for the Promotion of Science (JSPS) [26893213, 15K10787, 15K16399, 15K20214, 26861398, 26293370, 26670746, 26670178, 23590405]	GSK Japan Research Grant; Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the GSK Japan Research Grant (R.K.) and the Japanese Society for the Promotion of Science (JSPS) grants #26893213 and #15K10787 (R.K.), #15K16399 (A.S.), #15K20214 (K.K.), #26861398 (K.Y.), #26293370 and #26670746 (T.H.), #26670178 and #23590405 (S.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Basak S, 2012, EUR J OBSTET GYN R B, V164, P24, DOI 10.1016/j.ejogrb.2012.05.033; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Brorson Hakan, 2006, Lymphatic Research and Biology, V4, P199, DOI 10.1089/lrb.2006.4404; CASLEYS.J, 1961, Q J EXP PHYSIOL CMS, V46, P101, DOI 10.1113/expphysiol.1961.sp001502; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Corrigan CJ, 2011, P NATL ACAD SCI USA, V108, P1579, DOI 10.1073/pnas.1014241108; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fenton JI, 2006, CARCINOGENESIS, V27, P1507, DOI 10.1093/carcin/bgl018; Ferla R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-303; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Ji RC, 2005, HISTOL HISTOPATHOL, V20, P155, DOI 10.14670/HH-20.155; Kazmi A, 2013, J PAK MED ASSOC, V63, P245; Kim CY, 2014, J NUTR BIOCHEM, V25, P26, DOI 10.1016/j.jnutbio.2013.08.011; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kwan ML, 2010, ARCH SURG-CHICAGO, V145, P1055, DOI 10.1001/archsurg.2010.231; Laud K, 2002, MOL CELL ENDOCRINOL, V188, P219, DOI 10.1016/S0303-7207(01)00678-5; LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2; LealCerro A, 1996, HORM METAB RES, V28, P711, DOI 10.1055/s-2007-979884; Li J, 2006, DRUG DISCOV TODAY DI, V3, P387, DOI DOI 10.1016/J.DDMEC.2006.09.003; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; McLoughlin RM, 2004, J IMMUNOL, V172, P5676, DOI 10.4049/jimmunol.172.9.5676; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Ogata F, 2015, BRIT J DERMATOL, V172, P1286, DOI 10.1111/bjd.13482; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73; Paskett ED, 2007, CANCER EPIDEM BIOMAR, V16, P775, DOI 10.1158/1055-9965.EPI-06-0168; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Ridner SH, 2011, SUPPORT CARE CANCER, V19, P853, DOI 10.1007/s00520-011-1089-9; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rose D P, 2004, Obes Rev, V5, P153, DOI 10.1111/j.1467-789X.2004.00142.x; Rose DP, 2002, INT J ONCOL, V21, P1285; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x; Swenson KK, 2009, ONCOL NURS FORUM, V36, P185, DOI 10.1188/09.ONF.185-193; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Teramo A, 2013, BLOOD, V121, P3843, DOI 10.1182/blood-2012-07-441378; Wagoner B, 2006, AM J PHYSIOL-REG I, V290, pR1557, DOI 10.1152/ajpregu.00860.2005; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Yang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075551	55	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158408	10.1371/journal.pone.0158408	http://dx.doi.org/10.1371/journal.pone.0158408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366905	gold, Green Submitted, Green Published			2022-12-26	WOS:000378914900033
J	Carrier, M; Joint, M; Lutzing, R; Page, A; Rochette-Egly, C				Carrier, Marilyn; Joint, Mathilde; Lutzing, Regis; Page, Adeline; Rochette-Egly, Cecile			Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines	PLOS ONE			English	Article							RETINOIC ACID RECEPTORS; SIGNALING NETWORKS; RNA-SEQ; PHOSPHORYLATION; NUCLEAR; BINDING; ALPHA; DIFFERENTIATION; EXPRESSION; PROTEOMICS	Retinoic acid (RA), the main active vitamin A metabolite, controls multiple biological processes such as cell proliferation and differentiation through genomic programs and kinase cascades activation. Due to these properties, RA has proven anti-cancer capacity. Several breast cancer cells respond to the antiproliferative effects of RA, while others are RA-resistant. However, the overall signaling and transcriptional pathways that are altered in such cells have not been elucidated. Here, in a large-scale analysis of the phosphoproteins and in a genome-wide analysis of the RA-regulated genes, we compared two human breast cancer cell lines, a RA-responsive one, the MCF7 cell line, and a RA-resistant one, the BT474 cell line, which depicts several alterations of the "kinome". Using high-resolution nano-LC-LTQ-Orbitrap mass spectrometry associated to phosphopeptide enrichment, we found that several proteins involved in signaling and in transcription, are differentially phosphorylated before and after RA addition. The paradigm of these proteins is the RA receptor alpha (RAR alpha), which was phosphorylated in MCF7 cells but not in BT474 cells after RA addition. The panel of the RA-regulated genes was also different. Overall our results indicate that RA resistance might correlate with the deregulation of the phosphoproteome with consequences on gene expression.	[Carrier, Marilyn; Lutzing, Regis; Rochette-Egly, Cecile] Univ Strasbourg, Dept Funct Genom & Canc, INSERM, IGBMC,U964,CNRS,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France; [Joint, Mathilde; Page, Adeline] Univ Strasbourg, Prote Platform, INSERM, IGBMC,U964,CNRS,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France; [Carrier, Marilyn] Univ Montreal, Inst Rech Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Page, Adeline] IBCP, SFR Biosci, Prot Sci Facil, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montreal	Rochette-Egly, C (corresponding author), Univ Strasbourg, Dept Funct Genom & Canc, INSERM, IGBMC,U964,CNRS,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France.	cegly@igbmc.fr		Regis, Lutzing/0000-0002-9927-1825	CRE from the Agence Nationale pour la Recherche [ANR-09-BLAN-0297-01]; Association pour la recherche sur le Cancer [SL 220110603474, PJA20141201746]; Fondation pour la Recherche Medicale (FRM) [DEQ20090515423]; Institut National du Cancer [PL09-194]; ANR under the frame programme Investissements d'Avenir [ANR-10-IDEX-0002-02]; ARC; Canceropole Grand Est; Ligue nationale contre le cancer; CNRS, INSERM;  [ANR-10-LABX-0030-INRT]	CRE from the Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); ANR under the frame programme Investissements d'Avenir(French National Research Agency (ANR)); ARC(Australian Research Council); Canceropole Grand Est(Region Grand-Est); Ligue nationale contre le cancer(Ligue nationale contre le cancer); CNRS, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); 	This work was supported by funds from CNRS, INSERM and by funds raised by CRE from the Agence Nationale pour la Recherche (ANR-09-BLAN-0297-01, www.agence-nationale-recherche.fr), the Association pour la recherche sur le Cancer (SL 220110603474 and PJA20141201746, www.fondation-arc.org), the Fondation pour la Recherche Medicale (FRM, DEQ20090515423, www.frm.org), and the Institut National du Cancer (PL09-194, www.e-cancer.fr). It was also supported by ANR-10-LABX-0030-INRT, a French State fund managed by the ANR under the frame programme Investissements d'Avenir labeled ANR-10-IDEX-0002-02. ARC supported the acquisition of the Orbitrap mass spectrometer. The Canceropole Grand Est supported MJ. The Ligue nationale contre le cancer supported MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tanoury Z, 2014, J CELL SCI, V127, P2095, DOI 10.1242/jcs.145979; Al Tanoury Z, 2014, J CELL SCI, V127, P521, DOI 10.1242/jcs.131946; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Ali NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0437-3; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Dickhut C, 2014, J PROTEOME RES, V13, P2761, DOI 10.1021/pr401181y; Duong V, 2011, BBA-MOL BASIS DIS, V1812, P1023, DOI 10.1016/j.bbadis.2010.10.007; Engholm-Keller K, 2011, J PROTEOMICS, V75, P317, DOI 10.1016/j.jprot.2011.07.024; Fadloun A, 2008, ONCOGENE, V27, P477, DOI 10.1038/sj.onc.1210657; Ferry C, 2011, P NATL ACAD SCI USA, V108, P20603, DOI 10.1073/pnas.1102572108; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jones KA, 2013, J PROTEOME RES, V12, P4351, DOI 10.1021/pr400307u; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Kim BR, 2015, ONCOTARGET, V6, P31830, DOI 10.18632/oncotarget.5570; Lalevee S, 2010, METHODS MOL BIOL, V647, P251, DOI 10.1007/978-1-60761-738-9_15; Leitner A, 2011, ANAL CHIM ACTA, V703, P19, DOI 10.1016/j.aca.2011.07.012; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Piskunov A, 2014, SUBCELL BIOCHEM, V70, P103, DOI 10.1007/978-94-017-9050-5_6; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Tari AM, 2002, ONCOGENE, V21, P5224, DOI 10.1038/sj.onc.1205660; Tassy O, 2014, NUCLEIC ACIDS RES, V42, pD882, DOI 10.1093/nar/gkt807; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304	42	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157290	10.1371/journal.pone.0157290	http://dx.doi.org/10.1371/journal.pone.0157290			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362937	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200013
J	Jani, BD; Mair, FS; Roger, VL; Weston, SA; Jiang, RX; Chamberlain, AM				Jani, Bhautesh Dinesh; Mair, Frances S.; Roger, Veronique L.; Weston, Susan A.; Jiang, Ruoxiang; Chamberlain, Alanna M.			Comorbid Depression and Heart Failure: A Community Cohort Study	PLOS ONE			English	Article							MEDICAL-RECORDS LINKAGE; RISK PREDICTION MODELS; EVENT-FREE SURVIVAL; SOCIAL SUPPORT; HOSPITALIZED-PATIENTS; COGNITIVE THERAPY; OLDER PATIENTS; EPIDEMIOLOGY; SYMPTOMS; MORTALITY	Objective To examine the association between depression and clinical outcomes in heart failure (HF) in a community cohort. Patients and Methods HF patients in Minnesota, United States completed depression screening using the 9-item Patient Health Questionnaire (PHQ-9) between 1st Oct 2007 and 1st Dec 2011; patients with PHQ-9 >= 5 were labelled "depressed". We calculated the risk of death and first hospitalization within 2 years using Cox regression. Results were adjusted for 10 commonly used prognostic factors (age, sex, systolic blood pressure, estimated glomerular filtration rate, serum sodium, ejection fraction, blood urea nitrogen, brain natriuretic peptide, presence of diabetes and ischaemic aetiology). Area under the curve (AUC), integrated discrimination improvement (IDI) and net reclassification improvement (NRI) compared depression as a predictor against the aforementioned factors. Results 425 patients (mean age 74, 57.6% males) were included in the study; 179 (42.1%) had PHQ-9 >= 5. The adjusted hazard ratio of death was 2.02 (95% CI 1.34-3.04) and of hospitalization was 1.42 (95% CI 1.13-1.80) for those with compared to those without depression. Adding depression to the models did not appreciably change the AUC but led to statistically significant improvements in both the IDI (p = 0.001 and p = 0.005 for death and hospitalization, respectively) and NRI (for death and hospitalization, 35% (p = 0.002) and 27% (p = 0.007) were reclassified correctly, respectively). Conclusion Depression is frequent among community patients with HF and associated with increased risk of hospitalizations and death. Risk prediction for death and hospitalizations in HF patients can be improved by considering depression.	[Jani, Bhautesh Dinesh; Mair, Frances S.] Univ Glasgow, Inst Hlth & Wellbeing, Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Roger, Veronique L.; Weston, Susan A.; Jiang, Ruoxiang; Chamberlain, Alanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Roger, Veronique L.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	University of Glasgow; Mayo Clinic; Mayo Clinic	Chamberlain, AM (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA.	chamberlain.alanna@mayo.edu	Roger, Veronique/AAV-5951-2020	Chamberlain, Alanna/0000-0003-1888-9584; Mair, Frances/0000-0001-9780-1135; Jani, Bhautesh/0000-0001-7348-514X	NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG034676] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; [Anonymous], 2012, POPULATION ESTIMATES; Betihavas V, 2012, AUST CRIT CARE, V25, P31, DOI 10.1016/j.aucc.2011.07.004; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chung ML, 2013, QUAL LIFE RES, V22, P1555, DOI 10.1007/s11136-012-0294-4; Chung ML, 2013, HEART LUNG, V42, P85, DOI 10.1016/j.hrtlng.2012.12.003; Chung ML, 2011, HEART LUNG, V40, P492, DOI [10.1016/j.hrtlng.2010.08.001, 10.1016/j.hrtlng.2010.11.005]; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Cully JA, 2009, PRIM CARE COMPANION, V11, P103; Dekker RL, 2012, J CARD FAIL, V18, P10, DOI 10.1016/j.cardfail.2011.09.008; Dekker RL, 2011, HEART FAIL CLIN, V7, P127, DOI 10.1016/j.hfc.2010.10.001; Faris R, 2002, EUR J HEART FAIL, V4, P541, DOI 10.1016/S1388-9842(02)00101-0; Fraguas R, 2009, CONTEMP CLIN TRIALS, V30, P205, DOI 10.1016/j.cct.2009.01.007; Frasure-Smith N, 2009, CIRCULATION, V120, P134, DOI 10.1161/CIRCULATIONAHA.109.851675; Freedland KE, 2015, JAMA INTERN MED, V175, P1773, DOI 10.1001/jamainternmed.2015.5220; Fulop G, 2003, PSYCHOSOMATICS, V44, P367, DOI 10.1176/appi.psy.44.5.367; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Graven LJ, 2013, J CARDIOVASC NURS, V28, P429, DOI 10.1097/JCN.0b013e3182578b9d; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Health Quality Ontario, 2013, Ont Health Technol Assess Ser, V13, P1; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jiang W, 2011, AM J CARDIOL, V107, P545, DOI 10.1016/j.amjcard.2010.10.013; Joynt KE, 2004, J CARD FAIL, V10, P258, DOI 10.1016/j.cardfail.2003.09.008; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Koenig HG, 1998, GEN HOSP PSYCHIAT, V20, P29, DOI 10.1016/S0163-8343(98)80001-7; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; Nutter Andria L, 2010, Congest Heart Fail, V16, P196, DOI 10.1111/j.1751-7133.2010.00180.x; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Sullivan MJ, 2009, AM HEART J, V157, P84, DOI 10.1016/j.ahj.2008.08.033; Team RC, 2012, R LANG ENV STAT COMP; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	47	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158570	10.1371/journal.pone.0158570	http://dx.doi.org/10.1371/journal.pone.0158570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362359	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000378865200094
J	Prelog, M; Hilligardt, D; Schmidt, CA; Przybylski, GK; Leierer, J; Almanzar, G; El Hajj, N; Lesch, KP; Arolt, V; Zwanzger, P; Haaf, T; Domschke, K				Prelog, Martina; Hilligardt, Deborah; Schmidt, Christian A.; Przybylski, Grzegorz K.; Leierer, Johannes; Almanzar, Giovanni; El Hajj, Nady; Lesch, Klaus-Peter; Arolt, Volker; Zwanzger, Peter; Haaf, Thomas; Domschke, Katharina			Hypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder?	PLOS ONE			English	Article							REGULATORY T-CELLS; JUVENILE IDIOPATHIC ARTHRITIS; GENERALIZED ANXIETY DISORDER; CORONARY-HEART-DISEASE; TELOMERE LENGTH; THYMIC FUNCTION; TREG CELLS; LYMPHOCYTE SUBPOPULATIONS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES	Immunological abnormalities associated with pathological conditions, such as higher infection rates, inflammatory diseases, cancer or cardiovascular events are common in patients with panic disorder. In the present study, T cell receptor excision circles (TRECs), Fork-head-Box-Protein P3 gene (FOXP3) methylation of regulatory T cells (Tregs) and relative telomere lengths (RTLs) were investigated in a total and subsamples of 131 patients with panic disorder as compared to 131 age-and sex-matched healthy controls in order to test for a potential dysfunction and premature aging of the immune system in anxiety disorders. Significantly lower TRECs (p = 0.004) as well as significant hypermethylation of the FOXP3 promoter region (p = 0.005) were observed in female (but not in male) patients with panic disorder as compared to healthy controls. No difference in relative telomere length was discerned between patients and controls, but significantly shorter telomeres in females, smokers and older persons within the patient group. The presently observed reduced TRECs in panic disorder patients and FOXP3 hypermethylation in female patients with panic disorder potentially reflect impaired thymus and immunosuppressive Treg function, which might partly account for the known increased morbidity and mortality of anxiety disorders conferred by e.g. cancer and cardiovascular disorders.	[Prelog, Martina; Hilligardt, Deborah; Almanzar, Giovanni] Univ Hosp Wuerzburg, Dept Pediat, Wurzburg, Germany; [Schmidt, Christian A.; Przybylski, Grzegorz K.] Ernst Moritz Arndt Univ Greifswald, Clin Internal Med C, Greifswald, Germany; [Przybylski, Grzegorz K.] Polish Acad Sci, Inst Human Genet, Poznan, Poland; [Leierer, Johannes] Med Univ Innsbruck, Dept Internal Med, Innsbruck, Austria; [El Hajj, Nady; Haaf, Thomas] Univ Wurzburg, Inst Human Genet, Wurzburg, Germany; [Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Mol Psychiat, Wurzburg, Germany; [Arolt, Volker; Zwanzger, Peter] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Zwanzger, Peter] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Zwanzger, Peter] Kbo Inn Salzach Klinikum, Wasserburg, Germany; [Domschke, Katharina] Univ Hosp Wuerzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany	University of Wurzburg; Ernst Moritz Arndt Universitat Greifswald; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Medical University of Innsbruck; University of Wurzburg; University of Wurzburg; University of Munster; University of Munich; University of Wurzburg	Prelog, M (corresponding author), Univ Hosp Wuerzburg, Dept Pediat, Wurzburg, Germany.	Prelog_M@ukw.de	Almanzar, Giovanni/H-4725-2018; Lesch, Klaus-Peter/J-4906-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Leierer, Johannes/0000-0002-7884-9827; Przybylski, Grzegorz/0000-0001-5783-1567; El Hajj, Nady/0000-0003-3420-8531	Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR-58]; Bavarian Innovation Fond	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bavarian Innovation Fond	This paper was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; SFB-TRR-58, projects C02 to KD and KPL, and A05 to KPL) and the Bavarian Innovation Fond to MP.	Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; Almanzar G, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-57; Appay V, 2010, AGING-US, V2, P78, DOI 10.18632/aging.100122; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brennan AM, 2009, DIABETES CARE, V32, P926, DOI 10.2337/dc08-1979; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chalan Paulina, 2015, Curr Aging Sci, V8, P131; Cribbs AP, 2015, ARTHRITIS RHEUMATOL, V67, P1182, DOI 10.1002/art.39031; Dai RJ, 2014, THER CLIN RISK MANAG, V10, P151, DOI 10.2147/TCRM.S33517; Dalton VS, 2014, J AFFECT DISORDERS, V155, P1, DOI 10.1016/j.jad.2013.10.028; Denollet J, 2009, J CLIN EPIDEMIOL, V62, P452, DOI 10.1016/j.jclinepi.2008.08.006; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Duclot F, 2015, J EXP BIOL, V218, P21, DOI 10.1242/jeb.107086; Ferreira TB, 2011, J NEUROIMMUNOL, V238, P58, DOI 10.1016/j.jneuroim.2011.06.009; Garg SK, 2014, AGING CELL, V13, P441, DOI 10.1111/acel.12191; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Gimsa U, 2012, CYTOKINE, V59, P72, DOI 10.1016/j.cyto.2012.04.001; Goodwin RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-878; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Harpaz I, 2013, EUR J IMMUNOL, V43, P758, DOI 10.1002/eji.201242613; Harris JM, 2005, CLIN IMMUNOL, V115, P138, DOI 10.1016/j.clim.2004.12.008; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hoen PW, 2013, PSYCHOL MED, V43, P689, DOI 10.1017/S0033291712001766; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Hong M, 2013, NEUROIMMUNOMODULAT, V20, P39, DOI 10.1159/000343100; Irie M, 2006, ATHEROSCLEROSIS, V185, P320; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jia L, 2013, ATHEROSCLEROSIS, V228, P346, DOI 10.1016/j.atherosclerosis.2013.01.027; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kennedy A, 2014, EUR J IMMUNOL, V44, P2968, DOI 10.1002/eji.201444453; Kiecolt-Glaser JK, 2013, BRAIN BEHAV IMMUN, V34, P29, DOI 10.1016/j.bbi.2013.08.004; Kim S, 2012, IEEE INT SYMP INTELL, P7, DOI 10.1109/ISIC.2012.6398252; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; LaVia MF, 1996, PSYCHOSOM MED, V58, P138, DOI 10.1097/00006842-199603000-00007; Li XD, 2015, TRENDS IMMUNOL, V36, P344, DOI 10.1016/j.it.2015.04.006; Manfro GG, 2003, ARQ NEURO-PSIQUIAT, V61, P20, DOI 10.1590/S0004-282X2003000100004; Mayerl C, 2012, AUTOIMMUN REV, V11, P297, DOI 10.1016/j.autrev.2010.02.015; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nielsen CH, 2016, ARCH TOXICOL, V90, P231, DOI 10.1007/s00204-014-1426-0; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Prelog M, 2006, AUTOIMMUN REV, V5, P136, DOI 10.1016/j.autrev.2005.09.008; Prelog M, 2008, ARTHRITIS RHEUM-US, V58, P2153, DOI 10.1002/art.23599; Prelog Martina, 2011, Current Immunology Reviews, V7, P116, DOI 10.2174/157339511794474299; Rainbow DB, 2015, EUR J IMMUNOL, V45, P3200, DOI 10.1002/eji.201545646; Roberts S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.83; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Rubtsova K, 2015, J CLIN INVEST, V125, P2187, DOI 10.1172/JCI78082; Sahin M, 2013, HUM IMMUNOL, V74, P1061, DOI 10.1016/j.humimm.2013.05.009; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Shalev I, 2014, MOL PSYCHIATR, P1; Takahashi R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/943149; Thiel A, 2008, ACTA HAEMATOL-BASEL, V119, P22, DOI 10.1159/000117824; Tone M, 2011, NAT IMMUNOL, V12, P14, DOI 10.1038/ni0111-14; Vieira MMM, 2010, J NEUROIMMUNOL, V229, P212, DOI 10.1016/j.jneuroim.2010.07.018; Viveros MP, 2007, NEUROIMMUNOMODULAT, V14, P157, DOI 10.1159/000110640; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	68	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157930	10.1371/journal.pone.0157930	http://dx.doi.org/10.1371/journal.pone.0157930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362416	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200029
J	Tsuchida, J; Matsusaka, T; Ohtsuka, M; Miura, H; Okuno, Y; Asanuma, K; Nakagawa, T; Yanagita, M; Mori, K				Tsuchida, Junichi; Matsusaka, Taiji; Ohtsuka, Masato; Miura, Hiromi; Okuno, Yukiko; Asanuma, Katsuhiko; Nakagawa, Takahiko; Yanagita, Motoko; Mori, Kiyoshi			Establishment of Nephrin Reporter Mice and Use for Chemical Screening	PLOS ONE			English	Article							VITAMIN-D; TARGETED TRANSGENESIS; DIABETIC-NEPHROPATHY; GLOMERULAR SCLEROSIS; PODOCYTE; MOUSE; INJURY; EXPRESSION; DISEASE	Nephrin is a critical component of glomerular filtration barrier, which is important to maintain glomerular structure and avoid proteinuria. Downregulation of nephrin expression is commonly observed at early stage of glomerular disorders, suggesting that methods to increase nephrin expression in podocytes may have therapeutic utility. Here, we generated a knockin mouse line carrying single copy of 5.5 kb nephrin promoter controlling expression of enhanced green fluorescent protein (EGFP) at Rosa26 genomic locus (Nephrin-EGFP mouse). In these mice, EGFP was specifically expressed in podocytes. Next, we isolated and cultivated glomeruli from these mice, and developed a protocol to automatically quantitate EGFP expression in cultured glomeruli. EGFP signal was markedly reduced after 5 days of culture but reduction was inhibited by vitamin D treatment. We confirmed that vitamin D increased mRNA and protein expression of endogenous nephrin in cultivated glomeruli. Thus, we generated a mouse line converting nephrin promoter activity into fluorescence, which can be used to screen compounds having activity to enhance nephrin gene expression.	[Tsuchida, Junichi; Asanuma, Katsuhiko; Nakagawa, Takahiko; Yanagita, Motoko; Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TMK Project, Kyoto, Japan; [Tsuchida, Junichi] Mitsubishi Tanabe Pharma Corp, Innovat Res Div, Res Unit Nephrol & Endocrinol Sci, Toda, Saitama, Japan; [Matsusaka, Taiji; Ohtsuka, Masato; Miura, Hiromi] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Matsusaka, Taiji; Ohtsuka, Masato; Miura, Hiromi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa, Japan; [Okuno, Yukiko] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Kyoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Mori, Kiyoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka, Japan; [Mori, Kiyoshi] Shizuoka Prefectural Gen Hosp, Dept Nephrol & Kidney Res, Shizuoka, Japan	Kyoto University; Mitsubishi Tanabe Pharma Corporation; Tokai University; Tokai University; Kyoto University; Kyoto University; University of Shizuoka; Shizuoka General Hospital	Mori, K (corresponding author), Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TMK Project, Kyoto, Japan.; Mori, K (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka, Japan.; Mori, K (corresponding author), Shizuoka Prefectural Gen Hosp, Dept Nephrol & Kidney Res, Shizuoka, Japan.	mori@tmk.med.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351; Yanagita, Motoko/0000-0002-0339-9008; Tsuchida, Junichi/0000-0003-1010-4084; Ohtsuka, Masato/0000-0002-6952-4238	Mitsubishi Tanabe Pharma Corporation (MTPC); Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23700514]; Takeda Science Foundation; Tokai University School of Medicine; MTPC; Ministry of Education, Culture, Sports, Science and Technology, Japan	Mitsubishi Tanabe Pharma Corporation (MTPC); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokai University School of Medicine; MTPC; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research fund from Mitsubishi Tanabe Pharma Corporation (MTPC, KM), by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (KM, TM), by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, MO, 23700514), by Takeda Science Foundation (MO), and by 2011-2012 Tokai University School of Medicine, Project Research to M.O. MTPC provided support in the form of salaries for authors JT, KA, TN, and KM, but MTPC and other funders did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to RIKEN BioResource Center (a participant in the National BioResource Project of the MEXT, Japan) for providing FLPe mice. We also thank staffs of Support Center for Medical Research and Education, Tokai University for sequencing and generation of Tg mice. Screening compounds were kindly provided from Medical Research Support Center, Graduate School of Medicine, Kyoto University, which was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also thank C. Nakano, Y. Ogawa and other lab members in TMK Project for technical assistance.	Asano T, 2005, J AM SOC NEPHROL, V16, P2257, DOI 10.1681/ASN.2004121134; Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Da Sacco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081812; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Garsen M, 2015, J PATHOL, V237, P472, DOI 10.1002/path.4593; Itoh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106621; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Katsuya K, 2006, KIDNEY INT, V69, P2101, DOI 10.1038/sj.ki.5000398; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Lee HW, 2015, J AM SOC NEPHROL, V26, P2741, DOI 10.1681/ASN.2014090859; Matsui I, 2009, NEPHROL DIAL TRANSPL, V24, P2354, DOI 10.1093/ndt/gfp117; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Ohtsuka M, 2014, METHODS MOL BIOL, V1194, P3, DOI 10.1007/978-1-4939-1215-5_1; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; SATRIANO JA, 1993, J IMMUNOL, V150, P1971; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; Wanner N, 2014, J AM SOC NEPHROL, V25, P707, DOI 10.1681/ASN.2013050452; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157497	10.1371/journal.pone.0157497	http://dx.doi.org/10.1371/journal.pone.0157497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362433	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200018
J	Dunham, Y; Dotsch, R; Clark, AR; Stepanova, EV				Dunham, Yarrow; Dotsch, Ron; Clark, Amelia R.; Stepanova, Elena V.			The Development of White-Asian Categorization: Contributions from Skin Color and Other Physiognomic Cues	PLOS ONE			English	Article							RACIAL PREFERENCE; RACE FACES; PRESCHOOL; IDENTIFICATION; PERCEPTION; IDENTITY; CHILDREN; MEMORY; BLACK; SHAPE	We examined the development of racial categorizations of faces spanning the European-East Asian ("White-Asian") categorical continuum in children between the ages of four and nine as well as adults. We employed a stimulus set that independently varied skin color and other aspects of facial physiognomy, allowing the contribution of each to be assessed independently and in interaction with each other. Results demonstrated substantial development across this age range in children's ability to draw on both sorts of cue, with over twice as much variance explained by stimulus variation in adults than children. Nonetheless, children were clearly sensitive to both skin color and other aspects of facial physiognomy, suggesting that understanding of the White-Asian category boundary develops in a somewhat different way than understanding of the White-Black category boundary, in which attention to features other than skin color appear only somewhat later. Discussion focuses on the implications of these findings for theories of social categorization.	[Dunham, Yarrow; Clark, Amelia R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Dotsch, Ron] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Stepanova, Elena V.] Univ So Mississippi, Dept Psychol, Hattiesburg, MS 39406 USA	Yale University; Utrecht University; University of Southern Mississippi	Dunham, Y (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	yarrow.dunham@yale.edu	Stepanova, Elena/AAG-8183-2019	Stepanova, Elena/0000-0003-2447-9717				Anzures G, 2013, VISUAL COGNITIO 0805, P1; Balas B, 2015, J EXP CHILD PSYCHOL, V130, P56, DOI 10.1016/j.jecp.2014.09.009; Balas B, 2011, DEVELOPMENTAL SCI, V14, P892, DOI 10.1111/j.1467-7687.2011.01039.x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Bryk A. S., 1992, HIERARCHICAL LINEAR; Chen JM, 2012, J EXP SOC PSYCHOL, V48, P152, DOI 10.1016/j.jesp.2011.10.005; Clark KB, 1918, RACIAL IDENTIFICATIO; Cogsdill EJ, 2014, PSYCHOL SCI, V25, P1132, DOI 10.1177/0956797614523297; Corneille O, 2004, J PERS SOC PSYCHOL, V86, P236, DOI 10.1037/0022-3514.86.2.236; Craig BM, 2012, EMOTION, V12, P1303, DOI 10.1037/a0028622; CROOKS RC, 1970, J SOC ISSUES, V26, P137, DOI 10.1111/j.1540-4560.1970.tb01747.x; Dunham Y, 2013, CATEGORIES EXEMPLARS, P275; Dunham Y, 2015, DEVELOPMENTAL SCI, V18, P469, DOI 10.1111/desc.12228; Dyck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003628; Gaither SE, 2015, CURR DIR PSYCHOL SCI, V24, P114, DOI 10.1177/0963721414558115; Gelman A., 2007, DATA ANAL USING REGR; Guerrero S, 2010, COGNITIVE DEV, V25, P79, DOI 10.1016/j.cogdev.2009.07.001; Halberstadt J, 2011, PSYCHOL SCI, V22, P29, DOI 10.1177/0956797610390383; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; HIRSCHFELD LA, 1993, COGNITIVE PSYCHOL, V25, P317, DOI 10.1006/cogp.1993.1008; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; HRABA J, 1970, J PERS SOC PSYCHOL, V16, P398, DOI 10.1037/h0030043; Johnson KL, 2012, J PERS SOC PSYCHOL, V102, P116, DOI 10.1037/a0025335; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; LEYENS JP, 1992, EUR J SOC PSYCHOL, V22, P549, DOI 10.1002/ejsp.2420220604; Montague DPF, 2001, DEV PSYCHOL, V37, P826, DOI 10.1037//0012-1649.37.6.826; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pauker K, 2015, CHILD DEV PERSPECTIV; Pauker K, 2009, J SOC ISSUES, V65, P69, DOI 10.1111/j.1540-4560.2008.01588.x; RICE AS, 1974, J CROSS CULT PSYCHOL, V5, P100, DOI 10.1177/002202217400500107; Roesch EB, 2011, J NONVERBAL BEHAV, V35, P1, DOI 10.1007/s10919-010-0095-9; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Stepanova EV, 2012, J EXPT SOCIAL PSYCHO, P1; Strom MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041193; Todorov A, 2013, EMOTION	37	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158211	10.1371/journal.pone.0158211	http://dx.doi.org/10.1371/journal.pone.0158211			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355683	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400038
J	Kakuda, T; Shojo, H; Tanaka, M; Nambiar, P; Minaguchi, K; Umetsu, K; Adachi, N				Kakuda, Tsuneo; Shojo, Hideki; Tanaka, Mayumi; Nambiar, Phrabhakaran; Minaguchi, Kiyoshi; Umetsu, Kazuo; Adachi, Noboru			Multiplex APLP System for High-Resolution Haplogrouping of Extremely Degraded East-Asian Mitochondrial DNAs	PLOS ONE			English	Article							LENGTH POLYMORPHISM ANALYSIS; NATIVE-AMERICAN HAPLOGROUPS; PHYLOGENETIC ANALYSIS; JOMON SKELETONS; CONTROL REGION; HAN CHINESE; LINEAGES; SEQUENCE; POPULATIONS; DIVERSITY	Mitochondrial DNA (mtDNA) serves as a powerful tool for exploring matrilineal phylogeo-graphic ancestry, as well as for analyzing highly degraded samples, because of its polymorphic nature and high copy numbers per cell. The recent advent of complete mitochondrial genome sequencing has led to improved techniques for phylogenetic analyses based on mtDNA, and many multiplex genotyping methods have been developed for the hierarchical analysis of phylogenetically important mutations. However, few high-resolution multiplex genotyping systems for analyzing East-Asian mtDNA can be applied to extremely degraded samples. Here, we present a multiplex system for analyzing mitochondrial single nucleotide polymorphisms (mtSNPs), which relies on a novel amplified product-length polymorphisms (APLP) method that uses inosine-flapped primers and is specifically designed for the detailed haplogrouping of extremely degraded East-Asian mtDNAs. We used fourteen 6-plex polymerase chain reactions (PCRs) and subsequent electrophoresis to examine 81 haplogroup-defining SNPs and 3 insertion/deletion sites, and we were able to securely assign the studied mtDNAs to relevant haplogroups. Our system requires only 1x10(-13) g (100 fg) of crude DNA to obtain a full profile. Owing to its small amplicon size (< 110 bp), this new APLP system was successfully applied to extremely degraded samples for which direct sequencing of hypervariable segments using mini-primer sets was unsuccessful, and proved to be more robust than conventional APLP analysis. Thus, our new APLP system is effective for retrieving reliable data from extremely degraded East-Asian mtDNAs.	[Kakuda, Tsuneo; Shojo, Hideki; Tanaka, Mayumi; Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, 1110 Shimokato, Yamanashi 4093898, Japan; [Nambiar, Phrabhakaran] Univ Malaya, Fac Dent, Dept Gen Dent Practice & Oral & Maxillofacial Ima, Kuala Lumpur 50603, Malaysia; [Minaguchi, Kiyoshi] Tokai Univ, Sch Med, Dept Forens Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Umetsu, Kazuo] Yamagata Univ, Fac Med, Dept Forens Med, 2-2-2 Iida Nishi, Yamagata 9902331, Japan	University of Yamanashi; Universiti Malaya; Tokai University; Yamagata University	Adachi, N (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, 1110 Shimokato, Yamanashi 4093898, Japan.	nadachi@yamanashi.ac.jp	NAMBIAR, PHRABHAKARAN K N/B-9495-2010		Japan Society for the Promotion of Science [26440257, 25251043, 16H01954]; JSPS Core "Advanced Core Research Center for the History of Human Ecology in the North."; Grants-in-Aid for Scientific Research [25251043] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Core "Advanced Core Research Center for the History of Human Ecology in the North."; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 26440257, 25251043, 16H01954), and JSPS Core to Core Program (Advanced Research Networks) "Advanced Core Research Center for the History of Human Ecology in the North."	Adachi N, 2004, J ARCHAEOL SCI, V31, P1339, DOI 10.1016/j.jas.2004.02.011; Adachi N, 2013, DNA POLYM, V21, P130; Adachi N, 2014, LEGAL MED-TOKYO, V16, P52, DOI 10.1016/j.legalmed.2013.10.001; Adachi N, 2013, ANTHROPOL SCI, V121, P137, DOI 10.1537/ase.130313; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Adachi N, 2009, AM J PHYS ANTHROPOL, V138, P255, DOI 10.1002/ajpa.20923; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ballantyne KN, 2012, FORENSIC SCI INT-GEN, V6, P425, DOI 10.1016/j.fsigen.2011.08.010; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Coutinho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093292; Delfin F, 2014, EUR J HUM GENET, V22, P228, DOI 10.1038/ejhg.2013.122; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Lee HY, 2013, LEGAL MED-TOKYO, V15, P50, DOI 10.1016/j.legalmed.2012.08.002; Lee HY, 2006, ELECTROPHORESIS, V27, P4408, DOI 10.1002/elps.200600151; Maruyama S, 2010, INT J LEGAL MED, V124, P165, DOI 10.1007/s00414-009-0355-6; Maruyama S, 2003, INT J LEGAL MED, V117, P218, DOI 10.1007/s00414-003-0379-2; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Ren Z, 2015, ELECTROPHORESIS, V36, P633, DOI 10.1002/elps.201400396; Sato T, 2009, ANTHROPOL SCI, V117, P171, DOI 10.1537/ase.081202; Sekiguchi Kazumasa, 2008, Legal Medicine, V10, P284, DOI 10.1016/j.legalmed.2008.02.002; Shinoda K, 2006, AM J PHYS ANTHROPOL, V131, P98, DOI 10.1002/ajpa.20408; Shinoda Ken-ichi, 2014, Bulletin of the National Science Museum Series D (Anthropology), V40, P1; Shojo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136995; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Sukernik RI, 2012, AM J PHYS ANTHROPOL, V148, P123, DOI 10.1002/ajpa.22050; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Umetsu K, 2001, ELECTROPHORESIS, V22, P3533, DOI 10.1002/1522-2683(200109)22:16<3533::AID-ELPS3533>3.0.CO;2-S; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; van Oven Mannis, 2011, Investig Genet, V2, P6, DOI 10.1186/2041-2223-2-6; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	34	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158463	10.1371/journal.pone.0158463	http://dx.doi.org/10.1371/journal.pone.0158463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355212	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400070
J	Kanaan, SB; Onat, OE; Balandraud, N; Martin, GV; Nelson, JL; Azzouz, DF; Auger, I; Arnoux, F; Martin, M; Roudier, J; Ozcelik, T; Lambert, NC				Kanaan, Sami B.; Onat, Onur E.; Balandraud, Nathalie; Martin, Gabriel V.; Nelson, J. Lee; Azzouz, Doua F.; Auger, Isabelle; Arnoux, Fanny; Martin, Marielle; Roudier, Jean; Ozcelik, Tayfun; Lambert, Nathalie C.			Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis	PLOS ONE			English	Article							SHARED EPITOPE; FEMALE PREDISPOSITION; DISEASE SEVERITY; PREDICTIVE-VALUE; SCLERODERMA; AUTOIMMUNITY; ASSOCIATION; ANTIBODIES; WOMEN; MEN	Background Autoimmune diseases, including rheumatoid arthritis (RA) and systemic sclerosis (SSc) are characterized by a strong genetic susceptibility from the Human Leucocyte Antigen (HLA) locus. Additionally, disorders of epigenetic processes, in particular non-random X chromosome inactivation (XCI), have been reported in many female-predominant autoimmune diseases. Here we test the hypothesis that women with RA or SSc who are strongly genetically predisposed are less susceptible to XCI bias. Methods Using methylation sensitive genotyping of the androgen receptor (AR) gene, XCI profiles were performed in peripheral blood mononuclear cells from 161 women with RA, 96 women with SSc and 100 healthy women. HLA-DRB1 and DQB1 were genotyped. Presence of specific autoantibodies was documented for patients. XCI skewing was defined as having a ratio >= 80:20 of cells inactivating the same X chromosome. Results 110 women with RA, 68 women with SSc, and 69 controls were informative for the AR polymorphism. Among them 40.9% of RA patients and 36.8% of SSc patients had skewed XCI compared to 17.4% of healthy women (P = 0.002 and 0.018, respectively). Presence of RAsusceptibility alleles coding for the " shared epitope" correlated with higher skewing among RA patients (P = 0.002) and such correlation was not observed in other women, healthy or with SSc. Presence of SSc-susceptibility alleles did not correlate with XCI patterns among SSc patients. Conclusion Data demonstrate XCI skewing in both RA and SSc compared to healthy women. Unexpectedly, skewed XCI occurs more often in women with RA carrying the shared epitope, which usually reflects severe disease. This reinforces the view that loss of mosaicism in peripheral blood may be a consequence of chronic autoimmunity.	[Kanaan, Sami B.; Balandraud, Nathalie; Martin, Gabriel V.; Azzouz, Doua F.; Auger, Isabelle; Arnoux, Fanny; Martin, Marielle; Roudier, Jean; Lambert, Nathalie C.] INSERM, UMRs1097, Sci Pk Luminy, F-13258 Marseille, France; [Kanaan, Sami B.; Martin, Gabriel V.; Azzouz, Doua F.; Auger, Isabelle; Arnoux, Fanny; Martin, Marielle; Roudier, Jean; Lambert, Nathalie C.] Aix Marseille Univ, Marseille, France; [Onat, Onur E.; Ozcelik, Tayfun] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Balandraud, Nathalie; Roudier, Jean] Hop St Marguerite, AP HM, Serv Rhumatol, Marseille, France; [Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Nelson, J. Lee] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Ihsan Dogramaci Bilkent University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Lambert, NC (corresponding author), INSERM, UMRs1097, Sci Pk Luminy, F-13258 Marseille, France.; Lambert, NC (corresponding author), Aix Marseille Univ, Marseille, France.	nathalie.lambert@inserm.fr	Lambert, Nathalie C/P-6816-2016; Balandraud, Nathalie/ABD-6012-2020; Onat, Onur Emre/J-8126-2012; AUGER, ISABELLE/P-6294-2016; roudier, jean/A-8654-2011	Lambert, Nathalie C/0000-0001-5817-8686; Balandraud, Nathalie/0000-0002-3839-0185; Onat, Onur Emre/0000-0002-7105-1572; AUGER, ISABELLE/0000-0002-1414-8095; roudier, jean/0000-0001-5435-8567	Arthritis Fondation Courtin; Groupe Francophone de Recherche sur la Sclerodermie; Association des Sclerodermiques de France; Institut National de la Sante et de la Recherche Medicale (INSERM)	Arthritis Fondation Courtin; Groupe Francophone de Recherche sur la Sclerodermie; Association des Sclerodermiques de France; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Arthritis Fondation Courtin, Groupe Francophone de Recherche sur la Sclerodermie, Association des Sclerodermiques de France, and Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1991, J RHEUMATOL, V18, P1282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Avouac J, 2006, ANN RHEUM DIS, V65, P845, DOI 10.1136/ard.2006.051391; Azzouz DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036870; Balandraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064108; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; Broen JCA, 2010, ANN RHEUM DIS, V69, P2213, DOI 10.1136/ard.2010.129999; Brown CJ, 2000, CLIN GENET, V58, P353, DOI 10.1034/j.1399-0004.2000.580504.x; Chabchoub G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2759; del Rincon I, 2002, ARTHRITIS RHEUM, V46, P1480, DOI 10.1002/art.10295; DELFORGE M, 1995, BLOOD, V86, P3660, DOI 10.1182/blood.V86.10.3660.bloodjournal86103660; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hamaguchi Y, 2010, J DERMATOL, V37, P42, DOI 10.1111/j.1346-8138.2009.00762.x; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; KUWANA M, 1994, ARTHRITIS RHEUM-US, V37, P75, DOI 10.1002/art.1780370111; KUWANA M, 1993, J CLIN INVEST, V92, P1296, DOI 10.1172/JCI116703; Lambert NC, 2009, ARTHRITIS RHEUM-US, V60, P3164, DOI 10.1002/art.24962; Lambert NC, 2000, ARTHRITIS RHEUM-US, V43, P2005, DOI 10.1002/1529-0131(200009)43:9<2005::AID-ANR11>3.0.CO;2-#; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; LeRoy EC, 2001, J RHEUMATOL; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Loubiere LS, 2005, RHEUMATOLOGY, V44, P318, DOI 10.1093/rheumatology/keh489; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; Marotte H, 2006, ANN RHEUM DIS, V65, P905, DOI 10.1136/ard.2005.036913; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; Ozcelik T, 2006, EUR J HUM GENET, V14, P791, DOI 10.1038/sj.ejhg.5201614; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380511; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; REVEILLE JD, 1992, J CLIN INVEST, V90, P973, DOI 10.1172/JCI115974; Stewart JJ, 1998, IMMUNOL TODAY, V19, P352, DOI 10.1016/S0167-5699(98)01298-5; Uz E, 2008, CLIN REV ALLERG IMMU, V34, P352, DOI 10.1007/s12016-007-8044-z; Uz E, 2009, ARTHRITIS RHEUM-US, V60, P3410, DOI 10.1002/art.24956; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158550	10.1371/journal.pone.0158550	http://dx.doi.org/10.1371/journal.pone.0158550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355582	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400076
J	King, BL; Yin, VP				King, Benjamin L.; Yin, Viravuth P.			A Conserved MicroRNA Regulatory Circuit Is Differentially Controlled during Limb/Appendage Regeneration	PLOS ONE			English	Article							ZEBRAFISH FIN REGENERATION; GENE-EXPRESSION; HEART REGENERATION; SMALL RNAS; PROLIFERATION; MIGRATION; BLASTEMA; SEQUENCE; TARGET; AMPUTATION	Background Although regenerative capacity is evident throughout the animal kingdom, it is not equally distributed throughout evolution. For instance, complex limb/appendage regeneration is muted in mammals but enhanced in amphibians and teleosts. The defining characteristic of limb/appendage regenerative systems is the formation of a dedifferentiated tissue, termed blastema, which serves as the progenitor reservoir for regenerating tissues. In order to identify a genetic signature that accompanies blastema formation, we employ next-generation sequencing to identify shared, differentially regulated mRNAs and noncoding RNAs in three different, highly regenerative animal systems: zebrafish caudal fins, bichir pectoral fins and axolotl forelimbs. Results These studies identified a core group of 5 microRNAs (miRNAs) that were commonly upregulated and 5 miRNAs that were commonly downregulated, as well as 4 novel tRNAs fragments with sequences conserved with humans. To understand the potential function of these miRNAs, we built a network of 1,550 commonly differentially expressed mRNAs that had functional relationships to 11 orthologous blastema-associated genes. As miR-21 was the most highly upregulated and most highly expressed miRNA in all three models, we validated the expression of known target genes, including the tumor suppressor, pdcd4, and TGF beta receptor subunit, tgfbr2 and novel putative target genes such as the anti-apoptotic factor, bcl2l13, Choline kinase alpha, chka and the regulator of G-protein signaling, rgs5. Conclusions Our extensive analysis of RNA-seq transcriptome profiling studies in three regenerative animal models, that diverged in evolution similar to 420 million years ago, reveals a common miRNA-regulated genetic network of blastema genes. These comparative studies extend our current understanding of limb/appendage regeneration by identifying previously unassociated blastema genes and the extensive regulation by miRNAs, which could serve as a foundation for future functional studies to examine the process of natural cellular reprogramming in an injury context.	[King, Benjamin L.; Yin, Viravuth P.] Kathryn W Davis Ctr Regenerat Biol & Med, Biol Lab, Salsbury Cove, ME USA; [King, Benjamin L.; Yin, Viravuth P.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA	University of Maine System; University of Maine Orono	Yin, VP (corresponding author), Kathryn W Davis Ctr Regenerat Biol & Med, Biol Lab, Salsbury Cove, ME USA.; Yin, VP (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA.	vyin@mdibl.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336	National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103423, P20 GM104318]; US Department of Defense [W81XWH-BAA-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104318, P20GM103423] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers P20 GM103423 and P20 GM104318 to BLK and VPY, and US Department of Defense grant W81XWH-BAA-1 to VPY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Beauchemin M, 2015, DEVELOPMENT, V142, P4026, DOI 10.1242/dev.126649; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Brockes JP, 2001, J ANAT, V199, P3; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Campbell LJ, 2011, DEV DYNAM, V240, P1826, DOI 10.1002/dvdy.22669; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cuervo R, 2012, P NATL ACAD SCI USA, V109, P3838, DOI 10.1073/pnas.1006619109; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Dong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050960; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; Dutta B, 2014, PROFILING CHROMATIN; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Enright AJ, 2004, GENOME BIOL, V5; Feng YH, 2012, INT J MOL MED, V29, P920, DOI 10.3892/ijmm.2012.910; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Granata A, 2014, BRIT J CANCER, V110, P330, DOI 10.1038/bjc.2013.729; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumps C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052321; Lackner S, 2013, DEV DYNAM, V242, P122, DOI 10.1002/dvdy.23909; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JY, 2015, J BIOL CHEM, V290, P10216, DOI 10.1074/jbc.M114.612572; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makino S, 2005, P NATL ACAD SCI USA, V102, P14599, DOI 10.1073/pnas.0507408102; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; McIntyre JC, 2010, J NEUROSCI RES, V88, P3243, DOI 10.1002/jnr.22497; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Nolte H, 2015, PROTEOMICS, V15, P739, DOI 10.1002/pmic.201400316; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; WHITE JA, 1994, DEVELOPMENT, V120, P1861; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu M, 2013, ONCOL REP, V30, P1398, DOI 10.3892/or.2013.2548; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	78	34	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157106	10.1371/journal.pone.0157106	http://dx.doi.org/10.1371/journal.pone.0157106			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355827	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400009
J	Denis, MFL; Alvarez, HA; Lauri, N; Alvarez, CL; Chara, O; Schwarzbaum, PJ				Leal Denis, M. Florencia; Ariel Alvarez, H.; Lauri, Natalia; Alvarez, Cora L.; Chara, Osvaldo; Schwarzbaum, Pablo J.			Dynamic Regulation of Cell Volume and Extracellular ATP of Human Erythrocytes	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; MAXI-ANION CHANNEL; RED-BLOOD-CELLS; G-PROTEIN G(I); CHLORIDE CHANNELS; PANNEXIN 1; GOLDFISH HEPATOCYTES; NUCLEOTIDE RELEASE; OXYGEN DELIVERY; P2X(7) RECEPTOR	Introduction The peptide mastoparan 7 (MST7) triggered in human erythrocytes (rbcs) the release of ATP and swelling. Since swelling is a well-known inducer of ATP release, and extracellular (ATPe), interacting with P (purinergic) receptors, can affect cell volume (Vr), we explored the dynamic regulation between Vr and ATPe. Methods and Treatments We made a quantitative assessment of MST7-dependent kinetics of Vr and of [ATPe], both in the absence and presence of blockers of ATP efflux, swelling and P receptors. Results In rbcs 10 mu M MST7 promoted acute, strongly correlated changes in [ATPe] and Vr. Whereas MST7 induced increases of 10% in Vr and 190 nM in [ATPe], blocking swelling in a hyperosmotic medium + MST7 reduced [ATPe] by 40%. Pre-incubation of rbcs with 10 mu M of either carbenoxolone or probenecid, two inhibitors of the ATP conduit pannexin 1, reduced [ATPe] by 40-50% and swelling by 40-60%, while in the presence of 80 U/mL apyrase, an ATPe scavenger, cell swelling was prevented. While exposure to 10 mu M NF110, a blocker of ATP-P2X receptors mediating sodium influx, reduced [ATPe] by 48%, and swelling by 80%, incubation of cells in sodium free medium reduced swelling by 92%. Analysis and Discussion Results were analyzed by means of a mathematical model where ATPe kinetics and Vr kinetics were mutually regulated. Model dependent fit to experimental data showed that, upon MST7 exposure, ATP efflux required a fast 1960-fold increase of ATP permeability, mediated by two kinetically different conduits, both of which were activated by swelling and inactivated by time. Both experimental and theoretical results suggest that, following MST7 exposure, ATP is released via two conduits, one of which is mediated by pannexin 1. The accumulated ATPe activates P2X receptors, followed by sodium influx, resulting in cell swelling, which in turn further activates ATP release. Thus swelling and P2X receptors constitute essential components of a positive feedback loop underlying ATP-induced ATP release of rbcs.	[Leal Denis, M. Florencia; Lauri, Natalia; Alvarez, Cora L.; Schwarzbaum, Pablo J.] Univ Buenos Aires, CONICET, FFyB, Inst Quim & Fisicoquim Biol Prof AC Paladini, Buenos Aires, DF, Argentina; [Ariel Alvarez, H.; Chara, Osvaldo] Univ Nacl La Plata, CONICET, Inst Fis Liquidos & Sistemas Biol IFLYSIB, La Plata, Argentina; [Chara, Osvaldo] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp ZIH, Dresden, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Technische Universitat Dresden	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, CONICET, FFyB, Inst Quim & Fisicoquim Biol Prof AC Paladini, Buenos Aires, DF, Argentina.	pjs@qb.ffyb.uba.ar	Chara, Osvaldo/T-2798-2019; Alvarez, Hugo Ariel/E-3707-2016	Chara, Osvaldo/0000-0002-0868-2507; Alvarez, Hugo Ariel/0000-0002-6007-0452; Leal Denis, Florencia/0000-0002-6209-4378; schwarzbaum, pablo/0000-0002-5176-089X	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112 20110100639]; Universidad de Buenos Aires [20020130100027BA]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2014-0327]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT)	This work was supported by Grant PIP 112 20110100639, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PJS); Grant 20020130100027BA, Universidad de Buenos Aires (PJS); and Grant PICT 2014-0327, Agencia Nacional de Promocion Cientifica y Tecnica (PJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1992, No To Hattatsu, V24, P127; Alvarez CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096216; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Brown A., 1982, ATP ATPASE DETERMINA, P223; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; CHOU CL, 1989, AM J PHYSIOL, V257, pF359, DOI 10.1152/ajprenal.1989.257.3.F359; Clapham DE, 1998, J GEN PHYSIOL, V111, P623, DOI 10.1085/jgp.111.5.623; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Dourado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099596; Ellsworth ML, 2012, J PHYSIOL-LONDON, V590, P4985, DOI 10.1113/jphysiol.2012.233106; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Espelt MV, 2013, AM J PHYSIOL-CELL PH, V304, pC1013, DOI 10.1152/ajpcell.00254.2012; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Gonzalez-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Guest GM, 1942, J CLIN INVEST, V21, P257, DOI 10.1172/JCI101297; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hellsten Y, 2012, J PHYSIOL-LONDON, V590, P5015, DOI 10.1113/jphysiol.2012.234963; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Islam MR, 2012, AM J PHYSIOL-CELL PH, V303, pC924, DOI 10.1152/ajpcell.00459.2011; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Jiang LH, 2012, CELL HEALTH CYTOSKEL, V4, P83, DOI 10.2147/CHC.S27196; Kunapuli S, 1998, BIOCH J; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Denis MFL, 2013, BBA-GEN SUBJECTS, V1830, P4692, DOI 10.1016/j.bbagen.2013.05.033; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Nakao S, 2011, BBA-BIOMEMBRANES, V1808, P490, DOI 10.1016/j.bbamem.2010.10.007; Nemutlu E, 2005, ANAL BIOANAL CHEM, V383, P833, DOI 10.1007/s00216-005-0063-0; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V287, pH748, DOI 10.1152/ajpheart.00161.2004; Olearczyk JJ, 2004, J PHARMACOL EXP THER, V309, P1079, DOI 10.1124/jpet.103.064709; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V286, pH940, DOI 10.1152/ajpheart.00677.2003; Pafundo DE, 2004, AM J PHYSIOL-REG I, V287, pR833, DOI 10.1152/ajpregu.00199.2004; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; Pafundo DE, 2010, J BIOL CHEM, V285, P6134, DOI 10.1074/jbc.M109.078246; Park HS, 2000, BBA-MOL CELL BIOL L, V1484, P151, DOI 10.1016/S1388-1981(00)00002-0; Pirotton S, 1996, J AUTON PHARMACOL, V16, P353, DOI 10.1111/j.1474-8673.1996.tb00052.x; PONDER E, 1951, J GEN PHYSIOL, V34, P567, DOI 10.1085/jgp.34.5.567; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Sabirov R, 2009, J PHYSIOL SCI, V59, P3, DOI 10.1007/s12576-008-0008-4; Sands JM, 1997, AM J PHYSIOL-RENAL, V273, pF321, DOI 10.1152/ajprenal.1997.273.3.F321; Schwarzbaum PJ, 1998, AM J PHYSIOL-REG I, V274, pR1031, DOI 10.1152/ajpregu.1998.274.4.R1031; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Shakulashvili N, 2000, J CHROMATOGR A, V895, P205, DOI 10.1016/S0021-9673(00)00669-5; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Sluyter R, 2007, AM J PHYSIOL-REG I, V293, pR2090, DOI 10.1152/ajpregu.00166.2007; Sprague R, 2005, PHARMACOL REP, V57, P222; Sprague RS, 2011, ACTA PHYSIOL, V202, P285, DOI 10.1111/j.1748-1716.2010.02182.x; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Sprague RS, 2012, MICROCIRCULATION, V19, P430, DOI 10.1111/j.1549-8719.2011.00158.x; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Strehler B L, 1968, Methods Biochem Anal, V16, P99, DOI 10.1002/9780470110348.ch2; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Varela D, 2010, J BIOL CHEM, V285, P7566, DOI 10.1074/jbc.M109.063693; VAZQUEZ A, 1991, J BIOCHEM BIOPH METH, V23, P45, DOI 10.1016/0165-022X(91)90049-3; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; WILEY JS, 1979, BRIT J HAEMATOL, V41, P133, DOI 10.1111/j.1365-2141.1979.tb03689.x	81	23	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158305	10.1371/journal.pone.0158305	http://dx.doi.org/10.1371/journal.pone.0158305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355484	Green Published, gold			2022-12-26	WOS:000378859400047
J	Helland, O; Popa, M; Bischof, K; Gjertsen, BT; McCormack, E; Bjorge, L				Helland, Oystein; Popa, Mihaela; Bischof, Katharina; Gjertsen, Bjorn Tore; McCormack, Emmet; Bjorge, Line			The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; PLATINUM; PACLITAXEL; MANAGEMENT; TRIAL; ANGIOGENESIS; CHEMOTHERAPY; CISPLATIN; THERAPY; LBH589	Background In most epithelial ovarian carcinomas (EOC), epigenetic changes are evident, and overexpression of histone deacetylases (HDACs) represents an important manifestation. In this study, we wanted to evaluate the effects of the novel HDAC inhibitor (HDACi) panobinostat, both alone and in combination with carboplatin, on ovarian cancer cell lines and in a murine bioluminescent orthotopic surgical xenograft model for EOC. Methods The effects of panobinostat, both alone and in combination with carboplatin, on proliferation and apoptosis in ovarian cancer cell lines, were evaluated using colony and WST-1 assays, Hoechst staining and flow cytometry analysis. In addition, mechanisms were characterised by western blotting and phosphoflow analysis. Immuno-deficient mice were engrafted orthotopically with SKOV-3(luc+) cells and serial bioluminescence imaging monitored the effects of treatment with panobinostat and/or carboplatin and/or surgery. Survival parameters were also measured. Results Panobinostat treatment reduced cell growth and diminished cell viability, as shown by the induced cell cycle arrest and apoptosis in vitro. We observed increased levels of cleaved PARP and caspase-3, downregulation of cdc2 protein kinase, acetylation of H2B and higher pH2AX expression. The combined administration of carboplatin and panobinostat synergistically increased the anti-tumour effects compared to panobinostat or carboplatin treatment alone. In our novel ovarian cancer model, the mice showed significantly higher rates of survival when treated with panobinostat, carboplatin or a combination of both, compared to the controls. Panobinostat was as efficient as carboplatin regarding prolongation of survival. No significant additional effect on survival was observed when surgery was combined with carboplatin/panobinostat treatment. Conclusions Panobinostat demonstrates effective in vitro growth inhibition in ovarian cancer cells. The efficacy of panobinostat and carboplatin was equal in the orthotopic EOC model used. We conclude that panobinostat is a promising therapeutic alternative that needs to be further assessed for the treatment of EOC.	[Helland, Oystein; Bischof, Katharina; Bjorge, Line] Haukeland Hosp, Dept Obstet & Gynecol, Jonas Liesvei 72, N-5058 Bergen, Norway; [Helland, Oystein; Bischof, Katharina; Gjertsen, Bjorn Tore; McCormack, Emmet; Bjorge, Line] Univ Bergen, Dept Clin Sci, PB 7804, N-5020 Bergen, Norway; [Popa, Mihaela] Haukeland Hosp, Laboratoriebygget, KinN Therapeut, N-5021 Bergen, Norway; [Gjertsen, Bjorn Tore; McCormack, Emmet] Haukeland Hosp, Dept Internal Med, Jonas Lies Vei 65, N-5021 Bergen, Norway; [Gjertsen, Bjorn Tore; Bjorge, Line] Univ Bergen, Ctr Canc Biomarkers CCBIO, N-5020 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Helland, O (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Jonas Liesvei 72, N-5058 Bergen, Norway.	Oystein.Helland@uib.no	Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjorn T/O-1542-2015; Bjorge, Line/C-1307-2017; Bjorge, Line/AAD-6179-2021; Gjertsen, Bjørn T/AAP-3281-2020	Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjorn T/0000-0001-9358-9704; Bjorge, Line/0000-0002-0240-2770; Bjorge, Line/0000-0002-0240-2770; Gjertsen, Bjørn T/0000-0001-9358-9704	University of Bergen [11754]; Norwegian Cancer Society [421828, 732200]; Helse Vest [911789, 911884, 911809]; Bergen Research Foundation	University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Helse Vest; Bergen Research Foundation	This work was supported by The University of Bergen, award number 11754 and the Norwegian Cancer Society, award number 421828 to Oystein Helland; Helse Vest, award number 911789 and 911884, the Norwegian Cancer Society, award number 732200 and Bergen Research Foundation, no award number, to Emmet McCormack; The Norwegian Cancer Society, award number 421828 to Bjorn Tore Gjertsen; Helse Vest, award number 911809 to Line Bjorge. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne M, 2013, ONCOTARGETS THER, V6, P1613, DOI 10.2147/OTT.S30773; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bookman M A, 1999, Oncologist, V4, P87; Budman DR, 2011, INVEST NEW DRUG, V29, P1224, DOI 10.1007/s10637-010-9467-6; Chao HT, 2013, CANCER LETT, V329, P17, DOI 10.1016/j.canlet.2012.08.035; Chien WW, 2014, MOL CARCINOGEN, V53, P722, DOI 10.1002/mc.22024; Colombo N, 2007, CRIT REV ONCOL HEMAT, V64, P129, DOI 10.1016/j.critrevonc.2007.04.004; Colombo N, 2013, FUTURE ONCOL, V9, P19, DOI 10.2217/fon.13.206; Cooper AL, 2007, GYNECOL ONCOL, V104, P596, DOI 10.1016/j.ygyno.2006.09.011; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; Dunton CJ, 2002, ONCOLOGIST, V7, P11; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Firestone B, 2010, CURR OPIN PHARMACOL, V10, P391, DOI 10.1016/j.coph.2010.06.012; Garnock-Jones KP, 2015, DRUGS, V75, P695, DOI 10.1007/s40265-015-0388-8; GJERTSEN BT, 1994, J CELL SCI, V107, P3363; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Helland O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089527; Horowitz NS, 2004, GYNECOL ONCOL, V94, P67, DOI 10.1016/j.ygyno.2004.03.047; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Joerger M, 2012, ANN ONCOL, V23, P313, DOI 10.1093/annonc/mds314; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Khot A, 2013, EXPERT OPIN INV DRUG, V22, P1211, DOI 10.1517/13543784.2013.815165; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Morgan RJ, 2011, J NATL COMPR CANC NE, V9, P82, DOI 10.6004/jnccn.2011.0008; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Nguyen HT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00071; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Poveda A, 2014, CANCER TREAT REV, V40, P366, DOI 10.1016/j.ctrv.2013.08.001; Prince HM, 2009, FUTURE ONCOL, V5, P601, DOI [10.2217/fon.09.36, 10.2217/FON.09.36]; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Qian XZ, 2006, MOL CANCER THER, V5, P2086, DOI 10.1158/1535-7163.MCT-06-0111; Schwartz PE, 2008, ONCOLOGY-NY, V22, P1025; Sehouli J, 2012, ANN ONCOL, V23, P556, DOI 10.1093/annonc/mdr321; Shan Z, 2012, ASIAN PAC J CANCER P, V13, P3977, DOI 10.7314/APJCP.2012.13.8.3977; Sharma S, 2013, INVEST NEW DRUG, V31, P974, DOI 10.1007/s10637-013-9930-2; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stuart GCE, 2011, INT J GYNECOL CANCER, V21, P750, DOI 10.1097/IGC.0b013e31821b2568; Su WH, 2012, TAIWAN J OBSTET GYNE, V51, P167, DOI 10.1016/j.tjog.2012.04.002; Takai N, 2004, CANCER-AM CANCER SOC, V101, P2760, DOI 10.1002/cncr.20709; Takai N, 2010, J ONCOL, V2010, DOI 10.1155/2010/458431; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Wilson AJ, 2012, GYNECOL ONCOL, V127, P579, DOI 10.1016/j.ygyno.2012.09.016; Wilson PM, 2013, INVEST NEW DRUG, V31, P845, DOI 10.1007/s10637-012-9914-7; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583	58	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158208	10.1371/journal.pone.0158208	http://dx.doi.org/10.1371/journal.pone.0158208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352023	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900044
J	Lopes, JLS; Yoneda, JS; Martins, JM; DeMarco, R; Jameson, DM; Castro, AM; Bossolan, NRS; Wallace, BA; Araujo, APU				Lopes, Jose L. S.; Yoneda, Juliana S.; Martins, Julia M.; DeMarco, Ricardo; Jameson, David M.; Castro, Aline M.; Bossolan, Nelma R. S.; Wallace, B. A.; Araujo, Ana P. U.			Environmental Factors Modulating the Stability and Enzymatic Activity of the Petrotoga mobilis Esterase (PmEst)	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; SP NOV.; STRUCTURE PREDICTION; ENZYMES; LIPASES; FOLD; WELL	Enzymes isolated from thermophilic organisms found in oil reservoirs can find applications in many fields, including the oleochemical, pharmaceutical, bioenergy, and food/dairy industries. In this study, in silico identification and recombinant production of an esterase from the extremophile bacteria Petrotoga mobilis (designated PmEst) were performed. Then biochemical, bioinformatics and structural characterizations were undertaken using a combination of synchrotron radiation circular dichroism (SRCD) and fluorescence spectroscopies to correlate PmEst stability and hydrolytic activity on different substrates. The enzyme presented a high Michaelis-Menten constant (K-M 0.16 mM) and optimum activity at similar to 55 degrees C for p-nitrophenyl butyrate. The secondary structure of PmEst was preserved at acid pH, but not under alkaline conditions. PmEst was unfolded at high concentrations of urea or guanidine through apparently different mechanisms. The esterase activity of PmEst was preserved in the presence of ethanol or propanol and its melting temperature increased similar to 8 degrees C in the presence of these organic solvents. PmEst is a mesophilic esterase with substrate preference towards short-to medium-length acyl chains. The SRCD data of PmEst is in agreement with the prediction of an alpha/beta protein, which leads us to assume that it displays a typical fold of esterases from this family. The increased enzyme stability in organic solvents may enable novel applications for its use in synthetic biology. Taken together, our results demonstrate features of the PmEst enzyme that indicate it may be suitable for applications in industrial processes, particularly, when the use of polar organic solvents is required.	[Lopes, Jose L. S.; Yoneda, Juliana S.] Univ Sao Paulo, Inst Fis, CP 20516, BR-01498 Sao Paulo, Brazil; [Yoneda, Juliana S.; Wallace, B. A.] Univ London, Birkbeck Coll, Inst Struct & Mol Biol, London, England; [Martins, Julia M.; DeMarco, Ricardo; Bossolan, Nelma R. S.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Jameson, David M.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Castro, Aline M.] Ctr Res & Dev, Div Biotechnol, Petrobras, Brazil	Universidade de Sao Paulo; University of London; Birkbeck University London; Universidade de Sao Paulo; University of Hawaii System; University of Hawaii Manoa	Araujo, APU (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.	anapaula@ifsc.usp.br	DeMarco, Ricardo/A-7773-2008; Araujo, Ana Paula U/I-6664-2012; CASTRO, ALINE M/C-4984-2015; Lopes, Jose L S/D-3213-2012; Bossolan, Nelma/P-1866-2015; Yoneda, Juliana S/F-2130-2015; Lopes, Jose Luiz S/AAC-2917-2021; Wallace, B A/C-3753-2008	DeMarco, Ricardo/0000-0001-8944-1301; Araujo, Ana Paula U/0000-0001-5455-084X; CASTRO, ALINE M/0000-0002-1355-8455; Lopes, Jose L S/0000-0003-1281-0521; Bossolan, Nelma/0000-0002-5484-9283; Yoneda, Juliana S/0000-0003-2814-3022; Wallace, B A/0000-0001-9649-5092	Biotechnology and Biological Sciences Research Council (BBSRC) [J019747]; Brazil National Council of Technological and Scientific Development (CNPq) [553056/2011-5, 407337/2013-0]; BBSRC [J019135/1, N012763]; BBSRC-Sao Paulo Research Foundation (FAPESP) [FAPPA 15/50347-2]; CNPq [553056/2011-5, 150304/2015-3]; Petrobras [2012/00187-0]; ISA Synchrotron (Aarhus, Denmark); Soleil Synchrotron (France); BBSRC [BB/J019747/1, BB/N012763/1, BB/J019135/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019135/1, BBS/B/02959, BB/J019747/1, BB/N012763/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Brazil National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC-Sao Paulo Research Foundation (FAPESP)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); ISA Synchrotron (Aarhus, Denmark); Soleil Synchrotron (France); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for the support of paired UK-Brazil partnering grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (grant J019747 to BAW) and Brazil National Council of Technological and Scientific Development (CNPq) to APUA, grants 553056/2011-5 and 407337/2013-0; BBSRC grant J019135/1 (to BAW), BBSRC-Sao Paulo Research Foundation (FAPESP) grant FAPPA 15/50347-2 and BBSRC N012763 (to APUA and BAW, respectively), and CNPq for postdoctoral fellowships (to JLSL and JSY, grants 150304/2015-3 and 553056/2011-5, respectively); Petrobras (grant 2012/00187-0) to NRSB providing a DTI fellowship (to JMM) and agreeing with the decision to publish; and SRCD beamtime grants from the ISA Synchrotron (Aarhus, Denmark) (to JLSL and BAW), and the Soleil Synchrotron (France) (to BAW). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alex Deepthy, 2014, Enzyme Res, V2014, P494682, DOI 10.1155/2014/494682; Alvarez Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092257; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Cardenas F, 2001, ENZYME MICROB TECH, V28, P145, DOI 10.1016/S0141-0229(00)00278-7; DAVEY ME, 1993, SYST APPL MICROBIOL, V16, P191; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Elmi F, 2005, J BACTERIOL, V187, P8470, DOI 10.1128/JB.187.24.8470-8476.2005; Fang YW, 2015, INT J BIOL MACROMOL, V80, P334, DOI 10.1016/j.ijbiomac.2015.06.045; Gobbetti M, 1997, J DAIRY SCI, V80, P3099, DOI 10.3168/jds.S0022-0302(97)76280-5; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Huber R., 2006, PROKARYOTES, V7, P899, DOI [DOI 10.1007/0-387-30747-8_38., 10.1007/0-387-30747-8_38, DOI 10.1007/0-387-30747-8_38]; James NG, 2011, ANAL BIOCHEM, V410, P70, DOI 10.1016/j.ab.2010.11.011; JAMESON DM, 1984, APPL SPECTROSC REV, V20, P55, DOI 10.1080/05704928408081716; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim MH, 2008, PROTEINS, V70, P578, DOI 10.1002/prot.21680; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; L'Haridon S, 2002, INT J SYST EVOL MICR, V52, P1715, DOI [10.1099/ijs.0.02153-0, 10.1099/00207713-52-5-1715]; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Levisson M, 2007, FEBS J, V274, P2832, DOI 10.1111/j.1742-4658.2007.05817.x; Li X, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-108; Lien T, 1998, INT J SYST BACTERIOL, V48, P1007, DOI 10.1099/00207713-48-3-1007; Lopes JLS, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/2/025003; Lopez-Lopez Olalla, 2014, Curr Protein Pept Sci, V15, P445; Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905; Miranda-Tello E, 2004, INT J SYST EVOL MICR, V54, P169, DOI 10.1099/ijs.0.02702-0; Miranda-Tello E, 2007, INT J SYST EVOL MICR, V57, P40, DOI 10.1099/ijs.0.64516-0; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; OEHM HC, 1982, EUR J BIOCHEM, V129, P157, DOI 10.1111/j.1432-1033.1982.tb07034.x; Purwasena IA, 2014, ARCH MICROBIOL, V196, P313, DOI 10.1007/s00203-014-0972-4; Ross JA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1301, DOI 10.1039/b804450n; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stefl M, 2011, ANAL BIOCHEM, V410, P62, DOI 10.1016/j.ab.2010.11.010; Synowiecki J, 2010, AFR J BIOTECHNOL, V9, P7020; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wallace BA, 2011, NUCL INSTRUM METH A, V649, P177, DOI 10.1016/j.nima.2010.10.135; Wallace BA, 2009, Q REV BIOPHYS, V42, P317, DOI 10.1017/S003358351000003X; Wallace BA, 2000, NAT STRUCT BIOL, V7, P708, DOI 10.1038/78915; Wallace BA, 2001, CURR OPIN CHEM BIOL, V5, P567, DOI 10.1016/S1367-5931(00)00243-X; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	43	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158146	10.1371/journal.pone.0158146	http://dx.doi.org/10.1371/journal.pone.0158146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351338	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900038
J	Yang, HK; Kim, JH; Hwang, JM				Yang, Hee Kyung; Kim, Jae Hyoung; Hwang, Jeong-Min			Abducens Nerve in Patients with Type 3 Duane's Retraction Syndrome	PLOS ONE			English	Article							DISSOCIATED VERTICAL DEVIATION; ABDUCTION	Background We have previously reported that the presence of the abducens nerve was variable in patients with type 3 Duane's retraction syndrome (DRS), being present in 2 of 5 eyes (40%) and absent in 3 (60%) on magnetic resonance imaging (MRI). The previous study included only 5 eyes with unilateral DRS type 3. Objectives To supplement existing scarce pathologic information by evaluating the presence of the abducens nerve using high resolution thin-section MRI system in a larger number of patients with DRS type 3, thus to provide further insight into the pathogenesis of DRS. Data Extraction A retrospective review of medical records on ophthalmologic examination and high resolution thin-section MRI at the brainstem level and orbit was performed. A total of 31 patients who showed the typical signs of DRS type 3, including abduction and adduction deficit, globe retraction, narrowing of fissure on adduction and upshoot and/or downshoot, were included. The abducens nerve and any other extraocular muscle abnormalities discovered by MRI were noted. Results DRS was unilateral in 26 patients (84%) and bilateral in 5 patients (16%). Two out of 5 bilateral patients had DRS type 3 in the right eye and DRS type 1 in the left eye. Of the 34 affected orbits with DRS type 3 in 31 patients, the abducens nerve was absent or hypoplastic in 31 eyes (91%) and present in 3 eyes (9%). Patients with a present abducens nerve showed more limitation in adduction compared to patients with an absent abducens nerve (P = 0.030). Conclusions The abducens nerve is absent or hypoplastic in 91% of DRS type 3. Patients with a present abducens nerve showed more prominent limitation of adduction. As DRS type 3 partly share the same pathophysiology with type 1 and 2 DRS, the classification of DRS may have to be revised according to MRI findings.	[Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea; [Kim, Jae Hyoung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Radiol, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea.	hjm@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2013R1A1A2010606]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A2010606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramlar H, 2003, J PEDIAT OPHTH STRAB, V40, P182, DOI 10.3928/0191-3913-20030501-19; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P5505, DOI 10.1167/iovs.07-0772; Denis D, 2007, J NEURORADIOLOGY, V34, P137, DOI 10.1016/j.neurad.2007.01.002; Denis D, 2008, J AAPOS, V12, P91, DOI 10.1016/j.jaapos.2007.07.012; DUANE A, 1905, ARCH OPHTHALMOL-CHIC, V34, P133; Gutowski N J, 2003, Neuromuscul Disord, V13, P573, DOI 10.1016/S0960-8966(03)00043-9; HUBER A, 1974, BRIT J OPHTHALMOL, V58, P293, DOI 10.1136/bjo.58.3.293; Jiao YH, 2009, J PEDIAT OPHTH STRAB, V46, P278, DOI 10.3928/01913913-20090903-05; Kim JH, 2008, EUR J NEUROL, V15, pE25, DOI 10.1111/j.1468-1331.2008.02075.x; Kim JH, 2006, ARCH OPHTHALMOL-CHIC, V124, P918, DOI 10.1001/archopht.124.6.918; Kim JH, 2012, OPHTHALMOLOGY, V119, P403, DOI 10.1016/j.ophtha.2011.08.001; Kim JH, 2009, J NEUROL, V256, P1920, DOI 10.1007/s00415-009-5224-1; Kim JH, 2006, J NEUROL, V253, P390, DOI 10.1007/s00415-005-0977-7; Kim JH, 2005, AM J NEURORADIOL, V26, P702; Kim JH, 2005, J NEUROL, V252, P224, DOI 10.1007/s00415-005-0585-6; Kim JH, 2005, OPHTHALMOLOGY, V112, P109, DOI 10.1016/j.ophtha.2004.06.040; MULHERN M, 1994, BRIT J OPHTHALMOL, V78, P588, DOI 10.1136/bjo.78.7.588; Parsa CF, 1998, AM J OPHTHALMOL, V125, P399, DOI 10.1016/S0002-9394(99)80158-5; RIMMER S, 1990, J CLIN NEURO-OPHTHAL, V10, P38; She HC, 2012, CHINESE MED J-PEKING, V125, P2929, DOI 10.3760/cma.j.issn.0366-6999.2012.16.024; Xia S, 2014, CLIN RADIOL, V69, pE191, DOI 10.1016/j.crad.2013.12.010; Yuksel D, 2010, VISION RES, V50, P2334, DOI 10.1016/j.visres.2010.08.019	22	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0150670	10.1371/journal.pone.0150670	http://dx.doi.org/10.1371/journal.pone.0150670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352171	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900001
J	Adler, PH; Yadamsuren, O; Procunier, WS				Adler, Peter H.; Yadamsuren, Oyunchuluun; Procunier, William S.			Chromosomal Translocations in Black Flies (Diptera: Simuliidae)-Facilitators of Adaptive Radiation?	PLOS ONE			English	Article							SALIVARY-GLAND CHROMOSOMES; GROUP DIPTERA; CYTOLOGICAL DESCRIPTION; SIMULIUM-GUIANENSE; INTERCHANGE; VECTOR; IDENTIFICATION; CYTOTAXONOMY; EVOLUTION; DYNAMICS	A macrogenomic investigation of a Holarctic clade of black flies-the Simulium cholodkovskii lineage-provided a platform to explore the implications of a unique, synapomorphic whole-arm interchange in the evolution of black flies. Nearly 60 structural rearrangements were discovered in the polytene complement of the lineage, including 15 common to all 138 analyzed individuals, relative to the central sequence for the entire subgenus Simulium. Three species were represented, of which two Palearctic entities (Simulium cholodkovskii and S. decimatum) were sympatric; an absence of hybrids confirmed their reproductive isolation. A third (Nearctic) entity had nonhomologous sex chromosomes, relative to the other species, and is considered a separate species, for which the name Simulium nigricoxum is revalidated. A cytophylogeny is inferred and indicates that the two Palearctic taxa are sister species and these, in turn, are the sister group of the Nearctic species. The rise of the S. cholodkovskii lineage encompassed complex chromosomal and genomic restructuring phenomena associated with speciation in black flies, viz. expression of one and the same rearrangement as polymorphic, fixed, or sex linked in different species; taxon-specific differentiation of sex chromosomes; and reciprocal translocation of chromosome arms. The translocation is hypothesized to have occurred early in male spermatogonia, with the translocated chromosomal complement being transmitted to the X- and Y-bearing sperm during spermatogenesis, resulting in alternate disjunction of viable F1 translocation heterozygotes and the eventual formation of more viable and selectable F2 translocation homozygous progeny. Of 11 or 12 independently derived whole-arm interchanges known in the family Simuliidae, at least six are associated with subsequent speciation events, suggesting a facilitating role of translocations in adaptive radiations. The findings are discussed in the context of potential structural and functional interactions for future genomic research.	[Adler, Peter H.] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA; [Yadamsuren, Oyunchuluun] Mongolian Natl Univ Educ, Dept Biol, Ulaanbaatar, Mongolia; [Procunier, William S.] Nipissing Univ, Dept Psychol, North Bay, ON, Canada	Clemson University; Mongolian National University of Education; Nipissing University	Adler, PH (corresponding author), Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA.	padler@clemson.edu			National Science Foundation [DEB-0841636, DEB-0206674]; National Institute of Food and Agriculture of the US Department of Agriculture; Clemson University Experiment Station [SC-1700433]	National Science Foundation(National Science Foundation (NSF)); National Institute of Food and Agriculture of the US Department of Agriculture; Clemson University Experiment Station	This work was funded in part by National Science Foundation (http://www.nsf.gov/) award DEB-0841636 (Discovery and Prediction of Hidden Biodiversity in Black Flies (Diptera: Simuliidae)) to PHA. National Science Foundation (http://www.nsf.gov/) award DEB-0206674 (Survey and Inventory of the Aquatic Macroinvertebrates of the Selenge River Drainage Basin, Mongolia) to J.K. Gelhaus, B. Hayford, and J.C. Morse supported collections of specimens in Mongolia. National Institute of Food and Agriculture of the US Department of Agriculture (https://nifa.usda.gov/) partly supported the work of PHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J. K. Gelhaus, B. Hayford, and J. C. Morse whose NSF award (Survey and Inventory of the Aquatic Macroinvertebrates of the Selenge River Drainage Basin, Mongolia) partly supported collections in Mongolia; D. C. Currie (Royal Ontario Museum, Toronto) under whose 2002 scientific research permit for the Northwest Territories we collected the sample of S. nigricoxum; D. Tumurtsooj (Information and Research Institute of Meteorology, Hydrology and Environment, Mongolia) and Tuya Goulden for facilitating our sampling in Mongolia; and anonymous reviewers for insightful comments on the manuscript. This is Technical Contribution No. 6428 of the Clemson University Experiment Station, linked to project number SC-1700433.	Adler PH, 2015, MED VET ENTOMOL, V29, P276, DOI 10.1111/mve.12115; Adler P. H., 2016, WORLD BLACKFLIES DIP; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147673; Adler PH, 2015, ZOOTAXA, V3975, P1, DOI 10.11646/zootaxa.3975.1.1; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler PH, 2004, BLACK FLIES SIMULIID; Artemov GN, 2015, MED VET ENTOMOL, V29, P230, DOI 10.1111/mve.12113; BEDO DG, 1975, CAN J ZOOL, V53, P1147, DOI 10.1139/z75-134; BEDO DG, 1977, CHROMOSOMA, V64, P37, DOI 10.1007/BF00292888; Bohlander Stefan K, 2015, Recent Results Cancer Res, V200, P1, DOI 10.1007/978-3-319-20291-4_1; Chagas AC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-612; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; Conflitti IM, 2015, BIOL J LINN SOC, V115, P13, DOI 10.1111/bij.12480; Coscaron Arias Cecilia L., 2000, Revista Colombiana de Entomologia, V26, P137; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; CUPP MS, 1994, AM J TROP MED HYG, V50, P241, DOI 10.4269/ajtmh.1994.50.241; Garagna S, 2014, CHROMOSOMA, V123, P529, DOI 10.1007/s00412-014-0477-6; Golczyk H, 2014, PLANT CELL, V26, P1280, DOI 10.1105/tpc.114.122655; Halgos J., 1982, Acta Facultatis Rerum Naturalium Universitatis Comenianae Zoologia, V26, P1; Harewood L, 2014, HUM MOL GENET, V23, pR76, DOI 10.1093/hmg/ddu278; King M., 1993, SPECIES EVOLUTION; Li HX, 2015, J GENET GENOMICS, V42, P129, DOI 10.1016/j.jgg.2014.11.008; Obeso D, 2014, CHROMOSOMA, V123, P43, DOI 10.1007/s00412-013-0439-4; OTTONEN PO, 1969, CAN J ZOOLOG, V47, P943, DOI 10.1139/z69-154; Procunier W, 2005, J MED ENTOMOL, V42, P805, DOI 10.1603/0022-2585(2005)042[0805:CLOTAS]2.0.CO;2; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2866, DOI 10.1139/z82-365; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2852, DOI 10.1139/z82-364; PROCUNIER WS, 1986, TROP MED PARASITOL, V37, P49; PROCUNIER WS, 1994, GENOME, V37, P957, DOI 10.1139/g94-136; PROCUNIER WS, 1975, CAN J ZOOL, V53, P1622, DOI 10.1139/z75-196; Ribeiro JMC, 2010, AM J TROP MED HYG, V82, P1060, DOI 10.4269/ajtmh.2010.09-0769; ROTHFELS K, 1989, GENOME, V32, P500, DOI 10.1139/g89-475; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K, 1981, CAN J ZOOL, V59, P1857, DOI 10.1139/z81-255; ROTHFELS K, 1983, CAN J ZOOL, V61, P2612, DOI 10.1139/z83-342; ROTHFELS K, 1966, CAN J ZOOLOG, V44, P937, DOI 10.1139/z66-095; Rothfels K.H., 1980, Symposia of the Royal Entomological Society of London, P207; Rothfels K.H., 1988, BLACK FLIES ECOLOGY, P39; ROTHFELS KH, 1979, ANNU REV ENTOMOL, V24, P507, DOI 10.1146/annurev.en.24.010179.002451; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Rubtsov IA, 1956, FAUNA OF THE USSR, V64; Schwartz M, 2014, CURR OPIN GENET DEV, V25, P118, DOI 10.1016/j.gde.2013.12.008; Sharakhov IV, 2015, CURR OPIN INSECT SCI, V10, P110, DOI 10.1016/j.cois.2015.05.003; Sharakhova MV, 2013, INFECT GENET EVOL, V16, P341, DOI 10.1016/j.meegid.2013.03.010; Shields GF, 2016, FRESHW SCI, V35, P1023, DOI 10.1086/686913; SHIELDS GF, 1990, GENOME, V33, P683, DOI 10.1139/g90-102; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Turkosi E, 2014, GENOME, V57, P601, DOI 10.1139/gen-2014-0187; Vazquez J, 2002, CURR BIOL, V12, P1473, DOI 10.1016/S0960-9822(02)01090-4; Wang JB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-70; Yankovsky A.V., 1995, KATALOG TIPOVYKH EKZ, P1	53	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158272	10.1371/journal.pone.0158272	http://dx.doi.org/10.1371/journal.pone.0158272			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348428	gold, Green Published, Green Submitted			2022-12-26	WOS:000378801200056
J	Lippelt, DP; van der Kint, S; van Herk, K; Naber, M				Lippelt, D. P.; van der Kint, S.; van Herk, K.; Naber, M.			No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; TS65DN MOUSE MODEL; DIETARY CHOLINE; OLDER-ADULTS; BRAIN ACETYLCHOLINE; RAT-BRAIN; ALZHEIMERS-DISEASE; CONTROLLED-TRIAL; NUCLEUS BASALIS	Choline is a dietary component and precursor of acetylcholine, a crucial neurotransmitter for memory-related brain functions. In two double-blind, placebo-controlled cross-over experiments, we investigated whether the food supplement choline bitartrate improved declarative memory and working memory in healthy, young students one to two hours after supplementation. In experiment 1, 28 participants performed a visuospatial working memory task. In experiment 2, 26 participants performed a declarative picture memorization task. In experiment 3, 40 participants performed a verbal working memory task in addition to the visuospatial working memory and declarative picture task. All tasks were conducted approximately 60 minutes after the ingestion of 2.0-2.5g of either choline bitartrate or placebo. We found that choline did not significantly enhance memory performance during any of the tasks. The null hypothesis that choline does not improve memory performance as compared to placebo was strongly supported by Bayesian statistics. These results are in contrast with animal studies suggesting that choline supplementation boosts memory performance and learning. We conclude that choline likely has no acute effects on cholinergic memory functions in healthy human participants.	[Lippelt, D. P.; van der Kint, S.; van Herk, K.; Naber, M.] Leiden Univ, Cognit Psychol, Wassenaarseweg 52, NL-2333 AK Leiden, Netherlands; [Naber, M.] LUMC, Leiden Inst Brain & Cognit, NL-2300 RC Leiden, Netherlands; [Naber, M.] Univ Utrecht, Expt Psychol, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University	Naber, M (corresponding author), Leiden Univ, Cognit Psychol, Wassenaarseweg 52, NL-2333 AK Leiden, Netherlands.; Naber, M (corresponding author), LUMC, Leiden Inst Brain & Cognit, NL-2300 RC Leiden, Netherlands.; Naber, M (corresponding author), Univ Utrecht, Expt Psychol, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.	marnixnaber@gmail.com		Naber, Marnix/0000-0003-4208-8437				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ash JA, 2014, NEUROBIOL DIS, V70, P32, DOI 10.1016/j.nbd.2014.06.001; Babb SM, 2004, PSYCHIAT RES-NEUROIM, V130, P1, DOI 10.1016/S0925-4927(03)00104-5; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BARTUS RT, 1985, ANN NY ACAD SCI, V444, P332, DOI 10.1111/j.1749-6632.1985.tb37600.x; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; BARTUS RT, 1981, NEUROBIOL AGING, V2, P105, DOI 10.1016/0197-4580(81)90007-5; Best T, 2009, BRIT J NUTR, V101, P93, DOI 10.1017/S0007114508984257; BLUSZTAJN JK, 1987, J NEURAL TRANSM, P247; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; BLUSZTAJN JK, 1987, P NATL ACAD SCI USA, V84, P5474, DOI 10.1073/pnas.84.15.5474; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buchman AL, 2000, J AM COLL NUTR, V19, P768, DOI 10.1080/07315724.2000.10718076; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; COHEN BM, 1995, JAMA-J AM MED ASSOC, V274, P902, DOI 10.1001/jama.274.11.902; COHEN EL, 1976, SCIENCE, V191, P561, DOI 10.1126/science.1251187; COHEN EL, 1975, LIFE SCI, V16, P1095, DOI 10.1016/0024-3205(75)90194-0; Colzato LS, 2014, NEUROPSYCHOLOGIA, V62, P398, DOI 10.1016/j.neuropsychologia.2013.12.027; Colzato LS, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00200; Colzato LS, 2013, PSYCHOL SCI, V24, P2575, DOI 10.1177/0956797613500795; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; ETIENNE P, 1981, NEUROLOGY, V31, P1552, DOI 10.1212/WNL.31.12.1552; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; FUNDARO A, 1990, PROG NEURO-PSYCHOPH, V14, P949, DOI 10.1016/0278-5846(90)90080-Z; Gonzalez-Gross M, 2001, BRIT J NUTR, V86, P313, DOI 10.1079/BJN2001388; Harel BT, 2013, PSYCHOPHARMACOLOGY, V228, P673, DOI 10.1007/s00213-013-3072-2; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; HAUBRICH DR, 1975, LIFE SCI, V17, P975, DOI 10.1016/0024-3205(75)90451-8; Higgins J, 2000, COCHRANE DATABASE SY, V2; HIRSCH MJ, 1978, METABOLISM, V27, P953, DOI 10.1016/0026-0495(78)90139-7; HIRSCH MJ, 1978, SCIENCE, V202, P223, DOI 10.1126/science.694529; Hollenbeck CB, 2010, J AM DIET ASSOC, V110, P1162, DOI 10.1016/j.jada.2010.05.012; Hsu YY, 2001, J GERIATR PSYCH NEUR, V14, P145, DOI 10.1177/089198870101400308; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kim HG, 2013, BRIT J NUTR, V110, P86, DOI 10.1017/S0007114512004710; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Kukolja J, 2009, J NEUROSCI, V29, P8119, DOI 10.1523/JNEUROSCI.0203-09.2009; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Li L, 1996, FASEB J, P20814; Love J., 2015, JASP VERSION 0 6 5 C; MECK WH, 1987, BEHAV NEUROSCI, V101, P457, DOI 10.1037/0735-7044.101.4.457; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; MIZUMORI SJY, 1985, NEUROBIOL AGING, V6, P51, DOI 10.1016/0197-4580(85)90072-7; MOHS RC, 1980, NEUROBIOL AGING, V1, P21, DOI 10.1016/0197-4580(80)90020-2; Molinengo L, 1997, BEHAV BRAIN RES, V84, P145, DOI 10.1016/S0166-4328(96)00143-X; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Moreno MD, 2003, CLIN THER, V25, P178; Naber M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13188; Naber M, 2013, J VISION, V13, DOI 10.1167/13.2.11; Nagrecha N, 2013, CLIN PHARM BIOPHARMA, V2013; Parnetti L, 2001, MECH AGEING DEV, V122, P2041, DOI 10.1016/S0047-6374(01)00312-8; Riby LM, 2006, BRIT J NUTR, V95, P414, DOI 10.1079/BJN20051649; SASAKI H, 1991, PHARMACOL BIOCHEM BE, V38, P921, DOI 10.1016/0091-3057(91)90265-4; Scapicchio PL, 2013, INT J NEUROSCI, V123, P444, DOI 10.3109/00207454.2013.765870; Schenk F, 1995, PSYCHOBIOLOGY, V23, P302; Sinn N, 2012, BRIT J NUTR, V107, P1682, DOI 10.1017/S0007114511004788; SPECTOR SA, 1995, MED SCI SPORT EXER, V27, P668; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Tees RC, 1999, BEHAV BRAIN RES, V105, P173, DOI 10.1016/S0166-4328(99)00074-1; THAL LJ, 1981, NEUROBIOL AGING, V2, P205, DOI 10.1016/0197-4580(81)90022-1; Traini E, 2013, CURR ALZHEIMER RES, V10, P1070, DOI 10.2174/15672050113106660173; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; VONALLWORDEN HN, 1993, EUR J APPL PHYSIOL O, V67, P87, DOI 10.1007/BF00377711; Warber JP, 2000, INT J SPORT NUTR, V10, P170, DOI 10.1123/ijsnem.10.2.170; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; WECKER L, 1988, J NEUROCHEM, V51, P497, DOI 10.1111/j.1471-4159.1988.tb01066.x; WURTMAN RJ, 1976, BIOCHEM PHARMACOL, V25, P1691, DOI 10.1016/0006-2952(76)90400-7; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6; Zeisel SH, 2000, NUTRITION, V16, P669, DOI 10.1016/S0899-9007(00)00349-X; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413	74	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157714	10.1371/journal.pone.0157714	http://dx.doi.org/10.1371/journal.pone.0157714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341028	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600016
J	van Mansfeld, R; de Been, M; Paganelli, F; Yang, L; Bonten, M; Willems, R				van Mansfeld, Rosa; de Been, Mark; Paganelli, Fernanda; Yang, Lei; Bonten, Marc; Willems, Rob			Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHRONIC INFECTION; STRAINS; ADAPTATION; EPIDEMIC; EXPRESSION; REGULATOR; SEQUENCE; DATABASE; MEXT	This study investigates adaptation of ST406, a prevalent P. aeruginosa clone, present in 15% of chronically infected cystic fibrosis (CF) patients in the Netherlands, in a newly infected CF patient during three years using whole genome sequencing (WGS), transcriptomics, and phenotypic assays, including biofilm formation. WGS-based phylogeny demonstrates that ST406 is genetically distinct from other reported CF related strains or epidemic clones. Comparative genomic analysis of the early (S1) and late (S2) isolate yielded 42 single nucleotide polymorphisms (SNPs) and 10 indels and a single 7 kb genomic fragment only found in S2. Most SNPs and differentially expressed genes encoded proteins involved in metabolism, secretion and signal transduction or transcription. SNPs were identified in regulator genes mexT and exsA and coincided with differential gene expression of mexE and mexF, encoding the MexE/F efflux pump, genes encoding the type six secretion system (T6SS) and type three secretion system (T3SS), which have also been previously implicated in adaptation of other P. aeruginosa strains during chronic infection of CF lungs. The observation that genetically different strains from different patients have accumulated similar genetic adaptations supports the concept of adaptive parallel evolution of P. aeruginosa in chronically infected CF patients. Phenotypically, there was loss of biofilm maturation coinciding with a significant lower level of transcription of both bfmR and bfmS during chronic colonization. These data suggest that the high-prevalent Dutch CF clone ST406 displays adaptation to the CF lung niche, which involves a limited number of mutations affecting regulators controlling biofilm formation and secretion and genes involved in metabolism. These genes could provide good targets for anti-pseudomonal therapy.	[van Mansfeld, Rosa; de Been, Mark; Paganelli, Fernanda; Bonten, Marc; Willems, Rob] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Yang, Lei] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Copenhagen, Denmark	Utrecht University; Utrecht University Medical Center; Technical University of Denmark	van Mansfeld, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	r.vanmansfeld@vumc.nl	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Yang, Lei/0000-0002-6155-9268	Netherlands Organization for Scientific Research (VICI NWO Grant) [918.76.611]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [iLoop] Funding Source: researchfish	Netherlands Organization for Scientific Research (VICI NWO Grant)(Netherlands Organization for Scientific Research (NWO)); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	M. Bonten is supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611), http://www.nwo.nl/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashish A, 2013, J CYST FIBROS, V12, P790, DOI 10.1016/j.jcf.2013.04.003; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Cao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004340; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Cramer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050731; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Cystic fibrosis foundation, 2012, PAT REG ANN DAT REP; de Vrankrijker AMM, 2011, CLIN MICROBIOL INFEC, V17, P382, DOI 10.1111/j.1469-0691.2010.03295.x; Dettman JR, 2013, P NATL ACAD SCI USA, V110, P21065, DOI 10.1073/pnas.1307862110; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Halmerbauer G, 2000, CLIN EXP ALLERGY, V30, P1771, DOI 10.1046/j.1365-2222.2000.00988.x; Harmer C, 2013, MICROBIOL-SGM, V159, P2354, DOI 10.1099/mic.0.066985-0; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hogardt M, 2013, CURR TOP MICROBIOL, V358, P91, DOI 10.1007/82_2011_199; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jeukens J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087611; Jiricny N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083124; Jones AM, 2002, THORAX, V57, P924, DOI 10.1136/thorax.57.11.924; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; Klockgether J, 2013, ENVIRON MICROBIOL, V15, P191, DOI 10.1111/j.1462-2920.2012.02842.x; Kohler T, 1999, J BACTERIOL, V181, P6300; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lore NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035648; Luong PM, 2014, J BACTERIOL, V196, P504, DOI 10.1128/JB.01050-13; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Manos J, 2013, EUR J CLIN MICROBIOL, V32, P1583, DOI 10.1007/s10096-013-1916-7; Marvig RL, 2015, FUTURE MICROBIOL, V10, P599, DOI [10.2217/FMB.15.3, 10.2217/fmb.15.3]; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; NCFS, 2012, DUTCH CYST FIBR REG; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Olivares J, 2012, ENVIRON MICROBIOL, V14, P1968, DOI 10.1111/j.1462-2920.2012.02727.x; Paganelli FL, 2013, MBIO, V4, DOI 10.1128/mBio.00154-13; Petrova OE, 2011, MOL MICROBIOL, V81, P767, DOI 10.1111/j.1365-2958.2011.07733.x; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; Poon KKH, 2008, J BACTERIOL, V190, P1857, DOI 10.1128/JB.01546-07; Rau MH, 2012, ENVIRON MICROBIOL, V14, P2200, DOI 10.1111/j.1462-2920.2012.02795.x; Sarkisova SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098985; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tian ZX, 2009, MICROB PATHOGENESIS, V47, P237, DOI 10.1016/j.micpath.2009.08.003; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Tingpej P, 2010, RESPIROLOGY, V15, P923, DOI 10.1111/j.1440-1843.2010.01792.x; Tramper-Stranders GA, 2012, CLIN MICROBIOL INFEC, V18, P567, DOI 10.1111/j.1469-0691.2011.03627.x; Tramper-Stranders GA, 2008, CLIN MICROBIOL INFEC; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winstanley C, 2016, TRENDS MICROBIOL; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	75	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158106	10.1371/journal.pone.0158106	http://dx.doi.org/10.1371/journal.pone.0158106			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337151	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200111
J	Su, Q; Zhang, B; Zhang, L; Dang, T; Rowley, D; Ittmann, M; Xin, L				Su, Q.; Zhang, B.; Zhang, L.; Dang, T.; Rowley, D.; Ittmann, M.; Xin, L.			Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; STEM-CELLS; E-CADHERIN; NOTCH; MECHANISM; TUMORIGENESIS; PROGRESSION; EXPRESSION; MICROENVIRONMENT	The role of Notch signaling in prostate cancer has not been defined definitively. Several large scale tissue microarray studies have revealed that the expression of some Notch signaling components including the Jagged1 ligand are upregulated in advanced human prostate cancer specimens. Jagged1 expressed by tumor cells may activate Notch signaling in both adjacent tumor cells and cells in tumor microenvironment. However, it remains undetermined whether increased Jagged1 expression reflects a cause for or a consequence of tumor progression in vivo. To address this question, we generated a novel R26-LSL-JAG1 mouse model that enables spatiotemporal Jagged1 expression. Prostate specific upregulation of Jagged1 neither interferes with prostate epithelial homeostasis nor significantly accelerates tumor initiation or progression in the prostate-specific Pten deletion mouse model for prostate cancer. However, Jagged1 upregulation results in increased inflammatory foci in tumors and incidence of intracystic adenocarcinoma. In addition, Jagged1 overexpression upregulates Tgf beta signaling in prostate stromal cells and promotes progression of a reactive stromal microenvironment in the Pten null prostate cancer model. Collectively, Jagged1 overexpression does not significantly accelerate prostate cancer initiation and progression in the context of loss-of-function of Pten, but alters tumor histopathology and microenvironment. Our study also highlights an understudied role of Notch signaling in regulating prostatic stromal homeostasis.	[Su, Q.; Zhang, B.; Zhang, L.; Dang, T.; Rowley, D.; Xin, L.] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA; [Su, Q.] Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA; [Rowley, D.; Ittmann, M.; Xin, L.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Ittmann, M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, M.] Baylor Coll Med, Vet Affairs Med Ctr, Michael E DeBakey Dept, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Xin, L (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	xin@bcm.edu			NIH [P30 AI036211, P30 CA125123, S10 RR024574, R01 CA190378, CA196570]; Mouse Embryonic Stem Cell Core at Baylor College of Medicine; NCI; NATIONAL CANCER INSTITUTE [P30CA125123, R21CA196570, R01CA190378] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mouse Embryonic Stem Cell Core at Baylor College of Medicine; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr Spyros Artavanis-Tsakonas for providing the human Jagged1 cDNA, the technical support by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123 and S10 RR024574) and the expert assistance of Joel M. Sederstrom. This work is supported by NIH R01 CA190378 (L.X.), CA196570 (L.X.), NIH P30 CA125123 (the Cancer Center Shared Resources Grant), the Mouse Embryonic Stem Cell Core at Baylor College of Medicine and NCI.	Alme AKB, 2016, UROL ONCOL-SEMIN ORI, V34, P171, DOI 10.1016/j.urolonc.2016.01.006; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Dalrymple S, 2005, CANCER RES, V65, P9269, DOI 10.1158/0008-5472.CAN-04-3989; Danza G, 2013, INT J CANCER, V133, P2577, DOI 10.1002/ijc.28293; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gibb DR, 2011, J IMMUNOL, V186, P4244, DOI 10.4049/jimmunol.1003318; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kwon OJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5416; Kwon OJ, 2016, J CLIN INVEST; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Njuguna J., 2013, NANOPROD REV J, V1, P1, DOI DOI 10.1074/JBC.M112.443580; Orr B, 2009, ENDOCRINOLOGY, V150, P463, DOI 10.1210/en.2008-0383; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pedrosa AR, 2015, ONCOTARGET, V6, P24404, DOI 10.18632/oncotarget.4380; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Shou JY, 2001, CANCER RES, V61, P7291; Steg AD, 2011, CLIN CANCER RES, V17, P5674, DOI 10.1158/1078-0432.CCR-11-0432; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Terada N, 2014, J CELL BIOCHEM, V115, P1505, DOI 10.1002/jcb.24805; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Valdez JM, 2012, CELL STEM CELL, V11, P676, DOI 10.1016/j.stem.2012.07.003; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang Z., 2011, INFORM RES, V2011, P1, DOI DOI 10.1111/J.1365-313X.2011.04659.X; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Yong T, 2011, J CELL BIOCHEM, V112, P2340, DOI 10.1002/jcb.23157; Yu YC, 2014, ASIAN TEST SYMPOSIUM, P1, DOI 10.1109/ATS.2014.13	49	24	27	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					618	627		10.1038/onc.2016.232	http://dx.doi.org/10.1038/onc.2016.232			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27345403	Green Accepted			2022-12-26	WOS:000394167700004
J	Yiangou, L; Montandon, R; Modrzynska, K; Rosen, B; Bushell, W; Hale, C; Billker, O; Rayner, JC; Pance, A				Yiangou, Loukia; Montandon, Ruddy; Modrzynska, Katarzyna; Rosen, Barry; Bushell, Wendy; Hale, Christine; Billker, Oliver; Rayner, Julian C.; Pance, Alena			A Stem Cell Strategy Identifies Glycophorin C as a Major Erythrocyte Receptor for the Rodent Malaria Parasite Plasmodium berghei	PLOS ONE			English	Article							SOUTHEAST-ASIAN OVALOCYTOSIS; PAPUA-NEW-GUINEA; BAND-3 AE1 GENE; RED-BLOOD-CELL; IN-VITRO; FALCIPARUM INVASION; DUFFY ANTIGEN; HEREDITARY SPHEROCYTOSIS; TARGETED INACTIVATION; POPULATION-GENETICS	The clinical complications of malaria are caused by the parasite expansion in the blood. Invasion of erythrocytes is a complex process that depends on multiple receptor-ligand interactions. Identification of host receptors is paramount for fighting the disease as it could reveal new intervention targets, but the enucleated nature of erythrocytes makes genetic approaches impossible and many receptors remain unknown. Host-parasite interactions evolve rapidly and are therefore likely to be species-specific. As a results, understanding of invasion receptors outside the major human pathogen Plasmodium falciparum is very limited. Here we use mouse embryonic stem cells (mESCs) that can be genetically engineered and differentiated into erythrocytes to identify receptors for the rodent malaria parasite Plasmodium berghei. Two proteins previously implicated in human malaria infection: glycophorin C (GYPC) and Band-3 (Slc4a1) were deleted in mESCs to generate stable cell lines, which were differentiated towards erythropoiesis. In vitro infection assays revealed that while deletion of Band-3 has no effect, absence of GYPC results in a dramatic decrease in invasion, demonstrating the crucial role of this protein for P. berghei infection. This stem cell approach offers the possibility of targeting genes that may be essential and therefore difficult to disrupt in whole organisms and has the potential to be applied to a variety of parasites in diverse host cell types.	[Yiangou, Loukia; Montandon, Ruddy; Modrzynska, Katarzyna; Billker, Oliver; Rayner, Julian C.; Pance, Alena] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England; [Rosen, Barry] Wellcome Trust Sanger Inst, Mouse Dev Genet & ES Cells Mutagenesis, Cambridge, England; [Bushell, Wendy] Wellcome Trust Sanger Inst, Cellular Genet, Cambridge, England; [Hale, Christine] Wellcome Trust Sanger Inst, Microbial Pathogenesis, Cambridge, England; [Yiangou, Loukia] Univ Cambridge, Dept Med, Anne McLaren Lab, Wellcome Trust MRC Stem Cell Inst, Cambridge, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Cambridge	Rayner, JC; Pance, A (corresponding author), Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England.	julian.rayner@sanger.ac.uk; alena.pance@sanger.ac.uk	Pance, Alena/AAH-2878-2021	Pance, Alena/0000-0002-9017-2644; Billker, Oliver/0000-0003-1716-168X; Yiangou, Loukia/0000-0003-1477-005X; Rayner, Julian/0000-0002-9835-1014	Sanger Institute by the Wellcome Trust	Sanger Institute by the Wellcome Trust	This work was funded by core funding of the Sanger Institute by the Wellcome Trust.	Akimitsu N, 2004, PARASITOL RES, V93, P499, DOI 10.1007/s00436-004-1165-x; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Balu B, 2011, EUKARYOT CELL, V10, P1257, DOI 10.1128/EC.05099-11; Bartholdson SJ, 2013, CELL MICROBIOL, V15, P1304, DOI 10.1111/cmi.12151; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Carotta S, 2004, BLOOD, V104, P1873, DOI 10.1182/blood-2004-02-0570; Cromer D, 2006, INT J PARASITOL, V36, P1389, DOI 10.1016/j.ijpara.2006.07.009; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; Hassoun H, 1998, BLOOD, V91, P2146, DOI 10.1182/blood.V91.6.2146.2146_2146_2151; Hassoun H, 1998, BLOOD, V92, P1785, DOI 10.1182/blood.V92.5.1785.417k17_1785_1792; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jarolim P, 1996, BLOOD, V88, P4366; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Kariuki MM, 2005, BIOCHEM BIOPH RES CO, V338, P1690, DOI 10.1016/j.bbrc.2005.10.154; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Malpede BM, 2013, J BIOL CHEM, V288, P12406, DOI 10.1074/jbc.M113.450643; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Ng S, 2015, STEM CELL REP, V4, P348, DOI 10.1016/j.stemcr.2015.01.002; Pasvol G, 2003, TRENDS PARASITOL, V19, P430, DOI 10.1016/j.pt.2003.08.005; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Ribeiro ML, 2000, BLOOD, V96, P1602; Satchwell TJ, 2015, HAEMATOLOGICA, V100, P133, DOI 10.3324/haematol.2014.114538; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh AP, 2005, MOL MICROBIOL, V55, P1925, DOI 10.1111/j.1365-2958.2005.04523.x; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Swardson-Olver CJ, 2002, BLOOD, V99, P2677, DOI 10.1182/blood.V99.8.2677; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Wilder JA, 2009, J HUM GENET, V54, P182, DOI 10.1038/jhg.2009.12; Williams TN, 2006, MOL BIOCHEM PARASIT, V149, P121, DOI 10.1016/j.molbiopara.2006.05.007; Yeung ATY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08908; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	51	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158238	10.1371/journal.pone.0158238	http://dx.doi.org/10.1371/journal.pone.0158238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362409	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200051
J	Korzyukov, Y; Hetzel, U; Kipar, A; Vapalahti, O; Hepojoki, J				Korzyukov, Yegor; Hetzel, Udo; Kipar, Anja; Vapalahti, Olli; Hepojoki, Jussi			Generation of Anti-Boa Immunoglobulin Antibodies for Serodiagnostic Applications, and Their Use to Detect Anti-Reptarenavirus Antibodies in Boa Constrictor	PLOS ONE			English	Article							INCLUSION-BODY DISEASE; IMMUNE-RESPONSE; FINGER PROTEIN; BOID SNAKES; ARENAVIRUSES; IDENTIFICATION; REPTILES; FUTURE; RNA	Immunoglobulins (Igs), the key effectors of the adaptive immune system, mediate the specific recognition of foreign structures, i.e. antigens. In mammals, IgM production commonly precedes the production of IgG in the response to an infection. The reptilian counterpart of IgG is IgY, but the exact kinetics of the reptilian immune response are less well known. Boid inclusion body disease (BIBD), an often fatal disease of captive boas and pythons has been linked to reptarenavirus infection, and BIBD is believed to be immunosuppressive. However, so far, the study of the serological response towards reptarenaviruses in BIBD has been hampered by the lack of reagents. Thus we set up a purification protocol for boa constrictor IgY and IgM, which should also be applicable for other snake species. We used centrifugal filter units, poly ethylene glycol precipitation and gel permeation chromatography to purify and separate the IgM and IgY fractions from boa constrictor serum, which we further used to immunise rabbits. We affinity purified IgM and IgY specific reagents from the produced antiserum, and labelled the reagents with horseradish peroxidase. Finally, using the sera of snakes with known exposure to reptarenaviruses we demonstrated that the newly generated reagents can be utilised for serodiagnostic purposes, such as immunoblotting and immunofluorescent staining. To our knowledge, this is the first report to show reptarenavirus-specific antibodies in boa constrictors.	[Korzyukov, Yegor; Vapalahti, Olli; Hepojoki, Jussi] Univ Helsinki, Med, Dept Virol, Helsinki, Finland; [Hetzel, Udo; Kipar, Anja] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Vapalahti, Olli] Univ Helsinki, Helsinki, Finland; [Vapalahti, Olli] Helsinki Univ Hosp, Dept Virol, Helsinki, Finland	University of Helsinki; University of Zurich; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Hepojoki, J (corresponding author), Univ Helsinki, Med, Dept Virol, Helsinki, Finland.	jussi.hepojoki@uzh.ch	Korzyukov, Yegor/G-9621-2018; Hepojoki, Jussi/W-4667-2017; Kipar, Anja/L-7214-2014	Korzyukov, Yegor/0000-0001-8723-0885; Hepojoki, Jussi/0000-0001-5699-214X; Kipar, Anja/0000-0001-7289-3459; Vapalahti, Olli/0000-0003-2270-6824	Jenny and Antti Wihuri Foundation; University of Helsinki Doctoral Programme in Biomedicine; Academy of Finland (Terveyden Tutkimuksen Toimikunta); Finnish Foundation of Veterinary Research	Jenny and Antti Wihuri Foundation; University of Helsinki Doctoral Programme in Biomedicine; Academy of Finland (Terveyden Tutkimuksen Toimikunta)(Academy of Finland); Finnish Foundation of Veterinary Research	The research described in the manuscript was funded by the following foundations and institutions: Jenny and Antti Wihuri Foundation (http://wihurinrahasto.fi/?lang=en), University of Helsinki Doctoral Programme in Biomedicine (http://www.helsinki.fi/dpbm/), Academy of Finland (Terveyden Tutkimuksen Toimikunta) (http://www.aka.fi/en/), and the Finnish Foundation of Veterinary Research (http://www.sels.fi/index_eng.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPERIN DD, 1984, J VIROL, V52, P897, DOI 10.1128/JVI.52.3.897-904.1984; Bodewes R, 2013, J GEN VIROL, V94, P1206, DOI 10.1099/vir.0.051995-0; Brown DR, 2002, FRONT BIOSCI-LANDMRK, V7, pD1338, DOI 10.2741/brown; Chang LW, 2010, J EXOT PET MED, V19, P216, DOI 10.1053/j.jepm.2010.07.014; Charrel RN, 2011, ANTIVIR RES, V90, P102, DOI 10.1016/j.antiviral.2011.02.009; CLEGG JCS, 1991, VIRUS RES, V18, P151, DOI 10.1016/0168-1702(91)90015-N; Coico R, 2003, IMMUNOLOGY SHORT COU, P361; Fehling SK, 2012, VIRUSES-BASEL, V4, P2973, DOI 10.3390/v4112973; Gambon-Deza F, 2012, DEV COMP IMMUNOL, V38, P1, DOI 10.1016/j.dci.2012.03.001; GREY HM, 1963, J IMMUNOL, V91, P819; Hepojoki J, 2015, J VIROL, V89, P8657, DOI 10.1128/JVI.01112-15; Hepojoki J, 2015, J VIROL, V89, P1119, DOI 10.1128/JVI.03119-14; Hetzel U, 2013, J VIROL, V87, P10918, DOI 10.1128/JVI.01123-13; INGRAM GA, 1983, VET IMMUNOL IMMUNOP, V4, P479, DOI 10.1016/0165-2427(83)90008-9; Jaffredo T., 2006, ELS, DOI [10.1038/npg.els.0000521, DOI 10.1038/NPG.ELS.0000521]; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; MARCHALONIS JJ, 1969, AUST J EXP BIOL MED, V47, P367, DOI 10.1038/icb.1969.40; Mindell DP, 1999, SYST BIOL, V48, P138, DOI 10.1080/106351599260490; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Oldstone MBA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000523; Origgi FC, 2001, J CLIN MICROBIOL, V39, P3156, DOI 10.1128/JCM.39.9.3156-3163.2001; Pauly D, 2011, J VIS EXP; Pye GW, 2001, J ZOO WILDLIFE MED, V32, P196, DOI 10.1638/1042-7260(2001)032[0196:EIOBNC]2.0.CO;2; Pythoud C, 2012, J VIROL, V86, P7728, DOI 10.1128/JVI.00187-12; Radoshitzky SR, 2015, ARCH VIROL, V160, P1851, DOI 10.1007/s00705-015-2418-y; Ren H, 2016, ATLA-ALTERN LAB ANIM, V44, P11, DOI 10.1177/026119291604400111; SALVATO MS, 1989, VIROLOGY, V173, P1, DOI 10.1016/0042-6822(89)90216-X; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P511; Stenglein MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004900; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Wang T, 2012, J IMMUNOL, V189, P3557, DOI 10.4049/jimmunol.1200212; Work TM, 2000, VET IMMUNOL IMMUNOP, V74, P179, DOI 10.1016/S0165-2427(00)00168-9; Wozniak E, 2000, VET PATHOL, V37, P449, DOI 10.1354/vp.37-5-449; Xing JJ, 2015, J VIROL, V89, P2944, DOI 10.1128/JVI.03349-14; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	38	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158417	10.1371/journal.pone.0158417	http://dx.doi.org/10.1371/journal.pone.0158417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355360	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000378859400063
J	Salinero, MC; Michalski, F				Salinero, Maria Celeste; Michalski, Fernanda			Implications of Scientific Collaboration Networks on Studies of Aquatic Vertebrates in the Brazilian Amazon	PLOS ONE			English	Article							SOTALIA-FLUVIATILIS; PODOCNEMIS-UNIFILIS; NATIVE AMAZONIANS; CONSERVATION; GAME; BIODIVERSITY; TRENDS; PREDATION; PATTERNS; ANIMALS	The quantity of wildlife extracted from the Amazon has increased in the past decades as a consequence of an increase in human population density and income growth. To evaluate the spatial distribution of studies on subsistence and/or commercial hunting conducted in the Brazilian Amazon, we selected eight mid-sized and large-bodied aquatic vertebrate species with a history of human exploitation in the region. We used a combination of searches in the gray and scientific literature from the past 24 years to provide an updated distributional map of studies on the target species. We calculated the distances between the study sites and the locations of the research institutes/universities that the first and last authors of the same study were affiliated to. For the period of 1990 to 2014, we found 105 studies on the subsistence and/or commercial hunting of aquatic vertebrates in the Brazilian Amazon in 271 locations that involved 43 institutions (37 Brazilian and 6 international). The spatial distribution of the studies across the Brazilian Amazon varied, but over 80% took place in the northeast and central Amazon, encompassing three States of the Legal Brazilian Amazon (Amazonas, 51.42%; Para, 19.05%; and Amapa, 16.19%). Over half of the research study sites (52.91%) were within 500 km of the research institute/university of the first or last authors. Some research institutes/universities did not have any inter-institutional collaborations, while others collaborated with eight or more institutes. Some research institutes/universities conducted many studies, had an extensive collaboration network, and contributed greatly to the network of studies on Amazonian aquatic vertebrates. Our research contributes to the knowledge of studies on the subsistence and/or commercial hunting of the most exploited aquatic vertebrates of the Brazilian Amazon, illustrates the impact that collaboration networks have on research, and highlights potential areas for improvement and the generation of new collaborations.	[Salinero, Maria Celeste; Michalski, Fernanda] Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil; [Salinero, Maria Celeste; Michalski, Fernanda] Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil; [Michalski, Fernanda] Inst Procarnivoros, Atibaia, SP, Brazil	Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa	Michalski, F (corresponding author), Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Inst Procarnivoros, Atibaia, SP, Brazil.	fmichalski@gmail.com	Vicent, David/O-2255-2014; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Michalski, Fernanda/J-4691-2012	Vicent, David/0000-0002-6663-0350; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Michalski, Fernanda/0000-0002-8074-9964; Lahoz, Carlos/0000-0001-5690-7558; Gomez Campelo, Paloma/0000-0003-2299-1741	Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES) [88881.030414/2013-01]	Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MS received an MSc scholarship from the Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES). This work was partially funded by a research grant to FM (Project 88881.030414/2013-01) from the Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RRN, 2008, HUM ECOL, V36, P443, DOI 10.1007/s10745-008-9174-5; Alves RRN, 2012, HUM ECOL, V40, P751, DOI 10.1007/s10745-012-9516-1; Baia PC, 2010, REV BIOL TROP, V58, P1079; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Bian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111928; Coway-Gomez K, 2007, CHELONIAN CONSERV BI, V6, P199; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Da Silveira R, 1999, BIOL CONSERV, V88, P103, DOI 10.1016/S0006-3207(98)00084-6; ESRI, 2009, ARCGIS DESKT REL 9 3; FAO, FAO FOR MAN WORK PAP; Glanzel W, 2002, LIBR TRENDS, V50, P461; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leimu R, 2005, BIOSCIENCE, V55, P438, DOI 10.1641/0006-3568(2005)055[0438:DSCITI]2.0.CO;2; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; Martin AR, 2004, MAR MAMMAL SCI, V20, P189, DOI 10.1111/j.1748-7692.2004.tb01150.x; Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Alves RRN, 2012, ENVIRON MONIT ASSESS, V184, P6877, DOI 10.1007/s10661-011-2465-0; Alves RRN, 2010, HUM ECOL, V38, P691, DOI 10.1007/s10745-010-9352-0; Norris D, 2013, ZOOLOGIA-CURITIBA, V30, P482, DOI 10.1590/S1984-46702013000500003; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; R Development Core Team, 2014, R 3 1 1 LANG ENV STA; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; ROSAS FCW, 1994, MAMMAL REV, V24, P49, DOI 10.1111/j.1365-2907.1994.tb00134.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schneider L, 2011, CHELONIAN CONSERV BI, V10, P149, DOI 10.2744/CCB-0848.1; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Somaweera R, 2013, HERPETOL MONOGR, V27, P23, DOI 10.1655/HERPMONOGRAPHS-D-11-00001; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Uddin S, 2012, SCIENTOMETRICS, V90, P687, DOI 10.1007/s11192-011-0511-x; Verissimo A, 2011, AREAS PROTEGIDAS AMA; Visser J. A., 2000, AM J DISTANCE ED, V14, P21, DOI [10.1080/08923640009527062, DOI 10.1080/08923640009527062, 10.1080/]; Wright SJ, 2003, PERSPECT PLANT ECOL, V6, P73, DOI 10.1078/1433-8319-00043	47	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158413	10.1371/journal.pone.0158413	http://dx.doi.org/10.1371/journal.pone.0158413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352247	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900057
J	Vallerie, SN; Kramer, F; Barnhart, S; Kanter, JE; Breyer, RM; Andreasson, KI; Bornfeldt, KE				Vallerie, Sara N.; Kramer, Farah; Barnhart, Shelley; Kanter, Jenny E.; Breyer, Richard M.; Andreasson, Katrin I.; Bornfeldt, Karin E.			Myeloid Cell Prostaglandin E-2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes	PLOS ONE			English	Article							RESPONSE FACTOR-I; ATHEROSCLEROTIC LESIONS; GENE-EXPRESSION; ACCELERATED ATHEROSCLEROSIS; HUMAN MACROPHAGES; IMMUNE-RESPONSES; PERITONEAL-MACROPHAGES; SIGNALING PATHWAY; PLAQUE REGRESSION; CYCLIC-AMP	Type 1 diabetes mellitus (T1DM) is associated with cardiovascular complications induced by atherosclerosis. Prostaglandin E-2 (PGE(2)) is often raised in states of inflammation, including diabetes, and regulates inflammatory processes. In myeloid cells, a key cell type in atherosclerosis, PGE(2) acts predominately through its Prostaglandin E Receptor 4 (EP4; Ptger4) to modulate inflammation. The effect of PGE(2)-mediated EP4 signaling specifically in myeloid cells on atherosclerosis in the presence and absence of diabetes is unknown. Because diabetes promotes atherosclerosis through increased arterial myeloid cell accumulation, we generated a myeloid cell-targeted EP4-deficient mouse model (EP4(M-/-)) of T1DM-accelerated atherogenesis to investigate the relationship between myeloid cell EP4, inflammatory phenotypes of myeloid cells, and atherogenesis. Diabetic mice exhibited elevated plasma PGE metabolite levels and elevated Ptger4 mRNA in macrophages, as compared with non-diabetic littermates. PGE(2) increased II6, II1b, II23 and Ccr7 mRNA while reducing Tnfa mRNA through EP4 in isolated myeloid cells. Consistently, the stimulatory effect of diabetes on peritoneal macrophage II6 was mediated by PGE(2)-EP4, while PGE(2)-EP4 suppressed the effect of diabetes on Tnfa in these cells. In addition, diabetes exerted effects independent of myeloid cell EP4, including a reduction in macrophage Ccr7 levels and increased early atherogenesis characterized by relative lesional macrophage accumulation. These studies suggest that this mouse model of T1DM is associated with increased myeloid cell PGE(2)-EP4 signaling, which is required for the stimulatory effect of diabetes on IL-6, markedly blunts the effect of diabetes on TNF-alpha and does not modulate diabetes-accelerated atherogenesis.	[Vallerie, Sara N.; Kramer, Farah; Barnhart, Shelley; Kanter, Jenny E.; Bornfeldt, Karin E.] Univ Washington, UW Diabet Inst, Dept Med, Seattle, WA 98109 USA; [Bornfeldt, Karin E.] Univ Washington, UW Diabet Inst, Dept Pathol, Seattle, WA 98109 USA; [Breyer, Richard M.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Andreasson, Katrin I.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; Stanford University	Bornfeldt, KE (corresponding author), Univ Washington, UW Diabet Inst, Dept Med, Seattle, WA 98109 USA.; Bornfeldt, KE (corresponding author), Univ Washington, UW Diabet Inst, Dept Pathol, Seattle, WA 98109 USA.	bornf@u.washington.edu	Bornfeldt, Karin/AAI-2241-2019	Bornfeldt, Karin/0000-0001-9208-6523; Kanter, Jenny/0000-0003-3212-772X	National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases [R01HL062887, P01HL092969, R01HL126028, DP3DK108209]; Diabetes Research Center at the University of Washington [P30DK017047]; American Heart Association [14GRNT20410033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028, R01HL126028, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Research Center at the University of Washington; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases under award numbers R01HL062887, P01HL092969, R01HL126028, DP3DK108209, and the Diabetes Research Center at the University of Washington (P30DK017047), and by the American Heart Association (14GRNT20410033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; AXELROD L, 1986, DIABETES, V35, P1004, DOI 10.2337/diabetes.35.9.1004; Babaev VR, 2008, CELL METAB, V8, P492, DOI 10.1016/j.cmet.2008.09.005; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; CHASE HP, 1979, J PEDIATR-US, V94, P185, DOI 10.1016/S0022-3476(79)80819-7; Chen LH, 2014, P NATL ACAD SCI USA, V111, P6828, DOI 10.1073/pnas.1401797111; Chen SSH, 2009, DIABETIC MED, V26, P182, DOI 10.1111/j.1464-5491.2008.02658.x; Cote SC, 2009, MOL IMMUNOL, V46, P2682, DOI 10.1016/j.molimm.2008.08.269; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Distel E, 2014, CIRC RES, V115, P759, DOI 10.1161/CIRCRESAHA.115.304164; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ESMATJES E, 1987, DIABETES CARE, V10, P428, DOI 10.2337/diacare.10.4.428; Faour WH, 2005, J BIOL CHEM, V280, P9536, DOI 10.1074/jbc.M414067200; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Ikushima YM, 2013, BLOOD, V121, P1995, DOI 10.1182/blood-2012-06-437889; Jia ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093182; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanter JE, 2013, TRENDS ENDOCRIN MET, V24, P137, DOI 10.1016/j.tem.2012.10.002; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Koulis C, 2014, CLIN SCI, V127, P485, DOI 10.1042/CS20140045; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; MacDougall ED, 2006, AM J PATHOL, V168, P2064, DOI 10.2353/ajpath.2006.051009; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Mohamed R, 2013, LAB INVEST, V93, P933, DOI 10.1038/labinvest.2013.85; MOURITSANDERSEN T, 1986, PROSTAG LEUKOTR ESS, V22, P335, DOI 10.1016/0262-1746(86)90144-7; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nakatsuji M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005542; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Nathan DM, 2014, DIABETES, V63, P282, DOI 10.2337/db13-0782; Nishizawa T, 2014, CELL REP, V7, P356, DOI 10.1016/j.celrep.2014.03.028; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; QIU ZH, 1993, J BIOL CHEM, V268, P24506; Raychaudhuri Nupur, 2010, PLoS One, V5, pe15296, DOI 10.1371/journal.pone.0015296; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Schiffmann S, 2014, BIOCHEM PHARMACOL, V87, P625, DOI 10.1016/j.bcp.2013.12.006; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Shao SY, 2012, CELL IMMUNOL, V280, P16, DOI 10.1016/j.cellimm.2012.11.001; Sharma A, 2015, DIABETES, V64, P3937, DOI 10.2337/db15-0472; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang EHC, 2011, CARDIOVASC RES, V89, P234, DOI 10.1093/cvr/cvq262; Tang EHC, 2011, ARTERIOSCL THROM VAS, V31, P261, DOI 10.1161/ATVBAHA.110.216580; Vennemann A, 2012, DIABETES, V61, P1879, DOI 10.2337/db11-1396; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Wen YS, 2006, ENDOCRINOLOGY, V147, P2518, DOI 10.1210/en.2005-0519; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zhu XC, 2006, J IMMUNOL, V177, P4299, DOI 10.4049/jimmunol.177.7.4299	60	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158316	10.1371/journal.pone.0158316	http://dx.doi.org/10.1371/journal.pone.0158316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351842	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900053
J	Kurkcuoglu, Z; Doruker, P				Kurkcuoglu, Zeynep; Doruker, Pemra			Ligand Docking to Intermediate and Close-To-Bound Conformers Generated by an Elastic Network Model Based Algorithm for Highly Flexible Proteins	PLOS ONE			English	Article							ADENYLATE KINASE; CONFORMATIONAL-CHANGES; TRIOSEPHOSPHATE ISOMERASE; MOLECULAR-DYNAMICS; GLOBAL FLEXIBILITY; ESCHERICHIA-COLI; SINGLE-PARAMETER; BINDING-PROTEIN; TRANSITIONS; MOTIONS	Incorporating receptor flexibility in small ligand-protein docking still poses a challenge for proteins undergoing large conformational changes. In the absence of bound structures, sampling conformers that are accessible by apo state may facilitate docking and drug design studies. For this aim, we developed an unbiased conformational search algorithm, by integrating global modes from elastic network model, clustering and energy minimization with implicit solvation. Our dataset consists of five diverse proteins with apo to complex RMSDs 4.7-15 angstrom. Applying this iterative algorithm on apo structures, conformers close to the bound-state (RMSD 1.4-3.8 angstrom), as well as the intermediate states were generated. Dockings to a sequence of conformers consisting of a closed structure and its "parents" up to the apo were performed to compare binding poses on different states of the receptor. For two periplasmic binding proteins and biotin carboxylase that exhibit hinge-type closure of two dynamics domains, the best pose was obtained for the conformer closest to the bound structure (ligand RMSDs 1.5-2 angstrom). In contrast, the best pose for adenylate kinase corresponded to an intermediate state with partially closed LID domain and open NMP domain, in line with recent studies (ligand RMSD 2.9 angstrom). The docking of a helical peptide to calmodulin was the most challenging case due to the complexity of its 15 angstrom transition, for which a two-stage procedure was necessary. The technique was first applied on the extended calmodulin to generate intermediate conformers; then peptide docking and a second generation stage on the complex were performed, which in turn yielded a final peptide RMSD of 2.9 angstrom. Our algorithm is effective in producing conformational states based on the apo state. This study underlines the importance of such intermediate states for ligand docking to proteins undergoing large transitions.	[Kurkcuoglu, Zeynep; Doruker, Pemra] Bogazici Univ, Dept Chem Engn, TR-34342 Istanbul, Turkey; Bogazici Univ, Polymer Res Ctr, TR-34342 Istanbul, Turkey; [Kurkcuoglu, Zeynep] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Paduaalan 8, NL-3584 CH Utrecht, Netherlands	Bogazici University; Bogazici University; Utrecht University	Kurkcuoglu, Z; Doruker, P (corresponding author), Bogazici Univ, Dept Chem Engn, TR-34342 Istanbul, Turkey.; Kurkcuoglu, Z (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Paduaalan 8, NL-3584 CH Utrecht, Netherlands.	zeynep.kurkcuoglu@boun.edu.tr; doruker@boun.edu.tr	Kurkcuoglu, Zeynep/AAG-2591-2019	Doruker, Pemra/0000-0002-4824-2223	Scientific and Technological Research Council of Turkey (TUBITAK) [112M237]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) Project No: 112M237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, J CHEM INF MODEL, V51, P1604, DOI 10.1021/ci100461k; Akten ED, 2009, J BIOMOL STRUCT DYN, V27, P13, DOI 10.1080/07391102.2009.10507292; Al-Bluwi I, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-S1-S2; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Atilgan C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000544; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Bolia A, 2014, J CHEM INF MODEL, V54, P913, DOI 10.1021/ci4004927; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Case DA, 2012, AMBER 12; Cavasotto CN, 2005, J AM CHEM SOC, V127, P9632, DOI 10.1021/ja042260c; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Das A, 2014, PROTEIN SCI, V24, P267; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dietzen M, 2012, J CHEM INF MODEL, V52, P844, DOI 10.1021/ci2004847; Dobbins SE, 2008, P NATL ACAD SCI USA, V105, P10390, DOI 10.1073/pnas.0802496105; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Feng YP, 2009, PROTEINS, V77, P551, DOI 10.1002/prot.22467; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Flores SC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-417; Gur M, 2013, BIOPHYS J, V105, P1643, DOI 10.1016/j.bpj.2013.07.058; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Jimenez-Roldan JE, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016008; Kantarci-Carsibasi N, 2008, BIOPHYS J, V95, P5862, DOI 10.1529/biophysj.107.128447; Karaca E, 2013, METHODS, V59, P372, DOI 10.1016/j.ymeth.2012.12.004; Karaca E, 2011, STRUCTURE, V19, P555, DOI 10.1016/j.str.2011.01.014; Kim MK, 2005, BIOPHYS J, V89, P43, DOI 10.1529/biophysj.104.044347; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kirillova S, 2008, PROTEINS, V70, P131, DOI 10.1002/prot.21570; KOLINSKI A, 1994, PROTEINS, V18, P338, DOI 10.1002/prot.340180405; Kurkcuoglu O, 2009, BIOPHYS J, V97, P1178, DOI 10.1016/j.bpj.2009.06.009; Kurkcuoglu Z, 2015, BIOPHYS J, V109, P1169, DOI 10.1016/j.bpj.2015.06.031; Kurkcuoglu Z, 2011, MOL INFORM, V30, P986, DOI 10.1002/minf.201100109; Kursula P, MODE BINDIN IN PRESS; Leis S, 2011, J COMPUT CHEM, V32, P3433, DOI 10.1002/jcc.21923; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; May A, 2008, J MED CHEM, V51, P3499, DOI 10.1021/jm800071v; May A, 2008, PROTEINS, V70, P794, DOI 10.1002/prot.21579; Moal IH, 2010, INT J MOL SCI, V11, P3623, DOI 10.3390/ijms11103623; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; OH BH, 1993, J BIOL CHEM, V268, P11348; Pontiggia F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.048102; Pontiggia F, 2008, BIOPHYS J, V95, P5901, DOI 10.1529/biophysj.108.135467; Rueda M, 2009, J CHEM INF MODEL, V49, P716, DOI 10.1021/ci8003732; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; Schneidman-Duhovny D, 2007, PROTEINS, V69, P764, DOI 10.1002/prot.21759; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Seeliger D, 2007, STRUCTURE, V15, P1482, DOI 10.1016/j.str.2007.09.017; Seeliger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000634; SEYLER SL, 2014, MOL SIMULAT, V40, P1; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Uyar A, 2014, BIOPHYS J, V106, P2656, DOI 10.1016/j.bpj.2014.05.017; Vashisth H, 2012, J PHYS CHEM LETT, V3, P3379, DOI 10.1021/jz301650q; Wang Y, 2013, J CHEM THEORY COMPUT, V9, P84, DOI 10.1021/ct300720s; Zheng WJ, 2006, BIOPHYS J, V90, P4327, DOI 10.1529/biophysj.105.076836; Zheng WJ, 2005, BIOPHYS J, V88, P3109, DOI 10.1529/biophysj.104.058453	74	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158063	10.1371/journal.pone.0158063	http://dx.doi.org/10.1371/journal.pone.0158063			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348230	Green Published, gold			2022-12-26	WOS:000378801200032
J	Nishida, K; Kubota, T; Matsumoto, S; Kato, J; Watanabe, Y; Yamamoto, A; Furui, M; Ohishi, A; Nagasawa, K				Nishida, Kentaro; Kubota, Teruyo; Matsumoto, Saki; Kato, Junki; Watanabe, Yu; Yamamoto, Atsuko; Furui, Mari; Ohishi, Akihiro; Nagasawa, Kazuki			Expression of Prostatic Acid Phosphatase in Rat Circumvallate Papillae	PLOS ONE			English	Article							MOUSE TASTE-BUDS; ECTO-ATPASE; FUNCTIONAL EXPRESSION; CELLS; RECEPTORS; ECTONUCLEOTIDASE; ADENOSINE; COMMUNICATION; SWEET	ATP and its metabolites are important for taste signaling in taste buds, and thus a clearance system for them would play critical roles in maintenance of gustatory function. A previous report revealed that mRNAs for ecto-50-nucleotidase (NT5E) and prostatic acid phosphatase (PAP) were expressed by taste cells of taste buds, and NT5E-immunoreactivity was detected in taste cells. However, there was no information on PAP-immunoreactivity in taste buds. In this study, we examined the expression profile of PAP in rat taste buds. In the isolated rat taste buds, we detected expression of mRNA for PAP, but NT5E was not detected differing from the case of mouse ones (Dando et al., 2012, J Neuroscience). On immunohistochemical analysis, PAP-immunoreactivity was found predominantly in NTPDase2-positive type I and SNAP25-positive type III taste cells, while there were no apparent signals of it in PLC-beta 2-positive type II, alpha-gustducin-positive type II, AADC-positive type III and 5HT-positive type III ones. As for NT5E, we could not detect its immunoreactivity in rat taste buds, and co-localization of it with any taste cell markers, although mouse taste buds expressed NT5E as reported previously. These findings suggest that PAP expressed by type I and one of type III taste cells of rats may contribute to metabolic regulation of the extracellular levels of adenine nucleotides in the taste buds of circumvallate papillae, and the regulating mechanisms for adenine nucleotides in taste buds might be different between rats and mice.	[Nishida, Kentaro; Kubota, Teruyo; Matsumoto, Saki; Kato, Junki; Watanabe, Yu; Yamamoto, Atsuko; Furui, Mari; Ohishi, Akihiro; Nagasawa, Kazuki] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, 5 Nakauchi Cho, Kyoto 607, Japan	Kyoto Pharmaceutical University	Nagasawa, K (corresponding author), Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, 5 Nakauchi Cho, Kyoto 607, Japan.	nagasawa@mb.kyoto-phu.ac.jp		Nishida, Kentaro/0000-0001-8597-4848; Ohishi, Akihiro/0000-0003-2756-1177	Ministry of Education, Culture, Sports, Science and Technology, Japan [22790134]; Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Nakatomi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Nakatomi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities	This work was supported by a Grant-in-Aid for Young Scientists (B) (#22790134 to K. Nishida) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants from Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to K. Nishida), the Nakatomi Foundation (to K. Nishida), and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 (to K. Nishida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Dando R, 2012, J NEUROSCI, V32, P322, DOI 10.1523/JNEUROSCI.4070-11.2012; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Kataoka S, 2004, HISTOCHEM CELL BIOL, V121, P419, DOI 10.1007/s00418-004-0647-3; Kataoka S, 2012, PLOS ONE, V7, P339, DOI 10.1371/journal.pone.0030032; Kawano J, 2008, J COMP NEUROL, V510, P1, DOI 10.1002/cne.21734; Kegel B, 1997, NEUROPHARMACOLOGY, V36, P1189, DOI 10.1016/S0028-3908(97)00115-9; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Mateo J, 1999, BRIT J PHARMACOL, V128, P396, DOI 10.1038/sj.bjp.0702805; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Nishida K, 2014, HISTOCHEM CELL BIOL, V141, P499, DOI 10.1007/s00418-013-1171-0; Nishida K, 2013, NEUROSCI LETT, V533, P104, DOI 10.1016/j.neulet.2012.10.063; Oiso S, 2009, J NEUROCHEM, V109, P158, DOI 10.1111/j.1471-4159.2009.05928.x; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sowa NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004248; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Vandenbeuch A, 2013, P NATL ACAD SCI USA, V110, P14789, DOI 10.1073/pnas.1309468110; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; Vroman R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001864; Wang H, 2009, J COMP NEUROL, V512, P384, DOI 10.1002/cne.21899; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158401	10.1371/journal.pone.0158401	http://dx.doi.org/10.1371/journal.pone.0158401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348306	Green Submitted, gold, Green Published			2022-12-26	WOS:000378801200066
J	Lee, VHF; Lo, AWI; Leung, CY; Shek, WH; Kwong, DLW; Lam, KO; Tong, CC; Sze, CK; Leung, TW				Lee, Victor H. F.; Lo, Anthony W. I.; Leung, Chun-Yin; Shek, Wai-Hung; Kwong, Dora L. W.; Lam, Ka-On; Tong, Chi-Chung; Sze, Chun-Kin; Leung, To-Wai			Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma	PLOS ONE			English	Article							PROGRAMMED DEATH-1 LIGAND-1; EPIDERMAL-GROWTH-FACTOR; CLINICAL-SIGNIFICANCE; B7-H1 PD-L1; PHASE-II; RADIOTHERAPY; CANCER; CHEMOTHERAPY; CETUXIMAB; CHEMORADIATION	Purpose We investigated if programmed death-ligand 1 (PD-L1) expression levels were prognostic of survival outcomes after intensity-modulated radiation therapy (IMRT) for non-metastatic nasopharyngeal carcinoma (NPC). Methods and Materials 104 patients with non-metastatic NPC treated with radical IMRT were investigated for their PD-L1 expression by immunohistochemistry (IHC) which were correlated with survival end-points including locoregional failure-free survival (LRFFS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and overall survival (OS). Results After a median follow-up of 7.6 years, 21 (20.2%), 19 (18.3%) and 31 (29.8%) patients suffered from locoregional failure, distant metastases and overall disease progression, respectively, and 31 (29.8%) patients died. Patients whose tumors had PD-L1 IHC 2+ (moderate to strong membrane staining in >= 25% of tumor cells) enjoyed longer LRFFS (5-year 100% vs. 74.4%, Hazard ratio [HR], 0.159, 95% confidence interval [CI], 0.021-0.988; P = 0.042) and marginally longer PFS (5-year 95.0% vs. 65.2%, HR, 0.351, 95% CI, 0.08-0.999, P = 0.067) compared to those whose tumors had PD-L1 IHC 0 (minimal membrane staining with PD-L1 in <5% tumor cells or no staining with PD-L1) or 1+ (minimal to moderate membrane staining with PD-L1 in between 5-24% tumor cells). PD-L1 IHC 2+ was independently prognostic of both LRFFS (P = 0.014) and PFS (P = 0.045) in multivariable analyses. Only induction chemotherapy followed by concurrent chemoradiation was prognostic of DMFS (P = 0.003) and no prognostic factor for OS was identified. Conclusion PD-L1 expression levels correlated with LRRFS and PFS in non-metastatic NPC treated with radical IMRT. It may play a role in radiosensitivity for NPC, which should be further confirmed in prospective studies using immunotherapy together with IMRT.	[Lee, Victor H. F.; Kwong, Dora L. W.; Lam, Ka-On; Tong, Chi-Chung; Sze, Chun-Kin; Leung, To-Wai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lo, Anthony W. I.; Shek, Wai-Hung] Queen Mary Hosp, Anat Pathol, Hong Kong, Hong Kong, Peoples R China; [Leung, Chun-Yin] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Lee, VHF (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	vhflee@hku.hk	Leung, William Chun Yin/A-8990-2016; Lo, Anthony W. I./G-5414-2015; Leung, William C.Y./N-5281-2019; /D-7948-2011	Leung, William Chun Yin/0000-0001-7363-0239; Lo, Anthony W. I./0000-0002-9388-310X; Leung, William C.Y./0000-0001-7363-0239; Tong, Chi Chung/0000-0001-6400-5255; Lee, Victor/0000-0002-6283-978X; /0000-0002-7523-5088				Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Boland JM, 2013, CLIN LUNG CANCER, V14, P157, DOI 10.1016/j.cllc.2012.05.006; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BONNER JA, 1994, INT J RADIAT ONCOL, V29, P243, DOI 10.1016/0360-3016(94)90269-0; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; He X, 2013, FUTURE ONCOL, V9, P1459, DOI 10.2217/fon.13.151; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hsu MC, 2010, MODERN PATHOL, V23, P1393, DOI 10.1038/modpathol.2010.130; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; Lee VHF, 2012, INT J RADIAT ONCOL, V84, P176, DOI 10.1016/j.ijrobp.2011.10.010; Liang K, 2003, INT J RADIAT ONCOL, V57, P246, DOI 10.1016/S0360-3016(03)00511-X; Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Ma BBY, 2012, ANN ONCOL, V23, P1287, DOI 10.1093/annonc/mdr401; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Niu XS, 2013, J CANCER RES CLIN, V139, P1063, DOI 10.1007/s00432-013-1419-z; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Zhang JW, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0501-6	37	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157969	10.1371/journal.pone.0157969	http://dx.doi.org/10.1371/journal.pone.0157969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341634	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600023
J	Oszust, M				Oszust, Mariusz			Full-Reference Image Quality Assessment with Linear Combination of Genetically Selected Quality Measures	PLOS ONE			English	Article							STRUCTURAL SIMILARITY; FUSION; DEGRADATION; INFORMATION; INDEX	Information carried by an image can be distorted due to different image processing steps introduced by different electronic means of storage and communication. Therefore, development of algorithms which can automatically assess a quality of the image in a way that is consistent with human evaluation is important. In this paper, an approach to image quality assessment (IQA) is proposed in which the quality of a given image is evaluated jointly by several IQA approaches. At first, in order to obtain such joint models, an optimisation problem of IQA measures aggregation is defined, where a weighted sum of their outputs, i.e., objective scores, is used as the aggregation operator. Then, the weight of each measure is considered as a decision variable in a problem of minimisation of root mean square error between obtained objective scores and subjective scores. Subjective scores reflect ground-truth and involve evaluation of images by human observers. The optimisation problem is solved using a genetic algorithm, which also selects suitable measures used in aggregation. Obtained multimeasures are evaluated on four largest widely used image benchmarks and compared against state-of-the-art full-reference IQA approaches. Results of comparison reveal that the proposed approach outperforms other competing measures.	[Oszust, Mariusz] Rzeszow Univ Technol, Dept Comp & Control Engn, Rzeszow, Poland	Rzeszow University of Technology	Oszust, M (corresponding author), Rzeszow Univ Technol, Dept Comp & Control Engn, Rzeszow, Poland.	marosz@kia.prz.edu.pl	Oszust, Mariusz/AAC-3224-2022	Oszust, Mariusz/0000-0002-5482-6313				[Anonymous], 2012, MATLAB VERS 7 14 R20; Barri A, 2014, IEEE T IMAGE PROCESS, V23, P2446, DOI 10.1109/TIP.2014.2316379; Chandler D.M., 2013, ISRN SIGNAL PROCESSI, V2013, P1, DOI DOI 10.1155/2013/905685; Chang HW, 2015, NEUROCOMPUTING, V151, P1142, DOI 10.1016/j.neucom.2014.04.081; Chang HW, 2013, IEEE T IMAGE PROCESS, V22, P4007, DOI 10.1109/TIP.2013.2266579; Damera-Venkata N, 2000, IEEE T IMAGE PROCESS, V9, P636, DOI 10.1109/83.841940; Ghosh J, 2002, LECT NOTES COMPUT SC, V2364, P1; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Group VQE, 2003, FINAL REPORT VIDEO Q; Jin LN, 2012, INT CONF ACOUST SPEE, P1145, DOI 10.1109/ICASSP.2012.6288089; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kuncheva LI, 2000, IEEE T EVOLUT COMPUT, V4, P327, DOI 10.1109/4235.887233; Lahouhou Atidel, 2010, Journal of Computing and Information Technology - CIT, V18, P103, DOI 10.2498/cit.1001822; Larson EC, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3267105; Li SN, 2011, IEEE T MULTIMEDIA, V13, P935, DOI 10.1109/TMM.2011.2152382; Liu AM, 2012, IEEE T IMAGE PROCESS, V21, P1500, DOI 10.1109/TIP.2011.2175935; Liu MN, 2008, FIFTH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY, VOL 4, PROCEEDINGS, P10, DOI 10.1109/FSKD.2008.469; Liu TJ, 2013, IEEE T IMAGE PROCESS, V22, P1793, DOI 10.1109/TIP.2012.2236343; Okarma K, 2013, ELEKTRON ELEKTROTECH, V19, P129, DOI 10.5755/j01.eee.19.10.5908; Okarma K, 2010, LECT NOTES ARTIF INT, V6113, P539, DOI 10.1007/978-3-642-13208-7_67; Oszust M, 2016, IEEE SIGNAL PROC LET, V23, P65, DOI 10.1109/LSP.2015.2500819; Peng P, 2012, IEEE SYS MAN CYBERN, P2127, DOI 10.1109/ICSMC.2012.6378054; Peng P, 2012, LECT NOTES COMPUT SC, V7324, P123, DOI 10.1007/978-3-642-31295-3_15; Ponomarenko N., 2009, ADV MOD RADIOELECTRO, V10, P30; Ponomarenko N, 2015, SIGNAL PROCESS-IMAGE, V30, P57, DOI 10.1016/j.image.2014.10.009; Saha A, 2014, CORR; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P3440, DOI 10.1109/TIP.2006.881959; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P430, DOI 10.1109/TIP.2005.859378; Sheikh HR, 2005, IEEE T IMAGE PROCESS, V14, P2117, DOI 10.1109/TIP.2005.859389; Wang FL, 2015, IEEE SIGNAL PROC LET, V22, P1534, DOI 10.1109/LSP.2015.2413891; Wang Z, 2003, CONF REC ASILOMAR C, P1398; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wang Z, 2011, IEEE T IMAGE PROCESS, V20, P1185, DOI 10.1109/TIP.2010.2092435; Wu JJ, 2014, IEEE SIGNAL PROC LET, V21, P437, DOI 10.1109/LSP.2014.2304714; Wu JJ, 2013, IEEE T IMAGE PROCESS, V22, P43, DOI 10.1109/TIP.2012.2214048; Zhang H, 2012, P IEEE INT C E-SCI; Zhang L, 2010, P IEEE INT C IM PROC, DOI [10.1109/icip.2010.5649275, DOI 10.1109/ICIP.2010.5649275]; Zhang L, 2014, IEEE T IMAGE PROCESS, V23, P4270, DOI 10.1109/TIP.2014.2346028; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zhou F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116312	42	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158333	10.1371/journal.pone.0158333	http://dx.doi.org/10.1371/journal.pone.0158333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341493	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600051
J	Adonis, A; Taylor, GP				Adonis, Adine; Taylor, Graham P.			Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test	PLOS ONE			English	Article							GAIT SPEED; DISTANCE; STROKE; PERFORMANCE; DISABILITY	Background Five to ten million persons, are infected by HTLV-1 of which 3% will develop HTLV-1-associated myelopathy (HAM) a chronic, disabling inflammation of the spinal cord. Walking, a fundamental, complex, multi-functional task is demanding of multiple body systems. Restricted walking ability compromises activity and participation levels in people with HAM (pwHAM). Therapy aims to improve mobility but validated measures are required to assess change. Study Design Prospective observational study. Objectives To explore walking capacity in pwHAM, walking endurance using the 6 minute walk (6MW), and gait speed, using the timed 10m walk (10mTW). Setting Out-patient setting in an inner London Teaching hospital. Methods Prospective documentation of 10mTW and 6MW distance; walking aid usage and pain scores measured twice, a median of 18 months apart. Results Data analysis was completed for twenty-six pwHAM, (8 male; 18 female; median age: 57.8 years; median disease duration: 8 years). Median time at baseline to: complete 10m was 17.5 seconds, versus 21.4 seconds at follow up; 23% completed the 6MW compared to 42% at follow up and a median distance of 55m was covered compared to 71m at follow up. Using the 10mTW velocity to predict the 6MW distance, overestimated the distance walked in 6 minutes (p<0.01). Functional decline over time was captured using the functional ambulation categories. Conclusions The 10mTW velocity underestimated the degree of disability. Gait speed usefully predicts functional domains, shows direction of functional change and comparison with published healthy age matched controls show that these patients have significantly slower gait speeds. The measured differences over 18 months were sufficient to reliably detect change and therefore these assessments can be useful to detect improvement or deterioration within broader disability grades. Walking capacity in pwHAM should be measured using the 10mTW for gait speed and the 6MW for endurance.	[Adonis, Adine; Taylor, Graham P.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Natl Ctr Human Retrovirol, London W2 1NY, England; [Taylor, Graham P.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England	Imperial College London; Imperial College London	Adonis, A (corresponding author), Imperial Coll Healthcare NHS Trust, St Marys Hosp, Natl Ctr Human Retrovirol, London W2 1NY, England.	adine.adonis@imperial.nhs.uk	Adonis, Adine/AFR-0710-2022	Adonis, Adine/0000-0002-5372-8025				Amatachaya S, 2014, SPINAL CORD, V52, P333, DOI 10.1038/sc.2013.171; [Anonymous], 1988, WPCDSSICPPHC014; Asher L, 2012, AGE AGEING, V41, P690, DOI 10.1093/ageing/afs076; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P49; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dalgas U, 2012, ARCH PHYS MED REHAB, V93, P1167, DOI 10.1016/j.apmr.2012.02.026; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; Dobkin BH, 2006, NEUROLOGY, V66, P584, DOI 10.1212/01.wnl.0000198502.88147.dd; Dourado Victor Zuniga, 2011, Arq Bras Cardiol; Facchinetti LD, 2013, SPINAL CORD, V51, P222, DOI 10.1038/sc.2012.134; Franzoi AC, 2007, SPINAL CORD, V45, P64, DOI 10.1038/sj.sc.3101919; Franzoi AC, 2005, SPINAL CORD, V43, P236, DOI 10.1038/sj.sc.3101677; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; Hornyak V, 2012, TOP GERIATR REHABIL, V28, P27, DOI 10.1097/TGR.0b013e318233e75b; Kempen JCE, 2011, MULT SCLER J, V17, P980, DOI 10.1177/1352458511403641; Kuo HK, 2006, AM J PHYS MED REHAB, V85, P650, DOI 10.1097/01.phm.0000228527.34158.ed; Martin F, 2010, J NEUROL NEUROSUR PS, V81, P1336, DOI 10.1136/jnnp.2009.191239; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Peel NM, 2013, J GERONTOL A-BIOL, V68, P39, DOI 10.1093/gerona/gls174; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Salbach NM, 2004, CLIN REHABIL, V18, P509, DOI 10.1191/0269215504cr763oa; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Shublaq M, 2011, ARQ NEURO-PSIQUIAT, V69, P208, DOI 10.1590/S0004-282X2011000200013; Solway S, 2001, CHEST, V119, P256, DOI 10.1378/chest.119.1.256; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; Weiss RJ, 2008, GAIT POSTURE, V28, P229, DOI 10.1016/j.gaitpost.2007.12.001	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157132	10.1371/journal.pone.0157132	http://dx.doi.org/10.1371/journal.pone.0157132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336911	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200010
J	Cacialli, P; Gueguen, MM; Coumailleau, P; D'Angelo, L; Kah, O; Lucini, C; Pellegrini, E				Cacialli, Pietro; Gueguen, Marie-Madeleine; Coumailleau, Pascal; D'Angelo, Livia; Kah, Olivier; Lucini, Carla; Pellegrini, Elisabeth			BDNF Expression in Larval and Adult Zebrafish Brain: Distribution and Cell Identification	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR BDNF; SEX STEROID-HORMONES; RADIAL GLIAL-CELLS; NERVOUS-SYSTEM; TELEOST FISH; NEUROGENESIS; NEURONS; PROTEIN; MODELS	Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, has emerged as an active mediator in many essential functions in the central nervous system of mammals. BDNF plays significant roles in neurogenesis, neuronal maturation and/or synaptic plasticity and is involved in cognitive functions such as learning and memory. Despite the vast literature present in mammals, studies devoted to BDNF in the brain of other animal models are scarse. Zebrafish is a teleost fish widely known for developmental genetic studies and is emerging as model for translational neuroscience research. In addition, its brain shows many sites of adult neurogenesis allowing higher regenerative properties after traumatic injuries. To add further knowledge on neurotrophic factors in vertebrate brain models, we decided to determine the distribution of bdnf mRNAs in the larval and adult zebrafish brain and to characterize the phenotype of cells expressing bdnf mRNAs by means of double staining studies. Our results showed that bdnf mRNAs were widely expressed in the brain of 7 days old larvae and throughout the whole brain of mature female and male zebrafish. In adults, bdnf mRNAs were mainly observed in the dorsal telencephalon, preoptic area, dorsal thalamus, posterior tuberculum, hypothalamus, synencephalon, optic tectum and medulla oblongata. By combining immunohistochemistry with in situ hybridization, we showed that bdnf mRNAs were never expressed by radial glial cells or proliferating cells. By contrast, bdnf transcripts were expressed in cells with neuronal phenotype in all brain regions investigated. Our results provide the first demonstration that the brain of zebrafish expresses bdnf mRNAs in neurons and open new fields of research on the role of the BDNF factor in brain mechanisms in normal and brain repairs situations.	[Cacialli, Pietro; Gueguen, Marie-Madeleine; Coumailleau, Pascal; Kah, Olivier; Pellegrini, Elisabeth] Univ Rennes 1, Res Inst Hlth Environm & Occupat IRSET, INSERM U1085, Rennes, France; [Cacialli, Pietro; D'Angelo, Livia; Lucini, Carla] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Naples Federico II	Pellegrini, E (corresponding author), Univ Rennes 1, Res Inst Hlth Environm & Occupat IRSET, INSERM U1085, Rennes, France.; Lucini, C (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy.	elisabeth.pellegrini@univ-rennes1.fr; carla.lucini@unina.it	Lucini, Carla/E-6828-2013; Pellegrini, Elisabeth/K-1705-2015; kah, olivier/K-7624-2012; cacialli, pietro/AAO-1662-2020	Lucini, Carla/0000-0003-2216-6338; Pellegrini, Elisabeth/0000-0003-4821-0966; cacialli, pietro/0000-0003-1250-0793; D'ANGELO, Livia/0000-0001-5050-642X	University of Rennes 1, Inserm; European Trans Channel Neuroscience Network Program (TC2N); INSERM (France); University of Rennes 1 (France)	University of Rennes 1, Inserm; European Trans Channel Neuroscience Network Program (TC2N); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Rennes 1 (France)	This work was supported by the University of Rennes 1, Inserm, and the European Trans Channel Neuroscience Network Program (TC2N).; We greatly appreciate the help of the staff of the zebrafish Biosit facility (Laboratoire de Physiologie et Genetique des Poissons, INRA, Rennes). We thank Colette Vaillant-Capitaine, Prof. Paolo de Girolamo and Prof. Luciana Castaldo for reading the manuscript. We are thankful for INSERM and University of Rennes 1 (France) for funding our research. The European Trans Channel Neuroscience Network Program (TC2N) supported this research.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Babin PJ, 2014, PROG NEUROBIOL, V118, P36, DOI 10.1016/j.pneurobio.2014.03.001; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Brenowitz EA, 2013, NEUROSCIENCE, V239, P115, DOI 10.1016/j.neuroscience.2012.09.023; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; Carbone DL, 2013, NEUROSCIENCE, V239, P295, DOI 10.1016/j.neuroscience.2012.10.073; Carter AR, 2003, MOL CELL NEUROSCI, V22, P1, DOI 10.1016/S1044-7431(02)00015-5; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conner JM, 1997, J NEUROSCI, V17, P2295; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Coumailleau P, 2014, J NEUROENDOCRINOL, V26, P226, DOI 10.1111/jne.12142; Coumailleau P, 2015, GEN COMP ENDOCR, V221, P203, DOI 10.1016/j.ygcen.2015.08.008; D'Angelo L, 2014, J COMP NEUROL, V522, P1004, DOI 10.1002/cne.23457; Dalton VS, 2009, BRAIN BEHAV EVOLUT, V73, P43, DOI 10.1159/000204962; De Felice E, 2014, J ANAT, V224, P564, DOI 10.1111/joa.12168; Diotel N, 2015, MAPPING OF BRAIN LIP, DOI [10.1016/j.gep.2015.11.003, DOI 10.1016/J.GEP.2015.11.003]; Diotel N, 2013, HORM BEHAV, V63, P193, DOI 10.1016/j.yhbeh.2012.04.003; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Duprey-Diaz MV, 2002, J COMP NEUROL, V454, P456, DOI 10.1002/cne.10451; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fonseka TM, 2016, J NEUROSCI RES, V94, P3, DOI 10.1002/jnr.23639; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Heinrich G, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-19; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hill RA, 2012, J NEUROENDOCRINOL, V24, P1553, DOI 10.1111/j.1365-2826.2012.02365.x; Hill RA, 2012, J NEUROENDOCRINOL, V24, P774, DOI 10.1111/j.1365-2826.2012.02277.x; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ilieva M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00266; IP NY, 1993, J NEUROSCI, V13, P3394; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kidane AH, 2009, ENDOCRINOLOGY, V150, P1361, DOI 10.1210/en.2008-0993; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kim JY, 2016, STEM CELLS, V34, P888, DOI 10.1002/stem.2276; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Martin-Jimenez R, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0555-z; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Mueller T, 2005, AMERICAN JOURNAL OF; Mueller T, 2011, BRAIN RES, V1381, P95, DOI 10.1016/j.brainres.2010.12.089; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Newman M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00189; Nieuwenhuys R, 2009, BRAIN BEHAV EVOLUT, V74, P77, DOI 10.1159/000229014; Northcutt RG, 2011, BRAIN BEHAV EVOLUT, V78, P136, DOI 10.1159/000330830; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009; Preston MA, 2015, GLIA, V63, P177, DOI 10.1002/glia.22755; Quartu M, 2010, BRAIN RES, V1363, P49, DOI 10.1016/j.brainres.2010.09.106; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rupp B, 1996, ANAT EMBRYOL, V194, P187; Sambataro F, 2010, MOL PSYCHIATR, V15, P116, DOI 10.1038/mp.2009.64; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SchmidtKastner R, 1996, NEUROSCIENCE, V74, P161, DOI 10.1016/0306-4522(96)00093-0; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Stewart AM, 2014, PROG NEURO-PSYCHOPH, V50, P27, DOI 10.1016/j.pnpbp.2013.11.014; Tang YP, 2013, NEUROSCIENCE, V250, P578, DOI 10.1016/j.neuroscience.2013.07.062; Tang YP, 2016, J COMP NEUROL, V524, P1081, DOI 10.1002/cne.23893; Tang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043687; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tettamanti G, 2010, GENE, V450, P85, DOI 10.1016/j.gene.2009.07.023; Tokumine J, 2003, J NEUROSCI RES, V74, P552, DOI 10.1002/jnr.10760; Vissio PG, 2008, TISSUE CELL, V40, P261, DOI 10.1016/j.tice.2008.01.001; von Bohlen O, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00036; Wang LC, 2005, ANN NY ACAD SCI, V1040, P512, DOI 10.1196/annals.1327.106; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang F, 2012, J CLIN NEUROSCI, V19, P946, DOI 10.1016/j.jocn.2011.12.022; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569	93	39	39	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158057	10.1371/journal.pone.0158057	http://dx.doi.org/10.1371/journal.pone.0158057			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336917	Green Submitted, gold, Green Published			2022-12-26	WOS:000378389200099
J	Kim, WS; Cho, S; Baek, D; Bang, H; Paik, NJ				Kim, Won-Seok; Cho, Sungmin; Baek, Dongyoub; Bang, Hyunwoo; Paik, Nam-Jong			Upper Extremity Functional Evaluation by Fugl-Meyer Assessment Scoring Using Depth-Sensing Camera in Hemiplegic Stroke Patients	PLOS ONE			English	Article							UPPER-LIMB DEXTERITY; RECOVERY; SENSOR	Virtual home-based rehabilitation is an emerging area in stroke rehabilitation. Functional assessment tools are essential to monitor recovery and provide current function-based rehabilitation. We developed the Fugl-Meyer Assessment (FMA) tool using Kinect (Microsoft, USA) and validated it for hemiplegic stroke patients. Forty-one patients with hemiplegic stroke were enrolled. Thirteen of 33 items were selected for upper extremity motor FMA. One occupational therapist assessed the motor FMA while recording upper extremity motion with Kinect. FMA score was calculated using principal component analysis and artificial neural network learning from the saved motion data. The degree of jerky motion was also transformed to jerky scores. Prediction accuracy for each of the 13 items and correlations between real FMA scores and scores using Kinect were analyzed. Prediction accuracies ranged from 65% to 87% in each item and exceeded 70% for 9 items. Correlations were high for the summed score for the 13 items between real FMA scores and scores obtained using Kinect (Pearson's correlation coefficient = 0.873, P<0.0001) and those between total upper extremity scores (66 in full score) and scores using Kinect (26 in full score) (Pearson's correlation coefficient = 0.799, P<0.0001). Log transformed jerky scores were significantly higher in the hemiplegic side (1.81 +/- 0.76) compared to non-hemiplegic side (1.21 +/- 0.43) and showed significant negative correlations with Brunnstrom stage (3 to 6; Spearman correlation coefficient = -0.387, P = 0.046). FMA using Kinect is a valid way to assess upper extremity function and can provide additional results for movement quality in stroke patients. This may be useful in the setting of unsupervised home-based rehabilitation.	[Kim, Won-Seok; Paik, Nam-Jong] Seoul Natl Univ, Dept Rehabil Med, Coll Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea; [Cho, Sungmin; Baek, Dongyoub; Bang, Hyunwoo] Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Paik, NJ (corresponding author), Seoul Natl Univ, Dept Rehabil Med, Coll Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea.	njpaik@snu.ac.kr	, 김원석/AAJ-2334-2020; Paik, Nam-Jong/D-5798-2012; Cho, Sungmin/AAM-3840-2021	, 김원석/0000-0002-1199-5707; Paik, Nam-Jong/0000-0002-5193-8678; 	Microsoft Research, under ICT/SW Creative research program [NIPA-2014-(H0510-14-1014), NIPA-2013(H0503-13-1018)]; Ministry of Science, ICT and Future Planning (MSIP), Korea	Microsoft Research, under ICT/SW Creative research program; Ministry of Science, ICT and Future Planning (MSIP), Korea	This research was supported by the The Ministry of Science, ICT and Future Planning (MSIP), Korea and Microsoft Research, under ICT/SW Creative research program supervised by the National ICT Industry Promotion Agency (NIPA) [NIPA-2014-(H0510-14-1014)] and [NIPA-2013(H0503-13-1018)], which were received by N-J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2010, 2010 SECOND INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE, COMMUNICATION SYSTEMS AND NETWORKS (CICSYN), P44, DOI 10.1109/CICSyN.2010.9; Adams RJ, 2015, IEEE T NEUR SYS REH, V23, P287, DOI 10.1109/TNSRE.2014.2360149; Barton G, 2007, GAIT POSTURE, V25, P374, DOI 10.1016/j.gaitpost.2006.05.003; Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923; Centers for Disease Control and Prevention (CDC), 2007, MMWR MORBIDITY MORTA, V56, P504; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gabel M, ENG MED BIOL SOC EMB, P1964; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Guna J, 2014, SENSORS-BASEL, V14, P3702, DOI 10.3390/s140203702; Hsieh YW, 2007, STROKE, V38, P3052, DOI 10.1161/STROKEAHA.107.490730; KITAZAWA S, 1993, INT CONGR SER, V1024, P11; Kong KH, 2013, NEUROREHABILITATION, V32, P345, DOI 10.3233/NRE-130854; Kong KH, 2011, NEUROREHABILITATION, V28, P105, DOI 10.3233/NRE-2011-0639; Kowalczewski J, 2011, IEEE ENG MED BIO, P7332, DOI 10.1109/IEMBS.2011.6091710; Kurillo G, 2013, TECHNOL HEALTH CARE, V21, P641, DOI 10.3233/THC-130764; Lambercy O, 2013, IEEE INT C REHABIL R, V2013, P1; Lu Y, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P1816, DOI 10.1109/IJCNN.1998.687133; Nguyen GH, 2008, INT C PATT RECOG, P3759; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Olesh EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104487; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rohrer B, 2002, J NEUROSCI, V22, P8297; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Tresilian JR, 1997, BRAIN, V120, P2093, DOI 10.1093/brain/120.11.2093; Yu H, 2005, P 2005 INT C COMM CI; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24	30	60	63	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158640	10.1371/journal.pone.0158640	http://dx.doi.org/10.1371/journal.pone.0158640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367518	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900047
J	Smirnova, DS; Volodin, IA; Demina, TS; Volodina, EV				Smirnova, Darya S.; Volodin, Ilya A.; Demina, Tatyana S.; Volodina, Elena V.			Acoustic Structure and Contextual Use of Calls by Captive Male and Female Cheetahs (Acinonyx jubatus)	PLOS ONE			English	Article							AGE-CLASS DIFFERENCES; CAT FELIS-CATUS; ALARM CALLS; RED DEER; GAZELLA-SUBGUTTUROSA; VOCAL DEVELOPMENT; VOICE BREAKING; DOMESTIC CATS; ORAL CALLS; BODY-SIZE	The vocal repertoire of captive cheetahs (Acinonyx jubatus) and the specific role of meow vocalizations in communication of this species attract research interest about two dozen years. Here, we expand this research focus for the contextual use of call types, sex differences and individual differences at short and long terms. During 457 trials of acoustic recordings, we collected calls (n = 8120) and data on their contextual use for 13 adult cheetahs (6 males and 7 females) in four Russian zoos. The cheetah vocal repertoire comprised 7 call types produced in 8 behavioural contexts. Context-specific call types (chirr, growl, howl and hiss) were related to courting behaviour (chirr) or to aggressive behaviour (growl, howl and hiss). Other call types (chirp, purr and meow) were not context-specific. The values of acoustic variables differed between call types. The meow was the most often call type. Discriminant function analysis revealed a high potential of meows to encode individual identity and sex at short terms, however, the vocal individuality was unstable over years. We discuss the contextual use and acoustic variables of call types, the ratios of individual and sex differences in calls and the pathways of vocal ontogeny in the cheetah with relevant data on vocalization of other animals.	[Smirnova, Darya S.] Russian State Agrarian Univ, Moscow Timiryazev Agr Acad, Dept Anim Sci, Moscow, Russia; [Volodin, Ilya A.] Lomonosov Moscow State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia; [Volodin, Ilya A.; Demina, Tatyana S.; Volodina, Elena V.] Moscow Zoo, Sci Res Dept, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Lomonosov Moscow State University	Volodin, IA (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia.; Volodin, IA (corresponding author), Moscow Zoo, Sci Res Dept, Moscow, Russia.	volodinsvoc@gmail.com	Volodina, Elena V./Q-7903-2018; Volodin, Ilya/Q-7903-2018	Volodina, Elena V./0000-0001-9755-4576; Volodin, Ilya/0000-0001-6278-0354	Russian Science Foundation [14-14-00237]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (http://www.rscf.ru/) funding to IAV, DSS and EVV, grant number 14-14-00237. This research received no additional funding from any public, commercial or not-for-profit sectors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 1969, THE SPOTTED SPHINX; Adamson J, 1972, PIPPAS CHALLENGE; Adret P, 2012, J ORNITHOL, V153, P535, DOI 10.1007/s10336-011-0774-2; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Castro-Prieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049129; Chabert T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15547; Charruau P, 2011, MOL ECOL, V20, P706, DOI 10.1111/j.1365-294X.2010.04986.x; Chulkina MM, 2006, ZOOL ZH, V85, P544; Darden SK, 2003, J MAMMAL, V84, P1417, DOI 10.1644/BEM-031; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Efremova KO, 2016, J MORPHOL, V277, P826, DOI 10.1002/jmor.20538; Efremova KO, 2011, NATURWISSENSCHAFTEN, V98, P919, DOI 10.1007/s00114-011-0843-7; Eklund R., 2010, PROCEEDINGS FROM FON, P17; Eklund R., 2012, P FONETIK 2012, P37; Eklund R., 2012, P FONETIK 2012, P41; Ellis SLH, 2015, ANTHROZOOS, V28, P625, DOI 10.1080/08927936.2015.1070005; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Frey R, 2013, J MORPHOL, V274, P307, DOI 10.1002/jmor.20092; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Garcia M, 2016, ETHOLOGY, V122, P329, DOI 10.1111/eth.12472; Gogoleva SS, 2008, BIOACOUSTICS, V18, P99, DOI 10.1080/09524622.2008.9753595; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Johnson S, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00357.1; Jorgensen DD, 1998, ETHOLOGY, V104, P729, DOI 10.1111/j.1439-0310.1998.tb00107.x; JURGENS U, 1979, BEHAVIOUR, V69, P89; Klenova AV, 2014, BIOACOUSTICS, V23, P247, DOI 10.1080/09524622.2014.900648; Klenova AV, 2012, ACTA ETHOL, V15, P141, DOI 10.1007/s10211-011-0120-y; Klenova AV, 2010, BEHAVIOUR, V147, P505, DOI 10.1163/000579509X12591315521811; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Krengel A, 2015, CLIN VACCINE IMMUNOL, V22, P611, DOI 10.1128/CVI.00705-14; Leuchtenberger C, 2016, BIOACOUSTICS, V25, P279, DOI 10.1080/09524622.2016.1157704; Marker LL, 2003, J MAMMAL, V84, P840, DOI 10.1644/BRB-036; Matrosova VA, 2007, BEHAV ECOL SOCIOBIOL, V62, P181, DOI 10.1007/s00265-007-0452-9; Matrosova VA, 2011, NATURWISSENSCHAFTEN, V98, P181, DOI 10.1007/s00114-010-0757-9; Matrosova VA, 2010, NATURWISSENSCHAFTEN, V97, P707, DOI 10.1007/s00114-010-0686-7; Matrosova VA, 2010, J MAMMAL, V91, P620, DOI 10.1644/09-MAMM-A-143.1; Matrosova VA, 2009, J MAMMAL, V90, P158, DOI 10.1644/08-MAMM-A-032.1; McComb K, 2009, CURR BIOL, V19, pR507, DOI 10.1016/j.cub.2009.05.033; MEROLA M, 1994, CONSERV BIOL, V8, P961, DOI 10.1046/j.1523-1739.1994.08040961.x; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mills MGL, 2014, J ZOOL, V292, P136, DOI 10.1111/jzo.12087; Moreno-Gomez FN, 2015, J ACOUST SOC AM, V138, P1614, DOI 10.1121/1.4929750; Nicastro N, 2004, J COMP PSYCHOL, V118, P287, DOI 10.1037/0735-7036.118.3.287; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; Patel R, 2010, ETHOLOGY, V116, P554, DOI 10.1111/j.1439-0310.2010.01769.x; Peters G, 2002, MAMMAL REV, V32, P245, DOI 10.1046/j.1365-2907.2002.00113.x; PETERS G, 1978, Z ZOOL SPIXIANA, V1, P1; Peters Gustav, 1999, Journal of Mammalian Evolution, V6, P129, DOI 10.1023/A:1020620121416; PONTIER D, 1995, OIKOS, V73, P299, DOI 10.2307/3545954; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Riede T., 2013, NOVA ACTA LEOPOLDINA, V380, P295; Ruiz-Miranda CR, 1998, ZOO BIOL, V17, P1, DOI 10.1002/(SICI)1098-2361(1998)17:1<1::AID-ZOO1>3.0.CO;2-D; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Schassburger R.M., 1987, MAN WOLF ADV ISSUES, P313; Scheumann M, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-36; Schneiderova I, 2015, ZOO BIOL, V34, P503, DOI 10.1002/zoo.21233; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Sibiryakova OV, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-014-0094-5; SISSOM DEF, 1991, J ZOOL, V223, P67, DOI 10.1111/j.1469-7998.1991.tb04749.x; Smirnova D.S., 2015, Nauchnye Issledovaniya v Zoologicheskikh Parkakh, V31, P104; SOLOW AR, 1990, ECOLOGY, V71, P2379, DOI 10.2307/1938650; Swan DC, 2008, J MAMMAL, V89, P889, DOI 10.1644/07-MAMM-A-228.1; Swanson A, 2014, J ANIM ECOL, V83, P1418, DOI 10.1111/1365-2656.12231; Titze IR, 1994, PRINCIPLES VOICE PRO; Voigt CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101917; Volodin IA, 2009, ZH OBSHCH BIOL, V70, P210; VOLODIN IA, 2008, CASARCA B GOOSE SWAN, V11, P22; Volodin IA, 2001, ENTOMOL REV, V81, pS346; Volodin IA, 2016, MAMM BIOL, V81, P10, DOI 10.1016/j.mambio.2015.09.002; Volodin IA, 2015, ACTA ETHOL, V18, P19, DOI 10.1007/s10211-013-0179-8; Volodin IA, 2015, ETHOLOGY, V121, P103, DOI 10.1111/eth.12321; Volodin IA, 2011, ETHOLOGY, V117, P294, DOI 10.1111/j.1439-0310.2011.01874.x; Volodina E. V., 2006, Razprave - Razred za Naravoslovne Vede, Slovenska Akademija Znanosti in Umetnosti, V47, P257; Volodina E.V., 1997, SCI RESEARCHES ZOOS, V8, P149; Volodina E.V., 1998, SCI RESEARCHES ZOOS, V10, P143; Volodina E.V., 1996, SCI RESEARCHES ZOOS, V6, P142; Volodina E. V., 2000, ENTOMOLOGICAL REV S2, V80, pS368; Volodina EV, 2010, BIOACOUSTICS, V20, P87; Volodina EV, 1994, SCI RES ZOOS, V4, P70; Volodina EV, 1994, SCI RES ZOOS, V4, P92; Weissengruber GE, 2002, J ANAT, V201, P195, DOI 10.1046/j.1469-7580.2002.00088.x; Welch RJ, 2015, J ARID ENVIRON, V114, P91, DOI 10.1016/j.jaridenv.2014.11.012; Wielebnowski N, 1998, ZOO BIOL, V17, P193, DOI 10.1002/(SICI)1098-2361(1998)17:3<193::AID-ZOO4>3.0.CO;2-4; Wilden I., 1998, Bioacoustics, V9, P171; WILDT DE, 1993, ZOO BIOL, V12, P45, DOI 10.1002/zoo.1430120107; Yeon SC, 2011, BEHAV PROCESS, V87, P183, DOI 10.1016/j.beproc.2011.03.003; Yin S, 2002, J COMP PSYCHOL, V116, P189, DOI 10.1037//0735-7036.116.2.189; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; Zaytseva AS, 2015, BEHAV PROCESS, V118, P130, DOI 10.1016/j.beproc.2015.06.012	97	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158546	10.1371/journal.pone.0158546	http://dx.doi.org/10.1371/journal.pone.0158546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362643	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200087
J	Diop, A; Sambe-Ba, B; Seck, A; Dia, ML; Timbine, LG; Niang, AA; Ndiaye, EM; Sonko, MA; Wane, AA; Bercion, R; Ndiaye, O; Cisse, MF; Gassama-Sow, A				Diop, Amadou; Sambe-Ba, Bissoume; Seck, Abdoulaye; Dia, Mouhamadou Lamine; Timbine, Lassina Gadi; Niang, Aissatou Ameth; Ndiaye, El Hadji Momar; Sonko, Mouhamadou Abdoulaye; Wane, Abdoul Aziz; Bercion, Raymond; Ndiaye, Ousmane; Cisse, Moussa Fafa; Gassama-Sow, Amy			First Description of the Extended Spectrum-Beta-Lactamase Gene bla(CTX-M-109) in Salmonella Grumpensis Strains Isolated from Neonatal Nosocomial Infections in Dakar, Senegal	PLOS ONE			English	Article							ESCHERICHIA-COLI; CTX-M; RESISTANCE; OUTBREAK; EPIDEMIOLOGY; INTEGRONS; SHIGELLA; TANZANIA	Nosocomial infections are very common in African hospitals, particularly in neonatal units. These infections are most often caused by bacteria such as Escherichia coli, Klebsiella spp and Staphylococcus spp. Salmonella strains are rarely involved in nosocomial infections. Here, we report the first description of S. Grumpensis in neonatal infections in Senegal. Seventeen Salmonella strains were isolated from hospitalized infants' stool samples. The following resistance phenotype was described in strains: AMX(R)TIC(R)CF(R)FOX(R)CFX(R)CTX(R-)CAZ(R)IMP(S)ATM(R)NA(R)NOR(R)CIP(R)TM(R)GM(R)TE(R)SXT(R). All isolates were susceptible to imipenem, 15 out of 17 produced an extended spectrum beta-lactamase (ESBL). bla(OXA-1), bla(SHV-1), bla(TEM-1), bla(CTX-M1) genes were detected in strains 8, 13, 5 and 8, respectively. blaCTX-M1 sequencing revealed the presence of blaCTX-M-109. Thirteen of the 17 Salmonella Grumpensis strains were analyzed by PFGE. These 13 isolates belonged to a single pulsotype and were genotypically identical. This is the first report of neonatal S. Grumpensis infections in Senegal, and the first report of blaCTX-M-109 in the genus Salmonella.	[Diop, Amadou; Sambe-Ba, Bissoume; Timbine, Lassina Gadi; Niang, Aissatou Ameth; Wane, Abdoul Aziz; Gassama-Sow, Amy] Inst Pasteur, UBE, Dakar, Senegal; [Seck, Abdoulaye; Bercion, Raymond] Inst Pasteur, LABM, Dakar, Senegal; [Dia, Mouhamadou Lamine] Virol Ctr Hosp Natl FANN, Lab Bacteriol, Dakar, Senegal; [Diop, Amadou; Ndiaye, El Hadji Momar; Sonko, Mouhamadou Abdoulaye; Cisse, Moussa Fafa] Virol Ctr Hosp Natl Enfants Albert Royer Fann Dak, Lab Bacteriol, Dakar, Senegal; [Ndiaye, Ousmane] Ctr Hosp Abass Ndao, Unite Neonatol, Dakar, Senegal; [Diop, Amadou; Seck, Abdoulaye; Dia, Mouhamadou Lamine; Ndiaye, Ousmane; Cisse, Moussa Fafa] Pharm & Odontol Univ Cheikh Anta Diop Dakar, Fac Med, Dakar, Senegal; [Gassama-Sow, Amy] Univ Cheikh Anta Diop Dakar, Ecole Super Polytech, Dept Genie Chim & Biol Appl, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Gassama-Sow, A (corresponding author), Univ Cheikh Anta Diop Dakar, Ecole Super Polytech, Dept Genie Chim & Biol Appl, Dakar, Senegal.	gassama@pasteur.sn			Institut Pasteur de Dakar	Institut Pasteur de Dakar	We are very grateful to Institut Pasteur de Dakar for his support	Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Cabrera R, 2004, ANTIMICROB AGENTS CH, V48, P3934, DOI 10.1128/AAC.48.10.3934-3939.2004; Cavallo JD, 2010, COMITE ANTIBIOGRAMME; Danzmann L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-98; Denno DM, 2012, CID, V55, P97; Di Conza JA, 2005, ANTIMICROB AGENTS CH, V49, P3014, DOI 10.1128/AAC.49.7.3014-3017.2005; Garnier F, 2006, ANTIMICROB AGENTS CH, V50, P3200, DOI 10.1128/AAC.00293-06; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Hartman AB, 2003, J CLIN MICROBIOL, V41, P1023, DOI 10.1128/JCM.41.3.1023-1032.2003; Inweregbu K, 2005, CRITICAL CARE PAIN, V5, DOI [10.1093/bjaceaccp/mki006, DOI 10.1093/BJACEACCP/MKI006]; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Kim J, 2005, AGENTS CHEMOTHER, V49, P572; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P451, DOI 10.1093/jac/dki239; Mendonca N, 2007, ANTIMICROB AGENTS CH, V51, P1946, DOI 10.1128/AAC.01412-06; Ndugulile F, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-86; Olmsted R. N., 1996, APIC INFECT CONTROL, pA1; Ploy MC, 2000, ANTIMICROB AGENTS CH, V44, P2684, DOI 10.1128/AAC.44.10.2684-2688.2000; Popoff M.Y., 2001, ANTIGENIC FORMULAS S, V8th ed.; PRINCEDAVID M, 1987, MED MALADIES INFECT, V17, P124, DOI 10.1016/S0399-077X(87)80343-8; Ramdani-Bouguessa N, 2006, J CLIN MICROBIOL, V44, P4584, DOI 10.1128/JCM.01445-06; Sambe-Ba B, 2013, J GLOB ANTIMICROB RE, V1, P231, DOI 10.1016/j.jgar.2013.06.004; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shin JH, 2008, MICROB DRUG RESIST, V14, P221, DOI 10.1089/mdr.2008.0834; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17; Sow AG, 2007, J INFECT DEV COUNTR, V1, P284; Su LH, 2004, CLIN INFECT DIS, V39, P546, DOI 10.1086/422726; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Tatsuya A, 2012, J ANTIMICROB CHEMOTH, V67, P101, DOI [10.1093/jac/dkr414, DOI 10.1093/JAC/DKR414]; THONG KL, 1995, J CLIN MICROBIOL, V33, P1938, DOI 10.1128/JCM.33.7.1938-1941.1995; Uwaezuoke SN, 2013, NIGERIAN J PAEDIAT, V40, P125; Vaagland H, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-35; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Weill FX, 2004, FEMS MICROBIOL LETT, V238, P353, DOI 10.1016/j.femsle.2004.07.058; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157683	10.1371/journal.pone.0157683	http://dx.doi.org/10.1371/journal.pone.0157683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355480	Green Submitted, gold, Green Published			2022-12-26	WOS:000378859400016
J	Morales, I; Cooper, J; Amador, JA; Boving, TB				Morales, Ivan; Cooper, Jennifer; Amador, Jose A.; Boving, Thomas B.			Modeling Nitrogen Losses in Conventional and Advanced Soil-Based Onsite Wastewater Treatment Systems under Current and Changing Climate Conditions	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; TRANSPORT; RATES	Most of the non-point source nitrogen (N) load in rural areas is attributed to onsite wastewater treatment systems (OWTS). Nitrogen compounds cause eutrophication, depleting the oxygen in marine ecosystems. OWTS rely on physical, chemical and biological soil processes to treat wastewater and these processes may be affected by climate change. We simulated the fate and transport of N in different types of OWTS drainfields, or soil treatment areas (STA) under current and changing climate scenarios, using 2D/3D HYDRUS software. Experimental data from a mesocosm-scale study, including soil moisture content, and total N, ammonium (NH4+) and nitrate (NO3-) concentrations, were used to calibrate the model. A water content-dependent function was used to compute the nitrification and denitrification rates. Three types of drainfields were simulated: (1) a pipe-and-stone (P&S), (2) advanced soil drainfields, pressurized shallow narrow drainfield (PSND) and (3) Geomat (GEO), a variation of SND. The model was calibrated with acceptable goodness-of-fit between the observed and measured values. Average root mean square error (RSME) ranged from 0.18 and 2.88 mg L-1 for NH4+ and 4.45 mg L-1 to 9.65 mg L-1 for NO3- in all drainfield types. The calibrated model was used to estimate N fluxes for both conventional and advanced STAs under current and changing climate conditions, i.e. increased soil temperature and higher water table. The model computed N losses from nitrification and denitrification differed little from measured losses in all STAs. The modeled N losses occurred mostly as NO3- in water outputs, accounting for more than 82% of N inputs in all drainfields. Losses as N-2 were estimated to be 10.4% and 9.7% of total N input concentration for SND and Geo, respectively. The highest N-2 losses, 17.6%, were estimated for P&S. Losses as N-2 increased to 22%, 37% and 21% under changing climate conditions for Geo, PSND and P&S, respectively. These findings can provide practitioners with guidelines to estimate N removal efficiencies for traditional and advanced OWTS, and predict N loads and spatial distribution for identifying non-point sources. Our results show that N losses on OWTS can be modeled successfully using HYDRUS. Furthermore, the results suggest that climate change may increase the removal of N as N-2 in the drainfield, with the magnitude of the effect depending on a drainfield type.	[Morales, Ivan; Boving, Thomas B.] Univ Rhode Isl, Dept Civil & Environm Engn, Kingston, RI 02881 USA; [Cooper, Jennifer; Amador, Jose A.] Univ Rhode Isl, Lab Soil Ecol & Microbiol, Kingston, RI 02881 USA; [Boving, Thomas B.] Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA	University of Rhode Island; University of Rhode Island; University of Rhode Island	Boving, TB (corresponding author), Univ Rhode Isl, Dept Civil & Environm Engn, Kingston, RI 02881 USA.; Boving, TB (corresponding author), Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA.	boving@uri.edu	Boving, Thomas/X-7438-2019		U.S. Department of Agriculture - Multistate Project [NE 1045]	U.S. Department of Agriculture - Multistate Project	Funded by U.S. Department of Agriculture - Multistate Project (NE 1045). http://www.nrcs.usda.gov/wps/portal/nrcs/detail/ne/programs/farmbill/?cid=stelprdb1242732.	Anderson D. L., 1994, P 7 INT S IND SMALL, P209; Beach D. N, 2001, THESIS; Beal CD, 2005, AUST J SOIL RES, V43, P781, DOI 10.1071/SR05018; Beggs R.A., 2004, 10 NAT S IND SMALL C; Birkham TK, 2007, VADOSE ZONE J, V6, P67, DOI 10.2136/vzj2006.0005; Bollmann A, 1997, SOIL BIOL BIOCHEM, V29, P1067, DOI 10.1016/S0038-0717(97)00007-2; Bradshaw JK, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0150; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Breve MA, 1994, THESIS; Brooks R.H., 1966, J IRR DRAIN DIV-ASCE, V92, P61, DOI [DOI 10.1061/JRCEA4.0000425, 10.1061/JRCEA4.0000425]; Burks D.B., 1994, ONSITE WASTEWATER TR; Carlile BL, 1980, P 6 NAT C IND ONS WA, P371; Cooper JA, 2015, J ENV QUAL; Cote CM, 2003, IRRIGATION SCI, V22, P143, DOI 10.1007/s00271-003-0080-8; Curds C.R., 1983, ECOLOGICAL ASPECTS U, V2; Doran JW, 1988, TILLAGE TRAFFIC CROP, P49; Fischer E., 1999, THESIS; GELHAR LW, 1992, WATER RESOUR RES, V28, P1955, DOI 10.1029/92WR00607; Geza M, 2014, ENVIRON MODEL ASSESS, V19, P243, DOI 10.1007/s10666-013-9392-0; GIBLIN AE, 1990, BIOGEOCHEMISTRY, V10, P309; Gill LW, 2007, J ENVIRON QUAL, V36, P1843, DOI 10.2134/jeq2007.0064; Gill LW, 2009, WATER RES, V43, P2739, DOI 10.1016/j.watres.2009.03.024; Grady CP., 2011, BIOL WASTEWATER TREA; GRANT RF, 1995, SOIL BIOL BIOCHEM, V27, P1117, DOI 10.1016/0038-0717(95)00038-G; Harden HS, 2008, WATER RES, V42, P2585, DOI 10.1016/j.watres.2008.01.008; Hargett D. L., 1985, On-site waste water treatment., P131; Hassan G, 2008, MODELING EFFLUENT DI, P1937; Heatwole KK, 2007, J CONTAM HYDROL, V91, P184, DOI 10.1016/j.jconhyd.2006.08.012; Holden S.A., 2004, ON SITE WASTEWATER T, P432; Holden SA, 2004, EFFECTIVENESS SHALLO; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Loomis GW, 2001, ON-SITE WASTEWATER TREATMENT, PROCEEDINGS, P506; MALHI SS, 1982, SOIL BIOL BIOCHEM, V14, P393, DOI 10.1016/0038-0717(82)90011-6; McCray J., 2010, QUANTITATIVE TOOLS D; McCray JE, 2005, GROUND WATER, V43, P628, DOI 10.1111/j.1745-6584.2005.0077.x; MILLINGTON R. J., 1960, Transactions 7th int. Congr. Soil Sci., V1, P97; Morales I, 2014, WATER-SUI, V6, P818, DOI 10.3390/w6040818; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Poeter EP, 1999, COMPUT GEOSCI, V25, P457, DOI 10.1016/S0098-3004(98)00149-6; POWELSON DK, 1994, WATER RES, V28, P2175, DOI 10.1016/0043-1354(94)90029-9; PROSSER JI, 1990, ADV MICROB ECOL, V11, P263; Radcliffe DE, 2014, MODEL TEST PROPOSED, P97; RENEAU RB, 1989, J ENVIRON QUAL, V18, P135, DOI 10.2134/jeq1989.00472425001800020001x; Schaap MG, 2001, J HYDROL, V251, P163, DOI 10.1016/S0022-1694(01)00466-8; SELIM HM, 1987, SOIL SCI SOC AM J, V51, P876, DOI 10.2136/sssaj1987.03615995005100040007x; Siegrist R.L., 2001, NAT RES NEEDS C RISK; SIMUNEK J, 1995, WATER POLLUTION III, P21; SimUnek J., 2012, TECHNICAL MANUAL; Simunek J, 2008, VADOSE ZONE J, V7, P587, DOI 10.2136/vzj2007.0077; Standley L., 2008, WASTEWATER CONTAMINA; Stevik TK, 2004, WATER RES, V38, P1355, DOI 10.1016/j.watres.2003.12.024; STEWART LW, 1988, J ENVIRON QUAL, V17, P499, DOI 10.2134/jeq1988.00472425001700030026x; Swartz CH, 2006, ENVIRON SCI TECHNOL, V40, P4894, DOI 10.1021/es052595+; Tchobanoglous G., 2003, WASTEWATER ENG TREAT, V4th; Tucholke M. B., 2007, NAT ONS WAST REC ASS; Tyler E.J., 1977, P 2 NAT HOM SEW TREA, P5; Tyler K, 1960, SOIL SCI SOC AM; U. S. EPA, 2015, WAT ASS TRACK ENV RE; U.S. EPA (United States Environmental Protection Agency), 2006, WAD STREAMS ASS COLL; Valiela I, 2002, APPL GEOCHEM, V17, P935, DOI 10.1016/S0883-2927(02)00073-2; Vanderborght J, 2007, VADOSE ZONE J, V6, P29, DOI 10.2136/vzj2006.0096; VANGENUCHTEN MT, 1989, SOIL SCI SOC AM J, V53, P1303, DOI 10.2136/sssaj1989.03615995005300050001x; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Weast R, 1985, CRC HDB CHEM PHYS RE; Youssef MA, 2005, T ASAE, V48, P611, DOI 10.13031/2013.18335	66	13	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158292	10.1371/journal.pone.0158292	http://dx.doi.org/10.1371/journal.pone.0158292			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355369	gold, Green Submitted, Green Published			2022-12-26	WOS:000378859400045
J	Okumura, N; Kakutani, K; Inoue, R; Matsumoto, D; Shimada, T; Nakahara, M; Kiyanagi, Y; Itoh, T; Koizumi, N				Okumura, Naoki; Kakutani, Kazuya; Inoue, Ryota; Matsumoto, Daiki; Shimada, Tomoki; Nakahara, Makiko; Kiyanagi, Yumiko; Itoh, Takehiro; Koizumi, Noriko			Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction	PLOS ONE			English	Article							INTRAOCULAR IRRIGATING SOLUTIONS; PROLIFERATIVE CAPACITY; ROCK INHIBITOR; IN-VITRO; TRANSPLANTATION; KERATOPLASTY; MEMBRANE; CULTURE; EXPANSION; SURVIVAL	The corneal endothelium maintains corneal transparency by its pump and barrier functions; consequently, its decompensation due to any pathological reason causes severe vision loss due to corneal haziness. Corneal transplantation is the only therapeutic choice for treating corneal endothelial dysfunction, but associated problems, such as a shortages of donor corneas, the difficulty of the surgical procedure, and graft failure, still need to be resolved. Regenerative medicine is attractive to researchers as a means of providing innovative therapies for corneal endothelial dysfunction, as it now does for other diseases. We previously demonstrated the successful regeneration of corneal endothelium in animal models by injecting cultured corneal endothelial cells (CECs) in combination with a Rho kinase (ROCK) inhibitor. The purpose of the present study was to optimize the vehicle for clinical use in cell-based therapy. Our screening of cell culture media revealed that RELAR medium promoted CEC adhesion. We then modified RELAR medium by removing hormones, growth factors, and potentially toxic materials to generate a cell therapy vehicle (CTV) composed of amino acid, salts, glucose, and vitamins. Injection of CECs in CTV enabled efficient engraftment and regeneration of the corneal endothelium in the rabbit corneal endothelial dysfunction model, with restoration of a transparent cornea. The CECs retained > 85% viability after a 24 hour preservation as a cell suspension in CTV at 4 degrees C and maintained their potency to regenerate the corneal endothelium in vivo. The vehicle developed here is clinically applicable for cell-based therapy aimed at treating the corneal endothelium. Our strategy involves the generation of vehicle from a culture medium appropriate for a given cell type by removing materials that are not favorable for clinical use.	[Okumura, Naoki; Kakutani, Kazuya; Inoue, Ryota; Matsumoto, Daiki; Shimada, Tomoki; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Kiyanagi, Yumiko; Itoh, Takehiro] Cell Sci & Technol Inst Inc, Sendai, Miyagi, Japan	Doshisha University	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Program for the Strategic Research Foundation at Private Universities from Ministry of Education, Culture, Sports, Science and Technology http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm.	ARAIE M, 1990, ARCH OPHTHALMOL-CHIC, V108, P882, DOI 10.1001/archopht.1990.01070080126049; ARAIE M, 1988, INVEST OPHTH VIS SCI, V29, P1884; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Broggi A, 2015, MOL IMMUNOL, V63, P127, DOI 10.1016/j.molimm.2014.06.037; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; ENGELMANN K, 1995, CORNEA, V14, P62; Eye Bank Association of America, 2013, EYE BANKING STATISTI; GLASSER DB, 1985, AM J OPHTHALMOL, V99, P321, DOI 10.1016/0002-9394(85)90363-0; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kang R, 2014, MOL MED, V20, P466, DOI 10.2119/molmed.2014.00117; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Kruse FE, 2014, CURR OPIN OPHTHALMOL, V25, P325, DOI 10.1097/ICU.0000000000000072; LAND W, 1994, TRANSPLANTATION, V57, P211, DOI 10.1097/00007890-199401001-00010; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069009; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P2933, DOI 10.1167/iovs.14-15163; Okumura N, 2014, CORNEA, V33, pS37, DOI 10.1097/ICO.0000000000000229; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Patel SV, 2012, EXP EYE RES, V95, P40, DOI 10.1016/j.exer.2011.05.013; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Price MO, 2013, CURR OPIN OPHTHALMOL, V24, P329, DOI 10.1097/ICU.0b013e32836229ab; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shima N, 2011, INVEST OPHTH VIS SCI, V52, P8711, DOI 10.1167/iovs.11-7592; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Turner N.A., 2015, J MOL CELL CARDIOL; Veldman PB, 2014, CURR OPIN OPHTHALMOL, V25, P306, DOI 10.1097/ICU.0000000000000073; YAMANE I, 1981, EXP CELL RES, V134, P470, DOI 10.1016/0014-4827(81)90448-1; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158427	10.1371/journal.pone.0158427	http://dx.doi.org/10.1371/journal.pone.0158427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355373	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400064
J	Tan, MSF; White, AP; Rahman, S; Dykes, GA				Tan, Michelle S. F.; White, Aaron P.; Rahman, Sadequr; Dykes, Gary A.			Role of Fimbriae, Flagella and Cellulose on the Attachment of Salmonella Typhimurium ATCC 14028 to Plant Cell Wall Models	PLOS ONE			English	Article							O-ANTIGEN CAPSULE; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157-H7; BIOFILM FORMATION; LISTERIA-MONOCYTOGENES; GENETIC-ANALYSIS; RDAR MORPHOTYPE; HUMAN PATHOGENS; COLONIZATION; VEGETABLES	Cases of foodborne disease caused by Salmonella are frequently associated with the consumption of minimally processed produce. Bacterial cell surface components are known to be important for the attachment of bacterial pathogens to fresh produce. The role of these extracellular structures in Salmonella attachment to plant cell walls has not been investigated in detail. We investigated the role of flagella, fimbriae and cellulose on the attachment of Salmonella Typhimurium ATCC 14028 and a range of isogenic deletion mutants (Delta fliC fljB, Delta bcsA, Delta csgA, Delta csgA bcsA and Delta csgD) to bacterial cellulose (BC)-based plant cell wall models [BC-Pectin (BCP), BC-Xyloglucan (BCX) and BC-Pectin-Xyloglucan (BCPX)] after growth at different temperatures (28 degrees C and 37 degrees C). We found that all three cell surface components were produced at 28 degrees C but only the flagella was produced at 37 degrees C. Flagella appeared to be most important for attachment (reduction of up to 1.5 log CFU/cm(2)) although both cellulose and fimbriae also aided in attachment. The csgD deletion mutant, which lacks both cellulose and fimbriae, showed significantly higher attachment as compared to wild type cells at 37 degrees C. This may be due to the increased expression of flagella-related genes which are also indirectly regulated by the csgD gene. Our study suggests that bacterial attachment to plant cell walls is a complex process involving many factors. Although flagella, cellulose and fimbriae all aid in attachment, these structures are not the only mechanism as no strain was completely defective in its attachment.	[Tan, Michelle S. F.; Rahman, Sadequr] Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia; [White, Aaron P.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Dykes, Gary A.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia	Monash University; Monash University Sunway; University of Saskatchewan; Curtin University	Dykes, GA (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.	gary.dykes@curtin.edu.au		Dykes, Gary/0000-0001-5014-9282				Aruscavage D, 2006, J FOOD SCI, V71, pR89, DOI 10.1111/j.1750-3841.2006.00157.x; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Bordas MA, 1996, APPL ENVIRON MICROB, V62, P3650, DOI 10.1128/AEM.62.10.3650-3654.1996; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Cevallos-Cevallos JM, 2012, INT J FOOD MICROBIOL, V160, P58, DOI 10.1016/j.ijfoodmicro.2012.09.021; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Charkowski AO, 2002, APPL ENVIRON MICROB, V68, P3114, DOI 10.1128/AEM.68.6.3114-3120.2002; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cybulska J, 2010, INT AGROPHYS, V24, P107; Cybulska J, 2010, J FOOD ENG, V96, P287, DOI 10.1016/j.jfoodeng.2009.08.001; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gu GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027340; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; HERMAN KM, 2008, INT C EM INF DIS ATL; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Huang SW., 2004, WRS0406 USDA EC RES, P3; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Jacxsens L, 2010, FOOD RES INT, V43, P1925, DOI 10.1016/j.foodres.2009.07.009; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; KODAKA H, 1982, J CLIN MICROBIOL, V16, P948, DOI 10.1128/JCM.16.5.948-952.1982; Kroupitski Y, 2009, J APPL MICROBIOL, V106, P1876, DOI 10.1111/j.1365-2672.2009.04152.x; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Krtinic G, 2010, EUR J CLIN MICROBIOL, V29, P1321, DOI 10.1007/s10096-010-1001-4; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; MacKenzie KD, 2015, INFECT IMMUN, V83, P2312, DOI 10.1128/IAI.00137-15; Marshall JM, 2015, INFECT IMMUN, V83, P3946, DOI 10.1128/IAI.00634-15; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Ogasawara H, 2011, J BACTERIOL, V193, P2587, DOI 10.1128/JB.01468-10; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Reina LD, 2002, J FOOD PROTECT, V65, P1881, DOI 10.4315/0362-028X-65.12.1881; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 1998, J BACTERIOL, V180, P722; Saggers EJ, 2008, J APPL MICROBIOL, V105, P1239, DOI 10.1111/j.1365-2672.2008.03795.x; Shaw RK, 2011, ENV MICROBIOL REP, V3, P569, DOI 10.1111/j.1758-2229.2011.00263.x; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Takeuchi K, 2000, J FOOD PROTECT, V63, P1433, DOI 10.4315/0362-028X-63.10.1433; Tan MSF, 2016, APPL ENVIRON MICROB, V82, P680, DOI 10.1128/AEM.02609-15; Tan MSF, 2013, FOODBORNE PATHOG DIS, V10, P992, DOI 10.1089/fpd.2013.1536; Tan MSF, 2016, FOOD CONTROL, V67, P119, DOI 10.1016/j.foodcont.2016.02.039; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Viazis S, 2011, FOOD MICROBIOL, V28, P149, DOI 10.1016/j.fm.2010.09.009; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Warriner K, 2010, CURR OPIN BIOTECH, V21, P131, DOI 10.1016/j.copbio.2010.01.004; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; White AP, 2007, CAN J MICROBIOL, V53, P56, DOI 10.1139/W06-102; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657; Wiedemann A, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00791; Yaron S, 2014, MICROB BIOTECHNOL, V7, P496, DOI 10.1111/1751-7915.12186; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x; Zorraquino V, 2013, J BACTERIOL, V195, P417, DOI 10.1128/JB.01789-12	65	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158311	10.1371/journal.pone.0158311	http://dx.doi.org/10.1371/journal.pone.0158311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355584	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400048
J	Teng, YL; Chen, CL; Lou, SZ; Wang, WT; Wu, JY; Ma, HI; Chen, VCH				Teng, Ya-Ling; Chen, Chiung-Ling; Lou, Shu-Zon; Wang, Wei-Tsan; Wu, Jui-Yen; Ma, Hui-Ing; Chen, Vincent Chin-Hung			Postural Stability of Patients with Schizophrenia during Challenging Sensory Conditions: Implication of Sensory Integration for Postural Control	PLOS ONE			English	Article							NEUROLOGICAL SOFT SIGNS; MOVEMENT-DISORDERS; COGNITIVE FUNCTIONS; VISUAL INFORMATION; BALANCE CONTROL; DYSFUNCTION; CEREBELLAR; SWAY; ABNORMALITIES; SENSITIVITY	Postural dysfunctions are prevalent in patients with schizophrenia and affect their daily life and ability to work. In addition, sensory functions and sensory integration that are crucial for postural control are also compromised. This study intended to examine how patients with schizophrenia coordinate multiple sensory systems to maintain postural stability in dynamic sensory conditions. Twenty-nine patients with schizophrenia and 32 control subjects were recruited. Postural stability of the participants was examined in six sensory conditions of different level of congruency of multiple sensory information, which was based on combinations of correct, removed, or conflicting sensory inputs from visual, somatosensory, and vestibular systems. The excursion of the center of pressure was measured by posturography. Equilibrium scores were derived to indicate the range of anterior-posterior (AP) postural sway, and sensory ratios were calculated to explore ability to use sensory information to maintain balance. The overall AP postural sway was significantly larger for patients with schizophrenia compared to the controls [patients (69.62 +/- 8.99); controls (76.53 +/- 7.47); t(1,59) = -3.28, p<0.001]. The results of mixed-model ANOVAs showed a significant interaction between the group and sensory conditions [F-5,F-295 = 5.55, p<0.001]. Further analysis indicated that AP postural sway was significantly larger for patients compared to the controls in conditions containing unreliable somatosensory information either with visual deprivation or with conflicting visual information. Sensory ratios were not significantly different between groups, although small and non-significant difference in inefficiency to utilize vestibular information was also noted. No significant correlations were found between postural stability and clinical characteristics. To sum up, patients with schizophrenia showed increased postural sway and a higher rate of falls during challenging sensory conditions, which was independent of clinical characteristics. Patients further demonstrated similar pattern and level of utilizing sensory information to maintain balance compared to the controls.	[Teng, Ya-Ling; Ma, Hui-Ing] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan; [Teng, Ya-Ling; Chen, Chiung-Ling; Lou, Shu-Zon] Chung Shan Med Univ, Dept Occupat Therapy, Coll Med Sci & Technol, Taichung, Taiwan; [Teng, Ya-Ling; Chen, Chiung-Ling] Chung Shan Med Univ Hosp, Occupat Therapy Room, Taichung, Taiwan; [Wang, Wei-Tsan] Cen Der Hosp, Dept Psychiat, Taichung, Taiwan; [Wu, Jui-Yen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Ma, Hui-Ing] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	National Cheng Kung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Ma, HI (corresponding author), Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan.; Ma, HI (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan.	huingma@mail.ncku.edu.tw		Teng, Ya-Ling/0000-0002-8496-3861				Ahlgren-Rimpilainen A, 2010, J NERV MENT DIS, V198, P601, DOI 10.1097/NMD.0b013e3181ea16bc; Allain H, 2003, PSYCHOPHARMACOLOGY, V165, P419, DOI 10.1007/s00213-002-1272-2; Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Bernard JA, 2014, HUM BRAIN MAPP, V35, P4064, DOI 10.1002/hbm.22458; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P274, DOI 10.1016/j.apmr.2003.06.016; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; BROEKEMA V, 1975, J ABNORM PSYCHOL, V84, P30, DOI 10.1037/h0076250; Cantor-Graae E, 2000, ACTA PSYCHIAT SCAND, V101, P142, DOI 10.1034/j.1600-0447.2000.90054.x; Caron O, 1997, J BIOMECH, V30, P1169, DOI 10.1016/S0021-9290(97)00094-8; Chang BP, 2005, J ABNORM PSYCHOL, V114, P85, DOI 10.1037/0021-843X.114.1.85; Chaudhry H, 2011, J BODYW MOV THER, V15, P82, DOI 10.1016/j.jbmt.2008.03.003; Corbeil P, 2012, PSYCHOPHARMACOLOGY, V222, P59, DOI 10.1007/s00213-011-2623-7; de Groot MH, 2013, DRUG AGING, V30, P901, DOI 10.1007/s40266-013-0113-9; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235, DOI 10.1093/schbul/20.2.235; Fong SSM, 2011, RES DEV DISABIL, V32, P2376, DOI 10.1016/j.ridd.2011.07.025; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Fujino H, 2015, PSYCHIAT QUART, V86, P603, DOI 10.1007/s11126-015-9355-5; Gao KM, 2008, J CLIN PSYCHOPHARM, V28, P203, DOI 10.1097/JCP.0b013e318166c4d5; Gebhardt S, 2006, EUR CHILD ADOLES PSY, V15, P371, DOI 10.1007/s00787-006-0544-5; Gervin M, 1998, AM J PSYCHIAT, V155, P1202, DOI 10.1176/ajp.155.9.1202; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Ho BC, 2004, BIOL PSYCHIAT, V55, P1146, DOI 10.1016/j.biopsych.2004.02.020; Ismail B, 1998, AM J PSYCHIAT, V155, P84, DOI 10.1176/ajp.155.1.84; Janno S, 2004, AM J PSYCHIAT, V161, P160, DOI 10.1176/appi.ajp.161.1.160; Jeon HJ, 2007, PSYCHIAT RES, V152, P155, DOI 10.1016/j.psychres.2006.09.001; Kent JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041808; Kinney DK, 1999, SCHIZOPHR RES, V35, P99, DOI 10.1016/S0920-9964(98)00121-2; Koreki A, 2011, J CLIN PSYCHOPHARM, V31, P16, DOI 10.1097/JCP.0b013e318205e192; Kubota F, 1999, BIOL PSYCHIAT, V45, P412, DOI 10.1016/S0006-3223(97)00523-4; Lacour M, 1997, EXP BRAIN RES, V115, P300, DOI 10.1007/PL00005698; Le Seac'h A, 2012, PSYCHIAT RES, V198, P230, DOI 10.1016/j.psychres.2011.12.039; Lenzenweger MF, 2000, SCHIZOPHR RES, V42, P111, DOI 10.1016/S0920-9964(99)00120-6; LEVY DL, 1983, SCHIZOPHRENIA BULL, V9, P383, DOI 10.1093/schbul/9.3.383; Manzoni D, 2005, CEREBELLUM, V4, P178, DOI 10.1080/14734220500193493; Marvel CL, 2004, SCHIZOPHR RES, V68, P363, DOI 10.1016/j.schres.2003.09.003; Matsuura Y, 2015, GAIT POSTURE, V41, P847, DOI 10.1016/j.gaitpost.2015.03.006; Nashner LM, 2014, BALANCE FUNCTION ASS, P451; Nasrallah HA, 2005, J CLIN PSYCHIAT, V66, P34; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Picard H, 2008, SCHIZOPHRENIA BULL, V34, P155, DOI 10.1093/schbul/sbm049; Picard HJ, 2009, PROG NEURO-PSYCHOPH, V33, P676, DOI 10.1016/j.pnpbp.2009.03.012; Shumway-Cook A, 2001, MOTOR CONTROL; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Stensdotter AK, 2013, GAIT POSTURE, V38, P918, DOI 10.1016/j.gaitpost.2013.04.017; Stensdotter AK, 2013, J MOTOR BEHAV, V45, P279, DOI 10.1080/00222895.2013.791241; Sullivan EV, 2004, AM J PSYCHIAT, V161, P751, DOI 10.1176/appi.ajp.161.4.751; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Tsunoda K, 2010, INT J GERIATR PSYCH, V25, P1259, DOI 10.1002/gps.2465; Turner R, 2004, J NEUROPSYCH CLIN N, V16, P400, DOI 10.1176/appi.neuropsych.16.4.400; Varambally S, 2006, ACTA PSYCHIAT SCAND, V114, P352, DOI 10.1111/j.1600-0447.2006.00837.x	52	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158219	10.1371/journal.pone.0158219	http://dx.doi.org/10.1371/journal.pone.0158219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355830	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400039
J	Meng, K; Li, XM; Wang, SY; Zhong, CY; Yang, ZN; Feng, LY; Liu, QZ				Meng, Kun; Li, Xiaomei; Wang, Shengya; Zhong, Chunyan; Yang, Zhouning; Feng, Lingyan; Liu, Qingzhen			The Strica Homolog AaCASPS16 Is Involved in Apoptosis in the Yellow Fever Vector, Aedes albopictus	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CASPASE ACTIVATION; DROSOPHILA-MELANOGASTER; IN-VIVO; INHIBITION; MECHANISMS; MOSQUITO; GENES; DRONC; MODEL	Caspases are a family of cysteine proteases playing essential roles during apoptosis. Seven caspases identified in Drosophila were Dronc, Dredd, Strica, Dcp-1, Decay, Drice and Damm. Among them, Strica is an insect-specific caspase containing a long serine- and threonine- rich prodomain, of which function is not yet well studied. Here we identified a homolog of strica from Aedes albopictus, named as Aacasps16. Aacasps16 encoded a protein containing a putative serine- and threonine-rich prodomain and a well conserved caspase catalytic domain. AaCASPS16 shared high identity with dipteran insects Strica homologs. Alignment showed that the closest relative of AaCASPS16 was Aedes aegypti AeCASPS16. The expression profiles of Aacasps16 during developmental and adult stages were analyzed. Purified recombinant AaCASPS16 exhibited the highest caspase activity to WEHD, which is the substrate preferred by human caspase-9. AaCASPS16 induced apoptosis when over-expressed in C6/36 cells. AaCASPS16 was processed during apoptosis induced by actinomycin D and ultraviolet irradiation treatment, whereas partial silencing of Aacasps16 reduced actinomycin D- and ultraviolet irradiation-triggered apoptosis in C6/36 cells. Taken together, our study identified AaCASPS16 as a novel apoptotic caspase in Aedes albopictus.	[Liu, Qingzhen] Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China; Wuhan Univ, Modern Virol Res Ctr, Coll Life Sci, Wuhan, Peoples R China	Wuhan University; Wuhan University	Liu, QZ (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China.	qzhliu@whu.edu.cn		Meng, Kun/0000-0002-6541-9510	National Natural Science Foundation of China [31370186]; Chinese 111 project from The Department of Science & Technology, Ministry of Education [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project from The Department of Science & Technology, Ministry of Education	This project was supported by the grant from National Natural Science Foundation of China (#31370186; recipient: Qingzhen Liu; http://www.nsfc.gov.cn/publish/portal1/) and is partially supported by the Chinese 111 project from The Department of Science & Technology, Ministry of Education (#B06018;recipient: Hongbing Shu; http://www.dost.moe.edu.cn/dostmoe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012; Denault Jean-Bernard, 2004, IDrugs, V7, P315; Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Doumanis J, 2001, CELL DEATH DIFFER, V8, P387, DOI 10.1038/sj.cdd.4400864; Fiandalo MV, 2013, APOPTOSIS, V18, P766, DOI 10.1007/s10495-013-0821-y; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Girard YA, SALIVARY GLAND MORPH; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Kale A, 2015, CELL DEATH DIFFER; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lee GG, 2013, J COMP NEUROL, V521, P3972, DOI 10.1002/cne.23387; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112; Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393	31	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157846	10.1371/journal.pone.0157846	http://dx.doi.org/10.1371/journal.pone.0157846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351972	gold, Green Published, Green Submitted			2022-12-26	WOS:000378858900021
J	Srinivasan, R; Gothandam, KM				Srinivasan, Ramachandran; Gothandam, Kodiveri Muthukalianan			Synergistic Action of D-Glucose and Acetosyringone on Agrobacterium Strains for Efficient Dunaliella Transformation	PLOS ONE			English	Article							MEDIATED GENETIC-TRANSFORMATION; GREEN FLUORESCENT PROTEIN; TIME PCR ASSAY; CHLAMYDOMONAS-REINHARDTII; BINDING-PROTEIN; SUGAR BINDING; COPY NUMBER; TUMEFACIENS; ALGA; EXPRESSION	An effective transformation protocol for Dunaliella, a beta-carotene producer, was developed using the synergistic mechanism of D-glucose and Acetosyringone on three different Agrobacterium strains (EHA105, GV3101 and LBA4404). In the present study, we investigated the pre-induction of Agrobacterium strains harboring pMDC45 binary vector in TAP media at varying concentrations of D-glucose (5 mM, 10 mM, and 15mM) and 100 mu M of Acetosyringone for co-cultivation. Induction of Agrobacterium strains with 10 mM D-glucose and 100 mu M Acetosyringone showed higher rates of efficiency compared to other treatments. The presence of GFP and HPT transgenes as a measure of transformation efficiency from the transgenic lines were determined using fluorescent microscopy, PCR, and southern blot analyzes. Highest transformation rate was obtained with the Agrobacterium strain LBA4404 (181 +/- 3.78 cfu per 10(6) cells) followed by GV3101 (128 +/- 5.29 cfu per 10(6) cells) and EHA105 (61 +/- 5.03 cfu per 10(6) cells). However, the Agrobacterium strain GV3101 exhibited more efficient single copy transgene (HPT) transfer into the genome of D. salina than LBA4404. Therefore, future studies dealing with genetic modifications in D. salina can utilize GV3101 as an optimal Agrobacterium strain for gene transfer.	[Srinivasan, Ramachandran; Gothandam, Kodiveri Muthukalianan] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Gothandam, KM (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.	gothandam@gmail.com	Kodiveri Muthukaliannan, Gothandam/C-5734-2014; KM, Gothandam/ABI-2215-2020; Srinivasan, Ramachandran/AAC-3202-2022	Kodiveri Muthukaliannan, Gothandam/0000-0003-1576-5324; Srinivasan, Ramachandran/0000-0001-7248-142X	Council for Scientific and Industrial Research, India [38(1327)/12/EMR-II]	Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by Council for Scientific and Industrial Research (Grant No. 38(1327)/12/EMR-II dated 03.04.2012), India. Funders have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anila N, 2016, PHOTOSYNTH RES, V127, P321, DOI 10.1007/s11120-015-0188-8; Anila N, 2011, EUR J PHYCOL, V46, P36, DOI 10.1080/09670262.2010.550386; Anila N, 2013, J APPL PHYCOL, V25, P121, DOI 10.1007/s10811-012-9845-x; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Cha TS, 2012, WORLD J MICROB BIOT, V28, P1771, DOI 10.1007/s11274-011-0991-0; Cha TS, 2011, J MICROBIOL METH, V84, P430, DOI 10.1016/j.mimet.2011.01.005; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng RB, 2012, MICROBIOL RES, V167, P179, DOI 10.1016/j.micres.2011.05.003; Chetty VJ, 2013, PLANT CELL REP, V32, P239, DOI 10.1007/s00299-012-1358-1; DOTY SL, 1993, J BACTERIOL, V175, P7880, DOI 10.1128/JB.175.24.7880-7886.1993; Fang L, 2012, PLANT BIOTECHNOL J, V10, P1129, DOI 10.1111/pbi.12000; Feng SY, 2009, MOL BIOL REP, V36, P1433, DOI 10.1007/s11033-008-9333-1; Ortiz-Matamoros MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132693; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Gao R, 2005, J BACTERIOL, V187, P2182, DOI 10.1128/JB.187.6.2182-2189.2005; Guo SL, 2013, J BIOTECHNOL, V163, P61, DOI 10.1016/j.jbiotec.2012.10.020; Harris EH, 2009, CHLAMYDOMONAS SOURCE, DOI [10.1016/0092-8674(90)90467-S, DOI 10.1016/0092-8674(90)90467-S]; Hawkins RL, 1999, CURR MICROBIOL, V38, P335, DOI 10.1007/PL00006813; He FL, 2009, J BACTERIOL, V191, P5802, DOI 10.1128/JB.00451-09; Hu XZ, 2013, P NATL ACAD SCI USA, V110, P678, DOI 10.1073/pnas.1215033110; Ingham DJ, 2001, BIOTECHNIQUES, V31, P132, DOI 10.2144/01311rr04; Jeon K, 2013, KOREAN J CHEM ENG, V30, P1626, DOI 10.1007/s11814-013-0098-4; Kathiresan S, 2009, J PHYCOL, V45, P642, DOI 10.1111/j.1529-8817.2009.00688.x; KROES HW, 1971, LIMNOL OCEANOGR, V16, P869, DOI 10.4319/lo.1971.16.6.0869; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Maliakal S, 2001, J PHYCOL, V37, P1010, DOI 10.1046/j.1529-8817.2001.00120.x; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; NEUHAUS G, 1984, EMBO J, V3, P2169, DOI 10.1002/j.1460-2075.1984.tb02108.x; Ohnuma M, 2008, PLANT CELL PHYSIOL, V49, P117, DOI 10.1093/pcp/pcm157; Orset S, 1999, J PHYCOL, V35, P520, DOI 10.1046/j.1529-8817.1999.3530520.x; Peng WT, 1998, J BACTERIOL, V180, P5632, DOI 10.1128/JB.180.21.5632-5638.1998; Prasad B, 2014, APPL MICROBIOL BIOT, V98, P8629, DOI 10.1007/s00253-014-5900-7; Pratheesh PT, 2014, MOL BIOTECHNOL, V56, P507, DOI 10.1007/s12033-013-9720-2; Rajam MV, 2007, INDUCTION AGROBACTER, V92; Rathod J, 2013, PHOTOSYNTH RES, V118, P141, DOI 10.1007/s11120-013-9930-2; Rogers SO., 1994, PLANT MOL BIOL, V1, P183, DOI 10.1007/978-94-011-0511-8_12; Sanitha M, 2014, POL J MICROBIOL, V63, P387; SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684; Simon DP, 2015, ALGAL RES, V11, P121, DOI 10.1016/j.algal.2015.06.007; Subramoni S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00322; Tan CP, 2005, J MICROBIOL, V43, P361; ten Lohuis MR, 1998, PLANT J, V13, P427; Toyoda-Yamamoto A, 2000, MOL GEN GENET, V263, P939, DOI 10.1007/PL00008694; Wang P, 2006, J AGR FOOD CHEM, V54, P10033, DOI 10.1021/jf0611769; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07	48	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158322	10.1371/journal.pone.0158322	http://dx.doi.org/10.1371/journal.pone.0158322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351975	Green Published, Green Submitted, gold			2022-12-26	WOS:000378858900054
J	Liang, ZK; Schnable, JC				Liang, Zhikai; Schnable, James C.			RNA-Seq Based Analysis of Population Structure within the Maize Inbred B73	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME; TRANSCRIPTOME; COMPLEXITY; LANDSCAPE; LINES; CONTAMINATION; PHENOTYPES; DIVERSITY; MERISTEMS	Recent reports have shown than many identically named genetic lines used in research around the world actually contain large amounts of uncharacterized genetic variation as a result of cross contamination of stocks, unintentional crossing, residual heterozygosity within original stocks, or de novo mutation. 27 public, large scale, RNA-seq datasets from 20 independent research groups around the world were used to assess variation within the maize (Zea mays ssp. mays) inbred B73, a four decade old variety which served as the reference genotype for the original maize genome sequencing project and is widely used in genetic, genomic, and phenotypic research. Several clearly distinct clades were identified among putatively B73 samples. A number of these clades were defined by the presence of clearly defined genomic blocks containing a haplotype which did not match the published B73 reference genome. The overall proportion of the maize genotype where multiple distinct haplotypes were observed across different research groups was approximately 2.3%. In some cases the relationship among B73 samples generated by different research groups recapitulated mentor/mentee relationships within the maize genetics community.	[Schnable, James C.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Schnable, JC (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA.	schnable@unl.edu	Liang, Zhikai/AAZ-9184-2021; Liang, Zhikai/F-1723-2019	Liang, Zhikai/0000-0002-9963-8631; Liang, Zhikai/0000-0002-9963-8631; Schnable, James/0000-0001-6739-5527	start-up funds from University of Nebraska-Lincoln	start-up funds from University of Nebraska-Lincoln	This project is supported by start-up funds from University of Nebraska-Lincoln to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campbell MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120385; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Chettoor A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0414-2; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DARRAH LL, 1986, CROP SCI, V26, P1109, DOI 10.2135/cropsci1986.0011183X002600060004x; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Enders TA, 2015, PLANT CELL, V27, P1820, DOI 10.1105/tpc.15.00214; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Felsenstein J, PHYLIP PHYLOGENY INF; Frank MH, 2015, NEW PHYTOL, V207, P893, DOI 10.1111/nph.13407; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Gethi JG, 2002, CROP SCI, V42, P951, DOI 10.2135/cropsci2002.0951; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haun WJ, 2011, PLANT PHYSIOL, V155, P645, DOI 10.1104/pp.110.166736; He GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r57; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Johnston R, 2014, PLANT CELL, V26, P4718, DOI 10.1105/tpc.114.132688; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lipps PE, 1997, PLANT DIS, V81, P277, DOI 10.1094/PDIS.1997.81.3.277; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Lucey BP, 2009, ARCH PATHOL LAB MED, V133, P1463, DOI 10.1043/1543-2165-133.9.1463; MacLeod RAF, 1999, INT J CANCER, V83, P555; Makarevitch I, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1004915, 10.1371/journal.pgen.1005566]; Martin JA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04519; Mikel MA, 2008, CROP SCI, V48, P1686, DOI 10.2135/cropsci2008.01.0039; Money D, 2015, G3-GENES GENOM GENET, V5, P2383, DOI 10.1534/g3.115.021667; Olmos SE, 2014, MAYDICA, V59, P298; Opitz N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-741; Paschold A, 2012, GENOME RES, V22, P2445, DOI 10.1101/gr.138461.112; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; RUSSELL WA, 1972, CROP SCI, V12, P721, DOI 10.2135/cropsci1972.0011183X001200050085x; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Shao MR, 2016, PLANT CELL, V28, P603, DOI 10.1105/tpc.16.00053; Stelpflug SC, 2015, PLANT GENOME; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urbany C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-213; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Wang L, 2014, NAT BIOTECHNOL, V32, P1158, DOI 10.1038/nbt.3019; Weigel D, 2016, PLANT CELL, V28, P606, DOI [10.1105/tpc.15.00502, DOI 10.1105/TPC.15.00502]; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yi G, 2015, PLANT PHYSIOL, V167, P443, DOI 10.1104/pp.114.251413; Zhang M, 2014, GENOME RES, V24, P167, DOI 10.1101/gr.155879.113	53	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157942	10.1371/journal.pone.0157942	http://dx.doi.org/10.1371/journal.pone.0157942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348435	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200023
J	Goli, S; Moradhvaj; Rammohan, A; Shruti; Pradhan, J				Goli, Srinivas; Moradhvaj; Rammohan, Anu; Shruti; Pradhan, Jalandhar			High Spending on Maternity Care in India: What Are the Factors Explaining It?	PLOS ONE			English	Article							JANANI SURAKSHA YOJANA; OF-POCKET EXPENDITURE; INSTITUTIONAL DELIVERY; CASH TRANSFER; HEALTH; PROGRAM; BIRTHS; COSTS	Background and Objectives High maternity-related health care spending is often cited as an important barrier in utilizing quality health care during pregnancy and childbirth. This study has two objectives: (i) to measure the levels of expenditure on total maternity care in disaggregated components such as ANCs, PNCs, and Natal care expenditure; (ii) to quantify the extent of catastrophic maternity expenditure (CME) incurred by households and identify the factors responsible for it. Methods and Findings Data from the 71st round of the National Sample Survey (2014) was used to estimate maternity expenditure and its predictors. CME was measured as a share of consumption expenditure by different cut-offs. The two-part model was used to identify the factors associated with maternity spending and CME. The findings show that household spending on maternity care (US$149 in constant price) is much higher than previous estimates (US$50 in constant price). A significant proportion of households in India (51%) are incurring CME. Along with economic and educational status, type of health care and place of residence emerged as significant factors in explaining CME. Conclusion Findings from this study assume importance in the context of an emerging demand for higher maternity entitlements and government spending on public health care in India. To reduce CME, India needs to improve the availability and accessibility of better-quality public health services and increase maternity entitlements in line with maternity expenditure identified in this study.	[Goli, Srinivas; Moradhvaj] JNU, CSRD, SSS, New Delhi, India; [Rammohan, Anu] Univ Western Australia, Discipline Econ, Crawley, WA, Australia; [Shruti] BHU, Discipline Econ, Fac Social Sci, Varanasi, Uttar Pradesh, India; [Pradhan, Jalandhar] Natl Inst Technol, Dept Humanities & Social Sci, Rourkela, Orissa, India	University of Western Australia; Banaras Hindu University (BHU); National Institute of Technology (NIT System); National Institute of Technology Rourkela	Goli, S (corresponding author), JNU, CSRD, SSS, New Delhi, India.	sirispeaks2u@gmail.com	Pradhan, Jalandhar/N-1820-2017; Pradhan, Jalandhar/HIK-1917-2022; Goli, Srinivas/J-7238-2012	Pradhan, Jalandhar/0000-0001-5998-0363; Goli, Srinivas/0000-0002-8481-484X; Rammohan, Anu/0000-0002-9062-4508; , Moradhvaj/0000-0002-8798-385X				[Anonymous], 2012, JOURNAL OF HEALTH EC, V43, P154; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Berki S E, 1986, Health Aff (Millwood), V5, P138, DOI 10.1377/hlthaff.5.4.138; Bonu S., 2007, ERD WORKING PAPER SE, V102; Bonu S, 2009, HEALTH POLICY PLANN, V24, P445, DOI 10.1093/heapol/czp032; Canadian Institute for Health Information (CIHI), 2006, GIV BIRTH CAN; Coffey D, 2014, SOC SCI MED, V114, P89, DOI 10.1016/j.socscimed.2014.05.035; Deaton A., 2010, Economic and Political Weekly, V45, P78; Dhar RSG, 2009, J HEALTH POPUL NUTR, V27, P368; Dongre AA, 2010, EFFECT MONETARY INCE; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; Forum for Medical Ethics Society, 2015, ECON POLIT WEEKLY, V40, P22; Garg S, 2012, NATL MED J INDIA, V25, P111; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Horton R, 2011, LANCET, V377, P181, DOI 10.1016/S0140-6736(10)62179-4; Hussain Z, 2011, ECON POLIT WEEKLY, V46, P46; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Ministry of Finance, 2015, EC SURV IND; Ministry of Health and Family Welfare (MoHFW), 2014, ANN REP 2013 14; Ministry of Health and Family Welfare (MoHFW), 2009, ANN REP PEOPL HLTH; Modugu HR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1048; Mohanty SK, 2013, MATERN CHILD HLTH J, V17, P1441, DOI 10.1007/s10995-012-1151-3; Mohanty SK, 2013, HEALTH POLICY PLANN, V28, P247, DOI 10.1093/heapol/czs057; MOSPI, 2015, MILL DEV GOALS IND C; Murray CJ, 2000, GLOBAL PROGRAMME EVI, V24; Nalin T, 2011, PAYING PRICE I DELIV; National Sample Survey Organization (NSSO), 2015, 71 NSSO MIN STAT PRO; NSSO, 2004, HLTH CAR COND AG NSS; Office of the Registrar General India, 2013, SPEC B MAT MORT IND; Patnaik U., 2010, ECON POLIT WEEKLY, V45, P74; Patra S, 2016, HEALTH CARE WOMEN IN, V37, P531, DOI 10.1080/07399332.2014.946509; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Perkins M, 2009, HEALTH POLICY PLANN, V24, P289, DOI 10.1093/heapol/czp013; Roy K, 2007, HEALTH POLICY, V80, P297, DOI 10.1016/j.healthpol.2006.03.012; Sakthivel Selvaraj, 2009, Economic and Political Weekly, V44, P55; Sambo Mohd Nasiq, 2013, Niger Med J, V54, P87, DOI 10.4103/0300-1652.110034; Scott K, 2010, AIDS CARE, V22, P1606, DOI 10.1080/09540121.2010.507751; Sharma DC, 2015, LANCET, V385, P2031, DOI 10.1016/S0140-6736(15)60977-1; Shobha Malini, 2008, Health and Population - Perspectives and Issues, V31, P126; Shukla M, 2015, INDAN J COMMUNITY HE, V27, P241; Skordis-Worrall J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-150; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Subramanian SV., 2008, BROWN J WORLD AFF, V14, P127; Subramanyam MA, 2011, INDIAN J MED RES, V133, P461; Sundararaman T, 2015, EC POLITICAL WEEKLY, V50; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; United Nations, 2015, SUST DEV GOAL 3 SDGS; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WOR HEALT REP, P1; WHO UNICEF UNFPA, 2014, WORLD TRENDS MAT MOR; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	55	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0156437	10.1371/journal.pone.0156437	http://dx.doi.org/10.1371/journal.pone.0156437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3KZ	27341520	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600002
J	Ioannidis, J; Donadeu, FX				Ioannidis, Jason; Donadeu, F. Xavier			Circulating microRNA Profiles during the Bovine Oestrous Cycle	PLOS ONE			English	Article							MIRNA EXPRESSION; PLASMA; BLOOD; IDENTIFICATION; ENDOMETRIUM; INVOLVEMENT; MIRBASE; ESTRUS; TOOLS	Up to 50% of ovulations go undetected in modern dairy herds due to attenuated oestrus behavior and a lack of high-accuracy methods for detection of fertile oestrus. This significantly reduces overall herd productivity and constitutes a high economic burden to the dairy industry. MicroRNAs (miRNAs) are ubiquitous regulators of gene expression during both health and disease and they have been shown to regulate different reproductive processes. Extracellular miRNAs are stable and can provide useful biomarkers of tissue function; changes in circulating miRNA profiles have been reported during menstrual cycles. This study sought to establish the potential of circulating miRNAs as biomarkers of oestrus in cattle. We collected plasma samples from 8 Holstein-Friesian heifers on days Days 0, 8 and 16 of an oestrous cycle and analysed small RNA populations on each Day using two independent high-throughput approaches, namely, Illumina sequencing (n = 24 samples) and Qiagen PCR arrays (n = 9 sample pools, 3-4 samples/pool). Subsequently, we used RTqPCR (n = 24 samples) to validate the results of high-throughput analyses, as well as to establish the expression profiles of additional miRNAs previously reported to be differentially expressed during reproductive cycles. Overall, we identified four miRNAs (let-7f, miR-125b, miR-145 and miR-99a-5p), the plasma levels of which distinctly increased (up to 2.2-fold, P < 0.05) during oestrus (Day 0) relative to other stages of the cycle (Days 8 and 16). Moreover, we identified several hundred different isomiRs and established their relative abundance in bovine plasma. In summary, our results reveal the dynamic nature of plasma miRNAs during the oestrous cycle and provide evidence of the feasibility of using circulating miRNAs as biomarkers of reproductive function in livestock in the future.	[Donadeu, F. Xavier] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; Univ Edinburgh, R D SVS, Easter Bush, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Donadeu, FX (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	xavier.donadeu@roslin.ed.ac.uk		Ioannidis, Jason/0000-0003-1628-4928	Biotechnology and Biological Sciences Research Council [BB/K501578/1]; Zoetis Inc.; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221656, 1248216, BBS/E/D/20310000] Funding Source: researchfish; BBSRC [BBS/E/D/20310000, BBS/E/D/20221656] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis Inc.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), BB/K501578/1 to JI, Zoetis Inc., (https://www.zoetis.com) to FXD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baran-Gale J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00352; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Crowe MA, 2008, REPROD DOMEST ANIM, V43, P20, DOI 10.1111/j.1439-0531.2008.01210.x; Dobson H, 2007, REPROD DOMEST ANIM, V42, P17, DOI 10.1111/j.1439-0531.2007.00906.x; Donadeu FX, 2013, DOMEST ANIM ENDOCRIN, V45, P122, DOI 10.1016/j.domaniend.2013.06.006; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; Elsik CG, 2016, NUCLEIC ACIDS RES, V44, pD834, DOI 10.1093/nar/gkv1077; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Fricke PM, 2014, ANIMAL, V8, P134, DOI 10.1017/S1751731114000299; Fuchs RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126049; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hackenberg M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-214; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; HEERSCHE G, 1994, J DAIRY SCI, V77, P2754, DOI 10.3168/jds.S0022-0302(94)77218-0; Holman A, 2011, VET REC, V169, P47, DOI 10.1136/vr.d2344; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kresowik JDK, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.116590; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawrence MA, 2013, EZ EASY ANAL VISUALI; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miura K, 2015, J OBSTET GYNAECOL RE, V41, P1526, DOI 10.1111/jog.12749; Noferesti SS, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0208-5; Palma-Vera SE, 2015, REPROD DOMEST ANIM, V50, P800, DOI 10.1111/rda.12590; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; R Core Team, 2021, R LANGUAGE ENV STAT; Rekker K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081166; Rstudio Team, 2015, RSTUDIO INT DEV R; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Salilew-Wondim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106795; Schauer SN, 2013, REPRODUCTION, V146, P273, DOI 10.1530/REP-13-0107; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Sontakke SD, 2014, REPRODUCTION, V148, P271, DOI 10.1530/REP-14-0140; Spornraft M, 2015, BIOTECHNOL LETT, V37, P1165, DOI 10.1007/s10529-015-1788-2; Ul Hussain M, 2012, CELL TISSUE RES, V349, P405, DOI 10.1007/s00441-012-1438-0; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vilella F, 2015, DEVELOPMENT, V142, P3210, DOI 10.1242/dev.124289; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Williams Z, 2013, P NATL ACAD SCI US; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304	55	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158160	10.1371/journal.pone.0158160	http://dx.doi.org/10.1371/journal.pone.0158160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27340826	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600035
J	Kisomi, MG; Wong, LP; Tay, ST; Bulgiba, A; Zandi, K; Kho, KL; Koh, FX; Ong, BL; Jaafar, T; Nizam, QNH				Kisomi, Masoumeh Ghane; Wong, Li Ping; Tay, Sun Tee; Bulgiba, Awang; Zandi, Keivan; Kho, Kai Ling; Koh, Fui Xian; Ong, Bee Lee; Jaafar, Tariq; Nizam, Quaza Nizamuddin Hassan			Factors Associated with Tick Bite Preventive Practices among Farmworkers in Malaysia	PLOS ONE			English	Article							LYME-DISEASE PREVENTION; FEVER GROUP RICKETTSIAE; BORNE DISEASES; HUMAN EHRLICHIOSIS; FORESTRY WORKERS; SEROPREVALENCE; BEHAVIORS; KNOWLEDGE; RISK; ENCEPHALITIS	Background Farmworkers are at high-risk for tick bites, which potentially transmit various tick-borne diseases. Previous studies show that personal prevention against tick bites is key, and certain factors namely, knowledge, experience of tick bites, and health beliefs influence compliance with tick bites preventive behaviour. This study aimed to assess these factors and their associations with tick bite preventive practices among Malaysian farmworkers. Methods A total of eight cattle, goat and sheep farms in six states in Peninsular Malaysia participated in a cross-sectional survey between August and October 2013 Results A total of 151 (72.2%) out of 209 farmworkers answered the questionnaire. More than half of the farmworkers (n = 91) reported an experience of tick bites. Farms with monthly acaricide treatment had significantly (P<0.05) a low report of tick bites. Tick bite exposure rates did not differ significantly among field workers and administrative workers. The mean total knowledge score of ticks for the overall farmworkers was 13.6 (SD +/- 3.2) from 20. The mean total tick bite preventive practices score for all farmworkers was 8.3 (SD +/- 3.1) from 15. Fixed effect model showed the effects of four factors on tick bite prevention: (1) farms, (2) job categories (administrative workers vs. field workers), (3) perceived severity of tick bites, and (4) perceived barriers to tick bite prevention. Conclusions A high proportion of farmworkers, including administrative workers, reported an experience of tick bites. The effectiveness of monthly acaricide treatment was declared by low reports of tick bites on these farms. Tick bite preventive practices were insufficient, particularly in certain farms and for administrative workers. Our findings emphasise the need to have education programmes for all farmworkers and targeting farms with low prevention practices. Education and health programmes should increase the perception of the risk of tick bites and remove perceived barriers of tick bite prevention.	[Kisomi, Masoumeh Ghane; Wong, Li Ping; Bulgiba, Awang] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Wong, Li Ping; Bulgiba, Awang] Univ Malaya, Fac Med, JCUM, Kuala Lumpur, Malaysia; [Tay, Sun Tee; Zandi, Keivan; Kho, Kai Ling; Koh, Fui Xian] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Ong, Bee Lee] Univ Malaysia Kelantan, Fac Vet Med, Dept Vet Clin Studies, Kelantan, Malaysia; [Jaafar, Tariq; Nizam, Quaza Nizamuddin Hassan] Minist Agr & Agrobased Ind Malaysia, Fed Govt Adm Ctr, Dept Vet Serv, Putrajaya, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaysia Kelantan	Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.; Wong, LP (corresponding author), Univ Malaya, Fac Med, JCUM, Kuala Lumpur, Malaysia.	wonglp@ummc.edu.my	Bulgiba, Awang/B-8271-2010; ZANDI, KEIVAN ZANDI KEIVAN/B-8762-2010; Tay, Sun Tee/N-2295-2019; WONG, LI PING/B-2782-2010	Bulgiba, Awang/0000-0002-5313-0445; Tay, Sun Tee/0000-0002-3120-6998; WONG, LI PING/0000-0002-0107-0532; Zandi, Keivan/0000-0001-9728-5038; Kho, Kai Ling/0000-0001-7451-2234; Ghane Kisomi, Masoumeh/0000-0001-5614-620X	University Malaya Research Grant [UMRG/RP013-2012A, UMRG/RP013-2012E]; University of Malaya, Kuala Lumpur [PPP/PG026-2012B]	University Malaya Research Grant; University of Malaya, Kuala Lumpur(Universiti Malaya)	This research was funded by the University Malaya Research Grant (UMRG/RP013-2012A and E), and Postgraduate Research Grant (PPP/PG026-2012B), University of Malaya, Kuala Lumpur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan I, 2010, TROP ANIM HEALTH PRO, V42, P669, DOI 10.1007/s11250-009-9474-9; Baneth G, 2014, INT J PARASITOL, V44, P591, DOI 10.1016/j.ijpara.2014.03.011; Basta J, 1998, ZBL BAKT-INT J MED M, V288, P553; Bayles BR, 2013, TICKS TICK-BORNE DIS, V4, P352, DOI 10.1016/j.ttbdis.2013.01.001; Beaujean D, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2760; Beaujean DJMA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-225; Bina Rai S., 2011, OSIR, V4, P1; Chmielewska-Badora J, 1998, ANN AGR ENV MED, V5, P183; Cisak E, 1999, Wiad Parazytol, V45, P375; Cisak E, 1998, ANN AGR ENV MED, V5, P177; Clarke P, 2010, CHOICE FIXE IN PRESS; DUMLER JS, 1995, CLIN INFECT DIS, V20, P1102, DOI 10.1093/clinids/20.5.1102; FISHBEIN DB, 1994, ANN INTERN MED, V120, P736, DOI 10.7326/0003-4819-120-9-199405010-00003; Fritz CL, 2009, VET CLIN N AM-SMALL, V39, P265, DOI 10.1016/j.cvsm.2008.10.019; GOLDSTEIN MD, 1990, AM J PUBLIC HEALTH, V80, P1225, DOI 10.2105/AJPH.80.10.1225; Gould LH, 2008, VECTOR-BORNE ZOONOT, V8, P769, DOI 10.1089/vbz.2007.0221; Heller JE, 2010, J IMMIGR MINOR HEALT, V12, P377, DOI 10.1007/s10903-008-9187-6; Heppner DG, 1997, LANCET, V350, P785, DOI 10.1016/S0140-6736(05)62571-8; Herrington JE, 1997, AM J PUBLIC HEALTH, V87, P2035, DOI 10.2105/AJPH.87.12.2035; HOOGSTRAAL H, 1966, ANNU REV ENTOMOL, V11, P261, DOI 10.1146/annurev.en.11.010166.001401; Indudharan R, 1996, LANCET, V348, P613, DOI 10.1016/S0140-6736(05)64827-1; Jones TF, 2002, AM J PREV MED, V23, P47, DOI 10.1016/S0749-3797(02)00440-3; KAPLAN M M, 1955, Bull World Health Organ, V13, P829; Kaya AD, 2008, NEW MICROBIOL, V31, P203; Kho KL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0719-3; Lani R, 2015, EUR REV MED PHARMACO, V19, P461; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Magnarelli L. A., 2009, Clinical Microbiology Newsletter, V31, P33, DOI 10.1016/j.clinmicnews.2009.02.001; MARCHETTE NYVEN J., 1966, J MED ENTOMOL, V2, P339, DOI 10.1093/jmedent/2.4.339; McKinley RK, 1997, RELIABILITY VALIDITY; Minjauw B., 2003, RES REPORT; Mowbray F, 2014, TICKS TICK-BORNE DIS, V5, P392, DOI 10.1016/j.ttbdis.2014.01.006; Nadchatram M., 2008, TROPICAL BIOMEDICINE, V25, P1; Nadchatram M, 2008, TROPICAL BIOMEDICI S, V25, P1; Okuthe OS, 2006, VET PARASITOL, V141, P307, DOI 10.1016/j.vetpar.2006.05.016; Petney TN, 2007, PARASITOL RES, V101, pS201, DOI 10.1007/s00436-007-0687-4; Phillips CB, 2001, AM J PREV MED, V20, P219, DOI 10.1016/S0749-3797(00)00315-9; Piacentino JD, 2002, OCCUP ENVIRON MED, V59, P75, DOI 10.1136/oem.59.2.75; Poland GA, 2001, MAYO CLIN PROC, V76, P713, DOI 10.4065/76.7.713; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; SMITH CEG, 1956, NATURE, V178, P581, DOI 10.1038/178581a0; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Swai E.S., 2005, LIVEST RES RURAL DEV, V17, P2; Tay S. T., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P642; Tay S. T., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P787; Tay ST, 2000, T ROY SOC TROP MED H, V94, P280, DOI 10.1016/S0035-9203(00)90322-5; Vaughn MF, 2014, AM J PREV MED, V46, P473, DOI 10.1016/j.amepre.2014.01.008; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P324, DOI 10.1037/0278-6133.12.4.324; Wong LP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002310	49	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157987	10.1371/journal.pone.0157987	http://dx.doi.org/10.1371/journal.pone.0157987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3KZ	27341678	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600024
J	Zhao, Y; Liu, QX; Sun, H; Chen, DY; Li, ZH; Fan, BY; George, JL; Xue, CC; Cui, ZF; Wang, JB; Chen, J				Zhao, Yang; Liu, Qingxi; Sun, He; Chen, Deyong; Li, Zhaohui; Fan, Beiyuan; George, Julian; Xue, Chengcheng; Cui, Zhanfeng; Wang, Junbo; Chen, Jian			Electrical Property Characterization of Neural Stem Cells in Differentiation	PLOS ONE			English	Article							MEMBRANE CAPACITANCE; CYTOPLASM CONDUCTIVITY; BIOPHYSICAL CHARACTERIZATION; DIELECTRIC-PROPERTIES; MICROFLUIDIC SYSTEM; IMPEDANCE CYTOMETRY; FLOW-CYTOMETRY; SINGLE CELLS; CANCER CELLS; CLASSIFICATION	Electrical property characterization of stem cells could be utilized as a potential label-free biophysical approach to evaluate the differentiation process. However, there has been a lack of technology or tools that can quantify the intrinsic cellular electrical markers (e.g., specific membrane capacitance (C-specific membrane) and cytoplasm conductivity (sigma(cytoplasm))) for a large amount of stem cells or differentiated cells. In this paper, a microfluidic platform enabling the high-throughput quantification of C-specific membrane and sigma(cytoplasm) from hundreds of single neural stem cells undergoing differentiation was developed to explore the feasibility to characterize the neural stem cell differentiation process without biochemical staining. Experimental quantification using biochemical markers (e.g., Nestin, Tubulin and GFAP) of neural stem cells confirmed the initiation of the differentiation process featured with gradual loss in cellular stemness and increased cell markers for neurons and glial cells. The recorded electrical properties of neural stem cells undergoing differentiation showed distinctive and unique patterns: 1) in the suspension culture before inducing differentiation, a large distribution and difference in sigma(cytoplasm) among individual neural stem cells was noticed, which indicated heterogeneity that may result from the nature of suspension culture of neurospheres; and 2) during the differentiation in adhering monolayer culture, significant changes and a large difference in C-specific membrane were located indicating different expressions of membrane proteins during the differentiation process, and a small distribution difference in sigma(cytoplasm) was less significant that indicated the relatively consistent properties of cytoplasm during the culture. In summary, significant differences in C-specific membrane and sigma(cytoplasm) were observed during the neural stem cell differentiation process, which may potentially be used as label-free biophysical markers to monitor this process.	[Zhao, Yang; Chen, Deyong; Fan, Beiyuan; Xue, Chengcheng; Wang, Junbo; Chen, Jian] Chinese Acad Sci, Inst Elect, State Key Lab Transducer Technol, Beijing, Peoples R China; [Liu, Qingxi; Sun, He] Tianjin Weikai Bioeng Ltd, Tianjin, Peoples R China; [Liu, Qingxi] Tianjin Univ Sci & Technol, Tianjin, Peoples R China; [Li, Zhaohui; George, Julian; Cui, Zhanfeng] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Parks Rd, Oxford OX1 3PJ, England	Chinese Academy of Sciences; Institute of Electronics, CAS; Tianjin University Science & Technology; University of Oxford	Wang, JB; Chen, J (corresponding author), Chinese Acad Sci, Inst Elect, State Key Lab Transducer Technol, Beijing, Peoples R China.	jbwang@mail.ie.ac.cn; chenjian@mail.ie.ac.cn	zhao, yang/Z-3059-2019	Cui, Zhanfeng/0000-0002-9251-9752; George, Julian/0000-0002-0701-5040	National Basic Research Program of China (973 Program) [2014CB744602]; International Science & Technology Cooperation Program of China [MOST: 2011DFA31960]; Natural Science Foundation of China [61201077, 61431019, 81261120561]; Instrument Development Program of Chinese Academy of Sciences [20152016]; UK Biotechnology and Biological Science Research Council (BBSRC); Tianjin Weikai Bioeng Ltd.	National Basic Research Program of China (973 Program)(National Basic Research Program of China); International Science & Technology Cooperation Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Instrument Development Program of Chinese Academy of Sciences; UK Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tianjin Weikai Bioeng Ltd.	The authors would like to acknowledge financial support from the National Basic Research Program of China (973 Program, Grant No. 2014CB744602 (JW), http://program.most.gov.cn/), the International Science & Technology Cooperation Program of China (MOST: 2011DFA31960 (ZC), http://program.most.gov.cn/), the Natural Science Foundation of China (Grant No. 61201077 (JC), 61431019 (JW) and 81261120561 (JW), http://program.most.gov.cn/), the Instrument Development Program of Chinese Academy of Sciences (20152016 (JW), http://www.cas.ac.cn), and the UK Biotechnology and Biological Science Research Council (BBSRC (ZC), http://www.bbsrc.ac.uk/). Tianjin Weikai Bioeng Ltd. provided support in the form of salaries for authors [QL and HS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams TNG, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4895756; Broche LM, 2005, PHYS MED BIOL, V50, P2267, DOI 10.1088/0031-9155/50/10/006; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Chen J, 2015, INT J MOL SCI, V16, P9804, DOI 10.3390/ijms16059804; Chen J, 2011, LAB CHIP, V11, P3174, DOI 10.1039/c1lc20473d; Cheung KC, 2010, CYTOM PART A, V77A, P648, DOI 10.1002/cyto.a.20910; Cho Y, 2009, J MICROELECTROMECH S, V18, P808, DOI 10.1109/JMEMS.2009.2021821; Coley HM, 2007, BBA-GEN SUBJECTS, V1770, P601, DOI 10.1016/j.bbagen.2006.12.002; Du E, 2013, LAB CHIP, V13, P3903, DOI 10.1039/c3lc50540e; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Flanagan LA, 2008, STEM CELLS, V26, P656, DOI 10.1634/stemcells.2007-0810; Han KH, 2006, BIOSENS BIOELECTRON, V21, P1907, DOI 10.1016/j.bios.2006.01.024; Holmes D, 2010, ANAL CHEM, V82, P1455, DOI 10.1021/ac902568p; Holmes D, 2009, LAB CHIP, V9, P2881, DOI 10.1039/b910053a; Huang SB, 2015, MICROMACHINES-BASEL, V6, P163, DOI 10.3390/mi6020163; Labeed FH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025458; Liang X, 2014, INTEGR BIOL-UK, V6, P545, DOI 10.1039/c3ib40255j; Morgan H, 2007, J PHYS D APPL PHYS, V40, P61, DOI 10.1088/0022-3727/40/1/S10; Song HJ, 2013, LAB CHIP, V13, P2300, DOI 10.1039/c3lc41321g; Sun T, 2010, MICROFLUID NANOFLUID, V8, P423, DOI 10.1007/s10404-010-0580-9; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Valero A, 2010, LAB CHIP, V10, P2216, DOI 10.1039/c003982a; Watkins NN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006870; Weaver WM, 2014, CURR OPIN BIOTECH, V25, P114, DOI 10.1016/j.copbio.2013.09.005; Wootton RCR, 2010, NATURE, V464, P839, DOI 10.1038/464839a; Yin HB, 2012, CURR OPIN BIOTECH, V23, P110, DOI 10.1016/j.copbio.2011.11.002; Zhao Y, 2014, BIOSENS BIOELECTRON, V57, P245, DOI 10.1016/j.bios.2014.02.026; Zhao Y, 2013, LAB CHIP, V13, P2272, DOI 10.1039/c3lc41361f; Zhao Y, 2013, BIOSENS BIOELECTRON, V43, P304, DOI 10.1016/j.bios.2012.12.035; Zheng Y, 2013, LAB CHIP, V13, P2464, DOI [10.1039/c31c50355k, 10.1039/c3lc50355k]; Zheng Y, 2012, LAB CHIP, V12, P2560, DOI [10.1039/c21c21210b, 10.1039/c2lc21210b]	32	25	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158044	10.1371/journal.pone.0158044	http://dx.doi.org/10.1371/journal.pone.0158044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341032	Green Published, gold, Green Submitted			2022-12-26	WOS:000378393600026
J	Velandia-Romero, ML; Calderon-Pelaez, MA; Castellanos, JE				Velandia-Romero, Myriam L.; Calderon-Pelaez, Maria-Angelica; Castellanos, Jaime E.			In Vitro Infection with Dengue Virus Induces Changes in the Structure and Function of the Mouse Brain Endothelium	PLOS ONE			English	Article							WEST NILE VIRUS; CELL-ADHESION MOLECULES; NECROSIS-FACTOR-ALPHA; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; HEMORRHAGIC-FEVER; BARRIER; ENCEPHALITIS; DISRUPTION; CHEMOKINE	Background The neurological manifestations of dengue disease are occurring with greater frequency, and currently, no information is available regarding the reasons for this phenomenon. Some viruses infect and/or alter the function of endothelial organs, which results in changes in cellular function, including permeability of the blood-brain barrier (BBB), which allows the entry of infected cells or free viral particles into the nervous system. Methods In the present study, we standardized two in vitro models, a polarized monolayer of mouse brain endothelial cells (MBECs) and an organized co-culture containing MBECs and astrocytes. Using these cell models, we assessed whether DENV-4 or the neuro-adapted dengue virus (D4MB-6) variant infects cells or induces changes in the structure or function of the endothelial barrier. Results The results showed that MBECs, but not astrocytes, were susceptible to infection with both viruses, although the percentage of infected cells was higher when the neuro-adapted virus variant was used. In both culture systems, DENV infection changed the localization of the tight junction proteins Zonula occludens (ZO-1) and Claudin-1 (Cln1), and this process was associated with a decrease in transendothelial resistance, an increase in macromolecule permeability and an increase in the paracellular passing of free virus particles. MBEC infection led to transcriptional up-regulation of adhesion molecules (VCAM-1 and PECAM) and immune mediators (MCP-1 and TNF-alpha) that are associated with immune cell transmigration, mainly in D4MB-6-infected cells. Conclusion These results indicate that DENV infection in MBECs altered the structure and function of the BBB and activated the endothelium, affecting its transcellular and paracellular permeability and favoring the passage of viruses and the transmigration of immune cells. This phenomenon can be harnessed for neurotropic and neurovirulent strains to infect and induce alterations in the CNS.	[Velandia-Romero, Myriam L.; Calderon-Pelaez, Maria-Angelica; Castellanos, Jaime E.] Univ El Bosque, Virol Lab, Bogota, Colombia	Universidad El Bosque	Velandia-Romero, ML (corresponding author), Univ El Bosque, Virol Lab, Bogota, Colombia.	mlvelandiaro@gmail.com	Castellanos, Jaime/W-2635-2019	Castellanos, Jaime/0000-0003-1596-8383; Calderon Pelaez, Maria Angelica/0000-0003-0788-0795; Velandia-Romero, Myriam Lucia/0000-0002-3340-7304	Colombian Department for Science, Technology and Innovation (Colciencias) [1308-489-25267]; Vicerrectoria de Investigaciones of Universidad El Bosque and Banco de la Republica Foundation [3632-2015]; Colciencias Young Researcher Fellowship	Colombian Department for Science, Technology and Innovation (Colciencias); Vicerrectoria de Investigaciones of Universidad El Bosque and Banco de la Republica Foundation; Colciencias Young Researcher Fellowship	This work was supported by 1. Colombian Department for Science, Technology and Innovation (Colciencias), Project 1308-489-25267, MLVR; 2. Vicerrectoria de Investigaciones of Universidad El Bosque and Banco de la Republica Foundation (Project 3632-2015), MLVR; and 3. Colciencias Young Researcher Fellowship, MACP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x; Bhatt RS, 2015, IMMUNOBIOLOGY, V220, P1170, DOI 10.1016/j.imbio.2015.06.002; CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11; Dalrymple NA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/840654; Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P1, DOI 10.1007/s10571-004-1372-0; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; Elena SF, 2002, ANTON LEEUW INT J G, V81, P135, DOI 10.1023/A:1020589929125; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Hapuarachchi HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121696; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12; IMBERT JL, 1994, J MED VIROL, V42, P228, DOI 10.1002/jmv.1890420304; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211; Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccini LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140824; Rockfort KD, 2015, J NEUROCHEM, DOI [10.1111/jnc.13408, DOI 10.1111/JNC.13408]; Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Skaper SD, 2012, METHOD MOL BIOL, P846; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Weidenfeller C, 2005, BRAIN RES, V1053, P162, DOI 10.1016/j.brainres.2005.06.049; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Wiggins-Dohlvik K, 2014, AM J SURG, V208, P954, DOI 10.1016/j.amjsurg.2014.08.014; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886; Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08; Zhang Z, 2010, 246 DIG	53	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157786	10.1371/journal.pone.0157786	http://dx.doi.org/10.1371/journal.pone.0157786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336851	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200043
J	Ferrer, CM; Lu, TY; Bacigalupa, ZA; Katsetos, CD; Sinclair, DA; Reginato, MJ				Ferrer, C. M.; Lu, T. Y.; Bacigalupa, Z. A.; Katsetos, C. D.; Sinclair, D. A.; Reginato, M. J.			O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway	ONCOGENE			English	Article							BETA-N-ACETYLGLUCOSAMINE; PROTEIN-KINASE AMPK; GLCNAC TRANSFERASE; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS; CROSS-TALK; METABOLISM; TUMORIGENESIS; SIRTUINS; CELLS	Tumors utilize aerobic glycolysis to support growth and invasion. However, the molecular mechanisms that link metabolism with invasion are not well understood. The nutrient sensor O-linked-beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT) modifies intracellular proteins with N-acetylglucosamine. Cancers display elevated O-GlcNAcylation and suppression of O-GlcNAcylation inhibits cancer invasion and metastasis. Here, we show that the regulation of cancer invasion by OGT is dependent on the NAD+-dependent deacetylase SIRT1. Reducing O-GlcNAcylation elevates SIRT1 levels and activity in an AMPK (AMP-activated protein kinase a)-dependent manner. Reduced O-GlcNAcylation in cancer cells leads to SIRT1-mediated proteasomal degradation of oncogenic transcription factor FOXM1 in an MEK/ERK-dependent manner. SIRT1 is critical for OGT-mediated regulation of FOXM1 ubiquitination and reducing SIRT1 activity reverses OGT-mediated regulation of FOXM1. Moreover, we show that SIRT1 levels are required for OGT-mediated regulation of invasion and metastasis in breast cancer cells. Thus, O-GlcNAcylation is a central component linking metabolism to invasion and metastasis via an SIRT1/ERK/FOXM1 axis.	[Katsetos, C. D.] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Katsetos, C. D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19104 USA; [Sinclair, D. A.] Harvard Med Sch, Dept Genet, Paul F Glenn Labs Biol Mech Aging, Boston, MA USA	Drexel University; Drexel University; Harvard University; Harvard Medical School	Reginato, MJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245N 15th St,NCB Room 11117, Philadelphia, PA 19102 USA.	Mauricio.Reginato@drexelmed.edu		Sinclair, David/0000-0002-9936-436X	NCI [CA183574, CA155413]; NIH/NIA [AG028730]; NATIONAL CANCER INSTITUTE [R01CA155413, F31CA183574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028730, R37AG028730] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Valerie Sodi for critical reading of this manuscript. This work is supported by NCI grants CA183574 (to CMF), CA155413 (to MJR) and NIH/NIA grant AG028730 (to DAS).	Bajpe PK, 2015, ONCOGENE, V34, P531, DOI 10.1038/onc.2013.588; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Ferrer CM, 2014, METHODS MOL BIOL, V1176, P73, DOI 10.1007/978-1-4939-0992-6_7; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fulop N, 2008, BIOGERONTOLOGY, V9, P139, DOI 10.1007/s10522-007-9123-5; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lau AW, 2014, AM J CANCER RES, V4, P245; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Sodi VL, 2015, MOL CANCER RES, V13, P923, DOI 10.1158/1541-7786.MCR-14-0536; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yang YR, 2015, ONCOTARGET, V6, P12529, DOI 10.18632/oncotarget.3725; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yeung F, 2015, ONCOGENE, V34, P798, DOI 10.1038/onc.2014.39; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	52	61	63	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					559	569		10.1038/onc.2016.228	http://dx.doi.org/10.1038/onc.2016.228			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27345396	Green Accepted, Green Submitted			2022-12-26	WOS:000394166700012
J	Yu, PF; Huang, Y; Han, YY; Lin, LY; Sun, WH; Rabson, AB; Wang, Y; Shi, YF				Yu, P. F.; Huang, Y.; Han, Y. Y.; Lin, L. Y.; Sun, W. H.; Rabson, A. B.; Wang, Y.; Shi, Y. F.			TNF alpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2(+) neutrophils	ONCOGENE			English	Article							TUMOR-ASSOCIATED NEUTROPHILS; STEM-CELLS; BONE-MARROW; MIGRATION; MOBILIZATION; IMMUNOSUPPRESSION; INTERLEUKIN-6; CHEMOKINES; CONTRIBUTE; HALLMARKS	Mesenchymal stromal cells (MSCs) tend to infiltrate into tumors and form a major component of the tumor microenvironment. Our previous work demonstrated that tumor necrosis factor a (TNF alpha)-activated MSCs significantly promoted tumor growth. However, the role of TNF alpha-treated MSCs in tumor metastasis remains elusive. Employing a lung metastasis model of murine breast cancer, we found that TNF alpha-activated MSCs strikingly enhanced tumor metastasis compared with normal MSCs. We analyzed the chemokine profiles and found that the expression of CCL5, CCR2 and CXCR2 ligands were enhanced in TNF alpha-activated MSCs. Using genetic or pharmacological strategies to inhibit CCL5 or CCR2, we demonstrated that CCL5 and CCR2 ligands were indispensable in supporting TNF alpha-activated MSCs to promote tumor metastasis. Analysis of immune cells revealed that CXCR2 ligands (CXCL1, CXCL 2 and CXCL5) expressed by TNF alpha-activated MSCs efficiently recruited CXCR2(+) neutrophils into tumor. These neutrophils were responsible for the pro-metastatic effect of MSCs since inhibition of this chemotaxis abolished increased neutrophil recruitment and tumor metastasis. The interaction between neutrophils and tumor cells resulted in markedly elevated metastasis-related genes by tumor cells, including CXCR4, CXCR7, MMP12, MMP13, IL-6 and TGF beta. Importantly, in IL8(high) human breast cancer samples, we also observed similar alterations of gene expression. Collectively, our findings demonstrate that TNF alpha-activated MSCs promote tumor metastasis via CXCR2(+) neutrophil recruitment.	[Yu, P. F.; Huang, Y.; Han, Y. Y.; Lin, L. Y.; Sun, W. H.; Wang, Y.; Shi, Y. F.] Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai, Peoples R China; [Yu, P. F.; Huang, Y.; Han, Y. Y.; Lin, L. Y.; Sun, W. H.; Wang, Y.; Shi, Y. F.] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Rabson, A. B.; Shi, Y. F.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Shi, Y. F.] Soochow Univ, Inst Translat Med, Affiliated Hosp 1, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Rutgers State University New Brunswick; Rutgers State University Medical Center; Soochow University - China	Wang, Y; Shi, YF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Wang, Y; Shi, YF (corresponding author), Shanghai Jiao Tong Univ, Univ Chinese Acad Sci, Sch Med, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	yingwang@sibs.ac.cn; yufangshi@sibs.ac.cn	HUANG, YIN/AAH-6871-2020; Shi, Yufang/AAE-4431-2020; Yu, Pengfei/AHC-3497-2022	HUANG, YIN/0000-0001-5602-9871; Shi, Yufang/0000-0001-8964-319X; Yu, Pengfei/0000-0002-3894-5697; Sun, Weihong/0000-0002-6292-903X; wang, ying/0000-0002-2571-9367	Scientific Innovation Project of the Chinese Academy of Sciences [XDA 01040100]; Ministry of Science and Technology of China [2015CB964400]; Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone [ZJ2014-ZD-002]; Programs of National Natural Science of China [81330046, 81273316, 81571612, 81530043]; External Cooperation Program of BIC, Chinese Academy of Sciences [GJHZ201307]; Shanghai Rising-Star Program [14QA1404200]; Youth Innovation Promotion Association, Chinese Academy of Sciences	Scientific Innovation Project of the Chinese Academy of Sciences; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone; Programs of National Natural Science of China(National Natural Science Foundation of China (NSFC)); External Cooperation Program of BIC, Chinese Academy of Sciences; Shanghai Rising-Star Program; Youth Innovation Promotion Association, Chinese Academy of Sciences	This study was supported by grants from the Scientific Innovation Project of the Chinese Academy of Sciences (XDA 01040100), the Ministry of Science and Technology of China (2015CB964400), Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone (ZJ2014-ZD-002), the Programs of National Natural Science of China (81330046, 81273316, 81571612, 81530043), the External Cooperation Program of BIC, Chinese Academy of Sciences (GJHZ201307), Shanghai Rising-Star Program (14QA1404200) and Youth Innovation Promotion Association, Chinese Academy of Sciences.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Chaturvedi P, 2014, P NATL ACAD SCI USA, V111, pE2120, DOI 10.1073/pnas.1406655111; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; El-Haibi CP, 2010, J MAMMARY GLAND BIOL, V15, P399, DOI 10.1007/s10911-010-9196-7; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Giacobbe A, 2016, ONCOGENE, V35, P1602, DOI 10.1038/onc.2015.230; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Halpern JL, 2011, CANCER LETT, V308, P91, DOI 10.1016/j.canlet.2011.04.018; Han X, 2014, CELL DEATH DIFFER, V21, P1758, DOI 10.1038/cdd.2014.85; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Hu PP, 2015, TUMOR BIOL, V36, P7789, DOI 10.1007/s13277-015-3484-1; Huang Y, 2014, ONCOGENE, V33, P3830, DOI 10.1038/onc.2013.355; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Lourenco S, 2015, J IMMUNOL, V194, P3463, DOI 10.4049/jimmunol.1402097; Melino G, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1033; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Modi WS, 1999, MOL BIOL EVOL, V16, P180, DOI 10.1093/oxfordjournals.molbev.a026101; Ohnuki H, 2014, CANCER RES, V74, P2038, DOI 10.1158/0008-5472.CAN-13-3118; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; Ren G, 2014, ONCOGENE, V33, P4016, DOI 10.1038/onc.2013.387; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Yan B, 2013, J IMMUNOL, V190, P5882, DOI 10.4049/jimmunol.1201881; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang LL, 2008, EURASIP J WIREL COMM, DOI 10.1155/2008/541410; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946; Zhou SL, 2014, CARCINOGENESIS, V35, P597, DOI 10.1093/carcin/bgt397	52	127	129	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					482	490		10.1038/onc.2016.217	http://dx.doi.org/10.1038/onc.2016.217			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27375023	Green Published, hybrid			2022-12-26	WOS:000394166700005
J	Pozdzik, AA; Giordano, L; Li, G; Antoine, MH; Quellard, N; Godet, J; De Prez, E; Husson, C; Decleves, AE; Arlt, VM; Goujon, JM; Brocheriou-Spelle, I; Ledbetter, SR; Caron, N; Nortier, JL				Pozdzik, Agnieszka A.; Giordano, Laetitia; Li, Gang; Antoine, Marie-Helene; Quellard, Nathalie; Godet, Julie; De Prez, Eric; Husson, Cecile; Decleves, Anne-Emilie; Arlt, Volker M.; Goujon, Jean-Michel; Brocheriou-Spelle, Isabelle; Ledbetter, Steven R.; Caron, Nathalie; Nortier, Joelle L.			Blocking TGF-beta Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFR beta plus Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROXIMAL TUBULE INJURY; TUBULOINTERSTITIAL FIBROSIS; RENAL FIBROSIS; MYOFIBROBLAST TRANSITION; MESENCHYMAL TRANSITION; DIABETIC-NEPHROPATHY; CHINESE HERBS; DNA-ADDUCTS; MECHANISMS	Background The platelet-derived growth factor receptor beta (PDGFR beta)+ perivascular cell activation becomes increasingly recognized as a main source of scar-associated kidney myofibroblasts and recently emerged as a new cellular therapeutic target. Aims In this regard, we first confirmed the presence of PDGFR beta+ perivascular cells in a human case of end-stage aristolochic acid nephropathy (AAN) and thereafter we focused on the early fibrosis events of transforming growth factor beta (TGF beta) inhibition in a rat model of AAN. Materials and Methods Neutralizing anti-TGF beta antibody (1D11) and its control isotype (13C4) were administered (5 mg/kg, i.p.) at Days -1, 0, 2 and 4; AA (15 mg/kg, sc) was injected daily. Results At Day 5, 1D11 significantly suppressed p-Smad2/3 signaling pathway improving renal function impairment, reduced the score of acute tubular necrosis, peritubular capillaritis, interstitial inflammation and neoangiogenesis. 1D11 markedly decreased interstitial edema, disruption of tubular basement membrane loss of brush border, cytoplasmic edema and organelle ultrastructure alterations (mitochondrial disruption and endoplasmic reticulum edema) in proximal tubular epithelial cells. Moreover, 1D11 significantly inhibited p-PERK activation and attenuated dysregulation of unfolded protein response (UPR) pathways, endoplasmic reticulum and mitochondrial proteostasis in vivo and in vitro. Conclusions The early inhibition of p-Smad2/3 signaling pathway improved acute renal function impairment, partially prevented epithelial-endothelial axis activation by maintaining PTEC proteostasis and reduced early PDGFR beta+ pericytes-derived myofibroblasts accumulation.	[Pozdzik, Agnieszka A.; Antoine, Marie-Helene; De Prez, Eric; Husson, Cecile; Nortier, Joelle L.] ULB, Fac Med, Dept Biochem, Lab Expt Nephrol, Brussels, Belgium; [Pozdzik, Agnieszka A.; Nortier, Joelle L.] ULB, Erasme Hosp, Dept Nephrol, Brussels, Belgium; [Giordano, Laetitia; Decleves, Anne-Emilie; Caron, Nathalie] Univ Namur, URPHYM, Lab Gen Physiol, Namur, Belgium; [Li, Gang; Ledbetter, Steven R.] Genzyme Corp, Cell Biol, CardioMetabol & Renal Res, Framingham, MA 01701 USA; [Quellard, Nathalie; Godet, Julie; Goujon, Jean-Michel] CHU La Miletrie, Pathol & Electron Microscopy, Poitiers, France; [Quellard, Nathalie; Godet, Julie; Goujon, Jean-Michel] INSERM, U1082, Poitiers, France; [Arlt, Volker M.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Analyt & Environm Sci Div, London, England; [Brocheriou-Spelle, Isabelle] Tenon Hosp, Dept Pathol, Paris, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Namur; Sanofi-Aventis; Genzyme Corporation; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Pozdzik, AA (corresponding author), ULB, Fac Med, Dept Biochem, Lab Expt Nephrol, Brussels, Belgium.; Pozdzik, AA (corresponding author), ULB, Erasme Hosp, Dept Nephrol, Brussels, Belgium.	agapozdzik@gmail.com		Nortier, Joelle/0000-0003-3609-8217	Cancer Research UK [C313/A14329]; Cancer Research UK [14329] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The work at King's College London was supported by Cancer Research UK (grant C313/A14329).	Baudoux TER, 2012, KIDNEY INT, V82, P1105, DOI 10.1038/ki.2012.264; Benigni A, 2003, J AM SOC NEPHROL, V14, P1816, DOI 10.1097/01.ASN.0000074238.61967.B7; Benigni A, 2006, NEPHRON EXP NEPHROL, V104, pE158, DOI 10.1159/000094967; Bonventre JV, 2014, NEPHRON CLIN PRACT, V127, P61, DOI 10.1159/000363673; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Colson C R, 1999, Nephrol Dial Transplant, V14 Suppl 4, P16; COSYNS JP, 1994, KIDNEY INT, V45, P1680, DOI 10.1038/ki.1994.220; Crawford C, 2011, ACTA PHYSIOL, V202, P241, DOI 10.1111/j.1748-1716.2011.02310.x; Dahly AJ, 2002, AM J PHYSIOL-REG I, V283, pR757, DOI 10.1152/ajpregu.00098.2002; DASCH JR, 1989, J IMMUNOL, V142, P1536; Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431; Declves AE, 2012, NEPHROL DIAL TRANSPL, V27, P3771, DOI 10.1093/ndt/gfs098; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Geevarghese A, 2014, TRANSL RES, V163, P296, DOI 10.1016/j.trsl.2014.01.011; Gewin L, 2012, J AM SOC NEPHROL, V23, P2001, DOI 10.1681/ASN.2012020139; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Kelly FJ, 1999, J AM SOC NEPHROL, V10, P1264; Kida Y, 2011, CLIN EXP PHARMACOL P, V38, P417, DOI 10.1111/j.1440-1681.2011.05531.x; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lazzeri E, 2010, CURR OPIN NEPHROL HY, V19, P248, DOI 10.1097/MNH.0b013e32833680dc; Lebeau C, 2005, NEPHROL DIAL TRANSPL, V20, P2321, DOI 10.1093/ndt/gfi042; Lebeau C, 2001, KIDNEY INT, V60, P1332, DOI 10.1046/j.1523-1755.2001.00938.x; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li J, 2009, J RECEPT SIG TRANSD, V29, P280, DOI 10.1080/10799890903078465; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu BT, 2014, WIRES RNA, V5, P301, DOI 10.1002/wrna.1212; Ma LJ, 2004, KIDNEY INT, V65, P106, DOI 10.1111/j.1523-1755.2004.00381.x; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Neelisetty S, 2015, KIDNEY INT, V88, P503, DOI 10.1038/ki.2015.51; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Pozdzik AA, 2008, NEPHROL DIAL TRANSPL, V23, P2480, DOI 10.1093/ndt/gfn140; Pozdzik AA, 2010, HISTOPATHOLOGY, V56, P449, DOI 10.1111/j.1365-2559.2010.03509.x; Schmeiser HH, 2014, INT J CANCER, V135, P502, DOI 10.1002/ijc.28681; Stachurska A, 2011, TOXICOL LETT, V204, P118, DOI 10.1016/j.toxlet.2011.04.022; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tanjore H, 2013, BBA-MOL BASIS DIS, V1832, P940, DOI 10.1016/j.bbadis.2012.11.011; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Wen YJ, 2008, TRANSL RES, V152, P38, DOI 10.1016/j.trsl.2008.05.002; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Xavier S, 2015, J AM SOC NEPHROL, V26, P817, DOI 10.1681/ASN.2013101137; Yamamoto S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08505; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yu L, 2004, KIDNEY INT, V66, P1774, DOI 10.1111/j.1523-1755.2004.00901.x; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhu J, 2014, J INVEST DERMATOL, V134, P895, DOI 10.1038/jid.2013.484	66	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157288	10.1371/journal.pone.0157288	http://dx.doi.org/10.1371/journal.pone.0157288			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379382	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700005
J	Disayabutr, S; Kim, EK; Cha, SI; Green, G; Naikawadi, RP; Jones, KD; Golden, JA; Schroeder, A; Matthay, MA; Kukreja, J; Erle, DJ; Collard, HR; Wolters, PJ				Disayabutr, Supparerk; Kim, Eun Kyung; Cha, Seung-Ick; Green, Gary; Naikawadi, Ram P.; Jones, Kirk D.; Golden, Jeffrey A.; Schroeder, Aaron; Matthay, Michael A.; Kukreja, Jasleen; Erle, David J.; Collard, Harold R.; Wolters, Paul J.			miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; P53; EXPRESSION; BIOMARKER; CANCER; IDENTIFICATION; NORMALIZATION; PATHOGENESIS; ASSOCIATION; MUTATIONS	Pathologic features of idiopathic pulmonary fibrosis (IPF) include genetic predisposition, activation of the unfolded protein response, telomere attrition, and cellular senescence. The mechanisms leading to alveolar epithelial cell (AEC) senescence are poorly understood. MicroRNAs (miRNAs) have been reported as regulators of cellular senescence. Senescence markers including p16, p21, p53, and senescence-associated beta-galactosidase (SA-beta gal) activity were measured in type II AECs from IPF lungs and unused donor lungs. miRNAs were quantified in type II AECs using gene expression arrays and quantitative RTPCR. Molecular markers of senescence (p16, p21, and p53) were elevated in IPF type II AECs. SA-beta gal activity was detected in a greater percentage in type II AECs isolated from IPF patients (23.1%) compared to patients with other interstitial lung diseases (1.2%) or normal controls (0.8%). The relative levels of senescence-associated miRNAs miR-34a, miR-34b, and miR-34c, but not miR-20a, miR-29c, or miR-let-7f were significantly higher in type II AECs from IPF patients. Overexpression of miR-34a, miR-34b, or miR-34c in lung epithelial cells was associated with higher SA-beta gal activity (27.8%, 35.1%, and 38.2%, respectively) relative to control treated cells (8.8%). Targets of miR-34 miRNAs, including E2F1, c-Myc, and cyclin E2, were lower in IPF type II AECs. These results show that markers of senescence are uniquely elevated in IPF type II AECs and suggest that the miR-34 family of miRNAs regulate senescence in IPF type II AECs.	[Disayabutr, Supparerk; Kim, Eun Kyung; Cha, Seung-Ick; Green, Gary; Naikawadi, Ram P.; Golden, Jeffrey A.; Schroeder, Aaron; Matthay, Michael A.; Erle, David J.; Collard, Harold R.; Wolters, Paul J.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA; [Kim, Eun Kyung] CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea; [Cha, Seung-Ick] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; [Jones, Kirk D.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Kukreja, Jasleen] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Disayabutr, Supparerk] Mahidol Univ, Siriraj Hosp, Fac Med, Div Resp Dis & TB,Dept Med, Bangkok, Thailand	University of California System; University of California San Francisco; Pochon Cha University; Kyungpook National University; Kyungpook National University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mahidol University	Wolters, PJ (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.	paul.wolters@ucsf.edu			NIH [HL104422, HL108794, HL51856]; Nina Ireland Program in Lung Health	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nina Ireland Program in Lung Health	This work was supported in part by NIH grants HL104422 and HL108794 (PJW), and HL51856 (MAM) and the Nina Ireland Program in Lung Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Cha SI, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-105; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hanak V, 2008, CHEST, V134, P133, DOI 10.1378/chest.07-3005; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Noppe G, 2009, CYTOM PART A, V75A, P910, DOI 10.1002/cyto.a.20796; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; PINES J, 1994, NATURE, V369, P520, DOI 10.1038/369520a0; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006	53	82	85	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158367	10.1371/journal.pone.0158367	http://dx.doi.org/10.1371/journal.pone.0158367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362652	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200065
J	Kandalepas, PC; Mitchell, JW; Gillette, MU				Kandalepas, Patty C.; Mitchell, Jennifer W.; Gillette, Martha U.			Melatonin Signal Transduction Pathways Require E-Box-Mediated Transcription of Per1 and Per2 to Reset the SCN Clock at Dusk	PLOS ONE			English	Article							SUPRACHIASMATIC CIRCADIAN CLOCK; MPER2 ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA LEVELS; PHASE-SHIFTS; SLICE PREPARATION; ACTIVITY RHYTHMS; PERIOD HOMOLOGS; RAT; LIGHT; ENTRAINMENT	Melatonin is released from the pineal gland into the circulatory system at night in the absence of light, acting as "hormone of darkness" to the brain and body. Melatonin also can regulate circadian phasing of the suprachiasmatic nucleus (SCN). During the day-to-night transition, melatonin exposure advances intrinsic SCN neural activity rhythms via the melatonin type-2 (MT2) receptor and downstream activation of protein kinase C (PKC). The effects of melatonin on SCN phasing have not been linked to daily changes in the expression of core genes that constitute the molecular framework of the circadian clock. Using real-time RT-PCR, we found that melatonin induces an increase in the expression of two clock genes, Period 1 (Per1) and Period 2 (Per2). This effect occurs at CT 10, when melatonin advances SCN phase, but not at CT 6, when it does not. Using anti-sense oligodeoxynucleotides (a ODNs) to Per 1 and Per 2, as well as to E-box enhancer sequences in the promoters of these genes, we show that their specific induction is necessary for the phase-altering effects of melatonin on SCN neural activity rhythms in the rat. These effects of melatonin on Per1 and Per2 were mediated by PKC. This is unlike day-active non-photic signals that reset the SCN clock by non-PCK signal transduction mechanisms and by decreasing Per1 expression. Rather, this finding extends roles for Per1 and Per2, which are critical to photic phase-resetting, to a nonphotic zeitgeber, melatonin, and suggest that the regulation of these clock gene transcripts is required for clock resetting by diverse regulatory cues.	[Kandalepas, Patty C.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Mitchell, Jennifer W.; Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.; Gillette, MU (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	mgillett@illinois.edu			National Heart, Lung and Blood Institute [HL086870]; National Science Foundation [IOS 1354913]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086870] Funding Source: NIH RePORTER; Direct For Biological Sciences [1354913] Funding Source: National Science Foundation	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by The National Heart, Lung and Blood Institute (HL086870) and the National Science Foundation (IOS 1354913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Karen Weis for help with tissue collection, Ghazal Naseri Kouzehgarani for statistical consultation, Deavid Earnest for the gift of the original SCN2.2 cell line, and Ann Benefiel and Maureen Holtz for preparing the manuscript. Support from The National Heart, Lung and Blood Institute (HL086870) and the National Science Foundation (IOS 1354913) is gratefully acknowledged.	Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Benloucif S, 1996, J BIOL RHYTHM, V11, P113, DOI 10.1177/074873049601100204; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CASSONE VM, 1986, PHYSIOL BEHAV, V36, P1111, DOI 10.1016/0031-9384(86)90488-9; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dobler G, 2012, EPIDEMIOLOGY DISTRIB; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Dubocovich ML, 1996, BEHAV BRAIN RES, V73, P141; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Fukuhara C, 2001, NEUROSCI LETT, V314, P119, DOI 10.1016/S0304-3940(01)02304-7; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 1996, BEHAV BRAIN RES, V73, P135; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Hamada T, 2004, NEUROSCI LETT, V362, P87, DOI 10.1016/j.neulet.2004.02.061; HATTON GI, 1980, BRAIN RES BULL, V5, P405, DOI 10.1016/S0361-9230(80)80010-4; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Hunt AE, 2001, AM J PHYSIOL-CELL PH, V280, pC110, DOI 10.1152/ajpcell.2001.280.1.C110; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; Hurst WJ, 2001, THESIS; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; Mendoza JY, 2004, NEUROSCIENCE, V127, P529, DOI 10.1016/j.neuroscience.2004.05.026; Nagy AD, 2015, CHRONOBIOL INT, V32, P447, DOI 10.3109/07420528.2014.992525; Pfeffer M, 2012, CHRONOBIOL INT, V29, P415, DOI 10.3109/07420528.2012.667859; Pitrosky B, 1999, AM J PHYSIOL-REG I, V277, pR812, DOI 10.1152/ajpregu.1999.277.3.R812; Poirel VJ, 2003, NEUROSCIENCE, V120, P745, DOI 10.1016/S0306-4522(03)00344-0; PROSSER RA, 1989, P NATL ACAD SCI USA, V86, P6812, DOI 10.1073/pnas.86.17.6812; PROSSER RA, 1989, J NEUROSCI, V9, P1073; REDMAN J, 1983, SCIENCE, V219, P1089, DOI 10.1126/science.6823571; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Slotten HA, 1999, J BIOL RHYTHM, V14, P347, DOI 10.1177/074873099129000759; Sugiyama T, 2004, BIOCHEM BIOPH RES CO, V323, P479, DOI 10.1016/j.bbrc.2004.08.126; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tischkau SA, 2005, METHOD ENZYMOL, V393, P593, DOI 10.1016/S0076-6879(05)93031-0; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; VANECEK J, 1987, BRAIN RES, V435, P359, DOI 10.1016/0006-8993(87)91625-8; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; WEAVER DR, 1989, J NEUROSCI, V9, P2581; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	55	36	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157824	10.1371/journal.pone.0157824	http://dx.doi.org/10.1371/journal.pone.0157824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362940	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200024
J	Fuentes, MMPB; Delean, S; Grayson, J; Lavender, S; Logan, M; Marsh, H				Fuentes, Mariana M. P. B.; Delean, Steven; Grayson, Jillian; Lavender, Sally; Logan, Murray; Marsh, Helene			Spatial and Temporal Variation in the Effects of Climatic Variables on Dugong Calf Production	PLOS ONE			English	Article							TORRES STRAIT; LIFE-HISTORY; SEAGRASS COMMUNITIES; AERIAL SURVEYS; CONSERVATION; QUEENSLAND; ABUNDANCE; SUSTAINABILITY; AUSTRALIA; DYNAMICS	Knowledge of the relationships between environmental forcing and demographic parameters is important for predicting responses from climatic changes and to manage populations effectively. We explore the relationships between the proportion of sea cows (Dugong dugon) classified as calves and four climatic drivers (rainfall anomaly, Southern Oscillation El Nino Index [SOI], NINO 3.4 sea surface temperature index, and number of tropical cyclones) at a range of spatially distinct locations in Queensland, Australia, a region with relatively high dugong density. Dugong and calf data were obtained from standardized aerial surveys conducted along the study region. A range of lagged versions of each of the focal climatic drivers (1 to 4 years) were included in a global model containing the proportion of calves in each population crossed with each of the lagged versions of the climatic drivers to explore relationships. The relative influence of each predictor was estimated via Gibbs variable selection. The relationships between the proportion of dependent calves and the climatic drivers varied spatially and temporally, with climatic drivers influencing calf counts at sub-regional scales. Thus we recommend that the assessment of and management response to indirect climatic threats on dugongs should also occur at sub-regional scales.	[Fuentes, Mariana M. P. B.; Grayson, Jillian; Marsh, Helene] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Fuentes, Mariana M. P. B.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Delean, Steven] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Delean, Steven] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Lavender, Sally] CSIRO Oceans & Atmosphere Flagship, Aspendale, Vic, Australia; [Logan, Murray] Australian Inst Marine Sci, Townsville, Qld, Australia; [Marsh, Helene] James Cook Univ, Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia	James Cook University; State University System of Florida; Florida State University; University of Adelaide; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Institute of Marine Science; James Cook University	Marsh, H (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Marsh, H (corresponding author), James Cook Univ, Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia.	helene.marsh@jcu.edu.au		Lavender, Sally/0000-0003-4785-1569; Logan, Murray/0000-0001-5102-3972	Australian Fisheries Management Authority; Australian National Parks and Wildlife Service; CRC Torres Strait; Australian Marine Mammal Centre; National Environmental Research Program; Torres Strait Regional Authority	Australian Fisheries Management Authority; Australian National Parks and Wildlife Service; CRC Torres Strait(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Marine Mammal Centre; National Environmental Research Program; Torres Strait Regional Authority	Funding intitutions include: the Australian Fisheries Management Authority, http://www.afma.gov.au/; Australian National Parks and Wildlife Service, http://www.australia.gov.au/about-australia/australian-story/national-parks; CRC Torres Strait, http://rrrc.org.au/crc-torres-strait/; the Australian Marine Mammal Centre, http://www.marinemammals.gov.au/; the National Environmental Research Program, https://www.environment.gov.au/science/nerp; and the Torres Strait Regional Authority, http://www.tsra.gov.au/.	Albert S, 2005, MAR POLLUT BULL, V51, P428, DOI 10.1016/j.marpolbul.2004.10.016; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Boyd Ian L., 1999, P218; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Coles RG, 2015, ESTUAR COAST SHELF S, V153, pA1, DOI 10.1016/j.ecss.2014.07.020; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Crainiceanu C. M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I14; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Daniell JJ, 2008, CONT SHELF RES, V28, P2188, DOI 10.1016/j.csr.2008.03.036; Dellaportas P, 2002, STAT COMPUT, V12, P27, DOI 10.1023/A:1013164120801; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Fuentes MMPB, 2011, J BIOGEOGR, V38, P1886, DOI 10.1111/j.1365-2699.2011.02541.x; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Green D, 2010, CLIMATIC CHANGE, V102, P405, DOI 10.1007/s10584-009-9756-2; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heihsohn G.E., 1974, Biological Conserv, V6, P143; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Limpus C, 2000, ATMOS OCEAN SCI LIB, V21, P399; LIMPUS CJ, 1988, AUST WILDLIFE RES, V15, P157; Lough JM, 2015, CORAL REEFS, V34, P739, DOI 10.1007/s00338-015-1297-8; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Lyons MB, 2013, ESTUAR COAST SHELF S, V120, P42, DOI 10.1016/j.ecss.2013.01.015; MARSH H, 1989, AUST WILDLIFE RES, V16, P429; Marsh H, 2004, ANIM CONSERV, V7, P435, DOI 10.1017/S1367943004001635; MARSH H, 1989, AUST WILDLIFE RES, V16, P639; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Marsh H, 1997, CONSERV BIOL, V11, P1375, DOI 10.1046/j.1523-1739.1997.95309.x; Marsh H, 1999, MAR FRESHWATER RES, V50, P979, DOI 10.1071/MF99080; MARSH H, 1990, AUST WILDLIFE RES, V17, P511; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H, 1981, THE DUGONG; MARSH HE, 1989, MAR MAMMAL SCI, V5, P78, DOI 10.1111/j.1748-7692.1989.tb00215.x; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Marsh H, 2015, BIOL CONSERV, V192, P324, DOI 10.1016/j.biocon.2015.10.007; McKenzie L., 2014, REEF RESC MAR MON PR; Meager JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094849; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Poiner IR, 1996, STAT MARINE ENV REP; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; R Foundation for Statistical Computing, 2014, LANG ENV STAT COMP; Rasheed MA, 2014, MAR POLLUT BULL, V83, P491, DOI 10.1016/j.marpolbul.2014.02.013; Saint-Cast F, 2008, CONT SHELF RES, V28, P2214, DOI 10.1016/j.csr.2008.03.035; Schumann N, 2013, AUST J ZOOL, V61, P146, DOI 10.1071/ZO12131; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sobtzick S., 2012, AERIAL SURVEY URBAN; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Y-S Su, 2014, R2JAGS, pA	55	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0155675	10.1371/journal.pone.0155675	http://dx.doi.org/10.1371/journal.pone.0155675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355367	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000378859400004
J	Betancourt, T; Fawzi, MCS; Stevenson, A; Kanyanganzi, F; Kirk, C; Ng, L; Mushashi, C; Bizimana, JI; Beardslee, W; Raviola, G; Smith, S; Kayiteshonga, Y; Binagwaho, A				Betancourt, Theresa; Fawzi, Mary C. Smith; Stevenson, Anne; Kanyanganzi, Fredrick; Kirk, Catherine; Ng, Lauren; Mushashi, Christina; Bizimana, Justin I.; Beardslee, William; Raviola, Giuseppe; Smith, Stephanie; Kayiteshonga, Yvonne; Binagwaho, Agnes			Ethics in Community-Based Research with Vulnerable Children: Perspectives from Rwanda	PLOS ONE			English	Article							MENTAL-HEALTH; SOLDIERS; GENOCIDE; RISK	A "risk of harm" protocol to identify youth in need of immediate emergency assistance in a study on mental health and HIV in Rwanda among 680 youth ages 10-17 is described. Cases are presented that describe the experience in using this protocol to ensure safety of participants, with ethical and logistical challenges considered. Among the population of the study, 3.2% were deemed "risk of harm." The most prevalent presenting problem was non-fatal suicidal behavior (91% of risk of harm cases), with 36% having a history of a reported previous attempt. Challenges included: acute food insecurity/significant poverty; lack of support/adequate supervision from family members; family violence; alcohol abuse; and HIV-related stigma. Development of a "risk of harm" protocol and collaboration between study staff, community leadership, health authorities, and health workers are critical to ensuring participants' safety in research among vulnerable populations.	[Betancourt, Theresa; Stevenson, Anne; Kirk, Catherine; Ng, Lauren] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Fawzi, Mary C. Smith; Raviola, Giuseppe; Smith, Stephanie; Binagwaho, Agnes] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Kanyanganzi, Fredrick; Mushashi, Christina] Partners Hlth Rwanda Inshuti Mu Buzima PIH IMB, Kigali, Rwanda; [Bizimana, Justin I.; Kayiteshonga, Yvonne; Binagwaho, Agnes] Minist Hlth, Govt Rwanda, Kigali, Rwanda; [Beardslee, William] Boston Childrens Hosp, Boston, MA USA; [Raviola, Giuseppe; Smith, Stephanie] Partners Hlth, Boston, MA USA; [Binagwaho, Agnes] Dartmouth Coll, Hanover, NH 03755 USA; [Kayiteshonga, Yvonne; Binagwaho, Agnes] Univ Global Hlth Equ, Kigali, Rwanda; [Kayiteshonga, Yvonne] Rwanda Biomed Ctr, Kigali, Rwanda	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Partners Healthcare System; Dartmouth College; Rwanda Biomedical Center	Betancourt, T (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	theresa_betancourt@harvard.edu	Kirk, Catherine/T-2596-2019; Raviola, Giuseppe/AAE-9002-2021	Kirk, Catherine/0000-0001-9103-2611; Raviola, Giuseppe/0000-0003-3379-0371	Harvard University Center for AIDS Research [2P30AI060354-07]; Peter C. Alderman Foundation; Harvard Center on the Developing Child; Julie Henry Faculty Development Fund; FXB Center for Health and Human Rights; National Institute of Mental Health [K01MH077246-05, R34MH084679-02, T32MH093310]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093310, R34MH084679] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research; Peter C. Alderman Foundation; Harvard Center on the Developing Child; Julie Henry Faculty Development Fund; FXB Center for Health and Human Rights; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the Harvard University Center for AIDS Research (http://cfar.globalhealth.harvard.edu/; HU CFAR NIH/NIAID fund 2P30AI060354-07) with additional support to the overall research program in Rwanda from the Peter C. Alderman Foundation (http://www.petercaldermanfoundation.org/), the Harvard Center on the Developing Child (http://developingchild.harvard.edu/), the Julie Henry Faculty Development Fund, and the FXB Center for Health and Human Rights (http://fxb.harvard.edu/). This publication was additionally supported by grants K01MH077246-05, R34MH084679-02, and T32MH093310 from the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	10Wassenaar D. R., 2012, OXFORD HDB INT PSYCH, P268; Achenbach T. M., 1991, MANUAL SELF REPORT 1; Betancourt T, 2014, PEDIATRICS, V134, pE464, DOI 10.1542/peds.2013-2734; Betancourt TS, 2010, J AM ACAD CHILD PSY, V49, P606, DOI 10.1016/j.jaac.2010.03.008; Betancourt TS, 2010, CHILD DEV, V81, P1077, DOI 10.1111/j.1467-8624.2010.01455.x; Betancourt TS, 2014, GLOBAL MENTAL HLTH T; Binagwaho A, 2012, PASSAUER DISKUSSIONS; Dyregrov A, 2000, J TRAUMA STRESS, V13, P3, DOI 10.1023/A:1007759112499; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Kabeera B, 2008, INT SOC WORK, V51, P324, DOI 10.1177/0020872807088079; Richardson H.S., 2012, MORAL ENTANGLEMENTS, VVolume 253; Rwanda Ministry of Health, 2010, RWAND COMM BAS HLTH; Tangwa G, 2009, ACTA TROP, V1125, pS16; Thomas G, 2011, QUAL INQ, V17, P511, DOI 10.1177/1077800411409884; WHO Regional Office for Africa, 2009, WHO COUNTRY COOPERAT; World Health Organization, 2011, MENT HLTH ATL RWAND; World Medical Association, 2013, 64 WMA GEN ASS	20	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157042	10.1371/journal.pone.0157042	http://dx.doi.org/10.1371/journal.pone.0157042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351337	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900005
J	Gaio, V; Nunes, B; Pechirra, P; Conde, P; Guiomar, R; Dias, CM; Barreto, M				Gaio, Vania; Nunes, Baltazar; Pechirra, Pedro; Conde, Patricia; Guiomar, Raquel; Dias, Carlos Matias; Barreto, Marta			Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study	PLOS ONE			English	Article							VIRUS; SUSCEPTIBILITY	Background Recent studies suggest an association between the Interferon Inducible Transmembrane 3 (IFITM3) rs12252 variant and the course of influenza infection. However, it is not clear whether the reported association relates to influenza infection severity. The aim of this study was to estimate the hospitalization risk associated with this variant in Influenza Like Illness (ILI) patients during the H1N1 pandemic influenza. Methods A case-control genetic association study was performed, using nasopharyngeal/oropharyngeal swabs collected during the H1N1 pandemic influenza. Laboratory diagnosis of influenza infection was performed by RT-PCR, the IFITM3 rs12252 was genotyped by RFLP and tested for association with hospitalization. Conditional logistic regression was performed to calculate the confounder-adjusted odds ratio of hospitalization associated with IFITM3 rs12252. Results We selected 312 ILI cases and 624 matched non-hospitalized controls. Within ILI Influenza A(H1N1)pdm09 positive patients, no statistical significant association was found between the variant and the hospitalization risk (Adjusted OR: 0.73 (95% CI: 0.33-1.50)). Regarding ILI Influenza A(H1N1) pdm09 negative patients, CT/CC genotype carriers had a higher risk of being hospitalized than patients with TT genotype (Adjusted OR: 2.54 (95% CI: 1.54-4.19)). Conclusions The IFITM3 rs12252 variant was associated with respiratory infection hospitalization but not specifically in patients infected with Influenza A(H1N1) pdm09.	[Gaio, Vania; Nunes, Baltazar; Dias, Carlos Matias; Barreto, Marta] Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, P-1649016 Lisbon, Portugal; [Pechirra, Pedro; Conde, Patricia; Guiomar, Raquel] Inst Nacl Saude Doutor Ricardo Jorge, Dept Doencas Infeciosas, P-1649016 Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Instituto Nacional de Saude Dr. Ricardo Jorge	Barreto, M (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, P-1649016 Lisbon, Portugal.	marta.barreto@insa.min-saude.pt	Nunes, Baltazar/V-8903-2019; Dias, Carlos/I-6335-2012; Barreto, Marta/F-5591-2012	Nunes, Baltazar/0000-0001-6230-7209; Dias, Carlos/0000-0002-0206-5874; Gaio, Vania/0000-0001-7626-4991; Conde, Patricia/0000-0002-9346-305X; Guiomar, Raquel/0000-0002-4563-6315; Pechirra, Pedro/0000-0001-6352-1100; Barreto, Marta/0000-0001-6464-548X	National Health Institute Doutor Ricardo Jorge; National Institute of Health Doctor Ricardo Jorge (INSA)	National Health Institute Doutor Ricardo Jorge; National Institute of Health Doctor Ricardo Jorge (INSA)	This study was funded by the National Health Institute Doutor Ricardo Jorge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge all the Colleagues from Infectious Disease Department from National Institute of Health Doctor Ricardo Jorge (INSA) that supported influenza A(H1N1)pdm09 diagnosis during 2009 Pandemia and 2009/2010 influenza season, to address the excess samples sent to National Influenza Reference Laboratory at INSA.	[Anonymous], 2012, EURO SURVEILL, P17; Arcanjo AC, 2014, ACTA BIOCHIM POL, V61, P403; Bautista E., 2010, CLIN ASPECTS PANDEMI; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; European Centre for Disease Prevention and Control (ECDC), 2009, OV SURV INFL 2009 20; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Froes Filipe, 2014, Rev. Port. Sau. Pub., V32, P55; Graffelman J, 2012, HARDYWEINBERG GRAPHI; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; World Health Organization, 2010, PAND H1N1 2009; Yang X, 2015, INTERFERON INDUCIBLE; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	20	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158181	10.1371/journal.pone.0158181	http://dx.doi.org/10.1371/journal.pone.0158181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351739	gold, Green Submitted, Green Published			2022-12-26	WOS:000378858900041
J	Usui-Ouchi, A; Ouchi, Y; Kiyokawa, M; Sakuma, T; Ito, R; Ebihara, N				Usui-Ouchi, Ayumi; Ouchi, Yasuo; Kiyokawa, Masatoshi; Sakuma, Toshiro; Ito, Rei; Ebihara, Nobuyuki			Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIUM RPE; DIABETIC-RETINOPATHY; TGF-BETA; THERAPEUTIC TARGET; EXPRESSION; MICRORNAS; CELLS; FIBROSIS	MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by post transcriptional inhibition of mRNA translation. Dysregulation of miRNAs, including circulating miRNAs, has been reported to play an important role in the development of various diseases, including fibrotic diseases. Aberrant expression of miRNAs in the vitreous humor of vitreoretinal diseased eyes has been reported. However, the expression pattern of miRNAs present in the vitreous humor of proliferative vitreoretinal disease (PVD) patients, including proliferative diabetic retinopathy (PDR), and proliferative vitreoretinopathy (PVR), remains unknown. To investigate the factors important for the development of PVD, we characterized the miRNAs present in the vitreous humor of PVD patients and analyzed the expression profiles of 377 miRNAs using quantitative polymerase chain reaction-based miRNA arrays. The expression of a specific subset of miRNAs, previously reported to be associated with the development of angiogenesis and fibrosis, was significantly altered in the vitreous of PVD patients. Among these miRNAs, we identified miR-21 as a candidate fibrotic miRNA with an important role in the pathogenesis of PVD. Increased miR-21 levels in the vitreous were associated with retinal fibrosis, including PVR and PDR. Because epithelial-mesenchymal transition (EMT) of retinal pigment epithelial cells (RPECs) plays a critical role in retinal fibrosis, the expression of miR-21 in human RPECs was determined. Its expression in RPECs was induced by transforming growth factor-beta, a key growth factor involved in fibrogenesis, and was enhanced by high glucose culture conditions, suggesting that miR-21 expression positively correlates with disease progression. Gain- and loss-of-function studies revealed that miR-21 promoted cell proliferation and migration of ARPE-19 cells without affecting EMT-related gene expression. Together, our studies have identified miR-21 as a potential disease-modifying miRNA in the vitreous humor that is involved in the development of retinal fibrosis and may be a novel marker of PVD.	[Usui-Ouchi, Ayumi; Kiyokawa, Masatoshi; Sakuma, Toshiro; Ito, Rei; Ebihara, Nobuyuki] Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Chiba, Japan; [Ouchi, Yasuo] Univ Tokyo, Div Innate Regulat Int Res & Dev, Ctr Mucosal Vaccine, Inst Med Sci, Tokyo, Japan	Juntendo University; University of Tokyo	Usui-Ouchi, A (corresponding author), Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Chiba, Japan.	ausui@juntendo.ac.jp			JSPS KAKENHI [26861469]; Grants-in-Aid for Scientific Research [26870683] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B), grant number (26861469).	Abu El-Asrar Ahmed M., 2007, International Ophthalmology, V27, P11, DOI 10.1007/s10792-007-9053-x; Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Biasutto L, 2013, EXP CELL RES, V319, P2113, DOI 10.1016/j.yexcr.2013.05.005; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Burgos R, 1997, DIABETOLOGIA, V40, P1107, DOI 10.1007/s001250050794; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dunmire JJ, 2013, EXP EYE RES, V108, P68, DOI 10.1016/j.exer.2012.10.016; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hirota K, 2015, GRAEF ARCH CLIN EXP, V253, P335, DOI 10.1007/s00417-014-2692-5; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Madhyastha R, 2014, BIOCHEM BIOPH RES CO, V451, P615, DOI 10.1016/j.bbrc.2014.08.035; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pottier N, 2014, TRENDS PHARMACOL SCI, V35, P119, DOI 10.1016/j.tips.2014.01.003; Ragusa M, 2015, CANCER BIOL THER, V16, P1387, DOI 10.1080/15384047.2015.1046021; Ragusa M, 2013, MOL VIS, V19, P430; Rayner KJ, 2013, J LIPID RES, V54, P1174, DOI 10.1194/jlr.R034991; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Scian MJ, 2011, AM J TRANSPLANT, V11, P2110, DOI 10.1111/j.1600-6143.2011.03666.x; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tosi GM, 2014, J CELL PHYSIOL, V229, P1577, DOI 10.1002/jcp.24606; Tuo JS, 2014, AM J OPHTHALMOL, V157, P728, DOI 10.1016/j.ajo.2013.12.014; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yamada M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-95; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108005; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhou Y, 2013, AM J PATHOL, V183, P1183, DOI 10.1016/j.ajpath.2013.06.032; Zhu HL, 2013, J CLIN IMMUNOL, V33, P1100, DOI 10.1007/s10875-013-9896-z	49	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158043	10.1371/journal.pone.0158043	http://dx.doi.org/10.1371/journal.pone.0158043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351379	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900027
J	Hapke, WB; Morace, JL; Nilsen, EB; Alvarez, DA; Masterson, K				Hapke, Whitney B.; Morace, Jennifer L.; Nilsen, Elena B.; Alvarez, David A.; Masterson, Kevin			Year-Round Monitoring of Contaminants in Neal and Rogers Creeks, Hood River Basin, Oregon, 2011-12, and Assessment of Risks to Salmonids	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; LOWER COLUMBIA RIVER; PERSISTENT ORGANIC POLLUTANTS; BROMINATED FLAME RETARDANTS; PESTICIDE MIXTURES; URBAN STREAMS; TOXICITY; WATER; WASHINGTON; EXPOSURE	Pesticide presence in streams is a potential threat to Endangered Species Act listed salmonids in the Hood River basin, Oregon, a primarily forested and agricultural basin. Two types of passive samplers, polar organic chemical integrative samplers (POCIS) and semipermeable membrane devices (SPMDs), were simultaneously deployed at four sites in the basin during Mar. 2011-Mar. 2012 to measure the presence of pesticides, polybrominated diphenyl ethers (PBDEs), and polychlorinated biphenyls (PCBs). The year-round use of passive samplers is a novel approach and offers several new insights. Currently used pesticides and legacy contaminants, including many chlorinated pesticides and PBDEs, were present throughout the year in the basin's streams. PCBs were not detected. Time-weighted average water concentrations for the 2-month deployment periods were estimated from concentrations of chemicals measured in the passive samplers. Currently used pesticide concentrations peaked during spring and were detected beyond their seasons of expected use. Summed concentrations of legacy contaminants in Neal Creek were highest during July-Sept., the period with the lowest streamflows. Endosulfan was the only pesticide detected in passive samplers at concentrations exceeding Oregon or U.S. Environmental Protection Agency water-quality thresholds. A Sensitive Pesticide Toxicity Index (SPTI) was used to estimate the relative acute potential toxicity among sample mixtures. The acute potential toxicity of the detected mixtures was likely greater for invertebrates than for fish and for all samples in Neal Creek compared to Rogers Creek, but the indices appear to be low overall (<0.1). Endosulfans and pyrethroid insecticides were the largest contributors to the SPTIs for both sites. SPTIs of some discrete (grab) samples from the basin that were used for comparison exceeded 0.1 when some insecticides (azinphos methyl, chlorpyrifos, malathion) were detected at concentrations near or exceeding acute water-quality thresholds. Early life stages and adults of several sensitive fish species, including salmonids, are present in surface waters of the basin throughout the year, including during periods of peak estimated potential toxicity. Based on these data, direct toxicity to salmonids from in-stream pesticide exposure is unlikely, but indirect impacts (reduced fitness due to cumulative exposures or negative impacts to invertebrate prey populations) are unknown.	[Hapke, Whitney B.; Morace, Jennifer L.; Nilsen, Elena B.] US Geol Survey, Oregon Water Sci Ctr, Portland, OR USA; [Alvarez, David A.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA; [Masterson, Kevin] Oregon Dept Environm Qual, Bend, OR USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Morace, JL (corresponding author), US Geol Survey, Oregon Water Sci Ctr, Portland, OR USA.	jlmorace@usgs.gov			Confederated Tribes of Warm Springs (CTWS); Hood River Soil and Water Conservation District; U.S. Geological Survey Cooperative Water Program [6000001714]	Confederated Tribes of Warm Springs (CTWS); Hood River Soil and Water Conservation District; U.S. Geological Survey Cooperative Water Program	Funding was provided by the Confederated Tribes of Warm Springs (CTWS) (wsfish.org), the Hood River Soil and Water Conservation District (hoodriverswcd.org), and the U.S. Geological Survey Cooperative Water Program (water.usgs.gov/coop/), under Joint Funding Agreement #6000001714 (JLM). The authors led the study design process and were solely responsible for analysis and interpretation of data; writing of the paper; and the decision to submit for publication. Personnel from CTWS contributed to study design; selection of sampling locations, field work, and sample collection.	Alvarez D.A., 2010, ENV MONITORING STUDI, V38; Alvarez DA, 2011, WATER QUALITY CONCEP; Alvarez DA, 2004, POLAR ORGANIC CHEM I; Alvarez D, 2014, SCI TOTAL ENVIRON, V484, P322, DOI 10.1016/j.scitotenv.2013.07.128; Alvarez DA, 2008, J ENVIRON QUAL, V37, P1024, DOI 10.2134/jeq2006.0463; [Anonymous], 2015, FIN 2015 UPD NAT REC; [Anonymous], 2000, HEX REV HAZ SUMM; [Anonymous], 2015, W COAST SALM STELLH; [Anonymous], 2015, AGRIMET HIST ARCH WE; [Anonymous], 2014, COMPL PROJ; [Anonymous], 2008, RER EL DEC RED PENT; [Anonymous], NEAR REAL TIM HYDR D; [Anonymous], 2014, FREQ ASK QUEST; [Anonymous], 2015, HOOD RIV SPRING CHIN; [Anonymous], GEN FISH DISTR ALL S; [Anonymous], 2015, AQ LIF BENCHM; [Anonymous], 2015, AQ LIF WAT QUAL CRIT; [Anonymous], 2012, WAT QUAL ASS OR 2012; Babut M, 2013, ENVIRON SCI POLLUT R, V20, P8298, DOI 10.1007/s11356-013-2004-3; Baker C, 2015, 201101400 BONN POW A; Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Belden JB, 2007, INTEGR ENVIRON ASSES, V3, P364, DOI 10.1002/ieam.5630030307; Bidleman TF, 2015, ATMOS CHEM PHYS, V15, P1411, DOI 10.5194/acp-15-1411-2015; Biro PA, 2004, CAN J FISH AQUAT SCI, V61, P1513, DOI 10.1139/F04-083; Booij K, 2016, ENVIRON SCI TECHNOL, V50, P3, DOI 10.1021/acs.est.5b04050; Castagnoli S, 2015, 8203E EM OR STAT U E; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Coccoli H., 2004, HOOD RIVER SUBBASIN, DOI Hood River (OR); Columbia Gorge Fruit Growers Association, 2016, BEST MAN PRACT; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; Dietrich JP, 2014, CHEMOSPHERE, V108, P353, DOI 10.1016/j.chemosphere.2014.01.079; Dugger D, 2008, 0803020 WASH DEP EC; Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h; Ezemonye LIN, 2011, FOOD CHEM TOXICOL, V49, P1898, DOI 10.1016/j.fct.2010.10.025; Foster E, 2014, WILD SALMONIDS URBAN, P123; Gilliom RJ, 2007, ENVIRON SCI TECHNOL, V41, P3407; Hamilton MC, 2005, ENVIRON SCI TECHNOL, V39, P8622, DOI 10.1021/es050898y; Henny CJ, 2009, ECOTOXICOLOGY, V18, P802, DOI 10.1007/s10646-009-0323-4; Hladik M, 2008, SAN FR ESTUARY WATER, V6, P6, DOI [10.15447/sfews.2008v6iss3art2, DOI 10.15447/SFEWS.2008V6ISS3ART2]; Hladik ML, 2008, B ENVIRON CONTAM TOX, V80, P139, DOI 10.1007/s00128-007-9332-2; Hope BK, 2012, SCI TOTAL ENVIRON, V417, P263, DOI 10.1016/j.scitotenv.2011.12.028; HSRG, 2009, HATCH SCI REV GROUP; Jaward TM, 2005, ENVIRON SCI TECHNOL, V39, P8638, DOI 10.1021/es051382h; Johnson L, 2013, T AM FISH SOC, V142, P21, DOI 10.1080/00028487.2012.720627; Johnson LL, 2007, SCI TOTAL ENVIRON, V374, P342, DOI 10.1016/j.scitotenv.2006.11.051; Johnson WW, 1980, RESOURCE PUBLICATION; Kegley SE., 2000, PAN PESTICIDE DATABA; Keith L., 1991, ENV SAMPLING ANAL PR, V1; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; King KA, 2014, ENVIRON TOXICOL CHEM, V33, P1596, DOI 10.1002/etc.2593; King KA, 2013, ENVIRON TOXICOL CHEM, V32, P920, DOI 10.1002/etc.2117; Laetz CA, 2014, AQUAT TOXICOL, V146, P38, DOI 10.1016/j.aquatox.2013.10.022; Laetz CA, 2013, ENVIRON SCI TECHNOL, V47, P2925, DOI 10.1021/es305058y; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Landers DH, 2010, ENVIRON SCI TECHNOL, V44, P855, DOI 10.1021/es901866e; Lapointe NWR, 2014, ENVIRON REV, V22, P110, DOI 10.1139/er-2013-0038; Lorber M, 2008, J EXPO SCI ENV EPID, V18, P2, DOI 10.1038/sj.jes.7500572; Lydy MJ, 2004, ARCH ENVIRON CON TOX, V48, P49, DOI 10.1007/s00244-004-0056-6; MacFarlane RB, 2002, FISH B-NOAA, V100, P244; Macneale KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092436; Macneale KH, 2010, FRONT ECOL ENVIRON, V8, P475, DOI 10.1890/090142; Masterson K., 2012, 2012 HOOD RIVER WATE; McCarthy KA, 2013, US GEOLOGICAL SURVEY; Meador JP, 2006, CAN J FISH AQUAT SCI, V63, P2364, DOI 10.1139/F06-127; Morace J. L., 2012, 20125068 US GEOL SUR; Muir DCG, 2006, ENVIRON SCI TECHNOL, V40, P449, DOI 10.1021/es051707u; MUNN MD, 2001, 014077 US GEOL SURV; Murray K., 2014, PEST MANAGEMENT STRA; National Marine Fisheries Service, 2011, SUMM EV LOW COL RIV; Nilsen E, 2014, SCI TOTAL ENVIRON, V484, P344, DOI 10.1016/j.scitotenv.2013.04.012; Nilsen EB, 2015, ENVIRON POLLUT, V201, P121, DOI 10.1016/j.envpol.2015.03.003; Noel M, 2009, ENVIRON POLLUT, V157, P3404, DOI 10.1016/j.envpol.2009.06.025; Nowell L.H., 1999, PESTICIDES STREAM SE; Nowell LH, 2014, SCI TOTAL ENVIRON, V476, P144, DOI 10.1016/j.scitotenv.2013.12.088; O'Toole P., 1991, 88053 OR DEP FISH WI; ODFW, 2005, OREGON NATIVE FISH S; ODFW (Oregon Department of Fish and Wildlife), 2010, LOW COL RIV CONS REC; Oregon Department of Environmental Quality, 2012, LAB AN STOR RETR LAS; Oregon Department of Fish and Wildlife (ODFW), 2008, HATCH GEN MAN PLAN G; Oregon Department of Fish and Wildlife (ODFW), 2015, ODFW ANN REP JAN 201; Poulier G, 2015, ENVIRON SCI POLLUT R, V22, P8044, DOI 10.1007/s11356-014-2814-y; Rasmussen JJ, 2013, ENVIRON POLLUT, V182, P479, DOI 10.1016/j.envpol.2013.08.012; RASTOGI A, 1990, B ENVIRON CONTAM TOX, V45, P742, DOI 10.1007/BF01700995; Reagan RE, 2011, 198805304 OR DEP FIS; Riley S, 2011, STATE OREGON PESTICI, DOI Oregon Department of Agriculture, Oregon Department of Environmental Quality, Oregon Department of Forestry, and Oregon Department of Human Services; Ross PS, 2013, CAN J FISH AQUAT SCI, V70, P1252, DOI 10.1139/cjfas-2012-0540; Scholz NL, 2012, BIOSCIENCE, V62, P428, DOI 10.1525/bio.2012.62.4.13; Schreder ED, 2014, ENVIRON SCI TECHNOL, V48, P11575, DOI 10.1021/es502227h; Schuler LJ, 2005, ARCH ENVIRON CON TOX, V49, P173, DOI 10.1007/s00244-004-0224-8; Seeland A, 2012, ENVIRON POLLUT, V168, P161, DOI 10.1016/j.envpol.2012.04.020; Shivley D, 2006, HOOD RIVER BASIN AQU; Sloan CA, 2010, ARCH ENVIRON CON TOX, V58, P403, DOI 10.1007/s00244-009-9391-y; Starcevich S, 2006, HOOD RIVER BULL TROU; Temple WB, 2011, 20115082 US GEOL SUR; Thieman C., 2014, HOOD RIVER WATERSHED; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; US EPA (US Environmental Protection Agency), 2015, NAT REC WAT QUAL CRI; Van Metre PC, 2005, ENVIRON SCI TECHNOL, V39, P5567, DOI 10.1021/es0503175; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; WILLIS GH, 1987, T ASAE, V30, P394; 2009, HAZARDOUS SUBSTANCES	102	15	15	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158175	10.1371/journal.pone.0158175	http://dx.doi.org/10.1371/journal.pone.0158175			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348521	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200046
J	Henmyr, V; Lind-Hallden, C; Hallden, C; Sall, T; Carlberg, D; Bachert, C; Cardell, LO				Henmyr, Viktor; Lind-Hallden, Christina; Hallden, Christer; Sall, Torbjorn; Carlberg, Daniel; Bachert, Claus; Cardell, Lars-Olaf			Chronic Rhinosinusitis Patients Show Accumulation of Genetic Variants in PARS2	PLOS ONE			English	Article							ASSOCIATION	Genetic studies of chronic rhinosinusitis (CRS) have identified a total of 53 CRS-associated SNPs that were subsequently evaluated for their reproducibility in a recent study. The rs2873551 SNP in linkage disequilibrium with PARS2 showed the strongest association signal. The present study aims to comprehensively screen for rare variants in PARS2 and evaluate for accumulation of such variants in CRS-patients. Sanger sequencing and long-range PCR were used to screen for rare variants in the putative promoter region and coding sequence of 310 CRS-patients and a total of 21 variants were detected. The mutation spectrum was then compared with data from European populations of the 1000Genomes project (EUR) and the Exome Aggregation Consortium (ExAC). The CRS population showed a significant surplus of low-frequency variants compared with ExAC data. Haplotype analysis of the region showed a significant excess of rare haplotypes in the CRS population compared to the EUR population. Two missense mutations were also genotyped in the 310 CRS patients and 372 CRS-negative controls, but no associations with the disease were found. This is the first re-sequencing study in CRS research and also the first study to show an association of rare variants with the disease.	[Henmyr, Viktor; Lind-Hallden, Christina; Hallden, Christer; Carlberg, Daniel] Kristianstad Univ, Biomed, Kristianstad, Sweden; [Henmyr, Viktor; Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden; [Bachert, Claus] Univ Hosp Ghent, Upper Airways Res Lab, Ghent, Belgium; [Bachert, Claus; Cardell, Lars-Olaf] Karolinska Inst, CLINTEC, Div ENT Dis, Huddinge, Sweden	Kristianstad University; Lund University; Ghent University; Ghent University Hospital; Karolinska Institutet	Henmyr, V (corresponding author), Kristianstad Univ, Biomed, Kristianstad, Sweden.; Henmyr, V (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	viktor.henmyr@hkr.se	Bachert, Claus/J-8825-2012	Carlberg, Daniel/0000-0002-8098-6396				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Bousquet PJ, 2009, ALLERGY, V64, P1656, DOI 10.1111/j.1398-9995.2009.02169.x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Fokkens W, 2007, RHINOLOGY, P1; Henmyr V, 2014, J ALLERGY CLIN IMMUN, V133, P273, DOI 10.1016/j.jaci.2013.08.011; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Nilsson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053975; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115	18	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158202	10.1371/journal.pone.0158202	http://dx.doi.org/10.1371/journal.pone.0158202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348859	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200050
J	Liu, ZY; Liu, GH; Cai, HY; Shi, PJ; Chang, WH; Zhang, S; Zheng, AJ; Xie, Q; Ma, JS				Liu, Zhiyun; Liu, Guohua; Cai, Huiyi; Shi, Pengjun; Chang, Wenhuan; Zhang, Shu; Zheng, Aijuan; Xie, Qing; Ma, Jianshuang			Paecilomyces variotii: A Fungus Capable of Removing Ammonia Nitrogen and Inhibiting Ammonia Emission from Manure	PLOS ONE			English	Article							SIMULTANEOUS HETEROTROPHIC NITRIFICATION; NITRIFYING-DENITRIFYING BACTERIUM; AEROBIC DENITRIFICATION; BIOFILTRATION; PERFORMANCE; NITRATE; DIGESTIBILITY; NITRITE; TOLUENE; ACID	Ammonia (NH3) emissions from animal manure are a significant environmental and public concern. Despite the numerous studies regarding NH3 emissions from manure, few of them have considered microbial nitrification approaches, especially fungal nitrification. In this study, a filamentous fungus was isolated from chicken manure and was used for nitrification. The species was Paecilomyces variotii by morphological characteristics and 18S rDNA gene sequencing. It played the biggest role in the removal of ammonium at pH 4.0-7.0, C/N ratio of 10-40, temperature of 25-37 degrees C, shaking speed of 150 rpm, and with glucose as the available carbon source. Further analysis revealed that all ammonium was removed when the initial ammonium concentration was less than 100 mg/L; 40% ammonium was removed when the initial ammonium concentration was 1100 mg/L. The results showed that the concentration of ammonia from chicken manure with strain Paecilomyces variotii was significantly lower than that in the control group. We concluded that Paecilomyces variotii has good potential for future applications in in situ ammonium removal as well as ammonia emissions control from poultry manure.	[Liu, Zhiyun; Liu, Guohua; Cai, Huiyi; Shi, Pengjun; Chang, Wenhuan; Zhang, Shu; Zheng, Aijuan; Ma, Jianshuang] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Xie, Qing] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Liu, GH (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	liuguohua@caas.cn	Chang, Wenhuan/AAM-8625-2020		National Key Technologies R&D Program of China [2011BAD26B03]; Ministry of Science and Technology of People's Republic of China	National Key Technologies R&D Program of China(National Key Technology R&D Program); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Key Technologies R&D Program of China (2011BAD26B03), funded by Ministry of Science and Technology of People's Republic of China [http://www.most.gov.cn] to GHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen PZ, 2012, BIORESOURCE TECHNOL, V116, P266, DOI 10.1016/j.biortech.2012.02.050; Chen Q, 2012, J BIOSCI BIOENG, V113, P619, DOI 10.1016/j.jbiosc.2011.12.012; Chen YJ, 2006, ASIAN AUSTRAL J ANIM, V19, P587, DOI 10.5713/ajas.2006.587; Cox HHJ, 1997, BIOTECHNOL BIOENG, V53, P259; Duan QH, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/347675; Garcia-Pena EI, 2001, BIOTECHNOL BIOENG, V76, P61, DOI 10.1002/bit.1026; Garcia-Pena I, 2005, APPL ENVIRON MICROB, V71, P4280, DOI 10.1128/AEM.71.8.4280-4285.2005; Garcia-Pena I, 2008, INT BIODETER BIODEGR, V62, P442, DOI 10.1016/j.ibiod.2008.03.012; Guo Y, 2013, BIOTECHNOL LETT, V35, P2045, DOI 10.1007/s10529-013-1294-3; Guzev VS, 2001, MICROBIOLOGY+, V70, P263, DOI 10.1023/A:1010490924885; Hassan Md R., 2012, [Journal of Agriculture & Life Science, 농업생명과학연구], V46, P119; Hatanaka T, 2004, GENETICA, V122, P239, DOI 10.1007/s10709-004-2039-y; Jetten MSM, 2001, PLANT SOIL, V230, P9, DOI 10.1023/A:1004683807250; Joo HS, 2005, J BIOSCI BIOENG, V100, P184, DOI 10.1263/jbb.100.184; Joo HS, 2005, BIOTECHNOL LETT, V27, P773, DOI 10.1007/s10529-005-5634-9; Joo HS, 2006, WATER RES, V40, P3029, DOI 10.1016/j.watres.2006.06.021; Khardenavis AA, 2007, APPL MICROBIOL BIOT, V77, P403, DOI 10.1007/s00253-007-1176-5; Kim DJ, 2006, BIORESOURCE TECHNOL, V97, P459, DOI 10.1016/j.biortech.2005.03.032; Kim JK, 2005, BIORESOURCE TECHNOL, V96, P1897, DOI 10.1016/j.biortech.2005.01.040; LANG E, 1986, FEMS MICROBIOL ECOL, V38, P257, DOI 10.1111/j.1574-6968.1986.tb01736.x; Laughlin RJ, 2008, EUR J SOIL SCI, V59, P285, DOI 10.1111/j.1365-2389.2007.00995.x; Laughlin RJ, 2009, APPL SOIL ECOL, V42, P25, DOI 10.1016/j.apsoil.2009.01.004; Le PD, 2005, NUTR RES REV, V18, P3, DOI 10.1079/NRR200592; Liu XM, 2005, ENV SCI, V26, P143; Nishio T, 1998, J FERMENT BIOENG, V86, P351, DOI 10.1016/S0922-338X(99)89003-5; O'Connell JM, 2006, ANIM FEED SCI TECH, V127, P73, DOI 10.1016/j.anifeedsci.2005.09.002; ODU C T I, 1970, Soil Biology and Biochemistry, V2, P41, DOI 10.1016/0038-0717(70)90024-6; Salim HM, 2014, WORLD POULTRY SCI J, V70, P839, DOI 10.1017/S0043933914000890; Sommer SG, 2003, EUR J AGRON, V19, P465, DOI 10.1016/S1161-0301(03)00037-6; Sommer SG, 2001, EUR J AGRON, V15, P1, DOI 10.1016/S1161-0301(01)00112-5; Taylor SM, 2009, J ENVIRON SCI, V21, P1336, DOI 10.1016/S1001-0742(08)62423-7; Yang XP, 2011, BIORESOURCE TECHNOL, V102, P854, DOI 10.1016/j.biortech.2010.09.007; Yang XP, 2012, BIORESOURCE TECHNOL, V104, P65, DOI 10.1016/j.biortech.2011.10.026; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhang QL, 2012, BIORESOURCE TECHNOL, V108, P35, DOI 10.1016/j.biortech.2011.12.139; Zhao B, 2010, ENVIRON TECHNOL, V31, P409, DOI 10.1080/09593330903508922; Zhao LY, 2008, P LIV ENV 8 C 2008 A, P41; Zhou Q, 2007, J BIOSCI BIOENG, V103, P185, DOI 10.1263/jbb.103.185; Zhu L, 2012, ENVIRON SCI POLLUT R, V19, P3185, DOI 10.1007/s11356-012-0822-3	39	7	8	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158089	10.1371/journal.pone.0158089	http://dx.doi.org/10.1371/journal.pone.0158089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348533	Green Published, Green Submitted, gold			2022-12-26	WOS:000378801200035
J	Uno, K; Kikuchi, Y; Iwata, M; Uehara, T; Matsuoka, T; Sumiyoshi, T; Okamoto, Y; Jinno, H; Takada, T; Furukawa-Hibi, Y; Nabeshima, T; Miyamoto, Y; Nitta, A				Uno, Kyosuke; Kikuchi, Yuu; Iwata, Mina; Uehara, Takashi; Matsuoka, Tadasu; Sumiyoshi, Tomiki; Okamoto, Yoshinori; Jinno, Hideto; Takada, Tatsuyuki; Furukawa-Hibi, Yoko; Nabeshima, Toshitaka; Miyamoto, Yoshiaki; Nitta, Atsumi			Decreased DNA Methylation in the Shati/Nat8I Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype	PLOS ONE			English	Article							MICE; NEURONS; BRAIN; EXPRESSION; ADDICTION; ISLANDS; BINDING; STRESS; MECP2	The number of patients with schizophrenia has increased over the past decade. Previously, many studies have been performed to establish its diagnostic criteria, prophylactic methods, and effective therapies. In this study, we analyzed whether the ratios of DNA methylation in CpG islands of the Shati/Nat8l is decreased in model mice of schizophrenia-like phenotype using genomic DNA collected from brain regions and peripheral blood, since the mouse model of schizophrenia-like phenotype, mice treated repeatedly with methamphetamine showed increase of Shati/Nat8l mRNA expression in our previous experiment. The ratios of Shati/Nat8l CpG island methylation were significantly decreased in both the nucleus accumbens and the peripheral blood of model mice compared with those of control mice. We also investigated Shati/Nat8l methylation in the blood of patients with schizophrenia. We found that Shati/Nat8l CpG island methylation ratios were lower in the patients with schizophrenia than in the healthy controls, which is consistent with our findings in the mice model. To our knowledge, this is the first study to show similar alterations in methylation status of a particular genomic DNA site in both the brain and peripheral blood of mice. Furthermore, the same phenomenon was observed in corresponding human genomic sequences of the DNA extracted from the peripheral blood of patients with schizophrenia. Based on our findings, DNA methylation profiles of the CpG island of Shati/Nat8l might be a diagnostic biomarker of schizophrenia.	[Uno, Kyosuke; Kikuchi, Yuu; Iwata, Mina; Miyamoto, Yoshiaki; Nitta, Atsumi] Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 930, Japan; [Uehara, Takashi] Kanazawa Med Univ, Dept Neuropsychiat, Kahoku, Ishikawa 92002, Japan; [Matsuoka, Tadasu; Sumiyoshi, Tomiki] Toyama Univ, Dept Neuropsychiat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Matsuoka, Tadasu] Matsuoka Hosp, Med Corp Syoufukai, Oyabe, Japan; [Sumiyoshi, Tomiki] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Tokyo, Japan; [Okamoto, Yoshinori; Jinno, Hideto] Meijo Univ, Fac Pharm, Nagoya, Aichi 468, Japan; [Takada, Tatsuyuki] Ritsumeikan Univ, Dept Pharmaceut Sci, Kusatsu, Japan; [Furukawa-Hibi, Yoko] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4648601, Japan; [Nabeshima, Toshitaka] Fujita Hlth Univ, Grad Sch Hlth Sci, Adv Diagnost Syst Res Lab, Toyoake, Aichi, Japan; [Nabeshima, Toshitaka] Aino Univ, Toyoake, Aichi, Japan; [Nabeshima, Toshitaka] Fujita Hlth Univ, Grad Sch Hlth Sci, Adv Diagnost Syst Res Lab, Ibaraki, Japan; [Nabeshima, Toshitaka] Aino Univ, Ibaraki, Japan	University of Toyama; Kanazawa Medical University; University of Toyama; National Center for Neurology & Psychiatry - Japan; Meijo University; Ritsumeikan University; Nagoya University; Fujita Health University	Nitta, A (corresponding author), Toyama Univ, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 930, Japan.	nitta@pha.u-toyama.ac.jp	Sumiyoshi, Tomiki/K-4507-2019; Okamoto, Yoshinori/AAX-4825-2021; Muramatsu, Shin-ichi/K-9420-2013; Jinno, Hideto/GVU-0881-2022; Nitta, Atsumi/AAF-4211-2019	Okamoto, Yoshinori/0000-0001-6031-3250; Muramatsu, Shin-ichi/0000-0002-3185-7790; 	Japan Society for the Promotion of Science [LS047, I5H04622, I5K15050, 16K18933, 26460240, 16K10195, 14K08090]; SRF Grant for Biomedical Research and Foundation; Kobayashi International Foundation; Research on Regulatory Science of Pharmaceuticals	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SRF Grant for Biomedical Research and Foundation; Kobayashi International Foundation; Research on Regulatory Science of Pharmaceuticals	The work was supported by the following: Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html, AN (LS047, I5H04622, I5K15050), KU (16K18933), TN (26460240, 16K10195), YK (14K08090). AN and TN: SRF Grant for Biomedical Research and Foundation, http://www.srf.or.jp/. AN: Kobayashi International Foundation, http://www.kisf.or.jp/english/index.html. AN: Research on Regulatory Science of Pharmaceuticals, http://www.amed.go.jp/en/program/.	Abdolmaleky Hamid Mostafavi, 2008, V448, P187, DOI 10.1007/978-1-59745-205-2_9; BEDNARIK DP, 1990, EMBO J, V9, P1157, DOI 10.1002/j.1460-2075.1990.tb08222.x; BIRD A P, 1984, Journal of Embryology and Experimental Morphology, V83, P31; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Dong E, 2015, SCHIZOPHR RES, V167, P35, DOI 10.1016/j.schres.2014.10.030; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Iwamoto K, 2005, J NEUROSCI, V25, P5376, DOI 10.1523/JNEUROSCI.0766-05.2005; Jayanthi S, 2014, BIOL PSYCHIAT, V76, P47, DOI 10.1016/j.biopsych.2013.09.034; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; Lu K, 2012, CHEM RES TOXICOL, V25, P664, DOI 10.1021/tx200426b; MACHIYAMA Y, 1992, SCHIZOPHRENIA BULL, V18, P107, DOI 10.1093/schbul/18.1.107; Matrisciano F, 2013, NEUROPHARMACOLOGY, V68, P184, DOI 10.1016/j.neuropharm.2012.04.013; Miyamoto Y, 2014, INT J NEUROPSYCHOPH, V17, P1283, DOI 10.1017/S146114571400011X; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Niwa M, 2008, ANN NY ACAD SCI, V1141, P76, DOI 10.1196/annals.1441.024; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Niwa M, 2013, SCIENCE, V339, P335, DOI 10.1126/science.1226931; Numachi Y, 2004, ANN NY ACAD SCI, V1025, P102, DOI 10.1196/annals.1316.013; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sumi K, 2015, NEUROREPORT, V26, P740, DOI 10.1097/WNR.0000000000000416; TAKIGAWA M, 1993, CAN J PHYSIOL PHARM, V71, P321, DOI 10.1139/y93-050; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Yui K, 2000, ANN NY ACAD SCI, V914, P1, DOI 10.1111/j.1749-6632.2000.tb05178.x; Zhong XF, 2012, J NEUROSCI, V32, P12841, DOI 10.1523/JNEUROSCI.2784-12.2012; Zhubi A, 2009, SCHIZOPHR RES, V111, P115, DOI 10.1016/j.schres.2009.03.020	32	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157959	10.1371/journal.pone.0157959	http://dx.doi.org/10.1371/journal.pone.0157959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348532	Green Submitted, gold, Green Published			2022-12-26	WOS:000378801200024
J	Long, MT; Pedley, A; Massaro, JM; Hoffmann, U; Fox, CS				Long, Michelle T.; Pedley, Alison; Massaro, Joseph M.; Hoffmann, Udo; Fox, Caroline S.			The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INCREASED ARTERIAL STIFFNESS; PULSE PRESSURE; NONALCOHOLIC STEATOHEPATITIS; DIAGNOSIS; BIOPSY; ADULTS	Background & Aims Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular related death, particularly in those with hepatic fibrosis. We determined the prevalence of predicted fibrosis based on non-invasive fibrosis markers and the association of hepatic fibrosis with cardiovascular risk factors. Methods Cross-sectional study of 575 Framingham Heart Study participants with NAFLD based on computed tomography. We determined the prevalence of predicted fibrosis based on the aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, AST to platelet ratio index (APRI), the Fibrosis-4 score (FIB4), and the NAFLD Fibrosis Score (NFS). Using multivariable logistic regression models, we examined the association between low, indeterminate, or high risk for fibrosis according to the NFS and various cardiometabolic risk factors. Results The predicted risk of fibrosis was 12%, 4%, 5%, and 32% for the NFS, FIB4, APRI, and AST/ALT ratio, respectively. In multivariable models, participants with a high risk for advanced fibrosis by the NFS had a wider pulse pressure (adjusted mean difference = 6.87 mm Hg; p = 0.0002) and an increased odds of hypertension (OR 2.92; p = 0.007) compared to those with low risk of fibrosis. There were no statistically significant differences between other cardiovascular risk factors for those with a high versus low risk of fibrosis. Conclusions The AST/ALT ratio, APRI, and NFS give widely disparate predictions of liver fibrosis. Participants with a high risk for fibrosis based on NFS had wider pulse pressure and increased odds of hypertension. Whether modifying these risk factors impacts cardiovascular endpoints in NAFLD patients remains unknown.	[Long, Michelle T.] Boston Univ, Sch Med, Div Gastroenterol, Boston Med Ctr, Boston, MA 02118 USA; [Long, Michelle T.; Pedley, Alison; Massaro, Joseph M.; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Pedley, Alison] Merck Res Labs, Kenilworth, NJ USA; [Massaro, Joseph M.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Hoffmann, Udo] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Hypertens & Metab, Boston, MA 02115 USA	Boston Medical Center; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Merck & Company; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Long, MT (corresponding author), Boston Univ, Sch Med, Div Gastroenterol, Boston Med Ctr, Boston, MA 02118 USA.; Long, MT (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.	mtlong@bu.edu	Long, Michelle T/H-3801-2019	Long, Michelle/0000-0001-6131-3981	Boston University School of Medicine; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195, HHSN268201500001I]; Division of Intramural Research of the National Heart, Lung, and Blood Institute	Boston University School of Medicine; National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Boston University School of Medicine and the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract N01-HC-25195 and HHSN268201500001I), and the Division of Intramural Research of the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alison Pedley is an employee of Merck. The funder provided support in the form of salaries for authors [AP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Festi D, 2013, ALIMENT PHARM THER, V37, P392, DOI 10.1111/apt.12186; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Kruger FC, 2011, SAMJ S AFR MED J, V101, P477; Lee YJ, 2012, DIGEST DIS SCI, V57, P196, DOI 10.1007/s10620-011-1819-3; Long MT, 2015, ARTERIOSCL THROM VAS, V35, P1284, DOI 10.1161/ATVBAHA.114.305200; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Mitchell GF, 1997, CIRCULATION, V96, P4254; Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017; Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464; Roseman DA, 2014, AM J CARDIOL, V113, P156, DOI 10.1016/j.amjcard.2013.09.036; Salvi P, 2010, J HYPERTENS, V28, P1699, DOI 10.1097/HJH.0b013e32833a7de6; Sesti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104941; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Speliotes EK, 2008, J GASTROEN HEPATOL, V23, P894, DOI 10.1111/j.1440-1746.2008.05420.x; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P1183, DOI 10.1038/ajh.2010.144; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	31	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157517	10.1371/journal.pone.0157517	http://dx.doi.org/10.1371/journal.pone.0157517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341207	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600008
J	Tishchenko, I; Milioli, HH; Riveros, C; Moscato, P				Tishchenko, Inna; Milioli, Heloisa Helena; Riveros, Carlos; Moscato, Pablo			Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers	PLOS ONE			English	Article							GENE-EXPRESSION DATA; COMPLEMENT FACTOR-H; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; MOLECULAR PORTRAITS; COPY NUMBER; SURVIVAL; SUBTYPES; CLASSIFICATION; PATTERNS	Despite constituting approximately two thirds of all breast cancers, the luminal A and B tumours are poorly classified at both clinical and molecular levels. There are contradictory reports on the nature of these subtypes: some define them as intrinsic entities, others as a continuum. With the aim of addressing these uncertainties and identifying molecular signatures of patients at risk, we conducted a comprehensive transcriptomic and genomic analysis of 2,425 luminal breast cancer samples. Our results indicate that the separation between the molecular luminal A and B subtypes-per definition-is not associated with intrinsic characteristics evident in the differentiation between other subtypes. Moreover, t-SNE and MST-kNN clustering approaches based on 10,000 probes, associated with luminal tumour initiation and/or development, revealed the close connections between luminal A and B tumours, with no evidence of a clear boundary between them. Thus, we considered all luminal tumours as a single heterogeneous group for analysis purposes. We first stratified luminal tumours into two distinct groups by their HER2 gene cluster co-expression: HER2-amplified luminal and ordinary-luminal. The former group is associated with distinct transcriptomic and genomic profiles, and poor prognosis; it comprises approximately 8% of all luminal cases. For the remaining ordinary-luminal tumours we further identified the molecular signature correlated with disease outcomes, exhibiting an approximately continuous gene expression range from low to high risk. Thus, we employed four virtual quantiles to segregate the groups of patients. The clinico-pathological characteristics and ratios of genomic aberrations are concordant with the variations in gene expression profiles, hinting at a progressive staging. The comparison with the current separation into luminal A and B subtypes revealed a substantially improved survival stratification. Concluding, we suggest a review of the definition of luminal A and B subtypes. A proposition for a revisited delineation is provided in this study.	[Tishchenko, Inna; Milioli, Heloisa Helena; Moscato, Pablo] Hunter Med Res Inst, Information Based Med Program, New Lambton Hts, NSW, Australia; [Tishchenko, Inna; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia; [Milioli, Heloisa Helena] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Riveros, Carlos] Hunter Med Res Inst, CReDITSS Unit, New Lambton Hts, NS, Canada	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle	Moscato, P (corresponding author), Hunter Med Res Inst, Information Based Med Program, New Lambton Hts, NSW, Australia.; Moscato, P (corresponding author), Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au		Milioli, Heloisa Helena/0000-0001-5104-487X; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Future Fellowship [FT120100060]; ARC Discovery Project, Australia [DP120102576]; Big Data Big Impact Grant [13/DATA/1-03]; Cancer Research UK; British Columbia Cancer Agency Branch; Cancer Institute of New South Wales	Australian Research Council (ARC) Future Fellowship(Australian Research Council); ARC Discovery Project, Australia(Australian Research Council); Big Data Big Impact Grant; Cancer Research UK(Cancer Research UK); British Columbia Cancer Agency Branch; Cancer Institute of New South Wales	PM is supported by Australian Research Council (ARC) Future Fellowship FT120100060. This project is partially funded by ARC Discovery Project DP120102576, Australia. PM also acknowledges the support of Cancer Institute of New South Wales, Big Data Big Impact Grant 13/DATA/1-03 "The integration of bioinformatics, chemoinformatics, and toxicogenomics methods: a new approach for the identification of combination tailored therapies and novel drug targets in breast cancer."; This study makes use of data generated by the Molecular Taxonomy of Breast Cancer International Consortium. Funding for the project was provided by Cancer Research UK and the British Columbia Cancer Agency Branch.; PM is supported by Australian Research Council (ARC, http://www.arc.gov.au/) Future Fellowship FT120100060. This project is partially funded by ARC Discovery Project DP120102576, Australia.; PM also acknowledges the support of Cancer Institute of New South Wales (http://www.cancerinstitute.org.au/), Big Data Big Impact Grant 13/DATA/1-03 "The integration of bioinformatics, chemoinformatics, and toxicogenomics methods: a new approach for the identification of combination tailored therapies and novel drug targets in breast cancer."	Abdel-Fatah TMA, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P6-07-09; [Anonymous], 2014, R LANG ENV STAT COMP; Arefin AS, 2012, INT CONF COMP SCI ED, P585, DOI 10.1109/ICCSE.2012.6295143; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bredholt G, 2015, ONCOTARGET, V6, P39676, DOI 10.18632/oncotarget.5344; Carlson M., HGU133A DB AFFYMETRI; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen XS, 2014, CANCER EPIDEMIOL, V38, P286, DOI 10.1016/j.canep.2014.03.007; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ciriello G, 2013, BREAST CANCER RES TR, V141, P409, DOI 10.1007/s10549-013-2699-3; Cornen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081843; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Cross BM, 2014, AM J PHYSIOL-CELL PH, V306, pC515, DOI 10.1152/ajpcell.00330.2013; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cui TT, 2011, INT J ONCOL, V39, P161, DOI 10.3892/ijo.2011.1010; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Das M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069607; De Luca A, 2010, P NATL ACAD SCI USA, V107, P18628, DOI 10.1073/pnas.1010171107; de Moraes GN, 2015, CELL SIGNAL, V27, P2496, DOI 10.1016/j.cellsig.2015.09.013; Donaldson J, 2012, TSNE T DISTRIBUTED S; Dunning M, ILLUMINAHUMANV3 DB I; Esposito A, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.518; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Fox J., 2019, R COMPANION APPL REG, V.; Francis VG, 2012, J BIOL CHEM, V393; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fernandez AG, 2015, CLIN TRANSL ONCOL, V17, P238, DOI 10.1007/s12094-014-1220-8; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Gee HE, 2015, INT J RADIAT ONCOL, V93, P1104, DOI 10.1016/j.ijrobp.2015.08.046; Gluz O, 2013, BREAST CARE, V8, P414, DOI 10.1159/000357535; Gnant M, 2015, BREAST CARE, V10, P124, DOI 10.1159/000430488; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Guo X, 2012, ANAT REC, V295, P553, DOI 10.1002/ar.22417; Haibe-Kains B., 2014, GENEFU RELEVANT FUNC; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Harbeck N, 2013, BREAST CARE, V8, P110, DOI 10.1159/000350777; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inic Z, 2014, CLIN MED INSIGHTS-ON, V8, P107, DOI 10.4137/CMO.S18006; Kawai M, 2014, CANCER-AM CANCER SOC, V120, P1026, DOI 10.1002/cncr.28402; Kim HM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004723; Knox AJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0418-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li YH, 2015, CANCER BIOL THER, V16, P1316, DOI 10.1080/15384047.2015.1070980; Liu Z, 2014, SCI REP, P4; Lusa L, 2007, JNCI-J NATL CANCER I, V99, P1715, DOI 10.1093/jnci/djm216; Mackay A, 2011, JNCI-J NATL CANCER I, V103, P662, DOI 10.1093/jnci/djr071; Mahmood SF, 2014, CARCINOGENESIS, V35, P670, DOI 10.1093/carcin/bgt351; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Milioli HH, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-015-0078-9; Milioli HH, 2015, PLOS ONE, V10, DOI [10.1371/ journal. pone. 0129711, DOI 10.1371/J0URNAL.P0NE.0129711]; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pfeffer U., 2013, CANC GENOMICS MOL CL; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053850; Schutze H., 1999, FDN STAT NATURAL LAN; Sigurdsson V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060798; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staaf J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju386; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stock AM, 2015, ANTICANCER RES, V35, P5277; Sun Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0055-z; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Tot T, 2010, BREAST CANC LOBAR DI; Untch M, 2013, BREAST CARE, V8, P221, DOI 10.1159/000351692; Ur-Rehman S, 2013, BREAST CANCER RES TR, V139, P907, DOI 10.1007/s10549-013-2593-z; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vathipadiekal V, 2015, CLIN CANCER RES, V21, P4960, DOI 10.1158/1078-0432.CCR-14-3173; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Weier G HU., 2013, J DATA MINING GENOMI, V04; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wu JQ, 2013, ACS CHEM BIOL, V8, P2201, DOI 10.1021/cb400186w; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Yanagawa Masumi, 2012, BMC Res Notes, V5, P376, DOI 10.1186/1756-0500-5-376; Zhang Z, 2012, CANCER EPIDEMIOL, V36, pE111, DOI 10.1016/j.canep.2011.11.004	92	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158259	10.1371/journal.pone.0158259	http://dx.doi.org/10.1371/journal.pone.0158259			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341628	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600043
J	Alvarez, RS; Sacerdoti, F; Jancic, C; Paton, AW; Paton, JC; Ibarra, C; Amaral, MM				Alvarez, Romina S.; Sacerdoti, Flavia; Jancic, Carolina; Paton, Adrienne W.; Paton, James C.; Ibarra, Cristina; Amaral, Maria M.			Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; TOXIGENIC ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; TIGHT JUNCTION; VIRULENCE FACTORS; HELA-CELLS; IN-VITRO; APOPTOSIS; IDENTIFICATION; PATHOGENESIS	Postdiarrheal hemolytic uremic syndrome (HUS) affects children under 5 years old and is responsible for the development of acute and chronic renal failure, particularly in Argentina. This pathology is a complication of Shiga toxin (Stx)-producing Escherichia coli infection and renal damage is attributed to Stx types 1 and 2 (Stx1, Stx2) produced by Escherichia coli O157: H7 and many other STEC serotypes. It has been reported the production of Subtilase cytotoxin (SubAB) by non-O157 STEC isolated from cases of childhood diarrhea. Therefore, it is proposed that SubAB may contribute to HUS pathogenesis. The human kidney is the most affected organ because very Stx-sensitive cells express high amounts of biologically active receptor. In this study, we investigated the effects of Stx2 and SubAB on primary cultures of human glomerular endothelial cells (HGEC) and on a human tubular epithelial cell line (HK-2) in monoculture and coculture conditions. We have established the coculture as a human renal proximal tubule model to study water absorption and cytotoxicity in the presence of Stx2 and SubAB. We obtained and characterized cocultures of HGEC and HK-2. Under basal conditions, HGEC monolayers exhibited the lowest electrical resistance (TEER) and the highest water permeability, while the HGEC/HK-2 bilayers showed the highest TEER and the lowest water permeability. In addition, at times as short as 20-30 minutes, Stx2 and SubAB caused the inhibition of water absorption across HK-2 and HGEC monolayers and this effect was not related to a decrease in cell viability. However, toxins did not have inhibitory effects on water movement across HGEC/HK-2 bilayers. After 72 h, Stx2 inhibited the cell viability of HGEC and HK-2 monolayers, but these effects were attenuated in HGEC/HK-2 bilayers. On the other hand, SubAB cytotoxicity shows a tendency to be attenuated by the bilayers. Our data provide evidence about the different effects of these toxins on the bilayers respect to the monolayers. This in vitro model of communication between human renal microvascular endothelial cells and human proximal tubular epithelial cells is a representative model of the human proximal tubule to study the effects of Stx2 and SubAB related to the development of HUS.	[Alvarez, Romina S.; Sacerdoti, Flavia; Ibarra, Cristina; Amaral, Maria M.] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina; [Jancic, Carolina] Acad Nacl Med Buenos Aires, Inst Med Expt IMEX CONICET, Lab Inmunidad Innata, Buenos Aires, DF, Argentina; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Buenos Aires; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; University of Adelaide	Amaral, MM (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina.	mmamaral74@gmail.com	Ibarra, Cristina/D-6242-2016	Ibarra, Cristina/0000-0001-8182-501X; Sacerdoti, Flavia/0000-0002-8480-756X; Amaral, Maria Marta/0000-0002-3902-2464	National Agency for Promotion of Science and Technology [ANPCYT-PICT 12-0777]; University of Buenos Aires [UBACYT-770]; National Scientific and Technical Research Council [CONICET D4541, D3646]	National Agency for Promotion of Science and Technology(ANPCyT); University of Buenos Aires(University of Buenos Aires); National Scientific and Technical Research Council	This study was supported by the National Agency for Promotion of Science and Technology (ANPCYT-PICT 12-0777), http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt, and the University of Buenos Aires (UBACYT-770), http://www.uba.ar (CI). It was also supported by the National Scientific and Technical Research Council (CONICET D4541, D3646) (MMA), http://www.conicet.gov.ar/.	Amaral MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070431; Aydin S, 2008, AM J PHYSIOL-CELL PH, V294, pC543, DOI 10.1152/ajpcell.00307.2007; Bertocchi C, 2010, CELL PHYSIOL BIOCHEM, V26, P669, DOI 10.1159/000322334; Bielaszewska M, 2005, THROMB HAEMOSTASIS, V94, P312, DOI 10.1160/TH05-04-0265; Bijuklic K, 2007, AM J PHYSIOL-CELL PH, V293, pC486, DOI 10.1152/ajpcell.00419.2006; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Creydt VP, 2006, MICROBES INFECT, V8, P410, DOI 10.1016/j.micinf.2005.07.005; De Broe M E, 1998, Verh K Acad Geneeskd Belg, V60, P359; De Broe ME, 1998, VERH K ACAD GENEESKD, V60, P83; Dorr RA, 1997, COMPUT METH PROG BIO, V53, P9, DOI 10.1016/S0169-2607(96)01801-9; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Galli L, 2010, VET MICROBIOL, V143, P307, DOI 10.1016/j.vetmic.2009.11.028; Girard MC, 2015, TOXICON, V105, P27, DOI 10.1016/j.toxicon.2015.08.021; Gomez SA, 2013, CLIN EXP IMMUNOL, V173, P463, DOI 10.1111/cei.12124; Velandia CVG, 2011, BRAZ J MICROBIOL, V42, P711, DOI [10.1590/S1517-838220110002000037, 10.1590/S1517-83822011000200037]; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Kaplan BS, 1998, KIDNEY INT, V54, P648, DOI 10.1046/j.1523-1755.1998.00037.x; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Karpman D, 2002, CURR PAEDIAT, V12, P569, DOI DOI 10.1054/CUPE.2002.0346; KURIHARA H, 1992, P NATL ACAD SCI USA, V89, P7075, DOI 10.1073/pnas.89.15.7075; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Marquez LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087022; Matsuura G, 2009, INFECT IMMUN, V77, P2919, DOI 10.1128/IAI.01510-08; May KL, 2010, INFECT IMMUN, V78, P4691, DOI 10.1128/IAI.00801-10; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Repetto HA., 2009, NEFROLOGIA CLIN, P286; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Rivas M M, 2015, EDITORIAL ACAD ESPAN, P28; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Rivas M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0002-2013; Sanchez S, 2012, VET MICROBIOL, V159, P531, DOI 10.1016/j.vetmic.2012.04.036; Silberstein C, 2008, PEDIATR NEPHROL, V23, P1981, DOI 10.1007/s00467-008-0896-9; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; STEVENSON BR, 1988, MOL CELL BIOCHEM, V83, P129; Tasnim F, 2012, AM J PHYSIOL-RENAL, V302, pF1055, DOI 10.1152/ajprenal.00621.2011; Tesh VL, 2012, CELL MICROBIOL, V14, P1, DOI 10.1111/j.1462-5822.2011.01684.x; Valtin H., 1973, RENAL HEMODYNAMICS O; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x; Yahiro K, 2010, MICROB PATHOGENESIS, V49, P153, DOI 10.1016/j.micpath.2010.05.007	50	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158180	10.1371/journal.pone.0158180	http://dx.doi.org/10.1371/journal.pone.0158180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336788	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200120
J	Chatard, M; Puech, C; Roche, F; Perek, N				Chatard, Morgane; Puech, Clementine; Roche, Frederic; Perek, Nathalie			Hypoxic Stress Induced by Hydralazine Leads to a Loss of Blood-Brain Barrier Integrity and an Increase in Efflux Transporter Activity	PLOS ONE			English	Article							IN-VITRO; OXIDATIVE STRESS; P-GLYCOPROTEIN; PROTEIN EXPRESSION; ENDOTHELIAL-CELLS; PERMEABILITY; MODEL; ANGIOGENESIS; OPTIMIZATION; PHENOTYPE	Understanding cellular and molecular mechanisms induced by hypoxic stress is crucial to reduce blood-brain barrier (BBB) disruption in some neurological diseases. Since the brain is a complex organ, it makes the interpretation of in vivo data difficult, so BBB studies are often investigated using in vitro models. However, the investigation of hypoxia in cellular pathways is complex with physical hypoxia because HIF-1 alpha (factor induced by hypoxia) has a short half-life. We had set up an innovative and original method of induction of hypoxic stress by hydralazine that was more reproducible, which allowed us to study its impact on an in vitro BBB model. Our results showed that hydralazine, a mimetic agent of the hypoxia pathway, had the same effect as physical hypoxia, with few cytotoxicity effects on our cells. Hypoxic stress led to an increase of BBB permeability which corresponded to an opening of our BBB model. Study of tight junction proteins revealed that this hypoxic stress decreased ZO-1 but not occludin expression. In contrast, cells established a defence mechanism by increasing expression and activity of their efflux transporters (Pgp and MRP-1). This induction method of hypoxic stress by hydralazine is simple, reproducible, controllable and suitable to understand the cellular and molecular mechanisms involved by hypoxia on the BBB.	[Chatard, Morgane; Roche, Frederic] Univ Lyon, UJM St Etienne, SNA EPIS, EA4607, F-42023 St Etienne, France; [Chatard, Morgane; Puech, Clementine; Perek, Nathalie] Univ Lyon, UJM St Etienne, INSERM, SAINBIOSE Team DVH U1089, F-42023 St Etienne, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Roche, F (corresponding author), Univ Lyon, UJM St Etienne, SNA EPIS, EA4607, F-42023 St Etienne, France.	frederic.roche@univ-st-etienne.fr		Roche, Frederic/0000-0001-6115-7958	Jean Monnet University (from Saint Etienne, France)	Jean Monnet University (from Saint Etienne, France)	This work was supported by Jean Monnet University (from Saint Etienne, France). The funders had no role in study design, data collections and analysis, decision to publish, on preparation of the manuscript.	Al Ahmad A, 2012, MICROVASC RES, V84, P222, DOI 10.1016/j.mvr.2012.05.008; Al Ahmad A, 2011, J CEREBR BLOOD F MET, V31, P693, DOI 10.1038/jcbfm.2010.148; Berezowski V, 2004, BRAIN RES, V1018, P1, DOI 10.1016/j.brainres.2004.05.092; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Cecchelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099733; Cervellati F, 2014, FREE RADICAL RES, V48, P303, DOI 10.3109/10715762.2013.867484; Chen ZS, 2002, CANCER RES, V62, P3144; Cioni Chiara, 2012, Front Psychiatry, V3, P47, DOI 10.3389/fpsyt.2012.00047; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Fang WR, 2013, NEUROCHEM INT, V62, P23, DOI 10.1016/j.neuint.2012.10.012; Felix RA, 2002, J NEUROCHEM, V80, P64, DOI 10.1046/j.0022-3042.2001.00660.x; Fischer S, 2000, AM J PHYSIOL-CELL PH, V279, pC935, DOI 10.1152/ajpcell.2000.279.4.C935; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi K, 2004, REGUL PEPTIDES, V123, P77, DOI 10.1016/j.regpep.2004.05.023; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; HORSMAN MR, 1995, BRIT J CANCER, V72, P1474, DOI 10.1038/bjc.1995.532; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kido Yasuto, 2002, Drug Metab Pharmacokinet, V17, P34, DOI 10.2133/dmpk.17.34; Knowles HJ, 2004, CIRC RES, V95, P162, DOI 10.1161/01.RES.0000134924.89412.70; Liu XD, 2008, NEUROSCI LETT, V432, P184, DOI 10.1016/j.neulet.2007.12.017; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Ogunshola OO, 2012, HIGH ALT MED BIOL, V13, P153, DOI 10.1089/ham.2012.1052; Perek N, 2005, CANCER BIOTHER RADIO, V20, P391, DOI 10.1089/cbr.2005.20.391; Perek N, 2002, GEN PHYSIOL BIOPHYS, V21, P381; Rodrigues SF, 2008, EUR J PHARMACOL, V589, P206, DOI 10.1016/j.ejphar.2008.05.003; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Shweta, 2015, BIOMETALS, V28, P175, DOI 10.1007/s10534-014-9813-9; Wang YQ, 2012, MOL CELL BIOCHEM, V360, P235, DOI 10.1007/s11010-011-1061-5; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Yang SJ, 2004, J BIOCHEM MOL BIOL, V37, P480; Zhigalova Nadezhda, 2015, F1000Res, V4, P1518, DOI 10.12688/f1000research.7571.1	36	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158010	10.1371/journal.pone.0158010	http://dx.doi.org/10.1371/journal.pone.0158010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337093	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200087
J	Agaesse, G; Barbollat-Boutrand, L; Sulpice, E; Bhajun, R; El Kharbili, M; Berthier-Vergnes, O; Degoul, F; de la Fouchardiere, A; Berger, E; Voeltzel, T; Lamartine, J; Gidrol, X; Masse, I				Agaesse, G.; Barbollat-Boutrand, L.; Sulpice, E.; Bhajun, R.; El Kharbili, M.; Berthier-Vergnes, O.; Degoul, F.; de la Fouchardiere, A.; Berger, E.; Voeltzel, T.; Lamartine, J.; Gidrol, X.; Masse, I.			A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion	ONCOGENE			English	Article							MEDIATOR COMPLEX; CELL-PROLIFERATION; TRANSCRIPTIONAL REGULATION; HEPATOCELLULAR-CARCINOMA; TETRASPANIN CO-029; OVARIAN-CANCER; GROWTH; MED19; METASTASIS; EXPRESSION	Melanoma is the deadliest form of skin cancer owing to its proclivity to metastasise, and recently developed therapies have not yielded the expected results, because almost all patients relapse. Therefore, understanding the molecular mechanisms that underlie early invasion by melanoma cells is crucial to improving patient survival. We have previously shown that, whereas the Tetraspanin 8 protein (Tspan8) is undetectable in normal skin and benign lesions, its expression arises with the progression of melanoma and is sufficient to increase cell invasiveness. Therefore, to identify Tspan8 transcriptional regulators that could explain the onset of Tspan8 expression, thereby conferring an invasive phenotype, we performed an innovative RNA interference-based screen, which, for the first time, identified several Tspan8 repressors and activators, such as GSK3 beta, PTEN, IQGAP1, TPT1 and LCMR1. LCMR1 is a recently identified protein that is overexpressed in numerous carcinomas; its expression and role, however, had not previously been studied in melanoma. The present study identified Tspan8 as the first LCMR1 target that could explain its function in carcinogenesis. LCMR1 modulation was sufficient to positively regulate endogenous Tspan8 expression, with concomitant in vitro phenotypic changes such as loss of melanoma cell-matrix adherence and increase in invasion, and Tspan8 expression promoted tumourigenicity in vivo. Moreover, LCMR1 and Tspan8 overexpression were shown to correlate in melanoma lesions, and both proteins could be downregulated in vitro by vemurafenib. In conclusion, this study highlights the importance of Tspan8 and its regulators in the control of early melanoma invasion and suggests that they may be promising new therapeutic targets downstream of the RAF-MEK-ERK signalling pathway.	[Agaesse, G.; Barbollat-Boutrand, L.; El Kharbili, M.; Berthier-Vergnes, O.; Lamartine, J.; Masse, I.] Univ Lyon, Lyon, France; [Agaesse, G.; Barbollat-Boutrand, L.; El Kharbili, M.; Berthier-Vergnes, O.; Lamartine, J.; Masse, I.] Univ Lyon 1, Lyon, France; [Agaesse, G.; Barbollat-Boutrand, L.; El Kharbili, M.; Berthier-Vergnes, O.; Lamartine, J.; Masse, I.] CNRS, Ctr Genet & Physiol Mol & Cellulaires, UMR5534, Villeurbanne, France; [Sulpice, E.; Bhajun, R.; Gidrol, X.] Univ Grenoble Alpes, Grenoble, France; [Sulpice, E.; Bhajun, R.; Gidrol, X.] CEA, BIG BGE, Biom, Grenoble, France; [Sulpice, E.; Bhajun, R.; Gidrol, X.] INSERM, BGE, Grenoble, France; [Degoul, F.] Univ Auvergne, Clermont Univ, Imagerie Mol & Therapie Vectorisee, Clermont Ferrand, France; INSERM, U 990, Clermont Ferrand, France; [de la Fouchardiere, A.] Ctr Leon Berard, Dept Biopathol, Lyon, France; [Berger, E.] Univ Lyon, INRA 1397, INSA, Lab CarMeN,INSERM 1060, Lyon, France; [Voeltzel, T.] Univ Lyon 1, Inserm U1052, CNRS UMR5286, Ctr Rech Cancerol Lyon, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Masse, I (corresponding author), Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaires, CNRS, UMR5534, Batiment Mendel 2eme Etage,16 Rue Dubois, F-69622 Villeurbanne, France.	ingrid.masse@univ-lyon1.fr	de la Fouchardiere, Arnaud/I-2807-2019; DEGOUL, Francoise/L-4856-2015; DEGOUL, Francoise/Q-4745-2019	de la Fouchardiere, Arnaud/0000-0003-2251-8241; DEGOUL, Francoise/0000-0002-0206-3350; DEGOUL, Francoise/0000-0002-0206-3350; Lamartine, Jerome/0000-0003-2322-1618; MASSE, Ingrid/0000-0003-3193-970X; Voeltzel, Thibault/0000-0001-7099-8716; Gidrol, Xavier/0000-0002-4233-3749; Sulpice, Eric/0000-0001-7695-0561	French Society for Dermatological Research (SRD); La Ligue Contre le Cancer (Comite Ardeche); association 'Vaincre le Melanome'; Roche Company	French Society for Dermatological Research (SRD); La Ligue Contre le Cancer (Comite Ardeche); association 'Vaincre le Melanome'; Roche Company	We thank Elise Malandain for technical assistance and Cyril Py for immunohistochemical processing, Stephanie Combe and Patricia Obeid for RNAi screening, Alain Geloen for adhesion assays, and Tiffany Witkowski and Janine Papon for experiments on mice. This work was supported by a grant from the French Society for Dermatological Research (SRD) and a grant from La Ligue Contre le Cancer (Comite Ardeche) and a grant from the association 'Vaincre le Melanome'. We acknowledge the Roche Company for financial support for manuscript writing and publication.	Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Berthier-Vergnes O, 2011, BRIT J CANCER, V104, P155, DOI 10.1038/sj.bjc.6605994; BERTHIERVERGNES O, 1993, LANCET, V341, P1292, DOI 10.1016/0140-6736(93)91205-Z; Byers Hugh Randolph, 1992, Journal of Dermatology (Tokyo), V19, P847; Chen LA, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-18; Cochran AJ, 1999, HUM PATHOL, V30, P556, DOI 10.1016/S0046-8177(99)90201-0; Colombino M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.136; Conde-Perez A, 2012, FUTURE ONCOL, V8, P1109, DOI [10.2217/fon.12.106, 10.2217/FON.12.106]; Cui XG, 2011, BMB REP, V44, P547, DOI 10.5483/BMBRep.2011.44.8.547; Ding XF, 2012, GENE, V504, P262, DOI 10.1016/j.gene.2012.04.033; Felding-Habermann B, 2002, CLIN EXP METASTAS, V19, P427, DOI 10.1023/A:1016377114119; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Ishimura N, 2003, CANCER LETT, V199, P169, DOI 10.1016/S0304-3835(03)00384-7; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Ji-Fu E, 2012, MOL BIOL REP, V39, P3675, DOI 10.1007/s11033-011-1142-2; John JK, 2012, J INVEST DERMATOL, V132, P2818, DOI 10.1038/jid.2012.237; Kanetaka K, 2001, J HEPATOL, V35, P637, DOI 10.1016/S0168-8278(01)00183-0; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kubic JD, 2012, MOL CANCER RES, V10, P1065, DOI 10.1158/1541-7786.MCR-11-0387; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; LeNaour F, 1996, ONCOGENE, V13, P481; Li LH, 2011, CANCER CHEMOTH PHARM, V68, P207, DOI 10.1007/s00280-010-1468-9; Li XH, 2011, CANCER BIOTHER RADIO, V26, P495, DOI 10.1089/cbr.2010.0863; Liu YT, 2012, MOL MED REP, V6, P1050, DOI 10.3892/mmr.2012.1065; Lu Z., 2015, MATH PROBLEM ENG, V2015, P1, DOI DOI 10.3389/FPSYG.2015; Mekky RY, 2015, J INFECTION, V70, P78, DOI 10.1016/j.jinf.2014.08.013; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Park CS, 2016, ONCOGENE, V35, P4540, DOI 10.1038/onc.2015.520; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Sun M, 2011, MOL CELL BIOCHEM, V355, P27, DOI 10.1007/s11010-011-0835-0; Tikhmyanova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022102; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wang TJ, 2011, ONCOL RES, V19, P193, DOI 10.3727/096504011X12970940207760; Wei LS, 2015, INT J CLIN EXP MED, V8, P8599; Wen H, 2013, ANN DIAGN PATHOL, V17, P259, DOI 10.1016/j.anndiagpath.2012.11.004; Xu YQ, 2012, PROG NEUROBIOL, V97, P1, DOI 10.1016/j.pneurobio.2012.02.002; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yu WX, 2014, EUR J CANCER, V50, P1125, DOI 10.1016/j.ejca.2014.01.030; Yue SJ, 2015, ONCOTARGET, V6, P2366, DOI 10.18632/oncotarget.2958; Zhang H, 2012, UROL ONCOL-SEMIN ORI, V30, P920, DOI 10.1016/j.urolonc.2010.10.003; Zhou Z, 2008, CLIN EXP METASTAS, V25, P537, DOI 10.1007/s10585-008-9168-0; Zhu LJ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-116; Zou SW, 2011, ACTA PHARMACOL SIN, V32, P354, DOI 10.1038/aps.2010.223	55	13	13	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					446	457		10.1038/onc.2016.219	http://dx.doi.org/10.1038/onc.2016.219			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27375018				2022-12-26	WOS:000394166700002
J	Xu, LZ; Li, SS; Zhou, W; Kang, ZJ; Zhang, QX; Kamran, M; Xu, J; Liang, DP; Wang, CL; Hou, ZJ; Wan, XB; Wang, HJ; Lam, EWF; Zhao, ZW; Liu, Q				Xu, L-Z; Li, S-S; Zhou, W.; Kang, Z-J; Zhang, Q-X; Kamran, M.; Xu, J.; Liang, D-P; Wang, C-L; Hou, Z-J; Wan, X-B; Wang, H-J; Lam, E. W-F; Zhao, Z-W; Liu, Q.			p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA	ONCOGENE			English	Article							TUBEROUS SCLEROSIS COMPLEX; C-MYC; PROSPECTIVE IDENTIFICATION; INITIATING CELLS; BINDING PROTEIN; AURORA KINASE; P62; EXPRESSION; PHOSPHORYLATION; OVEREXPRESSION	Aberrant p62 overexpression has been implicated in breast cancer development. Here, we found that p62 expression was elevated in breast cancer stem cells (BCSCs), including CD44(+)CD24(-) fractions, mammospheres, ALDH1(+) populations and side population cells. Indeed, short-hairpin RNA (shRNA)-mediated knockdown of p62 impaired breast cancer cells from self-renewing under anchorageindependent conditions, whereas ectopic overexpression of p62 enhanced the self-renewal ability of breast cancer cells in vitro. Genetic depletion of p62 robustly inhibited tumor-initiating frequencies, as well as growth rates of BCSC-derived tumor xenografts in immunodeficient mice. Consistently, immunohistochemical analysis of clinical breast tumor tissues showed that high p62 expression levels were linked to poorer clinical outcome. Further gene expression profiling analysis revealed that p62 was positively correlated with MYC expression level, which mediated the function of p62 in promoting breast cancer stem-like properties. MYC mRNA level was reduced upon p62 deletion by siRNA and increased with p62 overexpression in breast cancer cells, suggesting that p62 positively regulated MYC mRNA. Interestingly, p62 did not transactivate MYC promoter. Instead, p62 delayed the degradation of MYC mRNA by repressing the expression of let-7a and let-7b, thus promoting MYC mRNA stabilization at the post-transcriptional level. Consistently, let-7a and let-7b mimics attenuated p62-mediated MYC mRNA stabilization. Together, these findings unveiled a previously unappreciated role of p62 in the regulation of BCSCs, assigning p62 as a promising therapeutic target for breast cancer treatments.	[Xu, L-Z; Li, S-S; Zhou, W.; Kang, Z-J; Kamran, M.; Xu, J.; Liang, D-P; Wang, C-L; Hou, Z-J; Liu, Q.] Dalian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, 9 Western Sect,Lvshun South St, Dalian 116044, Liaoning, Peoples R China; [Xu, L-Z; Li, S-S; Zhou, W.; Kang, Z-J; Kamran, M.; Xu, J.; Liang, D-P; Wang, C-L; Hou, Z-J; Liu, Q.] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Q-X] Guangdong Pharmaceut Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wan, X-B] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Wang, H-J] Dalian Med Univ, Affiliated Hosp 1, Dept Breast Surg, Dalian, Peoples R China; [Lam, E. W-F] Imperial Coll London, Dept Surg & Canc, London, England; [Zhao, Z-W] Dalian Med Univ, Affiliated Hosp 2, Dept Breast Surg, 467 Zhongshan Rd, Dalian 116000, Liaoning, Peoples R China	Dalian Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Guangdong Pharmaceutical University; Sun Yat Sen University; Dalian Medical University; Imperial College London; Dalian Medical University	Liu, Q (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, 9 Western Sect,Lvshun South St, Dalian 116044, Liaoning, Peoples R China.; Zhao, ZW (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Breast Surg, 467 Zhongshan Rd, Dalian 116000, Liaoning, Peoples R China.	dlzhaozw@163.com; liuq9@mail.sysu.edu.cn	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; KAMRAN, MUHAMMAD/0000-0002-5157-5459	National Basic Research Program of China (973 Program) [2012CB967000]; National Natural Science Foundation of China [81573025, 81201686, 81402445]; National Natural Science Foundation of Liaoning [NSF2014029102]; CRUK [A12011]; Breast Cancer Now [2012MayPR070, 2012NovPhD016]; MRC [MR/N012097/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish; Medical Research Council [MR/N012097/1] Funding Source: researchfish	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Liaoning; CRUK(Cancer Research UK); Breast Cancer Now; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Quentin Liu's laboratory members for their critical commends and technical support. We also thank them for their critical reading of the manuscript. This work is supported by the National Basic Research Program of China (973 Program; No. 2012CB967000 to QL), National Natural Science Foundation of China (No. 81573025 to QL), the Liaoning (NSF2014029102 to QL), National Natural Science Foundation of China (No. 81201686 to JX), National Natural Science Foundation of China (No. 81402445 to C- LW). EW-FL's work is supported by CRUK (A12011) and Breast Cancer Now (2012MayPR070; 2012NovPhD016). See Supplementary Materials and Methods.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Filipova A, 2014, TUMORI J, V100, P363, DOI 10.1700/1636.17886; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gaffan J, 2006, J CLIN ONCOL, V24, P1932, DOI 10.1200/JCO.2005.02.6617; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Ioannidis P, 2003, ANTICANCER RES, V23, P2179; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lafon I, 1998, ONCOGENE, V16, P3413, DOI 10.1038/sj.onc.1201895; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Lin Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-59; Linares JF, 2011, MOL CELL BIOL, V31, P105, DOI 10.1128/MCB.00620-10; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Luo Rong-Zhen, 2013, Onco Targets Ther, V6, P883, DOI 10.2147/OTT.S46222; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nigam A, 2013, INDIAN J SURG, V75, P170, DOI 10.1007/s12262-012-0616-3; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Wong TS, 2011, J CANCER RES CLIN, V137, P415, DOI 10.1007/s00432-010-0898-4; Xia MH, 2014, INT J ONCOL, V45, P2341, DOI 10.3892/ijo.2014.2669; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056919; Xu LZ, 2014, ONCOTARGET, V5, P7498, DOI 10.18632/oncotarget.2241; Yang XJ, 2015, ONCOL REP, V33, P1723, DOI 10.3892/or.2015.3757; Zheng FM, 2014, MOL CANCER THER, V13, P1991, DOI 10.1158/1535-7163.MCT-13-1029	62	52	53	2	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					304	317		10.1038/onc.2016.202	http://dx.doi.org/10.1038/onc.2016.202			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27345399	Green Published, hybrid			2022-12-26	WOS:000394166000002
J	Sircar, G; Jana, K; Dasgupta, A; Saha, S; Bhattacharya, SG				Sircar, Gaurab; Jana, Kuladip; Dasgupta, Angira; Saha, Sudipto; Bhattacharya, Swati Gupta			Epitope Mapping of Rhi o 1 and Generation of a Hypoallergenic Variant: A CANDIDATE MOLECULE FOR FUNGAL ALLERGY VACCINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergen; epitope mapping; immunoglobulin E (IgE); immunotherapy; mutagenesis; vaccine; asthma; mold allergy	B-CELL EPITOPES; BET V 1; MAJOR ALLERGEN; BIRCH POLLEN; IGE-BINDING; HYPERSENSITIVITY PNEUMONITIS; RECOMBINANT ALLERGENS; ASPERGILLUS-FUMIGATUS; RESPIRATORY ALLERGY; PREDICTION	Efficacy of allergen-specific immunotherapy is often severely impaired by detrimental IgE-mediated side effects of native allergen during vaccination. Here, we present the molecular determinants for IgE recognition of Rhi o 1 and eventually converting the allergen into a hypoallergenic immunogen to restrain health hazards during desensitization. Rhi o 1 is a respiratory fungal allergen. Despite having cross-reactivity with cockroach allergen, we observed that non-cross-reactive epitope predominantly determined IgE binding to Rhi o 1. Denaturation and refolding behavior of the allergen confirmed that its IgE reactivity was not essentially conformation-dependent. A combinatorial approach consisting of computational prediction and a peptide-based immunoassay identified two peptides ((44)TGEYLTQKYFNSQRNN and (311)GAEKNWAGQYVVDCNK) of Rhi o 1 that frequently reacted with IgE antibodies of sensitized patients. Interestingly, these peptides did not represent purely linear IgE epitopes but were presented in a conformational manner by forming a spatially clustered surface-exposed epitope conferring optimal IgE-binding capacity to the folded allergen. Site-directed alanine substitution identified four residues of the IgE epitope that were crucial for antibody binding. A multiple mutant (T49A/Y52A/K314A/W316A) showing 100-fold lower IgE binding and reduced allergenic activity was generated. The TYKW mutant retained T-cell epitopes, as evident from its lymphoproliferative capacity but down-regulated pro-allergic IL-5 secretion. The TYKW mutant induced enhanced focusing of blocking IgG antibodies specifically toward the IgE epitope of the allergen. Anti-TYKW mutant polyclonal IgG antibodies competitively inhibited binding of IgE antibodies to Rhi o 1 up to 70% and suppressed allergen-mediated histamine release by 10-fold. In conclusion, this is a simple yet rational strategy based on epitope mapping data to develop a genetically modified hypoallergenic variant showing protective antibody response for immunotherapeutic applications.	[Sircar, Gaurab; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, India; [Jana, Kuladip] Bose Inst, Div Mol Med, Centenary Bldg,P 1-12,CIT Rd,Scheme VIIM, Kolkata 700054, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Centenary Bldg,P 1-12,CIT Rd,Scheme VIIM, Kolkata 700054, India; [Dasgupta, Angira] BR Singh Hosp, Dept Chest Med, Kolkata 700014, India; [Dasgupta, Angira] Ctr Med Educ & Res, Kolkata 700014, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, India.	swati@jcbose.ac.in	Jana, Kuladip/GXG-3481-2022; Saha, Sudipto/AAF-1034-2020	Jana, Kuladip/0000-0003-4748-253X; Saha, Sudipto/0000-0001-9433-8894; Sircar, Gaurab/0000-0002-9067-4564	Department of Science and Technology, Government of India (Institutional Plan Project-1, Bose Institute); Council of Scientific and Industrial Research, Government of India [03/015(0414)/2011-EMR-I]; Department of Biotechnology, Government of India [BT/RLF/Re-entry/11/2011]	Department of Science and Technology, Government of India (Institutional Plan Project-1, Bose Institute); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a grant from the Department of Science and Technology, Government of India (Institutional Plan Project-1, Bose Institute). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Ph.D. Fellowship 03/015(0414)/2011-EMR-I from the Council of Scientific and Industrial Research, Government of India.; Recipient of Ramalingaswamy Fellowship BT/RLF/Re-entry/11/2011 from the Department of Biotechnology, Government of India.	Agarwal K, 2015, MYCOSES, V58, P531, DOI 10.1111/myc.12352; Banerjee B, 1999, INFECT IMMUN, V67, P2284, DOI 10.1128/IAI.67.5.2284-2291.1999; Bohle B, 2004, J IMMUNOL, V172, P6642, DOI 10.4049/jimmunol.172.11.6642; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852; Chen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034627; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chow LP, 2000, BIOCHEM J, V346, P423, DOI 10.1042/0264-6021:3460423; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Devars du Mayne Marie, 2015, Ear Nose Throat J, V94, pE17; Faerden K, 2014, INT J OCCUP ENV HEAL, V20, P167, DOI 10.1179/2049396714Y.0000000063; Flicker S, 2006, J ALLERGY CLIN IMMUN, V117, P1336, DOI 10.1016/j.jaci.2006.02.012; Focke-Tejkl M, 2015, J ALLERGY CLIN IMMUN, V135, P1207, DOI 10.1016/j.jaci.2014.09.012; Gafvelin G, 2007, J BIOL CHEM, V282, P3778, DOI 10.1074/jbc.M607938200; Ganguly HK, 2013, BIOCHEMISTRY-US, V52, P6348, DOI 10.1021/bi4007918; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; Gioulekas D, 2004, J INVEST ALLERG CLIN, V14, P225; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; KARLSSONBORGA A, 1989, ANN ALLERGY, V63, P521; Klaric MS, 2012, ANN AGR ENV MED, V19, P213; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kurup VP, 2003, PEPTIDES, V24, P179, DOI 10.1016/S0196-9781(03)00024-X; Kurup VP, 1998, PEPTIDES, V19, P1469, DOI 10.1016/S0196-9781(98)00113-2; Laffer S, 2003, BIOCHEM J, V373, P261, DOI 10.1042/BJ20030331; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Linhart B, 2015, J IMMUNOL, V194, P4008, DOI 10.4049/jimmunol.1400402; Marth K, 2013, J IMMUNOL, V190, P3068, DOI 10.4049/jimmunol.1202441; Matsuse H, 2013, ANN ALLERG ASTHMA IM, V111, P190, DOI 10.1016/j.anai.2013.06.022; Mueller GA, 2015, J ALLERGY CLIN IMMUN, V136, P1369, DOI 10.1016/j.jaci.2015.03.015; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; OCONNELL MA, 1995, J ALLERGY CLIN IMMUN, V95, P779, DOI 10.1016/S0091-6749(95)70188-5; Osborne NJ, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0572-7; Pedraza-Escalona M, 2009, MOL IMMUNOL, V46, P668, DOI 10.1016/j.molimm.2008.08.282; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Saha B, 2015, J PROTEOME RES, V14, P4823, DOI 10.1021/acs.jproteome.5b00657; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; Sircar G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144547; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Twaroch TE, 2015, ALLERGY ASTHMA IMMUN, V7, P205, DOI 10.4168/aair.2015.7.3.205; Valenta R, 2016, J ALLERGY CLIN IMMUN, V137, P351, DOI 10.1016/j.jaci.2015.12.1299; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Woodfolk JA, 2016, J BIOL CHEM, V291, P2288, DOI 10.1074/jbc.M115.702324; Yu CJ, 2002, BIOCHEM J, V363, P707, DOI 10.1042/bj3630707; Zhang YX, 2005, J OCCUP HEALTH, V47, P181, DOI 10.1539/joh.47.181	51	20	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18016	18029		10.1074/jbc.M116.732032	http://dx.doi.org/10.1074/jbc.M116.732032			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358405	hybrid, Green Published			2022-12-26	WOS:000383241300043
J	Fukui, K; Baba, S; Kumasaka, T; Yano, T				Fukui, Kenji; Baba, Seiki; Kumasaka, Takashi; Yano, Takato			Structural Features and Functional Dependency on -Clamp Define Distinct Subfamilies of Bacterial Mismatch Repair Endonuclease MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; DNA binding protein; DNA mismatch repair; endonuclease; x-ray crystallography; MutL; clamp	C-TERMINAL DOMAIN; STRAND-DISCRIMINATION; ALPHA; PROTEIN; RIBONUCLEOTIDES; REPLICATION; ACTIVATION; MLH1-MLH3; SIGNALS; SYSTEM	In early reactions of DNA mismatch repair, MutS recognizes mismatched bases and activates MutL endonuclease to incise the error-containing strand of the duplex. DNA sliding clamp is responsible for directing the MutL-dependent nicking to the newly synthesized/error-containing strand. In Bacillus subtilis MutL, the -clamp-interacting motif ( motif) of the C-terminal domain (CTD) is essential for both in vitro direct interaction with -clamp and in vivo repair activity. A large cluster of negatively charged residues on the B. subtilis MutL CTD prevents nonspecific DNA binding until clamp interaction neutralizes the negative charge. We found that there are some bacterial phyla whose MutL endonucleases lack the motif. For example, the region corresponding to the motif is completely missing in Aquifex aeolicus MutL, and critical amino acid residues in the motif are not conserved in Thermus thermophilus MutL. We then revealed the 1.35 -resolution crystal structure of A. aeolicus MutL CTD, which lacks the motif but retains the metal-binding site for the endonuclease activity. Importantly, there was no negatively charged cluster on its surface. It was confirmed that CTDs of motif-lacking MutLs, A. aeolicus MutL and T. thermophilus MutL, efficiently incise DNA even in the absence of -clamp and that -clamp shows no detectable enhancing effect on their activity. In contrast, CTD of Streptococcus mutans, a motif-containing MutL, required -clamp for the digestion of DNA. We propose that MutL endonucleases are divided into three subfamilies on the basis of their structural features and dependence on -clamp.	[Fukui, Kenji; Yano, Takato] Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan; [Baba, Seiki; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Sayo, Hyogo 6795198, Japan	Osaka Medical College; Japan Synchrotron Radiation Research Institute	Fukui, K; Yano, T (corresponding author), 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	k.fukui@osaka-med.ac.jp; med013@osaka-med.ac.jp	Kumasaka, Takashi/D-7428-2018	Kumasaka, Takashi/0000-0001-9289-1557; baba, seiki/0000-0002-2589-232X; Fukui, Kenji/0000-0003-2463-7578	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26850050]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 26850050 (to K. F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banasik M, 2014, MUTAT RES-FUND MOL M, V769, P69, DOI 10.1016/j.mrfmmm.2014.07.006; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Correa EME, 2011, DNA REPAIR, V10, P1106, DOI 10.1016/j.dnarep.2011.08.007; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Friedhoff P, 2016, DNA REPAIR, V38, P50, DOI 10.1016/j.dnarep.2015.11.013; Fukui K, 2011, DNA REPAIR PATHWAY F, P123; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Guarne A, 2015, PROG BIOPHYS MOL BIO, V117, P149, DOI 10.1016/j.pbiomolbio.2015.02.002; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mizushima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098554; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Namadurai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013726; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pillon MC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv918; Pillon MC, 2011, DNA REPAIR, V10, P87, DOI 10.1016/j.dnarep.2010.10.003; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Ranjha L, 2014, J BIOL CHEM, V289, P5674, DOI 10.1074/jbc.M113.533810; Repmann S, 2015, J BIOL CHEM, V290, P9986, DOI 10.1074/jbc.M114.629907; Rogacheva MV, 2014, J BIOL CHEM, V289, P5664, DOI 10.1074/jbc.M113.534644; Shimada A, 2013, FEBS J, V280, P3467, DOI 10.1111/febs.12344; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto T, 2011, J BIOL CHEM, V286, P42337, DOI 10.1074/jbc.M111.277335; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	59	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16990	17000		10.1074/jbc.M116.739664	http://dx.doi.org/10.1074/jbc.M116.739664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27369079	hybrid, Green Published			2022-12-26	WOS:000382643800006
J	Patil, N; Skjonsfjell, ETB; Van den Brande, N; Panduro, EAC; Claessens, R; Guizar-Sicairos, M; Van Mele, B; Breiby, DW				Patil, Nilesh; Skjonsfjell, Eirik Torbjorn Bakken; Van den Brande, Niko; Panduro, Elvia Anabela Chavez; Claessens, Raf; Guizar-Sicairos, Manuel; Van Mele, Bruno; Breiby, Dag Werner			X-Ray Nanoscopy of a Bulk Heterojunction	PLOS ONE			English	Article							POLYMER SOLAR-CELLS; SELF-ORGANIZATION; PHASE RETRIEVAL; THIN-FILMS; MICROSCOPY; BLENDS; PERFORMANCE; MORPHOLOGY; RESOLUTION; DIFFUSION	Optimizing the morphology of bulk heterojunctions is known to significantly improve the photovoltaic performance of organic solar cells, but available quantitative imaging techniques are few and have severe limitations. We demonstrate X-ray ptychographic coherent diffractive imaging applied to all-organic blends. Specifically, the phase-separated morphology in bulk heterojunction photoactive layers for organic solar cells, prepared from a 50: 50 blend of poly(3-hexylthiophene) (P3HT) and phenyl-C61-butyric acid methyl ester (PCBM) and thermally treated for different annealing times is imaged to high resolution. Moreover, using a fast-scanning calorimetry chip setup, the nano-morphological changes caused by repeated thermal annealing applied to the same sample could be monitored. X-ray ptychography resolves to better than 100 nm the phase-segregated domains of electron donor and electron acceptor materials over a large field of view within the active layers. The quantitative phase contrast images further allow us to estimate the local volume fraction of PCBM across the photovoltaically active layers. The volume fraction gradient for different regions provides insight on the PCBM diffusion across the depletion zone surrounding PCBM aggregates. Phase contrast X-ray microscopy is under rapid development, and the results presented here are promising for future studies of organic-organic blends, also under in situ conditions, e.g., for monitoring the structural stability during UV-Vis irradiation.	[Patil, Nilesh; Skjonsfjell, Eirik Torbjorn Bakken; Panduro, Elvia Anabela Chavez; Breiby, Dag Werner] Norwegian Univ Sci & Technol NTNU, Dept Phys, N-7491 Trondheim, Norway; [Van den Brande, Niko; Claessens, Raf; Van Mele, Bruno] Vrije Univ Brussel, Phys Chem & Polymer Sci FYSC, B-1050 Brussels, Belgium; [Guizar-Sicairos, Manuel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Breiby, Dag Werner] Univ Coll Southeast Norway, Dept Micro & Nanosyst Technol IMST, Campus Vestfold, N-3184 Borre, Norway	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Brussel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University College of Southeast Norway	Patil, N; Breiby, DW (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Phys, N-7491 Trondheim, Norway.; Breiby, DW (corresponding author), Univ Coll Southeast Norway, Dept Micro & Nanosyst Technol IMST, Campus Vestfold, N-3184 Borre, Norway.	nilesh.v.patil@ntnu.no; dag.breiby@ntnu.no	Guizar-Sicairos, Manuel/I-4899-2013; Guizar-Sicairos, Manuel/AAB-3793-2019; Patil, Nilesh/A-2897-2012; Van Mele, Bruno/AAU-2109-2021	Guizar-Sicairos, Manuel/0000-0002-8293-3634; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Patil, Nilesh/0000-0002-5130-689X; Claessens, Raf/0000-0002-5157-0359; Skjonsfjell, Eirik/0000-0002-6130-5348; Van den Brande, Niko/0000-0002-5324-6261	European Community [262348]; EU [234648/O70]; Norwegian PhD Network on Nanotechnology for Microsystems - Research Council of Norway, Division for Science [221860/F40]	European Community(European Commission); EU(European Commission); Norwegian PhD Network on Nanotechnology for Microsystems - Research Council of Norway, Division for Science	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 262348 (for ESMI). The M-ERA. NET project "RADESOL" is funded under the EU Seventh Framework Programme (FP7/2007-2013), grant agreement no. 234648/O70. Partial funding for this work was obtained from Norwegian PhD Network on Nanotechnology for Microsystems, sponsored by the Research Council of Norway, Division for Science, contract no. 221860/F40.	Aasmundtveit KE, 1999, SYNTHETIC MET, V101, P561, DOI 10.1016/S0379-6779(98)00315-4; Als-Nielsen J., 2011, ELEMENTS MODERN XRAY, DOI 10.1002/9781119998365; Berriman GA, 2015, AIP ADV, V5, DOI 10.1063/1.4932212; Bo Floystad J., 2015, ADV ENG MATER, V17, P545; Boudouris BW, 2011, MACROMOLECULES, V44, P6653, DOI 10.1021/ma201316a; Breiby DW, 2008, J APPL CRYSTALLOGR, V41, P262, DOI 10.1107/S0021889808001064; Burke KB, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265710; Campoy-Quiles M, 2008, NAT MATER, V7, P158, DOI 10.1038/nmat2102; Chen DA, 2011, NANO LETT, V11, P561, DOI 10.1021/nl103482n; Chiu MY, 2008, ADV MATER, V20, P2573, DOI 10.1002/adma.200703097; Chushkin Y, 2014, J SYNCHROTRON RADIAT, V21, P594, DOI 10.1107/S1600577514003440; Coffey DC, 2007, NANO LETT, V7, P738, DOI 10.1021/nl062989e; Collins BA, 2012, NAT MATER, V11, P536, DOI [10.1038/nmat3310, 10.1038/NMAT3310]; Collins BA, 2010, J PHYS CHEM LETT, V1, P3160, DOI 10.1021/jz101276h; Esmaeili M, 2013, MACROMOLECULES, V46, P434, DOI 10.1021/ma3021163; Felten A, 2007, NANO LETT, V7, P2435, DOI 10.1021/nl071134e; Giewekemeyer K, 2011, OPT EXPRESS, V19, P1037, DOI 10.1364/OE.19.001037; Grevin B, 2003, J CHEM PHYS, V118, P7097, DOI 10.1063/1.1561435; Guizar-Sicairos M, 2008, OPT EXPRESS, V16, P7264, DOI 10.1364/OE.16.007264; Guizar-Sicairos M, 2014, OPT EXPRESS, V22, P14859, DOI 10.1364/OE.22.014859; Guizar-Sicairos M, 2011, OPT EXPRESS, V19, P21345, DOI 10.1364/OE.19.021345; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; Holler M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03857; Hoppe H, 2004, ADV FUNCT MATER, V14, P1005, DOI 10.1002/adfm.200305026; Hoydalsvik K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4884598; Huang XJ, 2014, OPT EXPRESS, V22, P12634, DOI 10.1364/OE.22.012634; Klimov E, 2006, MACROMOLECULES, V39, P4493, DOI 10.1021/ma052590x; Krebs FC, 2009, J MATER CHEM, V19, P5442, DOI 10.1039/b823001c; Labram JG, 2011, ADV ENERGY MATER, V1, P1176, DOI 10.1002/aenm.201100413; Labram JG, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075344; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Li G, 2012, NAT PHOTONICS, V6, P153, DOI [10.1038/NPHOTON.2012.11, 10.1038/nphoton.2012.11]; McNeill CR, 2007, MACROMOLECULES, V40, P3263, DOI 10.1021/ma070132d; McNeill CR, 2006, SMALL, V2, P1432, DOI 10.1002/smll.200600300; McNeill CR, 2006, NANO LETT, V6, P1202, DOI 10.1021/nl060583w; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Nguyen LH, 2007, ADV FUNCT MATER, V17, P1071, DOI 10.1002/adfm.200601038; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Pedersen EBL, 2015, NANOSCALE, V7, P13765, DOI 10.1039/c5nr02824h; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Shapiro DA, 2014, NAT PHOTONICS, V8, P765, DOI [10.1038/nphoton.2014.207, 10.1038/NPHOTON.2014.207]; Swinnen A, 2006, ADV FUNCT MATER, V16, P760, DOI 10.1002/adfm.200500812; Thibault P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063004; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Treat ND, 2013, MACROMOLECULES, V46, P1002, DOI 10.1021/ma302337p; van Bavel SS, 2009, NANO LETT, V9, P507, DOI 10.1021/nl8014022; Van den Brande N, 2015, POLYMER, V57, P39, DOI 10.1016/j.polymer.2014.12.015; Van den Brande N, 2015, CRYST GROWTH DES, V15, P5614, DOI 10.1021/acs.cgd.5b01331; Vila-Comamala J, 2011, OPT EXPRESS, V19, P21333, DOI 10.1364/OE.19.021333; Watts B, 2009, MACROMOLECULES, V42, P8392, DOI 10.1021/ma901444u; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wodo O, 2013, ENERG ENVIRON SCI, V6, P3060, DOI 10.1039/c3ee41224e; Yang X, 2007, MACROMOLECULES, V40, P1353, DOI 10.1021/ma0618732; Zhao JB, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.27	56	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158345	10.1371/journal.pone.0158345	http://dx.doi.org/10.1371/journal.pone.0158345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367796	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900029
J	Yean, CYS; Raju, KS; Xavier, R; Subramaniam, S; Gopinath, SCB; Chinni, SV				Yean, Cheryl Yeap Soo; Raju, Kishanraj Selva; Xavier, Rathinam; Subramaniam, Sreeramanan; Gopinath, Subash C. B.; Chinni, Suresh V.			Molecular Detection of Methicillin-Resistant Staphylococcus aureus by Non-Protein Coding RNA-Mediated Monoplex Polymerase Chain Reaction	PLOS ONE			English	Article							LEVEL MUPIROCIN RESISTANCE; EXFOLIATIVE TOXINS; BACILLUS-SUBTILIS; NONCODING RNAS; MULTIPLEX PCR; MESSENGER-RNA; HUT OPERON; DNA PROBE; GENE; IDENTIFICATION	Non-protein coding RNA (npcRNA) is a functional RNA molecule that is not translated into a protein. Bacterial npcRNAs are structurally diversified molecules, typically 50-200 nucleotides in length. They play a crucial physiological role in cellular networking, including stress responses, replication and bacterial virulence. In this study, by using an identified npcRNA gene (Sau-02) in Methicillin-resistant Staphylococcus aureus (MRSA), we identified the Gram-positive bacteria S. aureus. A Sau-02-mediated monoplex Polymerase Chain Reaction (PCR) assay was designed that displayed high sensitivity and specificity. Fourteen different bacteria and 18 S. aureus strains were tested, and the results showed that the Sau-02 gene is specific to S. aureus. The detection limit was tested against genomic DNA from MRSA and was found to be similar to 10 genome copies. Further, the detection was extended to whole-cell MRSA detection, and we reached the detection limit with two bacteria. The monoplex PCR assay demonstrated in this study is a novel detection method that can replicate other npcRNA-mediated detection assays.	[Yean, Cheryl Yeap Soo; Raju, Kishanraj Selva; Xavier, Rathinam; Chinni, Suresh V.] AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Malaysia; [Subramaniam, Sreeramanan] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia	AIMST University; Universiti Sains Malaysia; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Chinni, SV (corresponding author), AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Malaysia.	v_suresh@aimst.edu.my	Chinni, Venkata Suresh/A-7313-2011; Raju, Kishan Raj Selva/AAV-1811-2020; Subramaniam, Sreeramanan/AAA-5094-2022; Subramaniam, Sreeramanan Sree/I-1130-2012; Yeap, Cheryl S.Y./AAY-4517-2021; Gopinath, Subash/D-2953-2015	Raju, Kishan Raj Selva/0000-0003-2874-7440; Subramaniam, Sreeramanan Sree/0000-0003-4392-285X; Yeap, Cheryl S.Y./0000-0002-7384-9254; Gopinath, Subash/0000-0002-8347-4687; Suresh Chinni, Venkata/0000-0002-4697-2994	Fundamental Research Grant Scheme (Ministry of Higher Education, Malaysia) [FRGS/1/2014/SG03/AIMST/02/2]	Fundamental Research Grant Scheme (Ministry of Higher Education, Malaysia)	SVC thanks Fundamental Research Grant Scheme (FRGS/1/2014/SG03/AIMST/02/2, Ministry of Higher Education, Malaysia (http://portal.mygrants.gov.my/main.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; ARCHER GL, 1990, ANTIMICROB AGENTS CH, V34, P1720, DOI 10.1128/AAC.34.9.1720; Chen C, 2015, INFECT IMMUN, V83, P3302, DOI 10.1128/IAI.00159-15; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; Delport JA, 2016, J MED MICROBIOL; Fournier P-E, 2014, GENOME MED, P6; Gopinath SCB, 2008, NUCLEIC ACIDS RES, V36, P3463, DOI 10.1093/nar/gkn199; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; HODGSON JE, 1994, ANTIMICROB AGENTS CH, V38, P1205, DOI 10.1128/AAC.38.5.1205; Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426, DOI 10.1128/JCM.29.3.426-430.1991; Krishnan PU, 2002, J CLIN PATHOL, V55, P745, DOI 10.1136/jcp.55.10.745; Kumarevel TS, 2004, NUCLEIC ACIDS RES, V32, P3904, DOI 10.1093/nar/gkh725; Lakshmipriya T, 2013, ANALYST, V138, P2863, DOI 10.1039/c3an00298e; LIGOZZI M, 1991, ANTIMICROB AGENTS CH, V35, P575, DOI 10.1128/AAC.35.3.575; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Nadzirah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139766; Nithya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118668; Panda RK, 2016, J CLIN DIAGN RES, V10, pDC19, DOI 10.7860/JCDR/2016/17476.7278; PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582; Perumal V, 2016, BIOSENS BIOELECTRON, V78, P14, DOI 10.1016/j.bios.2015.10.083; Pillai Manju M, 2012, J Lab Physicians, V4, P83, DOI 10.4103/0974-2727.105587; Proctor R. A., 2014, FRONT CELL INFECT MI, V4, DOI [10.3389/fcimb.2014.0009925120957, DOI 10.3389/FCIMB.2014.0009925120957]; Rasmussen AKI, 2010, J CLIN MICROBIOL, V48, P4253, DOI 10.1128/JCM.00088-10; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Seyedmonir E, 2015, B ENVIRON CONTAM TOX, V95, P131, DOI 10.1007/s00128-015-1510-z; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; UNAL S, 1992, J CLIN MICROBIOL, V30, P1685, DOI 10.1128/JCM.30.7.1685-1691.1992; VANNUFFEL P, 1995, J CLIN MICROBIOL, V33, P2864, DOI 10.1128/JCM.33.11.2864-2867.1995; Vannuffel P, 1998, J CLIN MICROBIOL, V36, P2366, DOI 10.1128/JCM.36.8.2366-2368.1998; Vijian D, 2016, BIOSENS BIOELECTRON, V77, P805, DOI 10.1016/j.bios.2015.10.057; Xu Z, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00947; Zhao WH, 2010, CRIT REV MICROBIOL, V36, P245, DOI 10.3109/1040841X.2010.481763	39	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158736	10.1371/journal.pone.0158736	http://dx.doi.org/10.1371/journal.pone.0158736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367909	Green Submitted, Green Published, gold			2022-12-26	WOS:000378914900051
J	de Castro, DB; Pinto, RC; de Albuquerque, BC; Sadahiro, M; Braga, JU				de Castro, Daniel Barros; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio; Sadahiro, Megumi; Braga, Jose Ueleres			The Socioeconomic Factors and the Indigenous Component of Tuberculosis in Amazonas	PLOS ONE			English	Article							SOCIAL DETERMINANTS; BRAZILIAN AMAZON; RISK-FACTORS	Despite the availability of tuberculosis prevention and control services throughout Amazonas, high rates of morbidity and mortality from tuberculosis remain in the region. Knowledge of the social determinants of tuberculosis in Amazonas is important for the establishment of public policies and the planning of effective preventive and control measures for the disease. To analyze the relationship of the spatial distribution of the incidence of tuberculosis in municipalities and regions of Amazonas to the socioeconomic factors and indigenous tuberculosis component, from 2007 to 2013. An ecological study was conducted based on secondary data from the epidemiological surveillance of tuberculosis. A linear regression model was used to analyze the relationship of the annual incidence of tuberculosis to the socioeconomic factors, performance indicators of health services, and indigenous tuberculosis component. The distribution of the incidence of tuberculosis in the municipalities of Amazonas was positively associated with the Gini index and the population attributable fraction of tuberculosis in the indigenous peoples, but negatively associated with the proportion of the poor and the unemployment rate. The spatial distribution of tuberculosis in the different regions of Amazonas was heterogeneous and closely related with the socioeconomic factors and indigenous component of tuberculosis.	[de Castro, Daniel Barros; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio; Sadahiro, Megumi] Hlth Surveillance Fdn Amazonas State, Manaus, Amazonas, Brazil; [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] PVS PECTI SAUDE Res Fdn State Amazonas, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Braga, JU (corresponding author), Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), PVS PECTI SAUDE Res Fdn State Amazonas, Manaus, Amazonas, Brazil.	ueleres@gmail.com	Braga, Jose Ueleres/AAB-1326-2021	Braga, Jose Ueleres/0000-0001-5247-007X	Government of the State of Amazonas, through the Research Foundation of the State of Amazonas	Government of the State of Amazonas, through the Research Foundation of the State of Amazonas	This work was supported by the Government of the State of Amazonas, through the Research Foundation of the State of Amazonas, by providing scholarships. DBC is a fellow of the RH-PhD program from the Research Foundation for the State of Amazonas-FAPEAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante JM, 2000, B PNEUMOLOGIA SANITA, V8, P5; [Anonymous], 2012, CENS DEM 2010 CAR GE; Baruzzi R G, 2001, Cad Saude Publica, V17, P407, DOI 10.1590/S0102-311X2001000200015; Basta RC, 2006, INT J TUBERC LUNG D, V10, P1354; Bhargava A, 2014, NATL MED J INDIA, V27, P128; Braga JU, 2007, REV SAUDE PUBL, V41; Brasil, 2011, MAN REC CONTR TUB BR; Brasil, 2015, IND DES SIST UN SAUD; Brasil, 2014, 44 MIN SAUD; Buchillet, 1998, Cad Saude Publica, V14, P181, DOI 10.1590/S0102-311X1998000100026; Costa DC, 1987, CAD SAUDE PUBLICA, V3, P388; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Rios DPG, 2013, REV PANAM SALUD PUBL, V33, P22, DOI 10.1590/S1020-49892013000100004; Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008; Holtgrave DR, 2004, AM J PREV MED, V26, P159, DOI 10.1016/j.amepre.2003.10.014; Instituto Brasileiro de Geografiae Estatistica. (IBGE), 2013, PROJ POP BRAS UN FED; IPEA-INSTITUTO DE PESQUISA ECONOMICA APLICADA, 2017, IND DES HUM MUN BRAS; Kawatsu Lisa, 2015, Kekkaku, V90, P395; Leung CC, 2004, INT J TUBERC LUNG D, V8, P958; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Marreiro LS, 2003, TUBERCULOSE MANAUS E, V237; Nazareth T, 2011, REV PARANA DESENVOLV, P201; Programa das Nacoes Unidas para o desenvolvimento (PNUD), 2013, ATL DES HUM BRAS; Santos RV, 2011, CAD SAUDE PUBLICA, V27, P1049, DOI 10.1590/S0102-311X2011000600001; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; Suk JE, 2009, EMERG INFECT DIS, V15, P1812, DOI 10.3201/eid1511.090916; Tanrikulu AC, 2008, PUBLIC HEALTH, V122, P613, DOI 10.1016/j.puhe.2007.09.005; WHO, 2014, GLOB TUB REP 2014	28	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158574	10.1371/journal.pone.0158574	http://dx.doi.org/10.1371/journal.pone.0158574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362428	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200095
J	Dhawan, U; Pan, HA; Lee, CH; Chu, YH; Huang, GS; Lin, YR; Chen, WL				Dhawan, Udesh; Pan, Hsu An; Lee, Chia Hui; Chu, Ying Hao; Huang, Guewha Steven; Lin, Yan Ren; Chen, Wen Liang			Spatial Control of Cell-Nanosurface Interactions by Tantalum Oxide Nanodots for Improved Implant Geometry	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX STIFFNESS; OSTEOBLAST-LIKE CELLS; TOPOGRAPHICAL CONTROL; SURFACE-TOPOGRAPHY; CYTOCHALASIN-D; TITANIUM; NANOTOPOGRAPHY; ADHESION; MODULATION; INDUCTION	Nanotopological cues can be exploited to understand the nature of interactions between cells and their microenvironment to generate superior implant geometries. Nanosurface parameters which modulate the cell behavior and characteristics such as focal adhesions, cell morphology are not clearly understood. Here, we studied the role of different nanotopographic dimensions in modulating the cell behavior, characteristics and ultimately the cell fate and accordingly, a methodology to improve implant surface geometry is proposed. Tantalum oxide nanodots of 50, 100nm dot diameter with an inter-dot spacing of 20, 70nm and heights 40, 100nm respectively, were engineered on Silicon substrates. MG63 cells were cultured for 72 hours and the modulation in morphology, focal adhesions, cell extensible area, cell viability, transcription factors and genes responsible for bone protein secretion as a function of the nanodot diameter, inter-dot distance and nanodot height were evaluated. Nanodots of 50nm diameter with a 20nm inter-dot spacing and 40nm height enhanced cell spreading area by 40%, promoted cell viability by 70% and upregulated transcription factors and genes twice as much, as compared to the 100nm nanodots with 70nm inter-dot spacing and 100nm height. Favorable interactions between cells and all dimensions of 50nm nanodot diameter were observed, determined with Scanning electron microscopy and Immunofluorescence staining. Nanodot height played a vital role in controlling the cell fate. Dimensions of nanodot features which triggered a transition in cell characteristics or behavior was also defined through statistical analysis. The findings of this study provide insights in the parameters of nanotopographic features which can vitally control the cell fate and should therefore be taken into account when designing implant geometries.	[Dhawan, Udesh; Pan, Hsu An; Lee, Chia Hui; Chu, Ying Hao] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu, Taiwan; [Huang, Guewha Steven] Hokan Life Technol, Taichung, Taiwan; [Lin, Yan Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Lin, Yan Ren] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Yan Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Wen Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Kaohsiung Medical University; Chung Shan Medical University; National Yang Ming Chiao Tung University	Lin, YR (corresponding author), Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan.; Lin, YR (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Lin, YR (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, WL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	h6213.lac@gmail.com; wenurea@yahoo.com.tw	Lin, Yan-Ren/AAU-4136-2020; Ying-Hao, Chu/A-4204-2008	Lin, Yan-Ren/0000-0002-9015-2678; Ying-Hao, Chu/0000-0002-3435-9084; Dhawan, Udesh/0000-0002-0393-9414; Chen, Wen Liang/0000-0003-4308-3128	National Science Council of Taiwan, Republic of China [104-2314-B-271-010, 104-2622-E-009-016-CC2]	National Science Council of Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was funded by National Science Council of Taiwan, Republic of China grants 104-2314-B-271-010 and 104-2622-E-009-016-CC2. The commercial affiliation, Hokan Life Technology, did not provide any funding for conducting this study. This commercial affiliation did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation, Hokan Life Technology, did not provide financial support in the form of author' salaries and/or research materials. The specific role of the author, Guewha Steven Huang, is mentioned in the "authors' contribution" section.	Abrams GA, 2003, UROL RES, V31, P341, DOI 10.1007/s00240-003-0347-9; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; ARONSON AS, 1985, SKELETAL RADIOL, V14, P207, DOI 10.1007/BF00355566; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; Barthes J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/921905; Bencharit S, 2014, CLIN IMPLANT DENT R, V16, P817, DOI 10.1111/cid.12059; Bergmair I, 2010, MICROELECTRON ENG, V87, P1008, DOI 10.1016/j.mee.2009.11.109; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; CLARK P, 1987, DEVELOPMENT, V99, P439; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; Dhawan U, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0144-y; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hung YC, 2010, LAB CHIP, V10, P1189, DOI 10.1039/b921354f; Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4; Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim DH, 2012, IEEE INT C NAN; Kumar S, 2016, J BIOMED MATER RES B, V104, P732, DOI 10.1002/jbm.b.33549; Lee CH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-250; Lu J, 2012, TISSUE ENG PT A, V18, P1389, DOI [10.1089/ten.tea.2011.0268, 10.1089/ten.TEA.2011.0268]; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394; Nazneen F, 2012, J BIOMED MATER RES B, V100B, P1989, DOI 10.1002/jbm.b.32772; Paganias CG, 2012, INDIAN J ORTHOP, V46, P505, DOI 10.4103/0019-5413.101032; Pamukcu Guven E, 2013, J APPL ORAL SCI, V21, P351, DOI [10.1590/1679-775720130047, 10.1590/1678-775720130047]; Pan HA, 2013, BIOMATERIALS, V34, P841, DOI 10.1016/j.biomaterials.2012.09.078; Pan HA, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/33/335703; Pan HA, 2012, BIOMATERIALS, V33, P20, DOI 10.1016/j.biomaterials.2011.09.054; Pan HA, 2009, NANOSCALE RES LETT, V4, P903, DOI 10.1007/s11671-009-9333-7; Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Squire MW, 1996, BIOMATERIALS, V17, P725, DOI 10.1016/0142-9612(96)86743-3; Tamjid E, 2013, J BIOMED MATER RES A, V101, P2796, DOI 10.1002/jbm.a.34584; Tamplenizza M, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-35; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002; Wallace JM, 2010, LANGMUIR, V26, P7349, DOI 10.1021/la100006a; Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021; Zhao MZ, 2013, J MATER CHEM B, V1, P1926, DOI 10.1039/c3tb00266g	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158425	10.1371/journal.pone.0158425	http://dx.doi.org/10.1371/journal.pone.0158425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362432	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200073
J	Kang, YN; Li, H; Wu, J; Xu, XT; Sun, X; Zhao, XD; Xu, NJ				Kang, Yani; Li, Hua; Wu, Jun; Xu, Xiaoting; Sun, Xue; Zhao, Xiaodong; Xu, Nianjun			Transcriptome Profiling Reveals the Antitumor Mechanism of Polysaccharide from Marine Algae Gracilariopsis lemaneiformis	PLOS ONE			English	Article							RED ALGA; CANCER; APOPTOSIS; PRODUCTS; THERAPY	Seaweed is one of the important biomass producers and possesses active metabolites with potential therapeutic effects against tumors. The red alga Gracilariopsis lemaneiformis (Gp. lemaneiformis) possesses antitumor activity, and the polysaccharide of Gp. lemaneiformis (PGL) has been demonstrated to be an ingredient with marked anticancer activity. However, the anticancer mechanism of PGL remains to be elucidated. In this study, we analyzed the inhibitory effect of PGL on the cell growth of 3 human cancer cell lines and found that PGL inhibited cell proliferation, reduced cell viability, and altered cell morphology in a time- and concentration-dependent manner. Our transcriptome analysis indicates that PGL can regulate the expression of 758 genes, which are involved in apoptosis, the cell cycle, nuclear division, and cell death. Furthermore, we demonstrated that PGL induced apoptosis and cell cycle arrest and modulated the expression of related genes in the A549 cell line. Our work provides a framework to understand the effects of PGL on cancer cells, and can serve as a resource for delineating the antitumor mechanisms of Gp. lemaneiformis.	[Kang, Yani; Xu, Xiaoting; Sun, Xue; Xu, Nianjun] Ningbo Univ, Key Lab Marine Biotechnol Zhejiang Prov, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Kang, Yani; Li, Hua; Wu, Jun; Zhao, Xiaodong] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Sch Biomed Engn, BioID Ctr, Shanghai, Peoples R China	Ningbo University; Shanghai Jiao Tong University	Xu, NJ (corresponding author), Ningbo Univ, Key Lab Marine Biotechnol Zhejiang Prov, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China.	xunianjun@nbu.edu.cn	Kang, Yani/AAQ-1503-2020	Kang, Yani/0000-0002-6753-386X; LI, HUA/0000-0003-2153-2500	SMC-Morningstar Excellent Young Scholars Program of Shanghai Jiao Tong University [15X100090011]; National Natural Science Foundation of China [91229123, 41376151, 31072229, 31501054]	SMC-Morningstar Excellent Young Scholars Program of Shanghai Jiao Tong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by SMC-Morningstar Excellent Young Scholars Program of Shanghai Jiao Tong University (15X100090011) and National Natural Science Foundation of China (91229123, 41376151, 31072229 and 31501054).	Arakaki N, 2015, PHYTOTAXA, V208, P175, DOI 10.11646/phytotaxa.208.2.7; [陈美珍 CHEN Meizhen], 2008, [中国海洋药物, Chinese Journal of Marine Drugs], V27, P46; Cui L, 2013, J THORAC DIS, V5, P698, DOI 10.3978/j.issn.2072-1439.2013.10.10; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Raposo MFD, 2015, MAR DRUGS, V13, P2967, DOI 10.3390/md13052967; Fan YL, 2012, ADV MATER RES-SWITZ, V468-471, P1941, DOI 10.4028/www.scientific.net/AMR.468-471.1941; Han Z, 2015, PHYS CHEM CHEM PHYS, V17, P21576, DOI 10.1039/c5cp02139a; Harada H, 1997, BIOL PHARM BULL, V20, P541, DOI 10.1248/bpb.20.541; Hornburger MC, 2014, FASEB J, V28, P1938, DOI 10.1096/fj.13-235754; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indovina P, 2015, ONCOTARGET, V6, P17873, DOI 10.18632/oncotarget.4286; Kang Y, 2015, J FISHERIES CHINA, V39; Khanavi M, 2010, BIOL RES, V43, P31, DOI [10.4067/S0716-97602010000100005, /S0716-97602010000100005]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Landstrom FJ, 2015, ACTA OTO-LARYNGOL, V135, P1070, DOI 10.3109/00016489.2015.1049663; Li YH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0537-8; Liao XB, 2015, FOOD FUNCT, V6, P2542, DOI [10.1039/c4fo01185f, 10.1039/C4FO01185F]; [卢佳芳 LU Jia-Fang], 2009, [海洋与湖沼, Oceanologia et Limnologia Sinica], V40, P484; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Rodrigues D, 2015, MAR DRUGS, V13, P713, DOI 10.3390/md13020713; Ropellato J, 2015, CARBOHYD POLYM, V117, P476, DOI 10.1016/j.carbpol.2014.09.089; Sun Y, 2015, J BIOCH MOL TOXICOLO; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang XM, 2014, INT J BIOL MACROMOL, V69, P542, DOI 10.1016/j.ijbiomac.2014.06.017; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534; Xiong ZQ, 2013, MAR DRUGS, V11, P700, DOI 10.3390/md11030700; Yusup A, 2011, EVIDENCE BASED COMPL, V2012; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	31	18	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158279	10.1371/journal.pone.0158279	http://dx.doi.org/10.1371/journal.pone.0158279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355352	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400043
J	Paez-Ribes, M; Man, S; Xu, P; Kerbel, RS				Paez-Ribes, Marta; Man, Shan; Xu, Ping; Kerbel, Robert S.			Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note	PLOS ONE			English	Article							NUDE-MOUSE MODEL; PHASE-III; COLON-CANCER; MICE; COMBINATION; SUNITINIB; SPECIMENS; IMMUNODEFICIENCY; CAPECITABINE; PATHOLOGY	Several approaches are being evaluated to improve the historically limited value of studying transplanted primary tumors derived by injection of cells from established cell lines for predicting subsequent cancer therapy outcomes in patients and clinical trials. These approaches include use of genetically engineered mouse models (GEMMs) of spontaneous tumors, or patient tumor tissue derived xenografts (PDXs). Almost all such therapy studies utilizing such models involve treatment of established primary tumors. An alternative approach we have developed involves transplanted human tumor xenografts derived from established cell lines to treat mice with overt visceral metastases after primary tumor resection. The rationale is to mimic the more challenging circumstance of treating patients with late stage metastatic disease. These metastatic models entail prior in vivo selection of heritable, phenotypically stable variants with increased aggressiveness for spontaneous metastasis; they were derived by orthotopic injection of tumor cells followed by primary tumor resection and serial selection of distant spontaneous metastases, from which variant cell lines having a more aggressive heritable metastatic phenotype were established. We attempted to adopt this strategy for breast cancer PDXs. We studied five breast cancer PDXs, with the emphasis on two, called HCI-001 and HCI-002, both derived from triple negative breast cancer patients. However significant technical obstacles were encountered. These include the inherent slow growth rates of PDXs, the rarity of overt spontaneous metastases (detected in only 3 of 144 mice), very high rates of tumor regrowths at the primary tumor resection site, the failure of the few human PDX metastases isolated to manifest a more aggressive metastatic phenotype upon re-transplantation into new hosts, and the formation of metastases which were derived from de novo mouse thymomas arising in aged SCID mice that we used for the experiments. We discuss several possible strategies that may be employed to overcome these limitations. Uncovering the basis of the failure to detect a high rate of overt spontaneous distant metastases having a heritable phenotype in PDX models may reveal new insights into the biology and treatment of advanced metastatic disease.	[Paez-Ribes, Marta; Man, Shan; Xu, Ping; Kerbel, Robert S.] Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Kerbel, Robert S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Kerbel, RS (corresponding author), Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada.; Kerbel, RS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	robert.kerbel@sri.utoronto.ca			Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR); Beatriu de Pinos fellowship (Generalitat de Catalunya)	Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Beatriu de Pinos fellowship (Generalitat de Catalunya)(Generalitat de Catalunya)	This work was supported by grants from the Canadian Breast Cancer Foundation (CBCF), and the Canadian Institutes of Health Research (CIHR) to RSK. Additionally, author MPR was a recipient of a Beatriu de Pinos fellowship (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cassandra Cheng for her excellent secretarial assistance, Erin Smith-Silk for her excellent help with the animal work, Jordi Sol for his artistic contribution, Alana Welm for generously providing the PDX tumors used in this study and Florence TH Wu for critical reading of the manuscript and helpful suggestions. MPR was a recipient of a Beatriu de Pinos fellowship (Generalitat de Catalunya). This work was supported by grants from the Canadian Breast Cancer Foundation (CBCF), and the Canadian Institutes of Health Research (CIHR) to RSK.	Adelaye-Ogala RM SL, AACR ANN MEETING2015; An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Bayoumi Y, 2014, BREAST CANCER-TARGET, V6, P151, DOI 10.2147/BCTT.S69309; Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Crown JP, 2013, J CLIN ONCOL, V31, P2870, DOI 10.1200/JCO.2012.43.3391; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; CUSTER RP, 1985, AM J PATHOL, V120, P464; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dominici LS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3197; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, INT J CANCER, V53, P608, DOI 10.1002/ijc.2910530414; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117417; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Jedeszko C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010722; Kato C, 2009, LAB ANIM-UK, V43, P402, DOI 10.1258/la.2009.009012; Kerbel RS, 2015, NAT REV CLIN ONCOL, V12, P313, DOI 10.1038/nrclinonc.2015.89; Kerbel RS, 1990, ADV CANC RES; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Milsom CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071270; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; WAGHORNE C, 1988, CANCER RES, V48, P6109; WANG XE, 1992, ANTICANCER RES, V12, P1403; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158034	10.1371/journal.pone.0158034	http://dx.doi.org/10.1371/journal.pone.0158034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355476	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400025
J	Zhang, YZ; Mu, Q; Zhou, Z; Song, HB; Zhang, Y; Wu, F; Jiang, M; Wang, F; Zhang, W; Li, L; Shao, L; Wang, XL; Li, SW; Yang, LJ; Wu, Q; Zhang, MX; Tang, DQ				Zhang, Yuzhu; Mu, Qian; Zhou, Zheng; Song, Haibo; Zhang, Yuan; Wu, Fei; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Shao, Lei; Wang, Xingli; Li, Shiwu; Yang, Lijun; Wu, Qi; Zhang, Mingxiang; Tang, Dongqi			Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CIRCULATING IRISIN; OBESITY; PATHOPHYSIOLOGY; EXERCISE; FAMILY; INJURY; RISK; FLOW	Irisin, a newly discovered myokine, is considered as a promising candidate for the treatment of metabolic disturbances and cardiovascular diseases. In the present study, we used two animal models, apolipoprotein E-deficient mice fed on a high-cholesterol diet and a mouse carotid partial ligation model to test the anti-atherosclerotic effect of irisin. Irisin treatment (0.5 mu g/g body weight/day) significantly reduced the severity of aortic atherosclerosis in apolipoprotein E-deficient mice fed on a high-cholesterol diet and suppressed carotid neointima formation in a carotid partial ligation model. It was associated with decreased inflammation and cell apoptosis in aortic tissues. In addition, in a cell culture model, irisin restored ox-LDL-induced human umbilical vein endothelial cell dysfunction by reducing the levels of inflammatory genes via inhibiting the reactive oxygen species (ROS)/p38 MAPK/NF-kappa B signaling pathway activation and inhibiting cell apoptosis via up-regulating Bcl-2 and down-regulating Bax and caspase-3 expression. Our study demonstrated that irisin significantly reduced atherosclerosis in apolipoprotein E-deficient mice via suppressing ox-LDL-induced cell inflammation and apoptosis, which might have a direct therapeutic effect on atherosclerotic diseases.	[Zhang, Yuzhu; Mu, Qian; Song, Haibo; Zhang, Yuan; Wu, Fei; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Shao, Lei; Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan, Peoples R China; [Zhou, Zheng] Community Hlth Ctr Qingdao, Chaohu Rd, Qingdao, Peoples R China; [Wang, Xingli; Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Li, Shiwu; Yang, Lijun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Wu, Qi] Shandong Univ, Sch Med, Dept Anat, Jinan, Peoples R China	Shandong University; Shandong University; State University System of Florida; University of Florida; Shandong University	Tang, DQ (corresponding author), Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan, Peoples R China.	tangdq@sdu.edu.cn	Zhang, Yuan/B-3806-2019		Tai shan Scholar Fund; National Natural Science Foundation of China [81570407]; Major State Basic Research Development Program of China (973 Program) [2015CB553600]	Tai shan Scholar Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Tai shan Scholar Fund, the National Natural Science Foundation of China [81570407], and the Major State Basic Research Development Program of China (973 Program) [2015CB553600].	[Anonymous], 1996, JAMA, V276, P241; Aronis KN, 2015, INT J OBESITY, V39, P156, DOI 10.1038/ijo.2014.101; Belardinelli R, 2001, J AM COLL CARDIOL, V37, P1891, DOI 10.1016/S0735-1097(01)01236-0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chen CH, 2000, CIRCULATION, V101, P171, DOI 10.1161/01.CIR.101.2.171; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065477; Held C, 2012, EUR HEART J, V33, P452, DOI 10.1093/eurheartj/ehr432; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Nunez Gabriel, 1994, Trends in Cell Biology, V4, P399, DOI 10.1016/0962-8924(94)90053-1; Ou HC, 2009, J APPL PHYSIOL, V106, P1674, DOI 10.1152/japplphysiol.91415.2008; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2007, ROLE MYOKINES EXERCI, P1093; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rizza S, 2015, ATHEROSCLEROSIS, V239, P459, DOI 10.1016/j.atherosclerosis.2015.01.029; Saing L, 2016, CLIN EXP PHARM PHYSL, V43, P720, DOI [10.1111/1440-1681.12374, DOI 10.1111/1440-1681.12374]; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Stewart R, 2013, EUR HEART J, V34, P3286, DOI 10.1093/eurheartj/eht258; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Sullivan CJ, 2002, ARTERIOSCL THROM VAS, V22, P1100, DOI 10.1161/01.ATV.0000023230.17493.E3; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Tao LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026055; Xiang L, 2014, ATHEROSCLEROSIS, V235, P328, DOI 10.1016/j.atherosclerosis.2014.04.036; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	44	75	87	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158038	10.1371/journal.pone.0158038	http://dx.doi.org/10.1371/journal.pone.0158038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355581	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400026
J	Huh, Y; Yu, K; Park, W				Huh, Yong; Yu, Kiyun; Park, Woojin			Detecting Corresponding Vertex Pairs between Planar Tessellation Datasets with Agglomerative Hierarchical Cell-Set Matching	PLOS ONE			English	Article							REGISTRATION	This paper proposes a method to detect corresponding vertex pairs between planar tessellation datasets. Applying an agglomerative hierarchical co-clustering, the method finds geometrically corresponding cell-set pairs from which corresponding vertex pairs are detected. Then, the map transformation is performed with the vertex pairs. Since these pairs are independently detected for each corresponding cell-set pairs, the method presents improved matching performance regardless of locally uneven positional discrepancies between dataset. The proposed method was applied to complicated synthetic cell datasets assumed as a cadastral map and a topographical map, and showed an improved result with the F-measures of 0.84 comparing to a previous matching method with the F-measure of 0.48.	[Huh, Yong; Park, Woojin] Korea Cadastral Surveying Corp, Spatial Informat Res Inst, Seoul, South Korea; [Yu, Kiyun] Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, South Korea	Seoul National University (SNU)	Park, W (corresponding author), Korea Cadastral Surveying Corp, Spatial Informat Res Inst, Seoul, South Korea.	spinsgis@gmail.com			National Spatial Information Research Program - Ministry of Land, Infrastructure, and Transport of Korean government [15CHUD-C061156-05]; Korea Cadastral Surveying Corp.	National Spatial Information Research Program - Ministry of Land, Infrastructure, and Transport of Korean government; Korea Cadastral Surveying Corp.	This research was supported by a grant (15CHUD-C061156-05) from National Spatial Information Research Program funded by the Ministry of Land, Infrastructure, and Transport of Korean government and Korea Cadastral Surveying Corp. Korea Cadastral Surveying Corp. provided support in the form of salaries for some authors [YH, WP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contribution section.; This research was supported by a grant (15CHUD-C061156-05) from National Spatial Information Research Program funded by the Ministry of Land, Infrastructure, and Transport of Korean government and Korea Cadastral Surveying Corp. Korea Cadastral Surveying Corp. provided support in the form of salaries for some authors [YH, WP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bel Hadj Ali A, 2000, B INF IGN, V71, P33; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Butenuth M, 2007, ISPRS J PHOTOGRAMM, V62, P328, DOI 10.1016/j.isprsjprs.2007.04.003; Cho M., 2009, P 12 IEEE INT C COMP; Dhillon Inderiit S., 2001, P 7 ACM SIGKDD INT C; Gosseln G., 2003, P INT C NEXT GEN GEO; Huh Y, 2015, ISPRS INT GEO-INF, V4, P2061, DOI 10.3390/ijgi4042061; Huh Y, 2014, ISPRS J PHOTOGRAMM, V88, P60, DOI 10.1016/j.isprsjprs.2013.11.017; Huh Y, 2011, COMPUT ENVIRON URBAN, V35, P250, DOI 10.1016/j.compenvurbsys.2010.08.001; Li LN, 2011, INT J IMAGE DATA FUS, V2, P309, DOI 10.1080/19479832.2011.577458; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Min D, 2007, INT J GEOGR INF SCI, V21, P459, DOI 10.1080/13658810601073315; Rege M, 2008, DATA MIN KNOWL DISC, V16, P276, DOI 10.1007/s10618-008-0091-4; Reimann C, 2005, SCI TOTAL ENVIRON, V346, P1, DOI 10.1016/j.scitotenv.2004.11.023; SAMEH AH, 1982, SIAM J NUMER ANAL, V19, P1243, DOI 10.1137/0719089; Sharma A, 2010, P 11 EUR C COMP VIS; Walter V, 1999, INT J GEOGR INF SCI, V13, P445, DOI 10.1080/136588199241157; Wang CX, 2008, PHOTOGRAMM ENG REM S, V74, P25, DOI 10.14358/PERS.74.1.25; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	22	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157913	10.1371/journal.pone.0157913	http://dx.doi.org/10.1371/journal.pone.0157913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348229	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200021
J	Eboreime, J; Choi, SK; Yoon, SR; Arnheim, N; Calabrese, P				Eboreime, Jordan; Choi, Soo-Kung; Yoon, Song-Ro; Arnheim, Norman; Calabrese, Peter			Estimating Exceptionally Rare Germline and Somatic Mutation Frequencies via Next Generation Sequencing	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; ACCURACY; RECURRENCE; MOSAICISM; SELECTION; CAPTURE; CANCER; ERRORS; DAMAGE	We used targeted next generation deep-sequencing (Safe Sequencing System) to measure ultra-rare de novo mutation frequencies in the human male germline by attaching a unique identifier code to each target DNA molecule. Segments from three different human genes (FGFR3, MECP2 and PTPN11) were studied. Regardless of the gene segment, the particular testis donor or the 73 different testis pieces used, the frequencies for any one of the six different mutation types were consistent. Averaging over the C>T/G>A and G>T/C>A mutation types the background mutation frequency was 2.6x10(-5) per base pair, while for the four other mutation types the average background frequency was lower at 1.5x10(-6) per base pair. These rates far exceed the well documented human genome average frequency per base pair (similar to 10(-8)) suggesting a non-biological explanation for our data. By computational modeling and a new experimental procedure to distinguish between pre-mutagenic lesion base mismatches and a fully mutated base pair in the original DNA molecule, we argue that most of the base-dependent variation in background frequency is due to a mixture of deamination and oxidation during the first two PCR cycles. Finally, we looked at a previously studied disease mutation in the PTPN11 gene and could easily distinguish true mutations from the SSS background. We also discuss the limits and possibilities of this and other methods to measure exceptionally rare mutation frequencies, and we present calculations for other scientists seeking to design their own such experiments.	[Eboreime, Jordan; Choi, Soo-Kung; Yoon, Song-Ro; Arnheim, Norman; Calabrese, Peter] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Arnheim, N; Calabrese, P (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	arnheim@usc.edu; petercal@usc.edu		Arnheim, Norman/0000-0003-1247-1347	National Institute of General Medical Sciences [R01GM36745]; NIH [2 U42 OD011158]; National Cancer Institute [P30CA014089]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036745] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences under award number R01GM36745 (N.A. and P.C.). The authors also acknowledge the use of tissues procured by the National Disease Research Interchange (NDRI) with support from NIH grant 2 U42 OD011158. Finally, the project described was supported in part by award number P30CA014089 from the National Cancer Institute. All content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mawsawi LQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0124-6; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Chen-Harris H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-96; Choi SK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002420; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cover TM, 1991, ELEMENTS INFORM THEO, Vxxii; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Friedberg EC, 2006, DNA REPAIR MUTAGENES, Vxxix; Giannoulatou E, 2013, P NATL ACAD SCI USA, V110, P20152, DOI 10.1073/pnas.1311381110; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; Liu Q, 2000, BIOTECHNIQUES, V29, P1072, DOI 10.2144/00295rr03; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Schmitt MW, 2015, NAT METHODS, V12, P423, DOI [10.1038/nmeth.3351, 10.1038/NMETH.3351]; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; SLATKIN M, 1991, GENETICS, V129, P555; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Yoon SR, 2013, AM J HUM GENET, V92, P917, DOI 10.1016/j.ajhg.2013.05.001	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158340	10.1371/journal.pone.0158340	http://dx.doi.org/10.1371/journal.pone.0158340			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341568	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600052
J	Steinbaum, L; Njenga, SM; Kihara, J; Boehm, AB; Davis, J; Null, C; Pickering, AJ				Steinbaum, Lauren; Njenga, Sammy M.; Kihara, Jimmy; Boehm, Alexandria B.; Davis, Jennifer; Null, Clair; Pickering, Amy J.			Soil-Transmitted Helminth Eggs Are Present in Soil at Multiple Locations within Households in Rural Kenya	PLOS ONE			English	Article							ASCARIS-LUMBRICOIDES; TRICHURIS-TRICHIURA; SOUTH-AFRICA; CONTAMINATION; GEOPHAGY; INFECTIONS; SCHOOLCHILDREN; TRANSMISSION; HOOKWORM; CHILDREN	Almost one-quarter of the world's population is infected with soil-transmitted helminths (STH). We conducted a study to determine the prevalence and location of STH-Ascaris, Trichuris, and hookworm spp.-egg contamination in soil within rural household plots in Kenya. Field staff collected soil samples from July to September 2014 from the house entrance and the latrine entrance of households in Kakamega County; additional spatial sampling was conducted at a subset of households (N = 22 samples from 3 households). We analyzed soil samples using a modified version of the US Environmental Protection Agency (EPA) method for enumerating Ascaris in biosolids. We found 26.8% of households had one or more species of STH eggs present in the soil in at least one household location (n = 18 out of 67 households), and Ascaris was the most commonly detected STH (19.4%, n = 13 out of 67 households). Prevalence of STH eggs in soil was equally likely at the house entrance (19.4%, N = 67) as at the latrine entrance (11.3%, N = 62) (p = 0.41). We also detected STH eggs at bathing and food preparation areas in the three houses revisited for additional spatial sampling, indicating STH exposure can occur at multiple sites within a household plot, not just near the latrine. The highest concentration of eggs in one house occurred in the child's play area. Our findings suggest interventions to limit child exposure to household soil could complement other STH control strategies.	[Steinbaum, Lauren; Boehm, Alexandria B.; Davis, Jennifer; Pickering, Amy J.] Stanford Univ, Civil & Environm Engn, Stanford, CA 94305 USA; [Njenga, Sammy M.; Kihara, Jimmy] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Null, Clair] Mathematica Policy Res, Princeton, NJ USA; [Null, Clair] Innovat Poverty Act, New Haven, CT USA	Stanford University; Kenya Medical Research Institute; Mathematica; Innovations for Poverty Action (IPA)	Pickering, AJ (corresponding author), Stanford Univ, Civil & Environm Engn, Stanford, CA 94305 USA.	amyjanel@gmail.com		Null, Clair/0000-0003-0819-536X; Boehm, Alexandria/0000-0002-8162-5090; Njenga, Sammy/0000-0001-6309-476X	National Science Foundation [1000160864]; U.S. Agency for International Development Research and Innovation Fellowships Program [2000004603]; Stanford Center for African Studies Summer Graduate Student Research Grant Program; Bill and Melinda Gates Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Agency for International Development Research and Innovation Fellowships Program(United States Agency for International Development (USAID)); Stanford Center for African Studies Summer Graduate Student Research Grant Program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding was provided in the form of student fellowships to Lauren Steinbaum by the National Science Foundation Graduate Research Fellowship Program (1000160864; www.nsfgrfp.org), the U.S. Agency for International Development Research and Innovation Fellowships Program (2000004603, www.usaid.gov/RIFellowships), and the Stanford Center for African Studies Summer Graduate Student Research Grant Program (http://africanstudies.stanford.edu/fellowships/research_and_language_fellowships). This study was made possible by utilizing the data collection infrastructure established by the WASH Benefits Kenya study (the WASH Benefits study is supported by a grant from the Bill and Melinda Gates Foundation to UC Berkeley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTM, 2010, STAND TEST METH LAB; Baker SM, 2012, T ROY SOC TROP MED H, V106, P709, DOI 10.1016/j.trstmh.2012.08.002; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blaszkowska J, 2011, HELMINTHOLOGIA, V48, P67, DOI 10.2478/s11687-011-0012-8; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Chongsuvivatwong Virasakdi, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P64; Collender PA, 2015, TRENDS PARASITOL, V31, P625, DOI 10.1016/j.pt.2015.08.007; Fallah AA, 2012, FOOD CONTROL, V25, P617, DOI 10.1016/j.foodcont.2011.12.004; Geissler PW, 1997, TROP MED INT HEALTH, V2, P624, DOI 10.1046/j.1365-3156.1997.d01-345.x; Geissler PW, 1998, T ROY SOC TROP MED H, V92, P7, DOI 10.1016/S0035-9203(98)90934-8; George CM, 2015, AM J TROP MED HYG, V92, P1117, DOI 10.4269/ajtmh.14-0672; Gyoten J., 2010, Tropical Medicine and Health, V38, P35, DOI 10.2149/tmh.2010-01; Horiuchi S, 2013, TROP BIOMED, V30, P495; Legesse W, 2007, ETHIOP J HEAL DEV, V21, P18; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P471, DOI 10.1111/j.1365-3156.2004.01216.x; Mwandawiro CS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-198; Nchito M, 2004, T ROY SOC TROP MED H, V98, P218, DOI 10.1016/S0035-9203(03)00045-2; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Saathoff E, 2002, T ROY SOC TROP MED H, V96, P485, DOI 10.1016/S0035-9203(02)90413-X; SCHULZ S, 1992, J TROP MED HYG, V95, P95; Ulukanligil M, 2001, MEM I OSWALDO CRUZ, V96, P903, DOI 10.1590/S0074-02762001000700004; United States Environmental Protection Agency, 1999, TEST METH DET EN DET, P616; WONG MS, 1990, T ROY SOC TROP MED H, V84, P567, DOI 10.1016/0035-9203(90)90043-E; WONG MS, 1991, T ROY SOC TROP MED H, V85, P89, DOI 10.1016/0035-9203(91)90172-U	26	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157780	10.1371/journal.pone.0157780	http://dx.doi.org/10.1371/journal.pone.0157780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341102	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600017
J	Lei, WY; Chang, CY; Wu, JH; Lin, FH; Chen, CH; Chang, CF; Lin, YR; Wu, HP				Lei, Wei-Yuan; Chang, Chih-Yu; Wu, Jr-Hau; Lin, Fei-Hung; Chen, Cheng Hsu; Chang, Chin-Fu; Lin, Yan-Ren; Wu, Han-Ping			An Initial Attack of Urinary Stone Disease Is Associated with an Increased Risk of Developing New-Onset Irritable Bowel Syndrome: Nationwide Population-Based Study	PLOS ONE			English	Article							PURINERGIC MECHANOSENSORY TRANSDUCTION; VISCERO-VISCERAL HYPERALGESIA; URIC-ACID NEPHROLITHIASIS; CROSS-TALK; RAT MODEL; RECEPTORS; PAIN; PHYSIOLOGY; DISORDERS; SEROTONIN	Background The neurotransmitter pathways in irritable bowel syndrome (IBS) and urinary stone attacks are both related to serotonin, and each disease may be influenced by viscero-visceral hyperalgesia. However, the relationship between urinary tract stone disease and IBS has never been addressed. We aimed to investigate the risk of suffering new-onset IBS after an initial urinary stone attack using a nationwide database. Methods A study group enrolled a total of 13,254 patients who were diagnosed with an initial urinary stone attack; a comparison group recruited 39,762 matched non-urinary stone participants during 2003 and 2007. We followed each patient for 3 years to determine new-onset IBS. We also used Cox proportional hazards models to analyze the risk of IBS between the study and comparison groups after modified by demographics, residence, patient characteristics and personal histories. Results The occurrence rates of IBS were 3.3% (n = 440) and 2.6% (n = 1,034) respectively in the study and comparison groups. A covariate-adjusted hazard ratio (HR) of IBS in the study group that was 1.28 times greater (HR = 1.29, 95% CI, 1.15-1.44) than that in the comparison group was showed in the stratified Cox proportional analysis. The adjusted HRs of IBS did not decrease after considering demographics and past histories. The majority of IBS (30.5%) occurred within the first 6 months after the stone attack. Conclusion Patients with an initial urinary stone attack are at increased risk of developing new-onset IBS. The HRs of IBS did not decrease even after adjusting for patient demographics and past histories. Most importantly, 30.5% of IBS occurred within the first 6 months after the urinary stone attack.	[Lei, Wei-Yuan; Chang, Chih-Yu; Wu, Jr-Hau; Lin, Fei-Hung; Chen, Cheng Hsu; Chang, Chin-Fu; Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Chang, Chih-Yu] Natl Chiao Tung Univ, Dept Biol Sci & Technol Biochem Engn, Hsinchu, Taiwan; [Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Yan-Ren] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Wu, Han-Ping] Chang Gung Mem Hosp Linko, Dept Pediat, Div Pediat Gen Med, Taoyuan, Taiwan; [Wu, Han-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Changhua Christian Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University	Lin, YR (corresponding author), Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan.; Lin, YR (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Lin, YR (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Wu, HP (corresponding author), Chang Gung Mem Hosp Linko, Dept Pediat, Div Pediat Gen Med, Taoyuan, Taiwan.; Wu, HP (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	h6213.lac@gmail.com; arthur1226@gmail.com	Lin, Yan-Ren/AAU-4136-2020	Lin, Yan-Ren/0000-0002-9015-2678	Changhua Christian Hospital; National Science Council [MOST 104-2314-B-371-010]; National Changhua Christian Hospital, Chiao Tung University; National Chiao Tung University	Changhua Christian Hospital; National Science Council(Ministry of Science and Technology, Taiwan); National Changhua Christian Hospital, Chiao Tung University; National Chiao Tung University	The authors thank the National Chiao Tung University, Changhua Christian Hospital, and National Science Council (MOST 104-2314-B-371-010) for financially supporting this research.; We appreciated the National Changhua Christian Hospital, Chiao Tung University and National Science Council (MOST 104-2314-B-371-010) for financially supporting this research.	Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Barbara G, 2006, AM J GASTROENTEROL, V101, P1295, DOI 10.1038/ajg2006242; Bardhan KD, 2000, ALIMENT PHARM THERAP, V14, P23; Bianchi ML, 2010, ARCH BIOCHEM BIOPHYS, V503, P54, DOI 10.1016/j.abb.2010.06.026; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG658, DOI 10.1152/ajpgi.00585.2005; Burnstock G, 2001, DRUG DEVELOP RES, V52, P1, DOI 10.1002/ddr.1093; Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; CANN PA, 1983, GUT, V24, P405, DOI 10.1136/gut.24.5.405; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cooke HJ, 2003, NEWS PHYSIOL SCI, V18, P43, DOI 10.1152/nips.01411.2002; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Cremonini F, 2005, GASTROENTEROL CLIN N, V34, P189, DOI 10.1016/j.gtc.2005.02.008; Crowell MD, 2004, BRIT J PHARMACOL, V141, P1285, DOI 10.1038/sj.bjp.0705762; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Erdem E, 2005, DIGEST DIS SCI, V50, P605, DOI 10.1007/s10620-005-2482-3; Gaudreau GA, 2004, BEHAV BRAIN RES, V150, P185, DOI 10.1016/j.bbr.2003.07.004; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Gershon MD, 2000, CURR OPIN GASTROEN, V16, P113, DOI 10.1097/00001574-200003000-00004; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Greenwood-Van Meerveld B, 2007, NEUROGASTROENT MOTIL, V19, P13, DOI 10.1111/j.1365-2982.2007.00964.x; Houghton LA, 2000, ALIMENT PHARM THER, V14, P775; Hsu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070458; Hulisz Darrell, 2004, J Manag Care Pharm, V10, P299; Korkmaz Ahmet, 2009, Interdiscip Toxicol, V2, P219, DOI 10.2478/v10102-009-0020-4; Kuo CL, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-181; Laird JMA, 2002, J NEUROSCI, V22, P8352; Lamb K, 2006, AM J PHYSIOL-GASTR L, V290, pG451, DOI 10.1152/ajpgi.00353.2005; Leong SA, 2003, ARCH INTERN MED, V163, P929, DOI 10.1001/archinte.163.8.929; Lopopolo M, 2014, FUND CLIN PHARMACOL, V28, P331, DOI 10.1111/fcp.12038; Malykhina AP, 2006, NEUROGASTROENT MOTIL, V18, P936, DOI 10.1111/j.1365-2982.2006.00807.x; Mearin F, 2009, GASTROENT HEPAT-BARC, V32, P364, DOI 10.1016/j.gastrohep.2008.12.007; Nerli Rajendra, 2015, Adv Biomed Res, V4, P180, DOI 10.4103/2277-9175.164012; Pak CYC, 2003, UROLOGY, V61, P523, DOI 10.1016/S0090-4295(02)02421-4; Peng HY, 2009, PAIN, V142, P75, DOI 10.1016/j.pain.2008.11.017; Pezzone MA, 2005, GASTROENTEROLOGY, V128, P1953, DOI 10.1053/j.gastro.2005.03.008; Sakhaee K, 2002, KIDNEY INT, V62, P971, DOI 10.1046/j.1523-1755.2002.00508.x; Stanghellini V, 2002, AM J GASTROENTEROL, V97, P2738; Tillisch K, 2011, GASTROENTEROLOGY, V140, P407, DOI 10.1053/j.gastro.2010.12.014; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Turk C, 2015, EUR UROL, V4, pS0302; Wang Wei Feng, 2006, Chin J Dig Dis, V7, P211, DOI 10.1111/j.1443-9573.2006.00273.x; WHORWELL PJ, 1986, GUT, V27, P37, DOI 10.1136/gut.27.1.37; Yang TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000616; Yen CM, 2014, EUR J INTERN MED, V25, P87, DOI 10.1016/j.ejim.2013.10.009	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157701	10.1371/journal.pone.0157701	http://dx.doi.org/10.1371/journal.pone.0157701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337114	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200034
J	Shirasu, T; Koyama, H; Miura, Y; Hoshina, K; Kataoka, K; Watanabe, T				Shirasu, Takuro; Koyama, Hiroyuki; Miura, Yutaka; Hoshina, Katsuyuki; Kataoka, Kazunori; Watanabe, Toshiaki			Nanoparticles Effectively Target Rapamycin Delivery to Sites of Experimental Aortic Aneurysm in Rats	PLOS ONE			English	Article							POLYMERIC MICELLES; ANTITUMOR-ACTIVITY; IV COLLAGENASE; DOUBLE-BLIND; BLOOD; MODEL; LOCALIZATION; DEGENERATION; GELATINASE; INHIBITION	Several drugs targeting the pathogenesis of aortic aneurysm have shown efficacy in model systems but not in clinical trials, potentially owing to the lack of targeted drug delivery. Here, we designed a novel drug delivery system using nanoparticles to target the disrupted aortic aneurysm micro-structure. We generated poly(ethylene glycol)-shelled nanoparticles incorporating rapamycin that exhibited uniform diameter and long-term stability. When injected intravenously into a rat model in which abdominal aortic aneurysm (AAA) had been induced by infusing elastase, labeled rapamycin nanoparticles specifically accumulated in the AAA. Microscopic analysis revealed that rapamycin nanoparticles were mainly distributed in the media and adventitia where the wall structures were damaged. Co-localization of rapamycin nanoparticles with macrophages was also noted. Rapamycin nanoparticles injected during the process of AAA formation evinced significant suppression of AAA formation and mural inflammation at 7 days after elastase infusion, as compared with rapamycin treatment alone. Correspondingly, the activities of matrix metalloproteinases and the expression of inflammatory cytokines were significantly suppressed by rapamycin nanoparticle treatment. Our findings suggest that the nanoparticle-based delivery system achieves specific delivery of rapamycin to the rat AAA and might contribute to establishing a drug therapy approach targeting aortic aneurysm.	[Shirasu, Takuro; Koyama, Hiroyuki; Hoshina, Katsuyuki; Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo, Japan; [Koyama, Hiroyuki] Tokyo Univ Hosp, Translat Res Ctr, Tokyo 113, Japan; [Koyama, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Dept Vasc Surg, Saitama, Japan; [Miura, Yutaka; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Tokyo, Japan; [Miura, Yutaka; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan; [Miura, Yutaka; Kataoka, Kazunori] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; Saitama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Koyama, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo, Japan.; Koyama, H (corresponding author), Tokyo Univ Hosp, Translat Res Ctr, Tokyo 113, Japan.; Koyama, H (corresponding author), Saitama Med Univ, Saitama Med Ctr, Dept Vasc Surg, Saitama, Japan.	hkoyama-tky@umin.ac.jp	Miura, Yutaka/Q-8383-2018; Kataoka, Kazunori/K-7108-2012; Miura, Yutaka/AAT-5859-2020	Miura, Yutaka/0000-0002-0506-7138; Kataoka, Kazunori/0000-0002-8591-413X; Miura, Yutaka/0000-0002-0506-7138	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [23591859]	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program, no specific number) from the Japan Society for the Promotion of Science (JSPS) and Grants-in-Aid for Scientific Research (No. 23591859 to K.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; ANIDJAR S, 1992, J VASC SURG, V16, P139, DOI 10.1016/0741-5214(92)90101-D; [Anonymous], 2011, CIRCULATION, V124, P2020, DOI [10.1161/CIR.0b013e31822e80c3, DOI 10.1161/CIR.0B013E31822E80C3]; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Cabral H, 2005, J CONTROL RELEASE, V101, P223, DOI 10.1016/j.jconrel.2004.08.022; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Cabral H, 2007, J CONTROL RELEASE, V121, P146, DOI 10.1016/j.jconrel.2007.05.024; CAMPA JS, 1987, ATHEROSCLEROSIS, V65, P13, DOI 10.1016/0021-9150(87)90003-7; Choke E, 2006, ANN NY ACAD SCI, V1085, P315, DOI 10.1196/annals.1383.007; Crowe A, 1999, DRUG METAB DISPOS, V27, P627; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Dobrin P B, 1994, Cardiovasc Surg, V2, P484; Forrest ML, 2006, J CONTROL RELEASE, V110, P370, DOI 10.1016/j.jconrel.2005.10.008; Golledge J, 2010, CARDIOVASC DRUG THER, V24, P373, DOI 10.1007/s10557-010-6262-8; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Harada M, 2011, CANCER SCI, V102, P192, DOI 10.1111/j.1349-7006.2010.01745.x; Hartford CM, 2007, CLIN PHARMACOL THER, V82, P381, DOI 10.1038/sj.clpt.6100317; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; Karlsson L, 2009, J VASC SURG, V50, P23, DOI 10.1016/j.jvs.2008.12.048; KEEN RR, 1994, J VASC SURG, V20, P774, DOI 10.1016/S0741-5214(94)70165-2; Kurosawa K, 2013, CIRC J, V77, P2860, DOI 10.1253/circj.CJ-13-1252; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lawrence DM, 2004, J VASC SURG, V40, P334, DOI 10.1016/j.jvs.2004.05.020; Lindholt JS, 1999, INT ANGIOL, V18, P52; LopezCandales A, 1997, AM J PATHOL, V150, P993; MCMILLAN WD, 1995, J VASC SURG, V22, P295, DOI 10.1016/S0741-5214(95)70144-3; MCMILLAN WD, 1995, ARTERIOSCL THROM VAS, V15, P1139, DOI 10.1161/01.ATV.15.8.1139; Miura Y, 2013, ACS NANO, V7, P8583, DOI 10.1021/nn402662d; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Napoli KL, 1997, CLIN BIOCHEM, V30, P135, DOI 10.1016/S0009-9120(96)00157-9; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; Nishiyama N, 2003, CANCER RES, V63, P8977; Nooteboom A, 2002, CRIT CARE MED, V30, P2063, DOI 10.1097/00003246-200209000-00019; NUGENT LJ, 1984, J PHARMACOKINET BIOP, V12, P451, DOI 10.1007/BF01062668; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Reeps C, 2009, PATHOBIOLOGY, V76, P243, DOI 10.1159/000228900; Samson R, 2012, SEMIN VASC SURG, V25, P25, DOI 10.1053/j.semvascsurg.2012.03.004; Shiraya S, 2009, ATHEROSCLEROSIS, V202, P34, DOI 10.1016/j.atherosclerosis.2008.03.020; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Steinmetz EF, 2005, ANN SURG, V241, P92, DOI 10.1097/01.sla.0000150258.36236.e0; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Thompson Robert W, 2002, Curr Probl Surg, V39, P110, DOI 10.1067/msg.2002.121421; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tolg C, 2012, AM J PATHOL, V181, P1250, DOI 10.1016/j.ajpath.2012.06.036; Uchino H, 2005, BRIT J CANCER, V93, P678, DOI 10.1038/sj.bjc.6602772; Wassef M, 2001, J VASC SURG, V34, P730, DOI 10.1067/mva.2001.116966; Woo HN, 2012, INT J NANOMED, V7, P2197, DOI 10.2147/IJN.S29480; Yanez JA, 2008, CANCER CHEMOTH PHARM, V61, P133, DOI 10.1007/s00280-007-0458-z	52	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157813	10.1371/journal.pone.0157813	http://dx.doi.org/10.1371/journal.pone.0157813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336852	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200054
J	Lam, L; Chin, L; Halder, RC; Sagong, B; Famenini, S; Sayre, J; Montoya, D; Rubbi, L; Pellegrini, M; Fiala, M				Lam, Larry; Chin, Lydia; Halder, Ramesh C.; Sagong, Bien; Famenini, Sam; Sayre, James; Montoya, Dennis; Rubbi, Liudmilla; Pellegrini, Matteo; Fiala, Milan			Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients	FASEB JOURNAL			English	Article						inflammation; ALS; SOD-1	AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD TISSUE; DISEASE PROGRESSION; EXPRESSION ANALYSIS; REPEAT EXPANSION; SEQUENCING DATA; MOTOR-NEURONS; MUTANT SOD1; MAST-CELLS; RECEPTOR	We have investigated transcriptional and epigenetic differences in peripheral blood mononuclear cells (PBMCs) of monozygotic female twins discordant in the diagnosis of amyotrophic lateral sclerosis (ALS). Exploring DNA methylation differences by reduced representation bisulfite sequencing (RRBS), we determined that, over time, the ALS twin developed higher abundances of the CD14 macrophages and lower abundances of T cells compared to the non-ALS twin. Higher macrophage signature in the ALS twin was also shown by RNA sequencing (RNA-seq). Moreover, the twins differed in the methylome at loci near several genes, including EGFR and TNFRSF11A, and in the pathways related to the tretinoin and H3K27me3 markers. We also tested cytokine production by PBMCs. The ALS twin's PBMCs spontaneously produced IL-6 and TNF-alpha, whereas PBMCs of the healthy twin produced these cytokines only when stimulated by superoxide dismutase (SOD)-1. These results and flow cytometric detection of CD45 and CD127 suggest the presence of memory T cells in both twins, but effector T cells only in the ALS twin. The ALS twin's PBMC supernatants, but not the healthy twin's, were toxic to rat cortical neurons, and this toxicity was strongly inhibited by an IL-6 receptor antibody (tocilizumab) and less well by TNF-alpha and TNF-beta antibodies. The putative neurotoxicity of IL-6 and TNF-alpha is in agreement with a high expression of these cytokines on infiltrating macrophages in the ALS spinal cord. We hypothesize that higher macrophage abundance and increased neurotoxic cytokines have a fundamental role in the phenotype and treatment of certain individuals with ALS.	[Lam, Larry; Montoya, Dennis; Rubbi, Liudmilla; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, UCLA Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Chin, Lydia; Halder, Ramesh C.; Sagong, Bien; Famenini, Sam; Fiala, Milan] Univ Calif Los Angeles, UCLA Sch Med, Dept Surg, Los Angeles, CA USA; [Sayre, James] Univ Calif Los Angeles, UCLA Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Fiala, M (corresponding author), UCLA Sch Med, 100 UCLA Med Plaza,Suite 200, Los Angeles, CA 90095 USA.	fiala@mednet.ucla.edu		Fiala, Milan/0000-0001-8023-6053; Pellegrini, Matteo/0000-0001-9355-9564	U.S. National Institutes of Health (NIH) National Institute of Human Genome Research Grant [T32 HG008553-01]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [3P50AR063020-03S1]; Genentech, Inc. (South San Francisco, CA, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008553] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Human Genome Research Grant; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Genentech, Inc. (South San Francisco, CA, USA)(Roche HoldingGenentech); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Giovanni Coppola for genetic screening of the twins, Anna Caputo for testing toxicities of PBMC supernatants in rat neurons, Julian Whitelegge for fibrillary wild-type SOD-1, Larry Magpantay for testing cytokines, and Elizabeth Rigali (all from UCLA School of Medicine) for assistance with manuscript preparation. Funding was provided by U.S. National Institutes of Health (NIH) National Institute of Human Genome Research Grant T32 HG008553-01 (to L.M.) and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 3P50AR063020-03S1 (to D.M.). M.F. was supported by and received paid travel to meetings from Genentech, Inc. (South San Francisco, CA, USA), and honoraria and paid travel from Smartfish AS (Oslo, Norway).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Baciu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-244; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Collins MA, 2015, J PROTEOME RES, V14, P4486, DOI 10.1021/acs.jproteome.5b00804; Cooper-Knock J, 2015, ACTA NEUROPATHOL, V130, P63, DOI 10.1007/s00401-015-1429-9; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Fiala Milan, 2013, Am J Neurodegener Dis, V2, P129; Fiala M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-76; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Holmoy T, 2008, EUR J NEUROL, V15, P360, DOI 10.1111/j.1468-1331.2008.02065.x; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; JONES AR, 2006, NEUROBIOL AGING, V2015; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Lam Larry, 2015, Am J Neurodegener Dis, V4, P28; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mesci P, 2015, BRAIN, V138, P53, DOI 10.1093/brain/awu312; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Paez-Colasante X, 2015, NAT REV NEUROL, V11, P266, DOI 10.1038/nrneurol.2015.57; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Pollack BP, 2012, ONCOIMMUNOLOGY, V1, P71, DOI 10.4161/onci.1.1.18073; Povlsen GK, 2008, J NEUROCHEM, V104, P624, DOI 10.1111/j.1471-4159.2007.05033.x; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Steinberg KM, 2015, AMYOTROPH LAT SCL FR, V16, P385, DOI 10.3109/21678421.2015.1040029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tovar-y-Romo LB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00061; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner MR, 2013, NEUROLOGY, V81, P1222, DOI 10.1212/WNL.0b013e3182a6cc13; Vucic S, 2014, TRENDS NEUROSCI, V37, P433, DOI 10.1016/j.tins.2014.05.006; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020	63	37	37	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3461	3473		10.1096/fj.201600259RR	http://dx.doi.org/10.1096/fj.201600259RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27368295	Green Published			2022-12-26	WOS:000384329800017
J	Zhang, CW; Xue, P; Gao, LZ; Chen, X; Lin, KB; Yang, XY; Dai, YF; Xu, EY				Zhang, Chenwang; Xue, Peng; Gao, Liuze; Chen, Xia; Lin, Kaibo; Yang, Xiaoyu; Dai, Yifan; Xu, Eugene Yujun			Highly conserved epigenetic regulation of BOULE and DAZL is associated with human fertility	FASEB JOURNAL			English	Article						DNA methylation; epigenetic mechanism; infertility; oligospermia; germ cells	GERM-CELL DEVELOPMENT; HUMAN MALE-INFERTILITY; AZOOSPERMIA-LIKE DAZL; DNA METHYLATION; RAPID EVOLUTION; MESSENGER-RNA; GENE; EXPRESSION; SPERMATOGENESIS; MEN	Separation of germ cells from somatic cells is a widespread feature of animal sexual reproduction, with a core set of germ cell factors conserved among diverse animals. It is not known what controls their conserved gonad-specific expression. Core components of epigenetic machinery are ancient, but its role in conserved tissue expression regulation remains unexplored. We found that promoters of the reproductive genes BOULE and DAZL exhibit differential DNA methylation, consistent with their gonad-specific expression in humans and mice. Low or little promoter methylation from the testicular tissue is attributed to spermatogenic cells of various stages in the testis. Such differential DNA methylation is present in the orthologous promoters not only of other mammalian species, but also of chickens and fish, supporting a highly conserved epigenetic mechanism. Furthermore, hypermethylation of DAZL and BOULE promoters in human sperm is associated with human infertility. Our data strongly suggest that epigenetic regulation may underlie conserved germ-cell-specific expression, and such a mechanism may play an important role in human fertility.	[Zhang, Chenwang; Xue, Peng; Gao, Liuze; Chen, Xia; Lin, Kaibo; Dai, Yifan; Xu, Eugene Yujun] Nanjing Med Univ, State Key Lab Reprod Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Xue, Peng; Yang, Xiaoyu] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xu, EY (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.	xuyujun@njmu.edu.cn	杨, 玉/W-7221-2019	Xu, Eugene/0000-0002-4344-6606; Lin, Kaibo/0000-0002-2001-8369	National Science Foundation of China [81270737]; National Basic Research Program of China (Program 973) [2013CB945201]; Natural Science Foundation of Jiangsu Province [BK2012838]; Provincial Innovation and Entrepreneurship Grant; Provincial Shuangchuan Program	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (Program 973)(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Provincial Innovation and Entrepreneurship Grant; Provincial Shuangchuan Program	The authors thank Dr. Rongfeng Li [Nanjing Medical University (NJMU), Nanjing, China] for facilitating the collection of the pig tissues; Dr. Xin Wu (NJMU) for the kind gift of mouse SSCs; Dr. Michael Rehli (University Hospital, Regensburg, Germany) for the CpG-free luciferase reporter vector; Zhiyuan Zhang for bioinformatics assistance; and Tong Zhu, Haixin Li, and Min Wang (NJMU) for technical assistance. This work was supported by National Science Foundation of China (Grant 81270737), National Basic Research Program of China (Program 973, Grant 2013CB945201), Natural Science Foundation of Jiangsu Province (Grant BK2012838), and a Provincial Innovation and Entrepreneurship Grant. Funding for the open access charge was provided by the Provincial Shuangchuan Program. The authors declare no conflicts of interest.	ARIEL M, 1994, NAT GENET, V7, P59, DOI 10.1038/ng0594-59; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Chai NN, 1997, MOL HUM REPROD, V3, P705, DOI 10.1093/molehr/3.8.705; Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; EIRINLOPEZ JM, 2011, INT J EVOL BIOL, V2011, P72457, DOI DOI 10.4061/2011/972457; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gao M, 2013, MOL REPROD DEV, V80, P610, DOI 10.1002/mrd.22115; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Karashima T, 2000, DEVELOPMENT, V127, P1069; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kostova E, 2007, MOL HUM REPROD, V13, P85, DOI 10.1093/molehr/gal101; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071215; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Liu JH, 2009, MOL CELL ENDOCRINOL, V311, P101, DOI 10.1016/j.mce.2009.06.003; Liu ZS, 2011, ANIM REPROD SCI, V126, P258, DOI 10.1016/j.anireprosci.2011.05.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Luetjens CM, 2004, J CLIN ENDOCR METAB, V89, P1926, DOI 10.1210/jc.2003-031178; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; *PRACT COMM AM SOC, 2006, FERTIL STERIL, V86, pS111; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Richardson ME, 2014, HUM MOL GENET, V23, P12, DOI 10.1093/hmg/ddt392; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tanaka SS, 2000, GENE DEV, V14, P841; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tung JY, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-40; Tung JY, 2006, HUM GENET, V118, P730, DOI 10.1007/s00439-005-0098-5; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Xu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006097; Yang ZS, 2013, REPRODUCTION, V146, P501, DOI 10.1530/REP-13-0311; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013; Yi S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-174	55	14	17	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3424	3440		10.1096/fj.201500167R	http://dx.doi.org/10.1096/fj.201500167R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27358391				2022-12-26	WOS:000384329800014
J	Irani, S; Pan, XY; Peck, BCE; Iqbal, J; Sethupathy, P; Hussain, MM				Irani, Sara; Pan, Xiaoyue; Peck, Bailey C. E.; Iqbal, Jahangir; Sethupathy, Praveen; Hussain, M. Mahmood			MicroRNA-30c Mimic Mitigates Hypercholesterolemia and Atherosclerosis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; high density lipoprotein (HDL); low density lipoprotein (LDL); microRNA (miRNA); microRNA mechanism; apoB; lipids	TRIGLYCERIDE TRANSFER PROTEIN; FAMILIAL HYPERCHOLESTEROLEMIA; PCSK9 INHIBITION; APOLIPOPROTEIN-B; CHOLESTEROL; STATINS; HYPERLIPIDEMIA; METABOLISM; MIPOMERSEN; EFFICACY	High plasma cholesterol levels are a major risk factor for atherosclerosis. Plasma cholesterol can be reduced by inhibiting lipoprotein production; however, this is associated with steatosis. Previously we showed that lentivirally mediated hepatic expression of microRNA-30c (miR-30c) reduced hyperlipidemia and atherosclerosis in mice without causing hepatosteatosis. Because viral therapy would be formidable, we examined whether a miR-30c mimic can be used to mitigate hyperlipidemia and atherosclerosis without inducing steatosis. Delivery of a miR-30c mimic to the liver diminished diet-induced hypercholesterolemia in C57BL/6J mice. Reductions in plasma cholesterol levels were significantly correlated with increases in hepatic miR-30c levels. Long term dose escalation studies showed that miR-30c mimic caused sustained reductions in plasma cholesterol with no obvious side effects. Furthermore, miR-30c mimic significantly reduced hypercholesterolemia and atherosclerosis in Apoe(-/-) mice. Mechanistic studies showed that miR-30c mimic had no effect on LDL clearance but reduced lipoprotein production by down-regulating microsomal triglyceride transfer protein expression. MiR-30c had no effect on fatty acid oxidation but reduced lipid synthesis. Additionally, whole transcriptome analysis revealed that miR-30c mimic significantly down-regulated hepatic lipid synthesis pathways. Therefore, miR-30c lowers plasma cholesterol and mitigates atherosclerosis by reducing microsomal triglyceride transfer protein expression and lipoprotein production and avoids steatosis by diminishing lipid syntheses. It mitigates atherosclerosis most likely by reducing lipoprotein production and plasma cholesterol. These findings establish that increasing hepatic miR-30c levels is a viable treatment option for reducing hypercholesterolemia and atherosclerosis.	[Irani, Sara] Suny Downstate Med Ctr, Sch Grad Studies, Mol & Cell Biol Program, Brooklyn, NY 11203 USA; [Irani, Sara; Pan, Xiaoyue; Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Irani, Sara; Pan, Xiaoyue; Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Peck, Bailey C. E.; Sethupathy, Praveen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Peck, Bailey C. E.; Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hussain, M. Mahmood] Vet Affairs New York Harbor Healthcare Syst, Brooklyn, NY 11422 USA; [Hussain, M. Mahmood] Winthrop Univ Hosp, Mineola, NY 11501 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Winthrop University Hospital	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	Mahmood.Hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271; Peck, Bailey/0000-0002-4316-0966	National Institutes of Health Genetics and Molecular Biology Training Grant [T32GM-709239]; National Institutes of Health [DK-091318, DK-46900, DK-081879]; American Heart Association; Veterans Affairs Merit Award [BX001728]; SUNY Research Foundation; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046900, R29DK046900, R00DK091318, P30DK056350, R56DK046900, R01DK081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001728] Funding Source: NIH RePORTER	National Institutes of Health Genetics and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Veterans Affairs Merit Award(US Department of Veterans Affairs); SUNY Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Genetics and Molecular Biology Training Grant T32GM-709239 (to B. C. E. P.); National Institutes of Health Grant DK-091318 (to P. S.); an American Heart Association predoctoral fellowship (to S. I.); and National Institutes of Health Grants DK-46900 and DK-081879, Veterans Affairs Merit Award BX001728, and a technology accelerator fund grant from SUNY Research Foundation (to M. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blumenthal RS, 2000, AM HEART J, V139, P577, DOI 10.1016/S0002-8703(00)90033-4; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Cornier MA, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0475-4; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Cuchel M, 2013, CURR OPIN LIPIDOL, V24, P246, DOI 10.1097/MOL.0b013e32836139df; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Finkel JB, 2015, TRENDS CARDIOVAS MED, V25, P340, DOI 10.1016/j.tcm.2014.10.015; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Iqbal J, 2012, CIRC RES, V110, P1575, DOI 10.1161/CIRCRESAHA.112.264283; Irani S, 2015, CURR OPIN LIPIDOL, V26, P139, DOI 10.1097/MOL.0000000000000162; Izaurralde E, 2015, SCIENCE, V349, P380, DOI 10.1126/science.1260969; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Qiu ZH, 2014, EXPERT OPIN INV DRUG, V23, P347, DOI 10.1517/13543784.2014.867327; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Rader DJ, 2014, CIRCULATION, V129, P1022, DOI 10.1161/CIRCULATIONAHA.113.001292; Ricotta DN, 2012, CARDIOL REV, V20, P90, DOI 10.1097/CRD.0b013e31823424be; Rizzo M, 2011, CURR PHARM DESIGN, V17, P943, DOI 10.2174/138161211795428768; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Robinson JG, 2014, J AM COLL CARDIOL, V63, P2779, DOI 10.1016/j.jacc.2014.04.009; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Stoekenbroek RM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0503-4; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; van Rooij E, 2014, EMBO MOL MED, V6, P851, DOI 10.15252/emmm.201100899; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	40	35	37	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18397	18409		10.1074/jbc.M116.728451	http://dx.doi.org/10.1074/jbc.M116.728451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365390	Green Published, hybrid			2022-12-26	WOS:000383241800030
J	Gao, SK; Tang, YL; Wei, K; Wang, XY; Yang, ZQ; Zhang, YL				Gao, Shangkun; Tang, Yanlong; Wei, Ke; Wang, Xiaoyi; Yang, Zhongqi; Zhang, Yanlong			Relationships between Body Size and Parasitic Fitness and Offspring Performance of Sclerodermus pupariae Yang et Yao (Hymenoptera: Bethylidae)	PLOS ONE			English	Article							AGRILUS-PLANIPENNIS COLEOPTERA; LIFE-HISTORY TRAITS; SEX-RATIO; DEVELOPMENTAL STRATEGIES; HOST SIZE; FECUNDITY; BEHAVIOR; BUPRESTIDAE; LONGEVITY; EVOLUTION	The relationship between body size and fitness in parasitoid wasps has several effects on parasitic ability, reproductive behavior in female wasps, and progeny fitness. Female wasps with various body sizes were obtained by mass-rearing a gregarious ectoparasitoid, Sclerodermus pupariae, which is one of the excellent parasites to control the larvae and pupae of Buprestidae and Cerambycidae. We investigated the effects of body size of adult females introduced on Thyestilla gebleri (Coleoptera: Cerambycidae) larvae on their paralysis time, pre-oviposition period, oviposition period and fecundity, and the related fitness of their offspring. Results showed that small female wasps needed more time to paralyze a host and had a higher mortality rate than large female wasps. More offspring were produced by large female wasps than by small female wasps, and the percentage and body size of female offspring was not affected by maternal body size. The duration of the egg stage was not affected by foundress size, nor was that of the pupal stage, but the duration of the larval stage and generation time of small female wasps was longer than that of large females. Our findings suggest that the parasitic fitness and offspring performance are affected by maternal size, and there is need to choose reasonable body size of female wasps, to optimally utilize mass rearing and to control target pests with the lowest mortality cost.	[Yang, Zhongqi] China State Forestry Adm, Key Lab Forest Protect, Beijing, Peoples R China; Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Yang, ZQ (corresponding author), China State Forestry Adm, Key Lab Forest Protect, Beijing, Peoples R China.	yangzhqi@126.com		Wang, Xiaoyi/0000-0001-8136-6642	State Key Program of National Natural Science Foundation of China [31230015]; National Natural Science Foundation of China [31370654]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Zhongqi Yang received the State Key Program of National Natural Science Foundation of China (No. 31230015). The funder had an important role in study design. Xiaoyi Wang received the National Natural Science Foundation of China (Grant No. 31370654). The funder had an important role in data analysis.	Andreas M, 2013, BIOLOGIA, V68, P170, DOI 10.2478/s11756-012-0139-1; BLACKBURN TM, 1991, FUNCT ECOL, V5, P65, DOI 10.2307/2389556; CHARNOV E L, 1982; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Charnov EL, THEORY SEX ALLOCATIO; Chen J., 1995, PLANT PROT, V17, P26; Dai Ping-Li, 2005, Chinese Bulletin of Entomology, V42, P308; Dor A, 2013, CAN J ZOOL, V91, P545, DOI 10.1139/cjz-2012-0308; Elzinga JA, 2003, ENTOMOL EXP APPL, V108, P95, DOI 10.1046/j.1570-7458.2003.00072.x; Fidgen JG, 2000, ECOL ENTOMOL, V25, P156, DOI 10.1046/j.1365-2311.2000.00248.x; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Gauld I. D., 1988, HYMENOPTERA; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Harvey JA, 1999, J INSECT PHYSIOL, V45, P173, DOI 10.1016/S0022-1910(98)00113-9; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Harvey JA, 2004, ENVIRON ENTOMOL, V33, P1488, DOI 10.1603/0046-225X-33.5.1488; Harvey JA, 2004, ECOL ENTOMOL, V29, P35, DOI 10.1111/j.0307-6946.2004.00568.x; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051246; Jervis M. A., 1996, P63; Johnson DW, 2011, J EVOLUTION BIOL, V24, P1653, DOI 10.1111/j.1420-9101.2011.02298.x; Karsai I, 1991, P 4 EUR C ENT 13 INT, P504; Kasamatsu E, 2015, PHYSIOL ENTOMOL, V40, P223, DOI 10.1111/phen.12106; KAZMER DJ, 1995, ECOLOGY, V76, P412, DOI 10.2307/1941200; Lauziere I, 2000, ANN ENTOMOL SOC AM, V93, P103, DOI 10.1603/0013-8746(2000)093[0103:EOFBSA]2.0.CO;2; LEATHER SR, 1988, OIKOS, V51, P386, DOI 10.2307/3565323; Li Guo-Qing, 2006, Acta Ecologica Sinica, V26, P1261; Lin Fangfang, 2015, Nanjing Nongye Daxue Xuebao, V38, P584; Mackauer M., 1997, Ecological Studies, V130, P191; Mayhew PJ, 1999, J ANIM ECOL, V68, P906, DOI 10.1046/j.1365-2656.1999.00338.x; Messina FJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P227; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nakamatsu Y, 2004, ANN ENTOMOL SOC AM, V97, P994, DOI 10.1603/0013-8746(2004)097[0994:FRUOHT]2.0.CO;2; Olson DM, 1998, ENVIRON ENTOMOL, V27, P508, DOI 10.1093/ee/27.2.508; OSBORNE L L, 1987, Journal of the North American Benthological Society, V6, P115, DOI 10.2307/1467221; Petersen G, 1996, ANIM BEHAV, V51, P1363, DOI 10.1006/anbe.1996.0139; Quicke D. L. J., 1997, PARASITIC WASPS; ROSENHEIM JA, 1992, ECOL ENTOMOL, V17, P263, DOI 10.1111/j.1365-2311.1992.tb01057.x; Sagarra LA, 2001, B ENTOMOL RES, V91, P363, DOI 10.1079/BER2001121; SANDLAN KP, 1982, ANN ENTOMOL SOC AM, V75, P217, DOI 10.1093/aesa/75.3.217; Santolamazza-Carbone S, 2007, ENTOMOL EXP APPL, V125, P23, DOI 10.1111/j.1570-7458.2007.00595.x; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Stearns S.C., 1992, pi; STONE GN, 1989, J EXP BIOL, V147, P303; Strand MR, 2000, PARASITOID POPULATION BIOLOGY, P139; Tang XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5942; Tang Yan-Long, 2012, Acta Entomologica Sinica, V55, P55; TAYLOR PD, 1981, NATURE, V291, P64, DOI 10.1038/291064a0; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Waage JK, 1986, FAMILY PLANNINGIN PA; Wang Xiao-Yi, 2010, Acta Entomologica Sinica, V53, P675; Wei K, 2013, J APPL ENTOMOL, V137, P469, DOI 10.1111/jen.12031; Wei K, 2016, ECOL ENTOMOL; Wei K, 2014, ECOL ENTOMOL, V39, P101, DOI 10.1111/een.12074; West SA, 1996, J ANIM ECOL, V65, P631, DOI 10.2307/5742; Wu Hui, 2008, Acta Entomologica Sinica, V51, P46; Wu W., 2008, J SOUTHWET FOR COLL, V28, P24; Yang ZQ, 2014, BIOL CONTROL, V68, P117, DOI 10.1016/j.biocontrol.2013.06.010; Yang ZQ, 2012, ANN ENTOMOL SOC AM, V105, P619, DOI 10.1603/AN12017; Zeng CH, 1997, J SICHUAN FOR SCI TE, V18, P14; Zhang XZ, 1980, ENTOMOL KNOWL, V27, P71; Zhou Na, 2006, Natural Enemies of Insects, V28, P97; Zhu L., 2003, J SICHUAN FORESTRY S, V24, P18	67	25	26	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156831	10.1371/journal.pone.0156831	http://dx.doi.org/10.1371/journal.pone.0156831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367523	Green Submitted, Green Published, gold			2022-12-26	WOS:000378914900007
J	Peng, HY; Cheng, YC; Hsu, YM; Wu, GH; Kuo, CC; Liou, JP; Chang, JY; Jin, SLC; Shiah, SG				Peng, Hsuan-Yu; Cheng, Yun-Ching; Hsu, Yuan-Ming; Wu, Guan-Hsun; Kuo, Ching-Chuan; Liou, Jing-Ping; Chang, Jang-Yang; Jin, Shiow-Lian Catherine; Shiah, Shine-Gwo			MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							IMMUNE-SYSTEM; IN-VIVO; CANCER; STAT3; HEAD; NECK; ACTIVATION; 5-FLUOROURACIL; REQUIREMENT; PROGRESSION	Microtubule inhibitors have been shown to inhibit Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signal transduction pathway in various cancer cells. However, little is known of the mechanism by which the microtubule inhibitors inhibit STAT3 activity. In the present study, we examined the effect of a novel small-molecule microtubule inhibitor, MPT0B098, on STAT3 signaling in oral squamous cell carcinoma (OSCC). Treatment of various OSCC cells with MPT0B098 induced growth inhibition, cell cycle arrest and apoptosis, as well as increased the protein level of SOCS3. The accumulation of SOCS3 protein enhanced its binding to JAK2 and TYK2 which facilitated the ubiquitination and degradation of JAK2 and TYK2, resulting in a loss of STAT3 activity. The inhibition of STAT3 activity led to sensitization of OSCC cells to MPT0B098 cytotoxicity, indicating that STAT3 is a key mediator of drug resistance in oral carcinogenesis. Moreover, the combination of MPT0B098 with the clinical drug cisplatin or 5-FU significantly augmented growth inhibition and apoptosis in OSCC cells. Taken together, our results provide a novel mechanism for the action of MPT0B098 in which the JAK2/STAT3 signaling pathway is suppressed through the modulation of SOCS3 protein level. The findings also provide a promising combinational therapy of MPT0B098 for OSCC.	[Peng, Hsuan-Yu; Hsu, Yuan-Ming; Wu, Guan-Hsun; Chang, Jang-Yang; Shiah, Shine-Gwo] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Peng, Hsuan-Yu; Jin, Shiow-Lian Catherine] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Cheng, Yun-Ching] Show Chwan Mem Hosp, Dept Med Res, Changhua, Taiwan; [Kuo, Ching-Chuan] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Hematol & Oncol,Dept Internal Med, Tainan, Taiwan	National Health Research Institutes - Taiwan; National Central University; Show Chwan Memorial Hospital; National Health Research Institutes - Taiwan; Taipei Medical University; National Cheng Kung University; National Cheng Kung University Hospital	Shiah, SG (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.	davidssg@nhri.org.tw		Shiah, Shine-Gwo/0000-0002-1003-973X	National RNAi Core Facility at Academia Sinica, Taiwan	National RNAi Core Facility at Academia Sinica, Taiwan	We are grateful for the support of the National RNAi Core Facility at Academia Sinica, Taiwan with the shRNA clones (such as SOCS3, STAT3 and pLKO_TRC vector).	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Bendell JC, 2014, CANCER CHEMOTH PHARM, V74, P125, DOI 10.1007/s00280-014-2480-2; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Brown ME, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0505-7; Bu LL, 2015, ONCOTARGET, V6, P41944, DOI 10.18632/oncotarget.5986; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chang JY, 2010, MEDCHEMCOMM, V1, P152, DOI 10.1039/c0md00052c; Cheng YC, 2013, MOL CANCER THER, V12, P1202, DOI 10.1158/1535-7163.MCT-12-0778; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Fang LA, 2011, TOXICOL APPL PHARM, V251, P8, DOI 10.1016/j.taap.2010.11.007; Gkouveris I, 2014, ONCOL REP, V32, P2175, DOI 10.3892/or.2014.3440; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; Jerjes W, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-9; Keil F, 2013, EUR J CANCER, V49, P352, DOI 10.1016/j.ejca.2012.08.004; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Macha MA, 2011, HEAD NECK-J SCI SPEC, V33, P482, DOI 10.1002/hed.21468; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Shiah SG, 2014, CANCER RES, V74, P7560, DOI 10.1158/0008-5472.CAN-14-0978; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Siavash H, 2004, CRIT REV ORAL BIOL M, V15, P298, DOI 10.1177/154411130401500505; Sivanantham B, 2016, ACS COMB SCI, V18, P22, DOI 10.1021/acscombsci.5b00043; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551; Zou TT, 2008, FEBS LETT, V582, P4015, DOI 10.1016/j.febslet.2008.10.055	37	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158440	10.1371/journal.pone.0158440	http://dx.doi.org/10.1371/journal.pone.0158440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367272	gold, Green Published, Green Submitted			2022-12-26	WOS:000378914900035
J	Gariou-Papalexiou, A; Giardini, MC; Augustinos, AA; Drosopoulou, E; Lanzavecchia, SB; Cladera, JL; Caceres, C; Bourtzis, K; Mavragani-Tsipidou, P; Zacharopoulou, A				Gariou-Papalexiou, Angeliki; Giardini, Maria Cecilia; Augustinos, Antonios A.; Drosopoulou, Elena; Lanzavecchia, Silvia B.; Cladera, Jorge L.; Caceres, Carlos; Bourtzis, Kostas; Mavragani-Tsipidou, Penelope; Zacharopoulou, Antigone			Cytogenetic Analysis of the South American Fruit Fly Anastrepha fraterculus (Diptera: Tephritidae) Species Complex: Construction of Detailed Photographic Polytene Chromosome Maps of the Argentinian Af. sp.1 Member	PLOS ONE			English	Article							CERATITIS-CAPITATA DIPTERA; BACTROCERA-OLEAE DIPTERA; ANOPHELES-GAMBIAE; MATING COMPATIBILITY; SEX-CHROMOSOMES; METAPHASE KARYOTYPES; POPULATION-GENETICS; RIBOSOMAL DNA; DROSOPHILA; DORSALIS	Genetic and cytogenetic studies constitute a significant basis for understanding the biology of insect pests and the design and the construction of genetic tools for biological control strategies. Anastrepha fraterculus is an important pest of the Tephritidae family. It is distributed from southern Texas through eastern Mexico, Central America and South America causing significant crop damage and economic losses. Currently it is considered as a species complex; until now seven members have been described based on multidisciplinary approaches. Here we report the cytogenetic analysis of an Argentinian population characterized as Af.sp.1 member of the Anastrepha fraterculus species complex. The mitotic karyotype and the first detailed photographic maps of the salivary gland polytene chromosomes are presented. The mitotic metaphase complement consists of six (6) pairs of chromosomes, including one pair of heteromorphic sex chromosomes, with the male being the heterogametic sex. The analysis of the salivary gland polytene complement shows a total number of five long chromosomes that correspond to the five autosomes of the mitotic karyotype and a heterochromatic network corresponding to the sex chromosomes. Comparison of the polytene chromosome maps between this species and Anastrepha ludens shows significant similarity. The polytene maps presented here are suitable for cytogenetic studies that could shed light on the species limits within this species complex and support the development of genetic tools for sterile insect technique (SIT) applications.	[Gariou-Papalexiou, Angeliki; Augustinos, Antonios A.; Zacharopoulou, Antigone] Univ Patras, Dept Biol, Patras, Greece; [Giardini, Maria Cecilia; Lanzavecchia, Silvia B.; Cladera, Jorge L.] Inst Nacl Tecnol Agr, Inst Genet EA Favret, Hurlingham, Provincia Bueno, Argentina; [Augustinos, Antonios A.; Caceres, Carlos; Bourtzis, Kostas] Joint FAO IAEA Div Nucl Techn Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Drosopoulou, Elena; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece	University of Patras; Instituto Nacional de Tecnologia Agropecuaria (INTA); International Atomic Energy Agency; Aristotle University of Thessaloniki	Zacharopoulou, A (corresponding author), Univ Patras, Dept Biol, Patras, Greece.	zacharop@upatras.gr	Drosopoulou, Elena/AAX-6493-2020; Augustinos, Antonios/C-1318-2019; DROSOPOULOU, ELENA/N-2176-2015	Drosopoulou, Elena/0000-0001-9805-0572; Augustinos, Antonios/0000-0003-3682-6077; Lanzavecchia, Silvia/0000-0001-5965-4082	Directo Council of the Natinal Institute of Agricultural Technology, Argentina (I.N.T.A.) [1126]; International Atomic Energy Agency (IAEA) [16974]; Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture; INTA (Instituto Nacional Tecnologia Agropecuaria)	Directo Council of the Natinal Institute of Agricultural Technology, Argentina (I.N.T.A.); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture; INTA (Instituto Nacional Tecnologia Agropecuaria)	This work was funded by 1126: Directo Council of the Natinal Institute of Agricultural Technology, Argentina (I.N.T.A.) (www.inta.gob.ar), and 16974: International Atomic Energy Agency (IAEA) (cra.iaea.org).; We gratefully acknowledge the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture for funding this work through CRP and SSA projects. We also thank INTA (Instituto Nacional Tecnologia Agropecuaria) for allocating funds for MCG (travel and stay in Greece and Austria).	Allinghi A, 2007, FLA ENTOMOL, V90, P27, DOI 10.1653/0015-4040(2007)90[27:CACOAL]2.0.CO;2; [Anonymous], 1992, DROSOPHILA INVERSION; Ashburner M, 1982, GENETICS BIOL DROSOP; Augustinos AA, 2015, ZOOKEYS, P273, DOI 10.3897/zookeys.540.9857; Augustinos AA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S16; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baimai V, 1999, ZOOL STUD, V38, P110; BAIMAI V, 1995, GENOME, V38, P1015, DOI 10.1139/g95-134; Baimai V, 2000, BIOL J LINN SOC, V69, P399, DOI 10.1111/j.1095-8312.2000.tb01213.x; Baimai Visut, 2000, Cytologia (Tokyo), V65, P409, DOI 10.1508/cytologia.65.409; Baker AC, 1944, REV STUDIES MEXICAN; Basso A, 2003, J ECON ENTOMOL, V96, P1237, DOI 10.1603/0022-0493-96.4.1237; BEDO DG, 1987, GENOME, V29, P598, DOI 10.1139/g87-101; BEDO DG, 1989, CHROMOSOMA, V98, P443, DOI 10.1007/BF00292790; BEDO DG, 1986, CAN J GENET CYTOL, V28, P180, DOI 10.1139/g86-025; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Brirzova R, 2013, FLA ENTOMOL, V96, P1107, DOI 10.1653/024.096.0351; BUSH GUY L., 1962, PSYCHE, V69, P87, DOI 10.1155/1962/20495; Caceres C, 2009, BIOL J LINN SOC, V97, P152, DOI 10.1111/j.1095-8312.2008.01193.x; Canal NA, 2015, ZOOKEYS, P41, DOI 10.3897/zookeys.540.6012; Carson Hampton L., 1992, P407; Cecilia GM, 2009, CARYOLOGIA, V62, P204, DOI 10.1080/00087114.2004.10589686; Giardini MC, 2015, ZOOKEYS, P83, DOI 10.3897/zookeys.540.6058; Cladera JL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S12; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Craddock EM, 2016, GENETICA, V144, P107, DOI 10.1007/s10709-016-9882-5; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Devescovi F, 2014, ENTOMOL EXP APPL, V152, P238, DOI 10.1111/eea.12219; Dias VS, 2016, BIOL J LINN SOC, V117, P725, DOI 10.1111/bij.12712; Drosopoulou E, 2011, GENETICA, V139, P723, DOI 10.1007/s10709-011-9575-z; Drosopoulou E, 2010, ANN ENTOMOL SOC AM, V103, P1003, DOI 10.1603/AN10059; Drosopoulou E, 2014, GENOME, V57, P573, DOI 10.1139/gen-2014-0172; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Drosopoulou E, 2011, GENETICA, V139, P1449, DOI 10.1007/s10709-012-9644-y; Dutra VS, 2012, ANN ENTOMOL SOC AM, V105, P529, DOI 10.1603/AN11180; Dutra VS, 2011, ANN ENTOMOL SOC AM, V104, P16, DOI 10.1603/AN10105; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Garcia-Martinez V, 2009, GENOME, V52, P20, DOI 10.1139/G08-099; Gariou-Papalexiou A, 2002, GENETICA, V116, P59, DOI 10.1023/A:1020959608886; Goday C, 2006, CYTOGENET GENOME RES, V114, P70, DOI 10.1159/000091931; Hernandez-Ortiz V, 2004, B ENTOMOL RES, V94, P487, DOI 10.1079/BER2004325; Hernandez-Ortiz Vicente, 1994, Folia Entomologica Mexicana, V88, P89; Hernandez-Ortiz V, 2015, ZOOKEYS, P95, DOI 10.3897/zookeys.540.6027; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Hunwattanakul N, 2008, KASETSART J NATSCI, V28, P142; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kounatidis I, 2008, GENOME, V51, P479, DOI 10.1139/G08-032; Kulathinal RJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000550; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Lefevre G, 1976, GENETICS BIOL DROSOP; MALAVASI A, 1983, GENETICA, V60, P207, DOI 10.1007/BF00122375; Manni M, 2015, ZOOKEYS, P157, DOI 10.3897/zookeys.540.6713; Mason JM, 2010, DNA REPLICATION CURR; Mavragani-Tsipidou P, 2002, GENETICA, V116, P45, DOI 10.1023/A:1020907624816; Mavragani-Tsipidou P, 2014, PROTOCOLS CYTOGENETI, P1; MAVRAGANITSIPIDOU P, 1992, GENOME, V35, P373, DOI 10.1139/g92-056; Mendes L.O.T., 1958, BRAGANTIA, V17, P29, DOI [10.1590/S0006-87051958000100034, DOI 10.1590/S0006-87051958000100034]; MORGANTE JS, 1980, ANN ENTOMOL SOC AM, V73, P622, DOI 10.1093/aesa/73.6.622; Muller H. J., 1940, The New Systematics Oxford, V1940, P185; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Norrbom AL, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P299; Ovruski S, 2003, J ECON ENTOMOL, V96, P1108, DOI 10.1603/0022-0493-96.4.1108; Pardue ML, 1975, METHOD CELL BIOL, P1; Petit-Marty N, 2004, ANN ENTOMOL SOC AM, V97, P1320, DOI 10.1603/0013-8746(2004)097[1320:SBAMCA]2.0.CO;2; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; Procunier W.S., 1993, Insect Molecular Biology, V2, P163, DOI 10.1111/j.1365-2583.1993.tb00136.x; RADU M, 1975, CYTOLOGIA, V40, P823, DOI 10.1508/cytologia.40.823; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Robinson AS, 2002, GENETICA, V116, P1, DOI 10.1023/A:1020943122999; Rosetto M, 2000, GENOME, V43, P707, DOI 10.1139/gen-43-4-707; Rull J, 2012, B ENTOMOL RES, V102, P435, DOI 10.1017/S0007485312000016; Rull J, 2013, ENTOMOL EXP APPL, V148, P213, DOI 10.1111/eea.12094; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schutze MK, 2014, SYST ENTOMOL; Segura DF, 2011, BIOL J LINN SOC, V102, P346, DOI 10.1111/j.1095-8312.2010.01590.x; Selivon D, 2005, NEOTROP ENTOMOL, V34, P273, DOI 10.1590/S1519-566X2005000200015; Selivon D, 1997, BRAZ J GENET, V20, P651, DOI 10.1590/S0100-84551997000400015; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Selivon D, 1997, BRAZ J GENET, V20, P587, DOI 10.1590/S0100-84551997000400006; Selivon D, 1998, ANN ENTOMOL SOC AM, V91, P473, DOI 10.1093/aesa/91.4.473; Selivon D, 2007, GENET MOL BIOL, V30, P1082, DOI 10.1590/S1415-47572007000600009; Sharakhova MV, 2014, MED VET ENTOMOL, V28, P337, DOI 10.1111/mve.12037; Sharakhova MV, 2006, J MED ENTOMOL, V43, P861, DOI 10.1603/0022-2585(2006)43[861:ASCPFT]2.0.CO;2; Sharakhova MV, 2011, INFECT GENET EVOL, V11, P746, DOI 10.1016/j.meegid.2010.06.015; Zepeda-Cisneros CS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S1; Smith-Caldas Martha R. B., 2001, Neotropical Entomology, V30, P565, DOI 10.1590/S1519-566X2001000400009; Stanyon R, 2008, CHROMOSOME RES, V16, P17, DOI 10.1007/s10577-007-1209-z; Stone A., 1942, FRUIT FLIES GENUS AN; Sturtevant AH, 1941, GENETICS, V26, P517; Sutton BD, 2015, ZOOKEYS, P175, DOI 10.3897/zookeys.540.6147; Sved JA, 2016, EVOLUTION, V70, P229, DOI 10.1111/evo.12831; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Tsoumani KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137050; Vanickova L, 2015, J APPL ENTOMOL, V139, P679, DOI 10.1111/jen.12204; Vanickova L, 2015, ZOOKEYS, P193, DOI 10.3897/zookeys.540.9649; Vanickova L, 2012, J CHEM ECOL, V38, P1133, DOI 10.1007/s10886-012-0177-8; Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; White I.M., 1992, P1; Willhoeft U, 1996, GENETICS, V144, P737; Willhoeft U, 1996, GENOME, V39, P884, DOI 10.1139/g96-111; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; YOON JS, 1975, EVOLUTION, V29, P249, DOI 10.1111/j.1558-5646.1975.tb00205.x; ZACHAROPOULOU A, 1992, CHROMOSOMA, V101, P448, DOI 10.1007/BF00582839; Zacharopoulou A, 2013, J ECON ENTOMOL, V106, P995, DOI 10.1603/EC12379; Zacharopoulou A, 2011, ANN ENTOMOL SOC AM, V104, P306, DOI 10.1603/AN10113; ZACHAROPOULOU A, 1990, GENOME, V33, P184, DOI 10.1139/g90-030; Zacharopoulou A, 2011, GENETICA, V139, P79, DOI 10.1007/s10709-010-9495-3; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhao JT, 1998, GENOME, V41, P510, DOI 10.1139/gen-41-4-510; Zhimulev IF, 2004, INT REV CYTOL, V241, P203, DOI 10.1016/S0074-7696(04)41004-3; Zucchi RA, 2000, MOSCAS DAS FRUTAS IM, P41	119	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157192	10.1371/journal.pone.0157192	http://dx.doi.org/10.1371/journal.pone.0157192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362546	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200009
J	Holzinger, D; Danilovic, I; Seemann, R; Kornek, G; Engelmann, J; Pillerstorff, R; Holawe, S; Psyrri, A; Erovic, BM; Farwell, G; Perisanidis, C				Holzinger, Daniel; Danilovic, Ivan; Seemann, Rudolf; Kornek, Gabriela; Engelmann, Johannes; Pillerstorff, Robert; Holawe, Simone; Psyrri, Amanda; Erovic, Boban M.; Farwell, Gregory; Perisanidis, Christos			Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FIBRIN(OGEN); SURGERY; BINDING	Background We aimed to determine the prognostic significance of pretreatment plasma fibrinigen in patients with oral and oropharyngeal squamous cell carcinoma (OOSCC). Methods A cohort of 183 patients with locally advanced OOSCC receiving preoperative chemoradiotherapy was retrospectively examined. Using ROC curve analysis, a pretreatment plasma fibrinogen cutoff value of 447mg/dL was determined. The primary endpoints were overall survival and recurrence-free survival. A secondary endpoint was to determine whether pretreatment plasma fibrinogen could predict treatment response to neoadjuvant chemoradiotherapy. Cox regression models and Kaplan-Meier curves were used for survival analyses. Results Seventy-one patients had an elevated pretreatment plasma fibrinogen (fibrinogen >447mg/dL). Patients with high fibrinogen showed significantly higher pathologic stages after neoadjuvant treatment than those with low fibrinogen (p = 0.037). In univariate analysis, elevated fibrinogen was associated with poor overall survival (p = 0.005) and recurrence-free survival (p = 0.008) Multivariate analysis revealed that elevated fibrinogen remained an independent risk factor for death (hazard ratio 1.78, 95% CI 1.09-2.90, p = 0.021) and relapse (hazard ratio 1.78, 95% CI 1.11-2.86, p = 0.016). Conclusion Elevated pretreatment plasma fibrinogen is associated with lack of response to neoadjuvant chemoradiotherapy and reduced OS and RFS in patients with OOSCC. Thus, plasma fibrinogen may emerge as a novel prognostic indicator and a potential therapeutic target in OOSCC.	[Holzinger, Daniel; Danilovic, Ivan; Seemann, Rudolf; Engelmann, Johannes; Pillerstorff, Robert; Holawe, Simone; Perisanidis, Christos] Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria; [Kornek, Gabriela] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Psyrri, Amanda] Attikon Univ Hosp, Dept Internal Med 2, Div Oncol, Athens, Greece; [Erovic, Boban M.] Med Univ Vienna, Dept Otolaryngol Head & Neck Surg, Vienna, Austria; [Farwell, Gregory] Univ Calif Davis, Dept Otolaryngol Head & Neck Surg, Sacramento, CA 95817 USA	Medical University of Vienna; Medical University of Vienna; University Hospital Attikon; Medical University of Vienna; University of California System; University of California Davis	Perisanidis, C (corresponding author), Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria.	christos.perisanidis@meduniwien.ac.at	Erovic, Boban/S-7824-2018	Erovic, Boban/0000-0002-7404-2583; Holzinger, Daniel/0000-0002-2924-0193; Seemann, Rudolf/0000-0003-4234-4090				CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Driemel O, 2009, STRAHLENTHER ONKOL, V185, P296, DOI 10.1007/s00066-009-1914-y; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freier K, 2008, ORAL ONCOL, V44, P116, DOI 10.1016/j.oraloncology.2007.01.006; Jagielska B, 2011, NEOPLASMA, V58, P129, DOI 10.4149/neo_2011_02_129; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Palumbo JS, 2010, THROMB RES, V125, pS39, DOI 10.1016/S0049-3848(10)70011-6; Peng P, 2014, INT J ORAL MAX SURG, V43, P393, DOI 10.1016/j.ijom.2013.09.011; Perisanidis C, 2015, CANCER TREAT REV, V41, P960, DOI 10.1016/j.ctrv.2015.10.002; Perisanidis C, 2013, OR SURG OR MED OR PA, V115, P293, DOI 10.1016/j.oooo.2012.03.033; Russmueller G, 2015, ORAL ONCOL, V51, P247, DOI 10.1016/j.oraloncology.2014.11.010; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460; Shu YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-566; Staton CA, 2003, EXPERT OPIN BIOL TH, V3, P1105, DOI 10.1517/eobt.3.7.1105.21272; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; Tang LQ, 2014, BRIT J CANCER, V111, P1102, DOI 10.1038/bjc.2014.393; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x	23	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158697	10.1371/journal.pone.0158697	http://dx.doi.org/10.1371/journal.pone.0158697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362659	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200109
J	Lu, Y; Qian, YJ; Zhang, JL; Gong, M; Wang, YT; Gu, N; Ma, L; Xu, M; Ma, JQ; Zhang, WB; Pan, YC; Wang, L				Lu, Yun; Qian, Yajing; Zhang, Jinglu; Gong, Miao; Wang, Yuting; Gu, Ning; Ma, Lan; Xu, Min; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin			Genetic Variants of BMP2 and Their Association with the Risk of Non-Syndromic Tooth Agenesis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; CHINESE HAN POPULATION; SIGNALING PATHWAYS; COMPLEX DISEASE; STEM-CELLS; MSX1; OLIGODONTIA; HYPODONTIA; FAMILIES; POLYMORPHISMS	Non-syndromic tooth agenesis (or non-syndromic congenitally missing tooth) is one of the most common congenital defects in humans affecting the craniofacial function and appearance. Single nucleotide polymorphisms (SNPs) have been associated with an individual's susceptibility to these anomalies. The aim of the present study was therefore to investigate the roles of the potentially functional SNPs of BMP2 in the occurrence of tooth agenesis. Overall, four potentially functional SNPs of BMP2 (rs15705, rs235768, rs235769 and rs3178250) were selected, and their associations with the susceptibility of tooth agenesis were evaluated in a case-control study of 335 non-syndromic tooth agenesis cases and 444 healthy controls. The SNPs rs15705 and rs3178250 were found to be associated with an individual's risk of tooth agenesis (P = 0.046 and P = 0.039, respectively). Both SNPs showed an increased risk of mandibular incisor agenesis (rs15705, AA/AC vs. CC = 1.58, 95% CI = [1.06-2.34], P = 0.024; rs3178250, TT/TC vs. CC = 1.60, 95% CI = [1.08-2.37], P = 0.020). Bioinformatics analysis indicated that these two SNPs located at the 3'-untranslated region (3'-UTR) of BMP2 might alter the binding ability of miR-1273d and miR-46395p, respectively, which was confirmed by luciferase activity assays in the 293A and COS7 cell lines (P < 0.001 in 293A and P < 0.01 in COS7 for miR-1273d; and P < 0.001 in both cells for miR-4639-5p). Furthermore, BMP2 mRNA expression decreased after transfecting either miR-1273d or miR-4639-5p into these two cell lines (P < 0.01 in 293A and P < 0.001 in COS7 for miR-1273d, and P < 0.01 in both cell lines for miR-4639-5p). Taken together, our findings indicate that rs15705 and rs317250 are associated with the susceptibility of non-syndromic tooth agenesis by possibly affecting miRNAs and mRNA interaction.	[Lu, Yun; Qian, Yajing; Zhang, Jinglu; Gong, Miao; Wang, Yuting; Gu, Ning; Ma, Lan; Xu, Min; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Lu, Yun; Qian, Yajing; Gong, Miao; Wang, Yuting; Gu, Ning; Xu, Min; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Orthodont, Nanjing, Jiangsu, Peoples R China; [Lu, Yun] Dalian Med Univ, Coll Stomatol, Dept Orthodont, Dalian, Peoples R China; [Zhang, Jinglu] Nanjing Med Univ, Affiliated Hosp Stomatol, Inst Stomatol, Orofacial Pain & TMD Res Unit, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Dalian Medical University; Nanjing Medical University	Pan, YC; Wang, L (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Pan, YC; Wang, L (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Orthodont, Nanjing, Jiangsu, Peoples R China.	panyongchu@njmu.edu.cn; lw603@njmu.edu.cn			National Natural Science Foundation of China [81570959, 81230022, 81170981, 81200808, 81400546]; Ph.D. Programs Foundation of Ministry of Education of China [20113234110003, 20123234120004]; China Postdoctoral Science Foundation Special Funded Project [201104537, 20100481164]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD-2014-37]; Natural Science Foundation of Jiangsu Province [BK2012447, 15KJA320002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation Special Funded Project; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was funded by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, 81570959 to Yongchu Pan, 81230022 to Lin Wang, 81170981 to Lin Wang, 81200808 to Yongchu Pan, 81400546 to Lan Ma; Ph.D. Programs Foundation of Ministry of Education of China, http://www.cutech.edu.cn/cn/index.htm, 20113234110003 to Lin Wang, 20123234120004 to Yongchu Pan; China Postdoctoral Science Foundation Special Funded Project, http://jj.chinapostdoctor.org.cn/V1/Program2/Default.aspx, 201104537 to Yongchu Pan, 20100481164 to Yongchu Pan; the Priority Academic Program Development of Jiangsu Higher Education Institutions, http://www.ec.js.edu.cn/, PAPD-2014-37 to Lin Wang; and the Natural Science Foundation of Jiangsu Province, http://www.jstd.gov.cn/, BK2012447 to Yongchu Pan, 15KJA320002 to Lin Wang.	Acevedo AC, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0154-5; Alshaiji Jasem M, 2014, Cutis, V94, pE18; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Devaney JM, 2009, J CELL BIOCHEM, V107, P1073, DOI 10.1002/jcb.22209; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Feng XY, 2013, EUR J ORAL SCI, V121, P412, DOI 10.1111/eos.12078; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Gong M, 2015, EUR REV MED PHARMACO, V19, P2188; Greenblatt MB, 2015, J BIOL CHEM, V290, P284, DOI 10.1074/jbc.M114.599274; Haga S, 2013, J HUM GENET, V58, P799, DOI 10.1038/jhg.2013.106; Halicioglu Koray, 2013, Eur J Dent, V7, pS111, DOI 10.4103/1305-7456.119087; Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802; Khalaf K, 2014, J ORTHOD, V41, P299, DOI 10.1179/1465313314Y.0000000116; Lai LH, 2015, PLAST RECONSTR SURG, V135, p142E, DOI 10.1097/PRS.0000000000000779; Liu HC, 2012, EUR J ORAL SCI, V120, P378, DOI 10.1111/j.1600-0722.2012.00986.x; Lopez SIN, 2013, TWIN RES HUM GENET, V16, P1112, DOI 10.1017/thg.2013.69; Lyngstadaas SP, 1996, J MED GENET, V33, P137, DOI 10.1136/jmg.33.2.137; Ma L, 2014, J DENT RES, V93, P559, DOI 10.1177/0022034514527617; Massink MPG, 2015, AM J HUM GENET, V97, P621, DOI 10.1016/j.ajhg.2015.08.014; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Mu Y, 2012, GENET MOL RES, V11, P4110, DOI 10.4238/2012.September.25.5; Mu YD, 2013, GENET MOL RES, V12, P4446, DOI 10.4238/2013.October.10.10; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Saadi I, 2013, DEVELOPMENT, V140, P2697, DOI 10.1242/dev.088393; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Suzuki T, 2001, BRIT J ORAL MAX SURG, V39, P289, DOI 10.1054/bjom.2000.0568; Tasli PN, 2014, APPL BIOCHEM BIOTECH, V172, P3016, DOI 10.1007/s12010-013-0706-0; Vogel P, 2015, VET PATHOL, V52, P224, DOI 10.1177/0300985814528218; Yuan GH, 2015, DEVELOPMENT, V142, P128, DOI 10.1242/dev.117887; Zhang J, 2015, CHIN J DENT RES, V18, P59, DOI 10.3290/j.cjdr.a33969,PubMed:25815384; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zou Chuan, 2015, Shanghai Kou Qiang Yi Xue, V24, P83	33	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158273	10.1371/journal.pone.0158273	http://dx.doi.org/10.1371/journal.pone.0158273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362534	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200053
J	Matkovich, SJ; Grubb, DR; McMullen, JR; Woodcock, EA				Matkovich, Scot J.; Grubb, David R.; McMullen, Julie R.; Woodcock, Elizabeth A.			Chronic Contractile Dysfunction without Hypertrophy Does Not Provoke a Compensatory Transcriptional Response in Mouse Hearts	PLOS ONE			English	Article							POTENTIAL CANDIDATE GENES; B SPLICE VARIANT; CARDIAC CONTRACTILITY; PHOSPHOLIPASE C-BETA-1; EXPRESSION ANALYSIS; FAILURE; ACTIVATION; GROWTH; CARDIOMYOPATHY; PATHWAYS	Diseased myocardium from humans and experimental animal models shows heightened expression and activity of a specific subtype of phospholipase C (PLC), the splice variant PLC beta 1b. Previous studies from our group showed that increasing PLC beta 1b expression in adult mouse hearts by viral transduction was sufficient to cause sustained contractile dysfunction of rapid onset, which was maintained indefinitely in the absence of other pathological changes in the myocardium. We hypothesized that impaired contractility alone would be sufficient to induce a compensatory transcriptional response. Unbiased, comprehensive mRNA-sequencing was performed on 6 biological replicates of rAAV6-treated blank, PLC beta 1b and PLC beta 1a (closely related but inactive splice variant) hearts 8 weeks after injection, when reduced contractility was manifest in PLC beta 1b hearts without evidence of induced hypertrophy. Expression of PLC beta 1b resulted in expression changes in only 9 genes at FDR<0.1 when compared with control and these genes appeared unrelated to contractility. Importantly, PLC beta 1a caused similar mild expression changes to PLC beta 1b, despite a complete lack of effect of this isoform on cardiac contractility. We conclude that contractile depression caused by PLC beta 1b activation is largely independent of changes in the transcriptome, and thus that lowered contractility is not sufficient in itself to provoke measurable transcriptomic alterations. In addition, our data stress the importance of a stringent control group to filter out transcriptional changes unrelated to cardiac function.	[Matkovich, Scot J.] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Grubb, David R.; McMullen, Julie R.; Woodcock, Elizabeth A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Washington University (WUSTL); Baker Heart and Diabetes Institute	Matkovich, SJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	smatkovi@dom.wustl.edu	Matkovich, Scot J/B-9077-2009; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857	Australian National Health and Medical Research Council (NHMRC) [1002328, 10007712, 1022678]; Victorian Government's Operational Infrastructure Support Program; Baker IDI Heart and Diabetes Institute	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Baker IDI Heart and Diabetes Institute	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) #1002328, #10007712, #1022678. EAW and JRM are Fellows of the NHMRC #586621, #1078985, respectively. Support was received from the Victorian Government's Operational Infrastructure Support Program and from a Commercialization Grant provided by the Baker IDI Heart and Diabetes Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; BAHK YY, 1994, J BIOL CHEM, V269, P8240; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chen HB, 2013, EUR REV MED PHARMACO, V17, P903; Chen J, 2013, GENET MOL RES, V12, P4687, DOI 10.4238/2013.October.18.7; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Florea S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0279-z; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Grubb DR, 2016, J MOL CELL CARDIOL, V93, P12, DOI 10.1016/j.yjmcc.2016.02.015; Grubb DR, 2015, J MOL CELL CARDIOL, V84, P95, DOI 10.1016/j.yjmcc.2015.04.016; Grubb DR, 2015, BIOCHEM BIOPH RES CO, V461, P519, DOI 10.1016/j.bbrc.2015.04.060; Haghighi K, 2014, J MOL CELL CARDIOL, V77, P160, DOI 10.1016/j.yjmcc.2014.10.005; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Matkovich SJ, 2014, P NATL ACAD SCI USA, V111, P12264, DOI 10.1073/pnas.1410622111; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Roe AT, 2015, CURR PHARM DESIGN, V21, P431; Rowell J, 2014, PHYSIOL GENOMICS, V46, P779, DOI 10.1152/physiolgenomics.00054.2014; Sipido KR, 2010, CIRC RES, V106, P230, DOI 10.1161/CIRCRESAHA.109.210740; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Song MS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1855; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Westenbrink BD, 2015, CIRC RES, V116, pE28, DOI 10.1161/CIRCRESAHA.116.304682; Woodcock EA, 2009, J MOL CELL CARDIOL, V47, P676, DOI 10.1016/j.yjmcc.2009.08.020; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhang Y, 2011, J BIOL CHEM, V286, P26943, DOI 10.1074/jbc.M111.234757; Ziolo MT, 2014, ANTIOXID REDOX SIGN, V21, P2044, DOI 10.1089/ars.2014.5873	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158317	10.1371/journal.pone.0158317	http://dx.doi.org/10.1371/journal.pone.0158317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359099	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200058
J	Shi, L; Qin, EQ; Zhou, JN; Zhao, JJ; Nie, WM; Jiang, TJ; Chen, WW; Wu, D; Huang, L; Liu, LY; Lv, LP; Zhao, M; Zhang, Z; Wang, FS				Shi, Lei; Qin, Enqiang; Zhou, Junnian; Zhao, Juanjuan; Nie, Weimin; Jiang, Tianjun; Chen, Weiwei; Wu, Dan; Huang, Lei; Liu, Liying; Lv, Liping; Zhao, Min; Zhang, Zheng; Wang, Fusheng			HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells	PLOS ONE			English	Article							C VIRUS; MORPHOGENIC PROTEIN; LIVER FIBROSIS; COINFECTION; MECHANISMS; REGENERATION; PROGRESSION; INFECTION; ADHESION; BIOLOGY	Accelerated fibrosis in patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) has been a major cause of mortality in the highly active anti-retroviral therapy (HAART) era. However, the role of co-infection in accelerating the progression of liver fibrosis, particularly with regard to the effects of co-infection on hepatic stellate cells (HSCs), remains unclear. We hypothesized that HIV and HCV induce liver fibrosis synergistically by altering the regulation of epimorphin production, and thereby indirectly alter HSC function. Here, we examined the effects of epimorphin on HSC proliferation and invasion, and the changes in fibrogenesis-related gene activity in HSCs (LX2) in the presence of inactivated CXCR4-tropic HIV and HCV (JFH1). The combination of HIV and HCV significantly increased epimorphin expression, which increased the proliferation and invasion capabilities of HSCs. Epimorphin also induced the expression of profibrogenic tissue inhibitor of metalloproteinase 1 (TIMP1) in an extracellular signal-regulated kinase (ERK)-dependent manner. These data indicated that the effects of HIV/HCV co-infection on hepatic fibrosis might be mediated in part by EPM. Strategies to limit the expression of EPM might represent a novel therapeutic approach to prevent the progression of hepatic fibrosis during HIV/HCV co-infection.	[Shi, Lei; Zhang, Zheng; Wang, Fusheng] Med Sch Chinese PLA, Beijing, Peoples R China; [Shi, Lei; Qin, Enqiang; Nie, Weimin; Jiang, Tianjun; Chen, Weiwei; Wu, Dan; Huang, Lei; Zhao, Min; Wang, Fusheng] Beijing 302 Hosp, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China; [Zhou, Junnian; Lv, Liping] Beijing Inst Transfus Med, Beijing, Peoples R China; [Zhao, Juanjuan; Zhang, Zheng] Beijing 302 Hosp, Res Ctr Clin & Translat Med, Beijing, Peoples R China; [Liu, Liying] Beijing 302 Hosp, Tumor Radiotherapy Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Zhang, Z; Wang, FS (corresponding author), Med Sch Chinese PLA, Beijing, Peoples R China.; Wang, FS (corresponding author), Beijing 302 Hosp, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China.; Zhang, Z (corresponding author), Beijing 302 Hosp, Res Ctr Clin & Translat Med, Beijing, Peoples R China.	zhangzheng1975@yahoo.com.cn; fswang302@163.com	lei, huang/AFS-7785-2022; zhang, zheng/V-9479-2018; Zhou, Junnian/CAI-2072-2022	Zhou, Junnian/0000-0002-7782-234X	National Nature Science Foundation of China [81200303, 81470097]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (no. 81200303 and no. 81470097) (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China [grant numbers 81200303, 81470097].	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Hirose M, 1996, BIOCHEM BIOPH RES CO, V225, P155, DOI 10.1006/bbrc.1996.1146; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Jia YL, 2011, J CELL PHYSIOL, V226, P2807, DOI 10.1002/jcp.22625; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mastroianni CM, 2014, INT J MOL SCI, V15, P9184, DOI 10.3390/ijms15069184; Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Pascual-Pareja JF, 2009, AIDS, V23, P971, DOI 10.1097/QAD.0b013e328329f994; Pritchett J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100091; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; World Health Organization, GLOB HLTH OBS HIV AI; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoshino R, 2006, HEPATOL RES, V34, P238, DOI 10.1016/j.hepres.2005.12.011; Zhou JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009732	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158386	10.1371/journal.pone.0158386	http://dx.doi.org/10.1371/journal.pone.0158386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362846	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200067
J	Vega, Y; Delgado, E; de la Barrera, J; Carrera, C; Zaballos, A; Cuesta, I; Marino, A; Ocampo, A; Miralles, C; Perez-Castro, S; Alvarez, H; Lopez-Miragaya, I; Garcia-Bodas, E; Diez-Fuertes, F; Thomson, MM				Vega, Yolanda; Delgado, Elena; de la Barrera, Jorge; Carrera, Cristina; Zaballos, Angel; Cuesta, Isabel; Marino, Ana; Ocampo, Antonio; Miralles, Celia; Perez-Castro, Sonia; Alvarez, Hortensia; Lopez-Miragaya, Isabel; Garcia-Bodas, Elena; Diez-Fuertes, Francisco; Thomson, Michael M.			Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MESSENGER-RNA; TYPE-1 INFECTION; DISEASE PROGRESSION; T-CELLS; TAT; REV; IDENTIFICATION; TRANSCRIPTS; ENV	HIV-1 RNAs are generated through a complex splicing mechanism, resulting in a great diversity of transcripts, which are classified in three major categories: unspliced, singly spliced (SS), and doubly spliced (DS). Knowledge on HIV-1 RNA splicing in vivo and by non-subtype B viruses is scarce. Here we analyze HIV-1 RNA splice site usage in CD4(+-)CD25(+) lymphocytes from HIV-1-infected individuals through pyrosequencing. HIV-1 DS and SS RNAs were amplified by RT-PCR in 19 and 12 samples, respectively. 13,108 sequences from HIV-1 spliced RNAs, derived from viruses of five subtypes (A, B, C, F, G), were identified. In four samples, three of non-B subtypes, five 3' splice sites (3' ss) mapping to unreported positions in the HIV-1 genome were identified. Two, designated A4i and A4j, were used in 22% and 25% of rev RNAs in two viruses of subtypes B and A, respectively. Given their close proximity (one or two nucleotides) to A4c and A4d, respectively, they could be viewed as variants of these sites. Three 3' ss, designated A7g, A7h, and A7i, located 20, 32, and 18 nucleotides downstream of A7, respectively, were identified in a subtype C (A7g, A7h) and a subtype G (A7i) viruses, each in around 2% of nef RNAs. The new splice sites or variants of splice sites were associated with the usual sequence features of 3'ss. Usage of unusual 3' ss A4d, A4e, A5a, A7a, and A7b was also detected. A4f, previously identified in two subtype C viruses, was preferentially used by rev RNAs of a subtype C virus. These results highlight the great diversity of in vivo splice site usage by HIV-1 RNAs. The fact that four of five newly identified splice sites or variants of splice sites were detected in non-subtype B viruses allows anticipating an even greater diversity of HIV-1 splice site usage than currently known.	[Vega, Yolanda; Delgado, Elena; Carrera, Cristina; Garcia-Bodas, Elena; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain; [de la Barrera, Jorge; Cuesta, Isabel] Inst Salud Carlos III, Ctr Nacl Microbiol, Bioinformat Unit, Madrid, Spain; [Zaballos, Angel] Inst Salud Carlos III, Ctr Nacl Microbiol, Genom Unit, Madrid, Spain; [Marino, Ana; Alvarez, Hortensia] Hosp Arquitecto Marcide, Ferrol, A Coruna, Spain; [Ocampo, Antonio; Miralles, Celia; Perez-Castro, Sonia; Lopez-Miragaya, Isabel] Complejo Hosp Univ Vigo, Vigo, Pontevedra, Spain; [Diez-Fuertes, Francisco] Inst Salud Carlos III, Ctr Nacl Microbiol, AIDS Immunopathogenesis Unit, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complejo Hospitalario Universitario de Ferrol; Complexo Hospitalario Universitario de Vigo; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Thomson, MM (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain.	mthomson@isciii.es	Thomson, Michael M/P-8949-2017; CARRERA, CRISTINA/N-1887-2019; Cuesta de la Plaza, Isabel/C-1628-2018; Díez-Fuertes, Francisco/AAA-9427-2019; Delgado, Elena/E-2785-2019	Thomson, Michael M/0000-0002-0622-7527; CARRERA, CRISTINA/0000-0003-1608-8820; Cuesta de la Plaza, Isabel/0000-0002-7911-9041; Díez-Fuertes, Francisco/0000-0003-2413-9229; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758; PEREZ CASTRO, SONIA/0000-0003-1734-1904; Zaballos, Angel/0000-0002-7555-5815; Delgado, Elena/0000-0002-0754-8533	Sara Borrell postdoctoral Program of the Spanish Government [2012 CD12/00515]; Ministerio de Economia y Competitividad, Spain [SAF2010-20961, SAF2013-48488-P]; Instituto de Salud Carlos III [MPY 1194/12]	Sara Borrell postdoctoral Program of the Spanish Government; Ministerio de Economia y Competitividad, Spain; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Francisco Diez-Fuertes is supported by the Sara Borrell postdoctoral Program of the Spanish Government 2012 CD12/00515. This work was also supported by Ministerio de Economia y Competitividad, Spain (URL: http://www.mineco.gob.es/portal/site/mineco/) Grant # SAF2010-20961, Grant # SAF2013-48488-P to MMT and Instituto de Salud Carlos III (URL: http://www.isciii.es) Grant # MPY 1194/12 to MMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2008, J VIROL, V82, P3090, DOI 10.1128/JVI.01479-07; ARENS M, 1993, AIDS RES HUM RETROV, V9, P1257, DOI 10.1089/aid.1993.9.1257; ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; Asparuhova MB, 2007, J GENE MED, V9, P323, DOI 10.1002/jgm.1027; Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Berkhout B, 1996, ARCH VIROL, V141, P839, DOI 10.1007/BF01718159; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; BORVAK J, 1995, J IMMUNOL, V155, P3196; Brachtel EF, 2002, AIDS RES HUM RETROV, V18, P785, DOI 10.1089/08892220260139521; BRUGGEMAN LA, 1994, VIROLOGY, V202, P940, DOI 10.1006/viro.1994.1416; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; Carrera C, 2010, AIDS RES HUM RETROV, V26, P815, DOI 10.1089/aid.2010.0011; Chang ST, 2011, MBIO, V2, DOI 10.1128/mBio.00134-11; Comar M, 1997, J CLIN INVEST, V100, P893, DOI 10.1172/JCI119605; Delgado E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030574; Erkelenz S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0154-8; FURTADO MR, 1995, J VIROL, V69, P2092, DOI 10.1128/JVI.69.4.2092-2100.1995; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Habara Y, 2008, J BIOCHEM, V143, P303, DOI 10.1093/jb/mvm227; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Jacquenet S, 2001, NUCLEIC ACIDS RES, V29, P464, DOI 10.1093/nar/29.2.464; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lutzelberger M, 2006, J BIOL CHEM, V281, P18644, DOI 10.1074/jbc.M513698200; Madsen JM, 2005, J VIROL, V79, P10478, DOI 10.1128/JVI.79.16.10478-10486.2005; Madsen JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-10; Mandal D, 2008, J VIROL, V82, P1600, DOI 10.1128/JVI.02295-07; Mandal D, 2010, J VIROL, V84, P12790, DOI 10.1128/JVI.01257-10; MICHAEL NL, 1991, J VIROL, V65, P7084, DOI 10.1128/JVI.65.12.7084-.1991; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; MICHAEL NL, 1995, J VIROL, V69, P1868, DOI 10.1128/JVI.69.3.1868-1877.1995; Mueller N, 2014, VIROLOGY, V468, P609, DOI 10.1016/j.virol.2014.09.018; NEUMANN M, 1994, AIDS RES HUM RETROV, V10, P1531, DOI 10.1089/aid.1994.10.1531; Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; Pasternak AO, 2010, AIDS, V24, P1641, DOI 10.1097/QAD.0b013e32833b3171; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; RAMILO O, 1993, J IMMUNOL, V150, P5202; RIGGS NL, 1994, VIROLOGY, V202, P264, DOI 10.1006/viro.1994.1342; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; SAKSELA K, 1995, ANN INTERN MED, V123, P641, DOI 10.7326/0003-4819-123-9-199511010-00001; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; Saltarelli MJ, 1996, AIDS RES HUM RETROV, V12, P1443, DOI 10.1089/aid.1996.12.1443; SCHNITTMAN SM, 1991, AIDS RES HUM RETROV, V7, P361, DOI 10.1089/aid.1991.7.361; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SESHAMMA T, 1992, P NATL ACAD SCI USA, V89, P10663, DOI 10.1073/pnas.89.22.10663; SHELLEY CS, 1987, NUCLEIC ACIDS RES, V15, P3787, DOI 10.1093/nar/15.9.3787; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; Smith CW, NATURE, V342, P243; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; SMITH J, 1992, J GEN VIROL, V73, P1825, DOI 10.1099/0022-1317-73-7-1825; Sonza S, 2002, J VIROL, V76, P12611, DOI 10.1128/JVI.76.24.12611-12621.2002; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; Stellbrink HJ, 1997, AIDS, V11, P1103, DOI 10.1097/00002030-199709000-00004; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vega Y, 2013, AIDS RES HUM RETROV, V29, P1075, DOI [10.1089/aid.2013.0053, 10.1089/AID.2013.0053]; Wentz MP, 1997, J VIROL, V71, P8542, DOI 10.1128/JVI.71.11.8542-8551.1997; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Zhabokritsky A, 2014, RNA, V20, P1238, DOI 10.1261/rna.043141.113	75	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158525	10.1371/journal.pone.0158525	http://dx.doi.org/10.1371/journal.pone.0158525			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355361	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400073
J	Said, EA; Al-Reesi, I; Al-Riyami, M; Al-Naamani, K; Al-Sinawi, S; Al-Balushi, MS; Koh, CY; Al-Busaidi, JZ; Idris, MA; Al-Jabri, AA				Said, Elias A.; Al-Reesi, Iman; Al-Riyami, Marwa; Al-Naamani, Khalid; Al-Sinawi, Shadia; Al-Balushi, Mohammed S.; Koh, Crystal Y.; Al-Busaidi, Juma Z.; Idris, Mohamed A.; Al-Jabri, Ali A.			Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68(+) Cells during Chronic HBV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; T-CELLS; UP-REGULATION; COSTIMULATORY MOLECULES; DUCTULAR REACTION; KUPFFER CELLS; VIRUS; MACROPHAGES; RESPONSES; CTLA-4	Background The failure to establish potent anti-HBV T cell responses suggests the absence of an effective innate immune activation. Kupffer cells and liver-infiltrating monocytes/macrophages have an essential role in establishing anti-HBV responses. These cells express the costimulatory molecules CD80 and CD86. CD80 expression on antigen-presenting cells (APCs) induces Th1 cell differentiation, whereas CD86 expression drives the differentiation towards a Th2 profile. The relative expression of CD80, CD86 and PD-L1 on APCs, regulates T cell activation. Few studies investigated CD80 and CD86 expression on KCs and infiltrating monocytes/macrophages in HBV-infected liver and knowledge about the expression of PD-L1 on these cells is controversial. The expression of these molecules together in CD68(+) cells has not been explored in HBV-infected livers. Methods Double staining immunohistochemistry was applied to liver biopsies of HBV-infected and control donors to explore CD80, CD86 and PD-L1 expression in the lobular and portal areas. Results Chronic HBV infection was associated with increased CD68(+)CD86(+) cell count and percentage in the lobular areas, and no changes in the count and percentage of CD68(+)CD80(+) and CD68(+)PD-L1(+) cells, compared to the control group. While CD68(+)CD80(+) cell count in portal areas correlated with the fibrosis score, CD68(+)CD80(+) cell percentage in lobular areas correlated with the inflammation grade. Conclusion The upregulation of CD86 but not CD80 and PD-L1 on CD68(+) cells in HBV-infected livers, suggests that these cells do not support the induction of potent Th1. Moreover, the expression of CD80 on CD68(+) cells correlates with liver inflammation and fibrosis.	[Said, Elias A.; Al-Reesi, Iman; Al-Balushi, Mohammed S.; Koh, Crystal Y.; Al-Busaidi, Juma Z.; Idris, Mohamed A.; Al-Jabri, Ali A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, POB 35,Code 123, Muscat, Oman; [Al-Riyami, Marwa; Al-Sinawi, Shadia] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pathol, POB 35,Code 123, Muscat, Oman; [Al-Naamani, Khalid] Armed Forces Hosp, Dept Med, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Said, EA (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, POB 35,Code 123, Muscat, Oman.	elias.said@gmail.com	Said, Elias/AAY-5557-2020					Akcam FZ, 2012, J INTERF CYTOK RES, V32, P570, DOI 10.1089/jir.2012.0048; Almajhdi FN, 2013, ANN HEPATOL, V12, P220, DOI 10.1016/S1665-2681(19)31360-2; Asai-Tajiri Y, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0132-z; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Burgio VL, 1998, HEPATOLOGY, V27, P1600, DOI 10.1002/hep.510270620; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chang JJ, 2007, HEPATOLOGY, V46, P1332, DOI 10.1002/hep.21844; Chen J, 2011, INFLAMM RES, V60, P47, DOI 10.1007/s00011-010-0233-1; Cheng ASL, 2004, MODERN PATHOL, V17, P1169, DOI 10.1038/modpathol.3800196; Cheng JD, 2005, J HEPATOL, V43, P465, DOI 10.1016/j.jhep.2005.02.033; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; DING L, 1993, J IMMUNOL, V151, P1224; Fishman M, 2008, J IMMUNOTHER, V31, P72, DOI 10.1097/CJI.0b013e31815ba792; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Gadd VL, 2013, LIVER INT, V33, P569, DOI 10.1111/liv.12050; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Khorramdelazad H, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7581; Kondo Y, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/810939; Kong LQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059771, 10.1371/journal.pone.0078275]; Leifeld L, 1999, AM J PATHOL, V154, P1711, DOI 10.1016/S0002-9440(10)65427-2; Li H, 2012, DIGEST LIVER DIS, V44, P328, DOI 10.1016/j.dld.2011.11.005; Liu MF, 1999, SCAND J IMMUNOL, V49, P82, DOI 10.1046/j.1365-3083.1999.00452.x; Maj T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/769239; Manzotti CN, 2006, EUR J IMMUNOL, V36, P1413, DOI 10.1002/eji.200535170; MCLELLAN AD, 1995, EUR J IMMUNOL, V25, P2064, DOI 10.1002/eji.1830250739; Mittal SK, 2015, J BIOL CHEM, V290, P27158, DOI 10.1074/jbc.M115.682708; Olesch C, 2015, ONCOTARGET, V6, P10284, DOI 10.18632/oncotarget.3581; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Said EA, 2016, PLOS ONE, V11; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sakai Y, 2001, GASTROENTEROLOGY, V120, pA469; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Schmidt J, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.14; Sigal SH, 2005, LIVER TRANSPLANT, V11, P82, DOI 10.1002/lt.20328; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Trautmann L, 2007, CURR OPIN HIV AIDS, V2, P219, DOI 10.1097/COH.0b013e3280ebb5c9; Wang BJ, 2011, WORLD J GASTROENTERO, V17, P3322, DOI 10.3748/wjg.v17.i28.3322; WHO MC, 2015, HEP B; Yang K, 2014, INT J MOL SCI, V15, P21286, DOI 10.3390/ijms151121286; Yoshida T, 2003, CYTOTECHNOLOGY, V43, P81, DOI 10.1023/B: CYTO.0000039895.11048.1b; Zajac E, 2013, BLOOD, V122, P4054, DOI 10.1182/blood-2013-05-501494; Zakaria S, 2016, J IMMUNOTOXICOL, P1; Zhang Q, 2014, J IMMUNOL, V192, P2913, DOI 10.4049/jimmunol.1302951; Zhang WC, 2012, CHIN CONT DECIS CONF, P2012, DOI 10.1109/CCDC.2012.6244324; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	50	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158265	10.1371/journal.pone.0158265	http://dx.doi.org/10.1371/journal.pone.0158265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348308	Green Submitted, gold, Green Published			2022-12-26	WOS:000378801200055
J	Javid, A; Zlotnikov, N; Petrosova, H; Tang, TT; Zhang, Y; Bansal, AK; Ebady, R; Parikh, M; Ahmed, M; Sun, CX; Newbigging, S; Kim, YR; Sosa, MS; Glogauer, M; Moriarty, TJ				Javid, Ashkan; Zlotnikov, Nataliya; Petrosova, Helena; Tang, Tian Tian; Zhang, Yang; Bansal, Anil K.; Ebady, Rhodaba; Parikh, Maitry; Ahmed, Mijhgan; Sun, Chunxiang; Newbigging, Susan; Kim, Yae Ram; Sosa, Marianna Santana; Glogauer, Michael; Moriarty, Tara J.			Hyperglycemia Impairs Neutrophil-Mediated Bacterial Clearance in Mice Infected with the Lyme Disease Pathogen	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTION; BORRELIA-BURGDORFERI INFECTION; POLYMORPHONUCLEAR LEUKOCYTES; GLUCOSE-HOMEOSTASIS; GLYCEMIC CONTROL; IMMUNE-RESPONSE; LABORATORY MICE; DIABETIC MICE; I IFN; ARTHRITIS	Insulin-insufficient type 1 diabetes is associated with attenuated bactericidal function of neutrophils, which are key mediators of innate immune responses to microbes as well as pathological inflammatory processes. Neutrophils are central to immune responses to the Lyme pathogen Borrelia burgdorferi. The effect of hyperglycemia on host susceptibility to and outcomes of B. burgdorferi infection has not been examined. The present study investigated the impact of sustained obesity-independent hyperglycemia in mice on bacterial clearance, inflammatory pathology and neutrophil responses to B. burgdorferi. Hyperglycemia was associated with reduced arthritis incidence but more widespread tissue colonization and reduced clearance of bacterial DNA in multiple tissues including brain, heart, liver, lung and knee joint. B. burgdorferi uptake and killing were impaired in neutrophils isolated from hyperglycemic mice. Thus, attenuated neutrophil function in insulin-insufficient hyperglycemia was associated with reduced B. burgdorferi clearance in target organs. These data suggest that investigating the effects of comorbid conditions such as diabetes on outcomes of B. burgdorferi infections in humans may be warranted.	[Javid, Ashkan; Zlotnikov, Nataliya; Petrosova, Helena; Tang, Tian Tian; Zhang, Yang; Bansal, Anil K.; Ebady, Rhodaba; Parikh, Maitry; Ahmed, Mijhgan; Sun, Chunxiang; Kim, Yae Ram; Sosa, Marianna Santana; Glogauer, Michael; Moriarty, Tara J.] Univ Toronto, Matrix Dynam Grp, Fac Dent, Fitzgerald Bldg,Room 241,150 Coll St, Toronto, ON M5S 3E2, Canada; [Newbigging, Susan] Mt Sinai Hosp, Res Inst, Toronto Ctr Phenogen, 25 Orde St, Toronto, ON M5T 3H7, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Moriarty, TJ (corresponding author), Univ Toronto, Matrix Dynam Grp, Fac Dent, Fitzgerald Bldg,Room 241,150 Coll St, Toronto, ON M5S 3E2, Canada.	tara.moriarty@utoronto.ca	Moriarty, Tara J./K-1684-2016; Glogauer, Michael/D-2504-2011	Moriarty, Tara J./0000-0002-1751-5145; Ahmed, Mijhgan/0000-0002-8356-0630	National Research Fund for Tick Borne Diseases; Canadian Institutes of Health Research (CIHR) [MOP-11959, TO-122068]; CIHR Bhagirath Singh Award [ICS-12398]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 401]; Banting Research Foundation; University of Toronto Faculty of Dentistry Bertha Rosenstadt Endowment Fund; Enrichment Endowment Fund; Canada Foundation for Innovation/Ontario Research Fund [27881]; Heart & Stroke/Richard Lewar Centre of Excellence; University of Toronto (UofT); UofT Faculty of Dentistry Harron; Queen Elizabeth II; CIHR Institute of Musculoskeletal Health and Arthritis; NSERC; UofT Faculty of Dentistry; UofT Work Study; Ontario Summer Experience Program	National Research Fund for Tick Borne Diseases; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Bhagirath Singh Award(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting Research Foundation; University of Toronto Faculty of Dentistry Bertha Rosenstadt Endowment Fund; Enrichment Endowment Fund; Canada Foundation for Innovation/Ontario Research Fund(Canada Foundation for Innovation); Heart & Stroke/Richard Lewar Centre of Excellence; University of Toronto (UofT)(University of Toronto); UofT Faculty of Dentistry Harron; Queen Elizabeth II; CIHR Institute of Musculoskeletal Health and Arthritis(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); UofT Faculty of Dentistry; UofT Work Study; Ontario Summer Experience Program	This study was funded by National Research Fund for Tick Borne Diseases (TJM); Canadian Institutes of Health Research (CIHR) operating grants: MOP-11959 (TJM) and TO-122068 (MG); CIHR Bhagirath Singh Award: ICS-12398 (TJM); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant: RGPIN 401 (TJM); Banting Research Foundation (TJM); University of Toronto Faculty of Dentistry Bertha Rosenstadt Endowment Fund (TJM) and Enrichment Endowment Fund (TJM); and Canada Foundation for Innovation/Ontario Research Fund: 27881 (TJM). Salaries: Postdoctoral fellowships: Heart & Stroke/Richard Lewar Centre of Excellence (HP); graduate scholarships: University of Toronto (UofT) (AJ, NZ, TTT, RE), UofT Faculty of Dentistry Harron (RE), Queen Elizabeth II (TTT); undergraduate scholarships: CIHR Institute of Musculoskeletal Health and Arthritis (MA, MP, YZ), NSERC (TTT), UofT Faculty of Dentistry (MA), UofT Work Study (YRK, TTT, MA), and Ontario Summer Experience Program (YRK).	ARMSTRONG AL, 1992, AM J TROP MED HYG, V47, P249, DOI 10.4269/ajtmh.1992.47.249; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold S.W., 2010, BORRELIA MOL BIOL HO, P359; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; BENACH JL, 1984, YALE J BIOL MED, V57, P599; BENACH JL, 1984, J INFECT DIS, V150, P497, DOI 10.1093/infdis/150.4.497; Bian Z, 2012, J IMMUNOL, V188, P844, DOI 10.4049/jimmunol.1101736; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brown CR, 2004, INFECT IMMUN, V72, P4956, DOI 10.1128/IAI.72.9.4956-4965.2004; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Cerar T, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0501-y; Crandall H, 2005, AM J PATHOL, V167, P775, DOI 10.1016/S0002-9440(10)62050-0; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; DURAY PH, 1988, ANN NY ACAD SCI, V539, P65, DOI 10.1111/j.1749-6632.1988.tb31839.x; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Farnsworth CW, 2015, INFECT IMMUN, V83, P2264, DOI 10.1128/IAI.03074-14; Ferreira CD, 2012, CELL BIOCHEM FUNCT, V30, P604, DOI 10.1002/cbf.2840; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garcia R, 1998, INFECT IMMUN, V66, P1408, DOI 10.1128/IAI.66.4.1408-1412.1998; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Grayson BE, 2013, NAT REV NEUROSCI, V14, P24, DOI 10.1038/nrn3409; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Hair PS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-35; Hanses F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023633; Hawley KL, 2015, INT J BIOL SCI, V11, P1269, DOI 10.7150/ijbs.13395; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kannan Y, 2004, CLIN EXP IMMUNOL, V137, P263, DOI 10.1111/j.1365-2249.2004.02532.x; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Lin YT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-56; Lochhead RB, 2012, J IMMUNOL, V189, P2488, DOI 10.4049/jimmunol.1201095; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; McManus LM, 2001, J LEUKOCYTE BIOL, V70, P395; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Menten-Dedoyart C, 2012, J IMMUNOL, V189, P5393, DOI 10.4049/jimmunol.1103771; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Moriarty TJ, 2012, MOL MICROBIOL, V86, P1116, DOI 10.1111/mmi.12045; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Norris S.J., 2010, BORRELIA MOL BIOL HO, P293; Odegaard JI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007724; PACHNER AR, 1990, NEUROLOGY, V40, P1535, DOI 10.1212/WNL.40.10.1535; Perner A, 2003, INTENS CARE MED, V29, P642, DOI 10.1007/s00134-002-1628-4; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; PETERSON PK, 1984, INFECT IMMUN, V46, P608, DOI 10.1128/IAI.46.2.608-611.1984; Pettersson US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022480; Pezzulo AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016166; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Ritzman AM, 2010, INFECT IMMUN, V78, P4593, DOI 10.1128/IAI.00798-10; Riyapa D, 2012, INFECT IMMUN, V80, P3921, DOI 10.1128/IAI.00806-12; Sahay B, 2011, AM J PATHOL, V178, P724, DOI 10.1016/j.ajpath.2010.10.025; SCHAIBLE UE, 1990, AM J PATHOL, V137, P811; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Stegenga ME, 2008, BLOOD, V112, P82, DOI 10.1182/blood-2007-11-121723; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Tagzirt M, 2014, AM J HYPERTENS, V27, P1096, DOI 10.1093/ajh/hpu021; Thomas J, 2014, J NUTR BIOCHEM, V25, P313, DOI 10.1016/j.jnutbio.2013.11.005; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Troxell B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084625; Van Belle T L, 2009, Drug Discov Today Dis Models, V6, P41; Ventura-Sobrevilla J, 2011, Proc West Pharmacol Soc, V54, P5; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weis J.J., 2010, BORRELIA MOL BIOL HO, P413; Wu K. K., 2008, CURRENT PROTOCOLS PH; YANG LM, 1994, INFECT IMMUN, V62, P492, DOI 10.1128/IAI.62.2.492-500.1994; Yano H, 2012, INFECT IMMUN, V80, P4409, DOI 10.1128/IAI.00787-12; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	77	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158019	10.1371/journal.pone.0158019	http://dx.doi.org/10.1371/journal.pone.0158019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27340827	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600025
J	Siebenkas, A; Schumacher, J; Roscher, C				Siebenkaes, Alrun; Schumacher, Jens; Roscher, Christiane			Resource Availability Alters Biodiversity Effects in Experimental Grass-Forb Mixtures	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; FERTILITY ENVIRONMENTS; ECOSYSTEM-FUNCTION; SPECIES-DIVERSITY; ELEVATED CO2; COMPETITION; PRODUCTIVITY; ROOT; LIGHT; COMPLEMENTARITY	Numerous experiments, mostly performed in particular environments, have shown positive diversity-productivity relationships. Although the complementary use of resources is discussed as an important mechanism explaining diversity effects, less is known about how resource availability controls the strength of diversity effects and how this response depends on the functional composition of plant communities. We studied aboveground biomass production in experimental monocultures, two-and four-species mixtures assembled from two independent pools of four perennial grassland species, each representing two functional groups (grasses, forbs) and two growth statures (small, tall), and exposed to different combinations of light and nutrient availability. On average, shade led to a decrease in aboveground biomass production of 24% while fertilization increased biomass production by 36%. Mixtures were on average more productive than expected from their monocultures (relative yield total, RYT>1) and showed positive net diversity effects (NE: +34% biomass increase; mixture minus mean monoculture biomass). Both trait-independent complementarity effects (TICE: +21%) and dominance effects (DE: +12%) positively contributed to net diversity effects, while trait-dependent complementarity effects were minor (TDCE: +1%). Shading did not alter diversity effects and overyielding. Fertilization decreased RYT and the proportion of biomass gain through TICE and TDCE, while DE increased. Diversity effects did not increase with species richness and were independent of functional group or growth stature composition. Trait-based analyses showed that the dominance of species with root and leaf traits related to resource conservation increased TICE. Traits indicating the tolerance of shade showed positive relationships with TDCE. Large DE were associated with the dominance of species with tall growth and low diversity in leaf nitrogen concentrations. Our field experiment shows that positive diversity effects are possible in grass-forb mixtures irrespective of differences in light availability, but that the chance for the complementary use of resources increases when nutrients are not available at excess.	[Siebenkaes, Alrun] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Theodor Lieser Str 4, D-06120 Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Math, Stochast, Ernst Abbe Pl 2, D-07743 Jena, Germany; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany; [Roscher, Christiane] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Roscher, C (corresponding author), Helmholtz Ctr Environm Res, UFZ, Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany.; Roscher, C (corresponding author), German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany.	christiane.roscher@ufz.de		Siebenkas, Alrun/0000-0001-9676-7094	German Science Foundation [RO2397/3, RO2397/4]	German Science Foundation(German Research Foundation (DFG))	This research was funded by the German Science Foundation (RO2397/3, RO2397/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Altermann M, 2005, J PLANT NUTR SOIL SC, V168, P725, DOI 10.1002/jpln.200521814; Barton K., 2015, MUMIN MULTIMODEL INF; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; de Wit CT, 1965, NETHERLANDS J AGRICU, V13, P212, DOI DOI 10.18174/NJAS.V13I2.17501; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dyer AR, 2001, FUNCT ECOL, V15, P85, DOI 10.1046/j.1365-2435.2001.00487.x; Ellenberg H., 1988, Vegetation ecology of Central Europe.; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; He JS, 2002, OIKOS, V97, P337, DOI 10.1034/j.1600-0706.2002.970304.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jager E, 2011, ROTHMALER EXKURSIONS; KORNER C, 1993, ECOL STU AN, V99, P117; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lanta V, 2007, ACTA OECOL, V32, P93, DOI 10.1016/j.actao.2007.03.007; Leps J, 1999, J VEG SCI, V10, P219, DOI 10.2307/3237143; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Nyfeler D, 2009, J APPL ECOL, V46, P683, DOI 10.1111/j.1365-2664.2009.01653.x; OLFF H, 1990, FUNCT ECOL, V4, P193, DOI 10.2307/2389338; Pontes LD, 2012, OECOLOGIA, V168, P761, DOI 10.1007/s00442-011-2129-3; R Core Team, 2013, R LANG ENV STAT COMP; Rajaniemi TK, 2003, BASIC APPL ECOL, V4, P239, DOI 10.1078/1439-1791-00151; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Roscher C, 2016, OECOLOGIA, V181, P571, DOI 10.1007/s00442-016-3587-4; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Roscher C, 2011, PERSPECT PLANT ECOL, V13, P1, DOI 10.1016/j.ppees.2010.11.001; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Siebenkas A, 2016, PLANT SOIL, V404, P399, DOI 10.1007/s11104-016-2853-x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Tilman D, 1987, FUNCT ECOL, V1, P304, DOI 10.2307/2389785; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; Vojtech E, 2008, OIKOS, V117, P1351, DOI 10.1111/j.0030-1299.2008.16700.x; Wacker L, 2009, ECOLOGY, V90, P637, DOI 10.1890/07-1946.1; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WILSON JB, 1988, J APPL ECOL, V25, P279, DOI 10.2307/2403626; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x	64	15	16	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158110	10.1371/journal.pone.0158110	http://dx.doi.org/10.1371/journal.pone.0158110			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341495	Green Submitted, Green Published, gold			2022-12-26	WOS:000378393600031
J	Hsiao, JJ; Smits, MM; Ng, BH; Lee, J; Wright, ME				Hsiao, Jordy J.; Smits, Melinda M.; Ng, Brandon H.; Lee, Jinhee; Wright, Michael E.			Discovery Proteomics Identifies a Molecular Link between the Coatomer Protein Complex I and Androgen Receptor-dependent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-BINDING CHARACTERISTICS; RESISTANT PROSTATE-CANCER; LNCAP CELLS; GENE-EXPRESSION; NUCLEAR IMPORT; BREFELDIN-A; PROTEASOME ACTIVITY; MASS-SPECTROMETRY; COACTIVATOR; DATABASE	Aberrant androgen receptor (AR)-dependent transcription is a hallmark of human prostate cancers. At the molecular level, ligand-mediated AR activation is coordinated through spatial and temporal protein-protein interactions involving AR-interacting proteins, which we designate the "AR-interactome." Despite many years of research, the ligand-sensitive protein complexes involved in ligand-mediated AR activation in prostate tumor cells have not been clearly defined. Here, we describe the development, characterization, and utilization of a novel human LNCaP prostate tumor cell line, N-AR, which stably expresses wild-type AR tagged at its N terminus with the streptavidin-binding peptide epitope (streptavidin-binding peptide-tagged wild-type androgen receptor; SBP-AR). A bio-analytical workflow involving streptavidin chromatography and label-free quantitative mass spectrometry was used to identify SBP-AR and associated ligand-sensitive cytosolic proteins/protein complexes linked to AR activation in prostate tumor cells. Functional studies verified that ligand-sensitive proteins identified in the proteomic screen encoded modulators of AR-mediated transcription, suggesting that these novel proteins were putative SBP-AR-interacting proteins in N-AR cells. This was supported by biochemical associations between recombinant SBP-AR and the ligand-sensitive coatomer protein complex I (COPI) retrograde trafficking complex in vitro. Extensive biochemical and molecular experiments showed that the COPI retrograde complex regulates ligand-mediated AR transcriptional activation, which correlated with the mobilization of the Golgilocalized ARA160 coactivator to the nuclear compartment of prostate tumor cells. Collectively, this study provides a bioanalytical strategy to validate the AR-interactome and define novel AR-interacting proteins involved in ligand-mediated AR activation in prostate tumor cells. Moreover, we describe a cellular system to study how compartment-specific AR-interacting proteins influence AR activation and contribute to aberrant AR-dependent transcription that underlies the majority of human prostate cancers.	[Hsiao, Jordy J.; Smits, Melinda M.; Ng, Brandon H.; Lee, Jinhee; Wright, Michael E.] Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA		Wright, ME (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 51 Newton Rd,Bowen Sci Bldg 5-630, Iowa City, IA 52242 USA.	michael-e-wright@uiowa.edu		Hsiao, Jordy/0000-0002-2487-5034; Wright, Michael/0000-0002-4243-2931	University of Iowa	University of Iowa	This work was supported by University of Iowa startup funds (to M. E. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander B, 2013, UROL ONCOL-SEMIN ORI, V31, P104, DOI 10.1016/j.urolonc.2010.11.009; An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Bahl A, 2014, CANCER TREAT REV, V40, P170, DOI 10.1016/j.ctrv.2013.06.008; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cookson MS, 2013, J UROLOGY, V190, P429, DOI 10.1016/j.juro.2013.05.005; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Eichholz A, 2012, MOL CELL ENDOCRINOL, V360, P68, DOI 10.1016/j.mce.2011.09.038; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; Johnson KY, 2002, BIOTECHNIQUES, V32, P1270, DOI 10.2144/02326st02; Kabler RL, 1996, J STEROID BIOCHEM, V59, P431, DOI 10.1016/S0960-0760(96)00126-4; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIANG T, 1975, P NATL ACAD SCI USA, V72, P706, DOI 10.1073/pnas.72.2.706; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lipman NS, 2005, ILAR J, V46, P258, DOI 10.1093/ilar.46.3.258; Loikkanen I, 2009, ONCOL REP, V22, P991, DOI 10.3892/or_00000526; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Magee JA, 2001, CANCER RES, V61, P5692; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Martinez Harryl D, 2011, Genes Cancer, V2, P956, DOI 10.1177/1947601912436422; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; MONTGOMERY BT, 1992, PROSTATE, V21, P63, DOI 10.1002/pros.2990210107; Moore SM, 2002, J ANDROL, V23, P163; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; Ni L, 2013, MOL CELL BIOL, V33, P4766, DOI 10.1128/MCB.00647-13; Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Paliouras M, 2011, INTEGR BIOL-UK, V3, P1020, DOI 10.1039/c1ib00038a; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rudomin EL, 2009, J PROTEOME RES, V8, P3154, DOI 10.1021/pr801017a; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schmidt A, 2009, CURR OPIN CHEM BIOL, V13, P510, DOI 10.1016/j.cbpa.2009.08.016; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Shi ZA, 2013, NAT METHODS, V10, P597, DOI 10.1038/nmeth.2517; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tosoian J, 2010, THESCIENTIFICWORLDJO, V10, P1919, DOI 10.1100/tsw.2010.182; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Vanaja DK, 2003, CANCER RES, V63, P3877; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wallen E, 2000, J UROLOGY, V164, P836, DOI 10.1016/S0022-5347(05)67323-5; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Welsh JB, 2001, CANCER RES, V61, P5974; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Zaman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113190; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	104	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18818	18842		10.1074/jbc.M116.732313	http://dx.doi.org/10.1074/jbc.M116.732313			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27365400	hybrid, Green Published			2022-12-26	WOS:000383242300019
J	de Souza, EN; Boerder, K; Matwin, S; Worm, B				de Souza, Erico N.; Boerder, Kristina; Matwin, Stan; Worm, Boris			Improving Fishing Pattern Detection from Satellite AIS Using Data Mining and Machine Learning	PLOS ONE			English	Article							MONITORING SYSTEMS VMS; SPATIAL-DISTRIBUTION; PURSE-SEINERS; HUMAN IMPACT; VESSEL; IDENTIFICATION; TRAJECTORIES; MODEL; SCALE; CATCH	A key challenge in contemporary ecology and conservation is the accurate tracking of the spatial distribution of various human impacts, such as fishing. While coastal fisheries in national waters are closely monitored in some countries, existing maps of fishing effort elsewhere are fraught with uncertainty, especially in remote areas and the High Seas. Better understanding of the behavior of the global fishing fleets is required in order to prioritize and enforce fisheries management and conservation measures worldwide. Satellite-based Automatic Information Systems (S-AIS) are now commonly installed on most ocean-going vessels and have been proposed as a novel tool to explore the movements of fishing fleets in near real time. Here we present approaches to identify fishing activity from S-AIS data for three dominant fishing gear types: trawl, longline and purse seine. Using a large dataset containing worldwide fishing vessel tracks from 2011-2015, we developed three methods to detect and map fishing activities: for trawlers we produced a Hidden Markov Model (HMM) using vessel speed as observation variable. For longliners we have designed a Data Mining (DM) approach using an algorithm inspired from studies on animal movement. For purse seiners a multi-layered filtering strategy based on vessel speed and operation time was implemented. Validation against expert-labeled datasets showed average detection accuracies of 83% for trawler and longliner, and 97% for purse seiner. Our study represents the first comprehensive approach to detect and identify potential fishing behavior for three major gear types operating on a global scale. We hope that this work will enable new efforts to assess the spatial and temporal distribution of global fishing effort and make global fisheries activities transparent to ocean scientists, managers and the public.	[de Souza, Erico N.; Matwin, Stan] Dalhousie Univ, Fac Comp Sci, Big Data Analyt Inst, Halifax, NS, Canada; [Boerder, Kristina; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Matwin, Stan] Polish Acad Sci, Inst Comp Sci, Warsaw, Poland	Dalhousie University; Dalhousie University; Polish Academy of Sciences; Institute of Computer Science of the Polish Academy of Sciences	de Souza, EN (corresponding author), Dalhousie Univ, Fac Comp Sci, Big Data Analyt Inst, Halifax, NS, Canada.; Boerder, K (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	erico.souza@dal.ca; kristina.boerder@dal.ca			NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); National Science and Engineering Council of Canada	NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partly funded by the NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST) and the National Science and Engineering Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly funded by the NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST) and the National Science and Engineering Council of Canada. We are grateful for AIS data access and technical support from Exact Earth and MEOPAR and the help of Ron Pelot and Casey Hilliard, as well as a a number of fishermen, fisheries experts and fisheries observers who provided labeling information. We further thank Paul Woods, David Kroodsma, Derek Tittensor and Douglas McCauley for helpful discussion.	Alemany D, 2013, ICES J MAR SCI, V70, P123, DOI 10.1093/icesjms/fss166; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Bez N, 2011, CAN J FISH AQUAT SCI, V68, P1998, DOI 10.1139/F2011-114; Cairns WR, 2005, J NAVIGATION, V58, P181, DOI 10.1017/S0373463305003267; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carson-Jackson J, 2012, J NAVIGATION, V65, P303, DOI 10.1017/S037346331100066X; Cervera MA, 2011, INT J SATELL COMM N, V29, P117, DOI 10.1002/sat.957; Cervera MA, 2008, 2008 10TH INTERNATIONAL WORKSHOP ON SIGNAL PROCESSING FOR SPACE COMMUNICATIONS, P135; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Charles C, 2014, CAN J FISH AQUAT SCI, V71, P1817, DOI 10.1139/cjfas-2013-0572; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; Ghahramani Z, 2001, INT J PATTERN RECOGN, V15, P9, DOI 10.1142/S0218001401000836; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; JOHNSON AR, 1992, ECOLOGY, V73, P1968, DOI 10.2307/1941448; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; LEE J, 2010, J CONSEIL, V67, P1260, DOI DOI 10.1093/ICESJMS/FSQ010; Lehner S., 2009, P OCEANS 2009 EUROPE, P1, DOI [10.1109/OCEANSE.2009.5278254, DOI 10.1109/OCEANSE.2009.5278254]; Liu B, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1113; Liu B, 2014, IEEE INT CONF BIG DA, P603, DOI 10.1109/BigData.2014.7004281; Mazzarella F, 2014, 2014 17TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION); McCauley DJ, 2016, SCIENCE, V351, P1148, DOI 10.1126/science.aad5686; Natale F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130746; Pallotta G, 2013, ENTROPY-SWITZ, V15, P2218, DOI 10.3390/e15062218; Peel D, 2011, CAN J FISH AQUAT SCI, V68, P1252, DOI 10.1139/F2011-055; Lamigueiro OP, 2012, J STAT SOFTW, V50, P1; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Skaar KL, 2011, ICES J MAR SCI, V68, P1615, DOI 10.1093/icesjms/fsr091; Soleimani BH, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1100; Torgo L., 2010, DATA MINING R LEARNI; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Vermard Y, 2010, ECOL MODEL, V221, P1757, DOI 10.1016/j.ecolmodel.2010.04.005; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	38	83	85	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158248	10.1371/journal.pone.0158248	http://dx.doi.org/10.1371/journal.pone.0158248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367425	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900026
J	Ayllnon, D; Gil-Pita, R; Seoane, F				Ayllnon, David; Gil-Pita, Roberto; Seoane, Fernando			Detection and Classification of Measurement Errors in Bioimpedance Spectroscopy	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; ELECTRODE MISMATCH; BODY; SELECTION	Bioimpedance spectroscopy (BIS) measurement errors may be caused by parasitic stray capacitance, impedance mismatch, cross-talking or their very likely combination. An accurate detection and identification is of extreme importance for further analysis because in some cases and for some applications, certain measurement artifacts can be corrected, minimized or even avoided. In this paper we present a robust method to detect the presence of measurement artifacts and identify what kind of measurement error is present in BIS measurements. The method is based on supervised machine learning and uses a novel set of generalist features for measurement characterization in different immittance planes. Experimental validation has been carried out using a database of complex spectra BIS measurements obtained from different BIS applications and containing six different types of errors, as well as error-free measurements. The method obtained a low classification error (0.33%) and has shown good generalization. Since both the features and the classification schema are relatively simple, the implementation of this pre-processing task in the current hardware of bioimpedance spectrometers is possible.	[Ayllnon, David] Fonetic, R&D Dept, Madrid 28037, Spain; [Ayllnon, David; Gil-Pita, Roberto] Univ Alcala De Henares, Signal Theory & Commun Dept, Alcala De Henares, Spain; [Seoane, Fernando] Univ Boras, Fac Care Sci Work Life & Social Welf, Boras, Sweden; [Seoane, Fernando] Royal Inst Technol, Sch Technol & Hlth, Huddinge, Sweden	Universidad de Alcala; University of Boras; Royal Institute of Technology	Ayllnon, D (corresponding author), Fonetic, R&D Dept, Madrid 28037, Spain.; Ayllnon, D (corresponding author), Univ Alcala De Henares, Signal Theory & Commun Dept, Alcala De Henares, Spain.	david.ayllon@uah.es	Seoane, Fernando/L-3113-2015; Gil-Pita, Roberto/N-3748-2014	Seoane, Fernando/0000-0002-6995-967X; Gil-Pita, Roberto/0000-0002-1790-3834				Al-Hatib F, 1998, PHYSIOL MEAS, V19, P285, DOI 10.1088/0967-3334/19/2/015; Aristovich KY, 2016, NEUROIMAGE, V124, P204, DOI 10.1016/j.neuroimage.2015.08.071; Atefi SR, 2012, IEEE ENG MED BIO, P3368, DOI 10.1109/EMBC.2012.6346687; Avila ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126268; Ayllon D, 2014, ENG APPL ARTIF INTEL, V34, P37, DOI 10.1016/j.engappai.2014.05.006; Ayllon D, 2009, IEEE ENG MED BIO, P3779, DOI 10.1109/IEMBS.2009.5334494; Bogonez-Franco P, 2009, PHYSIOL MEAS, V30, P573, DOI 10.1088/0967-3334/30/7/004; Bolton MP, 1998, PHYSIOL MEAS, V19, P235, DOI 10.1088/0967-3334/19/2/011; Brusco MJ, 2014, COMPUT STAT DATA AN, V77, P38, DOI 10.1016/j.csda.2014.03.001; Buendia R, 2014, PHYSIOL MEAS, V35, P1373, DOI 10.1088/0967-3334/35/7/1373; Buendia R, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/11/115802; Buendia R, 2013, THESIS; Buendia R., 2011, J ELECT BIOIMPEDANCE, V2, P72, DOI DOI 10.5617/JEB.197; Buendia R, 2012, MED ENG PHYS, V34, P1024, DOI 10.1016/j.medengphy.2012.05.011; Cole KS., 1940, QUANT BIOL, V8, P110, DOI [10.1101/SQB.1940.008.01.013, DOI 10.1101/SQB.1940.008.01.013]; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Duda R.O., 2006, PATTERN CLASSIFICATI; Ernstbrunner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111139; Grimnes S, 2011, BIOIMPEDANCE BIOELEC, P283; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Leonhardt S, 2012, INTENS CARE MED, V38, P1917, DOI 10.1007/s00134-012-2684-z; Liu H., 2012, FEATURE SELECTION KN; Mosteller F., 1968, HDB SOCIAL PSYCHOL; Paterno AS, 2012, WORLD C MED PHYS BIO, P957; Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Scharfetter H, 1998, PHYSIOL MEAS, V19, P247, DOI 10.1088/0967-3334/19/2/012; Seoane F, 2015, BIOMED RES IN PRESS; Seoane F, 2010, IEEE ENG MED BIO, P3495, DOI 10.1109/IEMBS.2010.5627790; Tan CJ, 2014, NEUROCOMPUTING, V125, P217, DOI 10.1016/j.neucom.2012.12.057; Tronstad S, 2014, J ELEC BIOIMP, V5, P14, DOI [10.5617/jeb.830, DOI 10.5617/JEB.830]; Ye J., 2007, C P 24 INT C MACH LE, P1087; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156522	10.1371/journal.pone.0156522	http://dx.doi.org/10.1371/journal.pone.0156522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362862	Green Published, gold, Green Submitted			2022-12-26	WOS:000378865200002
J	Buijs, RVC; Zeebregts, CJ; Willems, TP; Vainas, T; Tielliu, IFJ				Buijs, Ruben V. C.; Zeebregts, Clark J.; Willems, Tineke P.; Vainas, Tryfon; Tielliu, Ignace F. J.			Endograft Sizing for Endovascular Aortic Repair and Incidence of Endoleak Type 1A	PLOS ONE			English	Article							ANEURYSM REPAIR; NECK ANGULATION; VALVE-REPLACEMENT; MANAGEMENT; EUROSTAR; ANATOMY; HOSTILE	Objective In endovascular aortic aneurysm repair (EVAR), proximal type 1A endoleaks can occur as a result of hostile neck anatomy or over- or undersizing of the endograft. As the current standard is based on the diameter or average of the short and long axes in a central lumen reconstruction image, it can falter in irregularly shaped aortic necks. An alternative method is circumference-based, therefore minimizing the measurement error. In this study we aimed to assess the degree of discrepancy between both methods and the association of this discrepancy with the occurrence of endoleak type 1A. Methods All patients with early (< 30 days post-operative) endoleak type 1A after elective EVAR at our center between 2004 and 2016 were identified for a retrospective case-control study. Control patients were matched based on hostile neck anatomy, such as calcification, thrombus, reverse taper, and beta-angulation. The aortic neck diameter was measured using the traditional, diameter-based method as well as an alternative method, based on the circumference of the aortic neck. Results In 482 EVAR patients, 18 early endoleak type 1A cases were found (3.9%). After exclusion, 12 cases remained and 48 matching controls were found. No significant differences were found between the two measuring methods at any level below the renal arteries. The interobserver variability was significant for the D(mean) (0.4 +/- 1.69 mm, P = .02) and was larger than the D(circ) method (-0.1 +/- 1.03 mm, P = .35). In only four out of 12 cases the endograft size was 10-20% larger than the D(mean) and D(circ) measurements. The differences between the diameter of the D(mean) and D(circ) and the chosen endograft were smaller for the case group (-8 +/- 25.6% and -7 +/- 24%) than for the control group. (-12.4 +/- 12.4% and -11 +/- 10.7%). Conclusion The difference between the D(mean) and D(circ) methods for aortic neck measurement was not large enough to play a significant role in the incidence of endoleak type 1A. Inadequate oversizing and considerable beta-angulation of the aortic neck may have been the cause of endoleak type 1A in this population. Robust and well-investigated sizing methods are paramount for accurate endograft sizing and prevention of endoleak type 1A. Therefore the lack of studies in this field and a sizeable inter-observer variability do not justify the widespread reliance on the traditional diameter-based methods for endograft sizing.	[Buijs, Ruben V. C.; Zeebregts, Clark J.; Vainas, Tryfon; Tielliu, Ignace F. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands; [Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen	Tielliu, IFJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands.	i.f.j.tielliu@umcg.nl						AbuRahma AF, 2011, J VASC SURG, V54, P13, DOI 10.1016/j.jvs.2010.12.010; AbuRahma AF, 2009, J VASC SURG, V50, P738, DOI 10.1016/j.jvs.2009.04.061; [Anonymous], ZEN FLEX PLANN SIZ; [Anonymous], AN AAA STENT GRAFT S; Baas AF, 2008, J VASC SURG, V47, P277, DOI 10.1016/j.jvs.2007.10.018; Dillavou ED, 2003, J VASC SURG, V38, P657, DOI 10.1016/S0741-5214(03)00738-9; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Franks SC, 2007, EUR J VASC ENDOVASC, V33, P154, DOI 10.1016/j.ejvs.2006.10.017; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Hobo R, 2007, J ENDOVASC THER, V14, P1, DOI 10.1583/06-1914.1; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Kaladji A, 2010, ANN VASC SURG, V24, P912, DOI 10.1016/j.avsg.2010.03.018; Koole D, 2013, J VASC SURG, V57, P77, DOI 10.1016/j.jvs.2012.07.003; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Schultz CJ, 2010, EUR HEART J, V31, P849, DOI 10.1093/eurheartj/ehp534; Sternbergh WC, 2002, J VASC SURG, V35, P482, DOI 10.1067/mva.2002.119506; Tielliu IFJ, 2015, MED HYPOTHESES, V85, P230, DOI 10.1016/j.mehy.2015.05.004; van Keulen JW, 2010, EUR J VASC ENDOVASC, V40, P326, DOI 10.1016/j.ejvs.2010.05.009; van Keulen JW, 2010, J VASC SURG, V51, P821, DOI 10.1016/j.jvs.2009.10.114; van Marrewijk C, 2002, J VASC SURG, V35, P461, DOI 10.1067/mva.2002.118823; Van Prehn J, 2009, EUR J VASC ENDOVASC, V38, P42, DOI 10.1016/j.ejvs.2009.03.025; Veith FJ, 2002, J VASC SURG, V35, P1029, DOI 10.1067/mva.2002.123095; White GH, 1997, J ENDOVASC SURG, V4, P152, DOI 10.1583/1074-6218(1997)004<0152:EAACOE>2.0.CO;2	24	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158042	10.1371/journal.pone.0158042	http://dx.doi.org/10.1371/journal.pone.0158042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359115	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200036
J	Cason, AM; Kohtz, A; Aston-Jones, G				Cason, Angie M.; Kohtz, Amy; Aston-Jones, Gary			Role of Corticotropin Releasing Factor 1 Signaling in Cocaine Seeking during Early Extinction in Female and Male Rats	PLOS ONE			English	Article							STRESS-INDUCED REINSTATEMENT; INDUCED RELAPSE; DRUG-SEEKING; PREFRONTAL CORTEX; STRIA TERMINALIS; HEROIN-SEEKING; BED NUCLEUS; OXYTOCIN; BEHAVIOR; AMYGDALA	Locus coeruleus norepinephrine (LC-NE) and corticotropin releasing factor (CRF) neurons are involved in stress responses, including stress's ability to drive drug relapse. Previous animal studies indicate that female rats exhibit greater drug seeking than male rats during initial drug abstinence. Moreover, females are more sensitive to the effect of stress to drive drug seeking than males. Finally, LC-NE neurons are more sensitive to CRF in females compared to males. We hypothesized that increased drug seeking in females on extinction day one (ED1) is due to increased response to the stress of early withdrawal and is dependent upon the increased response of LC in females to CRF. We predicted that LC-NE neurons would exhibit Fos activation on ED1, and that blocking CRF1 signaling would decrease drug seeking on ED1 measured by responding on an active lever previously associated with cocaine self-administration. After chronic cocaine self-administration, female and male rats underwent a test for initial extinction responding by measuring lever pressing in the absence of cocaine. Prior to this Extinction Day 1 (ED1) session, rats were injected with vehicle or the selective CRF1 antagonist (CP) to measure effects of CRF antagonism on drug seeking during early abstinence. ED1 increased corticosterone in female rats, in proportion to lever responding in male and female, indicating that ED1 was stressful. Pretreatment with CP decreased cocaine seeking on ED1 more effectively in female compared to male rats. This increase in responding was associated with an increase in activation of LC NE neurons. Together, these findings indicate that stress, and signaling at CRF receptors in LC, may be involved in the increased drug seeking during initial abstinence.	[Cason, Angie M.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kohtz, Amy; Aston-Jones, Gary] Rutgers State Univ, Rutgers Biomed & Hlth Sci, Brain Hlth Inst, Piscataway, NJ USA	Medical University of South Carolina; Rutgers State University New Brunswick; Rutgers State University Medical Center	Cason, AM (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	casona@musc.edu		Kohtz, Amy/0000-0002-7625-6534	National Institute on Drug Abuse [P50DA 016511]; PHS grant [P50 DA 016511]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA016511] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); PHS grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute on Drug Abuse grant, PHS grant P50DA 016511. https://www.drugabuse.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by PHS grant P50 DA 016511.	ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P313, DOI 10.1111/j.1748-1716.1966.tb03318.x; Anker JJ, 2010, DRUG ALCOHOL DEPEN, V107, P264, DOI 10.1016/j.drugalcdep.2009.11.002; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bentzley BS, 2014, P NATL ACAD SCI USA, V111, P11822, DOI 10.1073/pnas.1406324111; Bjorklund A, 1984, CLASSICAL TRANSMIT 2; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Buffalari DM, 2012, PHYSIOL BEHAV, V105, P209, DOI 10.1016/j.physbeh.2011.08.020; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Curtis AL, 2006, NEUROPSYCHOPHARMACOL, V31, P544, DOI 10.1038/sj.npp.1300875; Erb S, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0006.1999; Erb S, 2000, NEUROPSYCHOPHARMACOL, V23, P138, DOI 10.1016/S0893-133X(99)00158-X; Erb S, 2001, Stress, V4, P289; Erb S, 1998, J NEUROSCI, V18, P5529, DOI 10.1523/JNEUROSCI.18-14-05529.1998; Feltenstein MW, 2011, PSYCHOPHARMACOLOGY, V216, P53, DOI 10.1007/s00213-011-2187-6; Feltenstein MW, 2009, PSYCHONEUROENDOCRINO, V34, P343, DOI 10.1016/j.psyneuen.2008.09.014; Fuchs RA, 2005, PSYCHOPHARMACOLOGY, V179, P662, DOI 10.1007/s00213-004-2080-7; Hearing MC, 2008, PSYCHOPHARMACOLOGY, V150, P317; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kippin TE, 2005, PSYCHOPHARMACOLOGY, V182, P245, DOI 10.1007/s00213-005-0071-y; Kosten TA, 2008, AM J DRUG ALCOHOL AB, V34, P473, DOI 10.1080/00952990802082206; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; Le AD, 2000, PSYCHOPHARMACOLOGY, V150, P317, DOI 10.1007/s002130000411; Leri F, 2002, J NEUROSCI, V22, P5713; Li Chiang-shan Ray, 2005, Gend Med, V2, P174, DOI 10.1016/S1550-8579(05)80046-4; Liberzon I, 1997, NEUROPSYCHOPHARMACOL, V17, P353, DOI 10.1016/S0893-133X(97)00070-5; McFarland K, 2001, J NEUROSCI, V21, P8655; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Morales-Rivera A, 2014, PSYCHOPHARMACOLOGY, V231, P4145, DOI 10.1007/s00213-014-3553-y; Przegalinski E, 2005, NEUROPEPTIDES, V39, P525, DOI 10.1016/j.npep.2005.07.002; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1997, J NEUROSCI, V17, P2605; Shaham Y, 2000, EUR J NEUROSCI, V12, P292, DOI 10.1046/j.1460-9568.2000.00899.x; Sinha R, 2007, EXP CLIN PSYCHOPHARM, V15, P445, DOI 10.1037/1064-1297.15.5.445; Smith RJ, 2011, BIOL PSYCHIAT, V70, P712, DOI 10.1016/j.biopsych.2011.06.010; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; VALENTINO RJ, 1992, NEUROSCIENCE, V48, P689, DOI 10.1016/0306-4522(92)90412-U; VALENTINO RJ, 1983, BRAIN RES, V270, P363, DOI 10.1016/0006-8993(83)90615-7; Van Bockstaele EJ, 2010, BRAIN RES, V1314, P162, DOI 10.1016/j.brainres.2009.09.036; Windle RJ, 2004, J NEUROSCI, V24, P2974, DOI 10.1523/JNEUROSCI.3432-03.2004; Zhou LY, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu009	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158577	10.1371/journal.pone.0158577	http://dx.doi.org/10.1371/journal.pone.0158577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362504	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200096
J	Chae, EY; Moon, WK; Kim, HH; Kim, WH; Cha, JH; Shin, HJ; Choi, WJ; Han, W; Noh, DY; Lee, SB; Ahn, SH				Chae, Eun Young; Moon, Woo Kyung; Kim, Hak Hee; Kim, Won Hwa; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung; Han, Wonshik; Noh, Dong-Young; Lee, Sae Byul; Ahn, Sei Hyun			Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer	PLOS ONE			English	Article							RT-PCR ASSAY; GENE-EXPRESSION; ECONOMIC-ANALYSIS; DUCTAL CARCINOMA; CHEMOTHERAPY; SUBTYPES; RISK; SONOGRAPHY; THERAPY; RELAPSE	A multigene expression assay corresponds to the likelihood of breast cancer recurrence after the initial diagnosis and can be used to guide the decision for additional chemotherapy. However, only few studies have investigated the associations between the imaging features of breast cancer and the results of multigene expression assays. Our study was to identify the relationship between imaging features on ultrasound (US) and the recurrence score (RS) on a 21-gene expression assay in patients with oestrogen receptor (ER)-positive, HER2-negative breast cancer. 267 patients with ER-positive, HER-negative invasive breast cancer who underwent examinations using US and Oncotype DX assay were included. US images were independently reviewed by dedicated breast radiologists who were blind to the RS. Tumour roundness was measured using a laboratory-developed software program. The pathological data were reviewed, including immunohistochemistry results. Univariate analysis was performed to assess the associations between the RS and each variable. Multiple logistic regression analysis was used to identify independent predictors of high RS. Of 267 patients, 147 (55%) had low, 96 (36%) intermediate, and 24 (9%) had high RS. According to the univariate analysis, parallel orientation, presence of calcification in the mass, and tumour roundness were positively associated with high RS. Multiple logistic regression analysis showed that parallel orientation (OR = 5.53) and tumour roundness (OR = 1.70 per 10 increase) were associated with high RS. Parallel orientation and tumour roundness are independent variables that may predict high RS in patients with ER-positive, HER2-negative breast cancer.	[Chae, Eun Young; Kim, Hak Hee; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea; [Chae, Eun Young; Kim, Hak Hee; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Moon, Woo Kyung; Kim, Won Hwa] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul Natl Univ Hosp, Seoul, South Korea; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul Natl Univ Hosp, Seoul, South Korea; [Lee, Sae Byul; Ahn, Sei Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center	Kim, HH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.; Kim, HH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.; Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul Natl Univ Hosp, Seoul, South Korea.	moonwk@snu.ac.kr; hhkim@amc.seoul.kr	Han, Wonshik/B-3699-2008	Han, Wonshik/0000-0001-7310-0764				American college of radiology, 2013, BI RADS ULTR BI RADS; Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375; Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Blaichman J, 2012, AM J ROENTGENOL, V199, pW402, DOI 10.2214/AJR.11.7374; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hong AS, 2005, AM J ROENTGENOL, V184, P1260, DOI 10.2214/ajr.184.4.01841260; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Irshad A, 2013, AM J ROENTGENOL, V200, P284, DOI 10.2214/AJR.12.8781; Lamb PM, 2000, CLIN RADIOL, V55, P40, DOI 10.1053/crad.1999.0333; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lyman GH, 2007, CANCER-AM CANCER SOC, V109, P1011, DOI 10.1002/cncr.22506; Montemurro F, 2007, EUR RADIOL, V17, P1490, DOI 10.1007/s00330-006-0505-x; National omprehensive cancer network, 2014, NCCN CLINICAL PRACTI; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsoi DT, 2010, ONCOLOGIST, V15, P457, DOI 10.1634/theoncologist.2009-0275; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang X, 2008, J DIGIT IMAGING, V21, P170, DOI 10.1007/s10278-008-9105-4; Yepes MM, 2014, BREAST CANCER RES TR, V148, P117, DOI 10.1007/s10549-014-3143-z	32	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158461	10.1371/journal.pone.0158461	http://dx.doi.org/10.1371/journal.pone.0158461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362843	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200078
J	Santacana, M; Arias, B; Mitjans, M; Bonillo, A; Montoro, M; Rosado, S; Guillamat, R; Valles, V; Perez, V; Forero, CG; Fullana, MA				Santacana, Marti; Arias, Barbara; Mitjans, Marina; Bonillo, Albert; Montoro, Maria; Rosado, Silvia; Guillamat, Roser; Valles, Vicenc; Perez, Victor; Forero, Carlos G.; Fullana, Miquel A.			Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment	PLOS ONE			English	Article							SELF-REPORT VERSION; ANXIETY DISORDERS; NEUROTROPHIC FACTOR; PSYCHOLOGICAL TREATMENT; EXPOSURE THERAPY; DSM-IV; POLYMORPHISM; SEVERITY; THERAPYGENETICS; RELIABILITY	Background Anxiety disorders are highly prevalent and result in low quality of life and a high social and economic cost. The efficacy of cognitive-behavioural therapy (CBT) for anxiety disorders is well established, but a substantial proportion of patients do not respond to this treatment. Understanding which genetic and environmental factors are responsible for this differential response to treatment is a key step towards "personalized medicine". Based on previous research, our objective was to test whether the BDNF Val66Met polymorphism and/or childhood maltreatment are associated with response trajectories during exposure-based CBT for panic disorder (PD). Method We used Growth Mixture Modeling to identify latent classes of change (response trajectories) in patients with PD (N = 97) who underwent groupmanualized exposure-based CBT. We conducted logistic regression to investigate the effect on these trajectories of the BDNF Val66Met polymorphism and two different types of childhood maltreatment, abuse and neglect. Results We identified two response trajectories ("high response" and "low response"), and found that they were not significantly associated with either the genetic (BDNF Val66Met polymorphism) or childhood trauma-related variables of interest, nor with an interaction between these variables. Conclusions We found no evidence to support an effect of the BDNF gene or childhood trauma-related variables on CBT outcome in PD. Future studies in this field may benefit from looking at other genotypes or using different (e.g. whole-genome) approaches.	[Santacana, Marti; Montoro, Maria; Guillamat, Roser; Valles, Vicenc] Consorci Sanitari Terrassa, Dept Mental Hlth, Terrassa, Spain; [Santacana, Marti; Fullana, Miquel A.] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Cerdanyola Del Valles, Spain; [Arias, Barbara] Univ Barcelona, Dept Anim Biol, Anthropol Unit, Barcelona, Spain; [Arias, Barbara; Mitjans, Marina; Perez, Victor] Inst Salud Carlos III, CIBERSAM Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Mitjans, Marina] Max Planck Inst Expt Med, Clin Neurosci, Gottingen, Germany; [Bonillo, Albert] Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, Cerdanyola Del Valles, Spain; [Rosado, Silvia; Perez, Victor; Fullana, Miquel A.] Hosp del Mar, Inst Neuropsychiat & Addict, Barcelona, Spain; [Forero, Carlos G.] Inst Salud Carlos III, CIBERESP Ctr Invest Biomed Red Epidemiol & Salud, Madrid, Spain; [Forero, Carlos G.] IMIM Inst Hosp del Mar Invest Med, Hlth Serv Res Grp, Barcelona, Spain; [Forero, Carlos G.] Univ Pompeu Fabra, Dept Expt & Life Sci DCEXS, Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Max Planck Society; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Fullana, MA (corresponding author), Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Cerdanyola Del Valles, Spain.; Fullana, MA (corresponding author), Hosp del Mar, Inst Neuropsychiat & Addict, Barcelona, Spain.; Forero, CG (corresponding author), Inst Salud Carlos III, CIBERESP Ctr Invest Biomed Red Epidemiol & Salud, Madrid, Spain.; Forero, CG (corresponding author), IMIM Inst Hosp del Mar Invest Med, Hlth Serv Res Grp, Barcelona, Spain.; Forero, CG (corresponding author), Univ Pompeu Fabra, Dept Expt & Life Sci DCEXS, Barcelona, Spain.	cgarcia@imim.es; miguelangelfullana@gmail.com	Bonillo, Albert/H-9927-2015; Mitjans, Marina/C-4758-2018; Fullana, Miguel A/D-3288-2011; Arias, Barbara/U-7560-2017; Garcia Forero, Carlos/B-4771-2009	Bonillo, Albert/0000-0002-6141-9708; Mitjans, Marina/0000-0001-5543-7320; Fullana, Miguel A/0000-0003-3863-5223; Arias, Barbara/0000-0001-9181-2132; Garcia Forero, Carlos/0000-0002-5245-0076; Perez, Victor/0000-0002-5825-2337; Montoro Ruiz, Maria/0000-0002-2088-1007	Carlos III Health Institute/Fondo Europeo de Desarrollo Regional [PI12/00273]; Spanish Ministry of Economy and Competitivity PN -Carlos III Health Institute/Fondo Europeo de Dessarrollo Regional [PI1200018]; Centro de Investigacion Biomedica en Red - Salud Mental; University and Research Secretariat, Ministry of the Vice-presidency [2014 SGR 1636]; University and Research Secretariat, Ministry of the Economy and Finance of the Catalan Government [2014 SGR 1636]	Carlos III Health Institute/Fondo Europeo de Desarrollo Regional; Spanish Ministry of Economy and Competitivity PN -Carlos III Health Institute/Fondo Europeo de Dessarrollo Regional; Centro de Investigacion Biomedica en Red - Salud Mental; University and Research Secretariat, Ministry of the Vice-presidency; University and Research Secretariat, Ministry of the Economy and Finance of the Catalan Government	This work was supported by a grant from Carlos III Health Institute/Fondo Europeo de Desarrollo Regional (www.isciii.es) to MAF (PI12/00273). The authors of this report would also like to thank the support of the Spanish Ministry of Economy and Competitivity PN 2008-2011 -Carlos III Health Institute/Fondo Europeo de Dessarrollo Regional-(PI1200018; www.mineco.gob.es), Centro de Investigacion Biomedica en Red - Salud Mental- (www.cibersam.es), and the Universities and Research Secretariat, Ministry of the Vice-presidency and of the Economy and Finance of the Catalan Government (2014 SGR 1636; http://universitatsirecerca.gencat.cat/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden LE, 2006, J COGN PSYCHOTHER, V20, P7, DOI 10.1891/jcop.20.1.7; Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bobes J, 1998, EUR PSYCHIAT, V13, P158, DOI 10.1016/S0924-9338(98)80141-7; Bobes J. G, 2002, BANCO INSTRUMENTOS B; Bruce LC, 2013, DEPRESS ANXIETY, V30, P662, DOI 10.1002/da.22112; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Clark, 2010, THESIS; Craske M. G., 2007, MASTERY YOUR ANXIETY; Craske MG, 2009, BEHAV RES THER, V47, P931, DOI 10.1016/j.brat.2009.07.012; da Luz ACDD, 2013, NEUROPSYCHOBIOLOGY, V68, P129, DOI 10.1159/000353269; Eley TC, 2012, MOL PSYCHIATR, V17, P236, DOI 10.1038/mp.2011.132; Eley TC, 2014, DEPRESS ANXIETY, V31, P617, DOI 10.1002/da.22292; Felmingham KL, 2013, BIOL PSYCHIAT, V73, P1059, DOI 10.1016/j.biopsych.2012.10.033; Fullana MA, 2012, EUR PSYCHIAT, V27, P386, DOI 10.1016/j.eurpsy.2011.09.005; Hedman E, 2012, ACTA PSYCHIAT SCAND, V126, P126, DOI 10.1111/j.1600-0447.2012.01834.x; Hernandez A, 2013, J INTERPERS VIOLENCE, V28, P1498, DOI 10.1177/0886260512468240; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2014, J CONSULT CLIN PSYCH, V82, P375, DOI 10.1037/a0035491; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Hovens JGFM, 2016, DEPRESS ANXIETY, V33, P27, DOI 10.1002/da.22429; Hudson JL, 2013, J CHILD PSYCHOL PSYC, V54, P1086, DOI 10.1111/jcpp.12092; Ishiguro S, 2011, EUR J CLIN PHARMACOL, V67, P1213, DOI 10.1007/s00228-011-1073-9; Joesch JM, 2013, DEPRESS ANXIETY, V30, P1099, DOI 10.1002/da.22149; Keers R, 2011, PHARMACOGENOMICS J, V11, P138, DOI 10.1038/tpj.2010.14; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knuts I, 2014, EUR NEUROPSYCHOPHARM, V24, P1222, DOI 10.1016/j.euroneuro.2014.05.007; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Lereya ST, 2015, LANCET PSYCHIAT, V2, P524, DOI 10.1016/S2215-0366(15)00165-0; Lester KJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.33; Lester KJ, 2016, BRIT J PSYCHIAT, V208, P182, DOI 10.1192/bjp.bp.114.154997; Lester KJ, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-4; Li XB, 2014, CHILD ABUSE NEGLECT, V38, P788, DOI 10.1016/j.chiabu.2013.09.002; Loerinc AG, 2015, CLIN PSYCHOL REV, V42, P72, DOI 10.1016/j.cpr.2015.08.004; Lonsdorf TB, 2015, SOC COGN AFFECT NEUR, V10, P664, DOI 10.1093/scan/nsu102; Lonsdorf TB, 2010, BEHAV NEUROSCI, V124, P9, DOI 10.1037/a0018261; Lutz W, 2014, J CONSULT CLIN PSYCH, V82, P287, DOI 10.1037/a0035535; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Muth?n B., 2001, NEW DEV TECHNIQUES S, V2, P1, DOI DOI 10.4324/9781410601858-6; Nagin DS, 2014, ANN NUTR METAB, V65, P205, DOI 10.1159/000360229; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; National Institute for Health and Care Excellence, 2016, NICE GUID PLAC UNKN; National Institute of Health, 2015, NAT I MENT HLTH STRA; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P143, DOI 10.1017/S0954579411000605; Notaras M, 2015, MOL PSYCHIATR, V20, P916, DOI 10.1038/mp.2015.27; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Perna G, 2005, NEUROPSYCHOPHARMACOL, V30, P2230, DOI 10.1038/sj.npp.1300822; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Prats E, 2014, ACTAS ESP PSIQUIATRI, V42, P176; Roberts S, 2015, DEPRESS ANXIETY, V32, P861, DOI 10.1002/da.22430; Santacana M, 2014, COMPR PSYCHIAT, V55, P1467, DOI 10.1016/j.comppsych.2014.04.007; Schulz A, 2014, INT J METH PSYCH RES, V23, P387, DOI 10.1002/mpr.1447; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Stein MB, 2006, PSYCHOPHARMACOLOGY, V187, P68, DOI 10.1007/s00213-006-0349-8; Stulz N, 2007, J CLIN PSYCHOL, V63, P817, DOI 10.1002/jclp.20397; Stulz N, 2010, J CONSULT CLIN PSYCH, V78, P409, DOI 10.1037/a0019267; Sunderland M, 2012, BEHAV RES THER, V50, P374, DOI 10.1016/j.brat.2012.03.005; Tietjen GE, 2010, HEADACHE, V50, P20, DOI 10.1111/j.1526-4610.2009.01556.x; Wardenaar KJ, 2014, DEPRESS ANXIETY, V31, P778, DOI 10.1002/da.22228; Yu H, 2009, J NEUROSCI, V29, P4056, DOI 10.1523/JNEUROSCI.5539-08.2009	66	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158224	10.1371/journal.pone.0158224	http://dx.doi.org/10.1371/journal.pone.0158224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355213	Green Published, Green Submitted, gold			2022-12-26	WOS:000378859400040
J	Wang, HY; Hsieh, CH; Wen, CN; Wen, YH; Chen, CH; Lu, JJ				Wang, Hsin-Yao; Hsieh, Chia-Hsun; Wen, Chiao-Ni; Wen, Ying-Hao; Chen, Chun-Hsien; Lu, Jang-Jih			Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENE-EXPRESSION ANALYSIS; YOUDEN INDEX; SENSITIVITY; SPECIFICITY; COMBINATION; MICROARRAY; PREDICTION	Background Analytic measurement of serum tumour markers is one of commonly used methods for cancer risk management in certain areas of the world (e.g. Taiwan). Recently, cancer screening based on multiple serum tumour markers has been frequently discussed. However, the risk-benefit outcomes appear to be unfavourable for patients because of the low sensitivity and specificity. In this study, cancer screening models based on multiple serum tumour markers were designed using machine learning methods, namely support vector machine (SVM), k-nearest neighbour (KNN), and logistic regression, to improve the screening performance for multiple cancers in a large asymptomatic population. Methods AFP, CEA, CA19-9, CYFRA21-1, and SCC were determined for 20 696 eligible individuals. PSA was measured in men and CA15-3 and CA125 in women. A variable selection process was applied to select robust variables from these serum tumour markers to design cancer detection models. The sensitivity, specificity, positive predictive value (PPV), negative predictive value, area under the curve, and Youden index of the models based on single tumour markers, combined test, and machine learning methods were compared. Moreover, relative risk reduction, absolute risk reduction (ARR), and absolute risk increase (ARI) were evaluated. Results To design cancer detection models using machine learning methods, CYFRA21-1 and SCC were selected for women, and all tumour markers were selected for men. SVM and KNN models significantly outperformed the single tumour markers and the combined test for men. All 3 studied machine learning methods outperformed single tumour markers and the combined test for women. For either men or women, the ARRs were between 0.003-0.008; the ARIs were between 0.119-0.306. Conclusion Machine learning methods outperformed the combined test in analysing multiple tumour markers for cancer detection. However, cancer screening based solely on the application of multiple tumour markers remains unfavourable because of the inadequate PPV, ARR, and ARI, even when machine learning methods were incorporated into the analysis.	[Wang, Hsin-Yao; Wen, Chiao-Ni; Wen, Ying-Hao; Lu, Jang-Jih] Chang Gung Mem Hosp Linkou, Dept Lab Med, Taoyuan, Taiwan; [Hsieh, Chia-Hsun] Chang Gung Mem Hosp Linkou, Dept Internal Med, Dept Hematol Oncol, Taoyuan, Taiwan; [Hsieh, Chia-Hsun] Chang Gung Univ, Taoyuan, Taiwan; [Chen, Chun-Hsien] Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan; [Lu, Jang-Jih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Lu, JJ (corresponding author), Chang Gung Mem Hosp Linkou, Dept Lab Med, Taoyuan, Taiwan.; Chen, CH (corresponding author), Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.	cchen@mail.cgu.edu.tw; janglu45@gmail.com	Wang, Hsin-Yao/ADR-9738-2022; Hsieh, Jason Chia-Hsun/G-5059-2010; Wang, Hsin-Yao/AAF-6727-2022	Wang, Hsin-Yao/0000-0001-5581-6793; Hsieh, Jason Chia-Hsun/0000-0002-5547-409X; Wang, Hsin-Yao/0000-0001-5581-6793; Chen, Chun-Hsien/0000-0001-8353-0215				Abrao MS, 1999, INT J GYNECOL OBSTET, V66, P19, DOI 10.1016/S0020-7292(99)00046-6; Becker N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-138; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; Chen FY, 2015, STAT MED, V34, P1560, DOI 10.1002/sim.6432; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cruz JA, 2006, CANCER INFORM, V2, P59; DUK JM, 1990, GYNECOL ONCOL, V39, P186, DOI 10.1016/0090-8258(90)90430-S; Erbagci AB, 1999, DIS MARKERS, V15, P259, DOI 10.1155/1999/960934; Fan XJ, 2012, BRIT J CANCER, V106, P1735, DOI 10.1038/bjc.2012.82; Farquad MAH, 2012, DECIS SUPPORT SYST, V53, P226, DOI 10.1016/j.dss.2012.01.016; Gjavotchanoff R, 2015, INT J WOMENS HEALTH, V7, P205, DOI 10.2147/IJWH.S75288; Gonzalez-Velez H, 2009, APPL INTELL, V30, P191, DOI 10.1007/s10489-007-0085-8; Gupta D, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-13; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Kim SY, 2011, KOREAN J RADIOL, V12, P588, DOI 10.3348/kjr.2011.12.5.588; Koga Y, 2014, ANTICANCER RES, V34, P169; Li DL, 2013, CHINESE MED J-PEKING, V126, P1150, DOI 10.3760/cma.j.issn.0366-6999.20123102; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Saito M, 2005, INT J GYNECOL CANCER, V15, P37, DOI 10.1111/j.1048-891X.2005.15004.x; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; TOUITOU Y, 1989, BRIT J CANCER, V60, P419, DOI 10.1038/bjc.1989.297; Tsao KC, 2006, J CLIN LAB ANAL, V20, P42, DOI 10.1002/jcla.20102; Verplancke T, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-56; Wan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031989; Wang H, 2011, MED ONCOL, V28, pS613, DOI 10.1007/s12032-010-9663-4; Wen YH, 2015, CLIN CHIM ACTA, V450, P273, DOI 10.1016/j.cca.2015.09.004; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119	30	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158285	10.1371/journal.pone.0158285	http://dx.doi.org/10.1371/journal.pone.0158285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355357	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400044
J	Wang, XG; Lu, XK; Wang, JJ; Wang, DL; Yin, ZJ; Fan, WL; Wang, S; Ye, WW				Wang, Xiaoge; Lu, Xuke; Wang, Junjuan; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Ye, Wuwei			Mining and Analysis of SNP in Response to Salinity Stress in Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-VARIATION; SALT TOLERANCE; CROP PLANTS; RICE; MUTATION; METHYLATION; ADAPTATION; DAMAGE	Salinity stress is a major abiotic factor that affects crop output, and as a pioneer crop in saline and alkaline land, salt tolerance study of cotton is particularly important. In our experiment, four salt-tolerance varieties with different salt tolerance indexes including CRI35 (65.04%), Kanghuanwei164 (56.19%), Zhong9807 (55.20%) and CRI44 (50.50%), as well as four salt-sensitive cotton varieties including Hengmian3 (48.21%), GK50 (40.20%), Xin-yan96-48 (34.90%), ZhongS9612 (24.80%) were used as the materials. These materials were divided into salt-tolerant group (ST) and salt-sensitive group (SS). Illumina Cotton SNP 70K Chip was used to detect SNP in different cotton varieties. SNPv (SNP variation of the same seedling pre- and after-salt stress) in different varieties were screened; polymorphic SNP and SNPr (SNP related to salt tolerance) were obtained. Annotation and analysis of these SNPs showed that (1) the induction efficiency of salinity stress on SNPv of cotton materials with different salt tolerance index was different, in which the induction efficiency on salt-sensitive materials was significantly higher than that on salt-tolerant materials. The induction of salt stress on SNPv was obviously biased. (2) SNPv induced by salt stress may be related to the methylation changes under salt stress. (3) SNPr may influence salt tolerance of plants by affecting the expression of salt-tolerance related genes.	[Wang, Xiaoge; Lu, Xuke; Wang, Junjuan; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Ye, Wuwei] Chinese Acad Agr Sci, Key Lab Cotton Genet Improvement, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Ye, WW (corresponding author), Chinese Acad Agr Sci, Key Lab Cotton Genet Improvement, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	yew158@163.com			National High-tech Research and Development Program of China (863 Program) [2013AA102601]	National High-tech Research and Development Program of China (863 Program)	This work was supported by the National High-tech Research and Development Program of China (863 Program): 2013AA102601.	Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; [Anonymous], 2015, PLOS ONE, V11; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Colautti RI, 2012, CURR OPIN PLANT BIOL, V15, P199, DOI 10.1016/j.pbi.2012.01.016; Duan DD, 2015, SCI CHINA LIFE SCI, V58, P827, DOI 10.1007/s11427-015-4907-3; Fam SS, 2003, CURR MED CHEM, V10, P1723, DOI 10.2174/0929867033457115; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Garg B, 2012, MOL BIOL REP, V39, P10865, DOI 10.1007/s11033-012-1983-3; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hainaut P, 2004, TOXICOL APPL PHARM, V197, P153; Jaiswal V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129400; JONES PA, 1992, BIOESSAYS, V14, P33, DOI 10.1002/bies.950140107; Khan MH, 2008, ACTA PHYSIOL PLANT, V30, P81, DOI 10.1007/s11738-007-0093-7; Li F, 2015, NATURE BIOTECHNOLOGY, V33; Li Z, 2015, INT J CANCER, V138, P74, DOI [10.1002/ijc.29677, DOI 10.1002/IJC.29677]; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; Nybom Hilde, 2014, Investig Genet, V5, P1, DOI 10.1186/2041-2223-5-1; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Tuteja N, 2008, CRITICAL REV BIOCH M, V36, P337; Tzuri G, 2015, PLANT J, V83, P940, DOI 10.1111/tpj.12950; Wu Y, 2012, PLOS ONE, V8; Xing AQ, 2015, J EXP BOT, V66, P3791, DOI 10.1093/jxb/erv182; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Zhang Lina, 2010, Biodiversity Science, V18, P137; Zhao YL, 2010, AGR SCI CHINA, V9, P783, DOI 10.1016/S1671-2927(09)60155-3	34	9	9	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158142	10.1371/journal.pone.0158142	http://dx.doi.org/10.1371/journal.pone.0158142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355327	Green Submitted, Green Published, gold			2022-12-26	WOS:000378859400031
J	Dutta, S; Choudhury, D; Roy, S; Dattagupta, JK; Biswas, S				Dutta, Sruti; Choudhury, Debi; Roy, Sumana; Dattagupta, Jiban Kanti; Biswas, Sampa			Mutation in the Pro-Peptide Region of a Cysteine Protease Leads to Altered Activity and Specificity-A Structural and Biochemical Approach	PLOS ONE			English	Article							HUMAN PROCATHEPSIN L; CONFORMATIONAL DIVERSITY; CRYSTAL-STRUCTURE; PAPAIN; INHIBITION; CATHEPSINS; PROSEQUENCE; SOFTWARE; PROTEINS; SUBSITE	Papain-like proteases contain an N-terminal pro-peptide in their zymogen form that is important for correct folding and spatio-temporal regulation of the proteolytic activity of these pro teases. Catalytic removal of the pro-peptide is required for the protease to become active. In this study, we have generated three different mutants of papain (186F, 186L and 186A) by replacing the residue 186 in its pro-peptide region, which blocks the specificity determining S2-subsite of the catalytic cleft of the protease in its zymogen form with a view to investigate the effect of mutation on the catalytic activity of the protease. Steady-state enzyme kinetic analyses of the corresponding mutant proteases with specific peptide substrates show significant alteration of substrate specificity-186F and 186L have 2.7 and 29.1 times higher k(cat)/K-m values compared to the wild-type against substrates having Phe and Leu at P2 position, respectively, while 186A shows lower catalytic activity against majority of the substrates tested. Far-UV CD scan and molecular mass analyses of the mature form of the mutant pro teases reveal similar CD spectra and intact masses to that of the wild-type. Crystal structures of zymogens of 186F and 186L mutants suggest that subtle reorganization of active site residues, including water, upon binding of the pro-peptide may allow the enzyme to achieve discriminatory substrate selectivity and catalytic efficiency. However, accurate and reliable predictions on alteration of substrate specificity require atomic resolution structure of the catalytic domain after zymogen activation, which remains a challenging task. In this study we demonstrate that through single amino acid substitution in pro-peptide, it is possible to modify the substrate specificity of papain and hence the pro-peptide of a protease can also be a useful target for altering its catalytic activity/specificity.	[Dutta, Sruti; Choudhury, Debi; Roy, Sumana; Dattagupta, Jiban Kanti; Biswas, Sampa] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1-AF Bidhannagar, Kolkata 700064, India	Saha Institute of Nuclear Physics	Biswas, S (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1-AF Bidhannagar, Kolkata 700064, India.	sampa.biswas@saha.ac.in			DBT, Govt. of India [BT/PR13895/BRB/10/789/2010]	DBT, Govt. of India(Department of Biotechnology (DBT) India)	The authors thank the beam-line staffs of BM14, at the ESRF for help during data collection and DBT, Govt. of India, for financial support and for providing access to the beam-line. MALDI-TOF experiments were carried out at IPLS-DBT facility of Calcutta University, Kolkata. This project was supported by institutional grant (MSACR project) and funding from DBT, Govt. of India (BT/PR13895/BRB/10/789/2010 dt. 15-06-2011).; We thank the beam-line staffs of BM14, at the ESRF for help during data collection and DBT, Govt. of India for financial support and for providing access to the beam-line. MALDI-TOF experiments were carried out at IPLS-DBT facility of Calcutta University, Kolkata. This project was supported by institutional grant (MSACR project) and funding from DBT, Govt. of India (BT/PR13895/BRB/10/789/2010 dt. 15-06-2011).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Choudhury D, 2010, PROTEIN ENG DES SEL, V23, P457, DOI 10.1093/protein/gzq016; Choudhury D, 2009, PHYTOCHEMISTRY, V70, P465, DOI 10.1016/j.phytochem.2009.02.001; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cygler M, 1997, BIOCHIMIE, V79, P645, DOI 10.1016/S0300-9084(97)83497-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Grzonka Z., 2007, IND ENZYMES STRUCTUR, V1st ed., P181; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Khan AR, 1998, PROTEIN SCI, V7, P815; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; MOLE JE, 1973, BIOCHEMISTRY-US, V12, P816, DOI 10.1021/bi00729a005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; Steverding D, 2006, MINI-REV MED CHEM, V6, P1025, DOI 10.2174/138955706778195207; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VERNET T, 1990, J BIOL CHEM, V265, P16661; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612	32	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158024	10.1371/journal.pone.0158024	http://dx.doi.org/10.1371/journal.pone.0158024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352302	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900025
J	Nakazawa, M; Matsubara, H; Matsushita, Y; Watanabe, M; Vo, N; Yoshida, H; Yamaguchi, M; Kataoka, T				Nakazawa, Mako; Matsubara, Hisanori; Matsushita, Yuka; Watanabe, Megumi; Vo, Nicole; Yoshida, Hideki; Yamaguchi, Masamitsu; Kataoka, Takao			The Human Bcl-2 Family Member Bcl-rambo Localizes to Mitochondria and Induces Apoptosis and Morphological Aberrations in Drosophila	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ACUTE LYMPHOBLASTIC-LEUKEMIA; OUTER-MEMBRANE; PROTEIN FAMILY; MECHANISMS; EXPRESSION; HOMOLOG; GENES; CASPASES; DISEASE	Bcl-2 family proteins play a central role in regulating apoptosis. We previously reported that human Bcl-rambo, also termed BCL2L13, localized to mitochondria and induced apoptosis when overexpressed in human embryonic kidney 293T cells. However, the physiological function of Bcl-rambo currently remains unclear. In the present study, human Bcl-rambo was ectopically expressed in Drosophila melanogaster. Bcl-rambo mainly localized to the mitochondria of Drosophila Schneider 2 (S2) cells. The overexpression of Bcl-rambo, but not Bcl-rambo lacking a C-terminal transmembrane domain, induced apoptosis in S2 cells. Moreover, the ectopic expression of Bcl-rambo by a GAL4-UAS system induced aberrant morphological changes characterized by atrophied wing, split thorax, and rough eye phenotypes. Bcl-rambo induced the activation of effector caspases in eye imaginal discs. The rough eye phenotype induced by Bcl-rambo was partly rescued by the co-expression of p35, Diap1, and Diap2. By using this Drosophila model, we showed that human Bcl-rambo interacted genetically with Drosophila homologues of adenine nucleotide translocators and the autophagy-related 8 protein. The results of the present study demonstrated that human Bcl-rambo localized to mitochondria and at least regulated an apoptosis signaling pathway in Drosophila.	[Nakazawa, Mako; Matsubara, Hisanori; Matsushita, Yuka; Watanabe, Megumi; Vo, Nicole; Yoshida, Hideki; Yamaguchi, Masamitsu; Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Vo, Nicole; Yoshida, Hideki; Yamaguchi, Masamitsu; Kataoka, Takao] Kyoto Inst Technol, CAIRP, Sakyo Ku, Kyoto 6068585, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Kataoka, T (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.; Kataoka, T (corresponding author), Kyoto Inst Technol, CAIRP, Sakyo Ku, Kyoto 6068585, Japan.	takao.kataoka@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	NOVARTIS Foundation (Japan); Ministry of Education, Science, Sports and Culture of Japan; Japan Science and Technology Agency; JSPS Core-to-Core Program; B. Asia-Africa Science Platforms	NOVARTIS Foundation (Japan)(Novartis); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); B. Asia-Africa Science Platforms	This work was partly supported by a research grant from the NOVARTIS Foundation (Japan) for the Promotion of Science (to TK) and Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, Japan Science and Technology Agency and JSPS Core-to-Core Program, B. Asia-Africa Science Platforms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Boumela I, 2014, CURR MED CHEM, V21, P1361, DOI 10.2174/09298673113206660278; Brachmann CB, 2000, CURR BIOL, V10, P547, DOI 10.1016/S0960-9822(00)00474-7; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Brill E, 2010, CANCER RES, V70, P6891, DOI 10.1158/0008-5472.CAN-10-0745; Brun S, 2002, ONCOGENE, V21, P6458, DOI 10.1038/sj.onc.1205839; Calleja M, 2000, DEVELOPMENT, V127, P3971; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Darding M, 2012, CELL DEATH DIFFER, V19, P58, DOI 10.1038/cdd.2011.163; Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galindo KA, 2009, DEVELOPMENT, V136, P275, DOI 10.1242/dev.019042; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gaumer S, 2000, CELL DEATH DIFFER, V7, P804, DOI 10.1038/sj.cdd.4400714; Heitzler P, 1996, GENETICS, V143, P1271; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Jenkins VK, 2013, TRENDS CELL BIOL, V23, P567, DOI 10.1016/j.tcb.2013.07.005; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim JY, 2012, FEBS LETT, V586, P3142, DOI 10.1016/j.febslet.2012.08.015; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Morimura S, 1996, DEV BIOL, V177, P136, DOI 10.1006/dbio.1996.0151; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Schouten M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12448; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; Sevrioukov EA, 2007, GENESIS, V45, P184, DOI 10.1002/dvg.20279; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Takahashi Y, 1999, NUCLEIC ACIDS RES, V27, P510, DOI 10.1093/nar/27.2.510; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527; Wang ZG, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0678-5; Yacobi-Sharon K, 2013, DEV CELL, V25, P29, DOI 10.1016/j.devcel.2013.02.002; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yi P, 2003, FEBS LETT, V534, P61, DOI 10.1016/S0014-5793(02)03778-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang H, 2000, J BIOL CHEM, V275, P27303; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	58	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157823	10.1371/journal.pone.0157823	http://dx.doi.org/10.1371/journal.pone.0157823			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348811	Green Submitted, Green Published, gold			2022-12-26	WOS:000378801200016
J	Glass, TJ; Connor, NP				Glass, Tiffany J.; Connor, Nadine P.			Digastric Muscle Phenotypes of the Ts65Dn Mouse Model of Down Syndrome	PLOS ONE			English	Article							MOTOR DYSFUNCTION; FIBER PROPERTIES; CHILDREN; ISOFORMS; DYSPHAGIA; ANTERIOR; DEFECTS; ADULTS	Down syndrome is frequently associated with complex difficulties in oromotor development, feeding, and swallowing. However, the muscle phenotypes underlying these deficits are unclear. We tested the hypotheses that the Ts65Dn mouse model of DS has significantly altered myosin heavy chain (MyHC) isoform profiles of the muscles involved in feeding and swallowing, as well as reductions in the speed of these movements during behavioral assays. SDS-PAGE, immunofluorescence, and qRT-PCR were used to assess MyHC isoform expression in pertinent muscles, and functional feeding and swallowing performance were quantified through videofluoroscopy and mastication assays. We found that both the anterior digastric (ADG) and posterior digastric (PDG) muscles in 11-day old and 5-6 week old Ts65Dn groups showed significantly lower MyHC 2b protein levels than in age-matched euploid control groups. In videofluoroscopic and videotape assays used to quantify swallowing and mastication performance, 5-6 week old Ts65Dn and euploid controls showed similar swallow rates, inter-swallow intervals, and mastication rates. In analysis of adults, 10-11 week old Ts65Dn mice revealed significantly less MyHC 2b mRNA expression in the posterior digastric, but not the anterior digastric muscle as compared with euploid controls. Analysis of MyHC 2b protein levels across an adult age range (10-53 weeks of age) revealed lower levels of MyHC 2b protein in the PDG of Ts65Dn than in euploids, but similar levels of MyHC 2b in the ADG. Cumulatively, these results indicate biochemical differences in some, but not all, muscles involved in swallowing and jaw movement in Ts65Dn mice that manifest early in post-natal development, and persist into adulthood. These findings suggest potential utility of this model for future investigations of the mechanisms of oromotor difficulties associated with Down syndrome.	[Glass, Tiffany J.; Connor, Nadine P.] Univ Wisconsin, Dept Surg, Madison, WI USA; [Connor, Nadine P.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Glass, TJ (corresponding author), Univ Wisconsin, Dept Surg, Madison, WI USA.	glass@surgery.wisc.edu			Jerome Lejeune Foundation [1326]; National Institute on Deafness and Other Communication Disorders (NIDCD) [T32DC009401, F32DC014885, R01DC005935, R01 DC008149]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC014885, T32DC009401, R01DC005935, R01DC008149] Funding Source: NIH RePORTER	Jerome Lejeune Foundation; National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors appreciate the support of the Jerome Lejeune Foundation, Agreement #1326. (URL: https://lejeuneusa.org/). This work was also supported in part through the National Institute on Deafness and Other Communication Disorders (NIDCD) T32DC009401, NIDCD F32DC014885, NIDCD R01DC005935 and R01 DC008149. (URL: https://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Shinichi, 2008, Bull Tokyo Dent Coll, V49, P53, DOI 10.2209/tdcpublication.49.53; Adreani CM, 2006, VET PATHOL, V43, P881, DOI 10.1354/vp.43-6-881; Barrow JR, 1999, DEVELOPMENT, V126, P5011; BERSU ET, 1980, AM J MED GENET, V5, P399, DOI 10.1002/ajmg.1320050411; Caiozzo VJ, 2003, AM J PHYSIOL-REG I, V285, pR570, DOI 10.1152/ajpregu.00646.2002; Cisterna Barbara, 2013, Muscles Ligaments Tendons J, V3, P287; Connor NP, 2013, MUSCLE NERVE, V47, P230, DOI 10.1002/mus.23499; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Costa ACS, 2011, DEV NEUROSCI-BASEL, V33, P414, DOI 10.1159/000330861; Costa ACS, 2010, BEHAV BRAIN RES, V206, P52, DOI 10.1016/j.bbr.2009.08.034; Cowley PM, 2012, AM J PHYSIOL-REG I, V303, pR1251, DOI 10.1152/ajpregu.00312.2012; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Delaney AL, 2008, DEV DISABIL RES REV, V14, P105, DOI 10.1002/ddrr.16; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Faulks D, 2008, J ORAL REHABIL, V35, P854, DOI 10.1111/j.1365-2842.2008.01877.x; Frazier JB, 1996, DEV MED CHILD NEUROL, V38, P695, DOI 10.1111/j.1469-8749.1996.tb12139.x; Fuchs C, 2012, LAB INVEST, V92, P1648, DOI 10.1038/labinvest.2012.117; Hashimoto M, 2014, DYSPHAGIA, V29, P509, DOI 10.1007/s00455-014-9538-5; Hennequin M, 2005, J DENT RES, V84, P1057, DOI 10.1177/154405910508401117; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Kent RD, 2013, J SPEECH LANG HEAR R, V56, P178, DOI 10.1044/1092-4388(2012/12-0148); Kletzien H, 2013, J APPL PHYSIOL, V114, P472, DOI 10.1152/japplphysiol.01370.2012; Lazenby T, 2008, DYSPHAGIA, V23, P88, DOI 10.1007/s00455-007-9096-1; Lever TE, 2015, JOVE-J VIS EXP, DOI 10.3791/52319; Lever TE, 2009, DYSPHAGIA, V24, P180, DOI 10.1007/s00455-008-9190-z; Maejima M, 2005, ARCH ORAL BIOL, V50, P988, DOI 10.1016/j.archoralbio.2005.03.007; Nariyama M, 2012, CELL BIOCHEM FUNCT, V30, P82, DOI 10.1002/cbf.1821; O'Neill AC, 2013, OTOLARYNG HEAD NECK, V149, P146, DOI 10.1177/0194599813483445; Okubo K, 2006, ZOOL SCI, V23, P1079, DOI 10.2108/zsj.23.1079; Pandorf CE, 2010, J APPL PHYSIOL, V108, P222, DOI 10.1152/japplphysiol.01233.2009; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pearson WG, 2013, INT J RADIAT ONCOL, V85, P735, DOI 10.1016/j.ijrobp.2012.07.2370; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pierson CR, 2005, J NEUROPATH EXP NEUR, V64, P555, DOI 10.1097/01.jnen.0000171653.17213.2e; PIPES PL, 1980, J AM DIET ASSOC, V77, P277; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Schaser AJ, 2011, DYSPHAGIA, V26, P256, DOI 10.1007/s00455-010-9297-x; Smith CH, 2014, DYSPHAGIA, V29, P52, DOI 10.1007/s00455-013-9479-4; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Spender Q, 1996, DEV MED CHILD NEUROL, V38, P681, DOI 10.1111/j.1469-8749.1996.tb12138.x; SPENDER Q, 1995, EUR J DISORDER COMM, V30, P77; Suzuki K, 2007, ANAT HISTOL EMBRYOL, V36, P103, DOI 10.1111/j.1439-0264.2006.00729.x; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Yoshii M, 2008, ANAT HISTOL EMBRYOL, V37, P147, DOI 10.1111/j.1439-0264.2007.00813.x; Zarate N, 2001, AM J GASTROENTEROL, V96, P1718, DOI 10.1016/S0002-9270(01)02427-3	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158008	10.1371/journal.pone.0158008	http://dx.doi.org/10.1371/journal.pone.0158008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336944	Green Submitted, gold, Green Published			2022-12-26	WOS:000378389200086
J	Wang, DL; Zhang, MH; Gao, X; Yu, LJ				Wang, Dalong; Zhang, Minghui; Gao, Xuan; Yu, Lijuan			Prognostic Value of Baseline F-18-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TOTAL LESION GLYCOLYSIS; METABOLIC TUMOR VOLUME; PREDICTS SURVIVAL; FDG PET/CT; CANCER; CRITERIA; IMPACT	The study objective was to retrospectively analyze the metabolic variables derived from 18 F-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) as predictors of progression-free survival (PFS) and overall survival (OS) in advanced lung adenocarcinoma stratified by epidermal growth factor receptor (EGFR) mutation status. A total of 176 patients (91, EGFR mutation; 85, wild-type EGFR) who underwent F-18-FDG PET/CT before treatment were enrolled. The main F-18-FDG PET/CTderived variables: primary tumor maximum standardized uptake value (SUVmaxT), primary tumor total lesion glycolysis (TLG(T)), the maximum SUVmax of all selected lesions in whole body determined using the Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 criteria (SUVmaxWBR), and whole-body total TLG determined using the RECIST 1.1 criteria (TLG(WBR)) were measured. Survival analysis regarding TLG(WBR), and other factors in advanced lung adenocarcinoma patients stratified using EGFR mutation status, were evaluated. The results indicated that high TLG(WBR) (>= 259.85), EGFR wild-type, and high serum LDH were independent predictors of worse PFS and OS in all patients with advanced lung adenocarcinoma. Among patients with wild-type EGFR, only TLG(WBR) retained significance as an independent predictor of both PFS and OS. Among patients with the EGFR mutation, high serum LDH level was an independent predictor of worse PFS and OS, and high TLG(WBR) (>= 259.85) was an independent predictor of worse PFS but not worse OS. In conclusion, TLG(WBR) is a promising parameter for prognostic stratification of patients with advanced lung adenocarcinoma and EGFR status; however, it cannot be used to further stratify the risk of worse OS for patients with the EGFR mutation. Further prospective studies are needed to validate our findings.	[Wang, Dalong] Harbin Med Univ, Dept Radiol, Affiliated Hosp 2, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Minghui] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Heilongjiang Pr, Peoples R China; [Gao, Xuan; Yu, Lijuan] Harbin Med Univ, Canc Hosp, Dept PET CT, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Yu, LJ (corresponding author), Harbin Med Univ, Canc Hosp, Dept PET CT, Harbin, Heilongjiang Pr, Peoples R China.	yulijuan2003@126.com			Natural Science Foundation of China [81171405]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Project Research (81171405) from the Natural Science Foundation of China. http://www.nsfc.gov.cn/; Lijuan Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Chung HW, 2014, J CANCER RES CLIN, V140, P89, DOI 10.1007/s00432-013-1545-7; Conde E, 2013, CLIN TRANSL ONCOL, V15, P503, DOI 10.1007/s12094-012-0983-z; de Langen AJ, 2012, J NUCL MED, V53, P701, DOI 10.2967/jnumed.111.095299; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Dong Y, 2015, ARCH VIROL, V160, P929, DOI 10.1007/s00705-014-2311-0; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ettinger DS, 2015, J NATL COMPR CANC NE, V13, P515, DOI 10.6004/jnccn.2015.0071; Fonti R, 2012, J NUCL MED, V53, P1829, DOI 10.2967/jnumed.112.106500; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hicks RJ, 2001, J NUCL MED, V42, P1596; Hicks RJ, 2001, J NUCL MED, V42, P1605; Ho TY, 2015, CLIN NUCL MED, V40, pE295, DOI 10.1097/RLU.0000000000000774; Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628; Hoekstra CJ, 2003, LUNG CANCER-J IASLC, V39, P151, DOI 10.1016/S0169-5002(02)00446-4; Hyun SH, 2014, EUR J NUCL MED MOL I, V41, P50, DOI 10.1007/s00259-013-2530-8; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Krawczyk P, 2013, ONCOL REP, V30, P1463, DOI 10.3892/or.2013.2553; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Liao SR, 2012, ACAD RADIOL, V19, P69, DOI 10.1016/j.acra.2011.08.020; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Maroun JA, 2011, CURR ONCOL, V18, pS3; Olivier A, 2014, NUCL MED COMMUN, V35, P908, DOI 10.1097/MNM.0000000000000145; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Sasaki R, 2005, J CLIN ONCOL, V23, P1136, DOI 10.1200/JCO.2005.06.129; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Ulas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114471; Wang XQ, 2014, INT J CLIN EXP PATHO, V7, P4310; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yoo SW, 2012, NUCL MED MOLEC IMAG, V46, P286, DOI 10.1007/s13139-012-0165-5; Zhang H, 2013, ACAD RADIOL, V20, P32, DOI 10.1016/j.acra.2012.07.002	34	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158307	10.1371/journal.pone.0158307	http://dx.doi.org/10.1371/journal.pone.0158307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336755	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200130
J	Scholl, ZN; Li, Q; Yang, WT; Marszalek, PE				Scholl, Zackary N.; Li, Qing; Yang, Weitao; Marszalek, Piotr E.			Single-molecule Force Spectroscopy Reveals the Calcium Dependence of the Alternative Conformations in the Native State of a -Crystallin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); calcium; crystallin; molecular dynamics; protein folding	BETA-GAMMA-CRYSTALLINS; MYXOCOCCUS-XANTHUS; BINDING-PROPERTIES; ENERGY LANDSCAPES; DOMAIN STABILITY; CA2+ BINDING; ION BINDING; EYE LENS; EVOLUTION; STABILIZATION	Although multidomain proteins predominate the proteome of all organisms and are expected to display complex folding behaviors and significantly greater structural dynamics as compared with single-domain proteins, their conformational heterogeneity and its impact on their interaction with ligands are poorly understood due to a lack of experimental techniques. The multidomain calcium-binding -crystallin proteins are particularly important because their deterioration and misfolding/aggregation are associated with melanoma tumors and cataracts. Here we investigate the mechanical stability and conformational dynamics of a model calcium-binding -crystallin protein, Protein S, and elaborate on its interactions with calcium. We ask whether domain interactions and calcium binding affect Protein S folding and potential structural heterogeneity. Our results from single-molecule force spectroscopy show that the N-terminal (but not the C-terminal) domain is in equilibrium with an alternative conformation in the absence of Ca2+, which is mechanically stable in contrast to other proteins that were observed to sample a molten globule under similar conditions. Mutagenesis experiments and computer simulations reveal that the alternative conformation of the N-terminal domain is caused by structural instability produced by the high charge density of a calcium binding site. We find that this alternative conformation in the N-terminal domain is diminished in the presence of calcium and can also be partially eliminated with a hitherto unrecognized compensatory mechanism that uses the interaction of the C-terminal domain to neutralize the electronegative site. We find that up to 1% of all identified multidomain calcium-binding proteins contain a similarly highly charged site and therefore may exploit a similar compensatory mechanism to prevent structural instability in the absence of ligand.	[Scholl, Zackary N.] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; [Li, Qing; Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Yang, Weitao] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Scholl, ZN (corresponding author), Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA.; Marszalek, PE (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.; Yang, WT (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	zns@duke.edu; weitao.yang@duke.edu; pemar@duke.edu	Yang, Weitao/C-1109-2008; Li, Qing/AAE-5788-2019	Yang, Weitao/0000-0001-5576-2828; 	National Science Foundation (NSF) [GRFP 1106401]; Katherine Goodman Stern Fellowship; NSF [MCB-1052208, MCB-1517245]; Div Of Molecular and Cellular Bioscience [1517245] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Katherine Goodman Stern Fellowship; NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) Grant GRFP 1106401 and the Katherine Goodman Stern Fellowship (to Z. N. S.) and by NSF Grants MCB-1052208 (to P. E. M.) and MCB-1517245 (to P. E. M. and W. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Aravind P, 2008, J MOL BIOL, V381, P509, DOI 10.1016/j.jmb.2008.06.019; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Bagby S, 1998, J MOL BIOL, V276, P669, DOI 10.1006/jmbi.1997.1563; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2001, J MOL BIOL, V311, P879, DOI 10.1006/jmbi.2001.4871; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Fitter J, 2009, CELL MOL LIFE SCI, V66, P1672, DOI 10.1007/s00018-009-8771-9; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Garai A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869869; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; Giancola C, 2005, FEBS J, V272, P1023, DOI 10.1111/j.1742-4658.2004.04536.x; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hoffmann T, 2012, CHEM SOC REV, V41, P4781, DOI 10.1039/c2cs35033e; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Kotamarthi HC, 2013, BIOPHYS J, V104, P2273, DOI [10.1016/j.bpj.2013.04.008, 10.1016/J.BPJ.2013.04.008]; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Lewis KM, 2015, J BIOL CHEM, V290, P28665, DOI 10.1074/jbc.M115.686261; LOWRY CL, 1992, PROTEINS, V12, P42, DOI 10.1002/prot.340120106; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Noy A, 2013, METHODS, V60, P142, DOI 10.1016/j.ymeth.2013.03.014; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Permyakov EA, 2000, FEBS LETT, V473, P269, DOI 10.1016/S0014-5793(00)01546-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Scholl ZN, 2015, ACS NANO, V9, P1189, DOI 10.1021/nn504686f; Scholl ZN, 2014, J BIOL CHEM, V289, P28607, DOI 10.1074/jbc.M114.582049; Scholl ZN, 2014, WIRES NANOMED NANOBI, V6, P211, DOI 10.1002/wnan.1253; Scholl ZN, 2014, ULTRAMICROSCOPY, V136, P7, DOI 10.1016/j.ultramic.2013.07.020; SHARMA Y, 1989, J BIOL CHEM, V264, P12794; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Spurway TD, 1997, J BIOL CHEM, V272, P17523, DOI 10.1074/jbc.272.28.17523; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Srivastava SS, 2014, J BIOL CHEM, V289, P10958, DOI 10.1074/jbc.O113.539569; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Takeuchi Y, 2009, BIOCHEMISTRY-US, V48, P10637, DOI 10.1021/bi901334b; TEINTZE M, 1988, J BIOL CHEM, V263, P1199; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Wenk M, 1998, FEBS LETT, V438, P127, DOI 10.1016/S0014-5793(98)01287-3; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Zoldak G, 2013, CURR OPIN STRUC BIOL, V23, P48, DOI 10.1016/j.sbi.2012.11.007	74	10	11	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18263	18275		10.1074/jbc.M116.729525	http://dx.doi.org/10.1074/jbc.M116.729525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27378818	hybrid, Green Published			2022-12-26	WOS:000383241800019
J	Gholkar, AA; Cheung, K; Williams, KJ; Lo, YC; Hamideh, SA; Nnebe, C; Khuu, C; Bensinger, SJ; Torres, JZ				Gholkar, Ankur A.; Cheung, Keith; Williams, Kevin J.; Lo, Yu-Chen; Hamideh, Shadia A.; Nnebe, Chelsea; Khuu, Cindy; Bensinger, Steven J.; Torres, Jorge Z.			Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell death; cell division; lipid metabolism; mitosis; Betulin; Fatostatin; PF-429242; SREBP	STEROL-REGULATORY-ELEMENT; PROSTATE-CANCER; SMALL-MOLECULE; SREBP; PROTEIN; IDENTIFICATION; TRANSCRIPTION; METABOLISM; BIOLOGY; BINDING	The sterol regulatory element-binding protein (SREBP) transcription factors have become attractive targets for pharmacological inhibition in the treatment of metabolic diseases and cancer. SREBPs are critical for the production and metabolism of lipids and cholesterol, which are essential for cellular homeostasis and cell proliferation. Fatostatin was recently discovered as a specific inhibitor of SREBP cleavage-activating protein (SCAP), which is required for SREBP activation. Fatostatin possesses antitumor properties including the inhibition of cancer cell proliferation, invasion, and migration, and it arrests cancer cells in G(2)/M phase. Although Fatostatin has been viewed as an antitumor agent due to its inhibition of SREBP and its effect on lipid metabolism, we show that Fatostatin's anticancer properties can also be attributed to its inhibition of cell division. We analyzed the effect of SREBP activity inhibitors including Fatostatin, PF-429242, and Betulin on the cell cycle and determined that only Fatostatin possessed antimitotic properties. Fatostatin inhibited tubulin polymerization, arrested cells in mitosis, activated the spindle assembly checkpoint, and triggered mitotic catastrophe and reduced cell viability. Thus Fatostatin's ability to inhibit SREBP activity and cell division could prove beneficial in treating aggressive types of cancers such as glioblastomas that have elevated lipid metabolism and fast proliferation rates and often develop resistance to current anticancer therapies.	[Gholkar, Ankur A.; Cheung, Keith; Lo, Yu-Chen; Hamideh, Shadia A.; Nnebe, Chelsea; Khuu, Cindy; Torres, Jorge Z.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA; [Williams, Kevin J.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Torres, Jorge Z.] Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA; [Bensinger, Steven J.; Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	torres@chem.ucla.edu		Torres, Jorge/0000-0002-2158-889X; Gholkar, Ankur/0000-0002-3490-234X	NCI, National Institutes of Health [P30CA016042]; Jonsson Comprehensive Cancer Center (JCCC) seed; University of California Cancer Research Coordinating Committee (UC-CRCC) grants; Cottrell Scholar Award from the Research Corporation for Science Advancement; National Institutes of Health [AI093768, HL126556]; Whitcome fellowship; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL126556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093768] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jonsson Comprehensive Cancer Center (JCCC) seed; University of California Cancer Research Coordinating Committee (UC-CRCC) grants; Cottrell Scholar Award from the Research Corporation for Science Advancement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NCI, National Institutes of Health Grant P30CA016042, Jonsson Comprehensive Cancer Center (JCCC) seed and University of California Cancer Research Coordinating Committee (UC-CRCC) grants, and a Cottrell Scholar Award from the Research Corporation for Science Advancement (to J.Z.T.); National Institutes of Health Grants AI093768 and HL126556 (to S.J.B.); and a Whitcome fellowship (to K.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Choi YM, 2003, J BIOL CHEM, V278, P7320, DOI 10.1074/jbc.M210283200; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hay BA, 2007, BIOORG MED CHEM LETT, V17, P4411, DOI 10.1016/j.bmcl.2007.06.031; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Li XY, 2015, ONCOTARGET, V6, P41018, DOI 10.18632/oncotarget.5879; Li XY, 2014, MOL CANCER THER, V13, P855, DOI 10.1158/1535-7163.MCT-13-0797; Lo YC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004153; Murai T, 2015, BIOL CHEM, V396, P1, DOI 10.1515/hsz-2014-0194; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Notarnicola M, 2014, CURR MED CHEM, V21, P2729, DOI 10.2174/0929867321666140303122426; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Senese S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.420; Singh A, 2014, CELL CYCLE, V13, P157, DOI 10.4161/cc.26951; Soyal SM, 2015, TRENDS PHARMACOL SCI, V36, P406, DOI 10.1016/j.tips.2015.04.010; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T	27	31	34	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17001	17008		10.1074/jbc.C116.737346	http://dx.doi.org/10.1074/jbc.C116.737346			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27378817	Green Published, hybrid			2022-12-26	WOS:000382643800007
J	Deng, YL; Chang, L; Yang, M; Huo, M; Zhou, RL				Deng, Yaling; Chang, Lei; Yang, Meng; Huo, Meng; Zhou, Renlai			Gender Differences in Emotional Response: Inconsistency between Experience and Expressivity	PLOS ONE			English	Article							SEX-DIFFERENCES; TIME-COURSE; INTENSITY; FEMALES; MALES	The present study investigated gender differences in both emotional experience and expressivity. Heart rate (HR) was recorded as an indicator of emotional experience while the participants watched 16 video clips that induced eight types of emotion (sadness, anger, horror, disgust, neutrality, amusement, surprise, and pleasure). We also asked the participants to report valence, arousal, and motivation as indicators of emotional expressivity. Overall, the results revealed gender differences in emotional experience and emotional expressivity. When watching videos that induced anger, amusement, and pleasure, men showed larger decreases in HR, whereas women reported higher levels of arousal. There was no gender difference in HR when the participants watched videos that induced horror and disgust, but women reported lower valence, higher arousal, and stronger avoidance motivation than did men. Finally, no gender difference was observed in sadness or surprise, although there was one exception-women reported higher arousal when watching videos that induced sadness. The findings suggest that, when watching videos that induce an emotional response, men often have more intense emotional experiences, whereas women have higher emotional expressivity, particularly for negative emotions. In addition, gender differences depend on the specific emotion type but not the valence.	[Deng, Yaling; Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Deng, Yaling; Zhou, Renlai] Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing, Jiangsu, Peoples R China; [Deng, Yaling; Yang, Meng; Zhou, Renlai] Beijing Normal Univ, Res Ctr Emot Regulat, Beijing, Peoples R China; [Chang, Lei] Univ Macau, Dept Psychol, Taipa, Macau, Peoples R China; [Huo, Meng] Univ Texas Austin, Dept Human Dev & Family Sci, Austin, TX 78712 USA	Beijing Normal University; Nanjing University; Beijing Normal University; University of Macau; University of Texas System; University of Texas Austin	Zhou, RL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Zhou, RL (corresponding author), Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing, Jiangsu, Peoples R China.; Zhou, RL (corresponding author), Beijing Normal Univ, Res Ctr Emot Regulat, Beijing, Peoples R China.	rlzhou@nju.edu.cn	Zhou, Renlai/ABA-1226-2021; Chang, Lei/AAB-4014-2020	Zhou, Renlai/0000-0001-7035-7097; Chang, Lei/0000-0001-6457-0254	National Basic Research Program of China [2011CB505101]; Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu [2015ZSJDXM001]	National Basic Research Program of China(National Basic Research Program of China); Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu	The work was supported by the National Basic Research Program of China (No. 2011CB505101) and the Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu (2015ZSJDXM001) to Professor Renlai Zhou, as well as the Shangshan funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett LF, 1998, COGNITION EMOTION, V12, P579, DOI 10.1080/026999398379574; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bluhm R, 2013, NEUROETHICS-NETH, V6, P319, DOI 10.1007/s12152-011-9143-3; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Brody LR., 2000, HDB EMOTIONS, V2, P325; Carvalho S, 2012, APPL PSYCHOPHYS BIOF, V37, P279, DOI 10.1007/s10484-012-9201-6; Christie IC, 2004, INT J PSYCHOPHYSIOL, V51, P143, DOI 10.1016/j.ijpsycho.2003.08.002; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Dichter GS, 2002, INT J PSYCHOPHYSIOL, V43, P191, DOI 10.1016/S0167-8760(01)00170-2; Evers C, 2014, BIOL PSYCHOL, V98, P43, DOI 10.1016/j.biopsycho.2013.11.003; Fernandez C, 2012, APPL PSYCHOPHYS BIOF, V37, P73, DOI 10.1007/s10484-012-9180-7; Fischer A.H., 2000, GENDER EMOTION SOCIA, P71, DOI [10.1017/CBO9780511628191.005, DOI 10.1017/CBO9780511628191, 10.1017/CBO9780511628191]; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Fisher RJ, 2005, J CONSUM RES, V31, P850, DOI 10.1086/426621; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Garnefski N, 2004, PERS INDIV DIFFER, V36, P267, DOI 10.1016/S0191-8869(03)00083-7; Gohier B, 2013, EUR PSYCHIAT, V28, P74, DOI 10.1016/j.eurpsy.2011.06.007; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; GROSSMAN M, 1993, J PERS SOC PSYCHOL, V65, P1010, DOI 10.1037/0022-3514.65.5.1010; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; HODES RL, 1985, PSYCHOPHYSIOLOGY, V22, P545, DOI 10.1111/j.1469-8986.1985.tb01649.x; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; Vigil JM, 2008, EVOL PSYCHOL, V6, P506; Vrana SR, 2002, COGNITION EMOTION, V16, P165, DOI 10.1080/02699930143000185; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; [蚁金瑶 Yi Jinyao], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P763; Zhang Z, 2001, CHIN J BEHAV MED SCI, V10, P19; 刘雷, 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P614	36	114	117	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158666	10.1371/journal.pone.0158666	http://dx.doi.org/10.1371/journal.pone.0158666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362361	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200105
J	Gomez, I; Ozen, G; Deschildre, C; Amgoud, Y; Boubaya, L; Gorenne, I; Benyahia, C; Roger, T; Leseche, G; Galardon, E; Topal, G; Jacob, MP; Longrois, D; Norel, X				Gomez, Ingrid; Ozen, Gulsev; Deschildre, Catherine; Amgoud, Yasmine; Boubaya, Lilia; Gorenne, Isabelle; Benyahia, Chabha; Roger, Thomas; Leseche, Guy; Galardon, Erwan; Topal, Gokce; Jacob, Marie-Paule; Longrois, Dan; Norel, Xavier			Reverse Regulatory Pathway (H2S/PGE(2)/MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity	PLOS ONE			English	Article							PROSTAGLANDIN-E SYNTHASE-1; MATRIX-METALLOPROTEINASE ACTIVITIES; HYDROGEN-SULFIDE; OXIDATIVE STRESS; ENDOGENOUS H2S; KAPPA-B; CELLS; PLAQUE; ARTERY; ATHEROSCLEROSIS	Hydrogen sulfide (H2S) is a mediator with demonstrated protective effects for the cardiovascular system. On the other hand, prostaglandin (PG)E-2 is involved in vascular wall remodeling by regulating matrix metalloproteinase (MMP) activities. We tested the hypothesis that endogenous H2S may modulate PGE(2), MMP-1 activity and endogenous tissue inhibitors of MMPs (TIMP-1/-2). This regulatory pathway could be involved in thinning of abdominal aortic aneurysm (AAA) and thickening of saphenous vein (SV) varicosities. The expression of the enzyme responsible for H2S synthesis, cystathionine-gamma-lyase (CSE) and its activity, were significantly higher in varicose vein as compared to SV. On the contrary, the endogenous H2S level and CSE expression were lower in AAA as compared to healthy aorta (HA). Endogenous H2S was responsible for inhibition of PGE(2) synthesis mostly in varicose veins and HA. A similar effect was observed with exogenous H2S and consequently decreasing active MMP-1/TIMP ratios in SV and varicose veins. In contrast, in AAA, higher levels of PGE(2) and active MMP-1/TIMP ratios were found versus HA. These findings suggest that differences in H2S content in AAA and varicose veins modulate endogenous PGE(2) production and consequently the MMP/TIMP ratio. This mechanism may be crucial in vascular wall remodeling observed in different vascular pathologies (aneurysm, varicosities, atherosclerosis and pulmonary hypertension).	[Gomez, Ingrid; Ozen, Gulsev; Deschildre, Catherine; Amgoud, Yasmine; Boubaya, Lilia; Benyahia, Chabha; Leseche, Guy; Jacob, Marie-Paule; Longrois, Dan; Norel, Xavier] INSERM, U1148, F-75018 Paris, France; [Gomez, Ingrid; Benyahia, Chabha; Norel, Xavier] Univ Paris 13, UMR S1148, F-75018 Paris, France; [Ozen, Gulsev; Topal, Gokce] Istanbul Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey; [Roger, Thomas; Galardon, Erwan] Univ Paris 05, CNRS, UMR 8601, LCBPT,Sorbonne Paris Cite, F-75006 Paris, France; [Leseche, Guy] Univ Paris Diderot, Sorbonne Paris Cite, AP HP CHU X Bichat, Dept Vasc & Thorac Surg,UMR S1148, F-75018 Paris, France; [Gorenne, Isabelle; Longrois, Dan] Univ Paris Diderot, Sorbonne Paris Cite, AP HP CHU X Bichat, Dept Anesthesia & Intens Care,UMR S1148, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Istanbul University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Norel, X (corresponding author), INSERM, U1148, F-75018 Paris, France.; Norel, X (corresponding author), Univ Paris 13, UMR S1148, F-75018 Paris, France.	xavier.norel@inserm.fr	Norel, Xavier/C-5978-2011; Galardon, Erwan/K-1063-2018; Ozen, Gulsev/AAD-4984-2020	Norel, Xavier/0000-0003-0734-3359; Galardon, Erwan/0000-0002-4371-6119; ingrid, gomez/0000-0002-8967-2481	INSERM (Institut National de la Sante et de la Recherche Medicale); Scientific and Technological Research Council of Turkey (TUBITAK) [BIDEB-2214]; Paris 13 University	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Paris 13 University	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale). Gulsev Ozen is a recipient of a postgraduate fellowship (BIDEB-2214) from the Scientific and Technological Research Council of Turkey (TUBITAK). Ingrid Gomez was supported by a PhD grant from Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thanks Tariya Zaoui (CHU X. Bichat; Paris, France) for her help in obtaining the vascular preparations and Dr Mary Osborne-Pellegrin and Ben Ward, MSc (Infection, Immunity and Cardiovascular Science, University of Sheffield, UK) for his help in editing the manuscript. This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale). Gulsev Ozen is a recipient of a postgraduate fellowship (BIDEB-2214) from the Scientific and Technological Research Council of Turkey (TUBITAK). Ingrid Gomez was supported by a PhD grant from Paris 13 University.	Al-Magableh MR, 2015, HYPERTENS RES, V38, P13, DOI 10.1038/hr.2014.125; Annabi B, 2002, J VASC SURG, V35, P539, DOI 10.1067/mva.2002.121124; BADESCH DB, 1989, AM J RESP CELL MOL, V1, P489, DOI 10.1165/ajrcmb/1.6.489; Badier-Commander C, 2000, J PATHOL, V192, P105, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1; Badier-Commander C, 2001, J PATHOL, V193, P398, DOI 10.1002/path.819; Beltowski J, 2014, MOLECULES, V19, P21183, DOI 10.3390/molecules191221183; Benjamin Mina M, 2012, Exp Suppl, V103, P209, DOI 10.1007/978-3-0348-0364-9_7; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Burguera EF, 2014, OSTEOARTHR CARTILAGE, V22, P1026, DOI 10.1016/j.joca.2014.04.031; Camacho M, 2013, J LIPID RES, V54, P3506, DOI 10.1194/jlr.M042481; Cao RY, 2012, AM J PATHOL, V181, P313, DOI 10.1016/j.ajpath.2012.03.016; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Cuccurullo C, 2006, ARTERIOSCL THROM VAS, V26, P2716, DOI 10.1161/01.ATV.0000249630.02085.12; Dejouvencel T, 2010, ARTERIOSCL THROM VAS, V30, P269, DOI 10.1161/ATVBAHA.109.198309; Deng DXF, 2006, ARTERIOSCL THROM VAS, V26, P1058, DOI 10.1161/01.ATV.0000208185.16371.97; Distrutti E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-36; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Du CC, 2014, BIOCHEM BIOPH RES CO, V451, P239, DOI 10.1016/j.bbrc.2014.07.107; Gomez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088021; Gomez I, 2013, INFLAMM RES, V62, P299, DOI 10.1007/s00011-012-0578-8; Gomez-Hernandez A, 2006, ATHEROSCLEROSIS, V187, P139, DOI 10.1016/j.atherosclerosis.2005.08.035; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Kalayarasan S, 2013, TOXICOL APPL PHARM, V271, P184, DOI 10.1016/j.taap.2013.04.021; Kucukguven A, 2013, CURR DRUG TARGETS, V14, P287; Li L, 2013, J CELL MOL MED, V17, P365, DOI 10.1111/jcmm.12016; Li Xiao-Hui, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P75; Li XH, 2009, EXP BIOL MED, V234, P504, DOI 10.3181/0807-RM-230; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; LopezCandales A, 1997, AM J PATHOL, V150, P993; Mancini S, 2003, VASA-J VASCULAR DIS, V32, P26, DOI 10.1024/0301-1526.32.1.26; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Martelli A, 2013, PHARMACOL RES, V70, P27, DOI 10.1016/j.phrs.2012.12.005; Olson KR, 2015, ANTIOXID REDOX SIGN, V22, P377, DOI 10.1089/ars.2014.5930; Qipshidze N, 2012, INT J BIOL SCI, V8, P430, DOI 10.7150/ijbs.3632; Reilly JM, 1999, SURGERY, V126, P624, DOI 10.1016/S0039-6060(99)70114-5; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Shin DY, 2010, TOXICOL IN VITRO, V24, P1569, DOI 10.1016/j.tiv.2010.06.014; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Talaei F, 2012, J EXP BIOL, V215, P2912, DOI 10.1242/jeb.067363; Tyagi N, 2010, NEUROCHEM INT, V56, P301, DOI 10.1016/j.neuint.2009.11.002; VANDERWAL AC, 1993, ATHEROSCLEROSIS, V103, P55, DOI 10.1016/0021-9150(93)90039-W; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Wei LP, 2014, CELL SIGNAL, V26, P1476, DOI 10.1016/j.cellsig.2014.03.008; Xu WM, 2015, INT J MOL MED, V35, P177, DOI 10.3892/ijmm.2014.2007; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724; Zhang CY, 2013, ACTA PHARMACOL SIN, V34, P1301, DOI 10.1038/aps.2013.84	51	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158421	10.1371/journal.pone.0158421	http://dx.doi.org/10.1371/journal.pone.0158421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362269	Green Submitted, gold, Green Published			2022-12-26	WOS:000378865200071
J	Zhou, JF; Chiba, A; Scheffel, DLS; Hebling, J; Agee, K; Niu, LN; Tay, FR; Pashley, DH				Zhou, Jianfeng; Chiba, Ayaka; Scheffel, Debora L. S.; Hebling, Josimeri; Agee, Kelli; Niu, Li-na; Tay, Franklin R.; Pashley, David H.			Effects of a Dicalcium and Tetracalcium Phosphate-Based Desensitizer on In Vitro Dentin Permeability	PLOS ONE			English	Article							FLUORIDE VARNISH; CLINICAL-EVALUATION; HYPERSENSITIVITY; PREVALENCE; POPULATION; SENSITIVITY; EFFICACY; CEMENTS; TEETH; LASER	The present study evaluated the effectiveness of a dicalcium and tetracalcium phosphate-based desensitizer in reducing dentin permeability in vitro. Dentin fluid flow was measured before and after treatment of dentin with patent dentinal tubules using 1 or 3 applications of the dicalcium and tetracalcium phosphate containing agent Teethmate (TM) (TM) and comparing the results with two sodium fluoride varnishes Vella (TM) (VLA) and Vanish (TM) (VAN), after storage in artificial saliva for 24 h, 48 h and 7 days. Significant differences were observed among the 4 methods employed for reducing dentin permeability (p < 0.001) and the 3 post-treatment times (p < 0.001). VLA and VAN never achieved 50% permeability reductions consistently in any of the 3 time periods. Only the calcium phosphate-based desensitizer applied for 3 times consistently reduced dentin permeability by 50% after 24 h. When applied once, the permeability reduction of TM increased progressively over the 3 time periods. After 7 days, only one and three applications of the calcium phosphate-based desensitizer consistently reduced dentin permeability by more than 50%. Permeability reductions corresponded well with scanning electron microscopy examination of dentinal tubule orifice occlusion in dentin specimens treated with the agents. Overall, the dicalcium and tetracalcium phosphate-based desensitizer is effective in reducing dentin permeability via a tubule occlusion mechanism. The ability of the agent to reduce dentin permeability renders it to be potentially useful as a clinical dentin desensitizing agent, which has to be confirmed in future clinical studies. By contrast, the two sodium fluoride varnishes are not effective in dentin permeability reduction and should be considered as topical fluoride delivering agents rather than tubular orifice-blocking agents.	[Zhou, Jianfeng] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing, Peoples R China; [Chiba, Ayaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Tokyo, Japan; [Scheffel, Debora L. S.; Hebling, Josimeri] Univ Estadual Paulista, UNESP, Araraquara Dent Sch, Dept Orthodont & Pediat Dent, Sao Paulo, Brazil; [Agee, Kelli; Tay, Franklin R.; Pashley, David H.] Augusta Univ, Dent Coll Georgia, Augusta, GA USA; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian, Peoples R China; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Shaanxi Key Lab Oral Dis, Xian, Peoples R China	Peking University; Tokyo Medical & Dental University (TMDU); Universidade Estadual Paulista; University System of Georgia; Augusta University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Pashley, DH (corresponding author), Augusta Univ, Dent Coll Georgia, Augusta, GA USA.; Niu, LN (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian, Peoples R China.; Niu, LN (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China.; Niu, LN (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Shaanxi Key Lab Oral Dis, Xian, Peoples R China.	niulina831013@126.com; dpashley@gru.edu	Scheffel, Debora LS/C-9979-2012; niu, lina/GWR-3585-2022; Hebling, Josimeri/C-7738-2012; Hebling, Josimeri/AAH-1737-2019	Scheffel, Debora LS/0000-0001-9121-0799; Hebling, Josimeri/0000-0002-2846-2325; Tay, Franklin/0000-0003-3769-0626	Sao Paulo Research Foundation-FAPESP of J.H.'s sabbatical at The Dental College of Georgia at Augusta University [2014/17232-4, 2014/18160-7]; NIDCR [R01 DE015306]; National High Technology Research and Development Program of China grant [2015AA020942]; National Nature Science Foundation of China grant [81400555]	Sao Paulo Research Foundation-FAPESP of J.H.'s sabbatical at The Dental College of Georgia at Augusta University; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National High Technology Research and Development Program of China grant; National Nature Science Foundation of China grant	The authors thank Sao Paulo Research Foundation-FAPESP for partial financial support (Process 2014/17232-4 and 2014/18160-7) of J.H.'s sabbatical at The Dental College of Georgia at Augusta University. DHP and FRT were supported by NIDCR R01 DE015306. LNN was supported by National High Technology Research and Development Program of China grant 2015AA020942 and National Nature Science Foundation of China grant 81400555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x; Arends J, 1997, CARIES RES, V31, P201, DOI 10.1159/000262399; Ayad F, 2009, J Clin Dent, V20, P115; Bahsi E, 2012, EUR REV MED PHARMACO, V16, P1107; Bamise Cornelius T, 2007, Oral Health Prev Dent, V5, P49; Banomyong D, 2013, J INVESTIG CLIN DENT, V4, DOI 10.1111/j.2041-1626.2012.00144.x; Brannstrom M, 1965, Odontol Revy, V16, P293; BRANNSTROM M, 1962, ARCH ORAL BIOL, V7, P59, DOI 10.1016/0003-9969(62)90048-1; Bubteina N, 2015, DENTISTRY, V5, P330, DOI DOI 10.4172/2161-1122.1000330; Chabanski MB, 1996, J CLIN PERIODONTOL, V23, P989, DOI 10.1111/j.1600-051X.1996.tb00525.x; Chen WC, 2003, J BIOMED MATER RES A, V64A, P664, DOI 10.1002/jbm.a.10250; Chow LC, 2009, DENT MATER J, V28, P1; Chow LC, 2001, MONOGRAPHS ORAL SCI, V18, P17; Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017; Ding YJ, 2014, AM J DENT, V27, P79; Draenert ME, 2013, AM J DENT, V26, P21; FISCHER C, 1992, J DENT, V20, P272, DOI 10.1016/0300-5712(92)90043-C; FLYNN J, 1985, J DENT, V13, P230, DOI 10.1016/0300-5712(85)90004-1; Gaffar A, 1999, Compend Contin Educ Dent, V20, P27; Gillam DG, 2002, J ORAL REHABIL, V29, P226, DOI 10.1046/j.1365-2842.2002.00813.x; Gysi A, 1900, BR J DENT SCI, V43, P865; HANSEN EK, 1992, SCAND J DENT RES, V100, P305; Hirayama S, 2008, J RES NATL INST STAN, V113, P311, DOI 10.6028/jres.113.025; Hoang-Dao BT, 2009, J ORAL REHABIL, V36, P124, DOI 10.1111/j.1365-2842.2008.01907.x; Ishikawa K, 1999, J BIOMED MATER RES, V46, P504, DOI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H; Kara C, 2009, J ENDODONT, V35, P971, DOI 10.1016/j.joen.2009.04.004; Kehua Q, 2009, INT DENT J, V59, P376, DOI 10.1922/IDJ_2293Xu05; LEVINE MJ, 1993, CRIT REV ORAL BIOL M, V4, P279, DOI 10.1177/10454411930040030401; Liu HC, 1998, J ENDODONT, V24, P45, DOI 10.1016/S0099-2399(98)80213-6; LUNDY T, 1969, ORAL SURG ORAL MED O, V27, P187, DOI 10.1016/0030-4220(69)90172-8; Mantzourani M, 2013, J DENT, V41, pS3, DOI 10.1016/S0300-5712(13)70002-2; Mehta D, 2014, ACTA ODONTOL SCAND, V72, P936, DOI 10.3109/00016357.2014.923112; Merika K, 2006, EUR J PROSTHODONT RE, V14, P38; Miles TS, 2004, CLIN ORAL PHYSL, P33; NARHI M, 1994, ARCH ORAL BIOL, V39, pS23, DOI 10.1016/0003-9969(94)90184-8; Nathoo S, 2009, J Clin Dent, V20, P123; Pashley D.H., 2008, INSIDE DENT, V29, P1; PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0; Petersson LG, 2013, CLIN ORAL INVEST, V17, pS63, DOI 10.1007/s00784-012-0916-9; Que K, 2013, J ORAL REHABIL, V40, P24, DOI 10.1111/j.1365-2842.2012.02342.x; Rahiotis C, 2013, J ORAL REHABIL, V40, P948, DOI 10.1111/joor.12109; Rees J S, 2004, Int J Dent Hyg, V2, P64, DOI 10.1111/j.1601-5029.2004.00068.x; Rees JS, 2003, J DENT, V31, P453, DOI 10.1016/S0300-5712(03)00092-7; Ritter AV, 2006, J AM DENT ASSOC, V137, P1013, DOI 10.14219/jada.archive.2006.0324; Taani DQ, 2001, QUINTESSENCE INT, V32, P372; Taani SDMQ, 2002, J CLIN PERIODONTOL, V29, P118, DOI 10.1034/j.1600-051x.2002.290205.x; Thanatvarakorn O, 2013, DENT MATER J, V32, P615, DOI 10.4012/dmj.2013-073; Thanatvarakorn O, 2013, J BIOMED MATER RES B, V101B, P303, DOI 10.1002/jbm.b.32840; Udoye C I, 2006, Odontostomatol Trop, V29, P19; Verzak Z, 1998, COLLEGIUM ANTROPOL, V22, P259; West N, 2014, MONOGR ORAL SCI, V25, P108, DOI 10.1159/000360749; Ye W, 2012, J ORAL REHABIL, V39, P182, DOI 10.1111/j.1365-2842.2011.02248.x; Yilmaz HG, 2011, PHOTOMED LASER SURG, V29, P721, DOI 10.1089/pho.2010.2974	53	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158400	10.1371/journal.pone.0158400	http://dx.doi.org/10.1371/journal.pone.0158400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359118	Green Submitted, Green Published, gold			2022-12-26	WOS:000378865200069
J	Lau, YL; Lee, WC; Gudimella, R; Zhang, GP; Ching, XT; Razali, R; Aziz, F; Anwar, A; Fong, MY				Lau, Yee-Ling; Lee, Wenn-Chyau; Gudimella, Ranganath; Zhang, GuiPing; Ching, Xiao-Teng; Razali, Rozaimi; Aziz, Farhanah; Anwar, Arif; Fong, Mun-Yik			Deciphering the Draft Genome of Toxoplasma gondii RH Strain	PLOS ONE			English	Article							DE-NOVO IDENTIFICATION; FAMILIES; ANTIGENS; TOXODB	Toxoplasmosis is a widespread parasitic infection by Toxoplasma gondii, a parasite with at least three distinct clonal lineages. This article reports the whole genome sequencing and de novo assembly of T. gondii RH (type I representative strain), as well as genome-wide comparison across major T. gondii lineages. Genomic DNA was extracted from tachyzoites of T. gondii RH strain and its identity was verified by PCR and LAMP. Subsequently, whole genome sequencing was performed, followed by sequence filtering, genome assembly, gene annotation assignments, clustering of gene orthologs and phylogenetic tree construction. Genome comparison was done with the already archived genomes of T. gondii. From this study, the genome size of T. gondii RH strain was found to be 69.35Mb, with a mean GC content of 52%. The genome shares high similarity to the archived genomes of T. gondii GT1, ME49 and VEG strains. Nevertheless, 111 genes were found to be unique to T. gondii RH strain. Importantly, unique genes annotated to functions that are potentially critical for T. gondii virulence were found, which may explain the unique phenotypes of this particular strain. This report complements the genomic archive of T. gondii. Data obtained from this study contribute to better understanding of T. gondii and serve as a reference for future studies on this parasite.	[Lau, Yee-Ling; Ching, Xiao-Teng; Fong, Mun-Yik] Univ Malaya, Fac Med, Dept Parasitol, TIDREC, Kuala Lumpur, Malaysia; [Lee, Wenn-Chyau] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Gudimella, Ranganath; Razali, Rozaimi; Aziz, Farhanah; Anwar, Arif] Univ Malaya, Sengen HIR, Kuala Lumpur, Malaysia; [Zhang, GuiPing] BGI Shenzhen, Shenzhen, Peoples R China	Universiti Malaya; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Universiti Malaya; Beijing Genomics Institute (BGI)	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, TIDREC, Kuala Lumpur, Malaysia.	lauyeeling@um.edu.my	Lau, Yee Ling/C-6996-2009; LEE, Wenn-Chyau/AAR-4072-2020; RAZALI, ROZAIMI/O-8694-2017; Razali, Rozaimi/AAF-9115-2021; FONG, MUN YIK/B-5443-2010	Lau, Yee Ling/0000-0002-2037-2165; LEE, Wenn-Chyau/0000-0002-7324-5792; RAZALI, ROZAIMI/0000-0002-8996-3975; Razali, Rozaimi/0000-0002-8996-3975; 	University of Malaya High Impact Research (HIR) Grant UM-MOHE from the Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/MED/16]	University of Malaya High Impact Research (HIR) Grant UM-MOHE from the Ministry of Higher Education, Malaysia	This research project was supported by University of Malaya High Impact Research (HIR) Grant UM-MOHE (UM.C/HIR/MOHE/MED/16) from the Ministry of Higher Education, Malaysia.	Arrizabalaga G, 2004, INT J PARASITOL, V34, P361, DOI 10.1016/j.ijpara.2003.11.017; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; BULOW R, 1991, J IMMUNOL, V147, P3496; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Contini C., 2008, Parassitologia (Rome), V50, P45; Darde Marie-Laure, 2004, Annali dell'Istituto Superiore di Sanita, V40, P57; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; Doliwa C, 2013, PARASITE, V20, DOI 10.1051/parasite/2013020; DUBEY JP, 1980, AM J VET RES, V41, P427; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Fatoohi AF, 2002, CLIN DIAGN LAB IMMUN, V9, P704, DOI 10.1128/CDLI.9.3.704-707.2002; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Ihara F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-248; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KAUFMAN HE, 1958, AM J OPHTHALMOL, V46, P255, DOI 10.1016/0002-9394(58)90805-5; Khan A, 2009, EUKARYOT CELL, V8, P1828, DOI 10.1128/EC.00150-09; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lau YL, 2010, J CLIN MICROBIOL, V48, P3698, DOI 10.1128/JCM.00462-10; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Paulsen I, 2007, NUCL SEQUENCES UNPUB; Pezzella-D'Alessandro N, 2001, J HISTOCHEM CYTOCHEM, V49, P445, DOI 10.1177/002215540104900404; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SIBLEY LD, 1992, MOL BIOCHEM PARASIT, V51, P291, DOI 10.1016/0166-6851(92)90079-Y; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Villard O, 1997, INT J PARASITOL, V27, P1555, DOI 10.1016/S0020-7519(97)00144-6; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Yang NH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-467; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360	52	18	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157901	10.1371/journal.pone.0157901	http://dx.doi.org/10.1371/journal.pone.0157901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355363	gold, Green Published, Green Submitted			2022-12-26	WOS:000378859400023
J	Nakamura, K; Kusama, K; Bai, R; Sakurai, T; Isuzugawa, K; Godkin, JD; Suda, Y; Imakawa, K				Nakamura, Keigo; Kusama, Kazuya; Bai, Rulan; Sakurai, Toshihiro; Isuzugawa, Kazuto; Godkin, James D.; Suda, Yoshihito; Imakawa, Kazuhiko			Induction of IFNT-Stimulated Genes by Conceptus-Derived Exosomes during the Attachment Period	PLOS ONE			English	Article							INTERFERON-TAU; TRANSCRIPTION FACTOR; PROTEOMIC ANALYSIS; EARLY-PREGNANCY; EXPRESSION; CELLS; BLOOD; IDENTIFICATION; ENDOMETRIUM; CHEMOKINE	Biochemical and/or physical communication between the conceptus and the uterine endometrium is required for conceptus implantation to the maternal endometrium, leading to placentation and the establishment of pregnancy. We previously reported that in vitro co-culture system with bovine trophoblast CT-1 cells, primary uterine endometrial epithelial cells (EECs), and uterine flushings (UFs) mimics in vivo conceptus attachment process. To identify molecules in UFs responsible for this change, we first characterized protein contents of UFs from day 17 cyclic (C17) and pregnant (P17) ewes through the use of two dimensional-Polyacrylamide Gel Electrophoresis (2D-PAGE), followed by Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) analysis. These analyses identified 266 proteins specific for P17 UFs, from which 172 proteins were identified as exosomal proteins. Among 172 exosomal proteins, 8 proteins that had been identified as exosomal proteins were chosen for further analysis, including macrophage-capping protein (CAPG), aldo-keto reductase family 1, member B1 protein (AKR1B1), bcl-2-like protein 15 (BCL2L15), carbonic anhydrase 2 (CA2), isocitrate dehydrogenase 2 (IDH2), eukaryotic translation elongation factor 2 (EEF2), moesin (MSN), and ezrin (EZR). CAPG and AKR1B1 were again confirmed in P15 and P17 UFs, and more importantly CAPG and AKR1B1, mRNA and protein, were found only in P15 and P17 conceptuses. Moreover, exosomes were isolated from C15, C17, P15, or P17 UFs. Only P15 and P17 exosomes, originated from the conceptus, contained interferon tau (IFNT) as well as CAPG and AKR1B1, and up-regulated STAT1, STAT2, MX1, MX2, BST2, and ISG15 transcripts in EECs. These observations indicate that in addition to endometrial derived exosomes previously described, conceptus-derived exosomes are present in UFs and could function to modify endometrial response. These results suggest that exosomes secreted from conceptuses as well as endometria are involved in cell to cell interactions for conceptus implantation to the maternal endometrium.	[Nakamura, Keigo; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan; [Kusama, Kazuya; Bai, Rulan] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol & Anim Breeding, Tokyo, Japan; [Sakurai, Toshihiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Occupat & Environm Hlth, Chiba, Japan; [Isuzugawa, Kazuto] Yokohama Univ Pharm, Dept Kampo Pharm, Yokohama, Kanagawa, Japan; [Godkin, James D.] Univ Tennessee, Dept Anim Sci, Knoxville, TN USA; [Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Kurokawa, Miyagi, Japan	University of Tokyo; University of Tokyo; Tokyo University of Science; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Miyagi University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; 	Science and Technology Research Promotion Program for Ministry of Agriculture, Forestry and Fisheries [25030AB]; Japan Society for the Promotion of Science [15K18767, 15K07697]	Science and Technology Research Promotion Program for Ministry of Agriculture, Forestry and Fisheries; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Science and Technology Research Promotion Program for Ministry of Agriculture, Forestry and Fisheries (25030AB, http://www.maff.go.jp/e/index.html) (to KI), Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (15K18767, https://www.jsps.go.jp/english/index.html) (to KK), and Grants-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (15K07697, https://www.jsps.go.jp/english/index.html) (to TS). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bai RL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128652; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Bazer FW, 2015, AMINO ACIDS, V47, P449, DOI 10.1007/s00726-014-1905-x; Berrone E, 2015, J GEN VIROL IN PRESS; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cleys ER, 2014, MOL REPROD DEV, V81, P983, DOI 10.1002/mrd.22420; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Dong J, 2015, TUMOUR BIOL IN PRESS; Forde N, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129296; Gray CA, 2004, P NATL ACAD SCI USA, V101, P7982, DOI 10.1073/pnas.0402669101; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Imakawa K, 2006, MOL REPROD DEV, V73, P559, DOI 10.1002/mrd.20457; Imakawa K, 2002, ENDOCR J, V49, P195, DOI 10.1507/endocrj.49.195; Jeong W, 2015, BIOCHEM BIOPH RES CO; Kang S, 2010, J PROTEOME RES, V9, P5638, DOI 10.1021/pr1004532; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Koch JM, 2010, J PROTEOME RES, V9, P3878, DOI 10.1021/pr100096b; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McGuire WJ, 2002, DOMEST ANIM ENDOCRIN, V23, P383, DOI 10.1016/S0739-7240(02)00181-9; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Nagaoka K, 2003, J BIOL CHEM, V278, P29048, DOI 10.1074/jbc.M300470200; Nagaoka K, 2003, BIOL REPROD, V68, P1413, DOI 10.1095/biolreprod.102.008912; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Oliveira JF, 2008, ENDOCRINOLOGY, V149, P1252, DOI 10.1210/en.2007-0863; Prunotto M, 2013, J PROTEOMICS, V82, P193, DOI 10.1016/j.jprot.2013.01.012; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Romero JJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132860; Ruiz-Gonzalez I, 2015, REPRODUCTION, V149, P281, DOI 10.1530/REP-14-0538; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Sakurai T, 2010, ENDOCRINOLOGY, V151, P5873, DOI 10.1210/en.2010-0458; Shirasuna K, 2015, REPRODUCTION, V150, P217, DOI 10.1530/REP-15-0085; Skarzynski DJ, 2000, BIOL REPROD, V62, P1116, DOI 10.1095/biolreprod62.5.1116; Soung YH, 2015, BMB REP IN PRESS; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Tammali R, 2011, ANGIOGENESIS, V14, P209, DOI 10.1007/s10456-011-9206-4; Voisin SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016352; Xu SG, 2010, J CANCER RES CLIN, V136, P1545, DOI 10.1007/s00432-010-0812-0; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Yankey SJ, 2001, J ENDOCRINOL, V170, pR7, DOI 10.1677/joe.0.170R007; Zablocki GJ, 2011, CHEM-BIOL INTERACT, V191, P351, DOI 10.1016/j.cbi.2011.02.005	46	58	60	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158278	10.1371/journal.pone.0158278	http://dx.doi.org/10.1371/journal.pone.0158278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351483	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900050
J	Nunes, PC; Aquino, JD; Rockenbach, II; Stamford, TLM				Nunes, Polyana Campos; Aquino, Jailane de Souza; Rockenbach, Ismael Ivan; Montenegro Stamford, Tania Lucia			Physico-Chemical Characterization, Bioactive Compounds and Antioxidant Activity of Malay Apple [Syzygium malaccense (L.) Merr. & LM Perry]	PLOS ONE			English	Article							IN-VITRO ANTIOXIDANT; ACUTE LUNG INJURY; PHENOLIC-COMPOUNDS; CYANIDIN-3-O-GLUCOSIDE; CYANIDIN-3-GLUCOSIDE; ANTHOCYANINS; INFLAMMATION; POMEGRANATE	The purpose of this study was to evaluate the physico-chemical characteristics, bioactive compounds and antioxidant activity of Malay apple fruit (Syzygium malaccense) grown in Brazil with regard to the geographical origin and its peel fractions and edible portion analyzed independently. Fruit diameter, weight, yield, and centesimal composition, ascorbic acid, reductive sugars, total soluble solids, pH and fiber content were determined. Total phenolics (1293 mg gallic acid equivalent/100 g) and total anthocyanins (1045 mg/100 g) contents were higher in the peel, with the major anthocyanin identified using HPLC-DAD-MS/MS as cyanidin 3-glucoside. Higher values for DPPH antiradical scavenging activity (47.52 mu Mol trolox equivalent antioxidant capacity/g) and Ferric Reducing Antioxidant Potential (FRAP, 0.19 mM ferreous sulfate/g) were also observed in the peel fraction. All extracts tested showed the ability to inhibit oxidation in the beta-carotene/linoleic acid system. This study highlights the potential of Malay apple fruit as a good source of antioxidant compounds with potential benefits to human health.	[Nunes, Polyana Campos; Montenegro Stamford, Tania Lucia] Fed Univ Pernambuco UFPE, Ctr Hlth Sci, Dept Nutr, Recife, PE, Brazil; [Aquino, Jailane de Souza] Fed Univ Paraiba UFPB, Ctr Hlth Sci, Dept Nutr, Joao Pessoa, Paraiba, Brazil; [Rockenbach, Ismael Ivan] Fed Univ Paraiba UFPB, Ctr Technol & Reg Dev, Dept Food Technol, Joao Pessoa, Paraiba, Brazil	Universidade Federal de Pernambuco; Universidade Federal da Paraiba; Universidade Federal da Paraiba	Rockenbach, II (corresponding author), Fed Univ Paraiba UFPB, Ctr Technol & Reg Dev, Dept Food Technol, Joao Pessoa, Paraiba, Brazil.	ismael.rockenbach@gmail.com	Rockenbach, Ismael I/P-2188-2014	Rockenbach, Ismael I/0000-0001-8513-5411; Stamford, Tania Lucia Montenegro/0000-0001-5816-9413; de Souza Aquino, Jailane/0000-0002-7221-9867	National Council for Scientific and Technological Development-Brazil	National Council for Scientific and Technological Development-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a research fellowship from National Council for Scientific and Technological Development-Brazil (http://cnpq.br) awarded to PCN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2002, OFF METH AN, V16; Arumugam B, 2014, LWT-FOOD SCI TECHNOL, V59, P707, DOI 10.1016/j.lwt.2014.06.041; Azevedo JCS, 2010, THESIS; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Banerjee A, 2005, FOOD CHEM, V90, P727, DOI 10.1016/j.foodchem.2004.04.033; Benherlal PS, 2007, J SCI FOOD AGR, V87, P2560, DOI 10.1002/jsfa.2957; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Clerici MTPS, 2011, FOOD RES INT, V44, P1658, DOI 10.1016/j.foodres.2011.04.020; Corley J, 2015, BRIT J NUTR, V114, P1088, DOI 10.1017/S000711451500210X; Costa Raquel Silva, 2006, Rev. Bras. Frutic., V28, P117, DOI 10.1590/S0100-29452006000100032; Doshi P, 2006, INT J FOOD SCI TECH, V41, P1, DOI 10.1111/j.1365-2621.2006.01214.x; Faria AF, 2011, FOOD CHEM, V126, P1571, DOI 10.1016/j.foodchem.2010.12.007; Fu YH, 2014, BIOCHEM PHARMACOL, V90, P126, DOI 10.1016/j.bcp.2014.05.004; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; [Institute of Medicine IOM], 2001, DIET REF INT VIT C V; Institute of Medicine, 2001, DIET REF INT EN CARB; Judprasong K, 2013, FOOD CHEM, V140, P507, DOI 10.1016/j.foodchem.2013.01.057; Khoshnam F, 2007, SCI HORTIC-AMSTERDAM, V114, P21, DOI 10.1016/j.scienta.2007.05.008; Lee J, 2005, J AOAC INT, V88, P1269; Longo L, 2007, INNOV FOOD SCI EMERG, V8, P329, DOI 10.1016/j.ifset.2007.03.023; Loypimai P, 2016, J FOOD SCI TECH MYS, V53, P461, DOI 10.1007/s13197-015-2002-1; MARCO GJ, 1968, J AM OIL CHEM SOC, V45, P594, DOI 10.1007/BF02668958; Morton JF, 1987, FRUITS WARM CLIMATES, P378; Oliveira FIP, 2011, FOOD BIOPROCESS TECH, V4, P610, DOI 10.1007/s11947-010-0351-3; Pratheeshkumar P, 2014, TOXICOL APPL PHARM, V280, P127, DOI 10.1016/j.taap.2014.06.028; Rabeque CS, 2011, ANC SCI LIFE, V30, P110; Rabeta MS, 2013, MALAY APPLE WATER AP, V20, P673; Radunic M, 2015, FOOD CHEM, V177, P53, DOI 10.1016/j.foodchem.2014.12.102; Reynertson KA, 2008, FOOD CHEM, V109, P883, DOI 10.1016/j.foodchem.2008.01.021; Rockenbach II, 2011, FOOD CHEM, V127, P174, DOI 10.1016/j.foodchem.2010.12.137; Rodrigues E, 2011, CIENCIA TECNOL ALIME, V31, P911, DOI 10.1590/S0101-20612011000400027; Satpathy G, 2011, FOOD RES INT, V44, P2076, DOI 10.1016/j.foodres.2011.01.040; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Song J, 2013, FOOD CHEM TOXICOL, V58, P306, DOI 10.1016/j.fct.2013.05.003; Tang L, 2016, FOOD CHEM, V196, P550, DOI 10.1016/j.foodchem.2015.09.089; Tsuda T, 1998, LIPIDS, V33, P583, DOI 10.1007/s11745-998-0243-5; [U. S. Department of Agriculture Agricultural Research Service USDA], 2014, FOOD GROUP 09 FRUITS; Xu YJ, 2014, HEART FAIL REV, V19, P113, DOI 10.1007/s10741-013-9379-6; Yan XR, 2015, J SURG RES, V199, P592, DOI 10.1016/j.jss.2015.06.013; Zanatta CF, 2007, FOOD CHEM, V101, P1526, DOI 10.1016/j.foodchem.2006.04.004	41	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158134	10.1371/journal.pone.0158134	http://dx.doi.org/10.1371/journal.pone.0158134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352306	Green Submitted, gold, Green Published			2022-12-26	WOS:000378858900036
J	Tsai, YJ; Hao, SP; Chen, CL; Wu, WB				Tsai, Yih-Jeng; Hao, Sheng-Po; Chen, Chih-Li; Wu, Wen-Bin			Thromboxane A(2) Regulates CXCL1 and CXCL8 Chemokine Expression in the Nasal Mucosa-Derived Fibroblasts of Chronic Rhinosinusitis Patients	PLOS ONE			English	Article							EPITHELIAL-CELLS; KAPPA-B; RECEPTOR; ACTIVATION; ALPHA; INTERLEUKIN-8; MODULATION; RELEASE; PGD(2); CRTH2	Background Chronic rhinosinusitis without nasal polyps (CRSsNP) is a common chronic disease and the etiology remains unclear. Thromboxane A(2) (TXA(2)) participates in platelet aggregation and tissue inflammation. In this study, the CXCL1/8 chemokine and TXA(2)-TP receptor expression in the CRSsNP mucosa was investigated. Experimental Approach Immunohistochemistry, chemokine release assay by ELISA, RT-PCR, Real-time PCR, Western blotting, pharmacological and siRNA knockdown analysis were applied in the CRSsNP tissue specimen and cultured nasal mucosa-derived fibroblasts. Results The immunohistochemistry results indicated that CXCL1 and CXCL8 were highly expressed in the CRSsNP mucosa compared with the controls; however, the TP receptors were expressed in both mucosa. Therefore, U46619 and IBOP, a TXA(2) analog and TP agonist, were used to explore the role of TP activation in CXCL1/8 expression; both of these induced CXCL1/8 mRNA and protein expression in CRSsNP mucosa-derived fibroblasts. U46619 phosphorylated PI-3K, cyclic AMP (cAMP)/PKA, PKC, and cAMP response element (CREB). Activation of cAMP/PKA, PKC, and CREB was the major pathway for cxcl1/8 gene transcription. Pharmacological and siRNA knockdown analyses revealed that activation of cAMP/PKA and PKC mu/PKD pathways were required for CREB phosphorylation and PKA/C crosstalked with the PI-3K pathway. Conclusion and Implications Our study provides the first evidence for abundant TP receptor and CXCL1/8 expression in human CRSsNP mucosa and for TXA2 stimulation inducing CXCL1/8 expression in nasal fibroblasts primarily through TP receptor, cAMP/PKA, PKC mu/PKD, and CREB-related pathways.	[Tsai, Yih-Jeng; Hao, Sheng-Po] Shin Kong Wu Ho Su Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Tsai, Yih-Jeng] Fu Jen Catholic Univ, Grad Inst Appl Sci & Engn, Dept Chem, Coll Sci & Engn, Taipei, Taiwan; [Tsai, Yih-Jeng] Fu Jen Catholic Univ, Grad Inst Basic Med, Taipei, Taiwan; [Tsai, Yih-Jeng; Hao, Sheng-Po; Chen, Chih-Li; Wu, Wen-Bin] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University	Wu, WB (corresponding author), Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan.	wenbin@mail.fju.edu.tw	Wu, Wen-Bin/GLT-4711-2022		National Science Council [NSC 102-2320-B-030-013MY3]; Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-103-DR-25]	National Science Council(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital	This work was supported by grants from National Science Council (NSC 102-2320-B-030-013MY3) and Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-103-DR-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VK, 2004, ANN OTO RHINOL LARYN, V113, P3, DOI 10.1177/00034894041130S502; Bachert C, 1999, INT ARCH ALLERGY IMM, V118, P375, DOI 10.1159/000024141; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen CP, 2010, N-S ARCH PHARMACOL, V381, P401, DOI 10.1007/s00210-010-0501-1; Dykewicz MS, 2010, J ALLERGY CLIN IMMUN, V125, pS103, DOI 10.1016/j.jaci.2009.12.989; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Honda T, 2015, ALLERGOL INT, V64, P11, DOI 10.1016/j.alit.2014.08.002; Idzko M, 2015, J ALLERGY CLIN IMMUN, V135, P1416, DOI 10.1016/j.jaci.2015.04.028; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Kim SR, 2010, BIOCHEM BIOPH RES CO, V397, P413, DOI 10.1016/j.bbrc.2010.05.106; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Li XL, 2014, MOL CARCINOGEN, V53, P659, DOI 10.1002/mc.22020; Lo HM, 2013, INT J MOL SCI, V14, P10090, DOI 10.3390/ijms140510090; Maesako K, 1998, ACTA OTO-LARYNGOL, P61; Perez-Novo CA, 2010, ALLERGY, V65, P304, DOI 10.1111/j.1398-9995.2009.02204.x; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rudack C, 2007, CLIN EXP ALLERGY, V37, P1009, DOI 10.1111/j.1365-2222.2007.02686.x; Rudack C, 2006, CLIN EXP ALLERGY, V36, P748, DOI 10.1111/j.1365-2222.2006.02501.x; Shieh JM, 2014, CELL PHYSIOL BIOCHEM, V34, P1373, DOI 10.1159/000366344; Shirasaki H, 2007, PROSTAG LEUKOTR ESS, V76, P315, DOI 10.1016/j.plefa.2007.04.002; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Sun HX, 2008, CANCER PREV RES, V1, P316, DOI 10.1158/1940-6207.CAPR-07-0002; Tsai YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126853; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Wood AJ, 2010, POSTGRAD MED J, V86, P359, DOI 10.1136/pgmj.2009.094813; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamamoto M, 2009, INT ARCH ALLERGY IMM, V148, P127, DOI 10.1159/000155743; Yoshikawa M, 2013, ALLERGOL INT, V62, P495, DOI 10.2332/allergolint.13-OA-0572	32	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158438	10.1371/journal.pone.0158438	http://dx.doi.org/10.1371/journal.pone.0158438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351369	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900060
J	Wheeler, MCG; Arias, CL; Righini, S; Badia, MB; Andreo, CS; Drincovich, MF; Saigo, M				Gerrard Wheeler, Mariel Claudia; Lucia Arias, Cintia; Righini, Silvana; Beatriz Badia, Mariana; Santiago Andreo, Carlos; Fabiana Drincovich, Maria; Saigo, Mariana			Differential Contribution of Malic Enzymes during Soybean and Castor Seeds Maturation	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; REVEALS DIFFERENCES; FATTY-ACID; METABOLISM; GENOME; PROTEOMICS; ENDOSPERM; KINETICS; FAMILY; PLANTS	Malic enzymes (ME) catalyze the decarboxylation of malate generating pyruvate, CO2 and NADH or NADPH. In some organisms it has been established that ME is involved in lipids biosynthesis supplying carbon skeletons and reducing power. In this work we studied the MEs of soybean and castor, metabolically different oilseeds. The comparison of enzymatic activities, transcript profiles and organic acid contents suggest different metabolic strategies operating in soybean embryo and castor endosperm in order to generate precursors for lipid biosynthesis. In castor, the malate accumulation pattern agrees with a central role of this metabolite in the provision of carbon to plastids, where the biosynthesis of fatty acids occurs. In this regard, the genome of castor possesses a single gene encoding a putative plastidic NADP-ME, whose expression level is high when lipid deposition is active. On the other hand, NAD-ME showed an important contribution to the maturation of soybean embryos, perhaps driving the carbon relocation from mitochondria to plastids to support the fatty acids synthesis in the last stages of seed filling. These findings provide new insights into intermediary metabolism in oilseeds and provide new biotechnological targets to improve oil yields.	[Gerrard Wheeler, Mariel Claudia; Lucia Arias, Cintia; Righini, Silvana; Beatriz Badia, Mariana; Santiago Andreo, Carlos; Fabiana Drincovich, Maria; Saigo, Mariana] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI CONICET, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Wheeler, MCG; Saigo, M (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI CONICET, RA-2000 Rosario, Santa Fe, Argentina.	gerrard@cefobi-conicet.gov.ar; saigo@cefobi-conicet.gov.ar	Drincovich, Maria F/F-3902-2017; Drincovich, Maria F/Q-4195-2019	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Badia, Mariana Beatriz/0000-0001-7981-8910; Saigo, Mariana/0000-0002-2312-8782	Agencia Nacional de Promocion Cientifica y Tecnologica PICT [2164]; Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP [112 201101 00766]; Fundacion Nuevo Banco de Santa Fe	Agencia Nacional de Promocion Cientifica y Tecnologica PICT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Nuevo Banco de Santa Fe	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica PICT 2164 (CSA) (http://agencia.mincyt.gob.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP No 112 201101 00766 (CSA) (http://www.conicet.gov.ar/), and Fundacion Nuevo Banco de Santa Fe (MFD) (www.fundacionbsf.org.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DK, 2013, PLANT PHYSIOL, V161, P1458, DOI 10.1104/pp.112.203299; Allen DK, 2009, PLANT J, V58, P220, DOI 10.1111/j.1365-313X.2008.03771.x; Alvarez CE, 2013, PHOTOSYNTH RES, V115, P65, DOI 10.1007/s11120-013-9839-9; Badia MB, 2015, PLANT SCI, V240, P193, DOI 10.1016/j.plantsci.2015.09.015; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Beeler S, 2014, PLANT PHYSIOL, V164, P1175, DOI 10.1104/pp.113.233866; Bonfini L, 2012, J AOAC INT, V95, P1713, DOI 10.5740/jaoacint.12-050; CHAPMAN KSR, 1977, ARCH BIOCHEM BIOPHYS, V184, P298, DOI 10.1016/0003-9861(77)90354-X; Chen GQ, 2007, LIPIDS, V42, P263, DOI 10.1007/s11745-007-3022-z; Christin PA, 2009, GENOME BIOL EVOL, V1, P221, DOI 10.1093/gbe/evp020; Drincovich MF, 2011, ADV PHOTOSYNTH RESP, V32, P277; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Genard M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00085; Wheeler MCG, 2009, FEBS J, V276, P5665, DOI 10.1111/j.1742-4658.2009.07258.x; Hajduch M, 2011, PROTEOMICS, V11, P1619, DOI 10.1002/pmic.201000644; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Muller GL, 2008, PLANT CELL PHYSIOL, V49, P469, DOI 10.1093/pcp/pcn022; Neus JD, 2005, CROP SCI, V45, P589, DOI 10.2135/cropsci2005.0589; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shearer HL, 2004, ARCH BIOCHEM BIOPHYS, V429, P134, DOI 10.1016/j.abb.2004.07.001; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Tronconi MA, 2008, PLANT PHYSIOL, V146, P1540, DOI 10.1104/pp.107.114975; Tronconi MA, 2010, J BIOL CHEM, V285, P11870, DOI 10.1074/jbc.M109.097477; Wheeler MCG, 2005, PLANT PHYSIOL, V139, P39, DOI 10.1104/pp.105.065953; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0	32	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158040	10.1371/journal.pone.0158040	http://dx.doi.org/10.1371/journal.pone.0158040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347875	gold, Green Published			2022-12-26	WOS:000378801200030
J	Pinto, TD; Garcia, AC; Guedes, JD; Sobrinho, NMBD; Tavares, OCH; Berbara, RLL				Pinto, Tatiana de O.; Garcia, Andres C.; Guedes, Jair do N.; Sobrinho, Nelson M. B. do A.; Tavares, Orlando C. H.; Berbara, Ricardo L. L.			Assessment of the Use of Natural Materials for the Remediation of Cadmium Soil Contamination	PLOS ONE			English	Article							VERMICOMPOST HUMIC ACIDS; ADSORPTION-ISOTHERMS; BIOCHAR APPLICATION; ORGANIC-MATTER; SEWAGE-SLUDGE; WASTE COMPOST; HEAVY-METALS; LEAD; TRANSLOCATION; ACCUMULATION	Rice plants accumulate cadmium (Cd2+) within the grain, increasing the danger of human exposure. Natural materials have been used in soil remediation, but few studies have examined the risks (based on the bioavailability of these metals to plants) of using these materials, so the practice remains controversial. In the present study, we evaluated the effectiveness of biochar produced from sugarcane bagasse, vermicompost (VC), vermicompost solid residue (VCR) and humin for remediation of Cd2+-contaminated soils. We characterized the interactions between these materials and Cd2+ and evaluated their capacity to alter Cd2+ availability to rice plants. Our results show that under the conditions in this study, biochar and humin were not effective for soil remediation. Although biochar had high Cd2+ retention, it was associated with high Cd2+ bioavailability and increased Cd2+ accumulation in rice plants. VC and VCR had high Cd2+ retention capacity as well as low Cd2+ availability to plants. These characteristics were especially notable for VCR, which was most effective for soil remediation. The results of our study demonstrate that in the tested materials, the bioavailability of Cd2+ to plants is related to their structural characteristics, which in turn determine their retention of Cd2+.	[Pinto, Tatiana de O.; Garcia, Andres C.; Guedes, Jair do N.; Sobrinho, Nelson M. B. do A.; Tavares, Orlando C. H.; Berbara, Ricardo L. L.] Fed Rural Univ Rio de Janeiro UFRRJ, Dept Soil Sci, Rodovia BR 465,Km 07, Seropedica Rio de Janeir, Brazil		Berbara, RLL (corresponding author), Fed Rural Univ Rio de Janeiro UFRRJ, Dept Soil Sci, Rodovia BR 465,Km 07, Seropedica Rio de Janeir, Brazil.	rberbara@hotmail.com	GarcÃa, AndrÃ©s C/G-6076-2014; Tavares, Orlando Carlos Huertas/AAV-7437-2020; Berbara, Ricardo L.L./F-6672-2012; García, Andrés Calderín/F-9592-2019; Tavares, Orlando Carlos Huertas/A-7966-2016; berbara, ricardo l/AAE-4318-2020	GarcÃa, AndrÃ©s C/0000-0001-5963-3847; Tavares, Orlando Carlos Huertas/0000-0001-9581-0994; Berbara, Ricardo L.L./0000-0002-3649-9443; García, Andrés Calderín/0000-0001-5963-3847; Tavares, Orlando Carlos Huertas/0000-0001-9581-0994; berbara, ricardo l/0000-0002-9133-7754; de Oliveira Pinto, Tatiana/0000-0002-1039-9233; Moura Brasil do Amaral Sobrinho, Nelson/0000-0002-5053-7338	CAPES/CNPq postdoctoral scholarship	CAPES/CNPq postdoctoral scholarship	A.C.G. (sisFaperj: 2012028010) thanks FAPERJ (Edital Pos-doutorado Nota 10), FAPERJ APQ1 and a CAPES/CNPq postdoctoral scholarship (Science without Borders-PVE A060/2013). The authors thank Universal/CNPq and CARBIOMA/CNPq.; A.C.G. (sisFaperj: 2012028010) thanks FAPERJ (Edital Pos-doutorado Nota 10), FAPERJ APQ1 and CAPES/CNPq postdoctoral scholarship (Science without Borders-PVE A060/2013). The authors thank Universal/CNPq and CARBIOMA/CNPq.	Amir S, 2010, J HAZARD MATER, V177, P524, DOI 10.1016/j.jhazmat.2009.12.064; Andreas R, 2014, B ENVIRON CONTAM TOX, V92, P352, DOI 10.1007/s00128-014-1205-x; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Benavides María P., 2005, Braz. J. Plant Physiol., V17, P21, DOI 10.1590/S1677-04202005000100003; Borchard N, 2012, SOIL USE MANAGE, V28, P177, DOI 10.1111/j.1475-2743.2012.00407.x; Garcia AC, 2013, J ENVIRON CHEM ENG, V1, P916, DOI 10.1016/j.jece.2013.08.001; Garcia AC, 2014, J GEOCHEM EXPLOR, V136, P48, DOI 10.1016/j.gexplo.2013.10.005; Canellas LP, 2002, PLANT PHYSIOL, V130, P1951, DOI 10.1104/pp.007088; Dobbss LB, 2010, J AGR FOOD CHEM, V58, P3681, DOI 10.1021/jf904385c; Droussi Z, 2009, J HAZARD MATER, V164, P1281, DOI 10.1016/j.jhazmat.2008.09.081; Elad Y, 2011, PHYTOPATHOL MEDITERR, V50, P335; Elad Y, 2010, PHYTOPATHOLOGY, V100, P913, DOI 10.1094/PHYTO-100-9-0913; Fellet G, 2014, SCI TOTAL ENVIRON, V468, P598, DOI 10.1016/j.scitotenv.2013.08.072; Fine P, 2005, ENVIRON POLLUT, V138, P358, DOI 10.1016/j.envpol.2005.03.003; Fontana A., 2001, Floresta e Ambiente, V8, P114; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Garcia AC, 2012, ECOL ENG, V47, P203, DOI 10.1016/j.ecoleng.2012.06.011; GILES CH, 1960, J CHEM SOC, P3973, DOI 10.1039/jr9600003973; Gill SS, 2011, PLANT SIGNAL BEHAV, V6, P215, DOI 10.4161/psb.6.2.14880; Gonzalez-Perez JA, 2004, ENVIRON INT, V30, P855, DOI 10.1016/j.envint.2004.02.003; Guareschi RF, 2013, SEMIN-CIENC AGRAR, V34, P2615, DOI 10.5433/1679-0359.2013v34n6p2615; Havelcova M, 2009, J HAZARD MATER, V161, P559, DOI 10.1016/j.jhazmat.2008.03.136; Hoagland DR, 1950, GROWING PLANTS SOIL; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jadia CD, 2008, ENVIRON ENG MANAG J, V7, P547, DOI 10.30638/eemj.2008.078; Jiang SL, 2012, INT J FOOD SCI NUTR, V63, P468, DOI 10.3109/09637486.2011.636343; Jordao CP, 2009, J HAZARD MATER, V162, P804, DOI 10.1016/j.jhazmat.2008.05.104; Karami N, 2011, J HAZARD MATER, V191, P41, DOI 10.1016/j.jhazmat.2011.04.025; Khan S, 2013, ENVIRON SCI TECHNOL, V47, P8624, DOI 10.1021/es400554x; Lakhdar A, 2009, COMMUN SOIL SCI PLAN, V40, P3524, DOI 10.1080/00103620903326040; Larison JR, 2000, NATURE, V406, P181, DOI 10.1038/35018068; Lehmann J., 2012, BIOCHAR ENV MANAGEME; Li XW, 2011, J HAZARD MATER, V185, P740, DOI 10.1016/j.jhazmat.2010.09.081; Lucchini P, 2014, AGR ECOSYST ENVIRON, V184, P149, DOI 10.1016/j.agee.2013.11.018; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Maksimovic I, 2007, BIOL PLANTARUM, V51, P589, DOI 10.1007/s10535-007-0129-2; Matos GD, 2003, PROCESS BIOCHEM, V39, P81, DOI 10.1016/S0032-9592(02)00315-1; Meharg AA, 2013, ENVIRON SCI TECHNOL, V47, P5613, DOI 10.1021/es400521h; Melo LCA, 2016, J SOIL SEDIMENT, V16, P226, DOI 10.1007/s11368-015-1199-y; Muscolo A, 2007, SOIL SCI SOC AM J, V71, P75, DOI 10.2136/sssaj2006.0055; Oo AN, 2015, LAND DEGRAD DEV, V26, P300, DOI 10.1002/ldr.2208; Park JH, 2016, CHEMOSPHERE, V142, P77, DOI 10.1016/j.chemosphere.2015.05.093; Perminova IV, 2005, USE HUMIC SUBSTANCES, P285; Renner R, 2007, ENVIRON SCI TECHNOL, V41, P5932, DOI 10.1021/es0726097; Rice JA, 2001, SOIL SCI, V166, P848, DOI 10.1097/00010694-200111000-00009; Russell L, 2006, PLANT SOIL, V283, P175, DOI 10.1007/s11104-006-0011-6; Sabir M, 2015, SOIL REMEDIATION AND PLANTS: PROSPECTS AND CHALLENGES, P85; SENESI N, 1987, SCI TOTAL ENVIRON, V62, P241, DOI 10.1016/0048-9697(87)90506-7; Tejada M, 2009, CATENA, V77, P238, DOI 10.1016/j.catena.2009.01.004; Uchimiya M, 2011, J HAZARD MATER, V190, P432, DOI 10.1016/j.jhazmat.2011.03.063; Ueno D, 2009, NEW PHYTOL, V182, P644, DOI 10.1111/j.1469-8137.2009.02784.x; Uraguchi S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-5; Uraguchi S, 2009, J EXP BOT, V60, P2677, DOI 10.1093/jxb/erp119; URE AM, 1993, INT J ENVIRON AN CH, V51, P135, DOI 10.1080/03067319308027619; Viger M, 2015, GCB BIOENERGY, V7, P658, DOI 10.1111/gcbb.12182; Xu HJ, 2014, ENVIRON SCI TECHNOL, V48, P9391, DOI 10.1021/es5021058; Zacchini M, 2009, WATER AIR SOIL POLL, V197, P23, DOI 10.1007/s11270-008-9788-7; Zhang JJ, 2013, ENVIRON CHEM LETT, V11, P41, DOI 10.1007/s10311-012-0375-1; Zhao X, 2014, SOIL USE MANAGE, V30, P311, DOI 10.1111/sum.12124; Zhuang P, 2007, WATER AIR SOIL POLL, V184, P235, DOI 10.1007/s11270-007-9412-2	61	7	7	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157547	10.1371/journal.pone.0157547	http://dx.doi.org/10.1371/journal.pone.0157547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341440	gold, Green Published, Green Submitted			2022-12-26	WOS:000378393600010
J	Ahmad, S; Ytterberg, AJ; Thulasingam, M; Tholander, F; Bergman, T; Zubarev, R; Wetterholm, A; Rinaldo-Matthis, A; Haeggstrom, JZ				Ahmad, Shabbir; Ytterberg, A. Jimmy; Thulasingam, Madhuranayaki; Tholander, Fredrik; Bergman, Tomas; Zubarev, Roman; Wetterholm, Anders; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.			Phosphorylation of Leukotriene C-4 Synthase at Serine 36 Impairs Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug development; eicosanoid specific enzyme; leukotriene; membrane enzyme; phosphoproteomics; MAPEG; cysteinyl leukotrienes; leukotriene C4 synthase; p70S6k; phosphoregulation	MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; RECEPTOR; PARAMETERIZATION; GLUTATHIONE; PREDICTION; MEDIATORS; SITES	Leukotriene C-4 synthase (LTC4S) catalyzes the formation of the proinflammatory lipid mediator leukotriene C-4 (LTC4). LTC4 is the parent molecule of the cysteinyl leukotrienes, which are recognized for their pathogenic role in asthma and allergic diseases. Cellular LTC4S activity is suppressed by PKC-mediated phosphorylation, and recently a downstream p70S6k was shown to play an important role in this process. Here, we identified Ser(36) as the major p70S6k phosphorylation site, along with a low frequency site at Thr(40), using an in vitro phosphorylation assay combined with mass spectrometry. The functional consequences of p70S6k phosphorylation were tested with the phosphomimetic mutant S36E, which displayed only about 20% (20 mol/min/mg) of the activity of WT enzyme (95 mol/min/mg), whereas the enzyme activity of T40E was not significantly affected. The enzyme activity of S36E increased linearly with increasing LTA(4) concentrations during the steady-state kinetics analysis, indicating poor lipid substrate binding. The Ser(36) is located in a loop region close to the entrance of the proposed substrate binding pocket. Comparative molecular dynamics indicated that Ser(36) upon phosphorylation will pull the first luminal loop of LTC4S toward the neighboring subunit of the functional homotrimer, thereby forming hydrogen bonds with Arg(104) in the adjacent subunit. Because Arg(104) is a key catalytic residue responsible for stabilization of the glutathione thiolate anion, this phosphorylation-induced interaction leads to a reduction of the catalytic activity. In addition, the positional shift of the loop and its interaction with the neighboring subunit affect active site access. Thus, our mutational and kinetic data, together with molecular simulations, suggest that phosphorylation of Ser(36) inhibits the catalytic function of LTC4S by interference with the catalytic machinery.	[Ahmad, Shabbir; Thulasingam, Madhuranayaki; Wetterholm, Anders; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden; [Ytterberg, A. Jimmy; Bergman, Tomas; Zubarev, Roman] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 1, SE-17177 Stockholm, Sweden; [Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Ytterberg, A. Jimmy] Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Haeggstrom, JZ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Ahmad, Shabbir/0000-0003-2374-1197	Swedish Research Council [10350, 2301153]; Stockholm County Council; NovoNordisk Foundation [NNF15CC0018346]; Karolinska Institutet; Novo Nordisk Fonden [NNF15SA0018346] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); NovoNordisk Foundation(Novo Nordisk Foundation); Karolinska Institutet(Karolinska Institutet); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by Swedish Research Council Grants 10350 and 2301153, Stockholm County Council (Cardiovascular Program), and NovoNordisk Foundation Grant NNF15CC0018346. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a distinguished professor award from Karolinska Institutet. To whom correspondence should be addressed. Tel.: 46-8-524-87612 or 46-8-524-87648; Fax: 46-8-736-0439; E-mail: jesper.haeggstrom@ki.se.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; ALI A, 1994, J IMMUNOL, V153, P776; Austen KF, 2008, NAT IMMUNOL, V9, P113, DOI 10.1038/ni0208-113; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Esser J, 2011, FASEB J, V25, P1417, DOI 10.1096/fj.10-175828; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleckenstein DS, 2003, LEUKEMIA RES, V27, P687, DOI 10.1016/S0145-2126(02)00325-9; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gupta N, 1999, FEBS LETT, V449, P66, DOI 10.1016/S0014-5793(99)00397-X; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Kleinschmidt TK, 2015, J PHARMACOL EXP THER, V355, P108, DOI 10.1124/jpet.115.227157; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lam BK, 2003, PROSTAG LEUKOTR ESS, V69, P111, DOI 10.1016/S0952-3278(03)00071-1; Lepley RA, 1996, J BIOL CHEM, V271, P6179, DOI 10.1074/jbc.271.11.6179; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyutvinskiy Y, 2013, MOL CELL PROTEOMICS, V12, P2324, DOI 10.1074/mcp.O112.023804; Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Marionneau C, 2015, J MOL CELL CARDIOL, V82, P36, DOI 10.1016/j.yjmcc.2015.02.013; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Niegowski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096763; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Rinaldo-Matthis A, 2012, BIOCHEMISTRY-US, V51, P848, DOI 10.1021/bi201402s; Rinaldo-Matthis A, 2010, J BIOL CHEM, V285, P40771, DOI 10.1074/jbc.M110.105940; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; Smith KP, 2015, PROTEINS, V83, P25, DOI 10.1002/prot.24605; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WETTERHOLM A, 1991, BIOCHIM BIOPHYS ACTA, V1080, P96, DOI 10.1016/0167-4838(91)90134-L; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	45	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18410	18418		10.1074/jbc.M116.735647	http://dx.doi.org/10.1074/jbc.M116.735647			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365393	Green Published, hybrid			2022-12-26	WOS:000383241800031
J	Pan, X; Cang, XH; Dan, SS; Li, JC; Cheng, J; Kang, B; Duan, XT; Shen, BH; Wang, YJ				Pan, Xiao; Cang, Xiaohui; Dan, Songsong; Li, Jingchao; Cheng, Jie; Kang, Bo; Duan, Xiaotao; Shen, Binghui; Wang, Ying-Jie			Site-specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; differentiation; epithelial-mesenchymal transition (EMT); pluripotency; post-translational modification (PTM); stem cells; transcription factor; tumor cell biology	EMBRYONIC STEM-CELLS; SIGNALING PATHWAYS; SELF-RENEWAL; CANCER-CELLS; OCT4; PROMOTES; SOX2; TRANSCRIPTION; PLURIPOTENCY; ENDODERM	Although the Oct4/Sox2 complex is crucial for maintaining the pluripotency of stem cells, the molecular basis underlying its regulation during lineage-specific differentiation remains unknown. Here, we revealed that the highly conserved Oct4/Lys-156 is important for maintaining the stability of the Oct4 protein and the intermolecular salt bridge between Oct4/Lys-151 and Sox2/Asp-107 that contributes to the Oct4/Sox2 interaction. Post-translational modifications at Lys-156 and K156N, a somatic mutation detected in bladder cancer patients, both impaired the Lys-151-Asp-107 salt bridge and the Oct4/Sox2 interaction. When produced as a recombinant protein or overexpressed in pluripotent stem cells, Oct4/K156N, with reduced binding to Sox2, significantly down-regulated the stemness genes that are cooperatively controlled by the Oct4/Sox2 complex and specifically up-regulated the mesendodermal genes and the SNAIL family genes that promote the epithelial-mesenchymal transition. Thus, we conclude that Oct4/Lys-156-modulated Oct4/Sox2 interaction coordinately controls the epithelial-mesenchymal transition and mesendoderm specification induced by specific differentiation signals.	[Pan, Xiao; Cang, Xiaohui; Li, Jingchao; Cheng, Jie] Zhejiang Univ, Coll Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Dan, Songsong; Cheng, Jie; Kang, Bo; Wang, Ying-Jie] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Affiliated Hosp 1, 79 QingChun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Duan, Xiaotao] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China; [Shen, Binghui] City Hope Natl Med Ctr, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Shen, Binghui] Beckman Res Inst, Duarte, CA 91010 USA	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Academy of Military Medical Sciences - China; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Wang, YJ (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Affiliated Hosp 1, 79 QingChun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	yingjiewang@zju.edu.cn		Duan, Xiaotao/0000-0001-9962-1234; Shen, Binghui/0000-0002-4408-407X; Kang, Bo/0000-0001-7864-252X	National Natural Science Foundation of China [31271465]; First Affiliated Hospital, School of Medicine, Zhejiang University [b2697]; Fundamental Research Funds for the Central Universities [2014QNA6004]; Scientific Research Fund of Zhejiang Provincial Education Department Grant [Y201432207]; NATIONAL CANCER INSTITUTE [R01CA085344] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First Affiliated Hospital, School of Medicine, Zhejiang University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Fund of Zhejiang Provincial Education Department Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Natural Science Foundation of China Grant 31271465 (to Y.-J. W.), First Affiliated Hospital, School of Medicine, Zhejiang University Intramural Grant b2697 (to Y.-J. W.), Fundamental Research Funds for the Central Universities Grant 2014QNA6004 (to X. C.), and Scientific Research Fund of Zhejiang Provincial Education Department Grant Y201432207 (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aksoy I, 2013, EMBO J, V32, P938, DOI 10.1038/emboj.2013.31; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050432; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8209; Dan SS, 2015, BIOCHEM BIOPH RES CO, V456, P714, DOI 10.1016/j.bbrc.2014.12.043; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Iovino N, 2011, CELL, V145, P815, DOI 10.1016/j.cell.2011.05.027; Izarzugaza JMG, 2009, PROTEINS, V77, P892, DOI 10.1002/prot.22512; Jerabek S, 2014, BBA-GENE REGUL MECH, V1839, P138, DOI 10.1016/j.bbagrm.2013.10.001; Jin WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20818; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lam CS, 2012, BIOCHEM J, V448, P21, DOI 10.1042/BJ20120725; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu QM, 2013, MOL CELL PROTEOMICS, V12, P473, DOI 10.1074/mcp.M112.022319; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Merino F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004287; Merino F, 2014, STRUCTURE, V22, P1274, DOI 10.1016/j.str.2014.06.014; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Richter A, 2014, STEM CELLS, V32, P636, DOI 10.1002/stem.1592; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Shu XD, 2014, CURR OPIN GENET DEV, V28, P32, DOI 10.1016/j.gde.2014.08.005; Slawny N, 2013, STEM CELLS DEV, V22, P1177, DOI 10.1089/scd.2012.0050; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Sun C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0503-1; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	45	19	21	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18353	18369		10.1074/jbc.M116.745414	http://dx.doi.org/10.1074/jbc.M116.745414			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27369080	Green Published, hybrid			2022-12-26	WOS:000383241800027
J	Szabo, A; Pilsak, C; Bence, M; Witt, H; Sahin-Toth, M				Szabo, Andras; Pilsak, Claudia; Bence, Melinda; Witt, Heiko; Sahin-Toth, Miklos			Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complex; metalloprotease; pancreas; proteolytic enzyme; serine protease; elastase; pancreatitis; zymogen activation	HUMAN CATIONIC TRYPSINOGEN; BOVINE PANCREATIC PROCARBOXYPEPTIDASE; A-S6 TERNARY COMPLEX; CHYMOTRYPSIN-C; BINARY-COMPLEX; PROPROTEINASE-E; HEREDITARY PANCREATITIS; SUBUNIT-III; PROTEASE-E; ACTIVATION PROCESSES	The pancreas secretes digestive proenzymes typically in their monomeric form. A notable exception is the ternary complex formed by proproteinase E, chymotrypsinogen C, and procarboxypeptidase A (proCPA) in cattle and other ruminants. In the human and pig pancreas binary complexes of proCPA with proelastases were found. To characterize complex formation among human pancreatic protease zymogens in a systematic manner, we performed binding experiments using recombinant proelastases CELA2A, CELA3A, and CELA3B; chymotrypsinogens CTRB1, CTRB2, CTRC, and CTRL1; and procarboxypeptidases CPA1, CPA2, and CPB1. We found that proCELA3B bound not only to proCPA1 (K-D 43 nm) but even more tightly to proCPA2 (K-D 18 nm), whereas proCELA2A bound weakly to proCPA1 only (K-D 152 nm). Surprisingly, proCELA3A, which shares 92% identity with proCELA3B, did not form stable complexes due to the evolutionary replacement of Ala(241) with Gly. The polymorphic nature of position 241 in both CELA3A (approximate to 4% Ala(241) alleles) and CELA3B (approximate to 2% Gly(241) alleles) points to individual variations in complex formation. The functional effect of complex formation was delayed procarboxypeptidase activation due to increased affinity of the inhibitory activation peptide, whereas proelastase activation was unchanged. We conclude that complex formation among human pancreatic protease zymogens is limited to a subset of proelastases and procarboxypeptidases. Complex formation stabilizes the inhibitory activation peptide of procarboxypeptidases and thereby increases zymogen stability and controls activation.	[Szabo, Andras; Pilsak, Claudia; Bence, Melinda; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Ctr Exocrine Disorders, Boston, MA 02118 USA; [Pilsak, Claudia; Witt, Heiko] Tech Univ Munich, Paediat Nutr Med, Klinikum Rechts Isar MRI, Else Kroner Fresenius Zentrum Ernahrungsmed EKFZ, D-85354 Freising Weihenstephan, Germany; [Witt, Heiko] ZIEL Inst Food & Hlth, D-85354 Freising Weihenstephan, Germany	Boston University; Boston University; Technical University of Munich	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01 DK095753, R01 DK082412, R01 DK058088]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK095753, R01 DK082412, and R01 DK058088. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AVILES FX, 1989, BIOCHEM BIOPH RES CO, V163, P1191, DOI 10.1016/0006-291X(89)91104-2; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Balazs A, 2016, AM J PHYSIOL-GASTR L, V310, pG477, DOI 10.1152/ajpgi.00444.2015; BROWN JR, 1963, BIOCHEMISTRY-US, V2, P877, DOI 10.1021/bi00904a041; BROWN JR, 1961, P NATL ACAD SCI USA, V47, P1554, DOI 10.1073/pnas.47.10.1554; BROWN JR, 1963, BIOCHEMISTRY-US, V2, P867, DOI 10.1021/bi00904a040; CHAPUS C, 1988, BIOCHIMIE, V70, P1143, DOI 10.1016/0300-9084(88)90179-4; Gomis-Ruth FX, 1998, EUR J BIOCHEM, V251, P839, DOI 10.1046/j.1432-1327.1998.2510839.x; GomisRuth FX, 1997, J MOL BIOL, V269, P861, DOI 10.1006/jmbi.1997.1040; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; GRANON S, 1990, J BIOL CHEM, V265, P10383; KELLER PJ, 1958, J BIOL CHEM, V230, P905; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; KERFELEC B, 1985, EUR J BIOCHEM, V151, P515, DOI 10.1111/j.1432-1033.1985.tb09132.x; KOBAYASHI R, 1978, J BIOL CHEM, V253, P5526; KOBAYASHI Y, 1981, J BIOL CHEM, V256, P2466; MARTINEZ MC, 1981, BIOCHEM J, V197, P141, DOI 10.1042/bj1970141; MICHON T, 1991, BIOCHEM BIOPH RES CO, V181, P449, DOI 10.1016/S0006-291X(05)81440-8; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; MOULARD M, 1990, FEBS LETT, V261, P179, DOI 10.1016/0014-5793(90)80665-6; MOULARD M, 1989, FEBS LETT, V250, P166, DOI 10.1016/0014-5793(89)80712-4; Nakano E, 2015, AM J PHYSIOL-GASTR L, V309, pG688, DOI 10.1152/ajpgi.00241.2015; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; OPPEZZO O, 1994, EUR J BIOCHEM, V222, P55, DOI 10.1111/j.1432-1033.1994.tb18841.x; PASCUAL R, 1989, EUR J BIOCHEM, V179, P609, DOI 10.1111/j.1432-1033.1989.tb14590.x; PASCUAL R, 1990, FEBS LETT, V277, P37, DOI 10.1016/0014-5793(90)80804-R; PIGNOL D, 1994, EMBO J, V13, P1763, DOI 10.1002/j.1460-2075.1994.tb06444.x; PUIGSERVER A, 1977, BIOCHEMISTRY-US, V16, P2497, DOI 10.1021/bi00630a028; PUIGSERVER A, 1972, BIOCHIM BIOPHYS ACTA, V276, P519, DOI 10.1016/0005-2744(72)91012-1; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rose SD, 1997, HUM MOL GENET, V6, P897, DOI 10.1093/hmg/6.6.897; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SHIRASU Y, 1988, J BIOCHEM-TOKYO, V104, P259, DOI 10.1093/oxfordjournals.jbchem.a122454; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; TANI T, 1987, J BIOCHEM-TOKYO, V101, P591, DOI 10.1093/jb/101.3.591; TANI T, 1988, J BIOL CHEM, V263, P1231; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; VENDRELL J, 1982, BIOCHEM J, V205, P449, DOI 10.1042/bj2050449; Ventura S, 1997, BIOL CHEM, V378, P161; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; YAMASAKI M, 1963, BIOCHEMISTRY-US, V2, P859, DOI 10.1021/bi00904a039; YONEDA T, 1980, COMP BIOCHEM PHYS B, V67, P81, DOI 10.1016/0305-0491(80)90272-2	51	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17706	17716		10.1074/jbc.M116.743237	http://dx.doi.org/10.1074/jbc.M116.743237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358403	hybrid, Green Published			2022-12-26	WOS:000383241300020
J	Correa-Galvis, V; Redekop, P; Guan, K; Griess, A; Truong, TB; Wakao, S; Niyogi, KK; Jahns, P				Correa-Galvis, Viviana; Redekop, Petra; Guan, Katharine; Griess, Annika; Truong, Thuy B.; Wakao, Setsuko; Niyogi, Krishna K.; Jahns, Peter			Photosystem II Subunit PsbS Is Involved in the Induction of LHCSR Protein-dependent Energy Dissipation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydomonas; light-harvesting complex (antenna complex); pH regulation; photosynthesis; photosystem II; light acclimation; NPQ; Photoprotection; PsbS	LIGHT-HARVESTING COMPLEXES; PHYSCOMITRELLA-PATENS; CARBONIC-ANHYDRASE; XANTHOPHYLL-CYCLE; SUPRAMOLECULAR ORGANIZATION; FLUORESCENCE; PHOTOSYNTHESIS; MUTANTS; ARABIDOPSIS; MECHANISMS	Non-photochemical quenching of excess excitation energy is an important photoprotective mechanism in photosynthetic organisms. In Arabidopsis thaliana, a high quenching capacity is constitutively present and depends on the PsbS protein. In the green alga Chlamydomonas reinhardtii, non-photochemical quenching becomes activated upon high light acclimation and requires the accumulation of light harvesting complex stress-related (LHCSR) proteins. Expression of the PsbS protein in C. reinhardtii has not been reported yet. Here, we show that PsbS is a light-induced protein in C. reinhardtii, whose accumulation under high light is further controlled by CO2 availability. PsbS accumulated after several hours of high light illumination at low CO2. At high CO2, however, PsbS was only transiently expressed under high light and was degraded after 1 h of high light exposure. PsbS accumulation correlated with an enhanced non-photochemical quenching capacity in high light-acclimated cells grown at low CO2. However, PsbS could not compensate for the function of LHCSR in an LHCSR-deficient mutant. Knockdown of PsbS accumulation led to reduction of both non-photochemical quenching capacity and LHCSR3 accumulation. Our data suggest that PsbS is essential for the activation of non-photochemical quenching in C. reinhardtii, possibly by promoting conformational changes required for activation of LHCSR3-dependent quenching in the antenna of photosystem II.	[Correa-Galvis, Viviana; Redekop, Petra; Griess, Annika; Jahns, Peter] Univ Dusseldorf, Plant Biochem, D-40225 Dusseldorf, Germany; [Guan, Katharine; Truong, Thuy B.; Wakao, Setsuko; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Niyogi, Krishna K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Correa-Galvis, Viviana] Max Planck Inst Mol Plant Physiol, Muhlenberg 1, D-14476 Potsdam, Germany; [Truong, Thuy B.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Niyogi, Krishna K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Niyogi, Krishna K.] Gordon & Betty Moore Fdn, Palo Alto, CA USA	Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Max Planck Society; Donald Danforth Plant Science Center; Howard Hughes Medical Institute	Jahns, P (corresponding author), Univ Dusseldorf, Plant Biochem, D-40225 Dusseldorf, Germany.	pjahns@hhu.de			Deutsche Forschungsgemeinschaft [GRK 1525, JA 665/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GRK 1525 and JA 665/11-1; to P. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Amarnath K, 2012, P NATL ACAD SCI USA, V109, P8405, DOI 10.1073/pnas.1205303109; Anwaruzzaman M, 2004, PHOTOSYNTH RES, V82, P265, DOI 10.1007/s11120-004-2439-y; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; Forster B, 2001, PHOTOSYNTH RES, V67, P5, DOI 10.1023/A:1010611509209; Gerotto C, 2015, PLANT PHYSIOL, V168, P1747, DOI 10.1104/pp.15.00361; Gerotto C, 2012, NEW PHYTOL, V196, P763, DOI 10.1111/j.1469-8137.2012.04345.x; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Johnson MP, 2011, J BIOL CHEM, V286, P19973, DOI 10.1074/jbc.M111.237255; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Krause GH, 2004, ADV PHOTO RESPIRAT, V19, P463; Kucho K, 2003, PLANT PHYSIOL, V133, P783, DOI 10.1104/pp.103.026492; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mettler T, 2014, PLANT CELL, V26, P2310, DOI 10.1105/tpc.114.124537; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Park YI, 1999, FEBS LETT, V444, P102, DOI 10.1016/S0014-5793(99)00037-X; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Schwarz N, 2015, PLANT CELL PHYSIOL, V56, P346, DOI 10.1093/pcp/pcu167; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Teramoto H, 2002, PLANT PHYSIOL, V130, P325, DOI 10.1104/pp.004622; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Xue HD, 2015, PLANT PHYSIOL, V167, P1566, DOI 10.1104/pp.15.00094; Zones JM, 2015, PLANT CELL, V27, P2743, DOI 10.1105/tpc.15.00498	54	67	72	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17478	17487		10.1074/jbc.M116.737312	http://dx.doi.org/10.1074/jbc.M116.737312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358399	Green Published, hybrid			2022-12-26	WOS:000382643800045
J	Yoshimoto, FK; Gonzalez, E; Auchus, RJ; Guengerich, FP				Yoshimoto, Francis K.; Gonzalez, Eric; Auchus, Richard J.; Guengerich, F. Peter			Mechanism of 17,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: O-18 LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; enzyme catalysis; enzyme mechanism; mass spectrometry (MS); nuclear magnetic resonance (NMR); steroid; steroidogenesis; oxygenase	H BOND ACTIVATION; COMPOUND I; REGIOSELECTIVE HYDROXYLATION; ESTROGEN BIOSYNTHESIS; ANDROGEN FORMATION; ESCHERICHIA-COLI; HUMAN P450C17; OXIDATION; EXPRESSION; CLEAVAGE	Cytochrome P450 (P450) reactions can involve C-C bond cleavage, and several of these are critical in steroid and sterol biosynthesis. The mechanisms of P450s 11A1, 17A1, 19A1, and 51A1 have been controversial, in the context of the role of ferric peroxide (FeO2-) versus perferryl (FeO3+, compound I) chemistry. We reinvestigated the 17-hydroxyprogesterone and 17-hydroxypregnenolone 17,20-lyase reactions of human P450 17A1 and found incorporation of one O-18 atom (from O-18(2)) into acetic acid, consonant with proposals for a ferric peroxide mechanism (Akhtar, M., Lee-Robichaud, P., Akhtar, M. E., and Wright, J. N. (1997) J. Steroid Biochem. Mol. Biol. 61, 127-132; Akhtar, M., Wright, J. N., and Lee-Robichaud, P. (2011) J. Steroid Biochem. Mol. Biol. 125, 2-12). However, the reactions were supported by iodosylbenzene (a precursor of the FeO3+ species) but not by H2O2. We propose three mechanisms that can involve the FeO3+ entity and that explain the O-18 label in the acetic acid, two involving the intermediacy of an acetyl radical and one a steroid 17,20-dioxetane. P450 17A1 was found to perform 16-hydroxylation reactions on its 17-hydroxylated products to yield 16,17-dihydroxypregnenolone and progesterone, suggesting the presence of an active perferryloxo active species of P450 17A1 when its lyase substrate is bound. The 6-hydroxylation of 16,17-dihydroxyprogesterone and the oxidation of both 16,17-dihydroxyprogesterone and 16,17-dihydroxypregnenolone to 16-hydroxy lyase products were also observed. We provide evidence for the contribution of a compound I mechanism, although contribution of a ferric peroxide pathway in the 17,20-lyase reaction cannot be excluded.	[Yoshimoto, Francis K.; Gonzalez, Eric; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Yoshimoto, Francis K.; Auchus, Richard J.] Univ Michigan, Dept Internal Med, Div Metab Diabet & Endocrinol, Ann Arbor, MI 48019 USA; [Yoshimoto, Francis K.; Auchus, Richard J.] Univ Michigan, Dept Pharmacol, Div Metab Diabet & Endocrinol, Ann Arbor, MI 48019 USA	Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Yoshimoto, Francis/0000-0002-2308-2999	National Institutes of Health [R37 CA090426, R01 GM118122, R01 GM103937, R01 GM086596]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103937, R01GM086596, R01GM118122, R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426, R01 GM118122, and R01 GM103937 (to F. P. G.) and R01 GM086596 (to R. J. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKHTAR M, 1976, J CHEM SOC CHEM COMM, P854, DOI 10.1039/c39760000854; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; Akhtar M, 1997, J STEROID BIOCHEM, V61, P127; AKHTAR M, 1994, J CHEM SOC PERK T 1, P263, DOI 10.1039/p19940000263; AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Akhtar M, 2015, ADV EXP MED BIOL, V851, P107, DOI 10.1007/978-3-319-16009-2_4; Akhtar M, 2011, J STEROID BIOCHEM, V125, P2, DOI 10.1016/j.jsbmb.2010.11.003; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Bakac A, 2002, J AM CHEM SOC, V124, P9136, DOI 10.1021/ja026365w; Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z; Bell SR, 2009, J AM CHEM SOC, V131, P9640, DOI 10.1021/ja903394s; BETANCOR C, 1988, J CHEM SOC CHEM COMM, P947, DOI 10.1039/c39880000947; Cai HL, 1999, J AM CHEM SOC, V121, P11656, DOI 10.1021/ja9914240; CASPI E, 1986, J AM CHEM SOC, V108, P1847, DOI 10.1021/ja00268a023; CASPI E, 1984, J AM CHEM SOC, V106, P7282, DOI 10.1021/ja00335a090; Cheng Q, 2012, J BIOL CHEM, V287, P29554, DOI 10.1074/jbc.M112.390047; Chowdhury G, 2012, BIOCHEMISTRY-US, V51, P9995, DOI 10.1021/bi301092c; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; COLE PA, 1990, J MED CHEM, V33, P2933, DOI 10.1021/jm00173a001; Davydov R, 2015, BIOCHEMISTRY-US, V54, P7089, DOI 10.1021/acs.biochem.5b00903; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; FISHMAN J, 1982, CANCER RES, V42, P3277; FOUST GP, 1969, ANAL BIOCHEM, V27, P530, DOI 10.1016/0003-2697(69)90066-9; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GOTO J, 1977, SCIENCE, V195, P80, DOI 10.1126/science.831259; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2011, ARCH BIOCHEM BIOPHYS, V507, P126, DOI 10.1016/j.abb.2010.08.017; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 1997, MOL PHARMACOL, V51, P147, DOI 10.1124/mol.51.1.147; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; HAHN EF, 1984, J BIOL CHEM, V259, P1689; Hamilton NM, 2012, J MED CHEM, V55, P4431, DOI 10.1021/jm300317k; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HAYAMIZU K, 1990, MAGN RESON CHEM, V28, P250, DOI 10.1002/mrc.1260280311; HOLM KA, 1985, ARCH BIOCHEM BIOPHYS, V237, P477, DOI 10.1016/0003-9861(85)90301-7; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P253; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; KADLUBAR FF, 1973, BIOCHEM BIOPH RES CO, V54, P1255, DOI 10.1016/0006-291X(73)91122-4; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; KIRK DN, 1990, J CHEM SOC PERK T 2, P1567, DOI 10.1039/p29900001567; KIRSCHNER MA, 1966, ACTA ENDOCRINOL-COP, V53, P584, DOI 10.1530/acta.0.0530584; Krauser JA, 2004, EUR J BIOCHEM, V271, P3962, DOI 10.1111/j.1432-1033.2004.04339.x; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; LEEROBICHAUD P, 1995, BIOCHEMISTRY-US, V34, P14104, DOI 10.1021/bi00043a015; LICHTENBERGER F, 1976, BIOCHEM BIOPH RES CO, V70, P939, DOI 10.1016/0006-291X(76)90682-3; MACDONALD TL, 1989, BIOCHEMISTRY-US, V28, P2071, DOI 10.1021/bi00431a016; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; Mak PJ, 2014, J AM CHEM SOC, V136, P4825, DOI 10.1021/ja500054c; MANSUY D, 1982, TETRAHEDRON LETT, V23, P2781, DOI 10.1016/S0040-4039(00)87457-2; MILLER SL, 1991, J CHEM SOC CHEM COMM, P157, DOI 10.1039/c39910000157; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; MORAND P, 1975, BIOCHEMISTRY-US, V14, P635, DOI 10.1021/bi00674a027; Niwa T, 1998, XENOBIOTICA, V28, P539, DOI 10.1080/004982598239290; NORDBLOM GD, 1977, ARCH BIOCHEM BIOPHYS, V180, P343, DOI 10.1016/0003-9861(77)90047-9; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Paraskevas PD, 2014, J PHYS CHEM A, V118, P9296, DOI 10.1021/jp503570e; Pechurskaya TA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P806, DOI 10.1134/S0006297908070092; Pestovsky O, 2004, J AM CHEM SOC, V126, P13757, DOI 10.1021/ja0457112; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; RENNEBERG R, 1981, BIOCHEM PHARMACOL, V30, P843, DOI 10.1016/S0006-2952(81)80005-6; RENNEBERG R, 1978, FEBS LETT, V96, P349, DOI 10.1016/0014-5793(78)80434-7; RENNEBERG R, 1983, BIOCHEM BIOPH RES CO, V113, P332, DOI 10.1016/0006-291X(83)90470-9; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Saltzman H., 1963, ORG SYNTH, V43, P60, DOI 10.15227/orgsyn.043.0060; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; Sen K, 2012, BIOCHEMISTRY-US, V51, P3039, DOI 10.1021/bi300017p; STEVENSON DE, 1988, J CHEM SOC PERK T 1, P2043, DOI 10.1039/p19880002043; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P2185, DOI 10.1021/bi00174a027; Vijaykumar D, 2002, J ORG CHEM, V67, P4904, DOI 10.1021/jo020190r; Walsh C., 1979, ENZYMATIC REACTION M, P121; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026; Yoshimoto FK, 2014, BIOCHEMISTRY-US, V53, P7531, DOI 10.1021/bi5011865; Yoshimoto FK, 2014, J AM CHEM SOC, V136, P15016, DOI 10.1021/ja508185d; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w	93	43	44	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17143	17164		10.1074/jbc.M116.732966	http://dx.doi.org/10.1074/jbc.M116.732966			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339894	Green Published, hybrid			2022-12-26	WOS:000382643800020
J	Mezuk, B; Choi, M; DeSantis, AS; Rapp, SR; Roux, AVD; Seeman, T				Mezuk, Briana; Choi, Moon; DeSantis, Amy S.; Rapp, Stephen R.; Roux, Ana V. Diez; Seeman, Teresa			Loneliness, Depression, and Inflammation: Evidence from the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; OLDER-ADULTS; SOCIAL SUPPORT; RISK-FACTORS; HEALTH; STRESS; SCALE; NEUROENDOCRINE; METAANALYSIS	Objective Both objective and subjective aspects of social isolation have been associated with alterations in immune markers relevant to multiple chronic diseases among older adults. However, these associations may be confounded by health status, and it is unclear whether these social factors are associated with immune functioning among relatively healthy adults. The goal of this study was to examine the associations between perceived loneliness and circulating levels of inflammatory markers among a diverse sample of adults. Methods Data come from a subset of the Multi-Ethnic Study of Atherosclerosis (n = 441). Loneliness was measured by three items derived from the UCLA Loneliness Scale. The association between loneliness and C-reactive protein (CRP) and fibrinogen was assessed using multivariable linear regression analyses. Models were adjusted for demographic and health characteristics. Results Approximately 50% of participants reported that they hardly ever felt lonely and 17.2% felt highly lonely. Individuals who were unmarried/unpartnered or with higher depressive symptoms were more likely to report being highly lonely. There was no relationship between perceived loneliness and ln(CRP) (beta = -0.051, p = 0.239) adjusting for demographic and health characteristics. Loneliness was inversely associated with ln(fibrinogen) (beta = -0.091, p = 0.040), although the absolute magnitude of this relationship was small. Conclusion These results indicate that loneliness is not positively associated with fibrinogen or CRP among relatively healthy middle-aged adults.	[Mezuk, Briana] Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Sch Med, Richmond, VA 23284 USA; [Mezuk, Briana] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Choi, Moon] Korea Adv Inst Sci & Technol, Daejeon, South Korea; [DeSantis, Amy S.] RAND, Santa Monica, CA USA; [Rapp, Stephen R.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Roux, Ana V. Diez] Drexel Univ, Dept Epidemiol & Biostat, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Seeman, Teresa] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA	Virginia Commonwealth University; University of Michigan System; University of Michigan; Korea Advanced Institute of Science & Technology (KAIST); RAND Corporation; Wake Forest University; Drexel University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mezuk, B (corresponding author), Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Sch Med, Richmond, VA 23284 USA.; Mezuk, B (corresponding author), Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA.	bmezuk@vcu.edu	Mezuk, Briana/AAY-5321-2020; Choi, Moon/I-1607-2014	Mezuk, Briana/0000-0003-1798-2285; Choi, Moon/0000-0001-8002-0113	NIH (National Institute of Mental Health) [K01-MH093642]; NIH (National Heart, Lung, and Blood Institute) [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, R01-HL101161]; National Research Foundation of Korea [NRF-2015S1A5A8018593]; National Institute on Minority Health and Health Disparities [P60MD002249] Funding Source: NIH RePORTER	NIH (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea(National Research Foundation of Korea); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH (K01-MH093642 from the National Institute of Mental Health and grant R01-HL101161 and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute). Additional support provided by the National Research Foundation of Korea (NRF-2015S1A5A8018593). The funders has no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Alpass FM, 2003, AGING MENT HEALTH, V7, P212, DOI 10.1080/1360786031000101193; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Davidson Karina W, 2010, Cleve Clin J Med, V77 Suppl 3, pS20, DOI 10.3949/ccjm.77.s3.04; Elovainio M, 2015, J PSYCHIATR RES, V71, P120, DOI 10.1016/j.jpsychires.2015.09.017; Ford ES, 2006, ANN EPIDEMIOL, V16, P78, DOI 10.1016/j.annepidem.2005.08.005; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Hackett RA, 2012, PSYCHONEUROENDOCRINO, V37, P1801, DOI 10.1016/j.psyneuen.2012.03.016; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawkley LC, 2010, PSYCHOL AGING, V25, P132, DOI 10.1037/a0017805; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Jaremka LM, 2013, PSYCHOL SCI, V24, P1089, DOI 10.1177/0956797612464059; Jaremka LM, 2013, DEPRESS ANXIETY, V30, P288, DOI 10.1002/da.22078; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kivimaki M, 2014, MOL PSYCHIATR, V19, P149, DOI 10.1038/mp.2013.35; Luanaigh CO, 2008, INT J GERIATR PSYCH, V23, P1213, DOI 10.1002/gps.2054; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; Mezuk B, 2010, BRAIN BEHAV IMMUN, V24, P1294, DOI 10.1016/j.bbi.2010.06.006; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Nausheen B, 2010, PSYCHOSOM MED, V72, P912, DOI 10.1097/PSY.0b013e3181f0bc1c; NEELEMAN J, 1994, SOC PSYCH PSYCH EPID, V29, P46; Peplau LA., 1985, SOCIAL SUPPORT THEOR, P269, DOI 10.1007/978-94-009-5115-0_15; Prince MJ, 1997, PSYCHOL MED, V27, P323, DOI 10.1017/S0033291796004485; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Rueggeberg R, 2012, PSYCHOSOM MED, V74, P937, DOI 10.1097/PSY.0b013e3182732dc6; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SEEMAN TE, 1994, J GERONTOL, V49, pM97, DOI 10.1093/geronj/49.3.M97; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Shiovitz-Ezra S, 2010, INT PSYCHOGERIATR, V22, P455, DOI 10.1017/S1041610209991426; Steptoe A, 2004, PSYCHONEUROENDOCRINO, V29, P593, DOI 10.1016/S0306-4530(03)00086-6; Thurston RC, 2009, PSYCHOSOM MED, V71, P836, DOI 10.1097/PSY.0b013e3181b40efc; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234	38	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158056	10.1371/journal.pone.0158056	http://dx.doi.org/10.1371/journal.pone.0158056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367428	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900016
J	Shimada, M; Matsuzaki, F; Kato, A; Kobayashi, J; Matsumoto, T; Komatsu, K				Shimada, Mikio; Matsuzaki, Fumio; Kato, Akihiro; Kobayashi, Junya; Matsumoto, Tomohiro; Komatsu, Kenshi			Induction of Excess Centrosomes in Neural Progenitor Cells during the Development of Radiation-Induced Microcephaly	PLOS ONE			English	Article							BREAKAGE SYNDROME GENE; DNA-DAMAGE; BRAIN-DEVELOPMENT; PLANAR DIVISIONS; CEREBRAL-CORTEX; AMPLIFICATION; APOPTOSIS; OVERDUPLICATION; NEUROGENESIS; DUPLICATION	The embryonic brain is one of the tissues most vulnerable to ionizing radiation. In this study, we showed that ionizing radiation induces apoptosis in the neural progenitors of the mouse cerebral cortex, and that the surviving progenitor cells subsequently develop a considerable amount of supernumerary centrosomes. When mouse embryos at Day 13.5 were exposed to gamma-rays, brains sizes were reduced markedly in a dose-dependent manner, and these size reductions persisted until birth. Immunostaining with caspase-3 antibodies showed that apoptosis occurred in 35% and 40% of neural progenitor cells at 4 h after exposure to 1 and 2 Gy, respectively, and this was accompanied by a disruption of the apical layer in which mitotic spindles were positioned in unirradiated mice. At 24 h after 1 Gy irradiation, the apoptotic cells were completely eliminated and proliferation was restored to a level similar to that of unirradiated cells, but numerous spindles were localized outside the apical layer. Similarly, abnormal cytokinesis, which included multipolar division and centrosome clustering, was observed in 19% and 24% of the surviving neural progenitor cells at 48 h after irradiation with 1 and 2 Gy, respectively. Because these cytokinesis aberrations derived from excess centrosomes result in growth delay and mitotic catastrophe-mediated cell elimination, our findings suggest that, in addition to apoptosis at an early stage of radiation exposure, radiation-induced centrosome overduplication could contribute to the depletion of neural progenitors and thereby lead to microcephaly.	[Shimada, Mikio; Kato, Akihiro; Kobayashi, Junya; Komatsu, Kenshi] Kyoto Univ, Dept Genome Repair Dynam, Ctr Radiat Biol, Kyoto, Japan; [Matsuzaki, Fumio] RIKEN, Lab Cell Asymmetry, Ctr Dev Biol, Kobe, Hyogo, Japan; [Matsumoto, Tomohiro] Kyoto Univ, Ctr Radiat Biol, Dept Radiat Syst Biol, Kyoto, Japan; [Shimada, Mikio] Tokyo Inst Technol, Inst Innovat Res, Lab Adv Nucl Energy, Tokyo, Japan; [Kato, Akihiro] Tohoku Med & Pharmaceut Univ, Div Radiat Biol & Med, Fac Med, Sendai, Miyagi, Japan	Kyoto University; RIKEN; Kyoto University; Tokyo Institute of Technology; Tohoku Medical & Pharmaceutical University	Komatsu, K (corresponding author), Kyoto Univ, Dept Genome Repair Dynam, Ctr Radiat Biol, Kyoto, Japan.	komatsu@house.rbc.kyoto-u.ac.jp	Kobayashi, Junya/AAX-6390-2021; Shimada, Mikio/E-1565-2015	Kobayashi, Junya/0000-0003-4645-7500; Shimada, Mikio/0000-0003-1980-9187; Matsuzaki, Fumio/0000-0001-7902-4520	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Dodson H, 2007, CELL CYCLE, V6, P364, DOI 10.4161/cc.6.3.3834; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Li HZ, 2008, RADIAT RES, V169, P513, DOI 10.1667/RR1230.1; Li R, 2012, CELL RES, V22, P859, DOI 10.1038/cr.2012.3; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; O'Driscoll M, 2004, DNA REPAIR, V3, P1227, DOI 10.1016/j.dnarep.2004.03.025; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Pulvers JN, 2009, DEVELOPMENT, V136, P1859, DOI 10.1242/dev.033498; Roque T, 2012, STEM CELLS, V30, P537, DOI 10.1002/stem.1010; Saha S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0783; Sessa A, 2010, GENE DEV, V24, P1816, DOI 10.1101/gad.575410; Shimada M, 2013, INT J RADIAT ONCOL, V86, P358, DOI 10.1016/j.ijrobp.2013.01.010; Shimada M, 2011, MUTAT RES-FUND MOL M, V716, P27, DOI 10.1016/j.mrfmmm.2011.07.017; Shimada M, 2010, CANCER SCI, V101, P2531, DOI 10.1111/j.1349-7006.2010.01702.x; Shimada M, 2009, CANCER RES, V69, P1768, DOI 10.1158/0008-5472.CAN-08-3016; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Takahashi I, 1996, BONE, V18, P341, DOI 10.1016/8756-3282(96)00012-9; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; WOOD JW, 1967, AM J PUBLIC HEALTH N, V57, P1381, DOI 10.2105/AJPH.57.8.1381; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158236	10.1371/journal.pone.0158236	http://dx.doi.org/10.1371/journal.pone.0158236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367050	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900024
J	Malausa, T; Delaunay, M; Fleisch, A; Groussier-Bout, G; Warot, S; Crochard, D; Guerrieri, E; Delvare, G; Pellizzari, G; Kaydan, MB; Al-Khateeb, N; Germain, JF; Brancaccio, L; Le Goff, I; Bessac, M; Ris, N; Kreiter, P				Malausa, Thibaut; Delaunay, Mathilde; Fleisch, Alexandre; Groussier-Bout, Geraldine; Warot, Sylvie; Crochard, Didier; Guerrieri, Emilio; Delvare, Gerard; Pellizzari, Giuseppina; Kaydan, M. Bora; Al-Khateeb, Nadia; Germain, Jean-Francois; Brancaccio, Lisa; Le Goff, Isabelle; Bessac, Melissa; Ris, Nicolas; Kreiter, Philippe			Investigating Biological Control Agents for Controlling Invasive Populations of the Mealybug Pseudococcus comstocki in France	PLOS ONE			English	Article							HEMIPTERA PSEUDOCOCCIDAE; MORPHOLOGICAL CHARACTERIZATION; NATURAL ENEMIES; HYMENOPTERA; PARASITOIDS; HOMOPTERA; IDENTIFICATION; PHYLOGENY; SEQUENCES; MARKERS	Pseudococcus comstocki (Hemiptera: Pseudococcidae) is a mealybug species native to Eastern Asia and present as an invasive pest in northern Italy and southern France since the start of the century. It infests apple and pear trees, grapevines and some ornamental trees. Biocontrol programmes against this pest proved successful in central Asia and North America in the second half of the 20th century. In this study, we investigated possible bio-control agents against P. comstocki, with the aim of developing a biocontrol programme in France. We carried out systematic DNA-barcoding at each step in the search for a specialist parasitoid. First we characterised the French target populations of P. comstocki. We then identified the parasitoids attacking P. comstocki in France. Finally, we searched for foreign mealybug populations identified a priori as P. comstocki and surveyed their hymenopteran parasitoids. Three mealybug species (P. comstocki, P. viburni and P. cryptus) were identified during the survey, together with at least 16 different parasitoid taxa. We selected candidate biological control agent populations for use against P. comstocki in France, from the species Allotropa burrelli (Hymenoptera: Platygastridae) and Acerophagus malinus (Hymenoptera: Encyrtidae). The coupling of molecular and morphological characterisation for both pests and natural enemies facilitated the programme development and the rejection of unsuitable or generalist parasitoids.	[Malausa, Thibaut; Delaunay, Mathilde; Fleisch, Alexandre; Groussier-Bout, Geraldine; Warot, Sylvie; Crochard, Didier; Brancaccio, Lisa; Le Goff, Isabelle; Bessac, Melissa; Ris, Nicolas; Kreiter, Philippe] Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, F-06900 Sophia Antipolis, France; [Guerrieri, Emilio] CNR, Ist Protez Sostenibile Piante, Via Univ 133, I-80055 Naples, Italy; [Delvare, Gerard] Montpellier Supagro, CIRAD, CS 30016, UMR,CBGP,INRA, 755 Ave Campus Agropolis, F-34988 Montferrier Sur Lez, France; [Pellizzari, Giuseppina] Univ Padua, Dipartimento Agron Anim Alimenti Risorse Nat & Am, Viale Univ 16, I-35020 Legnaro, Italy; [Kaydan, M. Bora] Cukurova Univ, Imamoglu Vocat Sch, TR-01330 Adana, Turkey; [Al-Khateeb, Nadia] Lattakia Ctr Rearing Nat Enemies, Latakia, Syria; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, CS 30016, 755 Ave Campus Agropolis, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of Padua; Cukurova University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, F-06900 Sophia Antipolis, France.	thibaut.malausa@paca.inra.fr	Kaydan, Mehmet Bora/F-1310-2018; Malausa, Thibaut/X-1614-2018; Guerrieri, Emilio/ABB-7498-2020	Kaydan, Mehmet Bora/0000-0002-0677-255X; Malausa, Thibaut/0000-0003-1681-7958; Ris, Nicolas/0000-0003-1183-234X; Germain, Jean-Francois/0000-0001-7927-6031	French "Agence Nationale de la Recherche" [ANR-10-JCJC-1708 BICORAMICS]; EU [324475 COLBICS, 265865 PURE]; Turkey-France Cooperation grant CNRS-TUBITAK; INRA Plant Health and Environment Division	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); EU(European Commission); Turkey-France Cooperation grant CNRS-TUBITAK; INRA Plant Health and Environment Division	This work was funded by the French "Agence Nationale de la Recherche" (grant ANR-10-JCJC-1708 BICORAMICS), by the EU Seventh Framework Programme (grants Marie-Curie IAPP #324475 COLBICS and KBBE #265865 PURE), by a Turkey-France Cooperation grant CNRS-TUBITAK, and by the INRA Plant Health and Environment Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beardsley J. W. Jr., 1966, Insects of Micronesia, V6, P377; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Charles JG, NZ PLANT PROTECTION, V55, P37; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Cox J.M., 1989, Bulletin of the British Museum (Natural History) Entomology, V58, P1; ERVIN RT, 1983, J ECON ENTOMOL, V76, P605, DOI 10.1093/jee/76.3.605; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Guerrieri E, 2009, B INSECTOL, V62, P179; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hantzberg H., 2008, AFPP - 8eme Conference Internationale sur les Ravageurs en Agriculture, Montpellier SupAgro, France, 22-23 Octobre 2008, P573; Heraty J, 2004, SYST ENTOMOL, V29, P544, DOI 10.1111/j.0307-6970.2004.00267.x; Hoelmer KA, 2005, BIOL CONTROL, V34, P255, DOI 10.1016/j.biocontrol.2005.05.001; Kobakhidze D. N., 1965, Entomophaga, V10, P323, DOI 10.1007/BF02387071; Kreiter Philippe, 2005, Bulletin de la Societe Entomologique de France, V110, P132; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; MEYERDIRK DE, 1979, J ECON ENTOMOL, V72, P70, DOI 10.1093/jee/72.1.70; MEYERDIRK DE, 1981, J ECON ENTOMOL, V74, P79, DOI 10.1093/jee/74.1.79; Mills NJ, 2010, BIOL CONTROL, V52, P255, DOI 10.1016/j.biocontrol.2009.03.018; Moore D., 1988, Biocontrol News and Information, V9, P209; Nakaune R, 2008, ARCH VIROL, V153, P1827, DOI 10.1007/s00705-008-0188-5; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Pellizzari G, 2012, B INSECTOL, V65, P209; ROSEN D, 1986, AGR ECOSYST ENVIRON, V15, P121, DOI 10.1016/0167-8809(86)90085-X; Rubtsov I., 1952, REV ENTOMOL URSS, V32, P96; Rubtsov I, 1957, ENTOMOPHAGA, V2, P125; Shashkova RV, 1977, ZASHCHITA RASTENII, V51; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sonina A, 1967, BIOL CONTROL COMSTOC, P61; Sonina A, 1965, SADOVODSTVO, V7, P19; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Triapitsyn SV, 2007, BIOL CONTROL, V41, P14, DOI 10.1016/j.biocontrol.2006.12.013; Williams D, 1992, MEALYBUGS CENTRAL SO; Williams D. J., 1990, The scale insects of the tropical South Pacific region. Part 3: the soft scales (Coccidae) and other families.; Williams D.J., 2004, MEALYBUGS SO ASIA, P896; Yigit A, 2013, TURK ENTOMOL DERG-TU, V37, P359	40	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157965	10.1371/journal.pone.0157965	http://dx.doi.org/10.1371/journal.pone.0157965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362639	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200032
J	Martin, R; Makino, H; Yavuz, AC; Ben-Amor, K; Roelofs, M; Ishikawa, E; Kubota, H; Swinkels, S; Sakai, T; Oishi, K; Kushiro, A; Knol, J				Martin, Rocio; Makino, Hiroshi; Yavuz, Aysun Cetinyurek; Ben-Amor, Kaouther; Roelofs, Mieke; Ishikawa, Eiji; Kubota, Hiroyuki; Swinkels, Sophie; Sakai, Takafumi; Oishi, Kenji; Kushiro, Akira; Knol, Jan			Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota	PLOS ONE			English	Article							SPECIES-SPECIFIC PRIMERS; FORMULA-FED INFANTS; CESAREAN-SECTION; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; PREDOMINANT BACTERIA; COMMENSAL BACTERIA; HYGIENE HYPOTHESIS; VAGINAL MICROBIOTA; ALLERGIC DISEASES	Colonization of the infant gut is believed to be critically important for a healthy growth as it influences gut maturation, metabolic, immune and brain development in early life. Understanding factors that influence this process is important, since an altered colonization has been associated with a higher risk of diseases later in life. Fecal samples were collected from 108 healthy neonates in the first half year of life. The composition and functionality of the microbiota was characterized by measuring 33 different bacterial taxa by qPCR/RT qPCR, and 8 bacterial metabolites. Information regarding gender, place and mode of birth, presence of siblings or pets; feeding pattern and antibiotic use was collected by using questionnaires. Regression analysis techniques were used to study associations between microbiota parameters and confounding factors over time. Bacterial DNA was detected in most meconium samples, suggesting bacterial exposure occurs in utero. After birth, colonization by species of Bifidobacterium, Lactobacillus and Bacteroides was influenced by mode of delivery, type of feeding and presence of siblings, with differences found at species level and over time. Interestingly, infant-type bifidobacterial species such as B. breve or B. longum subsp infantis were confirmed as early colonizers apparently independent of the factors studied here, while B. animalis subsp. lactis presence was found to be dependent solely on the type of feeding, indicating that it might not be a common infant gut inhabitant. One interesting and rather unexpected confounding factor was gender. This study contributes to our understanding of the composition of the microbiota in early life and the succession process and the evolution of the microbial community as a function of time and events occurring during the first 6 months of life. Our results provide new insights that could be taken into consideration when selecting nutritional supplementation strategies to support the developing infant gut microbiome.	[Martin, Rocio; Yavuz, Aysun Cetinyurek; Ben-Amor, Kaouther; Roelofs, Mieke; Swinkels, Sophie; Knol, Jan] Nutricia Res, Utrecht, Netherlands; [Makino, Hiroshi; Ishikawa, Eiji; Kubota, Hiroyuki; Sakai, Takafumi; Oishi, Kenji; Kushiro, Akira] Yakult Cent Inst, Tokyo, Japan; [Knol, Jan] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	Danone Nutricia; Yakult Honsha Company, Limited; Wageningen University & Research	Martin, R (corresponding author), Nutricia Res, Utrecht, Netherlands.	rocio.martin@danone.com	Knol, Jan/AAL-6487-2020; Knol, Jan/A-2178-2010	Knol, Jan/0000-0002-2103-5961; Knol, Jan/0000-0002-2103-5961; Ishikawa, Eiji/0000-0002-4179-9010	Yakult; Nutricia Research	Yakult; Nutricia Research(Danone Nutricia)	The study was funded by Yakult and Nutricia Research. The following authors are paid by Nutricia Research: RM, KBA, MR, SS, ACY, JK, whereas HM, HK, TS, EI, KO, AK are paid by Yakult. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; CHONAN O, 1995, BIOSCI BIOTECH BIOCH, V59, P236, DOI 10.1271/bbb.59.236; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Fan WG, 2014, J MICROBIOL BIOTECHN, V24, P133, DOI 10.4014/jmb.1309.09029; Fooladi Abbas Ali Imani, 2013, Inflammation & Allergy Drug Targets, V12, P410; Forsberg A, 2013, CLIN EXP ALLERGY, V43, P434, DOI 10.1111/cea.12082; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353, DOI 10.1111/j.1348-0421.2002.tb02706.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; Lahtinen SJ, 2009, J ALLERGY CLIN IMMUN, V123, P499, DOI 10.1016/j.jaci.2008.11.034; Lambert P, 2005, STAT MED, V24, P3977, DOI 10.1002/sim.2396; Laursen MF, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0477-6; Lee SA, 2015, NUTR RES PRACT, V9, P242, DOI [10.4162/nrp.2015.9.3.242;, 10.4162/nrp.2015.9.3.242]; Li HT, 2012, AM J CLIN NUTR, V96, P215, DOI 10.3945/ajcn.112.038760; Lindberg E, 2011, CLIN MICROBIOL INFEC, V17, P1209, DOI 10.1111/j.1469-0691.2010.03426.x; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Markle JGM, 2014, GUT MICROBES, V5, P485, DOI 10.4161/gmic.29795; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matsuki T, 1998, FEMS MICROBIOL LETT, V167, P113, DOI 10.1111/j.1574-6968.1998.tb13216.x; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Milani C, 2015, APPL ENVIRON MICROB, V81, P7078, DOI 10.1128/AEM.02037-15; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Munyaka PM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00109; Nermes M, J ALLERGY CLIN IMMUN; Nermes Merja, 2013, ISRN Allergy, V2013, P827934, DOI 10.1155/2013/827934; Ouwehand AC, 2001, J ALLERGY CLIN IMMUN, V108, P144, DOI 10.1067/mai.2001.115754; Pelzer ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049965; Penders J, 2014, GUT MICROBES, V5, P239, DOI 10.4161/gmic.27905; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Storro O, 2013, CURR OPIN ALLERGY CL, V13, P257, DOI 10.1097/ACI.0b013e328360968b; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Suzuki S, 2007, CLIN EXP ALLERGY, V37, P506, DOI 10.1111/j.1365-2222.2007.02676.x; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Ventura M, 2001, APPL ENVIRON MICROB, V67, P2760, DOI 10.1128/AEM.67.6.2760-2765.2001; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wopereis H, 2014, PEDIAT ALLERG IMM-UK, V25, P428, DOI 10.1111/pai.12232; Yap GC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-193; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x	91	170	181	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158498	10.1371/journal.pone.0158498	http://dx.doi.org/10.1371/journal.pone.0158498			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362264	gold, Green Published, Green Submitted			2022-12-26	WOS:000378865200082
J	Mitra, A; Herren, CD; Patel, IR; Coleman, A; Mukhopadhyay, S				Mitra, Arindam; Herren, Christopher D.; Patel, Isha R.; Coleman, Adam; Mukhopadhyay, Suman			Integration of AI-2 Based Cell-Cell Signaling with Metabolic Cues in Escherichia coli	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; RESPONSE REGULATOR; BIOFILM FORMATION; GLOBAL CONTROL; QUORUM; LUXS; SYSTEM; PROTEIN; COMMUNICATION; MOTILITY	The quorum sensing molecule Autoinducer-2 (AI-2) is generated as a byproduct of activated methyl cycle by the action of LuxS in Escherichia coli. AI-2 is synthesized, released and later internalized in a cell-density dependent manner. Here, by mutational analysis of the genes, uvrY and csrA, we describe a regulatory circuit of accumulation and uptake of AI-2. We constructed a single-copy chromosomal luxS-lacZ fusion in a luxS (+) merodiploid strain and evaluated its relative expression in uvrY and csrA mutants. At the entry of stationary phase, the expression of the fusion and AI-2 accumulation was positively regulated by uvrY and negatively regulated by csrA respectively. A deletion of csrA altered message stability of the luxS transcript and CsrA protein exhibited weak binding to 5' luxS regulatory region. DNA protein interaction and chromatin immunoprecipitation analysis confirmed direct interaction of UvrY with the luxS promoter. Additionally, reduced expression of the fusion in hfq deletion mutant suggested involvement of small RNA interactions in luxS regulation. In contrast, the expression of lsrA operon involved in AI-2 uptake, is negatively regulated by uvrY and positively by csrA in a cell-density dependent manner. The dual role of csrA in AI-2 synthesis and uptake suggested a regulatory crosstalk of cell signaling with carbon regulation in Escherichia coli. We found that the cAMP-CRP mediated catabolite repression of luxS expression was uvrY dependent. This study suggests that luxS expression is complex and regulated at the level of transcription and translation. The multifactorial regulation supports the notion that cell-cell communication requires interaction and integration of multiple metabolic signals.	[Mitra, Arindam; Herren, Christopher D.; Patel, Isha R.; Coleman, Adam; Mukhopadhyay, Suman] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Mitra, Arindam] Adamas Univ, Dept Microbiol, Kolkata, W Bengal, India; [Herren, Christopher D.] Kansas State Univ, Div Biol, Manhattan, KS USA; [Patel, Isha R.] US FDA, Div Mol Biol, Off Appl Res & Safety Assessment HFS 025, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Coleman, Adam] Maryland Dept Hlth & Mental Hyg, Div Newborn & Childhood Screening, Baltimore, MD USA; [Mukhopadhyay, Suman] NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD USA	University System of Maryland; University of Maryland College Park; Kansas State University; US Food & Drug Administration (FDA); Maryland Department of Health & Mental Hygiene; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mukhopadhyay, S (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.; Mukhopadhyay, S (corresponding author), NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD USA.	mukhopadhyays@mail.nih.gov	Mitra, Arindam/A-1379-2013	Mitra, Arindam/0000-0002-1591-6164	USDA-NRI-CSREES Competitive Grant [2004-35204-14749]; USDA-Animal Health [2002-1106-0195318]; Maryland Agriculture Experimental Station grant from the University of Maryland	USDA-NRI-CSREES Competitive Grant; USDA-Animal Health; Maryland Agriculture Experimental Station grant from the University of Maryland	This work was in part supported by USDA-NRI-CSREES Competitive Grant 2004-35204-14749, USDA-Animal Health 2002-1106-0195318 and Maryland Agriculture Experimental Station grant from the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Ahmer BMM, 1999, MOL MICROBIOL, V31, P971, DOI 10.1046/j.1365-2958.1999.01244.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bhardwaj Ashima K, 2013, Recent Pat Antiinfect Drug Discov, V8, P68; Brito PH, 2013, GENOME BIOL EVOL, V5, P16, DOI 10.1093/gbe/evs122; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Keersmaecker SCJ, 2006, TRENDS MICROBIOL, V14, P114, DOI 10.1016/j.tim.2006.01.003; Dong YH, 2005, MOL MICROBIOL, V56, P1287, DOI 10.1111/j.1365-2958.2005.04612.x; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; Eriksson ARB, 1998, MOL PLANT MICROBE IN, V11, P743, DOI 10.1094/MPMI.1998.11.8.743; Fujii T, 2008, J BACTERIOL, V190, P7655, DOI 10.1128/JB.01489-07; GAFFNEY TD, 1994, MOL PLANT MICROBE IN, V7, P455, DOI 10.1094/MPMI-7-0455; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Hardie KR, 2003, MICROBIOL-SGM, V149, P715, DOI 10.1099/mic.0.25853-0; Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06; IGO M M, 1990, New Biologist, V2, P5; Jang J, 2011, MICROBIOL-SGM, V157, P1466, DOI 10.1099/mic.0.043737-0; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Lee J, 2013, NAT CHEM BIOL, V9, P339, DOI [10.1038/NCHEMBIO.1225, 10.1038/nchembio.1225]; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mitra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055492; Mizuno T, 1998, J BIOCHEM, V123, P555; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Niu C, 2013, FEMS MICROBIOL ECOL, V83, P778, DOI 10.1111/1574-6941.12034; Palaniyandi S, 2013, VET MICROBIOL, V166, P567, DOI 10.1016/j.vetmic.2013.07.009; Palaniyandi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031348; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; PODKOVYROV SM, 1995, GENE, V156, P151, DOI 10.1016/0378-1119(95)00053-9; Queck SY, 2006, ENVIRON MICROBIOL, V8, P1017, DOI 10.1111/j.1462-2920.2006.00993.x; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Ray VA, 2012, MOL MICROBIOL, V86, P954, DOI 10.1111/mmi.12035; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sambrook J., 2001, MOL CLONING LAB MANU; Santiago-Rodriguez TM, 2014, FEMS MICROBIOL LETT, V350, P117, DOI 10.1111/1574-6968.12275; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Tsou AM, 2011, MICROBIOL-SGM, V157, P1620, DOI 10.1099/mic.0.046235-0; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Yang Q, 2015, ENVIRON MICROBIOL, V17, P960, DOI 10.1111/1462-2920.12420; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	63	9	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157532	10.1371/journal.pone.0157532	http://dx.doi.org/10.1371/journal.pone.0157532			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362507	gold, Green Submitted, Green Published			2022-12-26	WOS:000378865200019
J	Jian, HY; Zhang, YH; Qiu, XQ; Yan, HJ; Wang, QG; Zhang, H; Sun, H				Jian, Hongying; Zhang, Yonghong; Qiu, Xianqin; Yan, Huijun; Wang, Qigang; Zhang, Hao; Sun, Hang			Yalongjiang River Has Had an Important Role in the Dispersal and Divergence of Rosa soulieana in the Hengduan Mountains of China	PLOS ONE			English	Article							GENETIC DIVERSITY; AFLP; DIFFERENTIATION; CANINAE; DNA; CONSERVATION; POPULATIONS; COMPLEX; MARKERS; NUMBER	The Hengduan Mountains are the core of the Sino-Himalayan Floristic Region. Rosa soulieana Crep. is an important wild rose species that is widely distributed in the Hengduan Mountains. To provide better future utilization of this wild rose, and also to add some possible proof of the effect of geomorphological and ecological characteristics of the Hengduan Mountains on the current spatial distribution and genetic diversity of local species, the genetic diversity and genetic structure of 556 individuals from 37 populations of R. soulieana were studied using fluorescent amplified fragment length polymorphisms (AFLPs). R. soulieana showed a moderately high level of genetic diversity and a high level of genetic differentiation at the species level. The total percentage of polymorphic loci, total heterozygosity (Ht), Shannon index (I), and heterozygosity value within populations (Hs) were 97.8%, 0.253, 0.339, and 0.139, respectively. More than half of the total genetic variation (54.0%) occurred within populations, and the overall gene differentiation coefficient (Gst) was 0.451. The genetic differentiation among populations was positively and significantly correlated with geographic distance. The neighbor-joining cluster and the Bayesian analysis divided all the populations and individuals into 3 groups, and did not support the morphology based intraspecific varieties. The results confirmed that the ancient R. soulieana of the third group survived in northwestern Yunnan and Yalongjiang valley and then moved upnorth along the valley. The spatial distribution of the other two groups was the result of allopatric divergence due to long period of adaptation to the different climatic conditions of its distribution at either side of the Yalongjiang River.	[Jian, Hongying; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Jian, Hongying; Qiu, Xianqin; Yan, Huijun; Wang, Qigang; Zhang, Hao] Yunnan Acad Agr Sci, Natl Engn Res Ctr Ornamental Hort, Flower Res Inst, Kunming, Peoples R China; [Zhang, Yonghong] Yunnan Normal Univ, Dept Life Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Yunnan Academy of Agricultural Sciences; Yunnan Normal University	Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	hsun@mail.kib.ac.cn			Major Program of National Natural Science Foundation of China [31590820, 31590823]; National Natural Science Foundation of China [31260198, 31460050]; Academic and Technical Talents Training Project of Yunnan Province [2013 HB092]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic and Technical Talents Training Project of Yunnan Province	This study was supported by Major Program of National Natural Science Foundation of China (31590820 to HS), Major Program of National Natural Science Foundation of China (31590823 to HS), National Natural Science Foundation of China (31260198 to HYJ), National Natural Science Foundation of China (31460050 Dr. Yonghong Zhang), Academic and Technical Talents Training Project of Yunnan Province (2013 HB092 to HYJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], [No title captured]; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Basaki T, 2009, SCI HORTIC-AMSTERDAM, V120, P538, DOI 10.1016/j.scienta.2008.12.001; CHENG J, 2001, GEOSCIENCE, V15, P290; Soldati MC, 2013, BIOCHEM SYST ECOL, V47, P45, DOI 10.1016/j.bse.2012.10.011; De Cock K, 2008, ANN BOT-LONDON, V102, P685, DOI 10.1093/aob/mcn151; de Souza LB, 2013, GENET MOL BIOL, V36, P533, DOI [10.1590/S1415-47572013005000036, 10.1590/s1415-47572013005000036]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Ghosh R., 2009, THESIS; Gu C., 2003, FLORA CHINA, V9, P339; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; He Y. H., 1994, Acta Horticulturae Sinica, V21, P158; HERRERA CM, 1984, OECOLOGIA, V63, P386, DOI 10.1007/BF00390670; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HURST C. C., 1928, ZEITSCHR INDUKT ABSTAM U VERERBUNGSL SUPPLEMENTB, V2, P866; Ikeda H, 2009, J PLANT RES, V122, P141, DOI 10.1007/s10265-008-0213-5; Jian HY, 2015, ACTA HORTIC, V1064, P39; Jian HY, 2013, GENET RESOUR CROP EV, V60, P115, DOI 10.1007/s10722-012-9820-z; Jian HY, 2015, PLANT SYST EVOL, V301, P1819, DOI 10.1007/s00606-015-1195-0; Jian HY, 2015, THESIS; Juan A, 2012, EUR J FOREST RES, V131, P845, DOI 10.1007/s10342-011-0558-5; Kato S, 2011, J PLANT RES, V124, P11, DOI 10.1007/s10265-010-0352-3; Kellner A, 2014, BOT J LINN SOC, V174, P240, DOI 10.1111/boj.12124; Ku T.C., 1985, FLORA REIPUBLICAE PO, V37, P360; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li B, 1989, MT RES, V7, P13; LI J, 1979, SCI SINICA, V22, P1314; MANTEL N, 1967, CANCER RES, V27, P209; Mikulicek P, 2013, BIOL J LINN SOC, V108, P151, DOI 10.1111/j.1095-8312.2012.01999.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; Nybom H, 1997, PLANT SYST EVOL, V204, P207, DOI 10.1007/BF00989206; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J, 2007, GENET RESOUR CROP EV, V54, P451, DOI 10.1007/s10722-006-9174-5; Reisch C, 2015, BOT J LINN SOC, V177, P112, DOI 10.1111/boj.12221; Rois AS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-205; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Rusanov K, 2005, THEOR APPL GENET, V111, P804, DOI 10.1007/s00122-005-2066-9; SCHAAL BA, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P123; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Sun HL, 1988, FORMATION EVOLUTION; Vander Mijnsbrugge K, 2010, CONSERV GENET, V11, P2243, DOI 10.1007/s10592-010-0109-5; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang FY, 2008, BIOCHEM GENET, V46, P75, DOI 10.1007/s10528-007-9131-9; Wang W., 1994, VASCULAR PLANTS HENG, V2; WILSON E O, 1992; [伍翔宇 Wu Xiangyu], 2014, [园艺学报, Acta Horticulturae Sinica], V41, P2075; Wu ZY, 1988, J JPN BOT, V63, P1; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yu Yi, 2014, PLoS One, V9, pe107769, DOI 10.1371/journal.pone.0107769; Zhang L., 2005, SOIL ERODIBILITY ITS; Zhang X, 2015, BIOCHEM SYST ECOL, V58, P13, DOI 10.1016/j.bse.2014.10.015; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002; [周志琼 ZHOU Zhi-Qiong], 2009, [生态学报, Acta Ecologica Sinica], V29, P1931	68	4	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158586	10.1371/journal.pone.0158586	http://dx.doi.org/10.1371/journal.pone.0158586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355209	Green Submitted, gold, Green Published			2022-12-26	WOS:000378859400080
J	Hadjichristodoulou, C; Mpalaouras, G; Vasilopoulou, V; Katsioulis, A; Rachiotis, G; Theodoridou, K; Tzanakaki, G; Syriopoulou, V; Theodoridou, M				Hadjichristodoulou, Christos; Mpalaouras, George; Vasilopoulou, Vasiliki; Katsioulis, Antonios; Rachiotis, George; Theodoridou, Kalliopi; Tzanakaki, Georgia; Syriopoulou, Vassiliki; Theodoridou, Maria			A Case-Control Study on the Risk Factors for Meningococcal Disease among Children in Greece	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; NEISSERIA-MENINGITIDIS; SOCIAL DEPRIVATION; PARENTAL SMOKING; CARRIAGE; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISMS; MUTATIONS; GENE	Purpose The aim of this study was to identify environmental or genetic risk factors that are associated with invasive meningococcal disease (IMD) in children in Greece. Methods A case-control study was performed in 133 children (44 cases and 89 controls) aged between 0-14 years, who were hospitalized in a children's hospital in Athens. Demographics and possible risk factors were collected by the use of a structured questionnaire. To investigate the association of mannose binding lectin (MBL) with IMD, a frequency analysis of the haplotypes of the MBL2 gene and quantitative measurement of MBL serum protein levels were performed using Nanogen NanoChipR 400 technology and immuno-enzyme techniques, respectively. Results The multivariate analysis revealed that changes in a child's life setting (relocation or vacation, OR = 7.16), paternal smoking (OR = 4.51), upper respiratory tract infection within the previous month (OR = 3.04) and the density of people in the house/100m(2) (OR = 3.16), were independent risk factors associated with IMD. Overall 18.8% of patients had a MBL2 genotype with low functionality compared to 10.1% of healthy controls, but this was not statistically significant (p = 0.189). Conclusion Prevention strategies aimed at reducing parental smoking and other risk factors identified in this study could decrease the risk of IMD among children in Greece.	[Hadjichristodoulou, Christos; Mpalaouras, George; Katsioulis, Antonios; Rachiotis, George] Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece; [Vasilopoulou, Vasiliki; Theodoridou, Kalliopi; Syriopoulou, Vassiliki; Theodoridou, Maria] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Athens, Greece; [Tzanakaki, Georgia] Natl Sch Publ Hlth, Natl Reference Ctr Meningitis, Athens, Greece	University of Thessaly; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; National & Kapodistrian University of Athens	Hadjichristodoulou, C (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece.	xhatzi@med.uth.gr		Hadjichristodoulou, Christos/0000-0002-4769-8376				Baccarini C, 2013, HUM VACC IMMUNOTHER, V9, P162, DOI 10.4161/hv.22302; Bradley DT, 2012, INT J IMMUNOGENET, V39, P328, DOI 10.1111/j.1744-313X.2012.01095.x; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P27, DOI 10.1111/j.1574-695X.1999.tb01713.x; European Centre for Disease Prevention and Control, MEN DIS; Faber J, 2007, PEDIATR INFECT DIS J, V26, P243, DOI 10.1097/01.inf.0000256751.76218.7c; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; Fone DL, 2003, EPIDEMIOL INFECT, V130, P53, DOI 10.1017/S095026880200794X; Harrison LH, 2008, PEDIATR INFECT DIS J, V27, P193, DOI 10.1097/INF.0b013e31815c1b3a; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Hubert B, 1997, Euro Surveill, V2, P69; Jones IR, 1997, BRIT MED J, V314, P794, DOI 10.1136/bmj.314.7083.794; KREMASTINOU J, 1994, SCAND J INFECT DIS, V26, P719, DOI 10.3109/00365549409008641; Kriz P, 2000, ARCH DIS CHILD, V83, P117, DOI 10.1136/adc.83.2.117; Lee CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000374; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Palumbo E, 2012, METHODS MOL BIOL, V799, P361, DOI 10.1007/978-1-61779-346-2_21; Pereiro I, 2004, J INFECTION, V48, P320, DOI 10.1016/j.jinf.2003.10.015; Reintjes R, 2005, EUR J EPIDEMIOL, V20, P629, DOI 10.1007/s10654-005-6586-z; Sommers LM, 1999, PEDIATR INFECT DIS J, V18, P902, DOI 10.1097/00006454-199910000-00013; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Stephens DS, 1999, LANCET, V353, P941, DOI 10.1016/S0140-6736(98)00279-7; Stuart J M, 2002, Commun Dis Public Health, V5, P327; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; Tan JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141620; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Vardar F, 2007, TURKISH J PEDIATR, V49, P270; Vasilopoulou VA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-214; World Health Organization, 1998, WHOEMCBAC983EN; World Health Organization, MENINGITIS OUTBREAK	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158524	10.1371/journal.pone.0158524	http://dx.doi.org/10.1371/journal.pone.0158524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351742	Green Submitted, gold, Green Published			2022-12-26	WOS:000378858900063
J	Kim, SH; An, GS; Choi, I; Koo, JW; Lee, K; Song, JJ				Kim, Shin Hye; An, Gwang Seok; Choi, Inyong; Koo, Ja-Won; Lee, Kyogu; Song, Jae-Jin			Pre-Treatment Objective Diagnosis and Post-Treatment Outcome Evaluation in Patients with Vascular Pulsatile Tinnitus Using Transcanal Recording and Spectro-Temporal Analysis	PLOS ONE			English	Article							SINUS DIVERTICULUM; BRAIN	Objective Although vascular pulsatile tinnitus (VPT) has been classified as "objective", VPT is not easily recognizable or documentable in most cases. In response to this, we have developed transcanal sound recording (TSR) and spectro-temporal analysis (STA) for the objective diagnosis of VPT. By refining our initial method, we were able to apply TSR/STA to post-treatment outcome evaluation, as well as pre-treatment objective diagnosis. Methods TSR was performed on seven VPT patients and five normal controls before and after surgical or interventional treatment. VPT was recorded using an inserted microphone with the subjects placed in both upright and supine positions with 1) a neutral head position, 2) head rotated to the tinnitus side, 3) head rotated to the non-tinnitus side, and 4) a neutral position with ipsi-lesional manual cervical compression. The recorded signals were analyzed in both time and time-frequency domains by performing a short-time Fourier transformation. Results The pre-treatment ear canal signals of all VPT patients demonstrated pulse-synchronous periodic structures and acoustic characteristics that were representative of their presumptive vascular pathologies, whereas those the controls exhibited smaller peaks and weak periodicities. Compared with the pre-treatment signals, the post-treatment signals exhibited significantly reduced peak-and root mean square amplitudes upon time domain analysis. Additionally, further sub-band analysis confirmed that the pulse-synchronous signal of all subjects was not identifiable after treatment and, in particular, that the signal decrement was statistically significant at low frequencies. Moreover, the post-treatment signals of the VPT subjects revealed no significant differences when compared to those of the control group. Conclusion We reconfirmed that the TSR/STA method is an effective modality to objectify VPT. In addition, the potential role of the TSR/STA method in the objective evaluation of treatment outcomes in patients with VPT was proven. Further studies incorporating a larger sample size and more refined recording techniques are warranted.	[Kim, Shin Hye; Koo, Ja-Won; Song, Jae-Jin] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Shin Hye] Korea Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [An, Gwang Seok; Lee, Kyogu] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Mus & Audio Res Grp, Seoul, South Korea; [Choi, Inyong] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); University of Iowa	Song, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea.; Lee, K (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Mus & Audio Res Grp, Seoul, South Korea.	kglee@snu.ac.kr; jjsong96@gmail.com	Song, Jae-Jin/E-4633-2017	Song, Jae-Jin/0000-0002-6631-3232	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [HI14C2264]	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI14C2264) (https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan SF, 2015, LARYNGOSCOPE, V125, P284, DOI 10.1002/lary.24822; Elgoyhen AB, 2015, NAT REV NEUROSCI, V16, P632, DOI 10.1038/nrn4003; Eisenman DJ, 2011, OTOL NEUROTOL, V32, P1116, DOI 10.1097/MAO.0b013e31822a1c7d; Kim CS, 2016, J NEUROSURG, V125, P441, DOI 10.3171/2015.6.JNS15961; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Liyanage SH, 2006, J LARYNGOL OTOL, V120, P93, DOI 10.1017/S0022215105001714; Madani G, 2009, CLIN RADIOL, V64, P319, DOI 10.1016/j.crad.2008.08.014; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Oliveira Carlos A, 2003, Int Tinnitus J, V9, P37; Sismanis A, 2011, CURR OPIN OTOLARYNGO, V19, P348, DOI 10.1097/MOO.0b013e3283493fd8; Song JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123538; Song JJ, 2016, OTOL NEUROTOL, V37, P613, DOI 10.1097/MAO.0000000000001005; Song JJ, 2015, NEUROSURGERY, V77, P709, DOI 10.1227/NEU.0000000000000902; Song JJ, 2015, BRAIN STRUCT FUNCT, V220, P571, DOI 10.1007/s00429-013-0648-x; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Song JJ, 2013, HEARING RES, V299, P1, DOI 10.1016/j.heares.2013.02.001; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Song JJ, 2012, J NUCL MED, V53, P1550, DOI 10.2967/jnumed.112.102939; Wee JH, 2012, OTOL NEUROTOL, V33, pE41, DOI 10.1097/MAO.0b013e318245cb22	19	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157722	10.1371/journal.pone.0157722	http://dx.doi.org/10.1371/journal.pone.0157722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351198	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900015
J	Sclip, A; Bacaj, T; Giam, LR; Sudhof, TC				Sclip, Alessandra; Bacaj, Taulant; Giam, Louise R.; Sudhof, Thomas C.			Extended Synaptotagmin (ESyt) Triple Knock-Out Mice Are Viable and Fertile without Obvious Endoplasmic Reticulum Dysfunction	PLOS ONE			English	Article							PLASMA MEMBRANE JUNCTIONS; CONTACT SITES; NEURAL ACTIVITY; C-2 DOMAINS; E-SYTS; ER; PROTEINS; CELLS; DENDRITES; NEURONS	Extended synaptotagmins (ESyts) are endoplasmic reticulum (ER) proteins composed of an N-terminal transmembrane region, a central SMP-domain, and five (ESyt1) or three C-terminal cytoplasmic C2-domains (ESyt2 and ESyt3). ESyts bind phospholipids in a Ca(2+)dependent manner via their C2-domains, are localized to ER-plasma membrane contact sites, and may catalyze lipid exchange between the plasma membrane and the ER via their SMP-domains. However, the overall function of ESyts has remained enigmatic. Here, we generated triple constitutive and conditional knock-out mice that lack all three ESyt isoforms; in addition, we produced knock-in mice that express mutant ESyt1 or ESyt2 carrying inactivating substitutions in the Ca2+-binding sites of their C2A-domains. Strikingly, all ESyt mutant mice, even those lacking all ESyts, were apparently normal and survived and bred in a manner indistinguishable from control mice. ESyt mutant mice displayed no major changes in brain morphology or synaptic protein composition, and exhibited no large alterations in stress responses. Thus, in mice ESyts do not perform an essential role in basic cellular functions, suggesting that these highly conserved proteins may perform a specialized role that may manifest only during specific, as yet untested challenges.	[Sclip, Alessandra; Bacaj, Taulant; Giam, Louise R.; Sudhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA; [Sclip, Alessandra; Sudhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, 265 Campus Dr, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.; Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, 265 Campus Dr, Stanford, CA USA.	tcs1@stanford.edu			Conte Center grant from the NIMH	Conte Center grant from the NIMH	This work was supported by a Conte Center grant from the NIMH to TCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Aridor M, 2009, TRAFFIC, V10, P1669, DOI 10.1111/j.1600-0854.2009.00974.x; Banno T, 1998, J COMP NEUROL, V402, P252; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Herdman C, 2016, PHARMACOL RES, V107, P48, DOI 10.1016/j.phrs.2016.01.034; Herdman C, 2014, CELL CYCLE, V13, P2616, DOI 10.4161/15384101.2014.943573; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Idevall-Hagren O, 2015, EMBO J, V34, P2291, DOI 10.15252/embj.201591565; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Levy A, 2015, CURR BIOL, V25, P2018, DOI 10.1016/j.cub.2015.06.015; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Metuzals J, 1997, J NEUROCYTOL, V26, P529, DOI 10.1023/A:1015482407202; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Reinisch KM, 2016, BBA-MOL CELL BIOL L, V1861, P924, DOI 10.1016/j.bbalip.2015.12.003; Ridge RW, 1999, PLANT CELL PHYSIOL, V40, P1253, DOI 10.1093/oxfordjournals.pcp.a029513; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSENBLUTH J, 1962, J CELL BIOL, V13, P405, DOI 10.1083/jcb.13.3.405; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weclewicz K, 1998, BRAIN RES BULL, V46, P353, DOI 10.1016/S0361-9230(98)00013-6; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Xu JJ, 2014, STRUCTURE, V22, P269, DOI 10.1016/j.str.2013.11.011	48	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158295	10.1371/journal.pone.0158295	http://dx.doi.org/10.1371/journal.pone.0158295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348751	Green Published, gold, Green Submitted			2022-12-26	WOS:000378801200059
J	Nenadic, I; Mynderse, L; Husmann, D; Mehrmohammadi, M; Bayat, M; Singh, A; Denis, M; Urban, M; Alizad, A; Fatemi, M				Nenadic, Ivan; Mynderse, Lance; Husmann, Douglas; Mehrmohammadi, Mohammad; Bayat, Mahdi; Singh, Aparna; Denis, Max; Urban, Matthew; Alizad, Azra; Fatemi, Mostafa			Noninvasive Evaluation of Bladder Wall Mechanical Properties as a Function of Filling Volume: Potential Application in Bladder Compliance Assessment	PLOS ONE			English	Article							ULTRASOUND SHEAR ELASTOGRAPHY; ELASTICITY	Purpose We propose a novel method to monitor bladder wall mechanical properties as a function of filling volume, with the potential application to bladder compliance assessment. The proposed ultrasound bladder vibrometry (UBV) method uses ultrasound to excite and track Lamb waves on the bladder wall from which its mechanical properties are derived by fitting measurements to an analytical model. Of particular interest is the shear modulus of bladder wall at different volumes, which we hypothesize, is similar to measuring the compliance characteristics of the bladder. Materials and Methods Three experimental models were used: 1) an ex vivo porcine model where normal and aberrant (stiffened by formalin) bladders underwent evaluation by UBV; 2) an in vivo study to evaluate the performance of UBV on patients with clinically documented compliant and noncompliant bladders undergoing UDS; and 3) a noninvasive UBV protocol to assess bladder compliance using oral hydration and fractionated voiding on three healthy volunteers. Results The ex vivo studies showed a high correlation between the UBV parameters and direct pressure measurement (R-2 = 0.84-0.99). A similar correlation was observed for 2 patients with compliant and noncompliant bladders (R-2 = 0.89-0.99) undergoing UDS detrusor pressure-volume measurements. The results of UBV on healthy volunteers, performed without catheterization, were comparable to a compliant bladder patient. Conclusion The utility of UBV as a method to monitor changes in bladder wall mechanical properties is validated by the high correlation with pressure measurements in ex vivo and in vivo patient studies. High correlation UBV and UDS in vivo studies demonstrated the potential of UBV as a bladder compliance assessment tool. Results of studies on healthy volunteers with normal bladders demonstrated that UBV could be performed noninvasively. Further studies on a larger cohort are needed to fully validate the use of UBV as a clinical tool for bladder compliance assessment.	[Nenadic, Ivan; Mehrmohammadi, Mohammad; Bayat, Mahdi; Singh, Aparna; Urban, Matthew; Alizad, Azra; Fatemi, Mostafa] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55902 USA; [Mynderse, Lance; Husmann, Douglas] Mayo Clin, Coll Med, Dept Urol, Rochester, MN USA; [Denis, Max; Urban, Matthew; Alizad, Azra] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN USA; [Mehrmohammadi, Mohammad] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Wayne State University	Fatemi, M (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55902 USA.	Fatemi.Mostafa@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077	National Institutes of Health [R01DK099231, R01CA148994]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grants R01DK099231 awarded to MF and R01CA148994 awarded to AA from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Denis M, 2015, COMB PUSH ULTRASOUND; Denis M, 2015, IEEE T ULTRASON FERR, V62, P1644, DOI 10.1109/TUFFC.2015.007043; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Gregory A, 2015, ENG MED BIOL SOC EMB; Hasegawa H, 2006, IEEE T ULTRASON FERR, V53, P52, DOI 10.1109/TUFFC.2006.1588391; LANDAU EH, 1994, J UROLOGY, V152, P702, DOI 10.1016/S0022-5347(17)32685-X; MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3; Mehrmohammadi M, 2015, IEEE T MED IMAGING, V34, P97, DOI 10.1109/TMI.2014.2346498; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Nenadic IZ, 2013, PHYS MED BIOL, V58, P2675, DOI 10.1088/0031-9155/58/8/2675; Nenadic IZ, 2011, PHYS MED BIOL, V56, P2245, DOI 10.1088/0031-9155/56/7/021; Nitti VW, 2011, CAMPBELLS UROLOGY, P1847; O'Connell H, 1997, LEAK POINT PRESSURES, P93; Sarvazyan AP, 2013, ULTRASOUND MED BIOL, V39, P1133, DOI 10.1016/j.ultrasmedbio.2013.02.006; Scarpero HM, 2005, J UROLOGY, V173, P555, DOI 10.1097/01.ju.0000149968.60938.c0; Scarpero HM, 2003, UROLOGY, V61, P1118, DOI 10.1016/S0090-4295(03)00037-2; Wyndaele JJ, 2011, NEUROUROL URODYNAM, V30, P714, DOI 10.1002/nau.21129	20	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157818	10.1371/journal.pone.0157818	http://dx.doi.org/10.1371/journal.pone.0157818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341340	gold, Green Submitted, Green Published			2022-12-26	WOS:000378393600019
J	Sloan, RA; Haaland, BA; Sawada, SS; Lee, IM; Sui, XM; Lee, DC; Ridouane, Y; Muller-Riemenschneider, F; Blair, SN				Sloan, Robert A.; Haaland, Benjamin A.; Sawada, Susumu S.; Lee, I-Min; Sui, Xuemei; Lee, Duck-chul; Ridouane, Yassine; Muller-Riemenschneider, Falk; Blair, Steven N.			A Fit-Fat Index for Predicting Incident Diabetes in Apparently Healthy Men: A Prospective Cohort Study	PLOS ONE			English	Article							TO-HEIGHT RATIO; CARDIOMETABOLIC RISK-FACTORS; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; SCREENING TOOL; MORTALITY; DISEASE; ASSOCIATIONS; ADIPOSITY; OBESITY	Background The purpose of this study was to examine the impact of combined cardiorespiratory fitness and waist-to-height ratio in the form of a fit-fat index on incident diabetes risk. Additionally, the independent predictive performance of cardiorespiratory fitness, waist-to-height ratio, and body mass index also were estimated and compared. Methods This was a prospective cohort study of 10,381 men who had a normal electrocardiogram and no history of major chronic disease at baseline from 1979 to 2005. Random survival forest models and traditional Cox proportional hazards models were used to predict diabetes at 5-, 10-, and 15-year incidence horizons. Results Overall, 4.8% of the participants developed diabetes. Receiver operating characteristic curve analyses for incidence risk demonstrated good discrimination using random survival forest models across fitness and fatness measures; Cox models were poor to fair. The differences between fitness and fatness measures across horizons were clinically negligible. Smoothed random survival forest estimates demonstrated the impact of each fitness and fatness measure on incident diabetes was intuitive and graded. Conclusions Although fitness and fatness measures showed a similar discriminative ability in predicting incident diabetes, unique to the study was the ability of the fit-fat index to demonstrate a better indication of incident risk when compared to fitness or fatness alone. A single index combining cardiorespiratory fitness and waist-to-height ratio may be more useful because it can indicate improvements in either or both of the measures.	[Sloan, Robert A.] Kagoshima Univ, Grad Med & Dent Sch, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Haaland, Benjamin A.; Ridouane, Yassine] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Sawada, Susumu S.] Natl Inst Biomed Innovat Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo, Japan; [Lee, I-Min] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Lee, I-Min] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Lee, I-Min] Harvard Univ, Sch Med, Boston, MA USA; [Lee, I-Min] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Div Prevent Med,Dept Med, Cambridge, MA 02138 USA; [Lee, I-Min] Brigham & Womens Hosp, Cambridge, MA USA; [Lee, I-Min] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Sui, Xuemei; Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Lee, Duck-chul] Iowa State Univ, Dept Kinesiol, Coll Human Sci, Ames, IA USA; [Muller-Riemenschneider, Falk] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Kagoshima University; University System of Georgia; Georgia Institute of Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Iowa State University; National University of Singapore	Sloan, RA (corresponding author), Kagoshima Univ, Grad Med & Dent Sch, Dept Psychosomat Internal Med, Kagoshima 890, Japan.	rsloan@m.kufm.kagoshima-u.ac.jp	Lee, I-Min/ABD-5409-2021; Sawada, Susumu S/L-4173-2019	Sawada, Susumu S/0000-0002-7272-0790; Sloan, Robert/0000-0001-6492-8623; Muller-Riemenschneider, Falk/0000-0003-1402-7477	National Institutes of Health [AG06945, HL62508, DK088195]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants [AG06945, HL62508, and DK088195].	[Anonymous], 2014, DOPARALLEL FOREACH P; [Anonymous], 2012, PACKAGE SPAWAAMSR SU; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; CDC, 2014, NAT DIAB STAT REP; Earnest CP, 2013, MAYO CLIN PROC, V88, P259, DOI 10.1016/j.mayocp.2012.11.006; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Gerds TA, 2006, BIOMETRICAL J, V48, P1029, DOI 10.1002/bimj.200610301; Henson J, 2015, MED SCI SPORT EXER, V47, P1727, DOI 10.1249/MSS.0000000000000572; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085742; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kuwahara Keisuke, 2014, PLoS One, V9, pe98508, DOI 10.1371/journal.pone.0098508; LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lee DC, 2009, DIABETES CARE, V32, P257, DOI 10.2337/dc08-1377; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; RAaS Weston, 2014, FOREACH FOREACH LOOP; Senechal M, 2013, DIABETES CARE, V36, P2843, DOI 10.2337/dc12-2428; Su YS, 2011, J STAT SOFTW, V45, P1; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Uno H., 2007, J AM STAT ASSOC, V102, P478; Weinstein AR, 2006, EXERC SPORT SCI REV, V34, P10, DOI 10.1097/00003677-200601000-00004; WHO, 2016, GLOB REP PSOR; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001	30	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0157703	10.1371/journal.pone.0157703	http://dx.doi.org/10.1371/journal.pone.0157703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27340824	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600015
J	Park, GW; Collins, N; Barclay, L; Hu, LY; Prasad, BVV; Lopman, BA; Vinje, J				Park, Geun Woo; Collins, Nikail; Barclay, Leslie; Hu, Liya; Prasad, B. V. Venkataram; Lopman, Benjamin A.; Vinje, Jan			Strain-Specific Virolysis Patterns of Human Noroviruses in Response to Alcohols	PLOS ONE			English	Article							MURINE NOROVIRUS; FELINE CALICIVIRUS; HAND SANITIZERS; GASTROENTERITIS; INACTIVATION; SURROGATES; VIRUS; CARE; INFECTION; OUTBREAKS	Alcohol-based hand sanitizers are widely used to disinfect hands to prevent the spread of pathogens including noroviruses. Alcohols inactivate norovirus by destruction of the viral capsid, resulting in the leakage of viral RNA (virolysis). Since conflicting results have been reported on the susceptibility of human noroviruses against alcohols, we exposed a panel of 30 human norovirus strains (14 GI and 16 GII strains) to different concentrations (50%, 70%, 90%) of ethanol and isopropanol and tested the viral RNA titer by RT-qPCR. Viral RNA titers of 10 (71.4%), 14 (100%), 3 (21.4%) and 7 (50%) of the 14 GI strains were reduced by > 1 log(10) RNA copies/ml after exposure to 70% and 90% ethanol, and 70% and 90% isopropanol, respectively. RNA titers of 6 of the 7 non-GII 4 strains remained unaffected after alcohol exposure. Compared to GII strains, GI strains were more susceptible to ethanol than to isopropanol. At 90%, both alcohols reduced RNA titers of 8 of the 9 GII. 4 strains by >= 1 log(10) RNA copies/ml. After exposure to 70% ethanol, RNA titers of GII. 4 Den Haag and Sydney strains decreased by >= 1.9 log(10), whereas RNA reductions for GII. 4 New Orleans strains were < 0.5 log(10). To explain these differences, we sequenced the complete capsid gene of the 9 GII. 4 strains and identified 17 amino acid substitutions in the P2 region among the 3 GII. 4 variant viruses. When comparing with an additional set of 200 GII. 4 VP1 sequences, only S310 and P396 were present in all GII. 4 New Orleans viruses but not in the ethanol-sensitive GII. 4 Sydney and GII. 4 Den Haag viruses Our data demonstrate that alcohol susceptibility patterns between different norovirus genotypes vary widely and that virolysis data for a single strain or genotype are not representative for all noroviruses.	[Park, Geun Woo; Collins, Nikail; Barclay, Leslie; Lopman, Benjamin A.; Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Collins, Nikail] AREF, Atlanta, GA USA; [Hu, Liya; Prasad, B. V. Venkataram] Baylor Coll Med, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Centers for Disease Control & Prevention - USA; Baylor College of Medicine	Park, GW (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.	gpark@cdc.gov	Vinje, Jan/ABE-6336-2020	Prasad, B.V.Venkataram/0000-0002-1172-2071; Collins, Nikail/0000-0002-9987-6031; Vinje, Jan/0000-0002-1530-3675	NIH [P01 AI057788]; Robert Welch Foundation [Q1279]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation)	BVVP acknowledges support from NIH grant (P01 AI057788) and the Robert Welch Foundation (Q1279).	[Anonymous], 2004, TENTATIVE FINAL MONO; Barclay L, 2014, CLIN MICROBIOL INFEC, V20, P731, DOI 10.1111/1469-0691.12674; Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07; Blaney DD, 2011, AM J INFECT CONTROL, V39, P296, DOI 10.1016/j.ajic.2010.10.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; CDC, 2008, Jt Comm Perspect, V28, P4; Cliver DO, 2009, FOOD ENVIRON VIROL, V1, P123, DOI 10.1007/s12560-009-9020-y; Cromeans T, 2014, APPL ENVIRON MICROB, V80, P5743, DOI 10.1128/AEM.01532-14; D'Agostino SR, 2006, INTRO APPL BIOSTATIS; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; GERBA CP, 1984, ADV APPL MICROBIOL, V30, P133, DOI 10.1016/S0065-2164(08)70054-6; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Hill VR, 2010, FOOD ENVIRON VIROL, V2, P218, DOI 10.1007/s12560-010-9049-y; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Knight A, 2013, CRIT REV MICROBIOL, V39, P295, DOI 10.3109/1040841X.2012.709820; Kukkula M, 1999, J INFECT DIS, V180, P1771, DOI 10.1086/315145; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Liu PB, 2011, FOOD ENVIRON VIROL, V3, P35, DOI 10.1007/s12560-011-9053-x; Liu PB, 2010, APPL ENVIRON MICROB, V76, P394, DOI 10.1128/AEM.01729-09; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Macinga DR, 2008, APPL ENVIRON MICROB, V74, P5047, DOI 10.1128/AEM.00487-08; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; McKarns SC, 1997, FUND APPL TOXICOL, V36, P62, DOI 10.1006/faat.1996.2252; Nuanualsuwan S, 2002, J VIROL METHODS, V104, P217, DOI 10.1016/S0166-0934(02)00089-7; Park GW, 2015, APPL ENVIRON MICROB, V81, P5987, DOI 10.1128/AEM.01657-15; Park GW, 2014, J PHOTOCH PHOTOBIO B, V140, P315, DOI 10.1016/j.jphotobiol.2014.08.009; Park GW, 2011, FOODBORNE PATHOG DIS, V8, P1005, DOI 10.1089/fpd.2010.0782; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prince H.N., 2001, DISINFECTION STERILI, V5th, P543; Rosenthal NA, 2011, EPIDEMIOL INFECT, V139, P286, DOI 10.1017/S095026881000083X; Said Maria A., 2008, Infection Control and Hospital Epidemiology, V29, P1202, DOI 10.1086/592299; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; Wigginton KR, 2012, CURR OPIN VIROL, V2, P84, DOI 10.1016/j.coviro.2011.11.003	43	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157787	10.1371/journal.pone.0157787	http://dx.doi.org/10.1371/journal.pone.0157787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337036	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200044
J	Cai, H; Liu, XB; Zheng, J; Xue, YX; Ma, J; Li, Z; Xi, Z; Li, ZQ; Bao, M; Liu, YH				Cai, Heng; Liu, Xiaobai; Zheng, Jian; Xue, Yixue; Ma, Jun; Li, Zhen; Xi, Zhuo; Li, Zhiqing; Bao, Min; Liu, Yunhui			Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma	ONCOGENE			English	Article							COMPETING ENDOGENOUS RNA; GLIOMA-CELLS; EXPRESSION; CANCER; TUG1; GROWTH; PROLIFERATION; APOPTOSIS; DIFFERENTIATION; PROMOTE	Angiogenesis is one of the critical biological elements affecting the development and progression of cancer. Long non-coding RNAs (lncRNAs) are important regulators and aberrantly expressed in various types of human cancer. Our previous studies indicated that lncRNA taurine upregulated 1 (TUG1) implicated in the regulation of blood-tumor barrier permeability; however, its role in glioblastoma angiogenesis still unclear. Here we demonstrated that TUG1 was up-expressed in human glioblastoma tissues and glioblastoma cell lines. Knockdown of TUG1 remarkably suppressed tumor-induced endothelial cell proliferation, migration and tube formation as well as reducing spheroid-based angiogenesis ability in vitro, which are the critical steps for tumor angiogenesis. Besides, knockdown of TUG1 significantly increased the expression of mircroRNA-299 (miR-299), which was down-expressed in glioblastoma tissues and glioblastoma cell lines. Bioinformatics analysis and luciferase reporter assay revealed that TUG1 influenced tumor angiogenesis via directly binding to the miR-299 and there was a reciprocal repression between TUG1 and miR-299 in the same RNA-induced silencing complex. Moreover, knockdown of TUG1 reduced the expression of vascular endothelial growth factor A (VEGFA), which was defined as a functional downstream target of miR-299. In addition, knockdown of TUG1, shown in the in vivo studies, has effects on suppressing tumor growth, reducing tumor microvessel density and decreasing the VEGFA expression by upregulating miR-299 in xenograft glioblastoma model. Overall, the results demonstrated that TUG1 enhances tumor-induced angiogenesis and VEGF expression through inhibiting miR-299. Also, the inhibition of TUG1 could provide a novel therapeutic target for glioblastoma treatment.	[Cai, Heng; Liu, Xiaobai; Zheng, Jian; Xi, Zhuo; Li, Zhiqing; Bao, Min; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang 110004, Peoples R China; [Xue, Yixue; Ma, Jun; Li, Zhen] China Med Univ, Dept Neurobiol, Coll Basic Med, Shenyang, Peoples R China	China Medical University; China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang 110004, Peoples R China.	sj_neurosurgery@126.com			Natural Science Foundation of China [81172197, 81272564, 81272795, 81372484, 81573010]; Shenyang Science and Technology Plan Projects [F15-199-1-30, F15-199-1-57]; outstanding scientific fund of Shengjing hospital [201304]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenyang Science and Technology Plan Projects; outstanding scientific fund of Shengjing hospital	This work is supported by grants from the Natural Science Foundation of China (81172197, 81272564, 81272795, 81372484 and 81573010) and Shenyang Science and Technology Plan Projects (nos F15-199-1-30 and F15-199-1-57), and outstanding scientific fund of Shengjing hospital (no. 201304).	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Bai RY, 2011, TRENDS MOL MED, V17, P301, DOI 10.1016/j.molmed.2011.01.011; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Cai H, 2015, ONCOTARGET, V6, P19759, DOI 10.18632/oncotarget.4331; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862; Ezhilarasan R, 2007, INT J ONCOL, V30, P701; Folkerth RD, 2000, J NEURO-ONCOL, V50, P165, DOI 10.1023/A:1006499824379; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Gaiser T, 2009, NEUROCHEM INT, V54, P458, DOI 10.1016/j.neuint.2009.01.016; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Han YH, 2013, J SURG ONCOL, V107, P555, DOI 10.1002/jso.23264; Isin M, 2014, CLIN CHIM ACTA, V431, P255, DOI 10.1016/j.cca.2014.02.010; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jiang XC, 2016, J NEUROSURG, V124, P129, DOI [10.3171/2014.12.JNS1426, 10.3171/2014.12.JNS1426.test]; Jiao F, 2015, INT J MOL SCI, V16, P6677, DOI 10.3390/ijms16046677; Jouanneau E, 2008, NEUROSURGERY, V62, P31, DOI 10.1227/01.NEU.0000311060.65002.4E; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Ke J, 2015, ONCOTARGET, V6, P21934, DOI 10.18632/oncotarget.4290; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Liu Q, 2015, J NEURO-ONCOL, V122, P283, DOI 10.1007/s11060-015-1718-0; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rapicavoli NA, 2009, DEV DYNAM, V238, P2103, DOI 10.1002/dvdy.21844; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shevde LA, 2010, J CELL MOL MED, V14, P1693, DOI 10.1111/j.1582-4934.2009.00821.x; Shi ZM, 2014, NEURO-ONCOLOGY, V16, P1341, DOI 10.1093/neuonc/nou084; Tate MC, 2009, NEUROTHERAPEUTICS, V6, P447, DOI 10.1016/j.nurt.2009.04.001; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4596; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Wang P, 2015, CELL SIGNAL, V27, P275, DOI 10.1016/j.cellsig.2014.11.011; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Xu YT, 2015, TUMOR BIOL, V36, P1643, DOI 10.1007/s13277-014-2763-6; Yoon JH, 2014, SEMIN CELL DEV BIOL, V34, P9, DOI 10.1016/j.semcdb.2014.05.015; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhang Q, 2013, ASIAN PAC J CANCER P, V14, P2311, DOI 10.7314/APJCP.2013.14.4.2311; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	54	137	143	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					318	331		10.1038/onc.2016.212	http://dx.doi.org/10.1038/onc.2016.212			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27345398				2022-12-26	WOS:000394166000003
J	Li, K; Tian, L; Guo, ZJ; Guo, SY; Zhang, JZ; Gu, SH; Palli, SR; Cao, Y; Li, S				Li, Kang; Tian, Ling; Guo, Zhongjian; Guo, Sanyou; Zhang, Jianzhen; Gu, Shi-Hong; Palli, Subba R.; Cao, Yang; Li, Sheng			20-Hydroxyecdysone (20E) Primary Response Gene E75 Isoforms Mediate Steroidogenesis Autoregulation and Regulate Developmental Timing in Bombyx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; nuclear receptor; protein-protein interaction; signal transduction; steroidogenesis; Halloween genes; ROREs; feedback regulation; isoform-specific	NUCLEAR RECEPTOR E75; PROGRAMMED CELL-DEATH; DROSOPHILA METAMORPHOSIS; JUVENILE-HORMONE; FAT-BODY; REV-ERB; ORPHAN RECEPTOR; EGG CHAMBER; HEME; MORI	The temporal control mechanisms that precisely control animal development remain largely elusive. The timing of major developmental transitions in insects, including molting and metamorphosis, is coordinated by the steroid hormone 20-hydroxyecdysone (20E). 20E involves feedback loops to maintain pulses of ecdysteroid biosynthesis leading to its upsurge, whereas the underpinning molecular mechanisms are not well understood. Using the silkworm Bombyx mori as a model, we demonstrated that E75, the 20E primary response gene, mediates a regulatory loop between ecdysteroid biosynthesis and 20E signaling. E75 isoforms A and C directly bind to retinoic acid receptor-related response elements in Halloween gene promoter regions to induce gene expression thus promoting ecdysteroid biosynthesis and developmental transition, whereas isoform B antagonizes the transcriptional activity of isoform A/C through physical interaction. As the expression of E75 isoforms is differentially induced by 20E, the E75-mediated regulatory loop represents a fine autoregulation of steroidogenesis, which contributes to the precise control of developmental timing.	[Li, Kang; Li, Sheng] South China Normal Univ, Inst Insect Sci, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Guangzhou 510631, Guangdong, Peoples R China; [Li, Kang; Li, Sheng] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Li, Kang; Tian, Ling; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Tian, Ling; Guo, Sanyou; Cao, Yang] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Lab Insect Mol Biol & Biotechnol, Guangzhou 510642, Guangdong, Peoples R China; [Guo, Zhongjian] Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Jiangsu, Peoples R China; [Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China; [Zhang, Jianzhen] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Gu, Shi-Hong] Natl Museum Nat Sci, Dept Biol, 1 Kuan Chien Rd, Taichung 404, Taiwan; [Palli, Subba R.] Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA	South China Normal University; South China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; South China Agricultural University; Jiangsu University; Shanxi University; Shanxi University; University of Kentucky	Li, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	lisheng@scnu.edu.cn	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13030700]; 973 Program [2012CB114600]; National Science Foundation of China [31572325, 31472042]; National Program for the Development of New Transgenic Species of China [2014ZX08010-016B]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for the Development of New Transgenic Species of China	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB13030700 (to S. L.), 973 Program 2012CB114600 (to S. L. and Y. C.), National Science Foundation of China Grants 31572325 (to S. L.) and 31472042 (to L. T.), and National Program for the Development of New Transgenic Species of China Grant 2014ZX08010-016B (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Cruz J, 2012, MOL CELL ENDOCRINOL, V349, P262, DOI 10.1016/j.mce.2011.11.006; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; FEIGL G, 1989, NUCLEIC ACIDS RES, V17, P7167, DOI 10.1093/nar/17.18.7167; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Guo ZJ, 2010, VIRUS RES, V151, P185, DOI 10.1016/j.virusres.2010.05.003; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kostrouchova M, 2015, BBA-GENE REGUL MECH, V1849, P224, DOI 10.1016/j.bbagrm.2014.06.016; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Li K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12114; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Marchal E, 2012, J INSECT PHYSIOL, V58, P890, DOI 10.1016/j.jinsphys.2012.03.013; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Parvy JP, 2014, DEVELOPMENT, V141, P3955, DOI 10.1242/dev.102020; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Swevers L, 2002, J BIOL CHEM, V277, P41637, DOI 10.1074/jbc.M203581200; Swevers L, 2002, INSECT BIOCHEM MOLEC, V32, P1643, DOI 10.1016/S0965-1748(02)00104-2; Terashima J, 2006, CELL DEATH DIFFER, V13, P454, DOI 10.1038/sj.cdd.4401745; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007	43	32	38	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18163	18175		10.1074/jbc.M116.737072	http://dx.doi.org/10.1074/jbc.M116.737072			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365399	hybrid, Green Published			2022-12-26	WOS:000383241800010
J	Jensen, MR; Bajic, G; Zhang, XW; Laustsen, AK; Koldso, H; Skeby, KK; Schiott, B; Andersen, GR; Vorup-Jensen, T				Jensen, Maria Risager; Bajic, Goran; Zhang, Xianwei; Laustsen, Anne Kjaer; Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit; Andersen, Gregers R.; Vorup-Jensen, Thomas			Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; complement; inflammation; integrin; molecular dynamics; protein drug interaction; receptor structure-function; surface plasmon resonance (SPR); anti-inflammatory therapy; statin	I-DOMAIN; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; BETA-PROPELLER; A-DOMAIN; INTEGRIN; BINDING; RECOGNITION; STATINS; LIGAND	The complement system is an important part of the innate immune response to infection but may also cause severe complications during inflammation. Small molecule antagonists to complement receptor 3 (CR3) have been widely sought, but a structural basis for their mode of action is not available. We report here on the structure of the human CR3 ligand-binding I domain in complex with simvastatin. Simvastatin targets the metal ion-dependent adhesion site of the open, ligand-binding conformation of the CR3 I domain by direct contact with the chelated Mg2+ ion. Simvastatin antagonizes I domain binding to the complement fragments iC3b and C3d but not to intercellular adhesion molecule-1. By virtue of the I domain's wide distribution in binding kinetics to ligands, it was possible to identify ligand binding kinetics as discriminator for simvastatin antagonism. In static cellular experiments, 15-25 m simvastatin reduced adhesion by K562 cells expressing recombinant CR3 and by primary human monocytes, with an endogenous expression of this receptor. Application of force to adhering monocytes potentiated the effects of simvastatin where only a 50-100 nm concentration of the drug reduced the adhesion by 20-40% compared with untreated cells. The ability of simvastatin to target CR3 in its ligand binding-activated conformation is a novel mechanism to explain the known anti-inflammatory effects of this compound, in particular because this CR3 conformation is found in pro-inflammatory environments. Our report points to new designs of CR3 antagonists and opens new perspectives and identifies druggable receptors from characterization of the ligand binding kinetics in the presence of antagonists.	[Jensen, Maria Risager; Zhang, Xianwei; Vorup-Jensen, Thomas] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Bajic, Goran; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Laustsen, Anne Kjaer; Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Laustsen, Anne Kjaer; Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit; Vorup-Jensen, Thomas] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus C, Denmark; [Bajic, Goran; Andersen, Gregers R.; Vorup-Jensen, Thomas] Aarhus Univ, Lundbeck Fdn Nanomed Ctr Individualized Managemen, DK-8000 Aarhus C, Denmark; [Vorup-Jensen, Thomas] Aarhus Univ, MEMBRANES Res Ctr, DK-8000 Aarhus C, Denmark; [Jensen, Maria Risager] DE Shaw Res, New York, NY 10036 USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Lundbeckfonden; Aarhus University; D. E. Shaw Research	Vorup-Jensen, T (corresponding author), Aarhus Univ, Dept Biomed, Biophys Immunol Lab, Bartholin Bldg 1240,Bartholins Alle 6, DK-8000 Aarhus C, Denmark.	vorup-jensen@biomed.au.dk	Schiott, Birgit/F-5067-2011; Vorup-Jensen, Thomas/N-9082-2016	Schiott, Birgit/0000-0001-9937-1562; Vorup-Jensen, Thomas/0000-0002-4140-6563; Bajic, Goran/0000-0003-0480-4324; Andersen, Gregers Rom/0000-0001-6292-3319	Danish Multiple Sclerosis Association; Aarhus University Research Foundation; Lundbeck Foundation; Danish Council for Independent Research: Technology and Production Sciences; Danish National Research Foundation [DNFR59]; Novo Nordisk Fonden [NNF12OC0002082, NNF14OC0012261] Funding Source: researchfish	Danish Multiple Sclerosis Association; Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research: Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Multiple Sclerosis Association, the Aarhus University Research Foundation (to T.V.-J.), the Lundbeck Foundation (to T.V.-J. and G.R.A.), the Danish Council for Independent Research: Technology and Production Sciences (to B.S.), and Danish National Research Foundation Grant DNFR59 (to B.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Alvarez-Lueje A, 2005, J AOAC INT, V88, P1631; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Silveira AAA, 2013, INFLAMM RES, V62, P127, DOI 10.1007/s00011-012-0579-7; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Bergman E, 2006, EUR J PHARM SCI, V29, P205, DOI 10.1016/j.ejps.2006.04.015; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Canalli AA, 2011, HAEMATOL-HEMATOL J, V96, P526, DOI 10.3324/haematol.2010.032912; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Chello M, 2003, HEART, V89, P538, DOI 10.1136/heart.89.5.538; Curley GP, 1999, CELL MOL LIFE SCI, V56, P427, DOI 10.1007/s000180050443; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fossati-Jimack L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057082; Gao C, 2009, J CLIN INVEST, V119, P504, DOI 10.1172/JCI36745; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gorshkova II, 2008, LANGMUIR, V24, P11577, DOI 10.1021/la801186w; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KENAKIN TP, 1982, CAN J PHYSIOL PHARM, V60, P249, DOI 10.1139/y82-036; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; Liddington RC, 2014, ADV EXP MED BIOL, V819, P111, DOI 10.1007/978-94-017-9153-3_8; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Mahalingam B, 2014, J BIOL CHEM, V289, P13801, DOI 10.1074/jbc.M113.546929; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nunez S, 2012, DRUG DISCOV TODAY, V17, P10, DOI 10.1016/j.drudis.2011.06.013; Orr Y, 2007, J LEUKOCYTE BIOL, V82, P1115, DOI 10.1189/jlb.0906545; Petruzzelli L., 1995, LEUCOCYTE TYPING, P1581; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Tsai NW, 2009, J NEUROL, V256, P1296, DOI 10.1007/s00415-009-5117-3; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Vorup-Jensen T, 2012, ADV DRUG DELIVER REV, V64, P1759, DOI 10.1016/j.addr.2012.06.003; Vorup-Jensen T, 2011, METHODS MOL BIOL, V757, P55, DOI 10.1007/978-1-61779-166-6_5; Wang Y, 2009, BIOL BLOOD MARROW TR, V15, P1513, DOI 10.1016/j.bbmt.2009.08.013; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Zhang J, 2013, CYTOKINE, V61, P540, DOI 10.1016/j.cyto.2012.12.006; Zhang XW, 2016, BBA-PROTEINS PROTEOM, V1864, P471, DOI 10.1016/j.bbapap.2016.02.013; Zhao HY, 2013, METHODS, V59, P328, DOI 10.1016/j.ymeth.2012.12.007	65	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16963	16976		10.1074/jbc.M116.732222	http://dx.doi.org/10.1074/jbc.M116.732222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339893	Green Published, hybrid			2022-12-26	WOS:000382643800004
J	Marci, R; Gentili, V; Bortolotti, D; Lo Monte, G; Caselli, E; Bolzani, S; Rotola, A; Di Luca, D; Rizzo, R				Marci, Roberto; Gentili, Valentina; Bortolotti, Daria; Lo Monte, Giuseppe; Caselli, Elisabetta; Bolzani, Silvia; Rotola, Antonella; Di Luca, Dario; Rizzo, Roberta			Presence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained Infertility	PLOS ONE			English	Article							HUMAN-HERPESVIRUS 6; POLYMERASE-CHAIN-REACTION; MULTIPLE-SCLEROSIS; CELLULAR RECEPTOR; INFECTION; VIRUS; DNA; REACTIVATION; HUMAN-HERPESVIRUS-6; TISSUE	To elucidate the roles of human herpesvirus (HHV)-6 primary unexplained infertile women, a prospective randomized study was conducted on a cohort of primary unexplained infertile women and a cohort of control women, with at least one successful pregnancy. HHV-6 DNA was analyzed and the percentage and immune-phenotype of resident endometrial Natural Killer (NK) cells, as the first line of defense towards viral infections, was evaluated in endometrial biopsies. Cytokine levels in uterine flushing samples were analyzed. HHV-6A DNA was found in 43% of endometrial biopsies from primary unexplained infertile women, but not in control women. On the contrary, HHV-6B DNA was absent in endometrial biopsies, but present in PBMCs of both cohorts. Endometrial NK cells presented a different distribution in infertile women with HHV6-A infection compared with infertile women without HHV6-A infection. Notably, we observed a lower percentage of endometrial specific CD56brightCD16-NK cells. We observed an enhanced HHV-6A-specific endometrial NK cell response in HHV-6A positive infertile women, with a marked increase in the number of endometrial NK cells activating towards HHV-6A infected cells. The analysis of uterine flushing samples showed an increase in IL-10 levels and a decrease of IFN-gamma concentrations in infertile women with HHV6-A infection. Our study indicates, for the first time, that HHV-6A infection might be an important factor in female unexplained infertility development, with a possible role in modifying endometrial NK cells immune profile and ability to sustain a successful pregnancy.	[Marci, Roberto] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Gynecol & Obstet, Ferrara, Italy; [Marci, Roberto] Univ Geneva, Sch Med, Geneva, Switzerland; [Gentili, Valentina; Bortolotti, Daria; Caselli, Elisabetta; Bolzani, Silvia; Rotola, Antonella; Di Luca, Dario; Rizzo, Roberta] Univ Ferrara, Microbiol Sect, Dept Med Sci, Ferrara, Italy; [Lo Monte, Giuseppe] Brunico Hosp, Human Reprod Ctr, Brunico, BZ, Italy	University of Ferrara; University of Geneva; University of Ferrara	Rizzo, R (corresponding author), Univ Ferrara, Microbiol Sect, Dept Med Sci, Ferrara, Italy.	rbr@unife.it	Marci, Roberto/G-6927-2012; Gentili, Valentina/AAC-1028-2022; Bolzani, Silvia/O-5907-2017; Elisabetta, Caselli/H-1513-2012; Bortolotti, Daria/K-5125-2016; Rizzo, Roberta/K-4844-2016	Marci, Roberto/0000-0002-9230-6685; Gentili, Valentina/0000-0003-4572-5497; Bolzani, Silvia/0000-0002-1133-0326; Elisabetta, Caselli/0000-0001-6048-9141; Bortolotti, Daria/0000-0003-4496-9561; Rizzo, Roberta/0000-0001-9507-9126	Regione Emila Romagna-Young researcher Liberati grant	Regione Emila Romagna-Young researcher Liberati grant	Funded by Regione Emila Romagna-Young researcher Liberati grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; ANDO Y, 1992, LANCET, V340, P1289, DOI 10.1016/0140-6736(92)92990-W; Arena A, 1999, MICROBIOLOGICA, V22, P293; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; AUBIN JT, 1991, J CLIN MICROBIOL, V29, P367, DOI 10.1128/JCM.29.2.367-372.1991; Baecher-Lind LE, 2010, OBSTET GYNECOL SURV, V65, P53, DOI 10.1097/OGX.0b013e3181c9e7a1; Baillargeon J, 2000, J CLIN VIROL, V16, P149, DOI 10.1016/S1386-6532(99)00086-4; Broccolo F, 2013, J MED VIROL, V85, P1925, DOI 10.1002/jmv.23670; Caselli E, 2007, NEW MICROBIOL, V30, P173; Caselli E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002951; CHEN M, 1994, AM J PATHOL, V145, P1509; CHEN M, 1994, J VIROL, V68, P1173, DOI 10.1128/JVI.68.2.1173-1178.1994; Costa C, 2010, TRANSPL P, V42, P1270, DOI 10.1016/j.transproceed.2010.03.086; De Filippis L, 2006, J CLIN VIROL, V37, pS27, DOI 10.1016/S1386-6532(06)70008-7; DIPAOLO JA, 1994, TOXICOL LETT, V72, P7, DOI 10.1016/0378-4274(94)90004-3; DiPaolo JA, 1996, TOXICOL LETT, V88, P1, DOI 10.1016/0378-4274(96)03710-1; Drago F, 2014, J AM ACAD DERMATOL, V71, P198, DOI 10.1016/j.jaad.2014.02.023; Gervasi MT, 2012, J MATERN-FETAL NEO M, V25, P2002, DOI 10.3109/14767058.2012.683899; Gibson CS, 2008, BJOG-INT J OBSTET GY, V115, P492, DOI 10.1111/j.1471-0528.2007.01653.x; Hill JA, 2014, TRANSPL INFECT DIS, V16, P477, DOI 10.1111/tid.12208; Inazawa N, 2015, J MED VIROL, V87, P1427, DOI 10.1002/jmv.24161; Ishida T, 2014, ALLERGY, V69, P798, DOI 10.1111/all.12410; Ishikawa K, 2002, J GASTROENTEROL, V37, P523, DOI 10.1007/s005350200081; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; LEACH CT, 1994, J INFECT DIS, V169, P1281, DOI 10.1093/infdis/169.6.1281; Leibovitch EC, 2014, CURR OPIN VIROL, V9, P127, DOI 10.1016/j.coviro.2014.09.016; Li C, 1997, CLIN EXP IMMUNOL, V109, P421, DOI 10.1046/j.1365-2249.1997.4661362.x; Maeda T, 1997, ACTA PAEDIATR JAPON, V39, P653; Miguel RDV, 2010, J VIROL, V84, P565, DOI 10.1128/JVI.01374-09; Naumenko V, 2014, ANDROLOGY-US, V2, P687, DOI 10.1111/j.2047-2927.2014.00232.x; Ohashi M, 2002, J MED VIROL, V67, P354, DOI 10.1002/jmv.10083; OKUNO T, 1995, J CLIN MICROBIOL, V33, P1968, DOI 10.1128/JCM.33.7.1968-1970.1995; Ozkan ZS, 2014, J REPROD IMMUNOL, V103, P53, DOI 10.1016/j.jri.2013.11.002; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Pritchett JC, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/723062; Revest M, 2011, J CLIN VIROL, V51, P20, DOI 10.1016/j.jcv.2011.02.001; Rizzo R, 2012, J NEUROIMMUNOL, V251, P55, DOI 10.1016/j.jneuroim.2012.07.004; Romano N, 1996, J CLIN MICROBIOL, V34, P1589, DOI 10.1128/JCM.34.6.1589-1591.1996; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Siddon A, 2012, BRIT J HAEMATOL, V158, P635, DOI 10.1111/j.1365-2141.2012.09206.x; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Tang HM, 2013, P NATL ACAD SCI USA, V110, P9096, DOI 10.1073/pnas.1305187110; Tran-Thanh D, 2002, J MED VIROL, V68, P606, DOI 10.1002/jmv.10229; WANG H, 1994, J VIROL METHODS, V47, P297, DOI 10.1016/0166-0934(94)90026-4; Watanabe H, 2008, BRIT J DERMATOL, V158, P640, DOI 10.1111/j.1365-2133.2007.08382.x; Yadav M., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P86; Yadav M, 1996, CLIN DIAGN VIROL, V7, P23, DOI 10.1016/S0928-0197(96)00250-4	49	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158304	10.1371/journal.pone.0158304	http://dx.doi.org/10.1371/journal.pone.0158304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367597	Green Published, gold, Green Submitted			2022-12-26	WOS:000378914900028
J	Mackie, J; Szabo, EK; Urgast, DS; Ballou, ER; Childers, DS; MacCallum, DM; Feldmann, J; Brown, AJP				Mackie, Joanna; Szabo, Edina K.; Urgast, Dagmar S.; Ballou, Elizabeth R.; Childers, Delma S.; MacCallum, Donna M.; Feldmann, Joerg; Brown, Alistair J. P.			Host-Imposed Copper Poisoning Impacts Fungal Micronutrient Acquisition during Systemic Candida albicans Infections	PLOS ONE			English	Article							IRON; GENE; CERULOPLASMIN; METABOLISM; PROTEIN; EXPRESSION; TOLERANCE; TRANSPORT; VIRULENCE; HEPCIDIN	Nutritional immunity is a process whereby an infected host manipulates essential micronutrients to defend against an invading pathogen. We reveal a dynamic aspect of nutritional immunity during infection that involves copper assimilation. Using a combination of laser ablation inductively coupled mass spectrometry (LA-ICP MS) and metal mapping, immunohistochemistry, and gene expression profiling from infected tissues, we show that readjustments in hepatic, splenic and renal copper homeostasis accompany disseminated Candida albicans infections in the mouse model. Localized host-imposed copper poisoning manifests itself as a transient increase in copper early in the kidney infection. Changes in renal copper are detected by the fungus, as revealed by gene expression profiling and fungal virulence studies. The fungus responds by differentially regulating the Crp1 copper efflux pump (higher expression during early infection and down-regulation late in infection) and the Ctr1 copper importer (lower expression during early infection, and subsequent up-regulation late in infection) to maintain copper homeostasis during disease progression. Both Crp1 and Ctr1 are required for full fungal virulence. Importantly, copper homeostasis influences other virulence traits-metabolic flexibility and oxidative stress resistance. Our study highlights the importance of copper homeostasis for host defence and fungal virulence during systemic disease.	[Mackie, Joanna; Szabo, Edina K.; Ballou, Elizabeth R.; Childers, Delma S.; MacCallum, Donna M.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen Fungal Grp, Foresterhill, Aberdeen AB25 2ZD, Scotland; [Urgast, Dagmar S.; Feldmann, Joerg] Univ Aberdeen, Coll Phys Sci, Dept Chem, Trace Element Speciat Lab, Aberdeen AB24 3UE, Scotland; [Szabo, Edina K.] Univ Calgary, Biol Sci, 507 Campus Dr NW, Calgary, AB T2N 1N4, Canada	University of Aberdeen; University of Aberdeen; University of Calgary	Mackie, J (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen Fungal Grp, Foresterhill, Aberdeen AB25 2ZD, Scotland.	joanna.potrykus.mackie@gmail.com	Feldmann, Jörg/AAT-3703-2020; MacCallum, Donna M./D-7897-2011	MacCallum, Donna M./0000-0003-4833-0378; Feldmann, Joerg/0000-0002-0524-8254; Brown, Alistair JP/0000-0003-1406-4251; Ballou, Elizabeth/0000-0001-8051-2302	European Research Council [ERC-2009-AdG-249793]; UK Biotechnology and Biological Research Council [BB/F00513X/1, BB/K017365/1]; UK Medical Research Council [MR/M026663/1, MR/N006364/1]; Wellcome Trust [097377]; Biotechnology and Biological Sciences Research Council [BB/K017365/1, BB/F00513X/1] Funding Source: researchfish; Medical Research Council [MR/M026663/1, MR/N006364/1] Funding Source: researchfish; National Centre for the Replacement [NC/K50046X/1] Funding Source: researchfish; BBSRC [BB/F00513X/1, BB/K017365/1] Funding Source: UKRI; MRC [MR/M026663/1, MR/N006364/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council (http://erc.europa.eu/: STRIFE Advanced Grant ERC-2009-AdG-249793). A.J.P.B. was also supported by the UK Biotechnology and Biological Research Council (www.bbsrc.ac.uk: Research Grants BB/F00513X/1, BB/K017365/1), the UK Medical Research Council (www.mrc.ac.uk: Programme Grant MR/M026663/1; Centre Grant MR/N006364/1), and the Wellcome Trust (www.wellcome.ac.uk: Strategic Award 097377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS., 2012, ISRN INFLAMMATION, V2012, P953461, DOI [DOI 10.5402/2012/953461, 10.5402/2012/953461]; Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Brooks C, 2011, AM J PHYSIOL-CELL PH, V300, pC447, DOI 10.1152/ajpcell.00402.2010; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Childers DS, 2016, PLOS PATHOG IN PRESS; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Eck R, 1999, MICROBIOL-UK, V145, P2415, DOI 10.1099/00221287-145-9-2415; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Linder MC, 2013, NUTRIENTS, V5, P4022, DOI 10.3390/nu5104022; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Marvin ME, 2004, MICROBIOL-SGM, V150, P2197, DOI 10.1099/mic.0.27004-0; Marvin ME, 2003, MICROBIOL-SGM, V149, P1461, DOI 10.1099/mic.0.26172-0; MCMANUS JFA, 1950, J EXP MED, V91, P651, DOI 10.1084/jem.91.6.651; Meyer LA, 2001, J BIOL CHEM, V276, P36857, DOI 10.1074/jbc.M105361200; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Patterson MJ, 2013, ANTIOXID REDOX SIGN, V19, P2244, DOI 10.1089/ars.2013.5199; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Potrykus J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003910; Potrykus J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003676; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Riggle PJ, 2000, J BACTERIOL, V182, P4899, DOI 10.1128/JB.182.17.4899-4905.2000; Sandai D, 2012, MBIO, V3, DOI 10.1128/mBio.00495-12; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Shahana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100390; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; Szabo EK, 2014, VIRULENCE, V5, P286, DOI 10.4161/viru.27046; Tapryal N, 2009, J BIOL CHEM, V284, P1873, DOI 10.1074/jbc.M804079200; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Urgast DS, 2012, ANAL BIOANAL CHEM, V402, P287, DOI 10.1007/s00216-011-5461-x; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Wang HG, 2001, AM J KIDNEY DIS, V38, P1038, DOI 10.1053/ajkd.2001.28593; Weissman Z, 2000, P NATL ACAD SCI USA, V97, P3520, DOI 10.1073/pnas.97.7.3520; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Xu WJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002076; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441	67	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158683	10.1371/journal.pone.0158683	http://dx.doi.org/10.1371/journal.pone.0158683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362522	Green Published, Green Submitted, gold			2022-12-26	WOS:000378865200107
J	Maheswaran, R; Pearson, T; Beevers, SD; Campbell, MJ; Wolfe, CD				Maheswaran, Ravi; Pearson, Tim; Beevers, Sean D.; Campbell, Michael J.; Wolfe, Charles D.			Air Pollution and Subtypes, Severity and Vulnerability to Ischemic Stroke-A Population Based Case-Crossover Study	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; HEMORRHAGIC STROKE; REFERENT SELECTION; RISK; CLASSIFICATION; ASSOCIATION; POLLUTANTS; EXPOSURE	Background and Purpose Few studies have examined the association between air pollutants and ischemic stroke subtypes. We examined acute effects of outdoor air pollutants (PM10, NO2, O-3, CO, SO2) on subtypes and severity of incident ischemic stroke and investigated if pre-existing risk factors increased susceptibility. Methods We used a time stratified case-crossover study and stroke cases from the South London Stroke Register set up to capture all incident cases of first ever stroke occurring amongst residents in a geographically defined area. The Oxford clinical and TOAST etiological classifications were used to classify subtypes. A pragmatic clinical classification system was used to assess severity. Air pollution concentrations from the nearest background air pollution monitoring stations to patients' residential postcode centroids were used. Lags from 0 to 6 days were investigated. Results There were 2590 incident cases of ischemic stroke (1995-2006). While there were associations at various lag times with several pollutants, overall, there was no consistent pattern between exposure and risk of ischemic stroke subtypes or severity. The possible exception was the association between NO2 exposure and small vessel disease stroke-adjusted odds ratio of 1.51 (1.12-2.02) associated with an inter-quartile range increase in the lag 0-6 day average for NO2. There were no clear associations in relation to pre-existing risk factors. Conclusions Overall, we found little consistent evidence of association between air pollutants and ischemic stroke subtypes and severity. There was however a suggestion that increasing NO2 exposure might be associated with higher risk of stroke caused by cerebrovascular small vessel disease.	[Maheswaran, Ravi; Pearson, Tim] Univ Sheffield, Sch Hlth & Related Res, Publ Hlth GIS Unit, Sheffield, S Yorkshire, England; [Beevers, Sean D.] Kings Coll London, Environm Res Grp, London, England; [Campbell, Michael J.] Univ Sheffield, Sch Hlth & Related Res, Design Trials & Stat Sect, Sheffield, S Yorkshire, England; [Wolfe, Charles D.] Kings Coll London, Div Hlth & Social Care Res, London, England; [Wolfe, Charles D.] Guys & St Thomas NHS Fdn Trust & Kings Coll Londo, NIHR, Biomed Res Ctr, London, England	University of Sheffield; University of London; King's College London; University of Sheffield; University of London; King's College London; University of London; King's College London	Maheswaran, R (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Publ Hlth GIS Unit, Sheffield, S Yorkshire, England.	r.maheswaran@sheffield.ac.uk	Campbell, Michael J/I-4253-2014; Fazli, Ghazal/AAE-8320-2022	Campbell, Michael J/0000-0003-3529-2739; Maheswaran, Ravi/0000-0002-3899-4421	Colt Foundation; Department of Health via the NIHR Comprehensive Biomedical Research Centre; King's College London; National Institute for Health Research [RP-PG-0407-10184, NF-SI-0510-10060] Funding Source: researchfish	Colt Foundation; Department of Health via the NIHR Comprehensive Biomedical Research Centre; King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank the Colt Foundation, which supported this study through a research grant (http://www.coltfoundation.org.uk/). CDW acknowledges financial support from the Department of Health via the NIHR Comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London (http://www.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Hajat C, 2001, J NEUROL SCI, V190, P79, DOI 10.1016/S0022-510X(01)00597-4; Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maheswaran R, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-23; Maheswaran R, 2012, STROKE, V43, P22, DOI 10.1161/STROKEAHA.110.610238; O'Donnell MJ, 2011, EPIDEMIOLOGY, V22, P422, DOI 10.1097/EDE.0b013e3182126580; Ponka A, 1996, AM J PUBLIC HEALTH, V86, P1273, DOI 10.2105/AJPH.86.9.1273; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Strong M, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-38; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Villeneuve PJ, 2012, SCI TOTAL ENVIRON, V430, P193, DOI 10.1016/j.scitotenv.2012.05.002; Wang Y., 2014, J AM HEART ASSOC, V3; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Yang WS, 2014, INT J CARDIOL, V175, P307, DOI 10.1016/j.ijcard.2014.05.044	26	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158556	10.1371/journal.pone.0158556	http://dx.doi.org/10.1371/journal.pone.0158556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362783	Green Published, gold			2022-12-26	WOS:000378865200089
J	Ku, KM; Weir, RK; Silverman, JL; Berman, RF; Bauman, MD				Ku, Katherine M.; Weir, Ruth K.; Silverman, Jill L.; Berman, Robert F.; Bauman, Melissa D.			Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders	PLOS ONE			English	Article							SOCIAL PLAY-BEHAVIOR; ANIMAL-MODELS; ULTRASONIC VOCALIZATIONS; MOUSE MODELS; STRAINS; ANXIETY; COMMUNICATION; DEPRIVATION; ADOLESCENT; EXPERIENCE	The laboratory rat is emerging as an attractive preclinical animal model of autism spectrum disorder (ASD), allowing investigators to explore genetic, environmental and pharmacological manipulations in a species exhibiting complex, reciprocal social behavior. The present study was carried out to compare two commonly used strains of laboratory rats, Sprague-Dawley (SD) and Long-Evans (LE), between the ages of postnatal day (PND) 26-56 using high-throughput behavioral phenotyping tools commonly used in mouse models of ASD that we have adapted for use in rats. We detected few differences between young SD and LE strains on standard assays of exploration, sensorimotor gating, anxiety, repetitive behaviors, and learning. Both SD and LE strains also demonstrated sociability in the 3-chamber social approach test as indexed by spending more time in the social chamber with a constrained age/strain/sex matched novel partner than in an identical chamber without a partner. Pronounced differences between the two strains were, however, detected when the rats were allowed to freely interact with a novel partner in the social dyad paradigm. The SD rats in this particular testing paradigm engaged in play more frequently and for longer durations than the LE rats at both juvenile and young adult developmental time points. Results from this study that are particularly relevant for developing preclinical ASD models in rats are threefold: (i) commonly utilized strains exhibit unique patterns of social interactions, including strain-specific play behaviors, (ii) the testing environment may profoundly influence the expression of strain-specific social behavior and (iii) simple, automated measures of sociability may not capture the complexities of rat social interactions.	[Ku, Katherine M.; Weir, Ruth K.; Silverman, Jill L.; Bauman, Melissa D.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Silverman, Jill L.; Bauman, Melissa D.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Bauman, Melissa D.] Calif Natl Primate Res Ctr, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bauman, MD (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.; Bauman, MD (corresponding author), Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA.; Bauman, MD (corresponding author), Calif Natl Primate Res Ctr, Davis, CA USA.	mdbauman@ucdavis.edu	Bauman, Melissa/O-1256-2017	Bauman, Melissa/0000-0003-0701-3851; Ku, Katherine/0000-0002-1291-2117	NIH [U54 HD079125]; UC Davis Behavioral Health Center of Excellence; UC Davis Rat Phenotyping lab; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Behavioral Health Center of Excellence; UC Davis Rat Phenotyping lab; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the NIH-funded MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125) and from the UC Davis Behavioral Health Center of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the UC Davis Rat Phenotyping lab for supporting this research. The authors report no biomedical financial interests or potential conflicts of interest.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X; ARCHER T, 1987, SCAND J PSYCHOL, V28, P242, DOI 10.1111/j.1467-9450.1987.tb00761.x; Association AP, 2013, DIAGN STAT MAN MENT, V5; Baarendse PJJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1485, DOI 10.1038/npp.2013.47; Bauman MD, 2013, NEUROPSYCHIATRY-LOND, V3, P159, DOI 10.2217/NPY.13.18; BEATTY WW, 1982, PHARMACOL BIOCHEM BE, V16, P417, DOI 10.1016/0091-3057(82)90445-2; Bell HC, 2010, BEHAV BRAIN RES, V207, P7, DOI 10.1016/j.bbr.2009.09.029; Belzung C, 2014, NEUROPSYCHOPHARMACOL, V39, P1041, DOI 10.1038/npp.2013.342; Bishop SL, 2011, AUTISM RES, V4, P317, DOI 10.1002/aur.216; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Braff L, 2013, JAMA PSYCHIAT, V70, P777, DOI 10.1001/jamapsychiatry.2013.2184; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; Burgdorf J, 2013, BEHAV BRAIN RES, V251, P18, DOI 10.1016/j.bbr.2013.04.022; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dufour-Rainfray D, 2010, NEUROSCI LETT, V470, P55, DOI 10.1016/j.neulet.2009.12.054; Faraday MM, 2005, PHARMACOL BIOCHEM BE, V80, P577, DOI 10.1016/j.pbb.2005.01.015; Faraday MM, 2002, PHYSIOL BEHAV, V75, P507, DOI 10.1016/S0031-9384(02)00645-5; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Galvao MC, 2015, LIFE SCI, V120, P54, DOI 10.1016/j.lfs.2014.10.019; Gokcek-Sarac C, 2015, LEARN BEHAV, V43, P83, DOI 10.3758/s13420-014-0163-9; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hamilton SM, 2014, BEHAV NEUROSCI, V128, P103, DOI 10.1037/a0035988; Himmler BT, 2013, J COMP PSYCHOL, V127, P453, DOI 10.1037/a0032187; Himmler BT, 2013, JOVE-J VIS EXP, DOI 10.3791/4288; Himmler SM, 2014, INT J COMP PSYCHOL, V27; Himmler SM, 2014, J COMP PSYCHOL, V128, P318, DOI 10.1037/a0036104; Jordan R, 2003, AUTISM, V7, P347, DOI 10.1177/1362361303007004002; Kaffman A, 2012, METHODS MOL BIOL, V829, P3, DOI 10.1007/978-1-61779-458-2_1; Kantor S, 2000, PHYSIOL BEHAV, V71, P551, DOI 10.1016/S0031-9384(00)00374-7; Kas MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1125, DOI 10.1007/s00213-013-3268-5; Keeley RJ, 2015, BEHAV BRAIN RES, V288, P118, DOI 10.1016/j.bbr.2014.10.039; Kennedy BC, 2011, BEHAV PHARMACOL, V22, P147, DOI 10.1097/FBP.0b013e328343d7dd; Kirsten TB, 2015, LIFE SCI, V130, P12, DOI 10.1016/j.lfs.2015.02.027; Kirsten TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134565; Kisko TM, 2015, BEHAV PROCESS, V113, P113, DOI 10.1016/j.beproc.2015.01.016; Kumar G, 2015, PHYSIOL BEHAV, V144, P26, DOI 10.1016/j.physbeh.2015.03.001; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Llaneza DC, 2009, PHARMACOL BIOCHEM BE, V93, P337, DOI 10.1016/j.pbb.2009.05.003; Manduca A, 2014, EUR NEUROPSYCHOPHARM, V24, P1337, DOI 10.1016/j.euroneuro.2014.05.009; Manduca A, 2014, PSYCHOPHARMACOLOGY, V231, P1661, DOI 10.1007/s00213-013-3337-9; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; NIESINK RJM, 1989, NEUROPHARMACOLOGY, V28, P411, DOI 10.1016/0028-3908(89)90038-5; NIESINK RJM, 1983, PHYSIOL BEHAV, V30, P825, DOI 10.1016/0031-9384(83)90243-3; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Palagi E, 2015, BIOL REV CAMB PHILOS; PANKSEPP J, 1984, NEUROSCI BIOBEHAV R, V8, P465, DOI 10.1016/0149-7634(84)90005-8; PANKSEPP J, 1980, BEHAV NEURAL BIOL, V30, P197, DOI 10.1016/S0163-1047(80)91077-8; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; PELLIS SM, 1990, DEV PSYCHOBIOL, V23, P215, DOI 10.1002/dev.420230303; Pellis SM, 1998, NEUROSCI BIOBEHAV R, V23, P87, DOI 10.1016/S0149-7634(97)00071-7; Pellis SM, 1997, DEV PSYCHOBIOL, V31, P193; PELLIS SM, 1989, AGGRESSIVE BEHAV, V15, P297, DOI 10.1002/ab.2480150405; Peters SM, 2015, EUR J PHARMACOL, V759, P42, DOI 10.1016/j.ejphar.2015.03.043; POOLE TB, 1975, J ZOOL, V175, P61; POTEGAL M, 1989, DEV PSYCHOBIOL, V22, P159, DOI 10.1002/dev.420220206; Raza S, 2015, BEHAV PHARM; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2007, PSYCHONEUROENDOCRINO, V32, P651, DOI 10.1016/j.psyneuen.2007.04.003; Seffer D, 2014, J NEUROSCI METHODS; Servadio M, 2015, BEHAV PHARMACOL, V26, P522, DOI 10.1097/FBP.0000000000000163; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Siviy SM, 2003, PHYSIOL BEHAV, V80, P385, DOI 10.1016/j.physbeh.2003.09.002; Siviy SM, 2011, NEUROSCI BIOBEHAV R, V35, P1821, DOI 10.1016/j.neubiorev.2011.03.006; Smith LK, 1998, DEV PSYCHOBIOL, V33, P147, DOI 10.1002/(SICI)1098-2302(199809)33:2<147::AID-DEV5>3.0.CO;2-J; Spruijt BM, 2014, J NEUROSCI METH, V234, P2, DOI 10.1016/j.jneumeth.2014.03.001; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; THOR DH, 1984, NEUROSCI BIOBEHAV R, V8, P455, DOI 10.1016/0149-7634(84)90004-6; TONKISS J, 1992, DEV PSYCHOBIOL, V25, P567, DOI 10.1002/dev.420250804; Trezza V, 2011, DEV COGN NEUROS-NETH, V1, P444, DOI 10.1016/j.dcn.2011.05.007; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Turner KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093411; Turner KM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00097; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; VANDERSCHUREN LJMJ, 1995, PHYSIOL BEHAV, V58, P119, DOI 10.1016/0031-9384(94)00385-I; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Varlinskaya EI, 2008, BEHAV BRAIN RES, V188, P398, DOI 10.1016/j.bbr.2007.11.024; VARTY GB, 1994, J PSYCHOPHARMACOL, V8, P148, DOI 10.1177/026988119400800302; Watson DJ, 2009, BEHAV BRAIN RES, V205, P57, DOI 10.1016/j.bbr.2009.07.026; WEBSTER DG, 1981, BEHAV NEURAL BIOL, V31, P32, DOI 10.1016/S0163-1047(81)91034-7; Whishaw IQ, 2003, BEHAV BRAIN RES, V145, P221, DOI 10.1016/S0166-4328(03)00143-8; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Yang M, 2012, PHYSIOL BEHAV, V107, P649, DOI 10.1016/j.physbeh.2011.12.025; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young RL, 2003, AUTISM, V7, P125, DOI 10.1177/1362361303007002002; Zhang-James Y, 2014, BEHAV BRAIN RES, V269, P103, DOI 10.1016/j.bbr.2014.04.035	95	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158150	10.1371/journal.pone.0158150	http://dx.doi.org/10.1371/journal.pone.0158150			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351457	gold, Green Submitted, Green Published			2022-12-26	WOS:000378858900039
J	Qin, W; Liang, YZ; Qin, BY; Zhang, JL; Xia, N				Qin, Wen; Liang, Yu-Zhen; Qin, Bao-Yu; Zhang, Jia-Li; Xia, Ning			The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes	PLOS ONE			English	Article							HIGH-ABUNDANCE PROTEINS; LC-MS/MS ANALYSIS; DEPLETION; PLASMA; SERUM; LADA; AUTOANTIBODIES; IDENTIFICATION; MULTICENTER; EXPRESSION	Autoantibodies have been widely used as markers of latent autoimmune diabetes in adults (LADA); however, the specificity and sensitivity of autoantibodies as markers of LADA are weak compared with those found in type 1 diabetes (T1DM). In this study, we aimed to identify other plasma proteins as potential candidates that can be used effectively to determine early stage LADA and type 2 diabetes (T2DM) to facilitate early diagnosis and treatment. These issues were addressed by studying new-onset 'classic' T1DM (n = 156), LADA (n = 174), T2DM (n = 195) and healthy cohorts (n = 166). Plasma samples were obtained from the four cohorts. We employed isobaric tag for relative and absolute quantitation (iTRAQ) together with liquid chromatography tandem mass spectrometry (LC-MS) to identify plasma proteins with significant changes in LADA. The changes were validated by Western blot and ELISA analyses. Among the four cohorts, 311 unique proteins were identified in three iTRAQ runs, with 157 present across the three data sets. Among them, 49/311 (16.0%) proteins had significant changes in LADA compared with normal controls, including glycoprotein phospholipase D (GPLD1), which was upregulated in LADA. Western blot and ELISA analyses showed that GPLD1 levels were higher in both LADA and T1DM cohorts than in both T2DM and healthy cohorts, while there were no significant differences in the plasma concentrations of GPLD1 between the LADA and T1DM cohorts. GPLD1 is implicated as a potential candidate plasma protein for determining early stage LADA and T2DM.	[Qin, Wen] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Provinc, Peoples R China; [Liang, Yu-Zhen; Zhang, Jia-Li; Xia, Ning] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanning, Guangxi Provinc, Peoples R China; [Qin, Bao-Yu] Guangxi Med Univ, Affiliated Hosp 1, Dept Elderly Endocrinol, Nanning, Guangxi Provinc, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Xia, N (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanning, Guangxi Provinc, Peoples R China.	xianing12@sina.com			National Natural Science Foundation of China [81060070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81060070).	Andersen CD, 2013, DIABETOLOGIA, V56, P252, DOI 10.1007/s00125-012-2759-y; Borriello R, 2015, ANN CLIN LAB SCI, V45, P414; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265, DOI 10.4049/jimmunol.166.8.5265; Brophy S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006165.pub3; Campos A, 2015, J PROTEOMICS, V127, P264, DOI 10.1016/j.jprot.2015.05.012; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; Deeg MA, 2001, AM J PHYSIOL-ENDOC M, V281, pE147, DOI 10.1152/ajpendo.2001.281.1.E147; Deeg MA, 2012, BBA-MOL CELL BIOL L, V1821, P381, DOI 10.1016/j.bbalip.2011.12.009; Fourlanos S, 2006, DIABETES CARE, V29, P970, DOI 10.2337/dc05-2101; Fourlanos S, 2005, DIABETOLOGIA, V48, P2206, DOI 10.1007/s00125-005-1960-7; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gray DL, 2008, METABOLISM, V57, P473, DOI 10.1016/j.metabol.2007.11.007; Hyung SW, 2014, ANAL BIOANAL CHEM, V406, P7117, DOI 10.1007/s00216-014-8058-3; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Kucera P, 2003, CLIN EXP IMMUNOL, V133, P139, DOI 10.1046/j.1365-2249.2003.02205.x; Maddaloni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131837; Mann KJ, 2004, BIOCHEM J, V378, P641, DOI 10.1042/BJ20031326; Massa O, 2013, J PROTEOMICS, V82, P263, DOI 10.1016/j.jprot.2013.02.030; Naghibalhossaini F, 2006, CANCER LETT, V234, P158, DOI 10.1016/j.canlet.2005.03.028; Pakdel A, 2012, MOL BIOL REP, V39, P3695, DOI 10.1007/s11033-011-1144-0; Papadopoulos KP, 1996, DIABETES, V45, P1761, DOI 10.2337/diabetes.45.12.1761; Pham MN, 2011, DIABETOLOGIA, V54, P1630, DOI 10.1007/s00125-011-2088-6; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Rhode H, 1999, CLIN CHIM ACTA, V281, P127, DOI 10.1016/S0009-8981(98)00218-6; Schofield JN, 2002, MOL GENET METAB, V75, P154, DOI 10.1006/mgme.2001.3287; Schofield JN, 2000, BBA-GENE STRUCT EXPR, V1494, P189, DOI 10.1016/S0167-4781(00)00194-9; Tiberti C, 2011, CLIN EXP IMMUNOL, V166, P317, DOI 10.1111/j.1365-2249.2011.04479.x; Tiberti C, 2008, DIABETES, V57, P1276, DOI 10.2337/db07-0874; Tozzoli R, 2013, IMMUNOL RES, V56, P425, DOI 10.1007/s12026-013-8418-7; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zhou ZG, 2013, DIABETES, V62, P543, DOI 10.2337/db12-0207; Zhu SC, 2012, PROTEOMICS, V12, P3451, DOI 10.1002/pmic.201200036	35	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0156959	10.1371/journal.pone.0156959	http://dx.doi.org/10.1371/journal.pone.0156959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351175	gold, Green Submitted, Green Published			2022-12-26	WOS:000378858900004
J	Schroeder, H; Cronn, R; Yanbaev, Y; Jennings, T; Mader, M; Degen, B; Kersten, B				Schroeder, Hilke; Cronn, Richard; Yanbaev, Yulai; Jennings, Tara; Mader, Malte; Degen, Bernd; Kersten, Birgit			Development of Molecular Markers for Determining Continental Origin of Wood from White Oaks (Quercus L. sect. Quercus)	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; POSTGLACIAL COLONIZATION; LAND PLANTS; IDENTIFICATION; DIFFERENTIATION; BARCODE; PHYLOGEOGRAPHY; BIOGEOGRAPHY; INTRON; SET	To detect and avoid illegal logging of valuable tree species, identification methods for the origin of timber are necessary. We used next-generation sequencing to identify chloroplast genome regions that differentiate the origin of white oaks from the three continents; Asia, Europe, and North America. By using the chloroplast genome of Asian Q. mongolica as a reference, we identified 861 variant sites (672 single nucleotide polymorphisms (SNPs); 189 insertion/deletion (indel) polymorphism) from representative species of three continents (Q. mongolica from Asia; Q. petraea and Q. robur from Europe; Q. alba from North America), and we identified additional chloroplast polymorphisms in pools of 20 individuals each from Q. mongolica (789 variant sites) and Q. robur (346 variant sites). Genome sequences were screened for indels to develop markers that identify continental origin of oak species, and that can be easily evaluated using a variety of detection methods. We identified five indels and one SNP that reliably identify continent-of-origin, based on evaluations of up to 1078 individuals representing 13 white oak species and three continents. Due to the size of length polymorphisms revealed, this marker set can be visualized using capillary electrophoresis or high resolution gel (acrylamide or agarose) electrophoresis. With these markers, we provide the wood trading market with an instrument to comply with the U.S. and European laws that require timber companies to avoid the trade of illegally harvested timber.	[Schroeder, Hilke; Mader, Malte; Degen, Bernd; Kersten, Birgit] Thuenen Insitute Forest Genet, Grosshansdorf, Germany; [Cronn, Richard] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Yanbaev, Yulai] Bashkir State Univ, Ufa 450074, Russia; [Jennings, Tara] Oregon State Univ, Bot & Plant Pathol, Corvallis, OR 97331 USA	Johann Heinrich von Thunen Institute; United States Department of Agriculture (USDA); United States Forest Service; Bashkir State University; Oregon State University	Schroeder, H (corresponding author), Thuenen Insitute Forest Genet, Grosshansdorf, Germany.	hilke.schroeder@thuenen.de	Degen, Bernd/S-1730-2016; Yanbaev, Yulay/B-2266-2016	Degen, Bernd/0000-0001-9082-3163; Yanbaev, Yulay/0000-0003-1039-5344; Kersten, Birgit/0000-0001-9900-9133; Cronn, Richard/0000-0001-5342-3494	German Federal Ministry of Food and Agriculture (BMEL); Deutsche Bundesstiftung Umwelt (DBU); USDA Forest Service International Programs Office; US Agency for International Development; US Department of State	German Federal Ministry of Food and Agriculture (BMEL); Deutsche Bundesstiftung Umwelt (DBU); USDA Forest Service International Programs Office; US Agency for International Development(United States Agency for International Development (USAID)); US Department of State	This project has been financially supported by German Federal Ministry of Food and Agriculture (BMEL) (http://www.bmel.de), the Deutsche Bundesstiftung Umwelt (DBU) (http://www.dbu.de), the USDA Forest Service International Programs Office (http://www.fs.fed.us/about-agency/international-programs), the US Agency for International Development, and US Department of State (http://www.state.gov/s/d/rm/rls/dosstrat/). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baker CS, 2010, BIOL LETTERS, V6, P647, DOI 10.1098/rsbl.2010.0239; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bordacs S, 2002, FOREST ECOL MANAG, V156, P197, DOI 10.1016/S0378-1127(01)00643-0; Carvalho DC, 2015, FOOD CONTROL, V50, P784, DOI 10.1016/j.foodcont.2014.10.025; Cassens D., 2007, HARDWOOD LUMBER AND; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cottrell JE, 2002, FOREST ECOL MANAG, V156, P181, DOI 10.1016/S0378-1127(01)00642-9; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Csaikl UM, 2002, FOREST ECOL MANAG, V156, P131, DOI 10.1016/S0378-1127(01)00639-9; Deguilloux MF, 2003, MOL ECOL, V12, P1629, DOI 10.1046/j.1365-294X.2003.01836.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dormontt EE, 2015, BIOL CONSERV, V191, P790, DOI 10.1016/j.biocon.2015.06.038; Drabkova L, 2004, J MOL EVOL, V59, P1, DOI 10.1007/s00239-004-2598-7; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; Fineschi S, 2002, FOREST ECOL MANAG, V156, P103, DOI 10.1016/S0378-1127(01)00637-5; Goncalves PFM, 2015, J HERED, V106, P560, DOI 10.1093/jhered/esv035; Handy SM, 2011, J AGR FOOD CHEM, V59, P10995, DOI 10.1021/jf203215v; Hartvig I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138231; Holtken AM, 2012, HOLZFORSCHUNG, V66, P97, DOI 10.1515/HF.2011.142; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129295; Jensen JS, 2002, FOREST ECOL MANAG, V156, P167, DOI 10.1016/S0378-1127(01)00641-7; Kanno M, 2004, J PLANT RES, V117, P311, DOI 10.1007/s10265-004-0160-8; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Konig AO, 2002, FOREST ECOL MANAG, V156, P147, DOI 10.1016/S0378-1127(01)00640-5; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lowe A, 2015, International Patent, Patent No. [WO/2015/070279, 2015070279]; Lu S, 2015, MITOCHONDR DNA, P1; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Martin-Bravo S, 2007, MOL PHYLOGENET EVOL, V44, P1105, DOI 10.1016/j.ympev.2006.12.016; Mitchell A, 2015, MOL ECOL RESOUR, V15, P1102, DOI 10.1111/1755-0998.12380; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nithaniyal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107669; Olalde M, 2002, FOREST ECOL MANAG, V156, P89, DOI 10.1016/S0378-1127(01)00636-3; Pappalardo AM, 2015, FISH RES, V164, P153, DOI 10.1016/j.fishres.2014.11.004; Parks M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-100; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Pirie MD, 2007, AM J BOT, V94, P1003, DOI 10.3732/ajb.94.6.1003; Rehman A, 2015, J BIORESOUR MANAG, V2, P3, DOI [10.35691/JBM.5102.0017, DOI 10.35691/JBM.5102.0017]; Schroeder H, 2012, PLANT BIOLOGY, V14, P374, DOI 10.1111/j.1438-8677.2011.00502.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simeone MC, 2013, BOT J LINN SOC, V172, P478, DOI 10.1111/boj.12059; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Yan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055854; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	58	26	26	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158221	10.1371/journal.pone.0158221	http://dx.doi.org/10.1371/journal.pone.0158221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352242	Green Submitted, Green Published, gold			2022-12-26	WOS:000378858900046
J	Zhang, T; Cui, BT; Li, P; He, Z; Long, CY; Wei, L; Peng, ZY; Ji, GZ; Zhang, FM				Zhang, Ting; Cui, Bota; Li, Pan; He, Zhi; Long, Chuyan; Wei, Lu; Peng, Zhaoyuan; Ji, Guozhong; Zhang, Faming			Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; CHRONIC INTESTINAL INFLAMMATION; RANDOMIZED CONTROLLED-TRIAL; INNATE LYMPHOID-CELLS; T-CELLS; CROHNS-DISEASE; TH17 CELLS; IN-VIVO; RECEPTOR	Objective There were no reports on predicting long-term efficacy of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). This study aimed to detect short-term changes of cytokines and C-reactive protein (CRP) in patients with UC undergoing FMT, and to evaluate the predictive value of CRP and cytokines for the long-term efficacy of FMT. Methods Nineteen patients with moderate to severe UC (Mayo score >= 6) were treated with single fresh FMT through mid-gut. Serum samples were collected before and three days post-FMT. Clinical responses were evaluated by a minimum follow-up of three months. Patients with clinical improvement and remission at the assessment point of three-month were included as response group, while patients without clinical improvement or remission were included as non-response group. Serum concentrations of cytokines (IL-1 beta, IL-2, IL-4, IL-6, IL-10, IL-11, IL-17A, IFN-gamma, TNF, TNFR-1, TNFR-2, MCP-1, G-CSF, GM-CSF) and CRP were assayed to predict the clinical response of FMT. Results In total, 10.5% (2/19) of patients achieved clinical remission and 47.4% (9/19) achieved clinical improvement (Response group, including clinical remission and clinical improvement), 42.1% (8/19) failed to benefit from FMT (Non-response group). In both Response group and Non-response group, the level of CRP at three days after FMT didn't show significant decrease compared with that before FMT (p>0.05). However, in Response group, CRP level at three months after FMT decreased significantly than that before FMT (p<0.05). Compared with healthy controls (n = 9), patients with UC showed a higher baseline level of serum IL-6, TNFR-2 and G-CSF, and a lower level of IL-2 and IL-4 (p<0.05). In both Response group and Non-response group, none of the eleven detectable cytokines showed a significant difference between the value at three days after FMT and that before FMT (p>0.05). Conclusions Patients with moderate to severe UC presented a complex disorder of cytokines. However, the efficacy of FMT for UC might not be predicted by the short-term surveillance of cytokines and CRP.	[Zhang, Ting; Cui, Bota; Li, Pan; He, Zhi; Long, Chuyan; Wei, Lu; Peng, Zhaoyuan; Ji, Guozhong; Zhang, Faming] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Ting; Cui, Bota; Li, Pan; He, Zhi; Long, Chuyan; Wei, Lu; Peng, Zhaoyuan; Ji, Guozhong; Zhang, Faming] Nanjing Med Univ, Key Lab Holist Integrat Enterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Ji, GZ; Zhang, FM (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China.; Ji, GZ; Zhang, FM (corresponding author), Nanjing Med Univ, Key Lab Holist Integrat Enterol, Nanjing, Jiangsu, Peoples R China.	jgz@njmu.edu.cn; fzhang@njmu.edu.cn		Long, Chuyan/0000-0002-8800-3825	Intestine Initiative Foundation; Clinical Science and Technology Foundation of Jiangsu Province [BL2014097]; National Gastroenterology Research Project [2015BAI13B07]	Intestine Initiative Foundation; Clinical Science and Technology Foundation of Jiangsu Province; National Gastroenterology Research Project	This study was supported by publicly donated funds, the Intestine Initiative Foundation, Clinical Science and Technology Foundation of Jiangsu Province (BL2014097) and the National Gastroenterology Research Project (2015BAI13B07).	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Babickova J, 2015, WORLD J GASTROENTERO, V21, P11321, DOI 10.3748/wjg.v21.i40.11321; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; BENNET JD, 1989, LANCET, V1, P164; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; BREESE E, 1993, IMMUNOLOGY, V78, P127; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Chang S, 2015, WORLD J GASTROENTERO, V21, P11246, DOI 10.3748/wjg.v21.i40.11246; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Cui BT, 2016, GASTROENTEROLOGY, V150, P285, DOI 10.1053/j.gastro.2015.05.065; Cui BT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0646-2; Cui BT, 2015, J GASTROEN HEPATOL, V30, P51, DOI 10.1111/jgh.12727; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P1553, DOI 10.1016/j.mayocp.2014.07.002; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Francescone R, 2015, INFLAMM BOWEL DIS, V21, P409, DOI 10.1097/MIB.0000000000000236; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gordon H, 2014, J CROHNS COLITIS, V8, P256, DOI 10.1016/j.crohns.2013.10.007; Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Jiang WY, 2014, INFLAMM RES, V63, P943, DOI 10.1007/s00011-014-0768-7; Kai Y, 2005, GASTROENTEROLOGY, V128, P922, DOI 10.1053/j.gastro.2005.01.013; Kao DN, 2014, J CLIN GASTROENTEROL, V48, P625, DOI 10.1097/MCG.0000000000000131; Kleiner G, 2015, EXP THER MED, V9, P2047, DOI 10.3892/etm.2015.2370; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Liu L, 2008, INT IMMUNOPHARMACOL, V8, P1481, DOI 10.1016/j.intimp.2008.04.013; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Perrier C, 2013, INFLAMM BOWEL DIS, V19, P246, DOI 10.1002/ibd.23023; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Sakuraba A, 2009, GASTROENTEROLOGY, V137, P1736, DOI 10.1053/j.gastro.2009.07.049; Sands BE, 2015, GASTROENTEROLOGY, V149, P1275, DOI 10.1053/j.gastro.2015.07.003; Schuijt TJ, 2013, TRENDS MICROBIOL, V21, P221, DOI 10.1016/j.tim.2013.02.001; Sha S, 2014, ALIMENT PHARM THER, V39, P1003, DOI 10.1111/apt.12699; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Zhang FM, 2012, AM J GASTROENTEROL, V107, P1755, DOI 10.1038/ajg.2012.251	44	20	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158227	10.1371/journal.pone.0158227	http://dx.doi.org/10.1371/journal.pone.0158227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27347881	Green Published, gold, Green Submitted			2022-12-26	WOS:000378801200052
J	Caturegli, L; Corniglia, M; Gaetani, M; Grossi, N; Magni, S; Migliazzi, M; Angelini, L; Mazzoncini, M; Silvestri, N; Fontanelli, M; Raffaelli, M; Peruzzi, A; Volterrani, M				Caturegli, Lisa; Corniglia, Matteo; Gaetani, Monica; Grossi, Nicola; Magni, Simone; Migliazzi, Mauro; Angelini, Luciana; Mazzoncini, Marco; Silvestri, Nicola; Fontanelli, Marco; Raffaelli, Michele; Peruzzi, Andrea; Volterrani, Marco			Unmanned Aerial Vehicle to Estimate Nitrogen Status of Turfgrasses	PLOS ONE			English	Article							SPECTRAL REFLECTANCE; VEGETATION INDEXES; MULTISPECTRAL DATA; TIME-SERIES; CROP; IMAGERY; SATELLITE; NDVI; AIRCRAFT; BIOMASS	Spectral reflectance data originating from Unmanned Aerial Vehicle (UAV) imagery is a valuable tool to monitor plant nutrition, reduce nitrogen (N) application to real needs, thus producing both economic and environmental benefits. The objectives of the trial were i) to compare the spectral reflectance of 3 turfgrasses acquired via UAV and by a ground-based instrument; ii) to test the sensitivity of the 2 data acquisition sources in detecting induced variation in N levels. N application gradients from 0 to 250 kg ha(-1) were created on 3 different turfgrass species: Cynodon dactylon x transvaalensis (Cdxt) 'Patriot', Zoysia matrella (Zm) 'Zeon' and Paspalum vaginatum (Pv) 'Salam'. Proximity and remote-sensed reflectance measurements were acquired using a GreenSeeker handheld crop sensor and a UAV with onboard a multispectral sensor, to determine Normalized Difference Vegetation Index (NDVI). Proximity-sensed NDVI is highly correlated with data acquired from UAV with r values ranging from 0.83 (Zm) to 0.97 (Cdxt). Relating NDVI-UAV with clippings N, the highest r is for Cdxt (0.95). The most reactive species to N fertilization is Cdxt with a clippings N% ranging from 1.2% to 4.1%. UAV imagery can adequately assess the N status of turfgrasses and its spatial variability within a species, so for large areas, such as golf courses, sod farms or race courses, UAV acquired data can optimize turf management. For relatively small green areas, a hand-held crop sensor can be a less expensive and more practical option.	[Caturegli, Lisa; Corniglia, Matteo; Gaetani, Monica; Grossi, Nicola; Magni, Simone; Angelini, Luciana; Mazzoncini, Marco; Silvestri, Nicola; Fontanelli, Marco; Raffaelli, Michele; Peruzzi, Andrea; Volterrani, Marco] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Migliazzi, Mauro] GLOBI Hi Tech Srl, Genoa, Italy	University of Pisa	Caturegli, L (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	lisa.caturegli@gmail.com	Angelini, Luciana G./B-5780-2016; caturegli, lisa/O-3988-2019; Raffaelli, Michele/H-4280-2013; MAGNI, SIMONE/M-4513-2014; GROSSI, NICOLA/K-8098-2015	Angelini, Luciana G./0000-0002-7869-1548; caturegli, lisa/0000-0001-9749-2352; MAGNI, SIMONE/0000-0002-8956-7235; GROSSI, NICOLA/0000-0002-6997-1599	University of Pisa	University of Pisa	The present research was financed with public funds ("PRA Progetti di Ricerca di Ateneo") paid by University of Pisa. One author, Mauro Migliazzi, is employed by a commercial company: GLOBI Hi-Tech Srl. The Company provided support in the form of salary only for author Mauro Migliazzi, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Acevo-Herrera R, 2010, REMOTE SENS-BASEL, V2, P1662, DOI 10.3390/rs2071662; Agati G, 2015, EUR J AGRON, V63, P89, DOI 10.1016/j.eja.2014.11.007; Agati G, 2013, EUR J AGRON, V45, P39, DOI 10.1016/j.eja.2012.10.011; Aguilar C, 2012, ECOL INDIC, V23, P290, DOI 10.1016/j.ecolind.2012.04.008; Alsdorf J, 2007, THESIS; Barton CVM, 2012, PLANT SOIL, V354, P41, DOI 10.1007/s11104-011-1051-0; Bell GE, 2004, HORTSCIENCE, V39, P1130, DOI 10.21273/HORTSCI.39.5.1130; Bell GE, 2013, AGRON MONOGR, V56, P1151, DOI 10.2134/agronmonogr56.c30; Bell GE, 2008, BOOKS SOIL PLANT ENV, V122, P641; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Bremer DJ, 2011, CROP SCI, V51, P2219, DOI 10.2135/cropsci2010.12.0729; Bremner J. M., 1965, METHODS SOIL ANAL 2, P1149, DOI DOI 10.2134/AGRONMONOGR9.2.C33; Carrow RN, 2010, PRECIS AGRIC, V11, P115, DOI 10.1007/s11119-009-9136-y; Caturegli L, 2014, EUR J HORTIC SCI, V79, P97; Caturegli L, 2015, PRECIS AGRIC, V16, P297, DOI 10.1007/s11119-014-9376-3; Caturegli L, 2015, AGRIC AGRIC SCI PROC, V4, P59, DOI 10.1016/j.aaspro.2015.03.008; Caturegli L, 2015, INT J REMOTE SENS, V36, P2238, DOI 10.1080/01431161.2015.1035409; Chao H., 2008, IFAC WORLD C SEOUL K, DOI DOI 10.3182/20080706-5-KR-1001.01989; Coifman B., 2006, IEE Proceedings Intelligent Transport Systems, V153, P11, DOI 10.1049/ip-its:20055014; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P11, DOI 10.1016/j.compag.2004.10.005; Darvishsefat AA, 2011, J AGR SCI TECH-IRAN, V13, P1091; Doherty P, 2007, LECT NOTES COMPUT SC, V4830, P1; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Dorigo WA, 2007, INT J APPL EARTH OBS, V9, P165, DOI 10.1016/j.jag.2006.05.003; Fensholt R, 2012, REMOTE SENS ENVIRON, V119, P131, DOI 10.1016/j.rse.2011.12.015; FINKE PA, 1992, SOIL TECHNOL, V5, P257, DOI 10.1016/0933-3630(92)90026-W; Foschi L., 2009, INT TURFGRASS SOC, V11, P765; Gupta S. C., 2013, INT J ADV RES COMPUT, V2, P1646; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Herwitz S, 2004, P AIAA 3 UNM UNL TEC; Herwitz SR, 2003, INT GEOSCI REMOTE SE, P1692; Herwitz SR, 2004, COMPUT ELECTRON AGR, V44, P49, DOI 10.1016/j.compag.2004.02.006; Hruska R, 2012, REMOTE SENS-BASEL, V4, P2736, DOI 10.3390/rs4092736; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Jiang YW, 2007, CROP SCI, V47, P1611, DOI 10.2135/cropsci2006.09.0617; Johnsen AR, 2009, CROP SCI, V49, P2261, DOI 10.2135/cropsci2008.09.0544; Johnson L.F., 2003, P 30 INT S REM SENS, P845; Krum JM, 2010, CROP SCI, V50, P301, DOI 10.2135/cropsci2009.04.0173; Laliberte AS, 2011, GISCI REMOTE SENS, V48, P4, DOI 10.2747/1548-1603.48.1.4; Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557; Lin YC, 2012, IEEE INT CONF ROBOT, P3588, DOI 10.1109/ICRA.2012.6225112; Michez A, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-4996-2; Morris K. N., 2008, NTEP TURFGR EV WORKS, P1; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; Padilla FM, 2014, EUR J AGRON, V58, P39, DOI 10.1016/j.eja.2014.04.006; Pan ZK, 2015, INT J APPL EARTH OBS, V34, P188, DOI 10.1016/j.jag.2014.08.011; Perry EM, 2007, COMPUT ELECTRON AGR, V59, P56, DOI 10.1016/j.compag.2007.05.002; Rango A, 2011, REMOTE SENS-BASEL, V3, P2089, DOI 10.3390/rs3092089; Resop JP, 2011, APPL ENG AGRIC, V27, P25; Rossi S, 2010, J IRRIG DRAIN ENG, V136, P225, DOI 10.1061/(ASCE)IR.1943-4774.0000161; Rovira-Mas F, 2005, BIOSYST ENG, V90, P251, DOI 10.1016/j.biosystemseng.2004.11.013; Samborski SM, 2009, AGRON J, V101, P800, DOI 10.2134/agronj2008.0162Rx; Stowell L., 2006, GOLF COURSE MANAG, V74, P107; Stroppiana D, 2015, INT GEOSCI REMOTE SE, P4664, DOI 10.1109/IGARSS.2015.7326869; Sugiura R, 2005, BIOSYST ENG, V90, P369, DOI 10.1016/j.biosystemseng.2004.12.011; Swain KC, 2010, T ASABE, V53, P21; Trenholm LE, 1999, CROP SCI, V39, P763, DOI 10.2135/cropsci1999.0011183X003900030025x; Turner D, 2012, REMOTE SENS-BASEL, V4, P1392, DOI 10.3390/rs4051392; Valente J, 2011, SENSORS-BASEL, V11, P6088, DOI 10.3390/s110606088; Vina A, 2011, REMOTE SENS ENVIRON, V115, P3468, DOI 10.1016/j.rse.2011.08.010; Volterrani M., 2005, International Turfgrass Society Research Journal, V10, P1005; Walters DR, 2007, ANN APPL BIOL, V151, P307, DOI 10.1111/j.1744-7348.2007.00176.x; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Wu JD, 2012, REMOTE SENS-BASEL, V4, P849, DOI 10.3390/rs4040849; Xiang HT, 2011, BIOSYST ENG, V108, P104, DOI 10.1016/j.biosystemseng.2010.11.003; Xiong X, 2007, CROP SCI, V47, P1603, DOI 10.2135/cropsci2006.06.0400; Zarco-Tejada PJ, 2013, AGR FOREST METEOROL, V171, P281, DOI 10.1016/j.agrformet.2012.12.013; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5	69	69	71	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158268	10.1371/journal.pone.0158268	http://dx.doi.org/10.1371/journal.pone.0158268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341674	Green Published, gold			2022-12-26	WOS:000378393600044
J	Denoncourt, AM; Paquet, VE; Sedighi, A; Charette, SJ				Denoncourt, Alix M.; Paquet, Valerie E.; Sedighi, Ahmadreza; Charette, Steve J.			Identification of Proteins Associated with Multilamellar Bodies Produced by Dictyostelium discoideum	PLOS ONE			English	Article							CYSTEINE PROTEINASE; MEMBRANE-PROTEINS; PONTICULIN; PROTEOMICS; GLYCOSYLATION; LOCALIZATION; SECRETION; VESICLES; STRESS; SERINE	Dictyostelium discoideum amoebae produce and secrete multilamellar bodies (MLBs) when fed digestible bacteria. The aim of the present study was to elucidate the proteic content of MLBs. The lipid composition of MLBs is mainly amoebal in origin, suggesting that MLB formation is a protozoa-driven process that could play a significant role in amoebal physiology. We identified four major proteins on purified MLBs using mass spectrometry in order to better understand the molecular mechanisms governing MLB formation and, eventually, to elucidate the true function of MLBs. These proteins were SctA, PhoPQ, PonC and a protein containing a cytidine/deoxycytidylate deaminase (CDD) zinc-binding region. SctA is a component of pycnosomes, which are membranous materials that are continuously secreted by amoebae. The presence of SctA on MLBs was confirmed by immunofluorescence and Western blotting using a specific anti-SctA antibody. The CDD protein may be one of the proteins recognized by the H36 antibody, which was used as a MLB marker in a previous study. The function of the CDD protein is unknown. Immunofluorescence and flow cytometric analyses confirmed that the H36 antibody is a better marker of MLBs than the anti-SctA antibody. This study is an additional step to elucidate the potential role of MLBs and revealed that only a small set of proteins appeared to be present on MLBs.	[Denoncourt, Alix M.; Paquet, Valerie E.; Sedighi, Ahmadreza; Charette, Steve J.] Univ Laval, Inst Biol Integrat & Syst, Pavillon Charles Eugene Marchand, Quebec City, PQ, Canada; [Denoncourt, Alix M.; Paquet, Valerie E.; Sedighi, Ahmadreza; Charette, Steve J.] Hop Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Denoncourt, Alix M.; Paquet, Valerie E.; Sedighi, Ahmadreza; Charette, Steve J.] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Charette, SJ (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Pavillon Charles Eugene Marchand, Quebec City, PQ, Canada.; Charette, SJ (corresponding author), Hop Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.; Charette, SJ (corresponding author), Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.	steve.charette@bcm.ulaval.ca	Charette, Steve/GYJ-3058-2022	Charette, Steve/0000-0002-0199-2852	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); Chaire de pneumologie de la fondation J.-D. Begin of Universite Laval; Fonds Alphonse L'Esperance de la fondation de l'IUCPQ; Establishment of Young Researchers - Junior 1 grant from Fonds de Recherche du Quebec en Sante (FRQS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); Chaire de pneumologie de la fondation J.-D. Begin of Universite Laval; Fonds Alphonse L'Esperance de la fondation de l'IUCPQ; Establishment of Young Researchers - Junior 1 grant from Fonds de Recherche du Quebec en Sante (FRQS)	AMD received scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) and the Fonds de Recherche du Quebec - Nature et Technologies (FRQNT, http://www.frqnt.gouv.qc.ca). This research was funded by grants to SJC from the Chaire de pneumologie de la fondation J.-D. Begin of Universite Laval and the Fonds Alphonse L'Esperance de la fondation de l'IUCPQ, an Establishment of Young Researchers - Junior 1 grant from the Fonds de Recherche du Quebec en Sante (FRQS, http://www.frqs.gouv.qc.ca), and a grant from the Fonds de Recherche du Quebec - Nature et Technologies (FRQNT, http://www.frqnt.gouv.qc.ca). SJC is an FRQS research scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1985, J CELL BIOL, V100, P1825, DOI 10.1083/jcb.100.6.1825; Berk SG, 1998, APPL ENVIRON MICROB, V64, P279; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P1562, DOI 10.1128/AEM.71.3.1562-1569.2005; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Charette SJ, 2008, TRAFFIC, V9, P588, DOI 10.1111/j.1600-0854.2008.00706.x; COOPER DNW, 1986, DEV BIOL, V114, P416, DOI 10.1016/0012-1606(86)90206-X; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Denoncourt AM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00240; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Emslie KR, 1998, EUR J PROTISTOL, V34, P321, DOI 10.1016/S0932-4739(98)80059-X; FUKUZAWA M, 1993, EXP CELL RES, V204, P61, DOI 10.1006/excr.1993.1009; GEZELIUS K, 1961, EXP CELL RES, V23, P300, DOI 10.1016/0014-4827(61)90039-8; GOERKE J, 1974, BIOCHIM BIOPHYS ACTA, V344, P241, DOI 10.1016/0304-4157(74)90009-4; Gupta R, 1999, GLYCOBIOLOGY, V9, P1009, DOI 10.1093/glycob/9.10.1009; GUSTAFSON GL, 1979, J BIOL CHEM, V254, P2471; HITT AL, 1994, J CELL BIOL, V126, P1433, DOI 10.1083/jcb.126.6.1433; HITT AL, 1994, J CELL BIOL, V126, P1421, DOI 10.1083/jcb.126.6.1421; HOHL HR, 1965, J BACTERIOL, V90, P755, DOI 10.1128/JB.90.3.755-765.1965; Koubar M, 2011, FEMS MICROBIOL LETT, V325, P10, DOI 10.1111/j.1574-6968.2011.02402.x; Marchetti A, 2004, J CELL SCI, V117, P6053, DOI 10.1242/jcs.01524; Mehta DP, 1996, J BIOL CHEM, V271, P10897, DOI 10.1074/jbc.271.18.10897; MEHTA DP, 1995, ARCH BIOCHEM BIOPHYS, V321, P191, DOI 10.1006/abbi.1995.1385; Mercanti V, 2006, J CELL SCI, V119, P4079, DOI 10.1242/jcs.03190; MERCER EH, 1960, J BIOPHYS BIOCHEM CY, V7, P353, DOI 10.1083/jcb.7.2.353; Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539; Ord T, 1997, ARCH BIOCHEM BIOPHYS, V339, P64, DOI 10.1006/abbi.1996.9870; Paquet VE, 2013, EUKARYOT CELL, V12, P1326, DOI 10.1128/EC.00107-13; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Phillips JE, 2012, P NATL ACAD SCI USA, V109, P10990, DOI 10.1073/pnas.1206350109; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; Rabilloud T, 1999, METH MOL B, V112, P9; Raghu Nadhanan R, 2014, ENVIRON MICROBIOL, V16, P396, DOI 10.1111/1462-2920.12230; Rauchenberger R, 1997, CURR BIOL, V7, P215, DOI 10.1016/S0960-9822(97)70093-9; ROSEN SD, 1973, P NATL ACAD SCI USA, V70, P2554, DOI 10.1073/pnas.70.9.2554; Sabra A, 2016, PLOS ONE UNPUB; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Smith EW, 2010, EUKARYOT CELL, V9, P387, DOI 10.1128/EC.00285-09; SPRINGER WR, 1984, CELL, V39, P557, DOI 10.1016/0092-8674(84)90462-8; Wang P, 2009, PROTEOMICS, V9, P2955, DOI 10.1002/pmic.200800826; WUESTEHUBE LJ, 1987, J CELL BIOL, V105, P1741, DOI 10.1083/jcb.105.4.1741	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158270	10.1371/journal.pone.0158270	http://dx.doi.org/10.1371/journal.pone.0158270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27340834	gold, Green Submitted, Green Published			2022-12-26	WOS:000378393600045
J	Cabrera, E; Hernandez-Perez, S; Koundrioukoff, S; Debatisse, M; Kim, D; Smolka, MB; Freire, R; Gillespie, DA				Cabrera, E.; Hernandez-Perez, S.; Koundrioukoff, S.; Debatisse, M.; Kim, D.; Smolka, M. B.; Freire, R.; Gillespie, D. A.			PERK inhibits DNA replication during the Unfolded Protein Response via Claspin and Chk1	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM; TRANSLATION; ACTIVATION; DYNAMICS; IMPACT; LUMEN; CELLS; RATES	Stresses such as hypoxia, nutrient deprivation and acidification disturb protein folding in the endoplasmic reticulum (ER) and activate the Unfolded Protein Response (UPR) to trigger adaptive responses through the effectors, PERK, IRE1 and ATF6. Most of these responses relate to ER homoeostasis; however, here we show that the PERK branch of the UPR also controls DNA replication. Treatment of cells with the non-genotoxic UPR agonist thapsigargin led to a rapid inhibition of DNA synthesis that was attributable to a combination of DNA replication fork slowing and reduced replication origin firing. DNA synthesis inhibition was dependent on the UPR effector PERK and was associated with phosphorylation of the checkpoint adaptor protein Claspin and activation of the Chk1 effector kinase, both of which occurred in the absence of detectable DNA damage. Remarkably, thapsigargin did not inhibit bulk DNA synthesis or activate Chk1 in cells depleted of Claspin, or when Chk1 was depleted or subject to chemical inhibition. In each case thapsigargin-resistant DNA synthesis was due to an increase in replication origin firing that compensated for reduced fork progression. Taken together, our results unveil a new aspect of PERK function and previously unknown roles for Claspin and Chk1 as negative regulators of DNA replication in the absence of genotoxic stress. Because tumour cells proliferate in suboptimal environments, and frequently show evidence of UPR activation, this pathway could modulate the response to DNA replication-targeted chemotherapies.	[Cabrera, E.; Hernandez-Perez, S.; Freire, R.] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Ofra S-N, San Cristobal la Laguna, Tenerife, Spain; [Koundrioukoff, S.; Debatisse, M.] Inst Curie, Ctr Rech, CNRS, UMR 3244, Paris 05, France; [Koundrioukoff, S.; Debatisse, M.] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Koundrioukoff, S.; Debatisse, M.] CNRS, UMR 3244, Paris, France; [Kim, D.; Smolka, M. B.] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Gillespie, D. A.] Univ La Laguna, Fac Med, Ctr Invest Biomed Canarias, Inst Tecnol Biomed, Campus Ciencias Salud, San Cristobal la Laguna, Tenerife, Spain	Universidad de la Laguna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Cornell University; Universidad de la Laguna	Freire, R (corresponding author), Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Ofra S-N, San Cristobal la Laguna, Tenerife, Spain.; Gillespie, DA (corresponding author), Univ La Laguna, Hosp Univ Canarias, Unidad Invest, Inst Tecnol Biomed, San Cristobal la Laguna 38320, Tenerife, Spain.	rfreire@ull.es; dgillesp@ull.es	Gillespie, David/R-4771-2019; Freire, Raimundo/Q-7660-2019; Cabrera, Elisa/GPX-3455-2022	Gillespie, David/0000-0002-6338-0544; Freire, Raimundo/0000-0003-4473-8894; 	Spanish Ministry of Economy and Competitiveness [SAF2013-49149-R, BFU2014-51672-REDC]; Fundacion CajaCanarias [AP2015/008]; IMBRAIN Project - EU FP7 [FP7-REGPOT-2012-CT2012-31637-IMBRAIN]; Gobierno de Canarias; World Wide Cancer Research (WWCR) [12-0149]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion CajaCanarias; IMBRAIN Project - EU FP7; Gobierno de Canarias; World Wide Cancer Research (WWCR)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2013-49149-R, BFU2014-51672-REDC to RF) and Fundacion CajaCanarias (AP2015/008 to RF), the IMBRAIN Project (FP7-REGPOT-2012-CT2012-31637-IMBRAIN to DAG) funded by EU FP7 and Gobierno de Canarias, and World Wide Cancer Research (WWCR; Project grant no. 12-0149 to DAG).	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bianco JN, 2012, METHODS, V57, P149, DOI 10.1016/j.ymeth.2012.04.007; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Labit H, 2008, BIOTECHNIQUES, V45, P649, DOI 10.2144/000113002; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Maly DJ, 2014, NAT CHEM BIOL, V10, P892, DOI 10.1038/nchembio.1664; Malzer E, 2010, J CELL SCI, V123, P2892, DOI 10.1242/jcs.070078; Mann MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047931; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Palam LR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.264; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Pytel D, 2016, ONCOGENE, V35, P1207, DOI 10.1038/onc.2015.178; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200	31	45	46	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					678	686		10.1038/onc.2016.239	http://dx.doi.org/10.1038/onc.2016.239			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27375025				2022-12-26	WOS:000394167700009
J	Bausewein, D; Engel, J; Jank, T; Schoedl, M; Strahl, S				Bausewein, Daniela; Engel, Jakob; Jank, Thomas; Schoedl, Maria; Strahl, Sabine			Functional Similarities between the Protein O-Mannosyltransferases Pmt4 from Bakers' Yeast and Human POMT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mutation; glycosylation; glycosyltransferase; human; yeast; dystroglycanopathy; O-mannosylation; PMT4; POMT1	WALKER-WARBURG-SYNDROME; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MANNOSE GLYCOPROTEOME; MUSCULAR-DYSTROPHY; MENTAL-RETARDATION; ENZYMATIC-ACTIVITY; GENE FAMILY; MANNOSYLATION; GLYCOSYLATION	Protein O-mannosylation is an essential post-translational modification. It is initiated in the endoplasmic reticulum by a family of protein O-mannosyltransferases that are conserved from yeast (PMTs) to human (POMTs). The degree of functional conservation between yeast and human protein O-mannosyltransferases is uncharacterized. In bakers' yeast, the main in vivo activities are due to heteromeric Pmt1-Pmt2 and homomeric Pmt4 complexes. Here we describe an enzymatic assay that allowed us to monitor Pmt4 activity in vitro. We demonstrate that detergent requirements and acceptor substrates of yeast Pmt4 are different from Pmt1-Pmt2, but resemble that of human POMTs. Furthermore, we mimicked two POMT1 amino acid exchanges (G76R and V428D) that result in severe congenital muscular dystrophies in humans, in yeast Pmt4 (I112R and I435D). In vivo and in vitro analyses showed that general features such as protein stability of the Pmt4 variants were not significantly affected, however, the mutants proved largely enzymatically inactive. Our results demonstrate functional and biochemical similarities between POMT1 and its orthologue from bakers' yeast Pmt4.	[Bausewein, Daniela; Engel, Jakob; Jank, Thomas; Schoedl, Maria; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies, Cell Chem, Neuenheimer Feld 360, D-69120 Heidelberg, Germany; [Engel, Jakob] Boehringer Ingelheim GmbH & Co KG, Lab Analyt Dev, D-88400 Biberach, Germany; [Jank, Thomas] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Schoedl, Maria] Roche Diagnost GmbH, Dept Med & Sci Affairs, D-82377 Penzberg, Germany	Ruprecht Karls University Heidelberg; Boehringer Ingelheim; University of Freiburg; Roche Holding	Strahl, S (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Cell Chem, Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Jank, Thomas/R-9627-2017		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 638, project A18. The authors declare that they have no conflicts of interest with the contents of this article.	Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; BABCZINSKI P, 1973, BIOCHEM BIOPH RES CO, V54, P1119, DOI 10.1016/0006-291X(73)90808-5; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Beltran-Valero D, 2002, AM J HUM GENET, V71, P165; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Ecker M, 2003, EMBO REP, V4, P628, DOI 10.1038/sj.embor.embor864; GENTZSCH M, 1995, GLYCOBIOLOGY, V5, P77, DOI 10.1093/glycob/5.1.77; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; IMMERVOLL T, 1995, YEAST, V11, P1345, DOI 10.1002/yea.320111403; Judas M, 2009, NEUROPEDIATRICS, V40, P6, DOI 10.1055/s-0029-1224099; Loibl M, 2014, J BIOL CHEM, V289, P8599, DOI 10.1074/jbc.M113.543116; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2010, NEUROLOGY, V74, P157, DOI 10.1212/WNL.0b013e3181c919d6; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2010, METHOD ENZYMOL, V479, P323, DOI 10.1016/S0076-6879(10)79018-2; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schott A, 2010, J BIOL CHEM, V285, P18113, DOI 10.1074/jbc.M110.117176; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; Van Reeuwijk J, 2006, HUM MUTAT, V27, P453, DOI 10.1002/humu.20313; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Xu CC, 2015, SEMIN CELL DEV BIOL, V41, P129, DOI 10.1016/j.semcdb.2015.01.014; Yang HP, 2016, J HUM GENET, V61, P753, DOI 10.1038/jhg.2016.42	47	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18006	18015		10.1074/jbc.M116.739128	http://dx.doi.org/10.1074/jbc.M116.739128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358400	hybrid, Green Published			2022-12-26	WOS:000383241300042
J	Byrd, AK; Zybailov, BL; Maddukuri, L; Gao, J; Marecki, JC; Jaiswal, M; Bell, MR; Griffin, WC; Reed, MR; Chib, S; Mackintosh, SG; MacNicol, AM; Baldini, G; Eoff, RL; Raney, KD				Byrd, Alicia K.; Zybailov, Boris L.; Maddukuri, Leena; Gao, Jun; Marecki, John C.; Jaiswal, Mihir; Bell, Matthew R.; Griffin, Wezley C.; Reed, Megan R.; Chib, Shubeena; Mackintosh, Samuel G.; MacNicol, Angus M.; Baldini, Giulia; Eoff, Robert L.; Raney, Kevin D.			Evidence That G-quadruplex DNA Accumulates in the Cytoplasm and Participates in Stress Granule Assembly in Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; G-quadruplex; oxidative stress; signaling; stress granule; stress response; telomere	RNA HELICASE RHAU; TELOMERASE REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; RESOLVASE 1; TETRAMOLECULAR QUADRUPLEX; DELETION BREAKPOINTS; SHORTENS TELOMERES; PROTEOMIC ANALYSIS	Cells engage numerous signaling pathways in response to oxidative stress that together repair macromolecular damage or direct the cell toward apoptosis. As a result of DNA damage, mitochondrial DNA or nuclear DNA has been shown to enter the cytoplasm where it binds to DNA sensors, which in turn initiate signaling cascades. Here we report data that support a novel signaling pathway in response to oxidative stress mediated by specific guanine-rich sequences that can fold into G-quadruplex DNA (G4DNA). In response to oxidative stress, we demonstrate that sequences capable of forming G4DNA appear at increasing levels in the cytoplasm and participate in assembly of stress granules. Identified proteins that bind to endogenous G4DNA in the cytoplasm are known to modulate mRNA translation and participate in stress granule formation. Consistent with these findings, stress granule formation is known to regulate mRNA translation during oxidative stress. We propose a signaling pathway whereby cells can rapidly respond to DNA damage caused by oxidative stress. Guanine-rich sequences that are excised from damaged genomic DNA are proposed to enter the cytoplasm where they can regulate translation through stress granule formation. This newly proposed role for G4DNA provides an additional molecular explanation for why such sequences are prevalent in the human genome.	[Byrd, Alicia K.; Zybailov, Boris L.; Maddukuri, Leena; Gao, Jun; Marecki, John C.; Bell, Matthew R.; Griffin, Wezley C.; Reed, Megan R.; Chib, Shubeena; Mackintosh, Samuel G.; Baldini, Giulia; Eoff, Robert L.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA; [Mackintosh, Samuel G.; MacNicol, Angus M.; Eoff, Robert L.; Raney, Kevin D.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Zybailov, Boris L.; Jaiswal, Mihir] Univ Arkansas, Univ Arkansas Little Rock Univ Arkansas Med Sci U, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	RaneyKevinD@uams.edu		Zybailov, Boris/0000-0003-2432-9145; Byrd, Alicia/0000-0001-5484-0759; Reed, Megan/0000-0001-5086-7938; Bell, Matthew/0000-0003-4313-2989	Arkansas IDeA Network for Biomedical Research Excellence (National Institutes of Health) [P20GM103429]; University of Arkansas Center for Protein Structure and Function (National Institutes of Health) [P30GM103450]; UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses (National Institutes of Health) [P20GM103625]; UAMS Translational Research Institute (National Institutes of Health) [UL1TR000039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD082793, R01HD087057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098922, P20GM103625, R01GM117439, P20GM103429, P30GM110702, P30GM103450] Funding Source: NIH RePORTER	Arkansas IDeA Network for Biomedical Research Excellence (National Institutes of Health); University of Arkansas Center for Protein Structure and Function (National Institutes of Health); UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS Translational Research Institute (National Institutes of Health); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Arkansas for Medical Sciences (UAMS) Proteomics Core is supported by the Arkansas IDeA Network for Biomedical Research Excellence (National Institutes of Health Grant P20GM103429), the University of Arkansas Center for Protein Structure and Function (National Institutes of Health Grant P30GM103450), the UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses (National Institutes of Health Grant P20GM103625), and the UAMS Translational Research Institute (National Institutes of Health Grant UL1TR000039). We thank Shankar Balasubramanian, University of Cambridge, for the gift of the pSANG10-3F-BG4 plasmid encoding the BG4 single chain antibody. Monoclonal antibody 1H6 was kindly provided by Peter Lansdorp, European Research Institute for the Biology of Aging, University of Groningen. We thank Timothy Chambers for helpful discussions and Andrea Edwards for technical assistance.	An N, 2016, ACS CHEM BIOL, V11, P500, DOI 10.1021/acschembio.5b00844; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Benson BK, 2008, PROTEIN SCI, V17, P34, DOI 10.1110/ps.073186408; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen QM, 2000, J CELL SCI, V113, P4087; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202; Fleming AM, 2013, CHEM RES TOXICOL, V26, P593, DOI 10.1021/tx400028y; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Gao J, 2015, CHEM COMMUN, V51, P7242, DOI 10.1039/c5cc00742a; Nguyen GH, 2014, P NATL ACAD SCI USA, V111, P9905, DOI 10.1073/pnas.1404807111; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hatzakis E, 2010, BIOCHEMISTRY-US, V49, P9152, DOI 10.1021/bi100946g; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Islam MA, 2014, J BIOL CHEM, V289, P8521, DOI 10.1074/jbc.M113.505073; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jing NJ, 2006, MOL CANCER THER, V5, P279, DOI 10.1158/1535-7163.MCT-05-0302; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kaminski JJ, 2013, J IMMUNOL, V191, P3876, DOI 10.4049/jimmunol.1300530; Kawane K, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016394; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lemos H, 2014, J IMMUNOL, V192, P5571, DOI 10.4049/jimmunol.1303258; Leung CH, 2011, ANAL CHEM, V83, P463, DOI 10.1021/ac1025896; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Ming X, 2014, J AM CHEM SOC, V136, P4223, DOI 10.1021/ja411636j; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; PHILLIPS LL, 1956, SCIENCE, V124, P889, DOI 10.1126/science.124.3227.889; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shih JW, 2014, CLIN CHIM ACTA, V436, P45, DOI 10.1016/j.cca.2014.05.003; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Vasilyev N, 2015, P NATL ACAD SCI USA, V112, pE5391, DOI 10.1073/pnas.1515737112; Vatovec S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.015; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802; Waris S, 2014, INT J MOL SCI, V15, P23377, DOI 10.3390/ijms151223377; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Xiao S, 2014, ANGEW CHEM INT EDIT, V53, P13110, DOI 10.1002/anie.201407045; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhou J, 2015, NUCLEIC ACIDS RES, V43, P4039, DOI 10.1093/nar/gkv252; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Zybailov B, 2009, MOL CELL PROTEOMICS, V8, P1789, DOI 10.1074/mcp.M900104-MCP200	113	51	51	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18041	18057		10.1074/jbc.M116.718478	http://dx.doi.org/10.1074/jbc.M116.718478			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27369081	Green Published, hybrid			2022-12-26	WOS:000383241300045
J	Harsman, A; Schock, A; Hemmis, B; Wahl, V; Jeshen, I; Bartsch, P; Schlereth, A; Pertl-Obermeyer, H; Goetze, TA; Soll, J; Philippar, K; Wagner, R				Harsman, Anke; Schock, Annette; Hemmis, Birgit; Wahl, Vanessa; Jeshen, Ingrid; Bartsch, Philipp; Schlereth, Armin; Pertl-Obermeyer, Heidi; Goetze, Tom Alexander; Soll, Juergen; Philippar, Katrin; Wagner, Richard			OEP40, a Regulated Glucose-permeable -Barrel Solute Channel in the Chloroplast Outer Envelope Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; glucose transport; ion channel; membrane transport; outer membrane; beta-barrel protein; metabolite transport; solute channel	TREHALOSE 6-PHOSPHATE; SECONDARY STRUCTURE; STARCH DEGRADATION; DYNAMIC INTERFACE; COLD-ACCLIMATION; ARABIDOPSIS; METABOLISM; PREDICTION; TRANSCRIPTOME; TRANSPORTERS	Chloroplasts and mitochondria are unique endosymbiotic cellular organelles surrounded by two membranes. Essential metabolic networking between these compartments and their hosting cells requires the exchange of a large number of biochemical pathway intermediates in a directed and coordinated fashion across their inner and outer envelope membranes. Here, we describe the identification and functional characterization of a highly specific, regulated solute channel in the outer envelope of chloroplasts, named OEP40. Loss of OEP40 function in Arabidopsis thaliana results in early flowering under cold temperature. The reconstituted recombinant OEP40 protein forms a high conductance -barrel ion channel with subconductant states in planar lipid bilayers. The OEP40 channel is slightly cation-selective PK+/PCl- approximate to 4:1 and rectifying (i?/i? 2) with a slope conductance of G(max) 690 picosiemens. The OEP40 channel has a restriction zone diameter of 1.4 nm and is permeable for glucose, glucose 1-phosphate and glucose 6-phosphate, but not for maltose. Moreover, channel properties are regulated by trehalose 6-phosphate, which cannot permeate. Altogether, our results indicate that OEP40 is a glucose-gate in the outer envelope membrane of chloroplasts, facilitating selective metabolite exchange between chloroplasts and the surrounding cell.	[Harsman, Anke; Hemmis, Birgit; Bartsch, Philipp; Wagner, Richard] Univ Osnabruck, Inst Biophys, Dept Biol, Barbarastr 13, D-49076 Osnabruck, Germany; [Schock, Annette; Jeshen, Ingrid; Pertl-Obermeyer, Heidi; Goetze, Tom Alexander; Soll, Juergen; Philippar, Katrin] Univ Munich, Chair Plant Biochem & Physiol, Dept Biol Bot 1, Grosshadernerstr 2-4, D-82152 Planegg Martinsried, Germany; [Schock, Annette; Jeshen, Ingrid; Pertl-Obermeyer, Heidi; Goetze, Tom Alexander; Soll, Juergen; Philippar, Katrin] Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Wahl, Vanessa; Schlereth, Armin] Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Muhlenberg 1, D-14476 Potsdam, Germany	University Osnabruck; University of Munich; University of Munich; Max Planck Society	Philippar, K (corresponding author), Univ Munich, Dept Biol Bot 1, Grosshadernerstr 2-4, D-82152 Planegg Martinsried, Germany.; Wagner, R (corresponding author), Jacobs Univ Bremen gGmbH, Inst Biophys Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany.	philippar@lmu.de; ri.wagner@jacobs-university.de	Pertl-Obermeyer, Heidi/I-5849-2015; Philippar, Katrin/F-7942-2018; Wahl, Vanessa/ABC-3341-2020	Pertl-Obermeyer, Heidi/0000-0001-9180-5995; Wahl, Vanessa/0000-0001-7421-8801; Philippar, Katrin/0000-0002-2140-4907	Heisenberg Fellowship of the Deutsche Forschungsgemeinschaft [PH73/6-1]	Heisenberg Fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by a Heisenberg Fellowship PH73/6-1 of the Deutsche Forschungsgemeinschaft.	Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Blumel M, 2015, CURR OPIN BIOTECH, V32, P121, DOI 10.1016/j.copbio.2014.11.023; Bolter B, 1999, EMBO J, V18, P5505, DOI 10.1093/emboj/18.20.5505; Bolter B, 2001, EMBO J, V20, P935, DOI 10.1093/emboj/20.5.935; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Breuers FKH, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00097; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Capovilla G, 2015, J EXP BOT, V66, P59, DOI 10.1093/jxb/eru416; Carillo P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-21; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Duy D, 2007, BIOL CHEM, V388, P879, DOI 10.1515/BC.2007.120; Duy D, 2007, PLANT CELL, V19, P986, DOI 10.1105/tpc.106.047407; Fellerer C, 2011, MOL PLANT, V4, P1133, DOI 10.1093/mp/ssr037; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Figueroa CM, 2016, PLANT J, V85, P410, DOI 10.1111/tpj.13114; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Goetze TA, 2006, J BIOL CHEM, V281, P17989, DOI 10.1074/jbc.M600700200; Harsman A, 2011, EUR J CELL BIOL, V90, P721, DOI 10.1016/j.ejcb.2011.04.012; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Kammerer B, 1998, PLANT CELL, V10, P105, DOI 10.1105/tpc.10.1.105; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Klemens PAW, 2014, NEW PHYTOL, V202, P188, DOI 10.1111/nph.12642; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Nagele T, 2013, NEW PHYTOL, V198, P777, DOI 10.1111/nph.12201; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Nunes C, 2013, PLANT PHYSIOL, V162, P1720, DOI 10.1104/pp.113.220657; PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philippar K, 2007, PLANT SOLUTE TRANSPO, P133, DOI DOI 10.1002/9780470988862.CH7; Philippar K, 2007, P NATL ACAD SCI USA, V104, P678, DOI 10.1073/pnas.0610062104; Pohlmeyer K, 1998, PLANT CELL, V10, P1207, DOI 10.1105/tpc.10.7.1207; Pudelski B, 2012, J EXP BOT, V63, P1919, DOI 10.1093/jxb/err375; Purdy SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079412; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Roussel G, 2013, BIOTECHNOL BIOENG, V110, P417, DOI 10.1002/bit.24722; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; Schmedt D, 2010, THESIS; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Siriwardana NS, 2012, INT J DEV BIOL, V56, P207, DOI 10.1387/ijdb.113450ns; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Tsai AYL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00119; WAEGEMANN K, 1992, PLANTA, V187, P89, DOI 10.1007/BF00201628; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiese A, 1999, FEBS LETT, V461, P13, DOI 10.1016/S0014-5793(99)01417-9; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yu S, 2013, ELIFE, V2, DOI 10.7554/eLife.00269; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17848	17860		10.1074/jbc.M115.712398	http://dx.doi.org/10.1074/jbc.M115.712398			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339897	Green Published, hybrid			2022-12-26	WOS:000383241300030
J	Katuwal, HB; Basnet, K; Khanal, B; Devkota, S; Rai, SK; Gajurel, JP; Scheidegger, C; Nobis, MP				Katuwal, Hem Bahadur; Basnet, Khadga; Khanal, Bhaiya; Devkota, Shiva; Rai, Sanjeev Kumar; Gajurel, Jyoti Prasad; Scheidegger, Christoph; Nobis, Michael P.			Seasonal Changes in Bird Species and Feeding Guilds along Elevational Gradients of the Central Himalayas, Nepal	PLOS ONE			English	Article							LAND-USE; CLIMATE-CHANGE; TEMPORAL VARIATION; COSTA-RICA; RICHNESS; DIVERSITY; ALTITUDE; HABITAT; FOREST; DISTRIBUTIONS	The Himalayas are a global hotspot for bird diversity with a large number of threatened species, but little is known about seasonal changes in bird communities along elevational gradients in this region. We studied the seasonality of bird diversity in six valleys of the Central Himalayas, Nepal. Using 318 plots with a 50 m radius, located from 2200 to 3800 m a.s.l., and repeated sampling during different seasons (mainly pre-monsoon, monsoon, and post-monsoon), we analyzed 3642 occurrences of 178 species. Birds classified in the literature as resident were more species-rich than migratory birds (140 vs. 38 species). In all six valleys and within the studied elevation range, species richness of all birds showed a peak at mid-elevation levels of 2600 or 3000 m a.s.l. Similar patterns were found for the most species-rich feeding guilds of insectivores (96 species) and omnivores (24 species), whereas the species richness of herbivores (37 species including frugivores) increased towards higher elevations. Among these feeding guilds, only species richness of insectivores showed pronounced seasonal changes with higher species numbers during post-monsoon season. Similarly, individual bird species showed distinct spatio-temporal distribution patterns, with transitions from species dominated by elevational differences to those characterized by strong seasonal changes. In an era of climate change, the results demonstrate that individual bird species as well as feeding guilds might greatly differ in their responses to climate warming and changes in the seasonality of the precipitation regime, two aspects of climate change which should not be analyzed independently.	[Katuwal, Hem Bahadur; Basnet, Khadga] Tribhuvan Univ, Cent Dept Zool, Kathmandu, Nepal; [Katuwal, Hem Bahadur] Small Mammals Conservat & Res Fdn, Kathmandu, Nepal; [Khanal, Bhaiya] Tribhuvan Univ, Nat Hist Museum, Kathmandu, Nepal; [Devkota, Shiva; Rai, Sanjeev Kumar; Gajurel, Jyoti Prasad] Tribhuvan Univ, Cent Dept Bot, Kathmandu, Nepal; [Devkota, Shiva; Rai, Sanjeev Kumar; Gajurel, Jyoti Prasad; Scheidegger, Christoph; Nobis, Michael P.] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Tribhuvan University; Tribhuvan University; Tribhuvan University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Katuwal, HB (corresponding author), Tribhuvan Univ, Cent Dept Zool, Kathmandu, Nepal.; Katuwal, HB (corresponding author), Small Mammals Conservat & Res Fdn, Kathmandu, Nepal.; Nobis, MP (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	hello2hemu@gmail.com; michael.nobis@wsl.ch	Devkota, Shiva/C-5761-2019; Devkota, Shiva/X-3824-2019; Nobis, Michael P/F-6176-2010; Scheidegger, Christoph/C-6547-2011; Katuwal, Hem Bahadur/R-7895-2019	Devkota, Shiva/0000-0002-5290-1113; Scheidegger, Christoph/0000-0003-3713-5331; Katuwal, Hem Bahadur/0000-0001-6792-1363; Nobis, Michael/0000-0003-3285-1590	Swiss National Science Foundation [JRP IZ70Z0_131338/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant JRP IZ70Z0_131338/1 to Christoph Scheidegger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; [Anonymous], 2004, HOTSPOTS REVISITED E; Basnet TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150498; Becker A, 2007, MT RES DEV, V27, P58, DOI 10.1659/0276-4741(2007)27[58:EALUSA]2.0.CO;2; Bertuzzo E, 2016, P NATL ACAD SCI USA, V113, P1737, DOI 10.1073/pnas.1518922113; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Bonebrake TC, 2010, P NATL ACAD SCI USA, V107, P12581, DOI 10.1073/pnas.0911841107; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brooks Daniel M., 1997, Hornero, V14, P193; Chamberlain DE, 2013, BIOL CONSERV, V167, P127, DOI 10.1016/j.biocon.2013.07.036; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Ding TS, 2005, GLOBAL ECOL BIOGEOGR, V14, P299, DOI 10.1111/j.1466-822x.2005.00159.x; Ferger SW, 2014, GLOBAL ECOL BIOGEOGR, V23, P541, DOI 10.1111/geb.12151; Fleming RL Sr, 1984, BIRDS OF NEPAL, V3rd; Flousek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139465; Grimmett R, 2000, BIRDS NEPAL HELM FIE; Grimmett R, 2011, BIRDS INDIAN SUBCONT; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Hagen T., 1969, DENCKSCHRIFT DESSCHW, V86, P1; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; Herzog SK, 2003, WILSON BULL, V115, P438, DOI 10.1676/03-048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howard C, 2015, GLOBAL ECOL BIOGEOGR, V24, P1249, DOI 10.1111/geb.12377; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; INSKIPP C, 1989, INT COUNCIL BIRD PRE, V4; Inskipp C., 2005, IMPORTANT BIRD AREAS; Inskipp Carol, 2013, Journal of Threatened Taxa, V5, P3473; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Katuwal Hem Bahadur, 2013, Asian Journal of Conservation Biology, V2, P21; Kessler Michael, 2001, Diversity and Distributions, V7, P61, DOI 10.1046/j.1472-4642.2001.00097.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Laiolo P, 2004, BIOL CONSERV, V115, P251, DOI 10.1016/S0006-3207(03)00145-9; Lee PF, 2004, J BIOGEOGR, V31, P307, DOI 10.1046/j.0305-0270.2003.00988.x; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Maggini R, 2011, ECOL MODEL, V222, P21, DOI 10.1016/j.ecolmodel.2010.09.010; Manandhar MS, 1999, NEPAL NATURES PARADI; Manel S, 2000, J APPL ECOL, V37, P756, DOI 10.1046/j.1365-2664.2000.00537.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Miller-Rushing AJ, 2008, AUK, V125, P565, DOI 10.1525/auk.2008.07005; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Paudel PK, 2014, GLOB ECOL CONSERV, V2, P338, DOI 10.1016/j.gecco.2014.10.012; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Petit LJ, 1999, ECOGRAPHY, V22, P292, DOI 10.1111/j.1600-0587.1999.tb00505.x; de Bonilla EPD, 2012, J TROP ECOL, V28, P369, DOI 10.1017/S026646741200034X; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Renner Swen C., 2011, Ornithological Monographs, V70, P1; Renner SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053121; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Scheidegger C., 2010, BOT ORIENTALIS, V7, P7; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Shiu Hau-Jie, 2003, Acta Zoologica Taiwanica, V14, P1; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x; Wu YJ, 2013, J BIOGEOGR, V40, P2310, DOI 10.1111/jbi.12177	71	29	34	3	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158362	10.1371/journal.pone.0158362	http://dx.doi.org/10.1371/journal.pone.0158362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367903	Green Published, Green Submitted, gold			2022-12-26	WOS:000378914900031
J	Okello, S; Nasasira, B; Muiru, ANW; Muyingo, A				Okello, Samson; Nasasira, Benson; Muiru, Anthony Ndichu Wa; Muyingo, Anthony			Validity and Reliability of a Self-Reported Measure of Antihypertensive Medication Adherence in Uganda	PLOS ONE			English	Article							CARDIOVASCULAR RISK; PREDICTIVE-VALIDITY; HYPERTENSION; POPULATION; HEALTH; SCALE; CARE; SERVICES; VERSION; INCOME	Background The Morisky Medication Adherence scale (MMAS-8) is a widely used self-reported measure of adherence to antihypertensive medications that has not been validated in hypertensive patients in sub-Saharan Africa. Methods We carried out a cross-sectional study to examine psychometric properties of a translated MMAS-8 (MMAS-U) in a tertiary care hypertension clinic in Uganda. We administered the MMAS-U to consecutively selected hypertensive adults and used principal factor analysis and Cronbach's alpha to determine its validity and internal consistency respectively. Then we randomly selected one-sixth of participants for a 2-week test-retest telephone interview. Lastly, we used ordinal logistic regression modeling to explore factors associated with levels of medication adherence. Results Of the 329 participants, 228 (69%) were females, median age of 55 years [Interquartile range (IQR) (46-66)], and median duration of hypertension of 4 years [IQR (2-8)]. The adherence levels were low (MMAS-U score <= 5) in 85%, moderate (MMAS-U score 6-7) in 12% and high (MMAS-U score >= 8) in 3%. The factor analysis of construct validity was good (overall Kaiser's measure of sampling adequacy for residuals of 0.72) and identified unidimensionality of MMAS-U. The internal consistency of MMAS-U was moderate (Cronbach alpha = 0.65), and test-retest reliability was low (weighted kappa = 0.36; 95% CI -0.01, 0.73). Age of 40 years or greater was associated with low medication adherence (p = 0.02) whereas a family member buying medication for participants (p = 0.02) and purchasing medication from a private clinic (p = 0.02) were associated with high adherence. Conclusion The Ugandan version of the MMAS-8 (MMAS-U) is a valid and reliable measure of adherence to antihypertensive medication among Ugandan outpatients receiving care at a public tertiary facility. Though the limited supply of medication affected adherence, this easy to use tool can be adapted to assess medication adherence among adults with hypertension in Uganda.	[Okello, Samson; Nasasira, Benson; Muyingo, Anthony] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Okello, Samson; Muiru, Anthony Ndichu Wa] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Muiru, Anthony Ndichu Wa] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Mbarara University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Okello, S (corresponding author), Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda.; Okello, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	okello.samson@must.ac.ug	Okello, Samson/I-1877-2019	Okello, Samson/0000-0001-7377-6094	Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. School of Public Health, Boston, MA, USA	Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. School of Public Health, Boston, MA, USA	Author SO receives support from the Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. School of Public Health, Boston, MA, USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; [Anonymous], 2011, MAYO CLIN P; [Anonymous], PRACT ASSESS RES EVA; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Oliveira AD, 2014, RES SOC ADMIN PHARM, V10, P554, DOI 10.1016/j.sapharm.2013.10.006; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Gould E, 2010, GERIATR NURS, V31, P290, DOI 10.1016/j.gerinurse.2010.05.004; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Johnson M J, 1999, Clin Nurs Res, V8, P318, DOI 10.1177/10547739922158331; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Koning A. J., 2003, CONFIDENCE INTERVALS; Korb-Savoldelli V, 2012, J CLIN HYPERTENS, V14, P429, DOI 10.1111/j.1751-7176.2012.00634.x; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Krousel-Wood M, 2005, CURR OPIN CARDIOL, V20, P296, DOI 10.1097/01.hco.0000166597.52335.23; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Lavsa SM, 2011, J AM PHARM ASSOC, V51, P90, DOI 10.1331/JAPhA.2011.09154; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Moharamzad Y, 2015, GLOBAL J HLTH SCI, V7, pp173; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Norman S, 1984, AM J PREV MED, V1, P10; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Sakthong P, 2009, ANN PHARMACOTHER, V43, P950, DOI 10.1345/aph.1L453; Sankar UV, 2013, ASIA PACIFIC J PUBLI; SHEA S, 1992, AM J PUBLIC HEALTH, V82, P1607, DOI 10.2105/AJPH.82.12.1607; Streiner DL, 2008, REPORTING TEST RESUL, P373, DOI [10.1093/acprof:oso/, DOI 10.1093/ACPROF:OSO/]; Streiner DL, 2014, HLTH MEASUREMENT SCA; Taira DA, 2006, AM J MANAG CARE, V12, P678; Toll BA, 2007, NICOTINE TOB RES, V9, P597, DOI 10.1080/14622200701239662; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d	36	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158499	10.1371/journal.pone.0158499	http://dx.doi.org/10.1371/journal.pone.0158499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367542	Green Published, gold			2022-12-26	WOS:000378914900037
J	Rowley, MI; Coolen, ACC; Vojnovic, B; Barber, PR				Rowley, Mark I.; Coolen, Anthonius C. C.; Vojnovic, Borivoj; Barber, Paul R.			Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GLOBAL ANALYSIS; MICROSCOPY; FRET; CELLS; ACTIVATION; PARAMETERS; MOLECULES	We present novel Bayesian methods for the analysis of exponential decay data that exploit the evidence carried by every detected decay event and enables robust extension to advanced processing. Our algorithms are presented in the context of fluorescence lifetime imaging microscopy (FLIM) and particular attention has been paid to model the time-domain system (based on time-correlated single photon counting) with unprecedented accuracy. We present estimates of decay parameters for mono- and bi-exponential systems, offering up to a factor of two improvement in accuracy compared to previous popular techniques. Results of the analysis of synthetic and experimental data are presented, and areas where the superior precision of our techniques can be exploited in Forster Resonance Energy Transfer (FRET) experiments are described. Furthermore, we demonstrate two advanced processing methods: decay model selection to choose between differing models such as mono- and bi-exponential, and the simultaneous estimation of instrument and decay parameters.	[Rowley, Mark I.; Coolen, Anthonius C. C.; Barber, Paul R.] Kings Coll London, Inst Math & Mol Biomed, London, England; [Vojnovic, Borivoj; Barber, Paul R.] Univ Oxford, Dept Oncol, Canc Res UK & Med Res Council, Oxford Inst Radiat Oncol, Oxford, England	University of London; King's College London; Cancer Research UK; University of Oxford	Rowley, MI (corresponding author), Kings Coll London, Inst Math & Mol Biomed, London, England.	mark.rowley@kcl.ac.uk	Vojnovic, Borivoj/AAV-4756-2021; LARIJANI, Professor Banafshe/H-3909-2015	Vojnovic, Borivoj/0000-0001-9013-3816; Barber, Paul/0000-0002-8595-1141; LARIJANI, Professor Banafshe/0000-0003-4735-1169	Cancer Research UK [C133/A/1812]; Engineering and Physical Sciences Research Council [EP/C546105/1, EP/C546113/1]; Cancer Research UK [15677] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E032400/1] Funding Source: researchfish; Medical Research Council [MC_PC_15031] Funding Source: researchfish; EPSRC [EP/E032400/1, EP/C546113/1] Funding Source: UKRI; MRC [MC_PC_15031] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK (www.cancerresearchuk.org), Programme grant C133/A/1812: BV, and Engineering and Physical Sciences Research Council (www.epsrc.ac.uk), EP/C546105/1 and EP/C546113/1: BV ACCC.	Ameer-Beg SM, 2005, PROC SPIE, V5700, P152, DOI 10.1117/12.589202; BAJZER Z, 1991, EUR BIOPHYS J BIOPHY, V20, P247, DOI 10.1007/BF00450560; Barber PR, 2013, J MICROSC-OXFORD, V251, P154, DOI 10.1111/jmi.12057; Barber PR, 2010, BIOMED OPT EXPRESS, V1, P1148, DOI 10.1364/BOE.1.001148; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Barber PR, 2015, SLIM CURVE AN OPEN S; Becker W., 2008, THE BH TCSPC HANDBOO; Bhandari A, 2015, OPTICA, V2, P965, DOI 10.1364/OPTICA.2.000965; Bishop CM, 1995, NEURAL NETWORKS PATT; Cheng PC, 2006, THE HANDBOOK OF BIOL, P162; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabir AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103342; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Esposito A, 2012, REMOTE SENS-BASEL, V4, P111, DOI 10.3390/rs4010111; Flannery B. P., 1992, NUMERICAL RECIPES IN; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gerritsen HC, 2002, J MICROSC-OXFORD, V206, P218, DOI 10.1046/j.1365-2818.2002.01031.x; Grecco HE, 2009, OPT EXPRESS, V17, P6493, DOI 10.1364/OE.17.006493; HALL P, 1981, J PHYS CHEM-US, V85, P2941, DOI 10.1021/j150620a019; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jo JA, 2005, IEEE J SEL TOP QUANT, V11, P835, DOI 10.1109/JSTQE.2005.857685; LAKOWICZ JR, 1992, ANAL BIOCHEM, V202, P316, DOI 10.1016/0003-2697(92)90112-K; Lakowicz JR., 1983, PRINCIPLES OF FLUORE; Laurence TA, 2010, NAT METHODS, V7, P338, DOI 10.1038/nmeth0510-338; Lenz MO, 2011, P SOC PHOTO-OPT INS, V7903; Leung RWK, 2011, BIOMED OPT EXPRESS, V2, P2517, DOI 10.1364/BOE.2.002517; Levine Y., 1997, J FLUORESC, V7, P11, DOI DOI 10.1007/BF02764572; Makrogianneli K, 2009, MOL CELL BIOL, V29, P2997, DOI 10.1128/MCB.01008-08; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Nishimura G, 2005, PHYS MED BIOL, V50, P1327, DOI 10.1088/0031-9155/50/6/019; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pawley J., 2006, HANDBOOK OF BIOLOGIC; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; PLOEM JS, 1987, APPL OPTICS, V26, P3226, DOI 10.1364/AO.26.003226; Rowley MI, 2011, PROC SPIE, V7903, DOI 10.1117/12.873890; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; TELLINGHUISEN J, 1993, ANAL CHEM, V65, P1240, DOI 10.1021/ac00057a022; Turton DA, 2003, ANAL CHEM, V75, P4182, DOI 10.1021/ac034325k; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	44	27	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158404	10.1371/journal.pone.0158404	http://dx.doi.org/10.1371/journal.pone.0158404			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355322	Green Published, gold, Green Submitted			2022-12-26	WOS:000378859400061
J	He, XY; Lillemo, M; Shi, JR; Wu, JR; Bjornstad, A; Belova, T; Dreisigacker, S; Duveiller, E; Singh, P				He, Xinyao; Lillemo, Morten; Shi, Jianrong; Wu, Jirong; Bjornstad, Asmund; Belova, Tatiana; Dreisigacker, Susanne; Duveiller, Etienne; Singh, Pawan			QTL Characterization of Fusarium Head Blight Resistance in CIMMYT Bread Wheat Line Soru#1	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; X WANGSHUIBAI POPULATION; DEOXYNIVALENOL ACCUMULATION; ANTHER EXTRUSION; PLANT HEIGHT; IDENTIFICATION; BARLEY; GRAMINEARUM; INFECTION; SELECTION	Fusarium head blight (FHB) resistant line Soru#1 was hybridized with the German cultivar Naxos to generate 131 recombinant inbred lines for QTL mapping. The population was phenotyped for FHB and associated traits in spray inoculated experiments in El Batan (Mexico), spawn inoculated experiments in As (Norway) and point inoculated experiments in Nanjing (China), with two field trials at each location. Genotyping was performed with the Illumina iSelect 90K SNP wheat chip, along with a few SSR and STS markers. A major QTL for FHB after spray and spawn inoculation was detected on 2DLc, explaining 15-22% of the phenotypic variation in different experiments. This QTL remained significant after correction for days to heading (DH) and plant height (PH), while another QTL for FHB detected at the Vrn-A1 locus on 5AL almost disappeared after correction for DH and PH. Minor QTL were detected on chromosomes 2AS, 2DL, 4AL, 4DS and SDL. In point inoculated experiments, QTL on 2DS, 3AS, 4AL and 5AL were identified in single environments. The mechanism of resistance of Soru#1 to FHB was mainly of Type I for resistance to initial infection, conditioned by the major QTL on 2DLc and minor ones that often coincided with QTL for DH, PH and anther extrusion (AE). This indicates that phenological and morphological traits and flowering biology play important roles in resistance/escape of FHB. SNPs tightly linked to resistance QTL, particularly 2DLc, could be utilized in breeding programs to facilitate the transfer and selection of those QTL.	[He, Xinyao; Dreisigacker, Susanne; Duveiller, Etienne; Singh, Pawan] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Edo De Mexico, Mexico; [He, Xinyao; Lillemo, Morten; Bjornstad, Asmund; Belova, Tatiana] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Shi, Jianrong; Wu, Jirong] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Norwegian University of Life Sciences; Jiangsu Academy of Agricultural Sciences	Singh, P (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Edo De Mexico, Mexico.; Lillemo, M (corresponding author), Norwegian Univ Life Sci, Dept Plant Sci, As, Norway.	morten.lillemo@nmbu.no; pk.singh@cgiar.org	SINGH, PAWAN KUMAR/E-3408-2013; Shi, Jianrong/AAQ-3456-2020; Lillemo, Morten/H-9406-2019; Shi, Jianrong/AAQ-1805-2020	SINGH, PAWAN KUMAR/0000-0002-9598-7981; Shi, Jianrong/0000-0003-3818-5074; Lillemo, Morten/0000-0002-8594-8794; shi, jianrong/0000-0001-8650-248X; He, Xinyao/0000-0003-0217-9510; Singh, Pawan/0000-0003-4610-3120	CGIAR Research Program on Wheat; CGIAR scholarship by the Research Council of Norway [208340/H30]	CGIAR Research Program on Wheat(CGIAR); CGIAR scholarship by the Research Council of Norway(CGIAR)	Financial support by the CGIAR Research Program on Wheat is gratefully acknowledged. The first author is grateful for the financial support from a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30 - Breeding for Fusarium resistance in wheat.; Financial support by the CGIAR Research Program on Wheat is gratefully acknowledged. The first author is grateful for the financial support from a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30-Breeding for Fusarium resistance in wheat. The authors also like to thank Yalew Tarkegne and Anne Guri Maroy at As, and Francisco Lopez, Javier Segura and Nerida Lozano at El Batan for technical help.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Belova T, 2014, THEOR APPL GENET, V127, P2029, DOI 10.1007/s00122-014-2358-z; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Buerstmayr H, 2012, CABI PLANT PROT SER, P236, DOI 10.1079/9781845938185.0236; Buerstmayr M, 2015, THEOR APPL GENET, V128, P1519, DOI 10.1007/s00122-015-2527-8; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Chu CG, 2011, THEOR APPL GENET, V123, P1107, DOI 10.1007/s00122-011-1652-2; Diethelm M, 2014, MOL BREEDING, V34, P31, DOI 10.1007/s11032-013-0010-2; Dreisigacker S, 2011, P 21 INT TRIT MAPP I, P105; Duveiller E, 2014, MYCOTOXIN REDUCTION IN GRAIN CHAINS, P220; [EC] European Commission, 2006, OFF J EUR UNION, V364; Emrich K, 2008, THEOR APPL GENET, V117, P65, DOI 10.1007/s00122-008-0753-z; Faris J.D., 2014, GENOMICS PLANT GENET, P439, DOI 10.1007/978-94-007-7572-5_18/TABLES/1; Gervais L, 2003, THEOR APPL GENET, V106, P961, DOI 10.1007/S00122-002-1160-5; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; He XY, 2013, EUR J PLANT PATHOL, V136, P123, DOI 10.1007/s10658-012-0146-7; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Jiang GL, 2007, THEOR APPL GENET, V115, P1043, DOI 10.1007/s00122-007-0630-1; Jiang GL, 2007, THEOR APPL GENET, V116, P3, DOI 10.1007/s00122-007-0641-y; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kubo K, 2013, J PHYTOPATHOL, V161, P308, DOI 10.1111/jph.12060; Lewis JM, 2004, P 2 INT S FUS HEAD B, P89; Lin F, 2006, THEOR APPL GENET, V112, P528, DOI 10.1007/s00122-005-0156-3; Lin F, 2004, THEOR APPL GENET, V109, P1504, DOI 10.1007/s00122-004-1772-z; Liu SY, 2012, CROP SCI, V52, P2283, DOI 10.2135/cropsci2012.03.0144; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Long XY, 2015, PHYSIOL MOL PLANT P, V90, P1, DOI 10.1016/j.pmpp.2015.02.002; Lu QX, 2014, THEOR APPL GENET, V127, P2635, DOI 10.1007/s00122-014-2404-x; Lu QX, 2013, THEOR APPL GENET, V126, P317, DOI 10.1007/s00122-012-1981-9; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Mardi M, 2005, PLANT BREEDING, V124, P329, DOI 10.1111/j.1439-0523.2005.01103.x; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; MILLER JD, 1986, CAN J PLANT PATHOL, V8, P147; Osman M, 2015, EUPHYTICA, V205, P521, DOI 10.1007/s10681-015-1425-0; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Shi JR, 2008, GENETICA, V133, P77, DOI 10.1007/s10709-007-9186-x; Singh, 2013, FUSARIUM HEAD BLIGHT, P241; Skinnes H, 2010, PLANT BREEDING, V129, P149, DOI 10.1111/j.1439-0523.2009.01731.x; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Stack R. W., 1994, VISUAL SCALE ESTIMAT, P1095; Van Ginkel M., 2002, P NAT FUS HEAD BLIGH, P268; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xue S, 2010, THEOR APPL GENET, V121, P147, DOI 10.1007/s00122-010-1298-5; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Zhang QJ, 2014, MOL BREEDING, V34, P1677, DOI 10.1007/s11032-014-0180-6; Zhu ZW, 2016, EUPHYTICA, V208, P367, DOI 10.1007/s10681-015-1612-z	56	18	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158052	10.1371/journal.pone.0158052	http://dx.doi.org/10.1371/journal.pone.0158052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351632	Green Published, gold, Green Accepted			2022-12-26	WOS:000378858900029
J	Lee, SG; Huang, MQ; Obholzer, ND; Sun, S; Li, WY; Petrillo, M; Dai, P; Zhou, Y; Cotanche, DA; Megason, SG; Li, HW; Chen, ZY				Lee, Sang Goo; Huang, Mingqian; Obholzer, Nikolaus D.; Sun, Shan; Li, Wenyan; Petrillo, Marco; Dai, Pu; Zhou, Yi; Cotanche, Douglas A.; Megason, Sean G.; Li, Huawei; Chen, Zheng-Yi			Myc and Fgf Are Required for Zebrafish Neuromast Hair Cell Regeneration	PLOS ONE			English	Article							GROWTH-FACTOR FAMILY; INNER-EAR; LATERAL-LINE; C-MYC; GENE-EXPRESSION; DANIO-RERIO; IN-VIVO; DIFFERENTIAL EXPRESSION; EPITHELIAL TRANSITION; RECEPTOR SPECIFICITY	Unlike mammals, the non-mammalian vertebrate inner ear can regenerate the sensory cells, hair cells, either spontaneously or through induction after hair cell loss, leading to hearing recovery. The mechanisms underlying the regeneration are poorly understood. By microarray analysis on a chick model, we show that chick hair cell regeneration involves the activation of proliferation genes and downregulation of differentiation genes. Both MYC and FGF are activated in chick hair cell regeneration. Using a zebrafish lateral line neuromast hair cell regeneration model, we show that the specific inhibition of Myc or Fgf suppresses hair cell regeneration, demonstrating that both pathways are essential to the process. Rapid upregulation of Myc and delayed Fgf activation during regeneration suggest a role of Myc in proliferation and Fgf in differentiation. The dorsal-ventral pattern of fgfr1a in the neuromasts overlaps with the distribution of hair cell precursors. By laser ablation, we show that the fgfr1a-positive supporting cells are likely the hair cell precursors that directly give rise to new hair cells; whereas the anterior-posterior fgfr1a-negative supporting cells have heightened proliferation capacity, likely to serve as more primitive progenitor cells to replenish lost precursors after hair cell loss. Thus fgfr1a is likely to mark compartmentalized supporting cell subtypes with different capacities in renewal proliferation and hair cell regeneration. Manipulation of c-MYC and FGF pathways could be explored for mammalian hair cell regeneration.	[Lee, Sang Goo; Huang, Mingqian; Sun, Shan; Li, Wenyan; Petrillo, Marco; Chen, Zheng-Yi] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Lee, Sang Goo; Huang, Mingqian; Sun, Shan; Li, Wenyan; Petrillo, Marco; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Obholzer, Nikolaus D.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Sun, Shan; Li, Wenyan; Li, Huawei] Fudan Univ, Shanghai Med Coll, Shanghai Eye & ENT Hosp, Dept Otorhinolaryngol, Shanghai 200433, Peoples R China; [Dai, Pu] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing 100853, Peoples R China; [Zhou, Yi] Childrens Hosp Boston, Stem Cell Program, Boston, MA USA; [Zhou, Yi] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA USA; [Zhou, Yi] Dana Farber Canc Inst, Boston, MA 02115 USA; [Cotanche, Douglas A.] Univ Massachusetts, Sch Med, Cell & Dev Biol, Worcester, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Fudan University; Chinese People's Liberation Army General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester	Chen, ZY (corresponding author), Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA.; Chen, ZY (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.; Li, HW (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Eye & ENT Hosp, Dept Otorhinolaryngol, Shanghai 200433, Peoples R China.	hwli@shmu.edu.cn; Zheng-Yi_Chen@meei.harvard.edu	Sun, Shan/GLR-2365-2022	Sun, Shan/0000-0003-2142-4307; Huang, Mingqian/0000-0003-0870-9199; petrillo, marco/0000-0003-2526-6166	National Institutes of Health [R01 DC06908, DC010791]; Frederick & Ines Yeatts Hair Cell Regeneration Grant; Major State Basic Research Development Program of China (973 Program) [2011cb504506]; National Natural Science Foundation of China [81230019, 81470687, 81400463]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick & Ines Yeatts Hair Cell Regeneration Grant; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health (R01 DC06908 to ZYC and and DC010791 to SGM), The Frederick & Ines Yeatts Hair Cell Regeneration Grant (ZYC), The Major State Basic Research Development Program of China (973 Program) (2011cb504506) and The National Natural Science Foundation of China (nos. 81230019, 81470687, 81400463) (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bermingham-McDonogh O, 2001, DEV BIOL, V238, P247, DOI 10.1006/dbio.2001.0412; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Burns JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048704; Chen ZY, 2002, JARO-J ASSOC RES OTO, V3, P140, DOI 10.1007/s101620020029; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; CORWIN JT, 1981, J COMP NEUROL, V201, P541, DOI 10.1002/cne.902010406; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dominguez-Frutos E, 2011, J NEUROSCI, V31, P7178, DOI 10.1523/JNEUROSCI.0785-11.2011; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Giorello L, 1998, CANCER RES, V58, P3654; Hargrave Murray, 2006, Methods Mol Biol, V326, P103; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hayashi T, 2010, DEV DYNAM, V239, P1019, DOI 10.1002/dvdy.22236; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jacques BE, 2012, HEARING RES, V289, P27, DOI 10.1016/j.heares.2012.04.018; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Kopecky B, 2011, DEV DYNAM, V240, P1373, DOI 10.1002/dvdy.22620; Kwan KY, 2015, STEM CELL REP, V4, P47, DOI 10.1016/j.stemcr.2014.11.001; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lele Z, 1997, DEV GENET, V21, P123, DOI 10.1002/(SICI)1520-6408(1997)21:2<123::AID-DVG2>3.0.CO;2-9; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li C., 2003, ANAL GENE EXPRESSION, P120; Li H, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P173; Liang J, 2012, J NEUROSCI, V32, P10662, DOI 10.1523/JNEUROSCI.5785-10.2012; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Lush ME, 2014, DEV DYNAM, V243, P1187, DOI [10.1002/DVDY.24167, 10.1002/dvdy.24167]; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Marandel L, 2012, MOL REPROD DEV, V79, P85, DOI 10.1002/mrd.22004; May LA, 2013, J CLIN INVEST, V123, P3577, DOI 10.1172/JCI68480; Menescal LA, 2012, DIS MODEL MECH, V5, P492, DOI 10.1242/dmm.008730; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Murakami SL, 2003, HEARING RES, V186, P47, DOI 10.1016/S0378-5955(03)00259-4; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Roberson DW, 2000, HEARING RES, V141, P155, DOI 10.1016/S0378-5955(99)00218-X; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Romero-Carvajal A, 2015, DEV CELL, V34, P267, DOI 10.1016/j.devcel.2015.05.025; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; SCHREIBERAGUS N, 1993, MOL CELL BIOL, V13, P2765, DOI 10.1128/MCB.13.5.2765; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Steiner AB, 2014, P NATL ACAD SCI USA, V111, pE1393, DOI 10.1073/pnas.1318692111; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wibowo I, 2011, DEVELOPMENT, V138, P1143, DOI 10.1242/dev.060566; Wright TJ, 2003, CURR TOP DEV BIOL, V57, P225, DOI 10.1016/S0070-2153(03)57008-9; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	74	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157768	10.1371/journal.pone.0157768	http://dx.doi.org/10.1371/journal.pone.0157768			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351484	Green Published, gold, Green Submitted			2022-12-26	WOS:000378858900017
J	Blanco-Ameijeiras, S; Lebrato, M; Stoll, HM; Iglesias-Rodriguez, D; Muller, MN; Mendez-Vicente, A; Oschlies, A				Blanco-Ameijeiras, Sonia; Lebrato, Mario; Stoll, Heather M.; Iglesias-Rodriguez, Debora; Mueller, Marius N.; Mendez-Vicente, Ana; Oschlies, Andreas			Phenotypic Variability in the Coccolithophore Emiliania huxleyi	PLOS ONE			English	Article							CHANGING CARBONATE CHEMISTRY; SOUTHERN-OCEAN; CALCIFICATION; CO2; PRYMNESIOPHYCEAE; TEMPERATURE; MAGNESIUM; RESPONSES; CALCITE; GROWTH	Coccolithophores are a vital part of oceanic phytoplankton assemblages that produce organic matter and calcium carbonate (CaCO3) containing traces of other elements ( i.e. Sr and Mg). Their associated carbon export from the euphotic zone to the oceans' interior plays a crucial role in CO2 feedback mechanisms and biogeochemical cycles. The coccolithophore Emiliania huxleyi has been widely studied as a model organism to understand physiological, biogeochemical, and ecological processes in marine sciences. Here, we show the inter-strain variability in physiological and biogeochemical traits in 13 strains of E. huxleyi from various biogeographical provinces obtained from culture collections commonly used in the literature. Our results demonstrate that inter-strain genetic variability has greater potential to induce larger phenotypic differences than the phenotypic plasticity of single strains cultured under a broad range of variable environmental conditions. The range of variation found in physiological parameters and calcite Sr: Ca highlights the need to reconsider phenotypic variability in paleoproxy calibrations and model parameterizations to adequately translate findings from single strain laboratory experiments to the real ocean.	[Blanco-Ameijeiras, Sonia] Univ Southampton, Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England; [Lebrato, Mario] Kiel Univ CAU, Christian Albrechts Pl 4, D-24118 Kiel, Germany; [Stoll, Heather M.; Mendez-Vicente, Ana] Univ Oviedo, Dept Geol, Arias de Velasco S-N, Oviedo 33005, Spain; [Iglesias-Rodriguez, Debora] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Mueller, Marius N.] Univ Sao Paulo, Oceanog Inst, Praca Oceanog 191, BR-05508120 Sao Paulo, SP, Brazil; [Oschlies, Andreas] Helmholtz Ctr Ocean Res Kiel GEOMAR, Dusternbrooker Weg 20, D-24105 Kiel, Germany; [Blanco-Ameijeiras, Sonia] Univ Geneva, Inst FA Forel, Blvd Carl Vogt 66, CH-1211 Geneva, Switzerland	NERC National Oceanography Centre; University of Southampton; University of Oviedo; University of California System; University of California Santa Barbara; Universidade de Sao Paulo; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Geneva	Lebrato, M (corresponding author), Kiel Univ CAU, Christian Albrechts Pl 4, D-24118 Kiel, Germany.	mlebrato13@gmail.com	Oschlies, Andreas/F-9749-2012; Müller, Marius Nils/N-9338-2014; Stoll, Heather/G-9066-2012	Oschlies, Andreas/0000-0002-8295-4013; Müller, Marius Nils/0000-0003-4765-3933; Stoll, Heather/0000-0002-2953-7835; Blanco-Ameijeiras, Sonia/0000-0003-2698-1735; Mendez, Ana/0000-0001-7275-7588	European Community's Seventh Framework Program (FP7) [211384]; Helmholtz Centre for Ocean Research Kiel (GEOMAR); Center of Excellence "The Future Ocean"; Abbey-Santander Internationalization Fund; University of Basque Country (UPV/EHU); Ministry of Science and Education (Government of Spain); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brasil (CNPq) [405585/2013-6]; ASSEMBLE program [FP7-227799];  [ERC-STG-240222PACE]	European Community's Seventh Framework Program (FP7); Helmholtz Centre for Ocean Research Kiel (GEOMAR); Center of Excellence "The Future Ocean"; Abbey-Santander Internationalization Fund; University of Basque Country (UPV/EHU); Ministry of Science and Education (Government of Spain); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ASSEMBLE program; 	This work was funded by the "European Project on Ocean Acidification" (EPOCA) (which received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no 211384) and partly by the Helmholtz Centre for Ocean Research Kiel (GEOMAR) and by the Center of Excellence "The Future Ocean" to ML; the Abbey-Santander Internationalization Fund, University of Basque Country (UPV/EHU), and Ministry of Science and Education (Government of Spain) to SBA; the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brasil (CNPq, Processo: 405585/2013-6) to MNM; and ERC-STG-240222PACE for funding HS and AMV. Strains RCC1212 and RCC1258 were obtained from the RCC through the ASSEMBLE program (FP7-227799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bach LT, 2012, BIOGEOSCIENCES, V9, P3449, DOI 10.5194/bg-9-3449-2012; Bach LT, 2015, PROG OCEANOGR, V135, P125, DOI 10.1016/j.pocean.2015.04.012; Balch W, 2007, DEEP-SEA RES PT II, V54, P478, DOI 10.1016/j.dsr2.2006.12.006; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; BERGGREN WA, 1980, QUATERNARY RES, V13, P277, DOI 10.1016/0033-5894(80)90058-7; Biermann A, 2010, BIOGEOSCIENCES, V7, P1017, DOI 10.5194/bg-7-1017-2010; Blanco-Ameijeiras S, 2012, GEOCHIM COSMOCHIM AC, V89, P226, DOI 10.1016/j.gca.2012.04.043; Bolton CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10284; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Buitenhuis ET, 2008, LIMNOL OCEANOGR, V53, P1181, DOI 10.4319/lo.2008.53.3.1181; Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x; Buitenhuis ET, 2001, GLOBAL BIOGEOCHEM CY, V15, P577, DOI 10.1029/2000GB001292; Cook SS, 2013, PHYCOLOGIA, V52, P368, DOI 10.2216/12-111.1; Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; GALLAGHER JC, 1982, J PHYCOL, V18, P148, DOI 10.1111/j.0022-3646.1982.00148.x; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Green JC, 1996, J MARINE SYST, V9, P33, DOI 10.1016/0924-7963(96)00014-0; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; HILTON J, 1986, HYDROBIOLOGIA, V141, P269, DOI 10.1007/BF00014221; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001454; Iglesias-Rodriguez MD, 2002, MOL ECOL NOTES, V2, P495, DOI 10.1046/j.1471-8286.2002.00289.x; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Langer G, 2006, LIMNOL OCEANOGR, V51, P310, DOI 10.4319/lo.2006.51.1.0310; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lewis E., 1998, ORNLCDIAC105 US DEP; LINSCHOOTEN C, 1991, J PHYCOL, V27, P82, DOI 10.1111/j.0022-3646.1991.00082.x; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Mintrop L, 2008, VERSATILE INSTRUMENT; Muller MN, 2014, BIOGEOSCIENCES, V11, P1065, DOI 10.5194/bg-11-1065-2014; Muller MN, 2015, MAR ECOL PROG SER, V531, P81, DOI 10.3354/meps11309; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pagani M, 2002, PHILOS T ROY SOC A, V360, P609, DOI 10.1098/rsta.2001.0959; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Ra K, 2010, MAR MICROPALEONTOL, V77, P119, DOI 10.1016/j.marmicro.2010.08.003; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Reid EL, 2011, MAR DRUGS, V9, P586, DOI 10.3390/md9040586; Reusch TBH, 2013, EVOLUTION, V67, P1949; Rickaby REM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001408; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P481, DOI 10.5194/bg-4-481-2007; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Rost B, 2002, LIMNOL OCEANOGR, V47, P120, DOI 10.4319/lo.2002.47.1.0120; Schroeder DC, 2005, J PHYCOL, V41, P874, DOI 10.1111/j.1529-8817.2005.04188.x; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Stoll H, 2012, GEOCHIM COSMOCHIM AC, V80, P143, DOI 10.1016/j.gca.2011.12.003; Stoll HM, 2007, DEEP-SEA RES PT II, V54, P581, DOI 10.1016/j.dsr2.2007.01.003; Stoll HM, 2002, GLOBAL PLANET CHANGE, V34, P153, DOI 10.1016/S0921-8181(02)00112-1; Stoll HM, 2002, GEOCHIM COSMOCHIM AC, V66, P927, DOI 10.1016/S0016-7037(01)00836-5; Stoll HM, 2001, PALAEOGEOGR PALAEOCL, V168, P311, DOI 10.1016/S0031-0182(01)00205-X; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; WESTBROEK P, 1984, PHILOS T ROY SOC B, V304, P435, DOI 10.1098/rstb.1984.0037; WOOD AM, 1992, J PHYCOL, V28, P723, DOI 10.1111/j.0022-3646.1992.00723.x; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Zhang Y, 2014, LIMNOL OCEANOGR, V59, P1570, DOI 10.4319/lo.2014.59.5.1570; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	70	26	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157697	10.1371/journal.pone.0157697	http://dx.doi.org/10.1371/journal.pone.0157697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348427	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000378801200012
J	Li, J; Guo, Q; Lin, MF; Jiang, L; Ye, JW; Chen, DS; Li, ZG; Dai, JQ; Han, SC				Li, Jun; Guo, Qiang; Lin, Miaofeng; Jiang, Lu; Ye, Jingwen; Chen, Dasong; Li, Zhigang; Dai, Jianqing; Han, Shichou			Evaluation of a New Entomopathogenic Strain of Beauveria bassiana and a New Field Delivery Method against Solenopsis invicta	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; IMPORTED FIRE ANT; BIOLOGICAL-CONTROL AGENT; FRANKLINIELLA-OCCIDENTALIS; METARHIZIUM-ANISOPLIAE; ONION THRIPS; INSECTICIDE RESISTANCE; BUREN HYMENOPTERA; FUNGI; FORMICIDAE	Solenopsis invicta Buren is one of the most important pests in China, and control measures are mainly based on the use of synthetic pesticides, which may be inadequate and unsustainable. Hence, there is a growing interest in developing biological control alternatives for managing S. invicta, such as the use of entomopathogenic fungi. To facilitate the commercialization of entomopathogenic fungi against S. invicta, 10 Beauveria bassiana isolates originating from different hosts were tested for virulence in laboratory bioassays, and the most pathogenic strain, ZGNKY-5, was tested in field studies using an improved pathogen delivery system. The cumulative mortality rate reached 93.40% at 1x10(8) mL(-1) conidia after 504 h. The germination and invasion of the spores were observed under a scanning electron microscope, and several conidia adhered to the cuticle of S. invicta after 2 h. Furthermore, the germ tubes of the conidia oriented toward the cuticle after 48 h, and the mycelium colonized the entire body after 96 h. Based on the efficacy observed in the laboratory trials, further experiments were performed with ZGNKY-5 strain to evaluate its utility in an injection control technology against S. invicta in the field. We found that three dosage treatments of ZGNKY-5 strain (500 mL, 750 mL, and 1,000 mL per nest) had significant control effects. Our results show that this strain of Beauveria bassiana and our control method were effective against S. invicta in both laboratory and field settings.	[Li, Jun; Lin, Miaofeng; Ye, Jingwen; Chen, Dasong; Li, Zhigang; Dai, Jianqing; Han, Shichou] Guangdong Inst Appl Biol Resources, Guangdong Key Lab IPM Agr, Guangzhou, Guangdong, Peoples R China; [Li, Jun; Lin, Miaofeng; Ye, Jingwen; Chen, Dasong; Li, Zhigang; Dai, Jianqing; Han, Shichou] Guangdong Inst Appl Biol Resources, Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Guo, Qiang; Jiang, Lu] Shenzhen Wild Anim & Plant Protect Adm Agent, Shenzhen, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Han, SC (corresponding author), Guangdong Inst Appl Biol Resources, Guangdong Key Lab IPM Agr, Guangzhou, Guangdong, Peoples R China.; Han, SC (corresponding author), Guangdong Inst Appl Biol Resources, Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.	hansc@gdei.gd.cn			Guangdong Provincial Department of Science and Technology [2016A020223010]; Science and Information Technology Bureau of Guangzhou [2014J4100211]; Funds for Environment Construction & Capacity Building of the GDAS' Research Platform [2016GDASPT-0305, 2016GDASPT-0215]; Shenzhen Wild Animal and Plant Protection Administration Agent	Guangdong Provincial Department of Science and Technology; Science and Information Technology Bureau of Guangzhou; Funds for Environment Construction & Capacity Building of the GDAS' Research Platform; Shenzhen Wild Animal and Plant Protection Administration Agent	This research was supported by the Guangdong Provincial Department of Science and Technology (2016A020223010), Science and Information Technology Bureau of Guangzhou (2014J4100211), Funds for Environment Construction & Capacity Building of the GDAS' Research Platform (2016GDASPT-0305, 2016GDASPT-0215), and the Shenzhen Wild Animal and Plant Protection Administration Agent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; ALLEN CR, 1995, ECOL APPL, V5, P632, DOI 10.2307/1941972; Allen JKM, 2005, PEST MANAG SCI, V61, P809, DOI 10.1002/ps.1068; ALVES S B, 1988, Anais da Sociedade Entomologica do Brasil, V17, P379; Ansari MA, 2008, ENTOMOL EXP APPL, V127, P80, DOI 10.1111/j.1570-7458.2008.00674.x; Bextine BR, 2002, ENVIRON ENTOMOL, V31, P746, DOI 10.1603/0046-225X-31.4.746; Bielza P, 2008, PEST MANAG SCI, V64, P1131, DOI 10.1002/ps.1620; BUREN WF, 1974, J NEW YORK ENTOMOL S, V82, P113; DAOUST RA, 1986, ENVIRON ENTOMOL, V15, P1237, DOI 10.1093/ee/15.6.1237; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Gao YL, 2012, PEST MANAG SCI, V68, P1111, DOI 10.1002/ps.3305; Gao YL, 2012, BIOCONTROL SCI TECHN, V22, P491, DOI 10.1080/09583157.2012.662478; Herron GA, 2011, AUST J ENTOMOL, V50, P418, DOI 10.1111/j.1440-6055.2011.00817.x; [黄俊 Huang Jun], 2009, [植物保护, Plant Protection], V35, P145; INGLIS GD, 1993, BIOL CONTROL, V3, P258, DOI 10.1006/bcon.1993.1035; [李军 LI Jun], 2007, [广东农业科学, Guangdong Agricultural Sciences], P54; Liu Xiao-yan, 2010, Chinese Journal of Biological Control, V26, P373; LuLiHua, 2011, Journal of South China Agricultural University, V32, P35; Lv Li-Hua, 2006, Chinese Bulletin of Entomology, V43, P265; Maniania NK, 2003, CROP PROT, V22, P553, DOI 10.1016/S0261-2194(02)00221-1; Niassy S, 2012, LETT APPL MICROBIOL, V54, P487, DOI 10.1111/j.1472-765X.2012.03241.x; OI DH, 1994, J ECON ENTOMOL, V87, P623, DOI 10.1093/jee/87.3.623; PEREIRA RM, 1992, ENVIRON ENTOMOL, V21, P1427, DOI 10.1093/ee/21.6.1427; Shelton AM, 2006, J ECON ENTOMOL, V99, P1798, DOI 10.1603/0022-0493-99.5.1798; SIEBENEICHER SR, 1992, J INVERTEBR PATHOL, V59, P280, DOI 10.1016/0022-2011(92)90133-O; STIMAC J L, 1989, Anais da Sociedade Entomologica do Brasil, V18, P95; STIMAC JL, 1993, J ECON ENTOMOL, V86, P348, DOI 10.1093/jee/86.2.348; Taber SW, 2000, FIRE ANTS; VESTERGAARD S, 1995, BIOCONTROL SCI TECHN, V5, P185, DOI 10.1080/09583159550039909; Vinson S. Bradleigh, 1997, American Entomologist, V43, P23; Wang Long-Jiang, 2010, Acta Entomologica Sinica, V53, P118; Wang YaHui, 2011, Chinese Journal of Biological Control, V27, P324; Wang Yin, 2005, Acta Entomologica Sinica, V48, P188; Wen JinZeng, 2003, Plant Protection, V29, P50; Wilson EO, 1971, INSECT SOC, P100; Wu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084732; Wu SY, 2013, BIOCONTROL SCI TECHN, V23, P794, DOI 10.1080/09583157.2013.794896; [杨佳后 YANG Jia-Hou], 2009, [环境昆虫学报, Journal of Environmental Entomology], V31, P46; You MS, 2004, SYSTEME CONTROL DIAM, P121; Zeng Ling, 2005, Chinese Bulletin of Entomology, V42, P144; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	41	7	8	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2016	11	6							e0158325	10.1371/journal.pone.0158325	http://dx.doi.org/10.1371/journal.pone.0158325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3KZ	27341441	Green Published, Green Submitted, gold			2022-12-26	WOS:000378393600050
J	Meurer, SK; Ness, M; Weiskirchen, S; Kim, P; Tag, CG; Kauffmann, M; Huber, M; Weiskirchen, R				Meurer, Steffen K.; Ness, Melanie; Weiskirchen, Sabine; Kim, Philipp; Tag, Carmen G.; Kauffmann, Marlies; Huber, Michael; Weiskirchen, Ralf			Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice	PLOS ONE			English	Article							PURIFICATION; INTERLEUKIN-3	Mast cells (MCs) are a versatile cell type playing key roles in tissue morphogenesis and host defence against bacteria and parasites. Furthermore, they can enhance immunological danger signals and are implicated in inflammatory disorders like fibrosis. This granulated cell type originates from the myeloid lineage and has similarities to basophilic granulocytes, both containing large quantities of histamine and heparin. Immature murine mast cells mature in their destination tissue and adopt either the connective tissue (CTMC) or mucosal (MMC) type. Some effector functions are executed by activation/degranulation of MCs which lead to secretion of a typical set of MC proteases (MCPT) and of the preformed or newly synthesized mediators from its granules into the local microenvironment. Due to the potential accumulation of mutations in key signalling pathway components of corresponding MC cell-lines, primary cultured MCs are an attractive mean to study general features of MC biology and aspects of MC functions relevant to human disease. Here, we describe a simple protocol for the simultaneous isolation of mature CTMC-like murine MCs from the peritoneum (PMCs) and immature MC precursors from the bone marrow (BM). The latter are differentiated in vitro to yield BM-derived MCs (BMMC). These cells display the typical morphological and phenotypic features of MCs, express the typical MC surface markers, and can be propagated and kept in culture for several weeks. The provided protocol allows simple amplification of large quantities of homogenous, non-transformed MCs from the peritoneum and bone marrow-derived mast cells for cell-and tissue-based biomedical research.	[Meurer, Steffen K.; Ness, Melanie; Weiskirchen, Sabine; Kim, Philipp; Tag, Carmen G.; Weiskirchen, Ralf] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Aachen, Germany; [Kauffmann, Marlies; Huber, Michael] Rhein Westfal TH Aachen, Univ Hosp, Inst Biochem & Mol Immunol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Meurer, SK (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Aachen, Germany.	smeurer@ukaachen.de; rweiskirchen@ukaachen.de	Weiskirchen, Ralf/O-1734-2018	Weiskirchen, Ralf/0000-0003-3888-0931; Weiskirchen, Sabine/0000-0002-6374-3413	Deutsche Forschungsgemeinschaft [SFB/TRR57, HU794/10-1]; IZKF Aachen [E7-6]; German Research Foundation [SFB/TRR57, HU794/10-1, P13/Q3]; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (IZKF Aachen)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Aachen; German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (IZKF Aachen)	This study was supported by the Deutsche Forschungsgemeinschaft, www.dfg.de, grants SFB/TRR57 (P13, Q3) and HU794/10-1, and IZKF Aachen, www.izkf-aachen.de/#, grant E7-6. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RW is supported by grants from the German Research Foundation (SFB/TRR57, P13/Q3) and a grant from the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (IZKF Aachen, Project E7-6). MH is supported by a grant from the German Research Foundation (HU794/10-1).	Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Bulfone-Paus S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00394; CABADO AG, 1993, INT ARCH ALLERGY IMM, V100, P234, DOI 10.1159/000236417; Cooper P H, 1976, Methods Cell Biol, V14, P365, DOI 10.1016/S0091-679X(08)60496-3; Csaba G, 2015, ACTA MICROBIOL IMM H, V62, P207, DOI 10.1556/030.62.2015.3.1; ENERBACK L, 1980, J IMMUNOL METHODS, V39, P135, DOI 10.1016/0022-1759(80)90302-6; Gil HyunJi, 2015, J Acupunct Meridian Stud, V8, P288, DOI 10.1016/j.jams.2015.03.007; Holm M, 2008, J IMMUNOL METHODS, V336, P213, DOI 10.1016/j.jim.2008.04.019; Johnson C, 2016, AM J PATHOL, V186, P123, DOI 10.1016/j.ajpath.2015.09.016; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kulka M, 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im0725s01, DOI 10.1002/0471142735.IM0725S01]; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; da Silva EZM, 2014, J HISTOCHEM CYTOCHEM, V62, P698, DOI 10.1369/0022155414545334; Maurer M, 2003, EXP DERMATOL, V12, P886, DOI 10.1111/j.0906-6705.2003.0109a.x; Noli C, 2001, VET DERMATOL, V12, P303, DOI 10.1046/j.0959-4493.2001.00272.x; RAZIN E, 1984, J IMMUNOL, V132, P1479; Theoharides TC, 2015, NEW ENGL J MED, V373, P163, DOI 10.1056/NEJMra1409760; UNDEM BJ, 1985, J IMMUNOL METHODS, V81, P187, DOI 10.1016/0022-1759(85)90203-0; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; WILLHEIM M, 1995, J IMMUNOL METHODS, V182, P115, DOI 10.1016/0022-1759(95)00034-8	21	30	31	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158104	10.1371/journal.pone.0158104	http://dx.doi.org/10.1371/journal.pone.0158104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27337047	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200110
